PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Taylor, CA; Hutchens, S; Liu, CY; Jursa, T; Shawlot, W; Aschner, M; Smith, DR; Mukhopadhyay, S				Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Jursa, Thomas; Shawlot, William; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			SLC30A10 transporter in the digestive system regulates brain manganese under basal conditions while brain SLC30A10 protects against neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; transporter; metal homeostasis; Parkinson disease; mouse genetics; cation diffusion facilitator; solute carrier; thyroid; toxicity; ZnT; SLC30; ZnT10; parkinsonism; neurotoxicity	EFFLUX TRANSPORTER; HEPATIC CIRRHOSIS; ZIP14 SLC39A14; PARKINSONISM; MUTATIONS; EXCRETION; EXPOSURE; LIVER; GENE; POLYCYTHEMIA	The essential metal manganese becomes neurotoxic at elevated levels. Yet, the mechanisms by which brain manganese homeostasis is regulated are unclear. Loss-of-function mutations in SLC30A10, a cell surface-localized manganese efflux transporter in the brain and liver, induce familial manganese neurotoxicity. To elucidate the role of SLC30A10 in regulating brain manganese, we compared the phenotypes of whole-body and tissue-specific Slc30a10 knockout mice. Surprisingly, unlike whole-body knockouts, brain manganese levels were unaltered in pan-neuronal/glial Slc30a10 knockouts under basal physiological conditions. Further, although transport into bile is a major route of manganese excretion, manganese levels in the brain, blood, and liver of liver-specific Slc30a10 knockouts were only minimally elevated, suggesting that another organ compensated for loss-of-function in the liver. Additional assays revealed that SLC30A10 was also expressed in the gastrointestinal tract. In differentiated enterocytes, SLC30A10 localized to the apical/luminal domain and transported intracellular manganese to the lumen. Importantly, endoderm-specific knockouts, lacking SLC30A10 in the liver and gastrointestinal tract, had markedly elevated manganese levels in the brain, blood, and liver. Thus, under basal physiological conditions, brain manganese is regulated by activity of SLC30A10 in the liver and gastrointestinal tract, and not the brain or just the liver. Notably, however, brain manganese levels of endoderm-specific knockouts were lower than whole-body knockouts, and only whole-body knockouts exhibited manganese-induced neurobehavioral defects. Moreover, after elevated exposure, pan-neuronal/glial knockouts had higher manganese levels in the basal ganglia and thalamus than controls. Therefore, when manganese levels increase, activity of SLC30A10 in the brain protects against neurotoxicity.	[Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Inst Cellular & Mol Biol, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton St, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	aschner, michael/0000-0002-2619-1656	NIEHS, National Institutes of Health [R01-ES024812, R01-ES024812S1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health, Grants R01-ES024812 and R01-ES024812S1 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; BALLATORI N, 1987, AM J PHYSIOL, V252, pR842, DOI 10.1152/ajpregu.1987.252.5.R842; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Bouabid S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098952; Bowman AB, 2014, NEUROTOXICOLOGY, V41, P141, DOI 10.1016/j.neuro.2014.01.010; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Greenberg David M., 1943, JOUR BIOL CHEM, V147, P749; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jursa T, 2009, TOXICOL SCI, V107, P182, DOI 10.1093/toxsci/kfn231; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Liu XH, 2006, TOXICOL SCI, V91, P521, DOI 10.1093/toxsci/kfj150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Ma RE, 2018, NEUROTOXICOLOGY, V64, P30, DOI 10.1016/j.neuro.2017.08.013; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nam J, 2008, BIOL PHARM BULL, V31, P1894, DOI 10.1248/bpb.31.1894; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; PAPAVASILIOU PS, 1966, AM J PHYSIOL, V211, P211, DOI 10.1152/ajplegacy.1966.211.1.211; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Selyunin AS, 2017, J CELL BIOL, V216, P3249, DOI 10.1083/jcb.201704015; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zogzas CE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00115d; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	56	47	48	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1860	1876		10.1074/jbc.RA118.005628	http://dx.doi.org/10.1074/jbc.RA118.005628			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559290	hybrid, Green Published			2022-12-26	WOS:000459711400008
J	Guimaraes, KLA; de Sousa, MPA; Ribeiro, FRV; Porto, JIR; Rodrigues, LRR				Auzier Guimaraes, Karen Larissa; Alho de Sousa, Marcos Paulo; Vasconcelos Ribeiro, Frank Raynner; Rebelo Porto, Jorge Ivan; Ribeiro Rodrigues, Luis Reginaldo			DNA barcoding of fish fauna from low order streams of Tapajos River basin	PLOS ONE			English	Article							FRESH-WATER FISHES; FOREST STREAMS; ASSEMBLAGES; CHARACIFORMES; BIODIVERSITY; CHARACIDAE	The Amazon basin harbors a megadiverse fish fauna spread in an intricate network of big rivers and small streams. The Amazonian streams are home of many small sized fishes that remains poorly documented. In order to accelerate the scientific knowledge on these important aquatic systems we adopted a modern integrative approach joining morphology and molecular tools to investigate the ichthyofauna assemblages from low order streams situated on the lower Tapajos River Basin. Cytochrome c Oxidase I (COI) DNA barcodes from 252 specimens collected from 10 stream sites were obtained. The combined analysis revealed 29 species, 21 genera and 11 families. Cryptic diversity was evidenced in Knodus sp. 1, Aequidens epae and Copella callolepis, in which deep genetic divergence were detected (intraspecific distances: 20.48%, 7.99% and 3.77%, respectively). The putative new species showed closer relationships with their counterparts occurring in the Tapajos-Xingu water drainages.	[Auzier Guimaraes, Karen Larissa; Alho de Sousa, Marcos Paulo; Ribeiro Rodrigues, Luis Reginaldo] Univ Fed Oeste Para, Inst Ciencias Educ, Lab Genet & Biodiversidade, Santarem, Para, Brazil; [Auzier Guimaraes, Karen Larissa; Alho de Sousa, Marcos Paulo; Ribeiro Rodrigues, Luis Reginaldo] Univ Fed Oeste Para, Programa Pos Grad Recursos Nat Amazonia, Santarem, Para, Brazil; [Vasconcelos Ribeiro, Frank Raynner] Univ Fed Oeste Para, Inst Ciencias & Tecnol Aguas, Colecao Ictiol, Santarem, Para, Brazil; [Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Nucleo Apoio Pesquisa Para, Santarem, Para, Brazil; [Ribeiro Rodrigues, Luis Reginaldo] Univ Fed Oeste Para, Rua Vera Paz S-N,Campus Tapajos, Santarem, Para, Brazil	Universidade Federal do Oeste do Para; Universidade Federal do Oeste do Para; Universidade Federal do Oeste do Para; Institute Nacional de Pesquisas da Amazonia; Universidade Federal do Oeste do Para	Rodrigues, LRR (corresponding author), Univ Fed Oeste Para, Inst Ciencias Educ, Lab Genet & Biodiversidade, Santarem, Para, Brazil.; Rodrigues, LRR (corresponding author), Univ Fed Oeste Para, Programa Pos Grad Recursos Nat Amazonia, Santarem, Para, Brazil.; Rodrigues, LRR (corresponding author), Univ Fed Oeste Para, Rua Vera Paz S-N,Campus Tapajos, Santarem, Para, Brazil.	luisreginaldo.ufpa@hotmail.com	Ribeiro, Frank/ABD-3943-2020; Porto, Jorge/T-4694-2019; Rodrigues, Luis Reginaldo Ribeiro/AAE-4847-2021; Porto, Jorge/K-1441-2014	Ribeiro, Frank/0000-0002-6485-676X; Rodrigues, Luis/0000-0003-2849-0382; Guimaraes, Karen/0000-0002-3699-7629; Porto, Jorge/0000-0003-1393-6492	PIBIC/CNPq/UFOPA; CNPq [BrBOL-PRJ09, 09]; CAPES-PROAmazonia [AUXPE-3318/2013]	PIBIC/CNPq/UFOPA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-PROAmazonia	MPAS received Mastership from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); KLAG received Scholarship PIBIC/CNPq/UFOPA. This research is part of the Project 09 associated to the Brazilian Barcoding of Life (BrBOL-PRJ09 to JIRP) granted by CNPq. Supplemental funds were provided from CAPES-PROAmazonia (AUXPE-3318/2013 to LRRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Lima CARM, 1998, ACTA LIMNOL BRAS, V11, P127; Barbosa RP, 2003, ACTA LIMNOL BRAS, V15, P37; BENGTSON P, 1988, PALAEONTOLOGY, V31, P223; Benzaquem DC, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121160, 10.1371/journal.pone.0112217]; Buckup PA, 2010, B SOC BRASILEIRA ICT, P3; Buckup Paulo Andreas, 1993, Ichthyological Exploration of Freshwaters, V4, P97; Buhrnheim CM, 2003, COPEIA, P255, DOI 10.1643/0045-8511(2003)003[0255:SOFAIA]2.0.CO;2; Carvalho LN, 2009, TROPICAL BIOL CONSER; Paz FPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098603; de Carvalho Daniel C, 2011, Mitochondrial DNA, V22 Suppl 1, P80, DOI 10.3109/19401736.2011.588214; de Pinna M, 2018, ZOOL J LINN SOC-LOND, V182, P76, DOI 10.1093/zoolinnean/zlx028; dos Anjos MB, 2007, NEOTROP ICHTHYOL, V5, P45, DOI 10.1590/S1679-62252007000100006; Eigenmann C. H., 1911, Annals & Magazine of Natural History Series 8, V7; Eigenmann CH, 1893, ANN NY ACAD SCI, V7, P607, DOI [10.1111/j.1749-6632.1893.tb55412.x, DOI 10.1111/J.1749-6632.1893.TB55412.X]; Ferreira A, 2012, ECOL FRESHW FISH, V21, P12, DOI 10.1111/j.1600-0633.2011.00518.x; Ferreira KM, 2010, J FISH BIOL, V77, P468, DOI 10.1111/j.1095-8649.2010.02680.x; Ferreira M., 2007, THESIS; Gery J., 1977, CHARACOIDS WORLD; Gomes LC, 2015, GENETICA, V143, P581, DOI 10.1007/s10709-015-9856-z; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kullander SO, 1986, CICHLID FISHES AMAZO; Kullander Sven O., 1998, P461; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lowe-McConnell RH., 1999, ESTUDOS ECOLOGICOS C; Marinho MMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183069; Mendonca FP, 2005, COPEIA, P751, DOI 10.1643/0045-8511(2005)005[0751:RBHCAF]2.0.CO;2; Mendonca FP, 2002, THESIS; Musilova Z., 2006, THESIS; Musilova Z, 2008, MOL PHYLOGENET EVOL, V46, P659, DOI 10.1016/j.ympev.2007.10.011; Pazin VFV, 2006, FRESHWATER BIOL, V51, P1025, DOI 10.1111/j.1365-2427.2006.01552.x; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pugedo ML, 2016, GENETICA, V144, P341, DOI 10.1007/s10709-016-9903-4; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Ribeiro Odirlene Marinho, 2006, Acta Amaz., V36, P389, DOI 10.1590/S0044-59672006000300017; Roman-Valencia C., 2008, Animal Biodiversity and Conservation, V31, P15; Roman-Valencia C., 2003, REV ASOCIACION COLOM, P17; Roman-Valencia C., 2005, MEMORIA FUNDACION SA, P27; Santos GM, 1999, ESTUDOS ECOLOGICOS C; Schultz Leonard P, 1944, PROC U S NATION MUS, V95, P235; Silva GSC, 2016, ZOOTAXA, V4200, P1, DOI 10.11646/zootaxa.4200.1.1; Silva-Oliveira C, 2016, ZOOKEYS, P125, DOI 10.3897/zookeys.580.6659; Silva-Oliveira C, 2015, ZOOTAXA, V3994, P133, DOI 10.11646/zootaxa.3994.1.7; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Valsecchi J, 2017, ATUALIZACAO COMPOSIC; Vari R. P., 1992, SMITHSONIAN CONTRIBU, V529, P1, DOI DOI 10.5479/SI.00810282.529; Vitorino CA, 2015, NEOTROP ICHTHYOL, V13, P557, DOI 10.1590/1982-0224-20150037; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209430	10.1371/journal.pone.0209430	http://dx.doi.org/10.1371/journal.pone.0209430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576366	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400050
J	Vairo, F; Mammone, A; Lanini, S; Nicastri, E; Castilletti, C; Carletti, F; Puro, V; Di Lallo, D; Panella, V; Varrenti, D; Scaramozzino, P; di Caro, A; Scognamiglio, P; Capobianchi, MR; Ippolito, G				Vairo, Francesco; Mammone, Alessia; Lanini, Simone; Nicastri, Emanuele; Castilletti, Concetta; Carletti, Fabrizio; Puro, Vincenzo; Di Lallo, Domenico; Panella, Vincenzo; Varrenti, Donatella; Scaramozzino, Paola; di Caro, Antonino; Scognamiglio, Paola; Capobianchi, Maria Rosaria; Ippolito, Giuseppe		Chikungunya Lazio Outbreak Grp	Local transmission of chikungunya in Rome and the Lazio region, Italy	PLOS ONE			English	Article							VIRUS; OUTBREAK	On September 7, 2017, three potentially autochthonous cases of chikungunya were notified in the Lazio region. An Outbreak investigation based on established surveillance system data and molecular analysis of viral variant(s) were conducted. Epidemiological analysis suggested the occurrence of 3 main foci of local transmission. The major focus involved 317 cases with epidemiological link with the area of Anzio. The other two foci occurred in Rome (80 cases) and Latina (8 cases). Cumulative incidence in Anzio and Latina were 331.4 and 7.13 per 100,000 residents, respectively. Cumulative incidences ranged from 1.4 to 14.3/100,000 residents in Rome. This is the first report of a chikungunya outbreak involving a densely populated urban area in a western country. The outbreak probably started in Anzio, spread by continuity to neighbouring villages, and then to the metropolitan area of Rome and to the Latina area favoured by the touristic nature of the Anzio area.	[Vairo, Francesco; Mammone, Alessia; Lanini, Simone; Puro, Vincenzo; Scognamiglio, Paola] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Reg Serv Surveillance & Control Infect Dis SERESM, Rome, Italy; [Nicastri, Emanuele; Castilletti, Concetta; Carletti, Fabrizio; di Caro, Antonino; Capobianchi, Maria Rosaria; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy; [Di Lallo, Domenico; Panella, Vincenzo] Direz Reg Salute & Polit Sociali, Rome, Italy; [Varrenti, Donatella] Local Hlth Author Roma 6, Albano Laziale, Italy; [Scaramozzino, Paola] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IZS Lazio e Toscana	Capobianchi, MR (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy.	maria.capobianchi@inmi.it	Di Caro, Antonino/K-6854-2016; Scognamiglio, Paola/B-4754-2017; Scaramozzino, Paola/AAS-8717-2020; Scaramozzino, Paola/P-6860-2016; Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016; Mammone, Alessia/K-9217-2016; Lanini, Simone/C-7523-2012; nicastri, emanuele/K-7780-2016	Di Caro, Antonino/0000-0001-6027-3009; Scognamiglio, Paola/0000-0002-7938-6457; Scaramozzino, Paola/0000-0002-7871-8915; Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Mammone, Alessia/0000-0003-2250-1247; Ippolito, Giuseppe/0000-0002-1076-2979; puro, vincenzo/0000-0003-0291-4490; Lanini, Simone/0000-0002-6743-4001; nicastri, emanuele/0000-0002-5606-8712; PERNO, CARLO FEDERICO/0000-0002-0825-5388	Directorate of Health and Social Welfare, Latium Region; Local Public Health Units, Latium Region; Ricerca Corrente - Italian Ministry of Health	Directorate of Health and Social Welfare, Latium Region; Local Public Health Units, Latium Region; Ricerca Corrente - Italian Ministry of Health(Ministry of Health, Italy)	This intervention and the study were funded by Directorate of Health and Social Welfare, Latium Region, the Local Public Health Units, Latium Region and Ricerca Corrente - Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2017, LANCET INFECT DIS, V17, P483, DOI 10.1016/S1473-3099(17)30191-3; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413; Bonacci T, 2015, INT J SCI ENG RES, V6, P1186; Bordi L, 2018, EMERG INFECT DIS, P24; Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x; Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647; Carletti F, 2017, GENOME ANNOUNC, V5; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; CHARREL RN, 2008, EURO SURVEILL, V13; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108; ECDC, 2008, ENV CHANG INF DIS WO; ECDC Rapid Risk Assessment, 2017, CLUST AUT CHIK CAS I; Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51; Fortuna, 2017, EURO SURVEILL, V22; Fortuna C, 2018, EURO SURVEILL, V23; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Henry M, 2017, REV PANAM SALUD PUBL, V41; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773; LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503; Manica M., 2017, EURO SURVEILL, V22; Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Naqvi S, 2017, CUREUS, V9, DOI 10.7759/cureus.1430; Pastula DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005410; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Romi R., 1995, Parassitologia (Rome), V37, P99; ROSS R. W., 1956, JOUR HYG, V54, P177; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Vairo F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090501; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]	36	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208896	10.1371/journal.pone.0208896	http://dx.doi.org/10.1371/journal.pone.0208896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576334	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400022
J	Chen, XY; Shao, TY; Long, XH				Chen, Xiaoyan; Shao, Tianyun; Long, Xiaohua			Evaluation of the effects of different stocking densities on the sediment microbial community of juvenile hybrid grouper (female Epinephelus fuscoguttatus x male Epinephelus lanceolatus) in recirculating aquaculture systems	PLOS ONE			English	Article							BACTERIAL DIVERSITY; PERSPECTIVES; RESPONSES	Aquatic microorganisms are an important part of aquatic ecosystems because they are involved in nutrient cycling and water quality, eventually influencing fish productivity. However, at present, reports on the effect of stocking density on microorganisms in sediment samples in recirculating aquaculture systems (RAS) are relatively rare. In this study, the changes in the microbial community in an RAS were investigated under different stocking densities of juvenile hybrid grouper (female Epinephelus fuscoguttatus x male Epinephelus lanceolatus). Total DNA was extracted from the sediment samples, the 16S rDNA gene was amplified, and the bacterial community was analysed by Illumina high-throughput sequencing. We identified 741 OTUs from a total of 409,031 reads. Based on the analysis of bacterial composition, richness, diversity, bacterial 16S and rDNA gene abundance; sediment sample comparisons; and the existence of specific bacterial taxa within four densities, we concluded that the dominant phyla in all samples were similar and included: Proteobacteria, Bacteroidetes, Nitrospirae, Planctomycetes, Verrucomicrobia, and Chloroflexi. However, their relative distributions differed at different fish densities. Linear discriminant analysis further indicated that the stocking treatment influenced the sediment bacterial community. This study indicates that under RAS aquaculture, mode density is a factor regulating the microbial community, which provides insights into microbe management in RAS culture.	[Chen, Xiaoyan; Shao, Tianyun; Long, Xiaohua] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Long, XH (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.	longxiaohua@njau.edu.cn	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022		Jiangsu Agricultural Science and Technology Independent Innovation Fund Project [CX(15)1005]; National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of Jiangsu Province [BE2018387, BY2016077-02, BN2016145]; Agricultural Technology Extension Project of Research Institutes in Jiangsu Province (Demonstration and Promotion of High-Valued Ecological Agricultural Techniques in Coastal Areas of Jiangsu Province) [TG(17)004]; Agricultural Technology Extension Project of Research Institutes in Jiangsu Province (Fundamental Research Funds for the Central University) [KYZ201623, YZ2016-1, KYYJ201703]	Jiangsu Agricultural Science and Technology Independent Innovation Fund Project; National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of Jiangsu Province; Agricultural Technology Extension Project of Research Institutes in Jiangsu Province (Demonstration and Promotion of High-Valued Ecological Agricultural Techniques in Coastal Areas of Jiangsu Province); Agricultural Technology Extension Project of Research Institutes in Jiangsu Province (Fundamental Research Funds for the Central University)	All the funders or sources of support received during this specific study (including Jiangsu Agricultural Science and Technology Independent Innovation Fund Project [CX(15)1005], the National Key Project of Scientific and Technical Supporting Programs funded by the Ministry of Science & Technology of Jiangsu Province (BE2018387, BY2016077-02 and BN2016145), Agricultural Technology Extension Project of Research Institutes in Jiangsu Province (Demonstration and Promotion of High-Valued Ecological Agricultural Techniques in Coastal Areas of Jiangsu Province, (TG(17)004), and the Fundamental Research Funds for the Central University (KYZ201623, YZ2016-1 and KYYJ201703)) to XL, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade T, 2015, AQUACULTURE, V438, P6, DOI 10.1016/j.aquaculture.2014.12.034; Asami H, 2005, APPL ENVIRON MICROB, V71, P2925, DOI 10.1128/AEM.71.6.2925-2933.2005; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bissett A, 2006, FEMS MICROBIOL ECOL, V55, P48, DOI 10.1111/j.1574-6941.2005.00012.x; Bolasina S, 2006, AQUACULTURE, V259, P432, DOI 10.1016/j.aquaculture.2006.05.021; Bull AT, 2005, ANTON LEEUW INT J G, V87, P65, DOI 10.1007/s10482-004-6562-8; Castillo-Vargasmachuca S, 2012, N AM J AQUACULT, V74, P413, DOI 10.1080/15222055.2012.676002; Castine SA, 2009, AQUACULTURE, V297, P91, DOI 10.1016/j.aquaculture.2009.09.013; Cheng W, 2014, ANN MICROBIOL, V64, P875, DOI 10.1007/s13213-013-0712-z; Chinalia FA, 2006, CHEMOSPHERE, V64, P1675, DOI 10.1016/j.chemosphere.2006.01.022; Chng C., 2008, AQUAC SCI, V56, P505, DOI [10.11233/aquaculturesci.56.505, DOI 10.11233/AQUACULTURESCI.56.505]; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eroldogan OT, 2004, AQUACULTURE, V231, P501, DOI 10.1016/j.aquaculture.2003.10.020; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fan LM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1962-7; FAO (Food and Agriculture Organization), 2016, STAT WORLD FISH AQ 2, DOI 10.18356/8e4e0ebf-en; Fonseca AC, 2001, WATER RES, V35, P3817, DOI 10.1016/S0043-1354(01)00104-X; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Fukui Y, 2013, INT J SYST EVOL MICR, V63, P1665, DOI 10.1099/ijs.0.041434-0; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Kautsky N, 2000, AQUACULTURE, V191, P145, DOI 10.1016/S0044-8486(00)00424-5; Kawahara Naoki, 2008, Plankton & Benthos Research, V3, P42, DOI 10.3800/pbr.3.42; Krzmarzick MJ, 2012, APPL ENVIRON MICROB, V78, P393, DOI 10.1128/AEM.06510-11; Li LQ, 2014, ENVIRON EARTH SCI, V71, P3727, DOI 10.1007/s12665-013-2767-3; Liu G, 2011, ENVIRON MONIT ASSESS, V182, P187, DOI 10.1007/s10661-010-1868-7; Mannisto MK, 2001, WATER RES, V35, P2496, DOI 10.1016/S0043-1354(00)00527-3; Martins G, 2012, GEOMICROBIOL J, V29, P704, DOI 10.1080/01490451.2011.619633; Moriarty DJW, 1997, AQUACULTURE, V151, P333, DOI 10.1016/S0044-8486(96)01487-1; Ni M, 2014, FISH SHELLFISH IMMUN, V36, P325, DOI 10.1016/j.fsi.2013.12.002; Pierre S, 2008, AQUAT CONSERV, V18, P297, DOI 10.1002/aqc.840; Sakai T, 2002, MAR BIOTECHNOL, V4, P399, DOI 10.1007/s10126-002-0032-y; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Slater GF, 2008, ENVIRON POLLUT, V153, P60, DOI 10.1016/j.envpol.2007.08.009; Sobrino I, 2005, FISH RES, V76, P229, DOI 10.1016/j.fishres.2005.06.016; Srithep P, 2015, ANN MICROBIOL, V65, P267, DOI 10.1007/s13213-014-0858-3; Summerfelt S.T., 2008, ENV BEST MANAGEMENT, P389, DOI [10.1002/9780813818672.ch10, DOI 10.1002/9780813818672.CH10]; Tatiana AV, 2011, APPL ENVIRON MICROB, V77, P302, DOI [10.1128/AEM.01715-10, DOI 10.1128/AEM.01715-10]; Tinta T, 2015, ENVIRON MICROBIOL, V17, P3581, DOI 10.1111/1462-2920.12519; Yu X, 2009, ECOTOXICOLOGY, V18, P700, DOI 10.1007/s10646-009-0346-x	41	4	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208544	10.1371/journal.pone.0208544	http://dx.doi.org/10.1371/journal.pone.0208544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571690	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700014
J	Pohl, MAN; Wang, TH; Pohl, T; Sweetman, J; Martin, SAM; Secombes, CJ				Pohl, Moritz A. N.; Wang, Tiehui; Pohl, Thitiya; Sweetman, John; Martin, Samuel A. M.; Secombes, Christopher J.			Four selenoprotein P genes exist in salmonids: Analysis of their origin and expression following Se supplementation and bacterial infection	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; GENOME PROVIDES INSIGHTS; IMMUNE-RESPONSE; SELENIUM; SELENOCYSTEINE; CYTOKINES; KIDNEY; LIVER; DISRUPTION; COMPONENTS	The following research was conducted to elucidate the evolution and expression of salmonid selenoprotein P (SeIP), a selenoprotein that is unique in having multiple selenocysteine (Sec) residues, following supranutritional selenium supplementation and infection in rainbow trout. We show that in salmonids SeIP is present as four paralogues and that the diversification of SeIP genes during vertebrate evolution relates to whole genome duplication events. With 17 and 16 selenocysteine residues for rainbow trout (Oncorhynchus mykiss)/Atlantic salmon (Salmo salar) SelPa1 and SelPa2 proteins respectively and 1 or 2 (trout or salmon) and 4 or 3 (trout or salmon) selenocysteine residues for salmonid SelPb1 and SelPb2 proteins respectively, this is the highest number of (predicted) multiple selenocysteine containing SeIP proteins reported for any vertebrate species to date. To investigate the effects of selenium form on SeIP expression we added different concentrations (1 nM10 mu M) of organic or inorganic selenium to a trout cell line (RTG-2 cells) and analysed changes in mRNA abundance. We next studied the impact of supplementation on the potential modulation of these transcripts by PAMPs and proinflammatory cytokines in RTG-2 and RTS-11 cells. These experiments revealed that selenium type influenced the responses, and that SeIP gene subfunctionalisation was apparent. To get an insight into the expression patterns in vivo we conducted a feeding trial with 2 diets differing in selenium content and 5 weeks later challenged the trout with a bacterial pathogen (Aeromonas salmonicida). Four tissues were analysed for SeIP paralogue expression. The results show a significant induction of SelPa1 in gills and intestine following infection in selenium supplemented fish and for SelPa2 in gills. SelPb1 was significantly reduced in head kidney of both diet groups following infection, whilst SelPb2 was significantly upregulated in skin of both diet groups post infection. Overall these findings reveal differential expression profiles for the SelPa/SelPb paralogues in trout, influenced by selenium supply, cell type/tissue and stimulant. The increase of multiple Sec containing SeIP proteins in salmonids could indicate an enhanced requirement for selenium in this lineage.	[Pohl, Moritz A. N.; Wang, Tiehui; Pohl, Thitiya; Martin, Samuel A. M.; Secombes, Christopher J.] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Inst Biol & Environm Sci, Aberdeen, Scotland; [Sweetman, John] Alltech, Springcroft, Mosshill, Brora, Scotland	University of Aberdeen	Pohl, MAN; Secombes, CJ (corresponding author), Univ Aberdeen, Scottish Fish Immunol Res Ctr, Inst Biol & Environm Sci, Aberdeen, Scotland.	m.pohl@abdn.ac.uk; c.secombes@abdn.ac.uk		Wang, Tiehui/0000-0002-1148-8959; Martin, Samuel/0000-0003-0289-6317; Pohl, Moritz/0000-0002-8654-8020	Alltech [rg13398-10]; Alltech	Alltech; Alltech	M.A.N.P. received funding of his PhD studies by Alltech (https://www.alltech.com/) under the grant code rg13398-10. The research yielded this manuscript. The authors can confirm the funder provided support in the form of a studentship for author M.A.N.P. and salaries for JS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Alltech. We thank Dr. Jun Zou (Shanghai Ocean University) for the provision of the recombinant proteins and PAMPS used in this study.	Allendorf F.W., 1984, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berry MJ, 1993, EMBO J, DOI [10.1080/00288233.1972.10421630, DOI 10.1080/00288233.1972.10421630]; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Burk RF, 1999, BIOESSAYS, V21, P231, DOI 10.1002/(SICI)1521-1878(199903)21:3<231::AID-BIES7>3.3.CO;2-4; Burk RF, 1995, HEPATOLOGY, DOI [10.1016/0270-9139(95)90120-5, DOI 10.1016/0270-9139(95)90120-5]; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; HERRMAN JL, 1977, BIOCHIM BIOPHYS ACTA, V500, P61, DOI 10.1016/0304-4165(77)90046-0; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Hong S, 2001, VET IMMUNOL IMMUNOP, V81, P1, DOI 10.1016/S0165-2427(01)00328-2; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kryukov GV, 2000, GENES CELLS, V5, P1049, DOI 10.1046/j.1365-2443.2000.00392.x; Kurokawa S, 2014, J BIOL CHEM, V289, P9195, DOI 10.1074/jbc.M114.549014; Lappin FM, 2016, MAR GENOM, V30, P15, DOI 10.1016/j.margen.2016.06.003; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Mariotti M, 2018, METHODS MOL BIOL, V1661, P3, DOI 10.1007/978-1-4939-7258-6_1; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Martitz J, 2015, METALLOMICS, V7, P1515, DOI 10.1039/c5mt00211g; MILLAR KR, 1972, NEW ZEAL J AGR RES, V15, P756, DOI 10.1080/00288233.1972.10421630; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pacitti D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2418-7; Pacitti D, 2014, DEV COMP IMMUNOL, V42, P261, DOI 10.1016/j.dci.2013.09.013; Pacitti D, 2013, AQUAT TOXICOL, V130, P97, DOI 10.1016/j.aquatox.2012.12.020; Pacitti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127041; Rise ML, 2004, PHYSIOL GENOMICS, V20, P21, DOI 10.1152/physiolgenomics.00036.2004; Romagne F, 2014, NUCLEIC ACIDS RES, V42, pD437, DOI 10.1093/nar/gkt1045; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Scott CJW, 2013, VACCINE, V31, P3262, DOI 10.1016/j.vaccine.2013.05.025; Sheridan PA, 2007, J NUTR, V137, P1466, DOI 10.1093/jn/137.6.1466; Smith JJ, 2018, NAT GENET, V50, P270, DOI 10.1038/s41588-017-0036-1; Tian XY, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.01683, 10.3389/fimmu.2018.00473]; Tujebajeva RM, 2000, GENES CELLS, V5, P897, DOI 10.1046/j.1365-2443.2000.00375.x; Tujebajeva RM, SELENOPROTEIN P EXPR; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wang T, 2003, IMMUNOGENETICS, V55, P615, DOI 10.1007/s00251-003-0622-5; Wang TH, 2016, ONCOTARGET, V7, P10917, DOI 10.18632/oncotarget.7295; Wang TH, 2011, IMMUNOGENETICS, V63, P235, DOI 10.1007/s00251-010-0508-2; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010	55	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209381	10.1371/journal.pone.0209381	http://dx.doi.org/10.1371/journal.pone.0209381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571741	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700065
J	Bronstad, PM; Peli, E; Liu, R; Doherty, A; Fulton, AB				Bronstad, P. Matthew; Peli, Eli; Liu, Rui; Doherty, Amy; Fulton, Anne B.			High prevalence of strabismic visual field expansion in pediatric homonymous hemianopia	PLOS ONE			English	Article							ANOMALOUS RETINAL CORRESPONDENCE; EXOTROPIA; HEMISPHERECTOMY	If homonymous hemianopia develops in childhood it is frequently accompanied by strabismus. In some of these cases the strabismus increases the size of the binocular visual field. We determined how prevalent visual-field-expanding strabismus is in children who have homonymous hemianopia. Medical records were examined from 103 hemianopic patients with exotropia (XT) or esotropia (ET). For each participant, we determined whether their strabismus was in a direction that resulted in visual field expansion (i.e. left exotropia with left homonymous hemianopia). Ages at which hemianopia and strabismus were first noted were compared to determine which developed first. The prevalence of XT (24%) and ET (9%) with homonymous hemianopia were both much higher than in the general population (1.5% and 5%, respectively). More strabismic eyes pointed to the blind than seeing side (62 vs 41, 60% vs. 40%, p= 0.02). Exotropic eyes were five times more likely to point to the blind side than esotropic eyes (85% vs 15%). Strabismus, especially exotropia, is much more common in pediatric homonymous hemianopia than in the general population. The strabismus is significantly more often in a visual field-expanding direction. These results support an adaptive role for the strabismus. Patients with HH and exotropia or esotropia should be aware that their visual field could be reduced by strabismus surgery.	[Bronstad, P. Matthew; Peli, Eli; Liu, Rui; Doherty, Amy] Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02114 USA; [Bronstad, P. Matthew; Peli, Eli; Liu, Rui; Fulton, Anne B.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Fulton, Anne B.] Boston Childrens Hosp, Boston, MA USA; [Liu, Rui] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Fudan University	Bronstad, PM (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02114 USA.; Bronstad, PM (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.	matthew_bronstad@meei.harvard.edu		Bronstad, Philip M./0000-0002-3116-9322	NIH National Eye Institute [R01 EY024084]; Boston Children's Hospital Innovation Fund; Knights Templar Pediatric Ophthalmology; NIH National Eye Institute core grant [P30EY003790]; NATIONAL EYE INSTITUTE [P30EY003790] Funding Source: NIH RePORTER	NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Boston Children's Hospital Innovation Fund; Knights Templar Pediatric Ophthalmology; NIH National Eye Institute core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the NIH National Eye Institute (R01 EY024084), Boston Children's Hospital Innovation Fund (AF), Knights Templar Pediatric Ophthalmology career starter grant (PMB), and NIH National Eye Institute core grant P30EY003790.	Apfelbaum HL, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.4.2; BAGOLINI B, 1967, DOC OPHTHALMOL, V23, P346, DOI 10.1007/BF02550758; CHEW E, 1994, ARCH OPHTHALMOL-CHIC, V112, P1349, DOI 10.1001/archopht.1994.01090220099030; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Donahue SP, 2007, J NEURO-OPHTHALMOL, V27, P304, DOI 10.1097/WNO.0b013e31815b9c2a; Fowler MS, 1996, J NEUROL, V243, P86; Gamio Susana, 2003, Binocul Vis Strabismus Q, V18, P167; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Good Gregory W, 2005, Optometry, V76, P285, DOI 10.1016/S1529-1839(05)70311-0; Gote H, 1993, BINOCULAR VISION EYE, V8, P129; GRAHAM PA, 1974, BRIT J OPHTHALMOL, V58, P224, DOI 10.1136/bjo.58.3.224; Handley SE, 2017, AM J OPHTHALMOL, V177, P81, DOI 10.1016/j.ajo.2017.02.014; HERZAU V, 1988, GRAEF ARCH CLIN EXP, V226, P148, DOI 10.1007/BF02173304; Houston KE, 2017, AM J PHYS MED REHAB, V96, pE70, DOI 10.1097/PHM.0000000000000592; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; KATSUMI O, 1982, JPN J OPHTHALMOL, V26, P166; Koenraads Y, 2014, EPILEPSIA, V55, P909, DOI 10.1111/epi.12615; LEVY Y, 1995, J PEDIATR OPHTHALMOL, V32, P236; MCDONALD M, 1985, INVEST OPHTH VIS SCI, V26, P1158; Moses RA, 1981, ADLERS PHYSL EYE CLI, P575; NIXON RB, 1985, AM J OPHTHALMOL, V100, P798, DOI 10.1016/S0002-9394(14)73370-7; Rowe F, 2010, EYE, V24, P682, DOI 10.1038/eye.2009.138; Saleh GM, 2006, EYE, P1, DOI [10.1038/sj.eye.6701802, DOI 10.1038/SJ.EYE.6701802]; Satgunam P, 2012, OPTOMETRY VISION SCI, V89, pE1353, DOI 10.1097/OPX.0b013e3182678d42; Schor C, 2015, OPTOMETRY VISION SCI, V92, P544, DOI 10.1097/OPX.0000000000000586; Shinder R, 2009, J PEDIAT OPHTH STRAB, V46, P38, DOI 10.3928/01913913-20090101-21; Steeves JKE, 2008, SPATIAL VISION, V21, P509, DOI 10.1163/156856808786451426; van Waveren M, 2013, GRAEF ARCH CLIN EXP, V251, P575, DOI 10.1007/s00417-012-2045-1; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209213	10.1371/journal.pone.0209213	http://dx.doi.org/10.1371/journal.pone.0209213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566507	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300077
J	Chukwuma, VU; Kose, N; Sather, DN; Sapparapu, G; Falk, R; King, H; Singh, V; Lampley, R; Malherbe, DC; Ditto, NT; Sullivan, JT; Barnes, T; Doranz, BJ; Labranche, CC; Montefiori, DC; Kalams, SA; Haigwood, NL; Crowe, JE				Chukwuma, Valentine U.; Kose, Nurgun; Sather, D. Noah; Sapparapu, Gopal; Falk, Rachel; King, Hannah; Singh, Vidisha; Lampley, Rebecca; Malherbe, Delphine C.; Ditto, Noah T.; Sullivan, Jonathan T.; Barnes, Trevor; Doranz, Benjamin J.; Labranche, Celia C.; Montefiori, David C.; Kalams, Spyros A.; Haigwood, Nancy L.; Crowe, James E., Jr.			Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; HIV-1-NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODIES; ENVELOPE IMMUNOGENS; MATURATION PATHWAY; B-CELLS; BROAD; INFECTION	Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus type 1 (HIV-1) vaccine designs, but the presence of bNAbs in naturally infected individuals may be associated with high plasma viral loads, suggesting that the magnitude, duration, and diversity of viral exposure may contribute to the development of bNAbs. Here, we report the isolation and characterization of a panel of human monoclonal antibodies (mAbs) from two subjects who developed broadly neutralizing autologous antibody responses during HIV-1 infection. In both subjects, we identified collections of mAbs that exhibited specificity only to a few autologous envelopes (Envs), with some mAbs exhibiting specificity only to a subset of Envs within the quasispecies of a particular sample at one time point. Neutralizing antibodies (NAbs) isolated from these subjects mapped mostly to epi-topes in the Env V3 loop region and the CD4 binding site. None of the individual neutralizing mAbs recovered exhibited the cumulative breadth of neutralization present in the serum of the subjects. Surprisingly, however, the activity of polyclonal mixtures comprising individual mAbs that each possessed limited neutralizing activity, could achieve increased breadth of neutralizing activity against autologous isolates. While a single broadly neutralizing antibody targeting one epitope can mediate neutralization breadth, the findings presented here suggest that a cooperative polyclonal process mediated by diverse antibodies with more limited breadth targeting multiple epitopes also can achieve neutralization breadth against HIV-1.	[Chukwuma, Valentine U.; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Kose, Nurgun; Sapparapu, Gopal; Falk, Rachel; King, Hannah; Singh, Vidisha; Lampley, Rebecca; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37235 USA; [Sather, D. Noah] Ctr Infect Dis Res, Washington, DC USA; [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Malherbe, Delphine C.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Ditto, Noah T.] Carterra Inc, Salt Lake City, UT USA; [Sullivan, Jonathan T.; Barnes, Trevor; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA; [Labranche, Celia C.; Montefiori, David C.] Duke Univ, Div Surg Sci, Durham, NC USA; [Kalams, Spyros A.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Walter Reed Army Institute of Research (WRAIR); Vanderbilt University; Oregon Health & Science University; Oregon National Primate Research Center; Duke University; Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	james.crowe@vanderbilt.edu	Haigwood, Nancy Logan/AAV-7484-2020; Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Sullivan, Jonathan/0000-0002-5925-4203; Haigwood, Nancy/0000-0002-1477-9575	National Institute of Allergy and Infectious Diseases through U.S. National Institutes of Health [U01 AI 78407, P01 AI 078064, R43 AI096936]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI096936] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases through U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases through U.S. National Institutes of Health grants U01 AI 78407, (J.E.C., S.A.K.), P01 AI 078064 (N.L.H. and J.E.C., S.A.K.), R43 AI096936 (BJD). All other authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Several authors are employed by Integral Molecular, Inc. This funder provided support in the form of salaries for authors who contributed epitope mapping data including epitope data collection and analysis [JTS, TB, BJD], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the National Institute of Allergy and Infectious Diseases through U.S. National Institutes of Health grants U01 AI 78407, (J.E.C., S.A.K.), P01 AI 078064 (N.L.H. and J.E.C., S.A.K.), R43 AI096936 (BJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Several authors are employed by Integral Molecular, Inc. This funder provided support in the form of salaries for authors who contributed epitope mapping data including epitope data collection and analysis [JTS, TB, BJD], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. All other authors declare no conflict of interest.	Abdiche YN, 2016, MABS-AUSTIN, V8, P264, DOI 10.1080/19420862.2015.1118596; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cornelissen M, 2016, AIDS RES HUM RETROV, V32, P1135, DOI 10.1089/aid.2015.0324; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Goo L, 2012, J VIROL, V86, P10857, DOI 10.1128/JVI.01414-12; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Hessell AJ, 2016, J IMMUNOL, V196, P3064, DOI 10.4049/jimmunol.1500527; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kraft Z, 2008, J VIROL, V82, P5912, DOI 10.1128/JVI.00389-08; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Malherbe DC, 2014, J VIROL, V88, P12949, DOI 10.1128/JVI.01812-14; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2003, NAT MED, V9, P393, DOI 10.1038/nm0403-393; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; SANDERS RD, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PPAT.1003618; Sather DN, 2014, J VIROL, V88, P12968, DOI 10.1128/JVI.01816-14; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209437	10.1371/journal.pone.0209437	http://dx.doi.org/10.1371/journal.pone.0209437			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566528	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300091
J	Ehsani-Moghaddam, B; Queenan, JA; MacKenzie, J; Birtwhistle, RV				Ehsani-Moghaddam, Behrouz; Queenan, John A.; MacKenzie, Jennifer; Birtwhistle, Richard, V			Mucopolysaccharidosis type II detection by Naive Bayes Classifier: An example of patient classification for a rare disease using electronic medical records from the Canadian Primary Care Sentinel Surveillance Network	PLOS ONE			English	Article								Identifying patients with rare diseases associated with common symptoms is challenging. Hunter syndrome, or Mucopolysaccharidosis type II is a progressive rare disease caused by a deficiency in the activity of the lysosomal enzyme, iduronate 2-sulphatase. It is inherited in an X-linked manner resulting in males being significantly affected. Expression in females varies with the majority being unaffected although symptoms may emerge over time. We developed a Naive Bayes classification (NBC) algorithm utilizing the clinical diagnosis and symptoms of patients contained within their de-identified and unstructured electronic medical records (EMR) extracted by the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). To do so, we created a training dataset using published results in the scientific literature and from all MPS II symptoms and applied the training dataset and its independent features to compute the conditional posterior probabilities of having MPS II disease as a categorical dependent variable for 506497 male patients. The classifier identified 125 patients with the highest likelihood for having the disease and 18 features were selected to be necessary for forecasting. Next, a Recursive Backward Feature Elimination algorithm was employed, for optimal input features of the NBC model, using a k-fold Cross-Validation with 3 replicates. The accuracy of the final model was estimated by the Validation Set Approach technique and the bootstrap resampling. We also investigated that whether the NBC is as accurate as three other Bayesian networks. The Naive Bayes Classifier appears to be an efficient algorithm in assisting physicians with the diagnosis of Hunter syndrome allowing optimal patient management.	[Ehsani-Moghaddam, Behrouz; Queenan, John A.; Birtwhistle, Richard, V] Queens Univ, Dept Family Med, Ctr Studies Primary Care, Kingston, ON, Canada; [MacKenzie, Jennifer] McMaster Univ, Dept Pediat, Div Genet, Hamilton, ON, Canada	Queens University - Canada; McMaster University	Ehsani-Moghaddam, B (corresponding author), Queens Univ, Dept Family Med, Ctr Studies Primary Care, Kingston, ON, Canada.	behrouz.ehsani@dfm.queensu.ca		Birtwhistle, Richard/0000-0002-9937-7355; Ehsani-Moghaddam, Behrouz/0000-0002-5038-1118; MacKenzie, Jennifer/0000-0002-3374-8619	Shire Canada [2016SRSC68]	Shire Canada	This project was entirely funded by a grant from Shire Canada (https://www.shirecanada.com) to Dr Richard Birtwhistle's research project (2016SRSC68) and there was no additional external funding received for this study. Shire Canada has played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, MUCOPOLYSACCHARIDOSI; [Anonymous], 2018, SUPP CUTT EDG RAR DI; [Anonymous], 2017, ARXIV170607269; [Anonymous], 2005, P 22 INT C MACH LEAR; [Anonymous], 2017, GUID UND NUC MPS 2; [Anonymous], 2011, NTERNATIONAL J COMPU; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; Beleites C, 2013, ANAL CHIM ACTA, V760, P25, DOI 10.1016/j.aca.2012.11.007; Canada's Rare Disease Strategy, 2017, CAN RAR DIS STRAT; Cheng J, 2001, P 14 CAN C ART INT; COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ehsani-Moghaddam B, 2018, ZERO INFLATED UNPUB; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Heckerman D, 1997, DATA MIN KNOWL DISC, V1, P79, DOI 10.1023/A:1009730122752; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; James G, 2013, SPRINGER TEXTS STAT, V103, P175, DOI 10.1007/978-1-4614-7138-7_5; Johnson BA, 2013, CURR PROTOC HUM GENE, V79; Kuhn M., 2016, APPL PREDICTIVE MODE, V19, P491; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Madden MG, 2009, RES DEV INTELLIGENT; Maimon OZ, 2005, DATA MINING KNOWLEDG; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Menec V., 2000, DEFINING PRACTICE PO; Mohan V., DECISION TREES COMPA; Molnar C., 2020, INTERPRETABLE MACHIN; Muir SW, 2010, PHYS THER, V90, P338, DOI 10.2522/ptj.20090163; Needham M, 2015, J GENET COUNS, V24, P635, DOI 10.1007/s10897-014-9791-7; Schwartz IVD, 2007, ACTA PAEDIATR, V96, P63, DOI 10.1111/j.1651-2227.2007.00212.x; Shen Feichen, 2017, AMIA Annu Symp Proc, V2017, P1554; Stern MK, 1999, BAYES CLASSIFIERS US; Tulio Ribeiro M., 2016, ACM SIGKDD INT C KNO; Zhang H., 2004, P 17 INT FLOR ART IN	37	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209018	10.1371/journal.pone.0209018	http://dx.doi.org/10.1371/journal.pone.0209018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566525	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300064
J	Gainey, DP; Kim, JY; Maroja, LS				Gainey, D. Patrick; Kim, Jeremiah Y.; Maroja, Luana S.			Mapping reduced introgression loci to the X chromosome of the hybridizing field crickets, Gryllus firmus and G-pennsylvanicus	PLOS ONE			English	Article							MALE-ACCESSORY-GLAND; GENE EXCHANGE; PATTERNS; SPECIATION; ZONE; RECOMBINATION; DIVERGENCE; SELECTION; PROTEINS; BARRIERS	The genomic architecture of barriers to gene exchange during the speciation process is poorly understood. The genomic islands model suggests that loci associated with barriers to gene exchange prevent introgression of nearby genomic regions via linkage disequilibrium. But few analyses of the actual genomic location of non-introgressing loci in closely related species exist. In a previous study Maroja et al. showed that in the hybridizing field crickets, Gryllus firmus and G. pennsylvanicus, 50 non-introgressing loci are localized on two autosomal regions and the X chromosome, but they were not able to map the loci along the X chromosome because they used a male informative cross. Here, we localize the introgressing and non-introgressing loci on the X chromosome, and reveal that all X-linked non-introgressing loci are restricted to a 50-cM region with 10 of these loci mapped to a single location. We discuss the implications of this finding to speciation.	[Gainey, D. Patrick; Kim, Jeremiah Y.; Maroja, Luana S.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Gainey, D. Patrick] Harvard Univ, Dept Mol Biol, Cambridge, MA 02138 USA	Williams College; Harvard University	Maroja, LS (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	lsm1@williams.edu			National Science Foundation [1650887]; Williams College; NSF grant [1650887]	National Science Foundation(National Science Foundation (NSF)); Williams College; NSF grant(National Science Foundation (NSF))	This work was funded by grant 1650887 from the National Science Foundation (US) [https://www.nsf.gov] and Williams College to LM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank late Dr. Richard Harrison for helpful discussions and advice and Steve Bogdanowicz for help with the nextera illumina sequencing. This work was partially funded by a NSF grant 1650887 to L. S. Maroja and by Williams College.	Andres JA, 2013, GENETICS, V193, P501, DOI 10.1534/genetics.112.142299; Berg PR, 2017, HEREDITY, V119, P418, DOI 10.1038/hdy.2017.54; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 2007, CYTOGENET GENOME RES, V116, P311, DOI 10.1159/000100416; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; HARRISON RG, 1985, EVOLUTION, V39, P244, DOI 10.1111/j.1558-5646.1985.tb05664.x; Hooper DM, 2017, NAT ECOL EVOL, V1, P1526, DOI 10.1038/s41559-017-0284-6; JABLONKA E, 1988, J THEOR BIOL, V133, P23, DOI 10.1016/S0022-5193(88)80022-5; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Larson EL, 2012, J EVOLUTION BIOL, V25, P174, DOI 10.1111/j.1420-9101.2011.02415.x; Larson EL, 2014, MOL ECOL, V23, P1668, DOI 10.1111/mec.12601; Larson EL, 2013, EVOLUTION, V67, P3653, DOI 10.1111/evo.12205; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Maroja LS, 2015, G3-GENES GENOM GENET, V5, P2219, DOI 10.1534/g3.115.021246; Maroja LS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-65; Maroja LS, 2009, EVOLUTION, V63, P2999, DOI 10.1111/j.1558-5646.2009.00767.x; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Noor MAF, 2001, EVOLUTION, V55, P512, DOI 10.1554/0014-3820(2001)055[0512:TGORIA]2.0.CO;2; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Payseur BA, 2004, EVOLUTION, V58, P2064; Ram KR, 2005, INSECT BIOCHEM MOLEC, V35, P1059, DOI 10.1016/j.ibmb.2005.05.001; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sitnik JL, 2016, GENETICS, V202, P1029, DOI 10.1534/genetics.115.181644; Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Viera A, 2004, EMBO REP, V5, P385, DOI 10.1038/sj.embor.7400112; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208498	10.1371/journal.pone.0208498	http://dx.doi.org/10.1371/journal.pone.0208498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566487	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300044
J	Zangalli, CS; Vianna, JR; Reis, ASC; Miguel-Neto, J; Burgoyne, CF; Chauhan, BC; Costa, VP				Zangalli, Camila S.; Vianna, Jayme R.; Reis, Alexandre S. C.; Miguel-Neto, Jamil; Burgoyne, Claude F.; Chauhan, Balwantray C.; Costa, Vital P.			Bruch's membrane opening minimum rim width and retinal nerve fiber layer thickness in a Brazilian population of healthy subjects	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DISC MARGIN ANATOMY; OPTIC-NERVE; GENOMIC ANCESTRY; RACIAL-DIFFERENCES; AFRICAN DESCENT; REFERENCE PLANE; PRIMATE RETINA; VISUAL-FIELD; HEAD	Objective To determine Bruch's membrane opening (BMO) minimum rim width (MRW) and peripapillary retinal nerve fiber layer thickness (RNFLT) measurements, acquired with optical coherence tomography (OCT) in healthy Brazilian individuals self-reported as African Descent (AD), European Descent (ED) and Mixed Descent (MD). Methods 260 healthy individuals (78 AD, 103 ED and 79 MD) were included in this cross-sectional study conducted at the Clinics Hospital of the University of Campinas. We obtained optic nerve head (24 radial B scans) and peripapillary retinal nerve fiber layer (3.5-mm circle scan) images in one randomly selected eye of each subject. Results After adjustment for BMO area and age, there were no significant differences in mean global MRW (P = 0.63) or RNFLT (P = 0.07) among the three groups. Regionally, there were no significant differences in either MRW or RNFLT in most sectors, except in the superonasal sector, in which both MRW and RNFLT were thinner among ED (P = 0.04, P<0.001, respectively). RNFLT was also thinner in ED in the inferonasal sector (P = 0.009). In all races, global MRW decreased and global RNFLT increased with BMO area. AD subjects had higher rates of global RNFLT decay with age (-0.32 mu m/year) compared to ED and MD subjects (-0.10 mu m/year and -0.08 mu m/year, respectively; P = 0.01 and P = 0.02, respectively). Conclusions and relevance While we found no significant differences in global MRW and RNFLT among the three races, age-related thinning of the RNFLT was significantly higher in the AD subgroup, which warrants further study.	[Zangalli, Camila S.; Reis, Alexandre S. C.; Miguel-Neto, Jamil; Costa, Vital P.] Univ Estadual Campinas, Dept Ophthalmol, Campinas, SP, Brazil; [Vianna, Jayme R.; Chauhan, Balwantray C.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Burgoyne, Claude F.] Devers Eye Inst, Opt Nerve Head Res Lab, Portland, OR USA	Universidade Estadual de Campinas; Dalhousie University; Devers Eye Institute	Zangalli, CS (corresponding author), Univ Estadual Campinas, Dept Ophthalmol, Campinas, SP, Brazil.	czangalli@gmail.com	Vianna, Jayme/L-4307-2019; Miguel-Neto, Jamil/GLT-9254-2022	Vianna, Jayme/0000-0001-5302-7950; Miguel-Neto, Jamil/0000-0002-7024-1294; Burgoyne, Claude/0000-0002-2765-4739; Chauhan, Balwantray/0000-0002-7936-6907; Reis, AlessanRSS/0000-0001-8486-7469	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); NIH/NEI [R01-EY021281]; Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH, Heidelberg, Germany; Dalhousie Medical Research Foundation; Allergan; NATIONAL EYE INSTITUTE [R01EY021281] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH, Heidelberg, Germany; Dalhousie Medical Research Foundation; Allergan(AbbVieAllergan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Camila Zangalli was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); J. Vianna: None; A. Reis: None; J. Neto: None; C. Burgoyne: NIH/NEI R01-EY021281; Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH, Heidelberg, Germany; B. Chauhan: Heidelberg Engineering, GmbH, Heidelberg, Germany; Dalhousie Medical Research Foundation; Allergan; V. Costa: None. Drs. Burgoyne and Chauhan are consultants to Heidelberg Engineering. In this role, they receive unrestricted research support, instruments, software, and occasional travel support. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Both hold no patents and receive no honorariums or personal income. The above listed sponsors/funding organizations had no role in the design or conduct of this research.	ARMALY M F, 1960, J Iowa State Med Soc, V50, P501; Burk ROW, 2000, GRAEF ARCH CLIN EXP, V238, P375, DOI 10.1007/s004170050368; Chauhan BC, 2015, OPHTHALMOLOGY, V122, P1786, DOI 10.1016/j.ophtha.2015.06.001; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Friedman DS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1625, DOI 10.1001/archopht.124.11.1625; Gardiner SK, 2014, AM J OPHTHALMOL, V157, P540, DOI 10.1016/j.ajo.2013.11.007; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Girkin CA, 2003, INVEST OPHTH VIS SCI, V44, P3382, DOI 10.1167/iovs.02-0792; Girkin CA, 2004, INVEST OPHTH VIS SCI, V45, P2272, DOI 10.1167/iovs.03-0996; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Girkin CA, 2011, INVEST OPHTH VIS SCI, V52, P6148, DOI 10.1167/iovs.10-6698; Girkin CA, 2010, ARCH OPHTHALMOL-CHIC, V128, P541, DOI 10.1001/archophthalmol.2010.49; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; He L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092225; Hu ZH, 2010, INVEST OPHTH VIS SCI, V51, P5708, DOI 10.1167/iovs.09-4838; IBGE, 2017, CAR ETN POP ID 2013, DOI [10.1038/ncomms12522, DOI 10.1038/NCOMMS12522]; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Khachatryan N, 2015, AM J OPHTHALMOL, V159, P777, DOI 10.1016/j.ajo.2015.01.011; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Kutner MH, 2005, APPL LINEAR STAT MOD, Vxxviii; Leite TKM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027162; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; Marsh BC, 2010, J GLAUCOMA, V19, P310, DOI 10.1097/IJG.0b013e3181b6e5cd; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; Montinaro F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7596; Mwanza JC, 2011, OPHTHALMOLOGY, V118, P241, DOI 10.1016/j.ophtha.2010.06.036; OGDEN TE, 1983, VISION RES, V23, P581, DOI 10.1016/0042-6989(83)90063-9; OGDEN TE, 1978, INVEST OPHTH VIS SCI, V17, P499; ONDA E, 1995, AM J OPHTHALMOL, V120, P92, DOI 10.1016/S0002-9394(14)73763-8; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14191; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Poli A, 2008, INVEST OPHTH VIS SCI, V49, P3970, DOI 10.1167/iovs.08-1764; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773736; QUIGLEY HA, 1990, ARCH OPHTHALMOL-CHIC, V108, P51, DOI 10.1001/archopht.1990.01070030057028; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racette L, 2005, ARCH OPHTHALMOL-CHIC, V123, P1547, DOI 10.1001/archopht.123.11.1547; Rao HL, 2010, OPHTHALMOLOGY, V117, P275, DOI 10.1016/j.ophtha.2009.06.062; Reis ASC, 2017, ACTA OPHTHALMOL, V95, pE548, DOI 10.1111/aos.13464; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P1852, DOI 10.1167/iovs.11-9309; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Rhodes LA, 2017, AM J OPHTHALMOL, V174, P113, DOI 10.1016/j.ajo.2016.10.022; Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342; Savini G, 2005, BRIT J OPHTHALMOL, V89, P489, DOI 10.1136/bjo.2004.052498; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P214, DOI 10.1167/iovs.08-2302; Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Tan JCH, 2003, INVEST OPHTH VIS SCI, V44, P1132, DOI 10.1167/iovs.02-0039; Tan XL, 2017, OPEN OPHTHALMOL J, V11, P40, DOI 10.2174/1874364101711010040; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Zelefsky JR, 2006, J GLAUCOMA, V15, P548, DOI 10.1097/01.ijg.0000212289.00917.a8	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0206887	10.1371/journal.pone.0206887	http://dx.doi.org/10.1371/journal.pone.0206887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562371	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100005
J	Arai, K; Murata, D; Verissimo, AR; Mukae, Y; Itoh, M; Nakamura, A; Morita, S; Nakayama, K				Arai, Kenichi; Murata, Daiki; Verissimo, Ana Raquel; Mukae, Yosuke; Itoh, Manabu; Nakamura, Anna; Morita, Shigeki; Nakayama, Koichi			Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printer	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HEART-TRANSPLANTATION; TISSUE; STIMULATION; MUSCLE; MOUSE	A major challenge in cardiac tissue engineering is the host's immune response to artificial materials. To overcome this problem, we established a scaffold-free system for assembling cell constructs using an automated Bio-3D printer. This printer has previously been used to fabricate other three-dimensional (3D) constructs, including liver, blood vessels, and cartilage. In the present study, we tested the function in vivo of scaffold-free cardiac tubular construct fabricated using this system. Cardiomyocytes derived from induced pluripotent stem cells (iCells), endothelial cells, and fibroblasts were combined to make the spheroids. Subsequently, tubular cardiac constructs were fabricated by Bio-3D printer placing the spheroids on a needle array. Notably, the spheroid fusion and beat rate in the constructs were observed while still on the needle array. After removal from the needle array, electrical stimulation was used to test responsiveness of the constructs. An increased beat rate was observed during stimulation. Importantly, the constructs returned to their initial beat rate after stimulation was stopped. In addition, histological analysis shows cellular reorganization occurring in the cardiac constructs, which may mimic that observed during organ transplantation. Taken together, our results indicate that these engineered cardiac tubular constructs, which address both the limited supply of donor tissues as well as the immune-induced transplant rejection, has potential to be used for both clinical and drug testing applications. To our knowledge, this is the first time that cardiac tubular constructs have been produced using optimized Bio-3D printing technique and subsequently tested for their use as cardiac pumps.	[Arai, Kenichi; Murata, Daiki; Verissimo, Ana Raquel; Nakamura, Anna; Nakayama, Koichi] Saga Univ, Fac Med, Dept Regenerat Med & Biomed Engn, Saga, Japan; [Mukae, Yosuke; Itoh, Manabu; Morita, Shigeki] Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga, Japan	Saga University; Saga University	Nakayama, K (corresponding author), Saga Univ, Fac Med, Dept Regenerat Med & Biomed Engn, Saga, Japan.	nakayama@me.saga-u.ac.jp		Nakayama, Koichi/0000-0002-7324-8862; Arai, Kenichi/0000-0002-2556-4473	Japan Society for the Promotion of Science [16K19968]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 16K19968) from the Japan Society for the Promotion of Science to KA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 2016, ACTA BIOMATER, V33, P110, DOI 10.1016/j.actbio.2016.01.033; Beauchamp P, 2015, TISSUE ENG PART C-ME, V21, P852, DOI [10.1089/ten.tec.2014.0376, 10.1089/ten.TEC.2014.0376]; Emmert MY, 2014, ADV DRUG DELIVER REV, V69, P254, DOI 10.1016/j.addr.2013.12.004; Godier-Furnemont AFG, 2015, BIOMATERIALS, V60, P82, DOI 10.1016/j.biomaterials.2015.03.055; Grimm FA, 2015, ASSAY DRUG DEV TECHN, V13, P529, DOI 10.1089/adt.2015.659; Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681; Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173; Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026; Kadakia S, 2016, GEN THORAC CARDIOVAS, V64, P501, DOI 10.1007/s11748-016-0671-y; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kikuchi T, 2014, BIOMATERIALS, V35, P2428, DOI 10.1016/j.biomaterials.2013.12.014; Langer R, 2016, J PEDIATR SURG, V51, P8, DOI 10.1016/j.jpedsurg.2015.10.022; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Miller LW, 2013, CIRCULATION, V127, P743, DOI 10.1161/CIRCULATIONAHA.112.139824; Noguchi R, 2016, J HEART LUNG TRANSPL, V35, P137, DOI 10.1016/j.healun.2015.06.001; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Ong CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05018-4; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Sakaguchi K, 2015, J CONTROL RELEASE, V205, P83, DOI 10.1016/j.jconrel.2014.12.016; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273; Seta H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45499; Sousa M, 2017, HEART FAIL REV, V22, P317, DOI 10.1007/s10741-017-9601-z; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Stewart GC, 2014, HEART FAIL CLIN, V10, P207, DOI 10.1016/j.hfc.2013.09.007; Stoppel WL, 2016, ADV DRUG DELIVER REV, V96, P135, DOI 10.1016/j.addr.2015.07.009; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tandon N, 2013, IEEE ENG MED BIO, P6219, DOI 10.1109/EMBC.2013.6610974; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Uchida H, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.86492; van Marion MH, 2015, J MOL CELL CARDIOL, V87, P79, DOI 10.1016/j.yjmcc.2015.08.010	37	70	73	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209162	10.1371/journal.pone.0209162	http://dx.doi.org/10.1371/journal.pone.0209162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557409	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000076
J	Pavoni, S; Jarray, R; Nassor, F; Guyot, AC; Cottin, S; Rontard, J; Mikol, J; Mabondzo, A; Deslys, JP; Yates, F				Pavoni, Serena; Jarray, Rafika; Nassor, Ferid; Guyot, Anne-Cecile; Cottin, Steve; Rontard, Jessica; Mikol, Jacqueline; Mabondzo, Aloise; Deslys, Jean-Philippe; Yates, Frank			Small-molecule induction of A beta-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes	PLOS ONE			English	Article							PRION PROTEIN PRPC; IN-VITRO; A-BETA; CELLS; EXPRESSION; A-BETA(42); LESSONS; GENE	Human mini-brains (MB) are cerebral organoids that recapitulate in part the complexity of the human brain in a unique three-dimensional in vitro model, yielding discrete brain regions reminiscent of the cerebral cortex. Specific proteins linked to neurodegenerative disorders are physiologically expressed in MBs, such as APP-derived amyloids (A beta), whose physiological and pathological roles and interactions with other proteins are not well established in humans. Here, we demonstrate that neuroectodermal organoids can be used to study the A beta accumulation implicated in Alzheimer's disease (AD). To enhance the process of protein secretion and accumulation, we adopted a chemical strategy of induction to modulate post-translational pathways of APP using an Amyloid-beta Forty-Two Inducer named Aftin-5. Secreted, soluble A beta fragment concentrations were analyzed in MB-conditioned media. An increase in the A beta(42) fragment secretion was observed as was an increased A beta(42)/A beta(40) ratio after drug treatment, which is consistent with the pathological-like phenotypes described in vivo in transgenic animal models and in vitro in induced pluripotent stem cell-derived neural cultures obtained from AD patients. Notably in this context we observe time-dependent A beta accumulation, which differs from protein accumulation occurring after treatment. We show that mini-brains obtained from a non-AD control cell line are responsive to chemical compound induction, producing a shift of physiological A beta concentrations, suggesting that this model can be used to identify environmental agents that may initiate the cascade of events ultimately leading to sporadic AD. Increases in both A beta oligomers and their target, the cellular prion protein (PrPc), support the possibility of using MBs to further understand the pathophysiological role that underlies their interaction in a human model. Finally, the potential application of MBs for modeling age-associated phenotypes and the study of neurological disorders is confirmed.	[Pavoni, Serena; Jarray, Rafika; Nassor, Ferid; Cottin, Steve; Rontard, Jessica; Mikol, Jacqueline; Deslys, Jean-Philippe; Yates, Frank] Univ Paris Saclay, Inst Francois Jacob, SEPIA, CEA, Fontenay Aux Roses, France; [Jarray, Rafika; Yates, Frank] SupBiotech, Villejuif, France; [Guyot, Anne-Cecile; Mabondzo, Aloise] Univ Paris Saclay, CEA, Inst Biol & Technol Saclay IBITECS, Lab Drug Metab Res LEMM, Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Yates, F (corresponding author), Univ Paris Saclay, Inst Francois Jacob, SEPIA, CEA, Fontenay Aux Roses, France.; Yates, F (corresponding author), SupBiotech, Villejuif, France.	frank.yates@supbiotech.fr	yates, frank/B-8900-2013; yates, frank/GQZ-2219-2022	YATES, Frank/0000-0002-3590-5745; NASSOR, Ferid/0000-0001-9515-670X; Cottin, Steve/0000-0002-5339-0677	French national PIA2 program [P112331-3422142]; EU Joint Programme Neurodegenerative Diseases Research (JPND; 3DMiniBrain)	French national PIA2 program; EU Joint Programme Neurodegenerative Diseases Research (JPND; 3DMiniBrain)	This work was supported by the French national PIA2 program under contract No. P112331-3422142 (3DNS project) and the EU Joint Programme Neurodegenerative Diseases Research (JPND; 3DMiniBrain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adle-Biassette H, 2006, J NEUROPATH EXP NEUR, V65, P698, DOI 10.1097/01.jnen.0000228137.10531.72; Brawner Andrew T, 2017, Int J Physiol Pathophysiol Pharmacol, V9, P101; Brennand KJ, 2015, STEM CELL REP, V5, P933, DOI 10.1016/j.stemcr.2015.10.011; Cavanaugh SE, 2014, ALTEX-ALTERN ANIM EX, V31, P279, DOI 10.14573/altex.1310071; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cummings J, 2018, CTS-CLIN TRANSL SCI, V11, P147, DOI 10.1111/cts.12491; D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Freude K, 2014, J CLIN MED, V3, P1402, DOI 10.3390/jcm3041402; Ghaffari LT, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00056; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goldstein LSB, 2015, NEUROTHERAPEUTICS, V12, P121, DOI 10.1007/s13311-014-0326-6; Gonzalez C, 2018, MOL PSYCHIATR, V23, P2363, DOI 10.1038/s41380-018-0229-8; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hochard A, 2013, J ALZHEIMERS DIS, V35, P107, DOI 10.3233/JAD-121777; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kitazawa M, 2012, CURR PHARM DESIGN, V18, P1131, DOI 10.2174/138161212799315786; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewczuk P, 2017, J ALZHEIMERS DIS, V55, P813, DOI 10.3233/JAD-160722; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; MANSON J, 1992, DEVELOPMENT, V115, P117; Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807; Parr CJC, 2017, MOL PSYCHIATR, V22, P808, DOI 10.1038/mp.2017.66; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Sheridan SD, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/738910; Spies PE, 2010, CURR ALZHEIMER RES, V7, P470, DOI 10.2174/156720510791383796; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	46	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209150	10.1371/journal.pone.0209150	http://dx.doi.org/10.1371/journal.pone.0209150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557391	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000074
J	Wang, XC; Li, CL; Wang, MX; Zheng, P				Wang, Xiaocheng; Li, Chaolun; Wang, Minxiao; Zheng, Ping			Stable isotope signatures and nutritional sources of some dominant species from the PACManus hydrothermal area and the Desmos caldera	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MID-ATLANTIC RIDGE; DEEP-SEA; RIMICARIS-EXOCULATA; VENT COMMUNITIES; MANUS BASIN; COLD SEEP; BACK-ARC; ENVIRONMENTAL-IMPACT; CARBON FIXATION	Deep-sea hydrothermal vents in the western Pacific are increasingly explored for potential mineral extraction. The study of the composition of the food web plays an important guiding role in the ecological protection and restoration of potential mining areas. The general picture of the nutritional sources of species should be established to assess the potential impacts of future mining activities on the biological composition and food sources. To provide basic information, we analyzed the carbon and nitrogen stable isotope ratios of the dominant macrofauna (mussels, commensal scale worms, crustaceans, gastropods, and vestimentiferans) at three different sites in the PACManus hydrothermal area and the Desmos caldera. The delta C-13 ratio was significantly different between species: mussels and commensal scale worms showed lighter delta C-13 ratios, whereas crustaceans showed heavier ratios. In terms of delta N-15, mussels had the lowest values and the crustaceans had the highest values. By taking into account these stable isotope signatures, we were able to develop inferences of the food sources for vent community organisms. We found that the food web was based on various species of chemoautotrophic bacteria. Mussels appeared to rely primarily on sulfur-based endosymbionts, which use the Calvin-Benson-Bassham (CBB) cycle and RuBisCO form I as the CO2-fixing enzyme. Commensal polychaetes mostly obtained their nutrition from their hosts. Crustacean species were omnivorous, feeding on chemosynthetic bacteria, sedimentary debris, or even animals according to the local environment. In contrast, gastropods relied mainly on symbiotic bacteria with some supplementary consumption of detritus. Vestimentiferans obtained food from symbiotic bacteria using the RuBisCO form II enzyme in the CBB cycle and may have several symbionts using different fixation pathways. Although most macrofauna relied on symbiotic chemoautotrophic bacteria, our study suggested a closer trophic relationship between animals. Therefore, to evaluate the potential impacts of deep sea mining, it is necessary to study the cascade effects on the food web of the whole ecosystem. Before exploiting deep-sea resources, further systematic investigations concerning the protection of deep-sea ecosystems are necessary.	[Wang, Xiaocheng; Li, Chaolun; Wang, Minxiao; Zheng, Ping] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Wang, Xiaocheng; Li, Chaolun; Wang, Minxiao; Zheng, Ping] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Wang, Xiaocheng] Natl Marine Environm Monitoring Ctr, Dalian, Peoples R China; [Wang, Xiaocheng; Li, Chaolun; Wang, Minxiao; Zheng, Ping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Chaolun; Wang, Minxiao] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; National Marine Environmental Monitoring Center; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Li, CL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Li, CL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Li, CL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, CL (corresponding author), Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China.	lcl@qdio.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Minxiao, Wang/0000-0002-6567-3295; Li, Chaolun/0000-0003-1890-0587	Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2016ASKJ14]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11030202]; NSFC-Shandong Joint Fund for Marine Ecology and Environmental Sciences [U1406403]; Innovation of the Chinese Academy of Sciences International Partnership Project Team [20140491526]	Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Shandong Joint Fund for Marine Ecology and Environmental Sciences; Innovation of the Chinese Academy of Sciences International Partnership Project Team	This work was supported by the Scientific and Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology [No. 2016ASKJ14], the Strategic Priority Research Program of the Chinese Academy of Sciences [grant number XDA11030202], the NSFC-Shandong Joint Fund for Marine Ecology and Environmental Sciences [grant number U1406403], and the Innovation of the Chinese Academy of Sciences International Partnership Project Team [grant number 20140491526].	Amano K, 2013, PALEONTOL RES, V17, P325, DOI 10.2517/1342-8144-17.4.325; Barry JP, 2002, INVERTEBR BIOL, V121, P47; Beaulieu SE, 2013, GEOCHEM GEOPHY GEOSY, V14, P4892, DOI 10.1002/2013GC004998; Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; Bojar AV, 2018, DEEP-SEA RES PT I, V133, P49, DOI 10.1016/j.dsr.2018.02.002; Both R, 2013, EOS T AGU EOS WASHIN, V67, P489; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Cavanaugh C.M., 1985, Bulletin of the Biological Society of Washington, P373; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Collins PC, 2013, MAR POLICY, V42, P334, DOI 10.1016/j.marpol.2013.03.002; Comeault A, 2010, CAH BIOL MAR, V51, P351; Demina LL, 2008, OCEANOLOGY+, V48, P784, DOI 10.1134/S0001437008060040; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Desbruyeres D., 1985, Bulletin of the Biological Society of Washington, P103; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2011, GEOBIOLOGY, V9, P481, DOI 10.1111/j.1472-4669.2011.00300.x; Duperron S, 2010, TOP GEOBIOL, V33, P137, DOI 10.1007/978-90-481-9572-5_6; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; ESCOBARBRIONES E, 2002, CONTRIBUTIONS STUDY, V1, P37; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Feng D, 2015, DEEP-SEA RES PT I, V104, P52, DOI 10.1016/j.dsr.2015.06.011; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Galkin SV, 1997, MAR GEOL, V142, P197, DOI 10.1016/S0025-3227(97)00051-0; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Gena K, 2013, PROCED EARTH PLAN SC, V6, P226, DOI 10.1016/j.proeps.2013.01.031; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Hashimoto J., 1999, INTERRIDGE NEWS, V8, P12; Hashimoto Jun, 2007, Venus (Tokyo), V66, P57; Herzig PM, 1998, MINER DEPOSITA, V33, P226, DOI 10.1007/s001260050143; House CH, 2003, ORG GEOCHEM, V34, P345, DOI 10.1016/S0146-6380(02)00237-1; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jannasch H. W., 1989, AUTOTROPHIC BACTERIA, P147; Kiel S, 2010, VENT SEEP BIOTA, P33; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KROOPNIC.P, 1972, EARTH PLANET SC LETT, V16, P103, DOI 10.1016/0012-821X(72)90242-7; LeBris N., 2016, 1 GLOBAL INTEGRATED, P1; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; Levin LA, 2000, MAR ECOL PROG SER, V208, P21, DOI 10.3354/meps208021; LONSDALE P, 1977, DEEP-SEA RES, V24, P857, DOI 10.1016/0146-6291(77)90478-7; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; NELSON DC, 1995, AM ZOOL, V35, P91; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phleger CF, 2005, COMP BIOCHEM PHYS B, V141, P196, DOI 10.1016/j.cbpc.2005.03.001; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Portail M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162263; RAU GH, 1981, NATURE, V289, P484, DOI 10.1038/289484a0; RAU GH, 1979, SCIENCE, V203, P648, DOI 10.1126/science.203.4381.648; Reid WDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065553; Reid WDK, 2012, MAR ECOL PROG SER, V463, P89, DOI 10.3354/meps09863; Rieley G, 1999, MAR BIOL, V133, P495, DOI 10.1007/s002270050489; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; Roeske CA, 2002, BIOCHEM, V23, P6275; Saito H, 2010, LIPIDS, V45, P537, DOI 10.1007/s11745-010-3436-x; Sasaki T, 2010, TOP GEOBIOL, V33, P169, DOI 10.1007/978-90-481-9572-5_7; Sato-Okoshi Waka, 2003, Japanese Journal of Benthology, V58, P70; Seston SL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01074; Streit K, 2015, DEEP-SEA RES PT I, V100, P13, DOI 10.1016/j.dsr.2015.02.003; Suzuki Y, 2005, APPL ENVIRON MICROB, V71, P5440, DOI 10.1128/AEM.71.9.5440-5450.2005; Sweetman AK, 2013, MAR ECOL PROG SER, V473, P115, DOI 10.3354/meps10050; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thal J, 2014, MAR GEOL, V355, P98, DOI 10.1016/j.margeo.2014.05.011; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Von Cosel R, 1999, VELIGER, V42, P218; Wang TW, 2014, MAR BIOL, V161, P2447, DOI 10.1007/s00227-014-2479-6; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Windoffer R, 1997, BIOL BULL-US, V193, P381, DOI 10.2307/1542940; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Zhang X, 2017, DEEP-SEA RES PT I, V123, P1, DOI 10.1016/j.dsr.2017.02.005	80	5	5	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208887	10.1371/journaI.pone.0208887	http://dx.doi.org/10.1371/journaI.pone.0208887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557379				2022-12-26	WOS:000453451000054
J	dos Santos, LM; Magalhaes, CG; Telmo, PD; Cerqueira, MP; Donassolo, RA; Leite, FPL; Elefant, GR; Avila, LFD; Scaini, CJ; Moreira, AN; Conceicao, FR				dos Santos, Lucas Moreira; Magalhaes, Carolina Georg; Telmo, Paula de Lima; Cerqueira, Michele Pepe; Donassolo, Rafael Amaral; Leivas Leite, Fabio Pereira; Elefant, Guita Rubinsky; da Costa Avila, Luciana Farias; Scaini, Carlos James; Moreira, Angela Nunes; Conceicao, Fabricio Rochedo			Sensitivity and specificity of recombinant proteins in Toxocara spp. for serodiagnosis in humans: Differences in adult and child populations	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANTIGENS; INFECTION; CANIS; ASSAY; LONG; VIVO	Toxocariasis is a neglected zoonosis that affects children and adults. Recombinant proteins have been widely investigated for diagnosis, achieving high sensitivity and specificity in an overall population; however, little is known about age as a factor in its application. This study aims to investigate the diagnostic potential of Toxocara canis TES-30 and TES-120 recombinant proteins in humans, differentiating between its performance in children and adults. Serum samples collected from children and adults seropositive to Toxocara spp. were tested with indirect ELISA using T. canis TES-30 and TES-120 recombinant proteins produced in Escherichia coll. While rTES-30 sensitivity was not affected by age (81.8% in children and 87% in adults), rTES-120 sensitivity severely decreased in children to only 63.6%, down from 95.7% in adults. Furthermore, the sensitivity of rTES-30 increased to 97.8% after Western blotting confirmation. High specificity (>94%) against other geohelminths was reported for both recombinant proteins. Our study favors the use of rTES-30 with total IgG as the primary antibody in an indirect ELISA assay as a tool for epidemiological human studies.	[dos Santos, Lucas Moreira; Magalhaes, Carolina Georg; Telmo, Paula de Lima; Cerqueira, Michele Pepe; Donassolo, Rafael Amaral; Leivas Leite, Fabio Pereira; Moreira, Angela Nunes; Conceicao, Fabricio Rochedo] Univ Fed Pelotas, Dept Biotecnol, Pelotas, RS, Brazil; [Elefant, Guita Rubinsky] Univ Sao Paulo, Dept Med Trop, Sao Paulo, SP, Brazil; [da Costa Avila, Luciana Farias; Scaini, Carlos James] Univ Fed Rio Grande, Fac Med, Rio Grande, RS, Brazil	Universidade Federal de Pelotas; Universidade de Sao Paulo; Universidade Federal do Rio Grande	dos Santos, LM (corresponding author), Univ Fed Pelotas, Dept Biotecnol, Pelotas, RS, Brazil.	lucass1@hotmail.com	Moreira, Ângela N/D-1278-2019; Avila, Luciana/F-9402-2013; Santos, Lucas/AAQ-6837-2021	Moreira, Ângela N/0000-0001-5347-8559; Santos, Lucas/0000-0002-2402-8580; Georg Magalhaes, Carolina/0000-0001-7099-060X	Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly funded by: Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), finance code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Adderson EE, 2001, SPRINGER SEMIN IMMUN, V23, P387, DOI 10.1007/s281-001-8166-x; Anderson JP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004168; Dantas-Torres F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-22; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; Gonzalez-Paez GE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418708; Espinoza YA, 2008, REV INST MED TROP SP, V50, P101, DOI 10.1590/S0036-46652008000200007; Farmer A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005818; Fong Mun-Yik, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P723; Guillamet LJV, 2017, AM J CASE REP, V18, P339, DOI 10.12659/AJCR.902626; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Klouwenberg PK, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/628963; Li L, 2014, ANN ALLERG ASTHMA IM, V113, P187, DOI 10.1016/j.anai.2014.05.016; Lopez MD, 2005, MEDICINA-BUENOS AIRE, V65, P226; Ma GX, 2018, LANCET INFECT DIS, V18, pE14, DOI 10.1016/S1473-3099(17)30331-6; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Maizels RM, 2013, VET PARASITOL, V193, P365, DOI 10.1016/j.vetpar.2012.12.032; Maraghi S, 2012, J HELMINTHOL, V86, P241, DOI 10.1017/S0022149X11000307; Mohamad S, 2009, J CLIN MICROBIOL, V47, P1712, DOI 10.1128/JCM.00001-09; Noormahomed EV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003121; Paula FM, 2011, PARASITOLOGY, V138, P1331, DOI 10.1017/S003118201100120X; Peixoto PL, 2011, MEM I OSWALDO CRUZ, V106, P200, DOI 10.1590/S0074-02762011000200014; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; Salvador S, 2010, J PEDIAT-BRAZIL, V86, P531, DOI [10.1590/S0021-75572010000600015, 10.2223/JPED.2037]; Moreiral GMSG, 2014, TRENDS PARASITOL, V30, P456, DOI 10.1016/j.pt.2014.07.003; Schurer JM, 2016, AM J TROP MED HYG, V95, P168, DOI 10.4269/ajtmh.15-0729; Scott JT, 2004, PARASITE IMMUNOL, V26, P29, DOI 10.1111/j.0141-9838.2004.00680.x; Souto FMS, 2019, BRIT J OPHTHALMOL, V103, P636, DOI 10.1136/bjophthalmol-2018-312313; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Nguyen T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1780-2; Walker D, 2000, TROP MED INT HEALTH, V5, P237, DOI 10.1046/j.1365-3156.2000.00546.x; Walker MD, 2005, SEMIN NEUROL, V25, P252, DOI 10.1055/s-2005-917662; Watthanakulpanich D, 2008, ACTA TROP, V106, P90, DOI 10.1016/j.actatropica.2008.01.008; Wisniewska-Ligier M, 2012, PARASITOL RES, V110, P2363, DOI 10.1007/s00436-011-2772-y; Yazdanbakhsh M, 2010, NAT REV IMMUNOL, V10, P80, DOI 10.1038/nri2673; Zahabiun F, 2015, AM J TROP MED HYG, V93, P319, DOI 10.4269/ajtmh.15-0190; Zibaei M., 2013, EPILEPSY RES TREATME, V2013, P156815; Zibaei M, 2016, J CLIN LAB ANAL, V30, P248, DOI 10.1002/jcla.21844	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208991	10.1371/journal.pone.0208991	http://dx.doi.org/10.1371/journal.pone.0208991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543696	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500059
J	Trotter, P; Belovol, E; McGlone, F; Varlamov, A				Trotter, Paula; Belovol, Elena; McGlone, Francis; Varlamov, Anton			Validation and psychometric properties of the Russian version of the Touch Experiences and Attitudes Questionnaire (TEAQ-37 Rus)	PLOS ONE			English	Article							UNMYELINATED TACTILE AFFERENTS; PLEASANT TOUCH; HAIRY SKIN; HUMAN HAND; REPRESENTATION; BRAIN	It has been demonstrated that nurturing and affiliative touch is essential for human emotional and physical well-being throughout our entire life. Within the last 30 years a system of low-threshold mechanosensitive C fibers innervating the hairy skin was discovered and described; this system is hypothesized to represent the neurobiological substrate for the affective and rewarding properties of touch. This discovery opens new perspectives for multidisciplinary research of the role of affiliative social touch in health and disease, and calls for establishing novel psychometric tools assessing individual differences in the domain of affective touch. The main objective of the study was to construct and validate a Russian version of the Touch Experiences and Attitudes Questionnaire (TEAQ), a self-report measure recently developed to quantify individual experience and attitude to social and affective touch. A pool of 117 items was translated into Russian and all the items were assessed for appropriateness for Russian culture (232 participants). After exploring the factor structure (468 participants), we composed a 37-item questionnaire (TEAQ-37 Rus) characterized by good reliability and a clear 5-factor structure, covering the aspects of attitude to intimate touch, attitude to friendly touch, attitude to self-care, current intimate touch experiences, and childhood touch experiences. Confirmatory factor analysis (551 participants) has demonstrated good consistency and reliability of the 5-factor structure of the TEAQ-37 Rus. Cross-validation research demonstrated moderate positive correlations between predisposition to social touch and emotional intelligence; positive correlations with extraversion and openness facets of the Big Five personality model were also found. As predicted, participants with higher TEAQ-37 Rus scores rated all observed kinds of touch as more pleasant, with a particular preference for slow touch. We anticipate that this questionnaire will be a valuable tool for researchers of social touch, touch perception abnormalities, and the importance of touch experiences for emotional and mental health.	[Trotter, Paula; McGlone, Francis] Liverpool John Moores Univ, Nat Sci & Psychol, Liverpool, Merseyside, England; [Belovol, Elena; Varlamov, Anton] Pushkin State Russian Language Inst, Ctr Cognit & Commun, Moscow, Russia; [Belovol, Elena] Moscow State Univ Educ, Dept Psychol, Moscow, Russia; [McGlone, Francis] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England; [Varlamov, Anton] RAS, Lab Psychophysiol, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia	Liverpool John Moores University; Pushkin State Russian Language Institute; University of Liverpool; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences	Varlamov, A (corresponding author), Pushkin State Russian Language Inst, Ctr Cognit & Commun, Moscow, Russia.; Varlamov, A (corresponding author), RAS, Lab Psychophysiol, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	antonvarlamov@gmail.com	McGlone, Francis Philip/AAA-5058-2022; Varlamov, Anton A/G-8261-2011	Varlamov, Anton A/0000-0001-5387-7058; Belovol, Elena/0000-0003-0285-159X	Russian Government [25.9502.2017]	Russian Government	The research was funded by Russian Government contract, project 25.9502.2017/, "A cross-cultural study of tactile communication: linguistic, social, and psycho-emotional aspects". The funder's website is: http://r3HaYkap. The funder provided complete financial support for the Russian team covering all the expenses related to construction and validation of the Russian version of the TEAQ.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; ANDERSEN PA, 1978, ENVIRON PSYCH NONVER, V3, P89, DOI 10.1007/BF01135607; Andreeva G, 2015, J HYPERTENS, V33, pE38, DOI 10.1097/01.hjh.0000467450.61235.85; [Авдеева Н.Н. Avdeeva N.N.], 2017, [Современная зарубежная психология, Journal of Modern Foreign Psychology, Sovremennaya zarubezhnaya psikhologiya], V6, P7, DOI 10.17759/jmfp.2017060201; Berne E., 1968, GAMES PEOPLE PLAY PS, V2768; Biryukov SD, 1997, WORKS RAS I PSYCHOL, V2, P23; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Bodunov M.V., 1989, BIG 5 5 FACTOR INVEN; Bolshakov VP, 2015, SCI MODERN SOC, P150; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Burkova V. N., 2010, ETNOGRFICHESKOE OBOZ, p[3, 77]; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cochrane N, 1990, Acta Psychiatr Scand Suppl, V357, P1; Craig A. D., 2008, HDB EMOTIONS, P272; Crandall Floyd M., 1897, ARCH PEDIATR, V14, P448; DEETHARDT JF, 1983, J NONVERBAL BEHAV, V8, P143; Duhn Lenora, 2010, Adv Neonatal Care, V10, P294, DOI 10.1097/ANC.0b013e3181fd2263; EATON M, 1986, J GERONTOL, V41, P611, DOI 10.1093/geronj/41.5.611; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Field T, 1999, ADOLESCENCE, V34, P753; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Gladney K., 1979, SIGN LANG STUD, V24, P231; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Guest S, 2011, ATTEN PERCEPT PSYCHO, V73, P531, DOI 10.3758/s13414-010-0037-y; Haarer J., 1934, DTSCH MUTTER IHR 1 K; Hall E.T., 1966, HIDDEN DIMENSION, V609; HARLOW HARRY F., 1958, PROC AMER PHIL SOC, V102, P501; Heinz Brisch Karl, 2009, BINDUNGSSTORUNGEN BI; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Hertenstein MJ, 2011, HANDBOOK OF TOUCH: NEUROSCIENCE, BEHAVIORAL, AND HEALTH PERSPECTIVES, P299; Jones SE, 1996, J NONVERBAL BEHAV, V20, P147, DOI 10.1007/BF02281953; Kandel ER, 2013, PRINCIPLES NEURAL SC, DOI [10.1126/science.1239052, DOI 10.1126/SCIENCE.1239052]; Knyazev GG, 2010, PSIKHOL ZH, V31, P100; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; LOMRANZ J, 1976, J SOC PSYCHOL, V99, P21, DOI 10.1080/00224545.1976.9924743; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lyusin D.V., 2009, OPROSNIK EMOCIONALNY, P264; Lyusin D.V., 2006, PSIKHOLOGICHESKAYA D, V4, P3; Martin TA, 2002, INT CUL PSY, P261; Masson HL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190921; MAZUR A, 1977, J SOC PSYCHOL, V101, P53, DOI 10.1080/00224545.1977.9923983; McCabe C, 2008, SOC COGN AFFECT NEUR, V3, P97, DOI 10.1093/scan/nsn005; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; McGlone F, 2012, EUR J NEUROSCI, V35, P1782, DOI 10.1111/j.1460-9568.2012.08092.x; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; MELLER RE, 1980, PHARMACOL BIOCHEM BE, V13, P663, DOI 10.1016/0091-3057(80)90010-6; Morrison I, 2011, BRAIN, V134, P1116, DOI 10.1093/brain/awr011; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Murgatroyd C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.140; Novikova IA, 2016, INT J ENV SCI ED, V11, P10863; [Новикова И.А. Novikova Irina A.], 2017, [Вестник Российского университета дружбы народов. Серия: Психология и педагогика, Vestnik Rossiiskogo universiteta druzhby narodov. Seriya: Psikhologiya i pedagogika], V14, P326, DOI 10.22363/2313-1683-2017-14-3-326-338; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; REMLAND MS, 1995, J SOC PSYCHOL, V135, P281, DOI 10.1080/00224545.1995.9713958; Sailer U, 2019, DEV COGN NEUROS-NETH, V35, P109, DOI 10.1016/j.dcn.2017.07.008; Scheele D, 2014, NEUROPSYCHOPHARMACOL, V39, P2078, DOI 10.1038/npp.2014.78; Sergeeva AS, 2016, EKSP PSIKHOLOGIYA, V9, P138, DOI [10.17759/exppsy.2016090311, 10.17759/ exppsy.2016090311]; Spitz RA, 1945, PSYCHOANAL STUD CHIL, V1, P53, DOI 10.1080/00797308.1945.11823126; Stevens J. P, 1992, APPL MULTIVARIATE ST; Suvilehto JT, 2015, P NATL ACAD SCI USA, V112, P13811, DOI 10.1073/pnas.1519231112; Tabachnick B. G., 2013, USING MULTIVARIATE S; Triscoli C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00208; Trotter P, 2011, THESIS; Trotter PD, 2018, J NONVERBAL BEHAV, V42, P379, DOI 10.1007/s10919-018-0281-8; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Vallbo AB, 2004, J APPL PHYSIOL, V96, P1262, DOI 10.1152/japplphysiol.00470.2003; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; Walker SC, 2017, BEHAV BRAIN RES, V320, P91, DOI 10.1016/j.bbr.2016.11.046; Watson J.B., 1928, PSYCHOL CARE INFANT; Wilhelm FH, 2001, BIOL PSYCHOL, V58, P181, DOI 10.1016/S0301-0511(01)00113-2	75	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0206905	10.1371/journal.pone.0206905	http://dx.doi.org/10.1371/journal.pone.0206905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543628	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000453247500005
J	Peshenko, IV; Yu, QH; Lim, S; Cudia, D; Dizhoor, AM; Ames, JB				Peshenko, Igor V.; Yu, Qinhong; Lim, Sunghyuk; Cudia, Diana; Dizhoor, Alexander M.; Ames, James B.			Retinal degeneration 3 (RD3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); nuclear magnetic resonance (NMR); retinal degeneration; phototransduction; photoreceptor	LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEINS; MYRISTOYLATED RECOVERIN; LIGHT-SCATTERING; NMR STRUCTURE; 1 RETGC1; BINDING; CALCIUM; LOCALIZATION; TRAFFICKING	Retinal degeneration 3 (RD3) protein promotes accumulation of retinal membrane guanylyl cyclase (RetGC) in the photoreceptor outer segment and suppresses RetGC activation by guanylyl cyclase-activating proteins (GCAPs). Mutations truncating RD3 cause severe congenital blindness by preventing the inhibitory binding of RD3 to the cyclase. The high propensity of RD3 to aggregate in solution has prevented structural analysis. Here, we produced a highly soluble variant of human RD3 (residues 18-160) that is monomeric and can still bind and negatively regulate RetGC. The NMR solution structure of RD3 revealed an elongated backbone structure (70 A long and 30 A wide) consisting of a four-helix bundle with a long unstructured loop between helices 1 and 2. The structure reveals that RD3 residues previously implicated in the RetGC binding map to a localized and contiguous area on the structure, involving a loop between helices 2 and 3 and adjacent parts of helices 3 and 4. The NMR structure of RD3 was validated by mutagenesis. Introducing Trp(85) or Phe(29) to replace Cys or Leu, respectively, disrupts packing in the hydrophobic core and lowers RD3's apparent affinity for RetGC1. Introducing a positive charge at the interface (Glu(32) to Lys) also lowered the affinity. Conversely, introducing Val in place of Cys(93) stabilized the hydrophobic core and increased the RD3 affinity for the cyclase. The NMR structure of RD3 presented here provides a structural basis for elucidating RD3-RetGC interactions relevant for normal vision or blindness.	[Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Yu, Qinhong; Lim, Sunghyuk; Cudia, Diana; Ames, James B.] Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.; Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu; jbames@ucdavis.edu	Yu, Qinhong/ABH-1965-2020	Ames, James/0000-0003-0934-2595; Dizhoor, Alexander/0000-0001-6770-9186; Yu, Qinhong/0000-0003-3855-5469	National Institutes of Health [EY11522, EY012347]; Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) and a Pennsylvania Department of Health CURE Formula grant (to A. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W., 2007, V45, P71; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2016, J BIOMOL NMR, V65, P51, DOI 10.1007/s10858-016-0036-y; Lim S, 2018, BIOMOL NMR ASSIGN, V12, P167, DOI 10.1007/s12104-018-9802-y; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Preising MN, 2012, INVEST OPHTH VIS SCI, V53, P3463, DOI 10.1167/iovs.12-9519; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharon D, 2018, PROG RETIN EYE RES, V63, P69, DOI 10.1016/j.preteyeres.2017.10.003; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	50	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2318	2328		10.1074/jbc.RA118.006106	http://dx.doi.org/10.1074/jbc.RA118.006106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559291	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000458895400010
J	Correa, EC; Roque, FD; Utz, RM; Correa, JD; de Souza, FL; Covich, AP				Correa, Elaine Cristina; Roque, Fabio de Oliveira; Utz, Ryan Michael; Correa, Jonas de Sousa; de Souza, Franco Leandro; Covich, Alan Paul			Effects of macroconsumers on benthic communities: Rapid increases in dry-season accrual of calcium in a tropical karst stream	PLOS ONE			English	Article							INVERTEBRATE ASSEMBLAGES; TEMPORAL VARIABILITY; DOMINANT DETRITIVORE; ATLANTIC FOREST; PERIPHYTON; SEDIMENT; CRAYFISH; DISTURBANCE; CREEK; FISH	Species loss from upper trophic levels can result in some major changes in community structure and ecosystem functions. Here, we experimentally excluded macroconsumers (e.g., fish and shrimp) in a Brazilian karst tropical stream during the dry season to investigate if their loss affected the accrual of calcium, dry mass (DM) and ash-free dry mass (AFDM) of sediment, benthic invertebrates, and chlorophyll-a. We found that the exclusion of macroconsumers decreased accrual of calcium. The absence of fish and shrimp may have promoted increased grazing by mayflies and snails in the electrified treatment as expressed by the depressed calcium accrual and shift in periphyton community composition. However, the exclusion of macroconsumers had no effect on DM and AFDM, chlorophyll-a, or total abundance of invertebrates. Our findings shed new light on the impact of macroconsumer loss and consequences for calcium accrual in karstic streams.	[Correa, Elaine Cristina; Roque, Fabio de Oliveira; de Souza, Franco Leandro] Univ Fed Mato Grosso do Sul, Inst Biociencias, Campo Grande, MS, Brazil; [Roque, Fabio de Oliveira] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Australia; [Roque, Fabio de Oliveira] James Cook Univ, Coll Sci & Engn, Cairns, Australia; [Utz, Ryan Michael] Chatham Univ, Falk Sch Sustainabil, Gibsonia, PA USA; [Correa, Jonas de Sousa] Univ Estadual Mato Grosso do Sul, Aquidauana, MS, Brazil; [Covich, Alan Paul] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Universidade Federal de Mato Grosso do Sul; James Cook University; James Cook University; Universidade Estadual de Mato Grosso do Sul; University System of Georgia; University of Georgia	Correa, EC (corresponding author), Univ Fed Mato Grosso do Sul, Inst Biociencias, Campo Grande, MS, Brazil.	elaineccorrea@yahoo.com.br	Utz, Ryan/AAG-9599-2019	Utz, Ryan/0000-0001-8036-2228; Souza, Franco Leandro/0000-0002-7041-4036	PELD Planalto da Bodoquena: redes de interacoes em longo prazo, through the CNPq/FUNDECT-MS [23/200.668/2013]	PELD Planalto da Bodoquena: redes de interacoes em longo prazo, through the CNPq/FUNDECT-MS	This research was funded by the PELD Planalto da Bodoquena: redes de interacoes em longo prazo, through the CNPq/FUNDECT-MS process 23/200.668/2013 (http://memoria.cnpq.br/sitios-peld). The financial supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson LK, 2015, ECOLOGY, V96, P1329, DOI 10.1890/13-2138.1; Allan JD, 2012, STREAM ECOLOGY, P191; APHA, 2012, 3120 APHA, V22nd; APHA AWWA WEF, 1998, STANDARD METHODS EXA, V20; BARNES I, 1965, GEOCHIM COSMOCHIM AC, V29, P85, DOI 10.1016/0016-7037(65)90119-5; Bessa E, 2011, NEOTROP ICHTHYOL, V9, P351, DOI 10.1590/S1679-62252011005000016; Boggiani PC, 2011, SETUR SBE, V4, P55; Britski HA., 2007, PEIXES PANTANAL MANU; Carter CD, 2007, HYDROBIOLOGIA, V575, P329, DOI 10.1007/s10750-006-0379-6; Carthew KD, 2003, SEDIMENT GEOL, V162, P199, DOI 10.1016/S0037-0738(03)00151-9; Casatti Lilian, 2010, Acta Limnologica Brasiliensia, V22, P50; Casatti Lilian, 1998, Ichthyological Exploration of Freshwaters, V9, P229; Christensen R. H. B, 2016, LMER TEST TESTS LINE; CNPq-Sitios-PELD, 2012, PROGR PESQ EC LONG D; Cordeiro LM, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-06032014011414; Corman JR, 2016, ECOL MONOGR, V86, P448, DOI 10.1002/ecm.1229; Correa EC, 2017, THESIS; Creed RP, 2010, OIKOS, V119, P1870, DOI 10.1111/j.1600-0706.2010.18432.x; Creed RP, 2004, J N AM BENTHOL SOC, V23, P224, DOI 10.1899/0887-3593(2004)023&lt;0224:EEBCIA&gt;2.0.CO;2; Cross WF, 2008, BIOTROPICA, V40, P477, DOI 10.1111/j.1744-7429.2007.00388.x; Melo Madson Silveira de, 2013, Nauplius, V21, P25; De Souza ML, 2005, FRESHWATER BIOL, V50, P592, DOI 10.1111/j.1365-2427.2005.01348.x; Dodds WK, 2002, J N AM BENTHOL SOC, V21, P2, DOI 10.2307/1468295; Dominguez E., 2009, MACROINVERTEBRADOS B; Drysdale RN, 1999, J SEDIMENT RES, V69, P145, DOI 10.2110/jsr.69.145; Drysdale RN, 1998, GEOGRAFIA FISICA D S, V4, P53; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; EPA U.S., 1996, 3050B EPA; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Flecker AS, 1996, ECOLOGY, V77, P1845, DOI 10.2307/2265788; FLECKER AS, 1994, FRESHWATER BIOL, V31, P131, DOI 10.1111/j.1365-2427.1994.tb00847.x; Graciolli G, 2003, STUD NEOTROP FAUNA E, V38, P95, DOI 10.1076/snfe.38.2.95.15932; Ho BSK, 2016, FRESHWATER BIOL, V61, P57, DOI 10.1111/fwb.12678; Humphreys W. F., 1995, Journal of the Royal Society of Western Australia, V78, P43; KRESIC N., 2013, WATER KARST MANAGEME; Landeiro VL, 2008, FUND APPL LIMNOL, V172, P49, DOI 10.1127/1863-9135/2008/0172-0049; Lourenco-Amorim C, 2014, FRESHWATER BIOL, V59, P2365, DOI 10.1111/fwb.12441; Marks JC, 2006, GEOMORPHOLOGY, V77, P299, DOI 10.1016/j.geomorph.2006.01.008; Martinez A, 2015, SCI TOTAL ENVIRON, V503, P251, DOI 10.1016/j.scitotenv.2014.06.018; Mathers KL, 2018, BIOL INVASIONS, V20, P567, DOI 10.1007/s10530-017-1557-3; McIntosh AR, 2002, FRESHWATER BIOL, V47, P1497, DOI 10.1046/j.1365-2427.2002.00889.x; McIntosh AR, 2004, ECOLOGY, V85, P2279, DOI 10.1890/03-0196; McIntosh AR, 1996, OECOLOGIA, V108, P174, DOI 10.1007/BF00333229; Moulton TP, 2012, MAR FRESHWATER RES, V63, P834, DOI 10.1071/MF12063; Moulton TP, 2010, MAR FRESHWATER RES, V61, P57, DOI 10.1071/MF08326; Moulton TP, 2004, J N AM BENTHOL SOC, V23, P868, DOI 10.1899/0887-3593(2004)023<0868:EOEASO>2.0.CO;2; MUGNAI R., 2010, MANUAL MACROINVERTEB; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NUSCH E. A., 1980, ARCH HYDROBIOL BEIH, V14, P14; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parkyn SM, 1997, NEW ZEAL J MAR FRESH, V31, P685, DOI 10.1080/00288330.1997.9516798; Peckarsky BL, 2008, OECOLOGIA, V156, P431, DOI 10.1007/s00442-008-1004-3; Pentecost A., 2005, TRAVERTINE; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Polegatto C. M., 2003, RES UPDATE EPHEMEROP, P55; Pringle CM, 1998, ECOLOGY, V79, P269, DOI 10.1890/0012-9658(1998)079[0269:TROOIA]2.0.CO;2; PRINGLE CM, 1993, OECOLOGIA, V93, P1, DOI 10.1007/BF00321183; PRINGLE CM, 1994, CAN J FISH AQUAT SCI, V51, P1443, DOI 10.1139/f94-144; R Core Team, 2021, R LANGUAGE ENV STAT; Rice SP, 2016, J GEOPHYS RES-EARTH, V121, P890, DOI 10.1002/2015JF003726; Roque FO, 2016, CONSERV BIOL, V30, P1131, DOI 10.1111/cobi.12713; Rosemond AD, 1998, FRESHWATER BIOL, V39, P515, DOI 10.1046/j.1365-2427.1998.00301.x; Ruff H, 2000, FRESHWATER BIOL, V43, P99, DOI 10.1046/j.1365-2427.2000.00527.x; Sabino J, 2005, AN ENC NAC IN CIENT, P321; Sallun Filho W, 2009, REV I GEO, V3, P47; SALLUN FILHO W, 2010, CARSTE, V22, P27; Sallun W, 2007, J MAPS, P282, DOI 10.4113/jom.2007.84; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneider J, 2014, LIMNOLOGICA, V45, P24, DOI 10.1016/j.limno.2013.10.002; Statzner B, 2012, GEOMORPHOLOGY, V157, P49, DOI 10.1016/j.geomorph.2011.03.022; Taylor MP, 2004, SEDIMENTOLOGY, V51, P1089, DOI 10.1111/j.1365-3091.2004.00661.x; Turley MD, 2017, SCI TOTAL ENVIRON, V601, P186, DOI 10.1016/j.scitotenv.2017.05.106; Utz RM, 2017, FRESHW SCI, V36, P151, DOI 10.1086/690599; Utz RM, 2013, FISHERIES, V38, P26, DOI 10.1080/03632415.2013.748551; Valente-Neto F, 2016, ECOL INDIC, V61, P952, DOI 10.1016/j.ecolind.2015.10.052; van Beynen P, 2005, ENVIRON MANAGE, V36, P101, DOI 10.1007/s00267-004-0265-9	76	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209102	10.1371/journal.pone.0209102	http://dx.doi.org/10.1371/journal.pone.0209102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576363	Green Published, gold, Green Accepted			2022-12-26	WOS:000454149400028
J	Koganemaru, S; Mikami, Y; Maezawa, H; Matsuhashi, M; Ikeda, S; Ikoma, K; Mima, T				Koganemaru, Satoko; Mikami, Yusuke; Maezawa, Hitoshi; Matsuhashi, Masao; Ikeda, Satoshi; Ikoma, Katsunori; Mima, Tatsuya			Anodal transcranial patterned stimulation of the motor cortex during gait can induce activity-dependent corticospinal plasticity to alter human gait	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; MAGNETIC STIMULATION; CORTICAL EXCITABILITY; BRAIN-STIMULATION; MUSCLE-ACTIVITY; ELECTRICAL-STIMULATION; HUMAN WALKING; OSCILLATORY NETWORK; WORKING-MEMORY; SILENT PERIOD	The corticospinal system and local spinal circuits control human bipedal locomotion. The primary motor cortex is phase-dependently activated during gait; this cortical input is critical for foot flexor activity during the swing phase. We investigated whether gait-combined rhythmic brain stimulation can induce neuroplasticity in the foot area of the motor cortex and alter gait parameters. Twenty-one healthy subjects participated in the single-blinded, cross-over study. Each subject received anodal transcranial patterned direct current stimulation over the foot area of the right motor cortex during gait, sham stimulation during gait, and anodal transcranial patterned direct current stimulation during rest in a random order. Six subjects were excluded due to a failure in the experimental recording procedure. Complete-case analysis was performed using the data from the remaining 15 subjects. Self-paced gait speed and left leg stride length were significantly increased after the stimulation during gait, but not after the sham stimulation during gait or the stimulation during rest. In addition, a significant increase was found in the excitability of the corticospinal pathway of the left tibialis anterior muscle 30 min after stimulation during gait. Anodal transcranial patterned direct current stimulation during gait entrained the gait cycle to enhance motor cortical activity in some subjects. These findings suggest that the stimulation during gait induced neuroplasticity in corticospinal pathways driving flexor muscles during gait.	[Koganemaru, Satoko; Ikeda, Satoshi; Ikoma, Katsunori] Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan; [Mikami, Yusuke; Matsuhashi, Masao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Maezawa, Hitoshi] Hokkaido Univ, Grad Sch Dent Med, Div Oral Funct Sci, Dept Oral Physiol, Sapporo, Hokkaido, Japan; [Mima, Tatsuya] Ritsumeikan Univ, Grad Sch Core Eth & Frontier Sci, Kyoto, Japan	Hokkaido University; Kyoto University; Hokkaido University; Ritsumeikan University	Koganemaru, S (corresponding author), Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan.	kogane@huhp.hokudai.ac.jp	Maezawa, Hitoshi/V-3469-2019	Maezawa, Hitoshi/0000-0003-2530-4804; Mima, Tatsuya/0000-0001-7787-4855	Japan Society for the Promotion of Science [17K0145307, 26870321, 15H03044, 15H05880, 15H05871]; Nakatomi Foundation; Japan Agency for Medical Research and Development (AMED) [27280201, 2736040]; Brain Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakatomi Foundation; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Brain Science Foundation	This study was partly supported by a Grant-in-Aid for Scientific Research (C) (grant number 17K0145307), a Grant-in-Aid for Young Scientists (B) (26870321) from the Japan Society for the Promotion of Science, a research grant (2015) from the Nakatomi Foundation (to S.K.), a Grant-in-Aid for Scientific Research (B) 15H03044 and Grants-in-Aid for Scientific Research on Innovative Areas (15H05880, 15H05871) from the Japan Society for the Promotion of Science, Grants 27280201 and 2736040 from the Japan Agency for Medical Research and Development (AMED), and a research grant (2015) from the Brain Science Foundation (to T.M.).	Antal A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3616807; Antal A, 2011, RESTOR NEUROL NEUROS, V29, P365, DOI 10.3233/RNN-2011-0609; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Arai N, 2007, CLIN NEUROPHYSIOL, V118, P2227, DOI 10.1016/j.clinph.2007.07.006; Au J, 2016, J COGNITIVE NEUROSCI, V28, P1419, DOI 10.1162/jocn_a_00979; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Brittain JS, 2013, CURR BIOL, V23, P436, DOI 10.1016/j.cub.2013.01.068; Capaday C, 1999, J NEUROPHYSIOL, V81, P129, DOI 10.1152/jn.1999.81.1.129; Capaday C, 2002, TRENDS NEUROSCI, V25, P370, DOI 10.1016/S0166-2236(02)02173-2; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Castro-Alamancos MA, 2007, J PHYSIOL-LONDON, V578, P173, DOI 10.1113/jphysiol.2006.119016; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Dunning K, 2015, AM J PHYS MED REHAB, V94, P649, DOI 10.1097/PHM.0000000000000308; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Groppa S, 2010, NEUROSCIENCE, V166, P1219, DOI 10.1016/j.neuroscience.2010.01.019; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Harvey RL, 2010, PM&R, V2, pS269, DOI 10.1016/j.pmrj.2010.09.012; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Huang YZ, 2017, CLIN NEUROPHYSIOL, V128, P2318, DOI 10.1016/j.clinph.2017.09.007; Hunter T, 2009, J PHYSIOL-LONDON, V587, P2949, DOI 10.1113/jphysiol.2009.169284; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; ISLAM N, 1995, BRAIN RES, V684, P206, DOI 10.1016/0006-8993(95)00434-R; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Koganemaru S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00154; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Lavoie BA, 1997, J NEUROPHYSIOL, V78, P429, DOI 10.1152/jn.1997.78.1.429; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; Mazzocchio R, 2008, BRAIN STIMUL, V1, P33, DOI 10.1016/j.brs.2007.08.007; Mills PM, 2001, HUM MOVEMENT SCI, V20, P427, DOI 10.1016/S0167-9457(01)00061-6; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; NILSSON J, 1985, ACTA PHYSIOL SCAND, V123, P457, DOI 10.1111/j.1748-1716.1985.tb07612.x; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Reis J, 2015, CEREB CORTEX, V25, P109, DOI 10.1093/cercor/bht208; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schubert M, 1997, EXP BRAIN RES, V115, P234, DOI 10.1007/PL00005693; Siebner HR, 2000, NEUROSCI LETT, V284, P147, DOI 10.1016/S0304-3940(00)00990-3; Stinear JW, 2005, J PHYSIOL-LONDON, V567, P701, DOI 10.1113/jphysiol.2005.090654; Sugimura K, 2013, DEVELOPMENT, V140, P4091, DOI 10.1242/dev.094060; Takakusaki K, 2013, MOVEMENT DISORD, V28, P1483, DOI 10.1002/mds.25669; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Thut G, 2017, CLIN NEUROPHYSIOL, V128, P843, DOI 10.1016/j.clinph.2017.01.003; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073; van Hedel HJA, 2006, GAIT POSTURE, V24, P35, DOI 10.1016/j.gaitpost.2005.06.015; Veniero D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00477; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Yang YR, 2013, NEUROREHAB NEURAL RE, V27, P79, DOI 10.1177/1545968312451915; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; Zar JH, 1999, BIOSTATISTICAL ANAL	83	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208691	10.1371/journal.pone.0208691	http://dx.doi.org/10.1371/journal.pone.0208691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576315	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400012
J	Li, JP; Dong, LJ; Tian, DN; Zhao, Y; Yang, HF; Zhi, XY; Zhu, LQ				Li, Jiangping; Dong, Lijun; Tian, Danian; Zhao, Yu; Yang, Huifang; Zhi, Xiaoyu; Zhu, Lingqin			Association between pesticide exposure intensity and self-rated health among greenhouse vegetable farmers in Ningxia, China	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CHRONIC DISEASES; RISK-FACTOR; MORTALITY; POPULATION; DEPRESSION; APPLICATORS; PREDICTOR; WORKERS; ADULTS	Background Self-rated health (SRH) has been shown to be a stronger comprehensive predictor of health status than the clinical record. Although an association between specific pesticide exposures and health conditions has been reported in different populations, data on the relationship between pesticides exposure intensity (PEI) and SRH in greenhouse farmers is scarce. The aim of the current study was to evaluate this association among vegetable greenhouse farmers in Yinchuan City, western China. Methods Three consecutive cross-sectional studies were conducted in the years 2015, 2016 and 2017. Face-to-face interviews by trained investigators, using questionnaires, were performed. PEI was calculated by a validated method and then categorized into high, middle and low groups. SRH was measured via a single ten-point scale question and then divided into excellent (score >5) and poor SRH (score <= 5). A multivariable logistic regression model was used to evaluate the association. Meanwhile, the dose-response and interaction effects were estimated. Results A steady association between high PEI and poor SRH (OR: 1.55, 95% CI: 1.05-2.28 in the full model) was identified. Although high PEI was significantly associated with poor SRH in males and the Han ethnicity group, no significant association was found with poor SRH in females or those of Hui ethnicity. Interaction effects of education level and frequency of breakfast with PEI were determined (P-interaction = 0.04 and 0.02, respectively); synergistic enhanced effects for poor SRH were observed. Conclusion These findings indicate that high PEI might be associated with poor SRH among vegetable greenhouse farmers. A lower education level and never eating breakfast contributed to an increased likelihood of poor SRH in those with high PEI. The local government should be making great efforts to promote healthy behaviors and improve protection awareness.	[Li, Jiangping; Zhao, Yu] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol & Hlth Stat, Yinchuan, Peoples R China; [Dong, Lijun; Yang, Huifang; Zhu, Lingqin] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Occupat & Environm Hlth, Yinchuan, Peoples R China; [Tian, Danian] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Hygien Chem, Yinchuan, Peoples R China; [Zhi, Xiaoyu] First People Hosp Yinchuan, Dept Infect Control, Yinchuan, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Yang, HF (corresponding author), Ningxia Med Univ, Sch Publ Hlth & Management, Dept Occupat & Environm Hlth, Yinchuan, Peoples R China.	yanghf@nxmu.edu.cn		Li, Jiangping/0000-0001-5183-3713	National Natural Science Foundation of China [81460490]; Important Research Topic of Health and Family Planning Commission of Ningxia [2017-NW-018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Research Topic of Health and Family Planning Commission of Ningxia	This study was supported by the National Natural Science Foundation of China (No. 81460490), and the Important Research Topic of Health and Family Planning Commission of Ningxia (No. 2017-NW-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard JD, 2013, ENVIRON RES, V126, P31, DOI 10.1016/j.envres.2013.06.001; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bing W, 2016, J NINGXIA MED U, V38, P670; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Chen JY, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0348-1; Chen S, 2016, ENVIRON POLLUT, V218, P1128, DOI 10.1016/j.envpol.2016.08.066; Dosemeci M, 2002, ANN OCCUP HYG, V46, P245, DOI 10.1093/annhyg/mef011; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; French S, 1999, MENTAL HLTH RELIG CU, V2, P117, DOI DOI 10.1080/13674679908406340; Gangemi S, 2016, MOL MED REP, V14, P4475, DOI 10.3892/mmr.2016.5817; Garcia-Garcia CR, 2016, LIFE SCI, V145, P274, DOI 10.1016/j.lfs.2015.10.013; Hagquist CEI, 1998, J ADOLESCENT HEALTH, V22, P250, DOI 10.1016/S1054-139X(97)00168-7; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jurges H, 2008, EUR J EPIDEMIOL, V23, P773, DOI 10.1007/s10654-008-9287-6; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Koh SB, 2017, NEUROTOXICOLOGY, V62, P181, DOI 10.1016/j.neuro.2017.07.005; KUMPUSALO E, 1992, MED CARE, V30, P392, DOI 10.1097/00005650-199205000-00002; Lebov JF, 2015, ENVIRON RES, V143, P198, DOI 10.1016/j.envres.2015.10.002; Lee KM, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0162-3; Lee MC, 2015, SOC SCI MED, V130, P1, DOI 10.1016/j.socscimed.2015.01.047; Lelkes O, 2006, J ECON BEHAV ORGAN, V59, P173, DOI 10.1016/j.jebo.2004.03.016; Ling XX, 2013, J NINGBO RADIO TV U, V11, P82; Malagoli C, 2016, INT J HYG ENVIR HEAL, V219, P742, DOI 10.1016/j.ijheh.2016.09.015; Meyer-Baron M, 2015, ENVIRON RES, V136, P234, DOI 10.1016/j.envres.2014.09.030; Molarius A, 2002, J CLIN EPIDEMIOL, V55, P364, DOI 10.1016/S0895-4356(01)00491-7; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Negatu B, 2018, OCCUP ENVIRON MED, V75, P283, DOI 10.1136/oemed-2017-104538; Negatu B, 2017, THORAX, V72, P522, DOI 10.1136/thoraxjnl-2016-208924; Negatu B, 2016, ANN OCCUP HYG, V60, P669, DOI 10.1093/annhyg/mew022; Negatu B, 2016, ANN OCCUP HYG, V60, P551, DOI 10.1093/annhyg/mew004; Ohrnberger J, 2017, J ECON AGEING, V9, P52, DOI 10.1016/j.jeoa.2016.07.002; Rafiq R, 2014, J CLIN ENDOCR METAB, V99, P3136, DOI 10.1210/jc.2013-4431; Sun Rifei, 2009, Horticulture Environment and Biotechnology, V50, P267; Tyrovolas S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37083; Van Maele-Fabry G, 2017, ENVIRON INT, V106, P69, DOI 10.1016/j.envint.2017.05.018; Yang AM, 2017, CHEMOSPHERE, V186, P314, DOI 10.1016/j.chemosphere.2017.08.002	39	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209566	10.1371/journal.pone.0209566	http://dx.doi.org/10.1371/journal.pone.0209566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576364	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400057
J	Camacho-Alpizar, A; Fuchs, EJ; Barrantes, G				Camacho-Alpizar, Andres; Fuchs, Eric J.; Barrantes, Gilbert			Effect of barriers and distance on song, genetic, and morphological divergence in the highland endemic Timberline Wren (Thryorchilus browni, Troglodytidae)	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; MULTIVARIATE-ANALYSIS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; F-STATISTICS; FEMALE SONG; COSTA-RICA; BIRD-SONG; DIFFERENTIATION; EVOLUTION	Populations may become isolated by distance, geographic barriers or both. Isolated populations often diverge in behavioral, morphological and genetic traits as a result of reduced inter-population gene flow. Highland species commonly present naturally fragmented distributions that confine populations to the highest mountain peaks, isolated by mountain passes and distance. The endemic Timberline Wren (Thryorchilus brown!) inhabits the highlands of the Talamanca mountain range, including western Panama, and the highest peak in the Central Volcanic mountain range of Costa Rica. Using microsatellites and song recordings we studied the effect of a geographic barrier and distance on song, genetic and morphological divergence among four populations in Costa Rica. A lowland mountain pass resulted in the largest genetic, vocal, and morphological (bill length) differences among populations, likely due to reduce the gene flow. Cultural drift and assortative mating by females selecting songs from their own population likely accentuates the effect of isolation and limited gene flow between populations. This pattern of population divergence has been found in other Neotropical highland birds, but over larger geographical scales. We conclude that mountain passes and distance both reduce gene flow between populations in recently-isolated highland species with restricted distributions.	[Camacho-Alpizar, Andres; Fuchs, Eric J.; Barrantes, Gilbert] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	Universidad Costa Rica	Fuchs, EJ (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	e.j.fuchs@gmail.com	Fuchs, Eric J./A-9963-2010	Fuchs, Eric J./0000-0002-6645-9602	Vicerrectoria de Investigacion, Universidad de Costa Rica	Vicerrectoria de Investigacion, Universidad de Costa Rica	The authors received partial funding from Vicerrectoria de Investigacion, Universidad de Costa Rica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; BAKER MC, 1985, BEHAV BRAIN SCI, V8, P85, DOI 10.1017/S0140525X00019750; BAKER MC, 1978, EVOLUTION, V32, P712, DOI 10.1111/j.1558-5646.1978.tb04624.x; Barrantes Gilbert, 2002, Ornitologia Neotropical, V13, P121; Barrantes Gilbert, 2009, Rev. biol. trop, V57, P333; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Brar RK, 2007, MOL ECOL NOTES, V7, P69, DOI 10.1111/j.1471-8286.2006.01530.x; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Cabe PR, 2001, MOL ECOL NOTES, V1, P155, DOI 10.1046/j.1471-8278.2001.00057.x; Carriker M. A., 1910, ANN CARNEGIE MUSEUM, V6, P314; Chavarria-Pizarro T, 2010, WILSON J ORNITHOL, V122, P279, DOI 10.1676/09-111.1; Core Team R, 2016, R LANG ENV STAT COMP; Danner JE, 2011, AM NAT, V178, P53, DOI 10.1086/660283; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; HOOGHIEMSTRA H, 1992, J QUATERNARY SCI, V7, P205, DOI 10.1002/jqs.3390070303; Islebe GA, 1997, QUATERNARY SCI REV, V16, P589, DOI 10.1016/S0277-3791(96)00051-0; ISLEBE GA, 1995, PALAEOGEOGR PALAEOCL, V117, P73, DOI 10.1016/0031-0182(95)00124-5; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kaufman L., 2009, FINDING GROUPS DATA; Koetz AH, 2007, ANIM BEHAV, V74, P1573, DOI 10.1016/j.anbehav.2007.03.022; Lynch Alejandro, 1996, P181; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; Maldonado-Sanchez D, 2016, MOL PHYLOGENET EVOL, V99, P76, DOI 10.1016/j.ympev.2016.03.014; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Oksanen A. J., 2018, PACKAGE VEGAN VERSIO; Oliveira C.C., 2013, SPECIATION NATURAL P, P137; OLOGHLEN AL, 1995, BEHAV ECOL SOCIOBIOL, V36, P251, DOI 10.1007/s002650050147; Ortiz-Ramirez MF, 2016, MOL PHYLOGENET EVOL, V94, P74, DOI 10.1016/j.ympev.2015.08.017; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-Eman JL, 2005, MOL PHYLOGENET EVOL, V37, P511, DOI 10.1016/j.ympev.2005.04.013; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Sosa-Lopez JR, 2013, J AVIAN BIOL, V44, P27, DOI 10.1111/j.1600-048X.2012.05651.x; Sosa-Lopez JR, 2013, WILSON J ORNITHOL, V125, P24, DOI 10.1676/12-051.1; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rousset F, 1997, GENETICS, V145, P1219; Sandoval L, 2016, J ORNITHOL, V157, P1, DOI 10.1007/s10336-015-1237-y; Sandoval L, 2014, ORNITOL NEOTROP, V25, P219; SCHLUTER D, 1986, EVOLUTION, V40, P221, DOI 10.1111/j.1558-5646.1986.tb00465.x; Searcy WA, 1997, CONDOR, V99, P651, DOI 10.2307/1370477; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; STILES FG, 1983, AUK, V100, P311, DOI 10.1093/auk/100.2.311; Stiles FG, 1998, GUIDE BIRDS COSTA RI; Valderrama E, 2014, J BIOGEOGR, V41, P1533, DOI 10.1111/jbi.12317; Vargas-Castro LE, 2012, WILSON J ORNITHOL, V124, P446, DOI 10.1676/11-044.1; Venables WN., 2002, MODERN APPL STAT S 4; Weir JT, 2009, ANN MO BOT GARD, V96, P410, DOI 10.3417/2008011; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114	61	3	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209508	10.1371/journal.pone.0209508	http://dx.doi.org/10.1371/journal.pone.0209508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571751	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700084
J	Omoto, ACM; Gava, FN; Silva, CAA; Silva, HB; Parente, JM; Costa, RM; Castro, MM; Tostes, RD; Salgado, HC; Fazan, R				Mieko Omoto, Ana Carolina; Gava, Fabio Nelson; Aguiar Silva, Carlos Alberto; Silva, Hadder Batista; Parente, Juliana Montenegro; Costa, Rafael Menezes; Castro, Michele Mazzaron; Tostes, Rita de Cassia; Salgado, Helio Cesar; Fazan Jr, Rubens			Lack of scarring is not always a sign of cardiac health: Functional and molecular characterization of the rat heart's following chronic reperfusion	PLOS ONE			English	Article							FACTOR-KAPPA-B; ISCHEMIA-REPERFUSION; MATRIX METALLOPROTEINASE-2; MYOCARDIAL ISCHEMIA/REPERFUSION; OXIDATIVE STRESS; INJURY; ACTIVATION; DEGRADATION; INFARCTION; DISEASE	Even though the coronary reperfusion process is the most important tool to preserve cardiac function, after myocardial infarction, reperfusion of acutely ischemic myocardium can induce injury. We aimed to evaluate the functional and molecular aspects 4 weeks after myocardial ischemia-reperfusion (IR) in rats. Male Wistar rats (N = 47) were subjected to myocardial IR by short-term (30 min) ligation and subsequent reperfusion of the left descending coronary artery. Control rats (N = 7) underwent the same surgical maneuver without coronary ligation. After 4 weeks, rats had their cardiac function examined by ventricular pressure recording under basal condition or pharmacological stress. Myocardial fibrosis and molecular mediators of IR injury (reactive oxygen species, tumor necrosis factor-alpha and matrix-metalloproteinase-2) were assessed as well. Most of the rats subjected to IR did not show macroscopic signs of infarct, while only 17% of these animals showed large myocardial infarction scars. Of note, all animals submitted to IR presented the functional and molecular parameters altered when compared with the control subjects. Cardiac function was attenuated in all animals submitted to IR, regardless the presence or size of macroscopic cardiac scars. Interstitial fibrosis, matrix-metalloproteinase-2 activity and the expression of tumor necrosis factor-alpha were higher in the myocardium of all IR rats as compared to the control subjects (p<0.05). Myocardium superoxide anion and hydrogen peroxide were increased in rats without or with mild cardiac scars. These results show that IR leads to myocardial injury in rats. Besides, even the animals with an apparent healthy myocardium (without infarct scar) presented cardiac dysfunction and molecular changes that may contribute to the development of heart failure over time.	[Mieko Omoto, Ana Carolina; Gava, Fabio Nelson; Aguiar Silva, Carlos Alberto; Silva, Hadder Batista; Salgado, Helio Cesar; Fazan Jr, Rubens] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, SP, Brazil; [Parente, Juliana Montenegro; Costa, Rafael Menezes; Castro, Michele Mazzaron; Tostes, Rita de Cassia] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Fazan, R (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, SP, Brazil.	rfazan@usp.br	Costa, Rafael M/K-4606-2017; Parente, Juliana/ABE-1064-2020; Mazzaron de Castro, Michele/C-7412-2013; Junior, Rubens Fazan/V-3114-2019; Silva, Hadder/AAN-1303-2021	Costa, Rafael M/0000-0002-5174-5710; Mazzaron de Castro, Michele/0000-0002-3424-6573; Junior, Rubens Fazan/0000-0002-6200-6008; Omoto, Ana Carolina Mieko/0000-0003-1062-7109; Montenegro Parente, Juliana/0000-0001-9802-6302	Sao Paulo Research Foundation [2013/20549-7]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided by Sao Paulo Research Foundation, grant number: 2013/20549-7, to HCS and RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chandrasekar B, 2001, CIRCULATION, V103, P2296; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; CHRISTIAN TF, 1992, CIRCULATION, V86, P81, DOI 10.1161/01.CIR.86.1.81; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670; Fernandez-Patron C, 1999, CIRC RES, V85, P906; Frank A, 2012, SEMIN CARDIOTHORAC V, V16, P123, DOI 10.1177/1089253211436350; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; McDonough JL, 1999, CIRC RES, V84, P9; Neri M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7018393; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; Sawicki G, 1997, NATURE, V386, P616, DOI 10.1038/386616a0; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	29	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209190	10.1371/journal.pone.0209190	http://dx.doi.org/10.1371/journal.pone.0209190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571725	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700041
J	Weirich, M; Simpson, AP				Weirich, Melanie; Simpson, Adrian P.			Gender identity is indexed and perceived in speech	PLOS ONE			English	Article							MENS SEXUAL ORIENTATION; CHILDRENS SPEECH; GAY; ATTRACTIVENESS; TESTOSTERONE; MASCULINITY; STEREOTYPES; PERCEPTION; FEMININITY; FREQUENCY	This study investigates a possible relationship between perceived and self-ascribed gender identity and the respective acoustic correlates in a group of young heterosexual adult speakers. For the production study, a sample of 37 German speaking subjects (20 males, 17 females) filled out a questionnaire to assess their self-ascribed masculinity/femininity on two scales. A range of acoustic parameters (acoustic vowel space size, fundamental frequency, sibilant spectral characteristics) were measured in speech collected from a picture describing task. Results show that male speakers judging themselves to be less masculine exhibited larger vowel spaces and higher average fundamental frequency.For the perception experiment, a group of 21 listeners (11 males, 10 females) judged masculinity of single word male stimuli drawn from the collected speech sample. A significant correlation between speakers' self-ascribed and listeners' attributed gender identity was found with a stronger relationship for female listeners. Acoustic parameters used by listeners to attribute gender identity include those used by speakers to index masculinity/femininity.The investigation demonstrates the importance of including self-ascribed gender identity as a potential source of inter-speaker variation in speech production and perception even in a sample of heterosexual adult speakers.	[Weirich, Melanie; Simpson, Adrian P.] Friedrich Schiller Univ, Inst German Linguist, Jena, Germany	Friedrich Schiller University of Jena	Weirich, M (corresponding author), Friedrich Schiller Univ, Inst German Linguist, Jena, Germany.	melanie.weirich@uni-jena.de		Weirich, Melanie/0000-0002-2282-1104	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [WE 5757]; Thuringer Universitats-und Landesbibliothek Jena (ThULB)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Thuringer Universitats-und Landesbibliothek Jena (ThULB)	MW was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG grant WE 5757, http://www.dfg.de/). MW was supported by Thuringer Universitats-und Landesbibliothek Jena (ThULB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, J ACOUST SOC AM, V85, P1699, DOI [10.1121/1.397959, DOI 10.1121/1.397959]; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Arvaniti A, 2009, PHONOLOGY, V26, P43, DOI 10.1017/S0952675709001717; Avery JD, 1996, J ACOUST SOC AM, V99, P3738, DOI 10.1121/1.414970; Bandura A., 1977, SOCIAL LEARNING THEO, DOI [10.1177/105960117700200317, DOI 10.1177/105960117700200317]; Barton B, 2015, J HOMOSEXUAL, V62, P1615, DOI 10.1080/00918369.2015.1091207; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosson JK, 2013, J PERS SOC PSYCHOL, V105, P425, DOI 10.1037/a0033126; Bukmaier V, 2016, J INT PHON ASSOC, V46, P311, DOI 10.1017/S0025100316000062; Campbell-Kibler K, 2011, AM SPEECH, V86, P52, DOI 10.1215/00031283-1277510; Caroline H., 1995, P 13 INT C PHON SCI, P420; Cartei V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081022; Chambers Jack K., 2003, SOCIOLINGUISTIC THEO, V2nd; CONSTANTINOPLE A, 1973, PSYCHOL BULL, V80, P389, DOI 10.1037/h0035334; Falomir-Pichastor JM, 2009, PERS SOC PSYCHOL B, V35, P1233, DOI 10.1177/0146167209338072; Fant G., 1966, SPEECH TRANSMISSION, V7, P22; Fasoli F, 2018, PERS INDIV DIFFER, V130, P59, DOI 10.1016/j.paid.2018.03.046; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Foulkes P, 2005, LANGUAGE, V81, P177, DOI 10.1353/lan.2005.0018; Gusik KM, 2007, ADV SPEECH LANGUAGE, V9, P109; Guzik K.M., 2004, ARBEITSBERICHTE INST, V36, P15; Haan Judith., 2002, SPEAKING QUESTIONS E; Harrington J, 2006, J PHONETICS, V34, P439, DOI 10.1016/j.wocn.2005.08.001; Heffernan K, 2010, AM SPEECH, V85, P67, DOI 10.1215/00031283-2010-003; HENTON CG, 1989, LANG COMMUN, V9, P299, DOI 10.1016/0271-5309(89)90026-8; Jannedy S, 2017, J ACOUST SOC AM, V142, P395, DOI 10.1121/1.4991347; Kachel S, 2018, J SPEECH LANG HEAR R, V61, P1560, DOI 10.1044/2018_JSLHR-S-17-0125; Kachel S, 2017, J ACOUST SOC AM, V141, P4793, DOI 10.1121/1.4988684; Kachel S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00956; Kohler K.J., 2004, TRADITIONAL PHONOLOG, P205; Labov W, 2006, SOCIAL STRATIFICATIO; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Levon E, 2014, LANG SOC, V43, P539, DOI 10.1017/S0047404514000554; Li FF, 2016, J PHONETICS, V57, P59, DOI 10.1016/j.wocn.2016.05.004; Linville SE, 1998, FOLIA PHONIATR LOGO, V50, P35, DOI 10.1159/000021447; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Mack S, 2012, J PHONETICS, V40, P198, DOI 10.1016/j.wocn.2011.10.002; Mann S. L., 2012, J LANGUAGE SEXUALITY, V1, P206, DOI DOI 10.1075/JLS.1.2; Munson B, 2006, J ACOUST SOC AM, V119, P2427, DOI 10.1121/1.2173521; Munson B, 2007, LANG SPEECH, V50, P125, DOI 10.1177/00238309070500010601; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Munson B, 2015, J ACOUST SOC AM, V137, P1995, DOI 10.1121/1.4916202; Munson B, 2007, LANG LINGUIST COMPAS, V1, DOI 10.1111/j.1749-818x.2007.00028.x; National Geographic, 2017, GEND REV; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Niebuhr O, 2015, P 41 C GERM AC SOC N, P1; Nordstru┬m, 1977, J PHONETICS, V5, P81, DOI [DOI 10.1016/S0095-4470(19)31115-5, https://doi.org/10.1016/S0095-4470(19)31115-5]; Perry TL, 2001, J ACOUST SOC AM, V109, P2988, DOI 10.1121/1.1370525; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; R Core Team, R LANG ENV STAT COMP; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2011, PSYCHOL SCI, V22, P881, DOI 10.1177/0956797611412394; RUNGE TE, 1981, J CROSS CULT PSYCHOL, V12, P142, DOI 10.1177/0022022181122002; Simpson AP, 2009, LANG LINGUIST COMPAS, V3, P621, DOI 10.1111/j.1749-818x.2009.00125.x; SODERSTEN M, 1990, J SPEECH HEAR RES, V33, P601, DOI 10.1044/jshr.3303.601; Spence JT, 1978, MASCULINITY FEMININI, DOI [10.1177/036168438000400105, DOI 10.1177/036168438000400105]; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Sulpizio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128882; TERANGO L, 1966, J SPEECH HEAR RES, V9, P590, DOI 10.1044/jshr.0904.590; Valentova JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082417; Van Anders SM, 2006, HUM NATURE-INT BIOS, V17, P212, DOI 10.1007/s12110-006-1018-7; van Anders SM, 2015, P NATL ACAD SCI USA, V112, P13805, DOI 10.1073/pnas.1509591112; van Anders SM, 2015, ARCH SEX BEHAV, V44, P1177, DOI 10.1007/s10508-015-0490-8; van Anders SM, 2012, HORM BEHAV, V61, P31, DOI 10.1016/j.yhbeh.2011.09.012; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; Watson CI, 1999, J ACOUST SOC AM, V106, P458, DOI 10.1121/1.427069; Weirich M, 2016, P 12 M PHON PHON DEU, P224; Weirich M, 2015, P 18 INT C PHON SCI, P1; Weirich M, 2017, ACOUSTIC CORRELATES, P924, DOI [10.21437/interspeech.2017-1394, DOI 10.21437/INTERSPEECH.2017-1394]; Weirich M, 2016, J SPEECH LANG HEAR R, V59, pS1587, DOI 10.1044/2016_JSLHR-S-15-0040; Weirich M, 2014, J PHONETICS, V43, P1, DOI 10.1016/j.wocn.2014.01.001; Zimman L, 2012, THESIS; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630	76	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209226	10.1371/journal.pone.0209226	http://dx.doi.org/10.1371/journal.pone.0209226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571706	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700045
J	Sawall, Y; Hochberg, EJ				Sawall, Yvonne; Hochberg, Eric J.			Diel versus time-integrated (daily) photosynthesis and irradiance relationships of coral reef organisms and communities	PLOS ONE			English	Article							FUNCTIONAL CONVERGENCE; STYLOPHORA-PISTILLATA; NUTRIENT ENRICHMENT; HERMATYPIC CORAL; ENERGY BUDGETS; LIGHT; PRODUCTIVITY; OCEAN; CALCIFICATION; EFFICIENCY	The most important source of energy to tropical shallow water coral reefs is light, the transformation of which ultimately limits reef biomass and growth. Therefore, measurements of productivity (primary production, P) for benthic reef organisms and communities are critical to understand reef functioning. Short-term (minutes to hours) P measurements of reef photosynthesizers virtually always produce the classic hyperbolic tangent (or similar) P-E (irradiance) relationship, with P rapidly rising to a saturation point as E increases. Longer- term (days to weeks), larger-scale investigations of natural reef communities typically do not explore P-E relationships, but the few that do show no saturation of time-integrated P with high time-integrated E. In this paper we present a modeling study to reconcile this apparent contradiction. We used 52 published short-term (instantaneous) P-E curves of organisms (corals, algae) and communities (corals, mixed corals and algae) from different reefs in the Indo-Pacific and the Caribbean, each coupled with 928 diel light curves comprising a wide range of cloud cover scenarios. The diel light curves provided instantaneous E at 1-minute intervals, from which we calculated corresponding instantaneous P using the different published P-E relationships. We integrated both variables to calculate time-integrated E and P. Time-integrated E varied up to 18-fold due to changes in cloud cover and season. We found that, despite routine saturation of instantaneous P, day-scale P-E relationships were near linear in all cases, with slightly decreased linearity in cases where instantaneous light saturation occurred very early during the day. This indicates that the Functional Convergence Hypothesis (FCH) developed by terrestrial ecologists may also apply for reef photosynthesizers. The FCH states that despite short-term light saturation, plants on average do not absorb more light than they can use, since resource allocations are strictly coordinated and tailored towards an optimal use. Thus, there is no contradiction: At the growth time scale (>= day), P should be expected to be a near linear function of E. One implication is that reef P can be estimated using rapid optical measurements, as opposed to traditional, laborious respirometry methods. The requirement going forward is to derive appropriate values for light-use efficiency, which is the rate at which the plant or community converts absorbed light into fixed carbon.	[Sawall, Yvonne; Hochberg, Eric J.] Bermuda Inst Ocean Sci, Coral Reef Ecol & Opt Lab, St Georges, Bermuda	Bermuda Institute of Ocean Sciences	Sawall, Y (corresponding author), Bermuda Inst Ocean Sci, Coral Reef Ecol & Opt Lab, St Georges, Bermuda.	yvonne.sawall@bios.edu		Hochberg, Eric/0000-0001-5400-9252	National Aeronautics and Space Administration (NASA) Jet Propulsion Laboratory (JPL) [NNX16AB05G]	National Aeronautics and Space Administration (NASA) Jet Propulsion Laboratory (JPL)(National Aeronautics & Space Administration (NASA))	This work was funded by National Aeronautics and Space Administration (NASA) Jet Propulsion Laboratory (JPL) Grant NNX16AB05G to EJH, https://coral.jpl.nasa.gov.	ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; BARNES DJ, 1993, J EXP MAR BIOL ECOL, V174, P1, DOI 10.1016/0022-0981(93)90248-M; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Boucher G, 1998, J EXP MAR BIOL ECOL, V225, P269, DOI 10.1016/S0022-0981(97)00227-X; CHALKER BE, 1981, MAR BIOL, V63, P135, DOI 10.1007/BF00406821; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Dubinsky Z., 1994, Pacific Science, V48, P313; Dubinsky Z, 2009, AQUAT MICROB ECOL, V56, P163, DOI 10.3354/ame01345; DUSTAN P, 1982, MAR BIOL, V68, P253, DOI 10.1007/BF00409592; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Fensholt R, 2006, REMOTE SENS ENVIRON, V105, P173, DOI 10.1016/j.rse.2006.06.011; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Field CB, 1991, RESPONSE PLANTS MULT, P422, DOI DOI 10.1016/B978-0-08-092483-0.50007-4; Goetz SJ, 1999, ADV ECOL RES, V28, P57, DOI 10.1016/S0065-2504(08)60029-X; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; GRIGG RW, 1984, CORAL REEFS, V3, P23, DOI 10.1007/BF00306137; Haxeltine A, 1996, FUNCT ECOL, V10, P551, DOI 10.2307/2390165; Heikoop JM, 1998, LIMNOL OCEANOGR, V43, P909, DOI 10.4319/lo.1998.43.5.0909; Hochberg EJ, 2008, CORAL REEFS, V27, P49, DOI 10.1007/s00338-007-0289-8; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Jantzen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081834; Kinsey D.W., 1978, Monographs on Oceanographic Methodology, P439; Kirk J. T. O., 2010, LIGHT PHOTOSYNTHESIS, Vthird; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Marsh J.A. Jr, 1978, Monographs on Oceanographic Methodology, P361; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; McGillis WR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046179; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; MOREL A, 1978, DEEP-SEA RES, V25, P673, DOI 10.1016/0146-6291(78)90623-9; Muller-Parker G, 2001, INVERTEBR BIOL, V120, P104, DOI 10.1111/j.1744-7410.2001.tb00115.x; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; PLATT T, 1986, DEEP-SEA RES, V33, P149, DOI 10.1016/0198-0149(86)90115-9; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Ralph PJ, 1999, MAR ECOL PROG SER, V180, P139, DOI 10.3354/meps180139; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Takeshita Y, 2016, J GEOPHYS RES-OCEANS, V121, P5655, DOI 10.1002/2016JC011886; Teichberg M, 2013, AQUAT BOT, V104, P25, DOI 10.1016/j.aquabot.2012.09.010; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5	58	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208607	10.1371/journal.pone.0208607	http://dx.doi.org/10.1371/journal.pone.0208607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557343	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000033
J	Wang, SY; Yu, M; Wei, JQ; Huang, M; Shi, XF; Chen, H				Wang, Shuyan; Yu, Miao; Wei, Jiaqiang; Huang, Mu; Shi, Xuefa; Chen, Hao			Microbial community composition and diversity in the Indian Ocean deep sea REY-rich muds	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; PACIFIC; SEQUENCES; ARCHAEA	Studies about the composition and diversity of microbial community in the Rare Earth Elements-rich muds are limited. In this research, we conducted a characterization for the composition and diversity of bacterial and archaeal communities from rare earth elements-rich gravity core sediment at approximately 4800 meters deep in the Indian Ocean by Illumina high-throughput sequencing targeting 16S rRNA genes. The results showed that the most abundant bacteria were Proteobacteria, followed by Firmicutes and Actinobacteria. Amongst Proteobacteria, Gammaproteobacteria are present in all sections of this sediment core accounted for a particularly large proportion of bacterial sequences. Candidatus Nitro-sopumilus, with a higher relative abundance in our samples, belongs to Thaumarchaeota. This is the first report on the composition and diversity of rare earth elements-rich muds microbial communities in the Indian Ocean deep sea.	[Wang, Shuyan; Wei, Jiaqiang; Chen, Hao] SOA, Key Lab Marine Bioact Subst, Inst Oceanog 1, Qingdao, Peoples R China; [Wang, Shuyan; Wei, Jiaqiang; Chen, Hao] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Wang, Shuyan; Wei, Jiaqiang; Chen, Hao] Qingdao Key Lab Marine Nat Prod R&D, Qingdao, Peoples R China; [Yu, Miao; Huang, Mu; Shi, Xuefa] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Geol, Qingdao, Peoples R China	State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology	Chen, H (corresponding author), SOA, Key Lab Marine Bioact Subst, Inst Oceanog 1, Qingdao, Peoples R China.; Chen, H (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Chen, H (corresponding author), Qingdao Key Lab Marine Nat Prod R&D, Qingdao, Peoples R China.	hchen@fio.org.cn	Chen, Hao/AAU-5365-2020; shi, xuefa/AAC-6977-2022		National Basic Research Program of China [2015CB755906]; NSFC-Shandong Joint Fund for Marine Science Research Centers [U1606401]; National Natural Science Foundation of China; Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology [2016ASKJ14]	National Basic Research Program of China(National Basic Research Program of China); NSFC-Shandong Joint Fund for Marine Science Research Centers; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology	This work was supported by the National Basic Research Program of China (2015CB755906, Hao Chen), NSFC-Shandong Joint Fund for Marine Science Research Centers (U1606401, Xuefa Shi), National Natural Science Foundation of China, http://www.nsfc.gov.cn/, and The Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology Grant number No. 2016ASKJ14 awarded to Hao Chen.	Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; BRYNE TNJ, 2009, GEOCHIM COSMOCHIM AC, V73, P11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CATHERINE L, 2011, ISME JOURNAL, V5, P2; CHRISTIAN LL, 2013, THE ISME JOURNAL, V7, P8; CHRISTIAN Q, 2013, NUCLEIC ACIDS RES, V41, pD590; CHRISTOPHER AF, 2005, P NATL ACAD SCI USA, V102, P41; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EMIL SR, 2013, PLOS ONE, V8, P9; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; FRYDENLUND MC, 2014, POLAR BIOL, V37, P61; Gao JJ, 2017, ACTA OCEANOL SIN, V36, P109, DOI 10.1007/s13131-017-0991-5; Gao JJ, 2017, GEOCHEM J, V36, P109; GOSPACING D, 2007, J BASIC MICROB, V47, P6; HATJE V, 2016, ENVIRON TECHNOL, V50, P8; HATJE V, ENVIRON TECHNOL; HATJE V, 2015, ENVIRON TECHNOL, V81, P1715; Hugoni M, 2015, ENV MICROBIOL REP, V7, P321, DOI 10.1111/1758-2229.12251; Huo Y, 2015, J ASIAN EARTH SCI, V34, P92; Huo YY, 2015, ACTA OCEANOL SIN, V34, P92, DOI 10.1007/s13131-015-0650-7; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Jiao S, 2016, SOIL BIOL BIOCHEM, V98, P64, DOI 10.1016/j.soilbio.2016.04.005; Kato Y, 2011, NAT GEOSCI, V4, P535, DOI [10.1038/NGEO1185, 10.1038/ngeo1185]; Kazutaka Y, 2015, ENVIRON TECHNOL, V49, P621; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Merroun ML, 2003, CHEMOSPHERE, V52, P113, DOI 10.1016/S0045-6535(03)00220-0; PARASKEVI NP, 2005, MICROB ECOL, V50, P3; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; ROBERT CE, 2011, BIOINFORMATICS, V27, P2194; S B, SEA; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Takahashi Y, 2007, CHEM GEOL, V244, P569, DOI 10.1016/j.chemgeo.2007.07.005; Takahashi Y, 2010, GEOCHIM COSMOCHIM AC, V74, P5443, DOI 10.1016/j.gca.2010.07.001; TAKUO O, 2002, J NUCL SCI TECHNOL S, V39, P950; Tsuruta T, 2006, COLLOID SURFACE B, V52, P117, DOI 10.1016/j.colsurfb.2006.04.014; Wang CS, 2010, J MICROBIOL, V48, P573, DOI 10.1007/s12275-010-0151-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu JY, 2013, MAR DRUGS, V11, P3777, DOI 10.3390/md11103777; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Xu SQ, 2017, WETLANDS, V37, P99, DOI 10.1007/s13157-016-0843-7; Xu XK, 2005, SCI TOTAL ENVIRON, V293, P97; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; YOSHINORI S, 2005, J NUCL RADIOCHEM SCI, V6, P91; ZHANG T, DIVERSITY AND DISTRI; ENVIRON TECHNOL, P4159	48	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208230	10.1371/journal.pone.0208230	http://dx.doi.org/10.1371/journal.pone.0208230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557300	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000025
J	Ni, N; Gao, Y; Fang, X; Melgar, M; Vincent, DF; Lydon, JP; Bartholin, L; Li, QL				Ni, Nan; Gao, Yang; Fang, Xin; Melgar, Maria; Vincent, David F.; Lydon, John P.; Bartholin, Laurent; Li, Qinglei			Glandular defects in the mouse uterus with sustained activation of TGF-beta signaling is associated with altered differentiation of endometrial stromal cells and formation of stromal compartment	PLOS ONE			English	Article							GROWTH-FACTOR; GENE-EXPRESSION; IMMUNOCYTOCHEMICAL ANALYSIS; MYOMETRIAL DEVELOPMENT; UTERINE FUNCTION; MICE; FOXA2; FOXL2; PCR; DYSREGULATION	Uterine gland development, also known as adenogenesis, is a key uterine morphogenic process indispensable for normal uterine function and fertility. Our earlier studies have reported that overactivation of TGFB receptor 1 (TGFBR1) in the mouse uterus using progesterone receptor (Pgr)-Cre recombinase causes female infertility, defective decidualization, and reduced uterine gland formation, a developmental milestone of postnatal uterus. To understand mechanisms that underpin the disrupted uterine gland formation in mice with sustained activation of TGFBR1, we raised the question of whether early postnatal adenogenesis was compromised in these mice. Experiments were designed using mice with constitutive activation of TGFBR1 driven by Pgr-Cre to determine the timing of adenogenic defects and potential mechanisms associated with dysregulation of adenogenic genes, luminal epithelial cell proliferation and endometrial fibrotic changes. Uterine tissues from mice with constitutive activation of TGFBR1 were collected during the critical time window of adenogenesis and analyzed together with age-matched controls. Multiple approaches including immunohistochemistry, immunofluorescence, Trichrome staining, quantitative real-time PCR, western blot, conditional knockout and human endometrial cell culture were utilized. TGFBR1 activation in the mouse uterus suppressed adenogenesis during postnatal uterine development, concomitant with the aberrant differentiation of uterine stromal cells. Analysis of transcript expression of WNT pathway components revealed dysregulation of adenogenesis-associated genes. Notably, the adenogenic defects occurred in spite of the increased proliferation of uterine luminal epithelial cells, accompanied by increased expression of genes associated with fibrotic changes. Moreover, the adenogenic defects were alleviated in mice where TGFBR1 was activated in presumably half of the complement of uterine cells. Our results suggest that altered differentiation of endometrial stromal cells and formation of stromal compartment promote adenogenic defects.	[Ni, Nan; Gao, Yang; Fang, Xin; Melgar, Maria; Li, Qinglei] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Vincent, David F.] Canc Res United Kingdom Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Bartholin, Laurent] Univ Lyon 1, Ctr Leon Berard, CNRS UMR5286, Ctr Rech Cancerol Lyon,INSERM U1052, Lyon, France	Texas A&M University System; Texas A&M University College Station; Beatson Institute; Baylor College of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Li, QL (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	qli@cvm.tamu.edu	Bartholin, Laurent/Q-6655-2017	Bartholin, Laurent/0000-0002-5637-3223	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD087236, R03HD082416]; Texas AM T3 grant; Texas A&M College of Veterinary Medicine graduate research award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082416, R01HD087236] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Texas AM T3 grant; Texas A&M College of Veterinary Medicine graduate research award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Institutes of Health grants R01HD087236 and R03HD082416 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (to Q.L.), Texas A&M T3 grant (to Q.L.) and Texas A&M College of Veterinary Medicine graduate research award (to NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Barakat TS, 2012, DEVELOPMENT, V139, P2085, DOI 10.1242/dev.069328; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; Bellessort B, 2015, HUM MOL GENET, V24, P3092, DOI 10.1093/hmg/ddv061; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; BRODY JR, 1989, AM J ANAT, V186, P21, DOI 10.1002/aja.1001860103; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Cooke PS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097188; Cunha G R, 1992, Epithelial Cell Biol, V1, P76; CUNHA GR, 1976, J EXP ZOOL, V196, P361, DOI 10.1002/jez.1401960310; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Dunlap KA, 2011, BIOL REPROD, V85, P386, DOI 10.1095/biolreprod.111.091769; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gao Y, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125146; Gao Y, 2014, MOL ENDOCRINOL, V28, P380, DOI 10.1210/me.2013-1284; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2000, BIOL REPROD, V62, P448, DOI 10.1095/biolreprod62.2.448; Gray CA, 2001, BIOL REPROD, V64, P797, DOI 10.1095/biolreprod64.3.797; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Hawkins SM, 2012, MOL ENDOCRINOL, V26, P1552, DOI 10.1210/me.2012-1042; Hayashi K, 2011, BIOL REPROD, V84, P308, DOI 10.1095/biolreprod.110.088161; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kobayashi A, 2004, DEVELOPMENT, V131, P539, DOI 10.1242/dev.00951; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Li QL, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-52; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Ni N, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0303-0; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Reardon SN, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.098871; Simitsidellis I, 2016, ENDOCRINOLOGY, V157, P2116, DOI 10.1210/en.2015-2032; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stewart CA, 2013, MOL ENDOCRINOL, V27, P1442, DOI 10.1210/me.2012-1126; Stewart CA, 2011, BIOL REPROD, V85, P954, DOI 10.1095/biolreprod.111.091470; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Taylor HS, 1997, BIOL REPROD, V57, P1338, DOI 10.1095/biolreprod57.6.1338; Torres M, 1995, DEVELOPMENT, V121, P4057; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang P, 2018, ENDOCRINOLOGY, V159, P1897, DOI 10.1210/en.2018-00158; Xu HH, 2016, J BIOMED RES, V30, P496, DOI 10.7555/JBR.30.20160049; Young VJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16859; Yuhki M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-104	69	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209417	10.1371/journal.pone.0209417	http://dx.doi.org/10.1371/journal.pone.0209417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550590	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000062
J	Bybjerg-Grauholm, J; Hagen, CM; Goncalves, VF; Baekvad-Hansen, M; Hansen, CS; Hedley, PL; Kanters, JK; Nielsen, J; Theisen, M; Mors, O; Kennedy, J; Als, TD; Demur, AB; Nordentoft, M; Borglum, A; Mortensen, PB; Werge, TM; Hougaard, DM; Christiansen, M				Bybjerg-Grauholm, Jonas; Hagen, Christian M.; Goncalves, Vanessa F.; Baekvad-Hansen, Marie; Hansen, Christine S.; Hedley, Paula L.; Kanters, Jorgen K.; Nielsen, Jimmi; Theisen, Michael; Mors, Ole; Kennedy, James; Als, Thomas D.; Demur, Alfonso B.; Nordentoft, Merete; Borglum, Anders; Mortensen, Preben B.; Werge, Thomas M.; Hougaard, David M.; Christiansen, Michael			Complex spatio-temporal distribution and genomic ancestry of mitochondrial DNA haplogroups in 24,216 Danes	PLOS ONE			English	Article							ANATOMICALLY MODERN HUMANS; POPULATION-STRUCTURE; MTDNA VARIATION; GENETIC HISTORY; HUMAN-EVOLUTION; Y-CHROMOSOME; ANCIENT; AFRICAN; DISEASE; DISPERSAL	Mitochondrial DNA (mtDNA) haplogroups (hgs) are evolutionarily conserved sets of mtDNA SNP-haplotypes with characteristic geographical distribution. Associations of hgs with disease and physiological characteristics have been reported, but have frequently not been reproducible. Using 418 mtDNA SNPs on the PsychChip (Illumina), we assessed the spatio-temporal distribution of mtDNA hgs in Denmark from DNA isolated from 24,642 geographically un-biased dried blood spots (DBS), collected from 1981 to 2005 through the Danish National Neonatal Screening program. ADMIXTURE was used to establish the genomic ancestry of all samples using a reference of 100K+ autosomal SNPs in 2,248 individuals from nine populations. Median-joining analysis determined that the hgs were highly variable, despite being typically Northern European in origin, suggesting multiple founder events. Furthermore, considerable heterogeneity and variation in nuclear genomic ancestry was observed. Thus, individuals with hg H exhibited 95%, and U hgs 38.2% - 92.5%, Danish ancestry. Significant clines between geographical regions and rural and metropolitan populations were found. Over 25 years, macro-hg L increased from 0.2% to 1.2% (p = 1.1*E-10), and M from 1% to 2.4% (p = 3.7*E-8). Hg U increased among the R macro-hg from 14.1% to 16.5% (p = 1.9*E-3). Genomic ancestry, geographical skewedness, and sub-hg distribution suggested that the L, M and U increases are due to immigration. The complex spatio-temporal dynamics and genomic ancestry of mtDNA in the Danish population reflect repeated migratory events and, in later years, net immigration. Such complexity may explain the often contradictory and population-specific reports of mito-genomic association with disease.	[Bybjerg-Grauholm, Jonas; Hagen, Christian M.; Baekvad-Hansen, Marie; Hansen, Christine S.; Hedley, Paula L.; Theisen, Michael; Hougaard, David M.; Christiansen, Michael] Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark; [Goncalves, Vanessa F.; Kennedy, James] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Kanters, Jorgen K.; Christiansen, Michael] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Nielsen, Jimmi] Aalborg Univ Hosp, Aalborg Psychiat Hosp, Aalborg, Denmark; [Mors, Ole] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Als, Thomas D.; Borglum, Anders] Aarhus Univ, Inst Med Genet, Aarhus, Denmark; [Demur, Alfonso B.; Werge, Thomas M.] Sct Hans Capital Reg Denmark, Mental Hlth Ctr, Roskilde, Denmark; [Nordentoft, Merete] Capital Reg Denmark, Mental Hlth Ctr, Roskilde, Denmark; [Mortensen, Preben B.] Aarhus Univ, Ctr Register Res, Inst Econ, Aarhus, Denmark	Statens Serum Institut; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Christiansen, M (corresponding author), Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark.; Christiansen, M (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	mic@ssi.dk	Nordentoft, Merete/AAH-3253-2019; Kennedy, James Lowery/AAZ-6947-2020; Hougaard, David/AAD-6368-2019; Bybjerg-Grauholm, Jonas/AAO-5447-2020; Hedley, Paula L/E-6156-2011; Mortensen, Preben B/D-2358-2015; Christiansen, Michael/B-4588-2009	Kennedy, James Lowery/0000-0002-8733-3806; Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Hedley, Paula L/0000-0001-5801-960X; Mortensen, Preben B/0000-0002-5230-9865; Christiansen, Michael/0000-0003-4713-755X; Nordentoft, Merete/0000-0003-4895-7023; Hagen, Christian/0000-0002-0513-7722; Kanters, Jorgen/0000-0002-3267-4910; Borglum, Anders/0000-0001-8627-7219	Lundbeck Foundation Initiative for Integrative Psychiatric Research; Novo Nordisk Foundation - Lundbeck Foundation Initiative for Integrative Psychiatric Research; Novo Nordisk Foundation	Lundbeck Foundation Initiative for Integrative Psychiatric Research; Novo Nordisk Foundation - Lundbeck Foundation Initiative for Integrative Psychiatric Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The iPSYCH study was funded by The Lundbeck Foundation Initiative for Integrative Psychiatric Research. This research has been conducted using the Danish National Biobank resource, supported by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The iPSYCH study was funded by The Lundbeck Foundation Initiative for Integrative Psychiatric Research. This research has been conducted using the Danish National Biobank resource, supported by the Novo Nordisk Foundation.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Agerbo E, 2012, SCHIZOPHR RES, V134, P246, DOI 10.1016/j.schres.2011.10.025; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Andersson M, 2004, STONE AGE SCANIA SIG; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Arduino Daniela M, 2015, Methods Mol Biol, V1265, P415, DOI 10.1007/978-1-4939-2288-8_31; Athanasiadis G, 2016, GENETICS, V204, P711, DOI 10.1534/genetics.116.189241; Atilano SR, 2015, HUM MOL GENET, V24, P4491, DOI 10.1093/hmg/ddv173; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P, 2013, GLOBAL PREHISTORY HU; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Biffi A, 2010, AM J HUM GENET, V86, P904, DOI 10.1016/j.ajhg.2010.05.005; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Busby GBJ, 2015, CURR BIOL, V25, P2518, DOI 10.1016/j.cub.2015.08.007; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Campbell MC, 2014, CURR OPIN GENET DEV, V29, P120, DOI 10.1016/j.gde.2014.09.003; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Castro MG, 2007, MITOCHONDRION, V7, P354, DOI 10.1016/j.mito.2007.06.002; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Catelli Maria Laura, 2011, BMC Genet, V12, P77, DOI 10.1186/1471-2156-12-77; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Cunliffe B.W., 2008, EUROPE OCEANS; Derry T. K., 2000, HIST SCANDINAVIA NOR; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Egeland CP, 2014, ARCHAEOL ANTHROP SCI, V6, P31, DOI 10.1007/s12520-013-0117-8; Emery LS, 2015, AM J HUM GENET, V96, P183, DOI 10.1016/j.ajhg.2014.12.015; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Fortson BW, 2009, INDO EUROPEAN LANGUA; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hagen CM, 2013, MOL GENET GENOM MED, V1, P54, DOI 10.1002/mgg3.5; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Holm J, 1993, J DANISH ARCHAEOLOGY, V10, P7; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434; Hvidt K, 1976, DANES GO W BOOK EMIG; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kenney MC, 2014, HUM MOL GENET, V23, P3537, DOI 10.1093/hmg/ddu065; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Larsen NK, 2009, BOREAS, V38, P732, DOI 10.1111/j.1502-3885.2009.00101.x; Larsen S, 2014, BBA-BIOENERGETICS, V1837, P226, DOI 10.1016/j.bbabio.2013.10.009; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Li ST, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.282; Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Manco J, 2015, ANCESTRAL JOURNEYS; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Melchior L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011898; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mikkelsen M, 2010, FORENSIC SCI INT-GEN, V4, pE87, DOI 10.1016/j.fsigen.2009.07.007; Morozova I, 2016, DNA RES, V23, P295, DOI 10.1093/dnares/dsw029; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen VP, 1996, TRACKING LATE GLACIA, P80; Pihl Kasper, 2008, Ugeskr Laeger, V170, P2691; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Price TD, 2017, ARCHAEOL ANTHROP SCI, V9, P371, DOI 10.1007/s12520-015-0290-z; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040; R Core Team, 2021, R LANGUAGE ENV STAT; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Randsborg K, 2009, ANATOMY DENMARK ARCH; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verge B, 2011, EUR PSYCHIAT, V26, P45, DOI 10.1016/j.eurpsy.2010.08.008; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902; Wickham C, 2010, INHERITANCE ROME HIS; Zhang F, 2016, CELL MOL LIFE SCI, V73, P4577, DOI 10.1007/s00018-016-2282-2; Zupan A, 2016, ANN HUM BIOL, V43, P57, DOI 10.3109/03014460.2015.1006678	120	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208829	10.1371/journal.pone.0208829	http://dx.doi.org/10.1371/journal.pone.0208829			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543675	Green Published, gold			2022-12-26	WOS:000453247500044
J	Honma, M; Masaoka, Y; Koyama, S; Kuroda, T; Futamura, A; Shiromaru, A; Terao, Y; Ono, K; Kawamura, M				Honma, Motoyasu; Masaoka, Yuri; Koyama, Shinichi; Kuroda, Takeshi; Futamura, Akinori; Shiromaru, Azusa; Terao, Yasuo; Ono, Kenjiro; Kawamura, Mitsuru			Impaired cognitive modification for estimating time duration in Parkinson's disease	PLOS ONE			English	Article							WORKING-MEMORY; SUBTHALAMIC NUCLEUS; PERCEPTION; REPRODUCTION; DEPRESSION; INTERVALS; DOPAMINE; DEMENTIA; DEFICITS; MODEL	Parkinson's disease (PD) is associated with various cognitive impairments. However, the nature of cognitive modification in patients with PD remains to be elucidated. In the present study, we examined whether patients with PD could correct and maintain subjective time duration and line length estimation. After training sessions, in which participants repeatedly memorized either a duration or a length, we compared a learning performance in 20 PD patients with 20 healthy controls. In the case of duration in the PD patients, the learned durations immediately returned to baseline of pre-training within a few minutes. However, the patients' ability to learn length estimation remained unimpaired. In contrast, healthy controls were able to retain the learned duration and length estimations. Time compression in PD's internal clock may become entrained to their altered duration estimation even after learning of accurate time duration. These deficits may be associated with disrupting cognitive modification in PD.	[Honma, Motoyasu; Kuroda, Takeshi; Futamura, Akinori; Shiromaru, Azusa; Ono, Kenjiro; Kawamura, Mitsuru] Showa Univ, Dept Neurol, Sch Med, Shinagawa Ku, Tokyo, Japan; [Honma, Motoyasu; Terao, Yasuo] Kyorin Univ, Dept Physiol, Sch Med, Mitaka, Tokyo, Japan; [Masaoka, Yuri] Showa Univ, Dept Physiol, Sch Med, Shinagawa Ku, Tokyo, Japan; [Koyama, Shinichi] Univ Tsukuba, Sch Art & Design, Tsukuba, Ibaraki, Japan	Showa University; Kyorin University; Showa University; University of Tsukuba	Honma, M; Kawamura, M (corresponding author), Showa Univ, Dept Neurol, Sch Med, Shinagawa Ku, Tokyo, Japan.; Honma, M (corresponding author), Kyorin Univ, Dept Physiol, Sch Med, Mitaka, Tokyo, Japan.	mhonma@ks.kyorin-u.ac.jp; kawa@med.showa-u.ac.jp	Honma, Motoyasu/M-7124-2018	Honma, Motoyasu/0000-0003-4612-0115	 [JP18K03185];  [JP25119006];  [JP18H05525]	; ; 	This work was supported by funding from Grant-in-aids for Scientific Research (C) (JP18K03185) and on Innovative Areas (JP25119006; JP18H05525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Altgassen M, 2007, NEUROPSYCHOLOGIA, V45, P2393, DOI 10.1016/j.neuropsychologia.2007.02.018; Backman L, 2013, NEUROSCI BIOBEHAV R, V37, P2209, DOI 10.1016/j.neubiorev.2013.01.014; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Coulthard EJ, 2012, BRAIN, V135, P3721, DOI 10.1093/brain/aws273; Damier P, 2015, J PARKINSON DIS, V5, P637, DOI 10.3233/JPD-150600; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Drane DL, 1999, J CLIN EXP NEUROPSYC, V21, P385, DOI 10.1076/jcen.21.3.385.922; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Galvan A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00005; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; Honma M, 2018, NEUROLOGY, V90, pE977, DOI 10.1212/WNL.0000000000005110; Honma M, 2017, NEUROPSYCHOLOGIA, V102, P61, DOI 10.1016/j.neuropsychologia.2017.06.004; Honma M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25421; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Lange KW, 1995, J NEURAL TRANSM-SUPP, P433; Lara AH, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00173; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Price A, 2009, BRAIN COGNITION, V69, P252, DOI 10.1016/j.bandc.2008.07.013; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; SALMON DP, 1995, CURR OPIN NEUROBIOL, V5, P184, DOI 10.1016/0959-4388(95)80025-5; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Su L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09745; Suarez I, 2013, COGN NEUROPSYCHOL, V30, P195, DOI 10.1080/02643294.2013.842548; Suzuki A, 2006, BRAIN, V129, P707, DOI 10.1093/brain/awl011; Thones S, 2015, J AFFECT DISORDERS, V175, P359, DOI 10.1016/j.jad.2014.12.057; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; Yamasaki M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8602690	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208956	10.1371/journal.pone.0208956	http://dx.doi.org/10.1371/journal.pone.0208956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543694	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500054
J	Lin, YC; Chen, YT; Chen, MJ				Lin, Yu-Chun; Chen, Yung-Tsung; Chen, Ming-Ju			Lack of mutagenicity, genotoxicity and developmental toxicity in safety assessment tests of Lactobacillus mali APS1	PLOS ONE			English	Article							TOXICOLOGICAL EVALUATION; PROBIOTICS; FERMENTATION; PATIENT; POWDER	Lactobacillus (L.) mali APS1 isolated from sugary kefir grains has been proven to affect energy and glucose homeostasis. However, without proper safety assessment it cannot be recommended as probiotics for human consumption. For genotoxicity, the Ames test showed no mutagenic effect of L. mali APS1 in the presence or absence of S9 mix metabolic activation. In-vitro mammalian chromosomal aberration test showed that the number of Chinese hamster ovary cells with abnormal chromosomes was <5% after L. mali APS1 treatment. Moreover, L. mali APS1 showed no risk of genotoxicity potential compared to the control. L. mali APS1 administration did not cause significant (p>0.05) changes in body weight, the number of reticulocytes, or in the occurrence percentage of micronucleus in Imprinting Control Region (ICR) mice. Based on the absence of maternal or fetal effects at any dosage level investigated, the teratogenicity could be defined as greater than 1,670 mg/kg b.w./day for maternal general toxicity and fetal development when L. mali APS1 was orally administered by gavage to pregnant SD rats during gestation days 6 to 15.	[Lin, Yu-Chun] Execut Yuan, Council Agr, Livestock Res Inst, Tainan, Taiwan; [Lin, Yu-Chun; Chen, Ming-Ju] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Chen, Yung-Tsung] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan	Taiwan Livestock Research Institute; National Taiwan University; National Taiwan University	Chen, MJ (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.	cmj@ntu.edu.tw		CHEN, MING-JU/0000-0003-4403-6112	Ministry of Science and Technology, Taipei, Taiwan [104-2313-B-002-043 -MY3]	Ministry of Science and Technology, Taipei, Taiwan	This work was supported by the project of Ministry of Science and Technology, Taipei, Taiwan, grant number 104-2313-B-002 -043 -MY3 (https://www.most.gov.tw/) to M-JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the project of Ministry of Science and Technology, Taipei, Taiwan (grant number 104-2313-B-002-043 -MY3).	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Anadon A, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.888; [Anonymous], 1997, TEST NO 471 BACT REV; Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2379; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Cavas T, 2005, AQUAT TOXICOL, V74, P264, DOI 10.1016/j.aquatox.2005.06.001; Chen YT, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700903; Chiu YJ, 2013, SCI WORLD J, DOI 10.1155/2013/254239; Cukovic-Cavka S, 2006, DIGESTION, V73, P107, DOI 10.1159/000094041; Donohue D C, 1996, Asia Pac J Clin Nutr, V5, P25; Doron S, 2015, CLIN INFECT DIS, V60, pS129, DOI 10.1093/cid/civ085; Endres JR, 2009, FOOD CHEM TOXICOL, V47, P1231, DOI 10.1016/j.fct.2009.02.018; Falk MC, 2017, FOOD CHEM TOXICOL, V103, P270, DOI 10.1016/j.fct.2017.03.011; Fiorda FA, 2017, FOOD MICROBIOL, V66, P86, DOI 10.1016/j.fm.2017.04.004; Fooks LJ, 1999, INT DAIRY J, V9, P53, DOI 10.1016/S0958-6946(99)00044-8; Hao XY, 2017, FOOD CHEM TOXICOL, V103, P102, DOI 10.1016/j.fct.2017.02.025; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; Hirose Y, 2009, REGUL TOXICOL PHARM, V54, P214, DOI 10.1016/j.yrtph.2009.03.007; Hsieh HH, 2012, INT J FOOD MICROBIOL, V157, P73, DOI 10.1016/j.ijfoodmicro.2012.04.014; Isa K, 2016, HUM EXP TOXICOL, V35, P818, DOI 10.1177/0960327115607372; Jia X, 2011, FOOD CHEM TOXICOL, V49, P1148, DOI 10.1016/j.fct.2011.02.006; Kolber AR, 1979, IN VITRO TOXICITY TE; Lankaputhra WEV, 1998, MUTAT RES-FUND MOL M, V397, P169, DOI 10.1016/S0027-5107(97)00208-X; Lin YC, 2016, J FUNCT FOODS, V23, P580, DOI 10.1016/j.jff.2016.03.015; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Luzhna Lidiya, 2013, Frontiers in Genetics, V4, P131, DOI 10.3389/fgene.2013.00131; Magalhaes KT, 2010, BIORESOURCE TECHNOL, V101, P8843, DOI 10.1016/j.biortech.2010.06.083; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; OECD, 2001, TEST NO 414 PREN DEV; OECD (Organisation for Economic Co- operation and Development), 1997, TEST NO 474 MAMM ER; OECD (Organisation for Economic Co-Operation and Development), 1997, TEST NO 473 IN VITR; Pechacek N, 2013, FOOD CHEM TOXICOL, V62, P436, DOI 10.1016/j.fct.2013.08.080; PIDOUX M, 1989, MIRCEN J APPL MICROB, V5, P223, DOI 10.1007/BF01741847; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Schilter B, 2003, FOOD CHEM TOXICOL, V41, P1625, DOI 10.1016/S0278-6915(03)00221-7; Son Hee-Kyoung, 2015, Prev Nutr Food Sci, V20, P190, DOI 10.3746/pnf.2015.20.3.190; Tanzer JM, 2010, J DENT RES, V89, P921, DOI 10.1177/0022034510369460; Tsai Cheng-Chih, 2014, ScientificWorldJournal, V2014, P928652, DOI 10.1155/2014/928652; Tseng WT, 2015, REGUL TOXICOL PHARM, V71, P148, DOI 10.1016/j.yrtph.2014.11.008; Waldherr F, 2009, THESIS; Yakabe T, 2011, FOOD CHEM TOXICOL, V49, P722, DOI 10.1016/j.fct.2010.11.025	41	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208881	10.1371/journal.pone.0208881	http://dx.doi.org/10.1371/journal.pone.0208881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543670	gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500049
J	Lamar, JM; Xiao, YX; Norton, E; Jiang, ZG; Gerhard, GM; Kooner, S; Warren, JSA; Hynes, RO				Lamar, John M.; Xiao, Yuxuan; Norton, Emily; Jiang, Zhi-Gang; Gerhard, Genevieve M.; Kooner, Simrin; Warren, Janine S. A.; Hynes, Richard O.			SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Yes-associated protein (YAP); cancer; metastasis; Src; LATS (Warts, Wts); Hippo pathway; Non-receptor tyrosine kinase (nRTK); GIT1; TAZ; transcriptional regulator	HIPPO SIGNALING PATHWAY; C-SRC; REGULATES YAP; THERAPEUTIC TARGETS; CELL-PROLIFERATION; SUPPRESSOR LATS1; FAMILY KINASES; PHOSPHORYLATION; TAZ; PIX	When properly employed, targeted therapies are effective cancer treatments. However, the development of such therapies requires the identification of targetable drivers of cancer development and metastasis. The expression and nuclear localization of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are increased in many human cancers, and experimental evidence indicates that aberrant YAP or TAZ activation drives tumor formation and metastasis. Although these findings make YAP and TAZ appealing therapeutic targets, both have important functions in adult tissues, so directly targeting them could cause adverse effects. The identification of pathways active in cancer cells and required for YAP/TAZ activity could provide a way to inhibit YAP and TAZ. Here, we show that SRC proto-oncogene, nonreceptor tyrosine kinase (SRC) is an important driver of YAP/TAZ activity in human breast cancer and melanoma cells. SRC activation increased YAP/TAZ activity and the expression of YAP/TAZ-regulated genes. In contrast, SRC inhibition or knockdown repressed both YAP/TAZ activity and the expression of YAP/TAZ-regulated genes. We also show that SRC increases the activity of YAP and TAZ by repressing large tumor suppressor homolog (LATS), and we identify the GTPase-activating protein GIT ArfGAP 1 (GIT1) as an SRC effector that regulates both YAP and TAZ. Importantly, we demonstrate that SRC-mediated YAP/TAZ activity promotes tumor growth and enhances metastasis and that SRC-dependent tumor progression depends, at least in part, on YAP and TAZ. Our findings suggest that therapies targeting SRC could help manage some YAP/TAZ-dependent cancers.	[Lamar, John M.; Xiao, Yuxuan; Norton, Emily; Gerhard, Genevieve M.; Kooner, Simrin; Warren, Janine S. A.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Lamar, John M.; Jiang, Zhi-Gang; Hynes, Richard O.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hynes, Richard O.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jiang, Zhi-Gang; Hynes, Richard O.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Albany Medical College; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lamar, JM (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.; Hynes, RO (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Hynes, RO (corresponding author), MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lamarj@amc.edu; rohynes@mit.edu	Lamar, John Michael/R-5053-2019	Lamar, John Michael/0000-0001-5406-8391	Susan G. Komen Career Catalyst Grant [CCR17477184]; National Institutes of Health (NIH) National Research Service Award [CA1421442]; NCI, NIH, Integrative Center Biology Program [U54CA112967]; NIH Tumor Microenvironment Network Grant [U54CA163109]; Department of Defense Breast Cancer Research Program [W81XWH-14-1-0240]; Koch Institute Frontier Research Fund; MIT Ludwig Center for Molecular Oncology; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Susan G. Komen Career Catalyst Grant(Susan G. Komen Breast Cancer Foundation); National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH, Integrative Center Biology Program; NIH Tumor Microenvironment Network Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Koch Institute Frontier Research Fund; MIT Ludwig Center for Molecular Oncology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Susan G. Komen Career Catalyst Grant CCR17477184 (to J. M. L.); a National Institutes of Health (NIH) National Research Service Award CA1421442 (to J. M. L.); NCI, NIH, Integrative Center Biology Program Grant U54CA112967 (to R. O. H.); NIH Tumor Microenvironment Network Grant U54CA163109 (to R. O. H.); Department of Defense Breast Cancer Research Program Grant W81XWH-14-1-0240 (to R. O. H.); the Koch Institute Frontier Research Fund (to J. M. L.); the MIT Ludwig Center for Molecular Oncology; and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ames JJ, 2016, J BIOL CHEM, V291, P2731, DOI 10.1074/jbc.M115.669614; Ando T, 2018, ONCOGENE, V37, P263, DOI 10.1038/onc.2017.321; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bae JS, 2017, ONCOTARGET, V8, P16084, DOI 10.18632/oncotarget.14306; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Byun MR, 2017, CANCER LETT, V410, P32, DOI 10.1016/j.canlet.2017.09.003; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chen PH, 2011, J NUTR BIOCHEM, V22, P732, DOI 10.1016/j.jnutbio.2010.06.004; Cui X, 2018, BIOMATERIALS, V161, P164, DOI 10.1016/j.biomaterials.2018.01.053; Dent LG, 2015, CURR BIOL, V25, P124, DOI 10.1016/j.cub.2014.11.041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Felley-Bosco E, 2014, TRANSL LUNG CANCER R, V3, P75, DOI 10.3978/j.issn.2218-6751.2014.02.03; Feng JT, 2016, ONCOTARGETS THER, V9, P5235, DOI 10.2147/OTT.S109540; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Gong R, 2015, CURR MED CHEM, V22, P4104, DOI 10.2174/0929867322666151002112256; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Homsi J, 2007, EXPERT OPIN THER TAR, V11, P91, DOI 10.1517/14728222.11.1.91; Hu JKH, 2017, CELL STEM CELL, V21, P91, DOI 10.1016/j.stem.2017.03.023; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim MK, 2018, BMB REP, V51, P126, DOI 10.5483/BMBRep.2018.51.3.015; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lee JH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-116; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma JG, 2011, BREAST CANCER RES TR, V130, P85, DOI 10.1007/s10549-010-1302-4; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Naba A, 2014, ELIFE, V3, DOI 10.7554/eLife.01308; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Ren YX, 2012, MOL CELL BIOCHEM, V365, P109, DOI 10.1007/s11010-012-1249-3; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Shanzer M, 2015, ONCOGENE, V34, P4190, DOI 10.1038/onc.2014.347; Shanzer M, 2017, P NATL ACAD SCI USA, V114, P1678, DOI 10.1073/pnas.1610223114; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Smoot RL, 2018, J CELL BIOCHEM, V119, P824, DOI 10.1002/jcb.26246; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sun ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135119; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Thakur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10194; van Rensburg HJJ, 2016, CELL SIGNAL, V28, P1761, DOI 10.1016/j.cellsig.2016.08.004; Vergani E, 2011, NEOPLASIA, V13, P1132, DOI 10.1593/neo.111102; Vlahov N, 2015, CURR BIOL, V25, P3019, DOI 10.1016/j.cub.2015.09.072; Warren JSA, 2018, CANCERS, V10, DOI 10.3390/cancers10040115; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Ye S, 2016, PHARMACOL RES, V103, P270, DOI 10.1016/j.phrs.2015.11.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang SY, 2013, CANCER RES, V73, P5764, DOI 10.1158/0008-5472.CAN-12-1803; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110	85	88	90	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2302	2317		10.1074/jbc.RA118.004364	http://dx.doi.org/10.1074/jbc.RA118.004364			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559289	Green Published, hybrid			2022-12-26	WOS:000458895400009
J	Li, A; Schertzer, JW; Yong, X				Li, Ao; Schertzer, Jeffrey W.; Yong, Xin			Molecular conformation affects the interaction of the Pseudomonas quinolone signal with the bacterial outer membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular dynamics; Pseudomonas aeruginosa (P. aeruginosa); lipid A; small molecule; outer membrane; hydrogen bond; quorum sensing; cell communication; membrane dynamics; outer membrane vesicle biogenesis	VESICLES; GROMACS; BIOGENESIS; SIMULATION; SECRETION	Gram-negative bacteria produce outer-membrane vesicles (OMVs) that package genetic elements, virulence factors, and cell-to-cell communication signaling compounds. Despite their importance in many disease-related processes, how these versatile structures are formed is incompletely understood. A self-produced secreted small molecule, the Pseudomonas quinolone signal (PQS), has been shown to initiate OMV formation in Pseudomonas aeruginosa by interacting with the outer membrane (OM) and inducing its curvature. Other bacterial species have also been shown to respond to PQS, supporting a common biophysical mechanism. Here, we conducted molecular dynamics simulations to elucidate the specific interactions between PQS and a model P. aeruginosa OM at the atomistic scale. We discovered two characteristic states of PQS interacting with the biologically relevant membrane, namely attachment to the membrane surface and insertion into the lipid A leaflet. The hydrogen bonds between PQS and the lipid A phosphates drove the PQS-membrane association. An analysis of PQS trajectory and molecular conformation revealed sequential events critical for spontaneous insertion, including probing, docking, folding, and insertion. Remarkably, PQS bent its hydrophobic side chain into a closed conformation to lower the energy barrier for penetration through the hydrophilic headgroup zone of the lipid A leaflet, which was confirmed by the potential of mean force (PMF) measurements. Attachment and insertion were simultaneously observed in the simulation with multiple PQS molecules. Our findings uncover a sequence of molecular interactions that drive PQS insertion into the bacterial OM and provide important insight into the biophysical mechanism of small molecule-induced OMV biogenesis.	[Li, Ao; Yong, Xin] SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA; [Schertzer, Jeffrey W.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Schertzer, Jeffrey W.; Yong, Xin] SUNY Binghamton, Binghamton Biofilm Res Ctr, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Yong, X (corresponding author), SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA.	xyong@binghamton.edu	Yong, Xin/ABC-1912-2020; Yong, Xin/G-5828-2012	Yong, Xin/0000-0002-8894-2750; Yong, Xin/0000-0002-8894-2750	NIAID, National Institutes of Health [R21AI121848]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121848] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R21AI121848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Devos S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00298; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Florez C, 2017, MBIO, V8, DOI 10.1128/mBio.01034-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Horspool AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28042-4; Li A, 2018, PHYS CHEM CHEM PHYS, V20, P23635, DOI 10.1039/c8cp04278k; Li ZS, 1996, J BACTERIOL, V178, P2479, DOI 10.1128/jb.178.9.2479-2488.1996; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Mashburn-Warren L, 2009, J BACTERIOL, V191, P3411, DOI 10.1128/JB.00052-09; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Schertzer JW, 2013, J MOL MICROB BIOTECH, V23, P118, DOI 10.1159/000346770; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; van der Spoel D, 2006, J PHYS CHEM B, V110, P4393, DOI 10.1021/jp0572535; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vella BD, 2015, PSEUDOMONAS, VVII, P217, DOI DOI 10.1007/978-94-017-9555-5_9; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x	29	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1089	1094		10.1074/jbc.AC118.006844	http://dx.doi.org/10.1074/jbc.AC118.006844			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30563840	hybrid, Green Published			2022-12-26	WOS:000457879500002
J	AlOlaiwi, LA; AlHarbi, TJ; Tourkmani, AM				AlOlaiwi, Lina A.; AlHarbi, Turki J.; Tourkmani, Ayla M.			Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center	PLOS ONE			English	Article							GASTROINTESTINAL SYMPTOMS; RISK-FACTORS; QT INTERVAL; MELLITUS; ASSOCIATION; COMPLICATIONS; COHORT; HYPERGLYCEMIA; HYPERTENSION; DYSFUNCTION	Introduction Cardiovascular autonomic neuropathy (CAN) and gastroparesis are two types of diabetic autonomic neuropathy which could affect patients' quality of life and carry significant morbidity and mortality outcomes. The aim of this study was to estimate the prevalence and risk factors of both CAN and gastroparesis symptoms among patients with type 2 diabetes mellitus (T2DM) at primary health care level. Methods A cross-sectional study was conducted among 400 adults with T2DM from April 1, 2017 to March 20, 2018. CAN was defined by the presence of any of the followings: resting tachycardia, orthostatic hypotension or prolonged corrected QT interval in the electrocardiogram. Gastroparesis symptoms were assessed using a validated questionnaire: the Gastroparesis Cardinal Symptom Index. Results The mean age of study participants and disease duration were 55.26 +/- 10.65 years and 10.77 +/- 6.89 years, respectively. CAN was present in 15.3% of the participants. Hypertension, smoking, antihypertensive use, body mass index, dyslipidemia and albuminuria were significantly higher in participants with CAN than those without CAN (p<0.05). Prolonged disease duration (p = 0.007) and hypertension (p = 0.004) were independently associated with CAN. Gastroparesis symptoms were present in 6.3% of study participants and were significantly associated with those of female gender (P<0.05). Metformin use emerged as an independent predictor of the presence of at least one symptom (p = 0.001). Conclusion Among Saudi adults with T2DM at primary care level, the prevalence of CAN is significant and is independently related to disease duration and hypertension, indicating the importance of CAN screening, especially for those with prolonged disease duration, and the importance of controlling blood pressure in order to prevent CAN or its consequences. The prevalence of gastroparesis symptoms is 6% and is independently related to metformin use, and therefore, symptomatic screening is required to decide which patients need further evaluation.	[AlOlaiwi, Lina A.; AlHarbi, Turki J.; Tourkmani, Ayla M.] Prince Sultan Mil Med City, Family & Community Med Dept, Riyadh, Saudi Arabia	Prince Sultan Military Medical City	AlHarbi, TJ (corresponding author), Prince Sultan Mil Med City, Family & Community Med Dept, Riyadh, Saudi Arabia.	turkifcm@yahoo.com						Acquadro C., 2012, LINGUISTIC VALIDATIO; Ahmed AM, 2000, SAUDI MED J, V21, P1034; Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; Al-Rubeaan K, 2014, ANN SAUDI MED, V34, P465, DOI 10.5144/0256-4947.2014.465; Alam Uazman, 2010, Diabetes Ther, V1, P32, DOI 10.1007/s13300-010-0010-8; Almogbel RA, 2016, INT J HEALTH SCI-IJH, V10, P397; [Anonymous], 2007, AM J KIDNEY DIS, V49, pS62; Ayad F, 2010, DIABETIC MED, V27, P804, DOI 10.1111/j.1464-5491.2010.03027.x; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BELLAVERE F, 1988, BRIT HEART J, V59, P379; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Braunwald E., 1997, HEART DIS TXB CARDIO, P640; Brock C, 2016, WORLD J DIABETES, V7, P321, DOI 10.4239/wjd.v7.i16.321; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Carnethon MR, 2005, MED SCI SPORT EXER, V37, P606, DOI 10.1249/01.MSS.0000158190.56061.32; Carnethon MR, 2003, DIABETES CARE, V26, P3035, DOI 10.2337/diacare.26.11.3035; Chen HS, 2001, DIABETIC MED, V18, P268, DOI 10.1046/j.1464-5491.2001.00442.x; Choung RS, 2012, AM J GASTROENTEROL, V107, P82, DOI 10.1038/ajg.2011.310; DATZ FL, 1987, J NUCL MED, V28, P1204; Dickman R, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-34; Dickman R, 2013, J DIABETES COMPLICAT, V27, P376, DOI 10.1016/j.jdiacomp.2013.02.004; Dimitropoulos G, 2014, WORLD J DIABETES, V5, P17, DOI 10.4239/wjd.v5.i1.17; Dimova R, 2017, J DIABETES COMPLICAT, V31, P537, DOI 10.1016/j.jdiacomp.2016.11.002; El Bcheraoui C, 2014, INT J PUBLIC HEALTH, V59, P1011, DOI 10.1007/s00038-014-0612-4; EWING DJ, 1980, Q J MED, V49, P95; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Eze C, 2013, Niger J Med, V22, P24; Fatima M, 2018, BIOMED RES INT, V29, P2285; Fisher VL, 2017, DIABET METAB SYND OB, V10, P419, DOI 10.2147/DMSO.S129797; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; GROOP LC, 1989, LANCET, V2, P129; Huang Y, 2016, J NEUROGASTROEN 1107; Jones KL, 2001, DIABETES CARE, V24, P1264, DOI 10.2337/diacare.24.7.1264; Kempler P, 2002, DIABETIC MED, V19, P900, DOI 10.1046/j.1464-5491.2002.00821.x; Khatoon N, 2010, INT J PHARM BIO SCI, V1, P1; Knight L. C., 1997, AM J GASTROENTEROLOG, V92; Ko GTC, 1999, DIABETIC MED, V16, P670, DOI 10.1046/j.1464-5491.1999.00135.x; Kofod-Andersen K, 2012, J DIABETES COMPLICAT, V26, P89, DOI 10.1016/j.jdiacomp.2012.02.009; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahwi TO., 2014, J MED J, V48, P102; Maser RE, 2007, CURR DIABETES REV, V3, P204, DOI 10.2174/157339907781368931; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Mathur C, 2006, J INDIAN ACAD CLIN M, V17, P34; Memon A, 2017, INT J HEALTH SCI-IJH, V11, P26; Moran A, 2004, DIABETES CARE, V27, P972, DOI 10.2337/diacare.27.4.972; MOSS AJ, 1993, AM J CARDIOL, V72, pB23, DOI 10.1016/0002-9149(93)90036-C; Pappachan JM, 2008, POSTGRAD MED J, V84, DOI 10.1136/pgmj.2007.064048; Parkman HP, 2004, GASTROENTEROLOGY, V127, P1592, DOI 10.1053/j.gastro.2004.09.055; PONTA L, 2011, B TRANSILVANIA U B 6, V4; Pop-Busui R, 2017, DIABETES CARE, V40, P94, DOI 10.2337/dc16-1397; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Pop-Busui R, 2012, J CARDIOVASC TRANSL, V5, P463, DOI 10.1007/s12265-012-9367-6; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; Ricci JA, 2000, SCAND J GASTROENTERO, V35, P152; Rouquet T, 2014, OBESITY, V22, P2552, DOI 10.1002/oby.20902; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Spangeus A, 1999, SCAND J GASTROENTERO, V34, P1196, DOI 10.1080/003655299750024706; Tahrani AA, 2014, DIABETOLOGIA, V57, P1249, DOI 10.1007/s00125-014-3211-2; Takahashi N, 2001, J AM COLL CARDIOL, V38, P232, DOI 10.1016/S0735-1097(01)01363-8; Valensi P, 2003, METABOLISM, V52, P815, DOI 10.1016/S0026-0495(03)00095-7; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Voulgari C, 2011, J DIABETES COMPLICAT, V25, P159, DOI 10.1016/j.jdiacomp.2010.06.001; Whitsel EA, 2000, DIABETES CARE, V23, P241, DOI 10.2337/diacare.23.2.241; Zoppini G, 2015, DIABETES CARE, V38, P1487, DOI 10.2337/dc15-0081	67	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209500	10.1371/journal.pone.0209500	http://dx.doi.org/10.1371/journal.pone.0209500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576362	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400054
J	Real-Hohn, A; Navegantes, C; Ramos, K; Ramos, D; Cahue, B; Galina, A; Salerno, VP				Real-Hohn, Antonio; Navegantes, Clarice; Ramos, Katia; Ramos-Filho, Dionisio; Cahue, Bio; Galina, Antonio; Salerno, Veronica P.			The synergism of high-intensity intermittent exercise and every-other-day intermittent fasting regimen on energy metabolism adaptations includes hexokinase activity and mitochondrial efficiency	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; GLUCOSE-TRANSPORTER; INSULIN SENSITIVITY; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; PROTEIN; PHOSPHORYLATION; HYPERGLYCEMIA; EXPRESSION; INTERVAL	Visceral lipid accumulation, organ hypertrophy and a reduction in skeletal muscle strength are all signs associated with the severity of obesity-related disease. Intermittent fasting (IF) and high-intensity intermittent exercise (HIIE) are natural strategies that, individually, can prevent and help treat obesity along with metabolic syndrome and its associated diseases. However, the combinatorial effect of IF and HIIE on energetic metabolism is currently not well understood. We hypothesized that their combination could have a potential for more than strictly additive benefits. Here, we show that two months of every-other-day intermittent fasting regimen combined with a high-intensity intermittent exercise protocol (IF/HIIE) produced a synergistic effect, enhancing physical endurance (vs. control, HIIE and IF) and optimizing metabolic pathways of energy production in male Wistar rats. The IF/HIIE group presented enhanced glucose tolerance (vs. control, HIIE and IF), lower levels of plasma insulin (vs. control and HIIE), and a global activation of low Km hexokinases in liver (vs. control, HIIE and IF), heart (vs. control and HIIE) and skeletal muscle (vs. control, HIIE and IF). The IF/HIIE synergism, rather than a simply additive effect, is evidenced by increase in muscle mass and cross-section area, activation of the FoF1 ATP synthase, and the gain of characteristics suggestive of augmented mitochondrial mass and efficiency observed in this group. Finally, important reductions in plasma oxidative stress markers were present preferentially in IF/HIIE group. These findings provide new insights for the implementation of non-pharmaceutical strategies to prevent/treat metabolic syndrome and associated diseases.	[Real-Hohn, Antonio] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Navegantes, Clarice; Ramos, Katia; Cahue, Bio; Salerno, Veronica P.] Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, Biosci Dept, Lab Exercise Biochem & Mol Motors, Rio De Janeiro, Brazil; [Ramos-Filho, Dionisio; Galina, Antonio] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Lab Bioenerget & Mitochondrial Physiol, Rio De Janeiro, Brazil	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Real-Hohn, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, Vienna, Austria.; Salerno, VP (corresponding author), Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, Biosci Dept, Lab Exercise Biochem & Mol Motors, Rio De Janeiro, Brazil.	antonio.hohn@univie.ac.at; vpsalerno@yahoo.com.br	Real-Hohn, Antonio/AAS-3935-2020; Ramos-Filho, Dionizio/A-3687-2010; Salerno, Verônica/AAD-1137-2019	Real-Hohn, Antonio/0000-0003-0334-2877; Salerno, Verônica/0000-0002-4344-6710; Cahue, Fabio/0000-0003-2273-8893	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; ALESSIO HM, 1988, AM J PHYSIOL, V255, pC874, DOI 10.1152/ajpcell.1988.255.6.C874; An R, 2018, OBES REV, V19, P150, DOI 10.1111/obr.12624; BELTRANDELRIO H, 1991, ARCH BIOCHEM BIOPHYS, V286, P183, DOI 10.1016/0003-9861(91)90026-F; Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774; Bexfield NA, 2009, J APPL PHYSIOL, V107, P749, DOI 10.1152/japplphysiol.91446.2008; Blauw LL, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000317; Blumberg Y, 2017, J CARD FAIL, V23, P392, DOI 10.1016/j.cardfail.2016.12.010; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brandt C, 2015, METABOLISM, V64, P283, DOI 10.1016/j.metabol.2014.10.007; BURCELIN R, 1993, BIOCHEM J, V291, P109, DOI 10.1042/bj2910109; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Ceglia L, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-6; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chang PY, 1996, J BIOL CHEM, V271, P14834, DOI 10.1074/jbc.271.25.14834; Clamp LD, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.31; Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Jaspers RT, 2017, FASEB J, V31, P14, DOI 10.1096/fj.201600652R; Kahlmeier S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1412-3; Kong XX, 2018, CELL METAB, V28, P631, DOI 10.1016/j.cmet.2018.07.004; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Laursen PB, 2007, APPL PHYSIOL NUTR ME, V32, P434, DOI 10.1139/H07-006; Li CY, 2017, EXP CLIN ENDOCR DIAB, V125, P618, DOI 10.1055/s-0043-101700; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Liu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.31; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; de Moraes RCM, 2017, APPL PHYSIOL NUTR ME, V42, P1341, DOI 10.1139/apnm-2017-0435; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Marosi K, 2018, FASEB J, V32, P3844, DOI 10.1096/fj.201701378RR; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Mayevsky A, 2009, INT J BIOCHEM CELL B, V41, P1977, DOI 10.1016/j.biocel.2009.03.012; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; NAFTALIN RJ, 1989, BIOCHEM J, V260, P143, DOI 10.1042/bj2600143; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Patsoukis N, 2004, NEUROSCI LETT, V357, P83, DOI 10.1016/j.neulet.2003.10.080; POSTIC C, 1993, DIABETES, V42, P922, DOI 10.2337/diabetes.42.6.922; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; Ramos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131766; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rodriguez-Bies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013900; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SHARMA C, 1963, J BIOL CHEM, V238, P3840; Terada S, 2001, J APPL PHYSIOL, V90, P2019, DOI 10.1152/jappl.2001.90.6.2019; Touati S, 2011, MED SCI SPORT EXER, V43, P398, DOI 10.1249/MSS.0b013e3181eeb12d; VIITANEN PV, 1984, J BIOL CHEM, V259, P9679; Wu LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04035-7; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	62	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0202784	10.1371/journal.pone.0202784	http://dx.doi.org/10.1371/journal.pone.0202784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576325	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400002
J	Hwang, S; Greenlee, JJ; Vance, NM; Nicholson, EM				Hwang, Soyoun; Greenlee, Justin J.; Vance, Natalie M.; Nicholson, Eric M.			Source genotype influence on cross species transmission of transmissible spongiform encephalopathies evaluated by RT-QuIC	PLOS ONE			English	Article							CERVUS-ELAPHUS-NELSONI; CHRONIC WASTING DISEASE; PRION PROTEIN FIBRILS; SHEEP SCRAPIE; SUFFOLK SHEEP; PRP GENOTYPE; TIME; ELK; DISCRIMINATION; ASSOCIATION	Scrapie is a naturally occurring transmissible spongiform encephalopathy of sheep and goats. This fatal neurodegenerative disease is caused by misfolding of the cellular prion protein to pathogenic beta-rich conformers (PrPSc) that accumulate in higher order structures of the brain and other tissues. This conversion has been used for in vitro assays including serial protein misfolding amplification and real-time quaking induced conversion (RT-QuIC). RT-QuIC can be used for the detection of prions and for strain discrimination in a variety of biological tissues from humans and animals. In this study, we evaluated how PrPSc isolated from sheep of different genotypes after inoculation with the scrapie agent influence the fibril formation in vitro using RT-QuIC. We found that reaction mixtures seeded with PrPSc from genotype VRQ/VRQ sheep brains have better conversion efficiency with 132M elk substrate compared to reactions seeded with PrPSc from the brains of sheep with the ARQ/ARQ genotype no matter which strain of scrapie was used to seed the reactions. We also inoculated transgenic mice expressing 132M elk PRNP (Tg12) with the scrapie agent from different genotypes of sheep to compare with our RT-QuIC results. The bioassays support the data showing a significantly shorter incubation period for inoculum from VRQ/VRQ sheep when compared to inoculum from ARQ/ARQ sheep. Thus, we conclude that the genotype of both source and recipient can strongly influence transmission.	[Hwang, Soyoun; Greenlee, Justin J.; Vance, Natalie M.; Nicholson, Eric M.] ARS, USDA, Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, USDA, Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50010 USA.	Eric.Nicholson@ars.usda.gov		Greenlee, Justin/0000-0003-2202-3054; Vance, Natalie/0000-0003-3824-541X	United States Department of Agriculture, Agriculture Research Service	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agriculture Research Service. The funder of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Baylis M, 2002, J GEN VIROL, V83, P2907, DOI 10.1099/0022-1317-83-11-2907; Bulgin MS, 2006, AM J VET RES, V67, P498, DOI 10.2460/ajvr.67.3.498; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Cheng KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084812; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collinge J, 2010, SCIENCE, V328, P1111, DOI 10.1126/science.1190815; Dassanayake RP, 2016, J GEN VIROL, V97, P803, DOI 10.1099/jgv.0.000367; Douet JY, 2017, EMERG INFECT DIS, V23, P946, DOI 10.3201/eid2306.161734; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Greenlee JJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-107; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hamir AN, 2009, VET PATHOL, V46, P39, DOI 10.1354/vp.46-1-39; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hamir AN, 2004, J VET DIAGN INVEST, V16, P316, DOI 10.1177/104063870401600410; Hamir AN, 2003, VET PATHOL, V40, P81, DOI 10.1354/vp.40-1-81; Harnir AN, 2008, CAN J VET RES, V72, P63; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hwang S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172391; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Levavasseur E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172428; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Maheshwari A, 2015, EMERG INFECT DIS, V21, P750, DOI 10.3201/eid2105.142017; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Masujin K, 2016, J CLIN MICROBIOL, V54, P676, DOI 10.1128/JCM.02731-15; Moore SJ, 2016, VET PATHOL, V53, P1187, DOI 10.1177/0300985816629712; O'Rourke KI, 2007, NEUROREPORT, V18, P1935, DOI 10.1097/WNR.0b013e3282f1ca2f; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sano K, 2015, PRION, V9, P237, DOI 10.1080/19336896.2015.1062201; Sano K, 2014, J VIROL, V88, P11791, DOI 10.1128/JVI.00585-14; Schmitz M, 2016, NAT PROTOC, V11, P2233, DOI 10.1038/nprot.2016.120; Smith JD, 2012, J AGR FOOD CHEM, V60, P4758, DOI 10.1021/jf300639h; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Vrentas CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043060; Vrentas CE, 2012, PROTEIN EXPRES PURIF, V82, P380, DOI 10.1016/j.pep.2012.02.008; Weissmann C, 1996, FEBS LETT, V389, P3, DOI 10.1016/0014-5793(96)00610-2; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209106	10.1371/journal.pone.0209106	http://dx.doi.org/10.1371/journal.pone.0209106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571737	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700037
J	Feliciani, C; Murakami, H; Nishinari, K				Feliciani, Claudio; Murakami, Hisashi; Nishinari, Katsuhiro			A universal function for capacity of bidirectional pedestrian streams: Filling the gaps in the literature	PLOS ONE			English	Article							SOCIAL FORCE MODEL; JAMMING TRANSITION; DENSITY; CROWD; SIMULATION; BEHAVIOR; DYNAMICS; FLOW	In this work, we investigate properties of bidirectional pedestrian streams by studying different experimental datasets from multiple authors. Through the comparison of a scenario where lanes naturally form with two others where lane formation is either obstructed or facilitated, we show the relationship of different pedestrian quantities in regard to the flow ratio (or directional split). On this scope, two measures to account for the degree of congestion and self-organization are introduced. The analysis of the results reveals that the balanced case (where flow is almost equal in both directions) has very peculiar properties which depends on the existence or not of organized lanes and their stability. While the balanced case generally shows the highest level of congestion, this property can quickly change after lanes are formed and when they remain stable. An in-depth investigation revealed that capacity in bidirectional streams is characterized by a dual nature: conflicts with the counter flow and self-organization in lanes. Both aspects have been described using a mathematical model which allowed to define a function for capacity in relation with flow ratio and environmental/cognitive aspects. The expression for capacity proposed in our work agrees with several studies from the literature, eventually allowing to understand the differences among them. We believe our function for capacity enables a more universal treatment of bidirectional streams compared to previous definitions, since it allows to account for steady and non-steady state conditions which represent important mechanisms in their dynamics. The framework introduced here may also help measuring the influence of environmental/cognitive changes in relation with the capacity of bidirectional pedestrian streams.	[Feliciani, Claudio] Univ Tokyo, Grad Sch Engn, Dept Adv Interdisciplinary Studies, Meguro Ku, Tokyo, Japan; [Nishinari, Katsuhiro] Univ Tokyo, Grad Sch Engn, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo, Japan; [Feliciani, Claudio; Murakami, Hisashi; Nishinari, Katsuhiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Feliciani, C (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Adv Interdisciplinary Studies, Meguro Ku, Tokyo, Japan.; Feliciani, C (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan.	feliciani@jamology.rcast.u-tokyo.ac.jp	Nishinari, Katsuhiro/AAQ-9858-2020	Feliciani, Claudio/0000-0003-0718-8707	JST-Mirai Program [JPMJMI17D4]; JSPS KAKENHI [25287026]; Doctoral Student Special Incentives Program (SEUT RA); Foundation for Supporting International Students of the University of Tokyo	JST-Mirai Program; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Doctoral Student Special Incentives Program (SEUT RA); Foundation for Supporting International Students of the University of Tokyo	This work was supported by JST-Mirai Program Grant Number JPMJMI17D4, JSPS KAKENHI Grant Number 25287026, the Doctoral Student Special Incentives Program (SEUT RA) and the Foundation for Supporting International Students of the University of Tokyo.; This work was supported by JST-Mirai Program Grant Number JPMJMI17D4, JSPS KAKENHI Grant Number 25287026, the Doctoral Student Special Incentives Program (SEUT RA) and the Foundation for Supporting International Students of the University of Tokyo. In addition, the authors would like to thank all the researchers which openly provided their data, thus making this study possible. We finally need to thank Andrea Gorrini, Luca Crociani and Daichi Yanagisawa who contributed to the organization of some of the experiments discussed in this study.	AlGadhi SA, 2002, SPEED CONCENTRATION; Alhajyaseen WKM, 2010, IATSS RES, V34, P35, DOI 10.1016/j.iatssr.2010.06.002; Alhajyaseen WKM, 2011, PROCD SOC BEHV, V16, DOI 10.1016/j.sbspro.2011.04.473; Alonso-Marroquin F, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.063305; [Anonymous], 2004, MODELLING PASSENGER; [Anonymous], 2017, ARXIV171108225; [Anonymous], 2016, PROC PEDESTR EVACUAT; Bandini S, 2014, TRANSPORT RES C-EMER, V40, P251, DOI 10.1016/j.trc.2013.12.007; Boltes M, 2013, NEUROCOMPUTING, V100, P127, DOI 10.1016/j.neucom.2012.01.036; Boltes M, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P43, DOI 10.1007/978-3-642-04504-2_3; Canetti Elias., 1962, CROWDS POWER; Chen P, 2017, J ADV TRANSPORT, DOI 10.1155/2017/5202150; Cheung Cy, 1998, PEDESTRIAN FLOW CHAR; Daamen W., 2016, P PED EV DYN, DOI 10.17815/CD.2016.11; Duives DC, 2015, TRAFFIC AND GRANULAR FLOW '13, P251, DOI 10.1007/978-3-319-10629-8_30; Feliciani C., 2016, 8 INT C PED EV DYN P, P76; Feliciani C, 2018, TRANSPORT RES C-EMER, V91, P124, DOI 10.1016/j.trc.2018.03.027; Feliciani C, 2017, INTELL ARTIF, V11, P117, DOI 10.3233/IA-170110; Feliciani C, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032304; Feliciani C, 2016, PHYSICA A, V451, P135, DOI 10.1016/j.physa.2016.01.057; Feliciani C, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/10/P10003; Flotterod G, 2015, TRANSPORT RES B-METH, V71, P194, DOI 10.1016/j.trb.2014.11.001; Fruin J., 1987, PEDESTRIAN PLANNING; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Gorrini A, 2016, ARXIV 161008325; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Ikeda K, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.044004; Johansson A, 2008, ADV COMPLEX SYST, V11, P497, DOI 10.1142/S0219525908001854; Kretz T., 2006, J STAT MECH-THEORY E, V2006, P10, DOI DOI 10.1088/1742-5468/2006/10/P10014); Lam WHK, 2002, TRANSPORTATION, V29, P169, DOI 10.1023/A:1014226416702; Liu MX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180992; Muramatsu H, 2000, PHYSICA A, V275, P281, DOI 10.1016/S0378-4371(99)00447-1; Muramatsu M, 1999, PHYSICA A, V267, P487, DOI 10.1016/S0378-4371(99)00018-7; Navin F. P., 1969, PEDESTRIAN FLOW CHAR, V39; Nowak S, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066128; Rex M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051402; Saberi M, 2015, PHYSICA A, V434, P120, DOI 10.1016/j.physa.2015.04.008; Saberi M, 2014, TRANSPORT RES REC, P31, DOI 10.3141/2421-04; Seer S, 2014, TRANSPORT RES C-EMER, V48, P212, DOI 10.1016/j.trc.2014.08.012; Jacques JCS, 2010, IEEE SIGNAL PROC MAG, V27, P66, DOI 10.1109/MSP.2010.937394; Steffen B, 2010, PHYSICA A, V389, P1902, DOI 10.1016/j.physa.2009.12.015; Tajima Y, 2002, PHYSICA A, V313, P709, DOI 10.1016/S0378-4371(02)00965-2; Transportation Research Board, 2016, HIGHWAY CAPACITY MAN; Weidmann U., 1993, TRANSPORTTECHNIK FUS; Weng WG, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036102; Wong SC, 2010, J TRANSP ENG, V136, P234, DOI 10.1061/(ASCE)TE.1943-5436.0000086; Yanagisawa D., 2016, COLLECT DYN, V1, P1; Zeng WL, 2017, TRANSPORT RES C-EMER, V80, P37, DOI 10.1016/j.trc.2017.04.009; Zeng WL, 2014, PROCD SOC BEHV, V138, P521, DOI 10.1016/j.sbspro.2014.07.233; Zeng WL, 2014, TRANSPORT RES C-EMER, V40, P143, DOI 10.1016/j.trc.2014.01.007; Zhang J, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02002; Zhang J., 2016, COLLECTIVE DYNAMICS, V1, P126; Zhang J, 2012, PEDESTRIAN FUNDAMENT; Zhang XL, 2013, PHYSICA A, V392, P2781, DOI 10.1016/j.physa.2013.02.019	54	20	20	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208496	10.1371/journal.pone.0208496	http://dx.doi.org/10.1371/journal.pone.0208496			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566499	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300043
J	Siddiqui, H; Haniffa, HM; Jabeen, A; Atta-ur-Rahman; Choudhary, MI				Siddiqui, Hina; Haniffa, Haroon M.; Jabeen, Almas; Atta-ur-Rahman; Choudhary, M. Iqbal			Sulphamethazine derivatives as immunomodulating agents: New therapeutic strategies for inflammatory diseases	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BIOLOGICAL EVALUATION; ASSAY; SULFONAMIDES; GROWTH	Sulfamethazine (SMZ) (1) is an antibacterial sulfa drug which suppresses the synthesis of dihydrofolic acid. It is used for the treatment of infections in livestock; such as gastrointestinal, and respiratory tract infections. During the current study, synthesis, characterization, and evaluation of immunomodulatory activities of derivatives of sulfamethazine (SMZ) (3-39) was carried out. These derivatives were synthesized by the reaction of sulfamethazine with a range of acid chlorides. All the compounds were characterized by using modern spectroscopic techniques, such as H-1-, and C-13-NMR, E1-MS, and HRFAB-MS. Compounds 310, 14, and 15 were identified as new compounds. Immunomodulatory effect of compounds 3-39 on different parameters of innate immune response was evaluated, including the production of Reactive Oxygen Species (ROS) from human whole blood and isolated polymorphonuclear neutrophils (PMNs), nitric oxide (NO), and pro-inflammatory cytokine TNF-alpha. All the new compounds, except 14 and 15, showed a significant anti-inflammatory activity. Compounds 3-39 were also evaluated for their anti-bacterial activity and cytotoxicity (3T3 mouse fibroblast cell lines). All the compounds were found to be non-cytotoxic against normal cell lines.	[Siddiqui, Hina; Haniffa, Haroon M.; Atta-ur-Rahman; Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan; [Haniffa, Haroon M.] South Eastern Univ, Fac Appl Sci, Dept Phys Sci, Oluvil, Sri Lanka; [Jabeen, Almas; Atta-ur-Rahman; Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia	University of Karachi; South Eastern University of Sri Lanka; University of Karachi; King Abdulaziz University	Siddiqui, H; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	hinahej@gmail.com; hej@cyber.net.pk	Siddiqui, Hina/U-1858-2019; Rahman, Atta-ur/M-3329-2013	Siddiqui, Hina/0000-0003-0432-2237; Mohamed Haniffa, Haroon/0000-0001-7439-0724	ICCBS	ICCBS	HMH is thankful to the ICCBS for the post-doctoral fellowship for one year. HMH is also thankful to the COMSATS (The Commission on Science and Technology for Sustainable Development in the South) for the travel support.	Abdel-Monem Wafaa R, 2004, Boll Chim Farm, V143, P239; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Brown E Sherwood, 2001, Prim Care Companion J Clin Psychiatry, V3, P17; Chen LZ, 2015, CHEM BIOL DRUG DES, V86, P239, DOI 10.1111/cbdd.12486; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; El Ashry ESH, 2013, J ENZYM INHIB MED CH, V28, P105, DOI 10.3109/14756366.2011.636361; Grande B.C., 2001, J AGR FOOD CHEM, V49, P3145; Hassan HHAM, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0123-2; HELFAND SL, 1982, J EXP MED, V156, P492, DOI 10.1084/jem.156.2.492; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kratky M, 2012, EUR J MED CHEM, V50, P433, DOI 10.1016/j.ejmech.2012.01.060; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Rai US, 2015, ARAB J CHEM, V8, P317, DOI 10.1016/j.arabjc.2014.01.018; Rubin R, 2008, RUBINS PATHOLOGY CLI, V12, P1341; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Serhan CN., 2010, FUNDAMENTALS INFLAMM, DOI 10.1017/CBO9781139195737; Sisignano M, 2016, TRENDS PHARMACOL SCI, V37, P172, DOI 10.1016/j.tips.2015.11.006	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208933	10.1371/journal.pone.0208933	http://dx.doi.org/10.1371/journal.pone.0208933			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566465	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300062
J	Baas, J; Krens, L; Bohringer, S; Mol, L; Punt, C; Guchelaar, HJ; Gelderblom, H				Baas, Jara; Krens, Lisanne; Bohringer, Stefan; Mol, Linda; Punt, Cornelis; Guchelaar, Henk-Jan; Gelderblom, Hans			Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab	PLOS ONE			English	Article							OPEN-LABEL; PANITUMUMAB; RASH; CHEMOTHERAPY; TRIAL	EGFR-antibodies are associated with significant skin toxicity, including acneiform rash and folliculitis. It remains impossible to predict the occurrence of severe skin toxicity due to the lack of predictive markers. Here, we present the first genome-wide association study (GWAS) to find single nucleotide polymorphisms (SNPs) associated with EGFR inhibitor-induced skin toxicity using data of the multicentre randomized phase III CAIRO2 trial (clinicaltrials.gov NCT00208546). In this study, advanced or metastatic colorectal cancer patients were treated with capecitabine, oxaliplatin and bevacizumab with or without cetuximab. Germline DNA was available in 282 of the 368 patients in the cetuximab arm. Mild skin toxicity occurred in 195 patients (i.e. CTC grade 1 or 2, respectively 91 and 104 patients) and severe skin toxicity (i.e. grade 3) in 36 patients. Grade 4 skin toxicity did not occur. None of the SNPs reached the formal genome wide threshold for significance of 5x10(-8), though SNPs of at least 8 loci did show moderate association (p-value between 5x10(-7) and 5x10(-5)) with the occurrence of grade 3 (severe) skin toxicity. These SNPs did not overlap with SNPs associated with cetuximab efficacy as found in a previous GWAS in the same CAIRO2 cohort. If formally proven by replication, the SNPs associated with severe EGFR induced skin toxicity may be helpful to predict the occurrence and severity of skin toxicity in patients that will receive cetuximab and allow for adequate information on the risk of skin toxicity and prophylactic measurements.	[Baas, Jara; Gelderblom, Hans] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands; [Krens, Lisanne; Guchelaar, Henk-Jan] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands; [Bohringer, Stefan] Leiden Univ, Dept Med Stat, Med Ctr, Leiden, Netherlands; [Mol, Linda] Comprehens Canc Ctr Netherlands, Clin Trial Dept, Nijmegen, Netherlands; [Punt, Cornelis] Acad Med Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Baas, J (corresponding author), Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands.	j.m.baas@lumc.nl	guchelaar, henk-jan/AAP-1381-2021	Guchelaar, Henk-Jan/0000-0002-7085-1383; Gelderblom, Hans/0000-0001-9270-8636	Dutch Cancer Foundation KWF [2005-02]; Roche; Merck-Serono; Sanofi-Avantis; DxS	Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Roche(Roche Holding); Merck-Serono(Merck & Company); Sanofi-Avantis; DxS	The authors received no specific funding for this work. The CAIRO2 study was supported by the Dutch Cancer Foundation KWF (grant 2005-02) and by unrestricted scientific grants from Roche, Merck-Serono, Sanofi-Avantis en DxS. The funders had no role in study design, data collection and analysis, and preparation of the manuscript.	Baas JM, 2012, CANCER TREAT REV, V38, P505, DOI 10.1016/j.ctrv.2011.09.004; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CCRPMID, CCR; CCRPMID, 2006, CCR; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; GROUP, 2008, NEW ENGL J MED, V359, P789; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Joshi SS, 2010, CANCER-AM CANCER SOC, V116, P3916, DOI 10.1002/cncr.25090; Klinghammer K, 2010, CLIN CANCER RES, V16, P304, DOI 10.1158/1078-0432.CCR-09-1928; Lacouture ME, 2010, J CLIN ONCOL, V28, P1351, DOI 10.1200/JCO.2008.21.7828; Pander J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131091; PEREA S, 2005, J CLIN ONCOL, V15, P7; Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916; Petrelli F, 2013, TARGET ONCOL, V8, P173, DOI 10.1007/s11523-013-0257-x; Rushan X, 2007, J DERMATOL SCI, V48, P189, DOI 10.1016/j.jdermsci.2007.06.013; Solomon BM, 2008, CURR ONCOL REP, V10, P304, DOI 10.1007/s11912-008-0048-1; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Vallbohmer D, 2005, J CLIN ONCOL, V23, P3536, DOI 10.1200/jco.2005.23.16_suppl.3536; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vukcevic D, 2011, GENET EPIDEMIOL, V35, P278, DOI 10.1002/gepi.20576; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Yin J, 2018, CANCER LETT, V414, P181, DOI 10.1016/j.canlet.2017.11.013	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208080	10.1371/journal.pone.0208080	http://dx.doi.org/10.1371/journal.pone.0208080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557370	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000021
J	Blomquist, PB; Mighelsen, SJ; Wills, G; McClure, E; Ades, AE; Kounali, D; Dunbar, JK; McClure, MO; Soldan, K; Woodhall, SC; Horner, P				Blomquist, Paula B.; Mighelsen, Stephanie J.; Wills, Gillian; McClure, Eleanor; Ades, Anthony E.; Kounali, Daphne; Dunbar, J. Kevin; McClure, Myra O.; Soldan, Kate; Woodhall, Sarah C.; Horner, Patrick			Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BRITAIN	Background Seroprevalence surveys of Chlamydia trachomatis (CT) antibodies are promising for estimating age-specific CT cumulative incidence, however accurate estimates require improved understanding of antibody response to CT infection. Methods We used GUMCAD, England's national sexually transmitted infection (STI) surveillance system, to select sera taken from female STI clinic attendees on the day of or after a chlamydia diagnosis. Serum specimens were collected from laboratories and tested anonymously on an indirect and a double-antigen ELISA, both of which are based on the CT-specific Pgp3 antigen. We used cross-sectional and longitudinal descriptive analyses to explore the relationship between seropositivity and a) cumulative number of chlamydia diagnoses and b) time since most recent chlamydia diagnosis. Results 919 samples were obtained from visits when chlamydia was diagnosed and 812 during subsequent follow-up visits. Pgp3 seropositivity using the indirect ELISA increased from 57.1% (95% confidence interval: 53.2-60.7) on the day of a first-recorded chlamydia diagnosis to 89.6% (95%CI: 79.3-95.0) on the day of a third or higher documented diagnosis. With the double-antigen ELISA, the increase was from 61.1% (95%CI: 53.2-60.7) to 97.0% (95%CI: 88.5-99.3). Seropositivity decreased with time since CT diagnosis on only the indirect assay, to 49.3% (95%CI: 40.9-57.7) two or more years after a first diagnosis and 51.9% (95%CI: 33.2-70.0) after a repeat diagnosis. Conclusion Seropositivity increased with cumulative number of infections, and decreased over time after diagnosis on the indirect ELISA, but not on the double-antigen ELISA. This is the first study to demonstrate the combined impact of number of chlamydia diagnoses, time since diagnosis, and specific ELISA on Pgp3 seropositivity. Our findings are being used to inform models estimating age-specific chlamydia incidence over time using serial population-representative serum sample collections, to enable accurate public health monitoring of chlamydia.	[Blomquist, Paula B.; Mighelsen, Stephanie J.; Dunbar, J. Kevin; Soldan, Kate; Woodhall, Sarah C.] Publ Hlth England, Blood Safety Hepatitis Sexually Transmitted Infec, London, England; [Blomquist, Paula B.; Mighelsen, Stephanie J.; Dunbar, J. Kevin; Soldan, Kate; Woodhall, Sarah C.] UCL, Hlth Protect Res Unit Blood Borne & Sexually Tran, Publ Hlth England, London, England; [Blomquist, Paula B.; Mighelsen, Stephanie J.; Dunbar, J. Kevin; Soldan, Kate; Woodhall, Sarah C.] UCL, Hlth Protect Res Unit Blood Borne & Sexually Tran, London Sch Hyg & Trop Med, London, England; [Blomquist, Paula B.; Mighelsen, Stephanie J.; Ades, Anthony E.; Kounali, Daphne; Dunbar, J. Kevin; Soldan, Kate; Woodhall, Sarah C.; Horner, Patrick] Univ Bristol, Hlth Protect Res Unit Evaluat Intervent, Publ Hlth England, Bristol, Avon, England; [Wills, Gillian; McClure, Eleanor; McClure, Myra O.] Imperial Coll London, Fac Med, Wright Fleming Inst, Jefferiss Res Trust Labs,Sect Infect Dis, London, England; [Ades, Anthony E.; Kounali, Daphne; Horner, Patrick] Univ Bristol, Populat Hlth Sci Inst, Bristol, Avon, England	Public Health England; Public Health England; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London; Public Health England; University of Bristol; Imperial College London; University of Bristol	Blomquist, PB (corresponding author), Publ Hlth England, Blood Safety Hepatitis Sexually Transmitted Infec, London, England.; Blomquist, PB (corresponding author), UCL, Hlth Protect Res Unit Blood Borne & Sexually Tran, Publ Hlth England, London, England.; Blomquist, PB (corresponding author), UCL, Hlth Protect Res Unit Blood Borne & Sexually Tran, London Sch Hyg & Trop Med, London, England.; Blomquist, PB (corresponding author), Univ Bristol, Hlth Protect Res Unit Evaluat Intervent, Publ Hlth England, Bristol, Avon, England.	paula.blomquist@phe.gov.uk		Blomquist, Paula B/0000-0002-3962-4211; Horner, Paddy/0000-0003-0411-8332; Kounali, Daphne/0000-0002-6392-6690; Soldan, Kate/0000-0002-0361-3174; Ades, Tony/0000-0001-7822-3552	National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections at University College London; Public Health England (PHE); London School of Hygiene and Tropical Medicine (LSHTM) [HPRU-2012-10023]; NIHR HPRU in the Evaluation of Interventions at University of Bristol; PHE [HPRU-2012-10026]; NIHR BRC at Imperial Healthcare Trust; MRC [MC_U145079307, G0801947] Funding Source: UKRI	National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections at University College London; Public Health England (PHE); London School of Hygiene and Tropical Medicine (LSHTM); NIHR HPRU in the Evaluation of Interventions at University of Bristol; PHE; NIHR BRC at Imperial Healthcare Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections at University College London in partnership with Public Health England (PHE) and in collaboration with London School of Hygiene and Tropical Medicine (LSHTM) (Reference number HPRU-2012-10023), as well as the NIHR HPRU in the Evaluation of Interventions at University of Bristol in partnership with PHE (HPRU-2012-10026). The views expressed in this paper are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to all participating staff at the study sites: Dr Peter Muir at Bristol Public Health Laboratory; Dr Melinda Tenant-Flowers at the Department of Sexual Health and Dr Malur Sudhanva, Malcolm Goodwin, and Ralph Henderson at Viapath Laboratory at King's College Hospital NHS Foundation Trust; Dr Janet Wilson at Leeds Sexual Health and Dr Emma Page at the Microbiology department of Leeds General Infirmary; Dr Ade Apoola at London Road Community Hospital and Rebecca Turner at Royal Derby Hospital; Dr Reena Mani at St Mary's Sexual Health Service and Colin Walker at the Department of Clinical Microbiology in Portsmouth Hospitals NHS Trust; Dr Cecilia Priestly, Paul Davies, and Graham Marriot at Dorset County Hospital. Thank you also to contributing GUMCAD and laboratory staff at Public Health England, namely John Were, Martha Valencia, Dr Hamish Mohammed, Holly Mitchell, Francesco Tripodo, Hemanti Patel, Rachel Pitt, Dr Sarah Alexander, and Dr Aura Andreason. The authors acknowledge the Steering Committee members of the National Institute of Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections: Caroline Sabin, Anthony Nardone, Catherine Mercer, Gwenda Hughes, Greta Rait, Jackie Cassell, William Rosenberg, Tim Rhodes, Kholoud Porter, and Samreen Ijaz. Finally, we are grateful to the NIHR BRC at Imperial Healthcare Trust for its support of this study.	Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; GUMP DW, 1983, AM J OBSTET GYNECOL, V146, P153, DOI 10.1016/0002-9378(83)91044-X; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Horner PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151497; Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386; Johnson AM, 2008, SEX TRANSM INFECT, V84, P79, DOI 10.1136/sti.2007.028472; Migchelsen SJ, 2017, PUBL HLTH ENGL APPL; Price MJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20220; Public Health England, 2016, SEX TRANSM INF CHLAM; Public Health England, 2016, NAT CHLAM SCREEN PRO; Savage E J, 2012, Euro Surveill, V17; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; TREHARNE JD, 1979, BRIT J VENER DIS, V55, P26; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09; Woodhall SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0152810	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208652	10.1371/journaI.pone.0208652	http://dx.doi.org/10.1371/journaI.pone.0208652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557408				2022-12-26	WOS:000453451000036
J	Ferrer-Perez, C; Martinez, TE; Montagud-Romero, S; Ballestin, R; Reguilon, MD; Minarro, J; Rodriguez-Arias, M				Ferrer-Perez, Carmen; Escriva Martinez, Tamara; Montagud-Romero, Sandra; Ballestin, Raul; Reguilon, Marina D.; Minarro, Jose; Rodriguez-Arias, Marta			Indomethacin blocks the increased conditioned rewarding effects of cocaine induced by repeated social defeat	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; VENTRAL TEGMENTAL AREA; PLACE PREFERENCE; INDUCED NEUROINFLAMMATION; RECEPTOR ANTAGONISM; ETHANOL TREATMENT; ADOLESCENT MICE; STRESS; BRAIN; ABUSE	It is well established that repeated social defeat stress can induce negative long-term consequences such as increased anxiety-like behavior and enhances the reinforcing effect of psychostimulants in rodents. In the current study, we evaluated how the immune system may play a role in these long-term effects of stress. A total of 148 OF1 mice were divided into different experimental groups according to stress condition (exploration or social defeat) and pre-treatment (saline, 5 or 10 mg/kg of the anti-inflammatory indomethacin) before each social defeat or exploration episode. Three weeks after the last social defeat, anxiety was evaluated using an elevated plus maze paradigm. After this test, conditioned place preference (CPP) was induced by a subthreshold dose of cocaine (1 mg/kg). Biological samples were taken four hours after the first and the fourth social defeat, 3 weeks after the last defeat episode, and after the CPP procedure. Plasma and brain tissue (prefrontal cortex, striatum and hippocampus) were used to determine the levels of the pro-inflammatory cytokine interleukin 6 (IL-6). Results showed an increase of peripheral and brain IL-6 levels after the first and fourth social defeat that was reverted three weeks later. Intraperitoneal administration of the anti-inflammatory drug indomethacin before each episode of stress prevented this enhancement of IL-6 levels and also reversed the increase in the rewarding effects of cocaine in defeated mice. Conversely, this protective effect was not observed with respect to the anxiogenic consequences of social stress. Our results confirm the hypothesis of a modulatory proinflammatory contribution to stress-induced vulnerability to drug abuse disorders and highlight anti-inflammatory interventions as a potential therapeutic tool to treat stress-related addiction disorders.	[Ferrer-Perez, Carmen; Escriva Martinez, Tamara; Montagud-Romero, Sandra; Ballestin, Raul; Reguilon, Marina D.; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Fac Psychol, Dept Psychobiol, Valencia, Spain	University of Valencia	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psychol, Dept Psychobiol, Valencia, Spain.	marta.rodriguez@uv.es	Romero, Sandra Montagud/AAF-9408-2021; Rodriguez-Arias, Marta/B-5163-2011; Hinojosa, Raúl Ballestín/S-3626-2017; Minarro, Jose/B-4414-2011; /AAN-8627-2020; Ferrer-Pérez, Carmen/AAQ-9428-2020	Romero, Sandra Montagud/0000-0002-3380-7252; Hinojosa, Raúl Ballestín/0000-0003-1695-7010; Minarro, Jose/0000-0002-5731-7821; Ferrer-Pérez, Carmen/0000-0002-8890-4869; Rodriguez-Arias, Marta/0000-0002-1121-8879; Reguilon Romero, Marina Daiana/0000-0002-9844-7438; Escriva-Martinez, Tamara/0000-0001-6632-8402	Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion [PSI2014-51847-R, PSI 2017-83023-R]; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) [RETICS RD12/0028/0005, RD16/0017/0007]; Union Europea, Fondos FEDER "A way to build Europe"	Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA); Union Europea, Fondos FEDER "A way to build Europe"	This work was supported by the Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R and PSI 2017-83023-R; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) (RETICS RD12/0028/0005 and RD16/0017/0007) and Union Europea, Fondos FEDER "A way to build Europe". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Alavi M, 2012, J GASTROEN HEPATOL, V27, P957, DOI 10.1111/j.1440-1746.2011.07035.x; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Araos P, 2015, ADDICT BIOL, V20, P756, DOI 10.1111/adb.12156; Bhattacharya A, 2016, PSYCHOPHARMACOLOGY, V233, P1623, DOI 10.1007/s00213-016-4214-0; Birerdinc A, 2012, BRAIN BEHAV, V2, P525, DOI 10.1002/brb3.72; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Borgland SL, 2010, BRAIN RES, V1314, P139, DOI 10.1016/j.brainres.2009.10.068; Boyson CO, 2011, PSYCHOPHARMACOLOGY, V218, P257, DOI 10.1007/s00213-011-2266-8; Burke AR, 2016, PSYCHOPHARMACOLOGY, V233, P2727, DOI 10.1007/s00213-016-4336-4; Arenas MC, 2014, PHYSIOL BEHAV, V133, P152, DOI 10.1016/j.physbeh.2014.05.028; Charney DS., 2004, FOCUS, V2, P368, DOI [10.1176/foc.2.3.368, DOI 10.1176/FOC.2.3.368]; Chen CL, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-96; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Coller JK, 2012, PHARMACOL THERAPEUT, V134, P219, DOI 10.1016/j.pharmthera.2012.01.008; Covington HE, 2001, PSYCHOPHARMACOLOGY, V158, P388, DOI 10.1007/s002130100858; Crews FT, 2014, INT REV NEUROBIOL, V118, P315, DOI 10.1016/B978-0-12-801284-0.00010-5; Cui CH, 2014, INT REV NEUROBIOL, V118, P1, DOI 10.1016/B978-0-12-801284-0.00001-4; Daza-Losada M, 2009, NEUROTOXICOL TERATOL, V31, P49, DOI 10.1016/j.ntt.2008.07.005; Duque A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173182; Ferrer-Perez C, 2018, EUR J PHARMACOL, V823, P87, DOI 10.1016/j.ejphar.2018.01.052; Fiedorowicz JG, 2015, J AFFECT DISORDERS, V187, P172, DOI 10.1016/j.jad.2015.08.036; Finnell JE, 2018, BIOL PSYCHIAT, V84, P372, DOI 10.1016/j.biopsych.2018.01.013; Garcia-Pardo MP, 2015, PROG NEURO-PSYCHOPH, V63, P98, DOI 10.1016/j.pnpbp.2015.06.006; Goldstein BI, 2011, J CHILD ADOL PSYCHOP, V21, P479, DOI 10.1089/cap.2011.0009; Goldstein DS, 2002, STRESS, V5, P54, DOI 10.1080/10253890290012345; Gonzalez-Reimers E, 2014, WORLD J GASTROENTERO, V20, P14660, DOI 10.3748/wjg.v20.i40.14660; Haass-Koffler CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00091; Han X, 2017, PSYCHOPHARMACOLOGY, V234, P2813, DOI 10.1007/s00213-017-4676-8; Harricharan R, 2017, PROG BRAIN RES, V235, P65, DOI 10.1016/bs.pbr.2017.07.012; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; Hodes GE, 2016, NEUROBIOL STRESS, V4, P15, DOI 10.1016/j.ynstr.2016.03.003; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Holly EN, 2016, J NEUROSCI, V36, P4093, DOI 10.1523/JNEUROSCI.2232-15.2016; Hueston CM, 2011, PHYSIOL BEHAV, V104, P187, DOI 10.1016/j.physbeh.2011.03.013; Hutchinson MR, 2014, NEUROPHARMACOLOGY, V76, P218, DOI 10.1016/j.neuropharm.2013.05.039; Iniguez SD, 2014, STRESS, V17, P247, DOI 10.3109/10253890.2014.910650; Iwata M, 2016, BIOL PSYCHIAT, V80, P12, DOI 10.1016/j.biopsych.2015.11.026; Kalelioglu T, 2015, PSYCHIAT RES, V228, P925, DOI 10.1016/j.psychres.2015.05.110; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Khandaker GM, 2016, PSYCHOPHARMACOLOGY, V233, P1559, DOI 10.1007/s00213-015-3975-1; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lo Iacono L, 2018, BIOL PSYCHIAT, V84, P905, DOI 10.1016/j.biopsych.2018.05.022; Logrip ML, 2011, CNS DRUGS, V25, P271, DOI 10.2165/11587790-000000000-00000; Lu L, 2003, NEUROSCI BIOBEHAV R, V27, P457, DOI 10.1016/S0149-7634(03)00073-3; MacNicol B, 2017, CAN J ANESTH, V64, P141, DOI 10.1007/s12630-016-0771-2; Maldonado C, 2006, BEHAV PHARMACOL, V17, P119, DOI 10.1097/01.fbp.0000190685.84984.ec; Maza-Quiroga R, 2017, PEERJ, V5, DOI 10.7717/peerj.3926; Menard C, 2017, NEUROPSYCHOPHARMACOL, V42, P62, DOI 10.1038/npp.2016.90; Meyers RA, 2003, NEUROREPORT, V14, P2127, DOI 10.1097/00001756-200311140-00023; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Montagud-Romero S, 2016, PROG NEURO-PSYCHOPH, V71, P144, DOI 10.1016/j.pnpbp.2016.07.008; Montagud-Romero S, 2016, PROG NEURO-PSYCHOPH, V70, P39, DOI 10.1016/j.pnpbp.2016.04.016; Montagud-Romero S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092576; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Montesinos J, 2015, BRAIN BEHAV IMMUN, V45, P233, DOI 10.1016/j.bbi.2014.11.015; Moratalla R, 2017, PROG NEUROBIOL, V155, P149, DOI 10.1016/j.pneurobio.2015.09.011; Moreira FP, 2016, DRUG ALCOHOL DEPEN, V158, P181, DOI 10.1016/j.drugalcdep.2015.11.024; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Neisewander JL, 2012, PSYCHOPHARMACOLOGY, V224, P33, DOI 10.1007/s00213-012-2853-3; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pascual M, 2018, J NEUROSCI RES, V96, P765, DOI 10.1002/jnr.24203; Pfau ML, 2016, TRENDS NEUROSCI, V39, P353, DOI 10.1016/j.tins.2016.04.004; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Rodrigues LCM, 2014, ACTA NEUROPSYCHIATR, V26, P334, DOI 10.1017/neu.2014.24; Rodriguez-Arias M, 1998, EUR NEUROPSYCHOPHARM, V8, P95, DOI 10.1016/S0924-977X(97)00051-5; Rodriguez-Arias M, 2017, ADDICT BIOL, V22, P129, DOI 10.1111/adb.12301; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Silverman MN, 2004, ENDOCRINOLOGY, V145, P3580, DOI 10.1210/en.2003-1421; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Valles SL, 2004, BRAIN PATHOL, V14, P365; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Vidal-Infer A, 2012, PHARMACOL BIOCHEM BE, V102, P124, DOI 10.1016/j.pbb.2012.03.031; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Xu Enquan, 2017, Int J Physiol Pathophysiol Pharmacol, V9, P84; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Zhao Y, 2006, J NEUROSCI, V26, P9967, DOI 10.1523/JNEUROSCI.2384-06.2006; Zorrilla EP, 2014, FRONT NEUROENDOCRIN, V35, P234, DOI 10.1016/j.yfrne.2014.01.001	88	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209291	10.1371/journal.pone.0209291	http://dx.doi.org/10.1371/journal.pone.0209291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557308	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000089
J	Saleh, S; Bongololo, G; Banda, H; Thomson, R; Stenberg, B; Squire, B; Tolhurst, R; Dean, L				Saleh, Sepeedeh; Bongololo, Grace; Banda, Hastings; Thomson, Rachael; Stenberg, Berthe; Squire, Bertie; Tolhurst, Rachel; Dean, Laura			Health seeking for chronic lung disease in central Malawi: Adapting existing models using insights from a qualitative study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA	Background Chronic lung diseases contribute to the growing non-communicable disease (NCD) burden and are increasing, particularly in many low and middle-income countries (LMIC) in sub-Saharan African. Early engagement with health systems in chronic lung disease management is critical to maintain quality of life and prevent further damage. Our study sought to understand health seeking behaviour in relation to chronic lung disease and TB in a rural district in Malawi. Methods Qualitative data was collected between March-May 2015, exploring patterns of health seeking for lung disease amongst residents of two districts in rural Malawi. Participants included those with and without lung disease, health workers and village leaders. Participants with a history of TB were included in the sample due to similarities in clinical presentation and in view of potential to cause long-term damage to lung tissue. Results Our findings are ordered around a specific model of health seeking devised by adapting previous models. The model and findings span three broad areas that were found to influence health seeking: understandings of health and disease which shaped whether, when and where to seek care; the care seeking decision which was influenced by social and structural factors; and the care seeking experience which impacted future care decisions creating 'feedback loops'. Discussion Efforts to improve effective and accessible healthcare provision for chronic lung disease need to address all the determinants of health seeking behaviour identified. This may include: enhancing the structural and financial accessibility of health services, through the strengthening of community linkages; improving communication between formal health providers, patients and communities around symptoms, diagnosis and management of chronic lung diseases; and improving the quality of diagnostic and management services through the strengthening of health system 'hardware' (equipment availability) and 'software' (development of trusting and respectful relationships between providers and patients).	[Saleh, Sepeedeh; Thomson, Rachael; Squire, Bertie; Tolhurst, Rachel; Dean, Laura] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Bongololo, Grace; Banda, Hastings] Res Equ & Community Hlth REACH Trust, Lilongwe, Malawi; [Stenberg, Berthe] LHL Int TB Fdn, Oslo, Norway	Liverpool School of Tropical Medicine; University of Liverpool	Saleh, S (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England.	sepeedeh.saleh@lstmed.ac.uk		Thomson, Rachael/0000-0001-5010-3428; Saleh, Sepeedeh/0000-0003-1944-1677; Tolhurst, Rachel/0000-0002-3005-6641; Dean, Laura/0000-0002-4910-9707; Squire, Stephen/0000-0001-7173-9038	Norwegian Health and Lung Health Association's International Tuberculosis Foundation (LHL) International; Norwegian Government through The Norwegian Agency for Development Cooperation (NORAD); IMPALA [16/136/35]; Wellcome Trust [203919/Z/16/Z]	Norwegian Health and Lung Health Association's International Tuberculosis Foundation (LHL) International; Norwegian Government through The Norwegian Agency for Development Cooperation (NORAD); IMPALA; Wellcome Trust(Wellcome TrustEuropean Commission)	We express our gratitude to The Norwegian Health and Lung Health Association's International Tuberculosis Foundation (LHL) International and the Norwegian Government through The Norwegian Agency for Development Cooperation (NORAD) for the financial support towards this study. We also thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - "IMPALA" for helping to make this work possible. In relation to IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National Institute of Health Research using Official Development Assistance (ODA) funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Sepeedeh Saleh is a Wellcome Trust Supported Clinical PhD Programme Fellow (grant number 203919/Z/16/Z). Bertie Squire, Rachael Thomson, Rachel Tolhurst and Laura Dean are employed by the Liverpool School of Tropical Medicine (LSTM) which is a registered charitable, UK-based research and teaching institution. Its mission is to save lives in resource poor countries through research, education and capacity strengthening.	ABIIRO GA, 2014, BMC HEALTH SERV RES, V14; Ahmed R, 2017, MALAWI MED J, V29, P203, DOI 10.4314/mmj.v29i2.24; Allain TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168368; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, MALAWI NATIONAL TUBE; Banda HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188437; Chen Lincoln C., 1994, HLTH SOCIAL CHANGE I; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; De Gabriele J., 1999, WHEN PILLS DONT WORK, P9; Ewing VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125439; Ewing VL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-32; Good CM., 1987, ETHNOMEDICAL SYSTEMS; Husserl Edmund, 1970, INTRO PHENOMENOLOGIC; Ingstad B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-15; Janzen J.M., 1978, QUEST THERAPY LOWER; Makwakwa L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-132; Mishel M H, 1990, Image J Nurs Sch, V22, P256; MORRIS B, 1985, Society of Malawi Journal, V38, P14; Morris B., 1996, CHEWA MED BOT STUDY; Mortimer K, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA1127; Muela S Hausmann, 2012, MALARIA REPORTS, V2, P17; Muela SH, 2002, SOC SCI MED, V55, P403; Naghavi M, 2013, LANCET, V381, P95; National Statistical Office/ Malawi ICF, 2017, MALAWI DEMOGRAPHIC A; Pool R., 2005, MED ANTHROPOL; Rao D, 2006, ETHNIC HEALTH, V11, P153, DOI 10.1080/13557850500460306; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; ROMANUCCIROSS L, 1969, J HLTH SOCIAL BEHAV, V10, P201; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Steinforth AS, 2009, TROUBLED MINDS ON TH; Strutzel E., 1968, DISCOVERY GROUNDED T, V17, P364, DOI [10.1097/00006199-196807000-00014, DOI 10.1097/00006199-196807000-00014]; Theobald Sally, 2015, BMC Proc, V9, pS8, DOI 10.1186/1753-6561-9-S10-S8; Tomison T., 2013, WORLDS APART HEALTH; Vaga BB, 2002, SEARCH CARE CURE EXP; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; WHO, 2017, ASTHMA FACT SHEET; World Bank, 2013, COMP STAT METHODS DI; World Health Organization, 2017, CHRONIC OBSTRUCTIVE	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208188	10.1371/journal.pone.0208188	http://dx.doi.org/10.1371/journal.pone.0208188			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557307	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000453451000023
J	Terada, K; Migita, K; Matsushima, Y; Sugimoto, Y; Kamei, C; Matsumoto, T; Mori, M; Matsunaga, K; Takata, J; Karube, Y				Terada, Kazuki; Migita, Keisuke; Matsushima, Yukari; Sugimoto, Yumi; Kamei, Chiaki; Matsumoto, Taichi; Mori, Masayoshi; Matsunaga, Kazuhisa; Takata, Jiro; Karube, Yoshiharu			Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RAT-BRAIN; CHOLINERGIC SYSTEM; NUCLEUS BASALIS; DONEPEZIL; AGONISTS; KINASE; NEUROPROTECTION; ACTIVATION; EXPRESSION	Rivastigmine (Riv) is a potent and selective cholinesterase (acetylcholinesterase, AChE and butyrylcholinesterase, BuChE) inhibitor developed for the treatment of Alzheimer's disease (AD). To elucidate whether Riv causes neuronal differentiation, we examined its effect on nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. At concentrations of 0-100 mu M, Riv was non-toxic in PC12 cells. Riv caused dose-dependent (10-100 mu M) enhancement of NGF-induced neurite outgrowth, which was completely inhibited by the TrkA antagonist GW-441756. By contrast, Riv-mediated enhancement of neurite outgrowth was not blocked by the acetylcholine receptor antagonists, scopolamine and hexamethonium. However, the sigma-1 receptor (Sig-1R) antagonist NE-100 and sigma-2 receptor (Sig-2R) antagonist SM-21 each blocked about half of the Riv-mediated enhancement of NGF-induced neurite outgrowth. Interestingly, the simultaneous application of NE-100 and SM-21 completely blocked the enhancement of NGF-induced neurite outgrowth by Riv. These findings suggest that both Sig-1R and Sig-2R play important roles in NGF-induced neurite outgrowth through TrkA and that Riv may contribute to neuronal repair via Sig-1R and Sig-2R in AD therapy.	[Terada, Kazuki; Migita, Keisuke; Matsumoto, Taichi; Mori, Masayoshi; Matsunaga, Kazuhisa; Takata, Jiro; Karube, Yoshiharu] Fukuoka Univ, Dept Pharmaceut Sci, Fukuoka, Fukuoka, Japan; [Matsushima, Yukari; Kamei, Chiaki] Yasuda Womens Univ, Fac Pharmaceut Sci, Hiroshima, Japan; [Sugimoto, Yumi] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Himeji, Hyogo, Japan	Fukuoka University; Himeji Dokkyo University	Terada, K (corresponding author), Fukuoka Univ, Dept Pharmaceut Sci, Fukuoka, Fukuoka, Japan.	kterada@fukuoka-u.ac.jp	Migita, Keisuke/E-8274-2013		MEXT (Ministry of Education, Culture, Sports, Science and Technology)/JSPS (Japan Society for the Promotion of Science) KAKENHI [JP16K18888]	MEXT (Ministry of Education, Culture, Sports, Science and Technology)/JSPS (Japan Society for the Promotion of Science) KAKENHI	This work was supported by the grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology)/JSPS (Japan Society for the Promotion of Science) KAKENHI (grant number JP16K18888) to KT; https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16K18888/.	Albayrak Y, 2017, ADV EXP MED BIOL, V964, P153, DOI 10.1007/978-3-319-50174-1_11; Alon A, 2017, P NATL ACAD SCI USA, V114, P7160, DOI 10.1073/pnas.1705154114; Alonso G, 2000, NEUROSCIENCE, V97, P155, DOI 10.1016/S0306-4522(00)00014-2; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Behensky AA, 2013, J PHARMACOL EXP THER, V347, P458, DOI 10.1124/jpet.113.208348; Berkeley JL, 2000, J NEUROCHEM, V75, P487, DOI 10.1046/j.1471-4159.2000.0750487.x; BOWEN WD, 1989, EUR J PHARMACOL, V163, P309, DOI 10.1016/0014-2999(89)90200-8; Brammer MK, 2006, EUR J PHARMACOL, V553, P141, DOI 10.1016/j.ejphar.2006.09.038; Bullock R, 2005, CURR MED RES OPIN, V21, P1317, DOI 10.1185/030079905X56565; Cassano G, 2009, CELL CALCIUM, V45, P340, DOI 10.1016/j.ceca.2008.12.005; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Guroff G., 1985, CELL CULTURE NEUROSC, P245, DOI 10.1007/978-1-4613-2473-7_8; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hasselmann H, 2014, CNS NEUROL DISORD-DR, V13, P673, DOI 10.2174/1871527313666140618105710; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hefti F, 1996, CIBA F SYMP, V196, P54; HELLEWELL SB, 1990, BRAIN RES, V527, P244, DOI 10.1016/0006-8993(90)91143-5; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Islam M. R., 2014, ADV ALZHEIMERS DIS, V3, P128, DOI [DOI 10.4236/AAD.2014.33012, 10.4236/aad.2014.33012]; ITZHAK Y, 1985, MOL PHARMACOL, V27, P46; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Kasa P, 1997, PROG NEUROBIOL, V52, P511, DOI 10.1016/S0301-0082(97)00028-2; Kim Y, 2004, MOL CELLS, V18, P353; Kiss T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109538; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marrazzo A, 2005, NEUROREPORT, V16, P1223, DOI 10.1097/00001756-200508010-00018; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCCANN DJ, 1994, SYNAPSE, V17, P182, DOI 10.1002/syn.890170307; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; Natsvlishvili N, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0040-y; Nguyen L, 2017, ADV EXP MED BIOL, V964, P133, DOI 10.1007/978-3-319-50174-1_10; O'Brien JT, 2017, J PSYCHOPHARMACOL, V31, P147, DOI 10.1177/0269881116680924; Oda T, 2007, J PHARMACOL SCI, V104, P349, DOI 10.1254/jphs.FP0070563; OHNO M, 1995, BRAIN RES, V684, P237, DOI 10.1016/0006-8993(95)00489-D; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Rossi D, 2013, CHEMMEDCHEM, V8, P1514, DOI 10.1002/cmdc.201300218; Sahn JJ, 2017, ACS CHEM NEUROSCI, V8, P1801, DOI 10.1021/acschemneuro.7b00200; Salehi A, 1996, NEUROSCIENCE, V75, P373, DOI 10.1016/0306-4522(96)00273-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Seth P, 1998, J NEUROCHEM, V70, P922; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Takada-Takatori Y, 2009, BIOL PHARM BULL, V32, P318, DOI 10.1248/bpb.32.318; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Terada K, 2018, BOSNIAN J BASIC MED, V18, P217, DOI [10.17305/bjbms.2018.3133, DOI 10.17305/BJBMS.2018.3133]; Terada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093223; Weatherspoon JK, 1999, J PHARMACOL EXP THER, V289, P278; Webster NJG, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S1; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917; Yu CW, 2013, J MED CHEM, V56, P6775, DOI 10.1021/jm400564j	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209250	10.1371/journal.pone.0209250	http://dx.doi.org/10.1371/journal.pone.0209250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557385	gold, Green Submitted, Green Published			2022-12-26	WOS:000453451000084
J	Yodsurang, V; Tang, YQ; Takahashi, Y; Tanikawa, C; Kamatani, Y; Takahashi, A; Momozawa, Y; Fuse, N; Sugawara, J; Shimizu, A; Fukushima, A; Hishida, A; Furusyo, N; Naito, M; Wakai, K; Yamaji, T; Sawada, N; Iwasaki, M; Tsugane, S; Hirata, M; Murakami, Y; Kubo, M; Matsuda, K				Yodsurang, Varalee; Tang, Yaqi; Takahashi, Yukie; Tanikawa, Chizu; Kamatani, Yoichiro; Takahashi, Atsushi; Momozawa, Yukihide; Fuse, Nobuo; Sugawara, Junichi; Shimizu, Atsushi; Fukushima, Akimune; Hishida, Asahi; Furusyo, Norihiro; Naito, Mariko; Wakai, Kenji; Yamaji, Taiki; Sawada, Norie; Iwasaki, Motoki; Tsugane, Shoichiro; Hirata, Makoto; Murakami, Yoshinori; Kubo, Michiaki; Matsuda, Koichi			Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; HEREDITARY BREAST; RISK; IDENTIFICATION; PROJECT; DESIGN	Genome-wide association studies (GWAS) have identified greater than 30 variants associated with ovarian cancer, but most of these variants were investigated in European populations. Here, we integrated GWAS and subsequent functional analyses to identify the genetic variants with potential regulatory effects. We conducted GWAS for ovarian cancer using 681 Japanese cases and 17,492 controls and found that rs137672 on 22q13.1 exhibited a strong association with a P-value of 1.05 x 10(-7) and an odds ratio of 0.573 with a 95% confidence interval of 0.466-0.703. In addition, three previously reported SNPs, i.e., rs10088218, rs9870207 and rs1400482, were validated in the Japanese population (P < 0.05) with the same risk allele as noted in previous studies. Functional studies including regulatory feature analysis and electrophoretic mobility shift assay (EMSA) revealed two regulatory SNPs in 22q13.1, rs2072872 and rs6509, that affect the binding affinity to some nuclear proteins in ovarian cancer cells. The plausible regulatory proteins whose motifs could be affected by the allele changes of these two SNPs were also proposed. Moreover, the protective G allele of rs6509 was associated with a decreased SYNGR1 expression level in normal ovarian tissues. Our findings elucidated the regulatory variants in 22q13.1 that are associated with ovarian cancer risk.	[Yodsurang, Varalee; Tang, Yaqi; Takahashi, Yukie; Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Clin Genome Sequencing, Tokyo, Japan; [Tang, Yaqi] Univ Claude Bernard Lyon 1, Inst Pharmaceut & Biol Sci, Lyon, France; [Takahashi, Yukie] Teikyo Univ, Chiba Med Ctr, Dept Hematol, Chiba, Japan; [Tanikawa, Chizu; Hirata, Makoto; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Lab Genome Technol, Tokyo, Japan; [Kamatani, Yoichiro; Takahashi, Atsushi; Momozawa, Yukihide; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Fuse, Nobuo; Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Shimizu, Atsushi; Fukushima, Akimune] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Hishida, Asahi; Naito, Mariko; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan; [Furusyo, Norihiro] Kyushu Univ, Dept Environm Med & Infect Dis, Fukuoka, Fukuoka, Japan; [Naito, Mariko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral Epidemiol, Hiroshima, Japan; [Yamaji, Taiki; Sawada, Norie; Iwasaki, Motoki] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Epidemiol, Tokyo, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan	University of Tokyo; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Teikyo University; University of Tokyo; RIKEN; Tohoku University; Iwate Medical University; Nagoya University; Kyushu University; Hiroshima University; National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo	Matsuda, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Clin Genome Sequencing, Tokyo, Japan.; Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Human Genome Ctr, Lab Genome Technol, Tokyo, Japan.	kmatsuda@k.u-tokyo.ac.jp	Sugawara, Junichi/O-2190-2013; NAITO, Mariko/I-7264-2014; Yodsurang, Varalee/ADV-5400-2022	NAITO, Mariko/0000-0003-3794-2643; Yodsurang, Varalee/0000-0002-3622-532X; Tanikawa, Chizu/0000-0003-4759-4793	BioBank Japan project; Tohoku Medical Megabank project; Japan Agency for Medical Research and Development; National Cancer Center Research and Development Fund; Ministry of Health, Labour and Welfare of Japan; Japan Ministry of Education, Science, Sports, Culture and Technology [17015018, 221S0001]; JSPS KAKENHI Grant from the Japan Ministry of Education, Science, Sports, Culture and Technology [16H06277]; Ministry of Education, Culture, Sports, Sciences and Technology Japan	BioBank Japan project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku Medical Megabank project; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Ministry of Education, Science, Sports, Culture and Technology; JSPS KAKENHI Grant from the Japan Ministry of Education, Science, Sports, Culture and Technology; Ministry of Education, Culture, Sports, Sciences and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by the BioBank Japan project (to KM) and the Tohoku Medical Megabank project (to NF), which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology Japan and the Japan Agency for Medical Research and Development. The JPHC Study has been supported by the National Cancer Center Research and Development Fund since 2011 and was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan from 1989 to 2010 to ST. The J-MICC Study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (17015018) and Innovative Areas (221S0001) and the JSPS KAKENHI Grant (16H06277) from the Japan Ministry of Education, Science, Sports, Culture and Technology to KW.	Akiyama M, 2017, NAT GENET, V49, P1458, DOI 10.1038/ng.3951; Arai M, 2018, J HUM GENET, V63, P447, DOI 10.1038/s10038-017-0355-1; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bolton KL, 2012, J INTERN MED, V271, P366, DOI 10.1111/j.1365-2796.2011.02509.x; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen KX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5682; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Earp MA, 2014, HUM GENET, V133, P481, DOI 10.1007/s00439-013-1383-3; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hall MJ, 2009, CANCER-AM CANCER SOC, V115, P2222, DOI 10.1002/cncr.24200; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kelemen LE, 2015, NAT GENET, V47, P888, DOI 10.1038/ng.3336; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Petrov Alexey, 2004, RNA Biol, V1, P59; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Phelan CM, 2017, NAT GENET, V49, P680, DOI 10.1038/ng.3826; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Russo A, 2013, CELL CYCLE, V12, P76, DOI 10.4161/cc.22963; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sun JC, 2017, BMC SYST BIOL, V11, P27, DOI 10.1186/s12918-017-0464-7; Tanikawa C, 2018, CANCER SCI, V109, P4015, DOI 10.1111/cas.13815; Tanikawa C, 2018, CARCINOGENESIS, V39, P652, DOI 10.1093/carcin/bgy026; Tokunaga S, 2014, ANAL BIOCHEM, V465, P70, DOI 10.1016/j.ab.2014.06.020; Tsugane S, 2001, J Epidemiol, V11, pS24; Yamagami W, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e32; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209096	10.1371/journal.pone.0209096	http://dx.doi.org/10.1371/journal.pone.0209096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557369	Green Submitted, gold, Green Published			2022-12-26	WOS:000453451000067
J	Sodolescu, A; Dian, C; Terradot, L; Bouzhir-Sima, L; Lestini, R; Myllykallio, H; Skouloubris, S; Liebl, U				Sodolescu, Andreea; Dian, Cyril; Terradot, Laurent; Bouzhir-Sima, Latifa; Lestini, Roxane; Myllykallio, Hannu; Skouloubris, Stephane; Liebl, Ursula			Structural and functional insight into serine hydroxymethyltransferase from Helicobacter pylori	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; THYMIDYLATE-SYNTHASE; BACILLUS-STEAROTHERMOPHILUS; ANGSTROM RESOLUTION; GLYCINE; MECHANISM; CLONING; PROTEIN; GENES	Serine hydroxymethyltransferase (SHMT), encoded by the glyA gene, is a ubiquitous pyridoxal 5'-phosphate (PLP)-dependent enzyme that catalyzes the formation of glycine from serine. The thereby generated 5,10-methylene tetrahydrofolate (MTHF) is a major source of cellular one-carbon units and a key intermediate in thymidylate biosynthesis. While in virtually all eukaryotic and many bacterial systems thymidylate synthase ThyA, SHMT and dihydrofolate reductase (DHFR) are part of the thymidylate/folate cycle, the situation is different in organisms using flavin-dependent thymidylate synthase ThyX. Here the distinct catalytic reaction directly produces tetrahydrofolate (THF) and consequently in most ThyX-containing organisms, DHFR is absent. While the resulting influence on the folate metabolism of ThyX-containing bacteria is not fully understood, the presence of ThyX may provide growth benefits under conditions where the level of reduced folate derivatives is compromised. Interestingly, the third key enzyme implicated in generation of MTHF, serine hydroxymethyltransferase (SHMT), has a universal phylogenetic distribution, but remains understudied in ThyX-containg bacteria. To obtain functional insight into these ThyX-dependent thymidylate/folate cycles, we characterized the predicted SHMT from the ThyX-containing bacterium Helicobacter pylori. Serine hydroxymethyltransferase activity was confirmed by functional genetic complementation of a glyA-inactivated E. coli strain. A H. pylori Delta glyA strain was obtained, but exhibited markedly slowed growth and had lost the virulence factor CagA. Biochemical and spectroscopic evidence indicated formation of a characteristic enzyme-PLP-glycine-folate complex and revealed unexpectedly weak binding affinity of PLP. The three-dimensional structure of the H. pylori SHMT apoprotein was determined at 2.8 angstrom resolution, suggesting a structural basis for the low affinity of the enzyme for its cofactor. Stabilization of the proposed inactive configuration using small molecules has potential to provide a specific way for inhibiting HpSHMT.	[Sodolescu, Andreea; Bouzhir-Sima, Latifa; Lestini, Roxane; Myllykallio, Hannu; Skouloubris, Stephane; Liebl, Ursula] Univ Paris Saclay, INSERM, CNRS, Ecole Polytech,Lab Opt & Biosci, Palaiseau, France; [Dian, Cyril] Univ Paris Saclay, CNRS, Inst Integrat Biol Cell, Gif Sur Yvette, France; [Terradot, Laurent] Univ Lyon, CNRS, Inst Biol & Chim Prot, UMR 5086 Mol Microbiol & Struct Biochem, Lyon, France; [Skouloubris, Stephane] Univ Paris Saclay, Univ Paris Sud, Dept Biol, Orsay, France; [Bouzhir-Sima, Latifa] Univ Paris Saclay, Univ Paris Sud, INSERM UMR S 1174, Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Liebl, U (corresponding author), Univ Paris Saclay, INSERM, CNRS, Ecole Polytech,Lab Opt & Biosci, Palaiseau, France.	ursula.liebl@polytechnique.edu	Lestini, Roxane/R-9285-2017; Myllykallio, Hannu/Y-5462-2019; Dian, Cyril/I-4285-2012	Lestini, Roxane/0000-0001-7377-4734; Dian, Cyril/0000-0002-6349-3901; Myllykallio, Hannu/0000-0002-0541-1197; LIEBL, Ursula/0000-0003-0869-4388; Skouloubris, Stephane/0000-0001-6660-0023	Agence Nationale de la Recherche [PCV07_189094]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche grant PCV07_189094 to UL and HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Agrawal S, 2003, J MOL MICROB BIOTECH, V6, P67, DOI 10.1159/000076737; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Angelaccio S, 2014, PROTEINS, V82, P2831, DOI 10.1002/prot.24646; Angelucci F, 2014, PROTEINS, V82, P3437, DOI 10.1002/prot.24697; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Awad R, 2017, BIOCHIMIE, V137, P165, DOI 10.1016/j.biochi.2017.03.015; Baugh L, 2015, TUBERCULOSIS, V95, P142, DOI 10.1016/j.tube.2014.12.003; Bhatt AN, 2004, PROTEIN SCI, V13, P2184, DOI 10.1110/ps.04769004; BLAKLEY RL, 1955, BIOCHEM J, V61, P315, DOI 10.1042/bj0610315; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bury-Mone S, 2001, MOL MICROBIOL, V42, P1021, DOI 10.1046/j.1365-2958.2001.02689.x; CAI K, 1995, J BIOL CHEM, V270, P19294, DOI 10.1074/jbc.270.33.19294; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chaturvedi S, 2003, J BIOL CHEM, V278, P40793, DOI 10.1074/jbc.M306192200; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P1517, DOI 10.1107/S1399004714005598; CIOTTI MM, 1957, METHOD ENZYMOL, V3, P890, DOI 10.1016/S0076-6879(57)03472-2; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Dahal N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065973, 10.1371/journal.pone.0077528]; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DelleFratte S, 1997, J BACTERIOL, V179, P7456, DOI 10.1128/jb.179.23.7456-7461.1997; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Garg D, 2010, J MED CHEM, V53, P6539, DOI 10.1021/jm901869w; Giardina G, 2015, FEBS J, V282, P1225, DOI 10.1111/febs.13211; Giardina G, 2011, P NATL ACAD SCI USA, V108, P20514, DOI 10.1073/pnas.1111456108; GOTTESMAN S, 1981, J BACTERIOL, V148, P265, DOI 10.1128/JB.148.1.265-273.1981; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Humble MS, 2012, FEBS J, V279, P779, DOI 10.1111/j.1742-4658.2012.08468.x; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Keszthelyi A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120134; Kleanthous H, 2001, VACCINE, V19, P4883, DOI 10.1016/S0264-410X(01)00248-1; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Leduc D, 2007, J BACTERIOL, V189, P8537, DOI 10.1128/JB.01380-07; Levin I, 2004, MOL MICROBIOL, V54, P1307, DOI 10.1111/j.1365-2958.2004.04339.x; Liu JQ, 1998, EUR J BIOCHEM, V255, P220, DOI 10.1046/j.1432-1327.1998.2550220.x; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Maenpuen S, 2015, J BIOL CHEM, V290, P8656, DOI 10.1074/jbc.M114.612275; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD R, 1993, J BACTERIOL, V175, P5899; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Osipiuk J, 2009, NON TRADITIONAL REF; Pai VR, 2009, BIOCHEM J, V418, P635, DOI 10.1042/BJ20081739; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; PASCARELLA S, 1993, FEBS LETT, V331, P145, DOI 10.1016/0014-5793(93)80314-K; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; PIZER LI, 1965, J BACTERIOL, V89, P1145, DOI 10.1128/JB.89.4.1145-1150.1965; Rao NA, 2003, BBA-PROTEINS PROTEOM, V1647, P24, DOI 10.1016/S1570-9639(03)00043-8; RAVNIKAR PD, 1987, J BACTERIOL, V169, P2611, DOI 10.1128/jb.169.6.2611-2617.1987; Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9; Roy G, 2015, MOL BIOCHEM PARASIT, V204, P106, DOI 10.1016/j.molbiopara.2016.02.003; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sambrook J., 2001, MOL CLONING LAB MANU; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; Scarsdale JN, 1999, BIOCHEMISTRY-US, V38, P8347, DOI 10.1021/bi9904151; SCHIRCH L, 1968, J BIOL CHEM, V243, P5651; SCHIRCH L, 1980, J BIOL CHEM, V255, P7801; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Sharma S, 2007, PROTEIN EXPRES PURIF, V55, P189, DOI 10.1016/j.pep.2007.04.017; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; STOVER P, 1992, J BIOL CHEM, V267, P17679; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Tohidpour A, 2016, MICROB PATHOGENESIS, V93, P44, DOI 10.1016/j.micpath.2016.01.005; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200	82	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208850	10.1371/journal.pone.0208850	http://dx.doi.org/10.1371/journal.pone.0208850			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550583	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000029
J	Azhagesan, K; Ravindran, B; Raman, K				Azhagesan, Karthik; Ravindran, Balaraman; Raman, Karthik			Network-based features enable prediction of essential genes across diverse organisms	PLOS ONE			English	Article							CENTRALITY; DATABASE; UPDATE	Machine learning approaches to predict essential genes have gained a lot of traction in recent years. These approaches predominantly make use of sequence and network-based features to predict essential genes. However, the scope of network-based features used by the existing approaches is very narrow. Further, many of these studies focus on predicting essential genes within the same organism, which cannot be readily used to predict essential genes across organisms. Therefore, there is clearly a need for a method that is able to predict essential genes across organisms, by leveraging network-based features. In this study, we extract several sets of network-based features from protein-protein association networks available from the STRING database. Our network features include some common measures of centrality, and also some novel recursive measures recently proposed in social network literature. We extract hundreds of network-based features from networks of 27 diverse organisms to predict the essentiality of 87000+ genes. Our results show that network-based features are statistically significantly better at classifying essential genes across diverse bacterial species, compared to the current state-of-the-art methods, which use mostly sequence and a few 'conventional' network-based features. Our diverse set of network properties gave an AUROC of 0.847 and a precision of 0.320 across 27 organisms. When we augmented the complete set of network features with sequence-derived features, we achieved an improved AUROC of 0.857 and a precision of 0.335. We also constructed a reduced set of 100 sequence and network features, which gave a comparable performance. Further, we show that our features are useful for predicting essential genes in new organisms by using leave-one-species-out validation. Our network features capture the local, global and neighbourhood properties of the network and are hence effective for prediction of essential genes across diverse organisms, even in the absence of other complex biological knowledge. Our approach can be readily exploited to predict essentiality for organisms in interactome databases such as the STRING, where both network and sequence are readily available. All codes are available at https://github.com/RamanLab/nbfpeg.	[Azhagesan, Karthik; Raman, Karthik] Indian Inst Technol IIT Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Ravindran, Balaraman] IIT Madras, Dept Comp Sci & Engn, Madras 600036, Tamil Nadu, India; [Azhagesan, Karthik; Ravindran, Balaraman; Raman, Karthik] IIT Madras, IBSE, Madras 600036, Tamil Nadu, India; [Azhagesan, Karthik; Ravindran, Balaraman; Raman, Karthik] IIT Madras, RBCDSAI, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Raman, K (corresponding author), Indian Inst Technol IIT Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Ravindran, B (corresponding author), IIT Madras, Dept Comp Sci & Engn, Madras 600036, Tamil Nadu, India.; Ravindran, B; Raman, K (corresponding author), IIT Madras, IBSE, Madras 600036, Tamil Nadu, India.; Ravindran, B; Raman, K (corresponding author), IIT Madras, RBCDSAI, Madras 600036, Tamil Nadu, India.	ravi@cse.iitm.ac.in; kraman@iitm.ac.in	Raman, Karthik/Q-5278-2019; Raman, Karthik/A-6459-2011	Ravindran, Balaraman/0000-0002-5364-7639; Raman, Karthik/0000-0002-9311-7093	Intel Technology India Pvt Ltd [RB/18-19/CSE/002/INTI/BRAV]	Intel Technology India Pvt Ltd	The work was partly supported by a research grant RB/18-19/CSE/002/INTI/BRAV from Intel Technology India Pvt Ltd to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was partly supported by a research grant RB/18-19/CSE/002/INTI/BRAV from Intel Technology India Pvt Ltd to BR.	Barabasi A.-L., 2016, NETWORK SCI; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen WH, 2017, NUCLEIC ACIDS RES, V45, pD940, DOI 10.1093/nar/gkw1013; Cheng J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-910; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gupte PV, 2017, PROC INT CONF DATA, P771, DOI 10.1109/ICDE.2017.128; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Henderson K, 2011, INT ACM C KNOWL DISC, DOI DOI 10.1145/2020408.2020512; Henderson Keith, 2012, P 18 ACM SIGKDD INT, P1231, DOI DOI 10.1145/2339530.2339723; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Lin Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00053; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174638; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mobegi FM, 2017, BRIEF FUNCT GENOMICS, V16, P70, DOI 10.1093/bfgp/elv063; Nigatu D, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1884-5; Ning K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-505; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raman Karthik, 2014, Syst Synth Biol, V8, P73, DOI 10.1007/s11693-013-9123-5; Rancati G, 2018, NAT REV GENET, V19, P34, DOI 10.1038/nrg.2017.74; Song K, 2014, INTEGR BIOL-UK, V6, P460, DOI 10.1039/c3ib40241j; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Yu YM, 2017, MOL BIOSYST, V13, P577, DOI 10.1039/c6mb00806b; Zhang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113801; Zhang XY, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00151	31	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208722	10.1371/journal.pone.0208722	http://dx.doi.org/10.1371/journal.pone.0208722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543651	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500034
J	Sayed, ME; Yuan, L; Robin, JD; Tedone, E; Batten, K; Dahlson, N; Wright, WE; Shay, JW; Ludlow, AT				Sayed, Mohammed E.; Yuan, Laura; Robin, Jerome D.; Tedone, Enzo; Batten, Kimberly; Dahlson, Nicole; Wright, Woodring E.; Shay, Jerry W.; Ludlow, Andrew T.			NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells	ONCOGENE			English	Article							REVERSE-TRANSCRIPTASE HTERT; CATALYTIC SUBUNIT GENE; SPLICING PATTERNS; ALIGNMENT; HALLMARKS; ROLES	Alternative splicing is dysregulated in cancer cells, driving the production of isoforms that allow tumor cells to survive and continuously proliferate. Part of the reactivation of telomerase involves the splicing of hTERT transcripts to produce full-length (FL) TERT. Very few splicing factors to date have been described to interact with hTERT and promote the production of FL TERT. We recently described one such splicing factor, NOVA1, that acts as an enhancer of FL hTERT splicing, increases telomerase activity, and promotes telomere maintenance in cancer cells. NOVA1 is expressed primarily in neurons and is involved in neurogenesis. In the present studies, we describe that polypyrimidine-tract binding proteins (PTBPs), which are also typically involved in neurogenesis, are also participating in the splicing of hTERT to FL in cancer. Knockdown experiments of PTBP1 in cancer cells indicate that PTBP1 reduces hTERT FL splicing and telomerase activity. Stable knockdown of PTBP1 results in progressively shortened telomere length in H1299 and H920 lung cancer cells. RNA pulldown experiments reveal that PTBP1 interacts with hTERT pre-mRNA in a NOVA1 dependent fashion. Knockdown of PTBP1 increases the expression of PTBP2 which also interacts with NOVA1, potentially preventing the association of NOVA1 with hTERT pre-mRNA. These new data highlight that splicing in cancer cells is regulated by competition for splice sites and that combinations of splicing factors interact at cis regulatory sites on pre-mRNA transcripts. By employing hTERT as a model gene, we show the coordination of the splicing factors NOVA1 and PTBP1 in cancer by regulating telomerase that is expressed in the vast majority of cancer cell types.	[Sayed, Mohammed E.; Ludlow, Andrew T.] Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Yuan, Laura; Tedone, Enzo; Batten, Kimberly; Dahlson, Nicole; Wright, Woodring E.; Shay, Jerry W.] UT Southwestern Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Robin, Jerome D.] Aix Marseille Univ, UMR125, MMG, F-13385 Marseille, France	University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; Aix-Marseille Universite	Ludlow, AT (corresponding author), Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	atludlow@umich.edu	Robin, Jerome/AAD-4309-2019	Robin, Jerome/0000-0001-5865-8372; Ludlow, Andrew/0000-0003-0423-4800; Wright, Woodring/0000-0001-6838-6665	NIH [C06 RR30414]; National Institute on Aging [AG01228]; T32 Training Grant [CA124334]; Pathway to Independence award (National Cancer Institute (NCI)) [K99/R00 CA197672-01A1]; Harold Simmons NCI Designated Comprehensive Cancer Center Support Grant [CA142543]; NCI SPORE [CA070907]; NATIONAL CANCER INSTITUTE [K99CA197672, P30CA142543, T32CA124334, R00CA197672, P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001228] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); T32 Training Grant; Pathway to Independence award (National Cancer Institute (NCI)); Harold Simmons NCI Designated Comprehensive Cancer Center Support Grant; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. John Minna and Adi Gazdar for cell lines. We acknowledge Henrietta Lacks and her family members for the important contributions "HeLa" cells have made to this work. This work was performed in laboratories constructed with support from NIH Grant C06 RR30414. This work was supported by AG01228 from the National Institute on Aging (WEW and JWS) and by a T32 Training Grant CA124334 (JWS). A Pathway to Independence award to ATL (K99/R00 CA197672-01A1, National Cancer Institute (NCI)). We also acknowledge the Harold Simmons NCI Designated Comprehensive Cancer Center Support Grant (CA142543), the NCI SPORE (CA070907), and the Southland Financial Corporation Distinguished Chair in Geriatric Research (JWS and WEW).	Avilion AA, 1996, CANCER RES, V56, P645; Aviv A, 2017, TRENDS CANCER, V3, P253, DOI 10.1016/j.trecan.2017.02.005; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He X, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.47; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016; Lai TP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01291-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linares AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09268; Ludlow AT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05582-x; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Monaghan P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0435; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Saito Y, 2016, ELIFE, V5, DOI 10.7554/eLife.14371; Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Ulaner GA, 1998, CANCER RES, V58, P4168; Ulaner GA, 2000, INT J CANCER, V85, P330, DOI 10.1002/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U; Withers JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048016; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Wong MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4306; Wong MS, 2013, CELL REP, V3, P1028, DOI 10.1016/j.celrep.2013.03.011; Wright WE, 1996, EMBO J, V15, P1734, DOI 10.1002/j.1460-2075.1996.tb00519.x; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Young AJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0452; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	37	29	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					2937	2952		10.1038/s41388-018-0639-8	http://dx.doi.org/10.1038/s41388-018-0639-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30568224	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000465167600005
J	Park, JK; Kim, YS; Kang, SU; Lee, YS; Won, HR; Kim, CH				Park, Ju Kyeong; Kim, Yeon Soo; Kang, Sung Un; Lee, Yun Sang; Won, Ho-Ryun; Kim, Chul-Ho			Nonthermal atmospheric plasma enhances myoblast differentiation by eliciting STAT3 phosphorylation	FASEB JOURNAL			English	Article						muscle regeneration; myogenin; myosin heavy chain	MUSCLE SATELLITE CELLS; TISSUE; REGENERATION; CONTRIBUTES; PATHWAY	The use of nonthermal atmospheric plasma (NTP) in the biomedical field has recently expanded into cell death induction in cancer, infection prevention, inflammation treatment, and wound-healing enhancement. NTP has been demonstrated to enhance skin and muscle regeneration, but its effects on tissue regeneration, following deep tissue or muscle damage, remains underinvestigated. In this study, we determined the effects of NTP on muscle differentiation and the mechanisms of NTP's contribution to differentiation and regeneration. NTP treatment enhanced cell differentiation in primary normal human skeletal muscle myoblast cells and increased the relative expression of mRNA levels of MyoD which is one of the earliest markers of myogenic commitment, and myogenin, which are important transcription factors required for myogenic differentiation. Furthermore, NTP treatment induced increases in the levels of myosin heavy chain, a differentiated muscle-specific protein, and in myotube formation of myoblasts. We observed that signal transducer and activator of transcription 3 (STAT3) activation induced by NTP treatment affects the myogenic differentiation. In addition, STAT3 phosphorylation was also enhanced by NTP treatment in injured animal muscle. These findings indicate that NTP could enhance musculoskeletal differentiation by acting as an external stimulus for myoblast differentiation, suggesting its treatment potential in promoting regeneration of damaged muscle.Park, J. K., Kim, Y. S., Kang, S. U., Lee, Y. S., Won, H.-R., Kim, C.-H. Nonthermal atmospheric plasma enhances myoblast differentiation by eliciting STAT3 phosphorylation.	[Park, Ju Kyeong] Natl Inst Food & Drug Safety Evaluat, Toxicol Evaluat Res Dept, Lab Anim Resources Div, Cheongju, South Korea; [Kim, Yeon Soo] Konyang Univ, Konyang Univ Hosp, Coll Med, Dept Otorhinolaryngol,Myunggok Med Res Inst, Daejeon, South Korea; [Kang, Sung Un; Lee, Yun Sang; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, 164 World Cup Ro, Suwon 443380, South Korea; [Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Won, Ho-Ryun] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Konyang University; Konyang University Hospital; Ajou University; Ajou University; Chungnam National University; Chungnam National University Hospital	Kim, CH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, 164 World Cup Ro, Suwon 443380, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		Basic Science Research Program through the National Research Foundation (NRF) - Korean Ministry of Science, Information, and Communications Technology and Future Planning [2017M3A9F7079339]; Ministry of Education [2016R1D1A3B03933948]	Basic Science Research Program through the National Research Foundation (NRF) - Korean Ministry of Science, Information, and Communications Technology and Future Planning; Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Korean Ministry of Science, Information, and Communications Technology and Future Planning (Grant 2017M3A9F7079339 to C.-H.K.), and the Ministry of Education (Grant 2016R1D1A3B03933948 to Y.S.K.). The authors declare no conflicts of interest.	Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Assis L, 2013, LASER MED SCI, V28, P947, DOI 10.1007/s10103-012-1183-3; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019; Bryan N, 2014, J BIOMED MATER RES B, V102, P709, DOI 10.1002/jbm.b.33050; Chang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105705; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Choi JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28829; Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761; Jang YN, 2013, JAK STAT, V2; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kim SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20332; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee OJ, 2016, J TISSUE ENG REGEN M, V10, P348, DOI 10.1002/term.2074; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Rizzi Roberto, 2012, Muscles Ligaments Tendons J, V2, P230; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Steinbeck MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082143; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Xing HY, 2015, MUSCLE NERVE, V51, P400, DOI 10.1002/mus.24322	25	4	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4097	4106		10.1096/fj.201800695RR	http://dx.doi.org/10.1096/fj.201800695RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30548079	Bronze			2022-12-26	WOS:000459794800080
J	Chiodi, CG; Baptista-Hon, DT; Hunter, WN; Hales, TG				Chiodi, Carla Gottschald; Baptista-Hon, Daniel T.; Hunter, William N.; Hales, Tim G.			Amino acid substitutions in the human homomeric beta(3) GABA(A) receptor that enable activation by GABA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gamma-aminobutyric acid (GABA); GABA receptor; Cys-loop receptor; mutagenesis in vitro; receptor structure-function; anesthetic; ion channel; ligand-binding protein; patch clamp; gating; benzodiazepine; general anaesthetic; propofol	BINDING-SITE; GATING MECHANISM; AGONIST BINDING; LOOP G; DESENSITIZATION; PROPOFOL; REGION; DEACTIVATION; POTENTIATION; MODULATION	GABA(A) receptors (GABA(A)Rs) are pentameric ligand-gated ion channels that mediate synaptic inhibition throughout the central nervous system. The alpha(1)beta(2)gamma(2) receptor is the major subtype in the brain; GABA binds at the beta(2)(+)alpha(1)(-) interface. The structure of the homomeric beta(3) GABA(A)R, which is not activated by GABA, has been solved. Recently, four additional heteromeric structures were reported, highlighting key residues required for agonist binding. Here, we used a protein engineering method, taking advantage of knowledge of the key binding residues, to create a beta(3)(+)alpha(1)(-) heteromeric interface in the homomeric human beta(3) GABA(A)R that enables GABA-mediated activation. Substitutions were made in the complementary side of the orthosteric binding site in loop D (Y87F and Q89R), loop E (G152T), and loop G (N66D and A70T). The Q89R and G152T combination enabled low-potency activation by GABA and potentiation by propofol but impaired direct activation by higher propofol concentrations. At higher concentrations, GABA inhibited gating of beta(3) GABA(A)R variants containing Y87F, Q89R, and G152T. Reversion of Phe(87) to tyrosine abolished GABA's inhibitory effect and partially recovered direct activation by propofol. This tyrosine is conserved in homomeric GABA(A)Rs and in the Erwinia chrysanthemi ligand-gated ion channel and may be essential for the absence of an inhibitory effect of GABA on homomeric channels. This work demonstrated that only two substitutions, Q89R and G152T, in beta(3) GABA(A)R are sufficient to reconstitute GABA-mediated activation and suggests that Tyr(87) prevents inhibitory effects of GABA.	[Chiodi, Carla Gottschald; Hunter, William N.] Univ Dundee, Sch Life Sci, Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Baptista-Hon, Daniel T.; Hales, Tim G.] Univ Dundee, Ninewells Hosp, Sch Med, Inst Acad Anaesthesia,Div Syst Med, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Hales, TG (corresponding author), Univ Dundee, Ninewells Hosp, Sch Med, Inst Acad Anaesthesia,Div Syst Med, Dundee DD1 9SY, Scotland.	t.g.hales@dundee.ac.uk	Baptista-Hon, Daniel/AAI-6776-2021; Hunter, William/AAE-3947-2019; Gottschald Chiodi, Carla/D-4191-2013; Chiodi, Carla Gottschald/M-9242-2019	Baptista-Hon, Daniel/0000-0002-5358-1035; Gottschald Chiodi, Carla/0000-0002-6362-5388; Chiodi, Carla Gottschald/0000-0002-6362-5388	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme [BEX 0321/13-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme Grant BEX 0321/13-3 (to C. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Ashby JA, 2012, BIOPHYS J, V103, P2071, DOI 10.1016/j.bpj.2012.10.016; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Baptista-Hon DT, 2017, J PHYSIOL-LONDON, V595, P1725, DOI 10.1113/JP273752; Baptista-Hon DT, 2016, J PHYSIOL-LONDON, V594, P5555, DOI 10.1113/JP272463; Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; Dawson GR, 2005, CNS SPECTRUMS, V10, P21, DOI 10.1017/S1092852900009871; Defeudis F. V., 1986, THE RECEPTORS, P135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; Hales TG, 2006, J BIOL CHEM, V281, P17034, DOI 10.1074/jbc.M603599200; Harrison NJ, 2006, J BIOL CHEM, V281, P24455, DOI 10.1074/jbc.M601775200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; Hollands EC, 2009, J BIOMOL SCREEN, V14, P769, DOI 10.1177/1087057109335675; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jones MV, 1998, J NEUROSCI, V18, P8590; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; Kumar M, 2016, EUR J PHARMACOL, V775, P149, DOI 10.1016/j.ejphar.2016.02.031; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; McCartney MR, 2007, MOL PHARMACOL, V71, P539, DOI 10.1124/mol.106.028597; Mellor JR, 1997, J PHYSIOL-LONDON, V503, P353, DOI 10.1111/j.1469-7793.1997.353bh.x; Miller P, 2018, BIORXIV, DOI [10.1101/338343, DOI 10.1101/338343]; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; ORSER BA, 1994, J NEUROSCI, V14, P7747; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; ROGNAN D, 1992, J MED CHEM, V35, P1969, DOI 10.1021/jm00089a005; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; SCHWARTZ RD, 1986, MOL PHARMACOL, V30, P419; Seeger C, 2012, BIOCHEM PHARMACOL, V84, P341, DOI 10.1016/j.bcp.2012.04.008; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Szczot M, 2014, J NEUROSCI, V34, P3193, DOI 10.1523/JNEUROSCI.2533-13.2014; Thompson SA, 1996, BRIT J PHARMACOL, V117, P521, DOI 10.1111/j.1476-5381.1996.tb15221.x; Torres VI, 2002, J BIOL CHEM, V277, P43741, DOI 10.1074/jbc.M202007200; Trumper P., 2014, THESIS; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Zhang JL, 2013, MOL NEUROBIOL, V48, P97, DOI 10.1007/s12035-013-8420-z; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	58	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2375	2385		10.1074/jbc.RA118.006229	http://dx.doi.org/10.1074/jbc.RA118.006229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545943	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000458895400015
J	Chang, YLK; Miller, MJ; Tsukamoto, K; Miyazawa, Y				Chang, Yu-Lin K.; Miller, Michael J.; Tsukamoto, Katsumi; Miyazawa, Yasumasa			Effect of larval swimming in the western North Pacific subtropical gyre on the recruitment success of the Japanese eel	PLOS ONE			English	Article							EQUATORIAL CURRENT; ANGUILLA-ANGUILLA; AMERICAN EEL; POPULATION-STRUCTURE; ENCOUNTER VOLUME; OCEANIC CHANGES; KUROSHIO EAST; STCC EDDIES; MIGRATION; VARIABILITY	The possible effect of directional larval swimming on the recruitment success of the Japanese eel, Anguilla japonica, was examined with a three-dimensional particle-tracking ocean circulation model using horizontal northwestward swimming and diel vertical migration (DVM). Four separate experiments included virtual larvae (v-larvae) movement from the spawning area over 290 days (total migration) and 160 days (stage A), from the STCC eddy region in 70 days (stage B), and from the origin of the Kuroshio in 60 days (stage C) to evaluate the effect of directional swimming and DVM compared to simple drifting. Passive or random swimming were not the most effective strategies for larvae dispersing from the spawning area because most v-larvae remained south of 20 degrees N without entering the Kuroshio. Northwestward swimming resulted in wider dispersion and a better chance of successful recruitment, with v-larvae becoming widely distributed in the STCC eddy zone, arriving at the east coast of the Philippines (stage A), escaping the STCC eddy area and reaching the Kuroshio (stage B), and crossing the Kuroshio into the East China Sea shelf (stage C). DVM slightly shortened the migration period due to faster shallow layer ocean currents during nighttime. The NEC transported non-swimming v-larvae westward to the Kuroshio and occasionally northward into the Subtropical Countercurrent (STCC) area where eddies transported v-larvae westward into the Kuroshio, but less than with swimming. Directional swimming increased recruitment success, northwestward swimming was more effective than other directions, and a slower swimming speed was still better than no/random swimming in sensitivity tests. The present study demonstrated a first view of the possibility that Japanese eel larvae might be able to use a strategy of single-direction swimming to increase arrival at their recruitment areas.	[Chang, Yu-Lin K.; Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Miller, Michael J.; Tsukamoto, Katsumi] Nihon Univ, Dept Marine Sci & Resources, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Nihon University	Chang, YLK (corresponding author), Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan.	ychang@jamstec.go.jp	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272				Abernathey R, 2018, J PHYS OCEANOGR, V48, P667, DOI 10.1175/JPO-D-17-0102.1; Aida K, 2003, EEL BIOL, P497, DOI DOI 10.1007/978-4-431-65907-5; Andres M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004200; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Baltazar-Soares M, 2014, CURR BIOL, V24, P104, DOI 10.1016/j.cub.2013.11.031; Beguer-Pon M, 2016, MAR ECOL PROG SER, V549, P183, DOI 10.3354/meps11706; Beguer-Pon M, 2016, ICES J MAR SCI, V73, P57, DOI 10.1093/icesjms/fsv169; Blanke B, 2012, DYNAM ATMOS OCEANS, V55-56, P22, DOI 10.1016/j.dynatmoce.2012.04.003; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Bonhommeau S, 2009, FISH OCEANOGR, V18, P371, DOI 10.1111/j.1365-2419.2009.00517.x; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2014, J PHYS OCEANOGR, V44, P818, DOI 10.1175/JPO-D-13-0162.1; Chang YL, 2012, J CLIMATE, V25, P1597, DOI 10.1175/JCLI-D-11-00158.1; Chang Y-L, 2017, PLOS ONE; Chang YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161773; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chang YL, 2015, PROG OCEANOGR, V135, P64, DOI 10.1016/j.pocean.2015.04.006; Chang YL, 2014, OCEAN DYNAM, V64, P259, DOI 10.1007/s10236-013-0680-7; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Chen HX, 2009, OCEAN DYNAM, V59, P477, DOI 10.1007/s10236-009-0182-9; Chen JZ, 2014, ESTUAR COAST SHELF S, V151, P361, DOI 10.1016/j.ecss.2014.06.004; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Dekker W, 2004, SLIPPING OUR HANDS P; Dekker W, 2014, FISHERIES, V39, P613, DOI 10.1080/03632415.2014.979342; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; Fisher R, 2004, J EXP MAR BIOL ECOL, V312, P171, DOI 10.1016/j.jembe.2004.06.009; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Fukuda N, 2018, J FISH BIOL, V92, P1342, DOI 10.1111/jfb.13590; Han YS, 2012, FISH OCEANOGR, V21, P281, DOI 10.1111/j.1365-2419.2012.00624.x; Haro A, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:PDOTAE>2.0.CO;2; Hsiung KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195544; Hsu AC, 2017, FISH OCEANOGR, V26, P251, DOI 10.1111/fog.12189; Hwang C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002026; ICES, 2013, REP EIF ICES WORK GR; Itakura H, 2014, DECLINES CATCHES JAP; Johns WE, 2001, J PHYS OCEANOGR, V31, P1031, DOI 10.1175/1520-0485(2001)031<1031:TKEOTM>2.0.CO;2; Kettle AJ, 2006, CAN J FISH AQUAT SCI, V63, P90, DOI 10.1139/F05-198; Kida S, 2015, J OCEANOGR, V71, P469, DOI 10.1007/s10872-015-0283-7; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kurogi H, 2011, FISHERIES SCI, V77, P199, DOI 10.1007/s12562-010-0318-3; Kuroshio Qiu B., 2001, ENCY OCEAN SCI, P1413; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2002, ENVIRON BIOL FISH, V65, P199, DOI 10.1023/A:1020096720543; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; McCleave JD, 1998, J MAR BIOL ASSOC UK, V78, P285, DOI 10.1017/S0025315400040091; Melia P, 2013, MAR ECOL PROG SER, V487, P135, DOI 10.3354/meps10368; Miller M., 2010, ENLARGED CHROMATOPHO; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Miller MJ, 2016, ICES J MAR SCI, V73, P43, DOI 10.1093/icesjms/fsv063; Miller MJ, 2015, BIOL REV, V90, P1035, DOI 10.1111/brv.12144; Miller MJ, 2013, MAR FRESHW BEHAV PHY, V45, P375, DOI 10.1080/10236244.2013.773128; Miller MJ, 2009, AM FISH S S, V69, P231; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Ohashi K, 2015, ATMOS OCEAN, P1, DOI [10.1080/07055900.2015.1090390, DOI 10.1080/07055900.2015.1090390]; OKUBO A, 1970, DEEP-SEA RES, V17, P445, DOI 10.1016/0011-7471(70)90059-8; Otake T, 2006, EVIDENCE MIGRATION M; Pacariz S, 2014, ECOL FRESHW FISH, V23, P86, DOI 10.1111/eff.12048; Press W., 1992, NUMERICAL RECIPES FO; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Qiu B, 2015, OCEANOGRAPHY, V28, P24, DOI 10.5670/oceanog.2015.78; Qiu B, 2012, J PHYS OCEANOGR, V42, P193, DOI 10.1175/JPO-D-11-061.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Righton D, 2012, J FISH BIOL, V81, P365, DOI 10.1111/j.1095-8649.2012.03373.x; Rypina II, 2018, NONLINEAR PROC GEOPH, V25, P267, DOI 10.5194/npg-25-267-2018; Rypina II, 2017, NONLINEAR PROC GEOPH, V24, P189, DOI 10.5194/npg-24-189-2017; Rypina II, 2016, LIMNOL OCEANOGR, V61, P1574, DOI 10.1002/lno.10297; Rypina II, 2014, LIMNOL OCEANOGR, V59, P1704, DOI 10.4319/lo.2014.59.5.1704; Schabetsberger R, 2016, MAR ECOL PROG SER, V554, P141, DOI 10.3354/meps11824; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F.W., 2003, EEL, P408, DOI DOI 10.1111/J.0022-1112.2004.00509A.X; Thoppil PG, 2016, PROG OCEANOGR, V141, P239, DOI 10.1016/j.pocean.2015.12.013; Tsukamoto K, 2003, ENVIRON BIOL FISH, V66, P221, DOI 10.1023/A:1023926705906; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Tsukamoto Katsumi, 1990, Mer (Tokyo), V28, P188; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; WEISS J, 1991, PHYSICA D, V48, P273, DOI 10.1016/0167-2789(91)90088-Q; Westerberg H, 2018, CAN J FISH AQUAT SCI, V75, P224, DOI 10.1139/cjfas-2016-0256; Wuenschel MJ, 2008, MAR BIOL, V154, P775, DOI 10.1007/s00227-008-0970-7; Yamada Y, 2009, MAR ECOL PROG SER, V379, P241, DOI 10.3354/meps07912; Zenimoto K, 2011, MAR ECOL PROG SER, V438, P219, DOI 10.3354/meps09255; Zhang DX, 2001, J PHYS OCEANOGR, V31, P1054, DOI 10.1175/1520-0485(2001)031<1054:TKEOTM>2.0.CO;2	89	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208704	10.1371/journal.pone.0208704	http://dx.doi.org/10.1371/journal.pone.0208704			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571715	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700020
J	Kennedy, DW; White, NM; Benton, MC; Fox, A; Scott, RJ; Griffiths, LR; Mengersen, K; Lea, RA				Kennedy, Daniel W.; White, Nicole M.; Benton, Miles C.; Fox, Andrew; Scott, Rodney J.; Griffiths, Lyn R.; Mengersen, Kerrie; Lea, Rodney A.			Critical evaluation of linear regression models for cell-subtype specific methylation signal from mixed blood cell DNA	PLOS ONE			English	Article							DYNAMIC CHANGES; DECONVOLUTION	Epigenome-wide association studies seek to identify DNA methylation sites associated with clinical outcomes. Difference in observed methylation between specific cell-subtypes is often of interest; however, available samples often comprise a mixture of cells. To date, cell-subtype estimates have been obtained from mixed-cell DNA data using linear regression models, but the accuracy of such estimates has not been critically assessed. We evaluated linear regression performance for cell-subtype specific methylation estimation using a 450K methylation array dataset of both mixed-cell and cell-subtype sorted samples from six healthy males. CpGs associated with each cell-subtype were first identified using t-tests between groups of cell-subtype sorted samples. Subsequent reduced panels of reliably accurate CpGs were identified from mixed-cell samples using an accuracy heuristic (D). Performance was assessed by comparing cell-subtype specific estimates from mixed-cells with corresponding cell-sorted mean using the mean absolute error (MAE) and the Coefficient of Determination (R-2). At the cell-subtype level, methylation levels at 3272 CpGs could be estimated to within a MAE of 5% of the expected value. The cell-subtypes with the highest accuracy were CD56(+)NK (R-2= 0.56) and CD8(+)T (R-2= 0.48), where 23% of sites were accurately estimated. Hierarchical clustering and pathways enrichment analysis confirmed the biological relevance of the panels. Our results suggest that linear regression for cell-subtype specific methylation estimation is accurate only for some cell-subtypes at a small fraction of cell-associated sites but may be applicable to EWASs of disease traits with a blood-based pathology. Although sample size was a limitation in this study, we suggest that alternative statistical methods will provide the greatest performance improvements.	[Kennedy, Daniel W.; White, Nicole M.; Mengersen, Kerrie] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [Kennedy, Daniel W.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Benton, Miles C.; Griffiths, Lyn R.; Lea, Rodney A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld, Australia; [Fox, Andrew; Lea, Rodney A.] Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Ctr Informat Based Med, Newcastle, NSW, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Hunter Medical Research Institute; University of Newcastle	Lea, RA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld, Australia.; Lea, RA (corresponding author), Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia.	Rodney.Lea@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Scott, Rodney/B-2827-2013	White, Nicole/0000-0002-9292-0773; Griffiths, Lyn/0000-0002-6774-5475; Kennedy, Daniel/0000-0002-0034-3279; Scott, Rodney/0000-0001-7724-3404; Lea, Rodney/0000-0002-1148-5862	Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship; Australian Research Council Australian Centre for Mathematical and Statistical Frontiers (ACEMS)	Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council Australian Centre for Mathematical and Statistical Frontiers (ACEMS)	RL is partially supported by Multiple Sclerosis Research Australia funding for Bioinformatics. This research is supported by an Australian Government Research Training Program (RTP) Scholarship, and the Australian Research Council Australian Centre for Mathematical and Statistical Frontiers (ACEMS).	Ali O, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0048-6; [Anonymous], 2021, LANG ENV STAT COMP; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Horvath S, 2015, AGING-US, V7, P294, DOI 10.18632/aging.100742; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2016, REFERENCE FREE DECON, DOI [10.1101/037671, DOI 10.1101/037671]; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; Montano CM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r94; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stelzer Y, 2015, CELL, V163, P218, DOI 10.1016/j.cell.2015.08.046; Teschendorff AE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1511-5; Titus AJ, 2017, HUM MOL GENET, V26, pR216, DOI 10.1093/hmg/ddx275; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Zaghlool SB, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-014-0040-6; Zannas AS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0828-5	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208915	10.1371/journal.pone.0208915	http://dx.doi.org/10.1371/journal.pone.0208915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571772	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700028
J	Miyake, H; Sakagami, J; Yasuda, H; Sogame, Y; Kato, R; Suwa, K; Dainaka, K; Takata, T; Yokota, I; Itoh, Y				Miyake, Hayato; Sakagami, Junichi; Yasuda, Hiroaki; Sogame, Yoshio; Kato, Ryusuke; Suwa, Kanetoshi; Dainaka, Katsuyuki; Takata, Tomoki; Yokota, Isao; Itoh, Yoshito			Association of fatty pancreas with pancreatic endocrine and exocrine function	PLOS ONE			English	Article							DIABETES-MELLITUS; CYSTIC-FIBROSIS; STEATOSIS; CT; REPLACEMENT; PEPTIDE; OBESITY; LIVER	Aim The purpose of this study was to clarify whether fatty pancreas might lead to impaired pancreatic endocrine or exocrine function. Material and methods The study involved 109 participants who had undergone the glucagon stimulation test and N-benzoyl-L-tyros-p-amino benzoic acid (BT-PABA) test to assess pancreatic function as well as unenhanced abdominal computed tomography (CT). Pancreatic endocrine impairment was defined as AC peptide immunoreactivity less than 2 [mmol/L] in the glucagon stimulation test, and pancreatic exocrine impairment was defined as a urinary PABA excretion rate less than 70% on the BT-PABA test. We defined as the mean CT value of pancreas / CT value of spleen (P/S ratio) as a marker to assess fatty pancreas. We analyzed the association between fatty pancreas and pancreatic impairment using the logistic regression model. The odds ratio (OR) is shown per 0.1 unit. Results Pancreatic endocrine function was impaired in 33.0% of the participants, and 56.9% of those were regarded as having pancreatic exocrine impairment. The P/S ratio was significantly correlated with pancreatic endocrine impairment in univariate analysis (OR = 0.61, 95% confidence interval (CI) = 0.43-0.83, P = 0.0013) and multivariate analysis (OR = 0.38, 95% CI = 0.22-0.61, P < .0001) for all participants. Similar significant relationships were observed in both univariate (OR = 0.70, 95% CI = 0.49-0.99, P = 0.04) and multivariate (OR = 0.39, 95% CI = 0.21-0.66, P= 0.0002) analyses for the participants without diabetes (n = 93). The amount of pancreatic fat was not associated with exocrine impairment in univariate analysis (OR = 0.80, 95% CI = 0.59-1.06, P = 0.12). Conclusion Fatty pancreas was associated with pancreatic endocrine impairment but did not have a clear relationship with pancreatic exocrine impairment.	[Miyake, Hayato; Sakagami, Junichi; Yasuda, Hiroaki; Sogame, Yoshio; Kato, Ryusuke; Suwa, Kanetoshi; Dainaka, Katsuyuki; Takata, Tomoki; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Med, Div Gastroenterol & Hepatol, Kyoto, Japan; [Yokota, Isao] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Miyake, H (corresponding author), Kyoto Prefectural Univ Med, Dept Med, Div Gastroenterol & Hepatol, Kyoto, Japan.	mi3ya4ke@koto.kpu-m.ac.jp	Yokota, Isao/AAB-2910-2021; Yasuda, Hiroaki/ABA-8525-2021	Yokota, Isao/0000-0001-6254-2225; Yasuda, Hiroaki/0000-0002-8346-9853				Acharya C, 2014, PANCREATOLOGY, V14, P403, DOI 10.1016/j.pan.2014.06.004; Ambesh P, 2015, J CLIN DIAGN RES, V9, pUL1, DOI 10.7860/JCDR/2015/15089.6546; Boeck W G, 2001, Curr Gastroenterol Rep, V3, P95, DOI 10.1007/s11894-001-0004-9; Catanzaro R, 2016, WORLD J GASTROENTERO, V22, P7660, DOI 10.3748/wjg.v22.i34.7660; Chai J, 2016, EXP THER MED, V11, P476, DOI 10.3892/etm.2015.2925; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Fujita Y, 2015, ENDOCR J, V62, P329, DOI 10.1507/endocrj.EJ14-0456; GYR K, 1976, GUT, V17, P27, DOI 10.1136/gut.17.1.27; Hori M, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.5; Kim SY, 2014, RADIOLOGY, V271, P104, DOI 10.1148/radiol.13122883; Kirihara Y, 2013, ANN SURG, V257, P512, DOI 10.1097/SLA.0b013e31827827d0; Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869; Lee Y, 2010, INT J OBESITY, V34, P396, DOI 10.1038/ijo.2009.245; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; MATSUMOTO S, 1995, RADIOLOGY, V194, P453, DOI 10.1148/radiology.194.2.7824726; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1973, DOI 10.1016/0016-5085(85)90029-0; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Pezzilli R, 2014, WORLD J DIABETES, V5, P415, DOI 10.4239/wjd.v5.i4.415; Robertson MB, 2006, RADIOGRAPHICS, V26, P679, DOI 10.1148/rg.263055101; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; SO CB, 1987, AM J ROENTGENOL, V149, P67, DOI 10.2214/ajr.149.1.67; Sodhi KS, 2005, PEDIATR RADIOL, V35, P1157, DOI 10.1007/s00247-005-1520-9; Soyer P, 1999, RADIOLOGY, V210, P611, DOI 10.1148/radiology.210.3.r99mr08611; STAMM BH, 1984, HUM PATHOL, V15, P677, DOI 10.1016/S0046-8177(84)80294-4; Tahtaci M, 2018, TURK J GASTROENTEROL, V29, P588, DOI 10.5152/tjg.2018.17696; Terzin V, 2014, PANCREATOLOGY, V14, P356, DOI 10.1016/j.pan.2014.07.004; Toiviainen-Salo S, 2008, J PEDIATR, V152, P434, DOI 10.1016/j.jpeds.2007.12.013; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; Vendrik KEW, 2017, PANCREAS, V46, pE75, DOI 10.1097/MPA.0000000000000893; Wang CY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000297; Zyromski NJ, 2009, PANCREATOLOGY, V9, P410, DOI 10.1159/000199436	33	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209448	10.1371/journal.pone.0209448	http://dx.doi.org/10.1371/journal.pone.0209448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571730	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700076
J	Schubert, M; Hackl, H; Gassner, FJ; Greil, R; Geisberger, R				Schubert, Maria; Hackl, Hubert; Gassner, Franz Josef; Greil, Richard; Geisberger, Roland			Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; DNA METHYLATION DYNAMICS; HIGH EXPRESSION; POOR-PROGNOSIS; AID; DISEASE; CELLS; HYPERMUTATION; PROTEIN	Activation induced deaminase (AID) has two distinct and well defined roles, both relying on its deoxycytidine (dC) deaminating function: one as a DNA mutator and another in DNA demethylation. In chronic lymphocytic leukemia (CLL), AID was previously shown to be an independent negative prognostic factor. While there is substantial impact on DNA mutations, effects of AID on gene expression by promoter demethylation of disease related target genes in leukemia has not been addressed. To shed light on this question, we aimed at determining genome wide methylation changes as well as gene expression changes in response to AID expression in CLL. Although we found minor differences in individual methylation variable positions following AID expression, we could not find recurrent methylation changes of specific target sites or changes in global methylation.	[Schubert, Maria; Gassner, Franz Josef; Greil, Richard; Geisberger, Roland] Paracelsus Med Univ, Dept Internal Med Haematol Med Oncol Haemostaseol, Oncol Ctr, SCRI,LIMCR, Salzburg, Austria; [Schubert, Maria; Gassner, Franz Josef; Greil, Richard; Geisberger, Roland] Canc Cluster Salzburg, Salzburg, Austria; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, Innsbruck, Austria	Paracelsus Private Medical University; Medical University of Innsbruck	Geisberger, R (corresponding author), Paracelsus Med Univ, Dept Internal Med Haematol Med Oncol Haemostaseol, Oncol Ctr, SCRI,LIMCR, Salzburg, Austria.; Geisberger, R (corresponding author), Canc Cluster Salzburg, Salzburg, Austria.	r.geisberger@salk.at	Hackl, Hubert/B-3168-2018; Gassner, Franz/AAN-1735-2021	Hackl, Hubert/0000-0003-4055-3841; Schubert, Maria/0000-0001-5119-726X; Gassner, Franz J/0000-0001-9894-0313; Geisberger, Roland/0000-0002-0131-2191	SCRI-LIMCR; Province of Salzburg; City of Salzburg [20102-P1509466-FPR01-2015, 20102-P1601064-FPR01-2017]; Austrian Science Fund FWF [P28201]	SCRI-LIMCR; Province of Salzburg; City of Salzburg; Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the SCRI-LIMCR, the Province of Salzburg, the City of Salzburg (20102-P1509466-FPR01-2015 and 20102-P1601064-FPR01-2017 to R. G.) and a grant from the Austrian Science Fund FWF to R. G. (FWF; P28201).	Chuang HY, 2012, BLOOD, V120, P2639, DOI 10.1182/blood-2012-03-416461; Dominguez PM, 2015, CELL REP, V12, P2086, DOI 10.1016/j.celrep.2015.08.036; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Geisberger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030667; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; Leuenberger M, 2010, MODERN PATHOL, V23, P177, DOI 10.1038/modpathol.2009.156; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Patten PEM, 2012, BLOOD, V120, P4802, DOI 10.1182/blood-2012-08-449744; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rebhandl S, 2015, EUR J IMMUNOL, V45, P2208, DOI 10.1002/eji.201545832; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Tinhofer I, 2006, BLOOD, V108, P2950, DOI 10.1182/blood-2006-03-010553	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208753	10.1371/journal.pone.0208753	http://dx.doi.org/10.1371/journal.pone.0208753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571766	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700023
J	Tanaka, S; Kanazawa, I; Sugimoto, T				Tanaka, Sayuri; Kanazawa, Ippei; Sugimoto, Toshitsugu			Nerve conduction velocity is negatively associated with intima-media thickness and brachial-ankle pulse wave velocity in men with type 2 diabetes mellitus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PERIPHERAL NEUROPATHY; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; MORTALITY; COMPLICATIONS; RETINOPATHY; DISEASE; INDEX	Objective Previous studies suggest that the presence of diabetic peripheral polyneuropathy (DPN) is associated with atherosclerotic diseases; however, little is known about the relationship between diabetic nerve conduction velocity (NCV) versus arterial stiffness and atherosclerosis parameters. Methods The subjects in this study were 292 men with type 2 diabetes mellitus (T2DM). All subjects underwent NCV examination at median and tibial nerves as motor nerve (MCV) as well as median and sural nerves as sensory nerve (SCV). Brachial-ankle pulse wave velocity (baPWV) and carotid intima-media thickness (IMT) were evaluated as arterial stiffness and atherosclerosis parameters. Results Pearson's correlation coefficient showed that NCV at all sites negatively correlated with baPWV, maximal and mean IMT (IMT-Max and IMT-Mean), and plaque score (all p values p<0.01 at least). Multiple regression analyses adjusted for confounding factors such as age, duration of diabetes, body mass index, HbA1c, fasting C-peptide, systolic blood pressure, HDL-cholesterol, LDL-cholesterol and albuminuria showed that the association of NCV with IMT-Max, ITM-Mean, and plaque score remained significant (all p values p<0.05 at least) except that between SCV at median and IMT-Max. Moreover, SCV at median (forearm) and sural were significantly associated with baPWV (p = 0.023 and p = 0.027, respectively). Conclusion The present study showed that DPN estimated by quantitative NCV is linearly associated with the deterioration of arterial stiffness and atherosclerosis parameters in T2DM independently of various diabetic and atherosclerotic factors.	[Tanaka, Sayuri; Kanazawa, Ippei; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med 1, Matsue, Shimane, Japan	Shimane University	Kanazawa, I (corresponding author), Shimane Univ, Fac Med, Dept Internal Med 1, Matsue, Shimane, Japan.	ippei.k@med.shimane-u.ac.jp	Kanazawa, Ippei/F-8609-2010					Ando A, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2810914; Aubert CE, 2014, DIABETES-METAB RES, V30, P679, DOI 10.1002/dmrr.2529; Avci A, 2014, MED SCI MONITOR, V20, P2074, DOI 10.12659/MSM.892648; Brownrigg JRW, 2014, HEART, V100, P1837, DOI 10.1136/heartjnl-2014-305657; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cusick M, 2005, DIABETES CARE, V28, P617, DOI 10.2337/diacare.28.3.617; Fujishima M, 1979, DIABETES S3, V45, pS14; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Ha BK, 2012, DIABETES METAB J, V36, P443, DOI 10.4093/dmj.2012.36.6.443; Hussain G, 2014, DIABETES METAB SYND, V8, P48, DOI 10.1016/j.dsx.2013.02.003; Ishihara M, 2009, AM J CARDIOL, V104, P769, DOI 10.1016/j.amjcard.2009.04.055; Kanazawa I, 2008, ENDOCR J, V55, P667, DOI 10.1507/endocrj.K07E-130; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Khangholi S, 2016, PLANTA MED, V82, P32, DOI 10.1055/s-0035-1558086; Kim ES, 2011, DIABETES CARE, V34, P1403, DOI 10.2337/dc10-2222; Kim KJ, 2011, J ATHEROSCLER THROMB, V18, P328, DOI 10.5551/jat.5983; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Pop-Busui R, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0727-5; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stratmann B, 2009, BEST PRACT RES CL EN, V23, P291, DOI 10.1016/j.beem.2008.12.004; Suh BC, 2010, EUR NEUROL, V64, P219, DOI 10.1159/000319605; Tamita K, 2007, CIRC J, V71, P834, DOI 10.1253/circj.71.834; ter Avest E, 2007, CLIN SCI, V112, P507, DOI 10.1042/CS20060266; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ward RE, 2016, AGING DIS, V7, P466, DOI 10.14336/AD.2015.1127; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Yasuda H, 2007, DIABETES RES CLIN PR, V77, pS178, DOI 10.1016/j.diabres.2007.01.053; Yokoyama H, 2007, DIABETIC MED, V24, P1329, DOI 10.1111/j.1464-5491.2007.02278.x	33	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209503	10.1371/journal.pone.0209503	http://dx.doi.org/10.1371/journal.pone.0209503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571795	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700083
J	Holda, MK; Pietsch-Fulbiszewska, A; Trybus, M; Koziej, M				Holda, Mateusz K.; Pietsch-Fulbiszewska, Agnieszka; Trybus, Marek; Koziej, Mateusz			Morphological variations of the interatrial septum in ovine heart	PLOS ONE			English	Article							2-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY; LEFT ATRIAL; POUCH; ANATOMY; RISK	Smooth septum interatrial septum, patent foramen ovale (PFO) channel and atrial septal pouches (SPs) are commonly described variants in humans. Recent discoveries on the clinical significance of left-sided SP may encourage the creation of new strategies and devices for the management of SPs. However, these strategies may first be tested in the ovine model before implementation in humans. Unfortunately, little is known about the presence of SPs in ovine. In this study a total of 60 ovine (Ovis aries) hearts were examined. The interatrial septum morphology was assessed and the PFO channel and SPs were measured. The most commonly occurring variant were PFO channels (25.0%) with channel lengths of 5.4 +/- 2.3 mm. Smooth septums were observed in 18.3% of hearts. In the remaining cases, septums had a left septal ridge (15.0%), left SP (11.7%), left septal bridge (10.0%), right SP (10.0%), or had both a right SP and left septal ridge (10.0%). No double SPs were observed. The mean right SP depth was 3.4 +/- 1.2 mm, and its mean ostium width and height were 7.9 +/- 1.8 mm and 2.8 +/- 1.0, respectively. For the left SP, the mean depth was 6.0 +/- 1.7mm, the ostium width was 7.9 +/- 2.4mm, and the ostium height was 4.1 +/- 1.6mm (range: 2.3-6.4mm). In conclusion the interatrial septum of ovine hearts exhibit morphologies that are more similar to humans than they are to swine, which should be taken into account during experimental studies. The presence of a left SP in sheep hearts make ovine models a promising alternative to the human heart for developing left-sided SP management devices and techniques.	[Holda, Mateusz K.; Koziej, Mateusz] Jagiellonian Univ, Med Coll, HEART, Dept Anat, Krakow, Poland; [Pietsch-Fulbiszewska, Agnieszka] Jagiellonian Univ, Univ Ctr Vet Med, Univ Agr, Krakow, Poland; [Trybus, Marek] Jagiellonian Univ, Dept Gen Surg 2, Med Coll, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Agricultural University Krakow; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Holda, MK (corresponding author), Jagiellonian Univ, Med Coll, HEART, Dept Anat, Krakow, Poland.	mkh@onet.eu	Hołda, Mateusz K./H-4705-2019; Trybus, Marek/AAI-8705-2020; Hołda, Mateusz K/U-3199-2017	Hołda, Mateusz K./0000-0001-5754-594X; Hołda, Mateusz K/0000-0001-5754-594X; Pietsch-Fulbiszewska, Agnieszka/0000-0002-0251-5097				Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; Butters TD, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0067; Camacho P, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3040030; DAWES GS, 1954, J PHYSIOL-LONDON, V126, P563, DOI 10.1113/jphysiol.1954.sp005227; DiVincenti L, 2014, J AM ASSOC LAB ANIM, V53, P439; FRINK RJ, 1974, ANAT REC, V179, P189, DOI 10.1002/ar.1091790204; Hill AJ., 2015, HDB CARDIAC ANATOMY, P89, DOI [DOI 10.1007/978-3-319-19464-6_6, 10.1007/978-3-319-19464-6_6]; Holda MK, 2018, INT J CARDIOVAS IMAG, V34, P1305, DOI 10.1007/s10554-018-1342-0; Holda MK, 2018, J AM SOC ECHOCARDIOG, V31, P771, DOI 10.1016/j.echo.2018.01.023; Holda MK, 2018, ECHOCARDIOGR-J CARD, V35, P827, DOI 10.1111/echo.13847; Holda MK, 2018, ANN ANAT, V217, P24, DOI 10.1016/j.aanat.2018.01.002; Holda MK, 2017, INT J CARDIOL, V244, P163, DOI 10.1016/j.ijcard.2017.06.042; Holda MK, 2016, INT J CARDIOL, V220, P337, DOI 10.1016/j.ijcard.2016.06.141; Jux C, 2006, J AM COLL CARDIOL, V48, P161, DOI 10.1016/j.jacc.2006.02.057; Klimek-Piotrowska W, 2016, ANN ANAT, V205, P60, DOI 10.1016/j.aanat.2016.01.009; Krishnan SC, 2010, JACC-CARDIOVASC INTE, V3, P98, DOI 10.1016/j.jcin.2009.07.017; Lelovas PP, 2014, J AM ASSOC LAB ANIM, V53, P432; Michaelsson M, 2000, CONGENITAL HEART MAL; Sands M P, 1969, Ann Thorac Surg, V8, P407; Sigler M, 2007, HEART, V93, P444, DOI 10.1136/hrt.2006.098103; Sun JP, 2016, INT J CARDIOL, V214, P37, DOI 10.1016/j.ijcard.2016.03.119; Timek TA, 2002, AM J PHYSIOL-HEART C, V283, pH1929, DOI 10.1152/ajpheart.00149.2002; Uchida BT, 2011, CARDIOVASC INTER RAD, V34, P620, DOI 10.1007/s00270-010-9948-1	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209604	10.1371/journal.pone.0209604	http://dx.doi.org/10.1371/journal.pone.0209604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566482	Green Published, gold			2022-12-26	WOS:000453779300095
J	Damin, F; Galbiati, S; Soriani, N; Burgio, V; Ronzoni, M; Ferrari, M; Chiari, M				Damin, Francesco; Galbiati, Silvia; Soriani, Nadia; Burgio, Valentina; Ronzoni, Monica; Ferrari, Maurizio; Chiari, Marcella			Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients	PLOS ONE			English	Article							K-RAS MUTATIONS; NUCLEIC-ACIDS; DIGITAL PCR; DNA; GENES; POLYMORPHISM; GROWTH	Microarray technology fails in detecting point mutations present in a small fraction of cells from heterogeneous tissue samples or in plasma in a background of wild-type cell-free circulating tumor DNA (ctDNA). The aim of this study is to overcome the lack of sensitivity and specificity of current microarray approaches introducing a rapid and sensitive microarray-based assay for the multiplex detection of minority mutations of oncogenes (KRAS, NRAS and BRAF) with relevant diagnostics implications in tissue biopsies and plasma samples in metastatic colorectal cancer patients. In our approach, either wild-type or mutated PCR fragments are hybridized in solution, in a temperature gradient, with a set of reporters with a 5' domain, complementary to the target sequences and a 3' domain complementary to a surface immobilized probe. Upon specific hybridization in solution, which occurs specifically thanks to the temperature gradients, wild-type and mutated samples are captured at specific location on the surface by hybridization of the 3' reporter domain with its complementary immobilized probe sequence. The most common mutations in KRAS, NRAS and BRAF genes were detected in less than 90 minutes in tissue biopsies and plasma samples of metastatic colorectal cancer patients. Moreover, the method was able to reveal mutant alleles representing less than 0,3% of total DNA. We demonstrated detection limits superior to those provided by many current technologies in the detection of RAS and BRAF gene super-family mutations, a level of sensitivity compatible with the analysis of cell free circulating tumor DNA in liquid biopsy.	[Damin, Francesco; Chiari, Marcella] CNR, Ist Chim Riconoscimento Mol, Milan, Italy; [Galbiati, Silvia; Soriani, Nadia; Ferrari, Maurizio] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Unit Genom Diag Human Pathol, Milan, Italy; [Burgio, Valentina; Ronzoni, Monica] IRCCS Osped San Raffaele, Dipartimento Oncol Med, Milan, Italy; [Ferrari, Maurizio] IRCCS Osped San Raffaele, Lab Clin Mol Biol, Milan, Italy; [Ferrari, Maurizio] Univ Vita Salute San Raffaele, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Damin, F (corresponding author), CNR, Ist Chim Riconoscimento Mol, Milan, Italy.	francesco.damin@icrm.cnr.it	Damin, Francesco/AAL-8998-2021; Burgio, Valentina/AAC-1682-2019; Galbiati, Silvia/AAC-1218-2019	Damin, Francesco/0000-0003-1780-7823; Galbiati, Silvia/0000-0003-1642-8506; Ronzoni, Monica/0000-0002-2845-275X; Burgio, Valentina/0000-0002-0146-4136	European Union's Horizon 2020 research and innovation programme [766466]	European Union's Horizon 2020 research and innovation programme	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 766466.; This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 766466.	Allegra CJ, 2016, J CLIN ONCOL, V34, P179, DOI 10.1200/JCO.2015.63.9674; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Cretich M, 2009, ANAL CHEM, V81, P5197, DOI 10.1021/ac900658c; Damin F, 2016, BIOSENS BIOELECTRON, V78, P367, DOI 10.1016/j.bios.2015.11.091; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dieterle CP, 2004, CLIN CANCER RES, V10, P641, DOI 10.1158/1078-0432.CCR-1355-02; Galbiati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059939; Herreros-Villanueva M, 2014, CLIN CHIM ACTA, V431, P211, DOI 10.1016/j.cca.2014.01.049; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HOFFMAN M, 1992, SCIENCE, V255, P159, DOI 10.1126/science.1553541; Huggett JF, 2013, CLIN CHEM, V59, P1691, DOI 10.1373/clinchem.2013.214742; JACOBSON DR, 1994, ONCOGENE, V9, P553; KIARIS H, 1995, INT J ONCOL, V7, P413; Kodaz H, 2017, EURASIAN J MED ONCOL, V1, P1, DOI 10.14744/ejmo.2017.22931; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; Liu L, 2015, TRANSL CANCER RES, V4, P212, DOI 10.3978/j.issn.2218-676X.2015.05.04; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Mixich F, 2007, J GASTROINTEST LIVER, V16, P5; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Parsons BL, 2010, CANCER INVEST, V28, P364, DOI 10.3109/07357901003630975; Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629; Russo AL, 2014, CANCER-AM CANCER SOC, V120, P1482, DOI 10.1002/cncr.28599; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sham PC, 2008, CURR ORTHOPAED, V22, P251, DOI 10.1016/j.cuor.2008.05.006; Shen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081628; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Swaminathan R, 2006, ANN NY ACAD SCI, V1075, P1, DOI 10.1196/annals.1368.001; Therkildsen C, 2014, ACTA ONCOL, V53, P852, DOI 10.3109/0284186X.2014.895036; Toyooka S, 2003, ONCOL REP, V10, P1455; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188	34	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0207876	10.1371/journal.pone.0207876	http://dx.doi.org/10.1371/journal.pone.0207876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562355	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100009
J	Morales, M; Ludwig, G; Ercibengoa, M; Esteva, C; Sanchez-Encinales, LV; Alonso, M; Munoz-Almagro, C; Marimon, JM				Morales, Maria; Ludwig, Guillermo; Ercibengoa, Maria; Esteva, Cristina; Sanchez-Encinales, Viviana L.; Alonso, Marta; Munoz-Almagro, Carmen; Maria Marimon, Jose			Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; INVASIVE DISEASE; CHILDREN; PREVENTION; CULTURES	One of the beneficial effects of pneumococcal conjugate vaccines (PCVs) has been a decrease in the incidence of non-invasive infections, such as otitis media (OM) caused by vaccine serotypes. In this study, we analyzed the epidemiology of pneumococcal OM before and after PCV13 introduction in 2010. Between 2008 and 2016, the middle ear exudates from 2653 children under 14 years of age with OM were studied in two Spanish provinces (Gipuzkoa and Barcelona), and S. pneumoniae was isolated in 235 (8.9%) of cases. The 204 available isolates were serotyped and distributed in three 3-year periods: one before and two after PCV13 introduction (early and late post-PCV13). A significant decrease in the rate of OM caused by S. pneumoniae was observed mainly due to a decrease in infections caused by all PCV13 serotypes, although exceptions were observed including the persistence of serotype 3 in Gipuzkoa and a weak re-emergence of serotype 19F in both regions. The rate and diversity of non-PCV13 serotypes increased in both regions and an emerging clone causing OM was detected in each region: serotype 23B ST2372 in Gipuzkoa and serotype 11A ST838/ST6521 in Barcelona. The introduction of PCV13 has been followed by a change in the epidemiology of pneumococcal OM, with a decrease in the rate of vaccine serotypes accompanied by an increase in the diversity of non-vaccine serotype and the clonal spreading of different single clones in each region.	[Morales, Maria; Sanchez-Encinales, Viviana L.; Alonso, Marta; Maria Marimon, Jose] Donostia Univ Hosp, Biodonostia Hlth Res Inst, Donostia San Sebastian, Spain; [Morales, Maria; Ercibengoa, Maria; Alonso, Marta; Maria Marimon, Jose] Inst Salud Carlos III, GIBER Enfermedades Resp CIBERES, Madrid, Spain; [Ludwig, Guillermo; Esteva, Cristina; Munoz-Almagro, Carmen] St Joan de Deu Univ Hosp, Inst Recerca St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain; [Ercibengoa, Maria] Univ Basque Country, UPV EHU, Prevent Med & Hlth Publ Dept, Donostia San Sebastian, Spain; [Esteva, Cristina; Munoz-Almagro, Carmen] Inst Salud Carlos III, GIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Munoz-Almagro, Carmen] Sch Med, Univ Int Catalunya, Barcelona, Spain	Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; Instituto de Salud Carlos III; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universitat Internacional de Catalunya (UIC)	Marimon, JM (corresponding author), Donostia Univ Hosp, Biodonostia Hlth Res Inst, Donostia San Sebastian, Spain.; Marimon, JM (corresponding author), Inst Salud Carlos III, GIBER Enfermedades Resp CIBERES, Madrid, Spain.	josemaria.marimonortizdez@osakidetza.eus	Muñoz-Almagro, Carmen/N-7248-2015; Ludwig, Guillermo/E-5390-2018; MARIMON, JOSE MARIA/AAM-5581-2021; Ercibengoa, María/ABH-9481-2020; Alonso, Marta M/AAI-9457-2020	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Ludwig, Guillermo/0000-0001-9465-3085; MARIMON, JOSE MARIA/0000-0002-2787-7094; Alonso, Marta M/0000-0002-7520-7351; Sanchez Encinales, Viviana/0000-0002-6999-4555; Esteva Afonso, Cristina/0000-0001-7133-4540	Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias [CIBERES-26]; Centro de Investigacion Biomedica en Red de de Epidemiologia y Salud Publica [CIBERESP-57]; de Epidemiologia y Salud Publica [CIBERESP-57]	Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias; Centro de Investigacion Biomedica en Red de de Epidemiologia y Salud Publica; de Epidemiologia y Salud Publica	JMM was funded in part by the Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES-26). CMA was funded in part by the Centro de Investigacion Biomedica en Red de de Epidemiologia y Salud Publica (CIBERESP-57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by the Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES-26) and de Epidemiologia y Salud Publica (CIBERESP-57).	Aguinagalde L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137565; Alonso M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054333; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Ben-Shimol S, 2014, CLIN INFECT DIS, V59, P1724, DOI 10.1093/cid/ciu683; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Cilveti R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170316; Dagan R, 2016, LANCET INFECT DIS, V16, P480, DOI 10.1016/S1473-3099(15)00549-6; del Amo E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151125; Dominguez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183191; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Froom J, 1997, BRIT MED J, V315, P98, DOI 10.1136/bmj.315.7100.98; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Kapatai G, 2017, GENOME BIOL EVOL, V9, P2145, DOI 10.1093/gbe/evx092; Kaplan SL, 2015, CLIN INFECT DIS, V60, P1339, DOI 10.1093/cid/civ067; Kempf M, 2015, CLIN MICROBIOL INFEC, V21, P35, DOI 10.1016/j.cmi.2014.08.009; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Marimon JM, 2016, J CLIN MICROBIOL, V54, P2197, DOI 10.1128/JCM.01156-16; Martin JM, 2014, PEDIATR INFECT DIS J, V33, pE286, DOI 10.1097/INF.0000000000000445; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Palmu AA, 2014, LANCET INFECT DIS, V14, P205, DOI [10.1016, 10.1016/S1473-3099(13)70338-4]; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Van der Linden M, 2011, BMC INFECT DIS, V15, P207; van der Linden M, 2015, EUR J PEDIATR, V174, P355, DOI 10.1007/s00431-014-2409-0; Van Dyke MK, 2017, PEDIATR INFECT DIS J, V36, P274, DOI 10.1097/INF.0000000000001420; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7	31	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209048	10.1371/journal.pone.0209048	http://dx.doi.org/10.1371/journal.pone.0209048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562385	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100033
J	Chae, MS; Park, H; Choi, HJ; Park, M; Chung, HS; Hong, SH; Park, CS; Choi, JH; Lee, HM				Chae, Min Suk; Park, Hyunjoon; Choi, Ho Joong; Park, Misun; Chung, Hyun Sik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Lee, Hyung Mook			Role of serum levels of intraoperative brain natriuretic peptide for predicting acute kidney injury in living donor liver transplantation	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; HEART-FAILURE; RISK-FACTORS; VENOUS CONGESTION; PROGNOSTIC VALUE; MORTALITY; DYSFUNCTION; OUTCOMES; IMPACT	Background Patients with end-stage liver disease frequently experience acute kidney injury (AKI) after living donor liver transplantation (LDLT). Serum levels of brain natriuretic peptide (BNP) have increasingly been accepted as a predictor of AKI in clinical settings. This study investigated the predictive role of intraoperative BNP levels in the early development of AKI after LDLT. Patients and methods Adult patients (>= 19 years old) who had undergone elective LDLT from January 2011 to December 2017 were classified into the non-AKI and AKI groups according to the Kidney Disease: Improving Global Outcomes criteria. Serum levels of BNP were measured three times in the preanhepatic, anhepatic, and neohepatic phases. Perioperative data in recipients and donors were analyzed retrospectively. Results Sixty-one patients (22.4%) suffered from AKI immediately after LDLT. Severity according to AKI stage was as follows: 28 patients in stage 1 (10.3%), 18 patients in stage 2 (6.6%), and 15 patients in stage 3 (5.5%). In the neohepatic phase, both BNP levels and proportions of patients with high BNP levels (>= 100 pg/mL) were higher in the AKI group than in the non-AKI group. Only BNP levels in the non-AKI and AKI stage 1 groups significantly decreased from the preanhepatic phase to the neohepatic phase; those in AKI stages 2 and 3 groups did not. In particular, BNP levels of all AKI stage 3 patients increased to more than 100 pg/mL, and the proportion of patients with high levels also increased significantly through the surgical phases in the AKI stage 3 group. In multivariate analyses, BNP levels in the neohepatic phase were significantly associated with early development of AKI after LDLT, as well as the total amount of packed red blood cells in transfusions and total duration of graft ischemia. Conclusions Monitoring serum levels of BNP is useful for predicting the early development of AKI after LDLT.	[Chae, Min Suk; Park, Hyunjoon; Chung, Hyun Sik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Lee, Hyung Mook] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, Ho Joong] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Park, Misun] Catholic Univ Korea, Clin Res Coordinating Ctr, Catholic Med Ctr, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, HM (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	warmy0828@gmail.com		Chae, Min Suk/0000-0002-1426-4651; Chung, Hyun Sik/0000-0001-7527-1866; Lee, Hyungmook/0000-0002-5178-7240				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Akgul O, 2014, HERZ, V39, P507, DOI 10.1007/s00059-013-3853-8; ANDREOLI SP, 1990, KIDNEY INT, V38, P785, DOI 10.1038/ki.1990.272; Barreto AGC, 2015, ANN HEPATOL, V14, P688, DOI 10.1016/S1665-2681(19)30763-X; Chae MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007626; Chae MS, 2016, ANN TRANSPL, V21, P538, DOI 10.12659/AOT.899255; Chen J, 2011, TRANSPLANTATION, V91, P348, DOI 10.1097/TP.0b013e31820437da; Damman K, 2007, EUR J HEART FAIL, V9, P872, DOI 10.1016/j.ejheart.2007.05.010; Damman K, 2010, EUR J HEART FAIL, V12, P974, DOI 10.1093/eurjhf/hfq118; De Carlis R, 2017, LIVER TRANSPLANT, V23, P166, DOI 10.1002/lt.24666; Di Tommaso L, 2013, J THORAC CARDIOV SUR, V145, P171, DOI 10.1016/j.jtcvs.2011.10.096; Dutkowski P, 2015, ANN SURG, V262, P764, DOI 10.1097/SLA.0000000000001473; Gambardella I, 2016, INTERACT CARDIOV TH, V23, P800, DOI 10.1093/icvts/ivw229; Goldaracena N, 2015, AM J TRANSPLANT, V15, P1591, DOI 10.1111/ajt.13203; Gonzalez-Casas R, 2009, WORLD J GASTROENTERO, V15, P4653, DOI 10.3748/wjg.15.4653; Grewal J, 2008, AM J CARDIOL, V102, P733, DOI 10.1016/j.amjcard.2008.04.048; Grewal J, 2008, EUR J HEART FAIL, V10, P252, DOI 10.1016/j.ejheart.2008.01.017; Grune T, 2000, CLIN NEPHROL, V53, pS18; Haines R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1674-5; Hilmi IA, 2015, BRIT J ANAESTH, V114, P919, DOI 10.1093/bja/aeu556; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Hogan M, 2015, EUR J CARDIO-THORAC, V47, P218, DOI 10.1093/ejcts/ezu200; Karkouti K, 2012, BRIT J ANAESTH, V109, pI29, DOI 10.1093/bja/aes422; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim YK, 2011, TRANSPL P, V43, P1684, DOI 10.1016/j.transproceed.2011.02.010; Laskey HL, 2016, LIVER TRANSPLANT, V22, P1085, DOI 10.1002/lt.24488; Lee SK, 2007, TRANSPL P, V39, P1517, DOI 10.1016/j.transproceed.2006.11.018; Leithead JA, 2014, J HEPATOL, V60, P1180, DOI 10.1016/j.jhep.2014.02.019; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McCullough PA, 2003, AM J KIDNEY DIS, V41, P571, DOI 10.1053/ajkd.2003.50118; Moltrasio M, 2014, CRIT CARE MED, V42, P619, DOI 10.1097/CCM.0000000000000025; Moskowitz A, 2017, SHOCK, V48, P436, DOI 10.1097/SHK.0000000000000869; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Nohria A, 2008, J AM COLL CARDIOL, V51, P1268, DOI 10.1016/j.jacc.2007.08.072; Palazzuoli A, 2014, HEART FAIL REV, V19, P267, DOI 10.1007/s10741-013-9391-x; Patel UD, 2012, CIRCULATION, V125, P1347, DOI 10.1161/CIRCULATIONAHA.111.029686; Prowle JR, 2014, NAT REV NEPHROL, V10, P37, DOI 10.1038/nrneph.2013.232; Rahman S, 2017, WORLD J HEPATOL, V9, P823, DOI 10.4254/wjh.v9.i18.823; Ryding ADS, 2009, ANESTHESIOLOGY, V111, P311, DOI 10.1097/ALN.0b013e3181aaeb11; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Sherman DS, 2003, AM J KIDNEY DIS, V41, P269, DOI 10.1053/ajkd.2003.50035; Smoter P, 2014, TRANSPL P, V46, P2786, DOI 10.1016/j.transproceed.2014.09.044; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Thongprayoon C, 2016, J THORAC DIS, V8, pE305, DOI 10.21037/jtd.2016.03.62; Toussaint A, 2016, TRANSPLANTATION, V100, P819, DOI 10.1097/TP.0000000000001077; Trotter JF, 2013, LIVER TRANSPLANT, V19, P826, DOI 10.1002/lt.23672; Tung YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125282; WIESE S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI DOI 10.1038/NRGASTRO.2013.210; Yamamoto S, 2004, HEPATO-GASTROENTEROL, V51, P1815; Yin ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41555	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209164	10.1371/journal.pone.0209164	http://dx.doi.org/10.1371/journal.pone.0209164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557393	Green Submitted, gold, Green Published			2022-12-26	WOS:000453451000077
J	Li, R; Zhao, GG; Li, J; McGoogan, JM; Zhou, C; Zhao, Y; Liang, ZG; Zhang, HP; Zuo, Y; Lan, L; Wu, ZY				Li, Rui; Zhao, Guoguang; Li, Jia; McGoogan, Jennifer M.; Zhou, Chu; Zhao, Yan; Liang, Zhigang; Zhang, Haiping; Zuo, Ya; Lan, Lan; Wu, Zunyou			HIV screening among patients seeking care at Xuanwu Hospital: A cross-sectional study in Beijing, China, 2011-2016	PLOS ONE			English	Article								Objectives One-third of people living with HIV in China are still unaware of their status, so we sought to better understand HIV testing in the general hospital setting in China. Methods A cross-sectional study was conducted using the electronic medical records of all patients who attended Xuanwu Hospital in Beijing, January 1, 2011 to December 31, 2016. HIV screening and detection rates and characteristics of patients diagnosed with HIV were assessed. Results Overall, 235,961 patients were screened, for a screening rate of 1.4%. Although most were outpatients (98.4%), screening rate was higher among inpatients (70.0% versus 0.4%), and highest in internal medicine (36.1%) and surgery (33.3%) departments. A total of 140 patients were diagnosed with HIV, for a detection rate of 5.93 per 10,000. Detection rates were highest among outpatients (9.34 per 10,000), and patients attending the dermatology and sexually transmitted infection (STI) department (153.85 per 10,000). Most diagnoses were made among males (91.4%), aged 20-39 (67.1%), who reported becoming infected through homosexual contact (70.0%). Conclusions HIV screening in China's general hospitals needs to be improved. More focus should be placed on screening outpatients, especially in the dermatology and STI department, and young men.	[Li, Rui; Li, Jia; Liang, Zhigang] Capital Med Univ, Xuanwu Hosp, Informat Ctr, Beijing, Peoples R China; [Zhao, Guoguang] Capital Med Univ, Xuanwu Hosp, Med Dept, Beijing, Peoples R China; [McGoogan, Jennifer M.; Zhou, Chu; Zhao, Yan; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Haiping] Capital Med Univ, Xuanwu Hosp, Dept Dermatol & Venereol, Beijing, Peoples R China; [Zuo, Ya] Capital Med Univ, Xuanwu Hosp, Dis Control Dept, Beijing, Peoples R China; [Lan, Lan] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China; [Wu, Zunyou] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA	Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Capital Medical University; Sichuan University; University of California System; University of California Los Angeles	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.; Wu, ZY (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	wuzy@263.net		zhang, haiping/0000-0002-1390-643X	National Health and Family Planning Commission of the People's Republic of China [131-13-000 -105-01, 2012ZX10001-007]	National Health and Family Planning Commission of the People's Republic of China	This work was supported by the National Health and Family Planning Commission of the People's Republic of China (#131-13-000 -105-01 and # 2012ZX10001-007). URLs: http://www.moh.gov.cn/. ZW is the fund receipt. The funding organization had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Beijing Municipal Health Bureau, 2011, IND EV DIS CONTR PRE; Casalino E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046437; Cheng WB, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1631878; Chinese Center for Disease Control and Prevention, 2009, NAT GUID DET HIV AID; Joint United Nations Programme on HIV/AIDS, 2017, END AIDS PROGR 90 90; Joint United Nations Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Ma Y, 2018, CLIN INFECT DIS, V66, P833, DOI 10.1093/cid/cix911; National Health and Family Planning Commission, 2016, CHIN HLTH FAM PLANN; Song X J, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P81, DOI 10.3760/cma.j.issn.0254-6450.2017.01.016; Wu Z., 2017, HIV AIDS CHINA NUMBE; Wu Z.Q., 2015, INT J LAB MED, V36, P2133; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210	13	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208008	10.1371/journal.pone.0208008	http://dx.doi.org/10.1371/journal.pone.0208008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557352	gold, Green Submitted, Green Published			2022-12-26	WOS:000453451000018
J	Mehrabian, S; Thonberg, H; Raycheva, M; Lilius, L; Stoyanova, K; Forsell, C; Cavallin, L; Nesheva, D; Westman, E; Toncheva, D; Traykov, L; Winblad, B; Graff, C				Mehrabian, Shima; Thonberg, Hakan; Raycheva, Margarita; Lilius, Lena; Stoyanova, Katya; Forsell, Charlotte; Cavallin, Lena; Nesheva, Desislava; Westman, Eric; Toncheva, Draga; Traykov, Latchezar; Winblad, Bengt; Graff, Caroline			Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GGGGCC HEXANUCLEOTIDE REPEAT; ALZHEIMERS-DISEASE; C9ORF72 EXPANSION; BEHAVIORAL VARIANT; WRITING ERRORS; MUTATION; DIAGNOSIS; AGRAPHIA	Background The GGGGCC repeat expansion in the C9orf72 gene was recently identified as a major cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) in several European populations. The objective of this study was to determine the frequency of C9orf72 repeat expansions in a Bulgarian dementia cohort and to delineate the associated clinical features. Methods and findings PCR-based assessments of the C9orf72 hexanucleotide repeat expansion in all study samples (including 82 FTD, 37 Alzheimer's disease (AD), and 16 other neurodegenerative/ dementia disorder cases) were performed. We report the clinical, neuropsychological, and neuroimaging findings obtained for the C9orf72 repeat expansion carriers. Of the 135 cases screened, 3/82 (3.7%) of all FTD cases and 1/37 (2.7%) of all clinical AD cases had a C9orf72 repeat expansion. In this cohort, the C9orf72 pathological expansion was found in clinical diagnoses bridging the FTD, parkinsonism, ALS and AD spectrum. Interestingly, we showed early writing errors without aphasia in two subjects with C9orf72 expansions. Conclusions This study represents the first genetic screening for C9orf72 repeat expansions in a Bulgarian dementia cohort. The C9orf72 repeat expansion does not appear to be a common cause of FTD and related disorders. This report confirms the notion that C9orf72 repeat expansions underlie a broad spectrum of neurodegenerative phenotypes. Relatively isolated agraphia in two cases with C9orf72 repeat expansions is a strong motivation to provide detailed and sophisticated oral and written language assessments that can be used to more precisely characterize early cognitive deficits in these heterogeneous conditions.	[Mehrabian, Shima; Raycheva, Margarita; Stoyanova, Katya; Traykov, Latchezar] Med Univ Sofia, UH Alexandrovska, Depatment Neurol, Sofia, Bulgaria; [Thonberg, Hakan; Lilius, Lena; Forsell, Charlotte; Graff, Caroline] Karolinska Inst, Akad Straket, Dept NVS, Div Neurogeriatr,Bioclinicum, Solna, Sweden; [Thonberg, Hakan; Lilius, Lena; Forsell, Charlotte; Graff, Caroline] Karolinska Univ Hosp, Genet Unit, Theme Aging, Solna, Sweden; [Cavallin, Lena] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Dept Radiol, Stockholm, Sweden; [Nesheva, Desislava; Toncheva, Draga] Med Univ Sofia, Dept Genet, Sofia, Bulgaria; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Neo, Ctr Alzheimer Res,Div Clin Geriatr, Huddinge, Sweden; [Winblad, Bengt] Karolinska Univ Hosp, Clin Trial Unit, Theme Aging, Stockholm, Sweden; [Winblad, Bengt] Karolinska Inst, Dept NVS, Ctr Alzheimer Res, Div Neurogeriatr, Huddinge, Sweden	Medical University Sofia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Medical University Sofia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Mehrabian, S (corresponding author), Med Univ Sofia, UH Alexandrovska, Depatment Neurol, Sofia, Bulgaria.	shima_meh@yahoo.com	Westman, Eric/H-5771-2011; graff, caroline/A-2545-2009	Westman, Eric/0000-0002-3115-2977; Nesheva, Desislava/0000-0002-8574-8477; Graff, Caroline/0000-0002-9949-2951	Swedish Foundation Dementia; Swedish Dementia Foundation	Swedish Foundation Dementia; Swedish Dementia Foundation	This work has been financed by the Swedish Foundation Dementia.; We thank the patients and caregivers who agreed to participate in the study. This work was financed by the Swedish Dementia Foundation.	Adeli A, 2014, NEUROCASE, V20, P110, DOI 10.1080/13554794.2012.732090; Amieva H, 2005, BRAIN, V128, P1093, DOI 10.1093/brain/awh451; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Bieniek KF, 2013, ACTA NEUROPATHOL, V125, P289, DOI 10.1007/s00401-012-1048-7; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Cacace R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.019; Chiang HH, 2017, J HUM GENET, V62, P321, DOI 10.1038/jhg.2016.108; Coon EA, 2011, NEUROLOGY, V76, P1886, DOI 10.1212/WNL.0b013e31821d767b; Cooper-Knock J, 2013, NEUROLOGY, V81, P808, DOI 10.1212/WNL.0b013e3182a2cc38; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Ferguson J H, 1977, Neurol Neurocir Psiquiatr, V18, P79; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garrard P, 2000, J NEUROL, V247, P409, DOI 10.1007/s004150070169; Gijselinck I, 2017, COLD SPRING HARB PER; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gilbert RMW, 2010, MOVEMENT DISORD, V25, P1868, DOI 10.1002/mds.23200; Golden ChJ, GOLD CHJ STROOP COL; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Harms M, 2013, JAMA NEUROL, V70, P736, DOI 10.1001/2013.jamaneurol.537; Heilman KM., 2003, INT J CLIN NEUROPSYC; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Ichikawa H, 2008, BEHAV NEUROL, V19, P107, DOI 10.1155/2008/814846; Ichikawa H, 2011, EUR NEUROL, V65, P346, DOI 10.1159/000328216; Ishihara K, 2010, BEHAV NEUROL, V23, P153, DOI [10.3233/BEN-2010-0276, 10.1155/2010/146912]; Ismail A, 2013, J NEUROL NEUROSUR PS, V84, P79, DOI 10.1136/jnnp-2012-303326; Janyan A, 2006, HDB ORTHOGRAPHY LITE, P275; Kaplan E, 1978, BOSTON NAMING TEST; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Khan BK, 2012, J NEUROL NEUROSUR PS, V83, P358, DOI 10.1136/jnnp-2011-301883; Kipps CM, 2007, DEMENT GERIATR COGN, V23, P334, DOI 10.1159/000100973; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Kohli MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.003; Konno T, 2013, J NEUROL NEUROSUR PS, V84, P398, DOI 10.1136/jnnp-2012-302272; Lesage S, 2013, BRAIN, V136, P385, DOI 10.1093/brain/aws357; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lindquist SG, 2013, CLIN GENET, V83, P279, DOI 10.1111/j.1399-0004.2012.01903.x; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lorefice L, 2015, J NEUROL SCI, V357, P229, DOI 10.1016/j.jns.2015.07.036; Maeda K, 2015, INTERNAL MED, V54, P3065, DOI 10.2169/internalmedicine.54.4982; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; Mandic-Stojmenovic G, 2015, DEMENT GERIATR COGN, V40, P358, DOI 10.1159/000438748; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mcneil M. R., 2001, LANGUAGE INTERVENTIO, P472; Mendez EF, 2015, BRAIN RES, V1607, P26, DOI 10.1016/j.brainres.2014.09.041; Menichelli A, 2008, CORTEX, V44, P861, DOI 10.1016/j.cortex.2007.06.002; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; O'Dowd S, 2012, MOVEMENT DISORD, V27, P1072, DOI 10.1002/mds.25022; Origone P, 2013, AMYOTROPH LAT SCL FR, V14, P479, DOI 10.3109/21678421.2013.774020; Ostberg P, 2001, BRAIN LANG, V79, P333, DOI 10.1006/brln.2001.2491; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Pletnikova O, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.009; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratti A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rollinson S., 2012, NEUROBIOL AGING, V33; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shim H, 2012, NEUROPSYCHOLOGIA, V50, P1929, DOI 10.1016/j.neuropsychologia.2012.04.017; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Sitek EJ, 2014, NEUROCASE, V20, P69, DOI 10.1080/13554794.2012.732087; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snowden JS, 2012, J NEUROL NEUROSUR PS, V83, P1031, DOI 10.1136/jnnp-2012-303032; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Spreen O., 1991, PROFILE TEST RESULTS; Takada LT, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt141; Testi S, 2015, J ALZHEIMERS DIS, V44, P49, DOI 10.3233/JAD-141794; Ticozzi N, 2014, NEUROBIOL AGING, V35, DOI DOI 10.1016/J.NEUR0BI0LAGING.2013.09.037; Tsuji-Akimoto S, 2010, J NEUROL, V257, P2071, DOI 10.1007/s00415-010-5662-9; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Vrabec K, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.11.011; Wallon D, 2012, J ALZHEIMERS DIS, V32, P19, DOI 10.3233/JAD-2012-120877; Wojtas Aleksandra, 2012, Am J Neurodegener Dis, V1, P107; Woollacott IOC, 2014, ACTA NEUROPATHOL, V127, P319, DOI 10.1007/s00401-014-1253-7; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016; Yabe I, 2012, J NEUROL SCI, V315, P55, DOI 10.1016/j.jns.2011.11.039; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yokoyama JS, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt148	83	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208383	10.1371/journal.pone.0208383	http://dx.doi.org/10.1371/journal.pone.0208383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IQ	30550541	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000017
J	Vinnikov, D; Semizhon, S; Rybina, T; Zaitsev, V; Pleshkova, A; Rybina, A				Vinnikov, Denis; Semizhon, Sergey; Rybina, Tatsyana; Zaitsev, Viktor; Pleshkova, Anna; Rybina, Aliaksandra			Occupational exposure to metals and other elements in the tractor production	PLOS ONE			English	Article							OXIDATIVE STRESS; HUMAN HAIR; MANGANESE; CADMIUM; LEAD; NICKEL; RISK; BIOMARKER; WORKERS; COPPER	Background Exposure to metals via air sampling in workplace has been extensively studied; however, the magnitude of individual exposure in various occupational groups may vary dramatically. The aim of this cross-sectional study was to ascertain exposure to selected metals from metal fumes in a series of typical workplaces of contemporary tractor production. Methods Ninety-eight (median age 41 (interquartile range (IQR) 23) years, all men) workers from Minsk Tractor Plant were categorized into four groups, including assembly shop workers (group 1); thermal shop staff (group 2); steelmakers (group 3) and welders (group 4). Hair samples (0.25 g) of each worker were tested for Ca, Mg, P, Cu, Fe, Zn, Al, Mn, Cr, Ni, Pb and Cd using atomic emission spectrophotometry. We then tested between-group differences of log-transformed element concentrations using analysis of variance, followed by logistic regression to determine the odds ratio (OR) with its 95% confidence interval (CI) of high exposure for four selected groups. Results The median work duration in workers was 6 (IQR 15) years, more in group 1 (10 (IQR 23)). Eight out of 12 included elements yielded significant between-group differences, including Mg, P, Fe, Zn, Mn, Cr, Ni and Cd. Steelmakers had higher Mn hair concentrations (F-ratio 10.41, p<0.001); whereas Fe (F-ratio 12.48, p<0.001), P (F-ratio 12.68, p<0.001), Zn (F-ratio 6.07, p<0.001) and Cr (F-ratio 20.54, p<0.001) were higher in welders. OR of high exposure to Mg in group 3 was 10.00 (95% CI 1.14-87.52), whereas the OR of high exposure to P in group 4 was 18.64 (95% CI 2.22-156.85) compared to group 1. Conclusions In the modern full-cycle tractor production, welders may have higher exposure to Fe, P, Zn and Cr, as opposed to steelmakers with higher Mn hair concentrations.	[Vinnikov, Denis] Al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan; [Vinnikov, Denis] Natl Res Tomsk State Univ, Biol Inst, Tomsk, Russia; [Semizhon, Sergey] Minsk Tractor Plant, Minsk, BELARUS; [Rybina, Tatsyana; Rybina, Aliaksandra] Natl Ctr Occupat Safety & Hlth, Minsk, BELARUS; [Zaitsev, Viktor; Pleshkova, Anna] Republican Sci & Pract Ctr Hyg, Minsk, BELARUS	Al-Farabi Kazakh National University; Tomsk State University; Republican Unitary Enterprise Scientific & Practical Centre of Hygiene	Vinnikov, D (corresponding author), Al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan.; Vinnikov, D (corresponding author), Natl Res Tomsk State Univ, Biol Inst, Tomsk, Russia.	denisvinnikov@mail.ru	Vinnikov, Denis/A-5908-2011	Vinnikov, Denis/0000-0003-0991-6237; Rybina, Tatsyana/0000-0002-1022-9699	Tomsk State University competitiveness programme	Tomsk State University competitiveness programme	This study was supported by grant from "The Tomsk State University competitiveness programme". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2006, TOXICOL IND HEALTH, V22, P381, DOI 10.1177/0748233706073420; Alasia D D, 2010, Niger J Med, V19, P407; Bailey LA, 2018, NEUROTOXICOLOGY, V64, P166, DOI 10.1016/j.neuro.2017.06.009; Baker MG, 2014, J OCCUP ENVIRON HYG, V11, P210, DOI 10.1080/15459624.2013.852280; BENCKO V, 1995, TOXICOLOGY, V101, P29, DOI 10.1016/0300-483X(95)03018-B; Beveridge R, 2010, AM J IND MED, V53, P476, DOI 10.1002/ajim.20801; Bonberg N, 2017, INT J HYG ENVIR HEAL, V220, P998, DOI 10.1016/j.ijheh.2017.05.009; Buononato EV, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5311-6; Cespon-Romero RM, 2007, ANAL CHIM ACTA, V600, P221, DOI 10.1016/j.aca.2006.11.075; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Garcia-Leston J, 2012, ENVIRON INT, V43, P29, DOI 10.1016/j.envint.2012.03.001; Gil F, 2011, SCI TOTAL ENVIRON, V409, P1172, DOI 10.1016/j.scitotenv.2010.11.033; GORBAN LN, 1985, VRACHEBNOE DELO, P87; Grimsrud TK, 2002, AM J EPIDEMIOL, V156, P1123, DOI 10.1093/aje/kwf165; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Kendzia B, 2017, ANN WORK EXPOS HEAL, V61, P1108, DOI 10.1093/annweh/wxx080; Luse I, 2000, Cent Eur J Public Health, V8 Suppl, P51; Matovic V, 2011, ARH HIG RADA TOKSIKO, V62, P65, DOI 10.2478/10004-1254-62-2011-2075; Poreba R, 2011, ENVIRON TOXICOL PHAR, V31, P267, DOI 10.1016/j.etap.2010.12.002; Ramakrishna VVS, 1996, SCI TOTAL ENVIRON, V192, P259, DOI 10.1016/S0048-9697(96)05316-8; Reiss B, 2016, ANN OCCUP HYG, V60, P139, DOI 10.1093/annhyg/mev064; Sazakli E, 2017, J TRACE ELEM MED BIO, V43, P161, DOI 10.1016/j.jtemb.2017.02.001; Seilkop SK, 2017, ARCH ENVIRON OCCUP H, V72, P204, DOI 10.1080/19338244.2016.1199532; Siurin S. A., 2009, Meditsina Truda i Promyshlennaya Ekologiya, P35; Strumylaite L, 2004, INT J HYG ENVIR HEAL, V207, P345, DOI 10.1078/1438-4639-00281; Syurin S. A., 2010, Ekologiya Cheloveka / Human Ecology, P20; Syurin S. A., 2013, Meditsina Truda i Promyshlennaya Ekologiya, P22; Telisman S, 2000, ENVIRON HEALTH PERSP, V108, P45, DOI 10.2307/3454294	29	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208932	10.1371/journal.pone.0208932	http://dx.doi.org/10.1371/journal.pone.0208932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550545	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000033
J	Koker, SC; Jahja, E; Shehwana, H; Keskus, AG; Konu, O				Koker, Sahika Cingir; Jahja, Ermira; Shehwana, Huma; Keskus, Ayse Gokce; Konu, Ozlen			Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; MESENCHYMAL TRANSITION; DOWN-REGULATION; SUBUNIT GENES; GENOME; EXPRESSION; MIGRATION; CHK1; ACTIVATION; RESISTANCE	Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) is an important susceptibility locus for nicotine addiction and lung cancer. Depletion of CHRNA5 has been associated with reduced cell viability, increased apoptosis and alterations in cellular motility in different cancers yet not in breast cancer. Herein we first showed the expression of CHRNA5 was variable and positively correlated with the fraction of total genomic alterations in breast cancer cell lines and tumors indicating its potential role in DNA damage response (DDR). Next, we demonstrated that silencing of CHRNA5 expression in MCF7 breast cancer cell line by RNAi affected expression of genes involved in cytoskeleton, TP53 signaling, DNA synthesis and repair, cell cycle, and apoptosis. The transcription profile of CHRNA5 depleted MCF7 cells showed a significant positive correlation with that of A549 lung cancer cell line while exhibiting a negative association with the CHRNA5 co-expression profile obtained from Cancer Cell Line Encylopedia (CCLE). Moreover, it exhibited high similarities with published MCF7 expression profiles obtained from exposure to TP53 inducer nutlin-3a and topoisomerase inhibitors. We then demonstrated that CHRNA5 siRNA treatment reduced cell viability and DNA synthesis indicating G1 arrest while it significantly increased apoptotic sub-G1 cell population. Accordingly, we observed lower levels of phosphorylated RB (Ser807/811) and an increased BAX/BCL2 ratio in RNAi treated MCF7 cells. We also showed that CHRNA5 RNAi transcriptome correlated negatively with DDR relevant gene expression profile in breast cancer gene expression datasets while the coexposure to topoisomerase inhibitors in the presence of CHRNA5 RNAi enhanced chemosensitivity potentially due to reduced DDR. CHRNA5 RNAi consistently lowered total CHEK1 mRNA and protein levels as well as phosphorylated CHEK1 (Ser345) in MCF7 cells. We also detected a significant positive correlation between the expression levels of CHRNA5 and CHEK1 in CCLE, TCGA and METABRIC breast cancer datasets. Our study suggests CHRNA5 RNAi is associated with cell cycle inhibition, apoptosis as well as reduced DDR and increased drug sensitivity in breast cancer yet future studies are warranted since dose- and cell line-specific differences exist in response to CHRNA5 depletion. Gene expression microarray data can be accessed from GEO database under the accession number GSE89333.	[Koker, Sahika Cingir; Jahja, Ermira; Shehwana, Huma; Konu, Ozlen] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Shehwana, Huma] Natl Univ Med Sci, Dept Multidisciplinary Studies, Rawalpindi, Pakistan; [Keskus, Ayse Gokce; Konu, Ozlen] Bilkent Univ, Interdisciplinary Neurosci Program, Ankara, Turkey; [Konu, Ozlen] UNAM, Inst Mat Sci & Nanotechnol, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University	Konu, O (corresponding author), Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey.; Konu, O (corresponding author), Bilkent Univ, Interdisciplinary Neurosci Program, Ankara, Turkey.; Konu, O (corresponding author), UNAM, Inst Mat Sci & Nanotechnol, Ankara, Turkey.	konu@fen.bilkent.edu.tr		Keskus, Ayse Gokce/0000-0002-3934-8587	Scientific and Technological Research Council of TURKEY (TUBITAK) [111T316]; Higher Education Commission (HEC), Pakistan [111T316]	Scientific and Technological Research Council of TURKEY (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan)	This work was supported by a research grant, No: 111T316 (OK), from The Scientific and Technological Research Council of TURKEY (TUBITAK). SCK, EJ, and HS received PhD fellowships from 111T316. Higher Education Commission (HEC), Pakistan, provided a PhD fellowship to HS.	Akasaka H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-548; Al-Kaabi MM, 2015, BRIT J CANCER, V112, P901, DOI 10.1038/bjc.2014.576; Allen WL, 2012, MOL CANCER THER, V11, P1724, DOI 10.1158/1535-7163.MCT-12-0207; Antonucci LA, 2014, CELL CYCLE, V13, P3611, DOI 10.4161/15384101.2014.964093; Bae SY, 2018, BREAST CANCER RES TR, V172, P437, DOI 10.1007/s10549-018-4928-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benevolenskaya EV, 2015, CANCER RES, V75, P619, DOI 10.1158/0008-5472.CAN-14-2173; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishayee A, 2016, NUTR CANCER, V68, P120, DOI 10.1080/01635581.2016.1115094; Bordas A, 2017, ONCOTARGET, V8, P67878, DOI 10.18632/oncotarget.18948; Bryant C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-570; Bryant C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-147; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen PC, 2018, J CELL PHYSIOL, V233, P4972, DOI 10.1002/jcp.26334; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chung SW, 2018, BIOMATERIALS, V182, P35, DOI 10.1016/j.biomaterials.2018.08.007; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Craig Parman CH, 2016, AFFYQCREPORT QC REPO; Cruz-Martinez A, 1997, ELECTROMYOGR MOTOR C, V105, P458, DOI 10.1016/S0924-980X(97)00047-7; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Falvella FS, 2013, CARCINOGENESIS, V34, P1281, DOI 10.1093/carcin/bgt062; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fu JF, 2017, CANCER-AM CANCER SOC, V123, P2432, DOI 10.1002/cncr.30617; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerhard R, 2012, BREAST, V21, P354, DOI 10.1016/j.breast.2012.03.001; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goold RG, 2001, J CELL SCI, V114, P4273; Grohar PJ, 2014, CLIN CANCER RES, V20, P1190, DOI 10.1158/1078-0432.CCR-13-0901; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; HARPER JW, 1993, CELL, V75, P805; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jia YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149120; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Krisenko MO, 2015, BIOCHEMISTRY-US, V54, P60, DOI 10.1021/bi500325n; Krishnamoorthy M, 2010, REPROD TOXICOL, V30, P489, DOI 10.1016/j.reprotox.2010.04.011; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep25999; Liu Y, 2009, CANCER RES, V69, P7844, DOI 10.1158/0008-5472.CAN-09-1833; Ma F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112765; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Patil M, 2013, CELL MOL LIFE SCI, V70, P4009, DOI 10.1007/s00018-013-1307-3; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Qiu ZJ, 2018, RADIOTHER ONCOL, V126, P450, DOI 10.1016/j.radonc.2017.09.043; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Ray C, 2017, ACS CHEM BIOL, V12, P702, DOI 10.1021/acschembio.6b01117; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salakou S, 2007, IN VIVO, V21, P123; Samanta D, 2012, NEOPLASIA, V14, P644, DOI 10.1593/neo.12548; Samanta D, 2012, CANCER PREV RES, V5, P453, DOI 10.1158/1940-6207.CAPR-11-0313; Sarkar D., 2017, CATEGORY CATEGORY AN; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Sharifi S, 2014, ASIAN PAC J CANCER P, V15, P8617, DOI 10.7314/APJCP.2014.15.20.8617; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Sun HJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00573; Sun HJ, 2015, EXP TOXICOL PATHOL, V67, P477, DOI 10.1016/j.etp.2015.07.001; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Team RC, 2016, R LANG ENV STAT COMP; Tekpli X, 2013, INT J CANCER, V132, P1811, DOI 10.1002/ijc.27870; Teo MY, 2017, CLIN CANCER RES, V23, P3610, DOI 10.1158/1078-0432.CCR-16-2520; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venables WN., 2002, MODERN APPL STAT S 4; Wang F, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4527-y; Wang J, 2017, MOL CELL PROTEOMICS, V16, P121, DOI 10.1074/mcp.M116.060301; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamaguchi Shigeo, 2018, Oncotarget, V9, P14193, DOI 10.18632/oncotarget.24447; Yang B, 2002, KIDNEY INT, V62, P1301, DOI 10.1111/j.1523-1755.2002.kid587.x; Yeo CQX, 2016, CELL REP, V15, P132, DOI 10.1016/j.celrep.2016.03.011; Zhang Y, 2017, J GENET GENOMICS, V44, P355, DOI 10.1016/j.jgg.2017.03.003; Zhao XQ, 2015, VIRUSES-BASEL, V7, P2965, DOI 10.3390/v7062755	94	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208982	10.1371/journal.pone.0208982	http://dx.doi.org/10.1371/journal.pone.0208982			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543688	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500058
J	Mertens, R; Melchert, S; Gitler, D; Schou, MB; Saether, SG; Vaaler, A; Piepgras, J; Kochova, E; Benfenati, F; Ahnert-Hilger, G; Ruprecht, K; Holtje, M				Mertens, Robert; Melchert, Sarah; Gitler, Daniel; Schou, Morten Brix; Saether, Sverre Georg; Vaaler, Arne; Piepgras, Johannes; Kochova, Elena; Benfenati, Fabio; Ahnert-Hilger, Gudrun; Ruprecht, Klemens; Hoeltje, Markus			Epitope specificity of anti-synapsin autoantibodies: Differential targeting of synapsin I domains	PLOS ONE			English	Article							SERUM; AUTOIMMUNITY; ANTIBODIES; RELEASE; DISEASE	Objective To identify the specific domains of the presynaptic protein synapsin targeted by recently described autoantibodies to synapsin. Methods Sera of 20 and CSF of two patients with different psychiatric and neurological disorders previously tested positive for immunoglobulin (Ig)G antibodies to full-length synapsin were screened for IgG against synapsin I domains using HEK293 cells transfected with constructs encoding different domains of rat synapsin Ia. Additionally, IgG subclasses were determined using full-length synapsin Ia. Serum and CSF from one patient were also screened for IgA autoantibodies to synapsin I domains. Sera from nine and CSF from two healthy subjects were analyzed as controls. Results IgG in serum from 12 of 20 IgG synapsin full-length positive patients, but from none of the healthy controls, bound to synapsin domains. Of these 12 sera, six bound to the A domain, five to the D domain, and one to the B- (and possibly A-), D-, and E-domains of synapsin I. IgG antibodies to the D-domain were also detected in one of the CSF samples. Determination of IgG subclasses detected IgG(1) in two sera and one CSF, IgG(2) in none of the samples, IgG(3) in two sera, and IgG(4) in eight sera. One patient known to be positive for IgA antibodies to full-length synapsin had IgA antibodies to the D-domain in serum and CSF. Conclusions Anti-synapsin autoantibodies preferentially bind to either the A- or the D-domain of synapsin I.	[Mertens, Robert; Melchert, Sarah; Piepgras, Johannes; Kochova, Elena; Ahnert-Hilger, Gudrun; Hoeltje, Markus] Charite Univ Med Berlin, Inst Integrat Neuroanat, Berlin, Germany; [Mertens, Robert; Melchert, Sarah; Piepgras, Johannes; Kochova, Elena; Ahnert-Hilger, Gudrun; Ruprecht, Klemens; Hoeltje, Markus] Free Univ Berlin, Berlin, Germany; [Mertens, Robert; Melchert, Sarah; Piepgras, Johannes; Kochova, Elena; Ahnert-Hilger, Gudrun; Ruprecht, Klemens; Hoeltje, Markus] Humboldt Univ, Berlin, Germany; [Mertens, Robert; Melchert, Sarah; Piepgras, Johannes; Kochova, Elena; Ahnert-Hilger, Gudrun; Ruprecht, Klemens; Hoeltje, Markus] Berlin Inst Hlth, Berlin, Germany; [Gitler, Daniel] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Fac Hlth Sci, Beer Sheva, Israel; [Gitler, Daniel] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Schou, Morten Brix; Saether, Sverre Georg; Vaaler, Arne] St Olavs Univ Hosp, Dept Psychiat, Trondheim, Norway; [Schou, Morten Brix; Saether, Sverre Georg; Vaaler, Arne] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway; [Benfenati, Fabio] Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol, Genoa, Italy; [Ruprecht, Klemens] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Ben Gurion University; Ben Gurion University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Istituto Italiano di Tecnologia - IIT; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Holtje, M (corresponding author), Charite Univ Med Berlin, Inst Integrat Neuroanat, Berlin, Germany.; Holtje, M (corresponding author), Free Univ Berlin, Berlin, Germany.; Holtje, M (corresponding author), Humboldt Univ, Berlin, Germany.; Holtje, M (corresponding author), Berlin Inst Hlth, Berlin, Germany.	markus.hoeltje@charite.de	Gitler, Daniel/F-1304-2012	Gitler, Daniel/0000-0001-9544-3610; Holtje, Markus/0000-0003-3193-4140	Israel Science Foundation (ISF) [1427/12]; German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis)	Israel Science Foundation (ISF)(Israel Science Foundation); German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis)	DG was supported by Israel Science Foundation (ISF) grant 1427/12.KR was supported by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis). All other authors report no disclosures.	Arino H, 2016, NEUROLOGY, V87, P759, DOI 10.1212/WNL.0000000000003009; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bragina L, 2007, NEUROSCIENCE, V146, P1829, DOI 10.1016/j.neuroscience.2007.02.060; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Engelhart S, 2017, SEMIN ARTHRITIS RHEU, V47, P276, DOI 10.1016/j.semarthrit.2017.03.021; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Geis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016775; Geis C, 2010, BRAIN, V133, P3166, DOI 10.1093/brain/awq253; Gerth F, 2017, P NATL ACAD SCI USA, V114, P12057, DOI 10.1073/pnas.1715341114; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamano H, 2018, INTERNAL MED, V57, P1201, DOI 10.2169/internalmedicine.9533-17; Hara M, 2017, NEUROLOGY, V88, P1340, DOI 10.1212/WNL.0000000000003796; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Piepgras J, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000169; Pittock SJ, 2006, MAYO CLIN PROC, V81, P1207, DOI 10.4065/81.9.1207; Pittock SJ, 2005, ANN NEUROL, V58, P96, DOI 10.1002/ana.20529; Pittock SJ, 2003, ANN NEUROL, V53, P580, DOI 10.1002/ana.10518; Pruss H., 2017, BRAIN BEHAV IMM 0718, V2017, DOI [10.1016/j.immuni.2017.05.003, DOI 10.1016/J.IMMUNI.2017.05.003]; REIBER H, 1991, CLIN CHEM, V37, P1153; Schou M, 2016, PSYCHOL MED, V46, P3303, DOI 10.1017/S0033291716002038; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Vaccaro P, 1997, MOL BRAIN RES, V52, P1, DOI 10.1016/S0169-328X(97)00219-2; van Sonderen A, 2016, NEUROLOGY, V87, P521, DOI 10.1212/WNL.0000000000002917; Wang SW, 2011, J NEUROSCI, V31, P7275, DOI 10.1523/JNEUROSCI.6476-10.2011; Werner C, 2016, BRAIN, V139, P365, DOI 10.1093/brain/awv324	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208636	10.1371/journal.pone.0208636	http://dx.doi.org/10.1371/journal.pone.0208636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543686	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500030
J	Stendardo, M; Bonci, M; Casino, V; Miglio, R; Giovannini, G; Nardini, M; Campo, G; Fucili, A; Boschetto, P				Stendardo, Mariarita; Bonci, Melissa; Casino, Valeria; Miglio, Rossella; Giovannini, Giulia; Nardini, Marco; Campo, Gianluca; Fucili, Alessandro; Boschetto, Piera			Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION; RESUMPTION; EMPLOYMENT; IMPACT	Objectives Return to work after acute myocardial infarction (AMI), a leading cause of death globally, is a multidimensional process influenced by clinical, psychological, social and occupational factors, the single impact of which, however, is still not well defined. The objective of this study was to investigate these 4 factors on return to work (RTW) within 365 days after AMI in a homogeneous cohort of patients who had undergone an urgent coronary angioplasty. Participants We studied 102 patients, in employment at the time of AMI (88.24% of men), admitted to the Department of Cardiology of the University-Hospital of Ferrara between March 2015 to December 2016. Demographical and clinical characteristics were obtained from the cardiological records. After completing an interview on social and occupational variables and the Hospital Anxiety and Depression (HADS) questionnaire, patients underwent exercise capacity measurement and spirometry. Results Of the 102 patients, only 12 (12.76%) held a university degree, 68.63% were employees and 31.37% self-employed. The median number of sick-leave days was 44 (IQR 33-88). At day 30, 78.5% of all subjects had not returned to work, at day 60, 40.8% and at day 365 only 7.3% had not resumed working. At univariate analyses, educational degree (p = 0.026), self-employment status (p = 0.0005), white collar professional category (p = 0.020) and HADS depression score were significant for earlier return to work. The multivariate analysis confirms that having a university degree, being self-employed and presenting a lower value of HADS depression score increase the probability of a quicker return to work. Conclusions These findings suggest that the strongest predictors of returning to work within 1 year after discharge for an acute myocardial infarction are related more to socio-occupational than to clinical parameters.	[Stendardo, Mariarita; Bonci, Melissa; Casino, Valeria; Boschetto, Piera] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Miglio, Rossella; Giovannini, Giulia] Univ Bologna, Dept Stat Sci Paolo Fortunati, Bologna, Italy; [Nardini, Marco] Univ Hosp & Publ Hlth Serv Ferrara, Dept Prevent & Protect, Ferrara, Italy; [Campo, Gianluca; Fucili, Alessandro] Univ Hosp Ferrara, Cardiol Unit, Cona, Ferrara, Italy; [Campo, Gianluca; Fucili, Alessandro] Maria Cecilia Hosp, GVM Care & Res, ES Hlth Sci Fdn, Cotignola, Ravenna, Italy	University of Ferrara; University of Bologna; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; Maria Cecilia Hospital	Boschetto, P (corresponding author), Univ Ferrara, Dept Med Sci, Ferrara, Italy.	bsp@unife.it	Boschetto, Piera/AAM-3247-2020; Miglio, Rossella/AAE-6036-2022	Boschetto, Piera/0000-0003-3889-1681; Campo, Gianluca/0000-0002-5150-188X				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bhattacharyya MR, 2007, EUR HEART J, V28, P160, DOI 10.1093/eurheartj/ehl440; Biering K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049268; COSTA G, 1985, Giornale Italiano di Medicina del Lavoro, V7, P203; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dreyer RP, 2016, CIRC-CARDIOVASC QUAL, V9, pS45, DOI 10.1161/CIRCOUTCOMES.115.002611; Drory Y, 2005, CARDIOLOGY, V103, P37, DOI 10.1159/000081850; Farkas J, 2008, INT J CARDIOL, V130, pE14, DOI 10.1016/j.ijcard.2007.07.041; Holland P, 2009, SCAND J PUBLIC HEALT, V37, P450, DOI 10.1177/1403494809106501; Laut KG, 2014, AM J CARDIOL, V114, P1810, DOI 10.1016/j.amjcard.2014.09.018; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mandic S, 2013, DISABIL REHABIL, V35, P1853, DOI 10.3109/09638288.2012.759629; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Mital A, J CARDIOPULM REHABIL, V24, P365; Mittag O, 2001, SOC SCI MED, V52, P1441, DOI 10.1016/S0277-9536(00)00250-1; NIELSEN F E, 1992, Scandinavian Journal of Primary Health Care, V10, P47, DOI 10.3109/02813439209014035; O'Neil A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-95; Osler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086758; RONNEVIK PK, 1988, CARDIOLOGY, V75, P230, DOI 10.1159/000174377; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Smedegaard L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006486; Soderman E, 2003, SOC SCI MED, V56, P193, DOI 10.1016/S0277-9536(02)00024-2; Therneau T.M., 2000, MODELING SURVIVAL DA; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Voss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040952; Warraich HJ, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004528; Worcester MU, 2014, HEART LUNG CIRC, V23, P444, DOI 10.1016/j.hlc.2013.10.093; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208842	10.1371/journal.pone.0208842	http://dx.doi.org/10.1371/journal.pone.0208842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543689	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500045
J	Laouirem, S; Sannier, A; Norkowski, E; Cauchy, F; Doblas, S; Rautou, PE; Albuquerque, M; Garteiser, P; Sognigbe, L; Raffenne, J; van Beers, BE; Soubrane, O; Bedossa, P; Cros, J; Paradis, V				Laouirem, Samira; Sannier, Aurelie; Norkowski, Emma; Cauchy, Francois; Doblas, Sabrina; Rautou, Pierre Emmanuel; Albuquerque, Miguel; Garteiser, Philippe; Sognigbe, Laura; Raffenne, Jerome; van Beers, Bernard E.; Soubrane, Olivier; Bedossa, Pierre; Cros, Jerome; Paradis, Valerie			Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome	ONCOGENE			English	Article							UNITED-STATES; PPAR-GAMMA; CANCER; ADIPOCYTES; DISEASE; OBESITY; PROMOTE; EXPRESSION; METFORMIN; LEPTIN	Metabolic syndrome (MS) is becoming the leading risk factor for hepatocellular carcinoma (HCC). HCC development related to MS may occur in advanced or non-advanced liver fibrosis, suggesting specific molecular pathways. Among these pathways, basal inflammatory state and adipokines production are involved. The aim of this study was to evaluate the role of fatty acid-binding protein 4 (FABP4). In this study, we demonstrate the specific overexpression of FABP4 in human HCC samples from patients with MS compared to other risk factors for chronic liver disease with FABP4 expression restricted to peritumoral endothelial cells. In vitro, glucose, insulin, VEGFA and hypoxia upregulated endothelial FABP4, which was reversed by metformin through mTOR pathway inhibition. FABP4 exerts oncogenic effects on hepatoma cell lines by upregulating the angiogenesis gene signature and pathways involved in the cell cycle, leading to increased cell proliferation and migration, and downregulating HIF1 pathway; effects were reversed in the presence of a specific FABP4 inhibitor (BMS309403). We showed the role of microvesicles as FABP4 vectors between endothelial and tumor cells. In vivo, BMS309403 significantly reduces tumor growth in heterotopic and orthotopic xenografted mice model. In conclusion, this study demonstrates the emerging oncogenic role of liver endothelial cells through FABP4 in HCC related to MS, and highlights new anti-neoplastic mechanism of metformin.	[Laouirem, Samira; Sannier, Aurelie; Norkowski, Emma; Cauchy, Francois; Doblas, Sabrina; Garteiser, Philippe; Sognigbe, Laura; Raffenne, Jerome; van Beers, Bernard E.; Bedossa, Pierre; Cros, Jerome; Paradis, Valerie] INSERM UMR 1149, Ctr Rech Inflammat, Paris, France; [Cauchy, Francois; Soubrane, Olivier] Beaujon Hosp, Hepatobiliary Surg Dept, Clichy, France; [Rautou, Pierre Emmanuel] Beaujon Hosp, Hepatol Dept, 100 Bd Gen Leclerc, F-92110 Clichy, France; [Albuquerque, Miguel; Cros, Jerome; Paradis, Valerie] Beaujon Hosp, Pathol Dept, Clichy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Paradis, V (corresponding author), INSERM UMR 1149, Ctr Rech Inflammat, Paris, France.; Paradis, V (corresponding author), Beaujon Hosp, Pathol Dept, Clichy, France.	vparadis@teaser.fr	Paradis, Valerie/X-9097-2019; François, Cauchy/J-7031-2019; Van Beers, Bernard/N-2816-2016; raffenne, jerome/AAD-1601-2020; Soubrane, Olivier/ABB-4434-2021; Cros, Jerome/X-7677-2019; Garteiser, Philippe/P-5719-2017	François, Cauchy/0000-0002-4997-3730; Van Beers, Bernard/0000-0001-6429-1140; raffenne, jerome/0000-0002-5344-5674; Cros, Jerome/0000-0002-4935-3865; Rautou, Pierre-Emmanuel/0000-0001-9567-1859; Garteiser, Philippe/0000-0003-0157-8851	la Ligue Nationale de la Recherche Contre le Cancer; 2la Fondation de la Recherche Medicale	la Ligue Nationale de la Recherche Contre le Cancer; 2la Fondation de la Recherche Medicale	The study was supported by "la Ligue Nationale de la Recherche Contre le Cancer." A. Sannier received a research grant from "2la Fondation de la Recherche Medicale".	Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Cauchy F, 2017, CLIN SCI, V131, P27, DOI 10.1042/CS20160438; Cauchy F, 2015, GUT, V64, P1498, DOI 10.1136/gutjnl-2015-310069; Das R, 2001, CLIN CANCER RES, V7, P1706; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Guaita-Esteruelas S, 2017, MOL CARCINOGEN, V56, P208, DOI 10.1002/mc.22485; Hammamieh Rasha, 2004, J Exp Ther Oncol, V4, P195; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Harjes U, 2014, J BIOL CHEM, V289, P23168, DOI 10.1074/jbc.M114.576512; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hu BF, 2015, J HEPATOL, V63, P855, DOI 10.1016/j.jhep.2015.05.030; Queipo-Ortuno MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048605; Kaess BM, 2012, J CLIN ENDOCR METAB, V97, pE1943, DOI 10.1210/jc.2012-1458; Kim YC, 2011, J NUTR BIOCHEM, V22, P289, DOI 10.1016/j.jnutbio.2010.02.007; Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Lee D, 2014, ONCOL REP, V31, P1116, DOI 10.3892/or.2014.2975; Lemoinne S, 2015, HEPATOLOGY, V61, P1041, DOI 10.1002/hep.27318; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Saavedra P, 2015, BBA-MOL CELL RES, V1853, P2966, DOI 10.1016/j.bbamcr.2015.09.002; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Thompson KJ, 2017, LIVER INT, DOI [10.1111/liv, DOI 10.1111/LIV]; Wang Y, 2014, J CHEM INF MODEL, V54, P3046, DOI 10.1021/ci500503b; Wang Y, 2017, BIOMED PHARMACOTHER, V85, P272, DOI 10.1016/j.biopha.2016.11.021; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463	51	30	30	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3033	3046		10.1038/s41388-018-0597-1	http://dx.doi.org/10.1038/s41388-018-0597-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30575815	Green Published, hybrid			2022-12-26	WOS:000465167600012
J	Han, JH; Shin, H; Park, JY; Rho, JG; Son, DH; Kim, KW; Seong, JK; Yoon, SH; Kim, W				Han, Ji Hye; Shin, Hanho; Park, Ju-Young; Rho, Jun Gi; Son, Dong Hwee; Kim, Ki Woo; Seong, Je Kyung; Yoon, Sung-Hwa; Kim, Wook			A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice	FASEB JOURNAL			English	Article						cannabinoid receptor; CB1R antagonist; inflammation; insulin resistance; obesity	ENDOCANNABINOID SYSTEM; OVERWEIGHT PATIENTS; NLRP3 INFLAMMASOME; RISK-FACTORS; BODY-WEIGHT; FOOD-INTAKE; RIMONABANT; DERIVATIVES; ACTIVATION; REVERSES	The overactivity of cannabinoid 1 receptor (CB1R) is associated with obesity and type 2 diabetes. First-generation CB1R antagonists, such as rimonabant, offered therapeutic advantages for the control of obesity and related metabolic abnormalities, but their therapeutic potential was limited by undesirable neuropsychiatric side effects. Here, we evaluated AJ5012 as a novel potent peripheral CB1R antagonist and, using this antagonist, investigated the role of peripheral CB1R on adipose tissue inflammation in obese mouse models. AJ5012 had a high degree of CB1R and cannabinoid 2 receptor selectivity but a low brain:plasma concentration ratio without eliciting centrally mediated neurobehavioral effects. In diet-induced obese (DIO) mice, AJ5012 did not reduce food intake but did induce a significant weight loss, likely owing to an increased energy expenditure. It was as effective as rimonabant for the improvement of hormonal or metabolic abnormalities, glycemic control, and insulin sensitivity. The treatment of DIO and leptin receptor-deficient mice with AJ5012 also exhibited effects comparable to rimonabant for the prevention of macrophage infiltration, activation of the nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome, and production of proinflammatory cytokines, which resulted in the suppression of adipose tissue inflammation. In addition to macrophage, activation of CB1R in 3T3-L1 adipocytes induced the expression of proinflammatory genes, which was fully inhibited by AJ5012. Our findings identified AJ5012 as a novel peripheral CB1R antagonist and suggest that peripheral CB1R blockade might break the links between insulin resistance and adipose tissue inflammation.Han, J. H., Shin, H., Park, J.-Y., Rho, J. G., Son, D. H., Kim, K. W., Seong, J. K., Yoon, S.-H., Kim, W. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.	[Han, Ji Hye; Shin, Hanho; Park, Ju-Young; Rho, Jun Gi; Yoon, Sung-Hwa; Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea; [Son, Dong Hwee; Kim, Ki Woo] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Lab Dev Biol & Genom, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, KMPC, Seoul, South Korea	Ajou University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Yoon, SH; Kim, W (corresponding author), Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea.	shyoon@ajou.ac.kr; wookkim21@ajou.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515; Seong, Je Kyung/0000-0003-1177-6958	BK21 PLUS Program for Creative Veterinary Science Research; Interdisciplinary Program for Bioinformatics; Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT [2013M3A9D5072550, 2016R1E1A1A01941213]; Ministry of Education [2009-0093826]	BK21 PLUS Program for Creative Veterinary Science Research; Interdisciplinary Program for Bioinformatics; Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT; Ministry of Education	The authors thank the Korea Mouse Phenotyping Center for support with indirect calorimetry; Jung-Hyuck Park, Byungjeong Song, and Chang-Sik Choi (JW Pharmaceutical, Seoul, South Korea) for assistance with the measurement of antagonist levels; and JaeSung Yang and JaeSung Hwang (Dong-A ST Research Center, Youngin, South Korea) for assistance with the measurement of polar surface area and atom-based logarithm of the partition coefficient between n-octanol and water. J.K.S. was supported by the BK21 PLUS Program for Creative Veterinary Science Research, Interdisciplinary Program for Bioinformatics, and Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science and ICT (Grants 2013M3A9D5072550 and 2016R1E1A1A01941213) and the Ministry of Education (Grant 2009-0093826). The authors declare no conflicts of interest.	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Alam S, 2014, DRUG DES DEV THER, V8, P183, DOI 10.2147/DDDT.S51577; Boon MR, 2014, FASEB J, V28, P5361, DOI 10.1096/fj.13-247643; Chorvat RJ, 2013, BIOORG MED CHEM LETT, V23, P4751, DOI 10.1016/j.bmcl.2013.06.066; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; de Azua IR, 2017, J CLIN INVEST, V127, P4148, DOI 10.1172/JCI83626; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2009, NAT REV ENDOCRINOL, V5, P633, DOI 10.1038/nrendo.2009.197; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Ghose AK, 2012, ACS CHEM NEUROSCI, V3, P50, DOI 10.1021/cn200100h; Gomez R, 2002, J NEUROSCI, V22, P9612; Han JH, 2018, DIABETES OBES METAB, V20, P2179, DOI 10.1111/dom.13350; Jang HL, 2014, BIOORG MED CHEM LETT, V24, P571, DOI 10.1016/j.bmcl.2013.12.018; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Jourdan T, 2017, MOL METAB, V6, P1517, DOI 10.1016/j.molmet.2017.08.011; Jourdan T, 2017, DIABETES, V66, P994, DOI 10.2337/db16-1199; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Jourdan T, 2012, HEPATOLOGY, V55, P790, DOI 10.1002/hep.24733; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Meinguet C, 2015, EUR J MED CHEM, V94, P45, DOI 10.1016/j.ejmech.2015.02.044; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Rho JG, 2018, J CONTROL RELEASE, V279, P89, DOI 10.1016/j.jconrel.2018.04.006; Rosenstock J, 2008, DIABETES CARE, V31, P2169, DOI 10.2337/dc08-0386; Shin JJ, 2015, AGEING RES REV, V24, P66, DOI 10.1016/j.arr.2015.06.004; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228	43	20	20	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4314	4326		10.1096/fj.201801152RR	http://dx.doi.org/10.1096/fj.201801152RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566396	Bronze			2022-12-26	WOS:000459794800097
J	Zhao, YG; Wu, JY; Jia, H; Wang, XY; Zheng, RZ; Jiang, F; Chen, DN; Chen, ZH; Li, JD				Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Zheng, Ruizhi; Jiang, Fang; Chen, Dan-Na; Chen, Zhiheng; Li, Jia-Da			PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a G-protein leads to biased signaling	FASEB JOURNAL			English	Article						prokineticin receptor 2; GPCR; GnRH	GONADOTROPIN-RELEASING-HORMONE; KALLMANN-SYNDROME; INTRACELLULAR LOOP; COUPLED RECEPTORS; OLFACTORY-BULB; PROKINETICIN 2; DEFICIENCY; IDENTIFICATION; HETEROGENEITY; CHD7	Idiopathic hypogonadotropic hypogonadism (IHH) is a rare disorder caused by the deficient production, secretion, or action of gonadotropin-releasing hormone. Prokineticin (PROK) receptor 2 (PROKR2), a causative gene for IHH, encodes a GPCR PROKR2. When PROKR2 binds to its ligands PROKs, it may activate several signaling pathways, including IP3/Ca2+, MAPK, and cAMP pathways. However, the mutational spectrum of PROKR2 in Chinese patients with IHH has not been established. In the present study, we found that up to 13.3% (18/135) of patients with IHH in China carried mutations in PROKR2. Most of the variants in this study were private; however, a PROKR2 (c.533G > C; p.W178S) mutation was identified in 10 independent patients, implying a possible founder mutation. Functional studies indicated that 6 novel PROKR2 mutations led to decreased signaling to various extents. Two IHH-associated mutations (L218P and R270H) disrupted Gq-dependent signaling but maintained normal Gs and ERK1/2 signaling. A glutathione S-transferase pull-down experiment demonstrated that R270H mutation disrupted the interaction of intracellular loop 3 of PROKR2 to Gq protein but not Gs protein. Our results indicated that selective disruption of the interaction with a specific G-protein might underlie the biased signaling for certain IHH-associated PROKR2 mutations.Zhao, Y., Wu, J., Jia, H., Wang, X., Zheng, R., Jiang, F., Chen, D.-N., Chen, Z., Li, J.-D. PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a G-protein leads to biased signaling.	[Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Hunan, Peoples R China; [Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Hunan Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zheng, Ruizhi] Peoples Hosp Henan Prov, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha, Hunan, Peoples R China; [Chen, Zhiheng] Cent S Univ, Xiangya Hosp 3, Dept Pediat, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Zhengzhou University; Changsha Medical University; Central South University	Li, JD (corresponding author), Cent S Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.; Chen, ZH (corresponding author), Cent S Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.	chenzh_36@163.com; lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Wu, Jiayu/0000-0001-9802-0250; Li, Jia-Da/0000-0002-4236-3518	National High-Tech Research and Development Program [2015AA020502]; National Basic Research Program of China [2012CB517904]; National Natural Science Foundation of China [31371187, 81770780, 81728013]; Key Research and Development Programs from Hunan Province [2018DK2010, 2018DK2013]; Fundamental Research Funds for the Central Universities of Central South University [1053320181293, 1053320181270]; Natural Science Foundation of Hunan Province [2018JJ3573]; Training Program Foundation for Excellent Innovation Youth of Changsha [kq1802019]	National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Programs from Hunan Province; Fundamental Research Funds for the Central Universities of Central South University; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Training Program Foundation for Excellent Innovation Youth of Changsha	The authors thank Q. Y. Zhou (University of California, Irvine, Irvine, CA, USA) and P. Rondard (Institut de Genomique Fonctionnelle, Montpellier, France) for the reagents. This project was supported by National High-Tech Research and Development Program Grant 2015AA020502 (to J.-D.L.); National Basic Research Program of China Grant 2012CB517904 (to J.-D.L.); National Natural Science Foundation of China Grants 31371187 (to D.-N.C.), 81770780 (to J.-D.L.), and 81728013 (to J.-D.L.); Key Research and Development Programs from Hunan Province Grants 2018DK2010, 2018DK2013 (both to J.-D.L.); the Fundamental Research Funds for the Central Universities of Central South University (1053320181293 to J.Y.W., and 1053320181270 to X.Y.W.), Natural Science Foundation of Hunan Province (2018JJ3573 to D.-N.C.), and the Training Program Foundation for Excellent Innovation Youth of Changsha (kq1802019 to D.-N.C.). The authors declare no conflicts of interest.	Au MG, 2011, MOL CELL ENDOCRINOL, V346, P102, DOI 10.1016/j.mce.2011.05.041; Beneduzzi D, 2014, FERTIL STERIL, V102, P838, DOI 10.1016/j.fertnstert.2014.05.044; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; BOYAR RM, 1976, J CLIN ENDOCR METAB, V43, P1268, DOI 10.1210/jcem-43-6-1268; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Cariboni A, 2015, J CLIN INVEST, V125, P2413, DOI 10.1172/JCI78448; Chen DN, 2014, J BIOL CHEM, V289, P15518, DOI 10.1074/jbc.M114.556381; Di Pietro F, 2011, MOL CELL PROBE, V25, P44, DOI 10.1016/j.mcp.2010.10.003; Gutierrez-Amavizca Bianca Ethel, 2012, Rev Med Inst Mex Seguro Soc, V50, P157; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Jethwa PH, 2008, AM J PHYSIOL-REG I, V294, pR1968, DOI 10.1152/ajpregu.00778.2007; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Kim SH, 2015, ENDOCRINOL METAB, V30, P456, DOI 10.3803/EnM.2015.30.4.456; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Miraoui H, 2013, AM J HUM GENET, V92, P725, DOI 10.1016/j.ajhg.2013.04.008; Mitchell AL, 2011, TRENDS ENDOCRIN MET, V22, P249, DOI 10.1016/j.tem.2011.03.002; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Peng Z, 2011, J BIOL CHEM, V286, P16615, DOI 10.1074/jbc.M111.223784; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P4128, DOI 10.1210/jc.2002-020518; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; REITANO JF, 1975, J CLIN ENDOCR METAB, V41, P1035, DOI 10.1210/jcem-41-6-1035; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sarfati J, 2013, EUR J ENDOCRINOL, V169, P805, DOI 10.1530/EJE-13-0419; Sbai O, 2014, FASEB J, V28, P3734, DOI 10.1096/fj.13-243402; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Stefanija MA, 2012, HUM MOL GENET, V21, P4314, DOI 10.1093/hmg/dds264; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P4388, DOI 10.1210/jc.81.12.4388; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zhou WB, 2012, REGUL PEPTIDES, V179, P84, DOI 10.1016/j.regpep.2012.08.003; Zhou XT, 2013, BIOCHEM BIOPH RES CO, V439, P12, DOI 10.1016/j.bbrc.2013.08.039	43	13	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4538	4546		10.1096/fj.201801575R	http://dx.doi.org/10.1096/fj.201801575R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576231				2022-12-26	WOS:000459794800114
J	Choi, H; Magyar, CE; Nervina, JM; Tetradis, S				Choi, Hyewon; Magyar, Clara E.; Nervina, Jeanne M.; Tetradis, Sotirios			Different duration of parathyroid hormone exposure distinctively regulates primary response genes Nurr1 and RANKL in osteoblasts	PLOS ONE			English	Article							NUCLEAR RECEPTOR NURR1; PROTEIN-KINASE-A; NF-KAPPA-B; OSTEOCLAST FORMATION; HISTONE ACETYLATION; EXPRESSION; BONE; INVOLVEMENT; ACTIVATION; INHIBITION	Parathyroid hormone (PTH) exerts dual effects, anabolic or catabolic, on bone when administrated intermittently or continuously, via mechanisms that remain largely unknown. PTH binding to cells induces PTH-responsive genes including primary response genes (PRGs). PRGs are rapidly induced without the need for de novo protein synthesis, thereby playing pivotal roles in directing subsequent molecular responses. In this study, to understand the role of PRGs in mediating osteoblastic cellular responses to PTH, we investigated whether various durations of PTH differentially induce PRGs in primary osteoblasts and MC3T3-E1. Nurr1 and RANKL, PRGs known for their anabolic and catabolic roles in bone metabolism respectively, presented distinctive transient vs. sustained induction kinetics. Corroborating their roles, maximum induction of Nurr1 was sufficiently achieved by brief PTH in as little as 30 minutes and continued beyond that, while maximum induction of RANKL was achieved only by prolonged PTH over 4 hours. Our data suggested distinctive regulatory mechanisms for Nurr1 and RANKL: PKA-mediated chromatin rearrangement for transcriptional regulation of both PRGs and ERK-mediated transcriptional regulation for RANKL but not Nurr1. Lastly, we classified PRGs into two groups based on the induction kinetics: The group that required brief PTH for maximum induction included Nur77, cox-2, and Nurr1, all of which are reported to play roles in bone formation. The other group that required prolonged PTH for maximum induction included IL-6 and RANKL, which play roles in bone resorption. Together, our data suggested the crucial role of PRG groups in mediating differential osteoblastic cellular responses to intermittent vs. continuous PTH. Continued research into the regulatory mechanisms of PKA and ERK for PRGs will help us better understand the molecular mechanisms underlying the dual effects of PTH, thereby optimizing the current therapeutic use of PTH for osteoporosis.	[Choi, Hyewon; Tetradis, Sotirios] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Magyar, Clara E.] Univ Calif Los Angeles, Dept Pathol, Ctr Pathol Res Serv, Los Angeles, CA 90024 USA; [Nervina, Jeanne M.] NYU, Coll Dent, New York, NY USA; [Tetradis, Sotirios] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA; [Choi, Hyewon] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University	Tetradis, S (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA.; Tetradis, S (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA.	stetradis@dentistry.ucla.edu			National Institute of Health/National Institute of Dental and Craniofacial Research [R01-DE019465]; NIH/NIDCR [R01 DE019465]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019465] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Dr. Sotirios Tetradis received funding from National Institute of Health/National Institute of Dental and Craniofacial Research, R01-DE019465.; This work was supported by a grant from NIH/NIDCR R01 DE019465 (ST).	Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Datta NS, 2010, CELL SIGNAL, V22, P457, DOI 10.1016/j.cellsig.2009.10.017; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; Doggett TA, 2002, ENDOCRINOLOGY, V143, P1880, DOI 10.1210/en.143.5.1880; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Egan JJ, 2004, J CELL BIOCHEM, V45, P101; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Hamamura K, 2012, CONNECT TISSUE RES, V53, P398, DOI 10.3109/03008207.2012.671398; Hatton JP, 2013, J BONE MINER METAB, V18, P58, DOI DOI 10.1359/jbmr.2003.18.1.58; Homme M, 2004, J AM SOC NEPHROL, V15, P2844, DOI 10.1097/01.ASN.0000143472.13214.2C; Hou GQ, 2013, INT J MOL MED, V32, P503, DOI 10.3892/ijmm.2013.1406; Huang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100079; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Lammi J, 2008, MOL CELL ENDOCRINOL, V295, P87, DOI 10.1016/j.mce.2008.08.023; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Lee MK, 2006, J CELL BIOCHEM, V99, P986, DOI 10.1002/jcb.20990; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotinun S, 2002, ENDOCRINE, V17, P29, DOI 10.1385/ENDO:17:1:29; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Mehrotra M, 2006, J CELL BIOCHEM, V98, P1271, DOI 10.1002/jcb.20864; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Onan D, 2009, ENDOCRINOLOGY, V150, P2244, DOI 10.1210/en.2008-1597; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Pirih FQ, 2004, J BIOL CHEM, V279, P53167, DOI 10.1074/jbc.M405677200; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Radeff JM, 2004, J BONE MINER RES, V19, P1882, DOI 10.1359/JBMR.040806; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm14, DOI 10.1126/stke.3112005cm14; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Singh ATK, 2005, ENDOCRINOLOGY, V146, P2171, DOI 10.1210/en.2004-1283; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; Suttamanatwong S, 2007, J CELL BIOCHEM, V102, P496, DOI 10.1002/jcb.21314; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Takami M, 2005, FEBS LETT, V579, P832, DOI 10.1016/j.febslet.2004.12.066; Tetradis S, 2001, ENDOCRINOLOGY, V142, P663, DOI 10.1210/en.142.2.663; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15; Tokushima T, 1997, ADV EXP MED BIOL, V433, P307; Tseng W, 2010, J LIPID RES, V51, P1010, DOI 10.1194/jlr.M001099; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1; Zhang JS, 2006, J BONE MINER RES, V21, P1729, DOI 10.1359/JBMR.060722; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	56	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208514	10.1371/journal.pone.0208514	http://dx.doi.org/10.1371/journal.pone.0208514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576321	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400009
J	Jackson, M; Serada, N; Sheehan, M; Srinivasan, S; Mason, N; Guha, M; Avadhani, N				Jackson, Martina; Serada, Nicole; Sheehan, Maura; Srinivasan, Satish; Mason, Nicola; Guha, Manti; Avadhani, Narayan			Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype	PLOS ONE			English	Article							HUMAN-CELLS; ALTERED METABOLISM; MTDNA MUTATIONS; ACTIVATION; STRESS; DYNAMICS; FUSION; GENE; DOGS; METASTASIS	Osteosarcoma (OSA) is an aggressive mesenchymal tumor of the bone that affects children and occurs spontaneously in dogs. Human and canine OSA share similar clinical, biological and genetic features, which make dogs an excellent comparative model to investigate the etiology and pathogenesis of OSA. Mitochondrial (mt) defects have been reported in many different cancers including OSA, although it is not known whether these defects contribute to OSA progression and metastasis. Taking a comparative approach using canine OSA cell lines and tumor tissues we investigated the effects of mtDNA content and dysfunction on OSA biology. OSA tumor tissues had low mtDNA contents compared to the matched non-tumor tissues. We observed mitochondrial heterogeneity among the OSA cell lines and the most invasive cells expressing increased levels of OSA metastasis genes contained the highest amount of mitochondrial defects (reduced mtDNA copies, mt respiration, and expression of electron transport chain proteins). While mitochondria maintain a filamentous network in healthy cells, the mitochondrial morphology in OSA cells were mostly "donut shaped", typical of "stressed" mitochondria. Moreover the expression levels of mitochondrial retrograde signaling proteins Akt1, IGF1R, hnRNPA2 and NFkB correlated with the invasiveness of the OSA cells. Furthermore, we demonstrate the causal role of mitochondrial defects in inducing the invasive phenotype by Ethidium Bromide induced-mtDNA depletion in OSA cells. Our data suggest that defects in mitochondrial genome and function are prevalent in OSA and that lower mtDNA content is associated with higher tumor cell invasiveness. We propose that mt defects in OSA might serve as a prognostic biomarker and a target for therapeutic intervention in OSA patients.	[Jackson, Martina; Serada, Nicole; Sheehan, Maura; Srinivasan, Satish; Mason, Nicola; Guha, Manti; Avadhani, Narayan] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Guha, M; Avadhani, N (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.	manti@upenn.edu; narayan@upenn.edu			National Institutes of Health (NIH) [CA22762]; NIH [T35 OD-010919]; Merial LTD; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010919] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merial LTD; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research is supported by the National Institutes of Health (NIH) grant CA22762 (NGA), NIH Grant T35 OD-010919 (MJ) and a grant from Merial LTD (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allalunis-Turner J, 2006, CANCER LETT, V243, P193, DOI 10.1016/j.canlet.2005.11.035; Aplin AE, 1998, PHARMACOL REV, V50, P197; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Boston SE, 2006, JAVMA-J AM VET MED A, V228, P1905, DOI 10.2460/javma.228.12.1905; BRODEY RS, 1976, J AM VET MED ASSOC, V168, P1032; BRODEY RS, 1969, CLIN ORTHOP RELAT R, P54; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Dakubo GD, 2006, J CLIN PATHOL, V59, P10, DOI 10.1136/jcp.2005.027664; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Dong DW, 2015, GENOM DATA, V6, P99, DOI 10.1016/j.gdata.2015.07.031; Dow S, 2005, HUM GENE THER, V16, P937, DOI 10.1089/hum.2005.16.937; Fan DG, 2009, CELL BIOL INT, V33, P1263, DOI 10.1016/j.cellbi.2009.08.014; Federman N, 2009, CURR TREAT OPTION ON, V10, P82, DOI 10.1007/s11864-009-0087-3; Frezza C, 2014, INT J BIOCHEM CELL B, V48, P11, DOI 10.1016/j.biocel.2013.12.013; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Guha M, 2018, BBA-MOL BASIS DIS, V1864, P1060, DOI 10.1016/j.bbadis.2018.01.002; Guha M, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.45; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KNECHT CD, 1978, J AM VET MED ASSOC, V172, P72; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Li XR, 2016, ONCOTARGET, V7, P40297, DOI 10.18632/oncotarget.9610; Liptak JM, 2004, J AM ANIM HOSP ASSOC, V40, P461, DOI 10.5326/0400461; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Long Q, 2015, BIOPHYS J, V109, P892, DOI 10.1016/j.bpj.2015.07.039; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Mueller F, 2007, ANTICANCER RES, V27, P155; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Selvarajah GT, 2010, VET J, V185, P28, DOI 10.1016/j.tvjl.2010.04.010; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227; Srinivasan S, 2017, BBA-BIOENERGETICS, V1858, P602, DOI 10.1016/j.bbabio.2017.01.004; Srinivasan S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1085120; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tomlin JL, 2000, VET REC, V147, P129, DOI 10.1136/vr.147.5.129; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Walter C U, 2005, Vet Comp Oncol, V3, P1, DOI 10.1111/j.1476-5810.2005.00062.x; Warburg O., 1956, NATURE, V469, P314; WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; YAGEL S, 1989, CANCER RES, V49, P3553; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	74	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209489	10.1371/journal.pone.0209489	http://dx.doi.org/10.1371/journal.pone.0209489			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576337	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400053
J	Wang, Q; Barad, DH; Darmon, SK; Kushnir, VA; Wu, YG; Lazzaroni-Tealdi, E; Zhang, L; Albertini, DF; Gleicher, N				Wang, Qi; Barad, David H.; Darmon, Sarah K.; Kushnir, Vitaly A.; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Zhang, Lin; Albertini, David F.; Gleicher, Norbert			Reduced RNA expression of the FMR1 gene in women with low (CGG(n<26)) repeats	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-GENE; CGG REPEAT; MESSENGER-RNA; LOCALIZATION; INSTABILITY; PREMUTATION; NUCLEAR; METHYLATION; LENGTH	Low FMR1 variants (CGG(n<26)) have been associated with premature ovarian aging, female infertility and poor IVF treatment success. Until now, there is little published information concerning possible molecular mechanisms for this effect. We wished to examine whether relative expression of RNA and the FMR1 gene's fragile X mental retardation protein (FMRP) RNA isoforms differ in women with various FMR1 sub-genotypes (normal, low CGG(n<26) and/or high CGG(n >= 34)). This prospective cohort study was conducted between 2014 and 2017 in a clinical research unit of the Center for Human Reproduction in New York City. The study involved a total of 98 study subjects, including 18 young oocyte donors and 80 older infertility patients undergoing routine in vitro fertilization (IVF) cycles. The main outcome measure was RNA expression in human luteinized granulosa cells of 5 groups of FMRP isoforms. The relative expression of FMR1 RNA in human luteinized granulosa cells was measured by real-time PCR and a possible association with CGG(n) was explored. All 5 groups of FMRP RNA isoforms examined were found to be differentially expressed in human luteinized granulosa cells. The relative expression of four FMR1 RNA isoforms showed significant differences among 6 FMR1 sub-genotypes. Women with at least one low allele expressed significantly lower levels of all 5 sets of FRMP isoforms in comparison to the non-low group. While it would be of interest to see whether FMRP is also decreased in the low-group we recognize that in recent years it has been increasingly documented that information flow of genetics may be regulated by non-coding RNA, that is, without translation to a protein product. We, thus, conclude that various CGG expansions of FMR1 allele may lead to changes of RNA levels and ratios of distinct FMRP RNA isoforms, which could regulate the translation and/or cellular localization of FMRP, affect the expression of steroidogenic enzymes and hormonal receptors, or act in some other epigenetic process and therefore result in the ovarian dysfunction in infertility.	[Wang, Qi; Barad, David H.; Darmon, Sarah K.; Kushnir, Vitaly A.; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Zhang, Lin; Albertini, David F.; Gleicher, Norbert] Ctr Human Reprod, New York, NY 10021 USA; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY 10022 USA; [Kushnir, Vitaly A.] Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA; [Albertini, David F.] Univ Kansas Hosp, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Gleicher, Norbert] Rockefeller Univ, Stem Cell & Mol Embryol Lab, 1230 York Ave, New York, NY 10021 USA; [Gleicher, Norbert] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Vienna, Austria	Wake Forest University; University of Kansas; University of Kansas Medical Center; Rockefeller University; University of Vienna	Barad, DH (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.; Barad, DH (corresponding author), Fdn Reprod Med, New York, NY 10022 USA.	dbarad@thechr.com	Barad, David/AAF-4332-2021; Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828; Barad, David/0000-0002-7980-2369	Foundation for Reproductive Medicine; Center for Human Reproduction (CHR) - New York	Foundation for Reproductive Medicine; Center for Human Reproduction (CHR) - New York	This work was supported by the Foundation for Reproductive Medicine and intramural grants from the Center for Human Reproduction (CHR) - New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Banks N, 2016, FERTIL STERIL, V105, P1537, DOI 10.1016/j.fertnstert.2016.02.011; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Ferder I, 2013, REPRODUCTION, V145, P335, DOI 10.1530/REP-12-0305; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gleicher N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00284; Gleicher N, 2013, HUM REPROD, V28, P1084, DOI 10.1093/humrep/det033; Gleicher N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033638; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, OBSTET GYNECOL SURV, V65, P523, DOI 10.1097/OGX.0b013e3181f8bdda; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Kushnir VA, 2013, FERTIL STERIL, V100, pS114, DOI 10.1016/j.fertnstert.2013.07.1656; Kushnir VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102274; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Ni Wen-Juan, 2015, Biochem Biophys Rep, V4, P337, DOI 10.1016/j.bbrep.2015.10.011; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Okray Z, 2015, EMBO MOL MED, V7, P423, DOI 10.15252/emmm.201404576; Pretto DI, 2015, J MED GENET, V52, P42, DOI 10.1136/jmedgenet-2014-102593; Robinson VL, 2009, UROL ONCOL-SEMIN ORI, V27, P304, DOI 10.1016/j.urolonc.2008.11.004; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209309	10.1371/journal.pone.0209309	http://dx.doi.org/10.1371/journal.pone.0209309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576349	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400038
J	Geissler, DB; Weiler, E; Ehret, G				Geissler, Diana B.; Weiler, Elke; Ehret, Guenter			Adaptation and spectral enhancement at auditory temporal perceptual boundaries - Measurements via temporal precision of auditory brainstem responses	PLOS ONE			English	Article							DISCHARGE RATE REPRESENTATION; INFERIOR COLLICULUS NEURONS; VOICE-ONSET TIME; HEARING-LOSS; HOUSE-MOUSE; COCHLEAR NUCLEUS; NERVE FIBERS; COMMUNICATION CALLS; FREQUENCY-RESPONSE; SPEECH-PERCEPTION	In human and animal auditory perception the perceived quality of sound streams changes depending on the duration of inter-sound intervals (ISIs). Here, we studied whether adaptation and the precision of temporal coding in the auditory periphery reproduce general perceptual boundaries in the time domain near 20, 100, and 400 ms ISIs, the physiological origin of which are unknown. In four experiments, we recorded auditory brainstem responses with five wave peaks (P1 -P5) in response to acoustic models of communication calls of house mice, who perceived these calls with the mentioned boundaries. The newly introduced measure of average standard deviations of wave latencies of individual animals indicate the wave's temporal precision (latency jitter) mostly in the range of 30-100 mu s, very similar to latency jitter of single neurons. Adaptation effects of response latencies and latency jitter were measured for ISIs of 10-1000 ms. Adaptation decreased with increasing ISI duration following exponential or linear (on a logarithmic scale) functions in the range of up to about 200 ms ISIs. Adaptation effects were specific for each processing level in the auditory system. The perceptual boundaries near 20-30 and 100 ms ISIs were reflected in significant adaptation of latencies together with increases of latency jitter at P2-P5 for ISIs < similar to 30 ms and at P5 for ISIs < similar to 100 ms, respectively. Adaptation effects occurred when frequencies in a sound stream were within the same critical band. Ongoing low-frequency components/formants in a sound enhanced (decrease of latencies) coding of high-frequency components/formants when the frequencies concerned different critical bands. The results are discussed in the context of coding multi-harmonic sounds and stop-consonants-vowel pairs in the auditory brainstem. Furthermore, latency data at P1 (cochlea level) offer a reasonable value for the base-to-apex cochlear travel time in the mouse (0.342 ms) that has not been determined experimentally.	[Geissler, Diana B.; Weiler, Elke; Ehret, Guenter] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Weiler, Elke] Max Planck Inst Biol Cybernet, Tubingen, Germany	Ulm University; Max Planck Society	Ehret, G (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.	guenter.ehret@uni-ulm.de		Ehret, Gunter/0000-0002-1201-4878	Deutsche Forschungsgemeinschaft [EH 53/22-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (EH 53/22-1 to G.E.).	[Anonymous], 1961, R226 ISO; ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Ballachanda B B, 1992, J Am Acad Audiol, V3, P275; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brittan-Powell EF, 2005, J ACOUST SOC AM, V118, P314, DOI 10.1121/1.1928767; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Burkard R, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P603; Burkard R, 1996, J ACOUST SOC AM, V100, P978, DOI 10.1121/1.416209; BURKARD R, 1994, J ACOUST SOC AM, V95, P2126, DOI 10.1121/1.408674; BURKARD R, 1989, J ACOUST SOC AM, V85, P2514, DOI 10.1121/1.397746; Burkard R, 2012, TRANSLATIONAL PERSPE, P161; Burkard RF., 2007, AUDITORY EVOKED POTE; Carlson R., 1975, AUDITORY ANAL PERCEP, P55, DOI DOI 10.1016/B978-0-12-248550-3.50008-8; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Chen GD, 1996, AUDIT NEUROSCI, V3, P179; DARWIN CJ, 1984, Q J EXP PSYCHOL-A, V36, P193, DOI 10.1080/14640748408402155; DEBRUYNE F, 1986, AUDIOLOGY, V25, P101; DELGUTTE B, 1990, J ACOUST SOC AM, V87, P791, DOI 10.1121/1.398891; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; DON M, 1977, ANN OTO RHINOL LARYN, V86, P186, DOI 10.1177/000348947708600209; Drayton M, 2006, HEARING RES, V212, P128, DOI 10.1016/j.heares.2005.11.006; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Egorova M, 2001, EXP BRAIN RES, V140, P145, DOI 10.1007/s002210100786; Egorova M, 2008, EUR J NEUROSCI, V28, P675, DOI 10.1111/j.1460-9568.2008.06376.x; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; EHRET G, 1984, HEARING RES, V14, P45, DOI 10.1016/0378-5955(84)90068-6; EHRET G, 1975, BEHAVIOUR, V52, P38; EHRET G, 1975, J COMP PHYSIOL, V103, P329, DOI 10.1007/BF00612025; EHRET G, 1976, BIOL CYBERN, V24, P35, DOI 10.1007/BF00365592; EHRET G, 1985, SCIENCE, V227, P1245, DOI 10.1126/science.3975613; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1977, J COMP PHYSIOL, V122, P65, DOI 10.1007/BF00611249; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Ehret G, 1983, AUDITORY PSYCHOBIOLO, P1; Ehret G., 2013, EVOLUTION EMOTIONAL, P63; Ehret G, 2010, HBK BEHAV NEUROSCI, V19, P125, DOI 10.1016/B978-0-12-374593-4.00013-9; Finlayson PG, 1999, HEARING RES, V131, P177, DOI 10.1016/S0378-5955(99)00032-5; FULLERTON BC, 1987, ELECTROEN CLIN NEURO, V66, P547, DOI 10.1016/0013-4694(87)90102-7; Gaub S, 2005, J COMP PHYSIOL A, V191, P1131, DOI 10.1007/s00359-005-0036-y; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; GOLDING NL, 1995, J NEUROSCI, V15, P3138; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; HENRY KR, 1979, AUDIOLOGY, V18, P93; HENRY KR, 1978, DEV PSYCHOBIOL, V11, P161, DOI 10.1002/dev.420110208; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; HUANG C, 1980, BRAIN RES, V184, P215, DOI 10.1016/0006-8993(80)90601-0; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; KATBAMNA B, 1993, AUDIOLOGY, V32, P344; Klug A, 2000, HEARING RES, V148, P107, DOI 10.1016/S0378-5955(00)00146-5; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; KRAUS N, 1985, HEARING RES, V17, P219, DOI 10.1016/0378-5955(85)90066-8; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; Kurt S, 2009, BRAIN RES, V1289, P30, DOI 10.1016/j.brainres.2009.06.092; Land R, 2016, HEARING RES, V341, P109, DOI 10.1016/j.heares.2016.08.008; Langner  G., 2015, NEURAL CODE PITCH HA; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lina IA, 2013, HEARING RES, V298, P73, DOI 10.1016/j.heares.2013.01.002; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; MACHMERTH H, 1975, ACUSTICA, V34, P81; Malinina E S, 2016, Dokl Biol Sci, V470, P209; Malinina E S, 2005, Neurosci Behav Physiol, V35, P723, DOI 10.1007/s11055-005-0116-z; Mauger SJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036004; Mehraei G, 2017, HEARING RES, V346, P34, DOI 10.1016/j.heares.2017.01.016; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Melcher JR, 1996, HEARING RES, V93, P1, DOI 10.1016/0378-5955(95)00178-6; Muller M, 2010, HEARING RES, V268, P184, DOI 10.1016/j.heares.2010.05.021; Nelson PC, 2009, J NEUROSCI, V29, P2553, DOI 10.1523/JNEUROSCI.5359-08.2009; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Patuzzi R., 1996, COCHLEA, P186; PENNER MJ, 1975, PERCEPT PSYCHOPHYS, V18, P114, DOI 10.3758/BF03204097; Perez-Gonzalez D, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00019; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; PISONI DB, 1977, J ACOUST SOC AM, V61, P1352, DOI 10.1121/1.381409; PISONI DB, 1974, J ACOUST SOC AM, V55, P328, DOI 10.1121/1.1914506; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; PRIJS VF, 1981, HEARING RES, V4, P23, DOI 10.1016/0378-5955(81)90034-4; Reichenbach CS, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00047; Reimer K, 1996, AUDIOLOGY, V35, P55; RHODE WS, 1978, J NEUROPHYSIOL, V41, P692, DOI 10.1152/jn.1978.41.3.692; Rhode WS, 1992, MAMMALIAN AUDITORY P, P94; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Sachs L, 1999, ANGEW STAT, V9th; SAITOH Y, 1994, HEARING RES, V75, P27, DOI 10.1016/0378-5955(94)90052-3; Scharf B, 1978, HDB PERCEPTION, VIV, P187; SHAW NA, 1988, PROG NEUROBIOL, V31, P19, DOI 10.1016/0301-0082(88)90021-4; SINEX DG, 1989, J ACOUST SOC AM, V85, P1995, DOI 10.1121/1.397852; SINEX DG, 1988, J ACOUST SOC AM, V83, P1817, DOI 10.1121/1.396516; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Song L, 2006, J ACOUST SOC AM, V119, P2242, DOI 10.1121/1.2180533; STEVENS KN, 1974, J ACOUST SOC AM, V55, P653, DOI 10.1121/1.1914578; STIEBLER I, 1985, J COMP NEUROL, V238, P65, DOI 10.1002/cne.902380106; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Tan XD, 2008, HEARING RES, V235, P90, DOI 10.1016/j.heares.2007.10.002; Temchin AN, 2005, J NEUROPHYSIOL, V93, P3635, DOI 10.1152/jn.00885.2004; Temchin AN, 2012, J NEUROSCI, V32, P10522, DOI 10.1523/JNEUROSCI.1138-12.2012; WALTON JP, 1995, HEARING RES, V88, P19, DOI 10.1016/0378-5955(95)00093-J; Walton JP, 1997, J COMP PHYSIOL A, V181, P161, DOI 10.1007/s003590050103; WINTER IM, 1995, J NEUROPHYSIOL, V73, P141, DOI 10.1152/jn.1995.73.1.141; Wynne DP, 2013, BRAIN, V136, P1626, DOI 10.1093/brain/awt056; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107; Zwicker E., 1967, OHR ALS NACHRICHTENE; ZWISLOCKI J, 1962, J ACOUST SOC AM, V34, P1648	110	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208935	10.1371/journal.pone.0208935	http://dx.doi.org/10.1371/journal.pone.0208935			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571726	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700029
J	Akinlua, JT; Meakin, R; Bashir, I; Freemantle, N				Akinlua, James Tosin; Meakin, Richard; Bashir, Ibrahim; Freemantle, Nick			Beliefs about hypertension among primary health care workers and clients in Nigeria: A qualitative study	PLOS ONE			English	Article							ILLNESS; MODELS	Objective The main objective of the study was to elicit beliefs about hypertension among Nigerian Primary Health Care clients and workers. Background In many regions of Nigeria, the primary health care facility is usually the only source of formal health care available. Since hypertension is a chronic condition that requires lifelong life style modification and drug treatment, it is important to understand the context and background to the condition through the beliefs and perceptions among both lay persons and health care providers who manage the condition. Setting Rural and urban primary health care facilities in the Federal Capital Territory Nigeria. Participants A total of Eighty-one (81) primary health care clients and workers participated in the study. Methods and outcome measure A qualitative research using interviews, focus group discussions and reflective work as sources of data collection. The outcome measures were emerging themes from thematic framework analysis. Results There were four themes that summarize beliefs of both PHC workers and clients namely: (1) Meaning of hypertension (2) causes of hypertension, (3) Consequences of hypertension (4) Perceptions of treatment, one additional distinct theme was elicited among PHC workers "contextual explanation". However, under each of the shared four themes, there were both similarities and differences in beliefs expressed between PHC workers and clients. Conclusions This study highlights important similarities and differences in beliefs about hypertension among primary health care clients and primary health care workers that have significant implications for management of hypertension in primary care settings in Nigeria.	[Akinlua, James Tosin; Meakin, Richard; Freemantle, Nick] UCL, Med Sch, Dept Primary Care & Populat Hlth, Royal Free Campus, London, England; [Bashir, Ibrahim] PMB, State House Med Ctr, Dept Publ Hlth, Aso Rock Abuja, Nigeria	University of London; University College London	Freemantle, N (corresponding author), UCL, Med Sch, Dept Primary Care & Populat Hlth, Royal Free Campus, London, England.	nick.freemantle@ucl.ac.uk			Federal Government of Nigeria Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	Federal Government of Nigeria Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	This work forms part of research work towards a PhD (AKINLUA JT) at the University College London, funded by the Federal Government of Nigeria Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund. The sponsor had no role in study design, data collection, analysis, interpretation, or writing of the report.	Ai-Dharrab S A, 1996, J Family Community Med, V3, P57; Akinlua JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181909; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; [Anonymous], 2008, CAUS DEATH 2008; [Anonymous], 2009, NIG DEM HLTH SURV; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; BLUMHAGEN D, 1980, CULT MED PSYCHIAT, V4, P197, DOI 10.1007/BF00048414; Boutin-Foster C, 2007, ETHNIC DIS, V17, P29; HEURTINROBERTS S, 1992, AM J HYPERTENS, V5, P787, DOI 10.1093/ajh/5.11.787; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1980, PATIENTS HEALERS CON; Kusuma YS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-267; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; MORGAN M, 1995, INT J EPIDEMIOL, V24, pS79, DOI 10.1093/ije/24.Supplement_1.S79; Odusola A.O., 2017, HLTH CARE ED, V2, P1, DOI [10.15761/HEC.1000113, DOI 10.15761/HEC.1000113]; Odusola AO, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29041; Odusola AO, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0624-z; Okwuonu CG, 2014, INT J GEN MED, V7, P345, DOI 10.2147/IJGM.S63587; Organization WH, 2016, GLOBAL STATUS REPORT; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Osamor PE, 2011, MED SOCIOLOGY ONLINE, V6, P5; Osuala E. O., 2016, Health, V8, P1603, DOI 10.4236/health.2016.814157; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Schoenberg NE, 1997, HUM ORGAN, V56, P174, DOI 10.17730/humo.56.2.471j75q6k1206228; Sogunle PT, 2017, NIGERIAN J FAMILY PR, V7; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; Zibaeenezhad MJ, 2007, IRAN RED CRESCENT ME, V9, P4	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209334	10.1371/journal.pone.0209334	http://dx.doi.org/10.1371/journal.pone.0209334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566464	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300085
J	Arias, M; Coscarella, MA; Romero, MA; Sueyro, N; Svendsen, GM; Crespo, EA; Gonzalez, RAC				Arias, Magdalena; Coscarella, Mariano A.; Alejandra Romero, M.; Sueyro, Nicolas; Svendsen, Guillermo M.; Crespo, Enrique A.; Gonzalez, Raul A. C.			Southern right whale Eubalaena australis in Golfo San Matias (Patagonia, Argentina): Evidence of recolonisation	PLOS ONE			English	Article							MOVEMENTS; DISPERSAL; COASTAL; AFRICA; BIRDS	Since the 1980s, the distribution range of the southern right whale (Eubalaena australis) in Argentina was mostly located in the winter calving grounds around Peninsula Valdes. After the international moratorium that forbade the commercial hunting, southern right whales have shown signs of recovery during the last few decades. Nowadays, it is thought that the species is experiencing a density-dependent process while expanding its distribution range in Patagonia. From 2007 to 2016, data on right whale distribution, group composition and relative abundance were collected in Golfo San Matias, Patagonia through aerial surveys. Generalized linear models with a negative binomial error distribution were used to determine the population trend of right whales in this area. In addition, the group composition and the relative abundance of right whales among the northern Patagonian gulfs were compared. Finally, a literature review was conducted to assess the historical presence of right whales in Golfo San Matias, revealing the presence of right whales in Golfo San Matias during and after the commercial exploitation. During aerial surveys (2007-2016), right whales were observed from August to October in the area, with a peak in late August-early September. Our results suggested a geographic distribution change with a regular use of the northwest coast of the gulf in recent years and a positive trend in the population growth rate inside Golfo San Matias. This area was dominated by unaccompanied whales (solitary individuals and breeding groups) as opposed to Peninsula Valdes where the dominant group type was the mother calf pairs. Therefore, Golfo San Matias appears to be important for socializing and mating but not as a nursery ground. In addition, the density of whales was four times greater in the gulfs of Peninsula Valdes. Our findings contribute to a better understanding of the recovery of this species in Patagonia, Argentina and should be considered for the management measures for right whales in this region.	[Arias, Magdalena; Alejandra Romero, M.; Svendsen, Guillermo M.; Gonzalez, Raul A. C.] Consejo Nacl Invest Cient & Tecn, Ctr Invest Aplicada & Transferencia Tecnol Recurs, San Antonio Oeste, Rio Negro, Argentina; [Coscarella, Mariano A.; Sueyro, Nicolas; Crespo, Enrique A.] Consejo Nacl Invest Cient & Tecn, Ctr Estudios Sistemas Marinos CESIMAR, CENPAT, Puerto Madryn, Chubut, Argentina; [Coscarella, Mariano A.; Crespo, Enrique A.] UNPSJB, Puerto Madryn, Chubut, Argentina; [Alejandra Romero, M.; Svendsen, Guillermo M.; Gonzalez, Raul A. C.] UNCO, Escuela Super Ciencias Marinas ESCIMAR, San Antonio Oeste, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Arias, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Invest Aplicada & Transferencia Tecnol Recurs, San Antonio Oeste, Rio Negro, Argentina.	ariasmalala@gmail.com	Romero, Maria Alejandra/X-3361-2019	Arias, Magdalena/0000-0003-3260-8208; Romero, Maria Alejandra/0000-0003-3690-8179; Coscarella, Mariano Alberto/0000-0003-2131-5100	Consejo Federal de Inversiones; CONICET (Argentina)	Consejo Federal de Inversiones; CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The data collection was support by the Consejo Federal de Inversiones. Particulary, this funder financed the aerial surveys performed in this study (Argentina; http://cfi.org.ar/institucion/estados-miembro/rio-negro/). Also, Magdalena Arias was supported by fellowships of CONICET (Argentina; www.conicet.gov.ar/).; The authors would like to thank Secretaria de Medio Ambiente y Desarrollo Sustentable of Rio Negro province for the permits to work in the protected area. We gratefully acknowledge to the Consejo Federal de Inversiones (CFI) for the financial support for the aerial surveys performed during 2014, 2015 and 2016. The authors would also like to thank everyone who assisted in our fieldwork and to our pilot Peter Dominguez. In addition, we are grateful to Bob Brownell Jr. for his unpublished information, to Claire Charlton and Maria Isabel Rillo for revising the English of the manuscript, and to Nicolas Cetra for the collaboration with the figures. Finally, we would like to thank Els Vermeulen and one anonymous reviewer for their comments, which greatly improved this manuscript.	Aliotta S., 2000, DESARROLLO SECUENCIA, V7, P95; Arias M, 2018, TOUR MANAG PERSPECT, V27, P1, DOI 10.1016/j.tmp.2018.03.005; Bannister John, 2001, Journal of Cetacean Research and Management Special Issue, V2, P103; Barendse J, 2014, MAR MAMMAL SCI, V30, P1358, DOI 10.1111/mms.12116; BEST PB, 1987, FISH B-NOAA, V85, P403; BEST PB, 1993, MAR MAMMAL SCI, V9, P227, DOI 10.1111/j.1748-7692.1993.tb00451.x; BEST PB, 1990, MAR MAMMAL SCI, V6, P93, DOI 10.1111/j.1748-7692.1990.tb00232.x; Best PB, 2000, S AFR J MARINE SCI, V22, P43, DOI 10.2989/025776100784125618; Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; Burnell SR, 1997, J ZOOL, V241, P613, DOI 10.1111/j.1469-7998.1997.tb05736.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cammareri A, 2008, SO RIGHT WHALES EUBA; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; Childerhouse S, 2010, SC62BRG19; Constantine R., 2014, WHALE WATCHING SUSTA, P193; Cooke J. G., 2001, Journal of Cetacean Research and Management Special Issue, P125; Costa Paula, 2007, Journal of Cetacean Research and Management, V9, P45; Costa Paula, 2005, Latin American Journal of Aquatic Mammals, V4, P157; Crespo E, 2018, MARINE MAMMAL SCI; Crespo E. A., 2014, NUMBER SO RIGHT WHAL; Danchin E., 2008, BEHAV ECOLOGY; Danilewicz D, 2017, MAMMALIA, V81, P225, DOI 10.1515/mammalia-2015-0096; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; du Pasquier T., 1986, Reports of the International Whaling Commission Special Issue, P269; Elwen SH, 2004, MAR MAMMAL SCI, V20, P583, DOI 10.1111/j.1748-7692.2004.tb01181.x; Elwen SH, 2004, MAR MAMMAL SCI, V20, P567, DOI 10.1111/j.1748-7692.2004.tb01180.x; Estes JA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P1; Failla M, 2008, HIST RECORDS SO RIGH; Gonzalez R, 1992, 28911092BSAS REUN TR; Grandi MF, 2008, J MAMMAL, V89, P1218, DOI 10.1644/08-MAMM-A-088.1; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Groch Karina R., 2005, Latin American Journal of Aquatic Mammals, V4, P41; Holmberg AD, 1948, DOCUMENTACION UNPUB; Intrieri E., 1997, INFORM INTERNO DIREC; IWC, 2001, J CETACEAN RES MANAG, V2, P1; Jackson JA, 2008, MOL ECOL, V17, P236, DOI 10.1111/j.1365-294X.2007.03497.x; Kamil B., MUMIN MULTIMODEL INF; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; Morrell B., 1832, NARRATIVE 4 VOYAGES; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Payne R., 1990, REPORT INT WHALING C, P271; Pirzl R, 2009, MAR MAMMAL SCI, V25, P455, DOI 10.1111/j.1748-7692.2008.00276.x; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Core Team, 2021, R LANGUAGE ENV STAT; Richards R., 1993, S SEAS SO WHALE FISH; Richards R, 2009, NEW ZEAL J ZOOL, V36, P447, DOI 10.1080/03014223.2009.9651477; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Schnack E., 1996, THALASSAS, V12, P121; Seyboth E, 2015, MAR MAMMAL SCI, V31, P1521, DOI 10.1111/mms.12241; Smith TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034905; Sueyro N, 2018, DENSITY DEPENDENT CA; Svendsen GM, 2013, THESIS; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; Vermeulen Els, 2013, Journal of Cetacean Research and Management, V13, P47; Zerbini A., 2016, TRACKING SO RIGHT WH; Zerbini A.N., 2018, IWC SCI COMM SLOV	57	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207524	10.1371/journal.pone.0207524	http://dx.doi.org/10.1371/journal.pone.0207524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566480	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300011
J	Casanovas, P; Goldson, SL; Tylianakis, JM				Casanovas, Paula; Goldson, Stephen L.; Tylianakis, Jason M.			Asymmetry in reproduction strategies drives evolution of resistance in biological control systems	PLOS ONE			English	Article							WEEVIL LISTRONOTUS-BONARIENSIS; MICROCTONUS-AETHIOPOIDES; POPULATION-DYNAMICS; SITONA-DISCOIDEUS; INSECTICIDE RESISTANCE; CURCULIONIDAE; BRACONIDAE; COLEOPTERA; MANAGEMENT; SEX	The success of biological control may depend on the control agent co-evolving with its target pest species, precluding the emergence of resistance that often undermines chemical control. However, recent evidence of a decline in attack rates of a sexual pest weevil by its asexual parasitoid suggests that evolutionary arms races may not prevent the emergence of resistance if the host and parasitoid do not have reproductive strategies that generate equal amounts of genetic variation. To understand how these asymmetries in reproductive strategies may drive the emergence of resistance, we combined life history data from two pest weevils and their parasitoids (one sexual and one asexual) in the New Zealand pastoral ecosystem, with a population dynamic model that allows the coevolution of hosts and parasitoids. We found that the ratio of the genetic variance of hosts to parasitoids was a key determinant of the emergence of resistance. Host resistance eventually occurred unless the parasitoids had considerably greater additive genetic variance than their host. The higher reproductive rate of asexual parasitoids did little to offset the cost of reduced additive genetic variance. The model predictions were congruent with long-term parasitism rates observed in the field for both of the pests considered (one with a sexual and one with an asexual parasitoid). We then explored the consequences of introducing two parasitoids with different reproductive strategies that attack the same sexual host. The model showed that the sexually reproducing parasitoid always out-competed the asexually reproducing one. Our study shows that any asymmetry in reproductive strategies is extremely important for predicting the long-term success of biological control agents. Fortunately, introduction of sexually reproducing individuals after an initial introduction of asexual strains may overcome the problems of host resistance. We conclude that evolution must be considered when evaluating the long-term outcomes of importation biological control.	[Casanovas, Paula; Tylianakis, Jason M.] Univ Canterbury, Bio Protect Res Ctr, Sch Biol Sci, Christchurch, New Zealand; [Goldson, Stephen L.] Lincoln Univ, Bio Protect Res Ctr, Lincoln, New Zealand; [Goldson, Stephen L.] AgResearch, Christchurch, New Zealand; [Tylianakis, Jason M.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	University of Canterbury; Lincoln University - New Zealand; AgResearch - New Zealand; Imperial College London	Casanovas, P (corresponding author), Univ Canterbury, Bio Protect Res Ctr, Sch Biol Sci, Christchurch, New Zealand.	paulacasanovas@gmail.com	Goldson, Stephen/I-2550-2013	Goldson, Stephen/0000-0003-0057-6969	New Zealand Tertiary Education Commission via the BioProtection Research Centre based at Lincoln University, New Zealand	New Zealand Tertiary Education Commission via the BioProtection Research Centre based at Lincoln University, New Zealand	This work was funded by the New Zealand Tertiary Education Commission via the BioProtection Research Centre based at Lincoln University, New Zealand. AgResearch provided support in the form of salary for author SLG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Ameri M, 2015, ECOL ENTOMOL, V40, P50, DOI 10.1111/een.12155; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; [Anonymous], 2021, LANG ENV STAT COMP; BARKER GM, 1989, AGR ECOSYST ENVIRON, V26, P79, DOI 10.1016/0167-8809(89)90021-2; BARLOW ND, 1993, J APPL ECOL, V30, P165, DOI 10.2307/2404280; Barratt BIP, 2007, ENVIRON ENTOMOL, V36, P826, DOI 10.1603/0046-225X(2007)36[826:FPONWS]2.0.CO;2; Barratt BIP, 2012, BIOCONTROL, V57, P735, DOI 10.1007/s10526-012-9453-3; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; BURDON JJ, 1981, J APPL ECOL, V18, P649, DOI 10.2307/2402423; Chalom A, 2016, KNEGT LOPEZ PRADO PI; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Esson M. J., 1975, Proceedings of the Twenty-eighth New Zealand Weed and Pest Control Conference, Angus Inn, Hastings, August 5 to 7, 1975., P208; Fellowes MDE, 2000, POPUL ECOL, V42, P195, DOI 10.1007/PL00011998; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Goldson SL, 2014, BIOL CONTROL, V72, P76, DOI 10.1016/j.biocontrol.2014.02.012; GOLDSON SL, 1993, NEW ZEAL J ZOOL, V20, P89, DOI 10.1080/03014223.1993.10422866; GOLDSON SL, 1984, B ENTOMOL RES, V74, P249, DOI 10.1017/S000748530001138X; GOLDSON SL, 1990, J APPL ECOL, V27, P703, DOI 10.2307/2404313; Goldson SL, 2016, FRONT PLANT SCI, V7; GOULD F, 1991, AM SCI, V79, P496; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Gurr G.M., 2012, BIODIVERSITY INSECT, P1; Hales DF, 2002, GENET RES, V79, P203, DOI 10.1017/S0016672302005657; Heimpel GE, 2000, BIOL CONTROL, V19, P77, DOI 10.1006/bcon.2000.0849; Heimpel GE, 2017, BIOL CONTROL ECOLOGY; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; HOCHBERG ME, 1995, EVOL ECOL, V9, P633, DOI 10.1007/BF01237660; HOLT RD, 1993, J ANIM ECOL, V62, P89, DOI 10.2307/5485; Holt RD, 1997, ECOLOGY, V78, P1673, DOI 10.1890/0012-9658(1997)078[1673:WIBCES]2.0.CO;2; HOPPER KR, 1993, ANNU REV ENTOMOL, V38, P27, DOI 10.1146/annurev.en.38.010193.000331; Ikegawa Y, 2014, J FAC AGR KYUSHU U, V59, P305; Jervis MA, 1997, TRENDS ECOL EVOL, V12, P378, DOI 10.1016/S0169-5347(97)87378-8; KAREIVA P, 1990, UCLA SYM BI, V112, P65; Kean JM, 2000, BIOCONTROL SCI TECHN, V10, P215, DOI 10.1080/09583150050044493; Loan C.C., 1974, Entomophaga, V19, P7, DOI 10.1007/BF02371504; Lush J. L, 1947, ANIMAL BREEDING PLAN; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall GA, 1937, NEW CURCULIONIDAE CO, P316; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; Mills NJ, 2017, P NATL ACAD SCI USA, V114, P3792, DOI 10.1073/pnas.1702753114; Mitsui H, 2010, EUR J ENTOMOL, V107, P535, DOI 10.14411/eje.2010.061; Pascoal S, 2014, CURR BIOL, V24, P1369, DOI 10.1016/j.cub.2014.04.053; PIMENTEL D, 1963, AM NAT, V97, P141, DOI 10.1086/282265; Sandrock C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-348; Schilthuizen M, 1997, P ROY SOC B-BIOL SCI, V264, P361, DOI 10.1098/rspb.1997.0052; Schneider MV, 2002, J EVOLUTION BIOL, V15, P191, DOI 10.1046/j.1420-9101.2002.00394.x; Stenberg JA, 2017, TRENDS PLANT SCI, V22, P759, DOI 10.1016/j.tplants.2017.06.010; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; STOUTHAMER R, 1993, ENTOMOPHAGA, V38, P3, DOI 10.1007/BF02373133; Stufkens M. W., 1987, Proceedings of the New Zealand Weed and Pest Control Conference., P31; Sudo M, 2018, EVOL APPL, V11, P271, DOI 10.1111/eva.12550; Taft HR, 2012, CONSERV GENET, V13, P333, DOI 10.1007/s10592-011-0285-y; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tomasetto F, 2017, P NATL ACAD SCI USA, V114, P3885, DOI 10.1073/pnas.1618416114; VanLenteren JC, 1996, BIOL CONTROL, V6, P1, DOI 10.1006/bcon.1996.0001; Waage J., 2012, BIOL CONTROL MEASURE; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650	59	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207610	10.1371/journal.pone.0207610	http://dx.doi.org/10.1371/journal.pone.0207610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566468	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300012
J	Alberts, CJ; van der Loeff, MFS; Sadik, S; Zuure, FR; Beune, EJAJ; Prins, M; Snijder, MB; Bruisten, SM				Alberts, C. J.; van der Loeff, M. F. Schim; Sadik, S.; Zuure, F. R.; Beune, E. J. A. J.; Prins, M.; Snijder, M. B.; Bruisten, S. M.			Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands	PLOS ONE			English	Article							SHELTERED HOMELESS PERSONS; RISK-FACTORS; DEVELOPED-COUNTRIES; GLOBAL EPIDEMIOLOGY; HIV-INFECTION; DRUG-USERS; PREVALENCE; DISEASE; MEN; SEX	Background The epidemiology of hepatitis E virus (HEV) is not fully understood. In this study, we assessed putative risk factors for HEV seropositivity in various study populations in the Netherlands. Methods Data and samples from five different study populations were analysed: (A) blood donors (n = 5,239), (B) adults reporting a vegetarian life style since the age of 12 years (n = 231), (C) residents of Amsterdam, the Netherlands, with different ethnic backgrounds (n = 1,198), (D) men who have sex with men (MSM) (HIV positive and HIV negative) (n = 197), and (E) persons who use drugs (PWUD) (HIV positive and HIV negative) (n = 200). Anti-HEV immunoglobulin M (IgM) and immunoglobulin G (IgG) testing was performed using ELISA test (Wantai). Results HEV IgM seroprevalence was low across all study populations (<1% to 8%). The age and gender-adjusted HEV IgG seroprevalence was 24% among blood donors (reference group) and 9% among the vegetarian group (adjusted Relative Risk [aRR]:0.36, 95%CI:0.23-0.57). Among participants of different ethnic backgrounds, the adjusted HEV IgG seroprevalence was 16% among participants with a Dutch origin (aRR:0.64, 95%CI:0.40-1.02), 2% among South-Asian Surinamese (aRR:0.07, 95%CI:0.02-0.29), 3% among African Surinamese (aRR:0.11, 95%CI:0.04-0.34), 34% among Ghanaian (aRR:1.53, 95%CI:1.15-2.03), 19% among Moroccan (aRR:0.75, 95%CI:0.49-1.14), and 5% among Turkish (aRR:0.18, 95%CI:0.08-0.44) origin participants. First generation Moroccans had a higher risk for being IgG HEV seropositive compared to second generation Moroccan migrants. The statistical power to perform these analyses in the other ethnic groups was too low. In the MSM group the IgG HEV seroprevalence was 24% (aRR:0.99, 95%CI:0.76-1.29), and among PWUD it was 28% (aRR:1.19, 95%CI:0.90-1.58). The number of sexual partners in the preceding six months was not significantly associated with IgG HEV seropositivity in MSM. The association between HIV status and HEV seropositivity was significant in PWUD, yet absent in MSM. HIV viral load and CD4 cell count were not associated with HEV seropositivity in HIV positive MSM and PWUD. Conclusions Vegetarians were significantly less often HEV seropositive. Ethnic origin influenced the risk for being IgG HEV seropositive. MSM and PWUD were not at higher risk for being IgG HEV seropositive than blood donors.	[Alberts, C. J.; van der Loeff, M. F. Schim; Sadik, S.; Zuure, F. R.; Prins, M.; Bruisten, S. M.] Publ Hlth Serv Amsterdam GGD, Dept Infect Dis, Amsterdam, Netherlands; [Alberts, C. J.] Stanford Univ, Div Infect Dis, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [van der Loeff, M. F. Schim; Zuure, F. R.; Prins, M.; Bruisten, S. M.] Univ Amsterdam, Amsterdam Infect & Immun Inst, Acad Med Ctr, Amsterdam, Netherlands; [Beune, E. J. A. J.; Snijder, M. B.] Univ Amsterdam, Dept Publ Hlth, Acad Med Ctr, Amsterdam, Netherlands	Public Health Service Amsterdam; Stanford University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bruisten, SM (corresponding author), Publ Hlth Serv Amsterdam GGD, Dept Infect Dis, Amsterdam, Netherlands.; Bruisten, SM (corresponding author), Univ Amsterdam, Amsterdam Infect & Immun Inst, Acad Med Ctr, Amsterdam, Netherlands.	sbruisten@ggd.amsterdam.nl		Alberts, Catharina Johanna/0000-0002-5604-3689	Dutch Heart Foundation [2010T084]; Netherlands Organization for Health Research and Development (ZonMw) [200500003]; European Union (FP-7) [278901]; European Fund for the Integration of non-EU immigrants (EIF) [2013EIF013]; European Commission [278901]; GGD Amsterdam [2013-2155, 2014-2166, 2016, 2173]; Netherlands National Institute for Public Health and the Environment	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF); European Commission(European CommissionEuropean Commission Joint Research Centre); GGD Amsterdam; Netherlands National Institute for Public Health and the Environment	The HELIUS study is conducted by the Academic Medical Center Amsterdam and the Public Health Service of Amsterdam. Both organizations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation (2010T084 to MBS), the Netherlands Organization for Health Research and Development (ZonMw) (200500003 to MP), the European Union (FP-7) (278901 to MBS), and the European Fund for the Integration of non-EU immigrants (EIF) (2013EIF013 to MBS). RODAM study was supported by the European Commission under the Framework Programme (278901 to EJAJB). For the Vegetarian study, funding was kindly provided by Research and Development grants from GGD Amsterdam (numbers 2013-2155 and 2014-2166 to SMB). The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. Analyses current manuscript: Funding was kindly provided by a Research and Development grant from GGD Amsterdam (numbers 2016 and 2173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2017, ANN NY ACAD SCI, V1391, P54, DOI 10.1111/nyas.13204; ALTER MJ, 1990, MED CLIN N AM, V74, P1529, DOI 10.1016/S0025-7125(16)30493-X; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Chadha MS, 1999, J VIRAL HEPATITIS, V6, P457, DOI 10.1046/j.1365-2893.1999.00190.x; Christensen PB, 2002, J MED VIROL, V66, P49, DOI 10.1002/jmv.2110; Colson P, 2009, J CLIN VIROL, V45, P269, DOI 10.1016/j.jcv.2009.06.002; Coutinho RA, 1998, J ACQ IMMUN DEF SYND, V17, pS4, DOI 10.1097/00042560-199801001-00003; Crum-Cianflone NF, 2012, EMERG INFECT DIS, V18, P502, DOI 10.3201/eid1803.111278; Dalton HR, 2013, SEMIN LIVER DIS, V33, P50, DOI 10.1055/s-0033-1338114; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2016, DIGEST DIS, V34, P308, DOI 10.1159/000444468; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Danquah I, 2018, EUR J NUTR, V57, P2723, DOI 10.1007/s00394-017-1538-4; Dekker LH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-441; DIETZMAN DE, 1977, JAMA-J AM MED ASSOC, V238, P2625, DOI 10.1001/jama.238.24.2625; Dreier J, 2014, TRANSFUS MED HEMOTH, V41, P29, DOI 10.1159/000357098; Galbete C, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1341809; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Hartl J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080211; Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733; Kaba M, 2010, EMERG INFECT DIS, V16, P1761, DOI 10.3201/eid1611.091890; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Keane FE, 2012, HIV MED, V13, P83, DOI 10.1111/j.1468-1293.2011.00942.x; Kenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Kupferschmidt K, 2016, SCIENCE, V353, P862, DOI 10.1126/science.353.6302.862; Larrat S, 2012, EMERG INFECT DIS, V18, P1031, DOI 10.3201/eid1806.110632; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mirazo S, 2014, HEPATIC MED-EVID RES, V6, P45, DOI 10.2147/HMER.S63417; MONTELLA F, 1994, LANCET, V344, P1433, DOI 10.1016/S0140-6736(94)90598-3; Nelson KE, 2011, EXPERT REV ANTI-INFE, V9, P1133, DOI [10.1586/eri.11.138, 10.1586/ERI.11.138]; Payne BAI, 2013, EMERG INFECT DIS, V19, P333, DOI 10.3201/eid1902.121174; Sadik S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2007-z; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Slot E, 2013, EUROSURVEILLANCE, V2013, P18, DOI DOI 10.2807/1560-7917.ES2013.18.31.20550; Slot E, 2017, PLOS ONE, P12, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Slot E, 2016, TRANSFUSION, V56, P203, DOI 10.1111/trf.13298; Snijder M, 2017, BMJ OPEN, V7, P1; StataCorp, 2015, STAT STAT SOFTW REL; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Sturkenboom SM, 2016, PUBLIC HEALTH NUTR, V19, P682, DOI 10.1017/S1368980015001391; Sylvan SPE, 1998, SCAND J INFECT DIS, V30, P429, DOI 10.1080/00365549850160800; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; VANDENHOEK JAR, 1988, AIDS, V2, P55, DOI 10.1097/00002030-198802000-00010; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208522	10.1371/journal.pone.0208522	http://dx.doi.org/10.1371/journal.pone.0208522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557324	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000031
J	de Freitas, D; Aguiar, FN; Anton, C; Bacchi, CE; Carvalho, JP; Carvalho, FM				de Freitas, Daniela; Aguiar, Fernando Nalesso; Anton, Cristina; Bacchi, Carlos Eduardo; Carvalho, Jesus Paula; Carvalho, Filomena Marino			L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion	PLOS ONE			English	Article							NODE METASTASIS; CANCER; RECURRENCE; PREDICTOR; SURVIVAL; PATTERNS; IMPACT	Background Risk stratification of endometrial carcinomas is primarily based on surgical staging that requires extensive retroperitoneal lymph node dissection. One of the most powerful predictor of lymph node involvement is the lymph vascular space invasion (LVSI). The objective of this study was to determine the potential of L1 Cell Adhesion Molecule (L1CAM) to predict LVSI and its association with other risk factors in endometrioid endometrial carcinomas. Materials and methods We studied 47 consecutive patients aged 37-88 (61.34 +/- 10.52). Twenty-three patients (48.9%) were submitted to complete surgical staging. Nine patients (19.1%) underwent surgical staging without para-aortic dissection. Seven (14.9%) were submitted to hysterectomy with no lymph node dissection. Eight patients (17.0%) only had the biopsy material for analysis. The 32 patients submitted to lymphadenectomy were staged according to the FIGO system and classified among the risk categories of the ESMO-ESGO-ESTRO guidelines. The following histological characteristics were analyzed: tumor size (mm), depth of myometrial infiltration, presence of microcystic, elongated, and fragmented (MELF) pattern of myoinvasion, and lymph vascular space invasion (LVSI). Immunohistochemical analyses of mismatch repair (MMR) proteins MLH1, MSH2, MSH6, and PMS2, p53, and L1CAM were performed in formalin-fixed paraffin embedded whole tumor tissue sections. Results LVSI was identified in 26/41 (63,4%) of the cases. L1CAM was positive in 8/47 (17%) cases, all of them positive for LVSI and within the high-risk category of ESMO-ESGO-ESTRO. L1CAM-positive cases were associated with high histological grade and p53 aberrant immunohistochemical profile. Besides, it showed a trend to larger tumors, greater depth of myometrial infiltration, and with a higher frequency of the MELF pattern of myoinvasion. LVSI was also associated with FIGO stage, tumor size, depth of myometrial infiltration, and tumor grade. Conclusions L1CAM is highly associated with LVSI and could be used as a pre-operative predictor of lymph node involvement in endometrioid endometrial carcinomas.	[de Freitas, Daniela; Aguiar, Fernando Nalesso; Anton, Cristina; Carvalho, Jesus Paula] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Fac Med, Sao Paulo, SP, Brazil; [de Freitas, Daniela; Carvalho, Filomena Marino] Univ Sao Paulo, Dept Pathol, Fac Med, Sao Paulo, SP, Brazil; [Bacchi, Carlos Eduardo] Consultoria Patol, Botucatu, SP, Brazil; [Carvalho, Jesus Paula] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, FM (corresponding author), Univ Sao Paulo, Dept Pathol, Fac Med, Sao Paulo, SP, Brazil.	filomena.carvalho@fm.usp.br	Carvalho, Filomena Marino/D-3987-2012; CARVALHO, JESUS PAULA/G-8387-2018; Anton, Cristina/ABB-9783-2020; Anton, Cristina/AAS-7697-2020; Carvalho, Jesus Paula/O-7464-2019	Carvalho, Filomena Marino/0000-0002-5838-3636; CARVALHO, JESUS PAULA/0000-0003-4495-057X; Anton, Cristina/0000-0002-6259-2449; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2018/06717-8]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) financial research support (process 2018/06717-8) to FMC. FAPESP had no involvement in study design, collection, analysis or interpretation of data.	AlHilli MM, 2013, GYNECOL ONCOL, V131, P103, DOI 10.1016/j.ygyno.2013.06.037; [Anonymous], 2017, CANC STAGING MANUAL; Anton C, 2015, CLINICS, V70, P470, DOI 10.6061/clinics/2015(07)02; Belhadj H, 2014, INT J GYNECOL OBSTET, V125, P97, DOI 10.1016/j.ijgo.2014.02.003; Bosse T, 2014, EUR J CANCER, V50, P2602, DOI 10.1016/j.ejca.2014.07.014; Colombo N, 2016, INT J GYNECOL CANCER, V26, P2, DOI 10.1097/IGC.0000000000000609; Cusano E, 2018, INT J GYNECOL CANCER, V28, P890, DOI 10.1097/IGC.0000000000001229; Dellinger TH, 2016, GYNECOL ONCOL, V141, P336, DOI 10.1016/j.ygyno.2016.02.003; dos Reis R, 2015, INT J GYNECOL CANCER, V25, P1292, DOI 10.1097/IGC.0000000000000490; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Kommoss F, 2017, J CANCER RES CLIN, V143, P255, DOI 10.1007/s00432-016-2276-3; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Mariani A, 2000, AM J OBSTET GYNECOL, V182, P1506, DOI 10.1067/mob.2000.107335; Matsuo K, 2015, J SURG ONCOL, V112, P669, DOI 10.1002/jso.24049; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Pasanen A, 2016, INT J GYNECOL CANCER, V26, P1465, DOI 10.1097/IGC.0000000000000801; Piulats JM, 2017, GYNECOL ONCOL, V145, P200, DOI 10.1016/j.ygyno.2016.12.015; Roma AA, 2015, HUM PATHOL, V46, P1529, DOI 10.1016/j.humpath.2015.06.015; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Sari ME, 2017, INT J CLIN ONCOL, V22, P937, DOI 10.1007/s10147-017-1139-5; Talhouk A, 2016, Gynecol Oncol Res Pract, V3, P14, DOI 10.1186/s40661-016-0035-4; Talhouk A, 2017, CANCER-AM CANCER SOC, V123, P802, DOI 10.1002/cncr.30496; Talhouk A, 2016, GYNECOL ONCOL, V143, P46, DOI 10.1016/j.ygyno.2016.07.090; Tangen IL, 2017, BRIT J CANCER, V117, P840, DOI 10.1038/bjc.2017.235; Taskin S, 2017, ARCH GYNECOL OBSTET, V296, P803, DOI 10.1007/s00404-017-4477-7; van Esterik M, 2017, ONCOTARGET, V8, P25542, DOI 10.18632/oncotarget.16067; Van Gool IC, 2016, MODERN PATHOL, V29, P174, DOI 10.1038/modpathol.2015.147; Wang XY, 2016, INT J GYNECOL CANCER, V26, P918, DOI 10.1097/IGC.0000000000000692; Widschwendter P, 2018, INT J GYNECOL CANCER, V28, P1145, DOI 10.1097/IGC.0000000000001290; Zeimet AG, 2013, JNCI-J NATL CANCER I, V105, P1142, DOI 10.1093/jnci/djt144; Zhu MH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3671-0	31	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209294	10.1371/journal.pone.0209294	http://dx.doi.org/10.1371/journal.pone.0209294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557309	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000090
J	Espenshade, JL; Murdoch, JD; Donovan, TM; Manning, RE; Bettigole, CA; Austin, J				Espenshade, Jessica L.; Murdoch, James D.; Donovan, Therese M.; Manning, Robert E.; Bettigole, Charles A.; Austin, John			Public acceptability of development in the Northern Forest of Vermont, USA-The influence of wildlife information, recreation involvement, and demographic characteristics	PLOS ONE			English	Article							ENVIRONMENTAL CONCERN; MANAGEMENT; ATTITUDES; QUALITY; IMPACTS; OPINION	Increasing development such as roads and houses will alter future landscapes and result in biological, social, and economic trade-offs. Managing development requires information on the public's acceptability of development and understanding which factors shape acceptability. In this study, we examined three questions: 1) What is the public's acceptability of development? 2) Is acceptability of development influenced by wildlife information? and 3) Is the maximum amount of acceptable development influenced by views about wildlife, involvement in outdoor recreation, and demographic factors? We conducted a visual-preference survey of 9,000 households in Vermont, USA that asked about acceptable levels of development, acceptability of wildlife, involvement in recreation, and individual and town demographics. The survey response rate was 44%. Maximum acceptable condition (MAC) for development was 41 houses/km(2) and not meaningfully influenced by broader consequences of development on seven common wildlife species. MAC was influenced by views on individual species, including bear and coyote, but not by other species such as deer, fox, and bobcat. Respondents with a positive attitude toward bear favored less development, whereas the opposite relationship existed for coyote. Similarly, MAC was negatively influenced by involvement in birding and hunting, but not by other common recreational activities. Among demographic factors, respondents that were younger and not born in Vermont were more accepting of development. Population density also positively influenced development acceptability. Results provide measures of the public's acceptability of development that can help guide decision-making about development, wildlife, and recreation management.	[Espenshade, Jessica L.; Murdoch, James D.; Manning, Robert E.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Donovan, Therese M.] Univ Vermont, Vermont Cooperat Fish & Wildlife Res Unit, US Geol Survey, Burlington, VT USA; [Bettigole, Charles A.] Yale Univ, Yale Sch Forestry & Environm Studies, Ucross High Plains Stewardship Initiat, New Haven, CT USA; [Austin, John] Vermont Dept Fish & Wildlife, Barre, VT USA; [Espenshade, Jessica L.] Natl Wildlife Federat, Ann Arbor, MI 48104 USA	University of Vermont; United States Department of the Interior; United States Geological Survey; University of Vermont; Yale University	Espenshade, JL (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.; Espenshade, JL (corresponding author), Natl Wildlife Federat, Ann Arbor, MI 48104 USA.	jespenshade@gmail.com			Northeastern States Research Cooperative; U.S. Geological Survey, University of Vermont, Vermont Department of Fish and Wildlife; Wildlife Management Institute	Northeastern States Research Cooperative; U.S. Geological Survey, University of Vermont, Vermont Department of Fish and Wildlife; Wildlife Management Institute	This work was supported by the Northeastern States Research Cooperative (http://nsrcforest.org) to JDM, TMD, REM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Northeastern States Research Cooperative for funding for the project. The project also received logistical support from the University of Vermont and U.S. Geological Survey Vermont Cooperative Fish and Wildlife Research Unit. We are grateful to R. Mickey, S. Merrill, C. Hansen, and M. Brown for technical assistance, and the University of Vermont Print & Mail Center and Center for Rural Studies. C. Bernier of the Vermont Department of Fish and Wildlife also provided expert opinion on species occurrence. Use of trade names or products does not constitute endorsement by the U.S. Government. The Vermont Cooperative Fish and Wildlife Research Unit is jointly supported by the U.S. Geological Survey, University of Vermont, Vermont Department of Fish and Wildlife, and Wildlife Management Institute.	Agnone J, 2007, SOC FORCES, V85, P1593, DOI 10.1353/sof.2007.0059; Alig RJ, 2004, J FOREST, V102, P19; Barton K, 2015, MUMIN MULTIMODEL INT, V1, P4, DOI DOI 10.1111/J.2041-210X.2012.00261.X; Baur JWR, 2016, URBAN FOR URBAN GREE, V17, P42, DOI 10.1016/j.ufug.2016.03.012; Bernedo M, 2014, J CONSUM POLICY, V37, P437, DOI 10.1007/s10603-014-9266-0; Bettigole CA, 2014, BIOL CONSERV, V169, P392, DOI 10.1016/j.biocon.2013.07.009; Boglioli Marc, 2009, MATTER LIFE DEATH HU; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cooper C, 2015, J WILDLIFE MANAGE, V79, P446, DOI 10.1002/jwmg.855; Daigle J.J., 2002, HUM DIMENS WILDL, V7, P1, DOI [10.1080/108712002753574756, DOI 10.1080/108712002753574756]; Dillman D. A., 2014, INTERNET PHONE MAIL; Duda MD, 2015, OPINIONS FISH WILDLI; Espenshade JL, 2015, WILDLIFE INFORM RECR; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fidel J, 2014, INFORM LAND USE PLAN; Fuller Todd K., 2010, P13; Gehrt Stanley D., 2004, P81; Goodwin P., 2004, DECISION ANAL MANAGE; Hadidian John, 2010, P35; Hamilton LC, 2010, RURAL SOCIOL, V75, P326, DOI 10.1111/j.1549-0831.2010.00013.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hughes M, 2009, J PARK RECREAT ADM, V27, P38; Jackson EL, 1986, LEISURE SCI, V9, P235; JAMES JM, 1990, PUBLIC OPIN QUART, V54, P346, DOI 10.1086/269211; Kahn PH, 2009, CURR DIR PSYCHOL SCI, V18, P37, DOI 10.1111/j.1467-8721.2009.01602.x; Kellert SR, 1984, J ENVIRON MANAGE, V18, P1; Ken Cordell H., 1997, HUMAN DIMENSIONS WIL, V2, P1, DOI DOI 10.1080/10871209709359091; Lafon NW, 2002, EVOLUTION STAKEHOLDE; Lax JR, 2009, AM J POLIT SCI, V53, P107, DOI 10.1111/j.1540-5907.2008.00360.x; Lee TH, 2011, J SUSTAIN TOUR, V19, P895, DOI 10.1080/09669582.2011.570345; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manfredo MJ, 2009, SOC SCI QUART, V90, P407, DOI 10.1111/j.1540-6237.2009.00624.x; MANNING R, 1999, LEISURE STUDIES PROS, P323; Manning R.E., 2007, PARKS CARRYING CAPAC; Manning RE, 2004, J LEISURE RES, V36, P557, DOI 10.1080/00222216.2004.11950036; Miles B., 2008, PUTTING AESTHETICS I; PAGE BI, 1987, AM POLIT SCI REV, V81, P23, DOI 10.2307/1960777; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; R Core Team, 2021, R LANGUAGE ENV STAT; Riitters KH, 2002, ECOSYSTEMS, V5, P815, DOI 10.1007/s10021-002-0209-2; Rolston III H., 1987, VALUING WILDLIFE EC, P187; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sharp R.L., 2012, J INTERPRETATION RES, V17, P23, DOI [10.1177/109258721201700203, DOI 10.1177/109258721201700203]; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Tahvanainen L, 2001, LANDSCAPE URBAN PLAN, V53, P53, DOI 10.1016/S0169-2046(00)00137-7; Teel TL, 2009, CONSERV BIOL, V24, P28; Teisl MF, 2003, ENVIRON BEHAV, V35, P506, DOI 10.1177/0013916503035004004; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Theodori GL, 1998, RURAL SOCIOL, V63, P94, DOI 10.1111/j.1549-0831.1998.tb00666.x; U.S. Census Bureau, 2015, STAT COUNT QUICK FAC; U. S. Department of Agriculture, 2007, NAT RES INV 2003; U. S. Department of Agriculture, 2011, NAT REP SUST FOR 201; UN, 2004, WORLD POP 2300; *US FISH WILDL SER, 2012, 2011 NAT SURV FISH H; USDA Forest Service, 1997, REP US CRIT IND SUST; Vermont Fish and Wildlife Department, 2015, VERM WILDL ACT PLAN; Vermont Forum on Sprawl, 1999, EC SOC LAND US TREND; Vermont Monitoring Cooperative, 2009, VERM CHANG RESTS KEY; Walker JL, 2007, J GEOGR SYST, V9, P77, DOI 10.1007/s10109-006-0030-0; White EM, 2009, LANDSCAPE URBAN PLAN, V89, P37, DOI 10.1016/j.landurbplan.2008.09.004; Williams S., 2012, THESIS; Wolsink M, 2007, RENEW SUST ENERG REV, V11, P1188, DOI 10.1016/j.rser.2005.10.005; Zheng B, 2011, LANDSCAPE URBAN PLAN, V99, P1, DOI 10.1016/j.landurbplan.2010.08.006	63	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0203515	10.1371/journal.pone.0203515	http://dx.doi.org/10.1371/journal.pone.0203515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557372	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000007
J	Paul, N; Novais, SC; Lemos, MFL; Kunzmann, A				Paul, Nina; Novais, Sara C.; Lemos, Marco F. L.; Kunzmann, Andreas			Chemical predator signals induce metabolic suppression in rock goby (Gobius paganellus)	PLOS ONE			English	Article							RISK-ASSESSMENT; ASTERROPTERYX-SEMIPUNCTATUS; STRESS-RESPONSE; ALARM RESPONSE; SKIN EXTRACT; FISH; CUES; RECOGNITION; TEMPERATURE; STIMULI	In nature, a multitude of both abiotic and biotic stressors influence organisms with regard to their overall fitness. Stress responses that finally impair normal biological functions may ultimately result in consequences for whole populations. This study focused on the metabolic response of the intertidal rock pool fish Gobius paganellus towards simulated predation risk. Individuals were exposed to a mixture of skin extracts from conspecifics and chemical alarm cues from a top predator, Octopus vulgaris. Oxygen consumption rates of single fish were measured to establish standard (SMR) and routine metabolic rates (RMR) of G. paganellus, and to address the direct response towards simulated predation risk, compared to handling and light stress. The SMR of G. paganellus (0.0301 +/- 0.0081 mg O-2 h(-1) g(-1) WW) was significantly lower than the RMR (0.0409 +/- 0.0078 mg O-2 h(-1) g(-1) WW). In contrast to increased respiration due to handling and light stress, the exposure to chemical predation cues induced a significant reduction in oxygen consumption rates (0.0297 +/- 0.0077 mg O-2 h(-1) g(-1) WW). This metabolic suppression was interpreted as a result of the stereotypic freezing behaviour as antipredator response of gobiid fish. Results underline the importance of biotic interactions in environmental stress assessments and predation as a biotic factor that will provide more realistic scenarios when addressing stress impacts in tidal rock pool organisms.	[Paul, Nina; Kunzmann, Andreas] Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany; [Novais, Sara C.; Lemos, Marco F. L.] Inst Politecn Leiria, MARE Marine & Environm Sci Ctr, ESTM, Peniche, Portugal; [Paul, Nina] Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, Bremerhaven, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Polytechnic Institute of Leiria; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Paul, N (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany.; Paul, N (corresponding author), Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, Bremerhaven, Germany.	nina-paul@gmx.de	Kunzmann, Andreas/O-5459-2019; Lemos, Marco F.L./F-7951-2011; Novais, Sara C/A-9032-2012	Kunzmann, Andreas/0000-0002-9500-4332; Lemos, Marco F.L./0000-0001-9887-1864; Novais, Sara C/0000-0003-1306-3396; Paul, Nina/0000-0001-9967-4459	Fundacao para a Ciencia e a Tecnologia (FCT) [UID/MAR/04292/2013]; Integrated Programme of SRTD "SmartBioR" [Centro-01-0145-FEDER-000018]; Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund; ERASMUS+; project ProTEoME [PTDC/AAG-MAA/1302/2014]; project MARINE INVADERS [PTDC/BIA-CBI/31144/2017, POCI-01-0145-FEDER-031144];  [SFRH/BPD/94500/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Integrated Programme of SRTD "SmartBioR"; Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund; ERASMUS+; project ProTEoME; project MARINE INVADERS; 	This study had the support of Fundacao para a Ciencia e a Tecnologia (FCT) through the Strategic Project UID/MAR/04292/2013, project ProTEoME (PTDC/AAG-MAA/1302/2014), and project MARINE INVADERS (PTDC/BIA-CBI/31144/2017 and POCI-01-0145-FEDER-031144), and the post-doc grant of Sara C. Novais (SFRH/BPD/94500/2013). The project was also partially funded by the Integrated Programme of SR&TD "SmartBioR" (reference Centro-01-0145-FEDER-000018) co-funded by Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund. The stay abroad was financially supported by ERASMUS+. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; BARTON BA, 1987, T AM FISH SOC, V116, P257, DOI 10.1577/1548-8659(1987)116&lt;257:MCOAPS&gt;2.0.CO;2; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Brown GE, 2000, BEHAVIOUR, V137, P181, DOI 10.1163/156853900502015; BROWN GE, 1995, J FISH BIOL, V47, P387; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Chabot D, 2016, J FISH BIOL, V88, P1, DOI 10.1111/jfb.12873; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Evans D., 2013, CRC MARINE BIOL SERI; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Giaquinto PC, 2001, BEHAVIOUR, V138, P1205, DOI 10.1163/15685390152822175; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; HEALEY MC, 1972, J FISH RES BOARD CAN, V29, P187, DOI 10.1139/f72-030; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Jobling M, 1994, FISH BIOENERGETICS; Jordan AD, 2005, COMP BIOCHEM PHYS A, V141, pS213; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kegler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142744; Killen SS, 2012, FUNCT ECOL, V26, P134, DOI 10.1111/j.1365-2435.2011.01920.x; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; Larson JK, 2005, ANIM BEHAV, V69, P51, DOI 10.1016/j.anbehav.2004.04.005; LeBlanc S, 2011, J EXP BIOL, V214, P1721, DOI 10.1242/jeb.056135; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; Madeira D, 2014, ECOL INDIC, V46, P232, DOI 10.1016/j.ecolind.2014.06.029; MAGNHAGEN C, 1988, MAR ECOL PROG SER, V49, P21, DOI 10.3354/meps049021; Manassa RP, 2012, J EXP MAR BIOL ECOL, V426, P48, DOI 10.1016/j.jembe.2012.05.023; McBryan TL, 2013, INTEGR COMP BIOL, V53, P648, DOI 10.1093/icb/ict066; McCormick MI, 2008, CORAL REEFS, V27, P105, DOI 10.1007/s00338-007-0296-9; McCormick MI, 2007, CORAL REEFS, V26, P571, DOI 10.1007/s00338-007-0221-2; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Nelson JA, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1566; Paschke K, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01438; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; PFEIFFER W, 1960, Z VERGL PHYSIOL, V43, P578, DOI 10.1007/BF00298105; PICKERING AD, 1993, AQUACULTURE, V111, P51, DOI 10.1016/0044-8486(93)90024-S; Pink M, 2016, CAN J FISH AQUAT SCI, V73, P869, DOI 10.1139/cjfas-2015-0302; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; REHNBERG BG, 1987, CAN J ZOOL, V65, P481, DOI 10.1139/z87-074; Richards JG, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1764; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Smith ME, 2000, J CHEM ECOL, V26, P1635, DOI 10.1023/A:1005586812771; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; SMITH RJF, 1991, J CHEM ECOL, V17, P2253, DOI 10.1007/BF00988005; SMITH RJF, 1989, ETHOLOGY, V83, P19; SMITH RJF, 1989, ETHOLOGY, V81, P279; SMITH RJF, 1992, ENVIRON BIOL FISH, V34, P103; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; STRANGE RJ, 1978, J FISH RES BOARD CAN, V35, P345, DOI 10.1139/f78-061; Szulkin M, 2006, ANIM BEHAV, V71, P1013, DOI 10.1016/j.anbehav.2005.05.027; Toscano BJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1343, DOI 10.1007/s00265-015-1947-4; Vinagre C, 2014, MAR ENVIRON RES, V97, P10, DOI 10.1016/j.marenvres.2014.01.007; Vinagre C, 2013, J SEA RES, V81, P10, DOI 10.1016/j.seares.2013.03.011; Wisenden Brian D., 2003, P236, DOI 10.1007/978-0-387-22628-6_12; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	59	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209286	10.1371/journal.pone.0209286	http://dx.doi.org/10.1371/journal.pone.0209286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557310	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000088
J	Pervin, J; Nu, UT; Rahman, AMQ; Rahman, M; Uddin, B; Razzaque, A; Johnson, S; Kuhn, R; Rahman, A				Pervin, Jesmin; Nu, U. Tin; Rahman, A. M. Q.; Rahman, Mahabubur; Uddin, Borhan; Razzaque, Abdur; Johnson, Sandy; Kuhn, Randall; Rahman, Anisur			Level and determinants of birth preparedness and complication readiness among pregnant women: A cross sectional study in a rural area in Bangladesh	PLOS ONE			English	Article							DANGER SIGNS; MATERNAL HEALTH; DISTRICT; KNOWLEDGE; ETHIOPIA	Background Increasing the level of birth preparedness and complication readiness (BP/CR) is one of the key interventions to promote optimal utilization of skilled maternal health services. It is therefore essential to determine the women's ability to recognize the danger signs and the level of BP/CR. This information can be used to design more effective health interventions. Objectives This study was conducted to determine the knowledge in recognition of maternal complications, and the level and factors associated with BP/CR in rural Matlab, Bangladesh. Methods A community-based cross-sectional survey was conducted from June-October 2015 on a randomly selected 2262 women who delivered live or stillbirth during the year 2014. A pre-tested and structured questionnaire was used for data collection. Descriptive and analytical statistical methods were used. Results The proportion of study participants with "good knowledge", measured by the ability to recognise three or more danger signs, in pregnancy and delivery were 26% and 23%, respectively. Out of four BP/CR components, about 15% women saved money, 12% women identified facility for delivery, 9.6% women planned to deliver by skilled birth attendant and 5.3% of women arranged transport. About 12% of women were "well prepared", measured by planning of at least two components, for skilled childbirth and emergency obstetric complications. In the multivariable logistic regression analysis, asset index, antenatal care (ANC) visits and knowledge of danger signs during pregnancy and delivery were associated with BP/CR. The adjusted odds ratio (OR) of "well prepared" was 4.09 (95% confidence interval [CI]: 2.45-6.82) among women with an asset index of five (richest), compared with women in the asset index of one (poorest). The odds of "well prepared" was six times (OR 5.98, 95% CI: 3.85-9.28) higher for women with four or more ANC visits, compared to women with none or one ANC visit. In comparison to women with "poor knowledge" on maternal danger signs during pregnancy and delivery, the odds ratio of "well prepared" among women with good knowledge during pregnancy and in delivery were 1.95 (95% CI: 1.44-2.63) and 1.74 (95% CI: 1.28-2.36), respectively. Conclusion The study revealed a low level of maternal knowledge of danger signs and BP/CR among pregnant women. Further, low socioeconomic status, fewer ANC visits and poor knowledge in recognition of dangers signs on maternal health were associated with low BP/CR. More emphasis should be placed on the quality of information offered to the pregnant women during the prenatal contact and women from low socio-economic gradient should be prioritized to optimize the impact of future BP/CR interventions.	[Pervin, Jesmin; Nu, U. Tin; Rahman, A. M. Q.; Razzaque, Abdur; Rahman, Anisur] Icddr B, Dhaka, Bangladesh; [Rahman, Mahabubur; Uddin, Borhan] Minist Hlth & Family Welf, Upazilla Hlth & Family Planning, Chandpur, Bangladesh; [Johnson, Sandy] Univ Denver, Josef Korbel Sch Int Studies, Denver, CO USA; [Kuhn, Randall] Univ Calif Los Angeles, Dept Community Hlth Sci, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Denver; University of California System; University of California Los Angeles	Pervin, J (corresponding author), Icddr B, Dhaka, Bangladesh.	jpervin@icddrb.org		Kuhn, Randall/0000-0001-5664-6933	USAID & Partnerships for Enhanced Engagement in Research (PEER) Health [01122]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041022] Funding Source: NIH RePORTER	USAID & Partnerships for Enhanced Engagement in Research (PEER) Health(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the USAID & Partnerships for Enhanced Engagement in Research (PEER) Health, Grant Number: 01122 (https://www.usaid.gov/bd; http://sites.nationalacademies.org/pga/peer/index.htm).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104027; Afework MF, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-28; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; August F, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26922; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Bitew Yewondwossen, 2016, INT SCH RES NOTICES, V2016, P1, DOI [10.1155/2016/8727365, DOI 10.1155/2016/8727365]; Bogale D, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0508-1; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Ekwochi U, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0127-5; Elavarasan E, 2015, CROSS SECTIONAL STUD; Endeshaw DB, 2018, BMC NURS, V17, DOI 10.1186/s12912-018-0278-y; Farah S, 2015, BANGLADESH MED J; Gebre M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137570; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Hailu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083459; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197693; Joyce C, 2018, BIOMEDICAL J SCI TEC, V3, P1, DOI [10.26717/BJSTR.2018.03.000929, DOI 10.26717/BJSTR.2018.03.000929]; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Khanum P, 2002, USE OBSTET CARE SERV; Kuganab-Lem R., 2014, PUBLIC HLTH RES, V4, P195; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Markos D, 2014, ETHIOPIA, V14, P1; Mbalinda SN, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-60; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Miltenburg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143382; Moinuddin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189365; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; National Institute of Population Research and Training (NIPORT) MaA and ICF International, 2014, BANGL DEM HLTH SURV; Nigatu Solomon Gedlu, 2015, BMC Res Notes, V8, P309, DOI 10.1186/s13104-015-1278-6; NIPORT ACPR ICF International, 2016, BANGL HLTH FAC SURV; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; Rahman AE, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1882-2; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; Urassa DP, 2012, TANZAN J HLTH RES, V14, P42; USAID, 2016, BANGL MAT MORT HLTH; WHO, 2016, WHO TECH REP SER, V997, P1; WHO UNICEF UNFPA, 2003, PREGN CHILDB POSTP N; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	46	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209076	10.1371/journal.pone.0209076	http://dx.doi.org/10.1371/journal.pone.0209076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557336	Green Published, gold			2022-12-26	WOS:000453451000066
J	De Grazia, S; Lanave, G; Giammanco, GM; Medici, MC; De Conto, F; Tummolo, F; Calderaro, A; Bonura, F; Urone, N; Morea, A; Loconsole, D; Catella, C; Marinaro, M; Parisi, A; Martella, V; Chironna, M				De Grazia, Simona; Lanave, Gianvito; Giammanco, Giovanni Maurizio; Medici, Maria Cristina; De Conto, Flora; Tummolo, Fabio; Calderaro, Adriana; Bonura, Floriana; Urone, Noemi; Morea, Anna; Loconsole, Daniela; Catella, Cristiana; Marinaro, Mariarosaria; Parisi, Antonio; Martella, Vito; Chironna, Maria			Sentinel hospital-based surveillance for norovirus infection in children with gastroenteritis between 2015 and 2016 in Italy	PLOS ONE			English	Article							STRAINS; EMERGENCE; GII.17; VARIANTS	Noroviruses are one of the leading causes of gastro-enteric diseases worldwide in all age groups. Novel epidemic noroviruses with GII.P16 polymerase and GII.2 or GII.4 capsid type have emerged worldwide in late 2015 and in 2016. We performed a molecular epidemiological study of the noroviruses circulating in Italy to investigate the emergence of new norovirus strains. Sentinel hospital-based surveillance, in three different Italian regions, revealed increased prevalence of norovirus infection in children (<15 years) in 2016 (14.4% versus 9.8% in 2015) and the emergence of GII.P16 strains in late 2016, which accounted for 23.0% of norovirus infections. The majority of the strains with a GII.P16 polymerase showed a GII.2 capsid genotype (79.5%). Also, a marked circulation of strains with a GII.17 capsid (14.0%) was observed, chiefly in early 2016. The emergence and global spread of non-GII.4 noroviruses pose challenges for the development of vaccine strategies.	[De Grazia, Simona; Giammanco, Giovanni Maurizio; Bonura, Floriana; Urone, Noemi] Univ Palermo, Dipartimento Sci Promoz Salute & Materno Infantil, Palermo, Italy; [Lanave, Gianvito; Catella, Cristiana; Martella, Vito] Univ Aldo Moro Bari, Dipartimento Med Vet, Valenzano, Italy; [Medici, Maria Cristina; De Conto, Flora; Tummolo, Fabio; Calderaro, Adriana] Univ Parma, Dipartimento Med & Chirurg, Parma, Italy; [Morea, Anna; Loconsole, Daniela; Chironna, Maria] Univ Aldo Moro Bari, Dipartimento Sci Biomed & Oncol Umana, Bari, Italy; [Marinaro, Mariarosaria] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Rome, Italy; [Parisi, Antonio] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy	University of Palermo; Universita degli Studi di Bari Aldo Moro; University of Parma; Universita degli Studi di Bari Aldo Moro; Istituto Superiore di Sanita (ISS); IZS Puglia e Basilicata	Martella, V (corresponding author), Univ Aldo Moro Bari, Dipartimento Med Vet, Valenzano, Italy.	vito.martella@uniba.it	Giammanco, Giovanni M/G-4000-2012; Martella, Vito/K-3146-2016; De Conto, Flora/H-9760-2019	Giammanco, Giovanni M/0000-0002-7874-6289; Martella, Vito/0000-0002-5740-6947; De Conto, Flora/0000-0002-0493-2353; Loconsole, Daniela/0000-0003-2057-9745; Catella, Cristiana/0000-0002-9594-5255; MOREA, ANNA/0000-0002-3692-864X; chironna, maria/0000-0002-1043-1256; Parisi, Antonio/0000-0003-2744-1140	University of Bari	University of Bari	Financial support was obtained from the grants of Ateneo "Contributo per PRIN 2015", University of Bari.; Financial support was obtained from the grants of Ateneo "Contributo per PRIN 2015", University of Bari. The authors would like to acknowledge Dr. Daniele Casulli for technical support.	Bidalot M, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.15.30508; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; Choi YS, 2017, FOOD ENVIRON VIROL, V9, P168, DOI 10.1007/s12560-017-9278-4; Cortes-Penfield NW, 2017, CLIN THER, V39, P1537, DOI 10.1016/j.clinthera.2017.07.002; Drummond A., 2011, GENEIOUS V5 5; Giammanco GM, 2014, VIROLOGY, V450, P355, DOI 10.1016/j.virol.2013.12.007; Giammanco GM, 2013, EMERG INFECT DIS, V19, P1348, DOI 10.3201/eid1908.130619; Giammanco GM, 2017, EMERG INFECT DIS, V23, P1206, DOI 10.3201/eid2307.161255; Green KY, 2013, FIELDS VIROLOGY, P508; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kwok K, 2017, EMERG INFECT DIS, V23, P1852, DOI 10.3201/eid2311.170561; Lindesmith LC, 2017, J INFECT DIS, V216, P1227, DOI 10.1093/infdis/jix385; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Martella V, 2013, J CLIN MICROBIOL, V51, P3855, DOI 10.1128/JCM.01847-13; Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]; Ruis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179572; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tohma K, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00187-17; van Beek J, 2018, LANCET INFECT DIS, V18, P545, DOI 10.1016/S1473-3099(18)30059-8; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208184	10.1371/journal.pone.0208184	http://dx.doi.org/10.1371/journal.pone.0208184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550600	Green Published, gold			2022-12-26	WOS:000453248000015
J	Ciurte, A; Selicean, C; Soritau, O; Buiga, R				Ciurte, Anca; Selicean, Cristina; Soritau, Olga; Buiga, Rares			Automatic detection of circulating tumor cells in darkfield microscopic images of unstained blood using boosting techniques	PLOS ONE			English	Article							TRACKING	Circulating tumor cells (CTCs) are nowadays one of the most promising tumor biomarkers. It is well correlated with overall survival and progression-free survival in breast cancer, as well as in many other types of human cancer. In addition, enumeration and analysis of CTCs could be important for monitoring the response to different therapeutic agents, thus guiding the treatment of cancer patients and offering the promise of a more personalized approach. In this article, we present a new method that could be used for the automatic detection of CTC in blood, based on the microscopic appearance of unstained cells. The proposed method is based on the evaluation of image characteristics and boosting techniques. A dataset of 263 dark field microscopy images was constructed and used for our tests, containing blood spiked with three different types of tumor cells. An overall sensitivity of 92.87% and a specificity of 99.98% were obtained for the detection of CTC, performances which proved to be comparable to those obtained by human experts.	[Ciurte, Anca] Tech Univ Cluj Napoca, Dept Comp Sci, Cluj Napoca, Romania; [Selicean, Cristina] Oncol Inst Prof Dr Ion Chiricuta, Hematol Lab, Cluj Napoca, Romania; [Soritau, Olga; Buiga, Rares] Oncol Inst Prof Dr Ion Chiricuta, Cluj Napoca, Romania; [Buiga, Rares] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania	Technical University of Cluj Napoca; Oncology Institute Prof. Dr. Ion Chiricuta; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy	Ciurte, A (corresponding author), Tech Univ Cluj Napoca, Dept Comp Sci, Cluj Napoca, Romania.; Buiga, R (corresponding author), Oncol Inst Prof Dr Ion Chiricuta, Cluj Napoca, Romania.; Buiga, R (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania.	anca.ciurte@cs.utcluj.ro; raresbuiga@yahoo.fr	BUIGA, Rares/AAB-3196-2021	BUIGA, Rares/0000-0001-8195-0611	Ministry of National Education [PN-II-PT-PCCA-2013-4-2289, 137/2014]	Ministry of National Education	This work was supported by the CTC-VideoScope grant (Developing a method for real-time detection and isolation of circulating tumor cells from the bloodstream of cancer patients by means of image processing and pattern recognition) of the Ministry of National Education, project code PN-II-PT-PCCA-2013-4-2289, contract number 137/2014.; Like our previous work [18], this study was also supported by the CTC-VideoScope grant (Developing a method for real-time detection and isolation of circulating tumor cells from the bloodstream of cancer patients by means of image processing and pattern recognition) of the Ministry of National Education, project code PN-II-PT-PCCA-2013-4-2289, contract number 137/2014.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; Ciurte A, 2015, INT C INTELL COMP CO, P367, DOI 10.1109/ICCP.2015.7312686; Costea AD, 2016, IEEE INT VEH SYM, P328, DOI 10.1109/IVS.2016.7535406; Costea AD, 2014, PROC CVPR IEEE, P2393, DOI 10.1109/CVPR.2014.307; Dollar P, 2014, IEEE T PATTERN ANAL, V36, P1532, DOI 10.1109/TPAMI.2014.2300479; Esmaeilsabzali H, 2013, BIOTECHNOL ADV, V31, P1063, DOI 10.1016/j.biotechadv.2013.08.016; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Friedlander TW, 2014, PHARMACOL THERAPEUT, V142, P271, DOI 10.1016/j.pharmthera.2013.12.011; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; Huh S, 2011, I S BIOMED IMAGING, P2121, DOI 10.1109/ISBI.2011.5872832; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Lowes L., 2015, CIRCULATE NONINVASIV; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Schwiegerling J., 2004, FIELD GUIDE VISUAL O; Smith K., 2008, P IEEE C COMP VIS PA, V1, P1; Vercruysse D, 2015, LAB CHIP, V15, P1123, DOI 10.1039/c4lc01131g; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208385	10.1371/journal.pone.0208385	http://dx.doi.org/10.1371/journal.pone.0208385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543666	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500019
J	Darrah, K; Wang, T; Cook, I; Cacace, M; Deiters, A; Leyh, TS				Darrah, Kristie; Wang, Ting; Cook, Ian; Cacace, Mary; Deiters, Alexander; Leyh, Thomas S.			Allosteres to regulate neurotransmitter sulfonation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sulfotransferase; allosteric regulation; enzyme inhibitor; enzyme structure; neurotransmitter; catecholamine; dopamine; nuclear magnetic resonance (NMR); enzyme mechanism; enzyme kinetics; epinephrine; norepinephrine; serotonin; spin label; allostery; mechanism; inhibition	NUCLEAR-MAGNETIC-RESONANCE; MOLECULAR-DYNAMICS; MENTAL-DISORDERS; SULFOTRANSFERASE; DOPAMINE; PARALLEL; GROMACS; SITE; NMR; GOVERNS	Catecholamine neurotransmitter levels in the synapses of the brain shape human disposition-cognitive flexibility, aggression, depression, and reward seeking-and manipulating these levels is a major objective of the pharmaceutical industry. Certain neurotransmitters are extensively sulfonated and inactivated by human sulfotransferase 1A3 (SULT1A3). To our knowledge, sulfonation as a therapeutic means of regulating transmitter activity has not been explored. Here, we describe the discovery of a SULT1A3 allosteric site that can be used to inhibit the enzyme. The structure of the new site is determined using spin-label-triangulation NMR. The site forms a cleft at the edge of a conserved similar to 30-residue active-site cap that must open and close during the catalytic cycle. Allosteres anchor into the site via pi-stacking interactions with two residues that sandwich the planar core of the allostere and inhibit the enzyme through cap-stabilizing interactions with substituents attached to the core. Changes in cap free energy were calculated ab initio as a function of core substituents and used to design and synthesize a series of inhibitors intended to progressively stabilize the cap and slow turnover. The inhibitors bound tightly (34 nm to 7.4 mu m) and exhibited progressive inhibition. The cap-stabilizing effects of the inhibitors were experimentally determined and agreed remarkably well with the theoretical predictions. These studies establish a reliable heuristic for the design of SULT1A3 allosteric inhibitors and demonstrate that the free-energy changes of a small, dynamic loop that is critical for SULT substrate selection and turnover can be calculated accurately.	[Darrah, Kristie; Cacace, Mary; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Deiters, Alexander/L-3722-2013	Deiters, Alexander/0000-0003-0234-9209	National Institutes of Health [GM112728, GM121849, GM127144]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127144, R01GM121849, R01GM112728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM112728 (to A. D.) and GM121849 and GM127144 (to T. S. L.). A provisional patent covering the compounds described in this paper has been submitted. All authors listed are co-inventors on the patent. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2014, AMBER 14; Castanar L, 2015, ANNU REP NMR SPECTRO, V84, P163; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Gochin M, 2011, ACS CHEM BIOL, V6, P267, DOI 10.1021/cb100368d; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; HEROUX JA, 1988, MOL PHARMACOL, V34, P194; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; LECORRE P, 1993, CRIT CARE MED, V21, P1652; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Olgiati P, 2018, J AFFECT DISORDERS, V227, P777, DOI 10.1016/j.jad.2017.11.004; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; Tang QX, 2010, J PHYS CHEM B, V114, P16131, DOI 10.1021/jp1055528; Thomas SJ, 2015, PHARMACOTHERAPY, V35, P433, DOI 10.1002/phar.1576; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang B, 2006, J CHEM THEORY COMPUT, V2, P209, DOI 10.1021/ct050212s; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang T, 2016, DRUG METAB DISPOS, V44, P616, DOI 10.1124/dmd.115.068205err; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; YAMAMOTO T, 1985, J CHROMATOGR, V342, P261, DOI 10.1016/S0378-4347(00)84516-8	49	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2293	2301		10.1074/jbc.RA118.006511	http://dx.doi.org/10.1074/jbc.RA118.006511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545938	hybrid, Green Published			2022-12-26	WOS:000458895400008
J	Sabrin, A; Gioe, BW; Gupta, A; Grove, A				Sabrin, Afsana; Gioe, Brennan W.; Gupta, Ashish; Grove, Anne			An EmrB multidrug efflux pump in Burkholderia thailandensis with unexpected roles in antibiotic resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic; reactive oxygen species (ROS); transcription factor; gene regulation; multidrug transporter; oxidative stress; bacterial virulence; efflux pump; EmrB; MarR; multidrug resistance	SECONDARY STRUCTURE ANALYSES; DNA-BINDING; IDENTIFICATION; PSEUDOMALLEI; MECHANISMS; EXPRESSION	The antibiotic trimethoprim is frequently used to manage Burkholderia infections, and members of the resistance-nodulation-division (RND) family of efflux pumps have been implicated in multidrug resistance of this species complex. We show here that a member of the distinct Escherichia coli multidrug resistance B (EmrB) family is a primary exporter of trimethoprim in Burkholderia thailandensis, as evidenced by increased trimethoprim sensitivity after inactivation of emrB, the gene that encodes EmrB. We also found that the emrB gene is up-regulated following the addition of gentamicin and that this up-regulation is due to repression of the gene encoding OstR, a member of the multiple antibiotic resistance regulator (MarR) family. The addition of the oxidants H2O2 and CuCl2 to B. thailandensis cultures resulted in OstR-dependent differential emrB expression, as determined by qRT-PCR analysis. Specifically, OstR functions as a rheostat that optimizes emrB expression under oxidizing conditions, and it senses oxidants by a unique mechanism involving two vicinal cysteines and one distant cysteine (Cys(3), Cys(4), and Cys(169)) per monomer. Paradoxically, emrB inactivation increased resistance of B. thailandensis to tetracycline, a phenomenon that correlated with up-regulation of an RND efflux pump. These observations highlight the intricate mechanisms by which expression of genes that encode efflux pumps is optimized depending on cellular concentrations of antibiotics and oxidants.	[Sabrin, Afsana; Gioe, Brennan W.; Gupta, Ashish; Grove, Anne] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Gupta, Ashish] Novavax Inc, Proc Dev Dept, Gaithersburg, MD 20878 USA	Louisiana State University System; Louisiana State University	Grove, A (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	agrove@lsu.edu	Grove, Anne/O-5998-2015; Sabrin, Afsana/S-5527-2019	Grove, Anne/0000-0002-4390-0354; Gupta, Ashish/0000-0002-1800-2755; Sabrin, Afsana/0000-0002-7761-0881	National Science Foundation [MCB-1714219]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1714219 (to A. Grove) and by a donation from P. Campbell in support of undergraduate research. The authors declare that they have no conflicts of interest with the contents of this article.	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Biot FV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084068; Bordelon T, 2006, J MOL BIOL, V360, P168, DOI 10.1016/j.jmb.2006.05.005; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; Deochand DK, 2016, MOL BIOSYST, V12, P2417, DOI 10.1039/c6mb00304d; Deochand DK, 2017, CRIT REV BIOCHEM MOL, V52, P595, DOI 10.1080/10409238.2017.1344612; Deochand DK, 2016, ACS CHEM BIOL, V11, P2049, DOI 10.1021/acschembio.6b00168; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Garcia Erin C, 2017, Curr Protoc Microbiol, V45, DOI 10.1002/cpmc.27; Gupta A, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00039-18; Gupta A, 2017, BIOCHEMISTRY-US, V56, P2315, DOI 10.1021/acs.biochem.7b00103; Gupta A, 2014, BIOCHEMISTRY-US, V53, P4368, DOI 10.1021/bi500219t; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kushwaha AK, 2015, PROTEIN SCI, V24, P253, DOI 10.1002/pro.2612; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Pande A, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00322-18, 10.1128/iai.00322-18]; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Quade N, 2012, J BIOL CHEM, V287, P35796, DOI 10.1074/jbc.M112.379156; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Sahl JW, 2016, MBIO, V7, DOI 10.1128/mBio.00846-16; Saier MH, 2016, CURR OPIN STRUC BIOL, V38, P9, DOI 10.1016/j.sbi.2016.05.001; Scoffone VC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01592; Titball RW, 2017, VACCINE, V35, P5981, DOI 10.1016/j.vaccine.2017.03.022; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wigfield SM, 2002, J ANTIMICROB CHEMOTH, V49, P619, DOI 10.1093/jac/49.4.619; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	38	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1891	1903		10.1074/jbc.RA118.006638	http://dx.doi.org/10.1074/jbc.RA118.006638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30545940	Green Published, hybrid			2022-12-26	WOS:000459711400010
J	Warren, NJH; Eastman, A				Warren, Nicholas J. H.; Eastman, Alan			Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7-and CDK2-dependent replication catastrophe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cell division cycle 7-related protein kinase (Cdc7); cyclin-dependent kinase (CDK); DNA-damage response; Chk1; gemcitabine; replication catastrophe; single-strand binding protein RPA	MINICHROMOSOME MAINTENANCE PROTEINS; DNA-REPLICATION; CELL-CYCLE; ATAXIA-TELANGIECTASIA; COMET ASSAY; CHK1; ATR; PHOSPHORYLATION; CDK2; CANCER	Combining DNA-damaging drugs with DNA checkpoint inhibitors is an emerging strategy to manage cancer. Checkpoint kinase 1 inhibitors (CHK1is) sensitize most cancer cell lines to DNA-damaging drugs and also elicit single-agent cytotoxicity in 15% of cell lines. Consequently, combination therapy may be effective in a broader patient population. Here, we characterized the molecular mechanism of sensitization to gemcitabine by the CHK1i MK8776. Brief gemcitabine incubation irreversibly inhibited ribonucleotide reductase, depleting dNTPs, resulting in durable S phase arrest. Addition of CHK1i 18 h after gemcitabine elicited cell division cycle 7 (CDC7)- and cyclin-dependent kinase 2 (CDK2)-dependent reactivation of the replicative helicase, but did not reinitiate DNA synthesis due to continued lack of dNTPs. Helicase reactivation generated extensive single-strand (ss)DNA that exceeded the protective capacity of the ssDNA-binding protein, replication protein A. The subsequent cleavage of unprotected ssDNA has been termed replication catastrophe. This mechanism did not occur with concurrent CHK1i plus gemcitabine treatment, providing support for delayed administration of CHK1i in patients. Alternative mechanisms of CHK1i-mediated sensitization to gemcitabine have been proposed, but their role was ruled out; these mechanisms include premature mitosis, inhibition of homologous recombination, and activation of double-strand break repair nuclease (MRE11). In contrast, single-agent activity of CHK1i was MRE11-dependent and was prevented by lower concentrations of a CDK2 inhibitor. Hence, both pathways require CDK2 but appear to depend on different CDK2 substrates. We conclude that a small-molecule inhibitor of CHK1 can elicit at least two distinct, context-dependent mechanisms of cytotoxicity in cancer cells.	[Warren, Nicholas J. H.; Eastman, Alan] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center	Eastman, A (corresponding author), Norris Cotton Canc Ctr, Rubin Bldg,Level 6,One Med Ctr Dr, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu		Warren, Nicholas/0000-0003-4640-2868	National Institutes of Health [2RO1CA117874]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA117874] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 2RO1CA117874 (to A.E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Brown JS, 2017, CANCER DISCOV, V7, P20, DOI 10.1158/2159-8290.CD-16-0860; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen YH, 2015, MOL CELL, V58, P323, DOI 10.1016/j.molcel.2015.02.031; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Fugger K, 2015, CELL REP, V10, P1749, DOI 10.1016/j.celrep.2015.02.028; Fugger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2395; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hauge S, 2017, ONCOTARGET, V8, P10966, DOI 10.18632/oncotarget.14089; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Karp JE, 2012, CLIN CANCER RES, V18, P6723, DOI 10.1158/1078-0432.CCR-12-2442; King C, 2015, MOL CANCER THER, V14, P2004, DOI 10.1158/1535-7163.MCT-14-1037; Kohler C, 2016, CELL CYCLE, V15, P974, DOI 10.1080/15384101.2016.1152424; Koh SB, 2018, CANCER RES, V78, P3054, DOI 10.1158/0008-5472.CAN-17-3932; Koh SB, 2015, CANCER RES, V75, P3583, DOI 10.1158/0008-5472.CAN-14-3347; Lee AYL, 2012, J BIOL CHEM, V287, P2531, DOI 10.1074/jbc.M111.291104; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montano R, 2017, ONCOTARGET, V8, P67754, DOI 10.18632/oncotarget.18834; Montano R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-604; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8; Sakurikar N, 2016, CELL CYCLE, V15, P1184, DOI 10.1080/15384101.2016.1160983; Sakurikar N, 2016, ONCOTARGET, V7, P1380, DOI 10.18632/oncotarget.6364; Sanjiv K, 2016, CELL REP, V14, P298, DOI 10.1016/j.celrep.2015.12.032; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Swaffer MP, 2016, CELL, V167, P1750, DOI 10.1016/j.cell.2016.11.034; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Thompson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044021; Toledo L, 2017, MOL CELL, V66, P735, DOI 10.1016/j.molcel.2017.05.001; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	61	21	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1763	1778		10.1074/jbc.RA118.005231	http://dx.doi.org/10.1074/jbc.RA118.005231			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30573684	Green Published, hybrid			2022-12-26	WOS:000459711400001
J	Liu, CH; Liu, CJ; Su, TH; Yang, HC; Hong, CM; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH				Liu, Chen-Hua; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Hong, Chun-Ming; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng			Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ACTING ANTIVIRAL REGIMENS; FIXED-DOSE COMBINATION; HEPATOCELLULAR-CARCINOMA; TRANSPLANT RECIPIENTS; TREATMENT-NAIVE; PLUS RIBAVIRIN; HCV INFECTION; OPEN-LABEL; LEDIPASVIR/SOFOSBUVIR	Background The real-world data for the effectiveness and safety of sofosbuvir/ledipasvir (SOF/LDV) with or without ribavirin (RBV) in patients with hepatitis C virus genotype 1 (HCV-1) infection remain limited in Taiwan. Methods A total of 273 chronic HCV-1 patients receiving 8, 12, or 24 weeks of SOF/LDV with or without RBV were enrolled. The sustained virologic response rate at week 12 off-therapy (SVR12) by evaluable population (EP) and per-protocol population (PP) were assessed for effectiveness. The treatment discontinuation rate due to adverse events (AEs) and serious AE rate were assessed for safety. Baseline patient characteristics and on-treatment HCV viral kinetics associated with SVR12 were analyzed. Results The SVR12 rates by EP and PP analyses were 96.7% (95% confidence interval [CI]: 93.9%-98.3%) and 97.5% (95% CI: 94.8%-98.8%), respectively. The rates of treatment discontinuation due to AE and serious AE were 0.4% and 4.4%, respectively. Seven patients with true virologic failure were relapsers. In 2 patients who were lost-to follow-up, one expired at treatment week 3 due to pneumonia which was considered not related to treatment, and one declined follow-up at off-therapy week 4. The SVR12 rates were comparable in terms of baseline patient characteristics and viral decline at week 4 of treatment. Conclusions SOF/LDV with or without RBV for 8-24 weeks is well tolerated and achieves a high SVR12 rate in patients with HCV-1 infection in Taiwan.	[Liu, Chen-Hua; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Hong, Chun-Ming; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Liu, Chen-Hua; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chen-Hua] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Touliu, Taiwan; [Liu, Chen-Hua; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan; [Chen, Ding-Shinn] Acad Sinica, Genom Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan.; Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019	Kao, Jia-Horng/0000-0002-2442-7952; Chen, Pei-Jer/0000-0001-8316-3785; HONG, CHUN-MING/0000-0002-0075-1280; YANG, HUNG-CHIH/0000-0003-3864-9895; SU, TUNG-HUNG/0000-0002-6747-7941				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Al Marzooqi SH, 2015, LIVER INT, V35, P1923, DOI 10.1111/liv.12861; Alqahtani SA, 2015, HEPATOLOGY, V62, P25, DOI 10.1002/hep.27890; Backus LI, 2016, HEPATOLOGY, V64, P405, DOI 10.1002/hep.28625; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chuang WL, 2016, J GASTROEN HEPATOL, V31, P1323, DOI 10.1111/jgh.13305; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Colombo M, 2017, ANN INTERN MED, V166, P109, DOI 10.7326/M16-1205; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; D'Ambrosio R, 2016, LIVER INT, V36, P1585, DOI 10.1111/liv.13203; Fourati S, 2018, ALIMENT PHARM THER, V47, P665, DOI 10.1111/apt.14478; Hsu YC, 2015, GUT, V64, P495, DOI 10.1136/gutjnl-2014-308163; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Ji F, 2018, ALIMENT PHARM THER, V47, P550, DOI 10.1111/apt.14507; Kao JH, 2016, J FORMOS MED ASSOC, V115, P65, DOI 10.1016/j.jfma.2015.06.012; Keating GM, 2014, DRUGS, V74, P1127, DOI 10.1007/s40265-014-0247-z; Kowdley KV, 2017, HEPATOLOGY, V65, P1094, DOI 10.1002/hep.29005; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Liu CH, 2018, ALIMENT PHARM THER, V47, P1690, DOI 10.1111/apt.14647; Liu CH, 2018, ALIMENT PHARM THER, V48, P1290, DOI 10.1111/apt.15011; Liu CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32060-7; Liu CH, 2018, J GASTROEN HEPATOL, V33, P710, DOI 10.1111/jgh.13912; Liu CH, 2018, CLIN INFECT DIS, V66, P289, DOI 10.1093/cid/cix787; Liu CH, 2018, J GASTROEN HEPATOL, V33, P291, DOI 10.1111/jgh.13834; Liu CH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx028; Liu CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17410; Liu CH, 2015, J CLIN MICROBIOL, V53, P1754, DOI 10.1128/JCM.03548-14; Liu CH, 2014, INT J NANOMED, V9, P2051, DOI 10.2147/IJN.S41822; Liu CJ, 2018, GASTROENTEROLOGY, V154, P989, DOI 10.1053/j.gastro.2017.11.011; Calleja JL, 2017, J HEPATOL, V66, P1138, DOI 10.1016/j.jhep.2017.01.028; Maasoumy B, 2016, J HEPATOL, V65, P473, DOI 10.1016/j.jhep.2016.04.006; Mahale P, 2018, GUT, V67, P553, DOI 10.1136/gutjnl-2017-313983; Mallory MA, 2017, J CLIN VIROL, V90, P26, DOI 10.1016/j.jcv.2017.03.007; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Mucke MM, 2018, LANCET GASTROENTEROL, V3, P172, DOI 10.1016/S2468-1253(18)30002-5; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Seong MH, 2013, J MED VIROL, V85, P1724, DOI 10.1002/jmv.23661; Serti E, 2017, GUT, V66, P724, DOI 10.1136/gutjnl-2015-310033; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Zeuzem S, 2017, J HEPATOL, V66, P910, DOI 10.1016/j.jhep.2017.01.007	53	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209299	10.1371/journal.pone.0209299	http://dx.doi.org/10.1371/journal.pone.0209299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576344	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400036
J	Chytoudis-Peroudis, CC; Siskos, N; Kalyviotis, K; Fysekis, I; Ypsilantis, P; Simopoulos, C; Skavdis, G; Grigoriou, ME				Chytoudis-Peroudis, Charalampos Chrysovalantis; Siskos, Nikistratos; Kalyviotis, Konstantinos; Fysekis, Ioannis; Ypsilantis, Petros; Simopoulos, Constantinos; Skavdis, George; Grigoriou, Maria E.			Spatial distribution of the full-length members of the Grg family during embryonic neurogenesis reveals a "Grg-mediated repression map" in the mouse telencephalon	PLOS ONE			English	Article							GROUCHO-RELATED GENE; GROUCHO/TRANSDUCIN-LIKE ENHANCER; CORTICAL INTERNEURON FATE; TRANSCRIPTION FACTORS; HOMEOBOX GENE; MOLECULAR SPECIFICATION; DROSOPHILA-ENHANCER; CHOLINERGIC NEURONS; EXPRESSION; PROTEINS	The full-length members of the Groucho/Transducin-like Enhancer of split gene family, namely Grg1-4, encode nuclear corepressors that act either directly, via interaction with transcription factors, or indirectly by modifying histone acetylation or chromatin structure. In this work we describe a detailed expression analysis of Grg1-4 family members during embryonic neurogenesis in the developing murine telencephalon. Grg1-4 presented a unique, complex yet overlapping expression pattern; Grg1 and Grg3 were mainly detected in the proliferative zones of the telencephalon, Grg2 mainly in the subpallium and finally, Grg4 mainly in the subpallial post mitotic neurons. In addition, comparative analysis of the expression of Grg1-4 revealed that, at these stages, distinct telencephalic progenitor domains or structures are characterized by the presence of different combinations of Grg repressors, thus forming a "Grg-mediated repression map".	[Chytoudis-Peroudis, Charalampos Chrysovalantis; Siskos, Nikistratos; Kalyviotis, Konstantinos; Fysekis, Ioannis; Skavdis, George; Grigoriou, Maria E.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Ypsilantis, Petros; Simopoulos, Constantinos] Democritus Univ Thrace, Sch Med, Alexandroupolis, Greece; [Kalyviotis, Konstantinos] Imperial Coll London, Dept Bioengn, South Kensington Campus, London, England	Democritus University of Thrace; Democritus University of Thrace; Imperial College London	Grigoriou, ME (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	mgrigor@mbg.duth.gr	Grigoriou, Maria/AAM-8332-2021; Ypsilantis, Petros/ABH-2143-2021; Siskos, Nikistratos/AAG-3044-2019; Ypsilantis, Petros/AAO-8216-2021	Grigoriou, Maria/0000-0001-6336-5523; Siskos, Nikistratos/0000-0001-9301-314X; Kalyviotis, Konstantinos/0000-0002-7640-8905; Simopoulos, Konstantinos/0000-0002-7994-3583; Skavdis, George/0000-0001-8929-6431	Bodossakis Foundation; Thalis action, GRST Greek Ministry of Education, Research and Religious Affairs [1435]	Bodossakis Foundation; Thalis action, GRST Greek Ministry of Education, Research and Religious Affairs	This work was supported by the Bodossakis Foundation (https://www.bodossaki.gr/), Doctoral fellowship to Mr Charalampos Chrysovalantis Chytoudis-Peroudis; and by Thalis action, GRST (I.D.: 1435) Greek Ministry of Education, Research and Religious Affairs (https://www.minedu.gov.gr/) to Mr Ioannis Fysekis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00059; Agarwal M, 2015, IUBMB LIFE, V67, P472, DOI 10.1002/iub.1395; Agirman G, 2017, FEBS LETT, V591, P3978, DOI 10.1002/1873-3468.12924; Allaway KC, 2017, DEV BIOL, V421, P1, DOI 10.1016/j.ydbio.2016.11.007; Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Bachy I, 2009, MECH DEVELOP, V117, P163; Bajoghli B, 2007, DEV GENES EVOL, V217, P613, DOI 10.1007/s00427-007-0167-y; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; Marin O, 2000, J NEUROSCI, V20, P6063; Martynoga B., 2012, COLD SPRING HARBOR P, V4; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Medina L, 2005, BRAIN RES BULL, V66, P297, DOI 10.1016/j.brainresbull.2005.02.003; Medina L, 2012, MOUSE NERVOUS SYSTEM, P173, DOI 10.1016/B978-0-12-369497-3.10007-X; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Molenaar M, 2000, MECH DEVELOP, V91, P311, DOI 10.1016/S0925-4773(99)00259-2; Moreno N, 2008, BRAIN RES, V1239, P92, DOI 10.1016/j.brainres.2008.08.052; Moreno N, 2009, SEMIN CELL DEV BIOL, V20, P735, DOI 10.1016/j.semcdb.2009.04.007; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Patel SR, 2012, MOL CELL, V45, P185, DOI 10.1016/j.molcel.2011.11.007; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Roth M, 2010, DEVELOPMENT, V137, P1553, DOI 10.1242/dev.044909; Sandberg M, 2016, NEURON, V91, P1260, DOI 10.1016/j.neuron.2016.08.020; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Stylianopoulou E, 2014, METHODS MOL BIOL, V1211, P125, DOI 10.1007/978-1-4939-1459-3_11; Stylianopoulou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033898; Sussel L, 1999, DEVELOPMENT, V126, P3359; Toresson H, 2000, DEVELOPMENT, V127, P4361; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; Van den Akker WMR, 2008, J COMP NEUROL, V506, P211, DOI 10.1002/cne.21542; Vogt D, 2014, NEURON, V82, P350, DOI 10.1016/j.neuron.2014.02.030; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209369	10.1371/journal.pone.0209369	http://dx.doi.org/10.1371/journal.pone.0209369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571765	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700062
J	Friese, MB; Nathan, M; Culley, DJ; Crosby, G				Friese, Matthew B.; Nathan, Miriam; Culley, Deborah J.; Crosby, Gregory			Isoflurane anesthesia impairs the expression of immune neuromodulators in the hippocampus of aged mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; NITROUS OXIDE ANESTHESIA; NEURONAL EXPRESSION; RAT-BRAIN; NEUROTRANSMITTERS; COLOCALIZATION; ACQUISITION; MODULATION; MCP-1/CCL2; MICROGLIA	Cognitive dysfunction is one of the most common postoperative complications experienced by older patients after anesthesia and surgery but the cause remains unknown. Immune molecules are essential for many aspects of neural homeostasis, including learning and memory, and an imbalance in immune neuromodulators is implicated in the development of neural dysfunction. Aging alters the control of neuroinflammatory cascades and general anesthetics are immunosuppressants. Therefore, we hypothesized that general anesthesia disturbs neuroimmune signaling in an age-dependent fashion. We tested this hypothesis by examining gene expression of key immune neuromodulators including IL-1 beta, TNF alpha, and CCL2 in the hippocampus of young adult (3 mo) and aged (20 mo) mice following isoflurane anesthesia. We show that isoflurane anesthesia increases expression of these signaling molecules in the hippocampus of young adult mice but decreases it in the hippocampus of old mice. Furthermore, anesthetized old mice had an amplified hippocampal neuroimmune response to systemically administered lipopolysaccharide compared to age-matched carrier controls. Together, these data indicate that isoflurane anesthesia disrupts hippocampal neuroimmune mediator gene expression in the old brain and suggests a potential mechanism by which general anesthesia can contribute to disordered neuronal homeostasis and post-anesthesia cognitive disability in older subjects.	[Friese, Matthew B.] Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Lab Aging Neurosci, Boston, MA 02115 USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Friese, MB (corresponding author), Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Lab Aging Neurosci, Boston, MA 02115 USA.	mfriese@bwh.harvard.edu		Friese, Matthew/0000-0001-7410-285X; Nathan, Miriam/0000-0003-2055-9162	Harvard Anesthesia Training Program [GM007592]; National Institute on Aging [AG048522, AG053280, AG051812, AG048637]; Foundation for Anesthesia Education and Research GEMSSTAR Award; NATIONAL INSTITUTE ON AGING [R01AG051812] Funding Source: NIH RePORTER	Harvard Anesthesia Training Program; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Foundation for Anesthesia Education and Research GEMSSTAR Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the Harvard Anesthesia Training Program (MBF: GM007592), the National Institute on Aging (DJC: AG048522 MBF: AG053280 GC: AG051812, AG048637) and the Foundation for Anesthesia Education and Research GEMSSTAR Award (MBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banisadr G, 2005, J COMP NEUROL, V492, P178, DOI 10.1002/cne.20729; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Finlayson E, 2011, ANN SURG, V254, P921, DOI 10.1097/SLA.0b013e3182383a78; Forsberg A, 2017, ANN NEUROL, V81, P572, DOI 10.1002/ana.24909; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; Kelbel I, 1999, ACTA ANAESTH SCAND, V43, P71, DOI 10.1034/j.1399-6576.1999.430115.x; Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032; Liu WR, 2012, NEUROL RES, V34, P3, DOI 10.1179/1743132811Y.0000000047; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Purdon PL, 2015, BRIT J ANAESTH, V115, P46, DOI 10.1093/bja/aev213; Silbert B, 2015, ANESTHESIOLOGY, V122, P1224, DOI 10.1097/ALN.0000000000000671; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Tronson NC, 2017, J NEUROSCI RES, V95, P472, DOI 10.1002/jnr.23921; Wang HL, 2016, J CELL MOL MED, V20, P1632, DOI 10.1111/jcmm.12854; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766	32	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209283	10.1371/journal.pone.0209283	http://dx.doi.org/10.1371/journal.pone.0209283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571762	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700050
J	Zysk, M; Gapys, B; Ronowska, A; Gul-Hinc, S; Erlandsson, A; Iwanicki, A; Sakowicz-Burkiewicz, M; Szutowicz, A; Bielarczyk, H				Zysk, Marlena; Gapys, Beata; Ronowska, Anna; Gul-Hinc, Sylwia; Erlandsson, Anna; Iwanicki, Adam; Sakowicz-Burkiewicz, Monika; Szutowicz, Andrzej; Bielarczyk, Hanna			Protective effects of voltage-gated calcium channel antagonists against zinc toxicity in SN56 neuroblastoma cholinergic cells	PLOS ONE			English	Article							ACETYL-COA; CA2+ CHANNEL; ISOCITRATE DEHYDROGENASE; ACETYLCHOLINE METABOLISM; GLUCOSE DEPRIVATION; NEURONAL DEATH; ZN2+ TOXICITY; NITRIC-OXIDE; NEUROTOXICITY; INHIBITION	One of the pathological site effects in excitotoxic activation is Zn2+ overload to postsynaptic neurons. Such an effect is considered to be equivalent to the glutamate component of excitotoxicity. Excessive uptake of Zn2+ by active voltage-dependent transport systems in these neurons may lead to significant neurotoxicity. The aim of this study was to investigate whether and which antagonists of the voltage gated calcium channels (VGCC) might modify this Zn2+-induced neurotoxicity in neuronal cells. Our data demonstrates that depolarized SN56 neuronal cells may take up large amounts of Zn2+ and store these in cytoplasmic and mitochondrial sub-fractions. The mitochondrial Zn2+ excess suppressed pyruvate uptake and oxidation. Such suppression was caused by inhibition of pyruvate dehydrogenase complex, aconitase and NADP-isocitrate dehydrogenase activities, resulting in the yielding of acetyl-CoA and ATP shortages. Moreover, incoming Zn2+ increased both oxidized glutathione and malondialdehyde levels, known parameters of oxidative stress. In depolarized SN56 cells, nifedipine treatment (L-type VGCC antagonist) reduced Zn2+ uptake and oxidative stress. The treatment applied prevented the activities of PDHC, aconitase and NADP-IDH enzymes, and also yielded the maintenance of acetyl-CoA and ATP levels. Apart from suppression of oxidative stress, N- and P/Q-type VGCCs presented a similar, but weaker protective influence. In conclusion, our data shows that in the course of excitotoxity, impairment to calcium homeostasis is tightly linked with an excessive neuronal Zn2+ uptake. Hence, the VGCCs types L, N and P/Q share responsibility for neuronal Zn2+ overload followed by significant energy-dependent neurotoxicity. Moreover, Zn2+ affects the target tricarboxylic acid cycle enzymes, yields acetyl-CoA and energy deficits as well.	[Zysk, Marlena; Gapys, Beata; Ronowska, Anna; Gul-Hinc, Sylwia; Szutowicz, Andrzej; Bielarczyk, Hanna] Med Univ Gdansk, Dept Lab Med, Gdansk, Poland; [Erlandsson, Anna] Uppsala Univ, Dept Publ Hlth & Caring Sci Mol Geriatr, Uppsala, Sweden; [Iwanicki, Adam] Univ Gdansk, Dept Mol Bacteriol, Gdansk, Poland; [Iwanicki, Adam] Med Univ Gdansk, Gdansk, Poland; [Sakowicz-Burkiewicz, Monika] Med Univ Gdansk, Dept Mol Med, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Uppsala University; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zysk, M (corresponding author), Med Univ Gdansk, Dept Lab Med, Gdansk, Poland.	marzysk@gumed.edu.pl	Iwanicki, Adam/R-1767-2017	Iwanicki, Adam/0000-0001-7882-5529; Ronowska, Anna/0000-0001-5715-1211; Zysk, Marlena/0000-0002-0270-2503	Ministry of Research and Higher Education [MN001-0059/08, MN 01-0171/08/248]; Medical University of Gdansk fund [ST-57]; Ministry of Research and Higher Education (National Science Center) [2015/17/N/NZ3/01428]	Ministry of Research and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Medical University of Gdansk fund; Ministry of Research and Higher Education (National Science Center)	Work was supported by the Ministry of Research and Higher Education (MN001-0059/08 to MZ and MN 01-0171/08/248 to BG, National Science Center (2015/17/N/NZ3/01428 to MZ) projects and Medical University of Gdansk fund (ST-57) to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Bertoni-Freddari C, 2006, MECH AGEING DEV, V127, P590, DOI 10.1016/j.mad.2006.01.019; BIELARCZYK H, 1989, BIOCHEM J, V262, P377, DOI 10.1042/bj2620377; Bouron A, 2014, PFLUG ARCH EUR J PHY, V466, P381, DOI 10.1007/s00424-013-1295-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai AL, 2006, EUR J NEUROSCI, V24, P2169, DOI 10.1111/j.1460-9568.2006.05110.x; Calabresi P, 1999, STROKE, V30, P171, DOI 10.1161/01.STR.30.1.171; Chen CJ, 2003, NEUROCHEM INT, V42, P471, DOI 10.1016/S0197-0186(02)00154-7; Clair Timothy, 2005, Lipids Health Dis, V4, P5, DOI 10.1186/1476-511X-4-5; Clausen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083347; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; DIPIERRO D, 1995, ANAL BIOCHEM, V231, P407, DOI 10.1006/abio.1995.0071; Ekstein D, 2012, J PHYSIOL-LONDON, V590, P5895, DOI 10.1113/jphysiol.2012.242537; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Granzotto A, 2015, NEUROBIOL DIS, V81, P25, DOI 10.1016/j.nbd.2015.04.010; HESSLER JR, 1983, ARTERIOSCLEROSIS, V3, P215, DOI 10.1161/01.ATV.3.3.215; Horinouchi Y, 2011, CHEM PHARM BULL, V59, P208, DOI 10.1248/cpb.59.208; Jankowska-Kulawy A, 2010, J NEUROCHEM, V115, P333, DOI 10.1111/j.1471-4159.2010.06919.x; Ji SG, 2018, EXP NEUROL, V302, P181, DOI 10.1016/j.expneurol.2018.01.012; Kand'ar R, 2014, ANDROLOGIA, V46, P1079, DOI 10.1111/and.12176; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim EY, 2001, NEUROBIOL DIS, V8, P774, DOI 10.1006/nbdi.2001.0421; Kim SW, 2016, NEUROPHARMACOLOGY, V105, P411, DOI 10.1016/j.neuropharm.2016.02.001; Kushmerick C, 2001, BRAIN RES, V916, P199, DOI 10.1016/S0006-8993(01)02898-0; Lambert JC, 2003, EXP BIOL MED, V228, P406, DOI 10.1177/153537020322800411; Lee JY, 2000, J NEUROSCI, V20; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lu Q., 2016, ER GOLGI APPARATUS, V8, P35; MAK IT, 1992, CIRC RES, V70, P1099, DOI 10.1161/01.RES.70.6.1099; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Mizuno D, 2013, INT J MOL SCI, V14, P22067, DOI 10.3390/ijms141122067; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Murakami K, 1997, BIOMETALS, V10, P169, DOI 10.1023/A:1018395510334; Napoli E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00159; Needham K, 2010, NEUROGASTROENT MOTIL, V22, pe301, DOI 10.1111/j.1365-2982.2010.01567.x; Nolin F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148727; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pivovarova NB, 2014, J NEUROCHEM, V128, P592, DOI 10.1111/jnc.12489; Pochwat B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/591563; Quallo T, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.191; Qui Y, 2008, J NEUROCHEM, V107, P1304; Ronowska A, 2007, J NEUROCHEM, V103, P972, DOI 10.1111/j.1471-4159.2007.04786.x; Ronowska A, 2010, NEUROCHEM INT, V56, P143, DOI 10.1016/j.neuint.2009.09.012; SARIS NEL, 1994, FEBS LETT, V356, P195, DOI 10.1016/0014-5793(94)01256-3; Scarpa A, 1979, Methods Enzymol, V56, P301; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Slepchenko Kira G, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P44; Smolkova Katarina, 2012, Int J Cell Biol, V2012, P273947, DOI 10.1155/2012/273947; Snider BJ, 2000, NEUROSCIENCE, V100, P651, DOI 10.1016/S0306-4522(00)00311-0; Sreedhar B, 2005, FREE RADICAL BIO MED, V39, P999, DOI 10.1016/j.freeradbiomed.2005.05.026; Steinritz D, 2018, TOXICOL LETT, V293, P133, DOI 10.1016/j.toxlet.2017.09.008; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Sul JW, 2016, ARCH PHARM RES, V39, P1151, DOI 10.1007/s12272-016-0814-9; SZUTOWICZ A, 1987, ANAL BIOCHEM, V164, P292, DOI 10.1016/0003-2697(87)90495-7; Szutowicz A, 2013, NEUROCHEM RES, V38, P1523, DOI 10.1007/s11064-013-1060-x; Takeda A, 2017, J NEUROSCI, V37, P7253, DOI 10.1523/JNEUROSCI.0954-17.2017; Takeda Atsushi, 2010, Int J Alzheimers Dis, V2011, P491597, DOI 10.4061/2011/491597; Takeda A, 2011, MOL NEUROBIOL, V44, P166, DOI 10.1007/s12035-010-8158-9; Tuncay E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071014; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Yang J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006975; Zhang Y, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00088; Zysk M, 2017, J ALZHEIMERS DIS, V56, P1145, DOI 10.3233/JAD-160693	68	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209363	10.1371/journal.pone.0209363	http://dx.doi.org/10.1371/journal.pone.0209363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571745	gold, Green Submitted, Green Published			2022-12-26	WOS:000453841700061
J	Ismail, WM; Pagel, KA; Pejaver, V; Zhang, SV; Casasa, S; Mort, M; Cooper, DN; Hahn, MW; Radivojac, P				Ismail, Wazim Mohammed; Pagel, Kymberleigh A.; Pejaver, Vikas; Zhang, Simo, V; Casasa, Sofia; Mort, Matthew; Cooper, David N.; Hahn, Matthew W.; Radivojac, Predrag			The sequencing and interpretation of the genome obtained from a Serbian individual	PLOS ONE			English	Article							VARIATION DISCOVERY; ANALYSIS TOOLKIT; VARIANT ANALYSIS; READ ALIGNMENT; DNA; FRAMEWORK; GENES; PHARMACOGENOMICS; NEANDERTHAL; GENOTYPE	Recent genetic studies and whole-genome sequencing projects have greatly improved our understanding of human variation and clinically actionable genetic information. Smaller ethnic populations, however, remain underrepresented in both individual and large-scale sequencing efforts and hence present an opportunity to discover new variants of biomedical and demographic significance. This report describes the sequencing and analysis of a genome obtained from an individual of Serbian origin, introducing tens of thousands of previously unknown variants to the currently available pool. Ancestry analysis places this individual in close proximity to Central and Eastern European populations; i.e., closest to Croatian, Bulgarian and Hungarian individuals and, in terms of other Europeans, furthest from Ashkenazi Jewish, Spanish, Sicilian and Baltic individuals. Our analysis confirmed gene flow between Neanderthal and ancestral pan-European populations, with similar contributions to the Serbian genome as those observed in other European groups. Finally, to assess the burden of potentially disease-causing/clinically relevant variation in the sequenced genome, we utilized manually curated genotype-phenotype association databases and variant-effect predictors. We identified several variants that have previously been associated with severe early-onset disease that is not evident in the proband, as well as putatively impactful variants that could yet prove to be clinically relevant to the proband over the next decades. The presence of numerous private and low-frequency variants, along with the observed and predicted disease-causing mutations in this genome, exemplify some of the global challenges of genome interpretation, especially in the context of under-studied ethnic groups.	[Ismail, Wazim Mohammed; Pagel, Kymberleigh A.; Pejaver, Vikas; Zhang, Simo, V; Hahn, Matthew W.] Indiana Univ, Dept Comp Sci, Bloomington, IN 47405 USA; [Casasa, Sofia; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Mort, Matthew; Cooper, David N.] Cardiff Univ, Inst Med Genet, Cardiff, S Glam, Wales; [Radivojac, Predrag] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cardiff University; Northeastern University	Radivojac, P (corresponding author), Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA.	predrag@northwestern.edu	Mohammed Ismail, Wazim/AAT-7753-2021	Mohammed Ismail, Wazim/0000-0002-1782-7296; Pagel, Kymberleigh/0000-0001-8544-9250; Hahn, Matthew/0000-0002-5731-8808	Center for Bioinformatics Research at Indiana University	Center for Bioinformatics Research at Indiana University	This work was supported in part by the Center for Bioinformatics Research at Indiana University.; We thank Dr. Chuanchao Wang for his suggestions and discussion on testing for Neanderthal admixture in the Serbian genome. We also thank the Associate Editor and anonymous reviewers for their insightful comments that have improved the precision and quality of the paper. This work was supported by the Center for Bioinformatics Research at Indiana University, and was originally carried out as part of a class project for INFO-I590.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Azim MK, 2013, J HUM GENET, V58, P622, DOI 10.1038/jhg.2013.72; Bai HH, 2014, GENOME BIOL EVOL, V6, P3122, DOI 10.1093/gbe/evu242; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Becker T, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1404-6; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Chekanov NN, 2010, ACTA NATURAE, V2, P122, DOI 10.32607/20758251-2010-2-3-122-126; Cho YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13637; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davidovic S, 2017, ANN HUM BIOL, V44, P408, DOI 10.1080/03014460.2017.1287954; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Fan Xian, 2014, Curr Protoc Bioinformatics, V45, DOI 10.1002/0471250953.bi1506s45; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibson G., 2009, PRIMER GENOME SCI; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guda K, 2015, P NATL ACAD SCI USA, V112, P1149, DOI 10.1073/pnas.1417064112; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hodgkinson A, 2010, GENETICS, V184, P233, DOI 10.1534/genetics.109.110510; House GL, 2018, MOL ECOL RESOUR, V18, P448, DOI 10.1111/1755-0998.12747; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Kushniarevich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135820; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lencz T, 2018, HUM GENET, V137, P343, DOI 10.1007/s00439-018-1886-z; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lilleoja R, 2012, GENE, V493, P69, DOI 10.1016/j.gene.2011.11.022; Lindberg MR, 2015, BIOINFORMATICS, V31, P1286, DOI 10.1093/bioinformatics/btu771; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montinaro F, 2017, GENETICS, V205, P303, DOI 10.1534/genetics.116.189209; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Pagel KA, PATHOGENICITY UNPUB; Pagel KA, 2017, BIOINFORMATICS, V33, pI389, DOI 10.1093/bioinformatics/btx272; Pejaver V., 2017, 134981 BIORXIV, DOI 10.1093/bioinformatics/btx272; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113; Smyth N, 2018, CURR OPIN LIPIDOL, V29, P72, DOI 10.1097/MOL.0000000000000488; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; van Ninnwegen KJM, 2016, CLIN CHEM, V62, P1458, DOI 10.1373/clinchem.2016.258632; Wall JD, 2014, GENOME RES, V24, P1734, DOI 10.1101/gr.168393.113; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang S, 2017, ANN NY ACAD SCI, V1387, P73, DOI 10.1111/nyas.13259; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wright GEB, 2018, PHARMACOGENOMICS J, V18, P187, DOI 10.1038/tpj.2016.77; Zook J., 2018, 281006 BIORXIV	73	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208901	10.1371/journal.pone.0208901	http://dx.doi.org/10.1371/journal.pone.0208901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566479	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000453779300060
J	Qin, YW; Suh, S				Qin, Yuwei; Suh, Sangwon			Does the use of pre-calculated uncertainty values change the conclusions of comparative life cycle assessments? - An empirical analysis	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; ECOINVENT DATABASE; LCA; EXPANSION; INVENTORY; PRODUCTS	In life cycle assessment (LCA), performing Monte Carlo simulation (MCS) using fully dependent sampling typically involves repeated inversion of a technology matrix for a sufficiently large number of times. As the dimension of technology matrices for life cycle inventory (LCI) databases grows, MCS using fully dependent sampling is becoming a computational challenge. In our previous work, we pre-calculated the distribution functions of the entire LCI flows in the ecoinvent ver. 3.1 database to help reduce the computation time of running fully dependent sampling by individual LCA practitioners. However, it remains as a question whether the additional errors due to the use of pre-calculated uncertainty values are large enough to alter the conclusion of a comparative study, and, if so, what is the odds of such cases. In this study, we empirically tested the probability of altering the conclusion of a comparative LCA due to the use of pre-calculated uncertainty values. We sampled 10,000 random pairs of elementary flows of ecoinvent LCIs (a(i) and b(j)) and ran MCSs (1) using pre-calculated uncertainty values and (2) using fully dependent sampling. We analyzed the distribution of the differences between a(i) and b(i) (i.e., a(i)-b(i)) of each run, and quantified the probability of reversing (e.g., a(i) > b(i) became a(i)< b(i)) or moderating the conclusion (e.g., a(i)> b(i) became a(i) approximate to b(i)). In order to better replicate the situation under a comparative LCA setting, we also sampled 10,000 random pairs of elementary flows from the processes that produce electricity, and repeated the same procedure. The results show that no LCIs derived using pre-calculated uncertainty values constitute large enough differences from those using fully dependent sampling to reverse the conclusion. However, in 5.3% of the cases, the conclusion from one approach is moderated under the other approach or vice versa. When elementary flow pairs are sampled only from the electricity-producing processes, the probability of moderating the conclusions increases to 10.5%, while that of reversing the conclusions remains nil. As the number of unit processes in LCI databases increases, running full MCSs in a PC-environment will continue to be a challenge, which may lead some LCA practitioners to avoid uncertainty analysis altogether. Our results indicate that pre-calculated distributions for LCIs can be used as a proxy for comparative LCA studies in the absence of adequate computational resources for full MCS. Depending on the goal and scope of the study, LCA practitioners should consider using pre-calculated distributions if the benefits of doing so outweighs the associated risks of altering the conclusion.	[Qin, Yuwei; Suh, Sangwon] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Suh, S (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	suh@bren.ucsb.edu	Suh, Sangwon/E-2019-2011	Suh, Sangwon/0000-0001-8290-6276	U.S. Environmental Protection Agency [83557901]	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This publication was developed under Assistance Agreement No. 83557901 to SS awarded by the U.S. Environmental Protection Agency to University of California Santa Barbara. It has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Reinout Heijungs, Patrik Henriksson, and Jeroen Guinee for their comments on the earlier results of our analysis. This publication was developed under Assistance Agreement No. 83557901 awarded by the U.S. Environmental Protection Agency to University of California Santa Barbara. It has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.	[Anonymous], 2018, OPENLCA 1 7 US MAN; [Anonymous], 2016, SIMAPRO 8 2 US MAN; Azapagic A, 1999, CHEM ENG J, V73, P1, DOI 10.1016/S1385-8947(99)00042-X; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Burgess AA, 2001, CHEM ENG SCI, V56, P2589, DOI 10.1016/S0009-2509(00)00511-X; Castaings W, 2012, ENVIRON MODELL SOFTW, V38, P13, DOI 10.1016/j.envsoft.2012.04.017; Cederberg C, 2003, INT J LIFE CYCLE ASS, V8, P350, DOI 10.1007/BF02978508; Ciroth A, 2004, INT J LIFE CYCLE ASS, V9, P216, DOI 10.1007/BF02978597; De Bruijn H., 2002, HDB LIFE CYCLE ASSES; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; Frischknecht R, 2005, INT J LIFE CYCLE ASS, V10, P3, DOI 10.1065/lca2004.10.181.1; Geisler G, 2005, INT J LIFE CYCLE ASS, V10, P184, DOI 10.1065/lca2004.09.178; Gorree M, 2002, INT J LIFE CYCLE ASS, V7, P158, DOI 10.1007/BF02994050; Gregory JR, 2016, ENVIRON SCI TECHNOL, V50, P6397, DOI 10.1021/acs.est.5b04969; Heijungs R, 2005, INT J LIFE CYCLE ASS, V10, P248, DOI 10.1065/lca2004.09.177; Heijungs R., 2004, REV APPROACHES TREAT; Heijungs R, 2017, INT J LIFE CYCLE ASS, V22, P461, DOI 10.1007/s11367-017-1265-3; Heijungs R, 2014, INT J LIFE CYCLE ASS, V19, P1445, DOI 10.1007/s11367-014-0751-0; Helton JC, 2002, RISK ANAL, V22, P591, DOI 10.1111/0272-4332.00041; Henriksson PJG, 2015, ENVIRON SCI TECHNOL, V49, P14176, DOI 10.1021/acs.est.5b04634; Henriksson PJG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121221; Huijbregts M.A., 1998, INT J LIFE CYCLE ASS, V3, P273, DOI [10.1007/BF0297983519983:5, DOI 10.1007/BF02979835, 10.1007/BF02979835]; Huijbregts MAJ, 2001, INT J LIFE CYCLE ASS, V6, P127, DOI 10.1007/BF02978728; Hung ML, 2009, INT J LIFE CYCLE ASS, V14, P19, DOI 10.1007/s11367-008-0034-8; Imbeault-Tetreault H, 2013, J IND ECOL, V17, P485, DOI 10.1111/jiec.12001; ISO, 2006, 14044 ISO; Kloepffer W, 2008, INT J LIFE CYCLE ASS, V13, P89, DOI 10.1065/lca2008.02.376; Moreno Ruiz E., 2017, DOCUMENTATION CHANGE; Noshadravan A, 2013, TRANSPORT RES D-TR E, V25, P131, DOI 10.1016/j.trd.2013.10.002; Peters GP, 2007, INT J LIFE CYCLE ASS, V12, P373, DOI 10.1065/lca2006.06.254; Prado-Lopez V, 2014, INT J LIFE CYCLE ASS, V19, P405, DOI 10.1007/s11367-013-0641-x; Qin YW, 2017, INT J LIFE CYCLE ASS, V22, P1138, DOI 10.1007/s11367-016-1224-4; Ren Y, ENV IMPLICATIONS CHI; Bojaca CR, 2010, INT J LIFE CYCLE ASS, V15, P238, DOI 10.1007/s11367-010-0150-0; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Sonnemann GW, 2003, J CLEAN PROD, V11, P279, DOI 10.1016/S0959-6526(02)00028-8; Stothers Andrew James, 2010, THESIS U EDINBURGH; Sugiyama H, 2005, INT J LIFE CYCLE ASS, V10, P399, DOI 10.1065/lca2005.05.211; Suh SW, 2007, INT J LIFE CYCLE ASS, V12, P381, DOI 10.1065/lca2007.08.360; Suh S, 2017, INT J LIFE CYCLE ASS, V22, P827, DOI 10.1007/s11367-017-1287-x; Verbeeck G, 2010, BUILD ENVIRON, V45, P1037, DOI 10.1016/j.buildenv.2009.10.012; Vinodh S, 2014, J ENG DES TECHNOL, V12, P307, DOI 10.1108/JEDT-06-2010-0045; von Pfingsten S, 2017, ENVIRON SCI TECHNOL, V51, P13199, DOI 10.1021/acs.est.7b01406; Weidema B.P., 2013, SWISS CTR LIFE CYCLE; Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8; Williams VV, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P887; Wu K, 2014, OPT EXPRESS, V22, P295, DOI 10.1364/OE.22.000295	47	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209474	10.1371/journal.pone.0209474	http://dx.doi.org/10.1371/journal.pone.0209474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566497	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300092
J	Sun, HY; Zhang, A; Li, H				Sun, Hongyuan; Zhang, Ao; Li, He			Experimental study and dynamic characteristics analysis of partially liquid-filled annulus tubes	PLOS ONE			English	Article							VIBRATION; FLOW	As a useful technology, the horizontal drilling for underground coalmine has been applied in many fields such as gas drainage, water control, exploration and accurate drilling borehole engineering. In this paper, the annulus tubes are used to simulate the fluid transportation process between drilling rod and casing tube when drilling horizontally. The main goal of this research is to analyze the effects of eccentricity, fluid velocity, outer tube length and volume fraction on dynamic characteristics of partially liquid-filled annulus tube in a drillstring system. According to the Euler-Bernoulli beam model, the partially liquid-filled inner tube model and outer tube model are established respectively when considering the effect of transport fluid inside the annulus tubes. Based on the vibration characteristics of the tube, the added mass coefficient is proposed to calculate the natural frequencies of the outer tubes. And natural frequency is the frequency at which a system tends to oscillate in the absence of any driving or damping force. According to the compared results of experiments and simulations, the natural characteristics of outer tube depend on the tube design parameter (outer tube length) and the volume fraction of liquid filled in the outer tube. Furthermore, experiments have verified that the natural frequencies of the outer tubes can be directly calculated from the length of outer tubes. Therefore, it is feasible to propose the method of attaching liquid mass to tube mass to obtain the natural frequencies of outer tubes. According to the results, it can be concluded that: (i) The natural frequencies of tube decrease as the length of the tube increases; (ii) The increase of volume fraction of liquid in the tube can significantly reduce the natural frequencies of tube; (iii) The fluid velocity and eccentricity have less effects on the natural frequencies of tube; (IV) The added mass coefficient of outer tubes can be calculated and it is not a fixed value, it varies with the volume fraction of fluid in annulus tubes. In this work, the inner and outer tube models are established respectively for fluid transportation process between a horizontal drilling rod and casing tube. The effects of four factors on the natural frequencies are compared, and the concept of added mass coefficient is proposed to obtain reasonable tube natural frequencies.	[Sun, Hongyuan; Zhang, Ao; Li, He] Northeastern Univ, Sch Mech Engn & Automat, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Li, H (corresponding author), Northeastern Univ, Sch Mech Engn & Automat, Shenyang, Liaoning, Peoples R China.	hli@mail.neu.edu.cn	Zhang, Ao/AAH-5881-2019	Zhang, Ao/0000-0001-7713-2050	National Natural Science Foundation of China [51675091, 51705068]; Collaborative Innovation Center of Major Machine Manufacturing in Liaoning; Major Scientific and Technological Innovation Project of Liaoning Province [201506003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Major Machine Manufacturing in Liaoning; Major Scientific and Technological Innovation Project of Liaoning Province	This work was supported by the National Natural Science Foundation of China (Grant No. 51675091 and 51705068) and the Collaborative Innovation Center of Major Machine Manufacturing in Liaoning, the Major Scientific and Technological Innovation Project of Liaoning Province (Grant No. 201506003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna B, 2016, J NAT GAS SCI ENG, V34, P670, DOI 10.1016/j.jngse.2016.07.029; De La Torre O, 2013, J FLUID STRUCT, V39, P173, DOI 10.1016/j.jfluidstructs.2013.01.008; Ergin A, 2002, J SOUND VIB, V254, P951, DOI 10.1006/jsvi.2001.4139; Han SM, 2010, J PETROL SCI ENG, V70, P308, DOI 10.1016/j.petrol.2009.12.002; Han SM, 1999, J SOUND VIB, V225, P935, DOI 10.1006/jsvi.1999.2257; Kim YJ, 2003, KSME INT J, V17, P562, DOI 10.1007/BF02984457; Kong X, 2015, MATH PROBL ENG, V572, P1; Ozbelge TA, 2001, INT J MULTIPHAS FLOW, V27, P737, DOI 10.1016/S0301-9322(00)00047-1; Rocha RGD, 2001, J FLUIDS STRUCTURES, V201, P392; Hidalgo JAS, 2017, J SOUND VIB, V408, P31, DOI 10.1016/j.jsv.2017.07.011; Tijsseling AS, 2003, J FLUID STRUCT, V18, P179, DOI 10.1016/j.jfluidstructs.2003.07.001; Weaver DS, 2000, J PRESS VESS-T ASME, V122, P339, DOI 10.1115/1.556190; Zhao BinJuan, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P7	13	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209011	10.1371/journal.pone.0209011	http://dx.doi.org/10.1371/journal.pone.0209011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562380	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100032
J	Barlam, TF; Soria-Saucedo, R; Ameli, O; Cabral, HJ; Kaplan, WA; Kazis, LE				Barlam, Tamar F.; Soria-Saucedo, Rene; Ameli, Omid; Cabral, Howard J.; Kaplan, Warren A.; Kazis, Lewis E.			Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; INCREASED RISK; OUTCOMES; IMPACT; COSTS; MICROBIOTA; MORTALITY; DISEASE	Elderly patients and those with comorbid conditions are at high risk for poor outcomes after Clostridium difficile infection (CDI) but outcomes in a healthier, nonelderly population are not well described. We sought to investigate gastrointestinal diagnoses and CDI during hospitalizations in the 24 to 36 months after an initial episode of CDI in nonelderly patients in a cohort with an overall low prevalence of comorbid conditions. We performed a retrospective analysis of hospital admissions from 2010-2013 using the Truven MarketScan database of employment-based private insurance claims. Subjects <65 years of age and their adult dependents (> = 18 years old); a CDI diagnosis in 2011 (index date); at least 12 months of pre-index continuous enrollment; and 24-36 months of continuous post-index enrollment were included. The 12 months of each subject's enrollment prior to the index date for a CDI served as the reference period for the analyses of that subject's post-CDI time periods. Hospital claims during the follow-up period were evaluated for gastrointestinal diagnoses and/or CDI ICD-9 codes. The risk of gastrointestinal diagnoses was assessed using Cox proportional hazards models adjusted for a pre-specified set of baseline demographic and clinical factors. During 2011, 5,632 subjects with CDI met the inclusion criteria for our study. The risk of gastrointestinal diagnoses in patients with a CDI diagnostic code for the same admission was almost 8-fold higher 3 months post-CDI (hazard ratio (HR) = 7.56; 95% confidence interval (CI): 2.97-19.19) than for subjects without CDI and remained statistically significant until month 24 (HR = 1.47; 95% CI = 1.04-2.08). After CDI, patients remained at risk for gastrointestinal symptoms with CDI for up to two years. There is an important, long-term health-care burden after CDI in this population.	[Barlam, Tamar F.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Soria-Saucedo, Rene] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA; [Ameli, Omid] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kaplan, Warren A.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Hlth Outcomes Unit, Dept Hlth Law Policy & Management, Boston, MA USA; [Soria-Saucedo, Rene] Minist Hlth, Project Strengthen Training Syst Resources Human, La Paz, Bolivia	Boston University; State University System of Florida; University of Florida; Boston University; Boston University; Boston University; Boston University	Barlam, TF (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.	tbarlam@bu.edu	Ameli, Omid/AAA-1209-2020	Ameli, Omid/0000-0001-7878-0551; Barlam, Tamar/0000-0002-0511-7641				Abou Chakra CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098400; Abou Chakra CN, 2015, CLIN INFECT DIS, V61, P1781, DOI 10.1093/cid/civ749; Arriola V, 2016, INFECT CONT HOSP EP, V37, P1408, DOI 10.1017/ice.2016.194; Barlam TF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw045; Bishara J, 2013, CLIN INFECT DIS, V57, P489, DOI 10.1093/cid/cit280; Brown KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105454; CDC, 2013, ANTIBIOTIC RESISTANC; Chan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015603; Deshpande A, 2015, INFECT CONT HOSP EP, V36, P452, DOI 10.1017/ice.2014.88; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Doh YS, 2014, INTEST RES, V12, P299, DOI 10.5217/ir.2014.12.4.299; Dubberke ER, 2006, EMERG INFECT DIS, V12, P1576, DOI 10.3201/eid1210.060016; Dubberke ER, 2014, INFECT CONT HOSP EP, V35, P1400, DOI 10.1086/678428; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gutierrez RL, 2015, GASTROENTEROLOGY, V149, P1408, DOI 10.1053/j.gastro.2015.07.059; Hensgens MPM, 2013, CLIN INFECT DIS, V56, P1108, DOI 10.1093/cid/cis1209; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Jackson M, 2016, J CLIN GASTROENTEROL, V50, P742, DOI 10.1097/MCG.0000000000000447; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Kuntz JL, 2017, INFECT CONT HOSP EP, V38, P45, DOI 10.1017/ice.2016.232; Lee Ho Chan, 2016, Korean J Gastroenterol, V67, P81, DOI 10.4166/kjg.2016.67.2.81; Louie TJ, 2013, J AM GERIATR SOC, V61, P222, DOI 10.1111/jgs.12090; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; Murphy CR, 2012, INFECT CONT HOSP EP, V33, P20, DOI 10.1086/663209; Murthy SK, 2012, ALIMENT PHARM THER, V36, P1032, DOI 10.1111/apt.12073; Perez-Cobas AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00335; Piche T, 2007, CAN J GASTROENTEROL, V21, P727, DOI 10.1155/2007/262478; Razik R, 2016, AM J GASTROENTEROL, V111, P1141, DOI 10.1038/ajg.2016.187; Reacher M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149983; Reddy SS, 2013, J CLIN GASTROENTEROL, V47, P666, DOI 10.1097/MCG.0b013e31828b288a; Rodrigues R, 2017, INFECT CONT HOSP EP, V38, P196, DOI 10.1017/ice.2016.246; Rodriguez-Pardo D, 2013, J CLIN MICROBIOL, V51, P1465, DOI 10.1128/JCM.03352-12; Seekatz AM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0298-8; Shorr AF, 2016, INFECT CONT HOSP EP, V37, P1331, DOI 10.1017/ice.2016.188; Wadhwa A, 2016, ALIMENT PHARM THER, V44, P576, DOI 10.1111/apt.13737	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209152	10.1371/journal.pone.0209152	http://dx.doi.org/10.1371/journal.pone.0209152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557401	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000075
J	Nie, LJ; Zhang, H; Wu, ZK; Wang, YB; Liu, H; Wu, XL; Wang, W				Nie, Liangjie; Zhang, Hang; Wu, Zhaokun; Wang, Yibo; Liu, Hui; Wu, Xiaolin; Wang, Wei			Modified TCA/acetone precipitation of plant proteins for proteomic analysis	PLOS ONE			English	Article							SAMPLE EXTRACTION TECHNIQUES; TISSUES; SOLUBILIZATION; UNIVERSAL; RECOVERY	Protein extracts obtained from cells or tissues often require removal of interfering substances for the preparation of high-quality protein samples in proteomic analysis. A number of protein extraction methods have been applied to various biological samples. TCA/acetone precipitation and phenol extraction, a common method of protein extraction, is thought to minimize protein degradation and activity of proteases as well as reduce contaminants like salts and polyphenols. However, the TCA/acetone precipitation method relies on the complete pulverization and repeated rinsing of tissue powder to remove the interfering substances, which is laborious and time-consuming. In addition, by prolonged incubation in TCA/acetone, the precipitated proteins are more difficult to re-dissolve. We have described a modified method of TCA/acetone precipitation of plant proteins for proteomic analysis. Proteins of cells or tissues were extracted using SDS-containing buffer, precipitated with equal volume of 20% TCA/acetone, and washed with acetone. Compared to classical TCA/acetone precipitation and simple acetone precipitation, this protocol generates comparable yields, spot numbers, and proteome profiling, but takes less time (ca. 45 min), thus avoiding excess protein modification and degradation after extended-period incubation in TCA/acetone or acetone. The modified TCA/acetone precipitation method is simple, fast, and suitable for proteomic analysis of various plant tissues in proteomic analysis.	[Nie, Liangjie; Zhang, Hang; Wu, Zhaokun; Wang, Yibo; Liu, Hui; Wu, Xiaolin; Wang, Wei] Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Liu, H; Wang, W (corresponding author), Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	liuhuisw@henau.edu.cn; wangwei@henau.edu.cn	; Wang, Wei/R-7323-2016	Niu, Liangjie/0000-0002-7460-5489; Wang, Wei/0000-0002-3711-5181	National Natural Science Foundation of China [31771700]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province, china [15IRTSTHN015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province, china	Financial support for this study was provided to WW by National Natural Science Foundation of China (http://www.nsfc.gov.cn/, grant no. 31771700) and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province, china (http://www.haedu.gov.cn/, grant no. 15IRTSTHN015).	Alias Noraliza, 2017, Plant Omics, V10, P176, DOI 10.21475/poj.10.04.17.pne323; Balbuena TS, 2009, J PROTEOMICS, V72, P337, DOI 10.1016/j.jprot.2009.01.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Crowell AMJ, 2013, ANAL CHIM ACTA, V796, P48, DOI 10.1016/j.aca.2013.08.005; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Gorg A, 2004, PLANT J, V39, P715, DOI [10.1111/j.1365-313X.2004.02182.x, DOI 10.1111/J.1365-313X.2004.02182.X]; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Harder A, 1999, ELECTROPHORESIS, V20, P826, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<826::AID-ELPS826>3.0.CO;2-A; Hu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15626; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, P993, DOI 10.1101/pdb.prot5651; Mechin Valerie, 2007, V355, P1; Nandakumar MP, 2003, J PROTEOME RES, V2, P89, DOI 10.1021/pr025541x; Ning F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01824; Niu LJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00802; Rose JK, 1997, ELECTROPHORESIS, V18, P328, DOI [10.1002/elps.1150180306, DOI 10.1002/ELPS.1150180306]; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Simpson DM, 2010, J PROTEOME RES, V9, P444, DOI 10.1021/pr900806x; Wang N, 2015, J PROTEOMICS, V128, P113, DOI 10.1016/j.jprot.2015.07.027; Wang W, 2004, ANAL BIOCHEM, V329, P139, DOI 10.1016/j.ab.2004.02.044; Wang W, 2008, J SEP SCI, V31, P2032, DOI 10.1002/jssc.200800087; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00801; Wu XL, 2014, PROTEOMICS, V14, P645, DOI 10.1002/pmic.201300239; Wu XL, 2014, NAT PROTOC, V9, P362, DOI 10.1038/nprot.2014.022; Xiong EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112724; Zhang Y, 2015, ANAL BIOCHEM, V484, P40, DOI 10.1016/j.ab.2015.05.007	32	34	37	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0202238	10.1371/journal.pone.0202238	http://dx.doi.org/10.1371/journal.pone.0202238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557402	gold, Green Published			2022-12-26	WOS:000453451000004
J	Park, JW; Lee, JH; Cho, HJ; Ha, YJ; Kang, EH; Shin, K; Byun, SS; Lee, EY; Song, YW; Lee, YJ				Park, Jun Won; Lee, Jae Hyun; Cho, Hyon Joung; Ha, You-Jung; Kang, Eun Ha; Shin, Kichul; Byun, Seok-Soo; Lee, Eun Young; Song, Yeong Wook; Lee, Yun Jong			Influence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational study	PLOS ONE			English	Article							URIC-ACID; CLINICAL-IMPLICATIONS; TESTOSTERONE LEVELS; RISK-FACTORS; GOUT; MEN; HYPERURICEMIA; DEFICIENCY; METABOLISM; PLASMA	Objectives Although estrogenic modulation of serum urate levels is well-known, the androgenic effect on urate homeostasis remains controversial. We investigated the effect of androgen deprivation therapy (ADT) on serum urate levels. Methods We retrospectively enrolled a total of 489 prostate cancer patients with available serum urate levels at baseline and 3 and 6 months after ADT (n = 150) or prostate surgery (n = 339). We extracted the demographic, clinical, and laboratory data from a data warehouse and compared the changes in urate levels between the two treatment groups and between the different ADT regimens (with versus without luteinizing hormone-releasing hormone (LHRH) agonists) using generalized estimating equation (GEE). Results The baseline urate levels and the proportion of hyperuricemic subjects were comparable between the two groups. After 6 months, the urate levels were significantly decreased (by-0.66 mg/dL, 95% confidence interval (CI) [-0.81 to -0.51]) in the ADT group, whereas they did not significantly change in the surgery group in the univariate GEE analysis. The ADT group (4.7% from 18.0% at baseline) had a significantly lower proportion of hyperuricemic patients than surgery group (16.5% from 15.9% at baseline) at 6-month (p < 0.001). Regardless of whether LHRH agonists were used, the serial urate levels were lowered by the ADT. Temporal changes in the urate levels were significantly associated with the treatment group, baseline hyperuricemia, and poor functional or advanced cancer status. The ADT-related serum urate level reduction also remained significant in the multivariate GEE analysis (regression coefficient = -0.43 [-0.67 to -0.19] after 3 months and -0.37 [-0.64 to -0.10] after 6 months). Moreover, propensity-score-matched analyses yielded the same results. Conclusions Our results showed that longitudinal serum urate levels were significantly reduced in men receiving ADT. This finding suggests that androgen could have an independent role in urate homeostasis.	[Park, Jun Won; Lee, Jae Hyun; Lee, Eun Young; Song, Yeong Wook] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Park, Jun Won; Lee, Jae Hyun; Lee, Eun Young; Lee, Yun Jong] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Hyon Joung] Armed Forces Capital Hosp, Dept Internal Med, Seongnam, South Korea; [Ha, You-Jung; Kang, Eun Ha; Lee, Yun Jong] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Shin, Kichul] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Byun, Seok-Soo] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Song, Yeong Wook] Seoul Natl Univ, Med Res Inst, WCU Dept Mol Med & Biopharmaceut Sci, Coll Med, Seoul, South Korea; [Lee, Yun Jong] Seoul Natl Univ, Dept Translat Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, YJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Lee, YJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Lee, YJ (corresponding author), Seoul Natl Univ, Dept Translat Med, Coll Med, Seoul, South Korea.	yn35@snu.ac.kr	Lee, Jae Hyun/AAL-6917-2020	Lee, Jae Hyun/0000-0002-5668-4793; Lee, Eun Young/0000-0001-6975-8627; Ha, You-Jung/0000-0001-6107-9523	Yuhan Corporation, Ltd. [06-2014-138]	Yuhan Corporation, Ltd.	This work was supported by research fund (grant No. 06-2014-138 to YJL) from Yuhan Corporation, Ltd. (http://eng.yuhan.co.kr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2014, SCAND J RHEUMATOL, V43, P385, DOI 10.3109/03009742.2013.878387; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; DARLINGTON LG, 1991, ADV EXP MED BIOL, V309, P235; Demirbag R, 2005, ENDOCR RES, V31, P335, DOI 10.1080/07435800500449494; Emi Y, 2008, J OBSTET GYNAECOL RE, V34, P890, DOI 10.1111/j.1447-0756.2008.00857.x; Freedland SJ, 2009, PROSTATE CANCER P D, V12, P333, DOI 10.1038/pcan.2009.35; Fukai S, 2010, GERIATR GERONTOL INT, V10, P32, DOI 10.1111/j.1447-0594.2009.00552.x; Gambineri A, 2003, J ENDOCRINOL INVEST, V26, P493, DOI 10.1007/BF03345209; GEPHARDT MC, 1964, JAMA-J AM MED ASSOC, V189, P1028; GOTFREDSEN A, 1983, MATURITAS, V5, P9, DOI 10.1016/0378-5122(83)90016-6; Gozukara KH, 2015, INT UROL NEPHROL, V47, P1099, DOI 10.1007/s11255-015-0995-z; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; Han M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176786; Helsen C, 2014, ENDOCR-RELAT CANCER, V21, pT105, DOI 10.1530/ERC-13-0545; Heras-Herzig A, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P1337; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; Kacker R, 2012, J SEX MED, V9, P1681, DOI 10.1111/j.1743-6109.2012.02726.x; Krysiak R, 2016, PHARMACOL REP, V68, P196, DOI 10.1016/j.pharep.2015.08.009; Laviano A, 2003, LANCET ONCOL, V4, P686, DOI 10.1016/S1470-2045(03)01247-6; Li T, 2004, BBA-GENE STRUCT EXPR, V1681, P53, DOI 10.1016/j.bbaexp.2004.10.001; Li WM, 2018, PROSTATE CANCER P D, V21, P277, DOI 10.1038/s41391-018-0047-8; Liu RT, 2013, UROLOGY, V82, P124, DOI 10.1016/j.urology.2013.03.023; Mukhin IV, 2002, B EXP BIOL MED+, V133, P491, DOI 10.1023/A:1019826107916; Musch Wim, 2001, International Urology and Nephrology, V32, P475, DOI 10.1023/A:1017586004688; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nishiyama T, 2005, J CLIN ENDOCR METAB, V90, P657, DOI 10.1210/jc.2004-1611; Nuki G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1906; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; Ricci F, 2014, EXPERT OPIN DRUG SAF, V13, P1483, DOI 10.1517/14740338.2014.966686; ROSEN R, 1994, CLIN RHEUMATOL, V13, P219; Sharula, 2012, J OBSTET GYNAECOL RE, V38, P932, DOI 10.1111/j.1447-0756.2011.01815.x; Singh JA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0307-x; Smith MR, 2004, J CLIN ONCOL, V22, P2546, DOI 10.1200/JCO.2004.01.174; Tahara N, 2010, OXID MED CELL LONGEV, V3, P262, DOI 10.4161/oxim.3.4.12734; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; VERHELST J, 1994, CLIN ENDOCRINOL, V41, P525, DOI 10.1111/j.1365-2265.1994.tb02585.x; Yahyaoui R, 2008, J CLIN ENDOCR METAB, V93, P2230, DOI 10.1210/jc.2007-2467	37	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209049	10.1371/journal.pone.0209049	http://dx.doi.org/10.1371/journal.pone.0209049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557349	gold, Green Submitted, Green Published			2022-12-26	WOS:000453451000065
J	van Diepen, MT; Chapman, R; Moore, PL; Margolin, E; Hermanus, T; Morris, L; Ximba, P; Rybicki, EP; Williamson, AL				van Diepen, Michiel T.; Chapman, Rosamund; Moore, Penny L.; Margolin, Emmanuel; Hermanus, Tandile; Morris, Lynn; Ximba, Phindile; Rybicki, Edward P.; Williamson, Anna-Lise			The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; ENV TRIMERS; VACCINE; RESPONSES; PROTEIN; MATURATION; FEATURES; MF59	With the HIV-1 epidemic in southern Africa still rising, a prophylactic vaccine against the region's most prolific subtype (subtype C) would be a significant step forward. In this paper we report on the effect of 2 different adjuvants, AddaVax and AlhydroGel, formulated with HIV-1 subtype C gp140, on the development of binding and neutralising antibody titres in rabbits. AddaVax is a squalene-based oil-in-water nano-emulsion (similar to MF59) which can enhance both cellular and humoral immune responses, whilst AlhydroGel (aluminium hydroxide gel) mainly drives a Th2 response. The gp140 gene tested was derived from the superinfecting virus (SU) from participant CAP256 in the CAPRISA 002 Acute infection cohort. The furin cleavage site of the Env protein was replaced with a flexible linker and an I559P mutation introduced. Lectin affinity purified soluble Env protein was mainly trimeric as judged by molecular weight using BN-PAGE and contained intact broadly neutralising epitopes for the V3-glycan supersite (monoclonal antibodies PGT128 and PGT135), the CD4 binding site (VRC01) and the V2-glycan (PG9) but not for the trimer-specific monoclonal antibodies PG16, PGT145 and CAP256-VRC26_08. When this soluble Env protein was tested in rabbits, AlhydroGel significantly enhanced soluble Env and V1V2 binding antibodies when compared to AddaVax. Finally, AlhydroGel resulted in significantly higher neutralization titres for a subtype C Tier 1A virus (MW965.26) and increased neutralization breadth to Tier 1A and 1B viruses. However, no autologous Tier 2 neutralisation was observed. These data suggest that adjuvant selection is critical for developing a successful vaccine and AlhydroGel should be further investigated. Additional purification of trimeric native-like CAP256 Env and/or priming with DNA or MVA might enhance the induction of neutralizing antibodies and possible Tier 2 HIV-1 neutralisation.	[van Diepen, Michiel T.; Chapman, Rosamund; Margolin, Emmanuel; Ximba, Phindile; Rybicki, Edward P.; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Rondebosch, South Africa; [van Diepen, Michiel T.; Chapman, Rosamund; Margolin, Emmanuel; Ximba, Phindile; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, Dept Pathol, Rondebosch, South Africa; [Moore, Penny L.; Hermanus, Tandile; Morris, Lynn] Natl Hlth Lab Serv, Ctr HIV & STIs, Natl Inst Communicable Dis, Johannesburg, South Africa; [Moore, Penny L.; Morris, Lynn] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Moore, Penny L.; Morris, Lynn] Univ KwaZulu Natal, CAPRISA, Congella, South Africa; [Margolin, Emmanuel; Rybicki, Edward P.] Univ Cape Town, Biopharming Res Unit, Dept Mol & Cell Biol, Rondebosch, South Africa	University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Kwazulu Natal; University of Cape Town	Williamson, AL (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Rondebosch, South Africa.; Williamson, AL (corresponding author), Univ Cape Town, Div Med Virol, Dept Pathol, Rondebosch, South Africa.	Anna-Lise.Williarnson@uct.ac.za	Morris, Lynn/V-3941-2018; Chapman, Rosamund/AAJ-6490-2020; Margolin, Emmanuel/AAU-1727-2020	Morris, Lynn/0000-0003-3961-7828; Margolin, Emmanuel/0000-0003-4542-7684; van Diepen, Michiel/0000-0001-8156-4294; Chapman, Rosamund/0000-0001-9162-2099	South African Research Chairs Initiative of the Department of Science and Technology; South African Research Chairs Initiative of the National Research Foundation; Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council; South African Department of Science and Technology	South African Research Chairs Initiative of the Department of Science and Technology; South African Research Chairs Initiative of the National Research Foundation; Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Department of Science and Technology	This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Research was supported by the Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council with funds received from the South African Department of Science and Technology.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Apostolico JD, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1459394; Baxter C, 2016, AJAR-AFR J AIDS RES, V15, P109, DOI 10.2989/16085906.2016.1196224; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262; Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007; Capucci S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181886; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Fauci AS, 2017, JAMA-J AM MED ASSOC, V318, P1535, DOI 10.1001/jama.2017.13505; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Haynes BF, 2017, SCIENCE, V355, P1129, DOI 10.1126/science.aan0662; Haynes BF, 2017, IMMUNOL REV, V275, P5, DOI 10.1111/imr.12517; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; McElrath MJ, 2017, CURR OPIN HIV AIDS, V12, P278, DOI 10.1097/COH.0000000000000365; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moody MA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0851; Moore PL, 2016, CURR OPIN HIV AIDS, V11, P569, DOI 10.1097/COH.0000000000000317; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Mutua G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.61; Ott G, 1995, Pharm Biotechnol, V6, P277; Ozorowski G, 2018, J VIROL, V92, DOI 10.1128/JVI.00381-18; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Priya RS, 2015, J BIOL CHEM, V290, P9195, DOI 10.1074/jbc.M114.621185; Rerks-Ngarm S, 2017, J INFECT DIS, V215, P1255, DOI 10.1093/infdis/jix099; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shen XY, 2017, J VIROL, V91, DOI 10.1128/JVI.01077-17; Tanzer FL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-51; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Wang C, 2016, J IMMUNOL, V197, P1242, DOI 10.4049/jimmunol.1502472; Wu CY, 2014, VACCINE, V32, P4485, DOI 10.1016/j.vaccine.2014.06.043; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630	49	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208310	10.1371/journal.pone.0208310	http://dx.doi.org/10.1371/journal.pone.0208310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557314	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000027
J	Liu, YY; Zhu, H; Zhang, ZX; Tu, CC; Yao, DY; Wen, B; Jiang, R; Li, X; Yi, PF; Zhan, JJ; Hu, JP; Ding, JW; Jiang, LP; Zhang, FL				Liu, Yuying; Zhu, Hui; Zhang, Zhenxue; Tu, Changchun; Yao, Dongyuan; Wen, Bin; Jiang, Ru; Li, Xing; Yi, Pengfei; Zhan, Jiejie; Hu, Jiaping; Ding, Jianwu; Jiang, Liping; Zhang, Fanglin			Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma	PLOS ONE			English	Article							DNA METHYLATION; TET PROTEINS; CANCER; GENE; PROMOTES; CELL; EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; OVEREXPRESSION; PROLIFERATION	Tumor suppressor genes (TSGs), including Ten-eleven translocation 1 (TET1), are hypermethylated in hepatocellular carcinoma (HCC). TET1 catalytic domain (TET1-CD) induces genome-wide DNA demethylation to activate TSGs, but so far, anticancer effects of TET1-CD are unclear. Here we showed that after HCC cells were transiently transfected with TET1-CD, the methylation levels of TSGs, namely APC, p16, RASSF1A, SOCS1 and TET1, were distinctly reduced, and their mRNA levels were significantly increased and HCC cells proliferation, migration and invasion were suppressed, but the methylation and mRNA levels of oncogenes, namely C-myc, Bmi1, EMS1, Kpna2 and c-fos, were not significantly change. Strikingly, HCC subcutaneous xenografts in nude mice remained to be significantly repressed even 54 days after transient transfection of TET1-CD. So, transient transfection of TET1-CD may be a great advance in HCC treatment due to its activation of multiple TSGs and persistent anticancer effects.	[Liu, Yuying; Zhu, Hui; Zhang, Zhenxue; Tu, Changchun; Yao, Dongyuan; Jiang, Liping; Zhang, Fanglin] Nanchang Univ, Coll Pharm, Nanchang, Jiangxi, Peoples R China; [Wen, Bin; Hu, Jiaping] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Jiang, Ru] Jiangxi Maternal & Child Hlth Hosp, Nanchang, Jiangxi, Peoples R China; [Li, Xing] Gannan Med Univ, Ganzhou, Jiangxi, Peoples R China; [Yi, Pengfei; Zhan, Jiejie] Jiangxi Prov Childrens Hosp, Nanchang, Jiangxi, Peoples R China; [Ding, Jianwu] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Gannan Medical University; Nanchang University	Zhang, FL (corresponding author), Nanchang Univ, Coll Pharm, Nanchang, Jiangxi, Peoples R China.	zhangfl3@aliyun.com	Zhang, Fang/HHN-2153-2022		National Natural Science Foundation of China [81060273, 81260498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China: 81260498, zhan fanglin; National Natural Science Foundation of China: 81060273, zhan fanglin.	Ahn EY, 2013, MOL CANCER RES, V11, P748, DOI 10.1158/1541-7786.MCR-12-0665; Araujo OC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153796; Archer KJ, 2010, MOL GENET GENOMICS, V283, P341, DOI 10.1007/s00438-010-0522-y; Beldi-Ferchiou A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174835; Biswas S, 2017, PHARMACOL THERAPEUT, V173, P118, DOI 10.1016/j.pharmthera.2017.02.011; Chen H, 2017, ONCOGENE, V36, P4415, DOI 10.1038/onc.2017.73; Chen Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.142; Choi EK, 1996, MUTAT RES-FUND MOL M, V354, P123, DOI 10.1016/0027-5107(96)00056-5; Chuang KH, 2015, HEPATOLOGY, V62, P466, DOI 10.1002/hep.27816; Cordero FJ, 2017, MOL CANCER RES, V15, P1243, DOI 10.1158/1541-7786.MCR-16-0389; Coulter JB, 2017, EPIGENETICS-US, V12, P854, DOI 10.1080/15592294.2017.1359452; D'Arcangelo D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071591; Deng M, 2017, CANCER RES, V77, P6069, DOI 10.1158/0008-5472.CAN-16-2964; Duan HY, 2017, GYNECOL ONCOL, V147, P408, DOI 10.1016/j.ygyno.2017.08.010; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Formeister EJ, 2010, MUTAT RES-FUND MOL M, V692, P26, DOI 10.1016/j.mrfmmm.2010.07.013; Gougelet A, 2016, GUT, V65, P1024, DOI 10.1136/gutjnl-2014-308969; Grosser C, 2015, EPIGENETICS-US, V10, P819, DOI 10.1080/15592294.2015.1073879; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hinrichsen I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084453; Hlady RA, 2014, ONCOTARGET, V5, P9425, DOI 10.18632/oncotarget.2444; Hou R, 2016, TUMOR BIOL, V37, P16005, DOI 10.1007/s13277-016-5420-4; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026799; Jiang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02290-w; Jimenez AP, 2017, ONCOTARGET, V8, P88437, DOI 10.18632/oncotarget.18177; Jin CL, 2014, NUCLEIC ACIDS RES, V42, P6956, DOI 10.1093/nar/gku372; Kiran M, 2009, CANCER GENET CYTOGEN, V195, P112, DOI 10.1016/j.cancergencyto.2009.06.021; Lee MH, 2017, ONCOTARGET, V8, P89072, DOI 10.18632/oncotarget.21654; Li LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26591; Lin LL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0291-2; Liu CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062828; Okochi O, 2003, CLIN CANCER RES, V9, P5295; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Park MG, 2014, GENE, V538, P266, DOI 10.1016/j.gene.2014.01.045; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Ray EM, 2017, J HEPATOCELL CARCINO, V4, P131, DOI 10.2147/JHC.S124366; Rennoll SA, 2016, CANCERS, V8, DOI 10.3390/cancers8050052; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Sobhani Navid, 2017, Genes Cancer, V8, P495, DOI 10.18632/genesandcancer.138; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Tian YP, 2016, CHINESE MED J-PEKING, V129, P1744, DOI 10.4103/0366-6999.185873; Todd MC, 2017, J CANCER, V8, P190, DOI 10.7150/jca.15481; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Trierweiler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040638; Tsujiuchi T, 1999, JPN J CANCER RES, V90, P909, DOI 10.1111/j.1349-7006.1999.tb00834.x; Um TH, 2011, J HEPATOL, V54, P939, DOI 10.1016/j.jhep.2010.08.021; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Xu BY, 2014, ONCOL LETT, V7, P1683, DOI 10.3892/ol.2014.1951; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamada N, 2016, ONCOL REP, V35, P2228, DOI 10.3892/or.2016.4619; Yu L, 2016, TUMOR BIOL, V37, P13821, DOI 10.1007/s13277-016-5172-1; Zhang C, 2016, ONCOTARGET, V7, P81255, DOI 10.18632/oncotarget.13221; Zhang XY, 2016, CANCER RES, V76, P2824, DOI 10.1158/0008-5472.CAN-15-3010	58	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207139	10.1371/journal.pone.0207139	http://dx.doi.org/10.1371/journal.pone.0207139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30551127	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000006
J	Nakamura, T; Nakashima, C; Komiya, K; Kitera, K; Hirai, M; Kimura, S; Aragane, N				Nakamura, Tomomi; Nakashima, Chiho; Komiya, Kazutoshi; Kitera, Kazuki; Hirai, Mitsuharu; Kimura, Shinya; Aragane, Naoko			Mechanisms of acquired resistance to afatinib clarified with liquid biopsy	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; EGFR T790M; MUTATION; RECEPTOR; OSIMERTINIB; HETEROGENEITY; ACQUISITION; GEFITINIB; BIBW2992	Although mechanisms of acquired resistance to 1st and 3rd generation EGFR-TKI continue to be elucidated, there have been few clinical investigations into the mechanisms of acquired resistance to the 2nd generation EGFR-TKI afatinib. We analyzed data from 20 patients with advanced lung adenocarcinoma who acquired resistance to afatinib, including resistance during EGFR-TKI re-challenge. We examined EGFRT790M and C797S mutations, BRAFV600E mutation, and MET amplification with the MBP-QP method and with droplet digital PCR using ctDNA and re-biopsy samples obtained before and after afatinib treatment. Just before afatinib treatment, 15 of the 20 patients were T790M negative and five were positive. Among the T790M negative patients, 40.0% (6/15) became positive at the time of PD under afatinib. In patients positive for T790M, changes in T790M allele frequency were correlated with afatinib treatment efficacy. C797S was not detected in any patients just before afatinib treatment, but it appeared after treatment in three patients, although with very low allele frequency. Two of these three patients, although positive for both C797S and T790M, achieved PR to osimertinib. However, PFS of these patients was somewhat shorter than that of patients positive for T790M only. BRAFV600E was detected in one patient at PD under afatinib. MET amplification was not detected in this study. T790M is associated with acquired resistance to afatinib, as with 1st generation EGFR-TKI, but with somewhat lower frequency. The influence of C797S on resistance to afatinib is less than that of T790M, but C797S might cause shorter PFS under osimertinib.	[Nakamura, Tomomi; Nakashima, Chiho; Komiya, Kazutoshi; Kimura, Shinya; Aragane, Naoko] Saga Univ, Fac Med, Div Hematol Resp Med & Oncol, Dept Internal Med, Saga, Japan; [Kitera, Kazuki; Hirai, Mitsuharu] ARKRAY Inc, Kyoto, Japan	Saga University	Aragane, N (corresponding author), Saga Univ, Fac Med, Div Hematol Resp Med & Oncol, Dept Internal Med, Saga, Japan.	sueokan@cc.saga-u.ac.jp		Nakamura, Tomomi/0000-0003-1943-7352; Hirai, Mitsuharu/0000-0002-7633-9161	Ministry of Education, Culture, Science, and Technology, Japan [JP17K07197]	Ministry of Education, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	TN received funding support. This work was supported in part (data analysis) by Grants-in Aid for Cancer Research: Special Cancer Research, from the Ministry of Education, Culture, Science, and Technology, Japan (grant number JP17K07197). https://www.jsps.go.jp/j-grantsinaid/. ARKRAY Inc. provided support in the form of salaries for authors KK and MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported in part by "Grants-in Aid for Cancer Research: Special Cancer Research" from the Ministry of Education, Culture, Science, and Technology, Japan (grant number JP17K07197).	Azuma K, 2014, ONCOTARGET, V5, P5908, DOI 10.18632/oncotarget.1866; Campo M, 2016, J THORAC ONCOL, V11, P2022, DOI 10.1016/j.jtho.2016.06.032; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Coco S, 2015, TARGET ONCOL, V10, P393, DOI 10.1007/s11523-014-0344-7; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hashida S, 2015, CANCER SCI, V106, P1377, DOI 10.1111/cas.12749; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Khozin S, 2017, CLIN CANCER RES, V23, P2131, DOI 10.1158/1078-0432.CCR-16-1773; Kim TM, 2015, J THORAC ONCOL, V10, P1736, DOI 10.1097/JTO.0000000000000688; Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Kobayashi Y, 2017, MOL CANCER THER, V16, P357, DOI 10.1158/1535-7163.MCT-16-0407; Kuiper JL, 2014, LUNG CANCER, V85, P19, DOI 10.1016/j.lungcan.2014.03.016; Lee Y, 2016, MOL CARCINOGEN, V55, P991, DOI 10.1002/mc.22342; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lin CC, 2018, LANCET RESP MED, V6, P107, DOI 10.1016/S2213-2600(17)30480-0; Marquez-Medina D, 2015, FUTURE ONCOL, V11, P2525, DOI 10.2217/fon.15.183; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Minari R, 2016, TRANSL LUNG CANCER R, V5, P695, DOI 10.21037/tlcr.2016.12.02; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Nakamura T, 2011, J THORAC ONCOL, V6, P1639, DOI 10.1097/JTO.0b013e31822956e8; Nakashima Chiho, 2018, Oncotarget, V9, P25181, DOI 10.18632/oncotarget.25388; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sequist LV, 2017, J THORAC ONCOL; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Sueoka-Aragane N, 2016, CANCER SCI, V107, P162, DOI 10.1111/cas.12847; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tanaka K, 2017, ONCOTARGET, V8, P68123, DOI 10.18632/oncotarget.19243; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Wu SG, 2016, ONCOTARGET, V7, P12404, DOI 10.18632/oncotarget.7189; Xu J, 2017, ONCOTARGET, V8, P90557, DOI 10.18632/oncotarget.21164; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang JCH, 2017, J CLIN ONCOL, V35, P1288, DOI 10.1200/JCO.2016.70.3223; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0168604, 10.1371/journal.pone.0146784]	39	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209384	10.1371/journal.pone.0209384	http://dx.doi.org/10.1371/journal.pone.0209384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550608	Green Submitted, gold, Green Published			2022-12-26	WOS:000453248000061
J	Sanchez, E; Gonzalez, EA; Moreno, DS; Cardenas, RA; Ramos, MA; Davalos, AJ; Manllo, J; Rodarte, AI; Petrova, Y; Moreira, DC; Chavez, MA; Tortoriello, A; Lara, A; Gutierrez, BA; Burns, AR; Heidelberger, R; Adachi, R				Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Rodarte, Alejandro I.; Petrova, Youlia; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Lara, Adolfo; Gutierrez, Berenice A.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Syntaxin 3, but not syntaxin 4, is required for mast cell-regulated exocytosis, where it plays a primary role mediating compound exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; SNARE proteins; mast cell; allergy; immunoglobulin E (IgE); anaphylaxis; syntaxin	SNARE COMPLEX; CAPACITANCE MEASUREMENTS; SECRETORY GRANULES; FUSION; MOUSE; DEGRANULATION; SNAP-23; RELEASE; HISTAMINE; PROTEINS	Mast cells (MCs) participate in allergy, inflammation, and defense against pathogens. They release multiple immune mediators via exocytosis, a process that requires SNARE proteins, including syntaxins (Stxs). The identity of the Stxs involved in MC exocytosis remains controversial. Here, we studied the roles of Stx3 and -4 in fully developed MCs from conditional knockout mice by electrophysiology and EM, and found that Stx3, and not Stx4, is crucial for MC exocytosis. The main defect seen in Stx3-deficient MCs was their inability to engage multigranular compound exocytosis, while leaving most single-vesicle fusion events intact. We used this defect to show that this form of exocytosis is not only required to accelerate MC degranulation but also essential to achieve full degranulation. The exocytic defect was severe but not absolute, indicating that an Stx other than Stx3 and -4 is also required for exocytosis in MCs. The removal of Stx3 affected only regulated exocytosis, leaving other MC effector responses intact, including the secretion of cytokines via constitutive exocytosis. Our in vivo model of passive systemic anaphylaxis showed that the residual exocytic function of Stx3-deficient MCs was sufficient to drive a full anaphylactic response in mice.	[Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Petrova, Youlia; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Gutierrez, Berenice A.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Rodarte, Alejandro I.; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Gutierrez, Berenice A.] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, Nuevo Leon, Mexico; [Lara, Adolfo; Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Lara, Adolfo/0000-0002-4258-1304; Moreno McNeill, David/0000-0003-0049-1770; Adachi, Roberto/0000-0002-0146-0768; Heidelberger, Ruth/0000-0002-8033-2050	National Institutes of Health [AI093533, CA016672, EY007551, EY012128]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants AI093533, CA016672, EY007551, and EY012128. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Bin NR, 2015, J CELL SCI, V128, P1946, DOI 10.1242/jcs.165662; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dieckmann NMG, 2015, TRAFFIC, V16, P1330, DOI 10.1111/tra.12337; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; HELANDER HF, 1974, J MICROSC-OXFORD, V100, P315, DOI 10.1111/j.1365-2818.1974.tb03943.x; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KOPS SK, 1990, CELL TISSUE RES, V262, P415, DOI 10.1007/BF00305238; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu S, 2012, IMMUNOL CELL BIOL, V90, P337, DOI 10.1038/icb.2011.41; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Morey C, 2017, J BIOL CHEM, V292, P20449, DOI 10.1074/jbc.M117.811182; Naskar P, 2018, J BIOSCIENCES, V43, P127, DOI 10.1007/s12038-018-9740-y; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROYET JP, 1991, PROG NEUROBIOL, V37, P433, DOI 10.1016/0301-0082(91)90009-P; Salinas E, 2008, J INVEST ALLERG CLIN, V18, P366; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; Tadokoro S, 2016, CELL BIOL INT, V40, P589, DOI 10.1002/cbin.10600; Tadokoro S, 2010, CELL IMMUNOL, V261, P51, DOI 10.1016/j.cellimm.2009.10.011; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Teng FYH, 2001, GENOME BIOL, V2; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Yang Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00725; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	73	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3012	3023		10.1074/jbc.RA118.005532	http://dx.doi.org/10.1074/jbc.RA118.005532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30563839	hybrid, Green Published			2022-12-26	WOS:000464980100004
J	Cornell, RB; Taneva, SG; Dennis, MK; Tse, R; Dhillon, RK; Lee, J				Cornell, Rosemary B.; Taneva, Svetla G.; Dennis, Melissa K.; Tse, Ronnie; Dhillon, Randeep K.; Lee, Jaeyong			Disease-linked mutations in the phosphatidylcholine regulatory enzyme CCT alpha impair enzymatic activity and fold stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipodystrophy; phosphatidylcholine; protein folding; enzyme catalysis; mutant; PCYT1A; retinal dystrophy; Spondylometaphyseal dysplasia	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT-LIVER CTP; CAUSE SPONDYLOMETAPHYSEAL DYSPLASIA; MEMBRANE-BINDING DOMAIN; AMPHITROPIC ENZYME; TARGETED DELETION; AMPHIPATHIC HELIX; LIPID-MEMBRANES; PCYT1A; ACTIVATION	CTP:phosphocholine cytidylyltransferase (CCT) is the key regulatory enzyme in phosphatidylcholine (PC) synthesis and is activated by binding to PC-deficient membranes. Mutations in the gene encoding CCT alpha (PCYT1A) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy. Previous analyses showed that for some disease-linked PCYT1A variants steady state levels of CCT alpha and PC synthesis were reduced in patient fibroblasts, but other variants impaired PC synthesis with little effect on CCT levels. To explore the impact on CCT stability and function we expressed WT and mutant CCTs in COS-1 cells, which have very low endogenous CCT. Over-expression of two missense variants in the catalytic domain (V142M and P150A) generated aggregated enzymes that could not be refolded after solubilization by denaturation. Other mutations in the catalytic core that generated CCTs with reduced solubility could be purified. Five variants destabilized the catalytic domain-fold as assessed by lower transition temperatures for unfolding, and three of these manifested defects in substrate K-m values. A mutation (R223S) in a signal-transducing linker between the catalytic and membrane-binding domains also impaired enzyme kinetics. E280del, a single amino acid deletion in the autoinhibitory helix increased the constitutive (lipid-independent) enzyme activity similar to 4-fold. This helix also participates in membrane binding, and surprisingly E280del enhanced the enzyme's response to anionic lipid vesicles similar to 4-fold. These in vitro analyses on purified mutant CCTs will complement future measurements of their impact on PC synthesis in cultured cells and in tissues with a stringent requirement for CCT alpha.	[Cornell, Rosemary B.; Taneva, Svetla G.; Dennis, Melissa K.; Tse, Ronnie; Dhillon, Randeep K.; Lee, Jaeyong] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Dennis, Melissa K.] Symvivo Corp, 102,4475 Wayburne Dr, Burnaby, BC V5G 4X4, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.; Cornell, RB (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes for Health Research (to R. B. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Benedetti CE, 2003, MOL BIOCHEM PARASIT, V128, P157, DOI 10.1016/S0166-6851(03)00057-4; Cornell R, 2018, DEV CELL, V45, P419, DOI 10.1016/j.devcel.2018.05.001; Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; FELDMAN DA, 1978, J BIOL CHEM, V253, P4980; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Haider A, 2018, DEV CELL, V45, P481, DOI 10.1016/j.devcel.2018.04.012; Hanakam F, 1996, BIOCHEMISTRY-US, V35, P11036, DOI 10.1021/bi960789j; Hoover-Fong J, 2014, AM J HUM GENET, V94, P105, DOI 10.1016/j.ajhg.2013.11.018; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jank JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093852; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Jurgens J., 2017, THESIS; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Ramezanpour M, 2018, J BIOL CHEM, V293, P7070, DOI 10.1074/jbc.RA118.002053; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Testa F, 2017, EUR J HUM GENET, V25, P651, DOI 10.1038/ejhg.2017.23; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yamamoto GL, 2014, AM J HUM GENET, V94, P113, DOI 10.1016/j.ajhg.2013.11.022; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	47	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1490	1501		10.1074/jbc.RA118.006457	http://dx.doi.org/10.1074/jbc.RA118.006457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30559292	Green Published, hybrid			2022-12-26	WOS:000457879200006
J	Cho, H; Oh, SH; Lee, H; Cho, HJ; Kang, HY				Cho, Hyeonseok; Oh, Sung-Hee; Lee, Hankil; Cho, Hyun-Jai; Kang, Hye-Young			The incremental economic burden of heart failure: A population-based investigation from South Korea	PLOS ONE			English	Article							COSTS; EPIDEMIOLOGY; CARE; SMOKING; ASSOCIATION; PREVALENCE; MANAGEMENT; OUTCOMES	Background The prevalence of heart failure (HF) and its economic burden are increasing with age of the South Korean population. This study aimed to assess the economic impact of HF from the societal perspective. Methods A prevalence-based, incremental cost-of-patient study was performed to estimate the cost ratio between patients with HF and those without HF based on the claims database of the national health insurance in South Korea. We defined adult HF patients as those aged. 19 years who had at least one insurance claim record with a primary or secondary diagnosis of HF. Age-and gender-matched controls were defined using a 1: 4 greedy matching method. Costs were estimated by including medical costs for insurance-covered and non-covered services, transportation costs, caregiver's cost, and time costs of patients. The ratio of costs between patients with HF and those without HF was adjusted for age, gender, and type of universal health security program in the multivariate regression model. Results The average annual per-capita cost was estimated to be $6,601 for patients with HF (n = 14,252), which is about 3.38 (95% confidence interval [CI]: 3.31-3.46) times higher than that for patients without HF (n = 1,116,882) and 1.64 (95% CI: 1.59-1.70) times higher than that for the age-and gender-matched patients without HF (n = 57,008). In the multivariate regression model, the annual per-capita total costs were 1.98-fold (95% CI: 1.94-2.02) statistically higher for patients with HF than for patients without HF after adjustment for age, gender, and type of universal health security program. Conclusions This study demonstrates a significant incremental burden of HF. Given that the prevalence of HF is expected to increase with an increase in the aging population, the nationaleconomic burden is expected to be substantial in the future. Thus, greater emphasis on the prevention and treatment of HF is warranted.	[Cho, Hyeonseok; Oh, Sung-Hee; Lee, Hankil; Kang, Hye-Young] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Seoul National University Hospital	Kang, HY (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea.	hykang2@yonsei.ac.kr		Kang, Hye-Young/0000-0003-3260-2623; Lee, Hankil/0000-0002-7780-159X	Novartis Korea Ltd. [CLCZ696BKR03]	Novartis Korea Ltd.	The study was funded by Novartis Korea Ltd. (grant number: CLCZ696BKR03, URL: https://www.novartis.co.kr/) to H-YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia SC, 2011, J GEN INTERN MED, V26, P1145, DOI 10.1007/s11606-011-1725-6; Ahmed Ali, 2008, Heart Fail Clin, V4, P387, DOI 10.1016/j.hfc.2008.03.008; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SY, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-80; Christ M, 2016, EUR J HEART FAIL, V18, P1009, DOI 10.1002/ejhf.567; Echouffo-Tcheugui JB, 2017, AM HEART J, V186, P63, DOI 10.1016/j.ahj.2017.01.003; Fautrel B, 2007, MED DECIS MAKING, V27, P138, DOI 10.1177/0272989X06297389; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; HODGSON TA, 1992, MILBANK Q, V70, P81, DOI 10.2307/3350086; Huang J, 2017, J MED ECON, V20, P549, DOI 10.1080/13696998.2017.1297309; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Jung YH, 2010, REPORT KOREA HLTH PA, P38; Kang HY, 2003, TOB CONTROL, V12, P37, DOI 10.1136/tc.12.1.37; Kim Y, 2013, COSTING METHODS HEAL; Korea National Health Insurance Service, 2014 SURV MED EXP PA; Korean Ministry of Health and Welfare, 2006, NAT HLTH NUTR EX SUR; Korean National Statistical Office, 2014, ANN STAT REPT CAUS D; KOrean Statistical Information Service (KOSIS), SURV LAB COND EMPL T; KOrean Statistical Information Service (KOSIS), EC ACT P SUV GEND AG; KOrean Statistical Information Service (KOSIS), CONS PRIC IND IT; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lee H, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0404-2; Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658; Liao L, 2008, PHARMACOECONOMICS, V26, P447, DOI 10.2165/00019053-200826060-00001; Liao L, 2007, AM HEART J, V153, P245, DOI 10.1016/j.ahj.2006.11.010; LUCE BR, 1978, NEW ENGL J MED, V298, P569, DOI 10.1056/NEJM197803092981012; Moran JL, 2007, J EVAL CLIN PRACT, V13, P381, DOI 10.1111/j.1365-2753.2006.00711.x; Pagano E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1241-1; Preisser JS, 1997, ANNU REV PUBL HEALTH, V18, P51, DOI 10.1146/annurev.publhealth.18.1.51; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; Ryden-Bergsten T, 1999, J INTERN MED, V246, P275, DOI 10.1046/j.1365-2796.1999.00520.x; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Whellan DJ, 2010, CIRC-CARDIOVASC QUAL, V3, P33, DOI 10.1161/CIRCOUTCOMES.109.854760; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208731	10.1371/journal.pone.0208731	http://dx.doi.org/10.1371/journal.pone.0208731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576328	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400015
J	Erffelinck, ML; Ribeiro, B; Perassolo, M; Pauwels, L; Pollier, J; Storme, V; Goossens, A				Erffelinck, Marie-Laure; Ribeiro, Bianca; Perassolo, Maria; Pauwels, Laurens; Pollier, Jacob; Storme, Veronique; Goossens, Alain			A user-friendly platform for yeast two-hybrid library screening using next generation sequencing	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; PROTEIN-PROTEIN INTERACTIONS; CO-REPRESSOR TOPLESS; SPLIT-UBIQUITIN; TRANSCRIPTION; INTERACTOME; COMPLEXES; SELECTION; NETWORK; SYSTEM	Yeast two-hybrid (Y2H) is a well-established genetics-based system that uses yeast to selectively display binary protein-protein interactions (PPIs). To meet the current need to unravel complex PPI networks, several adaptations have been made to establish mediumto high-throughput Y2H screening platforms, with several having successfully incorporated the use of the next-generation sequencing (NGS) technology to increase the scale and sensitivity of the method. However, these have been to date mainly restricted to the use of fully annotated custom-made open reading frame (ORF) libraries and subject to complex downstream data processing. Here, a streamlined Y2H library screening strategy, based on integration of Y2H with NGS, called Y2H-seq, was developed, which allows efficient and reliable screening of Y2H cDNA libraries. To generate proof of concept, the method was applied to screen for interaction partners of two key components of the jasmonate signaling machinery in the model plant Arabidopsis thaliana, resulting in the identification of several previously reported as well as hitherto unknown interactors. Our Y2H-seq method offers a user-friendly, specific and sensitive screening method that allows identification of PPIs without prior knowledge of the organism's ORFs, thereby extending the method to organisms of which the genome has not entirely been annotated yet. The quantitative NGS readout allows to increase genome coverage, thereby overcoming some of the bottlenecks of current Y2H technologies, which will further strengthen the value of the Y2H technology as a discovery platform.	[Erffelinck, Marie-Laure; Ribeiro, Bianca; Perassolo, Maria; Pauwels, Laurens; Pollier, Jacob; Storme, Veronique; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Erffelinck, Marie-Laure; Ribeiro, Bianca; Perassolo, Maria; Pauwels, Laurens; Pollier, Jacob; Storme, Veronique; Goossens, Alain] VIB Ctr Plant Syst Biol, Ghent, Belgium; [Perassolo, Maria] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol, Catedra Biotecnol, Buenos Aires, DF, Argentina; [Perassolo, Maria] Univ Buenos Aires, CONICET, Inst Nanobiotecnol NANOBIOTEC, Buenos Aires, DF, Argentina	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Goossens, A (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium.; Goossens, A (corresponding author), VIB Ctr Plant Syst Biol, Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Pauwels, Laurens/Y-4080-2019; Pollier, Jacob/B-3091-2012	Pauwels, Laurens/0000-0002-0221-9052; Pollier, Jacob/0000-0002-1134-9238; Erffelinck, Marie-Laure/0000-0002-6854-3023; Perassolo, Maria/0000-0002-3819-8150; Ribeiro, Bianca/0000-0002-1843-0258; Goossens, Alain/0000-0002-1599-551X	Research Foundation Flanders [G004515N]; Program Ciencias Sem Fronteiras [201135/2014-0]; BEC.AR program for overseas training of Argentine professionals in the fields of science, technology and productive innovation; Special Research Fund from Ghent University [O1J14813]	Research Foundation Flanders(FWO); Program Ciencias Sem Fronteiras; BEC.AR program for overseas training of Argentine professionals in the fields of science, technology and productive innovation; Special Research Fund from Ghent University	This research was supported by the Research Foundation Flanders by a research project grant to A.G. (G004515N) and for postdoctoral fellowships to J.P. and L.P., the Program Ciencias Sem Fronteiras for a predoctoral fellowship to B.R. (Grant 201135/2014-0), the BEC.AR program for overseas training of Argentine professionals in the fields of science, technology and productive innovation for a scholarship to M.P. and the Special Research Fund from Ghent University (project O1J14813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2013, P NATL ACAD SCI USA, V110, P15473, DOI 10.1073/pnas.1307910110; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005; Cuellar Amparo Perez, 2013, Methods Mol Biol, V1011, P173, DOI 10.1007/978-1-62703-414-2_14; Dedecker M, 2015, CURR OPIN PLANT BIOL, V24, P1, DOI 10.1016/j.pbi.2015.01.001; Dunham WH, 2012, PROTEOMICS, V12, P1576, DOI 10.1002/pmic.201100523; Durand AN, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-30; Espinosa-Ruiz A, 2017, DEVELOPMENT, V144, P1619, DOI 10.1242/dev.143214; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gasperini D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005300; Gietz RD, 2014, METHODS MOL BIOL, V1163, P33, DOI 10.1007/978-1-4939-0799-1_4; Gnimpieba E.Z., 2013, RNA SEQ WORKFLOW TOP; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Goossens J, 2016, PLANT J, V88, P476, DOI 10.1111/tpj.13258; Goossens J, 2016, PLANT MOL BIOL, V91, P673, DOI 10.1007/s11103-016-0480-9; Goossens J, 2015, NEW PHYTOL, V206, P1229, DOI 10.1111/nph.13398; Goralogia GS, 2017, PLANT J, V92, P244, DOI 10.1111/tpj.13649; Graeff M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005959; Hauser R, 2012, METHODS MOL BIOL, V812, P1, DOI 10.1007/978-1-61779-455-1_1; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; James P, 1996, GENETICS, V144, P1425; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Lynch TJ, 2017, PLANT MOL BIOL, V93, P403, DOI 10.1007/s11103-016-0569-1; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Oh E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5140; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Perez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084891; Remy I, 2015, METHODS MOL BIOL, V1278, P467, DOI 10.1007/978-1-4939-2425-7_31; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Trigg SA, 2017, NAT METHODS, V14, P819, DOI [10.1038/nmeth.4343, 10.1038/NMETH.4343]; Uhrig JF, 2017, BBA-GENE REGUL MECH, V1860, P218, DOI 10.1016/j.bbagrm.2016.11.001; Van Leene J, 2015, NAT PROTOC, V10, P169, DOI 10.1038/nprot.2014.199; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Waaijers S, 2013, J PROTEOME RES, V12, P3181, DOI 10.1021/pr400047p; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Xing SP, 2016, PLANT PHYSIOL, V171, P727, DOI 10.1104/pp.16.00470; Yachie N, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156660; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	50	18	18	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0201270	10.1371/journal.pone.0201270	http://dx.doi.org/10.1371/journal.pone.0201270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576311	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400001
J	Shuai, CY; Lei, JY; Gong, ZWY; Ouyang, X				Shuai, Chunyan; Lei, Jiayou; Gong, Zeweiyi; Ouyang, Xin			Suitability of a new Bloom filter for numerical vectors with high dimensions	PLOS ONE			English	Article								The notable increase in the size and dimensions of data have presented challenges for data storage and retrieval. The Bloom filter and its generations, due to efficient space overheads and constant query delays, have been broadly applied to querying memberships of a big data set. However, the Bloom filter and most of the variants regard each element as a 1-dimensional string and adopt multiple different string hashes to project the data. The interesting problem is when the inputs are numerical vectors with high dimensions, it remains unknown whether they can be projected into the Bloom filter in their original format. Furthermore, we investigate whether the projection is random and uniform. To address these problems, this paper presents a new uniform Prime-HD-BKDERhash family and a new Bloom filter (P-HDBF) to retrieve the membership of a big data set with the numerical high dimensions. Since the randomness and uniformity of data mapping determines the performance of the Bloom filter, to verify these properties, we first introduce information entropy. Our theoretical and experimental results show that the P-HDBF can randomly and uniformly map the data in their native formats. Moreover, the P-HDBF provides an efficient solution alternative to implement membership search with space-time overheads. This advantage may be suitable for engineering applications that are resource-constrained or identification of the nuances of the graphics and images.	[Shuai, Chunyan; Lei, Jiayou] Kunming Univ Sci & Technol, Fac Transportat Engn, Kunming, Yunnan, Peoples R China; [Gong, Zeweiyi] Kunming Univ Sci & Technol, Fac Elect Power Engn, Kunming, Yunnan, Peoples R China; [Ouyang, Xin] Kunming Univ Sci & Technol, Fac Informat Engn, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Kunming University of Science & Technology; Kunming University of Science & Technology	Ouyang, X (corresponding author), Kunming Univ Sci & Technol, Fac Informat Engn, Kunming, Yunnan, Peoples R China.	kmoyx@hotmail.com			National Key RD Plan of China [2017YFB0306405]; National Natural Science Foundation of China [61562056, 61364008]	National Key RD Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Key R&D Plan of China (No. 2017YFB0306405) to XO, the National Natural Science Foundation of China (No. 61562056, No. 61364008) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsaleg L, 2017, DATASETS APPROXIMATE; Antikainen M, 2014, IEEE ACM T NETWORK, V22, P1463, DOI 10.1109/TNET.2013.2281614; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Bose P, 2008, INFORM PROCESS LETT, V108, P210, DOI 10.1016/j.ipl.2008.05.018; Christensen K, 2010, INFORM PROCESS LETT, V110, P944, DOI 10.1016/j.ipl.2010.07.024; Cohen S, 2003, P 2003 ACM SIGMOD IN; Crainiceanu A, 2015, INFORM SYST, V54, P311, DOI 10.1016/j.is.2015.01.002; Datar M., 2004, P 20 ANN S COMP GEOM, P253; Fagin R., 2003, P 2003 ACM SIGMOD IN, P301; Fan B, 2014, P 10 ACM INT C EM NE; Fan L, 2000, IEEE ACM T NETWORK, V8, P281, DOI 10.1109/90.851975; FEISTEL H, 1973, SCI AM, V228, P15, DOI 10.1038/scientificamerican0573-15; Fu Y, 2016, ACM T MODELING PERFO, V1, P19; Geravand S, 2013, COMPUT NETW, V57, P4047, DOI 10.1016/j.comnet.2013.09.003; Guo DK, 2010, IEEE T KNOWL DATA EN, V22, P120, DOI 10.1109/TKDE.2009.57; Heyde CC, 1984, CONVERGENCE STOCHAST, P3244; Hua Y, 2012, IEEE T COMPUT, V61, P817, DOI 10.1109/TC.2011.108; Jiang P, 2014, IEEE T SYST MAN CY-S, V44, P254, DOI 10.1109/TSMC.2013.2242884; Katz VJ, 2007, MATH EGYPT MESOPOTAM, P187; KERNIGHAN BW, 1988, PROGRAMMING LANGUAGE; Kirsch A, 2006, SIAM PROC S, P41; Ko H, 2016, IEEE T MOBILE COMPUT, V15, P516, DOI 10.1109/TMC.2015.2411603; Lim H, 2017, IEEE COMMUN LETT, V21, P278, DOI 10.1109/LCOMM.2016.2624286; Liu J, 2014, IEEE T CONSUM ELECTR, V60, P636, DOI 10.1109/TCE.2014.7027337; Mitzenmacher M, 2002, IEEE ACM T NETWORK, V10, P604, DOI 10.1109/TNET.2002.803864; Mun JH, 2016, IEEE T COMPUT, V65, P1558, DOI 10.1109/TC.2015.2444850; Oigawa Y, 2016, P INT C NETW BAS INF; Partow A., 2013, GEN PURPOSE HASH FUN; Pontarelli S, 2016, INFORM PROCESS LETT, V116, P304, DOI 10.1016/j.ipl.2015.11.002; Qian JB, 2016, IEEE COMMUN LETT, V20, P2125, DOI 10.1109/LCOMM.2016.2600670; Qian JB, 2015, IEEE T COMPUT, V64, P3500, DOI 10.1109/TC.2015.2401011; Qiao Y, 2014, IEEE T PARALL DISTR, V25, P93, DOI 10.1109/TPDS.2013.46; Reviriego P, 2016, IEEE T PARALL DISTR, V27, P303, DOI 10.1109/TPDS.2014.2378268; Rottenstreich O, 2015, IEEE ACM T NETWORK, V23, P703, DOI 10.1109/TNET.2014.2306060; Rottenstreich O, 2014, IEEE ACM T NETWORK, V22, P1092, DOI 10.1109/TNET.2013.2272604; Saravanan K, 2015, WIRELESS PERS COMMUN, V84, P821, DOI 10.1007/s11277-015-2662-1; Tarkoma S, 2012, IEEE COMMUN SURV TUT, V14, P131, DOI 10.1109/SURV.2011.031611.00024; Xiao B, 2010, IEEE T PARALL DISTR, V21, P20, DOI 10.1109/TPDS.2009.39; Xiao Ming-zhong, 2004, Acta Electronica Sinica, V32, P241; Zengin S, 2017, IEEE T PARALL DISTR, V28, P305, DOI 10.1109/TPDS.2016.2577033	40	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209159	10.1371/journal.pone.0209159	http://dx.doi.org/10.1371/journal.pone.0209159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576359	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400030
J	Tellman, B; McDonald, RI; Goldstein, JH; Vogl, AL; Florke, M; Shemie, D; Dudley, R; Dryden, R; Petry, P; Karres, N; Vigerstol, K; Lehner, B; Veiga, F				Tellman, Beth; McDonald, Robert I.; Goldstein, Joshua H.; Vogl, Adrian L.; Floerke, Martina; Shemie, Daniel; Dudley, Russ; Dryden, Rachel; Petry, Paulo; Karres, Nathan; Vigerstol, Kari; Lehner, Bernhard; Veiga, Fernando			Opportunities for natural infrastructure to improve urban water security in Latin America	PLOS ONE			English	Article							LAND-USE CHANGE; ECOSYSTEM SERVICES; CLIMATE-CHANGE; VULNERABILITY; IMPACT; WORLDS; COVER; MODEL; ENVIRONMENTS; MITIGATION	Governments, development banks, corporations, and nonprofits are increasingly considering the potential contribution of watershed conservation activities to secure clean water for cities and to reduce flood risk. These organizations, however, often lack decision-relevant, initial screening information across multiple cities to identify which specific city-watershed combinations present not only water-related risks but also potentially attractive opportunities for mitigation via natural infrastructure approaches. To address this need, this paper presents a novel methodology for a continental assessment of the potential for watershed conservation activities to improve surface drinking water quality and mitigate riverine and stormwater flood risks in 70 major cities across Latin America. We used publicly available geospatial data to analyze 887 associated watersheds. Water quality metrics assessed the potential for agricultural practices, afforestation, riparian buffers, and forest conservation to mitigate sediment and phosphorus loads. Flood reduction metrics analyzed the role of increasing infiltration, restoring riparian wetlands, and reducing connected impervious surface to mitigate riverine and stormwater floods for exposed urban populations. Cities were then categorized based on relative opportunity potential to reduce identified risks through watershed conservation activities. We find high opportunities for watershed activities to mitigate at least one of the risks in 42 cities, potentially benefiting 96 million people or around 60% of the urbanites living in the 70 largest cities in Latin America. We estimate water quality could be improved for 72 million people in 27 cities, riverine flood risk mitigated for 5 million people in 13 cities, and stormwater flooding mitigated for 44 million people in 14 cities. We identified five cities with the potential to simultaneously enhance water quality and mitigate flood risks, and in contrast, six cities where conservation efforts are unlikely to meaningfully mitigate either risk. Institutions investing in natural infrastructure to improve water security in Latin America can maximize their impact by focusing on specific watershed conservation activities either for cleaner drinking water or flood mitigation in cities identified in our analysis where these interventions are most likely to reduce risk.	[Tellman, Beth] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA; [McDonald, Robert I.] Nature Conservancy, Global Cities, 1815 N Lynn St, Arlington, VA USA; [Goldstein, Joshua H.] Nature Conservancy, Global Sci, Ft Collins, CO USA; [Vogl, Adrian L.] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [Floerke, Martina] Univ Kassel, Ctr Environm Syst Res, Kassel, Germany; [Shemie, Daniel] Nature Conservancy, Global Water, New York, NY USA; [Dudley, Russ] Tetra Tech Inc, Pasadena, CA USA; [Dryden, Rachel] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Petry, Paulo] Nature Conservancy, Latin Amer Reg, Hollis, NH USA; [Karres, Nathan; Vigerstol, Kari] Nature Conservancy, Global Water, Seattle, WA USA; [Lehner, Bernhard] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Veiga, Fernando] Nature Conservancy, Latin Amer Reg, Curitiba, Parana, Brazil	Arizona State University; Arizona State University-Tempe; Nature Conservancy; Nature Conservancy; Stanford University; Universitat Kassel; Nature Conservancy; Carnegie Mellon University; Nature Conservancy; McGill University	Tellman, B (corresponding author), Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	btellman@asu.edu	Floerke, Martina/ABE-6288-2020; Lehner, Bernhard/CAF-2153-2022	Lehner, Bernhard/0000-0003-3712-2581; Tellman, Beth/0000-0003-3026-6435; McDonald, Robert/0000-0002-7273-6549; Vogl, Adrian/0000-0001-9369-1071	SNAPP: Science for Nature and People Partnership; Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS); Gordon and Betty Moore Foundation	SNAPP: Science for Nature and People Partnership; Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was conducted by the Water Security Working Group supported in part by SNAPP: Science for Nature and People Partnership, a collaboration of The Nature Conservancy, the Wildlife Conservation Society and the National Center for Ecological Analysis and Synthesis (NCEAS), and an anonymous private foundation, and by the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors Russ Dudley, Rachel Dryden, and Beth Tellman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was conducted by the Water Security Working Group supported in part by SNAPP: Science for Nature and People Partnership, a collaboration of The Nature Conservancy, the Wildlife Conservation Society and the National Center for Ecological Analysis and Synthesis (NCEAS). Additional support came from an anonymous private foundation and the Gordon and Betty Moore Foundation. Special thanks to Caitlin Feehan who helped with the analysis, Billie Turner II and Jennifer Fair who aided in revisions, and Jeffrey Cowan who helped organize team meetings. This manuscript was greatly improved thanks to four anonymous reviewers.	Abell R., 2017, SOURCE ENV EC COMMUN; Alcott E., 2013, NATURAL ENG SOLUTION; Anderies JM, 2014, BUILD RES INF, V42, P130, DOI 10.1080/09613218.2013.857455; Balk D., 2009, GLOBAL MAPPING HUMAN, P145; Barredo Jose I., 2010, Sustainability, V2, P1327, DOI 10.3390/su2051327; Bathurst JC, 2011, J HYDROL, V400, P292, DOI 10.1016/j.jhydrol.2010.09.001; Bathurst JC, 2011, J HYDROL, V400, P281, DOI 10.1016/j.jhydrol.2010.11.044; Bathurst JC, 2010, WATER INT, V35, P114, DOI 10.1080/02508061003660714; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bennett G, 2016, ECOSYST SERV, V17, P293, DOI 10.1016/j.ecoser.2015.05.006; Bhagwat TN, 2011, CATENA, V87, P52, DOI 10.1016/j.catena.2011.05.007; Bizikova L, 2013, INT I SUSTAIN DEV, V28; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; Bright EA., 2012, LANDSCAN 2012; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; DeFries R, 2004, HYDROL PROCESS, V18, P2183, DOI 10.1002/hyp.5584; Doll P, 2003, J HYDROL, V270, P105, DOI 10.1016/S0022-1694(02)00283-4; Dorioz JM, 2006, AGR ECOSYST ENVIRON, V117, P4, DOI 10.1016/j.agee.2006.03.029; Dougherty M, 2004, PHOTOGRAMM ENG REM S, V70, P1275, DOI 10.14358/PERS.70.11.1275; Ellison D, 2012, GLOBAL CHANGE BIOL, V18, P806, DOI 10.1111/j.1365-2486.2011.02589.x; EPA, 2011, SPREADSH TOOL EST PO; EPA, 2013, NAT STORMW CALC US G; EPA, 2002, WAT TREATM MOD VERS, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; FAO, 2007, DIG SOIL MAP WORLD V; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fluet- Chouinard E, 2014, REMOTE SENS ENVIRON, DOI [10.1016/j.rse.2013.11.021, DOI 10.1016/J.RSE.2013.11.021]; Giambelluca TW, 2002, HYDROL PROCESS, V16, P1665, DOI 10.1002/hyp.5021; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Godsey S, 2004, J HYDROL, V295, P276, DOI 10.1016/j.jhydrol.2004.03.014; Gravelius H., 1914, GRUNDRIB GESAMTEN GE, VI; Green PA, 2015, GLOBAL ENVIRON CHANG, V34, P108, DOI 10.1016/j.gloenvcha.2015.06.007; Hansen R, 2014, AMBIO, V43, P516, DOI 10.1007/s13280-014-0510-2; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HARLIN JM, 1984, J HYDROL, V67, P141, DOI 10.1016/0022-1694(84)90238-5; Hermoso V, 2012, FRESHWATER BIOL, V57, P1, DOI 10.1111/j.1365-2427.2011.02693.x; Huber-Stearns HR, 2017, ECOL SOC, V22, DOI 10.5751/ES-08979-220118; Ilstedt U, 2007, FOREST ECOL MANAG, V251, P45, DOI 10.1016/j.foreco.2007.06.014; Kaspar T.C., 2008, GULF HYPOXIA LOCAL W, P129; Kawamura S., 1991, INTEGRATED DESIGN WA; Kline M, 2010, J AM WATER RESOUR AS, V46, P227, DOI 10.1111/j.1752-1688.2010.00417.x; Kousky C, 2014, ECOL ECON, V104, P119, DOI 10.1016/j.ecolecon.2014.05.001; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Li CY, 2017, J HYDROL, V549, P631, DOI 10.1016/j.jhydrol.2017.03.037; Mandle L, 2015, FRONT ECOL ENVIRON, V13, P309, DOI 10.1890/140337; Martinson E.J., 2013, FUEL TREATMENTS FIRE; McDonald R., 2009, J CONSERVAT PLANN, V5, P1; McDonald RI, 2014, URBAN WATER BLUEPRIN; McDonald RI, 2016, P NATL ACAD SCI USA, V113, P9117, DOI 10.1073/pnas.1605354113; Mejia AI, 2010, HYDROL PROCESS, V24, P3359, DOI 10.1002/hyp.7755; Merriman KR, 2009, APPL ENG AGRIC, V25, P199; Mitsch WJ, 2000, ECOL ECON, V35, P25, DOI 10.1016/S0921-8009(00)00165-8; Musy A., 2010, HYDROLOGY SCI NATURE; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Ogden FL, 2013, WATER RESOUR RES, V49, P8443, DOI 10.1002/2013WR013956; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pallard B, 2009, HYDROL EARTH SYST SC, V13, P1019, DOI 10.5194/hess-13-1019-2009; Palmer MA, 2015, SCIENCE, V349, P584, DOI 10.1126/science.aac7778; Poff NL, 2016, NAT CLIM CHANGE, V6, P25, DOI [10.1038/NCLIMATE2765, 10.1038/nclimate2765]; Postel SL, 2005, NAT RESOUR FORUM, V29, P98, DOI 10.1111/j.1477-8947.2005.00119.x; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Preston BL, 2011, SUSTAIN SCI, V6, P177, DOI 10.1007/s11625-011-0129-1; Preston SD, 2011, J AM WATER RESOUR AS, V47, P887, DOI 10.1111/j.1752-1688.2011.00585.x; Randerson JT, 2015, DATA SET, DOI [10.3334/ORNLDAAC/1293, DOI 10.3334/ORNLDAAC/1293]; Reckhow K.H., 1980, MODELING PHOSPHORUS; Romulo CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06538-x; Roose E., 1996, FAO SOILS B; Saghafian B, 2008, WATER RESOUR MANAG, V22, P1051, DOI 10.1007/s11269-007-9210-z; Sharp R., 2014, INVEST USERS GUIDE; Shuster WD, 2005, URBAN WATER J, V2, P263; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; Svendsen E, 2012, CITIES ENV, V5; Swallow BM, 2009, ECOL SOC, V14; Tellman B, 2016, REG ENVIRON CHANGE, V16, P1183, DOI 10.1007/s10113-015-0841-y; UN Habitat, 2016, INFORMAL SETTLEMENTS, DOI [10.3402/gha.v5i0.19065, DOI 10.3402/GHA.V5I0.19065]; UNPD, 2011, WORLD URB PROSP 2011; USDA- NRCS, 2004, HYDR NAT ENG HDB 630; Van Bogaert E., 2012, GLOBAL LAND COVER MA; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vogl A, 2013, RESOURCE INVESTMENT, V76; Vogl AL, 2017, ENVIRON SCI POLICY, V75, P19, DOI 10.1016/j.envsci.2017.05.007; Vorosmarty CJ, 2018, ECOHYDROL HYDROBIOL, V18, P317, DOI 10.1016/j.ecohyd.2018.07.004; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wagener T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008906; Water UN, 2013, WAT SEC GLOB WAT AG; World Research Institute, 2015, WORLDS 15 COUNTR MOS; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Zetland D., 2014, LIVING WATER SCARCIT	88	7	7	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209470	10.1371/journal.pone.0209470	http://dx.doi.org/10.1371/journal.pone.0209470			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576371	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400051
J	Paula, MC; Michelutti, KB; Eulalio, ADMM; Piva, RC; Cardoso, CAL; Antonialli, WF				Paula, Michele C.; Michelutti, Kamylla B.; Eulalio, Aylson D. M. M.; Piva, Raul C.; Cardoso, Claudia A. L.; Antonialli-Junior, William F.			New method for estimating the post-mortem interval using the chemical composition of different generations of empty puparia: Indoor cases	PLOS ONE			English	Article							CUTICULAR HYDROCARBON COMPOSITION; CHRYSOMYA-MEGACEPHALA; LUCILIA-SERICATA; DIPTERA; LARVAE; FLY; CALLIPHORIDAE; DECOMPOSITION; ADULTS; LIPIDS	Most flies of forensic importance are in two superfamilies, the Muscoidea and the Oestroidea, with similar life stages including the puparium. Upon completion of metamorphosis the adult fly emerges from the puparium, leaving behind an exuvia that is of potential significance in forensic investigation. The empty puparium is a durable piece of entomological evidence lasting several years. Through the study of chemical compounds, specifically the hydrocarbons of these puparia, it is possible to identify the species, in addition to how long they have been exposed to weathering and for this reason, these parameters can assist forensic entomologists in estimating long-term postmortem interval (minPMI). In corpses that take a relatively longer time to decompose, insects may use the same corpses for several oviposition cycles. Therefore, the aim of this study was to develop a new method to determine the PMI based on chemical compounds of the puparia from different oviposition cycles of the fly Chrysomya megacephala. The chemical composition of 50 puparia from different cycles of oviposition were evaluated by Gas Chromatography-Mass Spectrometry (GC-MS). In total, 60 compounds were identified ranging from C-18 to C-34, 38 of those were common to all generations. Our results demonstrate that chemical profiles can be used to differentiate puparia collected from successive cycles, and therefore valuable in the estimation of minPMI.	[Paula, Michele C.; Michelutti, Kamylla B.; Eulalio, Aylson D. M. M.; Antonialli-Junior, William F.] Univ Estadual Mato Grosso do Sul, Lab Ecol Comportamental, Ctr Estudos Recursos Nat, Dourados, MS, Brazil; [Paula, Michele C.; Eulalio, Aylson D. M. M.; Antonialli-Junior, William F.] Fundacao Univ Fed Grande Dourados, Programa Posgrad Entomol & Conservacao Biodiversi, Dourados, MS, Brazil; [Michelutti, Kamylla B.; Cardoso, Claudia A. L.; Antonialli-Junior, William F.] Univ Estadual Mato Grosso do Sul, Programa Posgrad Recursos Nat, Dourados, MS, Brazil; [Piva, Raul C.; Cardoso, Claudia A. L.] Fundacao Univ Fed Grande Dourados, Programa Posgrad Quim, Dourados, MS, Brazil	Universidade Estadual de Mato Grosso do Sul; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal da Grande Dourados	Paula, MC (corresponding author), Univ Estadual Mato Grosso do Sul, Lab Ecol Comportamental, Ctr Estudos Recursos Nat, Dourados, MS, Brazil.; Paula, MC (corresponding author), Fundacao Univ Fed Grande Dourados, Programa Posgrad Entomol & Conservacao Biodiversi, Dourados, MS, Brazil.	michelecastro.ufgd@gmail.com	Cardoso, Claudia Andrea Lima/AAK-5578-2020; Michelutti, Kamylla/AAS-5591-2020	Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Michelutti, Kamylla/0000-0003-4264-0703; Castro de Paula, Michele/0000-0002-5229-6136	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul [307998/2014-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [310801/2015-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307998/2014-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MCP, KBM and ADMME was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/ICG: Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul CALC and WFAJ: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br/, grant number 307998/2014-2 and grant number 310801/2015-0, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect). The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (WFAJ grant number 307998/2014-2), (CALC grant number 307998/2014-2).	Amendt J, 2004, NATURWISSENSCHAFTEN, V91, P51, DOI 10.1007/s00114-003-0493-5; Anderson Gail S., 2001, P143; Anderson GS, 2001, ADV FORENSIC TAPHONO, P173; Archer MS, 2003, MED VET ENTOMOL, V17, P263, DOI 10.1046/j.1365-2915.2003.00430.x; ARMOLD MT, 1975, J INSECT PHYSIOL, V21, P1827, DOI 10.1016/0022-1910(75)90249-8; Badhe RV, 2006, J VENOM ANIM TOXINS, V12, P612, DOI 10.1590/S1678-91992006000400008; de Carvalho CJB, 2008, REV BRAS ENTOMOL, V52, P390, DOI 10.1590/S0085-56262008000300012; Baz A, 2015, FORENSIC SCI INT, V248, P41, DOI 10.1016/j.forsciint.2014.12.012; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bonelli M, 2015, J CHEM ECOL, V41, P22, DOI 10.1007/s10886-014-0531-0; BROWN WV, 1991, COMP BIOCHEM PHYS B, V99, P553, DOI 10.1016/0305-0491(91)90337-D; Brown WV, 1998, COMP BIOCHEM PHYS B, V119, P391, DOI 10.1016/S0305-0491(97)00365-9; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Frere B, 2014, ANAL BIOANAL CHEM, V406, P1081, DOI 10.1007/s00216-013-7184-7; Gibbs AG, 1997, J EXP BIOL, V200, P1821; GOFF ML, 1991, J FORENSIC SCI, V36, P748; GOFF ML, 1987, AM J FOREN MED PATH, V8, P45, DOI 10.1097/00000433-198703000-00011; Golebiowski M, 2012, B ENTOMOL RES, V102, P453, DOI 10.1017/S0007485311000800; GOODRICH BS, 1970, J LIPID RES, V11, P1; Guillem RM, 2012, BIOL CONSERV, V148, P39, DOI 10.1016/j.biocon.2012.01.066; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Lommelen E, 2006, J CHEM ECOL, V32, P2023, DOI 10.1007/s10886-006-9126-8; Lorenzi MC, 2011, ANIM BEHAV, V82, P1143, DOI 10.1016/j.anbehav.2011.08.011; Manly BJF, 2008, METODOS ESTATISTICOS; Menzel F, 2016, EVOLUTION, V70, P2573, DOI 10.1111/evo.13068; Moore HE, 2014, FORENSIC SCI INT, V240, P48, DOI 10.1016/j.forsciint.2014.04.002; Nuorteva P., 1977, Tedeschi, C.G.; Eckert, W.G.; Tedeschi, L.G. (Editors). Forensic medicine: a study in trauma and environmental hazards. Volume II. Physical trauma., P1072; OLIVEIRA-COSTA, 2013, INSETOS PERITOS ENTO; Oliveira-Costa J., 2011, ENTOMOLOGIA FORENSE, V3rd; Paula MC, 2017, J MED ENTOMOL, V54, P14, DOI 10.1093/jme/tjw142; Pohjoismaki JLO, 2010, FORENSIC SCI INT, V199, P38, DOI 10.1016/j.forsciint.2010.02.033; Reibe S, 2010, FORENSIC SCI INT, V195, P52, DOI 10.1016/j.forsciint.2009.11.009; Roux O, 2008, MED VET ENTOMOL, V22, P309, DOI 10.1111/j.1365-2915.2008.00752.x; Roux O, 2006, BIOCHEM SYST ECOL, V34, P406, DOI 10.1016/j.bse.2005.10.013; SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013; Silahuddin SA, 2015, J MED ENTOMOL, V52, P9, DOI 10.1093/jme/tju001; Smith KGV, 1986, MANUAL FORENSIC ENTO; Stevens JR, 2003, INT J PARASITOL, V33, P1105, DOI 10.1016/S0020-7519(03)00136-X; Sukontason KL, 2007, PARASITOL RES, V101, P1407, DOI 10.1007/s00436-007-0660-2; TOOLSON EC, 1989, EVOLUTION, V43, P468, DOI 10.1111/j.1558-5646.1989.tb04242.x; Turner B, 1999, FORENSIC SCI INT, V101, P113, DOI 10.1016/S0379-0738(99)00018-3; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; WALL R, 1994, ENTOMOL EXP APPL, V73, P239, DOI 10.1007/BF02382475; Weiss K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098784; Wells Jeffrey D., 1994, Japanese Journal of Sanitary Zoology, V45, P303; Xu H, 2014, FORENSIC SCI INT, V242, P236, DOI 10.1016/j.forsciint.2014.07.003; Ye GY, 2007, J MED ENTOMOL, V44, P450, DOI 10.1603/0022-2585(2007)44[450:CHCIPE]2.0.CO;2; Zhu GH, 2006, MED VET ENTOMOL, V20, P438, DOI 10.1111/j.1365-2915.2006.00651.x; Zhu GH, 2007, FORENSIC SCI INT, V169, P1, DOI 10.1016/j.forsciint.2006.06.078; Zhu GH, 2017, INT J LEGAL MED, V131, P885, DOI 10.1007/s00414-016-1507-0; Zhu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073043; Zumpt T, 1965, Q REV BIOL, V41, P343, DOI [10.1086/405139, DOI 10.1086/405139]	54	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209776	10.1371/journal.pone.0209776	http://dx.doi.org/10.1371/journal.pone.0209776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571776	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700094
J	Carvalho, AMRS; Mendes, TAD; Coelho, EAF; Duarte, MC; Menezes-Souza, D				Ravena Severino Carvalho, Ana Maria; de Oliveira Mendes, Tiago Antonio; Ferraz Coelho, Eduardo Antonio; Duarte, Mariana Costa; Menezes-Souza, Daniel			New antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening	PLOS ONE			English	Article							ASYMPTOMATIC INFECTION; TRYPANOSOMA-CRUZI; INFANTUM ANTIGENS; SERODIAGNOSIS; TEGUMENTARY; BRAZILIENSIS; PROTEINS; REACTIVITY; ANTIBODIES; SEQUENCE	Visceral leishmaniasis (VL) still represents a serious public health problem in Brazil due to the inefficiency of the control measures currently employed, that included early diagnosis and treatment of human cases, vector control, euthanasia of infected dogs and, recently approved in Brazil, treatment with Milteforam drug. Effective clinical management depend largely on early and unequivocal diagnosis, however, cross-reactivity have also been described in serological tests, especially when it refers to individuals from areas where Chagas' disease is also present. Thus, to discover new antigens to improve the current serological tests for VL diagnosis is urgently needed. Here, we performed an immunogenomic screen strategy to identify conserved linear B-cell epitopes in the predicted L. infantum proteome using the following criteria: i) proteins expressed in the stages found in the vertebrate host, amastigote stage, and secreted/excreted, to guarantee greater exposure to the immune system; ii) divergent from proteins present in other infectious disease pathogens with incidence in endemic areas for VL, as T. cruzi; iii) highly antigenic to humans with different genetic backgrounds, independently of the clinical stage of the disease; iv) stable and adaptable to quality-control tests to guarantee reproducibility; v) using statistical analysis to determine a suitable sample size to evaluate accuracy of diagnostic tests established by receiver operating characteristic strategy. We selected six predicted linear B-cell epitopes from three proteins of L. infantum parasite. The results demonstrated that a mixture of peptides (Mix IV: peptides 3+6) were able to identify VL cases and simultaneously able to discriminate infections caused by T. cruzi parasite with high accuracy (100.00%) and perfect agreement (Kappa index = 1.000) with direct methods performed by laboratories in Brazil. The results also demonstrated that peptide-6, Mix III (peptides 2+6) and I (peptides 2+3+6) are potential antigens able to used in VL diagnosis, represented by high accuracy (Ac = 99.52%, 99.52% and 98.56%, respectively). This study represents an interesting strategy for discovery new antigens applied to serologic diagnosis which will contribute to the improvement of the diagnosis of VL and, consequently, may help in the prevention, control and treatment of the disease in endemic areas of Brazil.	[Ravena Severino Carvalho, Ana Maria; Ferraz Coelho, Eduardo Antonio; Duarte, Mariana Costa; Menezes-Souza, Daniel] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [de Oliveira Mendes, Tiago Antonio] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Ferraz Coelho, Eduardo Antonio; Duarte, Mariana Costa; Menezes-Souza, Daniel] Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais	Menezes-Souza, D (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.; Menezes-Souza, D (corresponding author), Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil.	dmsouza@ufmg.br	Menezes-Souza, Daniel DMS/N-7389-2014; COELHO, EA/V-7926-2017; Mendes, Tiago/AAG-1709-2021	COELHO, EA/0000-0002-6681-9014; Mendes, Tiago/0000-0002-5569-4893	PRPq/UFMG, Brazil [87-05/2016]; CAPES, Brazil [23038.004862/2015-74]; FAPEMIG, Brazil [APQ-03821-18]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; CNPq [408408/2016-2]	PRPq/UFMG, Brazil; CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by PRPq/UFMG (87-05/2016), CAPES (23038.004862/2015-74) and FAPEMIG (APQ-03599-18) to DM-S and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, for fellowships. MCD: CNPq (408408/2016-2) and FAPEMIG (APQ-03821-18) to EAFC and DM-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EAFC and DM-S thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, for fellowships.	Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ANTHONY RL, 1987, AM J TROP MED HYG, V37, P271, DOI 10.4269/ajtmh.1987.37.271; Artan R, 2006, J GASTROEN HEPATOL, V21, P299, DOI 10.1111/j.1440-1746.2006.04172.x; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barao SC, 2007, AM J TROP MED HYG, V77, P1051, DOI 10.4269/ajtmh.2007.77.1051; BASTIEN P, 1992, PARASITOL TODAY, V8, P174, DOI 10.1016/0169-4758(92)90016-U; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0; Costa LE, 2014, CLIN VACCINE IMMUNOL, V21, P96, DOI 10.1128/CVI.00583-13; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Mendes TAD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002524; Martinez LD, 2009, REV ESP ENFERM DIG, V101, P439, DOI 10.4321/s1130-01082009000600012; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Dias DS, 2018, CELL IMMUNOL, V323, P59, DOI 10.1016/j.cellimm.2017.11.001; Dias DS, 2018, PARASITOL INT, V67, P344, DOI 10.1016/j.parint.2018.02.001; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Duarte MC, 2015, CLIN VACCINE IMMUNOL, V22, P1187, DOI 10.1128/CVI.00465-15; Duarte MC, 2016, VET PARASITOL, V217, P81, DOI 10.1016/j.vetpar.2016.01.002; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Faria AR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001310; Faria AR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003429; Fonseca AM, 2014, ACTA TROP, V137, P25, DOI 10.1016/j.actatropica.2014.04.028; Grimaldi G, 2001, MED MICROBIOL IMMUN, V190, P3, DOI 10.1007/s004300100069; GUIMARAES MCS, 1990, B WORLD HEALTH ORGAN, V68, P39; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Lage DP, 2016, PARASITOL RES, V115, P1649, DOI 10.1007/s00436-016-4904-x; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lima BSS, 2017, J PROTEOMICS, V151, P174, DOI 10.1016/j.jprot.2016.05.017; Lima BSS, 2016, VET PARASITOL, V223, P115, DOI 10.1016/j.vetpar.2016.04.019; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mendes TM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005562; Menezes-Souza D, 2015, APPL MICROBIOL BIOT, V99, P1323, DOI 10.1007/s00253-014-6168-7; Obuchowski NA, 1997, STAT MED, V16, P1529, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1529::AID-SIM565>3.0.CO;2-H; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reus M, 2005, BRIT J RADIOL, V78, P158, DOI 10.1259/bjr/33263789; Ribeiro PAF, 2018, DIAGN MICR INFEC DIS, V92, P196, DOI 10.1016/j.diagmicrobio.2018.05.026; Salles BCS, 2017, DIAGN MICR INFEC DIS, V87, P219, DOI 10.1016/j.diagmicrobio.2016.11.012; Sato CM, 2017, J CLIN MICROBIOL, V55, P495, DOI 10.1128/JCM.01904-16; SIDDIG M, 1988, T ROY SOC TROP MED H, V82, P66, DOI 10.1016/0035-9203(88)90265-9; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Souto DEP, 2015, CURR PROTEIN PEPT SC, V16, P782, DOI 10.2174/1389203716666150505230416; Toledo-Machado CM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0747-z; Toledo-Machado CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/401509; Elisei RMT, 2018, APPL MICROBIOL BIOT, V102, P6069, DOI 10.1007/s00253-018-8992-7; Vale AM, 2009, ZOONOSES PUBLIC HLTH, V56, P41, DOI 10.1111/j.1863-2378.2008.01183.x; WHO, 2014, LEISHM REP NEGL DIS, V375; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	55	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209599	10.1371/journal.pone.0209599	http://dx.doi.org/10.1371/journal.pone.0209599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571783	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700089
J	Singer, RA; Love, KJ; Page, LM				Singer, Randal A.; Love, Kevin J.; Page, Lawrence M.			A survey of digitized data from US fish collections in the iDigBio data aggregator	PLOS ONE			English	Article								Recent changes in institutional cyberinfrastructure and collections data storage methods have dramatically improved accessibility of specimen-based data through the use of digital databases and data aggregators. This analysis of digitized fish collections in the U.S. demonstrates how information from data aggregators, in this case iDigBio, can be extracted and analyzed. Data from U.S. institutional fish collections in iDigBio were explored through a strictly programmatic approach using the ridigbio package and fishfindR web application. iDigBio facilitates the aggregation of collections data on a purely voluntary fashion that requires collection staff to consent to sharing of their data. Not all collections are sharing their data with iDigBio, but the data harvested from 38 of the 143 known fish collections in the U.S. that are in iDigBio account for the majority of fish specimens housed in U.S. collections. In the 22 years since publication of the last survey providing information on these 38 collections, 1,219,168 specimen records (lots), 15,225,744 specimens, 3,192 primary types, and 32,868 records of secondary types have been added. This is an increase of 65.1% in the number of cataloged records and an increase of 56.1% in the number of specimens. In addition to providing specimen-based data for research, education, and various outreach activities, data that are accessible via data aggregators can be used to develop accurate, up-to-date reports of information on institutional collections. Such reports present collections data in an organized and accessible fashion and can guide targeted efforts by collections personnel to meet discipline-specific needs and make data more transparent to downstream users. Data from this survey will be updated and published regularly in a dynamic web application that will aid collections staff in communicating collections value while simultaneously giving stakeholders a way to explore collections holdings as they relate to the institutions in which they are housed. It is through this resource that collections will be able to leverage their data against those of similar collections to aid in the procurement of financial and institutional support.	[Singer, Randal A.; Love, Kevin J.; Page, Lawrence M.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Singer, RA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	rsinger@flmnh.ufl.edu		Singer, Randal/0000-0003-2440-7625	Digitization HUB: A Collections Digitization Framework for the 21st Century [EF1115210]; Digitization: iDigBio: Integrated Digitized Biocollections Phase 2 [DBI 1547229]; National Science Foundation's Advancing Digitization of Biodiversity Collections Program [EF1115210, DBI 1547229]	Digitization HUB: A Collections Digitization Framework for the 21st Century; Digitization: iDigBio: Integrated Digitized Biocollections Phase 2; National Science Foundation's Advancing Digitization of Biodiversity Collections Program	Funded by Digitization HUB: A Collections Digitization Framework for the 21st Century (EF1115210). https://www.nsf.gov/awardsearch/showAward?AWD_ID=1115210. Digitization: iDigBio: Integrated Digitized Biocollections Phase 2 (DBI 1547229). https://www.nsf.gov/awardsearch/showAward?AWD_ID=1547229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by iDigBio with funding from the National Science Foundation's Advancing Digitization of Biodiversity Collections Program (EF1115210, DBI 1547229). We thank F. Michonneau for contributions to the development of the ridigbio R package and for continued support with collections-based analyses. We thank R. Robins, N. Rios, B. Sidlauskas, A. Williston, D. Werneke, K. Pearson Maslenikov, A. Bentley and J. McCaffrey for assistance in the vetting of data. We thank M. Sabaj for communications regarding symbolic codes for collections. We thank P. Reitz and three anonymous reviewers for editorial review of the manuscript.	Collette B.B., 1976, Copeia, V1976, P625; Eschmeyer WN, CATALOG FISHES GENER; Fegraus E.H., 2005, B ECOLOGICAL SOC AM, V86, P158, DOI DOI 10.1890/0012-9623(2005)86[158:MTVOED]2.0.CO;2; Hill A., 2012, INTERFACE DATA CARTO; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; Lemon J., 2014, R NEWS, V6, P8; Ooms J., ARXIV14032805; Page LM, 2015, BIOSCIENCE, V65, P841, DOI 10.1093/biosci/biv104; Plotly Technologies Inc, 2015, COLL DAT SCI MONTR; POSS SG, 1995, COPEIA, P48; Sabaj M. H., 2016, AM SOC ICHTHYOLOGIST; Singer RA., 2018, DATA SURVEY AGGREGAT; South A, 2011, R J, V3, P35; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1	15	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207636	10.1371/journal.pone.0207636	http://dx.doi.org/10.1371/journal.pone.0207636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566501	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300013
J	Tricot, T; Helsen, N; Kaptein, SJF; Neyts, J; Verfaillie, CM				Tricot, Tine; Helsen, Nicky; Kaptein, Suzanne J. F.; Neyts, Johan; Verfaillie, Catherine M.			Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals	PLOS ONE			English	Article							INFECTION; TRANSMISSION; PATHOGENESIS; OUTBREAK	Zika virus (ZIKV) infection during pregnancy has been extensively linked to microcephaly in newborns. High levels of ZIKV RNA were, however, also detected in mice and non-human primates in organs other than the brain, such as the liver. As ZIKV is a flavivirus closely related to the dengue and yellow fever virus, which are known to cause hepatitis, we here examined whether human hepatocytes are susceptible to ZIKV infection. We demonstrated that both human pluripotent stem cell (hPSC)-derived hepatocyte-like cells (HLCs) and the Huh7 hepatoma cell line support the complete ZIKV replication cycle. Of three antiviral molecules that inhibit ZIKV infection in Vero cells, only 7-deaza-2'-C-methyladenosine (7DMA) inhibited ZIKV replication in hPSC-HLCs, while all drugs inhibited ZIKV infection in Huh7 cells. ZIKV-infected hPSC-HLCs but not Huh7 cells mounted an innate immune and NF kappa beta response, which may explain the more extensive cytopathic effect observed in Huh7 cells. In conclusion, ZIKV productively infects human hepatocytes in vitro. However, significant differences in the innate immune response against ZIKV and antiviral drug sensitivity were observed when comparing hPSC-HLCs and hepatoma cells, highlighting the need to assess ZIKV infection as well as antiviral activity not only in hepatoma cells, but also in more physiologically relevant systems.	[Tricot, Tine; Helsen, Nicky; Verfaillie, Catherine M.] Univ Leuven KU Leuven, Stem Cell Inst, Leuven, Belgium; [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium; [Helsen, Nicky] Ismar Healthcare NV, Lier, Belgium	KU Leuven; KU Leuven	Tricot, T; Verfaillie, CM (corresponding author), Univ Leuven KU Leuven, Stem Cell Inst, Leuven, Belgium.	tine.tricot@kuleuven.be; catherine.verfaillie@kuleuven.be	Neyts, Johan/U-8267-2017; Kaptein, Suzanne JF/O-4714-2019; Kaptein, Suzanne JF/O-8855-2018; Verfaillie, Catherine/H-5148-2013	Neyts, Johan/0000-0002-0033-7514; Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne JF/0000-0002-7935-0219; Tricot, Tine/0000-0002-6710-4838; Verfaillie, Catherine/0000-0001-7564-4079	Research Foundation-Flanders (FWO) [1185918N]; agency for Innovation by Science and Technology (IWT) [SB/121396]; KU Leuven; BELSPO-IUAP-BELVIR; IWT-SBO-HILIM-3D; KU Leuven [ETH-C1900-PF]; BELSPO-IUAP-DEVREPAIR; H2020-EuTOX-Risk [681002]; European Union [734584, 734548]	Research Foundation-Flanders (FWO)(FWO); agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); BELSPO-IUAP-BELVIR; IWT-SBO-HILIM-3D; KU Leuven(KU Leuven); BELSPO-IUAP-DEVREPAIR; H2020-EuTOX-Risk; European Union(European Commission)	T.T. was funded by the Research Foundation-Flanders (FWO) (1185918N) (http://www.fwo.be). N.H.was funded by the agency for Innovation by Science and Technology (IWT) (SB/121396) (https://www.vlaio.be). Funding to J.N. was from KU Leuven, BELSPO-IUAP-BELVIR (http://www.belspo.be), IWT-SBO-HILIM-3D (https://www.vlaio.be). Funding to C.M.V. was from KU Leuven (ETH-C1900-PF), BELSPO-IUAP-DEVREPAIR (http://www.belspo.be), IWT-SBO-HILIM-3D (https://www.vlaio.be) and H2020-EuTOX-Risk (#681002) (https://ec.europa.eu/programmes/horizon2020). This work was partially funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement no. 734584 (ZikaPLAN) and No 734548 (ZIKAlliance) (https://ec.europa.eu/programmes/horizon2020) to C.M.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dowall SD, 2016, PLOS NEGLECT TROP D, V10, P1, DOI [10.1371/journal.pntd, DOI 10.1371/JOURNAL.PNTD]; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dyer O., 2015, BMJ; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Helsen N, 2016, J HEPATOL, V64, P565, DOI 10.1016/j.jhep.2015.11.013; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; KERR JA, 1973, T ROY SOC TROP MED H, V67, P882, DOI 10.1016/0035-9203(73)90020-5; Lang JS, 2016, STEM CELL REP, V7, P341, DOI 10.1016/j.stemcr.2016.07.012; Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022; Macnamara F., 1954, T R SOC TROP MED HYG, V48; Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015; Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Sakurai F, 2017, SCI REP-UK, V7, DOI 10.1038/srep45698; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shlomai A, 2014, P NATL ACAD SCI USA, V111, P12193, DOI 10.1073/pnas.1412631111; Sumpter R, RIG I, V79, P2689; Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Vanhove J, 2016, STEM CELL REP, V7, P192, DOI 10.1016/j.stemcr.2016.06.013; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002; Woodson SE, 2011, J GEN VIROL, V92, P2262, DOI 10.1099/vir.0.031617-0; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Wu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05790-3; Xia Y, 2017, J HEPATOL, V66, P494, DOI 10.1016/j.jhep.2016.10.009; Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zhou XL, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.018; Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695	52	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209097	10.1371/journal.pone.0209097	http://dx.doi.org/10.1371/journal.pone.0209097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566505	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300071
J	Hu, LI; Filippova, EV; Dang, J; Pshenychnyi, S; Ruan, JP; Kiryukhina, O; Anderson, WF; Kuhn, ML; Wolfe, AJ				Hu, Linda, I; Filippova, Ekaterina, V; Dang, Joseph; Pshenychnyi, Sergii; Ruan, Jiapeng; Kiryukhina, Olga; Anderson, Wayne F.; Kuhn, Misty L.; Wolfe, Alan J.			The spermidine acetyltransferase SpeG regulates transcription of the small RNA rprA	PLOS ONE			English	Article							MEMBRANE LIPOPROTEIN RCSF; ESCHERICHIA-COLI; RESPONSE REGULATOR; HIGH-THROUGHPUT; PROTEIN ACETYLATION; PHOSPHORELAY SYSTEM; CAPSULE SYNTHESIS; ENVELOPE STRESS; GENES; VIRULENCE	Spermidine N-acetyltransferase (SpeG) acetylates and thus neutralizes toxic polyamines. Studies indicate that SpeG plays an important role in virulence and pathogenicity of many bacteria, which have evolved SpeG-dependent strategies to control polyamine concentrations and survive in their hosts. In Escherichia coli, the two-component response regulator RcsB is reported to be subject to N-epsilon-acetylation on several lysine residues, resulting in reduced DNA binding affinity and reduced transcription of the small RNA rprA; however, the physiological acetylation mechanism responsible for this behavior has not been fully determined. Here, we performed an acetyltransferase screen and found that SpeG inhibits rprA promoter activity in an acetylation-independent manner. Surface plasmon resonance analysis revealed that SpeG can physically interact with the DNA-binding carboxyl domain of RcsB. We hypothesize that SpeG interacts with the DNA-binding domain of RcsB and that this interaction might be responsible for SpeG-dependent inhibition of RcsB-dependent rprA transcription. This work provides a model for SpeG as a modulator of E. coli transcription through its ability to interact with the transcription factor RcsB. This is the first study to provide evidence that an enzyme involved in polyamine metabolism can influence the function of the global regulator RcsB, which integrates information concerning envelope stresses and central metabolic status to regulate diverse behaviors.	[Hu, Linda, I; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Hlth Sci Div, Maywood, IL 60153 USA; [Filippova, Ekaterina, V; Ruan, Jiapeng; Kiryukhina, Olga; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Dang, Joseph; Kuhn, Misty L.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Pshenychnyi, Sergii] Northwestern Univ, Chem Life Proc Inst, Recombinant Prot Prod Core, Chicago, IL 60611 USA; [Hu, Linda, I] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Filippova, Ekaterina, V] Univ Chicago, Dept Biochem & Mol Biol, Knapp Ctr Biomed Discovery, 920 E 58Th St, Chicago, IL 60637 USA; [Ruan, Jiapeng] Yale Univ, Sch Med, Dept Digest Dis, New Haven, CT USA	Loyola University Chicago; Northwestern University; Feinberg School of Medicine; California State University System; San Francisco State University; Northwestern University; Northwestern University; Feinberg School of Medicine; University of Chicago; Yale University	Wolfe, AJ (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Hlth Sci Div, Maywood, IL 60153 USA.	awolfe@luc.edu		Kiryukhina, Olga/0000-0001-5962-8423	NIGMS [R01 GM066130]; NIAID [R01 AI108255]; NIAID, NIH, Department of Health and Human Services [HHSN272200700058C, HHSN272201200026C]; San Francisco State University; NIGMS = National Institute of General Medical Sciences; NIAID = National Institute of Allergy and Infectious Diseases; SFSU = San Francisco State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108255] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); San Francisco State University; NIGMS = National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID = National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); SFSU = San Francisco State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by R01 GM066130 (NIGMS to AJW), R01 AI108255 (NIAID to AJW), by contracts HHSN272200700058C and HHSN272201200026C (NIAID, NIH, Department of Health and Human Services to WFA), and by startup funds from San Francisco State University (to MLK); NIGMS = National Institute of General Medical Sciences, https://www.nigms.nih.gov/; NIAID = National Institute of Allergy and Infectious Diseases, https://www.niaid.nih.gov/; SFSU = San Francisco State University, http://www.sfsu.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson WFE, 2014, METHODS PROTOCOLS; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; BRILL JA, 1988, J BACTERIOL, V170, P2599, DOI 10.1128/jb.170.6.2599-2611.1988; Campilongo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106589; CARPER SW, 1991, J BIOL CHEM, V266, P12439; Castanie-Cornet MP, 2007, MICROBIOL-SGM, V153, P238, DOI 10.1099/mic.0.29278-0; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Castano-Cerezo S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145227; Chattopadhyay MK, 2015, J BIOL CHEM, V290, P17809, DOI 10.1074/jbc.M115.655688; Cho SH, 2014, CELL, V159, P1652, DOI 10.1016/j.cell.2014.11.045; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Filippova EV, 2018, MBIO, V9, DOI 10.1128/mBio.01993-17; Filippova EV, 2015, J MOL BIOL, V427, P3538, DOI 10.1016/j.jmb.2015.09.013; Filippova EV, 2015, J MOL BIOL, V427, P1316, DOI 10.1016/j.jmb.2015.01.009; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; FUKUCHI J, 1994, J BIOL CHEM, V269, P22581; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; Pucciarelli MG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02605; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; Howery KE, 2016, CURRENT GENETICS; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Hussein NA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007398; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Konovalova A, 2014, P NATL ACAD SCI USA, V111, pE4350, DOI 10.1073/pnas.1417138111; Kuhne C, 2016, MOL MICROBIOL, V101, P841, DOI 10.1111/mmi.13427; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Kuhn ML, 2013, PROTEIN SCI, V22, P222, DOI 10.1002/pro.2199; Kwon K, 2014, METHODS MOL BIOL, V1140, P61, DOI 10.1007/978-1-4939-0354-2_5; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lehti TA, 2012, J BACTERIOL, V194, P3475, DOI 10.1128/JB.06596-11; Limsuwun K, 2000, J BACTERIOL, V182, P5373, DOI 10.1128/JB.182.19.5373-5380.2000; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Majdalani N, 2001, MOL MICROBIOL, V39, P1382, DOI 10.1111/j.1365-2958.2001.02329.x; Majorek KA, 2017, BBA-PROTEINS PROTEOM, V1865, P55, DOI 10.1016/j.bbapap.2016.10.011; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Makowska-Grzyska M, 2014, METHODS MOL BIOL, V1140, P89, DOI 10.1007/978-1-4939-0354-2_7; Mariscotti JF, 2008, MICROBIOL-SGM, V154, P1372, DOI 10.1099/mic.0.2007/015891-0; Mariscotti JF, 2009, J BACTERIOL, V191, P1855, DOI 10.1128/JB.01604-08; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Pannen D, 2016, J BIOL CHEM, V291, P2357, DOI 10.1074/jbc.M115.696815; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Ren J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005458; Richter L, 2016, J EXPER MICROBIOL IM, V2, P42; Salazar ME, 2015, CURR OPIN MICROBIOL, V24, P7, DOI 10.1016/j.mib.2014.12.003; Sato T, 2017, MICROBIOL-SGM, V163, P1071, DOI 10.1099/mic.0.000483; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Silhavy T.J., 1984, EXPT GENE FUSIONS; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; Stratmann T, 2012, MOL MICROBIOL, V83, P1109, DOI 10.1111/j.1365-2958.2012.07993.x; Sugiyama S, 2016, INT J BIOCHEM CELL B, V76, P87, DOI 10.1016/j.biocel.2016.05.003; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Wang QF, 2009, MOL MICROBIOL, V74, P71, DOI 10.1111/j.1365-2958.2009.06851.x; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2016, CURR GENET, V62, P335, DOI 10.1007/s00294-015-0552-4	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0207563	10.1371/journal.pone.0207563	http://dx.doi.org/10.1371/journal.pone.0207563			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562360	Green Submitted, gold, Green Published			2022-12-26	WOS:000453774100007
J	Jin, CH; Chen, GH; Yu, CH; Shan, JS; Zhao, JY; Jin, Y				Jin, Chunhua; Chen, Guanhua; Yu, Changhui; Shan, Jinsong; Zhao, Jianyang; Jin, Ying			An efficient heterogeneous signcryption for smart grid	PLOS ONE			English	Article							AUTHENTICATION; SECURITY; INFORMATION; SCHEME; POWER	A smart grid, considered the next-generation type of power grid, combines a traditional power grid with information and communication technologies to effectively facilitate power generation and ensure transmission security and reliability in real-time. Only authorized consumers should be able to access the smart grid because the information gathered by smart meters includes users' private information. However, smart grid security is still a challenge. Motivated by this challenge, in this paper, we propose a heterogeneous signcryption (HSC) scheme for secure communication between smart meters and the utility. We demonstrate that this scheme is indistinguishable against adaptive chosen-ciphertext attacks (IND-CCA2), existentially unforgeable against adaptive chosen-message attacks (EUF-CMA) and ciphertext-anonymous against adaptive chosen ciphertext attacks (ANON-CCA2) under the computational Diffie-Hellman (CDH) problem in the random oracle model. Our scheme simultaneously achieves confidentiality, integrity, authentication, non-repudiation and ciphertext anonymity in a single logical step. It supports heterogeneous systems, allowing a meter in an identity-based cryptography (IBC) environment to transmit electrical usage data to a utility in a public key infrastructure (PKI) environment. Compared with other existing related schemes, our scheme has the lowest communication overhead and energy consumption for the smart grid. Based on these features, our scheme is highly suitable for secure power transmissions in a smart grid.	[Jin, Chunhua; Chen, Guanhua; Yu, Changhui; Shan, Jinsong; Zhao, Jianyang; Jin, Ying] Huaiyin Inst Technol, Fac Comp & Software Engn, Huaian, Peoples R China	Huaiyin Institute of Technology	Jin, CH (corresponding author), Huaiyin Inst Technol, Fac Comp & Software Engn, Huaian, Peoples R China.	xajch0206@163.com			Natural Science Foundation of Jiangsu Province [BK20161302]; Electric Power Company Technology Project of Jiangsu Province [J2017123]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Electric Power Company Technology Project of Jiangsu Province	This work is supported by the Natural Science Foundation of Jiangsu Province (Grant No. BK20161302 to JZ), Electric Power Company Technology Project of Jiangsu Province (Grant No. J2017123 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2002, LECT NOTES COMPUT SC, V2332, P83; Bao F., 1998, Public Key Cryptography. First International Workshop on Practice and Theory in Public Key Cryptography, PKC'98. Proceedings, P55, DOI 10.1007/BFb0054014; Barreto PSLM, 2005, LECT NOTES COMPUT SC, V3788, P515; Boneh D, 2003, SIAM J COMPUT, V32, P586, DOI 10.1137/S0097539701398521; Boyen  X., 2003, P CRYPTO 2003, P383, DOI [10.1007/978-3-540-45146-4_23, DOI 10.1007/978-3-540-45146-4_23]; Cao XF, 2008, COMPUT COMMUN, V31, P659, DOI 10.1016/j.comcom.2007.10.017; Chen LQ, 2005, LECT NOTES COMPUT SC, V3386, P362; Chim TW, 2015, IEEE T DEPEND SECURE, V12, P85, DOI 10.1109/TDSC.2014.2313861; Chow S.S.M., 2003, LECT NOTES COMPUTER, P352; Coron JS, 2000, LECT NOTES COMPUT SC, V1880, P229; Diao F, 2015, IEEE T SMART GRID, V6, P461, DOI 10.1109/TSG.2014.2358225; Erol-Kantarci M, 2012, IEEE T IND INFORM, V8, P1; Gamage C, 1999, LECT NOTES COMPUT SC, V1560, P69; Gura N, 2004, LECT NOTES COMPUT SC, V3156, P119; He DBA, 2016, WIREL NETW, V22, P491, DOI 10.1007/s11276-015-0983-3; Hu B, 2014, IEEE T SMART GRID, V5, P550, DOI 10.1109/TSG.2013.2277963; Huang Q, 2011, COMPUT J, V54, P525, DOI 10.1093/comjnl/bxq095; Jo HJ, 2014, IEEE T MOBILE COMPUT, V13, P1469, DOI 10.1109/TMC.2013.134; Komninos N, 2014, IEEE COMMUN SURV TUT, V16, P1933, DOI 10.1109/COMST.2014.2320093; Li CK, 2010, J COMPUT SECUR, V18, P451, DOI 10.3233/JCS-2009-0374; Li FG, 2016, WIRELESS PERS COMMUN, V89, P1391, DOI 10.1007/s11277-016-3327-4; Li FG, 2016, TELECOMMUN SYST, V62, P111, DOI 10.1007/s11235-015-0065-y; Li FG, 2013, IEEE SENS J, V13, P3677, DOI 10.1109/JSEN.2013.2262271; Li F, 2013, IEEE SYST J, V7, P420, DOI 10.1109/JSYST.2012.2221897; Li FJ, 2010, INT CONF SMART GRID, P327, DOI 10.1109/SMARTGRID.2010.5622064; Liang H, 2012, IEEE INFOCOM SER, P1674, DOI 10.1109/INFCOM.2012.6195538; Libert B., 2003, IACR CRYPTOL EPRINT, V2003, P23; Liu T, 2014, IEEE T SMART GRID, V5, P1175, DOI 10.1109/TSG.2013.2264537; Liu YN, 2016, IEEE SENS J, V16, P836, DOI 10.1109/JSEN.2015.2489258; Lu RX, 2012, IEEE T PARALL DISTR, V23, P1621, DOI 10.1109/TPDS.2012.86; Ma CS, 2014, SECUR COMMUN NETW, V7, P759, DOI 10.1002/sec.777; Malone-Lee J, 2003, LECT NOTES COMPUT SC, V2612, P211; Mets K, 2014, IEEE COMMUN SURV TUT, V16, P1771, DOI 10.1109/SURV.2014.021414.00116; Ren K, 2011, IEEE T SMART GRID, V2, P643, DOI 10.1109/TSG.2011.2175834; Saxena N, 2016, IEEE T INF FOREN SEC, V11, P907, DOI 10.1109/TIFS.2015.2512525; Shim KA, 2000, AD HOC NETW, V11, P182, DOI [10.1016/j.adhoc, DOI 10.1016/J.ADHOC]; Shim KA, 2014, AD HOC NETW, V19, P1, DOI 10.1016/j.adhoc.2014.01.011; So HKH, 2010, INT CONF SMART GRID, P321, DOI 10.1109/SMARTGRID.2010.5622061; Su WC, 2012, IEEE T IND INFORM, V8, P1, DOI 10.1109/TII.2011.2172454; Sun YX, 2010, SCI CHINA INFORM SCI, V53, P557, DOI 10.1007/s11432-010-0061-5; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	41	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208311	10.1371/journal.pone.0208311	http://dx.doi.org/10.1371/journal.pone.0208311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562351	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100012
J	Farhangi, MA; Najafi, M				Farhangi, Mandieh Abbasalizad; Najafi, Mandi			Empirically developed dietary inflammatory potential (EDIP) in patients candidate for coronary artery bypass grafting surgery (CABG): Association with metabolic parameters, dietary antioxidant quality score and dietary phytochemical index	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; CARDIOVASCULAR RISK; POPULATION	Aims It has been suggested that empirically developed dietary inflammatory potential (EDIP) is a diagnostic tool for assessment of inflammatory potential of diet in prediction of risk factors related to chronic disease. In the current work, we examined the association between EDIP with cardio-metabolic risk factors, dietary antioxidant quality score (DAQs), dietary phytochemical index (DPI) and Mediterranean dietary quality index (MEDQI) in patients candidate for CABG. Materials and methods In the current cross-sectional study, the data obtained from Tehran-Heart Center-Coronary Outcome Measurement (THC-COM) study from 454 patients candidate for the CABG were used. Laboratory measurements including hemoglobin (Hb)-A1C, serum lipids, creatinine, blood urea nitrogen (BUN), hematocrit, Lp(a), telomerase activity, serum vitamin D and c-reactive protein (CRP) were measured with commercial laboratory methods. Dietary indices were measured according to the data obtained from with semi-quantitative FFQ. Results In the current work, patients in top quintile of EDIP had higher BMI and higher prevalence of hyperlipidemia compared with patients in lowest quintile (BMI: 28.08 +/- 3.68 vs 26.69 +/- 3.67 and hyperlipidemia: 77.8 vs 65.5%; P < 0.05). Moreover, lower EDIP scores were accompanied with higher vitamin E (0.48 vs 0.4) and total dietary antioxidant scores (4.40 VS 4.28), higher dietary phytochemical scores (69.79 vs 58.29) and lower dietary Mediterranean quality scores (P < 0.05 and P <0.01 respectively). In male patients, being at highest quintiles of EDIP make patients 2-5% more likely to have higher concentrations of serum cholesterol, BUN and Lp (a), and 6 to 8 times more likely to have higher creatinine and 66% more likely to have lower albumin concentrations compared with male patients in lowest quintiles. In female patients, lower HCT, higher creatinine, higher CRP concentrations and higher telomerase activity were also achieved by higher EDIP scores (P < 0.05). Conclusion According to our finding, EDIP was associated with obesity, high prevalence of dyslipidemia and cardio-metabolic risk factors. Moreover, EDIP was in an inverse association with dietary antioxidant quality score and dietary phytochemical index. Therefore, EDIP could be assumed as a precise tool for estimating the CVD related risk factors among patients candidate for CABG.	[Farhangi, Mandieh Abbasalizad] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran; [Najafi, Mandi] Univ Tehran Med Sci, Tehran Heart Ctr, Dept Res, Tehran, Iran; [Najafi, Mandi] USERN, CORE, Tehran, Iran	Tabriz University of Medical Science; Tehran University of Medical Sciences	Najafi, M (corresponding author), Univ Tehran Med Sci, Tehran Heart Ctr, Dept Res, Tehran, Iran.; Najafi, M (corresponding author), USERN, CORE, Tehran, Iran.	najafik@sina.tums.ac.ir	Farhangi, Mahdieh Abbasalizad/AAC-6758-2019		Tabriz University of Medical Sciences	Tabriz University of Medical Sciences	The current work has been supported by a grant from Tabriz University of Medical Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawaked RA, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1328961; Alkerwi A, 2014, NUTR RES, V34, P1058, DOI 10.1016/j.nutres.2014.07.017; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Eckel RH, 2013, J AM COLL CARDIOL, V129; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Farhangi MA, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0325-2; Farhangi MA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0544-z; Hatmi Z N, 2007, BMC Cardiovasc Disord, V7, P32, DOI 10.1186/1471-2261-7-32; Hodge AM, 2016, CANCER CAUSE CONTROL, V27, P907, DOI 10.1007/s10552-016-0770-1; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Kalantar-Zadeh K, 2005, J RENAL NUTR, V15, P318, DOI 10.1016/j.jrn.2005.04.004; Kaysen GA, 2004, KIDNEY INT, V65, P1408, DOI 10.1111/j.1523-1755.2004.00520.x; Kizil M, 2016, NUTR RES PRACT, V10, P404, DOI 10.4162/nrp.2016.10.4.404; Neufcourt L, 2015, NUTR METAB CARDIOVAS, V25, P988, DOI 10.1016/j.numecd.2015.09.002; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Ramallal R, 2017, OBESITY, V25, P997, DOI 10.1002/oby.21833; Rivas A, 2012, NUTR HOSP, V27, P1886, DOI 10.3305/nh.2012.27.6.6039; Ruiz-Canela M, 2015, BRIT J NUTR, V113, P984, DOI 10.1017/S0007114514004401; Sadeghi M, 2017, IRAN J PUBLIC HEALTH, V46, P506; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Stewart J, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004016687211; Tabung FK, 2017, FASEB J, V31; Tabung FK, 2016, J NUTR, V146, P1560, DOI 10.3945/jn.115.228718; Tur JA, 2005, PUBLIC HEALTH NUTR, V8, P275, DOI 10.1079/PHN2004693; UK NCGC, 2014, LIP MOD CARD RISK AS; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wirth MD, 2014, J OCCUP ENVIRON MED, V56, P986, DOI 10.1097/JOM.0000000000000213; Xu H, 2015, J NUTR, V145, P729, DOI 10.3945/jn.114.205187; Zysset D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13151	30	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208711	10.1371/journal.pone.0208711	http://dx.doi.org/10.1371/journal.pone.0208711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557399	Green Submitted, gold, Green Published			2022-12-26	WOS:000453451000038
J	Nakasone, Y; Kumagai, K; Matsubaram, R; Shigematsu, H; Kitaura, K; Suzuki, S; Satoh, M; Hamada, Y; Suzuki, R				Nakasone, Yasunari; Kumagai, Kenichi; Matsubaram, Ryota; Shigematsu, Hiroaki; Kitaura, Kazutaka; Suzuki, Satsuki; Satoh, Masashi; Hamada, Yoshiki; Suzuki, Ryuji			Characterization of T cell receptors in a novel murine model of nickel-induced intraoral metal contact allergy	PLOS ONE			English	Article							ORAL LICHENOID LESIONS; INVARIANT NKT CELLS; LANGERHANS CELLS; DENDRITIC CELLS; IN-VITRO; SKIN; HYPERSENSITIVITY; DERMATITIS; INDUCTION; MUCOSA	Nickel is a component of several alloy types that are widely used in our environment, including several dental alloy types that cause intraoral metal contact allergy. However, metal-specific immune responses in the oral mucosa have not been elucidated because a suitable animal model has not been established. In this study, we established a novel murine model of nickel-induced intraoral metal contact allergy and aimed to elucidate the immune response in terms of T-cell receptor repertoire and cytokine profiles in inflamed oral mucosa. The intraoral metal contact allergy model was induced by two sensitizations of nickel plus lipopolysaccharide solution into the postauricular skin followed by a single nickel challenge of the buccal mucosa. Cytokine expression profiles and T-cell phenotypes were determined by quantitative polymerase chain reaction. T cells accumulated in the cervical lymph nodes and inflamed oral mucosa were characterized by analyzing their T-cell receptor alpha- and beta-chain repertoires, and the nucleotide sequences of complementary determining region 3. Significant swelling and pathological features were histologically evident at 1 day after challenge in mice with nickel allergy. At 1 day after the challenge, CD8-positive T cells producing high levels of T helper 1 type cytokines had accumulated in the allergic oral mucosa. At 7 days after the challenge, excessive nickel allergy in the oral mucosa was suppressed by regulatory T cells. Characterization of the T-cell receptor repertoire in nickel allergic mice revealed the presence of natural killer T cells and T cells bearing Trav6-6-Traj57 at 1 day after the challenge. Our murine model of nickel-induced intraoral metal contact allergy showed that natural killer T cells and T cells bearing Trav6-6-Traj57 might be involved in the immune responses of nickel-induced intraoral metal contact allergy.	[Nakasone, Yasunari; Kumagai, Kenichi; Shigematsu, Hiroaki; Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Nakasone, Yasunari; Kumagai, Kenichi; Matsubaram, Ryota; Shigematsu, Hiroaki; Kitaura, Kazutaka; Suzuki, Ryuji] Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Rheumatol & Allergy, Dept Clin Immunol, Sagamihara, Kanagawa, Japan; [Kumagai, Kenichi; Shigematsu, Hiroaki; Hamada, Yoshiki] Tsurumi Univ, Ctr Oral & Maxillofacial Implantol, Dent Hosp, Yokohama, Kanagawa, Japan; [Matsubaram, Ryota] Yokohama Gen Hosp, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Res Ctr Odontol, Sect Biol Sci, Sch Life Dent Tokyo, Tokyo, Japan; [Satoh, Masashi] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa, Japan	Tsurumi University; Tsurumi University; Nippon Dental University; Kitasato University	Kumagai, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan.; Kumagai, K; Suzuki, R (corresponding author), Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Rheumatol & Allergy, Dept Clin Immunol, Sagamihara, Kanagawa, Japan.; Kumagai, K (corresponding author), Tsurumi Univ, Ctr Oral & Maxillofacial Implantol, Dent Hosp, Yokohama, Kanagawa, Japan.	kumagai-kenichi@tsurumi-u.ac.jp; suzuki.ryuji.aj@mail.hosp.go.jp	Suzuki, Satsuki/ABE-1283-2020	nakasone, yasunari/0000-0002-6396-9025	JSPS KAKENHI [JP15K11329, JP16K20443]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K11329 (Y.H., K.Ku. and R.S.) and JP16K20443 (H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLFORS E, 1991, CLIN EXP IMMUNOL, V86, P449; Ahlfors E, 1996, CLIN EXP IMMUNOL, V104, P297, DOI 10.1046/j.1365-2249.1996.967659.x; Almogren A, 2013, CENT EUR J IMMUNOL, V38, P100, DOI 10.5114/ceji.2013.34365; Askenase PW, 2011, SCAND J IMMUNOL, V73, P465, DOI 10.1111/j.1365-3083.2011.02522.x; Balato A, 2009, J INVEST DERMATOL, V129, P1628, DOI 10.1038/jid.2009.30; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Campos RA, 2003, J EXP MED, V198, P1785, DOI 10.1084/jem.20021562; Cavani A, 2000, J INVEST DERMATOL, V114, P295, DOI 10.1046/j.1523-1747.2000.00881.x; Dashtsoodol N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01206; Ditrichova Dagmar, 2007, Biomedical Papers (Olomouc), V151, P333; Eguchi T, 2013, CELL IMMUNOL, V284, P163, DOI 10.1016/j.cellimm.2013.07.010; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; Gober MD, 2008, J INVEST DERMATOL, V128, P1460, DOI 10.1038/sj.jid.5701199; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Goubier A, 2013, J INVEST DERMATOL, V133, P980, DOI 10.1038/jid.2012.404; Hasseus B, 2004, CLIN EXP IMMUNOL, V136, P483, DOI 10.1111/j.1365-2249.2004.02469.x; Hasseus B, 1999, J DENT RES, V78, P751, DOI 10.1177/00220345990780030701; Hirunwidchayarat W, 2017, BIOCHEM BIOPH RES CO, V490, P1294, DOI 10.1016/j.bbrc.2017.07.012; Imirzalioglu P, 2012, J PROSTHET DENT, V107, P24, DOI 10.1016/S0022-3913(12)60013-4; Issa Y, 2005, BRIT DENT J, V198, P361, DOI 10.1038/sj.bdj.4812176; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kawano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086810; Khamaysi Z, 2006, CONTACT DERMATITIS, V55, P216, DOI 10.1111/j.1600-0536.2006.00905.x; Kitaura K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00389; Kitaura K, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0177-5; Kitaura K, 2011, J IMMUNOL, V187, P3919, DOI 10.4049/jimmunol.1100442; Kobayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076385; Kumagai K, 2018, J ORAL MAX SURG MED, V30, P1, DOI 10.1016/j.atoms.2017.08.001; Kumagai K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010087; McGinley EL, 2012, ACTA BIOMATER, V8, P432, DOI 10.1016/j.actbio.2011.08.017; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nosbaum A, 2009, EUR J DERMATOL, V19, P325, DOI 10.1684/ejd.2009.0686; Raap U, 2009, CONTACT DERMATITIS, V60, P339, DOI 10.1111/j.1600-0536.2009.01524.x; Radkevich A A, 2013, Stomatologiia (Mosk), V92, P73; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Scadding G, 2009, J ASTHMA, V46, P322, DOI 10.1080/02770900902785729; Schnuch A, 2012, ALLERGY, V67, P847, DOI 10.1111/j.1398-9995.2012.02834.x; Shigematsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085983; Shimizuhira C, 2014, J INVEST DERMATOL, V134, P2709, DOI 10.1038/jid.2014.200; SINIGAGLIA F, 1985, J IMMUNOL, V135, P3929; Sumiwi YAA, 2010, CUTAN OCUL TOXICOL, V29, P30, DOI 10.3109/15569520903496746; Takeda Y, 2017, INT J MOL SCI, V18, P1; Traidl C, 2000, J IMMUNOL, V165, P3058, DOI 10.4049/jimmunol.165.6.3058; VANWILSEM EJG, 1995, IMMUNOBIOLOGY, V194, P403, DOI 10.1016/S0171-2985(11)80107-5; VANWILSEM EJG, 1994, IMMUNOLOGY, V83, P128; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Vollmer J, 1997, EUR J IMMUNOL, V27, P1865, DOI 10.1002/eji.1830270808; Yamamoto T, 2016, INT ARCH ALLERGY IMM, V169, P146, DOI 10.1159/000445433; Yawalkar N, 2001, AM J PATHOL, V158, P803, DOI 10.1016/S0002-9440(10)64027-8	50	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209248	10.1371/journal.pone.0209248	http://dx.doi.org/10.1371/journal.pone.0209248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557354	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000083
J	Saeki, E; Yasuhira, S; Shibazaki, M; Tada, H; Doita, M; Masuda, T; Maesawa, C				Saeki, Eri; Yasuhira, Shinji; Shibazaki, Masahiko; Tada, Hiroshi; Doita, Minoru; Masuda, Tomoyuki; Maesawa, Chihaya			Involvement of C-terminal truncation mutation of kinesin-5 in resistance to kinesin-5 inhibitor	PLOS ONE			English	Article							CENTROSOME SEPARATION; MISMATCH REPAIR; EG5; PHOSPHORYLATION; RUNS	Cultured cells easily develop resistance to kinesin-5 inhibitors (K5Is) often by overexpressing a related motor protein, kinesin-12/KIF15, or by acquiring mutations in the N-terminal motor domain of kinesin-5/KIF11 itself. We aimed to identify novel mechanisms responsible for resistance to S-trityl L-cysteine (STLC), one of the K5Is, using human osteosarcoma cell lines. Among six lines examined, U-2OS and HOS survived chronic STLC treatment and gave rise to resistant cells with IC(50)s at least 10-fold higher than those of the respective parental lines. Depletion of KIF15 largely eliminated the acquired K5I resistance in both cases, consistent with the proposed notion that KIF15 is indispensable for it. In contrast to the KIF11-independent property of the cells derived from HOS, those derived from U-2OS still required KIF11 for their growth and, intriguingly, expressed a C-terminal truncated variant of KIF11 resulting from a frame shift mutation (S1017fs). All of the isolated clones harbored the same mutation, suggesting its clonal expansion in the cell population due to the growth advantage during chronic STLC treatment. Transgenic expression of KIF11(S1017fs) in the parental U-2OS cells, as well as in HeLa cells, conferred a moderate but reproducible STLC resistance, probably owing to STLC-resistant localization of the mutant KIF11 on mitotic spindle. Our observations indicate that both KIF15 and the C-terminal-truncated KIF11 contributes to the STLC resistance of the U-2OS derived cells.	[Saeki, Eri; Yasuhira, Shinji; Shibazaki, Masahiko; Maesawa, Chihaya] Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, 2-1-1 Nishitokuta, Yahaba, Iwate, Japan; [Saeki, Eri; Tada, Hiroshi; Doita, Minoru] Iwate Med Univ, Sch Med, Dept Orthopaed Surg, 16-1 Uchimaru, Morioka, Iwate, Japan; [Masuda, Tomoyuki] Iwate Med Univ, Sch Med, Dept Pathol, 2-1-1 Nishitokuta, Yahaba, Iwate, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University	Yasuhira, S (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, 2-1-1 Nishitokuta, Yahaba, Iwate, Japan.	syasuhir@iwate-med.ac.jp		Yasuhira, Shinji/0000-0003-0041-3545	JSPS KAKENHI [JP16K20066]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	H.T. was funded by JSPS KAKENHI Grant Number JP16K20066 (https://www.jsps.go.jp/j-grantsinaid/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Drosopoulos K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4686; Eibes S, 2018, CURR BIOL, V28, P121, DOI 10.1016/j.cub.2017.11.046; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Gragg H, 2002, MOL CELL BIOL, V22, P8756, DOI 10.1128/MCB.22.24.8756-8762.2002; Kasap C, 2014, NAT CHEM BIOL, V10, P626, DOI 10.1038/nchembio.1551; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Myers SM, 2016, FUTURE MED CHEM, V8, P463, DOI 10.4155/fmc.16.5; Okubo A, 2016, PIGM CELL MELANOMA R, V29, P309, DOI 10.1111/pcmr.12461; Raaijmakers JA, 2012, EMBO J, V31, P4179, DOI 10.1038/emboj.2012.272; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sturgill EG, 2016, J CELL BIOL, V213, P213, DOI 10.1083/jcb.201507036; Sturgill EG, 2013, CURR BIOL, V23, P1280, DOI 10.1016/j.cub.2013.05.043; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038	19	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209296	10.1371/journal.pone.0209296	http://dx.doi.org/10.1371/journal.pone.0209296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557316	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000091
J	Abreu-Mendoza, RA; Chamorro, Y; Garcia-Barrera, MA; Matute, E				Abreu-Mendoza, Roberto A.; Chamorro, Yaira; Garcia-Barrera, Mauricio A.; Matute, Esmeralda			The contributions of executive functions to mathematical learning difficulties and mathematical talent during adolescence	PLOS ONE			English	Article							WORKING-MEMORY; DEVELOPMENTAL DYSCALCULIA; INDIVIDUAL-DIFFERENCES; RATIONAL NUMBERS; INHIBITION; CHILDREN; DISABILITIES; ACHIEVEMENT; PREDICTORS; FRACTION	Are mathematical learning difficulties caused by impairment of the abilities that underlie mathematical talent? Or are mathematical difficulties and talent qualitatively different? The main goal of this study was to determine whether mathematical learning difficulties are explained by the same executive functions as mathematical talent. We screened a pool of 2,682 first-year high school students and selected 48 for evaluation, dividing them into three groups: those with mathematical learning difficulties (n = 16), those with typical performance (n = 16), and those with mathematical talent (n = 16). Adolescents from the learning difficulties and talented groups had age, reading skills, and verbal and non-verbal intelligence that were similar to those of the typical performance group. Participants were administered a suite of tasks to evaluate verbal and visual short-term memory and executive functions of inhibition, shifting, and updating. Different executive functions showed different contributions at the two ends of the math ability continuum: lower levels of performance in updating visual information were related to mathematical learning difficulties, while greater shifting abilities were related to mathematical talent. Effect sizes for the differences in performance between groups were large (Hedges' g>0.8). These results suggest that different executive functions are associated with mathematical learning difficulties and mathematical talent. We discuss how these differences in executive functions could be related to the different types of mathematical abilities that distinguish the three groups.	[Abreu-Mendoza, Roberto A.; Chamorro, Yaira; Matute, Esmeralda] Univ Guadalajara, Inst Neurociencias, CUCBA, Guadalajara, Jalisco, Mexico; [Abreu-Mendoza, Roberto A.] Rutgers State Univ, Newark, NJ USA; [Garcia-Barrera, Mauricio A.] Univ Victoria, Dept Psychol, Victoria, BC, Canada	Universidad de Guadalajara; Rutgers State University Newark; Rutgers State University New Brunswick; University of Victoria	Matute, E (corresponding author), Univ Guadalajara, Inst Neurociencias, CUCBA, Guadalajara, Jalisco, Mexico.	ematute@redudg.udg.mx	Abreu-Mendoza, Roberto A./AAL-3460-2020; Garcia-Barrera, Mauricio A./AAO-9757-2021; Chamorro, Yaira/AAO-9754-2021	Abreu-Mendoza, Roberto A./0000-0002-6841-0917; Garcia-Barrera, Mauricio A./0000-0002-4302-4964; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT): Programa Nacional de Posgrado de Calidad Fellowship [576221]; Investigacion en Fronteras de la Ciencia [783]	Consejo Nacional de Ciencia y Tecnologia (CONACyT): Programa Nacional de Posgrado de Calidad Fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Investigacion en Fronteras de la Ciencia	This work was supported by two grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT): Programa Nacional de Posgrado de Calidad Fellowship No. 576221 (awarded to the first author) and Investigacion en Fronteras de la Ciencia Grant No. 783 (awarded to the third author). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Mendoza RA, 2018, J PSYCHOEDUC ASSESS; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Ashkenazi S, 2017, J NUMERICAL COGNITIO, V3, P496, DOI DOI 10.5964/JNC.V3I2.64; Ashkenazi S, 2013, NEUROPSYCHOLOGIA, V51, P2305, DOI 10.1016/j.neuropsychologia.2013.06.031; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barrios Omar, 2016, Suma Psicol., V23, P101, DOI 10.1016/j.sumpsi.2016.05.001; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Carey S., 2009, ORIGIN CONCEPTS; Cirino PT, 2016, J EXP CHILD PSYCHOL, V145, P95, DOI 10.1016/j.jecp.2015.12.010; Clark CAC, 2013, CHILD DEV, V84, P662, DOI 10.1111/j.1467-8624.2012.01854.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corsi P.M., 1972, DISS ABSTR INT, V34; Coulanges L, 2018, 1 MATH COG LEARN SOC; Cragg L, 2017, COGNITION, V162, P12, DOI 10.1016/j.cognition.2017.01.014; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Doenyas C, 2018, J EXP CHILD PSYCHOL, V166, P485, DOI 10.1016/j.jecp.2017.09.014; Duggan E.C., 2015, HDB INTELLIGENCE EVO, P435, DOI DOI 10.1007/978-1-4939-1562-0_27; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio LK, 2016, J EXP PSYCHOL LEARN, V42, P1, DOI 10.1037/xlm0000153; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Graham A., 2002, CHILD ADOLESCENT MEN, V7, P131, DOI [DOI 10.1111/1475-3588.00024, 10.1111/1475-3588.00024]; Halberda J, 2012, P NATL ACAD SCI USA, P1; Hyde D, 2016, DEVELOPMENTAL SCI, P1; INEE, 2015, PAN ED MEX 2014; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Karr JE, 2018, PSYCHOL BULL, V144, P1147, DOI 10.1037/bul0000160; Kirby KN, 2013, BEHAV RES METHODS, V45, P905, DOI 10.3758/s13428-013-0330-5; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Lee K, 2013, CHILD DEV, V84, P1933, DOI 10.1111/cdev.12096; Li YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172046; Lortie-Forgues H, 2015, DEV REV, V38, P201, DOI 10.1016/j.dr.2015.07.008; Mammarella IC, 2017, BR J DEV PSYCHOL; Matute E., 2007, EVALUACION NEUROPSIC; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Mou Y, 2018, J EXP CHILD PSYCHOL, V166, P116, DOI 10.1016/j.jecp.2017.07.016; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Murphy MM, 2007, J LEARN DISABIL-US, V40, P458, DOI 10.1177/00222194070400050901; Myers T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01646; Parsons S, 1997, ED TRAIN, V54, P419; Parsons S., 2005, DOES NUMERACY MATTER; Peng P, 2016, J EDUC PSYCHOL, V108, P455, DOI 10.1037/edu0000079; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; Peterson RL, 2017, J LEARN DISABIL-US, V50, P408, DOI 10.1177/0022219415618500; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; R Core Team, 2021, R LANGUAGE ENV STAT; Ritchie SJ, 2013, PSYCHOL SCI, V24, P1301, DOI 10.1177/0956797612466268; Robertson G, 2006, WIDE RANGE ACHIEVEME; Secretari a de Educacion Publica, 2011, PROGR EST 2011 GUIA; Siegler RS, 2017, CURR DIR PSYCHOL SCI, V26, P346, DOI 10.1177/0963721417700129; Siegler RS, 2013, DEV PSYCHOL, V49, P1994, DOI 10.1037/a0031200; Swanson HL, 2006, J EXP CHILD PSYCHOL, V93, P239, DOI 10.1016/j.jecp.2005.09.006; Szucs D, 2016, PROG BRAIN RES, V227, P277, DOI 10.1016/bs.pbr.2016.04.027; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; Szucs D, 2014, DEVELOPMENTAL SCI, V17, P506, DOI 10.1111/desc.12144; Szucs D, 2013, TRENDS NEUROSCI EDUC, V2, P33, DOI 10.1016/j.tine.2013.06.004; Szucs D, 2013, CORTEX, V49, P2674, DOI 10.1016/j.cortex.2013.06.007; Testa R, 2012, ARCH CLIN NEUROPSYCH, V27, P213, DOI 10.1093/arclin/acr112; Vamvakoussi X, 2004, LEARN INSTR, V14, P453, DOI 10.1016/j.learninstruc.2004.06.013; van der Sluis S, 2007, INTELLIGENCE, V35, P427, DOI 10.1016/j.intell.2006.09.001; Van Hoof J, 2018, LEARN INDIVID DIFFER, V61, P99, DOI 10.1016/j.lindif.2017.11.010; Vosniadou S, 2014, EUR J DEV PSYCHOL, V11, P645, DOI 10.1080/17405629.2014.921153; Wechsler, 2007, ESCALA WECHSLER INTE; Zaitchik D, 2014, CHILD DEV, V85, P160, DOI 10.1111/cdev.12145	75	12	13	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209267	10.1371/journal.pone.0209267	http://dx.doi.org/10.1371/journal.pone.0209267			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543713	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500078
J	Marusiak, AA; Prelowska, MK; Mehlich, D; Lazniewski, M; Kaminska, K; Gorczynski, A; Korwat, A; Sokolowska, O; Kedzierska, H; Golab, J; Biernat, W; Plewczynski, D; Brognard, J; Nowis, D				Marusiak, Anna A.; Prelowska, Monika K.; Mehlich, Dawid; Lazniewski, Michal; Kaminska, Klaudia; Gorczynski, Adam; Korwat, Aleksandra; Sokolowska, Olga; Kedzierska, Hanna; Golab, Jakub; Biernat, Wojciech; Plewczynski, Dariusz; Brognard, John; Nowis, Dominika			Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells	ONCOGENE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; KINASE MLK4; SUBTYPES; METASTASIS; MLK4-BETA; CULTURE; JNK	Metastasis to distant organs is a major cause for solid cancer mortality, and the acquisition of migratory and invasive phenotype is a key factor in initiation of malignancy. In this study we investigated the contribution of Mixed-Lineage Kinase 4 (MLK4) to aggressive phenotype of breast cancer cells. Our TCGA cancer genomic data analysis revealed that amplification or mRNA upregulation of MLK4 occurred in 23% of invasive breast carcinoma cases. To find the association between MLK4 expression and the specific subtype of breast cancer, we performed a transcriptomic analysis of multiple datasets, which showed that MLK4 is highly expressed in triple-negative breast cancer compared to other molecular subtypes. Depletion of MLK4 in cell lines with high MLK4 expression impaired proliferation and anchorage-dependent colony formation. Moreover, silencing of MLK4 expression significantly reduced the migratory potential and invasiveness of breast cancer cells as well as the number of spheroids formed in 3D cultures. These in vitro findings translate into slower rate of tumor growth in mice upon MLK4 knock-down. Furthermore, we established that MLK4 activates NF-kappa B signaling and promotes a mesenchymal phenotype in breast cancer cells. Immunohistochemical staining of samples obtained from breast cancer patients revealed a strong positive correlation between high expression of MLK4 and metastatic potential of tumors, which was predominantly observed in TNBC subgroup. Taken together, our results show that high expression of MLK4 promotes migratory and invasive phenotype of breast cancer and may represent a novel target for anticancer treatment.	[Marusiak, Anna A.; Prelowska, Monika K.; Mehlich, Dawid; Kaminska, Klaudia; Sokolowska, Olga; Kedzierska, Hanna; Nowis, Dominika] Univ Warsaw, Ctr New Technol, Expt Med Lab, Warsaw, Poland; [Prelowska, Monika K.; Sokolowska, Olga] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Mehlich, Dawid; Nowis, Dominika] Med Univ Warsaw, Genom Med, Warsaw, Poland; [Lazniewski, Michal; Plewczynski, Dariusz] Univ Warsaw, Ctr New Technol, Lab Funct & Struct Genom, Warsaw, Poland; [Lazniewski, Michal] Med Univ Warsaw, Dept Phys Chem, Fac Pharm, Warsaw, Poland; [Gorczynski, Adam; Korwat, Aleksandra; Biernat, Wojciech] Med Univ Gdansk, Dept Pathomorphol, Gdansk, Poland; [Sokolowska, Olga; Golab, Jakub; Nowis, Dominika] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Golab, Jakub] Med Univ Warsaw, Ctr Preclin Res & Technol, Warsaw, Poland; [Plewczynski, Dariusz] Warsaw Univ Technol, Fac Math & Informat Sci, Warsaw, Poland; [Brognard, John] NCI, Frederick, MD 21701 USA	University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; University of Warsaw; Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Medical University of Warsaw; Warsaw University of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Marusiak, AA (corresponding author), Univ Warsaw, Ctr New Technol, Expt Med Lab, Warsaw, Poland.	a.marusiak@cent.uw.edu.pl	Nowis, Dominika/P-1213-2017; Golab, Jakub/K-6974-2013; Brognard, John/T-5099-2019; Nowis, Dominika/P-6866-2019; Marusiak, Anna/AAN-7020-2020	Nowis, Dominika/0000-0003-2748-9523; Golab, Jakub/0000-0002-2830-5100; Brognard, John/0000-0002-9243-6615; Nowis, Dominika/0000-0003-2748-9523; Gorczynski, Adam/0000-0002-1950-452X; Plewczynski, Dariusz/0000-0002-3840-7610; Korwat, Aleksandra/0000-0002-7418-1698; Lazniewski, Michal/0000-0003-0436-404X; Marusiak, Anna/0000-0001-8907-3131	European Union under the European Regional Development Fund; Polish National Science Centre [2013/10/E/NZ5/00778, 2014/15/B/ST6/05082, 015/16/S/NZ5/00088]; Foundation for Polish Science; Ministry of Science and Higher Education, Republic of Poland [DI2017 016 747]; NATIONAL CANCER INSTITUTE [ZIABC011691] Funding Source: NIH RePORTER	European Union under the European Regional Development Fund; Polish National Science Centre; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education, Republic of Poland(Ministry of Science and Higher Education, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr. J. Chlebowska-Tuz, Dr. S. Fawdar, Dr. P. Gaj, Dr. Z. Koledova, Dr. T. Stoklosa, M. Sobczak for technical help and insightful comments. The research was carried out within HOMING program of The Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund (to AAM) and Polish National Science Centre (015/16/S/NZ5/00088 to AAM). The research was also supported by The Foundation for Polish Science (TEAM to DP) and Polish National Science Centre (2013/10/E/NZ5/00778 to DN, 2014/15/B/ST6/05082 to DP) and Ministry of Science and Higher Education, Republic of Poland (DI2017 016 747 to DM).	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Blessing NA, 2017, CELL SIGNAL, V39, P66, DOI 10.1016/j.cellsig.2017.07.021; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang CY, 2017, J CELL PHYSIOL, V232, P1337, DOI 10.1002/jcp.25610; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Kim SH, 2016, CANCER CELL, V29, P201, DOI 10.1016/j.ccell.2016.01.005; Kumar P, 2016, ARCH GYNECOL OBSTET, V293, P247, DOI 10.1007/s00404-015-3859-y; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Martini M, 2013, CANCER RES, V73, P1912, DOI 10.1158/0008-5472.CAN-12-3074; Marusiak AA, 2016, CANCER RES, V76, P724, DOI 10.1158/0008-5472.CAN-15-0701-T; Marusiak AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4901; Maubant S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122333; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Pal A, 2014, JOVE-J VIS EXP, DOI 10.3791/51311; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pires BRB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169622; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Saab WFA, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.6; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Seit-Nebi A, 2012, CELL MOL IMMUNOL, V9, P27, DOI 10.1038/cmi.2011.15; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412	38	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2860	2875		10.1038/s41388-018-0618-0	http://dx.doi.org/10.1038/s41388-018-0618-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30552384	hybrid, Green Published			2022-12-26	WOS:000464121600014
J	Stavenschi, E; Hoey, DA				Stavenschi, Elena; Hoey, David A.			Pressure-induced mesenchymal stem cell osteogenesis is dependent on intermediate filament remodeling	FASEB JOURNAL			English	Article						bone; mechanobiology; cytoskeleton; mechanotherapeutic; DMSO	CYCLIC HYDRAULIC PRESSURE; FLUID-FLOW; HYDROSTATIC-PRESSURE; MECHANICAL-STRESS; PRIMARY CILIA; BONE-MARROW; INTRAMEDULLARY PRESSURE; DIFFERENTIATION; CYTOSKELETON; STIMULATION	Macroscale loading of bone generates a complex local mechanical microenvironment that drives osteogenesis and bone mechanoadaptation. One such mechanical stimulus generated is hydrostatic pressure (HP); however, the effect of HP on mesenchymal stem cells (MSCs) and the mechanotransduction mechanisms utilized by these cells to sense this stimulus are yet to be fully elucidated. In this study, we demonstrate that cyclic HP is a potent mediator of cytoskeletal reorganization and increases in osteogenic responses in MSCs. In particular, we demonstrate that the intermediate filament (IF) network undergoes breakdown and reorganization with centripetal translocation of IF bundles toward the perinuclear region. Furthermore, we show for the first time that this IF remodeling is required for loading-induced MSC osteogenesis, revealing a novel mechanism of MSC mechanotransduction. In addition, we demonstrate that chemical disruption of IFs with withaferin A induces a similar mechanism of IF breakdown and remodeling as well as a subsequent increase in osteogenic gene expression in MSCs, exhibiting a potential mechanotherapeutic effect to enhance MSC osteogenesis. This study therefore highlights a novel mechanotransduction mechanism of pressure-induced MSC osteogenesis involving the understudied cytoskeletal structure, the IF, and demonstrates a potential new therapy to enhance bone formation in bone-loss diseases such as osteoporosis.Stavenschi, E., Hoey, D. A. Pressure-induced mesenchymal stem cell osteogenesis is dependent on intermediate filament remodeling.	[Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland; [Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Sch Engn, Dept Mech & Mfg Engn, D02 DK07, Dublin 2, Ireland; [Hoey, David A.] Univ Limerick, Dept Mech Aeronaut & Biomed Engn, Limerick, Ireland; [Hoey, David A.] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr, Dublin, Ireland; [Hoey, David A.] RCSI, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Limerick; Trinity College Dublin; Royal College of Surgeons - Ireland	Hoey, DA (corresponding author), Trinity Coll Dublin, Sch Engn, Dept Mech & Mfg Engn, D02 DK07, Dublin 2, Ireland.	dahoey@tcd.ie	Hoey, David/X-9231-2019; Hoey, David/G-3301-2013	Hoey, David/0000-0001-5898-0409	European Research Council (ERC) Starting Grant [336882]; Science Foundation Ireland (SFI) [SFI 13/ERC/L2864]	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors acknowledge funding from European Research Council (ERC) Starting Grant (336882) and the Science Foundation Ireland (SFI) Support Grant SFI 13/ERC/L2864. The authors declare no conflicts of interest.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Becquart P, 2016, EUR CELLS MATER, V31, P160, DOI 10.22203/eCM.v031a11; BURGER EH, 1992, J BONE MINER RES, V7, pS397, DOI 10.1002/jbmr.5650071406; BURGER EH, 1991, J BIOMECH, V24, P101, DOI 10.1016/0021-9290(91)90381-V; Chen JC, 2016, FASEB J, V30, P1504, DOI 10.1096/fj.15-276402; Corrigan MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22174-3; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Espinha LC, 2014, CYTOSKELETON, V71, P435, DOI 10.1002/cm.21183; Feria-Diaz J. J., 2018, INDIAN J SCI TECHNOL, V11, P1, DOI DOI 10.17485/ijst/2018/v11i16/121405; Gardinier JD, 2014, CELL MOL BIOENG, V7, P266, DOI 10.1007/s12195-014-0329-8; Gardinier JD, 2009, CELL MOL BIOENG, V2, P133, DOI 10.1007/s12195-008-0038-2; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hu MY, 2012, BONE, V51, P819, DOI 10.1016/j.bone.2012.06.030; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Johnson GP, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222737; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Klein-Nulend J, 2012, EUR CELLS MATER, V24, P278, DOI 10.22203/eCM.v024a20; KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Liu C, 2010, BONE, V46, P1449, DOI 10.1016/j.bone.2010.02.006; Liu J, 2009, J CELL BIOCHEM, V107, P224, DOI 10.1002/jcb.22118; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MELGUIZO C, 1994, HISTOCHEM J, V26, P519, DOI 10.1007/BF00157897; Murray ME, 2014, MOL BIOL CELL, V25, P87, DOI 10.1091/mbc.E13-06-0326; Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Ng JL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00303; Nishio K, 2001, HISTOCHEM CELL BIOL, V116, P321, DOI 10.1007/s004180100325; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Ren L, 2015, J MECH BEHAV BIOMED, V50, P104, DOI 10.1016/j.jmbbm.2015.04.021; Ridge KM, 2016, METHOD ENZYMOL, V568, P389, DOI 10.1016/bs.mie.2015.09.036; Riehl BD, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1351; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Rubin Janet, 2017, Trans Am Clin Climatol Assoc, V128, P180; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Stavenschi E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1025-8; Stavenschi E, 2017, J BIOMECH, V55, P99, DOI 10.1016/j.jbiomech.2017.02.002; Steward AJ, 2013, EUR CELLS MATER, V25, P167, DOI 10.22203/eCM.v025a12; Sugimoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18089-0; Tewari D, 2015, STEM CELL REV REP, V11, P309, DOI 10.1007/s12015-014-9573-5; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zhang W, 2014, EUR SPINE J, V23, P2410, DOI 10.1007/s00586-014-3394-8; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3; Zhao YH, 2015, STEM CELL RES, V14, P283, DOI 10.1016/j.scr.2015.02.006; Zhao Y, 2016, ANN BIOMED ENG, V44, P2971, DOI 10.1007/s10439-016-1631-5	59	14	14	3	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4178	4187		10.1096/fj.201801474RR	http://dx.doi.org/10.1096/fj.201801474RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550359	Green Submitted			2022-12-26	WOS:000459794800086
J	Levanova, N; Mattheis, C; Carson, D; To, KN; Jank, T; Frankel, G; Aktories, K; Schroeder, GN				Levanova, Nadezhda; Mattheis, Corinna; Carson, Danielle; To, Ka-Ning; Jank, Thomas; Frankel, Gad; Aktories, Klaus; Schroeder, Gunnar Neels			The Legionella effector LtpM is a new type of phosphoinositide-activated glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; infection; host-pathogen interaction; glycosyltransferase; protein secretion; effector; endosomal system; Legionella; phosphoinositide binding domain; type IV secretion system (T4SS)	PNEUMOPHILA EFFECTOR; LEGIONNAIRES-DISEASE; STRUCTURAL BASIS; PROTEIN DRRA; GLYCOSYLTRANSFERASE; TRAFFICKING; FAMILY; TRANSFORMATION; AUTOPHAGOSOME; EXPRESSION	Legionella pneumophila causes Legionnaires' disease, a severe form of pneumonia. L. pneumophila translocates more than 300 effectors into host cells via its Dot/Icm (Defective in organelle trafficking/Intracellular multiplication) type IV secretion system to enable its replication in target cells. Here, we studied the effector LtpM, which is encoded in a recombination hot spot in L. pneumophila Paris. We show that a C-terminal phosphoinositol 3-phosphate (PI3P)-binding domain, also found in otherwise unrelated effectors, targets LtpM to the Legionella-containing vacuole and to early and late endosomes. LtpM expression in yeast caused cytotoxicity. Sequence comparison and structural homology modeling of the N-terminal domain of LtpM uncovered a remote similarity to the glycosyltransferase (GT) toxin PaTox from the bacterium Photorhabdus asymbiotica; however, instead of the canonical DxD motif of GT-A type glycosyltransferases, essential for enzyme activity and divalent cation coordination, we found that a DxN motif is present in LtpM. Using UDP-glucose as sugar donor, we show that purified LtpM nevertheless exhibits glucohydrolase and autoglucosylation activity in vitro and demonstrate that PI3P binding activates LtpM's glucosyltransferase activity toward protein substrates. Substitution of the aspartate or the asparagine in the DxN motif abolished the activity of LtpM. Moreover, whereas all glycosyltransferase toxins and effectors identified so far depend on the presence of divalent cations, LtpM is active in their absence. Proteins containing LtpM-like GT domains are encoded in the genomes of other L. pneumophila isolates and species, suggesting that LtpM is the first member of a novel family of glycosyltransferase effectors employed to subvert hosts.	[Levanova, Nadezhda; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Mattheis, Corinna; Carson, Danielle; To, Ka-Ning; Frankel, Gad; Schroeder, Gunnar Neels] Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Schroeder, Gunnar Neels] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland; [To, Ka-Ning] Imperial Coll London, Dept Med, St Marys Med Sch Bldg, London W2 1PG, England	University of Freiburg; Imperial College London; Queens University Belfast; Imperial College London	Aktories, K (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.; Schroeder, GN (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland.	klaus.aktories@pharmakol.uni-freiburg.de; g.schroeder@qub.ac.uk	Schroeder, Gunnar Neels/AAJ-2591-2020; Aktories, Klaus/CAJ-5682-2022	Schroeder, Gunnar Neels/0000-0002-0412-7741; Aktories, Klaus/0000-0002-5397-0436; Carson, Danielle/0000-0003-1200-2022	Medical Research Council UK [MR/L018225/1, MR/R010552/1]; German Academic Exchange Service; German Research Foundation (DFG) [DFG AK6/24-1, DFG SFB746]; MRC [G1001729, MR/R010552/1, MR/P028225/1, MR/L018225/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council UK Grants MR/L018225/1 (to G. N. S., G. F., and D. C.) and MR/R010552/1 (to G. N. S.), the German Academic Exchange Service (to C. M.), and German Research Foundation (DFG) Grants DFG AK6/24-1 (to K. A.) and DFG SFB746 (to K. A. and T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Brachmann CB, 1998, YEAST, V14, P115; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Castonguay J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10607-4; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Clements A, 2014, CELL MICROBIOL, V16, P1693, DOI 10.1111/cmi.12319; David S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006855; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Dolezal P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002459; EDELSTEIN PH, 1986, J HOSP INFECT, V8, P109, DOI 10.1016/0195-6701(86)90037-X; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finsel I, 2013, CELL HOST MICROBE, V14, P38, DOI 10.1016/j.chom.2013.06.001; Folly-Klan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003747; Franco IS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002546; GALAN JE, 1992, J BACTERIOL, V174, P4338; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Gomez-Valero L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0505-0; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Harding CR, 2013, INFECT IMMUN, V81, P4261, DOI 10.1128/IAI.01054-13; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Herwaldt LA, 2018, CURR OPIN INFECT DIS, V31, P325, DOI 10.1097/QCO.0000000000000468; Horenkamp FA, 2015, DEV CELL, V34, P569, DOI 10.1016/j.devcel.2015.08.010; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Isaac DT, 2014, FUTURE MICROBIOL, V9, P343, DOI 10.2217/fmb.13.162; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itzen A, 2011, CELL HOST MICROBE, V10, P89, DOI 10.1016/j.chom.2011.08.002; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Michard C, 2015, MBIO, V6, DOI 10.1128/mBio.00354-15; Mousnier A, 2014, MBIO, V5, DOI 10.1128/mBio.01148-14; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pham TTK, 2014, J BIOL CHEM, V289, P8041, DOI 10.1074/jbc.M113.545384; Qiu JZ, 2017, NAT REV MICROBIOL, V15, P591, DOI 10.1038/nrmicro.2017.67; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Rothmeier E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003598; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Schroeder GN, 2015, INFECT IMMUN, V83, P3989, DOI 10.1128/IAI.00785-15; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Soda EA, 2017, MMWR-MORBID MORTAL W, V66, P584, DOI 10.15585/mmwr.mm6622e1; Steiner B, 2018, INT J MED MICROBIOL, V308, P49, DOI 10.1016/j.ijmm.2017.08.004; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x	81	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2862	2879		10.1074/jbc.RA118.005952	http://dx.doi.org/10.1074/jbc.RA118.005952			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573678	Green Published, hybrid			2022-12-26	WOS:000459601600024
J	Mori, T; Koyama, N; Tan, J; Segawa, T; Maeda, M; Town, T				Mori, Takashi; Koyama, Naoki; Tan, Jun; Segawa, Tatsuya; Maeda, Masahiro; Town, Terrence			Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; flavonoid; amyloid precursor protein (APP); amyloid-beta (AB); secretase; transgenic mice; neuroinflammation; oxidative stress; nonamyloidogenic; phenol; plant; polyphenol	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE CLEAVAGE; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; GREEN TEA; MEMORY DEFICITS; A-BETA; EPIGALLOCATECHIN-3-GALLATE EGCG; CEREBRAL AMYLOIDOSIS; OXIDATIVE STRESS	"Nutraceuticals" are well-tolerated natural dietary compounds with drug-like properties that make them attractive as Alzheimer's disease (AD) therapeutics. Combination therapy for AD has garnered attention following a recent National Institute on Aging mandate, but this approach has not yet been fully validated. In this report, we combined the two most promising nutraceuticals with complementary anti-amyloidogenic properties: the plant-derived phenolics (-)-epigallocatechin-3-gallate (EGCG, an alpha-secretase activator) and ferulic acid (FA, a beta-secretase modulator). We used transgenic mice expressing mutant human amyloid beta-protein precursor and presenilin 1 (APP/PS1) to model cerebral amyloidosis. At 12 months of age, we orally administered EGCG and/or FA (30 mg/kg each) or vehicle once daily for 3 months. At 15 months, combined EGCG-FA treatment reversed cognitive impairment in most tests of learning and memory, including novel object recognition and maze tasks. Moreover, EGCG- and FA-treated APP/PS1 mice exhibited amelioration of brain parenchymal and cerebral vascular beta-amyloid deposits and decreased abundance of amyloid beta-proteins compared with either EGCG or FA single treatment. Combined treatment elevated nonamyloidogenic soluble APP-alpha and alpha-secretase candidate and down-regulated amyloidogenic soluble APP-beta, beta-C-terminal APP fragment, and beta-secretase protein expression, providing evidence for a shift toward nonamyloidogenic APP processing. Additional beneficial co-treatment effects included amelioration of neuroinflammation, oxidative stress, and synaptotoxicity. Our findings offer preclinical evidence that combined treatment with EGCG and FA is a promising AD therapeutic approach.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr & Univ, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL 33613 USA; [Segawa, Tatsuya; Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma 3750005, Japan; [Town, Terrence] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; Immuno-Biological Laboratories Co. Ltd.; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Town, T (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health [2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03, 5R21AG053884-02]; Japan Society for the Promotion of Science KAKENHI [JP26430058]; Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050253, P01AG052350, R21AG053884, RF1AG053982, R21AG055116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03 and 5R21AG053884-02 (to T. T.), the Japan Society for the Promotion of Science KAKENHI JP26430058 (to T. M.), an Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA; to T. T.), Cure Alzheimer's Fund (to T. T.), Coins for Alzheimer's Research Trust (to T. T.), and generous start-up funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bourne LC, 1998, BIOCHEM BIOPH RES CO, V253, P222, DOI 10.1006/bbrc.1998.9681; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gasperotti M, 2015, ACS CHEM NEUROSCI, V6, P1341, DOI 10.1021/acschemneuro.5b00051; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jeon SY, 2003, BIOORG MED CHEM LETT, V13, P3905, DOI 10.1016/j.bmcl.2003.09.018; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Mufson EJ, 2016, NEUROBIOL AGING, V37, P147, DOI 10.1016/j.neurobiolaging.2015.10.012; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Qin J, 2008, DRUG DEV IND PHARM, V34, P602, DOI [10.1080/03639040701833559, 10.1080/03639040701833559 ]; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Robinson JL, 2011, BRAIN, V134, P3705, DOI 10.1093/brain/awr308; Sabbagh MN, 2010, CURR ALZHEIMER RES, V7, P280, DOI 10.2174/156720510791162340; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van't Slot G, 2009, J AGR FOOD CHEM, V57, P8041, DOI 10.1021/jf900458e; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631; Wu K, 2014, J ETHNOPHARMACOL, V151, P1133, DOI 10.1016/j.jep.2013.12.027; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang C, 2007, J PHARMACEUT BIOMED, V43, P945, DOI 10.1016/j.jpba.2006.09.027; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	81	43	44	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2714	2731		10.1074/jbc.RA118.004280	http://dx.doi.org/10.1074/jbc.RA118.004280			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30563837	hybrid, Green Published			2022-12-26	WOS:000459601600013
J	Piccirillo, AR; Cattley, RT; D'Cruz, LM; Hawse, WF				Piccirillo, Ann R.; Cattley, Richard T.; D'Cruz, Louise M.; Hawse, William F.			Histone acetyltransferase CBP is critical for conventional effector and memory T-cell differentiation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell; T-cell receptor (TCR); Janus kinase (JAK); infection; differentiation; cytokine; histone; acetyllysine; bromo domain; CREB binding protein; signal transduction; CD8(+) T cell; memory T cell; proteomics; kinase signaling; Jak2; immune response; adaptive immunity	NAIVE; PHENOTYPE; SURVIVAL; INTERLEUKIN-15; PROLIFERATION; MATURATION; RECALL; IL-10	Compared with naive T cells, memory CD8(+) T cells have a transcriptional landscape and proteome that are optimized to generate a more rapid and robust response to secondary infection. Additionally, rewired kinase signal transduction pathways likely contribute to the superior recall response of memory CD8(+) T cells, but this idea has not been experimentally confirmed. Herein, we utilized an MS approach to identify proteins that are phosphorylated on tyrosine residues in response to Listeria-induced T-cell receptor (TCR) stimulation in both naive and memory CD8(+) T cells from mice and separated by fluorescence- and flow cytometry-based cell sorting. This analysis identified substantial differences in tyrosine kinase signaling networks between naive and memory CD8(+) T cells. We also observed that an important axis in memory CD8(+) T cells couples Janus kinase 2 (JAK2) hyperactivation to the phosphorylation of CREB-binding protein (CBP). Functionally, JAK2-catalyzed phosphorylation enabled CBP to bind with higher affinity to acetylated histone peptides, indicating a potential epigenetic mechanism that could contribute to rapid initiation of transcriptional programs in memory CD8(+) T cells. Moreover, we found that CBP itself is essential for conventional effector and memory CD8(+) T-cell formation. These results indicate how signaling pathways are altered to promote CD8(+) memory cell formation and rapid responses to and protection from repeat infections.	[Piccirillo, Ann R.; Cattley, Richard T.; D'Cruz, Louise M.; Hawse, William F.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Cruz, LM; Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA.	ldcruz@pitt.edu; whawse@pitt.edu			National Institutes of Health [R21AI135406]; University of Pittsburgh; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21AI135406 (to L. M. D. and W. F. H.) and seed funding from the University of Pittsburgh (to W. F. H. and L. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chandok MR, 2007, J IMMUNOL, V179, P3689, DOI 10.4049/jimmunol.179.6.3689; Cho JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13373; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Farber DL, 2009, SEMIN IMMUNOL, V21, P84, DOI 10.1016/j.smim.2009.02.003; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Ruby CE, 2007, EUR J IMMUNOL, V37, P157, DOI 10.1002/eji.200636428; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	32	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2397	2406		10.1074/jbc.RA118.006977	http://dx.doi.org/10.1074/jbc.RA118.006977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573679	Green Published, hybrid			2022-12-26	WOS:000458895400017
J	Murakami, N; Kawada, J; Watanabe, A; Arakawa, T; Kano, T; Suzuki, T; Tanaka, R; Kojima, D; Kawano, Y; Hoshino, S; Muramatsu, H; Takahashi, Y; Sato, Y; Koyama, M; Natsume, J				Murakami, Norihiro; Kawada, Jun-ichi; Watanabe, Azumi; Arakawa, Toshinao; Kano, Takamasa; Suzuki, Takako; Tanaka, Ryo; Kojima, Daiei; Kawano, Yoshihiko; Hoshino, Shin; Muramatsu, Hideki; Takahashi, Yoshiyuki; Sato, Yoshiaki; Koyama, Masashi; Natsume, Jun			Ureteral dilatation detected in magnetic resonance imaging predicts vesicoureteral reflux in children with urinary tract infection	PLOS ONE			English	Article							ACUTE PYELONEPHRITIS; FEBRILE INFANTS; DIAGNOSIS; MRI; UTI	Objective Urinary tract infection (UTI), one of the most common bacterial infections occurring during infancy and early childhood, is frequently associated with vesicoureteral reflux (VUR). Although several guidelines recommend performing ultrasonography as a screening test, its utility is not adequate and appropriate screening tests are strongly desirable. In this study, we evaluate the use of magnetic resonance imaging (MRI) as a screening test for VUR in children with UTI. Methods We prospectively studied 108 patients with suspected UTI between April 2014 and March 2016. UTI was diagnosed on the basis of diffusion-weighted MRI (DW-MRI) and urine culture findings. We measured ureteral dilatation using MRI in 96 patients with UTI and assessed the relationship between ureteral dilatation in MRI and VUR in 46 patients who underwent voiding cystourethrography (VCUG). Results Among 108 patients, 88 and 8 were diagnosed with upper and lower UTI, respectively. Among 46 patients who underwent VCUG, 23 had VUR (14 low grade and 9 high grade). Patients with ureteral dilatation detected on MRI had VUR more frequently than those without ureteral dilatation (any grades VUR, 71% vs. 32%; P = 0.02; high-grade VUR, 38% vs. 2%, P = 0.007). Overall, ureteral dilatation findings on MRI achieved sensitivity 65.2% and specificity 73.9% as a screening test for VUR. In addition, DW-MRI achieved sensitivity 100% and specificity 81.8% in the diagnosis of upper UTI. Conclusion These findings suggested that MRI is a valuable tool for screening of VUR as well as diagnosis of upper UTI.	[Murakami, Norihiro; Kawada, Jun-ichi; Kano, Takamasa; Suzuki, Takako; Tanaka, Ryo; Kojima, Daiei; Muramatsu, Hideki; Takahashi, Yoshiyuki; Sato, Yoshiaki; Natsume, Jun] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Watanabe, Azumi; Arakawa, Toshinao; Koyama, Masashi] Okazaki City Hosp, Dept Radiol, Okazaki, Aichi, Japan; [Kawano, Yoshihiko] Toyota Mem Hosp, Dept Pediat, Toyota, Japan; [Hoshino, Shin] Kasugai City Hosp, Dept Pediat, Kasugai, Aichi, Japan; [Sato, Yoshiaki] Nagoya Univ Hosp, Ctr Maternal Neonatal Care, Div Neonatol, Nagoya, Aichi, Japan; [Natsume, Jun] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi, Japan; [Natsume, Jun] Nagoya Univ, Grad Sch Med, Dept Dev Disabil Med, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Kawada, J (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan.	kawadaj@med.nagoya-u.ac.jp	Kawada, Jun-ichi/I-7322-2014; Muramatsu, Hideki/ABA-3376-2021; Sato, Yoshiaki/I-7414-2014; Kawada, Jun-ichi/AGA-5782-2022	Kawada, Jun-ichi/0000-0003-1553-2539; Muramatsu, Hideki/0000-0002-8801-0021; Sato, Yoshiaki/0000-0001-6320-9176; Kawada, Jun-ichi/0000-0003-1553-2539; Kawano, Yoshihiko/0000-0002-3513-9454				Arlen AM, 2017, J PEDIATR UROL, V13, P383, DOI 10.1016/j.jpurol.2017.01.012; Ataei N, 2005, PEDIATR NEPHROL, V20, P1439, DOI 10.1007/s00467-005-1925-6; Bergman DA, 1999, PEDIATRICS, V103, P843; Cerwinka WH, 2014, J PEDIATR UROL, V10, P344, DOI 10.1016/j.jpurol.2013.09.016; Coulthard MG, 2007, BRIT MED J, V335, P463, DOI 10.1136/bmj.39325.436667.3A; De Pascale A, 2013, EUR RADIOL, V23, P3077, DOI 10.1007/s00330-013-2906-y; Faletti R, 2018, ABDOM RADIOL, V43, P639, DOI 10.1007/s00261-017-1242-0; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lee HY, 2009, PEDIATR NEPHROL, V24, P2009, DOI 10.1007/s00467-009-1232-8; LEVITT SB, 1981, PEDIATRICS, V67, P392; Marks SD, 2008, PEDIATR NEPHROL, V23, P9, DOI 10.1007/s00467-007-0552-9; Narchi H, 2015, J PEDIAT UROL, V11, pe1; Nelson CP, 2014, PEDIATRICS, V133, pE394, DOI 10.1542/peds.2013-2109; Paterson A, 2004, EUR RADIOL, V14, pL89, DOI 10.1007/s00330-003-2038-x; Rathod SB, 2015, ACTA RADIOL, V56, P244, DOI 10.1177/0284185114520862; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Sieger N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2336-6; Vivier PH, 2014, EUR RADIOL, V24, P19, DOI 10.1007/s00330-013-2971-2; Yoo JM, 2010, KOREAN J UROL, V51, P260, DOI 10.4111/kju.2010.51.4.260	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209595	10.1371/journal.pone.0209595	http://dx.doi.org/10.1371/journal.pone.0209595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576373	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400063
J	Nazri, A; Mazlan, N; Muharam, F				Nazri, Azree; Mazlan, Norida; Muharam, Farrah			PENYEK: Automated brown planthopper detection from imperfect sticky pad images using deep convolutional neural network	PLOS ONE			English	Article							IDENTIFICATION	Rice is a staple food in Asia and it contributes significantly to the Gross Domestic Product (GDP) of Malaysia and other developing countries. Brown Planthopper (BPH) causes high levels of economic loss in Malaysia. Identification of BPH presence and monitoring of its abundance has been conducted manually by experts and is time-consuming, fatiguing and tedious. Automated detection of BPH has been proposed by many studies to overcome human fallibility. However, all studies regarding automated recognition of BPH are investigated based on intact specimen although most of the specimens are imperfect, with missing parts have distorted shapes. The automated recognition of an imperfect insect image is more difficult than recognition of the intact specimen. This study proposes an automated, deep-learning-based detection pipeline, PENYEK, to identify BPH pest in images taken from a readily available sticky pad, constructed by clipping plastic sheets onto steel plates and spraying with glue. This study explores the effectiveness of a convolutional neural network (CNN) architecture, VGG16, in classifying insects as BPH or benign based on grayscale images constructed from Euclidean Distance Maps (EDM). The pipeline identified imperfect images of BPH with an accuracy of 95% using deep-learning's hyperparameters: softmax, a mini-batch of 30 and an initial learning rate of 0.0001.	[Nazri, Azree] Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Serdang, Malaysia; [Nazri, Azree] Univ Putra Malaysia, Inst BioSci, Serdang, Malaysia; [Mazlan, Norida; Muharam, Farrah] Univ Putra Malaysia, Fac Agr, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Nazri, A (corresponding author), Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Serdang, Malaysia.; Nazri, A (corresponding author), Univ Putra Malaysia, Inst BioSci, Serdang, Malaysia.	azree@upm.edu.my	Muharam, Farrah Melissa/AAM-4139-2020		HICoE ITAFoS [HICoE - ITAFoS/2017/FC3]; GPIPM [9538100]; Fundamental Research Grant Scheme (FRGS) [5524959]	HICoE ITAFoS; GPIPM; Fundamental Research Grant Scheme (FRGS)	The authors gratefully acknowledge the support of the HICoE ITAFoS (HICoE - ITAFoS/2017/FC3), GPIPM (vote No: 9538100) and Fundamental Research Grant Scheme (FRGS) (Vote No: 5524959).; The authors gratefully acknowledge the support of the HICoE ITAFoS (HICoE-ITAFoS/2017/FC3), Fundamental Research Grant Scheme (FRGS) (Vote No: 5524959) and GP-IPM (vote No: 9538100).	Al-Saqer S.M., 2011, American Journal of Agricultural and Biological Sciences, V6, P69, DOI 10.3844/ajabssp.2011.69.79; Andreopoulos A, 2013, COMPUT VIS IMAGE UND, V117, P827, DOI 10.1016/j.cviu.2013.04.005; [Anonymous], 2007, INT J MATH COMPUTERS; Arbuckle T., 2001, Sustainability in the Information Society. 15th International Symposium Informatics for Environmental Protection, P425; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Fedor P, 2008, B ENTOMOL RES, V98, P437, DOI 10.1017/S0007485308005750; Kang SH, 2014, J ASIA-PAC ENTOMOL, V17, P143, DOI 10.1016/j.aspen.2013.12.004; Kang SH, 2012, J ASIA-PAC ENTOMOL, V15, P431, DOI 10.1016/j.aspen.2012.03.006; Kaya Y, 2014, VISUAL COMPUT, V30, P71, DOI 10.1007/s00371-013-0782-8; Khan Z. R., 1994, INSECT PESTS RICE, V27; Kumar R., ROBUST INSECT CLASSI; Larios N., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2624, DOI 10.1109/ICPR.2010.643; Larios N., 2011, 2011 IEEE WORKSH APP, P329; Li Xiao-Lin, 2009, 2009 1st International Conference on Information Science and Engineering (ICISE 2009), P1315, DOI 10.1109/ICISE.2009.705; Lu A., 2012, P INT C PATT REC; Lytle DA, 2010, J N AM BENTHOL SOC, V29, P867, DOI 10.1899/09-080.1; Martinez-Munoz G, 2009, PROC CVPR IEEE, P549, DOI 10.1109/CVPRW.2009.5206574; Mayo M, 2007, KNOWL-BASED SYST, V20, P195, DOI 10.1016/j.knosys.2006.11.012; Mundada R., DETECTION CLASSIFICA; Nikitenko Denis, 2008, Journal of Multimedia, V3, P9, DOI 10.4304/jmm.3.5.9-18; Qiao Mu, 2008, Journal of Asia-Pacific Entomology, V11, P25, DOI 10.1016/j.aspen.2008.03.002; Reddi S., OPTIMAL MULTIPLE THR; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; Venugoban  K., IMAGE CLASSIFICATION; Wang JN, 2012, KNOWL-BASED SYST, V33, P102, DOI 10.1016/j.knosys.2012.03.014; Weeks PJD, 1999, J APPL ENTOMOL, V123, P1, DOI 10.1046/j.1439-0418.1999.00307.x; Wen CL, 2012, COMPUT ELECTRON AGR, V89, P110, DOI 10.1016/j.compag.2012.08.008; Wen CL, 2009, BIOSYST ENG, V104, P299, DOI 10.1016/j.biosystemseng.2009.07.002; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yaakob SN, 2012, APPL INTELL, V37, P12, DOI 10.1007/s10489-011-0310-3; Yao Q, 2013, BIOSYST ENG, V114, P67, DOI 10.1016/j.biosystemseng.2012.11.008; Zhang X., OBJECT CLASS DETECTI; Zhu Le-Qing, 2010, 2010 Seventh International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2010), P2589, DOI 10.1109/FSKD.2010.5569848	33	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208501	10.1371/journal.pone.0208501	http://dx.doi.org/10.1371/journal.pone.0208501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571683	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700013
J	Gesser-Edelsburg, A; Diamant, A; Hijazi, R; Mesch, GS				Gesser-Edelsburg, Anat; Diamant, Alon; Hijazi, Rana; Mesch, Gustavo S.			Correcting misinformation by health organizations during measles outbreaks: A controlled experiment	PLOS ONE			English	Article							CONTINUED INFLUENCE; VACCINE ACCEPTANCE; RISK PERCEPTION; CARE WORKERS; INFORMATION; COMMUNICATION; TWITTER; CRISIS; MEDIA; RECOMMENDATIONS	Background During epidemic crises, some of the information the public receives on social media is misinformation. Health organizations are required to respond and correct the information to gain the public's trust and influence it to follow the recommended instructions. Objectives (1) To examine ways for health organizations to correct misinformation concerning the measles vaccination on social networks for two groups: pro-vaccination and hesitant; (2) To examine the types of reactions of two subgroups (pro-vaccination, hesitant) to misinformation correction; and (3) To examine the effect of misinformation correction on these two subgroups regarding reliability, satisfaction, self-efficacy and intentions. Methods A controlled experiment with participants divided randomly into two conditions. In both experiment conditions a dilemma was presented as to sending a child to kindergarten, followed by an identical Facebook post voicing the children mothers' concerns. In the third stage the correction by the health organization is presented differently in two conditions: Condition 1 -common information correction, and Condition 2-recommended (theory-based) information correction, mainly communicating information transparently and addressing the public's concerns. The study included (n = 243) graduate students from the Faculty of Social Welfare and Health Sciences at Haifa University. Results A statistically significant difference was found in the reliability level attributed to information correction by the Health Ministry between the Control condition and Experimental condition (sig<0.001), with the average reliability level of the subjects in Condition 2 (M = 5.68) being considerably higher than the average reliability level of subjects in Condition 1 (4.64). A significant difference was found between Condition 1 and Condition 2 (sig<0.001), with the average satisfaction from the Health Ministry's response of Condition 2 subjects (M = 5.75) being significantly higher than the average satisfaction level of Condition 1 subjects (4.66). Similarly, when we tested the pro and hesitant groups separately, we found that both preferred the response presented in Condition 2. Conclusion It is very important for the organizations to correct misinformation transparently, and to address the emotional aspects for both the pro-vaccination and the hesitant groups. The pro-vaccination group is not a captive audience, and it too requires a full response that addresses the public's fears and concerns.	[Gesser-Edelsburg, Anat; Diamant, Alon] Univ Haifa, Hlth & Risk Commun Res Ctr, Haifa, Israel; [Gesser-Edelsburg, Anat; Hijazi, Rana] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Mesch, Gustavo S.] Univ Haifa, Dept Sociol, Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Gesser-Edelsburg, A (corresponding author), Univ Haifa, Hlth & Risk Commun Res Ctr, Haifa, Israel.; Gesser-Edelsburg, A (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	ageser@univ.haifa.ac.il	mesch, gustavo/W-9537-2019; Mesch, Gustavo S./ABA-6420-2020	Gesser-Edelsburg, PhD, Prof. Anat/0000-0003-4467-8799				Adamo G, 2017, ANN IG MED PREV COMU, V29, P1, DOI 10.7416/ai.2017.2128; Adamo G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205147; [Anonymous], 2013, RISK COMMUNICATION H; [Anonymous], 2018, HAARETZ; Arzi Sror C., 2018, YEDIOTH AHRONOT 0803; Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018; Baxendale S, 2007, EPILEPSY BEHAV, V11, P192, DOI 10.1016/j.yebeh.2007.04.019; Bennett P., 2010, RISK COMMUNICATION P, V2 ed; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Biellik R, 2016, HEALTH AFFAIR, V35, P322, DOI 10.1377/hlthaff.2015.1055; Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312; Cataldi JR, 2016, VACCINE, V34, P6375, DOI 10.1016/j.vaccine.2016.10.048; CDC, 2018, MEASL CAS OUTBR; CDC, 2015, MISC SEAS FLU VACC Q; CDC, 2012, CDCS GUID WRIT SOC M; CDC, 2013, VACC RAT CHILDR KIND; Cobb MD, 2013, POLIT PSYCHOL, V34, P307, DOI 10.1111/j.1467-9221.2012.00935.x; Creswell J.W., 2018, RES DESIGN, V5th; Crook B, 2016, COMMUN RES REP, V33, P349, DOI 10.1080/08824096.2016.1224171; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Dube E, 2018, VACCINE, V36, P545, DOI 10.1016/j.vaccine.2017.12.005; Dube Eve, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9e239605f4d320c6ad27ce2aea5aaad2; ECDC, 2022, LANG HEN ECDC MON; Ehara A, 2003, LANCET, V362, P2026, DOI 10.1016/S0140-6736(03)15037-4; European Centre for Disease Prevention and Control (ECDC), 2018, MEASL OUTBR STILL ON; Filia A, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.37.30614, 10.2807/1560-7917.es.2017.22.37.30614]; Filia A, 2013, EUROSURVEILLANCE, V18, P18; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Fu LDY, 2017, VACCINE, V35, P802, DOI 10.1016/j.vaccine.2016.12.045; Gesser-Edelsburg A., 2016, RISK COMMUNICATION I; Gesser-Edelsburg A, 2017, AM J INFECT CONTROL, V45, P436, DOI 10.1016/j.ajic.2016.11.025; Gesser-Edelsburg A, 2017, AM J INFECT CONTROL, V45, P267, DOI 10.1016/j.ajic.2016.10.009; Gesser-Edelsburg A, 2017, HEALTH COMMUN, V32, P169, DOI 10.1080/10410236.2015.1110224; Gesser-Edelsburg A, 2015, DISASTER MED PUBLIC, V9, P447, DOI 10.1017/dmp.2015.31; Gesser-Edelsburg A, 2014, AM J INFECT CONTROL, V42, P829, DOI 10.1016/j.ajic.2014.04.012; Gesser-Edelsburg A, 2014, DISASTER MED PUBLIC, V8, P158, DOI 10.1017/dmp.2014.27; Gilkey MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159087; Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025; Guidry JPD, 2017, PUBLIC RELAT REV, V43, P477, DOI 10.1016/j.pubrev.2017.04.009; Henrich N, 2011, HEALTH PROMOT PRACT, V12, P610, DOI 10.1177/1524839910363536; Henrikson NB, 2017, PUBLIC HEALTH REP, V132, P451, DOI 10.1177/0033354917711175; Herman J., 2013, SOCIAL MEDIA METRICS; Herzog K., 2014, MED EXAMINER GIRLS D; Hovland C.I., 1953, COMMUN PERSUATION; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hughes AL, 2008, 5 INT ISCRAM C MAY 2; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Manyibe EO, 2006, J APPL REHABILITATIO, V37, P36; Massimi A, 2017, EPIDEMIOL BIOSTAT PU, V14, pe126251, DOI [10.2427/12625, DOI 10.2427/12625]; Matthews G., 2015, MDIGITALLIFE    0219; McNab C, 2009, B WORLD HEALTH ORGAN, V87, P566, DOI 10.2471/BLT.09.066712; Miller K., 2007, YOUTH VIOLENCE JUV J, V5, P207; Ministry of health Israel, 2018, HAARETZ         0605; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; Napolitano F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194920; Neiger BL, 2013, HEALTH PROMOT PRACT, V14, P157, DOI 10.1177/1524839912469378; Nowak GJ, 2017, HUM VACC IMMUNOTHER, V13, P687, DOI 10.1080/21645515.2016.1236881; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Paterson P, 2018, VACCINE, V36, P5397, DOI 10.1016/j.vaccine.2017.08.016; Powell D, 2018, PSYCHOL SCI, V29, P1104, DOI 10.1177/0956797617753393; Reuters, 2016, TIMES INDIA TEC 0204; Rogers EM, 1981, COMMUNICATIONS NETWO; Saleem S., 2011, GUARDIAN; Samarajiva R., 2016, SCIDEVNET, V6, P2013; Sandman P., 1989, EFFECTIVE RISK COMMU, P45, DOI 10.1007/978-1-4613-1569-8_6; Sandman PM, 2006, J APPL COMMUN RES, V34, P257, DOI 10.1080/00909880600771619; Sargent RG, 2009, WINT SIMUL C PROC, P162, DOI 10.1109/WSC.2009.5429327; Seifert CM, 2002, PSYCHOL LEARN MOTIV, V41, P265, DOI 10.1016/S0079-7421(02)80009-3; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Stiegler R, 2011, 2011 13 IEEE INT S W; Strekalova YA, 2016, AM J INFECT CONTROL, V44, P363, DOI 10.1016/j.ajic.2015.09.024; Tang L, 2018, AM J INFECT CONTROL, V46, P962, DOI 10.1016/j.ajic.2018.02.010; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; U. S. Department of State, 2017, DIG GOV STRAT 2013; Velan B, 2012, HUM VACC IMMUNOTHER, V8, P1272, DOI 10.4161/hv.21183	80	45	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209505	10.1371/journal.pone.0209505	http://dx.doi.org/10.1371/journal.pone.0209505			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566485	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300093
J	Song, S; Lee, SE; Oh, SK; Jeon, SA; Sung, JM; Park, JH; Chang, HJ				Song, Shinjeong; Lee, Sang-Eun; Oh, Sang Kwon; Jeon, Seong A.; Sung, Ji Min; Park, Jae-Hyeong; Chang, Hyuk-Jae			Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database	PLOS ONE			English	Review							THERAPY; DETERMINANTS	Epidemiologic data regarding pulmonary arterial hypertension (PAH) have relied on registries from Western countries. We assessed the current status of PAH in the Korean population. The Health Insurance Review and Assessment Service (HIRA) claim database, which comprises nationwide medical insurance data of Koreans from 2008-2016, was assessed to determine the current status of PAH. Overall, 1,307 patients were newly diagnosed with PAH from 2008-2016 (0.0005%, annual incidence: 4.84 patients/1 million people/year). The mean age at diagnosis was 44 +/- 13 years (range 18-65) and patients were mostly women (n = 906, 69.3%). Cases of idiopathic PAH (51.6%) accounted for the largest proportion, followed by acquired PAH (APAH) associated with congenital heart disease (25.8%) and APAH with connective tissue disease (17.2%). Overall, 807 (61.7%) patients received a single PAH-specific treatment based on their last prescription, of which bosentan (50.6%) was the most frequently used. Only 240 (18.4%) patients received combination therapy, with the bosentan-beraprost combination (32.9%) being the most common. During the mean follow-up of 1.9 years, the 1-, 2-, 3-, and 5-year estimated survival rates were 85%, 62%, 54%, and 46%, respectively. The prevalence and incidence of PAH in the Korean population is currently comparable with that in previous registries. The 5-year survival rate was slightly higher in the Korean population than previously reported.	[Song, Shinjeong; Lee, Sang-Eun; Jeon, Seong A.; Sung, Ji Min; Chang, Hyuk-Jae] Yonsei Univ, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol,Coll Med, Seoul, South Korea; [Lee, Sang-Eun; Jeon, Seong A.; Sung, Ji Min; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Yonsei Cedars Sinai Integrat Cardiovasc Imaging R, Seoul, South Korea; [Oh, Sang Kwon] Healthcare Review & Assessment Comm, Hlth Insurance Review Assessment Serv, Seoul, South Korea; [Park, Jae-Hyeong] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Coll Med, Daejeon, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Yonsei Univ Hlth Syst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Chungnam National University Hospital; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol,Coll Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Yonsei Cedars Sinai Integrat Cardiovasc Imaging R, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Yonsei Univ Hlth Syst, Seoul, South Korea.	hjchang@yuhs.ac	Park, Jae-Hyeong/AAD-9015-2021	Lee, Sang-Eun/0000-0001-6645-4038; Song, Shinjeong/0000-0002-5789-854X; Chang, Hyuk-Jae/0000-0002-6139-7545; Park, Jae-Hyeong/0000-0001-7035-286X				Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2001, CLIN CHEST MED, V22, P509, DOI 10.1016/S0272-5231(05)70287-2; Chung WJ, 2015, J KOREAN MED SCI, V30, P1429, DOI 10.3346/jkms.2015.30.10.1429; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; EnriquezSarano M, 1997, J AM COLL CARDIOL, V29, P153, DOI 10.1016/S0735-1097(96)00436-6; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; McGoon MD, 2012, EUR RESPIR REV, V21, P8, DOI 10.1183/09059180.00008211; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; O'Callaghan DS, 2011, NAT REV CARDIOL, V8, P526, DOI 10.1038/nrcardio.2011.104; Provencher S, 2006, EUR HEART J, V27, P589, DOI 10.1093/eurheartj/ehi728; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Simonneau G, 2008, ANN INTERN MED, V149, P521, DOI 10.7326/0003-4819-149-8-200810210-00004; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Tamura Y, 2018, CIRC J, V82, P275, DOI 10.1253/circj.CJ-17-0139; Tumminello G, 2007, EUR HEART J, V28, P569, DOI 10.1093/eurheartj/ehl561	25	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209148	10.1371/journal.pone.0209148	http://dx.doi.org/10.1371/journal.pone.0209148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566510	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300073
J	Dickey, AM; Schuller, G; Loy, JD; Clawson, ML				Dickey, Aaron M.; Schuller, Gennie; Loy, J. Dustin; Clawson, Michael L.			Whole genome sequencing of Moraxella bovoculi reveals high genetic diversity and evidence for interspecies recombination at multiple loci	PLOS ONE			English	Article							INFECTIOUS BOVINE KERATOCONJUNCTIVITIS; PROTECTIVE EFFICACY; FIELD TRIAL; SP-NOV; VACCINE; STRAINS; PINKEYE; SPP.; ASSOCIATION; CATTLE	Moraxella bovoculi is frequently cultured from the ocular secretions and conjunctiva of cattle with Infectious Bovine Keratoconjunctivitis (IBK). Previous work has shown that single nucleotide polymorphism (SNP) diversity in this species is quite high with 81,284 SNPs identified in eight genomes representing two distinct genotypes isolated from IBK affected eyes (genotype 1) and the nasopharynx of cattle without clinical IBK signs (genotype 2), respectively. The goals of this study were to identify SNPs from a collection of geographically diverse and epidemiologically unlinked M. bovoculi strains from the eyes of IBK positive cattle (n = 183) and another from the eyes of cattle (most from a single population at a single time-point) without signs of IBK (n = 63) and to characterize the genetic diversity. Strains of both genotypes were identified from the eyes of cattle without IBK signs. Only genotype 1 strains were identified from IBK affected eyes, however, these strains were isolated before the discovery of genotype 2, and the protocol for their isolation would have preferentially selected genotype 1 M. bovoculi. The core genome comprised similar to 74% of the whole and contained >127,000 filtered SNPs. More than 80% of these characterize diversity within genotype 1 while 23,611 SNPs (similar to 18%) delimit the two major genotypes. Genotype 2 strains lacked a repeats-in-toxin (RTX) putative pathogenesis factor and any of ten putative antibiotic resistance genes carried within a genomic island. Within genotype 1, prevalence of these elements was 0.85 and 0.12 respectively in strains from eyes that were IBK positive. Recombination appears to be an important source of genetic diversity for genotype 1 and undermines the utility of ribosomal-locus-based species identification. The extremely high genetic diversity in genotype 1 presents a challenge to the development of an efficacious vaccine directed against them, however, several low-diversity pilin-like genes were identified. Finally, the genotype-defining SNPs described in this study are a resource that can facilitate the development of more accurate M. bovoculi diagnostic tests.	[Dickey, Aaron M.; Schuller, Gennie; Clawson, Michael L.] ARS, Genet Breeding & Anim Hlth Res Unit, US Meat Anim Res Ctr, USDA, Clay Ctr, NE 68933 USA; [Loy, J. Dustin] Univ Nebraska, Vet Diagnost Ctr, Sch Vet Med & Biomed Sci, Lincoln, NE USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Clawson, ML (corresponding author), ARS, Genet Breeding & Anim Hlth Res Unit, US Meat Anim Res Ctr, USDA, Clay Ctr, NE 68933 USA.	Mike.Clawson@usda.gov	Loy, John/R-3840-2019	Loy, John/0000-0002-7282-096X; Dickey, Aaron/0000-0003-1250-1390	Nebraska Agricultural Experiment Station; Hatch Act from the Animal Health and Disease Research through the USDA National Institute of Food and Agriculture [1002196, 1433]; USDA National Institute of Food and Agriculture	Nebraska Agricultural Experiment Station; Hatch Act from the Animal Health and Disease Research through the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Funding for this research was supported in part by the Nebraska Agricultural Experiment Station with funding from the Hatch Act (accession 1007070) from the Animal Health and Disease Research (Section 1433) capacity funding program (accession 1002196) through the USDA National Institute of Food and Agriculture https://nifa.usda.gov/to JDL. There was no additional external funding received for this study. The remainder of financial support was provided by the USDA, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." (L423-429).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelos JA, 2007, VET MICROBIOL, V125, P274, DOI 10.1016/j.vetmic.2007.05.028; Angelos JA, 2007, J VET DIAGN INVEST, V19, P532, DOI 10.1177/104063870701900511; Angelos JA, 2007, INT J SYST EVOL MICR, V57, P789, DOI 10.1099/ijs.0.64333-0; Angelos JA, 2015, VET CLIN N AM-FOOD A, V31, P61, DOI 10.1016/j.cvfa.2014.11.006; Angelos JA, 2012, AM J VET RES, V73, P1670, DOI 10.2460/ajvr.73.10.1670; Angelos JA, 2010, VET CLIN N AM-FOOD A, V26, P73, DOI 10.1016/j.cvfa.2009.10.002; Brown MH, 1998, J VET INTERN MED, V12, P259, DOI 10.1111/j.1939-1676.1998.tb02120.x; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burns MJ, 2008, VACCINE, V26, P144, DOI 10.1016/j.vaccine.2007.10.014; Calcutt MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00612-14; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Cullen JN, 2017, JAVMA-J AM VET MED A, V251, P345, DOI 10.2460/javma.251.3.345; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dewell RD, 2014, J ANIM SCI, V92, P1161, DOI 10.2527/jas.2013-7264; Dickey AM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0316-2; FULKS KA, 1990, J BACTERIOL, V172, P310, DOI 10.1128/JB.172.1.310-316.1990; Funk L, 2009, VACCINE, V27, P4585, DOI 10.1016/j.vaccine.2009.05.082; Gentschev I, 2002, TRENDS MICROBIOL, V10, P39, DOI 10.1016/S0966-842X(01)02259-4; GERHARDT RR, 1982, J AM VET MED ASSOC, V180, P156; Gould S, 2013, VET MICROBIOL, V164, P108, DOI 10.1016/j.vetmic.2013.01.038; HALL RD, 1984, J MED ENTOMOL, V21, P361, DOI 10.1093/jmedent/21.4.361; HENSON JB, 1960, AM J VET RES, V21, P761; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KOPECKY KE, 1986, AM J VET RES, V47, P622; Kowalski AP, 2017, VET MICROBIOL, V210, P56, DOI 10.1016/j.vetmic.2017.08.016; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LEPPER AWD, 1987, AUST VET J, V64, P33, DOI 10.1111/j.1751-0813.1987.tb16125.x; LEPPER AWD, 1992, VET MICROBIOL, V32, P177, DOI 10.1016/0378-1135(92)90104-2; LEPPER AWD, 1995, VET MICROBIOL, V45, P129, DOI 10.1016/0378-1135(94)00123-E; Levisohn S, 2004, J VET DIAGN INVEST, V16, P579, DOI 10.1177/104063870401600615; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HM, 2014, J VET DIAGN INVEST, V26, P585, DOI 10.1177/1040638714535601; Loy JD, 2014, J VET DIAGN INVEST, V26, P761, DOI 10.1177/1040638714551403; MARRS CF, 1985, J BACTERIOL, V163, P132, DOI 10.1128/JB.163.1.132-139.1985; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; MOORE LJ, 1991, VET MICROBIOL, V29, P75, DOI 10.1016/0378-1135(91)90111-R; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; O'Connor AM, 2012, VET MICROBIOL, V155, P374, DOI 10.1016/j.vetmic.2011.09.011; O'Connor AM, 2011, J VET INTERN MED, V25, P1447, DOI 10.1111/j.1939-1676.2011.00803.x; O'Connor Annette M., 2006, Animal Health Research Reviews, V7, P119, DOI 10.1017/S146625230700120X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PUGH GW, 1986, AM J VET RES, V47, P2343; PUGH GW, 1977, AM J VET RES, V38, P1519; Riggio MP, 2011, VET MICROBIOL, V150, P394, DOI 10.1016/j.vetmic.2011.03.001; Robbins K, 2018, J VET DIAGN INVEST, V30, P739, DOI 10.1177/1040638718789725; RUEHL WW, 1993, AM J VET RES, V54, P248; Schnee C, 2015, VET J, V203, P92, DOI 10.1016/j.tvjl.2014.11.009; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh S, 2018, CARBOHYD RES, V467, P1, DOI 10.1016/j.carres.2018.07.002; SMITH PC, 1990, AM J VET RES, V51, P1147; Snowder GD, 2005, J ANIM SCI, V83, P507; Sosa V, 2013, J INFECT DEV COUNTR, V7, P819, DOI 10.3855/jidc.3458; Sosa V, 2012, VET J, V193, P595, DOI 10.1016/j.tvjl.2012.01.011; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; THRIFT FA, 1974, J ANIM SCI, V38, P1179, DOI 10.2527/jas1974.3861179x; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Tryland M, 2009, J CLIN MICROBIOL, V47, P3707, DOI 10.1128/JCM.01198-09; WEBBER JJ, 1981, J AM VET MED ASSOC, V179, P823; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	63	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209113	10.1371/journal.pone.0209113	http://dx.doi.org/10.1371/journal.pone.0209113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557405	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000070
J	Kim, YM; Kim, J; Cheong, HK; Jeon, BH; Ahn, K				Kim, Young-Min; Kim, Jihyun; Cheong, Hae-Kwan; Jeon, Byoung-Hak; Ahn, Kangmo			Exposure to phthalates aggravates pulmonary function and airway inflammation in asthmatic children	PLOS ONE			English	Article							DI(2-ETHYLHEXYL)PHTHALATE DEHP; OXIDATIVE STRESS; BISPHENOL-A; HUMAN URINE; METABOLITES; SYMPTOMS; ASSOCIATION; BIOMARKERS; SERUM; DUST	Introduction Studies on the associations between phthalate exposures and respiratory outcomes are limited. We investigated the association of phthalates exposure with pulmonary function and airway inflammation in asthmatic children. Methods Fifty-six children with asthma living in Seoul Metropolitan Area, Korea aged 6-16 years were enrolled. Their pulmonary function including forced expiratory volume in 1 sec (FEV1) and peak expiratory flow rate (PEFR) were measured, and the fractional exhaled nitric oxide (FeNO) as a marker of airway inflammation was examined repeatedly up to four times during the study period. Urinary levels of mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), metabolites for di-(2-ethylhexyl) phthalate (DEHP), and mono-n-butyl phthalate (MnBP), a metabolite of di-n-butyl phthalate (DnBP), were also measured on the same days. The effects of phthalate metabolites on the respiratory symptoms were analyzed using linear mixed effect models with adjustment for potential cofounders. Results An increase in phthalate metabolites was associated with a decrease in pulmonary function and an increase in FeNO in asthmatic children. As one natural log-unit (In-unit) levels of urinary MEHHP and MEOHP increased, FeNO levels on the same day increased by 19.47 ppb [95% confidence interval (CI): 9.28, 29.67] and 17.93 ppb (95% CI: 5.86, 30.01), respectively. An increases in the urinary level of MEHHP, MEOHP, and MnBP by one In-unit was associated with a decrease in PEFR on the next day by 12.17 L/min (95% CI: 2.59, 21.74), 10.80 L/min (95% CI: 0.29, 21.32), and 13.65 L/min (95% CI: 5.07, 22.24), respectively. Conclusion Phthalates, especially DEHP, may worsen pulmonary function and airway inflammation in asthmatic children. To control asthma symptoms, exposure to phthalates needs to be avoided.	[Kim, Young-Min; Kim, Jihyun; Ahn, Kangmo] Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea; [Kim, Young-Min; Kim, Jihyun; Ahn, Kangmo] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pediat, Seoul, South Korea; [Cheong, Hae-Kwan; Jeon, Byoung-Hak] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Ahn, K (corresponding author), Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea.; Ahn, K (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pediat, Seoul, South Korea.	kmaped@skk.edu	Jeon, Byoung-Hak/GXM-9445-2022; Ahn, Kangmo/F-4609-2014	Jeon, Byoung-Hak/0000-0001-5246-0357; Cheong, Hae-Kwan/0000-0003-2758-9399; Ahn, Kangmo/0000-0001-7751-9829	Korea Environment Industry & Technology Institute (KEITI) through Environmental Health Action Program - Korea Ministry of Environment (MOE) [2017001360006]	Korea Environment Industry & Technology Institute (KEITI) through Environmental Health Action Program - Korea Ministry of Environment (MOE)	This work was supported by Korea Environment Industry & Technology Institute (KEITI) through Environmental Health Action Program, funded by Korea Ministry of Environment (MOE) (Grant number 2017001360006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Maksoud FM, 2015, ENDOCRINOLOGY, V156, P4672, DOI 10.1210/en.2015-1077; Amadeo B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1382-5; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Beko G, 2015, ENVIRON RES, V137, P432, DOI 10.1016/j.envres.2015.01.012; Beko G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062442; Bertelsen RJ, 2013, ENVIRON HEALTH PERSP, V121, P251, DOI 10.1289/ehp.1205256; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Caldeira M, 2011, J CHROMATOGR A, V1218, P3771, DOI 10.1016/j.chroma.2011.04.026; CDC, 2009, 4 CDCP; Centers for Disease Control and Prevention National Center for Health Statistics (CDC), 2017, NAT REP HUM EXP ENV; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Ferguson KK, 2014, ENVIRON SCI TECHNOL, V48, P7018, DOI 10.1021/es502076j; Ferguson KK, 2012, ENVIRON SCI TECHNOL, V46, P477, DOI 10.1021/es202340b; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006; Gascon M, 2015, J ALLERGY CLIN IMMUN, V135, P370, DOI 10.1016/j.jaci.2014.09.030; Hsu NY, 2012, INDOOR AIR, V22, P186, DOI 10.1111/j.1600-0668.2011.00753.x; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC; Kho Y, 2011, HUMAN BIOMONITORING; Kim PG, 2007, EXPOSURE HUMAN RISK; Kim S, 2014, SCI TOTAL ENVIRON, V472, P49, DOI 10.1016/j.scitotenv.2013.10.118; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.2307/3435033; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Lin LY, 2018, SCI TOTAL ENVIRON, V615, P1282, DOI 10.1016/j.scitotenv.2017.08.318; Loureiro CC, 2014, J ALLERGY CLIN IMMUN, V133, P261, DOI 10.1016/j.jaci.2013.11.004; Manteiga S, 2017, ENVIRON HEALTH PERSP, V125, P615, DOI 10.1289/EHP464; Nassan FL, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP1374, 10.1289/ehp1374]; Sathyanarayana S., 2018, CURR PROB PEDIATR AD, V38, P34; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Song NR, 2013, ENVIRON INT, V54, P65, DOI 10.1016/j.envint.2013.01.007; Soomro MH, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP1829, 10.1289/ehp1829]; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Vernet C, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1015; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121	41	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208553	10.1371/journaI.pone.0208553	http://dx.doi.org/10.1371/journaI.pone.0208553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557318				2022-12-26	WOS:000453451000032
J	Rattay, F; Bassereh, H; Stiennon, I				Rattay, Frank; Bassereh, Hassan; Stiennon, Isabel			Compartment models for the electrical stimulation of retinal bipolar cells	PLOS ONE			English	Article							MEMBRANE-PROPERTIES; CALCIUM-CHANNELS; CURRENTS; EPILEPSY; VOLTAGE; SPIKES	Bipolar cells of the retina are among the smallest neurons of the nervous system. For this reason, compared to other neurons, their delay in signaling is minimal. Additionally, the small bipolar cell surface combined with the low membrane conductance causes very little attenuation in the signal from synaptic input to the terminal. The existence of spiking bipolar cells was proven over the last two decades, but until now no complete model including all important ion channel types was published. The present study amends this and analyzes the impact of the number of model compartments on simulation accuracy. Characteristic features like membrane voltages and spike generation were tested and compared for one-, two-, four- and 117-compartment models of a macaque bipolar cell. Although results were independent of the compartment number for low membrane conductances (passive membranes), nonlinear regimes such as spiking required at least a separate axon compartment. At least a four compartment model containing the functionally different segments dendrite, soma, axon and terminal was needed for understanding signaling in spiking bipolar cells. Whereas for intracellular current application models with small numbers of compartments showed quantitatively correct results in many cases, the cell response to extracellular stimulation is sensitive to spatial variation of the electric field and accurate modeling therefore demands for a large number of short compartments even for passive membranes.	[Rattay, Frank; Bassereh, Hassan; Stiennon, Isabel] Vienna Univ Technol, Inst Anal & Sci Comp, Wiedner Hauptstr, Vienna, Austria	Technische Universitat Wien	Rattay, F (corresponding author), Vienna Univ Technol, Inst Anal & Sci Comp, Wiedner Hauptstr, Vienna, Austria.	frank.rattay@tuwien.ac.at	Rattay, Frank/A-2231-2015	Rattay, Frank/0000-0002-2819-8827	European Institute of Innovation and Technology Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [674901]	European Institute of Innovation and Technology Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant	HB was supported by European Institute of Innovation and Technology Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 674901 (switchboard). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Benav H., 2012, THESIS; Chuang AT, 2014, BRIT J OPHTHALMOL, V98, P852, DOI 10.1136/bjophthalmol-2013-303708; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Deleuze C, 2012, J NEUROSCI, V32, P12228, DOI 10.1523/JNEUROSCI.1362-12.2012; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Encke J, 2013, BIOMED TECH, V58, P12236, DOI [10.1523/JNEUROSCI.1362-12.2012, DOI 10.1523/JNEUROSCI.1362-12.2012]; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Freeman DK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046005; Greschner M, 2014, J NEUROSCI, V34, P3597, DOI 10.1523/JNEUROSCI.3359-13.2014; Guo Tianruo, 2014, Critical Reviews in Biomedical Engineering, V42, P419, DOI 10.1615/CritRevBiomedEng.2014011732; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Hellmer CB, 2016, NEUROSCIENCE, V315, P246, DOI 10.1016/j.neuroscience.2015.12.016; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu CP, 2009, VISUAL NEUROSCI, V26, P177, DOI 10.1017/S0952523809090026; Ishihara A, 1998, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, P203; Ishihara A, 2003, KEIO U INT S LIFE SC, V11; Ishihara A, 2018, SENSOR MATER, V30, P299, DOI 10.18494/SAM.2018.1720; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; KLUMPP DJ, 1995, J NEUROSCI, V15, P5004; LASATER EM, 1988, J NEUROPHYSIOL, V60, P1460, DOI 10.1152/jn.1988.60.4.1460; Li YN, 2012, J COMP NEUROL, V520, P3786, DOI 10.1002/cne.23168; Light AC, 2012, J COMP NEUROL, V520, P2864, DOI 10.1002/cne.23068; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Newkirk GS, 2013, J NEUROPHYSIOL, V110, P536, DOI 10.1152/jn.00118.2013; Oltedal L, 2007, J NEUROPHYSIOL, V97, P1171, DOI 10.1152/jn.01010.2006; Oltedal L, 2009, J PHYSIOL-LONDON, V587, P829, DOI 10.1113/jphysiol.2008.165415; Protti DA, 1998, J NEUROSCI, V18, P3715; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Puthussery T, 2013, J NEUROSCI, V33, P16045, DOI 10.1523/JNEUROSCI.1249-13.2013; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 2012, NEUROSCIENCE, V214, P1, DOI 10.1016/j.neuroscience.2012.04.004; Rattay F, 2003, NEUROMODULATION, V6, P42, DOI 10.1046/j.1525-1403.2003.03006.x; Rattay F., 2002, HDB NEUROPROSTHETIC, P39; Rattay F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17603-8; Resatz S, 2003, P ANN INT IEEE EMBS, V25, P2039, DOI 10.1109/IEMBS.2003.1280136; Saszik S, 2012, J NEUROSCI, V32, P297, DOI 10.1523/JNEUROSCI.2739-08.2012; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Spampanato J, 2004, J NEUROPHYSIOL, V91, P2040, DOI 10.1152/jn.00982.2003; Strettoi E, 2010, PROG RETIN EYE RES, V29, P272, DOI 10.1016/j.preteyeres.2010.03.005; TESSIERLAVIGNE M, 1988, J GEN PHYSIOL, V91, P49, DOI 10.1085/jgp.91.1.49; Tsukamoto Y, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00104; Usui S, 1996, VISION RES, V36, P4069, DOI 10.1016/S0042-6989(96)00179-4; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; Vielma AH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30259; Werginz P, 2015, VISION RES, V111, P170, DOI 10.1016/j.visres.2014.12.002; Werginz P, 2015, MINERVA MED, V106, P65; Werginz P, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046013; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209123	10.1371/journal.pone.0209123	http://dx.doi.org/10.1371/journal.pone.0209123			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557410	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000072
J	Prudent, R; Demoncheaux, N; Diemer, H; Collin-Faure, V; Kapur, R; Paublant, F; Lafanechere, L; Cianferani, S; Rabilloud, T				Prudent, Renaud; Demoncheaux, Nathalie; Diemer, Helene; Collin-Faure, Veronique; Kapur, Reuben; Paublant, Fabrice; Lafanechere, Laurence; Cianferani, Sarah; Rabilloud, Thierry			A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1	PLOS ONE			English	Article							IMMOBILIZED PH GRADIENTS; HIGH-MOLECULAR-WEIGHT; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; PROTEINS; TUMOR; INVASION; POLYACRYLAMIDE; GROWTH; ELECTROPHORESIS	LIM kinases are located at a strategic crossroad, downstream of several signaling pathways and upstream of effectors such as microtubules and the actin cytoskeleton. Cofilin is the only LIM kinases substrate that is well described to date, and its phosphorylation on serine 3 by LIM kinases controls cofilin actin-severing activity. Consequently, LIM kinases inhibition leads to actin cytoskeleton disorganization and blockade of cell motility, which makes this strategy attractive in anticancer treatments. LIMK has also been reported to be involved in pathways that are deregulated in hematologic malignancies, with little information regarding cofilin phosphorylation status. We have used proteomic approaches to investigate quantitatively and in detail the phosphorylation status of cofilin in myeloid tumor cell lines of murine and human origin. Our results show that under standard conditions, only a small fraction (10 to 30% depending on the cell line) of cofilin is phosphorylated (including serine 3 phosphorylation). In addition, after a pharmacological inhibition of LIM kinases, a residual cofilin phosphorylation is observed on serine 3. Interestingly, this 2D gel based proteomic study identified new phosphorylation sites on cofilin, such as threonine 63, tyrosine 82 and serine 108.	[Prudent, Renaud; Demoncheaux, Nathalie; Paublant, Fabrice] CELLIPSE SAS, Grenoble, France; [Diemer, Helene; Cianferani, Sarah] Univ Strasbourg, Lab Spectrometrie Masse BioOrgan LSMBO, CNRS, IPHC UMR 7178, Strasbourg, France; [Collin-Faure, Veronique; Rabilloud, Thierry] Univ Grenoble Alpes, Chem & Biol Met, CNRS UMR5249, CEA,BIG LCBM, Grenoble, France; [Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Lafanechere, Laurence] Univ Grenoble Alpes, Inst Adv Biosci, CNRS UMR 5309, INSERM U1209, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Indiana University System; Indiana University Bloomington; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rabilloud, T (corresponding author), Univ Grenoble Alpes, Chem & Biol Met, CNRS UMR5249, CEA,BIG LCBM, Grenoble, France.; Lafanechere, L (corresponding author), Univ Grenoble Alpes, Inst Adv Biosci, CNRS UMR 5309, INSERM U1209, Grenoble, France.	laurence.lafanechere@univ-grenoble-alpes.fr; thierry.rabilloud@cea.fr	Lafanechère, Laurence MP/N-7474-2013	Lafanechère, Laurence MP/0000-0002-7902-7630; Cianferani, Sarah/0000-0003-4013-4129	Institut National du Cancer grant [2016-165]; CNRS; University of Strasbourg; "Agence Nationale de la Recherche" (ANR); French Proteomic Infrastructure (ProFI) [ANR-10-INBS-08-03]	Institut National du Cancer grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; "Agence Nationale de la Recherche" (ANR)(French National Research Agency (ANR)); French Proteomic Infrastructure (ProFI)	This work was supported by Institut National du Cancer grant 2016-165 to LL. This work was also supported by the CNRS (SC, TR), the University of Strasbourg (SC), the "Agence Nationale de la Recherche" (ANR) and the French Proteomic Infrastructure (ProFI; ANR-10-INBS-08-03) to SC. None of these funders had any influence in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charette SJ, 2010, J IMMUNOL METHODS, V353, P148, DOI 10.1016/j.jim.2009.12.007; Chatterjee A, 2015, ONCOTARGET, V6, P18250, DOI 10.18632/oncotarget.4213; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eynard L, 1998, ELECTROPHORESIS, V19, P1394, DOI 10.1002/elps.1150190833; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; GIANAZZA E, 1989, ELECTROPHORESIS, V10, P806, DOI 10.1002/elps.1150101115; GORG A, 1987, ELECTROPHORESIS, V8, P122, DOI 10.1002/elps.1150080207; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Heidebrecht F, 2009, J IMMUNOL METHODS, V345, P40, DOI 10.1016/j.jim.2009.03.018; Huyck L, 2012, FEBS LETT, V586, P296, DOI 10.1016/j.febslet.2012.01.018; Kapur R, 2016, ONCOTARGET, V7, P16936, DOI 10.18632/oncotarget.7851; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lagoutte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24925; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; Li R, 2013, CLIN EXP METASTAS, V30, P483, DOI 10.1007/s10585-012-9553-6; Liao Q, 2017, BRIT J CANCER, V117, P563, DOI 10.1038/bjc.2017.193; Lindstrom NO, 2011, GENE EXPR PATTERNS, V11, P221, DOI 10.1016/j.gep.2010.12.003; Luche S, 2004, PROTEOMICS, V4, P551, DOI 10.1002/pmic.200300589; Mali RS, 2012, ONCOTARGET, V3, P909; Manetti F, 2012, MED RES REV, V32, P968, DOI 10.1002/med.20230; Mardilovich K, 2015, ONCOTARGET, V6, P38469, DOI 10.18632/oncotarget.6288; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Nick HJ, 2012, BLOOD, V119, P1522, DOI 10.1182/blood-2011-02-338228; Ohashi K, 2014, MOL BIOL CELL, V25, P828, DOI 10.1091/mbc.E13-09-0540; Ou SR, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170202; Prudent R, 2012, CANCER RES, V72, P4429, DOI 10.1158/0008-5472.CAN-11-3342; Prunier C, 2017, ONCOTARGET, V8, P41749, DOI 10.18632/oncotarget.16978; Prunier C, 2016, ONCOTARGET, V7, P50816, DOI 10.18632/oncotarget.10816; Prunier C, 2016, CANCER RES, V76, P3541, DOI 10.1158/0008-5472.CAN-15-1864; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P1552, DOI 10.1002/elps.11501501223; Richert S, 2004, PROTEOMICS, V4, P909, DOI 10.1002/pmic.200300642; Ritchey L, 2014, BBA-MOL CELL RES, V1843, P2719, DOI 10.1016/j.bbamcr.2014.07.014; Sakuma M, 2012, MOL BIOL CELL, V23, P3707, DOI 10.1091/mbc.E12-01-0053; Sari-Hassoun M, 2016, BIOCHEM PHARMACOL, V102, P45, DOI 10.1016/j.bcp.2015.12.013; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Speicher K D, 2000, J Biomol Tech, V11, P74; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Triboulet S, 2013, MOL CELL PROTEOMICS, V12, P3108, DOI 10.1074/mcp.M113.030742; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yang EJ, 2004, J BIOL CHEM, V279, P8903, DOI 10.1074/jbc.M311913200; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319	56	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208979	10.1371/journal.pone.0208979	http://dx.doi.org/10.1371/journal.pone.0208979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550596	Green Submitted, Green Published, gold			2022-12-26	WOS:000453248000035
J	Vanden Hole, C; Cleuren, S; Van Ginneken, C; Prims, S; Ayuso, M; Van Cruchten, S; Aerts, P				Vanden Hole, Charlotte; Cleuren, Silke; Van Ginneken, Chris; Prims, Sara; Ayuso, Miriam; Van Cruchten, Steven; Aerts, Peter			How does intrauterine crowding affect locomotor performance in newborn pigs? A study of force generating capacity and muscle composition of the hind limb	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; BIRTH-WEIGHT; MECHANICAL-PROPERTIES; BODY-COMPOSITION; SHORTENING VELOCITY; ATPASE ACTIVITY; SINGLE FIBERS; PELVIC LIMB; LITTER SIZE; SKELETAL	Intrauterine crowding (IUC) considerably influences postnatal traits in a polytocous species such as the pig. Previously, our group described how IUC affects locomotion during the piglet's first days of life (until 96 h after birth). We noted a reduced motor performance in piglets with a low birth weight and low vitality (L piglets), compared to piglets with a normal birth weight and normal vitality (N piglets), indicating L piglets are unable to produce enough force. Our current study investigates whether this observed force deficit in L piglets is caused by a reduced force generating capacity in the muscles and/or a lower percentage of type II (fast-contracting) fibers. Volume and fiber length of the main extensor muscles of the hind limb were used to estimate the physiological cross-sectional area (PSCA) and hence calculate the maximal isometric force generating capacity (Fiso-max) of the hind limb. To check for developmental differences between the muscles of L and N piglets, Fiso-max was normalized to body weight (BW), thus yielding a dimensionless variable F'(iso-max). To check for differences in muscle composition, m. vastus lateralis was stained immunohistochemically in order to determine the percentage of type II fibers through image analysis. Our results indicate that L piglets have a reduced absolute force generating capacity due to a lesser muscle mass, compared to N piglets. However, when normalized to BW L piglets actually show a larger force generating capacity, suggesting their muscles are more voluminous, given their body mass, than those of N piglets. However, no differences between L and N piglets were detected with regard to muscle composition of the m. vastus lateralis. Based on our data, we can say that neither normalized force generating capacity, nor muscle composition (of the m. vastus lateralis) can explain the observed force deficit in L piglets and as such the effect of IUC on locomotor performance.	[Vanden Hole, Charlotte; Cleuren, Silke; Van Ginneken, Chris; Prims, Sara; Ayuso, Miriam; Van Cruchten, Steven] Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium; [Aerts, Peter] Univ Antwerp, Fac Sci, Dept Biol, Lab Funct Morphol, Antwerp, Belgium; [Aerts, Peter] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, Ghent, Belgium	University of Antwerp; University of Antwerp; Ghent University	Van Ginneken, C (corresponding author), Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium.	chris.vanginneken@uantwerpen.be	ayuso, miriam/GPX-8386-2022; Hernando, Miriam Ayuso/AAY-3751-2020; Van Ginneken, Chris/AAK-2559-2020	ayuso, miriam/0000-0001-6045-394X; Van Ginneken, Chris/0000-0002-1622-9120; Aerts, Peter/0000-0002-6867-5421; Cleuren, Silke/0000-0001-7458-8925	special research fund of the Universiteit Antwerpen [GOA-33927]	special research fund of the Universiteit Antwerpen	This work was supported by a special research fund of the Universiteit Antwerpen (grant number GOA-33927) to Peter Aerts and Chris Van Ginneken.	Alvarenga ALN, 2013, REPROD FERT DEVELOP, V25, P387, DOI 10.1071/RD12021; Andersen IL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1159, DOI 10.1007/s00265-010-1128-4; ANDERSON RH, 1970, J ANIM SCI, V31, P907, DOI 10.2527/jas1970.315907x; Bauer R, 2000, EXP TOXICOL PATHOL, V52, P271, DOI 10.1016/S0940-2993(00)80045-7; Bauer R, 2006, J PERINAT MED, V34, P235, DOI 10.1515/JPM.2006.042; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Baxter EM, 2012, ANIMAL, V6, P96, DOI 10.1017/S1751731111001224; Baxter EM, 2011, ANIMAL, V5, P580, DOI 10.1017/S1751731110002272; Beaulieu AD, 2010, J ANIM SCI, V88, P2767, DOI 10.2527/jas.2009-2222; Berard J, 2008, J ANIM SCI, V86, P2357, DOI 10.2527/jas.2008-0893; Berard J, 2010, J ANIM SCI, V88, P3242, DOI 10.2527/jas.2010-2867; Biewener AA., 2003, ANIMAL LOCOMOTION; BOCK W J, 1972, Anatomischer Anzeiger, V130, P222; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V481, P663, DOI 10.1113/jphysiol.1994.sp020472; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; De Vos M, 2016, ANIM PROD SCI, V56, P844, DOI 10.1071/AN13467; De Vos M, 2014, LIVEST SCI, V159, P165, DOI 10.1016/j.livsci.2013.11.012; Dziuk P, 1985, J Reprod Fertil Suppl, V33, P57; EDDINGER TJ, 1987, AM J PHYSIOL, V253, pC210, DOI 10.1152/ajpcell.1987.253.2.C210; Fraser D, 1990, J Reprod Fertil Suppl, V40, P355; Geiger PC, 2000, J APPL PHYSIOL, V89, P695, DOI 10.1152/jappl.2000.89.2.695; GLUCKSMANN A, 1974, BIOL REV, V49, P423, DOI 10.1111/j.1469-185X.1974.tb01171.x; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Herpin P, 2001, J ANIM SCI, V79, P5; HERPIN P, 1993, J ANIM SCI, V71, P2645, DOI 10.2527/1993.71102645x; Howard V., 2004, UNBIASED STEREOLOGY; LARSSON L, 1991, AM J PHYSIOL, V261, pC93, DOI 10.1152/ajpcell.1991.261.1.C93; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Lefaucheur L, 1998, J ANIM SCI, V76, P1584; Lefaucheur L, 2002, J HISTOCHEM CYTOCHEM, V50, P719, DOI 10.1177/002215540205000513; Lin X., 2012, SUSTAINABLE SWINE NU, DOI [10.1002/9781118491454.ch3, DOI 10.1002/9781118491454.CH3]; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Maltin CA, 2001, REPRODUCTION, V122, P359, DOI 10.1530/rep.0.1220359; Medler S, 2002, AM J PHYSIOL-REG I, V283, pR368, DOI 10.1152/ajpregu.00689.2001; MENDEZ J, 1960, METABOLISM, V9, P184; MERKENS HW, 1993, EQUINE VET J, V25, P134, DOI 10.1111/j.2042-3306.1993.tb02923.x; MERSMANN HJ, 1974, J ANIM SCI, V38, P1022, DOI 10.2527/jas1974.3851022x; Mount L. E., 1968, CLIMATIC PHYSL PIG; Payne RC, 2006, J ANAT, V208, P725, DOI 10.1111/j.1469-7580.2006.00564.x; Payne RC, 2006, J ANAT, V208, P709, DOI 10.1111/j.1469-7580.2006.00563.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; PERRY JS, 1969, J REPROD FERTIL, V19, P527, DOI 10.1530/jrf.0.0190527; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rutherford K.M.D., 2011, ETHICAL WELFARE IMPL; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sieck GC, 1998, COMP BIOCHEM PHYS B, V119, P435, DOI 10.1016/S0305-0491(98)00005-4; Swanstrom MD, 2005, J BIOMECH, V38, P579, DOI 10.1016/j.jbiomech.2004.03.030; Theil PK, 2011, J ANIM SCI, V89, P1805, DOI 10.2527/jas.2010-2856; Tuchscherer M, 2000, THERIOGENOLOGY, V54, P371, DOI 10.1016/S0093-691X(00)00355-1; Vanden Hole C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195961; Vanden Hole C, 2017, J EXP BIOL, V220, P2706, DOI 10.1242/jeb.157693; Wank V, 2000, AM J PHYSIOL-REG I, V278, pR304, DOI 10.1152/ajpregu.2000.278.2.R304; WELLS JB, 1965, J PHYSIOL-LONDON, V178, P252, DOI 10.1113/jphysiol.1965.sp007626; Widrick JJ, 1996, AM J PHYSIOL-CELL PH, V271, pC666, DOI 10.1152/ajpcell.1996.271.2.C666; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Wise T, 1997, J ANIM SCI, V75, P2197	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209233	10.1371/journal.pone.0209233	http://dx.doi.org/10.1371/journal.pone.0209233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550550	Green Submitted, Green Published, gold			2022-12-26	WOS:000453248000051
J	Madden, JM; Duffy, MJ; Zgaga, L; Bennett, K				Madden, J. M.; Duffy, M. J.; Zgaga, L.; Bennett, K.			Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; CHANGING PATTERNS; WOMEN; RISK; MORTALITY	Background Vitamin D has been linked with improved survival after breast cancer diagnosis but little is known about prescribing rates. This study investigates trends in vitamin D supplement use in both a general female and breast cancer population. Methods Women with a breast cancer diagnosis were identified from the National Cancer Registry of Ireland (n = 19870). Women who had any vitamin D claim between 2005 and 2011 were identified from pharmacy claims data (n = 8556). Prevalence rates were calculated as a proportion of all eligible women and by age (<55 years, >= 55 years). Poisson regression was used to compare rates of vitamin D prescribing across years (risk ratio (RR), 95% Cl). Results There was a statistically significant increase in women with a claim for vitamin D between 2005-2011, with the largest increase among breast cancer patients aged >= 55 years (RR = 2.26; 95% Cl, 2.11-2.42). Conclusion This may have significant public health implications if associations between vitamin D and improved breast cancer survival prove to be causal.	[Madden, J. M.; Bennett, K.] Royal Coll Surgeons Ireland, Populat Hlth Sci Div, Dublin, Ireland; [Duffy, M. J.] Univ Coll Dublin, UCD Sch Med, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Zgaga, L.] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland	Royal College of Surgeons - Ireland; University College Dublin; Trinity College Dublin	Madden, JM (corresponding author), Royal Coll Surgeons Ireland, Populat Hlth Sci Div, Dublin, Ireland.	jamiemadden@rcsi.ie	Zgaga, Lina/Q-9415-2018	Zgaga, Lina/0000-0003-4089-9703; Madden, Jamie/0000-0003-2383-5150; Bennett, Kathleen/0000-0002-2861-7665	Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]; Health Research Board Ireland [HRB-RL/2015/1579]	Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT; Health Research Board Ireland	This work was supported by the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT (CCRC13GAL) and the Health Research Board Ireland (HRB-RL/2015/1579). The Health Research Board Ireland and the Irish Cancer Society had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit for publication.	[Anonymous], 2017, PCRS ANN REPORTS STA; Barron TI, 2013, BRIT J CANCER, V109, P1513, DOI 10.1038/bjc.2013.518; Bilinski K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4743; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Cianferotti L, 2015, OSTEOPOROSIS INT, V26, P2695, DOI 10.1007/s00198-015-3187-x; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Hadji P, 2017, J BONE ONCOL, V7, P1, DOI 10.1016/j.jbo.2017.03.001; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kim Y, 2014, BRIT J CANCER, V110, P2772, DOI 10.1038/bjc.2014.175; Li MA, 2014, J CLIN ENDOCR METAB, V99, P2327, DOI 10.1210/jc.2013-4320; Madden JM, 2018, BREAST CANCER RES TR, V172, P179, DOI 10.1007/s10549-018-4896-6; Manson JE, 2015, JAMA-J AM MED ASSOC, V313, P1311, DOI 10.1001/jama.2015.1353; Mondul AM, 2017, EPIDEMIOL REV, V39, P28, DOI 10.1093/epirev/mxx005; Murray A, 2017, ENDOCR-RELAT CANCER, V24, P181, DOI 10.1530/ERC-16-0463; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Tai V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4183; Vaughan-Shaw PG, 2017, BRIT J CANC; Yao S, 2017, JAMA ONCOL, V3, P351, DOI 10.1001/jamaoncol.2016.4188; Zhao SZ, 2015, LONDON J PRIM CARE, V7, P15, DOI 10.1080/17571472.2015.11493430	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209033	10.1371/journal.pone.0209033	http://dx.doi.org/10.1371/journal.pone.0209033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543699	gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500064
J	Li, L; Cao, BR; Liang, XH; Lu, S; Luo, HC; Wang, ZH; Wang, SX; Jiang, J; Lang, JY; Zhu, GQ				Li, Ling; Cao, Bangrong; Liang, Xinhua; Lu, Shun; Luo, Huaichao; Wang, Zhaohui; Wang, Shaoxin; Jiang, Jian; Lang, Jinyi; Zhu, Guiquan			Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral gamma delta T cell equilibrium via tumor-derived exosomes	ONCOGENE			English	Article							SUPPRESSOR-CELLS; CARCINOMA-CELLS; EXPANSION; HYPOXIA; PROMOTE; ELICIT; REGULATORS; RESPONSES; PROTEINS; GROWTH	gamma delta T cells are a unique lymphocyte population that have been reported to have either anti- or pro-tumoral functions in several cancer types, but the mechanisms are underinvestigated. Exosomes, initially considered to be cellular "garbage dumpsters," are now implicated in mediating interactions with the cellular environment. Hypoxia is a common feature of solid tumors and is believed to alter tumor-derived exosomes (TEXs), which mediate the hypoxic evolution of the tumor microenvironment in return. This study sought to investigate whether TEXs mediate the anti- and pro-tumoral equilibrium of gamma delta T cells under different oxygen pressures in the tumor microenvironment. We show that TEXs can alter the expansion and cytotoxicity of gamma delta T cells in an HSP70-dependent but dendritic cell-independent manner. The stimulating effects of normoxic TEXs on gamma delta T-cell activity were absent from hypoxic TEXs, which enhanced the suppressive effect of myeloid-derived suppressor cells (MDSCs) on gamma delta T cells through a miR-21/PTEN/PD-L1 regulation axis. Finally, the therapeutic outcome benefited from combined miR-21 and PD-Ll targeting in oral squamous cell carcinoma (OSCC)-bearing immunocompetent mice. We conclude that oxygen pressure in the tumor microenvironment orchestrates an anti- and protumoral gamma delta T-cell equilibrium by altering TEX content, which subsequently regulates MDSC function in a miR-21/PTEN/PD-L1 -axis-dependent manner. Our results should prompt further investigation into integrated exosomal miRNA inhibition and immune checkpoint inhibitor therapeutic modalities for patients with OSCC.	[Li, Ling; Wang, Zhaohui; Wang, Shaoxin; Jiang, Jian; Zhu, Guiquan] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Dept Head & Neck Surg, Sichuan Canc Ctr,Sch Med, Chengdu, Sichuan, Peoples R China; [Cao, Bangrong] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Dept Basic Res, Sichuan Canc Ctr,Sch Med, Chengdu, Sichuan, Peoples R China; [Liang, Xinhua] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Sichuan, Peoples R China; [Lu, Shun; Lang, Jinyi] Univ Elect Sci & Technol China, Dept Radiat Oncol, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Sch Med, Chengdu, Peoples R China; [Luo, Huaichao] Univ Elect Sci & Technol China, Dept Clin Lab, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Sch Med, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Sichuan University; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Zhu, GQ (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Dept Head & Neck Surg, Sichuan Canc Ctr,Sch Med, Chengdu, Sichuan, Peoples R China.; Lang, JY (corresponding author), Univ Elect Sci & Technol China, Dept Radiat Oncol, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Sch Med, Chengdu, Peoples R China.	langjy610@163.com; zgq@sichuancancer.org	, 曹邦荣/AAN-3604-2020; Lu, Shun/ABF-8341-2021	Cao, Bangrong/0000-0002-3865-3563; lang, jinyi/0000-0002-5406-8671; Zhu, Guiquan/0000-0002-8316-5809	National Natural Science Foundation of China [81672690, 81772900, 81872196, 81302375]; Department of Science and Technology of Sichuan Province [2015SZ0053, 2017JQ0040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This work was supported by the National Natural Science Foundation of China (grant nos. 81672690, 81772900, 81872196, and 81302375) and the Department of Science and Technology of Sichuan Province (grant nos. 2015SZ0053 and 2017JQ0040).	Castella B, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1047580; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Florcken A, 2015, IMMUNOL LETT, V168, P260, DOI 10.1016/j.imlet.2015.10.001; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gu XY, 2015, INT J CANCER, V136, pE74, DOI 10.1002/ijc.29100; Hasan MS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/705831; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kondo M, 2008, CYTOTHERAPY, V10, P842, DOI 10.1080/14653240802419328; Kondo M, 2011, JOVE-J VIS EXP, V55, P3182; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Liu YF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027472; Lo Presti E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00607; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ludwig S, 2017, CLIN CANCER RES, V23, P4843, DOI 10.1158/1078-0432.CCR-16-2819; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; O'Loughlin AJ, 2012, CURR GENE THER, V12, P262, DOI 10.2174/156652312802083594; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Plebanek MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01433-3; Rao Q, 2016, HEPATOLOGY, V64, P456, DOI 10.1002/hep.28549; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Song MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055761; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wu D, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.992749; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Xiang XY, 2010, AM J PATHOL, V177, P1606, DOI 10.2353/ajpath.2010.100245; Zhu GQ, 2014, NEOPLASIA, V16, P168, DOI 10.1593/neo.132034	48	87	90	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2830	2843		10.1038/s41388-018-0627-z	http://dx.doi.org/10.1038/s41388-018-0627-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30546089				2022-12-26	WOS:000464121600012
J	Zhang, YH; Feng, XL; Sun, WQ; Zhang, J; Chen, XB				Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin			Serine 195 phosphorylation in the RNA-binding protein Rbm38 increases p63 expression by modulating Rbm38's interaction with the Ago2-miR203 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p63; protein phosphorylation; transcription factor; post-transcriptional regulation; microRNA (miRNA); Argonaute 2; mRNA stability; RNA-binding motif protein 38 (Rbm38)	GLYCOGEN-SYNTHASE KINASE-3; P53 FAMILY; TRANSLATIONAL REPRESSION; TARGET; RNPC1; PROLIFERATION; DIFFERENTIATION; DEADENYLATION; APOPTOSIS; HOMOLOG	The p63 transcription factor, a p53 family protein, regulates genes involved in various cellular processes, including cell growth and differentiation. We previously showed that RNA-binding motif protein (Rbm38) is a p63 target and, in turn, regulates p63 alpha mRNA stability by binding to the AU/U-rich element in its 3 ' UTR. Interestingly, Rbm38 can be phosphorylated at serine 195, altering its ability to regulate mRNA translation. However, whether the Ser-195 phosphorylation affects Rbm38's ability to destabilize p63 mRNA remains unclear. Here, using MCF7 and HaCaT cells, we showed that ectopic expression of phosphomimetic Rbm38-S195D increases, whereas WT Rbm38 and nonphosphorylatable Rbm38-S195A decrease p63 alpha protein and transcript levels. We also found that upon activation of glycogen synthase kinase 3 beta (GSK3 beta), phosphorylation of Rbm38 at Ser-195 is increased, enhancing p63 alpha expression in an Rbm38-dependent manner. To confirm this, we generated mouse embryo fibroblasts (MEFs) in which Ser-193 in mouse Rbm38 (equivalent to Ser-195 in human Rbm38) was substituted with aspartic acid (Rbm38(S193D/S193D)) or alanine (Rbm38(S193A/S193A)). We observed that the p63 transcript level was increased in Rbm38(S193D/S193D) MEFs, but decreased in Rbm38(S193A/S193A) MEFs. Mechanistically, we found that WT Rbm38, but not Rbm38-S195D, is required for p63 mRNA degradation mediated by microRNA 203 (miR203). Furthermore, we noted that Argonaute 2 (Ago2), a key regulator in microRNA-mediated mRNA decay, associates with WT Rbm38, and this association was reduced by Ser-195 phosphorylation. Together, our results reveal a critical mechanism by which Ser-195 phosphorylation in Rbm38 increases p63 expression by attenuating the association of Rbm38 with the Ago2-miR203 complex.	[Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Feng, Xiuli] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Nanjing Agricultural University	Chen, XB (corresponding author), Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA.; Chen, XB (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu		chen, xinbin/0000-0002-4582-6506	National Institutes of Health [CA195828]; NATIONAL CANCER INSTITUTE [R01CA195828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant CA195828. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Feldstein O, 2012, MOL CANCER RES, V10, P1169, DOI 10.1158/1541-7786.MCR-12-0331; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jiang YQ, 2018, ONCOGENE, V37, P2863, DOI 10.1038/s41388-018-0176-5; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouwenhoven EN, 2015, EMBO REP, V16, P863, DOI 10.15252/embr.201439941; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Levrero M, 2000, J CELL SCI, V113, P1661; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; Xu ES, 2014, MOL CANCER RES, V12, P359, DOI 10.1158/1541-7786.MCR-13-0526; Yan WS, 2017, ONCOTARGET, V8, P78327, DOI 10.18632/oncotarget.18463; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang J, 2018, CANCER RES, V78, P1511, DOI 10.1158/0008-5472.CAN-17-2457; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang M, 2013, GENE DEV, V27, P2246, DOI 10.1101/gad.221739.113; Zhang Y, 2014, ONCOGENE, V33, P1548, DOI 10.1038/onc.2013.101; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117	42	8	8	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2449	2459		10.1074/jbc.RA118.005779	http://dx.doi.org/10.1074/jbc.RA118.005779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30567739	Green Published, hybrid			2022-12-26	WOS:000458895400021
J	Kumagai, J; Taide, T; Ogasawara, S; Nakagawa, T; Lino, Y; Shingyoji, A; Ishikawa, K; Akizue, N; Yamato, M; Takahashi, K; Ohta, Y; Hamanaka, S; Okimoto, K; Nakamura, M; Ohyama, H; Saito, K; Kusakabe, Y; Maruoka, D; Yasui, S; Matsumura, T; Sugiyama, H; Sakai, Y; Mikata, R; Arai, M; Katsuno, T; Tsuyuguchi, T; Kato, N				Kumagai, Junichiro; Taide, Takashi; Ogasawara, Sadahisa; Nakagawa, Tomoo; Lino, Yotaro; Shingyoji, Ayako; Ishikawa, Kentaro; Akizue, Naoki; Yamato, Mutsumi; Takahashi, Koji; Ohta, Yuki; Hamanaka, Shinsaku; Okimoto, Kenichiro; Nakamura, Masato; Ohyama, Hiroshi; Saito, Keiko; Kusakabe, Yuko; Maruoka, Daisuke; Yasui, Shin; Matsumura, Tomoaki; Sugiyama, Harutoshi; Sakai, Yuji; Mikata, Rintaro; Arai, Makoto; Katsuno, Tatsuro; Tsuyuguchi, Toshio; Kato, Naoya			Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INCREASING INCIDENCE; INCREASED RISK; PSC-IBD; POPULATION; PREVALENCE; EPIDEMIOLOGY; DIAGNOSIS; PROGNOSIS; IMPACT	Background In Western countries, most patients with primary sclerosing cholangitis (PSC) have concurrent ulcerative colitis (UC). The number of patients with UC in East Asia has increased markedly over the past two decades. However, current clinical features of PSC and of PSC associated with UC (PSC-UC) have not yet been clarified in East Asia, particularly in Japan. We aimed to reveal the clinical courses and associations with UC in Japanese patients with PSC from the mutual viewpoint of PSC and UC. Methods We retrospectively retrieved medical records of patients with PSC (69) and UC (1242) who were diagnosed at Chiba University Hospital between June 1991 and August 2017. Results In the present cohort, 37 patients had PSC-UC; the cumulative risks of PSC in patients with UC and of UC in patients with PSC were 3.0% and 53.6%, respectively. We confirmed similar distinctive results by a Japanese nationwide survey, noting that younger patients with PSC had a notably high possibility of association with UC. From the viewpoint of the UC cohort, the occurrence of right-sided disease was significantly higher in patients with PSCUC than in those with UC (16.2% vs. 4.2%, P = 0.003). Pancolitis was more commonly observed in PSC-UC, and proctits/left-sided colitis was less commonly found in patients with UC. The number of patients with young-onset PSC-UC may be increasing similar to an increase in patients with UC in Japan. Conclusions In our cohort, the comorbidity rate of PSC-UC was higher than that obtained in previous reports. The incidence of PSC-UC and UC may increase in the future in East Asia, particularly in Japan.	[Kumagai, Junichiro; Taide, Takashi; Ogasawara, Sadahisa; Nakagawa, Tomoo; Lino, Yotaro; Shingyoji, Ayako; Ishikawa, Kentaro; Akizue, Naoki; Yamato, Mutsumi; Takahashi, Koji; Ohta, Yuki; Hamanaka, Shinsaku; Okimoto, Kenichiro; Nakamura, Masato; Ohyama, Hiroshi; Saito, Keiko; Kusakabe, Yuko; Maruoka, Daisuke; Yasui, Shin; Matsumura, Tomoaki; Sugiyama, Harutoshi; Sakai, Yuji; Mikata, Rintaro; Arai, Makoto; Katsuno, Tatsuro; Tsuyuguchi, Toshio; Kato, Naoya] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan	Chiba University	Tsuyuguchi, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan.	tsuyuguchi@faculty.chiba-u.jp	Ohyama, Hiroshi/AFU-2720-2022; Ogasawara, Sadahisa/GRF-7061-2022	Ohyama, Hiroshi/0000-0003-0614-581X; Ogasawara, Sadahisa/0000-0002-6540-9064; Takahashi, Koji/0000-0001-8134-8524	AbbVie; Otsuka; EA pharma; Mochida; JIMRO; Asahikasei-Medical; Nihonkayaku; MSD; Daiichi-Sankyo; Takeda	AbbVie(AbbVie); Otsuka(Otsuka Pharmaceutical); EA pharma; Mochida; JIMRO; Asahikasei-Medical; Nihonkayaku; MSD; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Takeda(Takeda Pharmaceutical Company Ltd)	Tomoo Nakagawa received unrestricted research grant from AbbVie, Otsuka, EA pharma, Mochida, JIMRO, Asahikasei-Medical, and Nihonkayaku. Makoto Arai received unrestricted research grant from MSD, Daiichi-Sankyo, and Takeda. Naoya Kato received unrestricted research grant from AbbVie. The remaining authors disclose no conflicts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabakken L, 2017, J HEPATOL, V66, P1265, DOI 10.1016/j.jhep.2017.02.013; Bjornsson E, 2002, GUT, V51, P731, DOI 10.1136/gut.51.5.731; Boonstra K, 2013, HEPATOLOGY, V58, P2045, DOI 10.1002/hep.26565; Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006; Gulamhusein AF, 2016, AM J GASTROENTEROL, V111, P705, DOI 10.1038/ajg.2016.55; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Henriksen EKK, 2017, J HEPATOL, V66, P116, DOI 10.1016/j.jhep.2016.09.002; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Inao M, 2004, J HEPATOL, V41, P584, DOI 10.1016/j.jhep.2004.06.033; Joo M, 2009, AM J SURG PATHOL, V33, P854, DOI 10.1097/PAS.0b013e318196d018; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Lindkvist B, 2010, HEPATOLOGY, V52, P571, DOI 10.1002/hep.23678; Lindor KD, 2015, AM J GASTROENTEROL, V110, P646, DOI 10.1038/ajg.2015.112; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; LUDWIG J, 1981, Hepatology, V1, P632, DOI 10.1002/hep.1840010612; Lunder AK, 2016, GASTROENTEROLOGY, V151, P660, DOI 10.1053/j.gastro.2016.06.021; Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008; Marelli L, 2011, GUT, V60, P1224, DOI 10.1136/gut.2010.235408; Matsuoka Katsuyoshi, 2016, Nihon Shokakibyo Gakkai Zasshi, V113, P407, DOI 10.11405/nisshoshi.113.407; Mizuno S, 2015, J HEPATO-BIL-PAN SCI, V22, P766, DOI 10.1002/jhbp.281; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Molodecky NA, 2011, HEPATOLOGY, V53, P1590, DOI 10.1002/hep.24247; Navaneethan U, 2012, ALIMENT PHARM THER, V35, P1045, DOI 10.1111/j.1365-2036.2012.05063.x; Navaneethan U, 2016, GASTROENTEROL REP, V4, P43, DOI 10.1093/gastro/gou074; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ng SC, 2015, GUT, V64, P1063, DOI 10.1136/gutjnl-2014-307410; Nordenvall C, 2018, ALIMENT PHARM THER, V47, P238, DOI 10.1111/apt.14393; Sano H, 2011, J HEPATO-BIL-PAN SCI, V18, P154, DOI 10.1007/s00534-010-0319-8; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Sorensen JO, 2018, LIVER INT, V38, P532, DOI 10.1111/liv.13548; Takikawa H, 1997, J GASTROENTEROL, V32, P134, DOI 10.1007/BF01213311; Tanaka A, 2017, J HEPATO-BIL-PAN SCI, V24, P217, DOI 10.1002/jhbp.432; Tanaka A, 2015, J HEPATO-BIL-PAN SCI, V22, P230, DOI 10.1002/jhbp.194; Thia KT, 2008, AM J GASTROENTEROL, V103, P3167, DOI 10.1111/j.1572-0241.2008.02158.x; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Weismuller TJ, 2017, GASTROENTEROLOGY, V152, P1975, DOI 10.1053/j.gastro.2017.02.038; Yang Y, 2016, GASTROENTEROLOGY, V151, pE1, DOI 10.1053/j.gastro.2016.10.034; Ye BD, 2011, INFLAMM BOWEL DIS, V17, P1901, DOI 10.1002/ibd.21569	40	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209352	10.1371/journal.pone.0209352	http://dx.doi.org/10.1371/journal.pone.0209352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571774	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700057
J	Ohmori, T; Kabata, T; Kajino, Y; Inoue, D; Taga, T; Yamamoto, T; Takagi, T; Yoshitani, J; Ueno, T; Ueoka, K; Tsuchiya, H				Ohmori, Takaaki; Kabata, Tamon; Kajino, Yoshitomo; Inoue, Daisuke; Taga, Tadashi; Yamamoto, Takashi; Takagi, Tomoharu; Yoshitani, Junya; Ueno, Takuro; Ueoka, Ken; Tsuchiya, Hiroyuki			A proposed new rotating reference axis for the tibial component after proximal tibial resection in total knee arthroplasty	PLOS ONE			English	Article							ANTEROPOSTERIOR AXIS; ALIGNMENT; PAIN	Purpose During total knee arthroplasty, few rotating reference axes can be reliably used after tibial resection. We speculated that a line that passes through the lateral edge of the posterior cruciate ligament (PCL) at its tibial attachment after resection and the most prominent point of the tibial tubercle [after-tibial resection (ATR) line] will provide a good reference axis. In this study, we aimed to evaluate the association between ATR and Akagi's lines. Materials and methods In this case-control simulation study, we retrospectively evaluated 38 patients with varus knee and 28 patients with valgus knee. We defined the reference cutting plane as 10 mm distal from the lateral articular surface of the tibia in varus group and as 7 mm distal from the medial articular surface in the valgus group. We measured angles between Akagi's line and the ATR line (ATR line angle) as well as between Akagi's line and 1/3 Akagi's line (1/3 Akagi's line angle), which passes through the midpoint of PCL and the medial third of the patellar tendon. We used paired t-tests to determine the significance of differences between these angles, with p < 0.05 indicating statistical significance. Intra- and interclass correlation coefficients for the reproducibility of 1/3 Akagi's line angle and ATR line angle were analyzed by two surgeons. Results We found that 1/3 Akagi's line angle was 10.2 degrees +/- 1.3 degrees in the varus group and 10.9 degrees +/- 1.3 degrees in the valgus group (p = 0.017). The ATR line was positioned externally compared with Akagi's line in all patients. Mean ATR line angles at 0 degrees, 3 degrees and 7 degrees posterior slopes were 6.1 degrees +/- 1.9 degrees , 5.8 degrees +/- 2.0 degrees and 6.0 degrees +/- 1.7 degrees in the varus group and 6.3 degrees +/- 2.3 degrees, 6.2 degrees +/- 2.3 degrees and 5.4 degrees +/- 2.1 degrees in the valgus group, respectively. There were no significant differences in the ATR line angle between the varus and valgus groups. (rho = 0.34-0.67) Intra- and interclass correlation coefficients for the reproducibility of 1/3 Akagi's line angle were 0.936 and 0.986 and those for the reproducibility of ATR line angle were 0.811 and 0.839. Conclusions The ATR line was positioned between Akagi's line and 1/3 Akagi's line in all patients and was a valid option for evaluating rotational tibial alignment after tibial resection.	[Ohmori, Takaaki; Kabata, Tamon; Kajino, Yoshitomo; Inoue, Daisuke; Taga, Tadashi; Yamamoto, Takashi; Takagi, Tomoharu; Yoshitani, Junya; Ueno, Takuro; Ueoka, Ken; Tsuchiya, Hiroyuki] Kanazawa Univ Hosp, Dept Orthopaed Surg, Takaramachi13-1, Kanazawa, Ishikawa, Japan	Kanazawa University	Kabata, T (corresponding author), Kanazawa Univ Hosp, Dept Orthopaed Surg, Takaramachi13-1, Kanazawa, Ishikawa, Japan.	tamonkabata@yahoo.ac.jp		Kabata, Tamon/0000-0002-1478-0146				Aglietti P, 2008, CLIN ORTHOP RELAT R, V466, P2751, DOI 10.1007/s11999-008-0452-8; Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Bedard M, 2011, CLIN ORTHOP RELAT R, V469, P2346, DOI 10.1007/s11999-011-1889-8; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Cheng FB, 2009, KNEE, V16, P341, DOI 10.1016/j.knee.2008.12.019; Dalury DF, 2001, CLIN ORTHOP RELAT R, P150; Forster-Horvath C, 2015, INT ORTHOP, V39, P2347, DOI 10.1007/s00264-015-2858-8; Hitt K, 2003, J BONE JOINT SURG AM, V85A, P115, DOI 10.2106/00004623-200300004-00015; Indelli PF, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.03; Kawahara S, 2014, KNEE SURG SPORT TR A, V22, P1070, DOI 10.1007/s00167-013-2468-1; Kim CW, 2014, BONE JOINT J, V96B, P1485, DOI 10.1302/0301-620X.96B11.33794; Kim JI, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1609-y; Kuriyama S, 2014, J ARTHROPLASTY, V29, P2352, DOI 10.1016/j.arth.2014.06.016; Lawrie CM, 2011, J ARTHROPLASTY, V26, P53, DOI 10.1016/j.arth.2011.04.026; Matziolis G, 2007, J BONE JOINT SURG AM, V89A, P236, DOI 10.2106/JBJS.F.00386; Mizu-Uchi H, 2008, J BONE JOINT SURG BR, V90B, P1025, DOI 10.1302/0301-620X.90B8.20265; MORELAND JR, 1988, CLIN ORTHOP RELAT R, P49; Nicoll D, 2010, J BONE JOINT SURG BR, V92B, P1238, DOI 10.1302/0301-620X.92B9.23516; Rossi R, 2010, KNEE SURG SPORT TR A, V18, P889, DOI 10.1007/s00167-009-1023-6; Saffarini M, 2019, KNEE SURG SPORT TR A, V27, P1018, DOI 10.1007/s00167-018-5131-z; Sanford BA, 2016, ORTHOPEDICS, V39, pS41, DOI 10.3928/01477447-20160509-13; Steinbruck A, 2016, KNEE SURG SPORT TR A, V24, P2395, DOI 10.1007/s00167-015-3503-1; Tashiro Y, 2012, KNEE SURG SPORT TR A, V20, P1463, DOI 10.1007/s00167-011-1691-x; Tilbury C, 2016, J ARTHROPLASTY, V31, P2139, DOI 10.1016/j.arth.2016.02.061; Ushio T, 2017, J ARTHROPLASTY, V32, P1006, DOI 10.1016/j.arth.2016.09.003; Wernecke Gregory C, 2016, HSS J, V12, P216; Yin L, 2015, CLIN BIOMECH, V30, P565, DOI 10.1016/j.clinbiomech.2015.04.003; YOSHIOKA Y, 1989, J ORTHOPAED RES, V7, P132, DOI 10.1002/jor.1100070118	30	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209317	10.1371/journal.pone.0209317	http://dx.doi.org/10.1371/journal.pone.0209317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571784	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700053
J	de Queiroz, RG; Domingues, CHD; Canozzi, MEA; Garcia, RG; Ruviaro, CF; Barcellos, JOJ; Borges, JAR				de Queiroz, Ricardo Guimaraes; de Faria Domingues, Carla Heloisa; Andrighetto Canozzi, Maria Eugenia; Garcia, Rodrigo Garofallo; Ruviaro, Clandio Favarini; Jardim Barcellos, Julio Otavio; Rossi Borges, Joao Augusto			How do Brazilian citizens perceive animal welfare conditions in poultry, beef, and dairy supply chains?	PLOS ONE			English	Article							VIEWS; PERCEPTION; ATTITUDES	The aim of this study was to understand the perceptions of Brazilian citizens about the general conditions of animal welfare in the poultry, beef, and dairy supply chains. To reach this aim, an online survey was conducted. The analysis was based on descriptive statistics and three logistic regression models. Results of descriptive statistics showed that citizens in Brazil had mostly negative perceptions about the conditions of animal welfare in the poultry, beef, and dairy supply chains. Results of the logistic regression models showed that citizens with a background in agricultural/veterinary sciences, and citizens who reported a higher level of knowledge about poultry and dairy supply chains were more likely to perceive the general conditions of animal welfare in these two supply chains as being bad. Citizens who reported previous contact with poultry farms were also more likely to perceive the general conditions of animal welfare in the poultry supply chain as being bad. In addition, the perception that farmers are mainly focused on the economic aspect of farming and less on animal welfare, the perception that animals do not have a good quality of life while housed on farms, and the perception that animals are not adequately transported and slaughtered, negatively impact on perceptions about the general conditions of animal welfare in the poultry, beef, and dairy supply chains.	[de Queiroz, Ricardo Guimaraes; de Faria Domingues, Carla Heloisa; Garcia, Rodrigo Garofallo; Ruviaro, Clandio Favarini; Rossi Borges, Joao Augusto] Fed Univ Grande Dourados, Dourados, MS, Brazil; [Andrighetto Canozzi, Maria Eugenia] Natl Inst Agr Res INIA, La Estanzuela, Uruguay; [Jardim Barcellos, Julio Otavio] Univ Fed Rio Grande do Sul, Ctr Estudos & Pesquisas Agronegocios, Porto Alegre, RS, Brazil	Universidade Federal da Grande Dourados; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA); Universidade Federal do Rio Grande do Sul	Borges, JAR (corresponding author), Fed Univ Grande Dourados, Dourados, MS, Brazil.	joaoborges@ufgd.edu.br	Domingues, Carla H F/H-2300-2016; Garcia, Rodrigo Garofallo/C-7846-2015; Canozzi, Maria Eugênia Andrighetto/B-2166-2016; Canozzi, Maria Eugênia Andrighetto/Y-1452-2019; Barcellos, Julio/A-9209-2013; Ruviaro, Clandio/E-9988-2010; Borges, Joao Augusto Rossi/F-4306-2016	Domingues, Carla H F/0000-0002-0878-2014; Garcia, Rodrigo Garofallo/0000-0002-4978-9386; Barcellos, Julio/0000-0001-9858-1728; Ruviaro, Clandio/0000-0003-3117-5359; Borges, Joao Augusto Rossi/0000-0002-2580-051X; Andrighetto Canozzi, Maria Eugenia/0000-0001-9263-8113				[Anonymous], 2010, SIN CENS DEM; Bayvel ACD, 2004, ANIM WELFARE, V13, pS163; Boogaard BK, 2006, LIVEST SCI, V104, P13, DOI 10.1016/j.livsci.2006.02.010; Boogaard BK, 2011, LIVEST SCI, V140, P189, DOI 10.1016/j.livsci.2011.03.028; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; de Graaf S, 2016, J DAIRY SCI, V99, P8304, DOI 10.3168/jds.2016-10886; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hotzel MJ, 2017, J DAIRY SCI, V100, P4150, DOI 10.3168/jds.2016-11933; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Kupsala S, 2015, J AGR ENVIRON ETHIC, V28, P601, DOI 10.1007/s10806-015-9545-z; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Ryan EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141878; Ferraz JBS, 2010, MEAT SCI, V84, P238, DOI 10.1016/j.meatsci.2009.06.006; Vanhonacker F, 2010, J AGR ENVIRON ETHIC, V23, P551, DOI 10.1007/s10806-010-9235-9; Ventura BA, 2015, J AGR ENVIRON ETHIC, V28, P109, DOI 10.1007/s10806-014-9523-x; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733; von Keyserlingk MAG, 2015, J AGR ENVIRON ETHIC, V28, P179, DOI 10.1007/s10806-014-9518-7; Weary DM, 2016, ANIMAL, V10, P309, DOI 10.1017/S1751731115001160; Weible D, 2016, BRIT FOOD J, V118, P1994, DOI 10.1108/BFJ-12-2015-0458; You XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109177; Yunes MC, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100075	24	13	13	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0202062	10.1371/journal.pone.0202062	http://dx.doi.org/10.1371/journal.pone.0202062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566475	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300003
J	Jung, YH; Kim, YD; Kim, J; Han, SW; Lee, KY				Jung, Yo Han; Kim, Young Dae; Kim, Jinkwon; Han, Sang Won; Lee, Kyung-Yul			Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; ORAL ANTICOAGULANTS; ISCHEMIC-STROKE; RISK-FACTORS; WARFARIN; PREVENTION; POPULATION; PREVALENCE; UNDERUSE; OUTCOMES	Background Atrial fibrillation (AF) is the most common cardiac arrhythmia among adults. Despite the proven advantages in primary and secondary stroke prevention in patients with AF, oral anticoagulation (OAC) therapy is still underused in many countries. In this study, we investigated the incidence of AF-related ischemic stroke over the past decade in South Korea and trends of preventive antithrombotic therapy use before stroke in a nationwide cohort. Methods and findings The data source for this study was a nationwide sample cohort comprising 1,025,340 individuals that was established by the nationwide health insurance system in 2002. A total of 10,215 patients with acute ischemic stroke (AIS) were selected from the cohort between 2004 and 2013. AF was identified in 1,662 patients, and 979 patients had preexisting AF before AIS. The annual proportion of patients with AIS with AF gradually increased from 13.4% to 22.6% over the study period (p for trends <0.001). Only 14.0% of patients with high risk AF were receiving OAC before the stroke, and this proportion remained relatively constant during the study period. However, the proportion of patients treated with antiplatelet agents had increased from 18.8% in 2004 to 45.3% in 2013, while that of patients receiving no antithrombotic agent decreased from 64.6% in 2004 to 43.9% in 2013. As a limitation, no information was available about non-vitamin K antagonist oral anticoagulants, because they were widely used since late 2014 in Korea. Conclusions The number of patients with AIS and AF has steadily increased over the last 10 years in Korea. However, a small portion of patients with AF were receiving OAC therapy before the stroke and about half of the patients did not receive any antithrombotic medication. Our study demonstrates that there is huge gap between clinical practice and treatment guidelines for patients with AF in Korea.	[Jung, Yo Han] Changwon Fatima Hosp, Dept Neurol, Chang Won, Gyeongsangnam D, South Korea; [Kim, Young Dae; Lee, Kyung-Yul] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Jinkwon] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Seongnam, Gyeonggi Do, South Korea; [Han, Sang Won] Inje Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Lee, Kyung-Yul] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Inje University; Yonsei University; Yonsei University Health System	Lee, KY (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.; Lee, KY (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea.	kylee@yuhs.ac		Kim, Young Dae/0000-0001-5750-2616; Lee, Kyung-Yul/0000-0001-5585-7739				[Anonymous], 2007, METAANALYSIS ANTITHR, P1; Bassand JP, 2012, EUROPACE, V14, P312, DOI 10.1093/europace/eur263; Bauersachs RM, 2012, THROMB RES, V129, P107, DOI 10.1016/j.thromres.2011.09.013; Chan EW, 2016, HEART RHYTHM, V13, P1581, DOI 10.1016/j.hrthm.2016.03.049; Choi EJ, 2016, INT J CARDIOL, V220, P647, DOI 10.1016/j.ijcard.2016.06.177; Ferro D, 2007, INTERN EMERG MED, V2, P24, DOI 10.1007/s11739-007-0005-2; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grond M, 2013, STROKE, V44, P3357, DOI 10.1161/STROKEAHA.113.001884; Gumbinger C, 2012, EUR J NEUROL, V19, P253, DOI 10.1111/j.1468-1331.2011.03519.x; Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061; Huisman MV, 2016, EUROPACE, V18, P1308, DOI 10.1093/europace/euw073; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Jeong JH, 2005, J KOREAN MED SCI, V20, P26, DOI 10.3346/jkms.2005.20.1.26; Kilander L, 1998, STROKE, V29, P1816, DOI 10.1161/01.STR.29.9.1816; Kim T, 2016, INT J STROKE, DOI [10.1177/1016/j.hrthm.2016.03.049, DOI 10.1177/1016/J.HRTHM.2016.03.049]; Kim WJ, 2016, J CLIN NEUROL, V12, P34, DOI 10.3988/jcn.2016.12.1.34; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee IH, 2015, J CARDIOL, V66, P475, DOI 10.1016/j.jjcc.2015.06.013; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425; Limdi NA, 2015, AM J KIDNEY DIS, V65, P701, DOI 10.1053/j.ajkd.2014.11.004; Lip GYH, 2007, LANCET, V370, P604, DOI 10.1016/S0140-6736(07)61300-2; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Melgaard L, 2015, JAMA-J AM MED ASSOC, V314, P1030, DOI 10.1001/jama.2015.10725; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nimmo C, 2013, AM HEART J, V166, P230, DOI 10.1016/j.ahj.2013.05.010; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Pereira-Da-Silva T, 2013, ACTA MEDICA PORT, V26, P127; Perera KS, 2016, STROKE, V47, P2197, DOI 10.1161/STROKEAHA.116.013378; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Schwartzenberg S, 2016, AM J CARDIOL, V117, P477, DOI 10.1016/j.amjcard.2015.10.065; Sellers MB, 2011, AM HEART J, V161, P241, DOI 10.1016/j.ahj.2010.11.002; Son MK, 2016, KOREAN CIRC J, V46, P515, DOI 10.4070/kcj.2016.46.4.515; Wehbe RM, 2016, TEX HEART I J, V43, P287, DOI 10.14503/THIJ-16-5785; Wilke T, 2015, J THROMB THROMBOLYS, V40, P97, DOI 10.1007/s11239-014-1136-8; Xian Y, 2017, JAMA-J AM MED ASSOC, V317, P1057, DOI 10.1001/jama.2017.1371	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209198	10.1371/journal.pone.0209198	http://dx.doi.org/10.1371/journal.pone.0209198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566502	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300075
J	Khan, AL; Mabood, F; Akber, F; Ali, A; Shahzad, R; Al-Harrasi, A; Al-Rawahi, A; Shinwari, ZK; Lee, IJ				Khan, Abdul Latif; Mabood, Fazal; Akber, Fazal; Ali, Amjad; Shahzad, Raheem; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Shinwari, Zabta Khan; Lee, In-Jung			Endogenous phytohormones of frankincense producing Boswellia sacra tree populations	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; NEAR-INFRARED SPECTROSCOPY; CRUDE PLANT-EXTRACTS; SIMULTANEOUS QUANTIFICATION; SALINITY STRESS; GROWTH; ACID; RESPONSES; ACCUMULATION; LIMITATIONS	Boswellia sacra, an endemic tree to Oman, is exposed to man-made incisions for commercial level frankincense production, whereas unsustainable harvesting may lead to population decline. In this case, assessment of endogenous phytohormones (gibberellic acid (GA), indole-acetic acid (IAA), salicylic acid (SA) and kinetin) can help to understand population health and growth dynamics. Hence, it was aimed to devise a robust method using Near-Infrared spectroscopy (NIRS) coupled with multivariate methods for phytohormone analysis of thirteen different populations of B. sacra. NIRS data was recorded in absorption mode (10000-4000 cm(-1)) to build partial least squares regression model (calibration set 70%). Model was externally cross validated (30%) as a test set to check their prediction ability before the application to quantify the unknown amount of phytohormones in thirteen different populations of B. sacra. The results showed that phytohormonal contents varied significantly, showing a trend of SA>GA/IAA>kinetin across different populations. SA and GA contents were significantly higher in Pop13 (Hasik), followed by Pop2 (Dowkah)-an extreme end of B. sacra tree cover in Dhofar region. A similar trend in the concentration of phytohormones was found when the samples from 13 populations were subjected to advance liquid chromatography mass spectrophotometer and gas chromatograph with selected ion monitor analysis. The current analysis provides alternative tool to assess plant health, which could be important to in situ propagation of tree population as well as monitoring tree population growth dynamics.	[Khan, Abdul Latif; Akber, Fazal; Ali, Amjad; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed] Univ Nizwa, Nat & Med Sci Res Ctr, Nizwa, Oman; [Mabood, Fazal] Univ Nizwa, Dept Biol Sci & Chem, Nizwa, Oman; [Shahzad, Raheem; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Shinwari, Zabta Khan] Quaid i Azam Univ, Dept Biotechnol, Islamabad, Pakistan	University of Nizwa; University of Nizwa; Kyungpook National University; Quaid I Azam University	Al-Harrasi, A (corresponding author), Univ Nizwa, Nat & Med Sci Res Ctr, Nizwa, Oman.; Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	aharrasi@unizwa.edu.om; ijlee@knu.ac.kr	Shinwari, Zabta/W-1882-2019; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022	Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; Khan, Abdul Latif/0000-0001-9700-8903; Shinwari, Zabta/0000-0002-0368-7966	Research Council Oman [ORG/BSER/15/007]	Research Council Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This study was supported by The Research Council Oman under their Open Research Grant (ORG/BSER/15/007). All the funding or sources of support received during this specific study (whether external or internal to your organization) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Agelet LE, 2014, TALANTA, V121, P288, DOI 10.1016/j.talanta.2013.12.038; Al-Harrasi A, 2017, SPECTROCHIM ACTA A, V184, P277, DOI 10.1016/j.saa.2017.05.018; Al-Harrasi A, 2014, ASIAN PAC J TROP MED, V7, pS485, DOI 10.1016/S1995-7645(14)60279-0; [Anonymous], ANN PLANT REV GIBBER; Atici O, 2005, BIOL PLANTARUM, V49, P215, DOI 10.1007/s10535-005-5222-9; Blum A, 2018, PLANT BREEDING STRES; Cao D, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02070; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Corcuera L, 2012, TREES-STRUCT FUNCT, V26, P799, DOI 10.1007/s00468-011-0651-x; Cozzolino D, 2009, PLANTA MED, V75, P746, DOI 10.1055/s-0028-1112220; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Dicke M, 2014, J CHEM ECOL, V40, P653, DOI 10.1007/s10886-014-0479-0; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Eshete A, 2012, FOREST ECOL MANAG, V274, P136, DOI 10.1016/j.foreco.2012.02.024; Fleta-Soriano E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135391; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; Fraire-Velazquez S, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P3; Goh CH, 2013, J CHEM ECOL, V39, P826, DOI 10.1007/s10886-013-0326-8; Grattapaglia D, 2009, CURR OPIN PLANT BIOL, V12, P148, DOI 10.1016/j.pbi.2008.12.008; Gro&beta;kinsky D.K., 2016, PLANT PATHOGEN RESIS, P131, DOI DOI 10.1002/9781118867716.CH7; Groenendijk P, 2012, J APPL ECOL, V49, P164, DOI 10.1111/j.1365-2664.2011.02078.x; HAIRFIELD EM, 1989, J CHROMATOGR SCI, V27, P127, DOI 10.1093/chromsci/27.3.127; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Juvany M, 2013, ENVIRON EXP BOT, V87, P10, DOI 10.1016/j.envexpbot.2012.09.007; Kebede T., 2010, THESIS; Khalid K. A., 2014, Thai Journal of Agricultural Science, V47, P195; Khan AL, 2017, ENVIRON EXP BOT, V133, P58, DOI 10.1016/j.envexpbot.2016.09.009; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Khan AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-86; Khan AL, 2015, J HAZARD MATER, V295, P70, DOI 10.1016/j.jhazmat.2015.04.008; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Kim YB, 2009, TREE PHYSIOL, V29, P737, DOI 10.1093/treephys/tpp002; Kroes A, 2016, PLANT BIOLOGY, V18, P981, DOI 10.1111/plb.12490; Lacombe B, 2016, CURR OPIN PLANT BIOL, V34, P1, DOI 10.1016/j.pbi.2016.06.007; Lang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134521; Lee IJ, 1998, PLANT PHYSIOL, V116, P1003, DOI 10.1104/pp.116.3.1003; Lequeue G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33183; Li DP, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010014; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Mabood F, 2017, FOOD CHEM, V221, P746, DOI 10.1016/j.foodchem.2016.11.109; Marden JH, 2017, MOL ECOL, V26, P2498, DOI 10.1111/mec.13999; Matsukura C., FUNCTIONAL GENOMICS; Mengistu T, 2013, TREE PHYSIOL, V33, P601, DOI 10.1093/treephys/tpt035; Mengistu T, 2012, FOREST ECOL MANAG, V278, P1, DOI 10.1016/j.foreco.2012.04.029; Min Tai Gi, 2003, Journal of the Korean Society for Horticultural Science, V44, P545; Nazir H, 2016, INT J PHYTOREMEDIAT, V18, P651, DOI 10.1080/15226514.2015.1094444; Nicolai BM, 2007, POSTHARVEST BIOL TEC, V46, P99, DOI 10.1016/j.postharvbio.2007.06.024; Ohsowski BM, 2016, BOTANY, V94, P501, DOI 10.1139/cjb-2016-0009; Olesen MH, 2011, SEED SCI TECHNOL, V39, P140, DOI 10.15258/sst.2011.39.1.12; Pan XQ, 2008, PHYTOCHEMISTRY, V69, P1773, DOI 10.1016/j.phytochem.2008.02.008; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Paparozzi ET, 2005, HORTSCIENCE AM SOC H, V40, P508; Park YG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173203; Pozo MJ, 2015, NEW PHYTOL, V205, P1431, DOI 10.1111/nph.13252; Raffaelli M., 2003, Webbia, V58, P133; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Siles L, 2017, PLANT ECOL DIVERS, V10, P231, DOI 10.1080/17550874.2017.1350765; Silpi U, 2006, TREE PHYSIOL, V26, P1579, DOI 10.1093/treephys/26.12.1579; Suhail MM, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-129; Tigabu M, 2007, NEW FOREST, V33, P155, DOI 10.1007/s11056-006-9020-9; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Vishwakarma K, 2017, FRONT PLANT SCI, V8; Wang L, 2006, FOOD CHEM, V95, P529, DOI 10.1016/j.foodchem.2005.04.015; Wani SH, 2016, CROP J, V4, P162, DOI 10.1016/j.cj.2016.01.010; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Workman J., 2012, PRACTICAL GUIDE SPEC, DOI 10.1201/b11894; Xiang Y, 2015, J NAT MED-TOKYO, V69, P278, DOI 10.1007/s11418-015-0889-5; Zandalinas SI, 2017, PHYSL PLANT; Zhang NN, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.992741	79	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207910	10.1371/journal.pone.0207910	http://dx.doi.org/10.1371/journal.pone.0207910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566477	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300019
J	Scott, NA; Strauss, A; Hublin, JJ; Gunz, P; Neubauer, S				Scott, Nadia A.; Strauss, Andre; Hublin, Jean-Jacques; Gunz, Philipp; Neubauer, Simon			Covariation of the endocranium and splanchnocranium during great ape ontogeny	PLOS ONE			English	Article							AUSTRALOPITHECUS-AFRICANUS; MORPHOLOGICAL INTEGRATION; CRANIAL INTEGRATION; GROWTH CHANGES; EVOLUTION; SKULL; SIZE; PAN; MODULARITY; ALLOMETRY	That great ape endocranial shape development persists into adolescence indicates that the splanchnocranium succeeds brain growth in driving endocranial development. However, the extent of this splanchnocranial influence is unknown. We applied two-block partial least squares analyses of Procrustes shape variables on an ontogenetic series of great ape crania to explore the covariation of the endocranium (the internal braincase) and splanchnocranium (face, or viscerocranium). We hypothesized that a transition between brain growth and splanchnocranial development in the establishment of final endocranial form would be manifest as a change in the pattern of shape covariation between early and adolescent ontogeny. Our results revealed a strong pattern of covariation between endocranium and splanchnocranium, indicating that chimpanzees, gorillas, and orangutans share a common tempo and mode of morphological integration from the eruption of the deciduous dentition onwards to adulthood: a reflection of elongating endocranial shape and continuing splanchnocranial prognathism. Within this overarching pattern, we noted that species variation exists in magnitude and direction, and that the covariation between the splanchnocranium and endocranium is somewhat weaker in early infancy compared to successive age groups. When correcting our covariation analyses for allometry, we found that an ontogenetic signal remains, signifying that allometric variation alone is insufficient to account for all endocranial-splanchnocranial developmental integration. Finally, we assessed the influence of the cranial base, which acts as the interface between the face and endocranium, on the shape of the vault using thin-plate spline warping. We found that not all splanchnocranial shape changes during development are tightly integrated with endocranial shape. This suggests that while the developmental expansion of the brain is the main driver of endocranial shape during early ontogeny, endocranial development from infancy onwards is moulded by the splanchnocranium in conjunction with the neurocranium.	[Scott, Nadia A.; Strauss, Andre; Hublin, Jean-Jacques; Gunz, Philipp; Neubauer, Simon] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl, Leipzig, Germany; [Scott, Nadia A.] Konrad Lorenz Inst Evolut & Cognit Res, Martinstr, Klosterneuburg, Austria	Max Planck Society	Scott, NA (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl, Leipzig, Germany.; Scott, NA (corresponding author), Konrad Lorenz Inst Evolut & Cognit Res, Martinstr, Klosterneuburg, Austria.	nadia_scott@eva.mpg.de	Gunz, Philipp/C-7748-2009; Neubauer, Simon/D-1317-2010; Strauss, Andre/K-4089-2015	Gunz, Philipp/0000-0002-2350-4450; Neubauer, Simon/0000-0001-9113-5063; Strauss, Andre/0000-0002-2336-1381	Max Planck Society; Konrad Lorenz Institute for Evolution and Cognition Research Writing-up Fellowship; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship [PGSD3 410109-11]; Ministry of the Environment and Forests; Ministry of Research; Swiss Centre for Scientific Research Abidjan; University of Zurich	Max Planck Society(Max Planck SocietyFoundation CELLEX); Konrad Lorenz Institute for Evolution and Cognition Research Writing-up Fellowship; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of the Environment and Forests; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Swiss Centre for Scientific Research Abidjan; University of Zurich	Funding for this study was provided by the Max Planck Society (https://www.mpg.de/en) to all authors. NAS was additionally funded by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (PGSD3 410109-11, http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/BellandPostgrad-BelletSuperieures_eng.asp) and by a Konrad Lorenz Institute for Evolution and Cognition Research Writing-up Fellowship (https://www.kli.ac.at/en/fellowships/fellowship_general_information). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank C. Boesch, H. Coqueugniot, W. Enard, C. Feja, F. Grine, M. von Harling, B. Herzig, J. L. Kahn, the Kyoto University Primate Research Institute, N. Lange, F. Mayer, U. Olbrich-Schwartz, K. Spanel-Borowski, F. Spoor, F. Veillon, G. Weber and A. Winter for access to specimens; P. Schonfeld (particularly for the scanning of the frozen neonates), P. Schubert, H. Temming and A. Winzer for CT scanning; and the Ivorian authorities, particularly the Ministry of the Environment and Forests and the Ministry of Research, the Swiss Centre for Scientific Research Abidjan, and the University of Zurich for their support of the Tai chimpanzee study. The authors are especially grateful to the editor and three anonymous reviewers, who greatly assisted in expanding the scope of this paper.	Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; ALBERCH P, 1985, SYST ZOOL, V34, P46, DOI 10.2307/2413344; Amano H, 2015, AM J PHYS ANTHROPOL, V158, P185, DOI 10.1002/ajpa.22777; [Anonymous], 1982, EVOL DEV; ASHTON E. H., 1957, PROC ZOOL SOC LONDON, V129, P61; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Berge C, 2004, AM J PHYS ANTHROPOL, V124, P124, DOI 10.1002/ajpa.10333; Biegert J., 1963, Publications in Anthropology Viking Fund, V37, P116; Biegert J., 1957, Gegenbaurs Jahrbuch, V98, P77; Bienvenu T, 2011, AM J PHYS ANTHROPOL, V145, P231, DOI 10.1002/ajpa.21488; BJORK A., 1955, AMER JOUR ORTHODONT, V41, P198, DOI 10.1016/0002-9416(55)90005-1; BLANEY SPA, 1986, FOLIA PRIMATOL, V47, P81, DOI 10.1159/000156267; BOOKSTEIN FL, 1991, LECT NOTES COMPUT SC, V511, P326, DOI 10.1007/BFb0033763; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bookstein FL, 2003, HOMO, P167; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bruner E, 2015, J ANAT, V227, P268, DOI 10.1111/joa.12355; Cardini A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3458; Carlson KJ, 2011, SCIENCE, V8; Cave AJE, 1940, J ANAT, V74, P493; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V87, P167, DOI 10.1002/ajpa.1330870205; Conroy GC, 2000, ANAT RECORD, V258, P391, DOI 10.1002/(SICI)1097-0185(20000401)258:4<391::AID-AR7>3.0.CO;2-R; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; de Leon MSP, 2008, P NATL ACAD SCI USA, V105, P13764, DOI 10.1073/pnas.0803917105; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dryden IL, 1998, STAT ANAL SHAPE; Duckworth WL, 1904, MORPHOLOGY ANTHR HDB; FALK D, 1987, ANNU REV ANTHROPOL, V16, P13; Falk D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00134; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; FOODEN J, 1983, AM J PRIMATOL, V5, P285, DOI 10.1002/ajp.1350050402; GILES E., 1956, HUMAN BIOL, V28, P43; Godinho RM, 2018, NAT ECOL EVOL, V2, P956, DOI 10.1038/s41559-018-0528-0; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GOULD SJ, 2002, STRUCTURE EVOLUTIONA, P1464; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grine FE, 2010, J HUM EVOL, V59, P1, DOI 10.1016/j.jhevol.2010.02.007; Gunz P., 2011, PALEO REV ARCHEOL PR, V22, P155; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevol.2006.08.010; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Gunz P, 2010, CURR BIOL, V20, pR921, DOI 10.1016/j.cub.2010.10.018; Hans M.G., 2008, ESSENTIALS FACIAL GR; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3, DOI [10.1002/0471663573, DOI 10.1002/0471663573]; Holloway RL, 2018, P NATL ACAD SCI USA, V115, P5738, DOI 10.1073/pnas.1720842115; HRDLICKA A, 1907, P US NAT MUS, V31, P539; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Hublin JJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0062; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; Keith A, 1910, J ANAT PHYSIOL, V44, P251; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2013, HYSTRIX, V24, P43, DOI 10.4404/hystrix-24.1-6367; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Koppe T, 1995, OKAJIMAS FOLIA ANATO, P72; Krogman WM, 1931, AM J ANAT, V47, P325, DOI 10.1002/aja.1000470205; Krogman WM, 1931, AM J ANAT, V47, P343, DOI 10.1002/aja.1000470206; Krogman WM, 1931, AM J ANAT, V47, P89, DOI 10.1002/aja.1000470104; LEIGH SR, 1995, AM J PRIMATOL, V36, P37, DOI 10.1002/ajp.1350360104; LEIGH SR, 1992, J HUM EVOL, V23, P27, DOI 10.1016/0047-2484(92)90042-8; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2009, EVOL BIOL, V36, P136, DOI 10.1007/s11692-009-9051-1; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Mitteroecker P, 2012, EVOL BIOL, V39, P536, DOI 10.1007/s11692-012-9178-3; Neaux D, 2017, AM J PHYS ANTHROPOL, V162, P732, DOI 10.1002/ajpa.23163; Neaux D, 2015, AM J PHYS ANTHROPOL, V158, P475, DOI 10.1002/ajpa.22807; Neaux D, 2013, ANAT REC, V296, P568, DOI 10.1002/ar.22654; Neubauer S, 2004, CAN ASSOC RADIOL J, V55, P271; Neubauer S, 2018, J HUMAN EVOLUTION; Neubauer S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5961; Neubauer S, 2014, BRAIN BEHAV EVOLUT, V84, P117, DOI 10.1159/000365276; Neubauer S, 2012, EVOL BIOL, V39, P568, DOI 10.1007/s11692-011-9156-1; Neubauer S, 2012, J HUM EVOL, V62, P498, DOI 10.1016/j.jhevol.2012.01.005; Neubauer S, 2010, J HUM EVOL, V59, P555, DOI 10.1016/j.jhevol.2010.06.011; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; Olson EC., 1999, MORPHOLOGICAL INTEGR; Polanski JM, 2006, AM J PHYS ANTHROPOL, V131, P38, DOI 10.1002/ajpa.20421; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Profico A, 2018, AM J PHYS ANTHR; Profico A, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22721; Raia P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25309-8; Rhode MP, 2006, AM J PHYS ANTHROPOL, V130, P462, DOI 10.1002/ajpa.20333; Richtsmeier JT, 2006, J EXP ZOOL PART B, V306B, P360, DOI 10.1002/jez.b.21092; Richtsmeier JT, 2013, ACTA NEUROPATHOL, V125, P469, DOI 10.1007/s00401-013-1104-y; Rijksen HD, 1978, MEDEDELINGEN LANDBOU; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohrer-Ertl O., 1988, P201; Scott JH, 1958, J DENT A SOUTH AFRIC, V13, P133; Scott N, 2014, EVOL BIOL, V41, P572, DOI 10.1007/s11692-014-9290-7; Selenka E., 1898, STUDIEN ENTWICKELUNG; Senck S, 2015, INT J PRIMATOL, V36, P489, DOI 10.1007/s10764-015-9837-1; SHEA BT, 1983, AM J PHYS ANTHROPOL, V62, P275, DOI 10.1002/ajpa.1330620307; SHEA BT, 1983, FOLIA PRIMATOL, V40, P32, DOI 10.1159/000156090; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Stelzer S, 2018, AM J PHYS ANTHR; Stelzer S, 2018, J HUM EVOL, V114, P154, DOI 10.1016/j.jhevol.2017.10.012; Stelzer S, 2017, J HUM EVOL, V107, P71, DOI 10.1016/j.jhevol.2017.02.010; Thompson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047282; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Welcker H., 1866, KRANIOLOGISCHE MITTH; Wilkins AS, 1997, BIOESSAYS, V19, P257, DOI 10.1002/bies.950190312; Zollikofer CPE, 2017, J ANAT, V230, P85, DOI 10.1111/joa.12531; Zollikofer CPE, 2013, EVOL ANTHROPOL, V22, P20, DOI 10.1002/evan.21333; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	117	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208999	10.1371/journal.pone.0208999	http://dx.doi.org/10.1371/journal.pone.0208999			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566462	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300063
J	Kellermann, M; Berecz, R; Bereczki, D				Kellermann, Monika; Berecz, Roland; Bereczki, Daniel			Does the severity of depressive symptoms after stroke affect long-term survival? An 18-year follow-up	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; POSTSTROKE DEPRESSION; NATURAL-HISTORY; RISK-FACTORS; MORTALITY; METAANALYSIS; PREDICTORS; DISEASE; SCALES	Objective We tested whether the severity of depressive symptoms in acute stroke and 4 years later are predictors of long-time survival. Method We evaluated the severity of stroke in 82 patients with acute stroke by the Barthel index, the Scandinavian Stroke Scale and the Orgogozo scale, and we also quantified the severity of depressive symptoms by the Beck and the Hamilton scales in the first week of stroke, in 1995. We re-evaluated the scales 4 years after stroke in 41 out of 48 survivors. We checked the survival status of the initial cohort 18 years after stroke. In the assessment Kaplan-Meier graphs were constructed and the outcomes between groups were compared with log-rank tests. Results Clinically important depressive symptoms (>= 10 on the Beck scale) was present in 16 patients (19,5%) with acute stroke one week after admission. Case fatality was 41% at 4 years and 84% at 18 years after stroke. Those patients who survived at 4 years were significantly younger (p<0,05). Depressive symptoms in acute stage were not independent predictor of the length of survival. More severe strokes were associated with more severe depressive symptoms 4 years after stroke. In the survival subgroup of patients, those who had more severe depression (>= 10 on the Beck scale) at 4 years, had shorter post-stroke survival than those with milder or no depression (Mann-Whitney test, p = 0.022; log-rank-test, p = 0.047). In multivariate analyses, adjusted for age, sex, stroke severity and the severity of depressive symptoms, age, sex and stroke severity remained the significant predictors of the length of survival. Conclusions The severity of depressive symptoms either in the acute phase or 4 years after stroke is not an independent predictor of the length of survival in an 18-year follow-up.	[Kellermann, Monika] Comedicum, Med Versorgungszentrum, Munich, Germany; [Berecz, Roland] Univ Debrecen, Dept Psychiat, Debrecen, Hungary; [Bereczki, Daniel] Semmelweis Univ, Dept Neurol, Budapest, Hungary	University of Debrecen; Semmelweis University	Bereczki, D (corresponding author), Semmelweis Univ, Dept Neurol, Budapest, Hungary.	bereczki.daniel@med.semmelweis-univ.hu	Berecz, Roland/N-1192-2013; Bereczki, Daniel/AAL-9886-2020	Berecz, Roland/0000-0002-6559-8125; Bereczki, Daniel/0000-0002-8374-0500	Hungarian Brain Research Program [KTIA-NAP-13-1-2013-0001]; Government of Hungary [TAMOP-4.2.1, B-09/1/KMR]	Hungarian Brain Research Program; Government of Hungary	The study was partly supported by grants No KTIA-NAP-13-1-2013-0001 from the Hungarian Brain Research Program, and TAMOP-4.2.1.B-09/1/KMR from the Government of Hungary to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arwert HJ, 2018, AM J PHYS MED REHAB, V97, P565, DOI 10.1097/PHM.0000000000000918; ASPLUND K, 1985, STROKE, V16, P885; Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bartoli F, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/862978; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; Bourgeois James A., 2004, Curr Treat Options Neurol, V6, P403, DOI 10.1007/s11940-996-0031-9; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; De Ryck A, 2014, INT J GERIATR PSYCH, V29, P144, DOI 10.1002/gps.3974; De Ryck A, 2013, CEREBROVASC DIS EXTR, V3, P1, DOI 10.1159/000345557; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Deng Linghui, 2018, Oncotarget, V9, P23718, DOI 10.18632/oncotarget.23891; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Dossa A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-311; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; Freak-Poli R, 2018, DEPRESS ANXIETY, V35, P18, DOI 10.1002/da.22689; GDB, 2013, LANCET, V385, P117; GRESHAM GE, 1980, ARCH PHYS MED REHAB, V61, P355; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANTSON L, 1994, CEREBROVASC DIS, V4, P7, DOI 10.1159/000108532; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; Karaahmet OZ, 2017, INT J REHABIL RES, V40, P71, DOI 10.1097/MRR.0000000000000210; Kellermann M, 1999, GEN HOSP PSYCHIAT, V21, P116, DOI 10.1016/S0163-8343(98)00067-X; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Kraglund KL, 2015, INT J STROKE, V10, P985, DOI 10.1111/ijs.12485; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; MAHONEY F I, 1965, Md State Med J, V14, P61; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Orgogozo JM, 1989, CLIN TRIAL METHODOLO, P35; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Razmara A, 2017, J STROKE CEREBROVASC, V26, P2870, DOI 10.1016/j.jstrokecerebrovasdis.2017.07.006; Robinson RG, 2017, AM J GERIAT PSYCHIAT, V25, P512, DOI 10.1016/j.jagp.2016.10.001; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Salter KL, 2013, J STROKE CEREBROVASC, V22, P1243, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.013; Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064; Sibolt G, 2013, CEREBROVASC DIS, V36, P336, DOI 10.1159/000355145; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; STUKENBERG KW, 1990, PSYCHOL ASSESSMENT, V2, P134, DOI DOI 10.1037/1040-3590.2.2.134; Sun XJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006100	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209157	10.1371/journal.pone.0209157	http://dx.doi.org/10.1371/journal.pone.0209157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562404	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100038
J	Vlerick, L; Peremans, K; Dockx, R; Audenaert, K; Baeken, C; De Spiegeleer, B; Saunders, J; Polis, I				Vlerick, Lise; Peremans, Kathelijne; Dockx, Robrecht; Audenaert, Kurt; Baeken, Chris; De Spiegeleer, Bart; Saunders, Jimmy; Polis, Ingeborgh			The influence of subanaesthetic ketamine on regional cerebral blood flow in healthy dogs measured with Tc-99(m)-HMPAO SPECT	PLOS ONE			English	Article							ELECTROCONVULSIVE-THERAPY; UNIPOLAR DEPRESSION; ANXIETY DISORDERS; BINDING INDEX; ANTIDEPRESSANT; RECEPTOR; PERFUSION; BEHAVIOR; PET; MEDETOMIDINE	Subanaesthetic ketamine has recently been proven to be a highly effective and fast acting alternative treatment for several psychiatric disorders. The mechanisms responsible for ketamine's antidepressant effects remain unclear, but a possible explanation could be that ketamine interacts with regional cerebral blood flow (rCBF). Therefore, the effects of two subanaesthetic ketamine doses on rCBF were evaluated. Twelve dogs were randomly assigned to one of the three treatment conditions (condition saline, condition 0.5 mg/kg ketamine or condition 2 mg/kg ketamine) and received in total five saline or ketamine infusions, with one week interval. Single Photon Emission Computed Tomography (SPECT) scans with the radiotracer Tc-99m-hexamethylpropylene amine oxime were performed before the start of the infusions (baseline) and 24 hours after the first (single) and last (multiple) infusion. After a wash out period of 3 months, the animals were again assigned to one of the three treatment conditions described above and the infusion/scan protocol was repeated. During the infusions, cardiovascular parameters were evaluated every ten minutes. A one-way repeated measure ANOVA was set up to assess perfusion index for each ketamine dose for the left frontal cortex (alpha = 0.05). The remaining 11 brain regions were post hoc assessed. Perfusion index was significantly increased in the left frontal cortex and in the thalamus 24 hours after single and multiple ketamine infusions compared to baseline in the 2 mg/kg condition. No clinically relevant cardiovascular effects were observed during the ketamine infusions. This study shows that subanaesthetic ketamine can increase neuronal perfusion and therefore alter neuronal function in brain regions involved in depression and anxiety disorders. These perfusion increases may possibly contribute to ketamine's beneficial effects in these psychiatric disorders.	[Vlerick, Lise; Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Dept Small Anim, Merelbeke, East Flanders, Belgium; [Peremans, Kathelijne; Saunders, Jimmy] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, East Flanders, Belgium; [Dockx, Robrecht; Audenaert, Kurt; Baeken, Chris] Univ Ghent, Ghent Expt Psychiat GHEP Lab, Dept Psychiat & Med Psychol, Ghent, East Flanders, Belgium; [De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, Ghent, East Flanders, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Vlerick, L (corresponding author), Univ Ghent, Fac Vet Med, Dept Small Anim, Merelbeke, East Flanders, Belgium.	lise.vlerick@ugent.be	Baeken, Chris/D-6790-2013		Ghent University [No01D26115]	Ghent University(Ghent University)	Funding for this study was provided by Special Research Fund Grant from the Ghent University (https://www.ugent.be/nl/onderzoek/financiering/bof., No01D26115, assigned to LV). The Ghent University had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abdallah CG, 2015, ANN NY ACAD SCI, V1344, P66, DOI 10.1111/nyas.12718; Adriaens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109680; Adriaens A, 2013, VET RADIOL ULTRASOUN, V54, P403, DOI 10.1111/vru.12028; Beata C, 2007, J VET BEHAV, V2, P175, DOI 10.1016/j.jveb.2007.08.001; Brockmann H, 2009, PSYCHIAT RES-NEUROIM, V173, P107, DOI 10.1016/j.pscychresns.2008.10.006; Carter JE, 2013, JAVMA-J AM VET MED A, V243, P1569, DOI 10.2460/javma.243.11.1569; Coyle CM, 2015, HUM PSYCHOPHARM CLIN, V30, P152, DOI 10.1002/hup.2475; Cyranoski D, 2010, NATURE, V466, P1036, DOI 10.1038/4661036a; Deckersbach T, 2006, J NEUROIMAGING, V16, P1, DOI 10.1177/1051228405001474; DeWilde KE, 2015, ANN NY ACAD SCI, V1345, P47, DOI 10.1111/nyas.12646; Drewniany E, 2015, J CLIN PHARM THER, V40, P125, DOI 10.1111/jcpt.12238; du Jardin KG, 2016, PROG NEURO-PSYCHOPH, V71, P27, DOI 10.1016/j.pnpbp.2016.05.007; Eren I, 2003, PSYCHIAT RES-NEUROIM, V123, P135, DOI 10.1016/S0925-4927(03)00062-3; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Feder A, 2014, JAMA PSYCHIAT, V71, P681, DOI 10.1001/jamapsychiatry.2014.62; Fitzgerald PB, 2008, META ANAL STUDY CHAN, V695, P683; Fond G, 2014, PSYCHOPHARMACOLOGY, V231, P3663, DOI 10.1007/s00213-014-3664-5; Gao M, 2016, ACTA PHARMACOL SIN, V37, P865, DOI 10.1038/aps.2016.5; Holcomb HH, 2001, NEUROPSYCHOPHARMACOL, V25, P165, DOI 10.1016/S0893-133X(01)00229-9; Holcomb HH, 2005, EFFECTS NONCOMPETITI, P2275; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jarnum H, 2011, LONGITUDINAL MRI STU, P435; Kastner S. B. R., 2016, BSAVA MANUAL CANINE, P190; Kohn Y, 2007, J NUCL MED, V48, P1273, DOI 10.2967/jnumed.106.039354; Kurdi Madhuri S, 2014, Anesth Essays Res, V8, P283, DOI 10.4103/0259-1162.143110; Kuusela E, 2000, J VET PHARMACOL THER, V23, P15, DOI 10.1046/j.1365-2885.2000.00245.x; Landsberg GM, 2008, J VET BEHAV, V3, P12, DOI 10.1016/j.jveb.2007.09.001; Lee EE, 2015, GEN HOSP PSYCHIAT, V37, P178, DOI 10.1016/j.genhosppsych.2015.01.003; Loo CK, 2003, PSYCHOL MED, V33, P997, DOI 10.1017/S0033291703007955; Luckenbaugh DA, 2014, J AFFECT DISORDERS, V159, P56, DOI 10.1016/j.jad.2014.02.017; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; Milo TJ, 2001, J ECT, V17, P15, DOI 10.1097/00124509-200103000-00004; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Murrell J C, 2016, BSAVA MANUAL CANINE, P170, DOI DOI 10.22233/9781910443231.13; Murrough JW, 2013, BIOL PSYCHIAT, V74, P250, DOI 10.1016/j.biopsych.2012.06.022; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Naughton M, 2014, J AFFECT DISORDERS, V156, P24, DOI 10.1016/j.jad.2013.11.014; Navarro V, 2002, NEUROIMAGE, V16, P781, DOI 10.1006/nimg.2002.1051; Nobler MS, 2000, DEPRESS ANXIETY, V12, P144; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Peremans K, 2003, EUR J NUCL MED MOL I, V30, P1538, DOI 10.1007/s00259-003-1250-x; Peremans K, 2001, VET RADIOL ULTRASOUN, V42, P562, DOI 10.1111/j.1740-8261.2001.tb00987.x; Pollak TA, 2015, PSYCHOPHARMACOLOGY, V232, P4515, DOI 10.1007/s00213-015-4078-8; Price RB, 2014, DEPRESS ANXIETY, V31, P335, DOI 10.1002/da.22253; Rajkumar R, 2015, PHARMACOL RES, V99, P23, DOI 10.1016/j.phrs.2015.05.003; Rasmussen KG, 2013, J PSYCHOPHARMACOL, V27, P444, DOI 10.1177/0269881113478283; Robinson R, 2016, BSAVA MANUAL CANINE, P308; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Rowland LM, 2010, INTERACTIVE EFFECTS, P575; Sarrau S, 2007, J SMALL ANIM PRACT, V48, P670, DOI 10.1111/j.1748-5827.2007.00362.x; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Shiroma PR, 2014, J AFFECT DISORDERS, V155, P123, DOI 10.1016/j.jad.2013.10.036; Sos P, 2013, ACT NERV SUPER REDIV, V55, P57; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Takeuchi Y, 2000, J AM VET MED ASSOC, P342; Trivedi S, 2016, J CLIN DIAGN RES, V10, pUC1, DOI 10.7860/JCDR/2016/18397.8225; Vangu MDT, 2003, PROG NEURO-PSYCHOPH, V27, P15, DOI 10.1016/S0278-5846(02)00309-3; Vermeire S, 2012, PSYCHIAT RES-NEUROIM, V201, P78, DOI 10.1016/j.pscychresns.2011.06.006; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vermeire ST, 2009, J NUCL MED, V50, P284, DOI 10.2967/jnumed.108.055731; Vlassenko A, 2012, J NEUROPSYCHIATRY CL, P360; Waelbers T, 2012, VET J, V192, P81, DOI 10.1016/j.tvjl.2011.04.017; Waelbers T, 2015, J VET BEHAV, V10, P332, DOI 10.1016/j.jveb.2015.03.009; Waelbers T, 2013, J NUCL MED, V54, P1428, DOI 10.2967/jnumed.112.114637; Wagner AE, 2002, J AM VET MED ASSOC, V221, P72, DOI 10.2460/javma.2002.221.72; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	66	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209316	10.1371/journal.pone.0209316	http://dx.doi.org/10.1371/journal.pone.0209316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562399	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100049
J	Dostalek, T; Rokaya, MB; Munzbergova, Z				Dostalek, Tomas; Rokaya, Maan Bahadur; Munzbergova, Zuzana			Altitude, habitat type and herbivore damage interact in their effects on plant population dynamics	PLOS ONE			English	Article							INTEGRAL PROJECTION MODELS; CLIMATE-CHANGE; INDIRECT DEFENSES; INSECT HERBIVORY; GROWTH RATES; TRADE-OFFS; DEMOGRAPHY; IMPACTS; SIZE; LIGHT	Insects represent one of the most abundant groups of herbivores, and many of them have significant impacts on the dynamics of plant populations. As insects are very sensitive to changes in climatic conditions, we hypothesize that their effects on plant population dynamics will depend on climatic conditions. Knowledge of the variation in herbivore effects on plant population dynamics is, however, still rather sparse. We studied population dynamics and herbivore damage at the individual plant level of Salvia nubicola along a wide altitudinal gradient representing a range of climatic conditions. Using integral projection models, we estimated the effect of changes in herbivore pressure on plant populations in different climates and habitat types. Since we recorded large differences in the extent of herbivore damage along the altitudinal gradient, we expected that the performance of plants from different altitudes would be affected to different degrees by herbivores. Indeed, we found that populations from low altitudes were better able to withstand increased herbivore damage, while populations from high altitudes were suppressed by herbivores. However, the pattern described above was evident only in populations from open habitats. In forest habitats, the differences in population dynamics between low and high altitudes were largely diminished. The effects of herbivores on plants from different altitudes were thus largely habitat specific. Our results indicate potential problems for plant populations from high altitudes in open habitats because of increased herbivore damage. However, forest habitats may provide refuges for the plants at these high altitudes.	[Dostalek, Tomas; Munzbergova, Zuzana] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Dostalek, Tomas; Rokaya, Maan Bahadur; Munzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Rokaya, Maan Bahadur] Czech Acad Sci, Global Change Res Ctr, Dept Biodivers Res, Brno, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Dostalek, T (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.; Dostalek, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	tomas.dostalek@ibot.cas.cz	Münzbergová, Zuzana/F-6321-2013; Rokaya, Maan B./ABH-1509-2021; Dostálek, Tomáš/A-1260-2011; Rokaya, Maan/G-1527-2014	Münzbergová, Zuzana/0000-0002-4026-6220; Dostálek, Tomáš/0000-0002-3681-5223; Rokaya, Maan/0000-0003-1459-093X	Czech Science Foundation [17-10280S];  [RVO 67985939]	Czech Science Foundation(Grant Agency of the Czech Republic); 	TD, MBR and ZM were supported by the Czech Science Foundation project no. 17-10280S (www.gacr.cz) and long-term research development project no. RVO 67985939 (www.cas.cz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikens ML, 2015, AM J BOT, V102, P1901, DOI 10.3732/ajb.1500198; ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Bhattarai KR, 2004, FOLIA GEOBOT, V39, P57, DOI 10.1007/BF02803264; Brodie JF, 2009, ECOLOGY, V90, P688, DOI 10.1890/08-0111.1; Bruelheide H, 1999, J ECOL, V87, P839, DOI 10.1046/j.1365-2745.1999.00403.x; Bucharova A, 2012, BIOL CONSERV, V145, P39, DOI 10.1016/j.biocon.2011.09.016; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Caswell, 2000, MATRIX POPULATION MO; Cerna L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075563; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Crawley M. J., 2009, PLANT ECOLOGY; Dahlgren JP, 2016, ECOLOGY, V97, P899, DOI 10.1890/15-0804.1; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dostalek T, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw026; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Efron B, 1993, INTRO BOOTSTRAP, DOI [10.1111/ecog.00833, DOI 10.1111/ECOG.00833]; EHRLEN J, 1995, J ECOL, V83, P297, DOI 10.2307/2261568; Fisher M, 1997, GLOBAL ECOL BIOGEOGR, V6, P379, DOI 10.2307/2997338; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Garcia-Camacho R, 2012, PLANT ECOL DIVERS, V5, P37, DOI 10.1080/17550874.2012.662534; Harrell FE, 2001, REGRESSION MODELING; Hartley SE., 1996, PLANT ECOL, P284, DOI [10.1002/9781444313642.ch10, DOI 10.1002/9781444313642.CH10]; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Hough-Goldstein J, 2012, ARTHROPOD-PLANT INTE, V6, P103, DOI 10.1007/s11829-011-9158-z; Hovenden MJ, 2008, GLOBAL CHANGE BIOL, V14, P1633, DOI 10.1111/j.1365-2486.2008.01597.x; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Johnson CA, 2016, FUNCT ECOL, V30, P1122, DOI 10.1111/1365-2435.12583; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; Katz DSW, 2016, OECOLOGIA, V182, P43, DOI 10.1007/s00442-016-3602-9; Kim E, 2011, J ECOL, V99, P1237, DOI 10.1111/j.1365-2745.2011.01831.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Koop AL, 2005, ECOLOGY, V86, P2661, DOI 10.1890/04-1483; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Kurkjian HM, 2017, J APPL ECOL, V54, P862, DOI 10.1111/1365-2664.12808; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; Maron JL, 2006, ECOLOGY, V87, P113, DOI 10.1890/05-0434; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Maron JL, 2014, J ECOL, V102, P1485, DOI 10.1111/1365-2745.12305; Merow C, 2014, METHODS ECOL EVOL, V5, P99, DOI 10.1111/2041-210X.12146; Miehe G., 1982, DISS BOT, V66, P1; Miller TEX, 2009, ECOL MONOGR, V79, P155, DOI 10.1890/07-1550.1; Montesinos D, 2010, ACTA OECOL, V36, P120, DOI 10.1016/j.actao.2009.10.010; Munzbergova Z, 2006, FOLIA GEOBOT, V41, P137, DOI 10.1007/BF02806475; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064639; Myers JH, 2017, ANNU REV ENTOMOL, V62, P207, DOI 10.1146/annurev-ento-010715-023826; Nicole F, 2011, J ECOL, V99, P1211, DOI 10.1111/j.1365-2745.2011.01852.x; PAIGE KN, 1987, AM NAT, V129, P407, DOI 10.1086/284645; Pellissier L, 2014, ECOGRAPHY, V37, P950, DOI 10.1111/ecog.00833; Pollnac FW, 2014, POPUL ECOL, V56, P81, DOI 10.1007/s10144-013-0391-4; Press JR., 2000, ANNOTATED CHECKLIST; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Rasmann S, 2014, J ECOL, V102, P930, DOI 10.1111/1365-2745.12253; Rasmann S, 2014, FUNCT ECOL, V28, P46, DOI 10.1111/1365-2435.12135; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Rokaya MB, 2017, FOLIA GEOBOT, V52, P239, DOI 10.1007/s12224-017-9287-y; Rokaya MB, 2016, ACTA OECOL, V77, P168, DOI 10.1016/j.actao.2016.10.011; Rose KE, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00096.1; Salgado-Luarte C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011460; Sauby KE, 2017, ECOL EVOL, V7, P6996, DOI 10.1002/ece3.3232; Schlinkert H, 2015, OECOLOGIA, V179, P455, DOI 10.1007/s00442-015-3353-z; Schoonhoven L. M., 2005, Insect-plant biology; Selakovic SD, 2018, ARCH BIOL SCI, V70, P469, DOI [10.2298/ABS171207007S, 10.2298/abs171207007s]; Siddappaji MH, 2013, GENETICS, V195, P589, DOI 10.1534/genetics.113.154351; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Verheyen K, 2009, PLANT BIOLOGY, V11, P49, DOI 10.1111/j.1438-8677.2009.00214.x; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Zheng JY, 2006, CLIMATIC CHANGE, V77, P449, DOI 10.1007/s10584-005-9038-6; Zidorn C, 2010, PHYTOCHEM REV, V9, P197, DOI 10.1007/s11101-009-9143-7	78	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209149	10.1371/journal.pone.0209149	http://dx.doi.org/10.1371/journal.pone.0209149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557339	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000073
J	Al Thaher, Y; Yang, LR; Jones, SA; Perni, S; Prokopovich, P				Al Thaher, Yazan; Yang, Lirong; Jones, Steve A.; Perni, Stefano; Prokopovich, Polina			LbL-assembled gentamicin delivery system for PMMA bone cements to prolong antimicrobial activity	PLOS ONE			English	Article							PERIPROSTHETIC JOINT INFECTION; TOTAL HIP; RELEASE; ARTHROPLASTY; MULTILAYERS; COMBINATION; BIOFILMS; PROFILE	Introduction Antibiotic-loaded poly(methyl methacrylate) bone cements (ALBCs) are widely used in total joint replacement (TJR), for local delivery of antibiotics to provide prophylaxis against prosthetic joint infections (PJI). One of the shortcomings of the current generation of ALBCs is that the antibiotic release profile is characterized by a burst over the first few hours followed by a sharp decrease in rate for the following several days (often below minimum inhibitory concentration (MIC)), and, finally, exhaustion (after, typically, similar to 20 d). This profile means that the ALBCs provide only short-term antimicrobial action against bacterial strains involved PJI. Rationale The purpose of the present study was to develop an improved antibiotic delivery system for an ALBC. This system involved using a layer-by-layer technique to load the antibiotic (gentamicin sulphate) (GEN) on silica nanoparticles, which are then blended with the powder of the cement. Then, the powder was mixed with the liquid of the cement (NP-GEN cement). For controls, two GEN-loaded brands were used (Cemex Genta and Palacos R+G). Gentamicin release and a host of other relevant properties were determined for all the cements studied. Results Compared to control cement specimens, improved GEN release, longer antimicrobial activity (against clinically-relevant bacterial strains), and comparable setting time, cytocompatibility, compressive strength (both prior to and after aging in PBS at 37 degrees C for 30 d), 4-point bend strength and modulus, fracture toughness, and PBS uptake. Conclusions NP-GEN cement may have a role in preventing or treating PJI.	[Al Thaher, Yazan; Yang, Lirong; Perni, Stefano; Prokopovich, Polina] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales; [Jones, Steve A.] Univ Hosp Llandough, Cardiff, S Glam, Wales; [Jones, Steve A.] Vale Univ Hlth Board, Vale Of Glamorgan, Wales	Cardiff University	Prokopovich, P (corresponding author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales.	prokopovichp@cf.ac.uk	Yang, Lirong/AAQ-7859-2021; Perni, Stefano/B-8158-2009	Prokopovich, Polina/0000-0002-5700-9570; Perni, Stefano/0000-0002-3101-0098; Al Thaher, Yazan/0000-0002-1643-6605	Philadelphia University (Amman, Jordan)	Philadelphia University (Amman, Jordan)	Funded by Philadelphia University (Amman, Jordan) to Yazan Al Thaher, Polina Prokopovich and Stefano Perni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102; Al Thaher Y, 2018, J COLLOID INTERF SCI, V526, P35, DOI 10.1016/j.jcis.2018.04.042; Al Thaher Y, 2017, ADV COLLOID INTERFAC, V249, P234, DOI 10.1016/j.cis.2017.04.017; Alotaibi HF, 2018, CURR OPIN COLLOID IN, V36, P130, DOI 10.1016/j.cocis.2018.02.008; Anagnostakos Konstantinos, 2017, J Bone Jt Infect, V2, P29, DOI 10.7150/jbji.16067; [Anonymous], 2017, UK NATL JOINT REGIST; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; Ayre WN, 2016, J BIOMED MATER RES B, V104, P1510, DOI 10.1002/jbm.b.33488; Barrett L, 2014, J ANTIMICROB CHEMOTH, V69, P25, DOI 10.1093/jac/dku250; Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568; Brimmo O, 2016, J ARTHROPLASTY, V31, P461, DOI 10.1016/j.arth.2015.08.044; Buller LT, 2012, J ARTHROPLASTY, V27, P857, DOI 10.1016/j.arth.2012.01.003; Cenni E, 2002, J BIOMAT SCI-POLYM E, V13, P1283, DOI 10.1163/15685620260449697; Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188; Chen A, 2014, J ORTHOP RES, V32, pS158, DOI 10.1002/jor.22561; Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h; Cobo J, 2011, PROSTHETIC JOINT INF; Deshmukh PK, 2013, J CONTROL RELEASE, V166, P294, DOI 10.1016/j.jconrel.2012.12.033; Farrar DF, 2001, BIOMATERIALS, V22, P3005, DOI 10.1016/S0142-9612(01)00047-3; Feng W, 2014, ACS APPL MATER INTER, V6, P8447, DOI 10.1021/am501337s; Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290; Gentile P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/42/422001; GRANCHI D, 1995, BIOMATERIALS, V16, P1187, DOI 10.1016/0142-9612(95)93585-2; ISO, 2002, 58332002 ISO; ISO, 2000, 135862000 ISO; Kong LD, 2017, INT WOUND J, V14, P529, DOI 10.1111/iwj.12640; Kremers HM, 2016, J ARTHROPLASTY, V31, P1163, DOI 10.1016/j.arth.2015.12.010; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Letchmanan K, 2017, J MECH BEHAV BIOMED, V72, P163, DOI 10.1016/j.jmbbm.2017.05.003; Liddle AD, 2014, LANCET, V384, P1437, DOI 10.1016/S0140-6736(14)60419-0; Liu XW, 2015, INT J CLIN EXP MED, V8, P27, DOI 10.14257/ijsip.2015.8.11.04; Liu YJ, 2015, POLYM CHEM-UK, V6, P7514, DOI 10.1039/c5py01190f; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]; Minelli EB, 2015, J CHEMOTHERAPY, V27, P17, DOI 10.1179/1973947813Y.0000000157; Nottrott M, 2008, ACTA ORTHOP, V79, P826, DOI 10.1080/17453670810016920; Perni S, 2018, COLLOID SURFACE A, V541, P212, DOI 10.1016/j.colsurfa.2017.04.063; Perni S, 2015, INT J NANOMED, V10, P6317, DOI 10.2147/IJN.S86440; Perni S, 2014, RSC ADV, V4, P51904, DOI 10.1039/c4ra10023a; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Shen SC, 2016, MAT SCI ENG C-MATER, V58, P233, DOI 10.1016/j.msec.2015.08.011; Shuman EK, 2012, INFECT DIS CLIN N AM, V26, P165, DOI 10.1016/j.idc.2011.09.010; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Strange S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1213-8; Swearingen MC, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv103; Tamanna T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5444-0; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tommasi G, 2016, TISSUE ENG PT A, V22, P862, DOI [10.1089/ten.tea.2016.0014, 10.1089/ten.TEA.2016.0014]; Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148; Wendling A, 2016, BONE JOINT RES, V5, P26, DOI 10.1302/2046-3758.52.2000412; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wu K, 2016, J AM ACAD ORTHOP SUR, V24, P188, DOI 10.5435/JAAOS-D-15-00469; Yu T, 2010, COLLOID SURFACE B, V75, P363, DOI 10.1016/j.colsurfb.2009.09.012	53	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0207753	10.1371/journal.pone.0207753	http://dx.doi.org/10.1371/journal.pone.0207753			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543660	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000453247500009
J	Birtel, J; Gliem, M; Mangold, E; Muller, PL; Holz, FG; Neuhaus, C; Lenzner, S; Zahnleiter, D; Betz, C; Eisenberger, T; Bolz, HJ; Issa, PC				Birtel, Johannes; Gliem, Martin; Mangold, Elisabeth; Mueller, Philipp L.; Holz, Frank G.; Neuhaus, Christine; Lenzner, Steffen; Zahnleiter, Diana; Betz, Christian; Eisenberger, Tobias; Bolz, Hanno J.; Issa, Peter Charbel			Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; COMPREHENSIVE MOLECULAR DIAGNOSIS; CONE-ROD DYSTROPHY; FUNDUS AUTOFLUORESCENCE; INCOMPLETE PENETRANCE; VISUAL FUNCTION; FREQUENT CAUSE; MUTATIONS; GENE; RPGR	Retinitis pigmentosa (RP) is an inherited degenerative disease causing severe retinal dystrophy and visual impairment mainly with onset in infancy or adolescence. Targeted next-generation sequencing (NGS) has become an efficient tool to encounter the enormous genetic heterogeneity of diverse retinal dystrophies, including RP. To identify disease-causing mutations in unselected, consecutive RP patients, we conducted Sanger sequencing of genes commonly involved in the suspected genetic RP subtype, followed by targeted large-panel NGS if no mutation was identified, or NGS as primary analysis. A high (70%) detection rate of disease-causing mutations was achieved in a large cohort of 116 unrelated patients. About half (48%) of the solved RP cases were explained by mutations in four genes: RPGR, EYS, PRPF31 and USH2A. Overall, 110 different mutations distributed across 30 different genes were detected, and 46 of these mutations were novel. A molecular diagnosis was achieved in the majority (82-100%) of patients if the family history was suggestive for a particular mode of inheritance, but only in 60% in cases of sporadic RP. The diagnostic potential of extensive molecular analysis in a routine setting is also illustrated by the identification of unexpected genotype-phenotype correlations for RP patients with mutations in CRX, CEP290, RPGRIP1, MFSD8. Furthermore, we identified numerous mutations in autosomal dominant (PRPF31, PRPH2, CRX) and X-linked (RPGR) RP genes in patients with sporadic RP. Variants in RP2 and RPGR were also found in female RP patients with apparently sporadic or dominant disease. In summary, this study demonstrates that massively parallel sequencing of all known retinal dystrophy genes is a valuable diagnostic approach for RP patients.	[Birtel, Johannes; Gliem, Martin; Mueller, Philipp L.; Holz, Frank G.; Issa, Peter Charbel] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Birtel, Johannes; Gliem, Martin; Mueller, Philipp L.; Holz, Frank G.; Issa, Peter Charbel] Univ Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany; [Mangold, Elisabeth] Univ Bonn, Inst Human Genet, Bonn, Germany; [Neuhaus, Christine; Lenzner, Steffen; Zahnleiter, Diana; Betz, Christian; Eisenberger, Tobias; Bolz, Hanno J.] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Issa, Peter Charbel] Univ Oxford, Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England; [Issa, Peter Charbel] Univ Oxford, Nuffield Lab Ophthalmol, Dept Clin Neurosci, Oxford, England	University of Bonn; University of Bonn; University of Bonn; University of Cologne; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Issa, PC (corresponding author), Univ Bonn, Dept Ophthalmol, Bonn, Germany.; Issa, PC (corresponding author), Univ Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.; Issa, PC (corresponding author), Univ Oxford, Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England.; Issa, PC (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Dept Clin Neurosci, Oxford, England.	study-enquiry@outlook.com	Müller, Philipp L./P-3350-2019; Issa, Peter Charbel/O-2580-2019	Issa, Peter Charbel/0000-0002-0351-6673	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC); ProRetina Foundation, Germany; German Research Foundation [GL920/1-1, MU4279/1-1]	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); ProRetina Foundation, Germany; German Research Foundation(German Research Foundation (DFG))	Bioscientia, a publicly traded diagnostic company, provided support in the form of salaries for C.N., S.L., D.Z., C.B., T.E. and H.J.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC); ProRetina Foundation, Germany and the German Research Foundation (MG, grant #GL920/1-1; PLM grant #MU4279/1-1). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. No sponsor or funding agency had any involvement in the design, collection, analysis and interpretation of the data, manuscript writing or the decision to submit the manuscript for publication.	Acton JH, 2013, EXP EYE RES, V113, P41, DOI 10.1016/j.exer.2013.05.003; Aiello C, 2009, HUM MUTAT, V30, pE530, DOI 10.1002/humu.20975; Aleman TS, 2007, INVEST OPHTH VIS SCI, V48, P4759, DOI 10.1167/iovs.07-0453; Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Almoguera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133624; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Birtel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22096-0; Booij JC, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035121; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Bravo-Gil N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41937; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Comander J, 2015, OPHTHALMOLOGY, V122, P1899, DOI 10.1016/j.ophtha.2015.05.039; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craiu D, 2015, EUR J PAEDIATR NEURO, V19, P78, DOI 10.1016/j.ejpn.2014.07.008; De La Camara CMF, 2018, EXPERT OPIN ORPHAN D, V6, P167, DOI 10.1080/21678707.2018.1444476; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Di Iorio V, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100280; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; Fahim AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023021; Ge ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18287; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Inglehearn CF, 1998, J MED GENET, V35, P1, DOI 10.1136/jmg.35.1.1; Jacobson SG, 2007, OPHTHALMOLOGY, V114, P895, DOI 10.1016/j.ophtha.2006.10.028; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Khan KN, 2017, INVEST OPHTH VIS SCI, V58, P2906, DOI 10.1167/iovs.16-20608; Kousi M, 2009, BRAIN, V132, P810, DOI 10.1093/brain/awn366; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Mahajnah M, 2012, PEDIATR NEUROL, V47, P303, DOI 10.1016/j.pediatrneurol.2012.05.016; Mandel H, 2014, EUR J MED GENET, V57, P607, DOI 10.1016/j.ejmg.2014.09.004; Manes G, 2015, AM J OPHTHALMOL, V159, P302, DOI 10.1016/j.ajo.2014.10.033; MOORE AT, 1993, BRIT J OPHTHALMOL, V77, P473, DOI 10.1136/bjo.77.8.473; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nguyen TMT, 2017, J MED GENET, V54, P624, DOI 10.1136/jmedgenet-2016-104200; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Ogino K, 2015, CLIN OPHTHALMOL, V9, P1467, DOI 10.2147/OPTH.S89371; Oishi M, 2014, INVEST OPHTH VIS SCI, V55, P7369, DOI 10.1167/iovs.14-15458; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Pomares E, 2009, INVEST OPHTH VIS SCI, V50, P5107, DOI 10.1167/iovs.08-3208; Riera M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42078; Roberts L, 2016, INVEST OPHTH VIS SCI, V57, P6374, DOI 10.1167/iovs.16-19785; Roosing S, 2015, OPHTHALMOLOGY, V122, P170, DOI 10.1016/j.ophtha.2014.07.040; Rose AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19450; Rozet JM, 2002, J MED GENET, V39, P284, DOI 10.1136/jmg.39.4.284; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Shen T, 2015, MOL MED REP, V11, P1827, DOI 10.3892/mmr.2014.2894; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Souied E, 1997, J MED GENET, V34, P793, DOI 10.1136/jmg.34.10.793; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Walia S, 2010, OPHTHALMOLOGY, V117, P1190, DOI 10.1016/j.ophtha.2009.09.056; Wang F, 2014, HUM GENET, V133, P331, DOI 10.1007/s00439-013-1381-5; Wang J, 2014, INVEST OPHTH VIS SCI, V55, P6213, DOI 10.1167/iovs.14-14936; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Wegscheider E, 2004, GRAEF ARCH CLIN EXP, V242, P501, DOI 10.1007/s00417-004-0891-1; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep32792; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7	71	50	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0207958	10.1371/journal.pone.0207958	http://dx.doi.org/10.1371/journal.pone.0207958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543658	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500014
J	Petrosyan, Y; Barnsley, JM; Kuluski, K; Liu, B; Wodchis, WP				Petrosyan, Yelena; Barnsley, Jan M.; Kuluski, Kerry; Liu, Barbara; Wodchis, Walter P.			Quality indicators for ambulatory care for older adults with diabetes and comorbid conditions: A Delphi study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE; MELLITUS; MULTIMORBIDITY	Background An increasing number of people are living with multiple chronic conditions and it is unclear which quality indicators should be used to guide care for this population. Objective To critically appraise and select the most appropriate set of quality indicators for ambulatory care for older adults with five selected disease combinations. Methods A two-round web-based Delphi process was used to critically appraise and select quality of care indicators for older adults with diabetes and comorbidities. A fifteen-member Canadian expert panel with broad geographical and clinical representation participated in this study. The panel evaluated process indicators for meaningfulness, potential for improvements in clinical practice, and overall value of inclusion, while outcome indicators were evaluated for importance, modifiability and overall value of inclusion. A 70% agreement threshold was required for high consensus, and 60-69% for moderate consensus as measured on a 5-point Likert type scale. Results Twenty high-consensus and nineteen medium-consensus process and outcome indicators were selected for assessing care for older adults with selected disease combinations, including 1) concordant (conditions with a common management plan), 2) discordant (conditions with unrelated management plans), and 3) both types. Panelists reached rapid consensus on quality indicators for care for older adults with concordant comorbid conditions, but not for those with discordant conditions. All selected indicators assess clinical aspects of care. The feedback from the panelists emphasized the importance of developing indicators related to patient-centred aspects of care, including patient self-management, education, patient-physician relationships, and patient's preferences. Conclusions The selected quality indicators are not intended to provide a comprehensive tool set for measuring quality of care for older adults with selected disease combinations. The recommended indicators address clinical aspects of care and can be used as a starting point for ambulatory care settings and development of additional quality indicators.	[Petrosyan, Yelena] Ottawa Hosp Res Inst, Clin Epidemiol, Ottawa, ON, Canada; [Barnsley, Jan M.; Kuluski, Kerry; Wodchis, Walter P.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kuluski, Kerry] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Liu, Barbara] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Wodchis, Walter P.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wodchis, Walter P.] Toronto Rehabil Inst, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Wodchis, WP (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Wodchis, WP (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Wodchis, WP (corresponding author), Toronto Rehabil Inst, Toronto, ON, Canada.	walter.wodchis@utoronto.ca		wodchis, walter/0000-0003-2494-7031	Canadian Institute for Health Research Community Based Primary Health Care Team Grant [TTF-128263]	Canadian Institute for Health Research Community Based Primary Health Care Team Grant	This work was supported by a research grant from a Canadian Institute for Health Research Community Based Primary Health Care Team Grant (#TTF-128263). There are no other sources of support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PRACTICAL ASSESSMENT, DOI [DOI 10.1576/T0AG.7.2.120.27071, DOI 10.7275/PDZ9-TH90]; Barkin RL, 2010, DRUG AGING, V27, P775, DOI 10.2165/11539430-000000000-00000; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barnsley J, 2005, CAN FAM PHYSICIAN, V51, P701; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2012, PUBLIC HLTH REV, V32, P451; Buchanan D., 2006, CAN J PSYCHIAT, V9, pS52; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Canadian Diabetes Association Expert Panel Committee, 2013, CAN J DIABETES, V37, pS168, DOI DOI 10.1016/J.JCJD.2013.01.009; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; EMSLIESMITH A, 2003, BR J DIABETES VASC D, V3, P54, DOI DOI 10.1177/14746514030030010901; Fitch K., 2001, RAND UCLA APPROPRIAT; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-74; Giovannetti ER, 2013, AM J MANAG CARE, V19, pE359; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Gruneir A, 2016, CAN J DIABETES, V40, P35, DOI 10.1016/j.jcjd.2015.09.002; Hutchings A, 2005, QUAL SAF HEALTH CARE, V14, P240, DOI 10.1136/qshc.2004.013227; Johnson JA, 2005, CAN J DIABETES, V29, P220; Kim J, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000133; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Martirosyan L, 2008, QUAL SAF HEALTH CARE, V17, P318, DOI 10.1136/qshc.2007.024224; Mutasingwa DR, 2011, CAN FAM PHYSICIAN, V57, pE253; Normand SLT, 1998, INT J QUAL HEALTH C, V10, P247, DOI 10.1093/intqhc/10.3.247; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Petrosyan Y, 2018, FAM PRACT, V35, P151, DOI 10.1093/fampra/cmx090; Petrosyan Y, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0530-7; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; RTI International & Telligen. Accountable Care Organization, 2013, QUAL PERF STAND NARR; Ryan M, 2001, Health Technol Assess, V5, P1; Shekelle P, 2007, J AM GERIATR SOC, V55, pS312, DOI 10.1111/j.1532-5415.2007.01337.x; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Young JM, 2014, COLORECTAL DIS, V16, P17, DOI 10.1111/codi.12399	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208888	10.1371/journal.pone.0208888	http://dx.doi.org/10.1371/journal.pone.0208888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543672	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500050
J	Cui, TT; Bell, EH; McElroy, J; Becker, AP; Gulati, PM; Geurts, M; Mladkova, N; Gray, A; Liu, K; Yang, LL; Liu, ZY; Fleming, JL; Haque, SJ; Barnholtz-Sloan, JS; Ligon, KL; Beroukhim, R; Robe, P; Chakravarti, A				Cui, Tiantian; Bell, Erica H.; McElroy, Joseph; Becker, Aline Paixao; Gulati, Pooja Manchanda; Geurts, Marjolein; Mladkova, Nikol; Gray, Ashley; Liu, Kevin; Yang, Linlin; Liu, Ziyan; Fleming, Jessica L.; Haque, S. Jaharul; Barnholtz-Sloan, Jill S.; Ligon, Keith L.; Beroukhim, Rameen; Robe, Pierre; Chakravarti, Arnab			miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma	ONCOGENE			English	Article							ORGAN SIZE CONTROL; MICRORNA EXPRESSION; HIPPO PATHWAY; PROLIFERATION; CANCER; YAP; TUMORIGENICITY; TEMOZOLOMIDE; HOMEOSTASIS; APOPTOSIS	Glioblastomas (GBMs) are the most aggressive primary brain tumors, with an average survival of less than 15 months. Therefore, there is a critical need to develop novel therapeutic strategies for GBM. This study aimed to assess the prognostic value of miR-4516 and investigate its oncogenic functions and the underlying cellular and molecular mechanisms in GBM. To determine the correlation between miR-4516 expression and overall survival of patients with GBM, total RNAs were isolated from 268 FFPE tumor samples, miR expression was assayed (simultaneously) using the nCounter human miRNA v3a assay followed by univariable and multivariable survival analyses. Further, in vitro and in vivo studies were conducted to define the role of miR-4516 in GBM tumorigenesis and the underlying molecular mechanisms. Upon multivariable analysis, miR-4516 was correlated with poor prognosis in GBM patients (HR = 1.49, 95%CI: 1.12-1.99, P = 0.01). Interestingly, the significance of miR-4516 was retained including MGMT methylation status. Overexpression of miR-4516 significantly enhanced cell proliferation and invasion of GBM cells both in vitro and in vivo. While conducting downstream targeting studies, we found that the tumor-promoting function of miR-4516, in part, was mediated by direct targeting of PTPN14 (protein tyrosine phosphatase, non-receptor type 14) which, in turn, regulated the Hippo pathway in GBM. Taken together, our data suggest that miR-4516 represents an independent negative prognostic factor in GBM patients and acts as a novel oncogene in GBM, which regulates the PTPN14/Hippo pathway. Thus, this newly identified miR-4516 may serve as a new potential therapeutic target for GBM treatment.	[Cui, Tiantian; Bell, Erica H.; Becker, Aline Paixao; Gulati, Pooja Manchanda; Yang, Linlin; Liu, Ziyan; Fleming, Jessica L.; Haque, S. Jaharul; Chakravarti, Arnab] Arthur G James Hosp, Dept Radiat Oncol, Ohio State Comprehens Canc Ctr, Columbus, OH 43210 USA; [McElroy, Joseph] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Geurts, Marjolein; Robe, Pierre] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Mladkova, Nikol] Columbia Univ, Dept Internal Med, Div Nephrol, New York, NY 10032 USA; [Gray, Ashley] Ohio State Univ, Columbus, OH 43210 USA; [Liu, Kevin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Ligon, Keith L.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Utrecht University; Utrecht University Medical Center; Columbia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Chakravarti, A (corresponding author), Arthur G James Hosp, Dept Radiat Oncol, Ohio State Comprehens Canc Ctr, Columbus, OH 43210 USA.	Chakravarti.7@osu.edu	Barnholtz-Sloan, Jill/A-4817-2011; Geurts, Marjolein/AAP-4148-2020; Becker, Aline/AAD-2209-2021	Barnholtz-Sloan, Jill/0000-0001-6190-9304; 	National Cancer Institute [R01CA169368, R01CA11522358, R01CA1145128, R01CA108633, R01CA188228, 1RC2CA148190, U10CA180850-01]; Brain Tumor Funders Collaborative Grant; Ohio State University Comprehensive Cancer Center Award; NATIONAL CANCER INSTITUTE [P30CA016058, UG1CA233331, R01CA169368, U10CA180850, R01CA188228] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Tumor Funders Collaborative Grant; Ohio State University Comprehensive Cancer Center Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute [R01CA169368 (to A.C.), R01CA11522358 (to A.C.), R01CA1145128 (to A.C.), R01CA108633 (to A.C.), R01CA188228 (to A.C., R.B., K.L., and J.B.), 1RC2CA148190 (to A.C.), and U10CA180850-01 (to A.C.)]; A Brain Tumor Funders Collaborative Grant (to A.C.); Ohio State University Comprehensive Cancer Center Award (to A.C.).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Bell EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118745; Belle L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005547; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Chang WH, 2016, TUMOR BIOL, V37, P14813, DOI 10.1007/s13277-016-5295-4; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Cui TT, 2015, ONCOTARGET, V6, P10060, DOI 10.18632/oncotarget.3542; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Du WZ, 2015, NEURO-ONCOLOGY, V17, P243, DOI 10.1093/neuonc/nou217; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Han CH, 2014, MOL CANCER RES, V12, P784, DOI 10.1158/1541-7786.MCR-13-0638; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Laczmanska I, 2011, ACTA BIOCHIM POL, V58, P467; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Li SW, 2017, NEURO-ONCOLOGY, V19, P55, DOI 10.1093/neuonc/now129; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; McNamara Mairead G, 2013, Cancers (Basel), V5, P1103, DOI 10.3390/cancers5031103; Michaloglou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061916; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Team RC, 2016, R LANG ENV STAT COMP; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang LJ, 2015, ONCOTARGET, V6, P5932, DOI 10.18632/oncotarget.3465; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xia HP, 2013, NEURO-ONCOLOGY, V15, P413, DOI 10.1093/neuonc/nos296; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zougman A, 2013, EUR J CANCER, V49, P531, DOI 10.1016/j.ejca.2012.07.031	41	37	37	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					2923	2936		10.1038/s41388-018-0601-9	http://dx.doi.org/10.1038/s41388-018-0601-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30559405	Green Accepted			2022-12-26	WOS:000465167600004
J	Li, YH; Guan, JM; Wang, WJ; Hou, C; Zhou, L; Ma, J; Cheng, YF; Jiao, S; Zhou, ZC				Li, Yehua; Guan, Jingmin; Wang, Wenjia; Hou, Chun; Zhou, Li; Ma, Jian; Cheng, Yunfeng; Jiao, Shi; Zhou, Zhaocai			TRAF3-interacting JNK-activating modulator promotes inflammation by stimulating translocation of Toll-like receptor 4 to lipid rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toll-like receptor 4 (TLR4); inflammation; lipopolysaccharide (LPS); lipid raft; macrophage; innate immunity; lipopolysaccharide; membrane transfer; Toll-like receptor; transmembrane protein	RECOGNITION; INNATE; TLR4; PATTERN; PROTEIN; MICRODOMAINS; ENDOCYTOSIS; MECHANISMS; RESPONSES; MST4	Toll-like receptors (TLRs) are key players of the innate immune system and contribute to inflammation and pathogen clearance. Although TLRs have been extensively studied, it remains unclear how exactly bacterial lipopolysaccharide (LPS)-induced conformational changes of the extracellular domain of the TLRs trigger the dimerization of their intracellular domain across the plasma membrane and thereby stimulate downstream signaling. Here, using LPS-stimulated THP-1-derived macrophages and murine macrophages along with immunoblotting and immunofluorescence and quantitative analyses, we report that in response to inflammatory stimuli, the coiled-coil protein TRAF3-interacting JNK-activating modulator (T3JAM) associates with TLR4, promotes its translocation to lipid rafts, and thereby enhances macrophage-mediated inflammation. T3JAM overexpression increased and T3JAM depletion decreased TLR4 signaling through both the MyD88-dependent pathway and TLR4 endocytosis. Importantly, deletion or mutation of T3JAM to disrupt its coiled-coil-mediated homoassociation abrogated TLR4 recruitment to lipid rafts. Consistently, T3JAM depletion in mice dampened TLR4 signaling and alleviated LPS-induced inflammatory damage. Collectively, our findings reveal an additional molecular mechanism by which TLR4 activity is regulated and suggest that T3JAM may function as a molecular clamp to "tighten up" TLR4 and facilitate its translocation to lipid rafts.	[Li, Yehua; Guan, Jingmin; Wang, Wenjia; Ma, Jian; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Hou, Chun; Zhou, Li; Zhou, Zhaocai] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai 200032, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Fudan University	Jiao, S; Zhou, ZC (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn			National Key R&D Program of China [2017YFA0504504]; National Natural Science Foundation of China [81725014, 81822035]; Strategic Priority Research Program [XDB19020202]; China Postdoctoral Science Foundation [2018M630482]; Science and Technology Commission of Shanghai Municipality [17YF1422200, 17ZR1435400]; Youth Innovation Promotion Association of Chinese Academy of Sciences	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Youth Innovation Promotion Association of Chinese Academy of Sciences	This work was supported by the National Key R&D Program of China (2017YFA0504504), National Natural Science Foundation of China Grants 81725014 and 81822035, the "Strategic Priority Research Program" (XDB19020202) and China Postdoctoral Science Foundation Funded Project (2018M630482), Science and Technology Commission of Shanghai Municipality Grants 17YF1422200 and 17ZR1435400, and the Youth Innovation Promotion Association of Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Cochet F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112318; Dadgostar H, 2003, FEBS LETT, V553, P403, DOI 10.1016/S0014-5793(03)01072-X; Dajon M, 2017, IMMUNOBIOLOGY, V222, P89, DOI 10.1016/j.imbio.2016.06.009; Daringer NM, 2015, J BIOL CHEM, V290, P8764, DOI 10.1074/jbc.M114.610063; Fekonja O, 2012, J BIOL CHEM, V287, P30993, DOI 10.1074/jbc.M112.376186; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Garibotto G, 2017, J NEPHROL, V30, P719, DOI 10.1007/s40620-017-0432-8; Guven-Maiorov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13128; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Kaisho T, 2001, ACTA ODONTOL SCAND, V59, P124, DOI 10.1080/000163501750266701; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kruger CL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan1308; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Lennartz Michelle, 2018, F1000Res, V7, P21, DOI 10.12688/f1000research.12679.1; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Parker LC, 2008, J IMMUNOL, V181, P5606, DOI 10.4049/jimmunol.181.8.5606; Peng S, 2015, CLIN EXP IMMUNOL, V182, P57, DOI 10.1111/cei.12658; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Schoeniger A, 2011, INT J MOL SCI, V12, P7510, DOI 10.3390/ijms12117510; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shang LM, 2014, J BIOL CHEM, V289, P15309, DOI 10.1074/jbc.M113.537936; Shi DW, 2013, J BIOL CHEM, V288, P12605, DOI 10.1074/jbc.M112.399477; Shi Z, 2016, ONCOGENE, V35, P4549, DOI 10.1038/onc.2016.9; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Vallance TM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9605894; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Yao Y, 2009, CELL RES, V19, P497, DOI 10.1038/cr.2009.27; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258; Zhang M, 2013, STRUCTURE, V21, P680, DOI 10.1016/j.str.2013.02.015; Zou Q, 2015, J EXP MED, V212, P1323, DOI 10.1084/jem.20150110	41	10	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2744	2756		10.1074/jbc.RA118.003137	http://dx.doi.org/10.1074/jbc.RA118.003137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573680	Green Published, hybrid			2022-12-26	WOS:000459601600015
J	Aguirre-von-Wobeser, E; Rocha-Estrada, J; Shapiro, LR; de la Torre, M				Aguirre-von-Wobeser, Eneas; Rocha-Estrada, Jorge; Shapiro, Lori R.; de la Torre, Mayra			Enrichment of Verrucomicrobia, Actinobacteria and Burkholderiales drives selection of bacterial community from soil by maize roots in a traditional milpa agroecosystem	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; 16S RIBOSOMAL-RNA; RHIZOSPHERE MICROBIOME; GENOME SEQUENCE; SP-NOV.; DIVERSITY; TAXA; GEMMATIMONAS; ABUNDANCE; DYNAMICS	Milpas are rain-fed agroecosystems involving domesticated, semi-domesticated and tolerated plant species that combine maize with a large variety of other crop, tree or shrub species. Milpas are low input and low-tillage, yet highly productive agroecosystems, which have been maintained over millennia in indigenous communities in Mexico and other countries in Central America. Thus, milpas may retain ancient plant-microorganisms interactions, which could have been lost in modern high-tillage monocultures with large agrochemical input. In this work, we performed high-throughput 16S ribosomal DNA sequencing of soil adjacent to maize roots and bulk soil sampled at 30 cm from the base of the plants. We found that the bacterial communities of maize root soil had a lower alpha diversity, suggesting selection of microorganisms by maize-roots from the bulk-soil community. Beta diversity analysis confirmed that these environments harbor two distinct microbial communities; differences were driven by members of phyla Verrucomicrobia and Actinobacteria, as well as the order Burkholderiales (Betaproteobacteria), all of which had higher relative abundance in soil adjacent to the roots. Numerous studies have shown the influence of maize plants on bacterial communities found in soil attached tightly to the roots; here we further show that the influence of maize roots at milpas on bacterial communities is detectable even in plant-free soil collected nearby. We propose that members of Verrucomicrobia and other phyla found in the rhizosphere may establish beneficial plant-microbe interactions with maize roots in milpas, and propose to address their cultivation for future studies on ecology and potential use.	[Aguirre-von-Wobeser, Eneas; Rocha-Estrada, Jorge] CONACyT, Ctr Invest & Desarrollo Agrobiotecnol Alimentaria, Pachuca Ciudad Conocimiento & Cultura, San Agustin Tlaxiaca, Hidalgo, Mexico; [Shapiro, Lori R.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [de la Torre, Mayra] Ctr Invest & Desarrollo Agrobiotecnol Alimentaria, Pachuca Ciudad Conocimiento & Cultura, San Agustin Tlaxiaca, Hidalgo, Mexico	Harvard University; Harvard Medical School	Aguirre-von-Wobeser, E (corresponding author), CONACyT, Ctr Invest & Desarrollo Agrobiotecnol Alimentaria, Pachuca Ciudad Conocimiento & Cultura, San Agustin Tlaxiaca, Hidalgo, Mexico.	eneas.aguirre@ciad.mx	Rocha, Jorge/GYU-8451-2022; Aguirre-von-Wobeser, Eneas/W-2652-2019; Aguirre-von-Wobeser, Eneas/I-3493-2015	Rocha, Jorge/0000-0002-8083-4325; Aguirre-von-Wobeser, Eneas/0000-0002-5604-0525	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [FOMIX Hidalgo 2015-01-267837]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico, https://www.conacyt.gob.mx/) grant FOMIX Hidalgo 2015-01-267837 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bakker MG, 2015, PLANT SOIL, V392, P115, DOI 10.1007/s11104-015-2446-0; Baldani VLD, 2000, BIOL FERT SOILS, V30, P485, DOI 10.1007/s003740050027; Basurto-Pena F, 1998, BOT SCI, V62, P49, DOI DOI 10.17129/botsci.1550; Benitez MS, 2009, APPL ENVIRON MICROB, V75, P915, DOI 10.1128/AEM.01296-08; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Broszat M, 2014, APPL ENVIRON MICROB, V80, P5282, DOI 10.1128/AEM.01295-14; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chauhan PS, 2011, J BASIC MICROB, V51, P15, DOI 10.1002/jobm.201000171; Chen YH, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00125; da Rocha UN, 2011, FEMS MICROBIOL ECOL, V78, P297, DOI 10.1111/j.1574-6941.2011.01156.x; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Dohrmann AB, 2013, ISME J, V7, P37, DOI 10.1038/ismej.2012.77; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Figuerola E.L., 2015, ENVIRON MICROBIOL, V17, P678, DOI [10.1111/1462-2920.12497, DOI 10.1111/1462-2920.12497]; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gomez-Pompa A., 1987, MEX STUD, V3, P1, DOI [10.2307/4617029, DOI 10.2307/4617029]; Hernandez M, 2015, APPL ENVIRON MICROB, V81, P2244, DOI 10.1128/AEM.03209-14; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kant R, 2011, J BACTERIOL, V193, P2902, DOI 10.1128/JB.00295-11; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma ZY, 2017, PLANT SOIL ENVIRON, V63, P574, DOI [10.17221/590/2017-PSE, 10.17221/590/2017-pse]; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Navarrete AA, 2015, ANTON LEEUW INT J G, V108, P741, DOI 10.1007/s10482-015-0530-3; Nigh R, 2013, FRONT ECOL ENVIRON, V11, pE45, DOI 10.1890/120344; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Perales H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114657; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Prashar P, 2014, REV ENVIRON SCI BIO, V13, P63, DOI 10.1007/s11157-013-9317-z; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rebollar EA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02478; Sathya A, 2017, 3 BIOTECH, V7, DOI [10.1007/s13205-017-0736-3, 10.]; Schmidt JE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00373; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TERAN S, 1995, BIODIVERS CONSERV, V4, P363, DOI 10.1007/BF00058422; Trivedi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00990; Van der Meij A, 2017, FEMS MICROBIOL REV, V41, P392, DOI 10.1093/femsre/fux005; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; van Passel MWJ, 2011, J BACTERIOL, V193, P2367, DOI 10.1128/JB.00228-11; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Wang L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1346-4; Wang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14936-2; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zeng YH, 2015, INT J SYST EVOL MICR, V65, P2410, DOI 10.1099/ijs.0.000272; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang YN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02449; Zizumbo-Villarreal D, 2012, ECON BOT, V66, P328, DOI 10.1007/s12231-012-9212-5	62	29	32	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208852	10.1371/journal.pone.0208852	http://dx.doi.org/10.1371/journal.pone.0208852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571782	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700026
J	Fletcher, K; Xiong, Y; Fletcher, E; Gustafsson, L				Fletcher, Kevin; Xiong, Ye; Fletcher, Erika; Gustafsson, Lars			Glucocorticoid response to both predictable and unpredictable challenges detected as corticosterone metabolites in collared flycatcher droppings	PLOS ONE			English	Article							BASE-LINE; BODY CONDITION; DAIRY-CATTLE; CLUTCH SIZE; STRESS; BIRDS; INCUBATION; BEHAVIOR; WILD; DISTURBANCE	In most vertebrate animals, glucocorticoid hormones are the chief mediators of homeostasis in response to ecological conditions and as they progress through their lifecycle. In addition, glucocorticoids are a major part of the stress response and stress induced elevations of the hormone can make it difficult to assess glucocorticoid secretion in response to changes in life-stage and current environmental conditions in wild animals. Particularly when quantifying circulating levels of glucocorticoids in the blood which fluctuate rapidly in response to stress. An alternative method of quantifying glucocorticoids is as hormone metabolites in faeces or urine giving a historical sample related to the gut passage time and urinary tract that is less sensitive to stressful events which cause spikes in the circulating hormone level. Although the concentration of glucocorticoid metabolites are influenced by faecal mass thereby potentially affecting any differences in hormone metabolites detected amongst samples. In the present study, we aimed to detect changes in levels of corticosterone, the primary bird glucocorticoid, in relation to the phase of reproduction, in a breeding population of collared flycatchers by sampling corticosterone metabolites in droppings. We also tested how corticosterone metabolite concentrations were affected by ambient temperature and related to body condition in adult birds. Our results indicate that the upregulation of corticosterone between incubation and nestling feeding in female birds is crucial for successful reproduction in this species. Also, females appear to downregulate corticosterone during incubation in response to lower ambient temperature and poorer body condition. Our results did not indicate a relationship between dropping mass and corticosterone metabolite concentrations, which suggests that our findings were linked to the regulation of corticosterone in response to predictable and unpredictable challenges.	[Fletcher, Kevin; Xiong, Ye; Gustafsson, Lars] Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden; [Fletcher, Erika] Uppsala Univ, Biomed Ctr, Pharmacuet Biosci, Uppsala, Sweden	Uppsala University; Uppsala University	Fletcher, K (corresponding author), Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden.	kwfletcher24@gmail.com	Gustafsson, Lars/O-8056-2019; Xiong, Ye/V-7264-2019; Gustafsson, Lars/A-7634-2012	Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Xiong, Ye/0000-0002-7903-9375; Fletcher, Kevin/0000-0002-1713-9303	Swedish Research Council (VR); Swedish Research Council for Environment (FORMAS); Stiftelsen for Zoologisk	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment (FORMAS)(Swedish Research Council Formas); Stiftelsen for Zoologisk	This study has been financially supported by grants for the long-term study from the Swedish Research Council (VR); the Swedish Research Council for Environment (FORMAS) (grants to LG) and the Stiftelsen for Zoologisk (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the field assistants that have helped with data collection over the past three years. Elizabeth Fletcher for advice and support. The data upon which this study is based, have been obtained following the Swedish guidelines for work on natural populations, and under licenses and permits from the Swedish Ringing Centre and Swedish National Board for Laboratory Animals, Stockholm. This study has been financially supported by grants for the long-term study from the Swedish Research Council (VR); the Swedish Research Council for Environment (FORMAS) (grants to LG) and the Stiftelsen for Zoologisk.	Adams NJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P69, DOI 10.1086/423740; Adkins-Regan E, 2008, PHILOS T R SOC B, V363, P1599, DOI 10.1098/rstb.2007.0005; Angrecka S, 2015, CZECH J ANIM SCI, V60, P81, DOI 10.17221/7978-CJAS; [Anonymous], 2017, R LANG ENV STAT COMP; Bates D, 2017, NLME LINEAR NONLINEA; Bonier F, 2011, BIOL LETTERS, V7, P944, DOI 10.1098/rsbl.2011.0391; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; Breuner CW, 1999, J EXP ZOOL, V284, P334, DOI 10.1002/(SICI)1097-010X(19990801)284:3<334::AID-JEZ11>3.3.CO;2-R; Brewer JH, 2008, J FIELD ORNITHOL, V79, P391, DOI 10.1111/j.1557-9263.2008.00187.x; Comendant T, 2003, J EVOLUTION BIOL, V16, P948, DOI 10.1046/j.1420-9101.2003.00598.x; Cramp S., 1993, HDB BIRDS EUROPE MID, V7; Crossin GT, 2012, AM NAT, V180, pE31, DOI 10.1086/666001; Cyr NE, 2008, GEN COMP ENDOCR, V158, P20, DOI 10.1016/j.ygcen.2008.05.001; de Heij ME, 2007, J EXP BIOL, V210, P2006, DOI 10.1242/jeb.001420; ELWAILLY AJ, 1966, CONDOR, V68, P582, DOI 10.2307/1366265; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; GUSTAFSSON L, 1985, IBIS, V127, P380, DOI 10.1111/j.1474-919X.1985.tb05081.x; HARVEY S, 1984, J EXP ZOOL, V232, P633, DOI 10.1002/jez.1402320332; Hill DL, 2015, ANIMAL, V9, P138, DOI 10.1017/S1751731114002456; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lattin CR, 2016, HORM BEHAV, V78, P107, DOI 10.1016/j.yhbeh.2015.10.020; Legagneux P, 2011, GEN COMP ENDOCR, V172, P440, DOI 10.1016/j.ygcen.2011.04.009; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Lobato E, 2008, HORM BEHAV, V53, P295, DOI 10.1016/j.yhbeh.2007.10.010; Ouyang JQ, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0497-8; Ouyang JQ, 2013, HORM BEHAV, V63, P776, DOI 10.1016/j.yhbeh.2013.03.002; Ouyang JQ, 2011, HORM BEHAV, V60, P559, DOI 10.1016/j.yhbeh.2011.08.004; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Ozella L, 2017, GEN COMP ENDOCR, V242, P49, DOI 10.1016/j.ygcen.2015.12.002; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Remage-Healey L, 2001, AM J PHYSIOL-REG I, V281, pR994, DOI 10.1152/ajpregu.2001.281.3.R994; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Romero LM, 1997, COMP BIOCHEM PHYS C, V116, P171, DOI 10.1016/S0742-8413(96)00208-3; Stearns S.C., 1992, pi; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; Taylor W, 1971, Vitam Horm, V29, P201; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209289	10.1371/journal.pone.0209289	http://dx.doi.org/10.1371/journal.pone.0209289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571789	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700051
J	Shih, CC; Liu, PY; Chen, JH; Liao, MH; Hsieh, CM; Ka, SM; Wu, CC; Lin, HT; Wu, TH; Chen, YC				Shih, Chih-Chin; Liu, Pei-Yao; Chen, Jye-Hann; Liao, Mei-Hui; Hsieh, Chih-Ming; Ka, Shuk-Man; Wu, Chin-Chen; Lin, Hui-Tsu; Wu, Ti-Hui; Chen, Ying-Chuan			Macrophage expression of E3 ubiquitin ligase Grail protects mice from lipopolysaccharide-induced hyperinflammation and organ injury	PLOS ONE			English	Article							SEVERE SEPSIS; UP-REGULATION; P53; POLARIZATION; TRANSCRIPTION; ACTIVATION; SUPPRESSOR	Multiple organ dysfunction caused by hyperinflammation remains the major cause of mortality during sepsis. Excessive M1-macrophage activation leads to systemic inflammatory responses. Gene related to anergy in lymphocytes (Grail) is regarded as an important regulator of T cells that functions by diminishing cytokine production. However, its role in regulating macrophage activation and organ injury during sepsis remains unclear. Our aim was to examine the effects of Grail on macrophage reactivity and organ injury in endotoxemic animals. Wild-type and Grail knockout mice were injected with vehicle or Escherichia coli lipopolysaccharide and observed for 24 h. Changes in blood pressure, heart rate, blood glucose, and biochemical variables were then examined. Moreover, levels of neutrophil infiltration, MMP-9, and caspase 3 were analyzed in the lungs of animals. The expression of pro-inflammatory cytokines in J774A, RAW264.7, and primary peritoneal macrophages stimulated with LPS were also assessed in the presence or absence of Grail. Results indicated that loss of Grail expression enhances the induction of pro-inflammatory cytokines in J774A, RAW264.7, and primary peritoneal macrophages treated with LPS. Furthermore, LPS-induced macrophage hyperactivation was alleviated by ectopic Grail overexpression. In vivo studies showed that Grail deficiency exacerbates organ damage in endotoxemic animals. Levels of neutrophil infiltration, MMP-9, and caspase 3 were significantly increased in the lungs of Grail-deficient endotoxemic mice. Thus, these results suggest that Grail contributes to the attenuation of hyperinflammation caused by activated macrophages and prevents organ damage in endotoxemic mice. We suggest that Grail signaling could be a therapeutic target for endotoxemia.	[Shih, Chih-Chin; Chen, Jye-Hann; Liao, Mei-Hui; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Liu, Pei-Yao; Chen, Ying-Chuan] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Hsieh, Chih-Ming] Taichung Armed Force Gen Hosp, Div Thorac Surg, Dept Surg, Taichung, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Lin, Hui-Tsu; Chen, Ying-Chuan] Natl Def Med Ctr, Inst Prevent Med, New Taipei, Taiwan; [Wu, Ti-Hui] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chen, YC (corresponding author), Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan.; Chen, YC (corresponding author), Natl Def Med Ctr, Inst Prevent Med, New Taipei, Taiwan.	addy0918@gmail.com		Wu, TiHui/0000-0002-2627-040X	Ministry of National Defense Medical Affairs Bureau, R.O.C., Taiwan [MAB-106-030, MAB-107-091]; Ministry of Science and Technology, R.O.C., Taiwan [MOST 106-2320-B-016-011, MOST 106-2320-B-016-008]; Taichung Armed Force General Hospital of the Republic of China [107B02]	Ministry of National Defense Medical Affairs Bureau, R.O.C., Taiwan; Ministry of Science and Technology, R.O.C., Taiwan; Taichung Armed Force General Hospital of the Republic of China	This study was supported by grants MAB-106-030 to CCS and MAB-107-091 to YCC from Ministry of National Defense Medical Affairs Bureau, R.O.C., Taiwan, and MOST 106-2320-B-016-011 to YCC and MOST 106-2320-B-016-008 to CCS from the Ministry of Science and Technology, R.O.C., Taiwan, and the Taichung Armed Force General Hospital of the Republic of China (107B02) to CMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Araujo CV, 2016, SHOCK, V45, P393, DOI 10.1097/SHK.0000000000000520; Aziz M, 2014, J IMMUNOL, V192, P2305, DOI 10.4049/jimmunol.1302160; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Billack B, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj7005102; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Chen YC, 2013, CELL DEATH DIFFER, V20, P732, DOI 10.1038/cdd.2013.1; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 2000, J IMMUNOL, V164, P3675, DOI 10.4049/jimmunol.164.7.3675; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Liu PY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0596-8; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Ranjan R, 2014, J INNATE IMMUN, V6, P754, DOI 10.1159/000362647; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang D, 2017, BIOCHEM BIOPH RES CO, V486, P726, DOI 10.1016/j.bbrc.2017.03.106	28	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208279	10.1371/journal.pone.0208279	http://dx.doi.org/10.1371/journal.pone.0208279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571701	gold, Green Submitted, Green Published			2022-12-26	WOS:000453841700009
J	Kim, ST; Yoo, JR; Park, JM				Kim, Sang-Tae; Yoo, Jae-Ryong; Park, Jong Min			An investigation into internal exposure management needs for nuclear medicine practitioners and temporary visitors through I-131 internal dose assessment: Focusing on large hospitals in South Korea	PLOS ONE			English	Article								Purpose To investigate the internal exposure of nuclear medicine practitioners in South Korea. Methods This study selected nuclear medicine practitioners among domestic hospitals and quantitatively measured their degree of internal exposure to radioisotopes, and conducted a dose assessment based on the results. For the dose assessment, 35 nuclear medicine practitioners at seven large hospitals were selected as the measurement subjects, and the measurements were obtained using the thyroid count, total body count, and a urine sample analysis. The internal exposure was measured once every two weeks, and measurements were obtained three to 15 times according to the practitioners. Results As a result of measuring and analyzing the radionuclides with urine samples, one or more detections above the minimum detectable activity (MDA) was identified in 52 (15%) among all 340 cases for 14 of the practitioners (43%). The committed effective doses were evaluated as have a distribution of zero to 5.4 mSv, and were mostly 1 mSv or less. There were four practitioners exceeding 1 mSv based on the whole-body measurements, whose results from a urine sample analysis and thyroid monitoring all showed exposure of 1 mSv or less. All of the practitioners participated directly in the distribution and handling of radioactive sources, and none of the nurses exceeded 1 mSv. Furthermore, it was noteworthy that, among medical assistants who do not directly handle radioisotopes and are mainly involved in the transport of contaminated patients, there was one person who exceeded the wholebody measurement standard of 1 mSv. Conclusions The committed effective dose of most nuclear medicine practitioners who participated in the survey was lower than 1 mSv. However, because the possibility of overexposure under special circumstances cannot be completely excluded, new strict radiation protection rules on the handling of open-source radioisotopes in hospitals are required for non-handling workers.	[Kim, Sang-Tae] Nucl Safety & Secur Commiss, Radiat Protect & Emergency Preparedness Bur, Nucl Emergency Div, Seoul, South Korea; [Yoo, Jae-Ryong] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Radiat Emergency Med Regulat Team, Seoul, South Korea; [Park, Jong Min] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, Jong Min] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Suwon, South Korea	Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Park, JM (corresponding author), Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Suwon, South Korea.	leodavinci@naver.com		Park, Jong Min/0000-0003-3617-3870	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1C1A1A01054192, 2017M2A2A7A02020639]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1C1A1A01054192, and No. 2017M2A2A7A02020639).r This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1C1A1A01054192, and No. 2017M2A2A7A02020639).	[Anonymous], 2017, RAD SAF REG AT; [Anonymous], 2014, 201470 NSSC; [Anonymous], 2005, IDEAS GEN GUID EST C; Baechler S, 2001, RADIAT PROT DOSIM, V144, P464; Bento J, 2012, RADIAT PROT DOSIM, V149, P438, DOI 10.1093/rpd/ncr319; Castellani CM, 2013, 201301 EURADOS; ICRP, 1997, ICRP PUBL, V27, P3; ICRP, 1995, ICRP PUBL, V26; ICRP, 2015, ICRP PUBL 1, V44	9	1	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209244	10.1371/journal.pone.0209244	http://dx.doi.org/10.1371/journal.pone.0209244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566458	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300079
J	Dachapak, S; Tomooka, N; Somta, P; Naito, K; Kaga, A; Srinives, P				Dachapak, Sujinna; Tomooka, Norihiko; Somta, Prakit; Naito, Ken; Kaga, Akito; Srinives, Peerasak			QTL analysis of domestication syndrome in zombi pea (Vigna vexillata), an underutilized legume crop	PLOS ONE			English	Article							ANGULARIS WILLD. OHWI; LINKAGE MAP; MICROSATELLITE MARKERS; SSR MARKERS; RESISTANCE; GENETICS; IMPROVEMENT; RADIATA; LINES	Zombi pea (Vigna vexillata (L.) A. Rich) is an underutilized crop belonging to the genus Vigna. Two domesticated forms of zombi pea are cultivated as crop plants; seed and tuber forms. The cultivated seed form is present in Africa, while the cultivated tuber form is present in a very limited part of Asia. Genetics of domestication have been investigated in most of cultivated Vigna crops by means of quantitative trait locus (QTL) mapping. In this study, we investigated genetics of domestication in zombi pea by QTL analysis using an F-2 population of 139 plants derived from a cross between cultivated tuber form of V. vexillata (JP235863) and wild V. vexillata (AusTRCF66514). A linkage map with 11 linkage groups (LGs) was constructed from this F-2 population using 145 SSR, 117 RAD-seq and 2 morphological markers. Many highly segregation distorted markers were found on LGs 5, 6, 7, 8, 10 and 11. Most of the distorted markers were clustered together and all the markers on LG8 were highly distorted markers. Comparing this V. vexillata linkage map with linkage maps of other four Vigna species demonstrated several genome rearrangements in V. vexillata. QTL analysis for 22 domestication-related traits was investigated by inclusive composite interval mapping in which 37 QTLs were identified for 18 traits; no QTL was detected for 4 traits. Number of QTLs detected in each trait ranged from 1 to 5 with an average of only 2.3. Five QTLs for tuber width and three QTLs for tuber weight. Interestingly, 2 QTLs each for tuber width and tuber weight detected on LG2 and LG4 were located at similar position and wild allele increased tuber width and weight. This indicated wild germplasm having small tuber have potential to increase yield of large tuber cultivated type. Large-effect QTLs (PVE > 20%) were on LG4 (pod length), LG5 (leaf size and seed thickness), and LG7 (for seed-related traits). Comparison of domestication-related QTLs of the zombi pea with those of cowpea (Vigna unguiculata), azuki bean (Vigna angularis), mungbean (Vigna radiata) and rice bean (Vigna umbellata) revealed that there was conservation of some QTLs for seed size, pod size and leaf size between zombi pea and cowpea and that QTLs associated with seed size (weight, length, width and thickness) in each species were clustered on same linkage.	[Dachapak, Sujinna; Somta, Prakit; Srinives, Peerasak] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Nakhon Pathom, Thailand; [Tomooka, Norihiko; Naito, Ken] Natl Agr & Food Res Org, Gene Bank, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Kaga, Akito] Natl Agr & Food Res Org, Inst Crop Sci, Soybean & Field Crop Appl Genom Res Unit, Tsukuba, Ibaraki, Japan	Kasetsart University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Somta, P (corresponding author), Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Nakhon Pathom, Thailand.	agrpks@ku.ac.th		Somta, Prakit/0000-0002-1002-8360; Naito, Ken/0000-0002-0273-7837	Royal Golden Jubilee PhD programme (RGJ); Thailand Research Fund (TRF); Kasetsart University	Royal Golden Jubilee PhD programme (RGJ); Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Kasetsart University	This research was financially supported by Royal Golden Jubilee PhD programme (RGJ) co-funded by the Thailand Research Fund (TRF) and Kasetsart University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by Royal Golden Jubilee PhD programme (RGJ) co-funded by the Thailand Research Fund (TRF) and Kasetsart University.	Andargie M, 2013, GENOME, V56, P289, DOI 10.1139/gen-2013-0028; Asati B.S., 2004, ENVIS B HIMAL ECOL, V12, P1; Bhattacharyya P. K., 1984, Seeds & Farms, V10, P33; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; Chankaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104990; Dachapak S, 2017, GENETICA, V145, P189, DOI 10.1007/s10709-017-9957-y; Damayanti F, 2010, CROP PASTURE SCI, V61, P785, DOI 10.1071/CP10060; Ferguson H., 1954, P FOOD SOC SUD PHILO; Funatsuki H, 2014, P NATL ACAD SCI USA, V111, P17797, DOI 10.1073/pnas.1417282111; Garba M., 1998, Proceedings of 2nd International Symposium on Tuberous Legumes, Celaya, Guanajuato, Mexico, 5-8 August 1996., P61; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; GOSAL SS, 1983, EUPHYTICA, V32, P129, DOI 10.1007/BF00036873; Gupta VP, 2002, PLANT BREEDING, V121, P182, DOI 10.1046/j.1439-0523.2002.00675.x; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Hanai LR, 2007, GENOME, V50, P266, DOI 10.1139/G07-007; Isemura T, 2007, ANN BOT-LONDON, V100, P1053, DOI 10.1093/aob/mcm155; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Karuniawan A, 2006, GENET RESOUR CROP EV, V53, P213, DOI 10.1007/s10722-005-1654-5; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kongjaimun A, 2012, ANN BOT-LONDON, V109, P1185, DOI 10.1093/aob/mcs048; Kongjaimun A, 2012, GENOME, V55, P81, DOI [10.1139/G11-078, 10.1139/g11-078]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LEMAGA B, 1990, POTATO RES, V33, P257, DOI 10.1007/BF02358455; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lo S, 2017, BIORXIV, P1; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; LUSH WM, 1981, EUPHYTICA, V30, P579, DOI 10.1007/BF00038783; Marubodee R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138942; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; National Research Council, 1979, TROP LEG RES FUT, DOI 10.17226/19836; Ogundiwin EA, 2002, PLANT BREEDING, V121, P517, DOI 10.1046/j.1439-0523.2002.00769.x; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Rak K, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0619-7; Seehalak W, 2009, MOL ECOL RESOUR, V9, P862, DOI 10.1111/j.1755-0998.2009.02655.x; Somta P, 2006, PLANT BREEDING, V125, P77, DOI 10.1111/j.1439-0523.2006.01123.x; Somta P, 2008, MOL ECOL RESOUR, V8, P1155, DOI 10.1111/j.1755-0998.2008.02219.x; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; Takahashi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147568; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Tomooka N, 2010, P 14 NIAS INT WORKSH, P11; Tomooka N, 2014, PLANT GENET RESOUR-C, V12, pS168, DOI 10.1017/S1479262114000483; Van Ooijien JW., 2006, JOIN MAP 4 0 SOFTWAR; Wang LX, 2015, J PLANT RES, V128, P653, DOI 10.1007/s10265-015-0720-0; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602	52	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0200116	10.1371/journal.pone.0200116	http://dx.doi.org/10.1371/journal.pone.0200116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562342	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100002
J	Ahmadzia, HK; Phillips, JM; James, AH; Rice, MM; Amdur, RL				Ahmadzia, Homa K.; Phillips, Jaclyn M.; James, Andra H.; Rice, Madeline M.; Amdur, Richard L.			Predicting peripartum blood transfusion in women undergoing cesarean delivery: A risk prediction model	PLOS ONE			English	Article							SEVERE POSTPARTUM HEMORRHAGE; EPIDEMIOLOGY	Objective There has been an appreciable rise in postpartum hemorrhage requiring blood transfusions in the United States. Our objective is to better define patients at greatest risk for peripartum transfusion at the time of cesarean in order to identify cases for early intervention and monitoring. Methods Our study is a secondary analysis of a retrospective cohort study. Cases of intraoperative and immediate postpartum blood transfusion among women undergoing cesarean delivery were identified. Multivariable logistic regression models were used to identify antepartum and intrapartum risk factors that were independently associated with blood transfusion. A risk calculator was then developed to predict the need for transfusion. Results Of 56,967 women, 1488 (2.6%) required any blood transfusion. The strongest risk factors for peripartum blood transfusion included anemia (odds ratio [OR] 3.7, 95% CI 3.3-4.3), abruption on presentation (OR 3.3, CI 2.6-4.1), general anesthesia (OR 5.2, CI 4.4-6.1) and abnormal placentation (OR 92.0, CI 57.4-147.6). An antepartum (model 1) and combined antepartum plus intrapartum risk model (model 2) were developed (model 1 AUC = 0.77, model 2 AUC = 0.83) and internally validated. Conclusions Among women who required cesarean delivery, we were able to identify risk factors which predispose women to peripartum blood transfusion and developed a prediction model with good discrimination.	[Ahmadzia, Homa K.; Phillips, Jaclyn M.] George Washington Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Washington, DC 20052 USA; [James, Andra H.] Duke Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC USA; [James, Andra H.] Duke Univ, Dept Med, Div Hematol, Durham, NC USA; [Rice, Madeline M.] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA; [Rice, Madeline M.] George Washington Univ, Biostat Ctr, Washington, DC USA; [Amdur, Richard L.] George Washington Univ, Dept Surg, Washington, DC USA	George Washington University; Duke University; Duke University; George Washington University; George Washington University; George Washington University	Ahmadzia, HK (corresponding author), George Washington Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Washington, DC 20052 USA.	hahmadzia@mfa.gwu.edu	Amdur, Richard L/AAE-5345-2019	Amdur, Richard/0000-0002-4900-653X; James, Andra/0000-0003-4570-6595	NIH National Center for Advancing Translational Sciences [UL1TR001876, KL2TR001877]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001876, KL2TR001877] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by Award Numbers UL1TR001876 and KL2TR001877 from the NIH National Center for Advancing Translational Sciences.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Allison P. D., 1999, LOGISTIC REGRESSION; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Callaghan WM, 2014, OBSTET GYNECOL, V123, P978, DOI 10.1097/AOG.0000000000000218; CAMANN WR, 1991, TRANSFUSION, V31, P12, DOI 10.1046/j.1537-2995.1991.31191096177.x; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; Ehrenthal DB, 2012, J WOMENS HEALTH, V21, P792, DOI 10.1089/jwh.2011.3248; Ekeroma AJ, 1997, BRIT J OBSTET GYNAEC, V104, P278, DOI 10.1111/j.1471-0528.1997.tb11454.x; Ekin A, 2015, ARCH GYNECOL OBSTET, V292, P1247, DOI 10.1007/s00404-015-3771-5; Grobman WA, 2014, OBSTET GYNECOL, V123, P804, DOI 10.1097/AOG.0000000000000173; Helman S, 2015, ARCH GYNECOL OBSTET, V292, P819, DOI 10.1007/s00404-015-3725-y; Knight M., 2010, OBSTET GYNECOL SURV, V65, P211, DOI [10.1097/01.ogx.0000371705.17102.c4, DOI 10.1097/01.OGX.0000371705.17102.C4]; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Larsen R, 2005, ACTA OBSTET GYN SCAN, V84, P448, DOI 10.1111/j.0001-6349.2005.00616.x; McLintock C, 2011, J THROMB HAEMOST, V9, P1441, DOI 10.1111/j.1538-7836.2011.04398.x; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Padmanabhan A, 2009, SEMIN PERINATOL, V33, P124, DOI 10.1053/j.semperi.2009.01.002; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Reyal F, 2004, EUR J OBSTET GYN R B, V112, P61, DOI 10.1016/j.ejogrb.2003.04.001; Ricbourg A, 2015, EUR J OBSTET GYN R B, V193, P140, DOI 10.1016/j.ejogrb.2015.07.020; Rouse DJ, 2006, OBSTET GYNECOL, V108, P891, DOI 10.1097/01.AOG.0000236547.35234.8c; Simonazzi G, 2016, ACTA OBSTET GYN SCAN, V95, P28, DOI 10.1111/aogs.12798; Spiegelman J, 2017, TRANSFUSION, V57, P2752, DOI 10.1111/trf.14274; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208417	10.1371/journal.pone.0208417	http://dx.doi.org/10.1371/journal.pone.0208417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30551126	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000019
J	Cho, JY; Kim, KH; Cho, HJ; Lee, HY; Choi, JO; Jeon, ES; Lee, SE; Kim, MS; Kim, JJ; Hwang, KK; Chae, SC; Baek, SH; Kang, SM; Choi, DJ; Yoo, BS; Ahn, Y; Park, HY; Cho, MC; Oh, BH				Cho, Jae Yeong; Kim, Kye Hun; Cho, Hyun-Jai; Lee, Hae-Young; Choi, Jin-Oh; Jeon, Eun-Seok; Lee, Sang Eun; Kim, Min-Seok; Kim, Jae-Joong; Hwang, Kyung-Kuk; Chae, Shung Chull; Baek, Sang Hong; Kang, Seok-Min; Choi, Dong-Ju; Yoo, Byung-Su; Ahn, Youngkeun; Park, Hyun-Young; Cho, Myeong-Chan; Oh, Byung-Hee			Nutritional risk index as a predictor of mortality in acutely decompensated heart failure	PLOS ONE			English	Article							BODY-MASS INDEX; VENTRICULAR DIASTOLIC FUNCTION; CARDIOVASCULAR-DISEASE; CATABOLIC/ANABOLIC IMBALANCE; EXERCISE; ALBUMIN; IMPACT; MEN	Background We investigated the role of nutritional risk index (NRI) in predicting 1-year mortality in patients with acute decompensated heart failure (ADHF). Methods Among 5,625 cohort patients enrolled in Korean Acute Heart Failure (KorAHF) Registry, a total of 5,265 patients who were possible to calculate NRI [NRI = (1.519 x serum albumin [g/dl]) + (41.7 x weight [kg]/ideal body weight [kg])] were enrolled. The patients were divided into 4 groups according to the NRI quartile; Q1 <89 (n = 1121, 69.9 +/- 14.5 years, 632 males), Q2 89-95 (n = 1234, 69.7 +/- 14.4 years, 677 males), Q3 95-100 (n = 1199, 68.8 +/- 14.0 years, 849 males), Q4>100 (n = 1711, 65.6 +/- 14.5 years, 779 males). Primary end-point was all-cause mortality at 1-year clinical follow-up. Results The 1-year mortality was significantly increased as the NRI quartile decreased, and the lowest NRI quartile was associated with the highest 1-year mortality (Q1: 27.5% vs. Q2: 20.9% vs. Q3: 12.9% vs. Q4: 8.7%, linear p <0.001). On Kaplan-Meier survival analysis, the significant inter-quartile difference was observed (p <0.001 for all). In multivariate analysis using Cox proportional hazard regression, the lowest NRI quartile was an independent predictor of 1-year mortality in patients with ADHF. Conclusions Poor nutritional status as assessed by NRI and quartile grading of NRI was associated with 1-year mortality in Korean patients with ADHF. The assessment of nutritional status by NRI may provide additional prognostic information and thus would be useful in the risk stratification of the patients with ADHF.	[Cho, Jae Yeong; Kim, Kye Hun; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea; [Cho, Hyun-Jai; Lee, Hae-Young; Oh, Byung-Hee] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Choi, Jin-Oh; Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Seoul, South Korea; [Lee, Sang Eun; Kim, Min-Seok; Kim, Jae-Joong; Cho, Myeong-Chan] Univ Ulsan, Coll Med, Seoul, South Korea; [Hwang, Kyung-Kuk] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Daegu, South Korea; [Baek, Sang Hong] Catholic Univ Korea, Seoul, South Korea; [Kang, Seok-Min] Yonsei Univ, Coll Med, Seoul, South Korea; [Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; [Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Wonju, South Korea; [Park, Hyun-Young] NIH, Osong, South Korea	Chonnam National University; Chonnam National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); University of Ulsan; Chungbuk National University; Kyungpook National University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Kim, KH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea.	christiankyehun@hanmail.net	Cho, Jae Yeong/GVT-2986-2022; choi, jo/O-5940-2014	Cho, Jae Yeong/0000-0002-9393-2821; Kim, Kye Hun/0000-0002-6885-1501; Kang, Seok-Min/0000-0001-9856-9227	Research of Korea Centers for Disease Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-E63003-01, 2013-E63003-02, 2016-ER6303-00, 2016-ER6303-01]	Research of Korea Centers for Disease Control and Prevention	The KorAHF registry was supported by Research of Korea Centers for Disease Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-E63003-01, 2013-E63003-02, 2016-ER6303-00, 2016-ER6303-01]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The KorAHF registry was supported by Research of Korea Centers for Disease Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-E63003-01, 2013-E63003-02, 2016-ER6303-00, 2016-ER6303-01].	Aggarwal A, 2013, NUTR CLIN PRACT, V28, P112, DOI 10.1177/0884533612457948; Bermejo RMA, 2017, INT J CARDIOL, V230, P108, DOI 10.1016/j.ijcard.2016.12.067; Anker SD, 1997, CIRCULATION, V96, P526; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Cui RZ, 2005, STROKE, V36, P1377, DOI 10.1161/01.STR.0000169925.57251.4e; Ekmekci A, 2016, AM J EMERG MED, V34, P2351, DOI 10.1016/j.ajem.2016.08.047; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Fang J, 2003, AM J PREV MED, V25, P283, DOI 10.1016/S0749-3797(03)00207-1; Honda Y, 2016, AM J CARDIOL, V118, P550, DOI 10.1016/j.amjcard.2016.05.045; Hong JS, 2007, ANN EPIDEMIOL, V17, P622, DOI 10.1016/j.annepidem.2007.03.004; Horiuchi Y, 2018, J CARDIOL, V71, P557, DOI 10.1016/j.jjcc.2017.11.006; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Kinugasa Y, 2017, HEART, V103, P184, DOI 10.1136/heartjnl-2016-309995; Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Narumi T, 2013, J CARDIOL, V62, P307, DOI 10.1016/j.jjcc.2013.05.007; Nieminen MS, 2005, EUR HEART J, V26, P384; Nishi I, 2017, HEART VESSELS, V32, P1337, DOI 10.1007/s00380-017-1001-8; Pai MP, 2000, ANN PHARMACOTHER, V34, P1066, DOI 10.1345/aph.19381; Park SK, 2016, CIRC J, V80, P2489, DOI 10.1253/circj.CJ-16-0625; PHILLIPS A, 1989, LANCET, V2, P1434; Rozentryt P, 2015, J CACHEXIA SARCOPENI, V6, P325, DOI 10.1002/jcsm.12026; Schulze PC, 2002, INT J CARDIOL, V85, P141, DOI 10.1016/S0167-5273(02)00243-7; Shah R, 2014, J AM COLL CARDIOL, V63, P778, DOI 10.1016/j.jacc.2013.09.072; Shirakabe A, 2018, HEART VESSELS, V33, P134, DOI 10.1007/s00380-017-1034-z; Sze S, 2018, JACC-HEART FAIL, V6, P476, DOI 10.1016/j.jchf.2018.02.018; Wang RT, 2016, CLIN CARDIOL, V39, P709, DOI 10.1002/clc.22592; Weber MA, 2013, LANCET, V381, P537, DOI 10.1016/S0140-6736(12)61343-9; Yamauti Aurea Kaoru, 2006, Arq. Bras. Cardiol., V87, P772, DOI 10.1590/S0066-782X2006001900014; Yoshihisa A, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000730	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209088	10.1371/journal.pone.0209088	http://dx.doi.org/10.1371/journal.pone.0209088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550609	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000042
J	Ding, XP; Mei, WL; Huang, SZ; Wang, H; Zhu, JH; Hu, W; Ding, ZH; Tie, WW; Peng, SQ; Dai, HF				Ding, Xupo; Mei, Wenli; Huang, Shengzhuo; Wang, Hui; Zhu, Jiahong; Hu, Wei; Ding, Zehong; Tie, Weiwei; Peng, Shiqing; Dai, Haofu			Genome survey sequencing for the characterization of genetic background of Dracaena cambodiana and its defense response during dragon's blood formation	PLOS ONE			English	Article							STEROIDAL SAPONINS; COCHINCHINENSIS; FLAVONOIDS; CINNABARI; EVOLUTION; FAMILIES; ENZYMES; DRACO; FLOW; SIZE	Dragon's blood collected from the genus Dracaena is used as a renowned traditional medicine in various cultures worldwide. However, the genetics of the genus Dracaena and the formation mechanism of dragon's blood remain poorly understood. Here, we generate the first draft genome reference assembly of an elite Chinese Dracaena species, Dracaena cambodiana, from next-generation sequencing data with 89.46x coverage. The reads were assembled into 2,640,704 contigs with an N50 length of 1.87 kb, and a 1.05 Gb assembly was finally assembled with 2,379,659 scaffolds. Furthermore, 97.75% of the 267,243 simple sequence repeats identified from these scaffolds were mononucleotide, dinucleotide, and trinucleotide repeats. Among all 53,700 predicted genes, 158 genes involved in cell wall and plant hormone synthesis and reactive oxygen species scavenging showed altered regulation during the formation of dragon's blood. This study provides a genomic characterization of D. cambodiana and improves understanding of the molecular mechanism of dragon's blood formation. This report represents the first genome-wide characterization of a Dracaena species in the Asparagaceae.	[Ding, Xupo; Mei, Wenli; Huang, Shengzhuo; Wang, Hui; Zhu, Jiahong; Hu, Wei; Ding, Zehong; Tie, Weiwei; Peng, Shiqing; Dai, Haofu] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr & Rural Affairs, Key Lab Biol & Genet Resources Trop Crops, Haikou, Hainan, Peoples R China; [Ding, Xupo; Mei, Wenli; Huang, Shengzhuo; Wang, Hui; Dai, Haofu] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Hainan Key Lab Res & Dev Nat Prod Lifolk Med, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Mei, WL; Peng, SQ; Dai, HF (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr & Rural Affairs, Key Lab Biol & Genet Resources Trop Crops, Haikou, Hainan, Peoples R China.; Mei, WL; Dai, HF (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Hainan Key Lab Res & Dev Nat Prod Lifolk Med, Haikou, Hainan, Peoples R China.	meiwenli@itbb.org.cn; pengshiqing@itbb.org.cn; daihaofu@itbb.org.cn		Ding, Xupo/0000-0001-9195-7112	Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences [1630052016002, 17CXTD-15]; National Natural Science Foundation of China [81803663]; Key Research and Development Project of Hainan Province [ZDYF2018226]; China Agriculture Research System [CARS-21]	Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Project of Hainan Province; China Agriculture Research System	This research was supported by the Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (1630052016002 and 17CXTD-15), www.catas.cn/; the National Natural Science Foundation of China (81803663), http://www.nsfc.gov.cn/; the Key Research and Development Project of Hainan Province (ZDYF2018226), www.dost.hainan.gov.cn/; and the China Agriculture Research System (CARS-21), http://www.moa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (1630052016002 and 17CXTD-15), the National Natural Science Foundation of China (81803663), the Key Research and Development Project of Hainan Province (ZDYF2018226) and the China Agriculture Research System (CARS-21). We are grateful to Biomarker Technologies Co., Ltd. (Beijing, China) and Beijing Genomics Institute (Shenzhen, China) for providing technical help.	Adelyna MAN, 2016, META GENE, V10, P67, DOI 10.1016/j.mgene.2016.10.005; Adolt R, 2004, TREES-STRUCT FUNCT, V18, P43, DOI 10.1007/s00468-003-0279-6; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Aslam J, 2013, SAUDI J BIOL SCI, V20, P63, DOI 10.1016/j.sjbs.2012.11.005; Tapondjou LA, 2008, ARCH PHARM RES, V31, P653, DOI 10.1007/s12272-001-1208-3; Bao HXGDL, 2015, PLANT CELL ENVIRON, V38, P600, DOI 10.1111/pce.12419; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Rejeb K, 2014, PLANT PHYSIOL BIOCH, V80, P278, DOI 10.1016/j.plaphy.2014.04.007; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blanco Enrique, 2007, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0403s18; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chen HQ, 2012, J ASIAN NAT PROD RES, V14, P436, DOI 10.1080/10286020.2012.668534; Chen W, 2017, MOL PLANT, V10, P899, DOI 10.1016/j.molp.2017.02.010; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cong Q, 2015, CELL REP, V10, P910, DOI 10.1016/j.celrep.2015.01.026; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding XP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00830; Du HL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15324; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fan JY, 2014, MOLECULES, V19, P10650, DOI 10.3390/molecules190710650; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Gonzalez AG, 2004, BIOCHEM SYST ECOL, V32, P179, DOI 10.1016/S0305-1978(03)00133-9; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gro&beta;kinsky D.K., 2016, PLANT PATHOGEN RESIS, P131, DOI DOI 10.1002/9781118867716.CH7; Gupta D, 2008, J ETHNOPHARMACOL, V115, P361, DOI 10.1016/j.jep.2007.10.018; Hall MR, 2017, NATURE, V544, P231, DOI 10.1038/nature22033; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Hirakawa H, 2015, DNA RES, V22, P171, DOI 10.1093/dnares/dsv002; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Khan A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1708-7; Kim NH, 2018, PLANT BIOTECHNOL J, V16, P1904, DOI 10.1111/pbi.12926; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kougan GB, 2010, J NAT PROD, V73, P1266, DOI 10.1021/np100153m; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kubituki K., 1998, FAMILIES GENERA VASC, V3, P125, DOI DOI 10.1007/S00122-011-1709-2; Kuo LY, 2017, NEW PHYTOL, V213, P1974, DOI 10.1111/nph.14291; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin BR, 2016, NEW PHYTOL, V209, P1159, DOI 10.1111/nph.13701; Lu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147530; Luo Y, 2011, PLANTA MED, V77, P2053, DOI 10.1055/s-0031-1280086; Maldonado-Bonilla LD, 2008, EUR J PLANT PATHOL, V121, P439, DOI 10.1007/s10658-007-9262-1; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mei WL, 2013, B KOREAN CHEM SOC, V34, P1791, DOI 10.5012/bkcs.2013.34.6.1791; Ming R, 2015, NAT GENET, V47, P1435, DOI 10.1038/ng.3435; Nadezhdina N, 2015, FUNCT PLANT BIOL, V42, P1092, DOI 10.1071/FP15079; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Qi JS, 2017, CURR OPIN PLANT BIOL, V38, P92, DOI 10.1016/j.pbi.2017.04.022; Schuman MC, 2016, ANNU REV ENTOMOL, V61, P373, DOI 10.1146/annurev-ento-010715-023851; Suda J, 2005, PLANT SYST EVOL, V252, P215, DOI 10.1007/s00606-004-0280-6; Sudhir Sharma, 2010, Agriculture and Biology Journal of North America, V1, P827, DOI 10.5251/abjna.2010.1.5.827.833; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Vesely P, 2012, ANN BOT-LONDON, V109, P65, DOI 10.1093/aob/mcr267; Wang XH, 2011, PLANT SCI, V180, P292, DOI 10.1016/j.plantsci.2010.09.007; Wuyun TN, 2018, MOL PLANT, V11, P429, DOI 10.1016/j.molp.2017.11.014; Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002; Xu M, 2010, J NAT PROD, V73, P1524, DOI 10.1021/np100351p; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yang JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-107; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Yuan Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03423-5; Zhang GH, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0104-3; Zhang N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00197; Zhong L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194863; Zhou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069909; Zhu JH, 2017, J PLANT RES, P1, DOI [10.1007/s10265-016-0885-1, DOI 10.1007/S10265-016-0885-1]; Zhu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38315	84	10	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209258	10.1371/journal.pone.0209258	http://dx.doi.org/10.1371/journal.pone.0209258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550595	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000053
J	Martinez-Valenzuela, M; Guzman, J; Moreno, S; Ahumada-Manuel, CL; Espin, G; Nunez, C				Martinez-Valenzuela, Marcelo; Guzman, Josefina; Moreno, Soledad; Leonel Ahumada-Manuel, Carlos; Espin, Guadalupe; Nunez, Cinthia			Expression of the sRNAs CrcZ and CrcY modulate the strength of carbon catabolite repression under diazotrophic or non-diazotrophic growing conditions in Azotobacter vinelandii	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; GLOBAL REGULATOR; DIAUXIC GROWTH; ALGINATE; ACETATE; PROTEINS; GENES; HFQ	Azotobacter vinelandii is a nitrogen-fixing bacterium of the Pseudomonadaceae family that prefers the use of organic acids rather than carbohydrates. Thus, in a mixture of acetate-glucose, glucose is consumed only after acetate is exhausted. In a previous work, we investigated the molecular basis of this carbon catabolite repression (CCR) process under diazotrophic conditions. In the presence of acetate, Crc-Hfq inhibited translation of the gluP mRNA, encoding the glucose transporter in A. vinelandii. Herein, we investigated the regulation in the expression of the small non-coding RNAs (sRNAs) crcZ and crcY, which are known to antagonize the repressing activity of Hfq-Crc. Our results indicated higher expression levels of the sRNAs crcZ and crcY under low CCR conditions (i.e. glucose), in relation to the strong one (acetate one). In addition, we also explored the process of CCR in the presence of ammonium. Our results revealed that CCR also occurs under non-diazotrophic conditions as we detected a hierarchy in the utilization of the supplied carbon sources, which was consistent with the higher expression level of the crcZ/Y sRNAs during glucose catabolism. Analysis of the promoters driving transcription of crcZ and crcY confirmed that they were RpoN-dependent but we also detected a processed form of CrcZ (CrcZ*) in the RpoN-deficient strain derived from a cbrB-crcZ co-transcript. CrcZ* was functional and sufficient to allow the assimilation of acetate.	[Martinez-Valenzuela, Marcelo; Guzman, Josefina; Moreno, Soledad; Leonel Ahumada-Manuel, Carlos; Espin, Guadalupe; Nunez, Cinthia] UNAM, Dept Microbiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Martinez-Valenzuela, Marcelo] UAEM, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos	Nunez, C (corresponding author), UNAM, Dept Microbiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico.	cinthia@ibt.unam.mx		Nunez, Cinthia/0000-0002-1807-3836	Consejo Nacional de Ciencia y Tecnologia; CONACyT	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (https://www.conacyt.gob.mx/), CONACyT (grant CB-240095) to CN. In addition, MMV was recipient of a scholarship from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank A.K. Trejo-Jaimes and M. Ramos-Millan for technical support, and R. Bahena and S. Becerra for computational support and for oligonucleotides synthesis. MMV was recipient of a scholarship from CONACyT.	Ahumada-Manuel CL, 2017, APPL MICROBIOL BIOT, V101, P1521, DOI 10.1007/s00253-016-7931-8; BARRY T, 1992, NUCLEIC ACIDS RES, V20, P4940, DOI 10.1093/nar/20.18.4940; Chowdhury-Paul S, 2018, J PROTEOMICS, V181, P47, DOI 10.1016/j.jprot.2018.03.031; Ensign SA, 2006, MOL MICROBIOL, V61, P274, DOI 10.1111/j.1365-2958.2006.05247.x; Muriel-Millan LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117184; Filiatrault MJ, 2013, RNA BIOL, V10, P245, DOI 10.4161/rna.23019; Gama-Castro S, 2001, J BACTERIOL, V183, P6169, DOI 10.1128/JB.183.21.6169-6174.2001; Garcia-Maurino SM, 2013, MOL MICROBIOL, V89, P189, DOI 10.1111/mmi.12270; Garrity G.M., 2005, BERGEYS MANUAL SYSTE, P384; GEORGE SE, 1985, J BACTERIOL, V164, P866, DOI 10.1128/JB.164.2.866-871.1985; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez-Arranz S, 2016, RNA, V22, P1902, DOI 10.1261/rna.058313.116; KENNEDY C, 1986, MOL GEN GENET, V205, P318, DOI 10.1007/BF00430445; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LARSEN B, 1971, CARBOHYD RES, V17, P287, DOI 10.1016/S0008-6215(00)82536-7; Liu YH, 2017, MOL MICROBIOL, V105, P589, DOI 10.1111/mmi.13720; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maerk M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-192; MCKENNEY D, 1986, J BACTERIOL, V165, P6, DOI 10.1128/jb.165.1.6-12.1986; Moreno R, 2015, ENVIRON MICROBIOL, V17, P105, DOI 10.1111/1462-2920.12499; Moreno R, 2012, MOL MICROBIOL, V83, P24, DOI 10.1111/j.1365-2958.2011.07912.x; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Noguez R, 2008, J MOL MICROB BIOTECH, V15, P244, DOI 10.1159/000108658; Nunez C, 2013, APPL MICROBIOL BIOT, V97, P2503, DOI 10.1007/s00253-012-4329-0; Quiroz-Rocha E, 2017, MICROBIOL-SGM, V163, P1105, DOI 10.1099/mic.0.000457; Quiroz-Rocha E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00980-5; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segura D, 2014, AZOTOBACTER CYSTS; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; Sonnleitner E, 2018, NUCLEIC ACIDS RES, V46, P1470, DOI 10.1093/nar/gkx1245; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; TAUCHERT K, 1990, J BACTERIOL, V172, P6447, DOI 10.1128/jb.172.11.6447-6451.1990; Valentini M, 2014, MICROBIOL-SGM, V160, P2243, DOI 10.1099/mic.0.078873-0; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691	39	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208975	10.1371/journal.pone.0208975	http://dx.doi.org/10.1371/journal.pone.0208975			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543677	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500055
J	Pirotte, EF; Holzhauser, S; Owens, D; Quine, S; Al-Hussaini, A; Christian, AD; Giles, PJ; Man, ST; Evans, M; Powell, NG				Pirotte, Evelyne F.; Holzhauser, Stefan; Owens, David; Quine, Stuart; Al-Hussaini, Ali; Christian, Adam D.; Giles, Peter J.; Man, Stephen T.; Evans, Mererid; Powell, Ned G.			Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus	PLOS ONE			English	Article							HPV-POSITIVE HEAD; POLY(ADP-RIBOSE) POLYMERASE; HOMOLOGOUS RECOMBINATION; CARCINOMA; SURVIVAL; DAMAGE; GAMMA-H2AX; MARKER; P16	The incidence of Human Papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is increasing rapidly in the UK. Patients with HPV-positive OPSCC generally show superior clinical responses relative to HPV-negative patients. We hypothesised that these superior responses could be associated with defective repair of DNA double strand breaks (DSB). The study aimed to determine whether defective DNA repair could be associated with sensitivity to inhibition of DNA repair using the PARP inhibitor Olaparib. Sensitivity to Olaparib, and induction and repair of DNA damage, were assessed in a panel of 8 OPSCC cell-lines, including 2 novel HPV-positive lines. Effects on cell cycle distribution and levels of PARP1 and p53 were quantified. RNA-sequencing was used to assess differences in activity of DNA repair pathways. Two HPV-positive OPSCC lines were sensitive to Olaparib at potentially therapeutic doses (0.1-0.5 mu M). Two HPV-negative lines were sensitive at an intermediate dose. Four other lines, derived from HPV-positive and HPV-negative tumours, were resistant to PARP inhibition. Only one cell-line, UPCISCC90, showed results consistent with the original hypothesis i.e. that in HPV-positive cells, treatment with Olaparib would cause accumulation of DSB, resulting in cell cycle arrest. There was no evidence that HPV-positive tumours exhibit defective repair of DSB. However, the data suggest that a subset of OPSCC may be susceptible to PARP-inhibitor based therapy.	[Pirotte, Evelyne F.; Holzhauser, Stefan; Powell, Ned G.] Cardiff Univ Sch Med, HPV Res Grp, Cardiff, S Glam, Wales; [Owens, David; Quine, Stuart; Al-Hussaini, Ali] Univ Hosp Wales, Ear Nose Throat Head & Neck Surg Dept, Cardiff, S Glam, Wales; [Owens, David; Quine, Stuart; Al-Hussaini, Ali; Christian, Adam D.] Vale Univ Hlth Board, Cardiff, S Glam, Wales; [Christian, Adam D.] Univ Hosp Wales, Dept Pathol, Cardiff, S Glam, Wales; [Giles, Peter J.] Cardiff Univ, Wales Gene Pk, Cardiff, S Glam, Wales; [Man, Stephen T.] Cardiff Univ, Div Canc & Genet, Sch Med, Cardiff, S Glam, Wales; [Evans, Mererid] Velindre Canc Ctr, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University; Cardiff University; Velindre Cancer Centre	Powell, NG (corresponding author), Cardiff Univ Sch Med, HPV Res Grp, Cardiff, S Glam, Wales.	powellng@cardiff.ac.uk	Man, Stephen/D-1391-2009	Man, Stephen/0000-0001-9103-1686	Cancer Research Wales	Cancer Research Wales	This study was supported by grant funding from Cancer Research Wales, Grant number CRW/201203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for the support provided by Cancer Research Wales. We are similarly grateful to the patients who took part in this study.	Anacker DC, 2017, VIRUS RES, V231, P41, DOI 10.1016/j.virusres.2016.11.006; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2010, DETECTION TP53 MUTAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blitzer GC, 2014, INT J RADIAT ONCOL, V88, P761, DOI 10.1016/j.ijrobp.2013.08.029; CAREY TE, 1983, OTOLARYNG HEAD NECK, V91, P482, DOI 10.1177/019459988309100503; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Evans M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-220; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hong AM, 2010, BRIT J CANCER, V103, P1510, DOI 10.1038/sj.bjc.6605944; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Masterson L, 2014, J SKIN CANCER, V2014, DOI 10.1155/2014/596459; Mirghani H, 2015, INT J CANCER, V136, P1494, DOI 10.1002/ijc.28847; Nickson CM, 2017, ONCOTARGET, V8, P29963, DOI 10.18632/oncotarget.16265; Owadally W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1598-x; Rieckmann T, 2013, RADIOTHER ONCOL, V107, P242, DOI 10.1016/j.radonc.2013.03.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schache AG, 2016, CANCER RES, V76, P6598, DOI 10.1158/0008-5472.CAN-16-0633; Smart DJ, 2011, MUTAT RES-FUND MOL M, V715, P25, DOI 10.1016/j.mrfmmm.2011.07.001; Spriggs CC, 2017, MBIO, V8, DOI 10.1128/mBio.02340-16; Stanley MA, 2002, CULTURE EPITHELIAL C, P137; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weaver AN, 2015, ONCOTARGET, V6, P26995, DOI 10.18632/oncotarget.4863; Wurster S, 2016, ONCOTARGET, V7, P9732, DOI 10.18632/oncotarget.6947; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0207934	10.1371/journal.pone.0207934	http://dx.doi.org/10.1371/journal.pone.0207934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543656	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500013
J	Rousseau, A; Rozenberg, P; Perrodeau, E; Ravaud, P				Rousseau, Anne; Rozenberg, Patrick; Perrodeau, Elodie; Ravaud, Philippe			Variation in severe postpartum hemorrhage management: A national vignette-based study	PLOS ONE			English	Article							PELVIC ARTERIAL EMBOLIZATION; OUTCOMES; PREVENTION; FERTILITY; LABOR	Objectives To assess variations in management of severe postpartum hemorrhage: 1) between obstetricians in the same situation 2) by the same obstetrician in different situations. Study design A link to a vignette-based survey was emailed to obstetricians of 215 maternity units; the questionnaire asked them to report how they would manage the PPH described in 2 previously validated case-vignettes of different scenarios of severe PPH. Vignette 1 described a typical immediate, severe PPH, and vignette 2 a less typical case of severe but gradual PPH. They were constructed in 3 successive steps and included multiple-choice questions proposing several types of clinical practice options at each step. Variations in PPH were assessed in a descriptive analysis; agreement about management and its timing between vignette 1 and vignette 2 was assessed with the Kappa coefficient. Results Analysis of complete responses from 119 (43.4%) obstetricians from 53 (24.6%) maternity units showed delayed or inadequate management in both vignettes. While 82.3% and 83.2% of obstetricians (in vignettes 1 and 2, respectively) would administer oxytocin 15 minutes after PPH diagnosis, only 52.9% and 29.4% would alert other team members. Management by obstetricians of the two vignette situations was inconsistent in terms of choice of treatment and timing of almost all treatments. Conclusion Case vignettes demonstrated inadequate management as well as variations in management between obstetricians and in different PPH situations. Protocols or procedures are necessary in all maternity units to reduce the variations in practices that may explain a part of the delay in management that leads to PPH-related maternal mortality and morbidity.	[Rousseau, Anne; Rozenberg, Patrick] Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France; [Rousseau, Anne; Perrodeau, Elodie; Ravaud, Philippe] Paris Descartes Sorbonne Paris Cite Univ, METHODS Methodes Evaluat Therapeut Malad Chron Re, INSERM U1153, Paris, France; [Rozenberg, Patrick] Versailles St Quentin Univ, Res Unit EA 7285, St Quentin En Yvelines, France; [Perrodeau, Elodie; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Rousseau, A (corresponding author), Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.; Rousseau, A (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, METHODS Methodes Evaluat Therapeut Malad Chron Re, INSERM U1153, Paris, France.	anne.rousseau@uvsq.fr	ravaud, philippe/C-1694-2009		Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris [PHRC-AOR13212]	Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris	This trial was supported by a research grant from the Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris, which also sponsored the study (PHRC-AOR13212). The study sponsor did not participate in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors had full access to all the data and had final responsibility for the decision to submit for publication.; This cross-sectional cohort study was supported by a research grant from the Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris, which also sponsored the study (PHRC-AOR13212).	[Anonymous], 2017, BJOG-INT J OBSTET GY, V124, pe106; Audureau E, 2009, BJOG-INT J OBSTET GY, V116, P1325, DOI 10.1111/j.1471-0528.2009.02238.x; Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50; Bonnet MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066882; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Doumouchtsis SK, 2014, BJOG-INT J OBSTET GY, V121, P382, DOI 10.1111/1471-0528.12546; Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93; Driessen M, 2011, OBSTET GYNECOL, V117, P21, DOI 10.1097/AOG.0b013e318202c845; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Geller SE, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.046; Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x; Kayem G, 2015, BJOG INT J OBSTET GY; Kim YJ, 2013, J VASC INTERV RADIOL, V24, P703, DOI 10.1016/j.jvir.2013.02.013; Laas E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.028; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leduc D, 2009, J OBSTET GYNAECOL CA, V31, P980, DOI 10.1016/S1701-2163(16)34329-8; Lee HY, 2012, RADIOLOGY, V264, P903, DOI 10.1148/radiol.12111383; Morau E, 2017, GYNECOL OBSTET FERTI; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128; Poujade O, 2011, BJOG-INT J OBSTET GY, V118, P433, DOI 10.1111/j.1471-0528.2010.02817.x; Revert M, 2017, BJOG-INT J OBSTET GY, V124, P1255, DOI 10.1111/1471-0528.14382; Rousseau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152863; Rousseau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138663; Saucedo M, 2013, OBSTET GYNECOL, V122, P752, DOI 10.1097/AOG.0b013e31829fc38c; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sentilhes L, 2008, HUM REPROD, V23, P1087, DOI 10.1093/humrep/den049; Sentilhes L, 2016, EUR J OBSTET GYN R B, V198, P12, DOI 10.1016/j.ejogrb.2015.12.012; Sentilhes L, 2009, OBSTET GYNECOL, V113, P992, DOI 10.1097/AOG.0b013e3181a114f7; Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636; Shields LE, 2017, OBSTET GYNECOL, V130, pE168; Winter C, 2007, BJOG-INT J OBSTET GY, V114, P845, DOI 10.1111/j.1471-0528.2007.01377.x; Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x; Zwart JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.003	36	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209074	10.1371/journal.pone.0209074	http://dx.doi.org/10.1371/journal.pone.0209074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543683	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500070
J	Suarez-Villota, EY; Quercia, CA; Diaz, LM; Vera-Sovier, V; Nunez, JJ				Suarez-Villota, Elkin Y.; Quercia, Camila A.; Diaz, Leila M.; Vera-Sovier, Victoria; Nunez, Jose J.			Speciation in a biodiversity hotspot: Phylogenetic relationships, species delimitation, and divergence times of Patagonian ground frogs from the Eupsophus roseus group (Alsodidae)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TREE ESTIMATION; COMPARATIVE PHYLOGEOGRAPHY; COALESCENT MODEL; DNA-SEQUENCES; MITOCHONDRIAL; LEPTODACTYLIDAE; INFERENCE; AMPHIBIA; RANGE	The alsodid ground frogs of the Eupsophus genus are divided into two groups, the roseus (2n = 30) and vertebralis (2n = 28), which are distributed throughout the temperate Nothofagus forests of South America. Currently, the roseus group is composed by four species, while the vertebralis group consists of two. Phylogenetic relationships and species delimitation within each group are controversial. In fact, previous analyses considered that the roseus group was composed of between four to nine species. In this work, we evaluated phylogenetic relationships, diversification times, and species delimitation within the roseus group using a multi-locus dataset. For this purpose, mitochondrial (D-loop, Cyt b, and COI) and nuclear (POMC and CRYBA1) partial sequences from 164 individuals were amplified, representing all species. Maximum Likelihood (ML) and Bayesian approaches were used to reconstruct phylogenetic relationships. Species tree was estimated using BEAST and singular value decomposition scores for species quartets (SVDquartets). Species limits were evaluated with six coalescent approaches. Diversification times were estimated using mitochondrial and nuclear rates with LogNormal relaxed clock in BEAST. Nine well-supported monophyletic lineages were recovered in Bayesian, ML, and SVDquartets, including eight named species and a lineage composed by specimens from the Villarrica population (Boot-strap:>70, PP:>0.99). Single-locus species delimitation analyses overestimated the species number in E. migueli, E. calcaratus, and E. roseus lineages, while multi-locus analyses recovered as species the nine lineages observed in phylogenetic analyses (Ctax = 0.69). It is hypothesized that Eupsophus diversification occurred during Mid-Pleistocene (0.42-0.14 Mya), with most species having originated after the Last Southern Patagonian Glaciation (0.18 Mya). Our results revitalize the hypothesis that the E. roseus group is composed of eight species and support the Villarrica lineage as a new putative species.	[Suarez-Villota, Elkin Y.; Quercia, Camila A.; Diaz, Leila M.; Vera-Sovier, Victoria; Nunez, Jose J.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Nunez, JJ (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	jjnunezn@gmail.com	Nunez, Jose J./J-2931-2017	Nunez, Jose J./0000-0001-9868-4807	Fondecyt [3160328]; DID-UACh 2014-16	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID-UACh 2014-16	This research was supported by Fondecyt 3160328 to E.Y.S.V. and by DID-UACh 2014-16 to J.J.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Engr. Nicolas Gonzalez for his field assistance. We appreciate the comments made by Dr. Rudolf von May, an anonymous reviewer, and the editor that significantly improved the manuscript. Fondecyt 3160328 to EYS-V and DID-UACh 2014-16 to JJN supported this research.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Astorga G, 2011, GEOL ACTA, V9, P45, DOI 10.1344/105.000001649; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Blotto BL, 2013, CLADISTICS, V29, P113; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Broquet T, 2007, CONSERV GENET, V8, P509, DOI 10.1007/s10592-006-9180-3; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chifman J, 2015, J THEOR BIOL, V374, P35, DOI 10.1016/j.jtbi.2015.03.006; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Correa C, 2006, REV CHIL HIST NAT, V79, P435, DOI 10.4067/S0716-078X2006000400003; Correa C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181026; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEGNAN SM, 1992, AUK, V109, P800, DOI 10.2307/4088154; Dellicour S, 2015, SYST BIOL, V4, P1; Dolman G, 2004, MOL ECOL NOTES, V4, P185, DOI 10.1111/j.1471-8286.2004.00609.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2765; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flot JF, 2015, SYST BIOL, V64, P897, DOI 10.1093/sysbio/syv071; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Formas JR, 2008, REV CHIL HIST NAT, V81, P3; FORMAS JR, 1992, COMP BIOCHEM PHYS B, V102, P57; FORMAS JR, 1978, STUD NEOTROP FAUNA E, V13, P1, DOI 10.1080/01650527809360528; Frost D. R., 2018, AMPHIBIAN SPECIES WO; Fujisawa T, 2016, SYST BIOL, V65, P759, DOI 10.1093/sysbio/syw028; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gallardo MH, 2013, BIOL J LINN SOC, V108, P453, DOI 10.1111/j.1095-8312.2012.02016.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Gratton P, 2016, SYST BIOL, V65, P292, DOI 10.1093/sysbio/syv087; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Hart MW, 2011, EVOLUTION, V65, P613, DOI 10.1111/j.1558-5646.2010.01202.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Ibarra-Vidal H., 2004, B SOC BIOL CONCEPCIO, V75, P91; Irisarri I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-626; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Latorre C., 2007, GEOLOGY CHILE, DOI [10.1144/GOCH.12, DOI 10.1144/GOCH.12]; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Luo A, 2018, SYST BIOL, V67, P830, DOI 10.1093/sysbio/syy011; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; Melnick D, 2003, 10 C GEOL CHIL U CON; MERCER JH, 1972, SCIENCE, V176, P1118, DOI 10.1126/science.176.4039.1118; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Nunez JJ, 1999, STUD NEOTROP FAUNA E, V34, P150, DOI 10.1076/snfe.34.3.150.8909; Nunez JJ, 2003, THESIS U AUSTR CHILE; Nunez JJ, 2012, ZOOTAXA, P53, DOI 10.11646/zootaxa.3305.1.3; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; ORTIZ JC, 1989, P BIOL SOC WASH, V102, P1031; Ortiz Juan C., 1992, Acta Zoologica Lilloana, V41, P75; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rannala B, 2003, GENETICS, V164, P1645; Reaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104008; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stamos DN, 2003, LEXINGT BOOKS; Suarez-Villota Elkin Y, 2018, J Genomics, V6, P98, DOI 10.7150/jgen.26122; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tavera Jerez J., 1958, Publicaciones Instituto de Geologia Universidad de Chile, V12, P157; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tulloch AIT, 2018, NAT ECOL EVOL, V2, P1209, DOI 10.1038/s41559-018-0608-1; Veloso A, 2005, HERPETOL J, V15, P159; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Xu B, 2016, GENETICS, V204, P1353, DOI 10.1534/genetics.116.190173; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yu GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16309-1	98	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0204968	10.1371/journal.pone.0204968	http://dx.doi.org/10.1371/journal.pone.0204968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543633	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500004
J	Peris, E; Micallef, P; Paul, A; Palsdottir, V; Enejder, A; Bauza-Thorbrugge, M; Olofsson, CS; Asterholm, IW				Peris, Eduard; Micallef, Peter; Paul, Alexandra; Palsdottir, Vilborg; Enejder, Annika; Bauza-Thorbruegge, Marco; Olofsson, Charlotta S.; Asterholm, Ingrid Wernstedt			Antioxidant treatment induces reductive stress associated with mitochondrial dysfunction in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reactive oxygen species (ROS); adipose tissue; adrenergic receptor; antioxidant; vitamin E; mitochondria; oxidative stress; adipocyte; metabolism; browning; glutathione; N-acetylcysteine	INCREASED OXIDATIVE STRESS; GLUTATHIONE; ROS; DIFFERENTIATION; EXPRESSION; NRF2; CELL	beta-Adrenergic stimulation of adipose tissue increases mitochondrial density and activity (browning) that are associated with improved whole-body metabolism. Whereas chronically elevated levels of reactive oxygen species (ROS) in adipose tissue contribute to insulin resistance, transient ROS elevation stimulates physiological processes such as adipogenesis. Here, using a combination of biochemical and cell and molecular biology-based approaches, we studied whether ROS or antioxidant treatment affects beta 3-adrenergic receptor (beta 3-AR) stimulation-induced adipose tissue browning. We found that beta 3-AR stimulation increases ROS levels in cultured adipocytes, but, unexpectedly, pretreatment with different antioxidants (N-acetylcysteine, vitamin E, or GSH ethyl ester) did not prevent this ROS increase. Using fluorescent probes, we discovered that the antioxidant treatments instead enhanced beta 3-AR stimulation-induced mitochondrial ROS production. This pro-oxidant effect of antioxidants was, even in the absence of beta 3-AR stimulation, associated with decreased oxygen consumption and increased lactate production in adipocytes. We observed similar antioxidant effects in WT mice: N-acetylcysteine blunted beta 3-AR stimulation-induced browning of white adipose tissue and reduced mitochondrial activity in brown adipose tissue even in the absence of beta 3-AR stimulation. Furthermore, N-acetylcysteine increased the levels of peroxiredoxin 3 and superoxide dismutase 2 in adipose tissue, indicating increased mitochondrial oxidative stress. We interpret this negative impact of antioxidants on oxygen consumption in vitro and adipose tissue browning in vivo as essential adaptations that prevent a further increase in mitochondrial ROS production. In summary, these results suggest that chronic antioxidant supplementation can produce a paradoxical increase in oxidative stress associated with mitochondrial dysfunction in adipocytes.	[Peris, Eduard; Micallef, Peter; Palsdottir, Vilborg; Bauza-Thorbruegge, Marco; Olofsson, Charlotta S.; Asterholm, Ingrid Wernstedt] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Box 432, SE-40530 Gothenburg, Sweden; [Paul, Alexandra; Enejder, Annika] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Chem Biol, SE-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Asterholm, IW (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Metab Physiol, Medicinaregatan 11,POB 434, SE-40530 Gothenburg, Sweden.	IWA@neuro.gu.se	Thorbrügge, Marco Bauzá/J-5792-2019; Paul, Alexandra/L-8289-2017; Asterholm, Ingrid Wernstedt/AAK-3682-2020; Pálsdóttir, Vilborg/AAH-3259-2020	Thorbrügge, Marco Bauzá/0000-0002-2147-9386; Paul, Alexandra/0000-0002-8368-9880; Pálsdóttir, Vilborg/0000-0002-5796-6047; Olofsson, Charlotta/0000-0001-8824-3151; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Peris Franquet, Eduard/0000-0002-9237-3263	Swedish Research Council [2012-1601, 2013-7107, 2017-00792]; Novo Nordisk Foundation Excellence project; VINNOVA (Swedish Governmental Agency for Innovation Systems); Swedish Diabetes Foundation; Diabetes Wellness Research Foundation; Ake Wiberg Foundation; IngaBritt and Arne Lundberg Foundation; Magnus Bergvall Foundation; European Union [607842]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation Excellence project; VINNOVA (Swedish Governmental Agency for Innovation Systems)(Vinnova); Swedish Diabetes Foundation; Diabetes Wellness Research Foundation; Ake Wiberg Foundation; IngaBritt and Arne Lundberg Foundation; Magnus Bergvall Foundation; European Union(European Commission)	This work was supported by Swedish Research Council Grants 2012-1601, 2013-7107, and 2017-00792; a Novo Nordisk Foundation Excellence project grant; VINNOVA (Swedish Governmental Agency for Innovation Systems); the Swedish Diabetes Foundation; the Diabetes Wellness Research Foundation; the Ake Wiberg Foundation; the IngaBritt and Arne Lundberg Foundation; the Magnus Bergvall Foundation; and the European Union's Seventh Framework Programme (FP7/2007-2013, Grant 607842). The authors declare that they have no conflicts of interest with the contents of this article.	Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brannmark C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113620; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Enejder A, 2010, IEEE J SEL TOP QUANT, V16, P506, DOI 10.1109/JSTQE.2009.2032512; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; Korge P, 2015, BBA-BIOENERGETICS, V1847, P514, DOI 10.1016/j.bbabio.2015.02.012; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maity S, 2016, CELL REP, V16, P851, DOI 10.1016/j.celrep.2016.06.025; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Oparka M, 2016, METHODS, V109, P3, DOI 10.1016/j.ymeth.2016.06.008; Polster BM, 2014, METHOD ENZYMOL, V547, P225, DOI 10.1016/B978-0-12-801415-8.00013-8; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Singh F, 2015, BBA-MOL CELL RES, V1853, P1574, DOI 10.1016/j.bbamcr.2015.03.006; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	33	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2340	2352		10.1074/jbc.RA118.004253	http://dx.doi.org/10.1074/jbc.RA118.004253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559295	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000458895400012
J	Gu, Y; Feng, C; Liu, T; Zhang, BW; Yang, L				Gu, Yi; Feng, Chao; Liu, Tong; Zhang, Bowei; Yang, Lan			The downregulation of IncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPT; PROTEIN EXPRESSION; MESSENGER-RNA; CARCINOMA; GROWTH	Homeobox protein Emx2 is a transcription factor that is encoded by the EMX2 gene. In this study, using data from the Cancer Genome Atlas-Thyroid Cancer (TCGA-THCA), we aimed to examine the expression profile of EMX2 and its antisense transcript EMX2OS in papillary thyroid cancer (PTC), their prognostic value and potential regulatory networks. Results showed that in the three variants of PTC, EMX2 was significantly downregulated in classical PTC, while EMX2OS were significantly downregulated in follicular and classical PTC, compared with adjacent normal tissues. Kaplan-Meier survival curves showed that EMX2 and EMX2OS expression was not related to RFS in follicular PTC. In comparison, the high EMX2 or EMX2OS group were associated with better RFS compared with their respective low expression group in classical PTC (p = 0.007 and 0.004 respectively). Correlation analysis showed that EMX2 and EMX2OS were highly co-expressed in PTC tissues (Spearman's r = 0.83). By performing stepwise regression, we found that EMX2OS was better than EMX2 in predicting RFS in classical PTC. Multivariate analysis confirmed that high EMX2OS expression was an independent indicator of favorable RFS in classical PTC (HR: 0.239, 95% CI: 0.100 = 0.569, p = 0.001), after adjustment of pathological stages and residual tumors. By performing in silico analysis, we found that the genes co-expressed with EMX2 or EMX2OS were highly overlapped. KEGG pathway analysis showed that these genes were enriched in the ECM-receptor interaction, focal adhesion, and PI3K-Akt signaling, protein digestion and absorption and proteoglycans in cancer pathways, which are closely related to cancer initiation and progression. Based on the findings, we infer that decreased EMX2OS expression might be a valuable prognostic biomarker of unfavorable RFS in classical PTC.	[Gu, Yi; Feng, Chao; Liu, Tong; Zhang, Bowei] Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Dept Vasc & Thyroid Surg, Chengdu, Sichuan, Peoples R China; [Gu, Yi; Feng, Chao; Liu, Tong; Zhang, Bowei] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Lan] Chengdu Univ Tradit Chinese Med, Dept Anat Histol & Embryol, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chengdu University of Traditional Chinese Medicine	Yang, L (corresponding author), Chengdu Univ Tradit Chinese Med, Dept Anat Histol & Embryol, Chengdu, Sichuan, Peoples R China.	lanyang72@163.com						Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P1352, DOI 10.1210/jc.2010-2708; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; de Melo TG, 2014, J ENDOCRINOL INVEST, V37, P1195, DOI 10.1007/s40618-014-0131-4; Falcone C, 2016, ONCOTARGET, V7, P41005, DOI 10.18632/oncotarget.9322; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Gong YP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197007; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045970; Li Q, 2012, P NATL ACAD SCI USA, V109, P14110, DOI 10.1073/pnas.1116597109; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Okamoto J, 2011, CLIN LUNG CANCER, V12, P237, DOI 10.1016/j.cllc.2011.03.025; Qiu HF, 2013, INT J GYNECOL PATHOL, V32, P193, DOI 10.1097/PGP.0b013e31825d8049; Shibata S, 2008, EPIGENETICS-US, V3, P246, DOI 10.4161/epi.3.5.6990; Spigoni G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008658; STEWART DJ, 2014, JNCI-J NATL CANCER I, V106, P1, DOI DOI 10.1093/JNCI/DJT356; Tole S, 2000, J NEUROSCI, V20, P2618; Toniato A, 2008, ANN SURG ONCOL, V15, P1518, DOI 10.1245/s10434-008-9859-4; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wichmann H, 2014, STRAHLENTHER ONKOL, V190, P912, DOI 10.1007/s00066-014-0655-8; Xu CS, 2014, BREAST CANCER-TOKYO, V21, P482, DOI 10.1007/s12282-012-0403-9; Xu YC, 2015, ONCOL REP, V34, P1883, DOI 10.3892/or.2015.4183; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yu XM, 2013, THYROID, V23, P1263, DOI 10.1089/thy.2012.0453; Yue DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132134; Zhao T, 2006, EUR J NEUROSCI, V23, P2895, DOI 10.1111/j.1460-9568.2006.04819.x	29	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209338	10.1371/journal.pone.0209338	http://dx.doi.org/10.1371/journal.pone.0209338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576338	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400042
J	Le-Ha, C; Beilin, LJ; Burrows, S; Huang, RC; Hickey, M; Mori, TA; Hart, RJ				Le-Ha, Chi; Beilin, Lawrence J.; Burrows, Sally; Huang, Rae-Chi; Hickey, Martha; Mori, Trevor A.; Hart, Roger J.			Age at menarche and childhood body mass index as predictors of cardio-metabolic risk in young adulthood: A prospective cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; WOMEN; CHILDREN; HEART; ASSOCIATION; PREVENTION; STATEMENT; GROWTH; BIRTH	Objective This study aimed to examine the association between age at menarche and a range of cardiovascular disease (CVD) risk factors at 17 and 20 years of age, and whether this was influenced by childhood body mass index (BMI). Methods Of the 1413 girls born in the Western Australian Pregnancy Cohort (Raine) Study, 846 had age at menarche recorded. Subsequently 557 underwent metabolic assessment at 17 years and 541 at 20 years. Associations between age at menarche and cardiovascular risk factors, and being in a high-risk metabolic cluster at 17 and 20 years, or having the metabolic syndrome at 20 years, were investigated by linear mixed effects and logistic regressions, respectively. Results Each year later of onset of menarche was associated with a 0.75 kg/m(2) reduction in BMI (coefficient -0.75 [95%CI -1.06, -0.44]), and an approximate 30% reduction in the odds of being in the high-risk metabolic cluster at 17 years (OR = 0.73 [95%CI 0.57, 0.94]) and 20 years of age (OR = 0.68 [95%CI 0.52, 0.87]), and a 40% reduction in the odds of having the metabolic syndrome at 20 years (OR = 0.60 [95%CI 0.41, 0.88]). These data show earlier age at menarche was associated with increased BMI and odds of being in the high-risk metabolic cluster at 17 and 20 years, and increased odds of having the metabolic syndrome at 20 years. However, these associations were no longer statistically significant after adjustment for BMI at age 8 years. Current smoking, alcohol consumption, physical activity, socioeconomic status, or hormonal contraceptives use did not affect these associations. Conclusions Earlier age at menarche may be indicative of a higher risk profile for CVD in young adulthood. Our findings suggest that targeted interventions to reduce BMI in girls who experience menarche at younger age may reduce CVD risk in the future.	[Le-Ha, Chi; Beilin, Lawrence J.; Burrows, Sally; Mori, Trevor A.] Univ Western Australia, Royal Perth Hosp Unit, Med Sch, Perth, WA, Australia; [Huang, Rae-Chi] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Hickey, Martha] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Hart, Roger J.] Univ Western Australia, King Edward Mem Hosp, Div Obstet & Gynaecol, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Melbourne; King Edward Memorial Hospital; University of Western Australia	Le-Ha, C (corresponding author), Univ Western Australia, Royal Perth Hosp Unit, Med Sch, Perth, WA, Australia.	chi.le-ha@uwa.edu.au	Mori, Trevor/H-5485-2014	Mori, Trevor/0000-0002-5264-9229; Le-Ha, Chi/0000-0003-2459-6673	University of Western Australia (UWA); Telethon Kids Institute; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Science; Women and Infants Research Foundation; Murdoch University; University of Notre Dame Australia; NHMRC [403981, 1053384, 1042255, APP1058935]; Curtin University; Edith Cowan University; National Health and Medical Research Council of Australia	University of Western Australia (UWA); Telethon Kids Institute; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Science; Women and Infants Research Foundation; Murdoch University; University of Notre Dame Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Curtin University; Edith Cowan University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Core funding of the Raine Study is contributed by the University of Western Australia (UWA), the Telethon Kids Institute, the Raine Medical Research Foundation, the UWA Faculty of Medicine, Dentistry and Health Science, the Women and Infants Research Foundation, Curtin University, Edith Cowan University, Murdoch University, and the University of Notre Dame Australia. The Raine Study has long-term support from the National Health and Medical Research Council of Australia. The data collection of the 17 year follow-up of the Raine Study was funded by an NHMRC grant (Beilin et al, ID 403981). Rae-Chi Huang and Trevor A Mori are supported by NHMRC fellowships 1053384 and 1042255, respectively. Martha Hickey is supported by NHMRC Practitioner Fellowship APP1058935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Canoy D, 2015, CIRCULATION, V131, P237, DOI 10.1161/CIRCULATIONAHA.114.010070; Celermajer DS, 2006, HEART, V92, P1701, DOI 10.1136/hrt.2005.081760; Daniels SR, 2011, CIRCULATION, V124, P1673, DOI 10.1161/CIRCULATIONAHA.110.016170; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; Dreyfus J, 2015, J PEDIATR-US, V167, P344, DOI 10.1016/j.jpeds.2015.04.032; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Freedman DS, 2003, RELATION MENARCHEAL, V3, P1; German A, 2015, PEDIATR RES, V78, P445, DOI 10.1038/pr.2015.129; Hannon TS, 2006, PEDIATR RES, V60, P759, DOI 10.1203/01.pdr.0000246097.73031.27; Huang RC, 2007, INT J OBESITY, V31, P236, DOI 10.1038/sj.ijo.0803394; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Li WX, 2017, INT J ADV ROBOT SYST, V14, DOI 10.1177/1729881417704544; McKnight CM, 2012, MED J AUSTRALIA, V197, P608, DOI 10.5694/mja12.10698; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Ryu S, 2018, CIRC J, V82, P708, DOI 10.1253/circj.CJ-17-0231; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Steinberger J, 2016, CIRCULATION, V134, pE236, DOI 10.1161/CIR.0000000000000441; Stockl D, 2012, DIABETOLOGIA, V55, P681, DOI 10.1007/s00125-011-2410-3; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Straker L, 2017, INT J EPIDEMIOL, V46, P1384, DOI 10.1093/ije/dyw308; Whitehouse AJO, 2011, J AUTISM DEV DISORD, V41, P1125, DOI 10.1007/s10803-010-1129-1; Yang L, 2017, INT J CARDIOL, V227, P497, DOI 10.1016/j.ijcard.2016.10.115; Zarow R, 2008, AM J HUM BIOL, V20, P146, DOI 10.1002/ajhb.20701	31	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209355	10.1371/journal.pone.0209355	http://dx.doi.org/10.1371/journal.pone.0209355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576345	Green Published, gold			2022-12-26	WOS:000454149400045
J	Elewa, YHA; Mizoguchi, T; Ichii, O; Nakamura, T; Kon, Y				Elewa, Yaser Hosny Ali; Mizoguchi, Tatsuya; Ichii, Osamu; Nakamura, Teppei; Kon, Yasuhiro			Morphofunctional analysis of antigen uptake mechanisms following sublingual immunotherapy with beads in mice	PLOS ONE			English	Article							ALLERGIC RHINITIS; DENDRITIC CELLS; SALIVARY-GLANDS; EFFICACY; SAFETY; TABLET	Background Recently, sublingual immunotherapy (SLIT) has been used as a safe and efficient method for the treatment of and immunization against asthma and various allergies. However, the routes of antigen/allergen (particulate antigen) uptake through the mucosa of the oral cavity remain incompletely understood, as do the roles of sex and age in the process. For this purpose, to elucidate the mechanism and efficacy of SLIT among different sexes and ages, microbeads were dripped into the sublingual region to mimic particulate antigen uptake by the sublingual mucosa. Methods Twenty microliters of either phosphate buffered saline (PBS) or fluorescently labelled microbeads (latex and silica beads) were placed under the tongue of both male and female C57BL/6 mice at young (3 months) and old (6 months) ages. The lower jaw was examined 30 min after administration, and beads were detected with a fluorescence stereomicro-scope. Morphological observations of the mucosa of the fluorescent areas were made with a scanning electron microscope (SEM) and an all-in-one light fluorescence microscope (LM). Fluorescence intensity was compared between both sexes and ages. Results Stereomicroscopic observation revealed fluorescent illuminations in three compartments of the sublingual mucosa: the sublingual caruncles (SC), the oral rostral mucosa (OR) and the buccal mucosa (BM). Interestingly, the fluorescence intensity tended to be higher among females than among males in the SC region in particular. However, there were no significant age-related differences. SEM and LM revealed beads in the lumina of both mandibular ducts and sublingual ducts (Sd). Additionally, the apical cytoplasm of some Sd cells contained silica beads. However, there was no specification in the OR mucosa or BM. Conclusions This study reveals the major role Sd plays in local immunity via the antigen uptake mechanisms. Furthermore, our data suggest that the efficacy of SLIT in humans could be affected by sex.	[Elewa, Yaser Hosny Ali] Zagazig Univ, Dept Histol & Cytol, Fac Vet Med, Zagazig, Egypt; [Elewa, Yaser Hosny Ali; Mizoguchi, Tatsuya; Ichii, Osamu; Nakamura, Teppei; Kon, Yasuhiro] Hokkaido Univ, Lab Anat, Fac Vet Med, Basic Vet Sci, Sapporo, Hokkaido, Japan; [Nakamura, Teppei] Japan Food Res Labs, Chitose Lab, Sect Biol Sci, Chitose, Japan	Egyptian Knowledge Bank (EKB); Zagazig University; Hokkaido University	Elewa, YHA (corresponding author), Zagazig Univ, Dept Histol & Cytol, Fac Vet Med, Zagazig, Egypt.; Elewa, YHA (corresponding author), Hokkaido Univ, Lab Anat, Fac Vet Med, Basic Vet Sci, Sapporo, Hokkaido, Japan.	y-elewa@vetmed.hokudai.ac.jp	Elewa, Yaser/T-7550-2019; Elewa, Yaser/ABD-8332-2020	Elewa, Yaser/0000-0002-7347-4587; NAKAMURA, Teppei/0000-0003-3204-0245	JSPS KAKENHI [17K15388]; Hokkaido University Tenure Track Program	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hokkaido University Tenure Track Program	This work was supported in part by funding from JSPS KAKENHI Grant Numbers 17K15388 and by the Hokkaido University Tenure Track Program.	Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; Brook I, 2009, ORAL MAXIL SURG CLIN, V21, P269, DOI 10.1016/j.coms.2009.05.001; Ciprandi G, 1999, ALLERGY, V54, P358, DOI 10.1034/j.1398-9995.1999.00920.x; Dahl R, 2008, J ALLERGY CLIN IMMUN, V121, P512, DOI 10.1016/j.jaci.2007.10.039; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; DeBoer DJ, 2016, VET DERMATOL, V27, P82, DOI 10.1111/vde.12284; Didier A, 2007, J ALLERGY CLIN IMMUN, V120, P1338, DOI 10.1016/j.jaci.2007.07.046; Diesel Alison, 2017, Vet Sci, V4, DOI 10.3390/vetsci4020025; GREENBERGER PA, 1992, IMMUNOL ALLERGY CLIN, V12, P1; Hase Koji, 2006, Nihon Rinsho Meneki Gakkai Kaishi, V29, P16; Hovav AH, 2014, MUCOSAL IMMUNOL, V7, P27, DOI 10.1038/mi.2013.42; Jay DC, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0473-1; Kimura S, 2018, ANAT SCI INT, V93, P23, DOI 10.1007/s12565-017-0418-6; Marsella R, 2010, VET DERMATOL, V21, P566, DOI 10.1111/j.1365-3164.2010.00890.x; Mascarell L, 2015, ALLERGY, V70, P408, DOI 10.1111/all.12576; Mascarell L, 2008, J ALLERGY CLIN IMMUN, V122, P603, DOI 10.1016/j.jaci.2008.06.034; Mascarell L, 2006, IMMUNOL ALLERGY CLIN, V26, P283, DOI 10.1016/j.iac.2006.02.009; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Nagler RM, 2004, BIOGERONTOLOGY, V5, P223, DOI 10.1023/B:BGEN.0000038023.36727.50; Nodtvedt A, 2006, VET REC, V159, P241, DOI 10.1136/vr.159.8.241; Ott H, 2009, ALLERGY, V64, P1394, DOI [10.1111/j.1398-9995.2008.01875.x, 10.1111/j.1398-9995.2009.02194.x]; Pajno Giovanni B, 2003, Paediatr Drugs, V5, P777, DOI 10.2165/00148581-200305110-00006; Passalacqua G, 2004, ANN ALLERG ASTHMA IM, V93, P3, DOI 10.1016/S1081-1206(10)61440-8; Penagos M, 2006, ANN ALLERG ASTHMA IM, V97, P141, DOI 10.1016/S1081-1206(10)60004-X; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Sakurai Y, 1998, PREV MED, V27, P617, DOI 10.1006/pmed.1998.0336; Thirion-Delalande C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183398; TOWNLEY RG, 1987, ANN ALLERGY, V58, P1; VINING RF, 1983, CLIN CHEM, V29, P1752; WILSON DR, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002893, 10.1002/14651858]; Zhang CY, 2014, VACCINE, V32, P5669, DOI 10.1016/j.vaccine.2014.08.013; Zhong C, 2018, IRISH J MED SCI, V187, P441, DOI 10.1007/s11845-017-1685-x; Zielen S, 2018, ALLERGY, V73, P165, DOI 10.1111/all.13213	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0201330	10.1371/journal.pone.0201330	http://dx.doi.org/10.1371/journal.pone.0201330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571699	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700003
J	Gualerzi, A; Bellan, M; Smirne, C; Minh, MT; Rigamonti, C; Burlone, ME; Bonometti, R; Bianco, S; Re, A; Favretto, S; Bellomo, G; Minisinil, R; Schianca, GPC; Pirisi, M				Gualerzi, Alessandro; Bellan, Mattia; Smirne, Carlo; Minh, Margherita Tran; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Bellomo, Giorgio; Minisinil, Rosalba; Schianca, Gian Piero Carnevale; Pirisi, Mario			Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; RECEPTOR SUBSTRATE-1; TYPE-2; GLUCOSE; RESISTANCE; HCV; MELLITUS; THERAPY	Background The increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infected patients is likely due to viral-induced insulin resistance (IR). Indeed, control of diabetes in these patients benefits of successful antiviral treatment; whether the same applies to subtler alterations of glucose metabolism is unknown. We aimed to fill this gap. Methods The study population included 82 HCV-RNA positive patients (48 males, median age 66 years, 73 with advanced fibrosis, 41 HCV-1b), attending the liver clinic of an academic hospital to receive direct antivirals. None was previously known to be diabetic. All underwent a standard oral glucose tolerance test (OGTT) before antiviral treatment and right after its conclusion. Results At baseline, the majority of patients had evidence of abnormal glucose metabolism (N. = 45, 55%; impaired fasting glucose 10%, impaired glucose tolerance 16%, both the above 12%, 17% diabetes), while only 37 (45%) were normally glucose tolerant (NGT). At the end of treatment, HCV-RNA quantification was below the detection threshold (HCV-RNA <12 UI/ml), for all patients enrolled. A significant decrease in glucose and insulin plasma concentrations was observed, leading to a significant reduction in Homeostasis Model Assessment (HOMA)-IR (from 3.42 [2.66-5.38] to 2.80 [1.78-3.95];p<0.001) and a corresponding increase in insulin sensitivity (ISI Belfiore from 0.49 [0.26-0.75] to 0.64 [0.42-0.91]; p<0.001), despite a significant reduction in insulin secretion (EFP Stumvoll from 1363 [9591730] to 1264 [976-1588];p = 0.027). Importantly, HOMA-IR reduction occurred also in the subgroup of NGT patients (p = 0.017). The number of NGT patients increased to 53, 65% (p = 0.013) paralleled by a reduced number of those satisfying criteria for prediabetic conditions (31 (38%) vs. 17 (21%); p = 0.025). Conclusions Glucose metabolism parameters of HCV infected patients improve early after antiviral treatment, with benefits that are not limited to diabetics. These findings confirm how deep and widespread is the impairment of insulin pathways exerted by HCV infection.	[Gualerzi, Alessandro; Bellan, Mattia; Smirne, Carlo; Minh, Margherita Tran; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Minisinil, Rosalba; Pirisi, Mario] UPO, Dept Translat Med, Novara, Italy; [Gualerzi, Alessandro; Smirne, Carlo; Minh, Margherita Tran; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Schianca, Gian Piero Carnevale; Pirisi, Mario] AOU Maggiore Carita, Div Internal Med, Novara, Italy; [Bellan, Mattia] St Andrea Hosp, Div Internal Med, Vercelli, Italy; [Bellan, Mattia] IRCAD, Novara, Italy; [Bellomo, Giorgio] UPO, Dept Hlth Sci, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Bellan, M (corresponding author), UPO, Dept Translat Med, Novara, Italy.; Bellan, M (corresponding author), St Andrea Hosp, Div Internal Med, Vercelli, Italy.; Bellan, M (corresponding author), IRCAD, Novara, Italy.	bellanmattia@yahoo.it	Pirisi, Mario/ABF-2102-2020; RIGAMONTI, CRISTINA/AAE-3161-2022; Bellan, Mattia/AAL-5472-2020					Adinolfi LE, 2018, J GASTROEN HEPATOL, V33, P1379, DOI 10.1111/jgh.14067; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Chang ML, 2016, WORLD J GASTROENTERO, V22, P1461, DOI 10.3748/wjg.v22.i4.1461; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Ciancio A, 2018, J MED VIROL, V90, P320, DOI 10.1002/jmv.24954; Delgado-Borrego A, 2010, CLIN GASTROENTEROL H, V8, P458, DOI 10.1016/j.cgh.2010.01.022; Doyle MA, 2015, AM J CASE REP, V16, P745, DOI 10.12659/AJCR.895064; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Fabrizio C, 2017, CLIN MICROBIOL INFEC, V23, P342, DOI 10.1016/j.cmi.2016.09.021; Giordanino C, 2008, AM J GASTROENTEROL, V103, P2481, DOI 10.1111/j.1572-0241.2008.02002.x; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Pandya P, 2017, J INVEST MED, V65, P765, DOI 10.1136/jim-2016-000343; Pavone P, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.030; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Ruhl CE, 2014, HEPATOLOGY, V60, P1139, DOI 10.1002/hep.27047; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006	27	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209216	10.1371/journal.pone.0209216	http://dx.doi.org/10.1371/journal.pone.0209216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571711	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700044
J	Ma, TT; Zhou, W; Chen, LK; Wu, LH; Christie, P; Liu, WX				Ma, Tingting; Zhou, Wei; Chen, Like; Wu, Longhua; Christie, Peter; Liu, Wuxing			Toxicity of phthalate esters to lettuce (Lactuca sativa) and the soil microbial community under different soil conditions	PLOS ONE			English	Article							N-BUTYL PHTHALATE; ACID ESTERS; RISK-ASSESSMENT; SEED-GERMINATION; GROWTH; BIODEGRADATION; VEGETABLES; WATER; PAES; PHYTOTOXICITY	Phthalate esters (PAEs) are globally used plasticizers and typical endocrine disruptors that can readily accumulate in agricultural products and represent a substantial risk to human health via the food chain. The range of soil properties has an important influence on the expression of PAE toxicity, and the mechanisms by which soil physical and chemical properties affect the expression of toxicity of target PAEs to plants and microorganisms requires further investigation. Important soil factors affecting the eco-toxicological effects of two typical PAEs, di-n-butyl phthalate (DnBP) and bis (2-ethylhexyl) phthalate (DEHP), on lettuce (Lactuca sativa) in a spiked soil were investigated in the present study. Soil at various pH values was spiked with three PAE concentrations (1, 5 and 20 mg DnBP or DEHP kg(-1) soil), organic matter contents and water holding contents to simulate the greenhouse soil environment for 30 days. Their influence on the biomass, photosynthetic pigment contents, various physiological changes and soil microbial communities was determined as endpoints. The toxicity to lettuce of DnBP was higher than that of DEHP in the soil and soil pH was the most important factor affecting their single toxicity, followed by soil organic matter content and soil moisture content in agreement with the Biolog test results. Under different soil conditions total protein, total soluble sugar and free amino acid contents were positively correlated with concentrations of the target PAEs, but leaf area, biomass, center dot O-2(-) activity, vitamin C content and soil microbial diversity indices showed the opposite trend. Chlorophyll a and carotenoid contents were more inhibited by DnBP together with impacts on indices of soil microbial diversity. The results suggest that soil conditions in greenhouses directly explain the patterns of pollutant toxicity displayed and impact the quantity, quality and food safety of vegetables produced using highly intensive production systems.	[Ma, Tingting] Minist Agr, Tianjin Key Lab Agroenvironm & Safe Prod, Key Lab Original Agroenvironm Pollut Prevent & Co, Tianjin, Peoples R China; [Ma, Tingting] Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China; [Ma, Tingting; Wu, Longhua; Christie, Peter; Liu, Wuxing] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei] Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Peoples R China; [Chen, Like] Shanghai Res Inst Chem Ind, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Hubei University of Arts & Science; Chinese Academy of Sciences; Institute of Soil Science, CAS; Hubei University of Arts & Science	Zhou, W (corresponding author), Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Peoples R China.	zhouwei0720@126.com	Christie, Peter/B-7919-2008	Christie, Peter/0000-0002-1939-7277	Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture/Tianjin Key Laboratory of Agro-environment and Safe-product [18nybcdhj-2]; National Natural Science Foundation of China [41877127, 41401581]; Natural Science Fund of Hubei Province [2018CFC873, 2017CFC878]; Key Laboratory of Soil Environment and Pollution Remediation, the Institute of Soil Science, Chinese Academy of Sciences [SEPR2017-02]; Training Fund Program for Scientific Research of Hubei University of Arts and Science [2017 KYPY002]; Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science [2020170320]; Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province	Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture/Tianjin Key Laboratory of Agro-environment and Safe-product; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hubei Province; Key Laboratory of Soil Environment and Pollution Remediation, the Institute of Soil Science, Chinese Academy of Sciences; Training Fund Program for Scientific Research of Hubei University of Arts and Science; Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science; Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province	Funded by (1) Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture/Tianjin Key Laboratory of Agro-environment and Safe-product (18nybcdhj-2), Tingting Ma; http://aepi.caas.cn/zxdt/tzgg/139151.htm.(2) the National Natural Science Foundation of China (41877127 and 41401581), Tingting Ma; https://isisn.nsfc.gov.cn/egrantweb/. (3) the Natural Science Fund of Hubei Province (2018CFC873 Tingting Ma and 2017CFC878 Wei Zhou); http://www.hbstd.gov.cn/shenbao.htm.(4) the Key Laboratory of Soil Environment and Pollution Remediation, the Institute of Soil Science, Chinese Academy of Sciences (SEPR2017-02), Tingting Ma; http://www.soilrem.ac.cn/shownews2.asp?id=760.(5) the Training Fund Program for Scientific Research of Hubei University of Arts and Science (2017 KYPY002), Wei Zhou. (6) the Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science (2020170320), Wei Zhou.; This work was funded by the Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture/Tianjin Key Laboratory of Agro-environment and Safe-products (18nybcdhj-2), the National Natural Science Foundation of China (41877127 and 41401581), the Natural Science Fund of Hubei Province (2018CFC873 and 2017CFC878), the Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province in 2018, the Key Laboratory of Soil Environment and Pollution Remediation, the Institute of Soil Science, Chinese Academy of Sciences (SEPR2017-02), the Training Fund Program for Scientific Research of Hubei University of Arts and Science (2017 KYPY002) and the Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science (2020170320).	Al-Saleh I, 2017, SCI TOTAL ENVIRON, V578, P440, DOI 10.1016/j.scitotenv.2016.10.207; [蔡全英 Cai Quanying], 2005, [生态学报, Acta Ecologica Sinica], V25, P283; Chai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095701; Chang Q, 2009, BIOINF BIOM ENG 2009, P1; Chen HL, 2013, ADV MATER RES-SWITZ, V726-731, P3653, DOI 10.4028/www.scientific.net/AMR.726-731.3653; Chen HL, 2013, B ENVIRON CONTAM TOX, V91, P217, DOI 10.1007/s00128-013-1033-4; Chen N, 2017, PEDOSPHERE, V27, P439, DOI 10.1016/S1002-0160(17)60340-0; Du QZ, 2010, FOOD ADDIT CONTAM A, V27, P1186, DOI 10.1080/19440041003793306; ELSTNER EF, 1982, ANNU REV PLANT PHYS, V33, P73, DOI 10.1146/annurev.pp.33.060182.000445; Fan YZ, 2004, INT BIODETER BIODEGR, V53, P57, DOI 10.1016/j.ibiod.2003.10.001; Feng Yan-hong, 2017, Journal of Ecology and Rural Environment, V33, P308, DOI 10.11934/j.issn.1673-4831.2017.04.003; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gao DW, 2016, SCI TOTAL ENVIRON, V541, P986, DOI 10.1016/j.scitotenv.2015.09.148; Gao HT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161253; Gao Jun, 2010, Agricultural Science & Technology - Hunan, V11, P189; [高军 Gao jun], 2008, [水土保持学报, Journal of Soil and Water Conservation], V22, P166; Gao ML, 2017, CHEMOSPHERE, V172, P418, DOI 10.1016/j.chemosphere.2017.01.034; Halliwell B, 1985, FREE RADICAL BIO MED, P75; Li KK, 2016, CHEMOSPHERE, V164, P314, DOI 10.1016/j.chemosphere.2016.08.068; Li X, 2016, ENVIRON SCI POLLUT R, V23, P1, DOI DOI 10.1007/s11356-015-5714-x; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Ling J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167914; [刘浩荣 LIU Haorong], 2007, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V16, P123; Luo L.X., 1998, ACTA SCI CIRCUMSTANT, V18, P495, DOI [10.13671/j.hjkxxb.1998.05.009, DOI 10.13671/J.HJKXXB.1998.05.009]; Ma TT, 2014, PEDOSPHERE, V24, P107, DOI 10.1016/S1002-0160(13)60085-5; Ma TT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173957; Ma TT, 2016, EUR J SOIL BIOL, V76, P53, DOI 10.1016/j.ejsobi.2016.07.004; Ma TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151128; Ma TT, 2015, FRONT ENV SCI ENG, V9, P259, DOI 10.1007/s11783-014-0652-2; Ma TT, 2013, ENVIRON SCI POLLUT R, V20, P5289, DOI 10.1007/s11356-013-1520-5; Ma TT, 2013, FRONT ENV SCI ENG, V7, P31, DOI 10.1007/s11783-012-0463-2; Mo CH, 2009, ARCH ENVIRON CON TOX, V56, P181, DOI 10.1007/s00244-008-9177-7; MOYA JL, 1993, PHOTOSYNTH RES, V36, P75, DOI 10.1007/BF00016271; Net S, 2015, ENVIRON SCI TECHNOL, V49, P4019, DOI 10.1021/es505233b; Poursafa P, 2015, J RES MED SCI, V20, P613, DOI 10.4103/1735-1995.165971; Ren H.X., 2001, ACTA AGR SIN, V27, P729; Santos HF, 2012, BRAZ J MICROBIOL, V43, P517, DOI 10.1590/S1517-83822012000200012; Shukla UC, 2002, ECOTOX ENVIRON SAFE, V51, P90, DOI 10.1006/eesa.2001.2136; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Starratt AN, 1999, CAN J PLANT PATHOL, V21, P33, DOI 10.1080/07060661.1999.10600129; Sun K, 2012, BIORESOURCE TECHNOL, V118, P120, DOI 10.1016/j.biortech.2012.05.008; Tang, 2015, PACK FOOD MAC, V33, P7; Wang J, 2015, SCI TOTAL ENVIRON, V523, P129, DOI 10.1016/j.scitotenv.2015.02.101; Wang L, 2015, ENVIRON EARTH SCI, V74, P1; [王晓娟 Wang Xiaojuan], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P1889; Wang XiaoJuan, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P1362; Wu Y, 2018, ENVIRON SCI POLLUT R, V25, P17768, DOI 10.1007/s11356-018-1938-x; Xu YingChun, 2001, Journal of Fruit Science, V18, P1; Yang F, 2013, CHEMOSPHERE, V93, P82, DOI 10.1016/j.chemosphere.2013.04.081; Yin R, 2003, CHEMOSPHERE, V50, P801, DOI 10.1016/S0045-6535(02)00222-9; [尹睿 Yin Rui], 2004, [农业环境科学学报, Journal of Agro-environment science], V23, P1; Yu LH, 2010, HEILONGJIANG AGR SCI, V1, P50; [于立红 YU Lihong], 2011, [水土保持研究, Research of Soil and Water Conservation], V18, P201; Zeng HH, 2017, ATMOS POLLUT RES, V8, P188, DOI 10.1016/j.apr.2016.08.009; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137998; Zhang ZM, 2018, SCI TOTAL ENVIRON, V619, P93, DOI 10.1016/j.scitotenv.2017.11.070; Zhang ZH, 2010, J WUHAN I CHEM TECHN, V32, P28; [郑顺安 Zheng Shunan], 2016, [农业环境科学学报, Journal of Agro-Environment Science], V35, P492	61	12	12	9	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208111	10.1371/journal.pone.0208111	http://dx.doi.org/10.1371/journal.pone.0208111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571793	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700008
J	Maharana, J; Panda, D; De, S				Maharana, Jitendra; Panda, Debashis; De, Sachinandan			Deciphering the ATP-binding mechanism(s) in NLRP-NACHT 3D models using structural bioinformatics approaches	PLOS ONE			English	Article							DANIO-RERIO NOD1; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; INFLAMMASOME; GENE; ACTIVATION; REVEALS; RECOGNITION; ASSOCIATION; DYNAMICS	Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs), the first line of defense, are the cytosolic pattern recognition receptors (PRRs) that regulate the inflammatory activity in response to invading pathogens. NLRs are the members of AAA+ ATPase superfamily that comprises of N-terminal EBD(s), a centrally positioned NOD/NACHT and varying range of LRRs towards the C-terminal end. Due to the lack of structural data, the functional aspects of NLRP-signaling mechanism, which includes pathogen recognition, nucleotide-binding, and sensor-adaptor-effector interactions, are not fully understood. In this study, we implemented structural bioinformatics approaches including protein modeling, docking, and molecular dynamics simulations to explore the structural-dynamic features of ADP-/ATP-Mg2+ binding in NLRP NACHT models. Our results indicate a similar mode of ATP-Mg2+ binding in all NLRP NACHT models and the interacting residues are found consistent with reported mutagenesis data. Accompanied by the key amino acids (proposed to be crucial for ATP-Mg2+ coordination), we further have noticed that some additional conserved residues (including 'Trp' of the PhhCW motif, and 'Phe' and 'Tyr' of the GFxxxxRxxYF motif) are potentially interacting with ATP during dynamics; which require further experimentation for legitimacy. Overall, this study will help in understanding the ADP-/ATP-Mg2+ binding mechanisms in NLRPs in a broader perspective and the proposed ATP-binding pocket will aid in designing novel inhibitors for the regulation of inflammasome activity.	[Maharana, Jitendra] Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar, Odisha, India; [Panda, Debashis] Assam Agr Univ, Dept Agr Biotechnol, Distributed Informat Ctr, Jorhat, Assam, India; [De, Sachinandan] ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal, Haryana, India	Orissa University of Agriculture & Technology; Assam Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Maharana, J (corresponding author), Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar, Odisha, India.; De, S (corresponding author), ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal, Haryana, India.	jitued@gmail.com; sachinandan@gmail.com	Maharana, Jitendra/B-5210-2014	Maharana, Jitendra/0000-0003-4628-5956; Panda, Debashis/0000-0002-7412-3615				Afanasyeva A, 2014, STRUCTURE, V22, P549, DOI 10.1016/j.str.2014.02.002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alkhateeb A, 2013, AUTOIMMUNITY, V46, P215, DOI 10.3109/08916934.2013.768617; Bentham A, 2016, ANN BOT-LONDON, V27, P698; Bhattacharjee P, 2013, MUTAT RES-GEN TOX EN, V755, P1, DOI 10.1016/j.mrgentox.2013.04.010; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bryant CE, 2015, PHARMACOL REV, V67, P462, DOI 10.1124/pr.114.009928; Buchan DW, 2003, NUCLEIC ACIDS RES, V41, pW349; Carlstrom M, 2012, EXP DERMATOL, V21, P932, DOI 10.1111/exd.12049; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Coit P, 2016, ANN RHEUM DIS, V75, P1196, DOI 10.1136/annrheumdis-2014-207116; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Docherty LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9086; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gong Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07447-9; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Huang JY, 2013, HUM REPROD, V28, P1127, DOI 10.1093/humrep/det001; Huber RG, 2015, PROTEIN SCI, V24, P174, DOI 10.1002/pro.2601; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacDonald JA, 2013, IUBMB LIFE, V65, P851, DOI 10.1002/iub.1210; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Maharana J, 2018, J MOL GRAPH MODEL, V80, P7, DOI 10.1016/j.jmgm.2017.12.016; Maharana J, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2632; Maharana J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170232; Maharana J, 2015, MOL BIOSYST, V11, P2324, DOI 10.1039/c5mb00212e; Maharana J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121415; Maharana J, 2014, MOL BIOSYST, V10, P2942, DOI 10.1039/c4mb00212a; Maharana J, 2014, J MOL RECOGNIT, V27, P260, DOI 10.1002/jmr.2357; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pellegrini E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06451-3; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Radian AD, 2015, MOL IMMUNOL, V67, P294, DOI 10.1016/j.molimm.2015.06.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Soellner L, 2017, EUR J HUM GENET, V25, P924, DOI 10.1038/ejhg.2017.94; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wang S, 2015, GENET MOL RES, V14, P17447, DOI 10.4238/2015.December.21.15; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Yu XJ, 2017, ONCOTARGET, V8, P67300, DOI 10.18632/oncotarget.18619; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhou MY, 2015, GENE DEV, V29, P2349, DOI 10.1101/gad.272278.115; Zhou Q, 2015, ARTHRITIS RHEUMATOL, V67, P2482, DOI 10.1002/art.39190; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	77	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209420	10.1371/journal.pone.0209420	http://dx.doi.org/10.1371/journal.pone.0209420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571723	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700070
J	Bashagaluke, JB; Logah, V; Opoku, A; Sarkodie-Addo, J; Quansah, C				Bashagaluke, Janvier Bigabwa; Logah, Vincent; Opoku, Andrews; Sarkodie-Addo, Joseph; Quansah, Charles			Soil nutrient loss through erosion: Impact of different cropping systems and soil amendments in Ghana	PLOS ONE			English	Article							BIOCHAR; RUNOFF; TILLAGE; GROWTH; ZONE	Soil erosion is a multifactor threat to crop production and the environment. Most studies on soil erosion characterization have not focused on soil nutrient loss associated with erosion. The aim of this study was therefore to quantify the magnitude of nutrient loss through soil erosion under different cropping systems and amendments to inform agronomic practices in sub-Saharan Africa (SSA). A field experiment was carried out on runoff plots with different cropping systems (sole maize, sole cowpea, sole maize and maize intercropped with soybean) as main plots and soil amendments (biochar, NPK (Nitrogen +Phosphorus +Potassium) fertilizer, NPK + biochar and a control (no amendment)) constituting the subplots in a randomized complete block design. For each block, a bare plot was included to assess the efficiency of the different crop and soil management practices on soil erosion. The study was carried out in three consecutive cropping seasons in the semi-deciduous forest zone of Ghana. The bare plots had the highest amounts of nitrogen (N), phosphorus (P), and potassium (K) eroded: 33.88, 12.35 and 12.75 kg ha(-1) respectively followed by the control plots with magnitude of 20.43, 8.42 and 7.87 kg ha(-1) respectively for N, P and K. Sole maize had the highest amounts of nutrient loss: 19.71, 8.12 and 7.27 for N, P and K respectively compared to all the other cropping systems where the losses varied respectively from 12.38 to 17.12, 6.67 to 7.49 and 5.81 to 6.75 kg ha(-1) The legume-based cropping systems under inorganic fertilizer and biochar management effectively reduced nutrient loss more than all other treatment combinations. The off-site effect of soil erosion expressed as enrichment ratio (ER) was higher for all plots, which received inorganic fertilizer inputs varying from 1.93 to 3.06 while the other treatments had ERs of 1.51 to 2.03. The ERs of fine soil particles were greater than 1 (ranging from 1.14 to 3.6) being relatively higher than that of coarse particles (sand) with values below 1 (ranging from 0.62 to 0.88). The least cumulative monetary value of nutrient loss (30.82 US$ ha(-1)) was observed under cowpea cropping system which received NPK + BC treatment. Soil erosion affected directly soil nutrient depletion through nutrient loss; however, integrated soil fertility management associated with legume-based cropping systems can be alternative options to reducing its effects on croplands in SSA.	[Bashagaluke, Janvier Bigabwa; Logah, Vincent; Opoku, Andrews; Sarkodie-Addo, Joseph; Quansah, Charles] KNUST, Dept Crop & Soil Sci, Kumasi, Ghana; [Bashagaluke, Janvier Bigabwa] UCB, Fac Agron, Bukavu, DEM REP CONGO; [Bashagaluke, Janvier Bigabwa] ISTD, Kalehe, DEM REP CONGO	Kwame Nkrumah University Science & Technology	Bashagaluke, JB (corresponding author), KNUST, Dept Crop & Soil Sci, Kumasi, Ghana.; Bashagaluke, JB (corresponding author), UCB, Fac Agron, Bukavu, DEM REP CONGO.; Bashagaluke, JB (corresponding author), ISTD, Kalehe, DEM REP CONGO.	bashbigabwa@gmail.com		Bashagaluke, Janvier/0000-0002-5404-053X	INTRA-ACP ACADEMIC MOBILITY project, in the department of crop and soil sciences at Kwame Nkrumah University of Science and Technology (KNUST); INTRA-ACP ACADEMIC MOBILITY project in the Department of Crop and Soil Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Ghana	INTRA-ACP ACADEMIC MOBILITY project, in the department of crop and soil sciences at Kwame Nkrumah University of Science and Technology (KNUST); INTRA-ACP ACADEMIC MOBILITY project in the Department of Crop and Soil Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Ghana	This study was part of the PhD research of the first author, supported by INTRA-ACP ACADEMIC MOBILITY project, in the department of crop and soil sciences at Kwame Nkrumah University of Science and Technology (KNUST).; This study was part of the PhD research of the first author, supported by INTRA-ACP ACADEMIC MOBILITY project in the Department of Crop and Soil Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Ghana. The authors are grateful to Mr. Ayuba Salifu and the Anwomasso Research Station team for their field assistance during the study period.	Amegashie B. K., 2014, THESIS KWAME NKRUMAH; Amegashie Bright K., 2011, Lakes & Reservoirs Research and Management, V16, P61, DOI 10.1111/j.1440-1770.2011.00459.x; Bertol I, 2017, ECOSYST SUSTAIN AGR, V2, P1; Bonsu M., 1992, P 12 13 ANN GEN M SO, P77; DELIA CF, 1986, CAN J FISH AQUAT SCI, V43, P397, DOI 10.1139/f86-050; Ebeheakey A. A., 2014, THESIS; Enters T., 1998, METHODS EC ASSESSMEN; Garcia-Diaz A, 2017, AGR ECOSYST ENVIRON, V236, P256, DOI 10.1016/j.agee.2016.12.013; Govers G, 2016, SOIL DISCUSS, V3, P45; Hardie M, 2014, PLANT SOIL, V376, P347, DOI 10.1007/s11104-013-1980-x; Jien SH, 2013, CATENA, V110, P225, DOI 10.1016/j.catena.2013.06.021; Kurothe RS, 2014, SOIL TILL RES, V140, P126, DOI 10.1016/j.still.2014.03.005; Lehmann J, 2006, BOOK SOIL P, V113, P517, DOI 10.1201/9781420017113.ch36; Li ZG, 2017, AGR WATER MANAGE, V185, P145, DOI 10.1016/j.agwat.2017.02.018; McHugh OV, 2007, SOIL TILL RES, V97, P19, DOI 10.1016/j.still.2007.08.002; Namara R., 2009, T JAPANESE SOC IRRIG, V77, P637; Nkrumah F, 2014, INT J GEOSCI, V5, P673, DOI DOI 10.4236/IJG.2014.57060; OFRA, 2012, OPT FERT REC AFR AN; Okalebo J, 1993, TROP SOIL BIOL FERTI; Pandey A, 2016, CATENA, V147, P595, DOI 10.1016/j.catena.2016.08.002; Quansah C, 2000, GHANA J AGR SCI, V33, P33; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Sahoo D. C., 2015, Journal of Environmental Biology, V36, P1039; Sidibe A, 2005, AGR WATER MANAGE, V71, P211, DOI 10.1016/j.agwat.2004.09.002; Uzoma KC, 2011, SOIL USE MANAGE, V27, P205, DOI 10.1111/j.1475-2743.2011.00340.x; Vaezi AR, 2017, SOIL TILL RES, V172, P22, DOI 10.1016/j.still.2017.05.001; World Bank, 2006, 36985GH WORLD BANK A; Zougmore R, 2003, SOIL TILL RES, V71, P143, DOI 10.1016/S0167-1987(03)00050-3	28	34	34	9	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208250	10.1371/journal.pone.0208250	http://dx.doi.org/10.1371/journal.pone.0208250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566517	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300031
J	Taylor, JA; Sommerfeld-Sager, JM; Meng, CX; Nagel, SC; Shioda, T; vom Saal, FS				Taylor, Julia A.; Sommerfeld-Sager, Jennifer M.; Meng, Chun-Xia; Nagel, Susan C.; Shioda, Toshi; vom Saal, Frederick S.			Reduced body weight at weaning followed by increased post-weaning growth rate interacts with part-per-trillion fetal serum concentrations of bisphenol A (BPA) to impair glucose tolerance in male mice	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; EARLY-CHILDHOOD; BLOOD-FLOW; EXPOSURE; OBESITY; HEALTH; MOUSE; PHARMACOKINETICS; ASSOCIATION; PERCENTILES	There is evidence from longitudinal studies that being light at birth and weaning is associated with subsequent rapid weight gain in infants. This is referred to as "centile crossing", which can lead to increased risk of lifetime obesity, glucose dysregulation and type 2 diabetes. Here, pregnant CD-1 mice were hemi-ovariectomized so that the entire litter was contained in one uterine horn to increase variability in fetal growth rate. Pregnant females were implanted on gestation day (GD) 9 with a Silastic capsule containing 6, 60 or 600 mu g bisphenol A (BPA). On GD 18 the mean fetal serum unconjugated BPA concentrations were 17, 177 and 1858 pg/ml, respectively. Capsules were not removed, to avoid maternal stress, and were predicted to release BPA for at least 3 weeks. Body weight at weaning was strongly negatively correlated with post-weaning weight gain in both control and BPA-treated male mice, consistent with human data; female offspring were excluded, avoiding complications associated with postpubertal estrogens. Within each treatment group, male offspring were sorted into tertiles based on relative weight gain during the two weeks after weaning, designated as having Rapid (R), Medium (M) or Slow (S) growth rate. BPA exposure was associated with altered growth rate between weaning and postnatal week 12 (young adulthood), when a low-dose (20 mg/kg, i.p.) glucose tolerance test (GTT) was performed. We found altered glucose regulation in response to all doses of BPA. However, glucose tolerance was only significantly impaired (blood glucose levels were elevated) compared to controls in males in the rapid post-weaning growth group exposed perinatally to BPA. We conclude that male mice that are light at weaning, but then experience rapid catch-up growth immediately after weaning, represent a sensitive sub-population that is vulnerable to the metabolic disrupting effects of very low pg/ml fetal serum concentrations of BPA.	[Taylor, Julia A.; Sommerfeld-Sager, Jennifer M.; vom Saal, Frederick S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Meng, Chun-Xia; Nagel, Susan C.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA; [Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Harvard University; Massachusetts General Hospital	Taylor, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	TaylorJA@missouri.edu		Shioda, Toshihiro/0000-0002-9434-7835; Taylor, Julia/0000-0003-1811-1844	NIEHS [ES021394]	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by a grant from to FvS and SCN (ES021394) from NIEHS (https://www.niehs.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USFaD, STAT S OSTR MD DEP C; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Angle BM, 2013, REPROD TOXICOL, V42, P256, DOI 10.1016/j.reprotox.2013.07.017; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Bansal A, 2019, J DEV ORIG HLTH DIS, V10, P164, DOI 10.1017/S2040174418000764; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Coe BL, 2008, BASIC CLIN PHARMACOL, V102, P162, DOI 10.1111/j.1742-7843.2007.00195.x; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Desai M, 2018, J DEV ORIG HLTH DIS, V9, P678, DOI 10.1017/S2040174418000600; EVEN MD, 1994, J REPROD FERTIL, V102, P245; Garcia-Arevalo M, 2016, ENDOCRINOLOGY, V157, P4158, DOI 10.1210/en.2016-1390; Garcia-Arevalo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100214; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001; Hormann AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110509; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Liu J., 2013, PLOS ONE, V8; Long XH, 2000, ENVIRON HEALTH PERSP, V108, P243, DOI 10.2307/3454441; Markey CM, 2001, ENVIRON HEALTH PERSP, V109, P55, DOI 10.2307/3434921; MCLAREN A, 1960, NATURE, V187, P363, DOI 10.1038/187363a0; Mei ZG, 2004, PEDIATRICS, V113, pE617, DOI 10.1542/peds.113.6.e617; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Patterson TA, 2013, TOXICOL APPL PHARM, V267, P41, DOI 10.1016/j.taap.2012.12.006; Pinney SE, 2017, REPROD TOXICOL, V67, P1, DOI 10.1016/j.reprotox.2016.11.007; Ruhlen RL, 2008, ENVIRON HEALTH PERSP, V116, P322, DOI 10.1289/ehp.10448; SAAL FSV, 1985, BIOL REPROD, V32, P1116, DOI 10.1095/biolreprod32.5.1116; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Stahlhut RW, 2018, J ENDOCR SOC, V2, P1173, DOI 10.1210/js.2018-00151; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Susiarjo M, 2015, ENDOCRINOLOGY, V156, P2049, DOI 10.1210/en.2014-2027; Taveras EM, 2011, ARCH PEDIAT ADOL MED, V165, P993, DOI 10.1001/archpediatrics.2011.167; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Trasande L, 2012, EXPERT REV PHARM OUT, V12, P39, DOI [10.1586/erp.11.93, 10.1586/ERP.11.93]; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; VANDENBERG LN, 2014, ENVIRON HEALTH GLOB; vom Saal FS, 2014, MOL CELL ENDOCRINOL, V398, P101, DOI 10.1016/j.mce.2014.09.028; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Warhurst M., STILL NOT PROTECTIVE; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208846	10.1371/journal.pone.0208846	http://dx.doi.org/10.1371/journal.pone.0208846			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557361	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000049
J	Mereness, JA; Bhattacharya, S; Wang, Q; Ren, Y; Pryhuber, GS; Mariani, TJ				Mereness, Jared A.; Bhattacharya, Soumyaroop; Wang, Qian; Ren, Yue; Pryhuber, Gloria S.; Mariani, Thomas J.			Type VI collagen promotes lung epithelial cell spreading and wound-closure	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE; NATURAL-HISTORY; GROWTH-FACTORS; STEM-CELLS; RHO-KINASE; INTEGRIN; ADHESION; MIGRATION; PROTEOGLYCAN	Basement membrane (BM) is an essential part of the extracellular matrix (ECM) that plays a crucial role in mechanical support and signaling to epithelial cells during lung development, homeostasis and repair. Abnormal composition and remodeling of the lung ECM have been associated with developmental abnormalities observed in multiple pediatric and adult respiratory diseases. Collagen VI (COL6) is a well-studied muscle BM component, but its role in the lung and its effect on pulmonary epithelium is largely undetermined. We report the presence of COLVI immediately subjacent to human airway and alveolar epithelium in the pediatric lung, in a location where it is likely to interact with epithelial cells. In vitro, both primary human lung epithelial cells and human lung epithelial cell lines displayed an increased rate of "wound healing" in response to a scratch injury when plated on COL6 as compared to other matrices. For the 16HBE cell line, wounds remained >5-fold larger for cells on COL1 (p<0.001) and >6-fold larger on matrigel (p<0.001), a prototypical basement membrane, when compared to COL6 (>96% closure at 10 hr). The effect of COL6 upon lung epithelial cell phenotype was associated with an increase in cell spreading. Three hours after initial plating, 16HBE cells showed >7-fold less spreading on matrigel (p<0.01), and >4-fold less spreading on COL1 (p<0.01) when compared to COL6. Importantly, the addition of COL6 to other matrices also enhanced cell spreading. Similar responses were observed for primary cells. Inhibitor studies indicated both integrin beta 1 activity and activation of multiple signaling pathways was required for enhanced spreading on all matrices, with the PI3K/AKT pathway (PI3K, CDC42, RAC1) showing both significant and specific effects for spreading on COL6. Genetic gain-of-function experiments demonstrated enhanced PI3K/AKT pathway activity was sufficient to confer equivalent cell spreading on other matrices as compared to COL6. We conclude that COL6 has significant and specific effects upon human lung epithelial cell-autonomous functions.	[Mereness, Jared A.; Bhattacharya, Soumyaroop; Wang, Qian; Ren, Yue; Pryhuber, Gloria S.; Mariani, Thomas J.] Univ Rochester, Dept Pediat, Div Neonatol, Rochester, NY 14627 USA; [Mereness, Jared A.; Bhattacharya, Soumyaroop; Wang, Qian; Ren, Yue; Pryhuber, Gloria S.; Mariani, Thomas J.] Univ Rochester, Dept Pediat, Pediat Mol & Personalized Med Program, Rochester, NY 14627 USA; [Mereness, Jared A.; Mariani, Thomas J.] Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Mariani, TJ (corresponding author), Univ Rochester, Dept Pediat, Div Neonatol, Rochester, NY 14627 USA.; Mariani, TJ (corresponding author), Univ Rochester, Dept Pediat, Pediat Mol & Personalized Med Program, Rochester, NY 14627 USA.; Mariani, TJ (corresponding author), Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA.	Tom_Mariani@urmc.rochester.edu		Bhattacharya, Soumyaroop/0000-0003-1140-7845	University of Rochester Pulmonary Training Grant [5 T32 HL 66988-14]; University of Rochester Howard Hughes Medical Institute Fellowship in Translational Cardiovascular Research; National Institutes of Health, National Heart, Lung, and Blood Institute, LungMAP Human Tissue Core [HL122700]; University of Rochester Pediatric Molecular and Personalized Medicine Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER	University of Rochester Pulmonary Training Grant; University of Rochester Howard Hughes Medical Institute Fellowship in Translational Cardiovascular Research; National Institutes of Health, National Heart, Lung, and Blood Institute, LungMAP Human Tissue Core; University of Rochester Pediatric Molecular and Personalized Medicine Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the University of Rochester Pulmonary Training Grant 5 T32 HL 66988-14 (JM), University of Rochester Howard Hughes Medical Institute Fellowship in Translational Cardiovascular Research (JM), National Institutes of Health, National Heart, Lung, and Blood Institute, LungMAP Human Tissue Core (HL122700) (GP), and the University of Rochester Pediatric Molecular and Personalized Medicine Program (TM).	Abdillahi SM, 2015, J INNATE IMMUN, V7, P506, DOI 10.1159/000381213; Asano S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13281; Balcioglu HE, 2015, J CELL SCI, V128, P1316, DOI 10.1242/jcs.156950; Bandyopadhyay G, 2018, AM J PHYSIOL-LUNG C, V315, pL576, DOI 10.1152/ajplung.00041.2018; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Braghetta P, 1996, J CELL BIOL, V135, P1163, DOI 10.1083/jcb.135.4.1163; Burgstaller G, 2018, AM J PHYSIOL-LUNG C, V314, pL708, DOI 10.1152/ajplung.00408.2017; Chetty A, 1999, EXP LUNG RES, V25, P701; Clark RAF, 2008, J INVEST DERMATOL, V128, P1354, DOI 10.1038/jid.2008.75; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Corvol H, 2009, INT J BIOCHEM CELL B, V41, P1643, DOI 10.1016/j.biocel.2009.02.009; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crawford JR, 1998, MOL BIOL CELL, V9, P3429, DOI 10.1091/mbc.9.12.3429; Dassah M, 2014, J CELL SCI, V127, P828, DOI 10.1242/jcs.137802; Desai L, 2005, RHOA RAC1 ARE BOTH R, pL1134; Desai L E, 2008, MECH STRETCH DECREAS, pL958; Desai L R, 2010, CYCLIC MECH STRETCH, P4511; DOANE KJ, 1992, EXP CELL RES, V200, P490, DOI 10.1016/0014-4827(92)90200-R; Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Fang XX, 1999, MOL BIOL CELL, V10, P3373, DOI 10.1091/mbc.10.10.3373; Fitzgerald J, 2013, CONNECT TISSUE RES, V54, P345, DOI 10.3109/03008207.2013.822865; Foley AR, 2013, BRAIN, V136, P3625, DOI 10.1093/brain/awt284; Furuyama A, 2000, J CELL SCI, V113, P859; Ghio AJ, 2013, PART FIBRE TOXICOL, V10, P8, DOI DOI 10.1186/1743-8977-10-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hamill KJ, 2011, J BIOL CHEM, V286, P26768, DOI 10.1074/jbc.M110.203646; Hamill KJ, 2010, DERMATOL CLIN, V28, P79, DOI 10.1016/j.det.2009.10.009; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hopkins AM, 2004, AM J PHYSIOL-GASTR L, V287, pG886, DOI 10.1152/ajpgi.00065.2004; IIDA J, 1995, CANCER RES, V55, P2177; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; Jiang Q, 2006, J OCUL PHARMACOL TH, V22, P93, DOI 10.1089/jop.2006.22.93; Kim HJ, 1997, AM J PHYSIOL-LUNG C, V273, pL134, DOI 10.1152/ajplung.1997.273.1.L134; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Lampe AK, 1993, GENEREVIEWS R; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Li JJ, 2013, J CELL SCI, V126, P5005, DOI 10.1242/jcs.133421; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MALCOVATI M, 1991, J CELL SCI, V99, P387; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; Moh MC, 2005, J BIOL CHEM, V280, P27366, DOI 10.1074/jbc.M500852200; Moore M, 2004, AM J RESP CELL MOL, V30, P379, DOI 10.1165/rcmb.2003-0019OC; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; Nisenholz N, 2014, SOFT MATTER, V10, P7234, DOI 10.1039/c4sm00780h; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; Ogunlesi F, 2004, BBA-MOL BASIS DIS, V1688, P112, DOI 10.1016/j.bbadis.2003.10.008; Petrou P, 2005, J BIOL CHEM, V280, P10350, DOI 10.1074/jbc.M412368200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Quondamatteo F, 2002, MATRIX BIOL, V21, P637, DOI 10.1016/S0945-053X(02)00100-2; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Randell Scott H, 2006, Proc Am Thorac Soc, V3, P718, DOI 10.1513/pats.200605-117SF; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Silva DMG, 2015, AM J PHYSIOL-LUNG C, V309, pL1239, DOI 10.1152/ajplung.00268.2015; SPECKS U, 1995, AM J RESP CRIT CARE, V151, P1956, DOI 10.1164/ajrccm.151.6.7767545; Stallcup WB, 2001, J CELL SCI, V114, P2315; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766; Tillet E, 2002, J CELL BIOCHEM, V86, P726, DOI 10.1002/jcb.10268; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Varner VD, 2014, DEVELOPMENT, V141, P2750, DOI 10.1242/dev.104794; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; White SR, 2001, AM J RESP CELL MOL, V24, P179, DOI 10.1165/ajrcmb.24.2.3993; White SR, 1999, AM J RESP CELL MOL, V20, P787, DOI 10.1165/ajrcmb.20.4.3318; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Yee M, 2014, AM J RESP CELL MOL, V50, P757, DOI 10.1165/rcmb.2013-0207OC; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	89	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209095	10.1371/journal.pone.0209095	http://dx.doi.org/10.1371/journal.pone.0209095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550606	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000044
J	Alaux, C; Soubeyrand, S; Prado, A; Peruzzi, M; Maisonnasse, A; Vallon, J; Hernandez, J; Jourdan, P; Le Conte, Y				Alaux, Cedric; Soubeyrand, Samuel; Prado, Alberto; Peruzzi, Mathilde; Maisonnasse, Alban; Vallon, Julien; Hernandez, Julie; Jourdan, Pascal; Le Conte, Yves			Measuring biological age to assess colony demographics in honeybees	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEE WORKERS; BEHAVIORAL MATURATION; CHRONOLOGICAL AGE; LIFE-SPAN; PHYSIOLOGY; INSECT; VITELLOGENIN; MECHANISMS; PLASTICITY	Honeybee colonies are increasingly exposed to environmental stress factors, which can lead to their decline or failure. However, there are major gaps in stressor risk assessment due to the difficulty of assessing the honeybee colony state and detecting abnormal events. Since stress factors usually induce a demographic disturbance in the colony (e.g. loss of foragers, early transition from nurse to forager state), we suggest that disturbances could be revealed indirectly by measuring the age- and task-related physiological state of bees, which can be referred to as biological age (an indicator of the changes in physiological state that occur throughout an individual lifespan). We therefore estimated the biological age of bees from the relationship between age and biomarkers of task specialization (vitellogenin and the adipokinetic hormone receptor). This relationship was determined from a calibrated sample set of known-age bees and mathematically modelled for biological age prediction. Then, we determined throughout the foraging season the evolution of the biological age of bees from colonies with low (conventional apiary) or high Varroa destructor infestation rates (organic apiary). We found that the biological age of bees from the conventional apiary progressively decreased from the spring (17 days) to the fall (6 days). However, in colonies from the organic apiary, the population aged from spring (13 days) to summer (18.5 days) and then rejuvenated in the fall (13 days) after Varroa treatment. Biological age was positively correlated with the amount of brood (open and closed cells) in the apiary with low Varroa pressure, and negatively correlated with Varroa infestation level in the apiary with high Varroa pressure. Altogether, these results show that the estimation of biological age is a useful and effective method for assessing colony demographic state and likely detrimental effects of stress factors.	[Alaux, Cedric; Prado, Alberto; Peruzzi, Mathilde; Le Conte, Yves] INRA, Abeilles & Environm, Avignon, France; [Alaux, Cedric; Maisonnasse, Alban; Vallon, Julien; Hernandez, Julie; Jourdan, Pascal; Le Conte, Yves] UMT PrADE, Avignon, France; [Soubeyrand, Samuel] INRA, BioSP, Avignon, France; [Maisonnasse, Alban; Hernandez, Julie; Jourdan, Pascal] ADAPI, Avignon, France; [Vallon, Julien] ITSAP Inst Abeille, Avignon, France	INRAE; INRAE	Alaux, C (corresponding author), INRA, Abeilles & Environm, Avignon, France.; Alaux, C (corresponding author), UMT PrADE, Avignon, France.	cedric.alaux@inra.fr	Alaux, Cedric/B-4667-2013; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves/M-4442-2018	Alaux, Cedric/0000-0002-3045-2599; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Prado, Alberto/0000-0003-2905-4769	France Agrimer [14-01-R]	France Agrimer	This work was funded by a grant from France Agrimer (Probee, 14-01-R), http://www.franceagrimer.fr/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Naggar Y, 2015, J APICULT RES, V54, P548, DOI 10.1080/00218839.2016.1186917; Alaux C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40568; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Amdam GV, 2010, ANIM BEHAV, V79, P973, DOI 10.1016/j.anbehav.2010.02.007; Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2011, J EXP BIOL, V214, P3808, DOI 10.1242/jeb.060244; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Bordier C, 2017, J INSECT PHYSIOL, V98, P47, DOI 10.1016/j.jinsphys.2016.11.013; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Di Pasquale G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162818; Doke MA, 2015, CURR OPIN INSECT SCI, V10, P185, DOI 10.1016/j.cois.2015.05.014; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Eyer M, 2017, EXP GERONTOL, V87, P84, DOI 10.1016/j.exger.2016.11.006; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Free J. B., 1960, Proceedings of the Royal Entomological Society of London (A), V35, P141; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jarman SN, 2015, MOL ECOL, V24, P4826, DOI 10.1111/mec.13357; KOLMES SA, 1985, Z TIERPSYCHOL, V68, P287; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Leoncini I, 2004, INSECT SOC, V51, P392, DOI 10.1007/s00040-004-0757-x; Maisonnasse A., 2016, INNOV AGRONOMIQUES, V53, P27, DOI DOI 10.15454/1.51358572217001E12; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Natsopoulou ME, 2016, BEHAV ECOL SOCIOBIOL, V70, P1019, DOI 10.1007/s00265-015-2019-5; NEUKIRCH A, 1982, J COMP PHYSIOL, V146, P35, DOI 10.1007/BF00688714; Omholt Stig W, 2004, Sci Aging Knowledge Environ, V2004, ppe28, DOI 10.1126/sageke.2004.26.pe28; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Rinkevich FD, 2016, PEERJ, V4, DOI 10.7717/peerj.2155; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schulz DJ, 2002, INSECT SOC, V49, P50, DOI 10.1007/s00040-002-8279-x; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, ETHOLOGY, V87, P284; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Straub L, 2015, CURR OPIN INSECT SCI, V12, P109, DOI 10.1016/j.cois.2015.10.010; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; van der Steen JJM, 2012, J APICULT RES, V51, P174, DOI 10.3896/IBRA.1.51.2.05; Wang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002779; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x	50	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209192	10.1371/journal.pone.0209192	http://dx.doi.org/10.1371/journal.pone.0209192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543711	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500077
J	Bhandage, AK; Jin, Z; Korol, SV; Tafreshiha, AS; Gohel, P; Hellgren, C; Espes, D; Carlsson, PO; Sundstrom-Poromaa, I; Birnir, B				Bhandage, Amol K.; Jin, Zhe; Korol, Sergiy V.; Tafreshiha, Atieh S.; Gohel, Priya; Hellgren, Charlotte; Espes, Daniel; Carlsson, Per-Ola; Sundstrom-Poromaa, Inger; Birnir, Bryndis			Expression of calcium release-activated and voltage-gated calcium channels genes in peripheral blood mononuclear cells is altered in pregnancy and in type 1 diabetes	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; ION CHANNELS; T-CELLS; STIM1; ORAI; PHYSIOLOGY; PROTEINS; SUBUNITS; RECEPTOR; GABA	Calcium (Ca2+) is an important ion in physiology and is found both outside and inside cells. The intracellular concentration of Ca2+ is tightly regulated as it is an intracellular signal molecule and can affect a variety of cellular processes. In immune cells Ca2+ has been shown to regulate e.g. gene transcription, cytokine secretion, proliferation and migration. Ca2+ can enter the cytoplasm either from intracellular stores or from outside the cells when Ca2+ permeable ion channels in the plasma membrane open. The Ca2+ release-activated (CRAC) channel is the most prominent Ca2+ ion channel in the plasma membrane. It is formed by ORAI1-3 and the channel is opened by the endoplasmic reticulum Ca2+ sensor proteins stromal interaction molecules (STIM) 1 and 2. Another group of Ca-2(+) channels in the plasma membrane are the voltage-gated Ca2+ (Ca-V) channels. We examined if a change in immunological tolerance is accompanied by altered ORAI, STIM and Ca-V gene expression in peripheral blood mononuclear cells (PBMCs) in pregnant women and in type 1 diabetic individuals. Our results show that in pregnancy and type 1 diabetes ORAI1-3 are up-regulated whereas STIM1 and 2 are down-regulated in pregnancy but only STIM2 in type 1 diabetes. Expression of L-, P/Q-, R- and T-type voltage-gated Ca2+ channels was detected in the PBMCs where the Ca(V)2.3 gene was up-regulated in pregnancy and type 1 diabetes whereas the Ca(V)2.1 and Ca(V)3.2 genes were up-regulated only in pregnancy and the Ca(V)1.3 gene in type 1 diabetes. The results are consistent with that expression of ORAI, STIM and Ca-V genes correlate with a shift in immunological status of the individual in health, as during pregnancy, and in the autoimmune disease type 1 diabetes. Whether the changes are in general protective or in type 1 diabetes include some pathogenic components remains to be clarified.	[Bhandage, Amol K.; Jin, Zhe; Korol, Sergiy V.; Tafreshiha, Atieh S.; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Gohel, Priya] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Hellgren, Charlotte; Sundstrom-Poromaa, Inger] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Espes, Daniel; Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Stockholm University; Uppsala University; Uppsala University	Birnir, B (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Bryndis.Birnir@neuro.uu.se	Jin, Zhe/C-5150-2008; Korol, Sergiy V./S-3442-2016; Bhandage, Amol K./AAY-2435-2020	Jin, Zhe/0000-0002-4717-1558; Korol, Sergiy V./0000-0001-8279-2790; Bhandage, Amol K./0000-0002-7116-0939; Birnir, Bryndis/0000-0002-1763-0266	Swedish Research Council; Swedish Children Diabetes Foundation; Swedish Diabetes Foundation; Stiftelsen Familjen Ernfors Fond; EXODIAB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Diabetes Foundation; Swedish Diabetes Foundation; Stiftelsen Familjen Ernfors Fond; EXODIAB	This study was funded by the Swedish Research Council, Swedish Children Diabetes Foundation (grant 2015-2017), Swedish Diabetes Foundation (grant 2016-2017), Stiftelsen Familjen Ernfors Fond, and EXODIAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandage AK, 2015, ACTA PHYSIOL, V213, P575, DOI 10.1111/apha.12440; Bhandage AK, 2017, J NEUROIMMUNOL, V305, P51, DOI 10.1016/j.jneuroim.2017.01.013; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Bonney EA, 2017, J REPROD IMMUNOL, V123, P65, DOI 10.1016/j.jri.2017.09.005; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chaudhari S, 2016, EXP BIOL MED, V241, P343, DOI 10.1177/1535370215609693; Cheng KT, 2012, P NATL ACAD SCI USA, V109, P14544, DOI 10.1073/pnas.1207354109; Chin-Smith EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00169; Clemens RA, 2017, BLOOD, V130, P1565, DOI 10.1182/blood-2016-11-751230; Davenport B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00375; Dawson NAJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01460; Demaurex N, 2016, AM J PHYSIOL-CELL PH, V310, pC496, DOI 10.1152/ajpcell.00360.2015; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Hartzell CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14850; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kinder JM, 2016, IMMUNITY, V44, P1085, DOI 10.1016/j.immuni.2016.04.021; Kreth S, 2010, NEURO-ONCOLOGY, V12, P570, DOI 10.1093/neuonc/nop072; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Leung FP, 2008, BRIT J PHARMACOL, V153, P846, DOI 10.1038/sj.bjp.0707455; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Nguyen N, 2013, BBA-MOL CELL RES, V1833, P1294, DOI 10.1016/j.bbamcr.2013.02.027; Niemeyer BA, 2016, AM J PHYSIOL-CELL PH, V310, pC701, DOI 10.1152/ajpcell.00034.2016; Omilusik KD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00164; Pan Z, 2014, BMB REP, V47, P69, DOI 10.5483/BMBRep.2014.47.2.015; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Targos B, 2005, ACTA BIOCHIM POL, V52, P397, DOI 10.18388/abp.2005_3452; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Toldi G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00099; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Vaeth M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14714; Wang HY, 2016, IMMUNITY, V44, P782, DOI 10.1016/j.immuni.2016.01.015; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Wolf IMA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00073; Zhang J, 2016, NEURON, V92, P461, DOI 10.1016/j.neuron.2016.09.014; Zhang SH, 2017, BIOCHEM BIOPH RES CO, V488, P74, DOI 10.1016/j.bbrc.2017.05.009	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208981	10.1371/journal.pone.0208981	http://dx.doi.org/10.1371/journal.pone.0208981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543678	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500057
J	Kunst, JR; Phillibert, EN				Kunst, Jonas R.; Phillibert, Esther N.			Skin-tone discrimination by Whites and Africans is associated with the acculturation of African immigrants in Norway	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; BLACK; IDENTITY; COLORISM; CULTURE; HEALTH	It is well-established that experiences of discrimination influence immigrants' acculturation. Yet, whereas a large body of research has demonstrated the role of discrimination by members of the dominant societal group, surprisingly little is known about how being discriminated by members of one's own group relates to the way immigrants acculturate. With a sample of 162 African first- and second-generation immigrants living in Norway, the present research investigated the relationship between both types of discrimination, acculturation and psychological well-being. It did so, focusing on discrimination based on one's skin tone, a type of discrimination Africans can experience from White as well as African individuals. Results showed that skin-tone discrimination by Whites was associated with a lower host culture orientation. By contrast, skin-tone discrimination by Africans was associated with a lower heritage culture orientation. Mediation analyses showed that the positive relationship of skin-tone discrimination by Whites and Africans with life satisfaction was mediated by a lower host and heritage culture orientation respectively. This indirect relationship did not reach significance with self-esteem as dependent variable. Participants' actual skin tone was unrelated to experiences of skin-tone discrimination. We discuss our results in light of previous research and highlight potential limitations.	[Kunst, Jonas R.; Phillibert, Esther N.] Univ Oslo, Dept Psychol, Oslo, Norway; [Kunst, Jonas R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Oslo; Yale University	Kunst, JR (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.; Kunst, JR (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	j.r.kunst@pskologi.uio.no			Norwegian Research Council [231157/F10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work received support from 231157/F10 from the Norwegian Research Council.	Akee R, 2010, IZA DISCUSSION PAPER, P5120; Alter AL, 2016, PERS SOC PSYCHOL B, V42, P1653, DOI 10.1177/0146167216669123; Arends-Toth J, 2006, CAMBRIDGE HDB ACCULT, P143; Berry J. W., 1974, CULTURE LEARNING, V2, P17; Berry J. W., 1980, ACCULTURATION VARIET; Berry J.W., 2006, IMMIGRANT YOUTH CULT; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Bodenhorn H, 2006, AM ECON REV, V96, P256, DOI 10.1257/000282806777211883; Bodenhorn H, 2003, NBER WORKING PAPER, V9962, P1, DOI [10.3386/w9962, DOI 10.3386/W9962]; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Hamilton D, 2009, J ECON BEHAV ORGAN, V72, P30, DOI 10.1016/j.jebo.2009.05.024; Hersch J, 2008, J LABOR ECON, V26, P345, DOI 10.1086/587428; Hersch J, 2011, SOC SCI RES, V40, P1337, DOI 10.1016/j.ssresearch.2010.12.006; Ho AK, 2013, J EXP SOC PSYCHOL, V49, P940, DOI 10.1016/j.jesp.2013.04.010; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; Horenczyk G, 1997, APPL PSYCHOL-INT REV, V46, P34, DOI 10.1080/026999497378476; Horenczyk G, 2013, Z PSYCHOL, V221, P205, DOI 10.1027/2151-2604/a000150; Hunt LM, 2004, SOC SCI MED, V59, P973, DOI 10.1016/j.socscimed.2003.12.009; Hunter M, 2007, SOCIOL COMPASS, V1, P237, DOI 10.1111/j.1751-9020.2007.00006.x; Jahren E, 2006, RASISME PANAERT HOLD; Jasinskaja-Lahti I, 2009, APPL PSYCHOL-INT REV, V58, P105, DOI 10.1111/j.1464-0597.2008.00384.x; Kunst JR, 2018, CRIM JUSTICE BEHAV, V45, P1888, DOI 10.1177/0093854818794742; Kunst JR, 2018, PERS SOC PSYCHOL B, V44, P265, DOI 10.1177/0146167217739279; Kunst JR, 2013, INT J INTERCULT REL, V37, P477, DOI 10.1016/j.ijintrel.2013.04.007; LAFROMBOISE T, 1993, PSYCHOL BULL, V114, P395, DOI 10.1037/0033-2909.114.3.395; Livingston RW, 2002, J PERS SOC PSYCHOL, V82, P5, DOI 10.1037//0022-3514.82.1.5; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; Massao PB, 2010, INT REV SOCIOL SPORT, V45, P147, DOI 10.1177/1012690210368233; Massey DS, 2003, SOURCE OF THE RIVER: THE SOCIAL ORIGINS OF FRESHMEN AT AMERICA'S SELECTIVE COLLEGES AND UNIVERSITIES, P1; Mok A, 2007, J CROSS CULT PSYCHOL, V38, P629, DOI 10.1177/0022022107305243; Monk EP, 2015, AM J SOCIOL, V121, P396, DOI 10.1086/682162; Montoya RM, 2008, EUR J SOC PSYCHOL, V38, P477, DOI 10.1002/ejsp.431; Nguyen AMD, 2013, J CROSS CULT PSYCHOL, V44, P122, DOI 10.1177/0022022111435097; Phelps JM, 2012, J COMMUNITY APPL SOC, V22, P187, DOI 10.1002/casp.1126; Phinney JS, 2001, J SOC ISSUES, V57, P493, DOI 10.1111/0022-4537.00225; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sam D.L., 2016, CAMBRIDGE HDB ACCULT, V2nd ed.; Sidanius J., 1999, SOCIAL DOMINANCE INT; Statistics Norway, 2018, LONN ALL ANS; Statistics Norway, 2018, INN ORG NOR INNV; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Tropp LR, 2003, GROUP PROCESS INTERG, V6, P131, DOI 10.1177/1368430203006002001; Uzogara EE, 2014, PSYCHOL MEN MASCULIN, V15, P201, DOI 10.1037/a0033479; Wang J., 2012, STRUCTURAL EQUATION, P391, DOI DOI 10.1002/9781118356258.CH7	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209084	10.1371/journal.pone.0209084	http://dx.doi.org/10.1371/journal.pone.0209084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543697	gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500072
J	MacKellar, D; Maruyama, H; Rwabiyago, OE; Steiner, C; Cham, H; Msumi, O; Weber, R; Kundi, G; Suraratdecha, C; Mengistu, T; Byrd, J; Pals, S; Churi, E; Madevu-Matson, C; Kazaura, K; Morales, F; Rutachunzibwa, T; Justman, J; Rwebembera, A				MacKellar, Duncan; Maruyama, Haruka; Rwabiyago, Oscar Ernest; Steiner, Claire; Cham, Haddi; Msumi, Omari; Weber, Rachel; Kundi, Gerald; Suraratdecha, Chutima; Mengistu, Tewodaj; Byrd, Johnita; Pals, Sherri; Churi, Eliufoo; Madevu-Matson, Caitlin; Kazaura, Kokuhumbya; Morales, Fernando; Rutachunzibwa, Thomas; Justman, Jessica; Rwebembera, Anath			Implementing the package of CDC and WHO recommended linkage services: Methods, outcomes, and costs of the Bukoba Tanzania Combination Prevention Evaluation: Peer-delivered, linkage case management program, 2014-2017	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV-INFECTION; PARTNER SERVICES; CARE; INTERVENTIONS; INITIATION; COMMUNITY; COUNTRIES; BARRIERS; CASCADE	Although several studies have evaluated one or more linkage services to improve early enrollment in HIV care in Tanzania, none have evaluated the package of linkage services recommended by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We describe the uptake of each component of the CDC/WHO recommended package of linkage services, and early enrollment in HIV care and antiretroviral therapy (ART) initiation among persons with HIV who participated in a peer-delivered, linkage case management (LCM) program implemented in Bukoba, Tanzania, October 2014-May 2017. Of 4206 participants (88% newly HIV diagnosed), most received recommended services including counseling on the importance of early enrollment in care and ART (100%); escort by foot or car to an HIV care and treatment clinic (CTC) (83%); treatment navigation at a CTC (94%); telephone support and appointment reminders (77% among clients with cellphones); and counseling on HIV-status disclosure and partner/family testing (77%), and on barriers to care (69%). During three periods with different ART-eligibility thresholds [CD4<350 (Oct 2014-Dec 2015, n = 2233), CD4 <= 500 (Jan 2016-Sept 2016, n = 1221), and Test & Start (Oct 2016-May 2017, n = 752)], 90%, 96%, and 97% of clients enrolled in HIV care, and 47%, 67%, and 86% of clients initiated ART, respectively, within three months of diagnosis. Of 463 LCM clients who participated in the last three months of the rollout of Test & Start, 91% initiated ART. Estimated per-client cost was $44 United States dollars (USD) for delivering LCM services in communities and facilities overall, and $18 USD for a facility-only model with task shifting. Well accepted by persons with HIV, peer-delivered LCM services recommended by CDC and WHO can achieve near universal early ART initiation in the Test & Start era at modest cost and should be considered for implementation in facilities and communities experiencing <90% early enrollment in ART care.	[MacKellar, Duncan; Cham, Haddi; Suraratdecha, Chutima; Mengistu, Tewodaj; Pals, Sherri] Ctr Dis Control & Prevent, Div Global HIV & TB, Natl Ctr Global Hlth, Atlanta, GA 30333 USA; [Maruyama, Haruka; Steiner, Claire; Msumi, Omari; Kundi, Gerald; Churi, Eliufoo; Morales, Fernando] Columbia Univ, ICAP, Dar Es Salaam, Tanzania; [Rwabiyago, Oscar Ernest; Kazaura, Kokuhumbya] Ctr Dis Control & Prevent, Dar Es Salaam, Tanzania; [Weber, Rachel] CTS Global Inc, Ctr Dis Control & Prevent, Dar Es Salaam, Tanzania; [Byrd, Johnita] ICF Int, Atlanta, GA USA; [Madevu-Matson, Caitlin; Justman, Jessica] Columbia Univ, ICAP, New York, NY USA; [Rutachunzibwa, Thomas] MoHCDGEC, Bukoba, Tanzania; [Rwebembera, Anath] MoHCDGEC, Natl AIDS Control Program, Dar Es Salaam, Tanzania	Centers for Disease Control & Prevention - USA; Columbia University	MacKellar, D (corresponding author), Ctr Dis Control & Prevent, Div Global HIV & TB, Natl Ctr Global Hlth, Atlanta, GA 30333 USA.	dym4@cdc.gov	Justman, Jessica/AAA-3572-2020	Mengistu, Tewodaj/0000-0003-3475-3599; MacKellar, Duncan/0000-0001-8217-9881	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention [5UGPS001998]; ICF International	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention; ICF International	This work was funded through the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (cooperative agreement 5UGPS001998). ICF International was contracted by the U.S. Centers for Disease Control and Prevention to provide data-management services only. Author Johnita Byrd is employed by ICF International. ICF International provided support in the form of salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Asiimwe S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21633; Auld AF, 2017, MMWR-MORBID MORTAL W, V66, P558, DOI 10.15585/mmwr.mm6621a3; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Bassett IV, 2017, JAIDS-J ACQ IMM DEF, V74, P432, DOI [10.1097/QAI.0000000000001277, 10.1097/qai.0000000000001277]; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Cherutich P, 2017, LANCET HIV, V4, pE74, DOI 10.1016/S2352-3018(16)30214-4; Fagan JL, 2012, AIDS CARE, V24, P737, DOI 10.1080/09540121.2011.630360; Ford N, 2018, AIDS, V32, P17, DOI [10.1097/QAD.0000000000001671, 10.1097/qad.0000000000001671]; Genberg BL, 2016, AIDS BEHAV, V20, P2452, DOI 10.1007/s10461-016-1307-z; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hayes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002292; Henley C, 2013, SEX TRANSM DIS, V40, P909, DOI 10.1097/OLQ.0000000000000032; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Kahabuka C, 2017, AIDS BEHAV, V21, P2551, DOI 10.1007/s10461-017-1750-5; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Little K, 2016, 11 INT C HIV TREATM; MacKellar D, 2018, MMWR-MORBID MORTAL W, V67, P663, DOI 10.15585/mmwr.mm6723a3; MacKellar DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150086; Maheu-Giroux M, 2017, AIDS, V31, P1017, DOI 10.1097/QAD.0000000000001435; Mavegam BO, 2017, AIDS CARE, V29, P1198, DOI 10.1080/09540121.2017.1306637; Meehan SA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2760-8; Ministry of Health Community Development Gender Elderly and Children, 2017, MAPP HIV SERV DEL ST, P24; National Bureau of Statistics United Republic of Tanzania, POP PROJ YEARS 2016; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; OANDA, 2014, HIST EXCH RAT; Ostermann J, 2015, AIDS CARE, V27, P59, DOI 10.1080/09540121.2015.1090534; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Reddy EA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1804-8; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Sanga ES, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013733; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Simmelink AM, 2014, MZIMA OPEN ADULT HLT; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Tucker JD, 2017, EBIOMEDICINE, V17, P163, DOI 10.1016/j.ebiom.2017.01.036; United States President's Emergency Plan for AIDS Relief (PEPFAR), 2018, PEPFAR SOL PLATF; Ware NC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20929; WHO, 2016, GUID HIV SELF TEST P; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization, 2016, CONS GUID US ANT DRU; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208919	10.1371/journal.pone.0208919	http://dx.doi.org/10.1371/journal.pone.0208919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543693	gold, Green Submitted, Green Published			2022-12-26	WOS:000453247500052
J	Batlle, JRM; van der Hoek, Y				Martinez Batlle, Jose Ramon; van der Hoek, Yntze			Clusters of high abundance of plants detected from local indicators of spatial association (LISA) in a semi-deciduous tropical forest	PLOS ONE			English	Article							DRY FOREST; PATTERNS; DIVERSITY; CONSERVATION; RECOVERY; ECOLOGY; GROWTH	Plants are rarely randomly distributed across communities, and patchiness is a common spatial pattern in most tropical forests. Clusters of high density of plant individuals are related to internal and external forces, as well as to historical events. The detection of aggregated patterns of plant individuals allows for a better understanding of the internal and external factors that guide the distribution of species. The aim of this research was to detect and characterize clusters of high abundance of plants and species richness in semi-deciduous forests in the Dominican Republic. For this, we collected vegetation data from 575 quadrats in 23 transects (2300 m(2) in total) within the Ocoa river basin. Using local Moran's/statistics, we isolated 18 quadrats of high density of individuals. We show that density of individuals can be 2.5 times larger on average than in non-aggregated quadrats, and can reach higher values for shrubs species as well as for palms and vines species. In addition, we found that shrub species are the most abundant group in aggregated quadrats, and density of tree species is significantly smaller than that of shrub species. High density quadrats are predominantly occupied by shrubs, palms and vines, following patterns of species composition and lithology. Detecting clusters of high density of individuals could help in the efficient assessment of richness in semi-deciduous tropical forests, and may support new conservation practices for this valuable but threatened ecosystem.	[Martinez Batlle, Jose Ramon] Univ Autonoma Santo Domingo, Fac Ciencias, Ciudad Univ, Santo Domingo Dn, Dominican Rep; [van der Hoek, Yntze] Dian Fossey Gorilla Fund Int, Musanze, Rwanda	Universidad Autonoma de Santo Domingo	Batlle, JRM (corresponding author), Univ Autonoma Santo Domingo, Fac Ciencias, Ciudad Univ, Santo Domingo Dn, Dominican Rep.	joseramon@geografiatisica.org	Martinez-Batlle, Jose Ramon/L-5544-2014	Martinez-Batlle, Jose Ramon/0000-0001-9924-0327	Ministry of Higher Education, Science and Technology of the Dominican Republic [FONDOCyT 2012-2B3-70]; National Fund for Scientific Innovation and Technological Development [FONDOCyT 2012-2B3-70]	Ministry of Higher Education, Science and Technology of the Dominican Republic; National Fund for Scientific Innovation and Technological Development	Funding for this research was given by Ministry of Higher Education, Science and Technology of the Dominican Republic (http://www.mescyt.gob.do/), specifically from its National Fund for Scientific Innovation and Technological Development. This research is part of the results of the project named "Fluvial environments, Ocoa river basin (Dominican Republic): hydro-geomorphological dynamics, disaster risks management and natural resources conservation", with grant number "FONDOCyT 2012-2B3-70" to JRMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to acknowledge the Ministry of Higher Education, Science and Technology of the Dominican Republic, specifically to its National Fund for Scientific Innovation and Technological Development, for funding this research within the project named "Fluvial environments, Ocoa river basin (Dominican Republic): hydro-geomorphological dynamics, disaster risks management and natural resources conservation", code FONDOCyT 2012-2B3-70.	Alados CL, 2010, BIOL J LINN SOC, V100, P935, DOI 10.1111/j.1095-8312.2010.01465.x; [Anonymous], 2010, ADV SPAT SCI, DOI DOI 10.1007/978-3-642-01976-0_1; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; ANSELIN L., 2017, PACKAGE SPDEP; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2015, SPATIAL POINT PATTER; Baddeley A, 2013, J STAT SOFTW, V55, P1; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burghardt KT, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00032.1; Burgos A, 2004, AGR ECOSYST ENVIRON, V104, P475, DOI 10.1016/j.agee.2004.01.038; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Artigas RC, 2013, ESTUD GEOGR, V74, P67, DOI 10.3989/estgeogr.201303; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Danz NP, 2013, J VEG SCI, V24, P1129, DOI 10.1111/jvs.12028; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Diggle P.J., 2013, STAT ANAL SPATIAL SP, V0, DOI [10.1201/b15326, DOI 10.1201/B15326]; Direccion de Vida Silvestre y Biodiversidad MdMAyRN, 2010, ESPECIES EXOTICAS IN; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Flugge AJ, 2014, METHODS ECOL EVOL, V5, P1214, DOI 10.1111/2041-210X.12295; Flugge AJ, 2012, ECOLOGY, V93, P1540, DOI 10.1890/11-1004.1; Font Quer P., 2001, DICCIONARIO BOT; GENTRY AH, 1982, EVOL BIOL, V15, P1; Graler B, 2016, R J, V8, P204; Hager Johannes, 1993, Moscosoa, V7, P39; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Kindt R., 2005, WORLD; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Licker Mark D, 2007, MCGRAW HILL ENCY SCI; Lowe S., 2000, 100 WORLDS WORST INV; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin PH, 2004, BIOTROPICA, V36, P297; Mejia M, 1981, INVENTARIO ECOFLORIS; MEJIA-P M M, 1984, Moscosoa, V3, P127; Ministerio de Medio Ambiente y Recursos Naturales de la Republica Dominicana, 2014, INF MET RES; Ministerio De Medio Ambiente y Recursos Naturales De La Republica Dominicana, 2011, LIST ESP PEL EXT AM; Oksanen J., 2015, VEGAN ECOLOGICAL DIV; Ord JK, 2010, ADV SPAT SCI, P165, DOI 10.1007/978-3-642-01976-0_12; Ostendorf B, 2001, ECOL MODEL, V145, P211, DOI 10.1016/S0304-3800(01)00392-1; Pebesma E.J., 2005, R NEWS, V5; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Philippi T, 2005, ECOLOGY, V86, P1091, DOI 10.1890/04-0621; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Puigdefabregas J, 2005, EARTH SURF PROC LAND, V30, P133, DOI 10.1002/esp.1181; R Core Team, 2013, R LANG ENV STAT COMP; Rivera LW, 2000, PLANT ECOL, V148, P115, DOI 10.1023/A:1009825211430; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Schubert Andreas, 1993, Oryx, V27, P115; Servicio Geologico Nacional. Mapa Geologico de la Republica Dominicana, 2000, MAP GEOL REP DOM ORD; Strong MT, 2012, SMITHSONIAN CONTRIBU, V98, P1, DOI [DOI 10.5479/SI.0081024X.98.1, 10.5479/si.0081024X.98.1]; Taylor AH, 2003, ECOL APPL, V13, P704, DOI 10.1890/1051-0761(2003)013[0704:SPACOH]2.0.CO;2; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wickham H, 2007, J STAT SOFTW, V21, P1; Wolf AT, 2000, CONSERV BIOL, V14, P454, DOI 10.1046/j.1523-1739.2000.98499.x; Yanes CV, ARBOLES ARBUSTOS NAT	62	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208780	10.1371/journal.pone.0208780	http://dx.doi.org/10.1371/journal.pone.0208780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543650	Green Published, gold			2022-12-26	WOS:000453247500038
J	Lan, Q; Peyvandi, S; Duffey, N; Huang, YT; Barras, D; Held, W; Richard, F; Delorenzi, M; Sotiriou, C; Desmedt, C; Lorusso, G; Ruegg, C				Lan, Qiang; Peyvandi, Sanam; Duffey, Nathalie; Huang, Yu-Ting; Barras, David; Held, Werner; Richard, Francois; Delorenzi, Mauro; Sotiriou, Christos; Desmedt, Christine; Lorusso, Girieca; Ruegg, Curzio			Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer	ONCOGENE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; IMMUNE-MEDIATED DORMANCY; CELLS; METASTASIS; MECHANISMS; EXPRESSION; RESISTANCE; PATHWAY; SITE	Neoadjuvant and adjuvant chemotherapies provide survival benefits to breast cancer patients, in particular in estrogen receptor negative (ER-) cancers, by reducing rates of recurrences. It is assumed that the benefits of (neo)adjuvant chemotherapy are due to the killing of disseminated, residual cancer cells, however, there is no formal evidence for it. Here, we provide experimental evidence that ER- breast cancer cells that survived high-dose Doxorubicin and Methotrexate based chemotherapies elicit a state of immunological dormancy. Hallmark of this dormant phenotype is the sustained activation of the IRF7/IFN-beta/IFNAR axis subsisting beyond chemotherapy treatment. Upregulation of IRF7 in treated cancer cells promoted resistance to chemotherapy, reduced cell growth and induced switching of the response from a myeloid derived suppressor cell-dominated immune response to a CD4(+)/CD8(+) T cell-dependent anti-tumor response. IRF7 silencing in tumor cells or systemic blocking of IFNAR reversed the state of dormancy, while spontaneous escape from dormancy was associated with loss of IFN-beta production. Presence of IFN-beta in the circulation of ER- breast cancer patients treated with neoadjuvant Epirubicin chemotherapy correlated with a significantly longer distant metastasis-free survival. These findings establish chemotherapy-induced immunological dormancy in ER- breast cancer as a novel concept for (neo)adjuvant chemotherapy activity, and implicate sustained activation of the IRF7/IFN-beta/IFNAR pathway in this effect. Further, IFN-beta emerges as a potential predictive biomarker and therapeutic molecule to improve outcome of ER- breast cancer patients treated with (neo)adjuvant chemotherapy.	[Lan, Qiang; Peyvandi, Sanam; Duffey, Nathalie; Huang, Yu-Ting; Lorusso, Girieca; Ruegg, Curzio] Univ Fribourg, Pathol Unit, Dept Oncol Microbiol & Immunol OMI, Fac Sci & Med, CH-1700 Fribourg, Switzerland; [Lan, Qiang; Huang, Yu-Ting; Lorusso, Girieca; Ruegg, Curzio] Ecole Polytech Fed Lausanne, NCCR, Swiss Inst Expt Canc Res ISREC, Mol Oncol, CH-1015 Lausanne, Switzerland; [Barras, David; Delorenzi, Mauro] SIB, CH-1015 Lausanne, Switzerland; [Held, Werner; Delorenzi, Mauro] Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Held, Werner; Delorenzi, Mauro] Univ Lausanne, Dept Fundamental Oncol, CH-1011 Lausanne, Switzerland; [Richard, Francois; Sotiriou, Christos; Desmedt, Christine] Univ Libre Bruxelles, Breast Canc Translat Res Lab, Inst Jules Bordet, B-1000 Brussels, Belgium; [Ruegg, Curzio] Swiss Integrat Ctr Human Hlth, Fribourg, Switzerland; [Lan, Qiang] Univ Helsinki, Dev Biol Program, Inst Biotechnol, Helsinki, Finland	University of Fribourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; Institut Jules Bordet; Universite Libre de Bruxelles; University of Helsinki	Ruegg, C (corresponding author), Univ Fribourg, Pathol Unit, Dept Oncol Microbiol & Immunol OMI, Fac Sci & Med, CH-1700 Fribourg, Switzerland.; Ruegg, C (corresponding author), Ecole Polytech Fed Lausanne, NCCR, Swiss Inst Expt Canc Res ISREC, Mol Oncol, CH-1015 Lausanne, Switzerland.; Ruegg, C (corresponding author), Swiss Integrat Ctr Human Hlth, Fribourg, Switzerland.	curzio.ruegg@unifr.ch	RICHARD, François/AAA-4193-2021; Desmedt, Christine/P-7438-2017	RICHARD, François/0000-0003-4353-3619; Lan, Qiang/0000-0002-7765-6767; Lorusso, Girieca/0000-0002-2807-3207; Desmedt, Christine/0000-0002-5223-5579	Swiss National Science Foundation [31003A_159824]; Swiss Cancer League [KFS-2814-08-2011]; Medic Foundation; Molecular Oncology Program of the National Center of Competence in Research (NCCR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Medic Foundation; Molecular Oncology Program of the National Center of Competence in Research (NCCR)	We thank Dr. J. Sleeman (Medical Faculty at Heidelberg University, Mannheim, Germany) for providing D2A1/D2.0R cells, Dr. Fred R. Miller (Michigan Cancer Foundation, Detroit, MI, USA) for providing 4T1 cells, Dr. Khalil Zaman (Department of Oncology), University Hospital, University of Lausanne, Lausanne, Switzerland) for providing chemotherapeutic drugs. This work was supported by grants from Swiss National Science Foundation (31003A_159824), The Swiss Cancer League (KFS-2814-08-2011); the Medic Foundation, the Molecular Oncology Program of the National Center of Competence in Research (NCCR), a research instrument of the Swiss National Science Foundation.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anampa J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0439-8; Barkan D, 2011, JOVE-J VIS EXP, DOI 10.3791/2914; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Castiello L, 2018, CANCER IMMUNOL RES, V6, P658, DOI 10.1158/2326-6066.CIR-17-0675; DEMICHELI R, 1994, J NATL CANCER I, V86, P45; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2011, J CLIN ONCOL, V29, P1578, DOI 10.1200/JCO.2010.31.2231; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Dushyanthen S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0431-3; Ejlertsen B, 2016, DAN MED J, V63; Erdal E, 2017, GENE DEV, V31, P353, DOI 10.1101/gad.289769.116; Forero A, 2016, CANCER IMMUNOL RES, V4, P390, DOI 10.1158/2326-6066.CIR-15-0243; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Goodison S, 2003, CLIN CANCER RES, V9, P3808; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Joensuu H, 2012, ANN ONCOL, V23, P40, DOI 10.1093/annonc/mds194; Kim ST, 2013, AM J CLIN ONCOL-CANC, V36, P224, DOI 10.1097/COC.0b013e3182467d90; Kim TK, 2000, CANCER RES, V60, P1153; Kim YA, 2016, BREAST CANCER RES TR, V156, P597, DOI 10.1007/s10549-016-3786-z; Klauber-DeMore N, 2001, CLIN CANCER RES, V7, P2434; Kroemer G, 2015, NAT MED, V21, P1128, DOI 10.1038/nm.3944; Lee HJ, 2016, J CLIN PATHOL, V69, P422, DOI 10.1136/jclinpath-2015-203089; Legrier M-E, 2015, BRIT J CANCER, V114, P177; Liu L, 2018, CLIN CANCER RES, V24, P2370, DOI 10.1158/1078-0432.CCR-17-2545; Liu YY, 2018, J CLIN INVEST, V128, P1057, DOI 10.1172/JCI96329; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071; Munzone E, 2012, ANN ONCOL, V23, P305, DOI 10.1093/annonc/mdr309; Naumov GN, 2002, CANCER RES, V62, P2162; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Perez EA, 2015, J CLIN ONCOL, V33, P701, DOI 10.1200/JCO.2014.57.6298; Romero I, 2014, CANCER RES, V74, P6750, DOI 10.1158/0008-5472.CAN-14-2406; Rubovszky G, 2017, J BREAST CANCER, V20, P119, DOI 10.4048/jbc.2017.20.2.119; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Stanton SE, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0165-6; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wang K, 2016, ONCOTARGET, V7, P44288, DOI 10.18632/oncotarget.9988; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	53	47	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2814	2829		10.1038/s41388-018-0624-2	http://dx.doi.org/10.1038/s41388-018-0624-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30546090	Green Published, hybrid			2022-12-26	WOS:000464121600011
J	Xu, XH; Hirata, H; Shiraki, M; Kamohara, A; Nishioka, K; Miyamoto, H; Kukita, T; Kukita, A				Xu, Xianghe; Hirata, Hirohito; Shiraki, Makoto; Kamohara, Asana; Nishioka, Kenichi; Miyamoto, Hiroshi; Kukita, Toshio; Kukita, Akiko			Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption	FASEB JOURNAL			English	Article						membrane trafficking; arthritis; Nedd4; TGF-; lysosome	UBIQUITIN LIGASE NEDD4; TGF-BETA; VESICULAR TRAFFICKING; CANCER CELLS; PMEPA1; TMEPAI; RECEPTOR; GENE; GROWTH; DIFFERENTIATION	Osteoclasts derived from hematopoietic cells are activated on bone surface. To resorb bone, osteoclasts release acid and lysosome acid hydrolase via membrane transport. Prostate transmembrane protein androgen induced 1 (Pmepa1) is a type I transmembrane protein that regulates proliferation, migration, and metastasis of cancer cells. Because recent reports showed that Pmepa1 is involved in membrane transport in cancer cells, we investigated the role of Pmepa1 in osteoclast function. Pmepa1 expression was barely detected in osteoclasts formed on plastic surfaces in vitro, but was markedly increased in activated osteoclasts formed on calcified matrix. Inhibitors of bone resorption, such as alendronate, bafilomycin A1, and the PI3K inhibitor LY294002, suppressed the expression of Pmepa1 in osteoclasts. Knockdown of Pmepa1 expression impaired bone resorption activity and inhibited formation of a ring-like, actin-rich podosome belt that is essential for osteoclast function. Pmepa1 protein localized to lysosomes in osteoclasts. In addition, in sites of bone destruction observed in rats with adjuvant-induced arthritis, a marked high level of Pmepa1 expression was associated with the osteoclasts' resorbing bone. Our results suggest that Pmepa1 is a critical regulator of bone resorption and is a promising marker for activated osteoclasts and a potential therapeutic target in pathologic bone destruction.Xu, X., Hirata, H., Shiraki, M., Kamohara, A., Nishioka, K., Miyamoto, H., Kukita, T., Kukita, A. Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption.	[Xu, Xianghe; Hirata, Hirohito; Shiraki, Makoto; Kamohara, Asana; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Dept Pathol & Microbiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan; [Xu, Xianghe; Kukita, Toshio] Kyushu Univ, Fac Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka, Fukuoka, Japan; [Nishioka, Kenichi] RIKEN Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa, Japan	Saga University; Kyushu University; RIKEN	Kukita, A (corresponding author), Saga Univ, Dept Pathol & Microbiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	kukita@cc.saga-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [P15K11046]; Medical Care Education Research Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Care Education Research Foundation	The authors thank Dr. Eric Milner (BioMedical Science Writers, Hamilton, MT, USA) for English language editing of the manuscript. This work was supported by the Japan Society for the Promotion of Science (KAKENHI) Grant-in-Aid for Scientific Research (C) (P15K11046 to A.K.) and a grant awarded by the Medical Care Education Research Foundation (to A.K). The authors declare no conflicts of interest.	Alford AI, 2015, INT J BIOCHEM CELL B, V65, P20, DOI 10.1016/j.biocel.2015.05.008; Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunschwig EB, 2003, CANCER RES, V63, P1568; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chung YH, 2014, INT J BIOCHEM CELL B, V54, P198, DOI 10.1016/j.biocel.2014.07.018; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; Funakubo N, 2018, J CELL PHYSIOL, V233, P3105, DOI 10.1002/jcp.26147; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Han ZY, 2014, J VIROL, V88, P7294, DOI 10.1128/JVI.00591-14; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; Kuratani T, 1998, HISTOL HISTOPATHOL, V13, P751, DOI 10.14670/HH-13.751; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Li H, 2015, ONCOTARGET, V6, P15137, DOI 10.18632/oncotarget.3526; Li YJ, 2009, LAB INVEST, V89, P26, DOI 10.1038/labinvest.2008.111; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16124; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Nakayama T, 2011, BONE, V49, P1331, DOI 10.1016/j.bone.2011.09.045; Oh Y, 2014, J CELL BIOCHEM, V115, P585, DOI 10.1002/jcb.24695; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; SHANKAR G, 1993, J CELL SCI, V105, P61; Shinohara M, 2012, J BONE MINER RES, V27, P2464, DOI 10.1002/jbmr.1703; Shugg RPP, 2013, J BIOL CHEM, V288, P35346, DOI 10.1074/jbc.M113.507525; Singha Prajjal K, 2014, Genes Cancer, V5, P320; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Stenbeck G, 2014, CURR OPIN PHARMACOL, V16, P7, DOI 10.1016/j.coph.2014.01.003; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; SUNDQUIST K, 1990, BIOCHEM BIOPH RES CO, V168, P309, DOI 10.1016/0006-291X(90)91709-2; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Tilli TM, 2015, ONCOL LETT, V9, P1845, DOI 10.3892/ol.2015.2939; Touaitahuata Heiani, 2014, Small GTPases, V5, pe28119, DOI 10.4161/sgtp.28119; Tow K, 2004, LAB INVEST, V84, P1092, DOI 10.1038/labinvest.3700132; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45375; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	50	8	8	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4365	4375		10.1096/fj.201801573R	http://dx.doi.org/10.1096/fj.201801573R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30557043	Bronze			2022-12-26	WOS:000459794800101
J	Zhou, J; Chen, Q				Zhou, Jie; Chen, Qing			Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway	FASEB JOURNAL			English	Article						miR-135b; CDDP; MKN28; MKN45	TUMOR-SUPPRESSOR; MDR1; MST1; PACLITAXEL; MIR-135B; KINASE; TRAIL; DRUGS	Gastric cancer (GC) has been classified as the fourth leading cause of cancer-related deaths worldwide. Due to their ability to suppress the expression of target genes, microRNAs (miRNAs) are listed as one of the key elements involved in the formation and development of tumors. This study was therefore conducted to investigate the effects of microRNA-135b (miR-135b) on cisplatin [cis-diamminedichloroplatinum (CDDP)] resistance of GC cells through the MAPK signaling pathway by targeting mammalian ste20-like kinase 1 (MST1). A microarray-based gene expression analysis was performed to screen the GC-related differentially expressed genes. The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay was performed to determine the sensitivity of GC cells to CDDP. The bioinformatics database and dual luciferase reporter gene assay were used to check whether MST1 was a direct target gene of miR-135b. GC cell lines were prepared with high CDDP resistance, after which they were cultured and transfected respectively, followed by the administration of transfected cells into nude mice and subsequent treatment with CDDP in an attempt to identify the underlying mechanisms and functions of miR-135b in relation to MST1 in GC progression. The results were highly indicative of the crucial role played by MST1 in the development of GC and the sensitivity of GC to CDDP. miR-135b was found to regulate MST1, which in turn had an impact on the development of GC. MKN28 was observed to be most sensitive to CDDP, whereas MKN45 presented with the poorest sensitivity to CDDP. Furthermore, the down-regulation of miR-135b resulted in inactivation of the MAPK signaling pathway; increased the expression of MST1 and Bax; and decreased expression of p-p38MAPK, p-ERK1/2, P-glycoprotein, p38MAPK, ERK1/2, multidrug resistance protein 1, multidrug resistance-associated protein 1, lung resistance-related protein, and Bcl-2, thus inhibiting CDDP resistance of GC cells. The down-regulation of miR-135b also restrained cell proliferation and induced the apoptosis rate of GC cells. In summary, the results of this study showed that the down-regulation of miR-135b induced apoptosis, and it inhibited proliferation and CDDP resistance of GC cells by inactivating the MAPK signaling pathway and increasing the expression of MST1.Zhou, J., Chen, Q. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.	[Zhou, Jie] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Hubei, Peoples R China; [Chen, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	ch_enqing0322@163.com			National Natural Science Foundation of China [81572985, 81371508, 31000471]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the reviewers for their helpful comments on this paper. This research was supported by the National Natural Science Foundation of China (81572985, 81371508, and 31000471). The authors declare no conflicts of interest.	Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Chen L, 2015, CANCER RES, V75, P3832, DOI 10.1158/0008-5472.CAN-14-3690; Chen SH, 2014, BIOCHIMIE, V103, P71, DOI 10.1016/j.biochi.2014.04.004; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guo CC, 2005, INT J CANCER, V116, P155, DOI 10.1002/ijc.20919; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li P, 2016, AM J TRANSL RES, V8, P3522; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Lu MD, 2018, INT J ONCOL, V52, P589, DOI 10.3892/ijo.2017.4222; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Nishide N, 2012, ENDOSCOPY, V44, P577, DOI 10.1055/s-0031-1291712; Park SR, 2004, ONCOL REP, V12, P1059; Shimazu T, 2015, CARCINOGENESIS, V36, P1291, DOI 10.1093/carcin/bgv125; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Su WM, 2016, BIOMED PHARMACOTHER, V84, P123, DOI 10.1016/j.biopha.2016.09.027; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Vidal AF, 2016, WORLD J GASTROENTERO, V22, P2060, DOI 10.3748/wjg.v22.i6.2060; Wang Lin-pei, 2012, Zhonghua Yi Xue Za Zhi, V92, P3269; Wu H, 2003, CANCER RES, V63, P1515; Xie Xiang-Quan, 2014, J Prev Med Public Health, V47, P281, DOI 10.3961/jpmph.14.018; Xu XM, 2012, ONCOL LETT, V4, P339, DOI 10.3892/ol.2012.714; Xu ZP, 2011, HEPATO-GASTROENTEROL, V58, P1611, DOI 10.5754/hge10669; Yang M, 2015, J CANCER RES CLIN, V141, P1037, DOI 10.1007/s00432-014-1865-2; Yu JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14539-x; Zhang CL, 2016, ONCOTARGETS THER, V9, P3555, DOI 10.2147/OTT.S105736; Zhang KG, 2012, HEPATO-GASTROENTEROL, V59, P2672, DOI 10.5754/hge11850; Zhou L, 2013, PATHOL ONCOL RES, V19, P677, DOI 10.1007/s12253-013-9630-4; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393	32	31	31	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3420	3436		10.1096/fj.201800618RRR	http://dx.doi.org/10.1096/fj.201800618RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576232	Bronze, Green Published			2022-12-26	WOS:000459794800028
J	Ogawa, S; Matsuoka, Y; Takada, M; Matsui, K; Yamane, F; Kubota, E; Yasuhara, S; Hieda, K; Kanayama, N; Hatano, N; Tokumitsu, H; Magari, M				Ogawa, Sayaka; Matsuoka, Yukiko; Takada, Miho; Matsui, Kazue; Yamane, Fumihiro; Kubota, Eri; Yasuhara, Shiori; Hieda, Kentaro; Kanayama, Naoki; Hatano, Naoya; Tokumitsu, Hiroshi; Magari, Masaki			Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						monocyte; cell differentiation; interleukin; cytokine; chaperone; GRP78; cell surface protein; plasma membrane; CRISPR/Cas; Western blot; colony-stimulating factor-1 receptor; follicular dendritic cell; interleukin 34	LYMPHOTOXIN BETA-RECEPTOR; ENDOPLASMIC-RETICULUM CHAPERONE; FOLLICULAR DENDRITIC CELLS; LANGERHANS CELLS; GERMINAL-CENTERS; GRP78; EXPRESSION; CSF-1; MACROPHAGES; NETWORKS	Interleukin 34 (IL-34) constitutes a cytokine that shares a common receptor, colony-stimulating factor-1 receptor (CSF-1R), with CSF-1. We recently identified a novel type of monocytic cell termed follicular dendritic cell-induced monocytic cells (FDMCs), whose differentiation depended on CSF-1R signaling through the IL-34 produced from a follicular dendritic cell line, FL-Y. Here, we report the functional mechanisms of the IL-34-mediated CSF-1R signaling underlying FDMC differentiation. CRIPSR/Cas9-mediated knockout of the Il34 gene confirmed that the ability of FL-Y cells to induce FDMCs completely depends on the IL-34 expressed by FL-Y cells. Transwell culture experiments revealed that FDMC differentiation requires a signal from a membrane-anchored form of IL-34 on the FL-Y cell surface, but not from a secreted form, in a direct interaction between FDMC precursor cells and FL-Y cells. Furthermore, flow cytometric analysis using an anti-IL-34 antibody indicated that IL-34 was also expressed on the FL-Y cell surface. Thus, we explored proteins interacting with IL-34 in FL-Y cells. Mass spectrometry analysis and pulldown assay identified that IL-34 was associated with the molecular chaperone 78-kDa glucose-regulated protein (GRP78) in the plasma membrane fraction of FL-Y cells. Consistent with this finding, GRP78-heterozygous FL-Y cells expressed a lower level of IL-34 protein on their cell surface and exhibited a reduced competency to induce FDMC differentiation compared with the original FL-Y cells. These results indicated a novel GRP78-dependent localization and specific function of IL-34 in FL-Y cells related to monocytic cell differentiation.	[Ogawa, Sayaka; Matsuoka, Yukiko; Takada, Miho; Matsui, Kazue; Yamane, Fumihiro; Yasuhara, Shiori; Hieda, Kentaro; Kanayama, Naoki; Tokumitsu, Hiroshi; Magari, Masaki] Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Kita Ku, Okayama 7008530, Japan; [Kubota, Eri] Okayama Univ, Fac Engn, Dept Appl Chem & Biotechnol, Kita Ku, Okayama 7008530, Japan; [Kanayama, Naoki; Hatano, Naoya; Tokumitsu, Hiroshi; Magari, Masaki] Okayama Univ, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Lab Appl Cell Biol, Kita Ku, Tsushima Naka 3-1-1, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Magari, M (corresponding author), Okayama Univ, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Lab Appl Cell Biol, Kita Ku, Tsushima Naka 3-1-1, Okayama 7008530, Japan.	magari@cc.okayama-u.ac.jp	MAGARI, Masaki/B-2555-2011; Kanayama, Naoki/G-1518-2010; Tokumitsu, Hiroshi/M-3978-2015	Kanayama, Naoki/0000-0003-1778-2005; Tokumitsu, Hiroshi/0000-0002-2193-6794; Magari, Masaki/0000-0002-4624-0160	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460590]; Ryobi Teien Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryobi Teien Foundation(Ryobi Teien Memory Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 25460590 and funds from the Ryobi Teien Foundation and the Takeda Science Foundation (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Aungier SR, 2015, IMMUNOLOGY, V144, P34, DOI 10.1111/imm.12342; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Ciccia F, 2013, RHEUMATOLOGY, V52, P1009, DOI 10.1093/rheumatology/kes435; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Knowlton ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013587; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Magari M, 2011, J IMMUNOL, V187, P4210, DOI 10.4049/jimmunol.1100934; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; NAKOINZ I, 1990, J IMMUNOL, V145, P860; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nishikawa Y, 2006, J IMMUNOL, V177, P5204, DOI 10.4049/jimmunol.177.8.5204; Oida T, 2010, J IMMUNOL, V185, P3529, DOI 10.4049/jimmunol.0904121; Park CS, 2005, IMMUNOLOGY, V114, P2, DOI 10.1111/j.1365-2567.2004.02075.x; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Segaliny AI, 2015, BBA-MOL CELL RES, V1853, P1010, DOI 10.1016/j.bbamcr.2015.01.023; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wang HX, 2017, MOLECULES, V22, DOI 10.3390/molecules22010035; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Yamane F, 2014, J LEUKOCYTE BIOL, V95, P19, DOI 10.1189/jlb.0613311; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhang TT, 2017, ELIFE, V6, DOI 10.7554/eLife.19552; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou RP, 2016, IMMUNOLOGY, V149, P362, DOI 10.1111/imm.12660	61	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2386	2396		10.1074/jbc.RA118.006226	http://dx.doi.org/10.1074/jbc.RA118.006226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573681	Green Published, hybrid			2022-12-26	WOS:000458895400016
J	Opitz, C; Ahrne, E; Goldie, KN; Schmidt, A; Grzesiek, S				Opitz, Christian; Ahrne, Erik; Goldie, Kenneth N.; Schmidt, Alexander; Grzesiek, Stephan			Deuterium induces a distinctive Escherichia coli proteome that correlates with the reduction in growth rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						isotope effect; cell growth; hydrogen-deuterium exchange; protein stability; enzyme kinetics; proteomics; clusters of orthologous groups database; deuteration; gene ontology database; isotope labeling; kinetic isotope effect; biomolecular stability; minimal medium	OXIDE HEAVY-WATER; HYDROGEN-BONDS; ELECTRON-TRANSFER; GENE ONTOLOGY; PTK2 CELLS; ISOTOPE; D2O; H2O; DENATURATION; IDENTIFICATION	Substitution of protium (H) for deuterium (D) strongly affects biological systems. Whereas higher eukaryotes such as plants and mammals hardly survive a deuterium content of >30%, many microorganisms can grow on fully deuterated media, albeit at reduced rates. Very little is known about how the H/D replacement influences life at the systems level. Here, we used MS-based analysis to follow the adaptation of a large part of the Escherichia coli proteome from growth on a protonated full medium, over a protonated minimal medium, to a completely deuterated minimal medium. We could quantify >1800 proteins under all conditions, several 100 of which exhibited strong regulation during both adaptation processes. The adaptation to minimal medium strongly up-regulated amino acid synthesis and sugar metabolism and down-regulated translational proteins on average by 9%, concomitant with a reduction in growth rate from 1.8 to 0.67 h(-1). In contrast, deuteration caused a very wide proteomic response over many cell functional categories, together with an additional down-regulation of the translational proteins by 5%. The latter coincided with a further reduction in growth rate to 0.37 h(-1), revealing a clear linear correlation between growth rate and abundance of translational proteins. No significant morphological effects are observed under light and electron microscopies. Across all protein categories, about 80% of the proteins up-regulated under deuteration are enzymes with hydrogen transfer functions. Thus, the H/D kinetic isotope effect appears as the major limiting factor of cellular functions under deuteration.	[Opitz, Christian; Ahrne, Erik; Schmidt, Alexander; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4058 Basel, Switzerland	University of Basel; University of Basel	Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	Stephan.Grzesiek@unibas.ch		Grzesiek, Stephan/0000-0003-1998-4225	Swiss National Science Foundation [31-149927, 31-173089]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31-149927 and 31-173089 (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beranova L, 2012, PHYS CHEM CHEM PHYS, V14, P14516, DOI 10.1039/c2cp41275f; Brooks SC, 1937, SCIENCE, V86, P497, DOI 10.1126/science.86.2239.497; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHANCE HL, 1946, J BACTERIOL, V51, P547, DOI 10.1128/JB.51.4.547-551.1946; Chellgren BW, 2004, J AM CHEM SOC, V126, P14734, DOI 10.1021/ja045425q; Cho Y, 2009, J AM CHEM SOC, V131, P15188, DOI 10.1021/ja9040785; CUPANE A, 1980, NUCLEIC ACIDS RES, V8, P4283, DOI 10.1093/nar/8.18.4283; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Dassain M, 1999, BIOCHIMIE, V81, P889, DOI 10.1016/S0300-9084(99)00207-2; Evans BR, 2015, METHOD ENZYMOL, V565, P213, DOI 10.1016/bs.mie.2015.07.014; Farver O, 2001, P NATL ACAD SCI USA, V98, P4426, DOI 10.1073/pnas.071043798; FLAUMENHAFT E., 1965, INT REV CYTOL, V18, P313, DOI 10.1016/S0074-7696(08)60557-4; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; GROSS PR, 1960, SCIENCE, V131, P37, DOI 10.1126/science.131.3392.37; GUARDFRIAR D, 1985, J PHYS CHEM-US, V89, P1810, DOI 10.1021/j100255a054; Guzzi R, 1998, J PHYS CHEM B, V102, P1021, DOI 10.1021/jp9724380; HATTORI A, 1965, BIOCHEMISTRY-US, V4, P1213, DOI 10.1021/bi00883a002; Haynes W.M., 2009, CRC HDB CHEM PHYS; Hochuli M, 2000, J BIOMOL NMR, V17, P33, DOI 10.1023/A:1008329124672; Hohlefelder LS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/592745; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; IZZO V, 1975, NUCLEIC ACIDS RES, V2, P1805, DOI 10.1093/nar/2.10.1805; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jaravine VA, 2004, J BIOMOL NMR, V29, P309, DOI 10.1023/B:JNMR.0000032516.87434.35; KATZ JJ, 1966, SCIENCE, V151, P1187, DOI 10.1126/science.151.3715.1187; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; KNOLL W, 1981, CHEM PHYS LIPIDS, V28, P337, DOI 10.1016/0009-3084(81)90019-0; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; KUCHITSU K, 1962, J CHEM PHYS, V36, P2470, DOI 10.1063/1.1732910; Kuhlman B, 1998, PROTEIN SCI, V7, P2405, DOI 10.1002/pro.5560071118; LAMPRECHT J, 1991, J CELL SCI, V98, P463; LAMPRECHT J, 1989, EUR J CELL BIOL, V50, P360; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; Mugridge JS, 2010, ANGEW CHEM INT EDIT, V49, P3635, DOI 10.1002/anie.200906569; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; PARK SJ, 1994, J BACTERIOL, V176, P5086, DOI 10.1128/jb.176.16.5086-5092.1994; Piszczek G, 2011, ARCH BIOCHEM BIOPHYS, V507, P332, DOI 10.1016/j.abb.2010.12.022; Ranieri A, 2012, LANGMUIR, V28, P15087, DOI 10.1021/la303363h; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; SCHROETER D, 1992, EUR J CELL BIOL, V58, P365; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; STEINER T, 1994, ACTA CRYSTALLOGR B, V50, P348, DOI 10.1107/S0108768193011966; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; UBBELOHDE AR, 1955, ACTA CRYSTALLOGR, V8, P71, DOI 10.1107/S0365110X55000340; UNNO K, 1988, CHEM PHARM BULL, V36, P1828; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WESTHEIMER FH, 1961, CHEM REV, V61, P265, DOI 10.1021/cr60211a004; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	60	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2279	2292		10.1074/jbc.RA118.006914	http://dx.doi.org/10.1074/jbc.RA118.006914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545941	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000458895400007
J	Kumar, S; Gosain, M; Sharma, H; Swetts, E; Amarchand, R; Kumar, R; Lafond, KE; Dawood, FS; Jain, S; Widdowson, MA; Read, JM; Krishnan, A				Kumar, Supriya; Gosain, Mudita; Sharma, Hanspria; Swetts, Eric; Amarchand, Ritvik; Kumar, Rakesh; Lafond, Kathryn E.; Dawood, Fatimah S.; Jain, Seema; Widdowson, Marc-Alain; Read, Jonathan M.; Krishnan, Anand			Who interacts with whom? Social mixing insights from a rural population in India	PLOS ONE			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; SEASONAL INFLUENZA; CONTACT PATTERNS; MORTALITY; PNEUMONIA; INFECTIONS; DYNAMICS; SPREAD	Acute lower respiratory infections (ALRI) are a leading cause of morbidity and mortality globally, with most ALRI deaths occurring in children in developing countries. Computational models can be used to test the efficacy of respiratory infection prevention interventions, but require data on social mixing patterns, which are sparse in developing countries. We describe social mixing patterns among a rural community in northern India. During October 2015-February 2016, trained field workers conducted cross-sectional face-to-face standardized surveys in a convenience sample of 330 households in Faridabad District, Haryana State, India. Respondents were asked about the number, duration, and setting of social interactions during the previous 24 hours. Responses were compared by age and gender. Among the 3083 residents who were approached, 2943 (96%) participated, of whom 51% were male and the median age was 22 years (interquartile range (IQR) 9-37). Respondents reported contact (defined as having had a face-to-face conversation within 3 feet, which may or may not have included physical contact) with a median of 17 (IQR 12-25) people during the preceding 24 hours. Median total contact time per person was 36 person-hours (IQR 26-52). Female older children and adults had significantly fewer contacts than males of similar age (Kruskal-Wallis chi 2 = 226.59, p<0.001), but spent a longer duration in contact with young children (Kruskal-Wallis chi 2 = 27.26, p<0.001), suggesting a potentially complex pattern of differential risk of infection between genders. After controlling for household size and day of the week, respondent age was significantly associated with number and duration of contacts. These findings can be used to model the impact of interventions to reduce lower respiratory tract infections in India.	[Kumar, Supriya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA 15260 USA; [Gosain, Mudita; Amarchand, Ritvik; Kumar, Rakesh; Krishnan, Anand] All India Inst Med Sci, Dept Community Med, New Delhi, India; [Sharma, Hanspria] Delhi Univ, New Delhi, India; [Swetts, Eric] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Lafond, Kathryn E.; Dawood, Fatimah S.; Jain, Seema] Ctr Dis Control & Prevent, Atlanta, GA USA; [Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Nairobi, Kenya; [Read, Jonathan M.] Univ Lancaster, Lancaster Med Sch, Ctr Hlth Informat Comp & Stat, Lancaster, England; [Kumar, Supriya] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Delhi; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Lancaster University; Bill & Melinda Gates Foundation	Kumar, S (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA 15260 USA.; Kumar, S (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	supriya@pitt.edu	Krishnan, Anand/D-8537-2012; Kumar, Rakesh/ABD-1065-2020	Krishnan, Anand/0000-0002-9173-7811; Kumar, Rakesh/0000-0001-7664-0803; , RITVIK/0000-0001-8300-3829; Read, Jonathan/0000-0002-9697-0962; gosain, mudita/0000-0002-2660-7578; Kumar, Supriya/0000-0001-8373-105X	CDC [14IPA141265003]; Engineering and Physical Sciences Research Council [EP/N014499/1]; EPSRC [EP/N014499/1] Funding Source: UKRI	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by CDC co-operative agreement number 14IPA141265003 to AK. JMR acknowledges support from the Engineering and Physical Sciences Research Council (EP/N014499/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ST, 2013, EPIDEMICS-NETH, V5, P157, DOI 10.1016/j.epidem.2013.08.001; ANDERSON R M, 1991; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; Chowdhry P, 1997, ECON POLIT WEEKLY, V32, P1019; CHOWDHRY P, 1993, ECON POLIT WEEKLY, V28, pA135; Danon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1037; DEBJANI RAM PURAKAYASTHA RA, 2016, OPTIONS P CONTROL IN; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; Dinno A, 2015, STATA J; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Fu YC, 2007, FIELD METHOD, V19, P194, DOI 10.1177/1525822X06298590; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; HealthMap, 2016, H5N8 AV INFL IND 201; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Krishnan A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1188-1; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kwok KO, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0709; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mills I D, 1986, Indian Econ Soc Hist Rev, V23, P1; Morris SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020119; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Office of the Registrar General & Census Commissioner I Ministry of Home Affairs Government of India, 2011, C 14 5 YEAR AG GROUP; Omer SB, 2017, NEW ENGL J MED, V376, P1256, DOI 10.1056/NEJMra1509044; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; StataCorp, 2016, STAT SE 14 2 MAC; United Nations Department of Economic and Social Affairs; Population Division, ESAPWP2482017; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209039	10.1371/journal.pone.0209039	http://dx.doi.org/10.1371/journal.pone.0209039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576333	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000454149400025
J	Van der Haegen, L; Brysbaert, M				Van der Haegen, Lise; Brysbaert, Marc			The relationship between behavioral language laterality, face laterality and language performance in left-handers	PLOS ONE			English	Article							VISUAL HALF-FIELD; HEMISPHERIC-SPECIALIZATION; CEREBRAL LATERALIZATION; HANDEDNESS; ASYMMETRY; DOMINANCE; PARADIGM; AREA	Left-handers provide unique information about the relationship between cognitive functions because of their larger variability in hemispheric dominance. This study presents the laterality distribution of, correlations between and test-retest reliability of behavioral lateralized language tasks (speech production, reading and speech perception), face recognition tasks, handedness measures and language performance tests based on data from 98 left-handers. The results show that a behavioral test battery leads to percentages of (a) typical dominance that are similar to those found in neuropsychological studies even though the incidence of clear atypical lateralization (about 20%) may be overestimated at the group level. Significant correlations were found between the language tasks for both reaction time and accuracy lateralization indices. The degree of language laterality could however not be linked to face laterality, handedness or language performance. Finally, individuals were classified less consistently than expected as being typical, bilateral or atypical across all tasks. This may be due to the often good (speech production and perception tasks) but sometimes weak (reading and face tasks) test-retest reliabilities. The lack of highly reliable and valid test protocols for functions unrelated to speech remains one of the largest impediments for individual analysis and cross-task investigations in laterality research.	[Van der Haegen, Lise; Brysbaert, Marc] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	Ghent University	Van der Haegen, L (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.	lise.vanderhaegen85@gmail.com	Brysbaert, Marc/A-3910-2011	Brysbaert, Marc/0000-0002-3645-3189	Research Council Flanders [12G2916N, 3G091808]	Research Council Flanders	This study was funded by (1) grant 12G2916N awarded by the Research Council Flanders (http://www.fwo.be/en/) to LVDH who designed the study, collected data, ran the analyses, and wrote the manuscript; (2) Odysseus grant 3G091808 awarded by the Research Council Flanders (http://www.fwo.be/en/) to MB who supervised the study and wrote the manuscript.	Allendorfer JB, 2016, HUM BRAIN MAPP; Baayen R. H., 1993, CELEX LEXICAL DATABA; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; Bishop D., 2017, BISHOPBLOG; Bless JJ, 2015, LATERALITY, V20, P434, DOI 10.1080/1357650X.2014.997245; Bless JJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00042; Boles DB, 2011, BRAIN COGNITION, V76, P1, DOI 10.1016/j.bandc.2011.01.013; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Brus B, 1991, MINUUT TEST VORM A B; BRYSBAERT M, 1990, NEUROPSYCHOLOGIA, V28, P901, DOI 10.1016/0028-3932(90)90107-Y; Bukowski H, 2013, CORTEX, V49, P2583, DOI 10.1016/j.cortex.2013.05.002; Cai Q, 2015, NEUROSCI BULL, V31, P220, DOI 10.1007/s12264-014-1505-5; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Callens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038081; Dundas EM, 2015, J COGNITIVE NEUROSCI, V27, P913, DOI 10.1162/jocn_a_00757; Dundas EM, 2013, J EXP PSYCHOL GEN, V142, P348, DOI 10.1037/a0029503; Hedge C., 2017, BEHAV RES METHODS; Hirnstein M, 2008, BEHAV BRAIN RES, V187, P297, DOI 10.1016/j.bbr.2007.09.023; Hirnstein M, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00997; Hirnstein M, 2010, BRAIN COGNITION, V73, P119, DOI 10.1016/j.bandc.2010.04.002; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Hunter ZR, 2008, NEUROPSYCHOLOGIA, V46, P316, DOI 10.1016/j.neuropsychologia.2007.07.007; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Klichowski M, 2017, NEUROPSYCHOLOGIA, V100, P93, DOI 10.1016/j.neuropsychologia.2017.04.019; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Kuperman V, 2011, J MEM LANG, V65, P42, DOI 10.1016/j.jml.2011.03.002; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Mazoyer B, 2016, NEUROIMAGE, V124, P1225, DOI 10.1016/j.neuroimage.2015.02.071; Mazoyer B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101165; Mellet E, 2014, LATERALITY, V19, P383, DOI 10.1080/1357650X.2013.796965; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Ocklenburg S, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01300, 10.3389/fpsyg.2014.01143]; Ocklenburg S, 2014, NEUROSCI BIOBEHAV R, V43, P191, DOI 10.1016/j.neubiorev.2014.04.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OREGAN JK, 1992, J EXP PSYCHOL HUMAN, V18, P185, DOI 10.1037/0096-1523.18.1.185; PETERS M, 1978, CAN J PSYCHOL, V32, P257, DOI 10.1037/h0081694; Porac C, 1981, LATERAL PREFERENCES; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Specht K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00629; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Tzourio-Mazoyer N, 2010, J NEUROSCI, V30, P13314, DOI 10.1523/JNEUROSCI.2593-10.2010; van den Bos K, 1999, KLEPEL VORM A B TEST; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Van der Haegen L, 2013, J COGNITIVE NEUROSCI, V25, P1442, DOI 10.1162/jocn_a_00412; Van der Haegen L, 2013, NEUROPSYCHOLOGIA, V51, P91, DOI 10.1016/j.neuropsychologia.2012.11.002; Van der Haegen L, 2012, BRAIN LANG, V122, P171, DOI 10.1016/j.bandl.2011.11.004; Van der Haegen L, 2011, NEUROPSYCHOLOGIA, V49, P2879, DOI 10.1016/j.neuropsychologia.2011.06.014; Willemin J., 2016, LATERALITY, P1, DOI [10.1080/1357650x.2015.1130716, DOI 10.1080/1357650X.2015.1130716, 10.1080/1357650X.2015.1047782]; Willems RM, 2014, NAT REV NEUROSCI, V15, P193, DOI 10.1038/nrn3679; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017	54	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208696	10.1371/journal.pone.0208696	http://dx.doi.org/10.1371/journal.pone.0208696			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576313	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400013
J	Cecchini, M; Smith, P				Cecchini, Michele; Smith, Peter			Assessing the dose-response relationship between number of office-based visits and hospitalizations for patients with type II diabetes using generalized propensity score matching	PLOS ONE			English	Article							PRIMARY-CARE; MEDICAL-CARE; MODEL; ASSOCIATION; SUBSTITUTE; SERVICES	Background Whether inpatient services can be successfully substituted by office-based services has been debated for many decades, but the evidence is still inconclusive. This study aims to investigate the effect of office-based care on use and the expenditure for other healthcare services in patients with type II diabetes (T2D). Methods A generalized propensity score matching approach was used on pooled Medical Expenditure Panel Survey (MEPS) data for 2000-2012 to explore a dose-response effect. Patients were matched by using a comprehensive set of variables selected following a standard model on access to care. Findings Office-based care (up to 5 visits/year) acts as a substitute for other healthcare services and is associated with lower use and expenditure for inpatient, outpatient and emergency care. After five visits, office-based care becomes a complement to other services and is associated with increases in expenditure for T2D. Above 20 to 26 visits per year, depending on the healthcare service under consideration, the marginal effect of an additional office-based visit becomes non-statistically significant. Conclusions Office-based visits appear to be an effective instrument to reduce use of inpatient care and other services, including outpatient and emergency-care, in patients with T2D without any increase in total healthcare expenditure.	[Cecchini, Michele] Imperial Coll London, Inst Global Hlth Innovat, London, England; [Cecchini, Michele] OECD, Hlth Div, Paris, France; [Smith, Peter] Imperial Coll London, Imperial Coll Business Sch, London, England	Imperial College London; Organisation for Economic Co-operation & Development (OECD); Imperial College London	Cecchini, M (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, London, England.; Cecchini, M (corresponding author), OECD, Hlth Div, Paris, France.	michele.cecchini@oecd.org		Smith, Peter/0000-0003-0058-7588				Agency for Healthcare Research and Quality, 2015, MED EXP PAN SURV; Agency for Healthcare Research and Quality, 2013, US APPR PRIC IND AN; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2015, HARRISONS PRINCIPLES; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Bia M., 2007, POLIS DEP WORKING PA, V80; Blundell R., 2001, ESTIMATING RETURNS E; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Centers for Disease Control and Prevention, 2015, 2014 NAT DIAB STAT R; DAVIS K, 1972, REV ECON STAT, V54, P109, DOI 10.2307/1926271; Decker SL, 2009, HEALTH AFFAIR, V28, P26, DOI 10.1377/hlthaff.28.1.26; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Fortney JC, 2005, HEALTH SERV RES, V40, P1422, DOI 10.1111/j.1475-6773.2005.00424.x; Foster EM, 2003, MED CARE, V41, P1183, DOI 10.1097/01.MLR.0000089629.62884.22; Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS; Guardabascio B, 2014, STATA J, V14, P141, DOI 10.1177/1536867X1401400110; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Office of the Actuary of the Centers for Medicare and Medicaid Services, 2011, NAT HLTH EXP ACC MET; Powers AC, 2015, HARRISONS PRINCIPLES, P2422, DOI 10.1001/jama.308.17.1813-b; Roberts E, 1998, HEALTH POLICY, V44, P191, DOI 10.1016/S0168-8510(98)00021-9; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The Agency for Healthcare Research and Quality, 2007, GUID PREV QUAL IND H; van Dijk CE, 2014, HEALTH POLICY, V118, P48, DOI 10.1016/j.healthpol.2014.04.001; Zhao YJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-466	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209197	10.1371/journal.pone.0209197	http://dx.doi.org/10.1371/journal.pone.0209197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571732	Green Published, Green Accepted, gold			2022-12-26	WOS:000453841700042
J	Hammes, J; Hohberg, M; Tager, P; Wild, M; Zlatopolskiy, B; Krapf, P; Neumaier, B; Schomacker, K; Kobe, C; Schmidt, M; Dietlein, M; Drzezga, A				Hammes, Jochen; Hohberg, Melanie; Taeger, Philipp; Wild, Markus; Zlatopolskiy, Boris; Krapf, Philipp; Neumaier, Bernd; Schoemacker, Klaus; Kobe, Carsten; Schmidt, Matthias; Dietlein, Markus; Drzezga, Alexander			Uptake in non-affected bone tissue does not differ between [F-18]-DCFPyL and [Ga-68]-HBED-CC PSMA PET/CT	PLOS ONE			English	Article							IN-VIVO; PROSTATE; F-18	Introduction [Ga-68]PSMA-HBED-CC and [F-18]DCFPyL show a high potential for the detection of recurrent prostate cancer. While F-18-based tracers have several advantages in availability and image resolution, their sensitivity in the skeleton might be impaired by released [F-18]fluoride due to its high bone affinity. In turn, chemically unbound trivalent 68 Ga might also accumulate in osseous tissue, in cases of occupied binding sites of plasma proteins and thereby influence bone signal. Methods A comparison of average bone SUV was performed in 17 bone-negative and 4 bone-positive patients. All patients underwent PET/CT 125 minutes after application of [F-18]DCFPyL and 73 minutes after application of [Ga-68]PSMA-HBED-CC at another date. Results Native SUVs in unaffected bone tissue and SUVs relative to liver uptake were lower in [F-18] DCFPyL (0.49) than in [Ga-68]PSMA-HBED-CC scans (0.52). SUVs relative to gluteal muscles did not differ between the two tracers. Average lesional SUVs did not differ between tracers. Conclusion No difference of average bone signal intensity was observed for [F-18]DCFPyL-PET/CT in comparison to [Ga-68]PSMA-HBED-CC scans indicating that diagnostic assessment of the skeleton is not affected by non-specific accumulation of free [F-18]fluoride or 68 Ga.	[Hammes, Jochen; Hohberg, Melanie; Taeger, Philipp; Wild, Markus; Schoemacker, Klaus; Kobe, Carsten; Schmidt, Matthias; Dietlein, Markus; Drzezga, Alexander] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany; [Zlatopolskiy, Boris; Neumaier, Bernd] Univ Hosp Cologne, Inst Radiochem & Expt Mol Imaging, Cologne, Germany; [Krapf, Philipp; Neumaier, Bernd] Res Ctr Julich, Inst Neurosci & Med 5 Nucl Chem, Julich, Germany	University of Cologne; University of Cologne; Helmholtz Association; Research Center Julich	Hammes, J (corresponding author), Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany.	jochen.hammes@uk-koeln.de	Hammes, Jochen/AAN-7202-2020; Schomäcker, Klaus/AAW-4196-2021; Zlatopolskiy, Boris/W-3521-2017	Drzezga, Alexander/0000-0001-6018-716X; Zlatopolskiy, Boris/0000-0001-5818-1260; Krapf, Philipp/0000-0003-1671-2443				Dietlein F, 2017, J NUCL MED, V58, P947, DOI 10.2967/jnumed.116.185538; Dietlein M, 2015, MOL IMAGING BIOL, V17, P575, DOI 10.1007/s11307-015-0866-0; Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153; Fonager RF, 2018, ACTA ONCOL, V57, P1063, DOI 10.1080/0284186X.2018.1438651; Giesel FL, 2017, EUR J NUCL MED MOL I, V44, P678, DOI 10.1007/s00259-016-3573-4; Hammes J, 2018, J NUCL MED, V59, P1070, DOI 10.2967/jnumed.117.203265; HAYES RL, 1983, INT J NUCL MED BIOL, V10, P257, DOI 10.1016/0047-0740(83)90090-6; Hohberg M, 2016, MOL IMAGING BIOL, V18, P437, DOI 10.1007/s11307-016-0942-0; Jahan M, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-33; Kesch C, 2017, J NUCL MED, V58, P687, DOI 10.2967/jnumed.117.190157; Ponde DE, 2007, J NUCL MED, V48, P420; Rowe SP, 2016, MOL IMAGING BIOL, V18, P411, DOI 10.1007/s11307-016-0957-6; Tipre DN, 2006, J NUCL MED, V47, P345; Vollmar S., 2004, FORSCHUNG WISSENSCHA, P115	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209613	10.1371/journal.pone.0209613	http://dx.doi.org/10.1371/journal.pone.0209613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571794	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700090
J	Oda, Y; Nakano, S; Suh, JM; Oh, HJ; Jin, MY; Kim, YJ; Sakamoto, M; Chang, KH				Oda, Yusuke; Nakano, Sho; Suh, Jong-Mo; Oh, Hye-Ji; Jin, Mei-Yan; Kim, Yong-Jae; Sakamoto, Masaki; Chang, Kwang-Hyeon			Spatiotemporal variability in a copepod community associated with fluctuations in salinity and trophic state in an artificial brackish reservoir at Saemangeum, South Korea	PLOS ONE			English	Article							CALANOID COPEPOD; KUROSHIO CURRENT; ESTUARY; LAKE; BAY; WATER; EUTROPHICATION; ABUNDANCE; DYNAMICS; GRADIENT	Saemangeum Reservoir in South Korea is an estuarine system enclosed by a dyke construction, where seawater inflow and retained water outflow are managed by the opening/closing of sluice gates installed in the southern part of the dyke. An exchange of the reservoir water can cause spatiotemporal fluctuations in the salinity and trophic state, which are major drivers determining variation in the composition of biological communities in estuarine systems. Here, we investigated the seasonal and spatial variability in the copepod community and environmental conditions (water temperature, salinity, transparency, chlorophyll a concentration, total nitrogen, total phosphorus and Carlson's trophic state index) based on seasonally conducted field monitoring in the Saemangeum Reservoir from July 2013 to January 2018. In addition to the role of temperature, salinity and chlorophyll a concentration in structuring the copepod community and diversity, the biological indices of copepods with respect to salinity range and trophic state, were evaluated. The spatiotemporal variability in the salinity and trophic state variables showed contrasting patterns, and chlorophyll a concentration was negatively affected by salinity, indicating that the reservoir water was being highly exchanged with opening of the sluice gates. The mean trophic state index values, however, were constant in the eutrophic state (50-70). Dominant copepods were Acartia (A. hudsonica, A. sinjiensis, Acartia spp.) and Oithona (O. devisee and Oithona spp.), which are common species in eutrophic neritic water. Variation in the copepod community was mainly associated with the seasonal succession of the dominant species rather than a spatial gradient (from around the estuary to the sluice gates); however, site-specific differences in frequencies of several non-dominant species could be detected around the estuary (Sinocalanus tenellus) and the sluice gates (Centropages spp., Tigriopus spp. and Labidocera rotunda). The copepod diversity increased with species-richness from around the estuary to the sluice gates, which could result from variation in the site-specific location of non-dominant species. The frequency of particular species was also able to discriminate in terms of the salinity range (oligohaline: A. pacifica, S. tenellus and A. sinjiensis; mesohaline: Pseudo-diaptomus inopinus; and polyhaline: C. abdominalis and Centropages spp.) and the trophic state (mesotrophic: C. abdominalis, Calanus sinicus and Centropagesspp.; and hypereutrophic: S. tenellus, P. inopinus and Sinocalanus spp.). The findings from this study not only identify the factors determining spatiotemporal variation in the copepod community in the Saemangeum Reservoir, but also expand the applicability of copepods as biological indicators of conditions associated with salinity range and trophic state in other enclosed estuarine systems.	[Oda, Yusuke; Nakano, Sho; Suh, Jong-Mo; Oh, Hye-Ji; Jin, Mei-Yan; Chang, Kwang-Hyeon] Kyung Hee Univ, Dept Appl Environm Sci, Yongin, Gyeonggi do, South Korea; [Kim, Yong-Jae] Daejin Univ, Dept Life Sci, Pochon, Gyeonggi do, South Korea; [Sakamoto, Masaki] Toyama Prefectural Univ, Dept Environm Engn, Imizu, Toyama, Japan	Kyung Hee University; Daejin University; Toyama Prefectural University	Oda, Y; Chang, KH (corresponding author), Kyung Hee Univ, Dept Appl Environm Sci, Yongin, Gyeonggi do, South Korea.	odayusuke543@gmail.com; chang38@khu.ac.kr		Sakamoto, Masaki/0000-0003-4493-5863; chang, Kwang-Hyeon/0000-0002-7952-4047; Oda, Yusuke/0000-0002-6555-1335				Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albaina A, 2009, J PLANKTON RES, V31, P739, DOI 10.1093/plankt/fbp025; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; APHA (American Public Health Association), 1995, STANDARD METHODS EXA, P1000; BANNINK BA, 1984, NETH J SEA RES, V18, P179, DOI 10.1016/0077-7579(84)90001-2; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Carlson R.E., 1996, COORDINATORS GUIDE V, V96, P305; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chang Kwang-Hyeon, 2009, Open Marine Biology Journal, V3, P83; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Hayami Y, 2016, MAR POLLUT BULL, V102, P250, DOI 10.1016/j.marpolbul.2015.10.017; Hemraj DA, 2017, ESTUAR COAST SHELF S, V184, P102, DOI 10.1016/j.ecss.2016.10.045; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; Hsiao SH, 2011, ZOOL STUD, V50, P475; Islam MS, 2006, ESTUAR COAST SHELF S, V68, P62, DOI 10.1016/j.ecss.2006.01.010; JAE LIE HEUNG, 2008, Ocean and Polar Research, V30, P475; Ka S, 2011, ZOOL STUD, V50, P155; Koh Chul-hwan, 2010, 한국해양환경•에너지학회지, V13, P327; Lawrence D, 2004, ESTUAR COAST SHELF S, V61, P547, DOI 10.1016/j.ecss.2004.06.018; Lee CH, 2014, OCEAN COAST MANAGE, V102, P545, DOI 10.1016/j.ocecoaman.2013.12.018; Lee Chang-Rae, 2009, Ocean and Polar Research, V31, P327; Lee Hee Jun, 2012, Ocean Science Journal, V47, P395, DOI 10.1007/s12601-012-0037-z; Lee HW, 2013, J ENVIRON MANAGE, V115, P278, DOI 10.1016/j.jenvman.2012.10.055; Lee S, 2008, J OCEANOGR, V64, P763, DOI 10.1007/s10872-008-0064-7; Liang D, 1997, MAR BIOL, V128, P415, DOI 10.1007/s002270050107; Marcus N, 2004, ZOOL STUD, V43, P211; Marques SC, 2008, MAR BIOL, V155, P531, DOI 10.1007/s00227-008-1052-6; Menendez MC, 2016, J COASTAL RES, V32, P1051, DOI 10.2112/JCOASTRES-D-14-00236.1; Milione M, 2008, AQUACULTURE, V275, P116, DOI 10.1016/j.aquaculture.2007.12.010; Rakhesh M, 2013, ESTUAR COAST SHELF S, V126, P7, DOI 10.1016/j.ecss.2013.03.025; Ryu J, 2011, J SEA RES, V65, P390, DOI 10.1016/j.seares.2011.03.003; Sullivan BK, 2007, ESTUAR COAST SHELF S, V73, P259, DOI 10.1016/j.ecss.2007.01.018; Tseng LC, 2016, CONT SHELF RES, V118, P165, DOI 10.1016/j.csr.2016.02.018; Ueda H, 2001, GLOBAL ENVIRON CHANG, V6, P29; Ueda H., B PLANKTON SOC JAPAN, V1991, P143; Uye S, 2000, J MARINE SYST, V26, P193, DOI 10.1016/S0924-7963(00)00054-3; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; UYE S, 1994, HYDROBIOLOGIA, V293, P513, DOI 10.1007/BF00229979; Uye S, 2011, HYDROBIOLOGIA, V666, P71, DOI 10.1007/s10750-010-0208-9; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zervoudaki S, 2009, J PLANKTON RES, V31, P1475, DOI 10.1093/plankt/fbp084; 유정규, 2006, Ocean and Polar Research, V28, P305	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209403	10.1371/journal.pone.0209403	http://dx.doi.org/10.1371/journal.pone.0209403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571703	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700068
J	Dumitrescu, EF; Fisher, AL; Goodrich, TD; Humble, TS; Sullivan, BD; Wright, AL				Dumitrescu, Eugene F.; Fisher, Allison L.; Goodrich, Timothy D.; Humble, Travis S.; Sullivan, Blair D.; Wright, Andrew L.			Benchmarking treewidth as a practical component of tensor network simulations	PLOS ONE			English	Article								Tensor networks are powerful factorization techniques which reduce resource requirements for numerically simulating principal quantum many-body systems and algorithms. The computational complexity of a tensor network simulation depends on the tensor ranks and the order in which they are contracted. Unfortunately, computing optimal contraction sequences (orderings) in general is known to be a computationally difficult (NP-complete) task. In 2005, Markov and Shi showed that optimal contraction sequences correspond to optimal (minimum width) tree decompositions of a tensor network's line graph, relating the contraction sequence problem to a rich literature in structural graph theory. While treewidth-based methods have largely been ignored in favor of dataset-specific algorithms in the prior tensor networks literature, we demonstrate their practical relevance for problems arising from two distinct methods used in quantum simulation: multi-scale entanglement renormalization ansatz (MERA) datasets and quantum circuits generated by the quantum approximate optimization algorithm (QAOA). We exhibit multiple regimes where treewidth-based algorithms outperform domain-specific algorithms, while demonstrating that the optimal choice of algorithm has a complex dependence on the network density, expected contraction complexity, and user run time requirements. We further provide an open source software framework designed with an emphasis on accessibility and extendability, enabling replicable experimental evaluations and future exploration of competing methods by practitioners.	[Dumitrescu, Eugene F.; Humble, Travis S.] Oak Ridge Natl Lab, Quantum Comp Inst, Oak Ridge, TN USA; [Fisher, Allison L.; Goodrich, Timothy D.; Sullivan, Blair D.; Wright, Andrew L.] North Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; North Carolina State University	Goodrich, TD (corresponding author), North Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA.	tdgoodri@ncsu.edu	Humble, Travis/AAC-6694-2019	Sullivan, Blair/0000-0001-7720-6208; Goodrich, Timothy/0000-0003-4947-666X	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; Gordon & Betty Moore Foundation's Data-Driven Discovery Initiative [GBMF4560]; NC State Provost's Professional Experience Program; DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; U.S. Department of Energy, Office of Science Advanced Scientific Computing Research and Early Career Research programs; U.S. Department of Energy [DE-AC05-00OR22725]	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; Gordon & Betty Moore Foundation's Data-Driven Discovery Initiative; NC State Provost's Professional Experience Program; DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship; U.S. Department of Energy, Office of Science Advanced Scientific Computing Research and Early Career Research programs; U.S. Department of Energy(United States Department of Energy (DOE))	Eugene Dumitrescu acknowledges support from the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for the U.S. Department of Energy. Allison Fisher, Blair D. Sullivan and Andrew Wright were supported in part by the Gordon & Betty Moore Foundation's Data-Driven Discovery Initiative through Grant GBMF4560 to Blair D. Sullivan, and the NC State Provost's Professional Experience Program. Timothy D. Goodrich was funded with Government support under and awarded by DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. Travis Humble acknowledges support from the U.S. Department of Energy, Office of Science Advanced Scientific Computing Research and Early Career Research programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; Biamonte J., 2017, ARXIV170800006; Biamonte JD, 2015, J STAT PHYS, V160, P1389, DOI 10.1007/s10955-015-1276-z; Bodlaender HL, 1998, THEOR COMPUT SCI, V209, P1, DOI 10.1016/S0304-3975(97)00228-4; Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Bouchitte V, 2001, SIAM J COMPUT, V31, P212, DOI 10.1137/S0097539799359683; Chi-Chung Lam, 1997, Parallel Processing Letters, V7, P157, DOI 10.1142/S0129626497000176; Dang A, 2017, ARXIV171207311; Darmawan AS, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.040502; Dell Holger, 2017, LEIBN INT P INF LIPI, V63; Dell Holger, 2018, LEIBNIZ INT P INFORM, V89; Dumitrescu E, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.062322; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Evenbly G, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144108; Evenbly G, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245118; Fried E. S, 2017, ARXIV170903636; Gogate V., 2004, P 20 ANN C UNC ART I, P201; Larisch L, 2017, FREETDI PACE 2017 SU; Markov IL, 2008, SIAM J COMPUT, V38, P963, DOI 10.1137/050644756; Merkel Dirk, 2014, LINUX J, V239, P2, DOI DOI 10.5555/2600239.2600241; Ohtsuka H, 2017, MEIJI PACE 2017 SUBM; Pastawski F, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2015)149; Pednault Edwin, 2017, J ENV SCI CHINA; Pfeifer R.N.C., 2014, ARXIV14020939; Pichler T, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.011023; Rico E, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.201601; Schuch N, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165139; Svore K.M., 2014, ARXIV14024467; Van Der Zanden T.C., 2017, ARXIV170909990; Verstraete F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207204; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902; Vidal G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.110501; Werner AH, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.237201	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0207827	10.1371/journal.pone.0207827	http://dx.doi.org/10.1371/journal.pone.0207827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562341	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100008
J	Edwards, ES; Burke, K; Booth, JR; McNorgan, C				Edwards, Erica S.; Burke, Kali; Booth, James R.; McNorgan, Chris			Dyslexia on a continuum: A complex network approach	PLOS ONE			English	Article							WORD FORM AREA; WHITE-MATTER; ARCUATE FASCICULUS; FUNCTIONAL CONNECTIVITY; PHONOLOGICAL AWARENESS; NEURAL SYSTEMS; BRAIN; CHILDREN; INTEGRATION; DISRUPTION	We investigated the efficacy of graph-theoretic metrics of task-related functional brain connectivity in predicting reading difficulty and explored the hypothesis that task conditions emphasizing audiovisual integration would be especially diagnostic of reading difficulty. An fMR1 study was conducted in which 24 children (8 to 14 years old) who were previously diagnosed with dyslexia completed a rhyming judgment task under three presentation modality conditions. Regression analyses found that characteristic connectivity metrics of the reading network showed a presentation modality dependent relationship with reading difficulty: Children with more segregated reading networks and those that used fewer of the available connections were those with the least severe reading difficulty. These results are consistent with the hypothesis that a lack of coordinated processing between the neural regions involved in phonological and orthographic processing contributes towards reading difficulty.	[Edwards, Erica S.; Burke, Kali; McNorgan, Chris] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Booth, James R.] Vanderbilt Univ, Dept Psychol & Human Dev, 221 Kirkland Hall, Nashville, TN 37235 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Vanderbilt University	McNorgan, C (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	cpmcnorg@buffalo.edu	McNorgan, Chris/AAC-9834-2019	McNorgan, Chris/0000-0002-0173-1425; Burke, Kali/0000-0002-1736-480X	NICHD [HD042049]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant HD042049 to JRB from NICHD(https://www.nichd.nih.gov/).The sponsor had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2017, NEUROIMAGE; [Anonymous], [No title captured]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bitan T, 2007, HUM BRAIN MAPP, V28, P880, DOI 10.1002/hbm.20313; Bitan T, 2006, NEUROIMAGE, V33, P991, DOI 10.1016/j.neuroimage.2006.07.007; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Booth JR, 2002, HUM BRAIN MAPP, V16, P251, DOI 10.1002/hbm.10054; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cao F, 2006, J CHILD PSYCHOL PSYC, V47, P1041, DOI 10.1111/j.1469-7610.2006.01684.x; Davies R, 2007, ANN DYSLEXIA, V57, P179, DOI 10.1007/s11881-007-0010-1; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Finn ES, 2014, BIOL PSYCHIAT, V76, P397, DOI 10.1016/j.biopsych.2013.08.031; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; Frye RE, 2012, CEREB CORTEX, V22, P1923, DOI 10.1093/cercor/bhr265; Gold BT, 2007, NEUROPSYCHOLOGIA, V45, P2439, DOI 10.1016/j.neuropsychologia.2007.04.011; Gonzalez GF, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010010; Graves A, 2012, STUD COMPUT INTELL, V385, P37; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gullick MM, 2015, DEV COGN NEUROS-NETH, V13, P68, DOI 10.1016/j.dcn.2015.05.002; Gullick MM, 2014, J COGNITIVE NEUROSCI, V26, P1331, DOI 10.1162/jocn_a_00581; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Horowitz-Kraus T, 2016, ANN DYSLEXIA, V66, P301, DOI 10.1007/s11881-016-0124-4; Horowitz-Kraus T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133762; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; JORM AF, 1983, APPL PSYCHOLINGUIST, V4, P103, DOI 10.1017/S0142716400004380; JORM AF, 1984, APPL PSYCHOLINGUIST, V5, P201, DOI 10.1017/S0142716400005075; Koyama MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055454; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Kronschnabel J, 2014, NEUROPSYCHOLOGIA, V62, P245, DOI 10.1016/j.neuropsychologia.2014.07.024; Liu X, 2018, HUM BRAIN MAPP, V39, P662, DOI 10.1002/hbm.23871; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McNorgan C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00388; McNorgan C, 2011, J NEUROSCI, V31, P9641, DOI 10.1523/JNEUROSCI.0334-11.2011; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Plaut DC, 1999, COGNITIVE SCI, V23, P543, DOI 10.1207/s15516709cog2304_7; Pugh KR, 1997, J EXP PSYCHOL HUMAN, V23, P299, DOI 10.1037/0096-1523.23.2.299; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Schlaggar BL, 2009, CURR DIR PSYCHOL SCI, V18, P21, DOI 10.1111/j.1467-8721.2009.01599.x; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; Torgesen J.K., 1999, TOWRE TEST WORD READ; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Atteveldt NM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-11; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vidyasagar TR, 2005, PERCEPTION, V34, P903, DOI 10.1068/p5332; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Vijayalakshmi R, 2015, NEUROCOMPUTING, V170, P15, DOI 10.1016/j.neucom.2015.03.092; Vogel AC, 2013, BRAIN LANG, V125, P231, DOI 10.1016/j.bandl.2012.12.016; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T; Yeatman JD, 2012, P NATL ACAD SCI USA, V109, pE3045, DOI 10.1073/pnas.1206792109; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Younger JW, 2017, NEUROIMAGE, V158, P90, DOI 10.1016/j.neuroimage.2017.06.044; Zeno S.M., 1995, ED WORD FREQUENCY GU; Ziegler JC, 1997, BEHAV RES METH INS C, V29, P600, DOI 10.3758/BF03210615	75	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208923	10.1371/journal.pone.0208923	http://dx.doi.org/10.1371/journal.pone.0208923			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557304	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000057
J	Marvin-Dowle, K; Kilner, K; Burley, V; Soltani, H				Marvin-Dowle, Katie; Kilner, Karen; Burley, Victoria; Soltani, Hora			Differences in dietary pattern by maternal age in the Born in Bradford cohort: A comparative analysis	PLOS ONE			English	Article							BIRTH-WEIGHT; EATING PATTERNS; PREGNANCY; ASSOCIATIONS; NUTRITION; QUALITY; TEENAGE; INFANT; HEALTH; FOOD	Objective Explore associations between dietary patterns and maternal age Design Population based cohort study Setting Maternity department of a large hospital in northern England Sample Women delivering a singleton at Bradford Royal Infirmary between March 2007 and December 2010 (N = 5,083). Methods Survey data including maternal dietary patterns derived from food frequency questionnaire data using principal component analysis (PCA) were compared by maternal age using one-way ANOVA and chi-squared as appropriate. Main outcome measures Dietary pattern PCA scores, supplement use, familiarity and compliance with 5-a-day fruit and vegetable recommendations, consumption of cola, maternal BMI. Results Three distinct dietary patterns were derived from the data; snack and processed foods, meat and fish and grains and starches. Mean PCA score for snack and processed foods was higher among women aged <= 19 (0.6, CI 0.4 to 0.8) than women aged 20-34 (-0.02, CI -0.1 to 0.01) and those aged 35 >= (-0.3, CI -0.4 to -0.2). Women aged 35 >= had a significantly higher mean PCA score for the grains and starches dietary pattern (0.1, CI 0.03 to 0.3) compared to both the 20-34 years (-0.01, CI -0.05 to 0.02) and the <= 19 (-0.04, CI -0.2 to 0.1) groups. No differences were observed between groups in mean PCA scores for the meat and fish dietary pattern. Adolescent women also had higher intakes of sugar sweetened cola (0.9 cups per day, CI 0.7 to 1.1) and reported lower levels of fruit and vegetable and supplement intake. Women aged 35 >= had a higher mean BMI (28.0, CI 27.5 to 28.4) and higher prevalence of overweight (36.8%) and obesity (29.6%, p<0.001). Conclusions Significant differences were observed between age groups both in terms of diet quality and BMI. Interventions targeted by age group may be advantageous in improving maternal nutrition and contribute to healthy pregnancies.	[Marvin-Dowle, Katie; Kilner, Karen; Soltani, Hora] Sheffield Hallam Univ, Ctr Hlth & Social Care Res, Sheffield, S Yorkshire, England; [Burley, Victoria] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	Sheffield Hallam University; University of Leeds	Marvin-Dowle, K (corresponding author), Sheffield Hallam Univ, Ctr Hlth & Social Care Res, Sheffield, S Yorkshire, England.	k.marvin-dowle@shu.ac.uk		Marvin-Dowle, Katie/0000-0001-6945-923X	Sheffield Hallam University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber; Programme Grants for Applied Research funding scheme [RP-PG-0407-10044]; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber (NIHR CLAHRC YH)	Sheffield Hallam University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber; Programme Grants for Applied Research funding scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber (NIHR CLAHRC YH)	This study has been carried out as part of a White Rose University Consortium PhD project supported by Sheffield Hallam University and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber. Therefore the authors received no specific funding for this work. The Born in Bradford study presents independent research commissioned by the National Institute for Health Research Collaboration for Applied Health Research and Care (NIHR CLAHRC YH) and the Programme Grants for Applied Research funding scheme (RP-PG-0407-10044).; The authors would also like to thank the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber (NIHR CLAHRC YH) for supporting us in conducing this work. Further details about the new NIHR CLAHRC YH can be found at www.clahrc-yh.nihr.ac.uk.The views and opinions expressed are those of the authors, and not necessarily those of the NHS, the NIHR or the Department of Health.	Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Blumfield ML, 2012, NUTR REV, V70, P322, DOI 10.1111/j.1753-4887.2012.00481.x; Burke BS, 1943, J PEDIATR-US, V23, P506, DOI 10.1016/S0022-3476(43)80253-5; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Devine CM, 2000, SOC SCI MED, V50, P567, DOI 10.1016/S0277-9536(99)00314-7; Green EC, 2014, WILEY BLACKWELL ENCY; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Haines PS, 1999, J AM DIET ASSOC, V99, P697, DOI 10.1016/S0002-8223(99)00168-6; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; Jones RL, 2010, BJOG-INT J OBSTET GY, V117, P200, DOI 10.1111/j.1471-0528.2009.02371.x; Marvin-Dowle K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016258; Marvin-Dowle K, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1059-9; Moore LV, 2008, AM J EPIDEMIOL, V167, P917, DOI 10.1093/aje/kwm394; Neumark-Sztainer D, 2003, J AM DIET ASSOC, V103, P317, DOI 10.1053/jada.2003.50048; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Northstone K, 2008, EUR J CLIN NUTR, V62, P471, DOI 10.1038/sj.ejcn.1602741; Petherick ES, 2014, EUR J CLIN NUTR, V68, P404, DOI 10.1038/ejcn.2013.267; Public Health England, 2012, RES YEARS 5 6 COMB R; SCHOLL TO, 1995, SEMIN PERINATOL, V19, P171, DOI 10.1016/S0146-0005(05)80023-0; SCHWERIN HS, 1982, AM J CLIN NUTR, V35, P1319, DOI 10.1093/ajcn/35.5.1319; Wall CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050300; Willett W., 2012, NUTR EPIDEMIOLOGY, DOI [10.1097/EDE.0b013e31825afb0b, DOI 10.1097/EDE.0B013E31825AFB0B]; Wright J, 2013, INT J EPIDEMIOL, V42, P978, DOI 10.1093/ije/dys112	24	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208879	10.1371/journal.pone.0208879	http://dx.doi.org/10.1371/journal.pone.0208879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543673	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500048
J	Nagy, A; Kovacs, L; Lipinszki, Z; Pal, M; Deak, P				Nagy, Agota; Kovacs, Levente; Lipinszki, Zoltan; Pal, Margit; Deak, Peter			Developmental and tissue specific changes of ubiquitin forms in Drosophila melanogaster	PLOS ONE			English	Article							QUANTIFICATION; DEGRADATION; PROTEINS; OVEREXPRESSION; QUANTITATION; INHIBITOR; LETHALITY; DEFECTS; SYSTEM; CHAINS	In most Eukaryotes, ubiquitin either exists as free monoubiquitin or as a molecule that is covalently linked to other proteins. These two forms cycle between each other and due to the concerted antagonistic activity of ubiquitylating and deubiquitylating enzymes, an intracellular ubiquitin equilibrium is maintained that is essential for normal biological function. However, measuring the level and ratio of these forms of ubiquitin has been difficult and time consuming. In this paper, we have adapted a simple immunoblotting technique to monitor ubiquitin content and equilibrium dynamics in different developmental stages and tissues of Drosophila. Our data show that the level of total ubiquitin is distinct in different developmental stages, lowest at the larval-pupal transition and in three days old adult males, and highest in first instar larvae. Interestingly, the ratio of free mono-ubiquitin remains within 30-50% range of the total throughout larval development, but peaks to 70-80% at the larval-pupal and the pupal-adult transitions. It stays within the 70-80% range in adults. In developmentally and physiologically active tissues, the ratio of free ubiquitin is similarly high, most likely reflecting a high demand for ubiquitin availability. We also used this method to demonstrate the disruption of the finely tuned ubiquitin equilibrium by the abolition of proteasome function or the housekeeping deubiquitylase, Usp5. Our data support the notion that the ubiquitin equilibrium is regulated by tissue- and developmental stage-specific mechanisms.	[Nagy, Agota; Kovacs, Levente; Deak, Peter] Univ Szeged, Dept Genet, Szeged, Hungary; [Nagy, Agota; Kovacs, Levente; Lipinszki, Zoltan; Pal, Margit; Deak, Peter] Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Lipinszki, Zoltan] Biol Res Ctr, MTA SZBK Lendulet Lab Cell Cycle Regulat, Szeged, Hungary; [Kovacs, Levente] Univ Cambridge, Dept Genet, Cambridge, England	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Cambridge	Deak, P (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.; Deak, P (corresponding author), Biol Res Ctr, Inst Biochem, Szeged, Hungary.	deakp@bio.u-szeged.hu	Kovacs, Levente/AAA-6730-2022; Deák, Péter/M-5674-2018; Lipinszki, Zoltan/I-6739-2012; Lipinszki, Zoltan/AAI-9548-2021	Lipinszki, Zoltan/0000-0002-2067-0832; Lipinszki, Zoltan/0000-0002-2067-0832; Deak, Peter/0000-0002-8849-0352; Kovacs, Levente/0000-0002-3226-3740	National Research, Development and Innovation Office [OTKA-K116372, OTKA-PD115404]; Ministry for National Economy of Hungary [GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00032]; Hungarian Academy of Sciences [bo_329_15, LP2017-7/2017]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Ministry for National Economy of Hungary; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was funded by grants from the National Research, Development and Innovation Office (OTKA-K116372 and OTKA-PD115404), Ministry for National Economy of Hungary (GINOP-2.3.2-15-2016-00001 and GINOP-2.3.2-15-2016-00032) and Hungarian Academy of Sciences (Bolyai Fellowship (bo_329_15) and Lendulet Program Grant (LP2017-7/2017)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Emmerich CH, 2015, BIOCHEM BIOPH RES CO, V466, P1, DOI 10.1016/j.bbrc.2015.08.109; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jaedicke KM, 2012, J IMMUNOL METHODS, V377, P62, DOI 10.1016/j.jim.2012.01.010; Jones LJ, 2003, BIOTECHNIQUES, V34, P850, DOI 10.2144/03344pt03; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120875; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lipinszki Z, 2011, FEBS J, V278, P4833, DOI 10.1111/j.1742-4658.2011.08383.x; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Song J, 2009, PROTEIN SCI, V18, P2492, DOI 10.1002/pro.254; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; TAKADA K, 1995, EUR J BIOCHEM, V233, P42, DOI 10.1111/j.1432-1033.1995.042_1.x; Takada K, 1996, BBA-GEN SUBJECTS, V1290, P282, DOI 10.1016/0304-4165(96)00032-3; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Truman James W., 1993, P1245; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Wang CH, 2014, BIOCHEM BIOPH RES CO, V452, P369, DOI 10.1016/j.bbrc.2014.08.069; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209080	10.1371/journal.pone.0209080	http://dx.doi.org/10.1371/journal.pone.0209080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543682	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000453247500071
J	Burri, S; Niklaus, PA; Grassow, K; Buchmann, N; Kahmen, A				Burri, Susanne; Niklaus, Pascal A.; Grassow, Karin; Buchmann, Nina; Kahmen, Ansgar			Effects of plant productivity and species richness on the drought response of soil respiration in temperate grasslands	PLOS ONE			English	Article							CO2 FLUX; SUMMER DROUGHT; COMMUNITY COMPOSITION; TIME-LAG; CLIMATE; PHOTOSYNTHESIS; BIODIVERSITY; DIVERSITY; VARIABILITY; EFFLUX	Soil respiration plays a crucial role in global carbon cycling. While the response of soil respiration to abiotic drivers like soil temperature and moisture is fairly well understood, less is known about the effects of biotic drivers, such as plant above- and belowground productivity or plant diversity, and their interactions with abiotic drivers on soil respiration. Thus, current predictions of soil respiration to summer droughts might miss relevant biological drivers and their interactions with abiotic drivers. Since drought events are expected to increase in Central Europe in the future, we simulated early summer drought using rainout shelters at 19 grassland sites, which differed in plant productivity and species richness in central Germany in 2002 and 2003. We tested the potentially interacting effects of drought with biotic drivers, i.e. annual above-ground productivity, species richness and root biomass, on the drought response of soil respiration in temperate grasslands. In both years, drought led to a significant reduction in soil respiration. The drought-induced reduction in soil respiration was largely driven by the reduction in above-ground productivity in response to drought. The extent of the drought response of soil respiration was dependent on the species richness level of the site and this interacting effect was explainable by the variation in root biomass (root biomass and species richness were positively correlated). Our findings highlight the importance of biotic drivers for the quantification of the drought response of soil respiration in grasslands.	[Burri, Susanne; Kahmen, Ansgar] Univ Basel, Dept Environm Sci Bot, Basel, Switzerland; [Burri, Susanne; Buchmann, Nina] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Grassow, Karin] Max Planck Gesell, Fritz Haber Inst, Berlin, Germany	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Max Planck Society; Fritz Haber Institute of the Max Planck Society	Burri, S (corresponding author), Univ Basel, Dept Environm Sci Bot, Basel, Switzerland.	susanne.burri@usys.ethz.ch	Niklaus, Pascal A/G-5786-2010; Buchmann, Nina/E-6095-2011; Kahmen, Ansgar/AAC-4899-2019	Niklaus, Pascal A/0000-0002-2360-1357; Buchmann, Nina/0000-0003-0826-2980; 	BIOLOG program of the German Federal Ministry for Education and Research (BMBF) [LC0013]	BIOLOG program of the German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was funded by grant LC0013 in the BIOLOG program of the German Federal Ministry for Education and Research (BMBF), https://www.bmbf.de/en/research-funding-1411.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Balogh J, 2016, BIOGEOSCIENCES, V13, P5171, DOI 10.5194/bg-13-5171-2016; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barthel M, 2011, NEW PHYTOL, V192, P925, DOI 10.1111/j.1469-8137.2011.03848.x; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Burri S, 2014, BIOGEOSCIENCES, V11, P961, DOI 10.5194/bg-11-961-2014; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Coleman K, 1999, ROTHC 26 3 MODEL TUR; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; Craine JM, 2001, GLOBAL CHANGE BIOL, V7, P947, DOI 10.1046/j.1354-1013.2001.00455.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; De Boeck HJ, 2007, NEW PHYTOL, V175, P512, DOI 10.1111/j.1469-8137.2007.02122.x; Dias ATC, 2010, OECOLOGIA, V163, P805, DOI 10.1007/s00442-010-1569-5; Garcia FC, 2018, P NATL ACAD SCI USA, V115, P10989, DOI 10.1073/pnas.1805518115; Hagedorn F, 2014, BIOGEOCHEMISTRY, V117, P395, DOI 10.1007/s10533-013-9881-x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Heinemeyer A, 2012, EUR J SOIL SCI, V63, P249, DOI 10.1111/j.1365-2389.2012.01433.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hoover DL, 2016, J GEOPHYS RES-BIOGEO, V121, P1034, DOI 10.1002/2015JG003256; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Johnson D, 2008, BIOL LETTERS, V4, P345, DOI 10.1098/rsbl.2008.0121; Joos O, 2010, BIOGEOSCIENCES, V7, P1031, DOI 10.5194/bg-7-1031-2010; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kahmen A, 2005, OECOLOGIA, V142, P606, DOI 10.1007/s00442-004-1749-2; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Yand, 2006, SOIL RESP ENV; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Salmon Y, 2014, FUNCT PLANT BIOL, V41, P850, DOI 10.1071/FP13212; Sanaullah M, 2012, SOIL BIOL BIOCHEM, V55, P132, DOI 10.1016/j.soilbio.2012.06.004; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Subke JA, 2010, SOIL BIOL BIOCHEM, V42, P1653, DOI 10.1016/j.soilbio.2010.05.026; Vicca S, 2014, BIOGEOSCIENCES, V11, P2991, DOI 10.5194/bg-11-2991-2014; Vogel A, 2013, GLOBAL CHANGE BIOL, V19, P2795, DOI 10.1111/gcb.12225; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang YF, 2014, J SOIL SEDIMENT, V14, P99, DOI 10.1007/s11368-013-0799-7; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002	44	8	8	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209031	10.1371/journal.pone.0209031	http://dx.doi.org/10.1371/journal.pone.0209031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576332	Green Published, gold			2022-12-26	WOS:000454149400023
J	Wilke, ABB; Vasquez, C; Petrie, W; Caban-Martinez, AJ; Beier, JC				Wilke, Andre B. B.; Vasquez, Chalmers; Petrie, William; Caban-Martinez, Alberto J.; Beier, John C.			Construction sites in Miami-Dade County, Florida are highly favorable environments for vector mosquitoes	PLOS ONE			English	Article							ZIKA VIRUS; MULTIPLE INTRODUCTIONS; URBANIZATION; BIODIVERSITY; EPIDEMIOLOGY; TRANSMISSION; DENGUE	Urbanization is increasing globally, and construction sites are an integral part of the urbanization process. It is unknown to what extent construction sites create favorable breeding conditions for mosquitoes. The main objectives of the present study were to identify what species of mosquitoes are present at construction sites and the respective physical features associated with their production. Eleven construction sites were cross-sectionally surveyed for the presence of mosquitoes in Miami-Dade County, Florida including in areas previously affected by the Zika virus outbreak in 2016. A total of 3.351 mosquitoes were collected; 2.680 adults and 671 immatures. Aedes aegypti and Culex quinquefasciatus comprised 95% of all collected mosquitoes and were the only species found in their immature forms breeding inside construction sites. Results for the Shannon and Simpson indices, considering both immature and adult specimens, yielded the highest values for Cx. quinquefasciatus and Ae. aegypti. The individual rarefaction curves indicated that sampling sufficiency was highly asymptotic for Cx. quinquefasciatus and Ae. aegypti, and the plots of cumulative species abundance (In S), Shannon index (H) and log evenness (In E) (SHE) revealed the lack of heterogeneity of species composition, diversity and evenness for the mosquitoes found breeding in construction sites. The most productive construction site breeding features were elevator shafts, Jersey plastic barriers, flooded floors and stair shafts. The findings of this study indicate that vector mosquitoes breed in high numbers at construction sites and display reduced biodiversity comprising almost exclusively Ae. aegypti and Cx. quinquefasciatus. Such findings suggest that early phase construction sites have suitable conditions for the proliferation of vector mosquitoes. More studies are needed to identify modifiable worker- and organizational-level factors to improve mosquito control practices and guide future mosquito control strategies in urban environments.	[Wilke, Andre B. B.; Caban-Martinez, Alberto J.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014; Caban-Martinez, Alberto/AAG-1499-2019	Wilke, Andre B B/0000-0002-6629-7666; Caban-Martinez, Alberto/0000-0002-5960-1308	CDC [1U01CK000510-01]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by CDC (https://www.cdc.gov/) grant 1U01CK000510-01: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program to JB. CDC had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026; Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664; Zuluaga WA, 2012, BIOMEDICA, V32, P321, DOI [10.1590/S0120-41572012000300003, 10.7705/biomedica.v32i3.668]; [Anonymous], 2018, CONSTR CHART BOOK US; BAUMGARTNER DL, 1987, J AM MOSQUITO CONTR, V3, P26; Bennet F.L., 2003, MANAGEMENT CONSTRUCT; Brown C., 2014, INT J SCI TECHNOL RE, V3, P94; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Bureau of Labor Statistics, 2016, LAB FORC STAT CURR P, P230; Buzas MA, 1998, J FORAMIN RES, V28, P233; Colwell R.K., 2009, PRINCET GUIDE ECOL P, V663, P257, DOI DOI 10.1515/9781400833023.257; Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Darsie R. F. Jr., 2000, KEYS ADULT FEMALES 4, V1; Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Icheku V., 2016, UNIVERSAL J PUBLIC H, V4, P203; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Kenea O, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1668-9; Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Legros M, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1515; Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959; Sampaio AMM, 2009, WASTE MANAGE, V29, P2867, DOI 10.1016/j.wasman.2009.06.017; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Musso D, 2018, LANCET INFECT DIS, V3099, P1, DOI [10.1016/S1473-3099(18)30269-X, DOI 10.1016/S1473-3099(18)30269-X]; Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919; Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Saifur RGM, 2016, 1 RECORD DENGUE VECT, P114, DOI [10.15242/IIE.A.1216020, DOI 10.15242/IIE.A.1216020]; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tserng HP, 2009, AUTOMAT CONSTR, V18, P994, DOI 10.1016/j.autcon.2009.05.005	51	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209625	10.1371/journal.pone.0209625	http://dx.doi.org/10.1371/journal.pone.0209625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571764	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700091
J	Blacklock, KB; Birand, Z; Biasoli, D; Fineberg, E; Murphy, S; Flack, D; Bass, J; Di Palma, S; Blackwood, L; McKay, J; Whitbread, T; Fox, R; Eve, T; Beaver, S; Starkey, M				Blacklock, Kelly Bowlt; Birand, Zeynep; Biasoli, Deborah; Fineberg, Elena; Murphy, Sue; Flack, Debs; Bass, Joyce; Di Palma, Stefano; Blackwood, Laura; McKay, Jenny; Whitbread, Trevor; Fox, Richard; Eve, Tom; Beaver, Stuart; Starkey, Mike			Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysis	PLOS ONE			English	Article							C-KIT; CANCER METASTASIS; PROSTATE-CANCER; BREAST-CANCER; APOPTOSIS; SUPPRESSOR; DOGS; MIGRATION; MARKER; GROWTH	Cutaneous mast cell tumours are one of the most common canine cancers. Approximately 25% of the tumours metastasise. Activating c-kit mutations are present in about 20% of tumours, but metastases occur in the absence of mutations. Tumour metastasis is associated with significantly diminished survival in spite of adjuvant chemotherapy. Available prognostic tests do not reliably predict whether a tumour will metastasise. In this study we compared the global expression profiles of 20 primary cutaneous mast cell tumours that metastasised with those of 20 primary tumours that did not metastasise. The objective was to identify genes associated with mast cell tumour metastatic progression that may represent targets for therapeutic intervention and biomarkers for prediction of tumour metastasis. Canine Gene 1.1 ST Arrays were employed for genome-wide expression analysis of formalin-fixed, paraffin-embedded biopsies of mast cell tumours borne by dogs that either died due to confirmed mast cell tumour metastasis, or were still alive more than 1000 days post-surgery. Decreased gene expression in the metastasising tumours appears to be associated with a loss of cell polarity, reduced cell-cell and cell-ECM adhesion, and increased cell deformability and motility. Dysregulated gene expression may also promote extracellular matrix and base membrane degradation, suppression of cell cycle arrest and apoptosis, and angiogenesis. Down-regulation of gene expression in the metastasising tumours may be achieved at least in part by small nucleolar RNA-derived RNA and microRNA-effected gene silencing. Employing cross-validation, a linear discriminant analysis-based classifier featuring 19 genes that displayed two-fold differences in expression between metastasising and non-metastasising tumours was estimated to classify metastasising and non-metastasising tumours with accuracies of 90-100% and 70-100%, respectively. The differential expression of 9 of the discriminator genes was confirmed by quantitative reverse transcription-PCR.	[Blacklock, Kelly Bowlt; Birand, Zeynep; Biasoli, Deborah; Fineberg, Elena; Murphy, Sue; Flack, Debs; Bass, Joyce; Di Palma, Stefano; Starkey, Mike] Anim Hlth Trust, Newmarket, Suffolk, England; [Blackwood, Laura] Univ Liverpool, Inst Vet Sci, Neston, England; [McKay, Jenny] IDEXX Labs Ltd, Wetherby, England; [Whitbread, Trevor] Abbey Vet Serv, Newton Abbot, England; [Bass, Joyce; Fox, Richard; Eve, Tom] Finn Pathol, Harleston, England; [Beaver, Stuart] Nationwide Lab Serv, Poulton Le Fylde, England; [Murphy, Sue] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Flack, Debs] Univ Cambridge, Cambridge, England	Animal Health Trust; University of Liverpool; University of Edinburgh; University of Cambridge	Starkey, M (corresponding author), Anim Hlth Trust, Newmarket, Suffolk, England.	mike.starkey@aht.org.uk	Di Palma, Stefano/AAX-5649-2020	Di Palma, Stefano/0000-0002-9466-3918; Bowlt Blacklock, Kelly/0000-0001-6482-7224	UK Kennel Club	UK Kennel Club	Funding provided by UK Kennel Club (https://www.thekennelclub.org.uk/).JM is employed by and received salary from Idexx Laboratories. TW is employed by and received salary from Abbey Veterinary Services. RF and TE are employed by and received salary from Finn Pathologists. SB is employed by and received salary from Nationwide Laboratory Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl MR, 2015, ONCOTARGET, V6, P28693, DOI 10.18632/oncotarget.4981; [Anonymous], SUMM BAS AFF QUAL AS; Attardi LD, 2005, MUTAT RES-FUND MOL M, V569, P145, DOI 10.1016/j.mrfmmm.2004.04.019; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Berlato D, 2012, VET COMP ONCOL, V10, P135, DOI 10.1111/j.1476-5829.2011.00287.x; Blackwood L, 2012, VET COMP ONCOL, V10, pe1, DOI 10.1111/j.1476-5829.2012.00341.x; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Chun MGH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001120; Das M, 1998, MAMM GENOME, V9, P64, DOI 10.1007/s003359900681; Daves MH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-56; Davies DR, 2004, J AM ANIM HOSP ASSOC, V40, P124, DOI 10.5326/0400124; Davies L, 2009, J CELL MOL MED, V13, P1995, DOI 10.1111/j.1582-4934.2008.00590.x; Debily MA, 2004, HUM MOL GENET, V13, P323, DOI 10.1093/hmg/ddh024; Depondt J, 1999, EUR J ORAL SCI, V107, P183, DOI 10.1046/j.0909-8836.1999.eos1070305.x; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Downing S, 2002, AM J VET RES, V63, P1718, DOI 10.2460/ajvr.2002.63.1718; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fenger JM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-84; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Giantin M, 2016, VET J, V212, P36, DOI 10.1016/j.tvjl.2016.03.024; Giantin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095481; Golan T, 2015, MOL CELL, V59, P664, DOI 10.1016/j.molcel.2015.06.028; Hartmann M, 2015, MOL CANCER RES, V13, P879, DOI 10.1158/1541-7786.MCR-15-0020-T; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu R, 1998, LUNG CANCER, V20, P25, DOI 10.1016/S0169-5002(97)00097-4; Jark PC, 2017, RES VET SCI, V111, P26, DOI 10.1016/j.rvsc.2016.11.009; JENSEN BA, 1988, CANCER, V62, P869, DOI 10.1002/1097-0142(19880901)62:5<869::AID-CNCR2820620503>3.0.CO;2-6; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Jong VL, 2016, BIOINFORMATICS, V32, P1814, DOI 10.1093/bioinformatics/btw034; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kiupel M, 2011, VET PATHOL, V48, P147, DOI 10.1177/0300985810386469; Krick EL, 2009, VET COMP ONCOL, V7, P130, DOI 10.1111/j.1476-5829.2009.00185.x; Krick EL, 2017, J AM ANIM HOSP ASSOC, V53, P258, DOI 10.5326/JAAHA-MS-6265; LaTulippe E, 2002, CANCER RES, V62, P4499; Gutierrez ML, 2017, ONCOTARGET, V8, P107685, DOI 10.18632/oncotarget.22591; Li DJ, 2009, CANCER LETT, V279, P65, DOI 10.1016/j.canlet.2009.01.028; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lopez-Farre AJ, 2012, J NEUROCHEM, V121, P314, DOI 10.1111/j.1471-4159.2012.07683.x; Ma R, 2016, MOL CANCER RES, V14, DOI [10.1158/1557-3125, DOI 10.1158/1557-3125]; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mitra A, 2012, LAB INVEST, V92, P1310, DOI 10.1038/labinvest.2012.87; MIYAKE M, 1995, CANCER RES, V55, P4127; Mochizuki H, 2017, CHROMOSOME RES, V25, P129, DOI 10.1007/s10577-016-9543-7; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Ozturk S, 2003, CANCER CELL, V3, P537; Ozturk S, 2016, P NATL ACAD SCI USA, V113, P638, DOI 10.1073/pnas.1514663113; Page GP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-84; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pandya P, 2017, MOL ONCOL, V11, P5, DOI 10.1002/1878-0261.12019; PATNAIK AK, 1984, VET PATHOL, V21, P469, DOI 10.1177/030098588402100503; Patterson DG, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0032-8; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; Romansik EM, 2007, VET PATHOL, V44, P335, DOI 10.1354/vp.44-3-335; Roux KJ, 2005, MOL BIOL CELL, V16, P1142, DOI 10.1091/mbc.E04-07-0551; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Scase TJ, 2006, J VET INTERN MED, V20, P151, DOI 10.1892/0891-6640(2006)20[151:CMCTCO]2.0.CO;2; Setoguchi T, 2011, CANCER SCI, V102, P883, DOI 10.1111/j.1349-7006.2011.01872.x; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; SIMOES JPC, 1994, VET PATHOL, V31, P637, DOI 10.1177/030098589403100602; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Stefanello D, 2015, JAVMA-J AM VET MED A, V246, P765, DOI 10.2460/javma.246.7.765; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Takeda T, 2007, CANCER RES, V67, P1744, DOI 10.1158/0008-5472.CAN-06-3090; Taylor F, 2010, VET COMP ONCOL, V8, P263, DOI 10.1111/j.1476-5829.2010.00220.x; Thamm DH, 1999, J VET INTERN MED, V13, P491, DOI 10.1892/0891-6640(1999)013&lt;0491:PAVCFC&gt;2.3.CO;2; Townson JL, 2003, CURR MOL MED, V3, P631, DOI 10.2174/1566524033479483; TRAWEEK ST, 1993, AM J PATHOL, V142, P1111; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Wang SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172498; Wang TH, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.62; Warland J, 2013, VET J, V197, P496, DOI 10.1016/j.tvjl.2013.02.017; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yang C, 2013, VIRCHOWS ARCH, V463, P379, DOI 10.1007/s00428-013-1452-y; Yang LL, 2012, CARCINOGENESIS, V33, P1863, DOI 10.1093/carcin/bgs226; Zemke D, 2002, VET PATHOL, V39, P529, DOI 10.1354/vp.39-5-529; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang HH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05416; Zhu JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21549; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	96	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208026	10.1371/journal.pone.0208026	http://dx.doi.org/10.1371/journal.pone.0208026			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566430	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300021
J	Buccini, G; Perez-Escamilla, R; Benicio, MHD; Giugliani, ERJ; Venancio, SI				Buccini, Gabriela; Perez-Escamilla, Rafael; D'Aquino Benicio, Maria Helena; Justo Giugliani, Elsa Regina; Venancio, Sonia Isoyama			Exclusive breastfeeding changes in Brazil attributable to pacifier use	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; 1ST 6 MONTHS; RISK-FACTOR; DETERMINANTS; DURATION; OUTCOMES; TRENDS; IMPACT; TRIAL; LIFE	Background Identifying key interventions to increase exclusive breastfeeding duration has been a challenge. Pacifier use has been associated with exclusive breastfeeding discontinuation in Brazil. However, the proportion of the improvement in exclusive breastfeeding duration attributable to pacifier use remains unknown. Research aim Quantify the proportion of increases in exclusive breastfeeding prevalence that can be attributed to reduced pacifier use over time. Methods Secondary data analyses of two nationally representative cross-sectional surveys conducted in States' capitals in 1999 and in 2008 (N = 42,395 Brazilian infants under 6 months of age). We estimated the fraction of exclusive breastfeeding prevalence improvements that could be attributed to pacifier use based on multilevel regression analysis. Results From 1999 to 2008, there was an increase of 15.2 percentage points in exclusive breastfeeding prevalence and a decrease of approximately 17 percentage points in the prevalence of pacifier use among infants under 6 months. Reduction in pacifier use explained an increase in 5.5 percentage points' exclusive breastfeeding rates. If pacifier use were to decrease from 41.6% (prevalence in 2008) to 14% (as found in New Zealand), there would be an expected additional increase in exclusive breastfeeding of approximately 12 percentage points. Conclusions About one-third of the improvements in EBF prevalence observed in Brazil over a decade can be attributed to the corresponding decline in pacifier use.	[Buccini, Gabriela; D'Aquino Benicio, Maria Helena; Venancio, Sonia Isoyama] Univ Sao Paulo, Dept Nutr, Sao Paulo, SP, Brazil; [Buccini, Gabriela; Perez-Escamilla, Rafael] Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA; [Justo Giugliani, Elsa Regina] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil; [Venancio, Sonia Isoyama] Inst Saude, Dept Director, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Yale University; Universidade Federal do Rio Grande do Sul	Buccini, G (corresponding author), Univ Sao Paulo, Dept Nutr, Sao Paulo, SP, Brazil.; Buccini, G (corresponding author), Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA.	gabriela.buccini@yale.edu	Giugliani, Elsa Regina Justo/Y-9236-2019; Venancio, Sonia Isoyama/O-2588-2013; Buccini, Gabriela/M-4739-2013	Buccini, Gabriela/0000-0001-6008-0987	Brazilian government through the Coordination for the Improvement of Higher Level Personnel-CAPES Foundation	Brazilian government through the Coordination for the Improvement of Higher Level Personnel-CAPES Foundation	GB has received a doctorate fellowship funding from the Brazilian government through the Coordination for the Improvement of Higher Level Personnel-CAPES Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Balogun OO, 2015, MATERN CHILD NUTR, V11, P433, DOI 10.1111/mcn.12180; Batista CLC, 2018, J PEDIAT-BRAZIL, V94, P596, DOI 10.1016/j.jped.2017.10.005; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Boccolini CS, 2017, REV SAUDE PUBL, V51, DOI 10.11606/S1518-8787.2017051000029; Boccolini CS, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005971; Brasileiro AA, 2012, REV SAUDE PUBL, V46, P642, DOI 10.1590/S0034-89102012005000053; Buccini GD, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12384; Buccini GD, 2016, J HUM LACT, V32, pNP52, DOI 10.1177/0890334415609611; Buccini GD, 2014, REV SAUDE PUBL, V48, P571, DOI 10.1590/S0034-8910.2014048005128; Buccini Gabriela dos Santos, 2011, Rev. Bras. Saude Mater. Infant., V11, P239, DOI 10.1590/S1519-38292011000300004; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; da Silveira LM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-89102013000100006; de Oliveira LD, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-73; Feldens CA, 2013, COMMUNITY DENT ORAL, V41, P317, DOI 10.1111/cdoe.12030; Ferreira HR, 2015, EUR ADDICT RES, V21, P33, DOI 10.1159/000365351; Haider R, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0077-6; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; Hohman EE, 2017, CHILD OBES; Howard CR, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e33; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Huang YY, 2011, MACAU JOURNAL OF NUR, V10; Jaafar SH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007202.pub4; JAMA, 2001, JAMA-J AM MED ASSOC, V286; Jenik AG, 2009, J PEDIATR-US, V155, P350, DOI 10.1016/j.jpeds.2009.03.038; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kramer MS, 2001, JAMA-J AM MED ASSOC, V286, P322, DOI 10.1001/jama.286.3.322; Kronborg H, 2009, BIRTH-ISS PERINAT C, V36, P34, DOI 10.1111/j.1523-536X.2008.00293.x; Lindau JF, 2015, EUR J PEDIATR, V174, P533, DOI 10.1007/s00431-014-2428-x; de Lima ALL, 2010, REV SAUDE PUBL, V44, P17, DOI 10.1590/S0034-89102010000100002; Lubbe W, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1306-8; Lucas A, 1996, LANCET, V347, P1765; Lumbiganon P, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006425.pub4; Lutter CK, 2013, ADV NUTR, V4, P213, DOI 10.3945/an.112.003111; Merten S, 2005, PEDIATRICS, V116, pE702, DOI 10.1542/peds.2005-0537; Moon RY, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2940; Morgenstern H, 1982, J Community Health, V7, P292, DOI 10.1007/BF01318961; Nelson EAS, 2005, J HUM LACT, V21, P289, DOI 10.1177/0890334405278489; Niemela M, 2000, PEDIATRICS, V106, P483, DOI 10.1542/peds.106.3.483; North K, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.3.e34; Organization WH, 2008, IND ASS INF YOUNG 1; Parizoto GM, 2009, J PEDIAT-BRAZIL, V85, P201, DOI [10.2223/JPED.1888, 10.1590/S0021-75572009000300004]; Peres KG, 2007, REV SAUDE PUBL, V41, P343, DOI 10.1590/S0034-89102007000300004; Perez-Escamilla R, 2016, MATERN CHILD NUTR, V12, P402, DOI 10.1111/mcn.12294; Psaila K, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011147.pub2; Rea Marina Ferreira, 2003, Cad. Saúde Pública, V19, pS37, DOI 10.1590/S0102-311X2003000700005; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Rovers MM, 2008, FAM PRACT, V25, P233, DOI 10.1093/fampra/cmn030; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sertorio SCM, 2005, REV SAUDE PUBL, V39, P156, DOI 10.1590/S0034-89102005000200003; Shotts L. L., 2008, CONT ISSUES COMMUNIC, V2008, P72; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Sipsma HL, 2017, J HUM LACT, V33, P692, DOI 10.1177/0890334417725033; Venancio S., 2012, BIS B I SAUDE, V13, P239; Venancio SI, 2006, PUBLIC HEALTH NUTR, V9, P40, DOI 10.1079/PHN2005760; Venancio SI, 2010, J PEDIAT-BRAZIL, V86, P317, DOI 10.2223/JPED.2016; Venancio SI, 2013, REV SAUDE PUBL, V47, P1205, DOI 10.1590/S0034-8910.2013047004676; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Victora CG, 1997, PEDIATRICS, V99, P445, DOI 10.1542/peds.99.3.445; Vogel AM, 2001, J PAEDIATR CHILD H, V37, P58, DOI 10.1046/j.1440-1754.2001.00581.x; Warren JJ, 2002, AM J ORTHOD DENTOFAC, V121, P347, DOI 10.1067/mod.2002.121445; Xu FL, 2007, ASIA PAC J CLIN NUTR, V16, P316	67	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208261	10.1371/journal.pone.0208261	http://dx.doi.org/10.1371/journal.pone.0208261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566449	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300032
J	Diosdado, JAV; Barker, ZE; Hodges, HR; Amory, JR; Croft, DP; Bell, NJ; Codling, EA				Diosdado, Jorge A. Vazquez; Barker, Zoe E.; Hodges, Holly R.; Amory, Jonathan R.; Croft, Darren P.; Bell, Nick J.; Codling, Edward A.			Space-use patterns highlight behavioural differences linked to lameness, parity, and days in milk in barn-housed dairy cows	PLOS ONE			English	Article							FEEDING-BEHAVIOR; LYING BEHAVIOR; HINDLIMB LAMENESS; SIDE PREFERENCE; ENTRANCE ORDER; HOME RANGES; MOVEMENT; SYSTEM; ASSOCIATIONS; OVERLAP	Lameness is a key health and welfare issue affecting commercial herds of dairy cattle, with potentially significant economic impacts due to the expense of treatment and lost milk production. Existing lameness detection methods can be time-intensive, and under-detection remains a significant problem leading to delayed or missed treatment. Hence, there is a need for automated monitoring systems that can quickly and accurately detect lameness in individual cows within commercial dairy herds. Recent advances in sensor tracking technology have made it possible to observe the movement, behaviour and space-use of a range of animal species over extended time-scales. However, little is known about how observed movement behaviour and space-use patterns in individual dairy cattle relate to lameness, or to other possible confounding factors such as parity or number of days in milk. In this cross-sectional study, ten lame and ten non-lame barn-housed dairy cows were classified through mobility scoring and subsequently tracked using a wireless local positioning system. Nearly 900,000 spatial locations were recorded in total, allowing a range of movement and spaceuse measures to be determined for each individual cow. Using linear models, we highlight where lameness, parity, and the number of days in milk have a significant effect on the observed space-use patterns. Non-lame cows spent more time, and had higher site fidelity (on a day-to-day basis they were more likely to revisit areas they had visited previously), in the feeding area. Non-lame cows also had a larger full range size within the barn. In contrast, lame cows spent more time, and had a higher site-fidelity, in the cubicle (resting) areas of the barn than non-lame cows. Higher parity cows were found to spend more time in the right-hand-side area of the barn, closer to the passageway to the milking parlour. The number of days in milk was found to positively affect the core range size, but with a negative interaction effect with lameness. Using a simple predictive model, we demonstrate how it is possible to accurately determine the lameness status of all individual cows within the study 16 using only two observed space-use measures, the proportion of time spent in the feeding area and the full range size. Our findings suggest that differences in individual movement and space-use behaviour could be used as indicators of health status for automated monitoring within a Precision Livestock Farming approach, potentially leading to faster diagnosis and treatment, and improved animal welfare for dairy cattle and other managed animal species.	[Diosdado, Jorge A. Vazquez; Codling, Edward A.] Univ Essex, Dept Math Sci, Colchester, Essex, England; [Barker, Zoe E.; Hodges, Holly R.; Amory, Jonathan R.] Writtle Univ Coll, Chelmsford, Essex, England; [Croft, Darren P.] Univ Exeter, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England; [Bell, Nick J.] Royal Vet Coll, Hatfield, Herts, England; [Diosdado, Jorge A. Vazquez] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Leicester, Leics, England; [Bell, Nick J.] Bos Int Ltd, Wimborne, Dorset, England	University of Essex; University of Exeter; University of London; University of London Royal Veterinary College; University of Nottingham	Codling, EA (corresponding author), Univ Essex, Dept Math Sci, Colchester, Essex, England.	ecodling@essex.ac.uk	Codling, Edward A/F-1922-2011; Codling, Edward/ABB-4283-2021; Croft, Darren P/B-5503-2009	Codling, Edward A/0000-0001-5124-3334; Codling, Edward/0000-0001-5124-3334; Croft, Darren P/0000-0001-6869-5097; Bell, Nick/0000-0001-6415-0786; Amory, Jonathan Richard/0000-0002-0047-8739	UK Biotechnology and Biological Sciences Research Council [BB/K002562/1, BB/K002376/1, BB/K001302/1, BB/K003070/1]; Colin Spedding Memorial Research Studentship - Farm Animal Welfare Trust; BBSRC [BB/K001302/1, BB/K002376/1, BB/K003070/1, BB/K002562/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Colin Spedding Memorial Research Studentship - Farm Animal Welfare Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is supported by the UK Biotechnology and Biological Sciences Research Council thorough grants BB/K002562/1 (EC & JVD), BB/K002376/1 (JA & ZB), BB/K001302/1 (DC), BB/K003070/1 (NB). HH was supported by the Colin Spedding Memorial Research Studentship awarded by The Farm Animal Welfare Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarifi A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050707; Archer S, 2010, IN PRACTICE, V32, P492, DOI 10.1136/inp.c6672; Arcidiacono C, BIOSYST ENG, DOI [10.1016/j.biosystemseng.2017.04.011, DOI 10.1016/J.BIOSYSTEMSENG.2017.04.011]; Arthur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120888; Azizi O, 2009, LIVEST SCI, V122, P156, DOI 10.1016/j.livsci.2008.08.009; Azizi O, 2010, ARCH TIERZUCHT, V53, P130, DOI 10.5194/aab-53-130-2010; Barasona JA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0122-7; Barker ZE, 2018, J DAIRY SCI, V101, P6310, DOI 10.3168/jds.2016-12172; Beer G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155796; Bell Nick, 2009, Vet Rec, V164, P726; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Berckmans D, 2014, REV SCI TECH OIE, V33, P189, DOI 10.20506/rst.33.1.2273; Bewley JM, 2010, J DAIRY RES, V77, P1, DOI 10.1017/S0022029909990227; Bhattacharyya A, 1946, SANKHYA, V7, P401; Blackie N, 2013, J DAIRY SCI, V96, P3564, DOI 10.3168/jds.2012-5597; Blackie N, 2011, APPL ANIM BEHAV SCI, V134, P85, DOI 10.1016/j.applanim.2011.08.004; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Brough AM, 2017, FOREST ECOL MANAG, V389, P220, DOI 10.1016/j.foreco.2016.11.034; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Ceballos A, 2004, J DAIRY SCI, V87, P2042, DOI 10.3168/jds.S0022-0302(04)70022-3; Chapinal N, 2010, J DAIRY SCI, V93, P2007, DOI 10.3168/jds.2009-2803; Clapp JG, 2015, ECOL EVOL, V5, P3869, DOI 10.1002/ece3.1655; Dawkins MS, 2012, ANIM BEHAV, V84, P219, DOI 10.1016/j.anbehav.2012.04.036; Deming JA, 2013, J DAIRY SCI, V96, P344, DOI 10.3168/jds.2012-5985; DeVries TJ, 2003, J DAIRY SCI, V86, P3354, DOI 10.3168/jds.S0022-0302(03)73938-1; Diosdado J. A. V., 2015, ANIM BIOTELEM, V3, P1, DOI 10.1186/S40317-015-0045-8; DONCASTER CP, 1991, J ANIM ECOL, V60, P423, DOI 10.2307/5288; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Galindo Francisco, 2002, Journal of Applied Animal Welfare Science, V5, P193, DOI 10.1207/S15327604JAWS0503_03; Garitano-Zavala A, 2013, WILSON J ORNITHOL, V125, P491, DOI 10.1676/12-151.1; Ghotoorlar SM, 2012, VET REC, V170, P126, DOI 10.1136/vr.100429; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Gonzalez LA, 2015, COMPUT ELECTRON AGR, V110, P91, DOI 10.1016/j.compag.2014.10.018; Grasso F, 2007, ITAL J ANIM SCI, V6, P187; Gygax L, 2007, COMPUT ELECTRON AGR, V56, P23, DOI 10.1016/j.compag.2006.12.004; Hair J, 2016, MULTIVARIATE DATA AN; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Homburger H, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0053-6; Homburger H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114522; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horseman SV, 2014, ANIM WELFARE, V23, P157, DOI 10.7120/09627286.23.2.157; Juarez ST, 2003, APPL ANIM BEHAV SCI, V83, P1, DOI 10.1016/S0168-1591(03)00107-2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Leach KA, 2012, VET J, V193, P626, DOI 10.1016/j.tvjl.2012.06.043; Leach KA, 2010, RES VET SCI, V89, P311, DOI 10.1016/j.rvsc.2010.02.014; Long JA, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0064-3; Main DCJ, 2010, J DAIRY SCI, V93, P1970, DOI 10.3168/jds.2009-2500; MANSON FJ, 1990, APPL ANIM BEHAV SCI, V26, P69, DOI 10.1016/0168-1591(90)90088-U; Martin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118461; Martinez-Miranzo B, 2016, J ORNITHOL, V157, P971, DOI 10.1007/s10336-016-1347-1; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; Maselyne J, 2017, RES VET SCI, V110, P1, DOI 10.1016/j.rvsc.2016.10.003; Medrano-Galarza C, 2012, J DAIRY SCI, V95, P6994, DOI 10.3168/jds.2011-5247; Meunier B, BIOSYST ENG, DOI [10.1016/j.biosystemseng.2017.04.011, DOI 10.1016/J.BIOSYSTEMSENG.2017.04.011]; Myers R., 1990, CLASSICAL MODERN REG; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Norring M, 2014, J DAIRY SCI, V97, P4317, DOI 10.3168/jds.2013-7512; Omnisense Ltd, 2013, SER 500 CLUST GEOL S; OSTFELD RS, 1986, J ANIM ECOL, V55, P691, DOI 10.2307/4748; Palmer MA, 2012, APPL ANIM BEHAV SCI, V140, P121, DOI 10.1016/j.applanim.2012.06.005; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Polikarpus A, 2015, APPL ANIM BEHAV SCI, V166, P20, DOI 10.1016/j.applanim.2015.02.016; Polikarpus A, 2014, J DAIRY RES, V81, P24, DOI 10.1017/S0022029913000587; Powell RA, 2000, METH C CONS, P65; R Core Team, 2020, R LANG ENV STAT COMP; Riotte-Lambert L, 2013, J THEOR BIOL, V317, P238, DOI 10.1016/j.jtbi.2012.10.026; Romanzin A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8050076; Sepulveda-Varas P, 2016, APPL ANIM BEHAV SCI, V175, P8, DOI 10.1016/j.applanim.2014.09.022; Shane DD, 2016, COMPUT ELECTRON AGR, V127, P460, DOI 10.1016/j.compag.2016.07.005; Signer J, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1771; Solano L, 2016, J DAIRY SCI, V99, P2086, DOI 10.3168/jds.2015-10336; Sorensen AA, 2015, BASIC APPL ECOL, V16, P601, DOI 10.1016/j.baae.2015.05.001; Spence AJ, 2008, EQUINE VET J, V40, P680, DOI 10.2746/042516408X330338; Tullo E, 2016, J DAIRY SCI, V99, P7489, DOI 10.3168/jds.2016-11014; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Van Nuffel A, 2015, ANIMALS, V5, P861, DOI 10.3390/ani5030388; Weigele HC, 2018, J DAIRY SCI, V101, P2370, DOI 10.3168/jds.2017-13120; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Williams ML, 2016, J DAIRY SCI, V99, P2063, DOI 10.3168/jds.2015-10254; Wilshire JA, 2009, CATTLE PRACT, V17, P136, DOI 10.1386/corn.17.1.136_1; Wood-Gush D. G. M., 1989, Journal of Agricultural Ethics, V2, P161, DOI 10.1007/BF01826929; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zengeya F.M., 2015, REMOTE SENS APPL SOC, V2, P56, DOI DOI 10.1016/J.RSASE.2015.11.001	87	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208424	10.1371/journal.pone.0208424	http://dx.doi.org/10.1371/journal.pone.0208424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566490	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000453779300041
J	Lambertos, A; Ramos-Molina, B; Lopez-Contreras, AJ; Cremades, A; Penafiel, R				Lambertos, Ana; Ramos-Molina, Bruno; Lopez-Contreras, Andres J.; Cremades, Asuncion; Penafiel, Rafael			New insights of polyamine metabolism in testicular physiology: A role of ornithine decarboxylase antizyme inhibitor 2 (AZIN2) in the modulation of testosterone levels and sperm motility	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; CELL-SPECIFIC EXPRESSION; IN-VITRO; GENE; RAT; PROTEIN; MICE; SPERMATOGENESIS; LOCALIZATION; DISEASE	The specific role of polyamines in the testis physiology is not fully understood. Antizymes (OAZs) and antizyme inhibitors (AZINs) are modulators of ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis and polyamine uptake. Although the three known OAZs are expressed in the testis, only OAZ3 is testis specific and has been proven to have an essential role in male fertility. Regarding the two existing AZINs, AZIN2 is the most abundantly expressed member in this gonad. Whereas previous studies suggested that AZIN2 might participate in mouse spermatogenesis, immunohistological analysis of human testicular sections revealed that AZIN2 is also detected in the steroidogenic Leydig cells but not in the germinal epithelium. In the present study, we found a close ontogenic similarity in the mRNA levels of OAZs and AZINs between mice and rats, but an opposite expression pattern of ODC activity. Further analysis of AZIN2 and OAZ3 in the testis of mice with different alterations in spermatogenesis and fertility, induced either genetically or pharmacologically, corroborated that both AZIN2 and OAZ3 are mainly expressed in the haploid germinal cells. Finally, by using transgenic mice with a truncated Azin2 gene fused to the bacterial lacZ gene, we studied the expression of Azin2 in testes, epididymides and spermatozoa. AZIN2 was detected in spermatids and spermatozoa, as well as in Leydig cells, and in epithelial epidydimal cells. Azin2 knock-out male mice were fertile; however, they showed marked decreases in testicular putrescine and plasma and testicular testosterone levels, and a dramatic reduction in the sperm motility. These results suggest an important role for AZIN2 in testicular cells by modulating polyamine concentrations, testosterone synthesis and sperm function. Overall, our data corroborate the relevance of polyamine regulation in testis functions, where both AZIN2 and OAZ3 play fundamental roles.	[Lambertos, Ana; Ramos-Molina, Bruno; Lopez-Contreras, Andres J.; Penafiel, Rafael] Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, Murcia, Spain; [Lambertos, Ana; Penafiel, Rafael] IMIB, Murcia, Spain; [Cremades, Asuncion] Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain; [Ramos-Molina, Bruno] Virgen de la Victoria Univ Hosp, Dept Endocrinol & Nutr, Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Ramos-Molina, Bruno] Inst Hlth Carlos III, CIBER Physiopathol Obes & Nutr CIBERObn, Madrid, Spain; [Lopez-Contreras, Andres J.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Ctr Chromosome Stabil, Copenhagen, Denmark	University of Murcia; University of Murcia; Hospital Virgen de la Victoria; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Copenhagen	Penafiel, R (corresponding author), Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, Murcia, Spain.; Penafiel, R (corresponding author), IMIB, Murcia, Spain.	rapegar@um.es	Ramos-Molina, Bruno/K-8303-2019; Lopez-Contreras, Andres J/AAA-1110-2020; Lambertos, Ana/AAQ-1089-2020; Penafiel, Rafael/H-2660-2015	Ramos-Molina, Bruno/0000-0001-6804-5449; Penafiel, Rafael/0000-0002-5816-1056; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327; Lambertos Escudero, Ana/0000-0001-5616-2218	Spanish Ministry of Economy and Competitiveness (European Community FEDER support) [SAF2011-29051]; Seneca Foundation (Autonomous Community of Murcia) [19875/GERM/15]; Ministry of Science and Innovation; ISCIII, Spain [CD16/0003]	Spanish Ministry of Economy and Competitiveness (European Community FEDER support); Seneca Foundation (Autonomous Community of Murcia)(Fundacion Seneca); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII, Spain(Instituto de Salud Carlos III)	This work was supported by the Spanish Ministry of Economy and Competitiveness, SAF2011-29051 (with European Community FEDER support) and by Seneca Foundation (Autonomous Community of Murcia), 19875/GERM/15. AL was recipient of a fellowship (FPU) from the Ministry of Science and Innovation. BRM was recipient of a Sara Borrell postdoctoral fellowship, ISCIII, Spain (CD16/0003).	ALCIVAR AA, 1989, BIOL REPROD, V41, P1133, DOI 10.1095/biolreprod41.6.1133; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; BLACKSHEAR PJ, 1989, MOL ENDOCRINOL, V3, P68, DOI 10.1210/mend-3-1-68; CHARAK BS, 1990, CANCER, V65, P1903, DOI 10.1002/1097-0142(19900501)65:9<1903::AID-CNCR2820650905>3.0.CO;2-#; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Elangovan N, 2006, TOXICOLOGY, V222, P60, DOI 10.1016/j.tox.2006.01.027; HAKOVIRTA H, 1993, MOL ENDOCRINOL, V7, P1430, DOI 10.1210/me.7.11.1430; HALMEKYTO M, 1991, BIOCHEM J, V278, P895, DOI 10.1042/bj2780895; HALMEKYTO M, 1991, J BIOL CHEM, V266, P19746; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Janne J, 2005, J CELL MOL MED, V9, P865, DOI 10.1111/j.1582-4934.2005.tb00385.x; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; KAIPIA A, 1990, MOL CELL ENDOCRINOL, V73, P45, DOI 10.1016/0303-7207(90)90043-8; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kaur F, 1997, Indian J Exp Biol, V35, P771; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Lopez-Contreras AJ, 2008, J BIOL CHEM, V283, P20761, DOI 10.1074/jbc.M801024200; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Lopez-Contreras AJ, 2010, AMINO ACIDS, V38, P603, DOI 10.1007/s00726-009-0419-4; Lopez-Contreras AJ, 2009, J CELL BIOCHEM, V107, P732, DOI 10.1002/jcb.22168; Lopez-Contreras AJ, 2009, INT J BIOCHEM CELL B, V41, P1070, DOI 10.1016/j.biocel.2008.09.029; Lopez-Garcia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069188; MACINDOE JH, 1973, J CLIN INVEST, V52, P1972, DOI 10.1172/JCI107381; Makitie LT, 2009, HISTOCHEM CELL BIOL, V132, P633, DOI 10.1007/s00418-009-0636-7; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; Martinez-de-la-Torre M, 2018, J NEUROSCI RES, V96, P1490, DOI 10.1002/jnr.24053; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; OSTERMAN J, 1983, J ANDROL, V4, P175; PAJUNEN AEI, 1982, J BIOL CHEM, V257, P8190; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; QIAN ZU, 1985, BIOL REPROD, V33, P1189, DOI 10.1095/biolreprod33.5.1189; Ramos-Molina B, 2012, AMINO ACIDS, V42, P539, DOI 10.1007/s00726-011-1031-y; Rasila T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151175; REDDY PRK, 1975, BIOCHEM BIOPH RES CO, V65, P1350, DOI 10.1016/S0006-291X(75)80378-0; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Ruan YB, 2011, J BIOL CHEM, V286, P29417, DOI 10.1074/jbc.M111.274647; SHUBHADA S, 1989, J ANDROL, V10, P152; SWIFT TA, 1987, ENDOCRINOLOGY, V120, P394, DOI 10.1210/endo-120-1-394; SWIFT TA, 1988, ENDOCRINOLOGY, V123, P687, DOI 10.1210/endo-123-2-687; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Weiger TM, 2014, AMINO ACIDS, V46, P681, DOI 10.1007/s00726-013-1536-7; Weiner KX, DEV REGULATION ORNIT; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112	55	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209202	10.1371/journal.pone.0209202	http://dx.doi.org/10.1371/journal.pone.0209202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566531	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300076
J	Liu, WW; Yuan, SW; Wei, FQ; Yang, J; Ma, J				Liu, Wenwei; Yuan, Suwei; Wei, Fengqin; Yang, Jing; Ma, Jin			Inappropriate admissions of the cardiology and orthopedics departments of a tertiary hospital in Shanghai, China	PLOS ONE			English	Article							APPROPRIATENESS; COST	Objectives Admission rates have increased in China, despite the fact that accessibility to primary care is improving. Hospital care could be cost-inefficient, and little is currently known about the appropriateness of admissions to tertiary hospitals in China. This study aims to measure the extent of inappropriate admissions in the cardiology and orthopedics departments of a tertiary hospital in Shanghai, to explore the factors associated with inappropriateness for each department, and to identify the causes of inappropriate admissions. Methods The records of inpatients discharged on randomly sampled two days each week during March 2013 to February 2014 from the two departments were extracted. Two reviewers were recruited to assess the records according to the Chinese version of the Appropriateness Evaluation Protocol (C-AEP). Demographic, socio-economic, and other admissions-related variables were collected. Logistic regression analysis was adopted to determine the associated factors of inappropriateness. Results 35.0% (N = 120) of the 343 admissions and 38.7% (N = 179) of the 463 admissions of the cardiology and orthopedics departments were not justified by the C-AEP, respectively. Age (OR = 0.717), self-pay (OR = 3.752), admission via outpatient sector (OR = 5.332), and readmission (OR = 2.501) were identified as factors affecting the appropriateness of admissions in the cardiology department. Age (OR = 0.930), self-pay (OR = 2.597), admission during 12:00-17:59 (OR = 3.211), and admission via outpatient sector (OR = 7.060) were determined to be associated with appropriateness of admission in the orthopedics department. The main reason for inappropriateness was premature admission for both departments. Conclusions The magnitude of inappropriate admissions was considerable in the departments. To improve appropriateness, the results suggest that further interventions should be focused on both external and internal factors.	[Liu, Wenwei] Shanghai Normal Univ, Coll Philosophy Law & Polit Sci, Shanghai, Peoples R China; [Yuan, Suwei; Wei, Fengqin; Ma, Jin] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China; [Yuan, Suwei] Shanghai Jiao Tong Univ, China Hosp Dev Inst, Shanghai, Peoples R China; [Yang, Jing] Shanghai Rui Jin Hosp, Dept Med Adm, Shanghai, Peoples R China	Shanghai Normal University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ma, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China.	majin@shsmu.edu.cn		Liu, Wenwei/0000-0002-5086-9033	National Natural Science Foundation of China [71273175]; Shanghai Normal University [A-7031-18-004021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Normal University	This work was supported by National Natural Science Foundation of China [grant number 71273175 to JM], Shanghai Normal University [grant number A-7031-18-004021 to WL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo IF, 2000, PUBLIC HEALTH, V114, P9, DOI 10.1038/sj.ph.1900609; [Anonymous], 2010, CHIN HLTH STAT YB 20; Apolone G, 1997, EUR J PUBLIC HEALTH, V7, P34, DOI 10.1093/eurpub/7.1.34; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Brabrand M, 2011, BMC HEALTH SERV RES, V11, P1; Brabrand M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-152; Rodriguez FC, 2006, ARCH BRONCONEUMOL, V42, P440, DOI 10.1016/S1579-2129(06)60566-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chopard P, 1998, INT J EPIDEMIOL, V27, P513, DOI 10.1093/ije/27.3.513; ERMANN D, 1988, J HEALTH POLIT POLIC, V13, P683, DOI 10.1215/03616878-13-4-683; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; Guangjun Y, 2013, CHINESE HOSP, P1; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Jepsen HK, 2013, DAN MED J, V60, P1; Khabiri R, 2015, GLOB J HLTH SCI, V7, P82; Langenbrunner JC, 2002, HOSP CHANGING EUROPE; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136498; Mannocci A, 2015, J MATERN-FETAL NEO M, V28, P1542, DOI 10.3109/14767058.2014.960833; National Health and Family Planning Commission of the People's Republic of China, 2015, CHIN HLTH STAT YB 20; Perneger TV, 1997, ARCH INTERN MED, V157, P1495, DOI 10.1001/archinte.157.13.1495; Pileggi C, 2004, PUBLIC HEALTH, V118, P284, DOI 10.1016/j.puhe.2003.06.002; Poppa G, 2012, ITALIAN J PUBLIC HLT, V6, P341; RESTUCCIA JD, 1995, INT J QUAL HEALTH C, V7, P253, DOI 10.1093/intqhc/7.3.253; Soria-Aledo V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-361; Soria-Aledo V, 2009, AM J MED QUAL, V24, P321, DOI 10.1177/1062860609337252; SWEENEY GH, 1982, SOUTHERN ECON J, V48, P594, DOI 10.2307/1058653; Tamames S, 2007, BMC HEALTH SERV RES, V7, P1; [陶婧婧 Tao Jingjing], 2013, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V33, P1146; Winickoff RN, 1991, MED CARE, P64; Zhan YQ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-144; Zhang Y., 2014, CHIN HLTH SERV MANAG, V31, P678; Zhou XY, 2013, CHINESE HLTH QUALITY, V20, P33	34	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208146	10.1371/journal.pone.0208146	http://dx.doi.org/10.1371/journal.pone.0208146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566422	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300024
J	Fuirst, M; Veit, RR; Hahn, M; Dheilly, N; Thorne, LH				Fuirst, Matthew; Veit, Richard R.; Hahn, Megan; Dheilly, Nolwenn; Thorne, Lesley H.			Effects of urbanization on the foraging ecology and microbiota of the generalist seabird Larus argentatus	PLOS ONE			English	Article							GUT MICROBIOTA; ANTHROPOGENIC RESOURCES; HABITAT SELECTION; ESCHERICHIA-COLI; 1ST-PASSAGE TIME; URBAN; GULLS; COMMUNITIES; RESPONSES; BEHAVIOR	Larus gull species have proven adaptable to urbanization and due to their generalist feeding behaviors, they provide useful opportunities to study how urban environments impact foraging behavior and host-associated microbiota. We evaluated how urbanization influenced the foraging behavior and microbiome characteristics of breeding herring gulls (Larus argentatus) at three different colonies on the east coast of the United States. Study colonies represented high, medium and low degrees of urbanization, respectively. At all colonies, gulls frequently foraged at landfills and in other urban environments, but both the use of urban environments and gull foraging metrics differed with the degree of urbanization. Gulls at the more urban colonies used urban environments more frequently, showed higher rates of site fidelity and took shorter trips. Gulls at less urban colonies used a greater diversity of habitat types and foraged offshore. We observed high microbial diversity at all colonies, though microbial diversity was highest at the least urban colony where gulls used a wider variety of foraging habitats. This suggests that gulls may acquire a wider range of bacteria when visiting a higher variety of foraging sites. Our findings highlight the influence of urban habitats on gull movements and microbiome composition and diversity during the breeding season and represent the first application of amplicon sequence variants, an objective and repeatable method of bacterial classification, to study the microbiota of a seabird species.	[Fuirst, Matthew; Hahn, Megan; Dheilly, Nolwenn; Thorne, Lesley H.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Veit, Richard R.] CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; College of Staten Island (CUNY)	Fuirst, M (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	mfuirst@gmail.com	Dheilly, Nolwenn/AAU-9185-2020; Dheilly, Nolwenn Marie M/A-7213-2011	Dheilly, Nolwenn/0000-0002-3675-5013; Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Fuirst, Matthew/0000-0001-7488-4150	Waterbird Society	Waterbird Society	The author MF received a small award of $ 565 from the Waterbird Society to support minor field expenses. This was the Nisbet Research Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm EW, 2018, SCI TOTAL ENVIRON, V615, P123, DOI 10.1016/j.scitotenv.2017.09.232; Aponte V, 2014, CAN J ZOOL, V92, P629, DOI 10.1139/cjz-2013-0268; Atterby Clara, 2016, Infection Ecology & Epidemiology, V6, P32334, DOI 10.3402/iee.v6.32334; Auman HJ, 2008, WATERBIRDS, V31, P122, DOI 10.1675/1524-4695(2008)31[122:SMDAFC]2.0.CO;2; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bisson IA, 2009, MICROB ECOL, V58, P212, DOI 10.1007/s00248-009-9490-3; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Bozek Clare K., 2007, Urban Ecosystems, V10, P413, DOI 10.1007/s11252-007-0033-8; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Breitburg DL, 2009, HYDROBIOLOGIA, V629, P31, DOI 10.1007/s10750-009-9762-4; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Byrne CM, 2007, MICROBIOL-SGM, V153, P561, DOI 10.1099/mic.0.2006/000711-0; Calado JG, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01463; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Casey MM, 2014, BIOL CONSERV, V170, P137, DOI 10.1016/j.biocon.2013.12.037; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Craven SE, 2000, AVIAN DIS, V44, P715, DOI 10.2307/1593118; Dewar ML, 2014, FEMS MICROBIOL ECOL, V89, P47, DOI 10.1111/1574-6941.12332; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Duchamp JE, 2004, CAN J ZOOL, V82, P1157, DOI [10.1139/z04-095, 10.1139/Z04-095]; Duhem C, 2003, BIRD STUDY, V50, P61, DOI 10.1080/00063650309461291; Ebert LA, 2016, INT J CURR MICROBIOL, V5, P458, DOI DOI 10.20546/IJCMAS.2016.505.048; Evans JK, 2017, HORM BEHAV, V88, P112, DOI 10.1016/j.yhbeh.2016.12.003; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Garthe S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159630; Gehrt Stanley D., 2004, P81; Gering JC, 1999, ECOGRAPHY, V22, P532, DOI 10.1111/j.1600-0587.1999.tb00542.x; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Haagsma J., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P749; Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]; Howell SN, PETERSON REFERENCE G; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Isaksson N, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0078-5; Jansson DS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193265; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kotzerka J, 2011, CONDOR, V113, P80, DOI 10.1525/cond.2011.090158; Krauss S, 2010, P ROY SOC LOND B BIO; Kreisinger J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00050; Kreisinger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137401; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Laviad-Shitrit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08434-8; Lederberg J, 2001, SCIENTIST, V15, P2; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lewis WB, 2016, J AVIAN BIOL, V47, P659, DOI 10.1111/jav.00954; Lopez G., 2014, LONG ISLAND SOUND PR, P285, DOI [10.1007/978-1-4614-6126-5_6, DOI 10.1007/978-1-4614-6126-5_6]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Marchesi JR, VOCABULARY MICROBIOM; Margulis L, 1991, SYMBIOSISOURCE EVO; Martinez-Garcia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158158; Martiny AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00238; Maszenan AM, 2000, J APPL MICROBIOL, V88, P826, DOI 10.1046/j.1365-2672.2000.01022.x; Maszenan AM, 1997, INT J SYST BACTERIOL, V47, P727, DOI 10.1099/00207713-47-3-727; McIlroy SJ, 2011, ENVIRON SCI TECHNOL, V45, P8794, DOI 10.1021/es2018576; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merkeviciene L, 2017, J VET RES, V61, P27, DOI 10.1515/jvetres-2017-0004; Migura-Garcia L, 2017, J WILDLIFE DIS, V53, P148, DOI 10.7589/2016-03-051; Morgan ER, 2007, ECOL MODEL, V200, P511, DOI 10.1016/j.ecolmodel.2006.09.002; Navarro J, 2017, MAR ECOL PROG SER, V578, P243, DOI 10.3354/meps12124; Newbold LK, 2017, ISME J, V11, P663, DOI 10.1038/ismej.2016.153; Nisbet ICT, 2017, HERRING GULL LARUS A; Noguera JC, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171743; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Pauchard A, 2006, BIOL CONSERV, V127, P272, DOI 10.1016/j.biocon.2005.05.015; Pearce DS, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0365-4; Pierotti R, AVIAN ECOLOGY CONSER, P307; PONS JM, 1995, J ANIM ECOL, V64, P592, DOI 10.2307/5802; Prange S, 2004, J MAMMAL, V85, P483, DOI 10.1644/BOS-121; Reese AT, 2016, ISME J, V10, P751, DOI 10.1038/ismej.2015.152; Risely A, 2018, J ANIM ECOL, V87, P428, DOI 10.1111/1365-2656.12784; Rock Peter, 2016, Ringing & Migration, V31, P47, DOI 10.1080/03078698.2016.1197698; Rouffaerl LO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189509; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Seto KC, 2012, P NATL ACAD SCI, V109; Shaffer SA, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0118-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Simoes RR, 2010, EMERG INFECT DIS, V16, P110, DOI 10.3201/eid1601.090896; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Su HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099826; Suffolk County Department of Economic Development and Planning, 2015, COMPR PLAN 2035; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Tella JL, 2002, J EVOLUTION BIOL, V15, P32, DOI 10.1046/j.1420-9101.2002.00375.x; Teyssier A, 2018, SCI TOTAL ENVIRON, V612, P1276, DOI 10.1016/j.scitotenv.2017.09.035; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tyson C, 2015, ICES J MAR SCI, V72, P1882, DOI 10.1093/icesjms/fsv021; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Wakefield ED, 2015, ECOLOGY, V96, P3058, DOI 10.1890/14-1300.1; Weaver D. K, 1970, Bird Banding, V41, P28, DOI 10.2307/4511621; Weiser EL, 2010, CONDOR, V112, P530, DOI 10.1525/cond.2010.100020; Weiskerger CJ, 2018, SCI TOTAL ENVIRON, V619, P1236, DOI 10.1016/j.scitotenv.2017.11.167; White, 2013, MARINE BIRDS E US BA; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Zagalska-Neubauer M, 2016, J ORNITHOL, V157, P525, DOI 10.1007/s10336-015-1291-5	102	41	41	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209200	10.1371/journal.pone.0209200	http://dx.doi.org/10.1371/journal.pone.0209200			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562368	Green Published, gold			2022-12-26	WOS:000453774100043
J	Holt, ME; Salay, LE; O'Brien, E; Barton, JK; Chazin, WJ				Holt, Marilyn E.; Salay, Lauren E.; O'Brien, Elizabeth; Barton, Jacqueline K.; Chazin, Walter J.			Functional and structural similarity of human DNA primase [4Fe4S] cluster domain constructs	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CRYSTAL PACKING; P58 SUBUNIT; MECHANISM; POLYMERASE; REPLICATION; INITIATION; INSIGHTS; AFFINITY; SYSTEM	The regulatory subunit of human DNA primase has a C-terminal domain (p58C) that contains a [4Fe4S] cluster and binds DNA. Previous electrochemical analysis of a p58C construct revealed that its affinity for DNA is sensitive to the redox state of the [4Fe4S] cluster. Concerns about the validity of this conclusion have been raised, based in part on differences in X-ray crystal structures of the p58C(272-464) construct used for that study and that of a N-terminally shifted p58C(266-456) construct and consequently, an assumption that p58C(272-464) has abnormal physical and functional properties. To address this controversy, a new p58C(266-464) construct containing all residues was crystallized under the conditions previously used for crystallizing p58C(272-464), and the solution structures of both constructs were assessed using circular dichroism and NMR spectroscopy. In the new crystal structure, p58C(266-464) exhibits the same elements of secondary structure near the DNA binding site as observed in the crystal structure of p58C(272-464). Moreover, in solution, circular dichroism and N-15, H-1-heteronuclear single quantum coherence (HSQC) NMR spectra show there are no significant differences in the distribution of secondary structures or in the tertiary structure or the two constructs. To validate that the two constructs have the same functional properties, binding of a primed DNA template was measured using a fluorescence-based DNA binding assay, and the affinities for this substrate were the same (3.4 +/- 0.5 mu M and 2.7 +/- 0.3 mu M, respectively). The electrochemical properties of p58C(266-464) were also measured and this p58C construct was able to engage in redox switching on DNA with the same efficiency as p58C(272-464). Together, these results show that although p58C can be stabilized in different conformations in the crystalline state, in solution there is effectively no difference in the structure and functional properties of p58C constructs of different lengths.	[Holt, Marilyn E.; Salay, Lauren E.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Holt, Marilyn E.; Salay, Lauren E.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [O'Brien, Elizabeth; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Vanderbilt University; Vanderbilt University; California Institute of Technology	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.	walter.chazin@vanderbilt.edu		Chazin, Walter/0000-0002-2180-0790	National Institutes of Health [R35 GM118089, R01 GM126904, T32 GM80320, T32 GM07616, S10 RR025677, S10 OD021483]; Moore Foundation; Ralph M. Parsons fellowship; DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Science Foundation [0922862]; Vanderbilt University; NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R35GM118089, R35GM126904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moore Foundation(Gordon and Betty Moore Foundation); Ralph M. Parsons fellowship; DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Science Foundation(National Science Foundation (NSF)); Vanderbilt University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (https://www.nih.gov/) grants R35 GM118089 (W.J.C.), R01 GM126904 (J.K.B.), T32 GM80320 (M.E.H, L.E.S.) and T32 GM07616 (E.O.B.) with additional support from the Moore Foundation (https://www.moore.org/) (J.K.B.) and a Ralph M. Parsons fellowship (http://rmpf.org/) (E.O.B.). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). NMR data collection was supported in part by instrumentation grants from the National Science Foundation (https://www.nsf.gov/) (0922862) and National Institutes of Health (S10 RR025677), and matching funds from Vanderbilt University (https://www.vanderbilt.edu/). Fluorescence data collection was supported in part by an instrumentation grant from the National Institutes of Health (S10 OD021483). Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Baranovskiy AG, 2017, SCIENCE, V357, DOI 10.1126/science.aan2396; Baranovskiy AG, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020062; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Diener JL, 2003, NAT STRUCT BIOL, V10, P494, DOI 10.1038/nsb0703-494a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Holt ME, 2017, METHOD ENZYMOL, V595, P361, DOI 10.1016/bs.mie.2017.07.002; Holzer S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01707-w; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Layten M, 2006, J AM CHEM SOC, V128, P13360, DOI 10.1021/ja065133k; Linke P, 2016, J BIOMOL SCREEN, V21, P414, DOI 10.1177/1087057115618347; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; O'Brien E, 2017, SCIENCE, V357, DOI 10.1126/science.aan2762; O'Brien E, 2017, SCIENCE, V355, DOI 10.1126/science.aag1789; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2017, SCIENCE, V357, DOI 10.1126/science.aan2954; Pellegrini L, 2016, TRENDS BIOCHEM SCI, V41, P859, DOI 10.1016/j.tibs.2016.07.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Schrodinger, 2015, SMALL MOL DRUG DISCO; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Stodola JL, 2017, ADV EXP MED BIOL, V1042, P117, DOI 10.1007/978-981-10-6955-0_6; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Tse ECM, 2017, J AM CHEM SOC, V139, P12784, DOI 10.1021/jacs.7b07230; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yao N, 2016, JSM BIOCH MOL BIOL, V3; Yeeles JTP, 2017, MOL CELL, V65, P105, DOI 10.1016/j.molcel.2016.11.017; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209345	10.1371/journal.pone.0209345	http://dx.doi.org/10.1371/journal.pone.0209345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562384	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000453774100051
J	Vo, LNQ; Vu, TN; Nguyen, HT; Truong, TT; Khuu, CM; Pham, PQ; Nguyen, LH; Le, GT; Creswell, J				Luan Nguyen Quang Vo; Thanh Nguyen Vu; Hoa Trung Nguyen; Tung Thanh Truong; Canh Minh Khuu; Phuong Quoc Pham; Lan Huu Nguyen; Giang Truong Le; Creswell, Jacob			Optimizing community screening for tuberculosis: Spatial analysis of localized case finding from door-to-door screening for TB in an urban district of Ho Chi Minh City, Viet Nam	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; TRANSMISSION; CONTACT; RISK; HOUSEHOLD; PATTERNS; PROGRAM; AREA; GEE	Background Tuberculosis (TB) is the deadliest infectious disease globally. Current case finding approaches may miss many people with TB or detect them too late. Data and methods This study was a retrospective, spatial analysis of routine TB surveillance and cadastral data in Go Vap district, Ho Chi Minh City. We geocoded TB notifications from 2011 to 2015 and calculated theoretical yields of simulated door-to-door screening in three concentric catchment areas (50m, 100m, 200m) and three notification window scenarios (one, two and four quarters) for each index case. We calculated average yields, compared them to published reference values and fit a GEE (Generalized Estimating Equation) linear regression model onto the data. Results The sample included 3,046 TB patients. Adjusted theoretical yields in 50m, 100m and 200m catchment areas were 0.32% (95%CI: 0.27,0.37), 0.21% (95%CI: 0.14,0.29) and 0.17% (95%CI: 0.09,0.25), respectively, in the baseline notification window scenario. Theoretical yields in the 50m-catchment area for all notification window scenarios were significantly higher than a reference yield from literature. Yield was positively associated with treatment failure index cases (beta = 0.12, p = 0.001) and short-term inter-province migrants (beta = 0.06, p = 0.022), while greater distance to the DTU (beta = -0.02, p<0.001) was associated with lower yield. Conclusions This study is an example of inter-departmental collaboration and application of repurposed cadastral data to progress towards the end TB objectives. The results from Go Vap showed that the use of spatial analysis may be able to identify areas where targeted active case finding in Vietnam can help improve TB case detection.	[Luan Nguyen Quang Vo] Friends Int TB Relief, Ho Chi Minh City, Vietnam; [Thanh Nguyen Vu; Giang Truong Le] Ho Chi Minh City Publ Hlth Assoc, Ho Chi Minh City, Vietnam; [Hoa Trung Nguyen] Go Vap Dist Prevent Hlth Ctr, Ho Chi Minh City, Vietnam; [Tung Thanh Truong; Canh Minh Khuu; Phuong Quoc Pham] Ctr Appl Geog Informat Syst HCMGIS, Ho Chi Minh City Dept Sci & Technol, Ho Chi Minh City, Vietnam; [Lan Huu Nguyen] Pham Ngoc Thach Hosp, Ho Chi Minh City, Vietnam; [Creswell, Jacob] Stop TB Partnership, Geneva, Switzerland		Vo, LNQ (corresponding author), Friends Int TB Relief, Ho Chi Minh City, Vietnam.	luan.vo@tbhelp.org	Vo, Luan/AAG-4240-2020	Vo, Luan/0000-0002-5937-6286	 [STBP/TBR/GSA/2016-06]		LNQV received an award for conducting this study. The grant number is STBP/TBR/GSA/2016-06. The funder's full name is Stop TB Partnership (http://www.stoptb.org/).The funder reviewed and provided suggested edits for the final manuscript.	Tomas BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082440; Agresti A., 2002, CATEGORICAL DATA ANA, DOI [10.1198/tech.2003.s28, DOI 10.1198/TECH.2003.S28]; Alene KA, 2017, GEOSPATIAL HEALTH, V12, P342, DOI 10.4081/gh.2017.575; Aly HAA, 2015, WHO TECH REP SER, V994, P1; [Anonymous], 1974, WHO TECHN REP SER; Bakker M, 2017, MATCH MAPPING ANAL T, DOI [10.1016/j.jegh.2014.11.001, DOI 10.1016/J.JEGH.2014.11.001]; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; BENYOUSSEF A, 1974, SOC SCI MED, V8, P243, DOI 10.1016/0037-7856(74)90093-6; Blok L, 2017, INT J TUBERC LUNG D, V21, P475, DOI 10.5588/ijtld.17.0025-3; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Bocquier Philipe, 2014, Etude Popul Afr, V28, P691; Bonadonna LV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185018; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Center for Applied Geographic Information Systems Department of Science and Technology, 2017, HCMGIS MAPS; Chheng P, 2015, CLIN EPIDEMIOL, V7, P411, DOI 10.2147/CLEP.S82389; Churchyard G, 2017, J INFECT DIS, V216, pS629, DOI 10.1093/infdis/jix362; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; Cook VJ, 2012, INT J TUBERC LUNG D, V16, P297, DOI 10.5588/ijtld.11.0350; Cook VJ, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18643; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Crampin AC, 2008, INT J TUBERC LUNG D, V12, P612; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Cruz AT, 2010, PEDIATR REV, V31, P13, DOI 10.1542/pir.31-1-13; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Duc LV, 2007, INT J TUBERC LUNG D, V11, P567; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fatima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165813; Festenstein F., 1970, LANCET, V317, P603; Fox GJ, 2017, CLIN MICROBIOL INFEC, V23, P147, DOI 10.1016/j.cmi.2016.08.024; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Gashu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160514; General Statistics Office, 2009, AG SEX STRUCT MAR ST; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Gomes MGM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1464-8; Hagood TM, 1994, RADIOGRAPHICS, P1; Hoa NB, 2011, TROP MED INT HEALTH, V16, P1260, DOI 10.1111/j.1365-3156.2011.02823.x; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Izumi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138831; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Khanal S, 2016, PUBLIC HEALTH ACTION, V6, P136, DOI 10.5588/pha.16.0015; Kirkwood BR, 2003, MED STAT, P513, DOI [10.1002/sim.1961, DOI 10.1002/SIM.1961]; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Kolifarhood G, 2015, J EPIDEMIOL GLOB HEA, V5, P221, DOI 10.1016/j.jegh.2014.11.001; Kontgis C, 2014, APPL GEOGR, V53, P377, DOI 10.1016/j.apgeog.2014.06.029; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Le BD, 2011, CSP RES REP, V08, P1, DOI [10.1353/dem.2004.0010, DOI 10.1353/DEM.2004.0010]; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00596-9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Nguyen LD, 2015, WORLD DEV, V71, P79, DOI 10.1016/j.worlddev.2013.11.002; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Bui LV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207068; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; Menzies D, 1997, CAN J PUBLIC HEALTH, V88, P197, DOI 10.1007/BF03403887; Morishita F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171310; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Nguyen TH, 2015, VIET NAM J PUBLIC HL, V38, P6; Ortblad KF, 2013, LANCET, V381, P104; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patterson B, 2017, SCI TOTAL ENVIRON, V583, P97, DOI 10.1016/j.scitotenv.2017.01.026; Pisu M, 2009, J PUBLIC HEALTH MAN, V15, P319, DOI 10.1097/PHH.0b013e31819c3ef2; Ratovonirina NH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2653-9; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; S.P.P.s. Government, 2016, URB SYST PLANN SICH; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; Shah L, 2014, INT J TUBERC LUNG D, V18, P1307, DOI 10.5588/ijtld.14.0011; Shapiro AE, 2013, SYSTEMATIC REV NUMBE; Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646; Supramaniam V, 1980, Med J Malaysia, V34, P301; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Uys P, 2011, CLIN INFECT DIS, V52, P1399, DOI 10.1093/cid/cir229; Van Rie A, 2014, INT J TUBERC LUNG D, V18, P377, DOI 10.5588/ijtld.13.0924; Vassall A., 2014, HLTH TUBERCULOSIS PE, P28; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R; Viet Nam National TB Control Programme, 2015, VIET NAM NATL TB CON; Viet Nam National TB Control Programme, 2016, VIET NAM NATL TB CON; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; Wells WA, 2017, INT J TUBERC LUNG D, V21, P1101, DOI 10.5588/ijtld.17.0271; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; World Bank, 2011, VIETN URB REV TECHN, P263, DOI [DOI 10.1017/CBO9781107415324.004, 10.1017/CBO9781107415324.004]; World Health Organization, 2004, TOM TUB; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2017, WHOHTMTB201723; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419; Ypma RJF, 2013, EPIDEMIOLOGY, V24, P395, DOI 10.1097/EDE.0b013e3182878e19; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zelner JL, 2016, J INFECT DIS, V213, P287, DOI 10.1093/infdis/jiv387; Zhao Q, 2016, INT J TUBERC LUNG D, V20, P1370, DOI 10.5588/ijtld.16.0045	92	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209290	10.1371/journal.pone.0209290	http://dx.doi.org/10.1371/journal.pone.0209290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562401	Green Published, gold, Green Submitted			2022-12-26	WOS:000453774100047
J	Sriram, S; Shaginurova, G; Tossberg, JT; Natarajan, C; Spurlock, CF; Aune, TM				Sriram, Subramaniam; Shaginurova, Guzel; Tossberg, John T.; Natarajan, Chandramohan; Spurlock, Charles F., III; Aune, Thomas M.			Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; HISTONE DEACETYLASE; REQUIREMENT; MACROPHAGES; IMMUNOLOGY; MRI	Objective We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to reflect the clinical and radiological changes during the course of RRMS. Methods MS with either clinical or radiological relapses were recruited for the study and followed for one year. IL-33 and a panel of genes was measured by q PCR and flow cytometry at different time points. Results Among 22 RRMS patients, 4 patients showed highest levels of IL-33 at the time they were recruited to the study (Month 0); in 14 patients highest levels of IL-33 were seen between 6-11 months after relapse and in 4 patients maximal levels of IL-33 were seen 12 months after relapse. A similar pattern of IL-33 kinetics was seen when IL-33 was measured by flow cytometry in an additional cohort of 12 patients. The timing of the improvement clinically did not correlate with IL-33 expression with highest expression levels either preceding or following clinical recovery. From our whole genome RNA-sequencing data we found a strong correlation between expression levels of IL-33 and a similar to 2000 mRNA genes. However, none of these genes encoded proteins involved in either innate or adaptive immunity. Rather, many of the genes that correlated highly with IL-33 encoded to proteins involved in DNA repair or mitochondrial function and mRNA splicing pathways. Interpretation Given the neuro-reparative and remodeling functions attributed to IL-33, it is likely that some of the novel genes we have uncovered may be involved in repair and recovery of the CNS in MS.	[Sriram, Subramaniam; Natarajan, Chandramohan] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Shaginurova, Guzel; Spurlock, Charles F., III; Aune, Thomas M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Shaginurova, Guzel; Tossberg, John T.] IQuity Inc, Nashville, TN USA; [Aune, Thomas M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Sriram, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA.	subramaniam.sriram@vanderbilt.edu		Shaginurova, Guzel/0000-0001-8314-1308	Serono; NIH [R01AI44924, R44AI124766]; IQuity Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI124766] Funding Source: NIH RePORTER	Serono; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IQuity Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded in part by grants from Serono and grants from the NIH: R01AI44924 (TMA) and R44AI124766 (CFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also partly funded by IQuity Inc. IQuity Inc. provided support in the form of salaries for authors GS and JTT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Ciccarelli O, 2010, NEUROLOGY, V74, P721, DOI 10.1212/WNL.0b013e3181d26968; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deng XQ, 2005, ANN NEUROL, V58, P577, DOI 10.1002/ana.20600; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HARRIS JO, 1991, ANN NEUROL, V29, P548, DOI 10.1002/ana.410290515; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kearney H, 2015, NAT REV NEUROL, V11, P327, DOI 10.1038/nrneurol.2015.80; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lublin FD, 2007, J NEUROL SCI, V256, pS14, DOI 10.1016/j.jns.2007.01.062; Mahad D, 2008, NEUROPATH APPL NEURO, V34, P577, DOI 10.1111/j.1365-2990.2008.00987.x; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Planas AM, 2015, BRAIN BEHAV IMMUN, V50, P39, DOI 10.1016/j.bbi.2015.07.027; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spurlock CF, 2017, MULT SCLER J, V23, P11; Spurlock CF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0629-x; SRINIVASAN S, 2016, PLOS ONE, V11; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Tossberg John T, 2013, J Clin Bioinforma, V3, P18, DOI 10.1186/2043-9113-3-18; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang F, 2014, ANN CLIN TANSLATIONA; Zhang FL, 2014, ANN CLIN TRANSL NEUR, V1, P307, DOI 10.1002/acn3.47; Zhang FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016795	44	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208755	10.1371/journal.pone.0208755	http://dx.doi.org/10.1371/journal.pone.0208755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562364	gold, Green Submitted, Green Published			2022-12-26	WOS:000453774100020
J	Dubin, RF; Whooley, M; Pico, A; Genz, P; Schiller, NB; Meyer, C				Dubin, Ruth F.; Whooley, Mary; Pico, Alexander; Genz, Peter; Schiller, Nelson B.; Meyer, Craig			Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; ALL-CAUSE; RISK; MORTALITY; EVENTS; ASSOCIATIONS; ALBUMINURIA; BIOMARKERS	Background Patients with chronic kidney disease (CKD) are at increased risk for heart failure (HF). We aimed to investigate differences in proteins associated with HF hospitalizations among patients with and without CKD in the Heart and Soul Study. Methods and results We measured 1068 unique plasma proteins from baseline samples of 974 participants in The Heart and Soul Study who were followed for HF hospitalization over a median of 7 years. We sequentially applied forest regression and Cox survival analyses to select prognostic proteins. Among participants with CKD, four proteins were associated with HF at Bonferroni-level significance (p<2.5x10(-4)): Angiopoietin-2 (HR[95%CI] 1.45[1.33, 1.59]), Spondin-1 (HR[95%CI] 1.13[1.06, 1.20]), tartrate-resistant acid phosphatase type 5 (HR[95%CI] 0.65[0.53, 0.78]) and neurogenis locus notch homolog protein 1 (NOTCH1) (HR[95%CI] 0.67[0.55, 0.80]). These associations persisted at p<0.01 after adjustment for age, estimated glomerular filtration and history of HF. CKD was a significant interaction term in the associations of NOTCH1 and Spondin-1 with HF. Pathway analysis showed a trend for higher representation of the Cardiac Hypertrophy and Complement/Coagulation pathways among proteins prognostic of HF in the CKD sub-group. Conclusions These results suggest that markers of heart failure differ between patients with and without CKD. Further research is needed to validate novel markers in cohorts of patients with CKD and adjudicated HF events.	[Dubin, Ruth F.] Univ Calif San Francisco, San Francisco VA Med Ctr, Div Nephrol, San Francisco, CA 94143 USA; [Whooley, Mary; Meyer, Craig] Univ Calif San Francisco, Dept Med, San Francisco VA Med Ctr, San Francisco, CA USA; [Pico, Alexander] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Genz, Peter] Univ Calif San Francisco, Div Cardiol, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Schiller, Nelson B.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dubin, RF (corresponding author), Univ Calif San Francisco, San Francisco VA Med Ctr, Div Nephrol, San Francisco, CA 94143 USA.	ruth.dubin@ucsf.edu	Pico, Alexander/HCH-4305-2022	Ganz, Peter/0000-0002-0437-8882	Department of Veterans Affairs, Washington, DC; National Heart Lung and Blood Institute [R01 HL079235]; American Federation for Aging Research (Paul Beeson Scholars Program), New York, NY; Robert Wood Johnson Foundation (Faculty Scholars Program), Princeton, NJ; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK108809]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK108809] Funding Source: NIH RePORTER	Department of Veterans Affairs, Washington, DC(US Department of Veterans Affairs); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Aging Research (Paul Beeson Scholars Program), New York, NY; Robert Wood Johnson Foundation (Faculty Scholars Program), Princeton, NJ(Robert Wood Johnson Foundation (RWJF)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Heart and Soul Study was supported by grants from the Department of Veterans Affairs, Washington, DC, the National Heart Lung and Blood Institute (R01 HL079235), the American Federation for Aging Research (Paul Beeson Scholars Program), New York, NY, the Robert Wood Johnson Foundation (Faculty Scholars Program), Princeton, NJ. The proteomic assays were done by Somalogic, Inc., Boulder, CO. Drs. Dubin and Ganz were supported by U01DK108809 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowolodu Oluwole, 2016, Intrinsically Disord Proteins, V4, pe1255295, DOI 10.1080/21690707.2016.1255295; [Anonymous], 2017, R LANG ENV STAT COMP; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Bureau USC, 2010, AD POP US US CENS BU; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; Diercks GFH, 2000, EUR HEART J, V21, P1922, DOI 10.1053/euhj.2000.2248; Dubin R, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-3; Dubin RF, 2017, CLIN J AM SOC NEPHRO, V12, P60, DOI 10.2215/CJN.02700316; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Eleuteri E, 2016, INT J CARDIOL, V212, P364, DOI 10.1016/j.ijcard.2016.03.005; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397; Ishwaran H., 2010, STAT ANAL DATA MIN, V4, P115; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Isoda K, 2003, CIRCULATION, V107, P679, DOI 10.1161/01.CIR.0000055739.13639.D7; Kim SH, 2013, KIDNEY RES CLIN PRAC, V32, P66, DOI 10.1016/j.krcp.2013.05.001; Knobler H, 2004, J AM COLL CARDIOL, V44, P2142, DOI 10.1016/j.jacc.2004.09.006; Li YX, 2010, TRENDS CARDIOVAS MED, V20, P228, DOI 10.1016/j.tcm.2011.11.006; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mazzaferro S, 2014, SEMIN NEPHROL, V34, P598, DOI 10.1016/j.semnephrol.2014.09.006; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Ngo D, 2016, CIRCULATION, V134, P270, DOI 10.1161/CIRCULATIONAHA.116.021803; Palmer GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098388; Park M, 2017, CLIN J AM SOC NEPHRO, V12, P761, DOI 10.2215/CJN.08560816; Park M, 2012, J AM SOC NEPHROL, V23, P1725, DOI 10.1681/ASN.2012020145; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Sica DA, 2014, SEMIN NEPHROL, V34, P323, DOI 10.1016/j.semnephrol.2014.04.007; Siekmann AF, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4488; Smink PA, 2012, AM J KIDNEY DIS, V60, P804, DOI 10.1053/j.ajkd.2012.06.017; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tanaka S, 2015, KIDNEY DIS-BASEL, V1, P80, DOI 10.1159/000381515; Thurston G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006650; USRDS, 2017, CARD DIS PAT CHRON K, V1; USRDS, 2013, CARD DIS PAT CKD, V1; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Verbeke FH, 2011, CLIN J AM SOC NEPHRO, V6, P2009, DOI 10.2215/CJN.01260211; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Young JM, 2009, CLIN J AM SOC NEPHRO, V4, P1115, DOI 10.2215/CJN.06671208	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208042	10.1371/journal.pone.0208042	http://dx.doi.org/10.1371/journal.pone.0208042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557359	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000020
J	Kim, J; Kim, H; Lee, JC; Kim, JW; Paik, WH; Lee, SH; Hwang, JH; Ryu, JK; Kim, YT				Kim, Jaihwan; Kim, Haeryoung; Lee, Jong-Chan; Kim, Jin Won; Paik, Woo Hyun; Lee, Sang Hyub; Hwang, Jin-Hyeok; Ryu, Ji Kon; Kim, Yong-Tae			Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer	PLOS ONE			English	Article							SURVIVAL; 2,2-DIFLUORODEOXYCYTIDINE; PROTEIN; ABSENCE	Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of human equilibrative nucleoside transporter 1 (hENT1) is regarded as a potential predictive biomarker for a gemcitabine response in some cancers. This study was conducted to investigate the association between hENT1 expression and the effects of gemcitabine on BTC cell lines and on patients with advanced BTC receiving gemcitabine-based chemotherapy. A total of four BTC cell lines, HuCCT1, SNU-478, SNU-1079, and SNU-1196, were tested. mRNA and protein expression levels of hENT1 were measured by quantitative reverse-transcription polymerase chain reaction and western blotting, respectively. Cell viability after gemcitabine treatment was measured in a chemosensitivity assay. For clinical assessment, 40 patients with unresectable or recurrent BTC who were treated with gemcitabine (1000 mg/m(2)) and cisplatin (25 mg/m(2)) between June 2012 and May 2014 were enrolled. Among the four cell lines, SNU1196 showed the highest mRNA and protein levels of hENT1. Expression of hENT1 showed a linear correlation with the log value of the half-maximal inhibitory concentration of gemcitabine. During incubation with gemcitabine, pretreatment with hENT1-specific small interfering RNA (siRNA) resulted in higher cell viability than that in samples pretreated with control siRNA. In a clinical evaluation, the median progression-free survival was 24 and 11 weeks among patients with strong and weak intratumoral hENT1 immunohistochemical stain- ing (P = 0.05), and the median overall survival was 52 and 26 weeks (P = 0.15), respectively. In conclusion, this study showed that increased hENT1 expression is associated with a stronger toxic effect of gemcitabine on BTC cell lines. The clinical outcomes in this study suggest that increased intratumoral hENT1 immunohistochemical staining is a possible biomarker predicting better therapeutic effects of gemcitabine on patients with advanced BTC. Further studies are needed to determine the precise role of hENT1 in BTC.	[Kim, Jaihwan; Lee, Jong-Chan; Kim, Jin Won; Hwang, Jin-Hyeok] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Haeryoung] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Paik, Woo Hyun; Lee, Sang Hyub; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Paik, Woo Hyun; Lee, Sang Hyub; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Seoul Natl Univ Hosp, Liver Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, YT (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.; Kim, YT (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Liver Res Inst, Coll Med, Seoul, South Korea.	yontkim@snu.ac.kr		Kim, Jaihwan/0000-0003-0693-1415; Kim, Haeryoung/0000-0002-4205-9081	SNUBH Research Fund [09-2014-003]	SNUBH Research Fund	This work was supported by grant no. 09-2014-003 from the SNUBH Research Fund (JK). Gemcitabine for in vitro experiments was a gift from Lilly Korea (Seoul, Korea) (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borbath I, 2012, EUR J CANCER, V48, P990, DOI 10.1016/j.ejca.2011.11.006; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; HEINEMANN V, 1992, CANCER RES, V52, P533; HUANG P, 1991, CANCER RES, V51, P6110; HUANG P, 1995, SEMIN ONCOL, V22, P19; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kobayashi H, 2012, ANN SURG, V256, P288, DOI 10.1097/SLA.0b013e3182536a42; Mackey JR, 2002, CLIN CANCER RES, V8, P110; Marechal R, 2009, CLIN CANCER RES, V15, P2913, DOI 10.1158/1078-0432.CCR-08-2080; Matsumura N, 2011, BJU INT, V108, pE110, DOI 10.1111/j.1464-410X.2010.09932.x; Mori R, 2007, ONCOL REP, V17, P1201; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Oguri T, 2007, CANCER LETT, V256, P112, DOI 10.1016/j.canlet.2007.06.012; Ormanns S, 2014, EUR J CANCER, V50, P1891, DOI 10.1016/j.ejca.2014.04.023; Plunkett W, 1996, SEMIN ONCOL, V23, P3; Randi G, 2009, ANN ONCOL, V20, P146, DOI 10.1093/annonc/mdn533; Santini D, 2008, ANN ONCOL, V19, P724, DOI 10.1093/annonc/mdm576; Santini D, 2011, CURR CANCER DRUG TAR, V11, P123, DOI 10.2174/156800911793743600; Santini D, 2010, J CELL PHYSIOL, V223, P384, DOI 10.1002/jcp.22045; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209104	10.1371/journal.pone.0209104	http://dx.doi.org/10.1371/journal.pone.0209104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557411	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000068
J	Wu, YY; Hsieh, CT; Chiu, YM; Chou, SC; Kao, JT; Shieh, DC; Lee, YJ				Wu, Yi-Ying; Hsieh, Chin-Tung; Chiu, Ying-Ming; Chou, Shen-Chieh; Kao, Jung-Ta; Shieh, Dong-Chen; Lee, Yi-Ju			GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells	PLOS ONE			English	Article							UP-REGULATION; CANCER; EXPRESSION; DIFFERENTIATION; PATHWAY; DEATH; PD-1	Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis has been reported in some cancer cells, including AGS human gastric adenocarcinoma cells. Reducing this resistance might shed light on the treatment of human gastric adenocarcinoma. In this study, we examined whether glycogen synthase kinase-3 (GSK-3) inhibitors can restore TRAIL responsiveness in gastric adenocarcinoma cells. The effect of two GSK-3 inhibitors, SB-415286, and LiCl, on apoptosis signaling of TRAIL in human gastric adenocarcinoma cell lines and primary gastric epithelial cells was analyzed. Both inhibitors can sensitize gastric adenocarcinoma cells, but not primary gastric epithelial cells, to TRAIL-induced apoptosis by increasing caspase-8 activity and its downstream signal transmission. Adding p53 siRNA can downregulate GSK-3 inhibitor-related sensitization to TRAIL-induced apoptosis and caspase-3 activity. GSK-3 inhibitors strongly activate the phosphorylation of JNK. Inhibition of JNK leads to earlier and more intense apoptosis, showing that the activation of JNK may provide anti-apoptotic equilibrium of pro-apoptotic cells. Our observations indicate that GSK-3 inhibitors can sentize AGS gastric adenocarcinoma cells to TRAIL-induced apoptosis. Therefore, in certain types of gastric adenocarcinoma, GSK-3 inhibitor might enhance the antitumor activity of TRAIL and might be a promising candidate for the treatment of certain types of gastric adenocarcinoma.	[Wu, Yi-Ying] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Wu, Yi-Ying] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan; [Wu, Yi-Ying] China Med Univ, Res Ctr Chinese Herbal Med, Taichung, Taiwan; [Hsieh, Chin-Tung] Lotung Poh Ai Hosp, Lo Hsu Med Fdn, Dept Pediat, Ilan, Taiwan; [Chiu, Ying-Ming; Shieh, Dong-Chen] Hungkuang Univ, Dept Nursing, Coll Med & Nursing, Taichung, Taiwan; [Chiu, Ying-Ming] Changhua Christian Hosp, Div Allergy Immunol & Rheumatol, Changhua, Taiwan; [Chou, Shen-Chieh] China Med Univ, Dept Biol Sci & Technol, Sch Med, Taichung, Taiwan; [Kao, Jung-Ta] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Jung-Ta] China Med Univ Hosp, Dept Internal Med, Sch Med, Taichung, Taiwan; [Kao, Jung-Ta] China Med Univ, Taichung, Taiwan; [Lee, Yi-Ju] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Hungkuang University; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University	Wu, YY (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.; Wu, YY (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.; Wu, YY (corresponding author), China Med Univ, Res Ctr Chinese Herbal Med, Taichung, Taiwan.	yyw@mail.cmu.edu.tw			"Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan [CMU107-CR-02, CMRC-CHM-5]; Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; National Science Council, Taiwan [NSC 98-2320-B-039 -012 -MY3]	"Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan; Ministry of Health and Welfare, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported by the "Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMU107-CR-02) (CMRC-CHM-5), the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), and the National Science Council, Taiwan (NSC 98-2320-B-039 -012 -MY3).; This work was financially supported by the "Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education(MOE) in Taiwan (CMU107-CR-02) (CMRC-CHM-5) and the National Science Council, Taiwan (NSC 98-2320-B-039-012 -MY3).	Abdallah FM, 2018, NAUNYN SCHMIEDEBERGS; Beurel E, 2011, FRONT MOL NEUROSCI, P4; Brown KM, 2013, THER ADV PSYCHOPHARM, V3, P163, DOI 10.1177/2045125312471963; Cerbone A, 2012, PPAR RES, V2012, DOI 10.1155/2012/269751; Chang WJ, 2014, WORLD J GASTROENTERO, V20, P4586, DOI 10.3748/wjg.v20.i16.4586; Chiu YM, 2018, ANTICANCER RES, V38, P2069, DOI 10.21873/anticanres.12446; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; Doan TKP, 2012, TISSUE ENG REGEN MED, V9, P283, DOI 10.1007/s13770-012-0352-6; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, P4; Gasparian ME, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1080, DOI 10.1134/S0006297915080143; Geismann C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.417; Georgievska B, 2013, J NEUROCHEM, V125, P446, DOI 10.1111/jnc.12203; Harati K, 2012, ANTICANCER RES, V32, P2967; He JY, 2015, INT J ONCOL, V47, P1725, DOI 10.3892/ijo.2015.3146; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Ji FJ, 2015, GENET MOL RES, V14, P15564, DOI 10.4238/2015.December.1.7; Jung YH, 2012, INT J ONCOL, V40, P1941, DOI 10.3892/ijo.2012.1402; Kirby LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039329; Kook Seunghyi, 2014, Handb Exp Pharmacol, V219, P309, DOI 10.1007/978-3-642-41199-1_16; Lim SC, 2017, ONCOL LETT, V13, P3837, DOI 10.3892/ol.2017.5923; Lin WC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.81; Mamaghani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041102; Maurer U, 2014, J CELL SCI, V127, P1369, DOI 10.1242/jcs.138057; Pandey MK, 2016, THERANOSTICS, V6, P571, DOI 10.7150/thno.14334; Qi L, 2011, APOPTOSIS, V16, P1150, DOI 10.1007/s10495-011-0645-6; Reddy CE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.381; Siebring-van Olst E, 2017, MOL ONCOL, V11, P534, DOI 10.1002/1878-0261.12052; Spokoini R, 2010, MOL ENDOCRINOL, V24, P1136, DOI 10.1210/me.2009-0466; Tsai CH, 2018, EUR J PHARMACOL, V832, P104, DOI 10.1016/j.ejphar.2018.05.024; Tsai CL, 2018, EUR CYTOKINE NETW, V29, P36, DOI 10.1684/ecn.2018.0407; Tsai CL, 2018, ANTICANCER RES, V38, P2057, DOI 10.21873/anticanres.12445; Tzeng HE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29257-1; Tzeng HE, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2196-7; Weledji EP, 2017, INT J SURG-ONCOL, V2, DOI 10.1097/IJ9.0000000000000011; Wu YY, 2010, CLIN EXP IMMUNOL, V161, P551, DOI 10.1111/j.1365-2249.2010.04217.x; Wu YY, 2004, WORLD J GASTROENTERO, V10, P2334; Wu YY, 2011, CLIN VACCINE IMMUNOL, V18, P1198, DOI 10.1128/CVI.00422-10; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Zhang JS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.102	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208094	10.1371/journal.pone.0208094	http://dx.doi.org/10.1371/journal.pone.0208094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557366	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000022
J	Oliveira, MM; Marti, C; Ramlawi, M; Sarasin, FP; Grosgurin, O; Poletti, PA; Rouyer, F; Rutschmann, OT				Oliveira, Marta Morais; Marti, Christophe; Ramlawi, Majd; Sarasin, Francois P.; Grosgurin, Olivier; Poletti, Pierre-Alexandre; Rouyer, Frederic; Rutschmann, Olivier T.			Impact of a patient-flow physician coordinator on waiting times and length of stay in an emergency department: A before-after cohort study	PLOS ONE			English	Article							TEAM TRIAGE; THROUGHPUT	Objective Overcrowding is common in most emergency departments (ED). Despite the use of validated triage systems, some patients are at risk of delayed medical evaluation. The objective of this study was to assess the impact of a patient-flow physician coordinator (PFPC) on the proportion of patients offered medical evaluation within time limits imposed by the Swiss Emergency Triage Scale (SETS) and on patient flow within the emergency department of a teaching urban hospital. Methods In this before-after retrospective cohort study, we compared the proportions of patients who received their first medical contact within SETS-imposed time limits, mean waiting times before first medical consultation, mean length of stay, and number of patients who left with-out being seen by a physician, between two periods before and after introducing a PFPC. The PFPC was a senior physician charged with quickly assessing in the waiting area patients who could not immediately be seen and managing patient flow within the department. Results Before introducing the PFPC position, 33,605 patients were admitted, versus 36,288 after. Introducing a PFPC enabled the department to increase the proportion of patients seen within the SETS-imposed time limits from 60.1% to 69.0% (p <0.0001). Waiting times until first medical consultation were reduced on average by 27.7 minutes (95% confidence interval [95% CI]: 25.9-29.5, p < .0001). No significant differences were observed as to length of stay or number of patients who left without being seen between the two study periods. Conclusions Introducing a physician dedicated to managing patient flow enabled waiting times until first medical consultation to be reduced, yet had no significant benefit for patient flow within the ED, nor did it reduce the number of patients who left without being seen.	[Oliveira, Marta Morais] Geneva Sch Med, Geneva, Switzerland; [Marti, Christophe] Geneva Univ Hosp, Div Gen Internal Med, Dept Internal Med Rehabil & Geriatr, Geneva, Switzerland; [Marti, Christophe; Ramlawi, Majd; Sarasin, Francois P.; Grosgurin, Olivier; Poletti, Pierre-Alexandre; Rouyer, Frederic; Rutschmann, Olivier T.] Sch Med, Geneva, Switzerland; [Ramlawi, Majd; Sarasin, Francois P.; Grosgurin, Olivier; Poletti, Pierre-Alexandre; Rouyer, Frederic; Rutschmann, Olivier T.] Geneva Univ Hosp, Dept Community Primary Care & Emergency Med, Div Emergency Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Rutschmann, OT (corresponding author), Sch Med, Geneva, Switzerland.; Rutschmann, OT (corresponding author), Geneva Univ Hosp, Dept Community Primary Care & Emergency Med, Div Emergency Med, Geneva, Switzerland.	olivier.rutschmann@hcuge.ch	grosgurin, olivier/AAT-5605-2021	rouyer, frederic/0000-0002-5727-0859				Abdulwahid MA, 2016, EMERG MED J, V33, P504, DOI 10.1136/emermed-2014-204388; Begaz T, 2017, ANN EMERG MED, V69, P298, DOI 10.1016/j.annemergmed.2016.06.040; Burstrom L, 2016, UPSALA J MED SCI, V121, P38, DOI 10.3109/03009734.2015.1100223; Chan TC, 2005, ANN EMERG MED, V46, P491, DOI 10.1016/j.annemergmed.2005.06.013; Cheng I, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-17; Grant S, 1999, EMERGEN MED, V11, p72?7, DOI DOI 10.1046/J.1442-2026.1999.00017.X; Han JH, 2010, J EMERG MED, V39, P227, DOI 10.1016/j.jemermed.2008.10.006; Holroyd BR, 2007, ACAD EMERG MED, V14, P702, DOI 10.1197/j.aem.2007.04.018; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Lauks J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154372; Nestler DM, 2012, ACAD EMERG MED, V19, P1235, DOI 10.1111/acem.12010; Partovi SN, 2001, ACAD EMERG MED, V8, P990, DOI 10.1111/j.1553-2712.2001.tb01099.x; Rowe BH, 2011, ACAD EMERG MED, V18, P111, DOI 10.1111/j.1553-2712.2010.00984.x; Rutschmann OT, 2018, EUR J EMERG MED, V25, P264, DOI 10.1097/MEJ.0000000000000449; Rutschmann OT, 2006, J CLIN EPIDEMIOL, V59, P615, DOI 10.1016/j.jclinepi.2005.11.003; Subash F, 2004, EMERG MED J, V21, P542, DOI 10.1136/emj.2002.003665; Terris J, 2004, EMERG MED J, V21, P537, DOI 10.1136/emj.2002.003913; Travers JP, 2006, EUR J EMERG MED, V13, P342; van der Linden N, 2016, EUR J EMERG MED, V23, P337, DOI 10.1097/MEJ.0000000000000268; Veit-Rubin N, 2017, BJOG-INT J OBSTET GY, V124, P1867, DOI 10.1111/1471-0528.14535	20	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209035	10.1371/journal.pone.0209035	http://dx.doi.org/10.1371/journal.pone.0209035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550579	Green Submitted, Green Published, gold			2022-12-26	WOS:000453248000039
J	Schneberger, D; DeVasure, JM; Kirychuk, SA; Wyatt, TA				Schneberger, David; DeVasure, Jane M.; Kirychuk, Shelley A.; Wyatt, Todd A.			Organic barn dust inhibits surfactant protein D production through protein kinase-c alpha dependent increase of GPR116	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; LUNG INFLAMMATION; CONFINEMENT DUST; COUPLED RECEPTOR; D BINDS; EXPOSURE; TOLL-LIKE-RECEPTOR-2; ENDOTOXIN; MONOCYTE; LAVAGE	Prolonged exposure to organic barn dusts can lead to chronic inflammation and a broad range of lung problems over time, mediated by innate immune mechanisms. The immune surfactant or collectin surfactant protein D (SP-D) is a crucial multifunctional innate immune receptor. Little work to date has examined the effect of such collectins in response to organic dusts. We provide evidence here that agricultural organic dusts can inhibit mRNA and protein expression of SP-D in a human alveolar epithelial cell line, and an in vivo mouse model. This inhibition was not a result of lipopolysaccharide (LPS) or peptidoglycans, the two most commonly cited immune active components of these dusts. We further show that inhibition of the signaling molecule protein kinase C alpha (PKC alpha) can reverse this inhibition implicating it as a mechanism of SP-D inhibition. Examination of the SP-D regulatory receptor GPR116 showed that its mRNA expression was increased in response to dust and inhibited by blocking PKC alpha, implicating it as a means of inhibiting SP-D in the lungs in response to organic dusts. This reduction shows that organic barn dust can reduce lung SP-D, thus leaving workers potentially at risk for a host of pathogens.	[Schneberger, David; DeVasure, Jane M.; Wyatt, Todd A.] Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Div, Omaha, NE 68198 USA; [Schneberger, David; Kirychuk, Shelley A.] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [Wyatt, Todd A.] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE 68198 USA; [Wyatt, Todd A.] VA Nebraska Western Iowa Hlth Care Syst, Dept Vet Affairs, Res Serv, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center; University of Saskatchewan; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Wyatt, TA (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Div, Omaha, NE 68198 USA.; Wyatt, TA (corresponding author), Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE 68198 USA.; Wyatt, TA (corresponding author), VA Nebraska Western Iowa Hlth Care Syst, Dept Vet Affairs, Res Serv, Omaha, NE 68105 USA.	twyatt@unmc.edu		Schneberger, David/0000-0002-6270-1502; Wyatt, Todd/0000-0002-9273-6730	National Institute for Occupational Safety and Health [U54OH010162]; U.S. Department of Veterans Affairs [IK6BX003781]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH010162] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003635, IK6BX003781] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute for Occupational Safety and Health, U54OH010162, TAW; U.S. Department of Veterans Affairs, IK6BX003781, TAW. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; Bailey KL, 2008, AM J PHYSIOL-LUNG C, V294, pL1049, DOI 10.1152/ajplung.00526.2007; Bauer C, 2013, AM J RESP CELL MOL, V48, P781, DOI 10.1165/rcmb.2012-0479OC; Boissy RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095578; Brown K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93700; Charavaryamath C, 2008, EXP LUNG RES, V34, P19, DOI 10.1080/01902140701807779; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fukuzawa T, 2006, J BIOCHEM, V140, P445, DOI 10.1093/jb/mvj170; Fukuzawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069451; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Larsson BM, 1997, THORAX, V52, P638, DOI 10.1136/thx.52.7.638; May S, 2012, J TOXICOL ENV HEAL B, V15, P524, DOI 10.1080/10937404.2012.744288; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Nie XM, 2008, BIOCHEMISTRY-US, V47, P12878, DOI 10.1021/bi8010175; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Poole JA, 2007, J ALLERGY CLIN IMMUN, V120, P366, DOI 10.1016/j.jaci.2007.04.033; Poole JA, 2012, CURR OPIN ALLERGY CL, V12, P126, DOI 10.1097/ACI.0b013e3283511d0e; Poole JA, 2010, J TOXICOL ENV HEAL A, V73, P684, DOI 10.1080/15287390903578539; Romberger DJ, 2015, AM J PHYSIOL-LUNG C, V309, pL388, DOI 10.1152/ajplung.00025.2015; Romberger DJ, 2002, J APPL PHYSIOL, V93, P289, DOI 10.1152/japplphysiol.00815.2001; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schiffman SS, 2005, ENVIRON HEALTH PERSP, V113, P567, DOI 10.1289/ehp.6814; Schneberger D, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0155-8; Schneberger D, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0121-x; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; van de Wetering JK, 2001, J INFECT DIS, V184, P1143, DOI 10.1086/323746; van Rozendaal BAWM, 1999, BBA-MOL BASIS DIS, V1454, P261, DOI 10.1016/S0925-4439(99)00042-3; Vogelzang PFJ, 2000, CHEST, V117, P1488, DOI 10.1378/chest.117.5.1488; Von Essen S, 2003, J Agric Saf Health, V9, P185; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Wyatt TA, 2007, AM J PHYSIOL-LUNG C, V293, pL1163, DOI 10.1152/ajplung.00103.2007; Wyatt TA, 2010, AM J RESP CELL MOL, V42, P706, DOI 10.1165/rcmb.2009-0065OC; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019	37	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208597	10.1371/journal.pone.0208597	http://dx.doi.org/10.1371/journal.pone.0208597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543664	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500027
J	Assali, EA; Shlomo, D; Zeng, JL; Taddeo, EP; Trudeau, KM; Erion, KA; Colby, AH; Grinstaff, MW; Liesa, M; Las, G; Shirihai, OS				Assali, Essam A.; Shlomo, Dovi; Zeng, Jialiu; Taddeo, Evan P.; Trudeau, Kyle M.; Erion, Karel A.; Colby, Aaron H.; Grinstaff, Mark W.; Liesa, Marc; Las, Guy; Shirihai, Orian S.			Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in cells under lipotoxicity	FASEB JOURNAL			English	Article						autophagy; islets; bioenergetics; free fatty acids; photoactivated nanoparticles	AUTOPHAGY; GLUCOSE; FUSION; DYSFUNCTION; MITOTIMER; FISSION	Chronic exposure of pancreatic cells to high concentrations of free fatty acids leads to lipotoxicity (LT)-mediated suppression of glucose-stimulated insulin secretion. This effect is in part caused by a decline in mitochondrial function as well as by a reduction in lysosomal acidification. Because both mitochondria and lysosomes can alter one another's function, it remains unclear which initiating dysfunction sets off the detrimental cascade of LT, ultimately leading to -cell failure. Here, we investigated the effects of restoring lysosomal acidity on mitochondrial function under LT. Our results show that LT induces a dose-dependent lysosomal alkalization accompanied by an increase in mitochondrial mass. This increase is due to a reduction in mitochondrial turnover as analyzed by MitoTimer, a fluorescent protein for which the emission is regulated by mitochondrial clearance rate. Mitochondrial oxygen consumption rate, citrate synthase activity, and ATP content are all reduced by LT. Restoration of lysosomal acidity using lysosome-targeted nanoparticles is accompanied by stimulation of mitochondrial turnover as revealed by mitophagy measurements and the recovery of mitochondrial mass. Remarkably, re-acidification restores citrate synthase activity and ATP content in an insulin secreting -cell line (INS-1). Furthermore, nanoparticle-mediated lysosomal reacidification rescues mitochondrial maximal respiratory capacity in both INS-1 cells and primary mouse islets. Therefore, our results indicate that mitochondrial dysfunction is downstream of lysosomal alkalization under lipotoxic conditions and that recovery of lysosomal acidity is sufficient to restore the bioenergetic defects.Assali, E. A., Shlomo, D., Zeng, J., Taddeo, E. P., Trudeau, K. M., Erion, K. A., Colby, A. H., Grinstaff, M. W., Liesa, M., Las, G., Shirihai, O. S. Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in cells under lipotoxicity.	[Assali, Essam A.; Shlomo, Dovi; Las, Guy; Shirihai, Orian S.] Ben Gurion Univ Negev, Dept Clin Biochem, Fac Hlth Sci, Beer Sheva, Israel; [Assali, Essam A.; Taddeo, Evan P.; Erion, Karel A.; Liesa, Marc; Shirihai, Orian S.] Univ Calif Los Angeles, Dept Med, Div Endocrinol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Liesa, Marc] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Liesa, Marc] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA; [Zeng, Jialiu; Colby, Aaron H.; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zeng, Jialiu; Grinstaff, Mark W.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Zeng, Jialiu; Grinstaff, Mark W.] Boston Univ, Dept Med, Boston, MA 02215 USA; [Trudeau, Kyle M.] Boston Univ, Sch Med, Dept Med, Obes & Nutr Sect,Evans Biomed Res Ctr, Boston, MA 02118 USA	Ben Gurion University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Boston University; Boston University; Boston University; Boston University	Las, G (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84103 Beer Sheva, Israel.; Shirihai, OS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Hlth Sci 33 131, 650 Charles E Young St, Los Angeles, CA 90095 USA.	las@post.bgu.ac.il; oshirihai@mednet.ucla.edu	Assali, Essam/AAA-7601-2021; Zeng, Jialiu/AAB-3039-2019; Liesa, Marc/K-8590-2019	Zeng, Jialiu/0000-0001-7802-1432; Liesa, Marc/0000-0002-5909-8570	Azrieli Foundation; Kreitman Predoctoral Scholarship from Ben Gurion University; Israeli Council for Higher Education Fellowship; Israel Science Foundation [2018/13]; National Institute for Biotechnology in the Negev; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1-DK35914, R01-DK56690, R01-DK074778]; Diabetes Research Center at UCLA; University of California, San Diego (UCSD) [NIH NIDDK P30-DK063491]; Department of Medicine Chair at UCLA	Azrieli Foundation; Kreitman Predoctoral Scholarship from Ben Gurion University; Israeli Council for Higher Education Fellowship; Israel Science Foundation(Israel Science Foundation); National Institute for Biotechnology in the Negev; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Research Center at UCLA; University of California, San Diego (UCSD); Department of Medicine Chair at UCLA	The authors thank those who contributed helpful discussions, insight, and support of the research, including Drs. Assaf Rudich (Ben-Gurion University), Alicia Kowaltowski (Universidade de Sao Paulo, Sao Paulo, Brazil), Fernanda Cerqueirra (Ben-Gurion University), Eleni Ritou [University of California, Los Angeles (UCLA)], Kiana Mahdaviani (Boston University), Michael Shum (UCLA), Nathanael Miller (UCLA), Siyouneh Baghdasarian (UCLA), Dani Dagan (Technion-Israel Institute of Technology, Haifa, Israel), Jeniffer Ngo (UCLA), and Michaela Veliova (UCLA). E.A.A. is supported by the Azrieli Foundation, the Kreitman Predoctoral Scholarship from Ben Gurion University, and the Israeli Council for Higher Education Fellowship. G.L. was supported by the Israel Science Foundation under Grant 2018/13, and by the National Institute for Biotechnology in the Negev. O.S.S. is funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants RO1-DK35914, R01-DK56690, and R01-DK074778. M.L. is funded by a pilot grant from the Diabetes Research Center at UCLA, and University of California, San Diego (UCSD) (NIH NIDDK P30-DK063491), and the Department of Medicine Chair at UCLA. The authors declare no conflicts of interest.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Alsabeeh N, 2018, BBA-MOL CELL BIOL L, V1863, P143, DOI 10.1016/j.bbalip.2017.11.006; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079; Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Guan J, 2015, EMBO MOL MED, V7, P688, DOI 10.15252/emmm.201505318; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Taddeo EP, 2018, MOL METAB, V16, P150, DOI 10.1016/j.molmet.2018.07.003; Trudeau KM, 2016, J CELL BIOL, V214, P25, DOI 10.1083/jcb.201511042; Trudeau KM, 2014, METHOD ENZYMOL, V547, P21, DOI 10.1016/B978-0-12-801415-8.00002-3; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	28	21	21	6	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4154	4165		10.1096/fj.201801292R	http://dx.doi.org/10.1096/fj.201801292R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550357	Green Published, Bronze			2022-12-26	WOS:000459794800084
J	Zheng, SL; Krump, NA; McKenna, MM; Li, YH; Hannemann, A; Garrett, LJ; Gibson, JS; Bodine, DM; Low, PS				Zheng, Suilan; Krump, Nathan A.; McKenna, Mary M.; Li, Yen-Hsing; Hannemann, Anke; Garrett, Lisa J.; Gibson, John S.; Bodine, David M.; Low, Philip S.			Regulation of erythrocyte Na+/K+/2Cl(-) cotransport by an oxygen-switched kinase cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythrocyte; hemoglobin; Na-K-Cl cotransporter (NKCC); protein-protein interaction; protein phosphorylation; band 3-deoxyhemoglobin interactions; O2 regulation of cation transport; OSR1; WNK1	K-CL COTRANSPORTER; RED-BLOOD-CELLS; PROTEIN-PHOSPHORYLATION; POTASSIUM-TRANSPORT; NA+-K+-2CL(-) COTRANSPORT; MEMBRANE TRANSPORTERS; CYTOPLASMIC DOMAIN; SPAK/OSR1 KINASES; O-2 REGULATION; ION-TRANSPORT	Many erythrocyte processes and pathways, including glycolysis, the pentose phosphate pathway (PPP), KCl cotransport, ATP release, Na+/K+-ATPase activity, ankyrin-band 3 interactions, and nitric oxide (NO) release, are regulated by changes in O-2 pressure that occur as a red blood cell (RBC) transits between the lungs and tissues. The O-2 dependence of glycolysis, PPP, and ankyrin-band 3 interactions (affecting RBC rheology) are controlled by O-2-dependent competition between deoxyhemoglobin (deoxyHb), but not oxyhemoglobin (oxyHb), and other proteins for band 3. We undertook the present study to determine whether the O-2 dependence of Na+/K+/2Cl(-) cotransport (catalyzed by Na+/K+/2Cl(-) cotransporter 1 [NKCC1]) might similarly originate from competition between deoxyHb and a protein involved in NKCC1 regulation for a common binding site on band 3. Using three transgenic mouse strains having mutated deoxyhemoglobin-binding sites on band 3, we found that docking of deoxyhemoglobin at the N terminus of band 3 displaces the protein with no lysine kinase 1 (WNK1) from its overlapping binding site on band 3. This displacement enabled WNK1 to phosphorylate oxidative stress-responsive kinase 1 (OSR1), which, in turn, phosphorylated and activated NKCC1. Under normal solution conditions, the NKCC1 activation increased RBC volume and thereby induced changes in RBC rheology. Because the deoxyhemoglobin-mediated WNK1 displacement from band 3 in this O-2 regulation pathway may also occur in the regulation of other O-2-regulated ion transporters, we hypothesize that the NKCC1-mediated regulatory mechanism may represent a general pattern of O-2 modulation of ion transporters in erythrocytes.	[Zheng, Suilan; Li, Yen-Hsing; Low, Philip S.] Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA; [Zheng, Suilan; Li, Yen-Hsing; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Krump, Nathan A.; McKenna, Mary M.; Bodine, David M.] NHGRI, Hematopoiesis Sect, NIH, Bethesda, MD 20815 USA; [Garrett, Lisa J.] NHGRI, Embryon Stem Cell & Transgen Mouse Core Facil, NIH, Bethesda, MD 20815 USA; [Hannemann, Anke; Gibson, John S.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cambridge	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Bodine, DM (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	tedyaz@mail.nih.gov; plow@purdue.edu	Hannemann, Anke/AAE-2445-2019; Zheng, Suilan/AAW-6471-2021	Hannemann, Anke/0000-0002-2925-1124; 	NIGMS, National Institutes of Health [R01GM24417]; National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200339, ZICHG200349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM24417 (to P. S. L.) and National Human Genome Research Institute, National Institutes of Health intramural funds (to D. M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; [Anonymous], 2004, NAT METHODS, V1, P275, DOI DOI 10.1038/NMETH1204-275; Barvitenko NN, 2005, CELL PHYSIOL BIOCHEM, V15, P1, DOI 10.1159/000083634; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Berenbrink M, 2000, J PHYSIOL-LONDON, V526, P69, DOI 10.1111/j.1469-7793.2000.t01-1-00069.x; Bogdanova A, 2003, ADV EXP MED BIOL, V536, P231; Bogdanova A, 2009, ACTA PHYSIOL, V195, P305, DOI 10.1111/j.1748-1716.2008.01934.x; Bogdanova AY, 2003, J MEMBRANE BIOL, V195, P33, DOI 10.1007/s00232-003-2042-8; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Caro Colin G., 1995, Perfusion, V10, P131, DOI 10.1177/026765919501000302; Chu HY, 2008, BLOOD, V111, P932, DOI 10.1182/blood-2007-07-100180; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2016, BLOOD, V128, P2708, DOI 10.1182/blood-2016-01-692079; Cordat E, 2014, CURR TOP MEMBR, V73, P1, DOI 10.1016/B978-0-12-800223-0.00001-3; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI DOI 10.1073/pnas.0510947103; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; DING Y, 1994, J BIOL CHEM, V269, P32201; Drew C, 2004, BIOELECTROCHEMISTRY, V62, P153, DOI 10.1016/j.bioelechem.2003.07.003; DUNHAM PB, 1981, J PHYSIOL-LONDON, V318, P511; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Flatman PW, 2005, J PHYSIOL-LONDON, V563, P421, DOI 10.1113/jphysiol.2004.080507; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GARDNER K, 1986, J BIOL CHEM, V261, P1339; Gibson JS, 2000, J EXP BIOL, V203, P1395; Gibson JS, 1998, J PHYSIOL-LONDON, V511, P225, DOI 10.1111/j.1469-7793.1998.225bi.x; GOODMAN SR, 1982, J BIOL CHEM, V257, P4564; HAAS M, 1985, J GEN PHYSIOL, V85, P649, DOI 10.1085/jgp.85.5.649; HAAS M, 1982, J GEN PHYSIOL, V80, P125, DOI 10.1085/jgp.80.1.125; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Hadchouel J, 2016, ANNU REV PHYSIOL, V78, P367, DOI 10.1146/annurev-physiol-021115-105431; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; Joiner CH, 2001, BLOOD CELL MOL DIS, V27, P158, DOI 10.1006/bcmd.2000.0365; JONES SA, 1995, ANN BIOMED ENG, V23, P21, DOI 10.1007/BF02368297; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; KANIEWSKI WS, 1994, BIORHEOLOGY, V31, P91; Khan AI, 2004, BIOELECTROCHEMISTRY, V62, P141, DOI 10.1016/j.bioelechem.2003.07.005; Kristensen K, 2007, J EXP BIOL, V210, P2290, DOI 10.1242/jeb.002824; Lang F, 2014, ANTIOXID REDOX SIGN, V21, P138, DOI 10.1089/ars.2013.5747; Lewis IA, 2009, P NATL ACAD SCI USA, V106, P18515, DOI 10.1073/pnas.0905999106; Lux S. E., 1995, BLOOD PRINCIPLES PRA, P1709; Matskevich L, 2005, BBA-BIOMEMBRANES, V1714, P25, DOI 10.1016/j.bbamem.2005.06.001; Messana I, 1996, FEBS LETT, V390, P25, DOI 10.1016/0014-5793(96)00624-2; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mount DB, 1998, J EXP BIOL, V201, P2091; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; ORSKOV SL, 1954, ACTA PHYSIOL SCAND, V31, P221, DOI 10.1111/j.1748-1716.1954.tb01133.x; PALFREY HC, 1993, PFLUG ARCH EUR J PHY, V425, P321, DOI 10.1007/BF00374182; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; Perrotta S, 2005, BLOOD, V106, P4359, DOI 10.1182/blood-2005-07-2806; PEWITT EB, 1990, J BIOL CHEM, V265, P20747; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; REITHMEIER RAF, 1989, ANN NY ACAD SCI, V574, P75; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Roper D., 2011, DACIE LEWIS PRACTICA, P245; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sega MF, 2012, BIOCHEMISTRY-US, V51, P3264, DOI 10.1021/bi201623v; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Sprague RS, 2012, MICROCIRCULATION, V19, P430, DOI 10.1111/j.1549-8719.2011.00158.x; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Stefanovic M, 2013, BIOCHEM J, V449, P143, DOI 10.1042/BJ20120869; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; TOSTESON DC, 1956, J CELL COMPAR PHYSL, V47, P147, DOI 10.1002/jcp.1030470110; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; WALDER JA, 1984, J BIOL CHEM, V259, P238; Wang CC, 1997, BLOOD, V89, P3019, DOI 10.1182/blood.V89.8.3019; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	79	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2519	2528		10.1074/jbc.RA118.006393	http://dx.doi.org/10.1074/jbc.RA118.006393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30563844	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000458895400026
J	Bachu, M; Tamura, T; Chen, C; Narain, A; Nehru, V; Sarai, N; Ghosh, SB; Ghosh, A; Kavarthapu, R; Dufau, ML; Ozato, K				Bachu, Mahesh; Tamura, Tomohiko; Chen, Chao; Narain, Ankur; Nehru, Vishal; Sarai, Naoyuki; Ghosh, Sukhendu B.; Ghosh, Anu; Kavarthapu, Raghuveer; Dufau, Maria L.; Ozato, Keiko			A versatile mouse model of epitope-tagged histone H3.3 to study epigenome dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; transcription; epigenetics; chromatin; ChIP-sequencing (ChIP-seq); H3; 3; Histone variant	VARIANT H3.3; TRANSCRIPTION ELONGATION; CHROMATIN; EXPRESSION; DEPOSITION; MUTATIONS; LOCI	The variant histone H3.3 is incorporated into the genome in a transcription-dependent manner. This histone is thus thought to play a role in epigenetic regulation. However, our understanding of how H3.3 controls gene expression and epigenome landscape has remained incomplete. This is partly because precise localization of H3.3 in the genome has been difficult to decipher particularly for cells in vivo. To circumvent this difficulty, we generated knockin mice, by homologous recombination, to replace both of the two H3.3 loci (H3f3a and H3f3b) with the hemagglutinin-tagged H3.3 cDNA cassette, which also contained a GFP gene. We show here that the hemagglutinin-tagged H3.3 and GFP are expressed in the majority of cells in all adult tissues tested. ChIP-seq data, combined with RNA-seq, revealed a striking correlation between the level of transcripts and that of H3.3 accumulation in expressed genes. Finally, we demonstrate that H3.3 deposition is markedly enhanced upon stimulation by interferon on interferon-stimulated genes, highlighting transcription-coupled H3.3 dynamics. Together, these H3.3 knockin mice serve as a useful experimental model to study epigenome regulation in development and in various adult cells in vivo.	[Bachu, Mahesh; Tamura, Tomohiko; Chen, Chao; Narain, Ankur; Nehru, Vishal; Sarai, Naoyuki; Ghosh, Sukhendu B.; Ghosh, Anu; Ozato, Keiko] NICHD, Div Dev Biol, NIH, Bethesda, MD 20892 USA; [Kavarthapu, Raghuveer; Dufau, Maria L.] NICHD, Sect Mol Endocrinol, NIH, Bethesda, MD 20892 USA; [Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Narain, Ankur] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol Biochem, Galway H91 TK33, Ireland; [Ghosh, Sukhendu B.; Ghosh, Anu] Bhabha Atom Res Ctr, Mumbai 400085, Maharashtra, India	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Yokohama City University; Bhabha Atomic Research Center (BARC)	Ozato, K (corresponding author), NICHD, Div Dev Biol, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Ghosh, Anu/ABF-4180-2020; Kavarthapu, Raghuveer/ABA-8485-2020; Bachu, Mahesh/I-4343-2015; Nehru, Vishal/X-9950-2019; Kavarthapu, Raghuveer/ABA-8497-2020	Kavarthapu, Raghuveer/0000-0002-2198-2029; Bachu, Mahesh/0000-0002-6494-6642; Chen, Chao/0000-0001-9526-0099; Ghosh, Anu/0000-0003-4528-8602	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Aihara K, 2014, NEURO-ONCOLOGY, V16, P140, DOI 10.1093/neuonc/not144; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; Delbarre E, 2010, MOL BIOL CELL, V21, P1872, DOI 10.1091/mbc.E09-09-0839; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Gielen GH, 2013, AM J CLIN PATHOL, V139, P345, DOI 10.1309/AJCPABOHBC33FVMO; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Ivanauskiene K, 2014, GENOME RES, V24, P1584, DOI 10.1101/gr.173831.114; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Orsi GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003285; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Schneiderman JI, 2012, P NATL ACAD SCI USA, V109, P19721, DOI 10.1073/pnas.1206629109; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sitbon D, 2017, COLD SH Q B, V82, P1, DOI 10.1101/sqb.2017.82.033753; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036; Wen DC, 2014, GENESIS, V52, P959, DOI 10.1002/dvg.22827; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yuen BTK, 2014, DEVELOPMENT, V141, P3483, DOI 10.1242/dev.106450	36	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1904	1914		10.1074/jbc.RA118.005550	http://dx.doi.org/10.1074/jbc.RA118.005550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30552116	Green Published, hybrid			2022-12-26	WOS:000459711400011
J	Musa, KI; Keegan, TJ				Musa, Kamarul Imran; Keegan, Thomas J.			The change of Barthel Index scores from the time of discharge until 3-month post- discharge among acute stroke patients in Malaysia: A random intercept model	PLOS ONE			English	Article							MODIFIED RANKIN SCALE; ISCHEMIC-STROKE; FUNCTIONAL RECOVERY; OUTCOME MEASURES; RISK-FACTORS; AGE; IMPACT; REHABILITATION; DISABILITY; TELEPHONE	Background Acute stroke results in functional disability measurable using the well-known Barthel Index. The objectives of the study are to describe the change in the Barthel Index score and to model the prognostic factors for Barthel Index change from discharge up to 3 months post-discharge using the random intercept model among patients with acute first ever stroke in Kelantan, Malaysia. Methods A total 98 in-hospital first ever acute stroke patients were recruited, and their Barthel Index scores were measured at the time of discharge, at 1 month and 3 months post-discharge. The Barthel Index was scored through telephone interviews. We employed the random intercept model from linear mixed effect regression to model the change of Barthel Index scores during the three months intervals. The prognostic factors included in the model were acute stroke subtypes, age, sex and time of measurement (at discharge, at 1 month and at 3 month post-discharge). Results The crude mean Barthel Index scores showed an increased trend. The crude mean Barthel Index at the time of discharge, at 1-month post-discharge and 3 months post-discharge were 35.1 (SD = 39.4), 64.4 (SD = 39.5) and 68.8 (SD = 38.9) respectively. Over the same period, the adjusted mean Barthel Index scores estimated from the linear mixed effect model increased from 39.6 to 66.9 to 73.2. The adjusted mean Barthel Index scores decreased as the age increased, and haemorrhagic stroke patients had lower adjusted mean Barthel Index scores compared to the ischaemic stroke patients. Conclusion Overall, the crude and adjusted mean Barthel Index scores increase from the time of discharge up to 3-month post-discharge among acute stroke patients. Time after discharge, age and stroke subtypes are the significant prognostic factors for Barthel Index score changes over the period of 3 months.	[Musa, Kamarul Imran] Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kbg Kerian, Kelantan, Malaysia; [Keegan, Thomas J.] Univ Lancaster, CHICAS, Lancaster Med Sch, Lancaster, England	Universiti Sains Malaysia; Lancaster University	Musa, KI (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kbg Kerian, Kelantan, Malaysia.	drkamarul@usm.my	Musa, Kamarul Imran/N-3198-2015	Musa, Kamarul Imran/0000-0002-3708-0628; Keegan, Thomas/0000-0003-3691-953X	Universiti Sains Malaysia (USM) Short-term Grant [304/PPSP/61312028]	Universiti Sains Malaysia (USM) Short-term Grant	This study and KIM were funded by Universiti Sains Malaysia (USM) Short-term Grant (304/PPSP/61312028). USM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saeed AH, 2016, DIABETES CARE, V39, P823, DOI 10.2337/dc15-0991; Asuzu D, 2015, NEUROCRIT CARE, V23, P172, DOI 10.1007/s12028-015-0154-5; Balu S, 2009, CURR MED RES OPIN, V25, P2765, DOI 10.1185/03007990903297741; Berge E, 2002, CEREBROVASC DIS, V13, P73, DOI 10.1159/000047752; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Carr EC., 2001, J RES NURSING, V6, P511, DOI [DOI 10.1177/136140960100600107, 10.1177/136140960100600107]; Chindaprasirt Jarin, 2013, ISRN Neurol, V2013, P710681, DOI 10.1155/2013/710681; Cioncoloni D, 2012, NEUROREHABILITATION, V30, P315, DOI 10.3233/NRE-2012-0761; Coelho BP, 2014, NEUROSCI RES, V88, P67, DOI 10.1016/j.neures.2014.08.007; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Della Pietra GL, 2011, STROKE, V42, P2077, DOI 10.1161/STROKEAHA.111.613521; Dhamoon MS, 2017, JAMA NEUROL, V74, P1439, DOI 10.1001/jamaneurol.2017.2802; Di Carlo A, 2006, J NEUROL SCI, V244, P143, DOI 10.1016/j.jns.2006.01.016; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Draca S, 2012, NEUROREHABILITATION, V30, P247, DOI 10.3233/NRE-2012-0752; Duffy L, 2013, STROKE, V44, P462, DOI 10.1161/STROKEAHA.112.678615; Ervasti J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017910; Fabiana NL, 2016, J CLIN NEUROSCI, V33, P269, DOI 10.1016/j.jocn.2016.04.013; Freundlieb N, 2015, RESTOR NEUROL NEUROS, V33, P221, DOI 10.3233/RNN-140454; Frontera JA, 2015, J NEUROL NEUROSUR PS, V86, P71, DOI 10.1136/jnnp-2013-307313; Go S., 2008, ALZHEIMERS DEMENT, V4, pT452; Gunathilake R, 2014, INT J STROKE, V9, pE36, DOI 10.1111/ijs.12347; Harrison JK, 2013, CLIN INTERV AGING, V8, P201, DOI 10.2147/CIA.S32405; Hartigan Irene, 2011, Appl Nurs Res, V24, pe1, DOI 10.1016/j.apnr.2009.11.002; Hoffmann T, 2010, TOP STROKE REHABIL, V17, P119, DOI 10.1310/tsr1702-119; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Khan MS, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-7; Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001; Kim Y, 2018, MOL NEUROBIOL, V55, P7153, DOI 10.1007/s12035-018-0910-6; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; Kong KH, 2014, NEUROREHABILITATION, V35, P221, DOI 10.3233/NRE-141110; KORNERBITENSKY N, 1995, AM J PHYS MED REHAB, V74, P9, DOI 10.1097/00002060-199501000-00003; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Li F, 2014, J NEUROL SCI, V341, P128, DOI 10.1016/j.jns.2014.04.021; Lindmark B, 1988, Scand J Rehabil Med Suppl, V21, P1; Lisabeth LD, 2014, STROKE, V45, P1096, DOI 10.1161/STROKEAHA.113.003912; McNaughton H, 2001, CLIN REHABIL, V15, P422, DOI 10.1191/026921501678310225; Nakao S, 2010, J MED INVESTIG, V57, P81, DOI 10.2152/jmi.57.81; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Paci M, 2011, EUR J PHYS REHAB MED, V47, P19; Pinheiro J., NLME LINEAR NONLINEA; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sangha H, 2005, INT J REHABIL RES, V28, P135, DOI 10.1097/00004356-200506000-00006; Sarker SJ, 2012, STROKE, V43, P1362, DOI 10.1161/STROKEAHA.111.645234; Sharrief AZ, 2017, J STROKE CEREBROVASC, V26, P2686, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.039; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; Tsang RCC, 2014, PHYSIOTHER THEOR PR, V30, P353, DOI 10.3109/09593985.2013.876563; Tveiten A, 2014, ACTA NEUROL SCAND, V129, P269, DOI 10.1111/ane.12185; van Almenkerk S, 2013, DISABIL REHABIL, V35, P1774, DOI 10.3109/09638288.2012.756941; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Volpato S, 2001, GERONTOLOGY, V47, P36, DOI 10.1159/000052768; von Vogelsang AC, 2015, WORLD NEUROSURG, V83, P1090, DOI 10.1016/j.wneu.2014.12.027; Wong ES, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-175	55	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208594	10.1371/journal.pone.0208594	http://dx.doi.org/10.1371/journal.pone.0208594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571691	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700016
J	Rucinski, KB; Powers, KA; Schwartz, SR; Pence, BW; Chi, BH; Black, V; Rees, H; Pettifor, AE				Rucinski, Katherine B.; Powers, Kimberly A.; Schwartz, Sheree R.; Pence, Brian W.; Chi, Benjamin H.; Black, Vivian; Rees, Helen; Pettifor, Audrey E.			Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; PREGNANCY INTENTIONS; POSITIVE WOMEN; CARE; FERTILITY; INTEGRATION; COHORT; KENYA	Objectives Fertility intentions and contraceptive use are often not assessed in the context of clinical HIV care, representing a possible programming gap if women's family planning needs change over time. We aimed to identify longitudinal patterns of unmet need for contraception over a 12-month period among women living with HIV taking antiretroviral therapy (ART). Study design 850 non-pregnant, HIV-positive women aged 18-35 on or initiating ART in Johannesburg, South Africa, were enrolled into a prospective cohort study in 2009-2010. Fertility intentions and contraceptive use were assessed during routine HIV care visits via an interviewer-administered questionnaire, and women were referred for on-site contraceptive counseling. We used group-based trajectory modeling to identify patterns of unmet need for contraception over 12 months, first in the entire population and then in a subset of recent ART initiators. Results In the full population we identified four patterns of unmet need for contraception over one year. Half of the enrolled women were predicted to have a consistently high probability of unmet need, 22.9% a consistently low probability, 16.7% a decreasing probability, and 10.4% an increasing probability over time. Contraceptive method discontinuation and rapidly changing fertility intentions were the primary drivers of changing (increasing or decreasing) unmet need over follow-up. Results were similar in recent ART initiators. Conclusions Half of women were estimated to have a high probability of unmet need that persisted over time, and more than a quarter were estimated to experience patterns of changing unmet need over 12 months. Family planning needs should be assessed more regularly in HIV-positive women to prevent unintended pregnancies and support safer conception among women trying to conceive.	[Rucinski, Katherine B.; Powers, Kimberly A.; Pence, Brian W.; Pettifor, Audrey E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Rucinski, Katherine B.; Schwartz, Sheree R.; Black, Vivian; Rees, Helen] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Rucinski, Katherine B.; Schwartz, Sheree R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Chi, Benjamin H.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Black, Vivian] Univ Witwatersrand, Fac Hlth Sci, Clin Microbiol & Infect Dis, Johannesburg, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Witwatersrand	Rucinski, KB (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Rucinski, KB (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.; Rucinski, KB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	rucinski@jhu.edu		Pettifor, Audrey/0000-0002-3387-0817; Rucinski, Katherine/0000-0002-9858-5953; Rees, Helen/0000-0003-1442-6734	PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development; United States Centers for Disease Control and Prevention (CDC) public health dissertation grant [R36 PS001584]; Society of Family Planning Research Fund [SFPRF11-T8]; NIH/NIAID [K24 AI120796, T32 AI102623]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI102623, K24AI120796, P30AI050410] Funding Source: NIH RePORTER	PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development(United States Agency for International Development (USAID)); United States Centers for Disease Control and Prevention (CDC) public health dissertation grant; Society of Family Planning Research Fund; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was conducted in clinics supported by PEPFAR (President's Emergency Plan For AIDS Relief) and the United States Agency for International Development. The original parent study received funding from the United States Centers for Disease Control and Prevention (CDC) public health dissertation grant R36 PS001584 to SRS. KBR was supported by an award through the Society of Family Planning Research Fund (SFPRF11-T8) and through NIH/NIAID T32 AI102623. BHC was supported through NIH/NIAID (K24 AI120796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachanas P, 2016, AIDS BEHAV, V20, P2110, DOI 10.1007/s10461-016-1349-2; Bradley SarahE.K., 2012, DHS ANAL STUDIES; Burgos-Soto J, 2014, JAIDS-J ACQ IMM DEF, V67, pE45, DOI 10.1097/QAI.0000000000000279; Chersich MF, 2017, SAMJ S AFR MED J, V107, P307, DOI 10.7196/SAMJ.2017.v107i4.12141; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Cohen CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172992; Cooper D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1577-9; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; Haberlen SA, 2017, STUD FAMILY PLANN, V48, P153, DOI 10.1111/sifp.12018; Haddad L, 2013, AIDS, V27, pS93, DOI 10.1097/QAD.0000000000000039; Haider TL, 2013, INT Q COMMUNITY HEAL, V33, P403, DOI 10.2190/IQ.33.4.g; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kosgei RJ, 2011, JAIDS-J ACQ IMM DEF, V58, pE121, DOI 10.1097/QAI.0b013e318237ca80; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010243.pub2; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Marlow HM, 2014, HEALTH CARE WOMEN IN, V35, P175, DOI 10.1080/07399332.2013.815753; Mumford SL, 2016, FERTIL STERIL, V106, P1453, DOI 10.1016/j.fertnstert.2016.07.1067; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Republic of South Africa Department of Health, 2014, S AFR NAT CONTR FERT; Republic of South Africa Department of Health, 2016, IMPL UN TEST TREAT S; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Robinson JA, 2012, INFECT DIS OBSTET GY, V2012, DOI DOI 10.1155/2012/890160; Rocca CH, 2017, POP ASS AM ANN M CHI; Sarnquist CC, 2013, CURR HIV RES, V11, P160, DOI 10.2174/1570162X11311020008; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shade SB, 2016, AIDS S1, V27, pS87; Singh S, 2012, ADDING IT COSTS BENE; Steiner RJ, 2016, J ACQUIR IMMUNE DEFI; Tang JH, 2016, INFECT DIS OBSTET GY; Todd CS, 2018, CONTRACEPTION; Tweya H, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1383724; Wilson KS, 2018, JAIDS-J ACQ IMM DEF, V78, P276, DOI 10.1097/QAI.0000000000001680; Yotebieng M, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.235.5859; Zash R, 2018, NEW ENGL J MED, V379, P979, DOI 10.1056/NEJMc1807653	43	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209114	10.1371/journal.pone.0209114	http://dx.doi.org/10.1371/journal.pone.0209114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571702	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700038
J	Arantes, R; Welch, JR; Tavares, FG; Ferreira, AA; Vettore, MV; Coimbra, CEA				Arantes, Rui; Welch, James R.; Tavares, Felipe Guimaraes; Ferreira, Aline Alves; Vettore, Mario Vianna; Coimbra, Carlos E. A., Jr.			Human ecological and social determinants of dental caries among the Xavante Indigenous people in Central Brazil	PLOS ONE			English	Article							ORAL-HEALTH INEQUALITIES; INDIANS; TRANSITION; GENDER; GROWTH; SALIVA	This community study evaluates complex interactions between macro and micro determinants of oral health in a local Indigenous population based on a theoretical framework of demographic, economic, and healthcare transformation over the last half century. The study population included all residents of eight Xavante villages in Central Brazil. Our hypothetical model posited multiple direct and indirect associations between dental caries and village groups with differentiated territorial and oral care histories, as well as household socioeconomic indicators and food acquisition patterns, individual sociodemographic characteristics, use of dental health services, and oral hygiene practices. Structural equation modelling methods were used to evaluate direct and indirect associations linking exogenous factors and dental caries. Results include 18 direct and 14 indirect statistically significant pathways between determinant variables and dental caries. Significant links with dental caries were shown for socioeconomic indicators, oral healthcare variables, household food acquisition patterns, sex, and age. These findings suggest that the oral health of Xavante residents in the villages studied is associated with determinant factors of different epidemiological and historical scales. The specific historical frame of territorial circumscription and demographic crisis followed by rapid population increase since the 1970s should be considered a causeof-cause determinant of the economic, healthcare, and sociodemographic profile contributing to oral health among the Xavante. Considering the limitations of cross-sectional studies, our findings underline the importance for oral health determination of historical currents affecting minority ethnic groups within national societies.	[Arantes, Rui] Fundacao Oswaldo Cruz Mato Grosso do Sul, Campo Grande, MS, Brazil; [Welch, James R.; Coimbra, Carlos E. A., Jr.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Tavares, Felipe Guimaraes] Univ Fed Fluminense, Escola Enfermagem Aurora de Afonso Costa, Niteroi, RJ, Brazil; [Ferreira, Aline Alves] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, RJ, Brazil; [Vettore, Mario Vianna] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of Sheffield	Arantes, R (corresponding author), Fundacao Oswaldo Cruz Mato Grosso do Sul, Campo Grande, MS, Brazil.	rui.arantes@fiocruz.br	Tavares, Felipe/Z-3979-2019; Welch, James R/B-5042-2013; Vettore, Mario/N-5347-2016	Tavares, Felipe/0000-0002-8308-6203; Welch, James R/0000-0002-9094-5491; Vettore, Mario/0000-0001-6299-4432; Ferreira, Aline Alves/0000-0001-5081-3462; Coimbra Jr., Carlos E. A./0000-0003-4085-1080; , Rui/0000-0002-0318-9465	Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, through the INOVA-ENSP program [0059]	Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, through the INOVA-ENSP program	Research funding was generously provided by the Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, through the INOVA-ENSP program (Registration 0059). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Alves P, 2014, REV PANAM SALUD PUBL, V35, P67; Andersen AMN, 2007, INT J EPIDEMIOL, V36, P540, DOI 10.1093/ije/dym110; Anderson I, 2016, LANCET, V388, P131, DOI 10.1016/S0140-6736(16)00345-7; [Anonymous], 2002, XAVANTE TRANSITION H; [Anonymous], 2013, HUMAN ENV INTERACTIO; Arantes R, 2001, Cad Saude Publica, V17, P375, DOI 10.1590/S0102-311X2001000200012; Arantes Rui, 2010, Rev. bras. epidemiol., V13, P223, DOI 10.1590/S1415-790X2010000200005; Arantes R, 2016, J HEALTH CARE POOR U, V27, P81, DOI 10.1353/hpu.2016.0043; Arantes R, 2010, INT DENT J, V60, P235, DOI 10.1922/IDJ_2569Arantes06; Arantes R, 2009, ANN HUM BIOL, V36, P162, DOI 10.1080/03014460802672844; Barker G., 2009, AGR REVOLUTION PREHI; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Boing Antonio Fernando, 2014, Rev. bras. epidemiol., V17, P102, DOI 10.1590/1809-4503201400060009; Bond C., 2007, BANDAIDS EXPLORING U, P229; Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137; Buikstra J. E., 1992, DIS DEMOGRAPHY AM, P87; CARLOS J. P., 1965, ARCH ORAL BIOL, V10, P739, DOI 10.1016/0003-9969(65)90127-5; Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52; Coimbra Jr CEA, 1991, CAD SAUDE PUBLICA, V4, P538; Costa SD, 2013, CIENC SAUDE COLETIVA, V18, P461, DOI 10.1590/S1413-81232013000200017; Diehl EE, 2014, CAD SAUDE PUBLICA, V30, P867, DOI 10.1590/0102-311X00030014; Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009; Eggers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023962; Ferreira Aline Alves, 2017, Rev. bras. epidemiol., V20, P102, DOI 10.1590/1980-5497201700010009; Ferreira AA, 2016, ANN HUM BIOL, V43, P293, DOI 10.1080/03014460.2016.1195445; Ferreira AA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-3; Flowers NM, 1988, S AM INDIAN STUD, V5, P18; Flowers NM, 1944, S AM INDIAN STUD, V4, P18; Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Graham LR, 2014, PERFORMING INDIGENEITY: GLOBAL HISTORIES AND CONTEMPORARY EXPERIENCES, P305; Guiotoku SK, 2012, REV PANAM SALUD PUBL, V31, P135, DOI 10.1590/S1020-49892012000200007; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kuh D, 1997, LIFE COURSE APPROACH; Kuhnlein HV, 1996, ANNU REV NUTR, V16, P417, DOI 10.1146/annurev.nu.16.070196.002221; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lucena JRM, 2016, BMC NUTR, V2; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Narvai PC, 2006, REV PANAM SALUD PUBL, V19, P385, DOI 10.1590/S1020-49892006000600004; NEEL JV, 1964, AM J HUM GENET, V16, P52; NISWANDER JD, 1967, AM J HUM GENET, V19, P543; Oliver JR, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P185, DOI 10.1007/978-0-387-74907-5_12; Patrick Donald L, 2006, BMC Oral Health, V6 Suppl 1, pS4, DOI 10.1186/1472-6831-6-S1-S4; Peres MA, 2013, REV SAUDE PUBL, V47, P78, DOI 10.1590/S0034-8910.2013047004226; Schuch HS, 2017, COMMUNITY DENT ORAL, V45, P434, DOI 10.1111/cdoe.12307; Sisson KL, 2007, COMMUNITY DENT ORAL, V35, P81, DOI 10.1111/j.1600-0528.2007.00354.x; Thomson WM, 2012, COMMUNITY DENT ORAL, V40, P28, DOI 10.1111/j.1600-0528.2012.00716.x; Wagner G, 2011, QUATERN INT, V239, P51, DOI 10.1016/j.quaint.2011.03.009; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P44, DOI 10.1111/j.1600-0528.2012.00719.x; Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x; Welch J. R., 2013, 1 MARGEM RIO TERRITO; Welch JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081226, 10.1371/journal.pone.0083443, 10.1371/journal.pone.0059853]; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Williams DR, 2016, J HEALTH POLIT POLIC, V41, P627, DOI 10.1215/03616878-3620857; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208312	10.1371/journal.pone.0208312	http://dx.doi.org/10.1371/journal.pone.0208312			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566453	gold, Green Published, Green Accepted			2022-12-26	WOS:000453779300034
J	Dao, DT; Anez-Bustillos, L; Jabbouri, SS; Pan, A; Kishikawa, H; Mitchell, PD; Fell, GL; Baker, MA; Watnick, RS; Chen, H; Rogers, MS; Bielenberg, DR; Puder, M				Dao, Duy T.; Anez-Bustillos, Lorenzo; Jabbouri, Sahir S.; Pan, Amy; Kishikawa, Hiroko; Mitchell, Paul D.; Fell, Gillian L.; Baker, Meredith A.; Watnick, Randolph S.; Chen, Hong; Rogers, Michael S.; Bielenberg, Diane R.; Puder, Mark			A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; GENE-EXPRESSION; ANGIOGENESIS; INJURY; MOUSE	Exogenous vascular endothelial growth factor (VEGF) accelerates compensatory lung growth (CLG) in mice after unilateral pneumonectomy. In this study, we unexpectedly discovered a method to enhance CLG with a VEGF inhibitor, soluble VEGFR1. Eight-week-old C57BL/6 male mice underwent left pneumonectomy, followed by daily intraperitoneal (ip) injection of either saline (control) or 20 mu g/kg of VEGFR1-Fc. On post-operative day (POD) 4, mice underwent pulmonary function tests (PFT) and lungs were harvested for volume measurement and analyses of the VEGF signaling pathway. To investigate the role of hypoxia in mediating the effects of VEGFR1, experiments were repeated with concurrent administration of PT-2385, an inhibitor of hypoxia-induced factor (HIF)2 alpha, via orogastric gavage at 10 mg/kg every 12 hours for 4 days. We found that VEGFR1-treated mice had increased total lung capacity (P= 0.006), pulmonary compliance (P= 0.03), and post-euthanasia lung volume (P= 0.049) compared to control mice. VEGFR1 treatment increased pulmonary levels of VEGF (P= 0.008) and VEGFR2 (P= 0.01). It also stimulated endothelial proliferation (P < 0.0001) and enhanced pulmonary surfactant production (P = 0.03). The addition of PT-2385 abolished the increase in lung volume and endothelial proliferation in response to VEGFR1. By paradoxically stimulating angiogenesis and enhancing lung growth, VEGFR1 could represent a new treatment strategy for neonatal lung diseases characterized by dysfunction of the HIF-VEGF pathway.	[Dao, Duy T.; Anez-Bustillos, Lorenzo; Jabbouri, Sahir S.; Pan, Amy; Kishikawa, Hiroko; Fell, Gillian L.; Baker, Meredith A.; Watnick, Randolph S.; Chen, Hong; Rogers, Michael S.; Bielenberg, Diane R.; Puder, Mark] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Dao, Duy T.; Anez-Bustillos, Lorenzo; Jabbouri, Sahir S.; Pan, Amy; Kishikawa, Hiroko; Fell, Gillian L.; Baker, Meredith A.; Watnick, Randolph S.; Chen, Hong; Rogers, Michael S.; Bielenberg, Diane R.; Puder, Mark] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Mitchell, Paul D.] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Puder, M (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Puder, M (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.	mark.puder@childrens.harvard.edu	Rogers, Michael S/A-9814-2009; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Rogers, Michael/0000-0002-5250-8434; Dao, Duy/0000-0001-9915-7080	Boston Children's Hospital Surgical Foundation; National Institutes of Health [5T32HL007734, 1F32DK104525, 5T35HL110843]	Boston Children's Hospital Surgical Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research funding for this study was provided by the Boston Children's Hospital Surgical Foundation (LAB, AP, MP), and the National Institutes of Health Grants 5T32HL007734 (DTD, MAB), 1F32DK104525 (GLF) and 5T35HL110843 (SSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Mrs. Kristin Johnson (Vascular Biology Program, Boston Children's Hospital) for her work in preparation of the figures and the neurodevelopmental behavior core at Boston Children's Hospital (CHB IDDRC -1U54HD090255) for their expertise in physical activity measurements. Research funding for this study was provided by the Boston Children's Hospital Surgical Foundation (LAB, AP, MP), and the National Institutes of Health Grants 5T32HL007734 (DTD, MAB), 1F32DK104525 (GLF) and 5T35HL110843 (SSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarregui MJ, 1999, AM J RESP CELL MOL, V20, P14, DOI 10.1165/ajrcmb.20.1.3251; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Chang R, 2004, J PEDIATR SURG, V39, P825, DOI 10.1016/j.jpedsurg.2004.02.015; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dao DT, 2018, PEDIATR RES, V83, P1182, DOI 10.1038/pr.2018.41; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Duncan WC, 2008, ENDOCRINOLOGY, V149, P3313, DOI 10.1210/en.2007-1649; Elberson V, 2016, J NEONATAL PERINAT M, V8, P313; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Healy AM, 2000, DEV DYNAM, V219, P341, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1061>3.0.CO;2-M; Herraiz I, 2018, FETAL DIAGN THER, V43, P81, DOI 10.1159/000477903; Jiang X, 2018, CIRCULATION; Kho AT, 2013, AM J PHYSIOL-LUNG C, V305, pL542, DOI 10.1152/ajplung.00403.2012; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohamed AA, 2010, J CANCER, V1, P197; Morini F, 2017, SEMIN PEDIATR SURG, V26, P301, DOI 10.1053/j.sempedsurg.2017.09.002; Muehlethaler V, 2008, IMPAIRED VEGF NITRIC, V294, P110; Mura M, 2010, AM J PATHOL, V176, P1725, DOI 10.2353/ajpath.2010.090209; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Principi N, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1417-7; Rajatapiti P, 2008, PEDIATR DEVEL PATHOL, V11, P193, DOI 10.2350/07-04-0257.1; Sakurai MK, 2007, AM J PHYSIOL-LUNG C, V292, pL742, DOI 10.1152/ajplung.00064.2006; Sakurai MK, 2005, J INVEST SURG, V18, P201, DOI 10.1080/08941930591004485; SCHERLE W, 1970, Mikroskopie, V26, P57; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; van der Horst IWJM, 2011, PEDIATR DEVEL PATHOL, V14, P384, DOI 10.2350/09-09-0705-OA.1; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Woik N, 2015, CELL MOL LIFE SCI, V72, P2709, DOI 10.1007/s00018-015-1907-1	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208579	10.1371/journal.pone.0208579	http://dx.doi.org/10.1371/journal.pone.0208579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566445	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300050
J	Hogberg, U; Andersson, J; Hogberg, G; Thiblin, I				Hogberg, Ulf; Andersson, Jacob; Hogberg, Goran; Thiblin, Ingemar			Metabolic bone disease risk factors strongly contributing to long bone and rib fractures during early infancy: A population register study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PREMATURE-INFANTS; BODY-COMPOSITION; CHILDREN; ULTRASOUND; EPIDEMIOLOGY; PRETERM; QUALITY; ADULT; FETAL	Background The aim of this study was to assess the incidence of fractures in infancy, overall and by type of fracture, its association with accidents, metabolic bone disease risk factors, and abuse diagnosis. Methods The design was a population-based register study in Sweden. Participants: Children born 1997-2014,0-1 years of age diagnosed with fracture-diagnosis according to International Classification of Diseases (ICD10) were retrieved from the National Patient Register and linked to the Swedish Medical Birth Register and the Death Cause Register. Main outcome measures were fractures of the skull, long bone, clavicle and ribs, categorized by age (younger or older than 6 months), and accident or not. Findings The incidence of fractures during infancy was 251 per 100 000 infants (n = 4663). Major fracture localisations were long bone (44.9%), skull (31.7%), and clavicle (18.6%), while rib fractures were few (1.4%). Fall accidents were reported among 71-4%. One-third occurred during the first 6 months. Metabolic bone disease risk factors, such as maternal obesity, pre-term birth, vitamin D deficiency, rickets, and calcium metabolic disturbances, had increased odds of fractures of long bones and ribs in early infancy (0-6 months): birth 32-36 weeks and long bone fracture [AOR 2.13 (95%CI 1.67-2.93)] and rib fracture [AOR 4.24 (95%Cl 1.40-12.8)]. Diagnosis of vitamin D deficiency/rickets/disorders of calcium metabolism had increased odds of long bone fracture [AOR 49.5 (95%CI 18.3-134)] and rib fracture [AOR 617 (95%CI 162-2506)]. Fractures without a reported accident had higher odds of metabolic risk factors than those with reported accidents. Abuse diagnosis was registered in 105 infants, with overrepresentation of preterm births, multiple births and small-for-gestational age. Interpretation Metabolic bone disease risk factors are strongly associated with fractures of long bone and ribs in early infancy. Fracture cases with abuse diagnosis had a metabolic bone risk factor profile.	[Hogberg, Ulf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Andersson, Jacob; Thiblin, Ingemar] Uppsala Univ, Dept Surg Sci, Forens Med, Uppsala, Sweden; [Hogberg, Goran] Karolinska Inst, Dept Womens & Childrens Hlth, Child & Adolescent Psychiat Unit, Stockholm, Sweden	Uppsala University; Uppsala University; Karolinska Institutet	Hogberg, U (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	ulf.hogberg@kbh.uu.se		Hogberg, Ulf/0000-0002-2121-7511; Andersson, Jacob/0000-0001-8266-1926				Ambrose CG, 2018, BONE, V113, P151, DOI 10.1016/j.bone.2018.05.015; Barsness KA, 2003, J TRAUMA, V54, P1107, DOI 10.1097/01.TA.0000068992.01030.A8; Berkowitz CD, 2017, NEW ENGL J MED, V376, P1659, DOI 10.1056/NEJMcp1701446; Bishop N, 2007, ARCH DIS CHILD, V92, P251, DOI 10.1136/adc.2006.106120; Boskey Adele L, 2013, Bonekey Rep, V2, P447, DOI 10.1038/bonekey.2013.181; Bozzetti V, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-20; Busse B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006286; Carroll DM, 2007, J PERINAT MED, V35, P366, DOI 10.1515/JPM.2007.067; Christoffersen T, 2016, ARCH OSTEOPOROS, V11, DOI 10.1007/s11657-016-0294-z; Clark EM, 2008, J BONE MINER RES, V23, P173, DOI 10.1359/JBMR.071010; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Depalle B, 2018, BONE, V110, P107, DOI 10.1016/j.bone.2018.01.024; Dolan AL, 1998, ANN RHEUM DIS, V57, P630, DOI 10.1136/ard.57.10.630; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Folkestad L, 2017, J BONE MINER RES, V32, P125, DOI 10.1002/jbmr.2920; Galthen-Sorensen M, 2014, ULTRASOUND OBST GYN, V44, P633, DOI 10.1002/uog.13431; Gascoin G, 2017, SURG OBES RELAT DIS, V13, P1384, DOI 10.1016/j.soard.2017.03.017; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Harrison CM, 2008, ACTA PAEDIATR, V97, P407, DOI 10.1111/j.1651-2227.2007.00721.x; Hedstrom EM, 2010, ACTA ORTHOP, V81, P148, DOI 10.3109/17453671003628780; Hogberg U, 2018, EUR J PUBLIC HEALTH, V28, P641, DOI 10.1093/eurpub/cky062; Holick MF, 2017, DERM-ENDOCRINOL, V9, DOI 10.1080/19381980.2017.1279768; LANDIN L, 1983, CLIN ORTHOP RELAT R, P292; LANDIN LA, 1983, ACTA ORTHOP SCAND, V54, P1; Lempesis V, 2017, ACTA ORTHOP, V88, P440, DOI 10.1080/17453674.2017.1334284; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Maruyama H, 2017, EARLY HUM DEV, V106, P75, DOI [10.1016/j.earlhumdev.2017.02.0134, 10.1016/j.earlhumdev.2017.02.004]; Mazziotti G, 2016, BONE, V84, P88, DOI 10.1016/j.bone.2015.12.007; Miller M, 2014, OSTEOPOROSIS INT, V25, P1861, DOI 10.1007/s00198-014-2690-9; Mitchell JA, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.50; O'Callaghan KM, 2018, P NUTR SOC, V77, P164, DOI 10.1017/S0029665117004116; Paine CW, 2018, CHILD ABUSE NEGLECT, V76, P237, DOI 10.1016/j.chiabu.2017.11.004; Paterson CR, 2015, CLIN NUTR, V34, P793, DOI 10.1016/j.clnu.2014.12.006; Paterson CR, 2009, ACTA PAEDIATR, V98, P1935, DOI 10.1111/j.1651-2227.2009.01388.x; Paterson CR, 2015, BONE DISORDERS SCREE; Pieltain C, 2013, WORLD REV NUTR DIET, V106, P181, DOI 10.1159/000342680; Rack B, 2012, J PERINATOL, V32, P218, DOI 10.1038/jp.2011.82; Rauch F, 2002, ARCH DIS CHILD-FETAL, V86, P82, DOI 10.1136/fn.86.2.F82; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Sharp M, 2007, EARLY HUM DEV, V83, P653, DOI 10.1016/j.earlhumdev.2007.07.009; Swedish National Board of Health and Welfare, 2016, HLTH REG; Swedish National Board of Health and Welfare, 2016, SWED NAT PAT REG; Swedish National Board of Health and Welfare, 2003, RES REP EPC, P112; VANSTUIJVENBERG ME, 1995, AM J OBSTET GYNECOL, V172, P1585, DOI 10.1016/0002-9378(95)90501-4	47	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208033	10.1371/journal.pone.0208033	http://dx.doi.org/10.1371/journal.pone.0208033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566429	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300022
J	Steurer, C; Eder, N; Kerschbaum, S; Wegrostek, C; Gabrie, S; Pardo, N; Ortner, V; Czerny, T; Riegel, E				Steurer, Christoph; Eder, Noreen; Kerschbaum, Sarah; Wegrostek, Christina; Gabrie, Stefan; Pardo, Natalia; Ortner, Viktoria; Czerny, Thomas; Riegel, Elisabeth			HSF1 mediated stress response of heavy metals	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; LUCIFERASE REPORTER; GENE-EXPRESSION; HUMAN-CELLS; OXIDATIVE STRESS; KEY FEATURES; PROMOTER; PROTEINS; METALLOTHIONEIN; ACTIVATION	The heat shock response (HSR) pathway is a highly conserved cellular stress response and mediated by its master regulator HSF1. Activation of the pathway results in the expression of chaperone proteins (heat shock proteins; HSP) to maintain protein homeostasis. One of the genes strongest upregulated upon stress is HSPA1A (HSP72). Heavy metals are highly toxic to living organisms and known as environmental contaminants, due to industrialisation. Furthermore, many of them are well-described inducers of the HSR pathway. Here we compare the effect of different heavy metals, concerning their potential to activate HSF1 with a sensitive artificial heat shock reporter cell line, consisting of heat shock elements (HSE). In general the responses of the artificial promoter to heavy metal stress were in good agreement with those of well-established HSF1 target genes, like HSPA1A. Nevertheless, differences were observable when effects of heat and heavy metal stress were compared. Whereas heat stress preferentially activated the HSE promoter, heavy metals more strongly induced the HSPA1A promoter. We therefore analysed the HSPA1A promoter in more detail, by isolating and mutating the HSEs. The results indicate that the importance of the individual binding sites for HSF1 is determined by their sequence similarity to the consensus sequence and their position relative to the transcription start site, but they were not differentially affected by heat or heavy metal stress. In contrast, we found that other parts of the HSPA1A promoter have different impact on the response under different stress conditions. In this work we provide deeper insights into the regulation of HSP72 expression as a well as a method to quantitatively and sensitively evaluate different stressor on their potential to activate HSF1.	[Steurer, Christoph; Eder, Noreen; Kerschbaum, Sarah; Wegrostek, Christina; Gabrie, Stefan; Pardo, Natalia; Ortner, Viktoria; Czerny, Thomas; Riegel, Elisabeth] Univ Appl Sci, Dept Appl Life Sci, FH Campus Wien,Helmut Qualtinger Gasse 2, Vienna, Austria		Riegel, E (corresponding author), Univ Appl Sci, Dept Appl Life Sci, FH Campus Wien,Helmut Qualtinger Gasse 2, Vienna, Austria.	elisabeth.riegel@th-campuswien.ac.at	Lorente, Natalia Pardo/AAA-9237-2019	Lorente, Natalia Pardo/0000-0003-1847-4223; Kerschbaum, Sarah/0000-0001-9298-733X; Riegel, Elisabeth/0000-0002-1267-7073	Austrian Science Fund (FWF) [P25086-B19]; City of Vienna (MA23-project) [18-18]; Austrian Research Promotion Agency (FFG) [839053]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); City of Vienna (MA23-project); Austrian Research Promotion Agency (FFG)	The work was supported by the Austrian Science Fund (FWF, grant P25086-B19)(https://www.fwf.ac.at/), by the City of Vienna (MA23-project 18-18)(https://www.wien.gv.at/kontakte/ma23/) and the Austrian Research Promotion Agency (FFG, grant 839053)(https://www.ffg.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; BAUMAN JW, 1993, FUND APPL TOXICOL, V21, P15, DOI 10.1006/faat.1993.1066; Caruccio L, 1997, BIOCHEM J, V327, P341, DOI 10.1042/bj3270341; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; Duruibe JO, 2007, INT J PHYS SCI, V2, P112; Finka A, 2015, CELL STRESS CHAPERON, V20, P605, DOI 10.1007/s12192-015-0583-2; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Gaubin Y, 2000, BBA-MOL CELL RES, V1495, P4, DOI 10.1016/S0167-4889(99)00149-4; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hazra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168165; Hensen SMM, 2013, BIOCHIMIE, V95, P1245, DOI 10.1016/j.biochi.2013.01.017; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kim BM, 2014, COMP BIOCHEM PHYS C, V166, P65, DOI 10.1016/j.cbpc.2014.07.005; Koizumi S, 2013, GENE, V522, P184, DOI 10.1016/j.gene.2013.03.090; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; Neudegger T, 2016, NAT STRUCT MOL BIOL, V23, P140, DOI 10.1038/nsmb.3149; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ortner V, 2013, BIOENCAPSULATION LIV, P93, DOI [10.2174/9781608057207113010007, DOI 10.2174/9781608057207113010007]; Ortner V, 2015, CELL STRESS CHAPERON, V20, P277, DOI 10.1007/s12192-014-0540-5; Ortner V, 2012, J CONTROL RELEASE, V158, P424, DOI 10.1016/j.jconrel.2011.12.006; OVELGONNE H, 1995, TOXICOL APPL PHARM, V135, P100, DOI 10.1006/taap.1995.1212; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Riegel E, 2017, BIOTECHNIQUES, V62, P206, DOI 10.2144/000114544; Fernandez-Fernandez MR, 2017, FEBS LETT, V591, P2648, DOI 10.1002/1873-3468.12751; RYAN JA, 1994, ENVIRON TOXICOL CHEM, V13, P1231, DOI 10.1897/1552-8618(1994)13[1231:EOHITI]2.0.CO;2; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Vonbrull M, 2018, MOL BIOTECHNOL, V60, P339, DOI 10.1007/s12033-018-0058-7; Voon DC, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni030; Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026; WILLIAMS GT, 1990, MOL CELL BIOL, V10, P3125, DOI 10.1128/MCB.10.6.3125; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xin LL, 2016, TOXICOL APPL PHARM, V304, P9, DOI 10.1016/j.taap.2016.05.010; Xin LL, 2012, CELL STRESS CHAPERON, V17, P567, DOI 10.1007/s12192-012-0332-8; Zheng YH, 2013, CELL STRESS CHAPERON, V18, P203, DOI 10.1007/s12192-012-0374-y; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	46	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209077	10.1371/journal.pone.0209077	http://dx.doi.org/10.1371/journal.pone.0209077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566508	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300069
J	Acosta, ICL; Soares, RM; Mayorga, LFSP; Alves, BF; Soares, HS; Gennari, SM				Acosta, Igor Cunha Lima; Soares, Rodrigo Martins; Pereira Mayorga, Luis Felipe Silva; Alves, Brune Farias; Soares, Herbert Sousa; Gennari, Solange Maria			Occurrence of tissue cyst forming coccidia in Magellanic penguins (Spheniscus magellanicus) rescued on the coast of Brazil	PLOS ONE			English	Article							TOXOPLASMA-GONDII ANTIBODIES; FALCATULA-LIKE INFECTION; SARCOCYSTIS-FALCATULA; HAMMONDIA-HEYDORNI; INTERMEDIATE HOST; OOCYSTS; BIRDS; OPOSSUMS; IDENTIFICATION; SURVIVAL	The main motivation for this study was to determine the occurrence of Toxoplasma gondii, a cosmopolitan widespread zoonotic parasite distribution that can infect a wide variety of mals and birds, in Magellanic penguins (Spheniscus magellanicus) in Brazil. In recent decades there has been a significant increase in the number of penguins originating from Argentinian and Chilean Patagonia, where these birds are born, that arrive on the Brazilian coast, where many of them are stranded and rescued. Tissue samples were collected from 330 individuals surveyed from 2012-2015 at the Institute for Marine Animal Research and Rehabilitation (IPRAM) located in Cariacica, state of Espirito Santo, Brazil. Serum were collected from 145 animals surveyed in 2015 for the detection of anti-T. gondii antibodies using the Modified Agglutination Test (MAT >= 20) and 18 birds were positive, with titers of 20 (7 birds), 40 (9 birds) and 80 (2 birds). Mouse bioassay for the isolation of T. gondii was performed using tissues from 54 penguins that were also surveyed in 2015, but no isolates were obtained. DNA from tissue samples of 330 individuals was PCR amplified and sequenced to detect tissue cyst forming coccidians by using pan sarcocystids-directed primers (based on 18S rDNA). These samples were from animals surveyed in 2015 and from frozen stocked tissues from animals surveyed in the years 2012 and 2013. The positives were PCR amplified and sequenced with genus Sarcocystis-specific primers (based on internal transcribed spacer 1, RNA polymerase beta subunit coding gene, and cytochrome B coding gene) and with Sarcocystis falcatula/Sarcocystis neurone-specific primers (based on surface antigens SAG2, SAG3 and SAG4). Sixteen (3.0%) of pectoral muscle samples were positive by all the seven molecular markers and all the samples were identical to each other. Organisms close related to Sarcocystis falcatula were confirmed in all cases. This is the first report on molecular detection of infection by S. falcatula-related organisms and the first report of seropositivity for T. gondii in free-living Magellanic penguins in Brazil. Felids and didephid opossums are definitive hosts of T. gondii and S. falcatula, respectively. Where the penguins acquire the infective forms of the parasites shed by the terrestrial mammals remains to be elucidated.	[Acosta, Igor Cunha Lima; Soares, Rodrigo Martins; Alves, Brune Farias; Soares, Herbert Sousa; Gennari, Solange Maria] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, SP, Brazil; [Pereira Mayorga, Luis Felipe Silva] IPRAM, Cariacica, ES, Brazil; [Gennari, Solange Maria] Univ Santo Amaro, Med & Bem Estar Anim, Av Prof Eneas de Siqueira Neto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Gennari, SM (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, SP, Brazil.; Gennari, SM (corresponding author), Univ Santo Amaro, Med & Bem Estar Anim, Av Prof Eneas de Siqueira Neto, Sao Paulo, Brazil.	sgennari@usp.br	Soares, Rodrigo M/E-8747-2015; Soares, Herbert/AAR-8828-2021; da Cunha Lima Acosta, Igor/AGR-6833-2022	Soares, Rodrigo M/0000-0002-7736-7914; da Cunha Lima Acosta, Igor/0000-0002-2865-9806; Gennari, Solange/0000-0001-7500-5277	Sao Paulo State Research Foundation (FAPESP), Brazil [2013/25303-6, FAPESP - 2018/24954-8]; Brazilian Research Council (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Sao Paulo State Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thanks Sao Paulo State Research Foundation (FAPESP), Brazil, for the financial support to this project (2013/25303-6) and for the scholarship to I. Acosta and S.M Gennari (FAPESP - 2018/24954-8). S.M Gennari are in receipt of a scholarship from Brazilian Research Council (CNPq). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX ED, 1982, J PARASITOL, V68, P668, DOI 10.2307/3280926; Cesar MO, 2018, EXP PARASITOL, V188, P42, DOI 10.1016/j.exppara.2018.03.004; Cole RA, 2000, J PARASITOL, V86, P526, DOI 10.1645/0022-3395(2000)086[0526:BAMCOT]2.0.CO;2; Deem SL, 2010, J WILDLIFE DIS, V46, P1005, DOI 10.7589/0090-3558-46.3.1005; Dubey JP, 2016, PARASITOLOGY, V143, P314, DOI 10.1017/S0031182015001316; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Dubey JP, 2001, J PARASITOL, V87, P824, DOI 10.1645/0022-3395(2001)087[0824:ASFLII]2.0.CO;2; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Dubey JP, 2015, SARCOCYSTOSIS ANIMAL, V2nd; Ecco R, 2008, AVIAN DIS, V52, P706, DOI 10.1637/8303-040408-Case.1; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Garcia-Borboroglu P., 2013, PENGUINS NATURAL HIS; Gennari SM, 2014, VET PARASITOL, V200, P193, DOI 10.1016/j.vetpar.2013.10.003; Gennari SM, 2016, VET PARASITOL, V226, P50, DOI 10.1016/j.vetpar.2016.06.016; Gennari SM, 2016, J ZOO WILDLIFE MED, V47, P364, DOI 10.1638/2015-0103.1; Gennari Solange Maria, 2017, Brazilian Journal of Veterinary Research and Animal Science, V54, P197, DOI 10.11606/issn.1678-4456.bjvras.2017.1; Godoy SN, 2009, J AVIAN MED SURG, V23, P18, DOI 10.1647/2008-006R.1; Gondim LSQ, 2017, VET PARASITOL, V243, P192, DOI 10.1016/j.vetpar.2017.07.002; Hillyer E V., 1991, J ZOO WILDLIFE MED, V22, P1991; Konradt G, 2017, PARASITOL RES, V116, P809, DOI 10.1007/s00436-016-5341-6; Leite AS, 2007, MED VET-RECIFE, V1, P55; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2003, J EUKARYOT MICROBIOL, V50, P687, DOI 10.1111/j.1550-7408.2003.tb00688.x; Lindsay DS, 1999, VET PARASITOL, V80, P341, DOI 10.1016/S0304-4017(98)00228-3; Lindsay DS, 2001, J EUKARYOT MICROBIOL, p197S; Luznar SL, 2001, VET PARASITOL, V95, P327, DOI 10.1016/S0304-4017(00)00399-X; Mader A, 2011, PROJETO NACL MONITOR, V1, P8; MASON RW, 1991, J PARASITOL, V77, P328, DOI 10.2307/3283109; Miller E.A., 2012, MINIMUM STANDARDS WI, V4th ed.; Monteiro RM, 2013, VET PARASITOL, V196, P64, DOI 10.1016/j.vetpar.2013.01.019; PAGE CD, 1992, J ZOO WILDLIFE MED, V23, P77; Ploeg M, 2011, AVIAN DIS, V55, P701, DOI 10.1637/9700-030411-Case.1; Porter RA, 2001, VET PARASITOL, V95, P313, DOI 10.1016/S0304-4017(00)00397-6; RATCLIFFE HL, 1951, AM J PATHOL, V27, P655; Sercundes MK, 2016, REV BRAS PARASITOL V, V25, P82, DOI 10.1590/S1984-29612016015; Sick H., 2001, ORNITOLOGIA BRASILEI, V3; Slapeta JR, 2002, VET J, V163, P147, DOI 10.1053/tvjl.2001.0599; Soares HS, 2010, ARQ BRAS MED VET ZOO, V62, P489, DOI 10.1590/S0102-09352010000200033; Soares RM, 2011, VET PARASITOL, V175, P168, DOI 10.1016/j.vetpar.2010.09.022; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Suedmeyer WK, 2001, J ZOO WILDLIFE MED, V32, P252, DOI 10.1638/1042-7260(2001)032[0252:APSFLI]2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valadas SYOB, 2016, EXP PARASITOL, V164, P71, DOI 10.1016/j.exppara.2016.02.008; Verma SK, 2018, J PARASITOL, V104, P710, DOI 10.1645/18-78; Villar D, 2008, AVIAN DIS, V52, P187, DOI 10.1637/8104-090207-Case; Williams TD, 1995, PENGUINS SPHENISCIDA; Wunschmann A, 2010, J VET DIAGN INVEST, V22, P282, DOI 10.1177/104063871002200222	48	12	12	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209007	10.1371/journal.pone.0209007	http://dx.doi.org/10.1371/journal.pone.0209007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562391	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100031
J	Such-Miguel, L; Brines, L; Alberola, AM; Zarzoso, M; Chorro, FJ; Guerrero, J; Parra, G; Gallego, N; Soler, C; Del Canto, I; Guill, A; Such, L				Such-Miguel, Luis; Brines, Laia; Alberola, Antonio M.; Zarzoso, Manuel; Chorro, Francisco J.; Guerrero, Juan; Parra, German; Gallego, Nathalia; Soler, Carlos; Del Canto, Irene; Guill, Antonio; Such, Luis			Effect of chronic exercise on myocardial electrophysiological heterogeneity and stability. Role of intrinsic cholinergic neurons: A study in the isolated rabbit heart	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; ATRIAL-FIBRILLATION; HCN CHANNELS; REFRACTORINESS; AUTOMATISM; CONDUCTION	A study has been made of the effect of chronic exercise on myocardial electrophysiological heterogeneity and stability, as well as of the role of cholinergic neurons in these changes. Determinations in hearts from untrained and trained rabbits on a treadmill were performed. The hearts were isolated and perfused. A pacing electrode and a recording multielectrode were located in the left ventricle. The parameters determined during induced VF, before and after atropine (1 mu M), were: fibrillatory cycle length (VV), ventricular functional refractory period (FRPVF), normalized energy (NE) of the fibrillatory signal and its coefficient of variation (CV), and electrical ventricular activation complexity, as an approach to myocardial heterogeneity and stability. The VV interval was longer in the trained group than in the control group both prior to atropine (78 +/- 10 vs. 68 +/- 10 ms) and after atropine (76 +/- 8 vs. 67 +/- 10 ms). Likewise, FRPVF was longer in the trained group than in the control group both prior to and after atropine (53 +/- 8 vs. 42 +/- 7 ms and 50 +/- 6 vs. 40 +/- 6 ms, respectively), and atropine did not modify FRPVF. The CV of FRPVF was lower in the trained group than in the control group prior to atropine (12.5 +/- 1.5% vs. 15.1 +/- 3.8%) and, decreased after atropine (15.1 +/- 3.8% vs. 12.2 +/- 2.4%) in the control group. The trained group showed higher NE values before (0.40 +/- 0.04 vs. 0.36 +/- 0.05) and after atropine (0.37 +/- 0.04 vs. 0.34 +/- 0.06; p = 0.08). Training decreased the CV of NE both before (23.3 +/- 2% vs. 25.2 +/- 4%; p = 0.08) and after parasympathetic blockade (22.6 +/- 1% vs. 26.1 +/- 5%). Cholinergic blockade did not modify these parameters within the control and trained groups. Activation complexity was lower in the trained than in the control animals before atropine (34 +/- 8 vs. 41 +/- 5), and increased after atropine in the control group (41 +/- 5 vs. 48 +/- 9, respectively). Thus, training decreases the intrinsic heterogeneity of the myocardium, increases electrophysiological stability, and prevents some modifications due to muscarinic block.	[Such-Miguel, Luis; Zarzoso, Manuel] Univ Valencia, Dept Physiotherapy, Valencia, Spain; [Such-Miguel, Luis; Brines, Laia; Alberola, Antonio M.; Zarzoso, Manuel; Chorro, Francisco J.; Parra, German; Gallego, Nathalia; Soler, Carlos; Del Canto, Irene; Such, Luis] Hlth Res Inst INCLIVA, Valencia, Spain; [Brines, Laia; Alberola, Antonio M.; Parra, German; Soler, Carlos; Such, Luis] Univ Valencia, Dept Physiol, Valencia, Spain; [Chorro, Francisco J.] Univ Valencia, Dept Med, Valencia, Spain; [Guerrero, Juan] Univ Valencia, Dept Elect Engn, Valencia, Spain; [Guill, Antonio] Univ Politecn Valencia, ITACA, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia; University of Valencia; Universitat Politecnica de Valencia	Such, L (corresponding author), Hlth Res Inst INCLIVA, Valencia, Spain.; Such, L (corresponding author), Univ Valencia, Dept Physiol, Valencia, Spain.	luis.such@uv.es	Ibañez, Antonio Guill/AAA-5920-2019; Zarzoso, Manuel/AAA-6129-2019; Chorro, Francisco J/AAB-6766-2020; del Canto, Irene/ABH-1032-2020; Parra, Germán/K-9401-2013	Ibañez, Antonio Guill/0000-0001-8546-264X; Zarzoso, Manuel/0000-0003-3372-4497; Parra, Germán/0000-0001-7154-1806; Such-Miquel, Luis/0000-0001-8499-7183; Alberola, Antonio/0000-0001-8531-4161	Spanish Ministry of Education and Science [DEP2007-73234-C03-01]; Generalitat Valenciana [PROMETEO 2010/093, FPI/2008/003]	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported by the Spanish Ministry of Education and Science, (DEP2007-73234-C03-01 to AMA), http://www.mecd.gob.es/portada-mecd/; and the Generalitat Valenciana (PROMETEO 2010/093 to FJC, and FPI/2008/003 to MZ), http://www.gva.es/va/inicio/presentacion; jsessionid=ydprbDQZTsCTz85W1	Abramochkin DV, 2010, EXP PHYSIOL, V95, P265, DOI 10.1113/expphysiol.2009.050302; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; ARMOUR JA, 1990, AM J PHYSIOL, V258, pH326, DOI 10.1152/ajpheart.1990.258.2.H326; Armour JA, 1998, AM J PHYSIOL-REG I, V274, pR939, DOI 10.1152/ajpregu.1998.274.4.R939; Arora RC, 2001, AM J PHYSIOL-REG I, V280, pR1736, DOI 10.1152/ajpregu.2001.280.6.R1736; Beaumont E, 2013, J PHYSIOL-LONDON, V591, P4515, DOI 10.1113/jphysiol.2013.259382; Billman GE, 2002, J APPL PHYSIOL, V92, P446, DOI 10.1152/japplphysiol.00874.2001; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Chorro FJ, 2000, PACE, V23, P1594, DOI 10.1046/j.1460-9592.2000.01594.x; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; DICARLO SE, 1990, AM J PHYSIOL, V258, pH212, DOI 10.1152/ajpheart.1990.258.1.H212; Dor-Haim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066658; Duytschaever M, 2001, CIRCULATION, V104, P957, DOI 10.1161/hc3401.093156; Hajnal A, 2005, LIFE SCI, V77, P1960, DOI 10.1016/j.lfs.2005.02.015; Hamer M, 2008, OPEN SPORTS SCI J, V1, P1; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; Herrmann S, 2011, J MOL CELL CARDIOL, V51, P997, DOI 10.1016/j.yjmcc.2011.09.005; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; Liu LL, 1997, AM J PHYSIOL-HEART C, V273, pH805, DOI 10.1152/ajpheart.1997.273.2.H805; NOAKES TD, 1983, CIRCULATION, V67, P24, DOI 10.1161/01.CIR.67.1.24; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Sartiani L, 2015, CURR DRUG TARGETS, V16, P868, DOI 10.2174/1389450116666150531152047; Such L, 2008, ACTA PHYSIOL, V193, P331, DOI 10.1111/j.1748-1716.2008.01851.x; Such L, 2002, J APPL PHYSIOL, V92, P225, DOI 10.1152/jappl.2002.92.1.225; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Zaitsev AV, 2000, CIRC RES, V86, P408, DOI 10.1161/01.RES.86.4.408; Zarzoso M, 2012, EUR J APPL PHYSIOL, V112, P2185, DOI 10.1007/s00421-011-2189-4	29	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209085	10.1371/journal.pone.0209085	http://dx.doi.org/10.1371/journal.pone.0209085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562383	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100036
J	Ahmed, SF; Shabayek, MI; Ghany, MEA; El-Hefnawy, MH; El-Mesallamy, HO				Ahmed, Sara F.; Shabayek, Marwa, I; Ghany, Mostafa E. Abdel; El-Hefnawy, Mohamed H.; El-Mesallamy, Hala O.			Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females	PLOS ONE			English	Article							INSULIN-RESISTANCE; FAMILY; INFLAMMATION; ADIPONECTIN; ADIPOKINES; PROTEINS	C1q complement/tumor necrosis factor (TNF)-related protein (CTRP) family comprises of 15 proteins that posses important implications in energy homeostasis, infection and inflammation. However, their roles in diabetes mellitus (DM) and its vascular complications have not been completely assessed. This works aims to study the association of two CTRPs; 3 and 9, with pro-inflammatory cytokine monocyte chemoattractant protein-1 (MCP-1), and biochemical parameters of type 2 diabetes (T2D), dyslipidemia and coronary artery disease (CAD). Methods: Biochemical markers and serum levels of CTRPs and MCP-1 were measured in 86 postmenopausal females. Subjects were divided over four groups; 13 apparent healthy subjects as control (group I), 29 patients with CAD (group II), 29 patients with T2D >= 5 years (group III) and 15 patients with CAD secondary to T2D (group IV). Serum CTRP3, CTRP9, MCP-1 and insulin were measured by ELISA. Results: Serum CTRP3 levels were found to be significantly higher in group III and IV, whereas, it was significantly lower in group II on comparing to group I. While, CTRP9 levels were significantly decreased in group II, III and IV on comparing to group I. MCP-1 levels were found to be significantly increased in groups II, III and IV on comparison with group I. Both CTRPs were significantly negatively correlated with each other. While MCP-1 was significantly correlated negatively to CTRP9. Conclusion: This study associates the possible role of CTRP3, CTRP9 and MCP-1/CCL2 in the diagnosis/prognosis of CAD complication in T2D postmenopausal females.	[Ahmed, Sara F.; Shabayek, Marwa, I] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Biochem Dept, 5th Settlement, Cairo, Egypt; [Ghany, Mostafa E. Abdel] Al Azhar Univ, Fac Med, Cardiol Dept, Cairo, Egypt; [El-Hefnawy, Mohamed H.] NIDE, Cairo, Egypt; [El-Mesallamy, Hala O.] Ain Shams Univ, Fac Pharm, Biochem Dept, African Union Author St Abassia, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Future University in Egypt; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); National Institute of Diabetes & Endocrinology; Egyptian Knowledge Bank (EKB); Ain Shams University	El-Mesallamy, HO (corresponding author), Ain Shams Univ, Fac Pharm, Biochem Dept, African Union Author St Abassia, Cairo, Egypt.	hala_elmosalamy@hotmail.com		Faisal Ahmed Haridy, Sara/0000-0002-4283-4594				Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Atlas ID, 2016, 7 INT DIAB FED; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Choi KM, 2012, DIABETES; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Fadaei R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168773; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Juskewitch JE, 2012, AM J PATHOL, V180, P32, DOI 10.1016/j.ajpath.2011.10.001; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Sebastiao I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00110; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; WHO, 2016, GLOB DAT BOD MASS IN; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Yi W, 2012, CIRCULATION, V112; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	26	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208038	10.1371/journal.pone.0208038	http://dx.doi.org/10.1371/journal.pone.0208038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557342	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000019
J	Tuekprakhon, A; Puiprom, O; Sasaki, T; Michiels, J; Bartholomeeusen, K; Nakayama, EE; Meno, MK; Phadungsombat, J; Huits, R; Arien, KK; Luplertlop, N; Shioda, T; Leaungwutiwong, P				Tuekprakhon, Aekkachai; Puiprom, Orapim; Sasaki, Tadahiro; Michiels, Johan; Bartholomeeusen, Koen; Nakayama, Emi E.; Meno, Michael K.; Phadungsombat, Juthamas; Huits, Ralph; Arien, Kevin K.; Luplertlop, Natthanej; Shioda, Tatsuo; Leaungwutiwong, Pornsawan			Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development	PLOS ONE			English	Article							ALPHAVIRUS CAPSID PROTEIN; PLASMA-MEMBRANE; VIRAL SURFACE; E1; EPITOPE; ENTRY; E2; SERODIAGNOSIS; GLYCOPROTEINS; EXPRESSION	In response to the aggressive global spread of the mosquito-borne chikungunya virus (CHIKV), an accurate and accessible diagnostic tool is of high importance. CHIKV, an arthritogenic alphavirus, comprises three genotypes: East/Central/South African (ECSA), West African (WA), and Asian. A previous rapid immunochromatographic (IC) test detecting CHIKV E1 protein showed promising performance for detection of the ECSA genotype. Unfortunately, this kit exhibited lower capacity for detection of the Asian genotype, currently in circulation in the Americas, reflecting the low avidity of one of the monoclonal antibodies (mAbs) in this IC kit for the E1 protein of the Asian-genotype because of a variant amino acid sequence. To address this shortcoming, we set out to generate a new panel of broad- spectrum mouse anti-CHIKV mAbs using hybridoma technology. We report here the successful generation of mouse anti-CHIKV mAbs targeting CHIKV E1 and capsid proteins. These mAbs possessed broad reactivity to all three CHIKV genotypes, while most of the mAbs lacked cross-reactivity towards Sindbis, dengue, and Zika viruses. Two of the mAbs also lacked cross-reactivity towards other alphaviruses, including O'nyong-nyong, Ross River, Mayaro, Western Equine Encephalitis, Eastern Equine Encephalitis, and Venezuelan Equine Encephalitis viruses. In addition, another two mAbs cross-reacted weakly only with most closely related O'nyong-nyong virus. Effective diagnosis is one of the keys to disease control but to date, no antibody-based rapid IC platform for CHIKV is commercially available. Thus, the application of the mAbs characterized here in the rapid diagnostic IC kit for CHIKV detection is expected to be of great value for clinical diagnosis and surveillance purposes.	[Tuekprakhon, Aekkachai; Luplertlop, Natthanej; Leaungwutiwong, Pornsawan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Tuekprakhon, Aekkachai; Puiprom, Orapim; Sasaki, Tadahiro; Nakayama, Emi E.; Meno, Michael K.; Phadungsombat, Juthamas; Shioda, Tatsuo] Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand; [Michiels, Johan; Bartholomeeusen, Koen] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Nakayama, Emi E.; Arien, Kevin K.; Shioda, Tatsuo] Osaka Univ, RIMD, Osaka, Japan; [Huits, Ralph] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Mahidol University; Mahidol University; Institute of Tropical Medicine (ITM); Osaka University; Institute of Tropical Medicine (ITM); University of Antwerp	Leaungwutiwong, P (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.; Shioda, T (corresponding author), Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand.; Shioda, T (corresponding author), Osaka Univ, RIMD, Osaka, Japan.	shioda@biken.osaka-u.ac.jp; pornsawan.lea@mahidol.ac.th	Tuekprakhon, Aekkachai/GLT-2776-2022; Huits, Ralph/I-8361-2019	Huits, Ralph/0000-0001-8803-9468; Tuekprakhon, Aekkachai/0000-0003-1275-0581	Japan Agency for Medical Research and Development (AMED); Program: Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) [JP18fm0108003]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Program: Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	This work was supported by funder Japan Agency for Medical Research and Development (AMED), https://www.amed.go.jp/; Program: Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) JP18fm0108003 to T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn A, 1999, J VIROL, V73, P10029, DOI 10.1128/JVI.73.12.10029-10039.1999; Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681; Angelini R, 2007, EUROSURVEILLANCE, V12; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262; Cho B, 2008, J VIROL METHODS, V154, P154, DOI 10.1016/j.jviromet.2008.07.031; Damle RG, 2016, ARCH VIROL, V161, P1611, DOI 10.1007/s00705-016-2829-4; FLYNN DC, 1990, J VIROL, V64, P3643, DOI 10.1128/JVI.64.8.3643-3653.1990; Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2; Goh LYH, 2015, VIRUSES-BASEL, V7, P2943, DOI 10.3390/v7062754; Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002; Hammar L, 2003, J BIOL CHEM, V278, P7189, DOI 10.1074/jbc.M206015200; Hasan MK, 1997, J GEN VIROL, V78, P2813, DOI 10.1099/0022-1317-78-11-2813; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong EM, 2006, J VIROL, V80, P8848, DOI 10.1128/JVI.00619-06; Huits R, 2018, CLIN MICROBIOL INFEC, V24, P78, DOI 10.1016/j.cmi.2017.06.004; Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kanai Y, 2010, VIRUS RES, V153, P218, DOI 10.1016/j.virusres.2010.08.005; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Khan K., 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5, DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5]; Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796; Kishishita N, 2013, J CLIN MICROBIOL, V51, P1389, DOI 10.1128/JCM.03109-12; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kumar S, 2015, ARCH VIROL, V160, P2749, DOI 10.1007/s00705-015-2564-2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44; Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x; Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268; LILJESTROM P, 1991, J VIROL, V65, P147; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Miggiano V., 1982, RES DISCL, V217, P155; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Nsoesie EO, 2016, EUROPEAN COMMUNICABL, V21, P1, DOI DOI 10.2807/1560-7917.ES.2016.21.20.30234; Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000; ROSS R. W., 1956, JOUR HYG, V54, P177; Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423; SHAPIRA E, 1969, J BIOL CHEM, V244, P1026; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Snyder AJ, 2012, J VIROL, V86, P13609, DOI 10.1128/JVI.01805-12; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Tuekprakhon A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19174-8; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Wengler G, 2003, J GEN VIROL, V84, P173, DOI 10.1099/vir.0.18696-0; Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x	61	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208851	10.1371/journal.pone.0208851	http://dx.doi.org/10.1371/journal.pone.0208851			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557365	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000050
J	Gomel, N; Negari, S; Frucht-Pery, J; Wajnsztajn, D; Strassman, E; Solomon, A				Gomel, Nir; Negari, Shay; Frucht-Pery, Joseph; Wajnsztajn, Denise; Strassman, Eyal; Solomon, Abraham			Predictive factors for efficacy and safety in refractive surgery for myopia	PLOS ONE			English	Article							ASSISTED SUBEPITHELIAL KERATECTOMY; IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; SURFACE ABLATION; LASER; OUTCOMES; LASIK; GLAUCOMA; AGE	Purpose To evaluate the predictive factors for safety and efficacy in laser refractive surgery for myopia Setting A singular refractive surgery center, at a University-affiliated tertiary medical center. Design Retrospective cohort study Methods Study population-A total 8,775 eyes having laser refractive laser procedures for myopia (in4,623 patients). Observation procedures-Using a prospective database of refractive procedures performed over the span of 13 years, variables such as gender, age, type of surgery, date of surgery, pre-operative corneal thickness and Spherical Equivalent (SEQ) were evaluated. Main outcome measures-Proportion of patients with Safety index higher than 0.85 and Efficacy index higher than 0.80. Results 91.9% and 86.0% of all evaluated eyes were above the safety and efficacy cut-off levels, respectively. Younger age was significantly correlated with safety and efficacy indices above the cut-off levels (p<0.001). Male gender was significantly correlated with efficacy above the cut-off level (p<0.001). Myopic eyes with lower SEQ were associated with both safety (p = 0.002) and efficacy (p<0.001) indices above the cut-offs. The surgical procedure was found to significantly affect the outcome only using univariate analysis: Safety was higher in Photorefractive Keratectomy (PRK), while Efficacy was higher in Laser Assisted In Situ Keratomileusis (LASIK) (p<0.001, respectively) but no difference was found using multivariate analysis. Safety index above the cut-off level increased over the years (p<0.001). Conclusions Efficacy in refractive surgery for myopia is correlated with younger age, male gender and low myopia. Safety is correlated with younger age, low myopia and increases over the years. Multivariate analysis found no differences between PRK and LASIK regarding safety and efficacy.	[Gomel, Nir; Negari, Shay; Frucht-Pery, Joseph; Wajnsztajn, Denise; Strassman, Eyal; Solomon, Abraham] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Negari, Shay] Hadassah Hebrew Univ, Med Ctr, Dept Publ Hlth, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Solomon, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	dr.avi.solomon@gmail.com		Gomel, Nir/0000-0002-4771-1374; Solomon, Abraham/0000-0003-3222-9507				Al-Tobaigy FM, 2012, MIDDLE EAST AFR J OP, V19, P304, DOI 10.4103/0974-9233.97931; Albelda-Valles JC, 2007, J REFRACT SURG, V23, P592; Bailey MD, 2007, CORNEA, V26, P246, DOI 10.1097/ICO.0b013e318033dbf0; de Rojas V, 2011, J CATARACT REFR SURG, V37, P1822, DOI 10.1016/j.jcrs.2011.04.037; DUTT S, 1994, ARCH OPHTHALMOL-CHIC, V112, P1427, DOI 10.1001/archopht.1994.01090230041018; Ehlke GL, 2016, ASIA-PAC J OPHTHALMO, V5, P434, DOI 10.1097/APO.0000000000000237; Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814; Hammond MD, 2005, OPHTHALMOLOGY, V112, P184, DOI 10.1016/j.ophtha.2004.08.014; Kuryan J, 2017, LASER ASSISTED SUBEP; LASS JH, 1995, CORNEA, V14, P89; Linke SJ, 2012, OPTOMETRY VISION SCI, V89, P1156, DOI 10.1097/OPX.0b013e318263c165; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Moshirfar M, 2010, J CATARACT REFR SURG, V36, P1336, DOI 10.1016/j.jcrs.2010.02.012; Ortega-Usobiaga J, 2015, J CATARACT REFR SURG, V41, P1210, DOI 10.1016/j.jcrs.2014.09.041; POLSE KA, 1989, INVEST OPHTH VIS SCI, V30, P392; Reinstein DZ, 2014, J REFRACT SURG, V30, P654, DOI 10.3928/1081597X-20140903-01; Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5; Sandoval HP, 2005, J CATARACT REFR SURG, V31, P221, DOI 10.1016/j.jcrs.2004.08.047; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shahinian L, 2002, J CATARACT REFR SURG, V28, P1334, DOI 10.1016/S0886-3350(02)01444-X; Shortt AJ, 2013, LASER ASSISTED IN SI; Shortt AJ, 2006, OPHTHALMOLOGY, V113, P1897, DOI 10.1016/j.ophtha.2006.08.013; STAATZ WD, 1980, INVEST OPHTH VIS SCI, V19, P983; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yang Xin-Jun, 2003, Journal of Medical Investigation, V50, P180; Yuen LH, 2010, OPHTHALMOLOGY, V117, P1236, DOI 10.1016/j.ophtha.2009.10.042	26	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208608	10.1371/journal.pone.0208608	http://dx.doi.org/10.1371/journal.pone.0208608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550575	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000021
J	Ko, HS; Ha Wie, J; Choi, SK; Park, IY; Park, YG; Shin, JC				Ko, Hyun Sun; Ha Wie, Jeong; Choi, Sae Kyung; Park, In Yang; Park, Yong-Gyu; Shin, Jong Chul			Optimal time of delivery to reduce the risk of infant mortality in small and normally grown fetuses: A national cohort study in Korea	PLOS ONE			English	Article							LATE-PRETERM; OUTCOMES; BIRTH; TERM; STILLBIRTH; DEATH; FETAL	Purpose To examine the competing risks of stillbirth versus infant death and to evaluate the optimal time of delivery in the population of small for gestational age (SGA) and non-SGA late preterm and term fetuses. Methods This was a retrospective national cohort study of all singleton births between 34 0/7 and 42 6/7 weeks of gestation using the Korean vital statistics (n = 2,106,159). We compared the risk of infant mortality with a composite of fetal-infant mortality risk that would occur after expectant management for one additional week and evaluated the optimal time of delivery, in SGA and non-SGA pregnancies. Results In the total population, the risk of expectant management became significantly higher than the risk of delivery, at 39 weeks and beyond, similar with non-SGA group. In the SGA group, the risk of stillbirth was significantly greater at all GAs than for non-SGA pregnancies, and the risk of infant death was significantly increased until 38 weeks (25.8 per 10,000 live births, 95% CI 20.11-32.47), and the risk of stillbirth was significantly increased at 41 weeks (11.65 per 10,000 ongoing pregnancies, 95% CI 6.95-18.09), compared to 39 weeks (12 per 10,000 live births, 95% CI 8.98-15.64 and 5.12 per 10,000 ongoing pregnancies, 95% CI 3.84-6.66, respectively). Conclusion In Korean women, delivery between 39 and 41 weeks minimizes fetal/infant mortality, in non-SGA pregnancies. In uncomplicated SGA pregnancies, delivery between 39 and 40 weeks can be considered to decrease risk of infant death and stillbirths.	[Ko, Hyun Sun; Ha Wie, Jeong; Choi, Sae Kyung; Park, In Yang; Shin, Jong Chul] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Yong-Gyu] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Shin, JC (corresponding author), Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jcshin@catholic.ac.kr		KO, HYUN SUN/0000-0001-6310-6206	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	This study is funded by the Catholic Medical Center Research Foundation made in the program year of 2017.	Adanu RMK, 2009, INT J GYNECOL OBSTET, V106, P179, DOI 10.1016/j.ijgo.2009.03.036; [Anonymous], 2013, Obstet Gynecol, V121, P911, DOI 10.1097/01.AOG.0000428649.57622.a7; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Chen H Y, 2011, AM J OBSTET GYNECOL, V204; Gillet E, 2014, INT J GYNECOL OBSTET, V124, P128, DOI 10.1016/j.ijgo.2013.07.031; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Glavind J, 2013, BJOG-INT J OBSTET GY, V120, P1123, DOI 10.1111/1471-0528.12278; Glavind J, 2015, CURR OPIN OBSTET GYN, V27, P121, DOI 10.1097/GCO.0000000000000158; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; Kirby RS, 2011, BIRTH-ISS PERINAT C, V38, P354, DOI 10.1111/j.1523-536X.2011.00505.x; Korea National Statistical Office, 2010, KOR VIT STAT BIRTH C, P12; Lee JK, 2016, J KOREAN MED SCI, V31, P939, DOI 10.3346/jkms.2016.31.6.939; MacDorman MF, 2011, SEMIN PERINATOL, V35, P200, DOI 10.1053/j.semperi.2011.02.017; Pilliod RA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.039; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Rosenstein MG, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.008; Rosenstein MG, 2012, OBSTET GYNECOL, V120, P76, DOI 10.1097/AOG.0b013e31825bd286; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Trilla CC, 2014, EUR J OBSTET GYN R B, V179, P105, DOI 10.1016/j.ejogrb.2014.05.030; Tsai ML, 2012, PEDIATR NEONATOL, V53, P171, DOI 10.1016/j.pedneo.2012.04.003	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209308	10.1371/journal.pone.0209308	http://dx.doi.org/10.1371/journal.pone.0209308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550584	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000057
J	Rahutomo, S; Kovar, JL; Thompson, ML				Rahutomo, Suroso; Kovar, John L.; Thompson, Michael L.			Varying redox potential affects P release from stream bank sediments	PLOS ONE			English	Article							PHOSPHORUS RELEASE; WALNUT-CREEK; ORGANIC-MATTER; TAIHU LAKE; WATER; SOIL; ADSORPTION; GROUNDWATER; RETENTION; PHOSPHATE	Sediments in streams that drain agricultural watersheds may be sinks that can adsorb P from the stream or sources that can release P to the stream. Sediment characteristics and environmental factors, including the oxidation-reduction (redox) potential of the water associated with the sediment, determine whether P will be adsorbed or released by the sediment. We investigated P adsorption and release by four sediments [three Holocene-age sediments (Camp Creek, Roberts Creek and Gunder) as well as Pre-Illinoian-age Till] that occur in Walnut Creek, a second-order stream in Jasper County, Iowa, that is representative of many small streams in the glaciated upper Midwest of the US. The effects of two redox potentials on phosphorus buffering capacity (PBC) and equilibrium phosphorus concentration (EPC) were evaluated in batch adsorption experiments. We also simulated aerobic and anerobic conditions over a 24-day period and measured solution-phase P concentrations in stirred systems where the sediments were isolated from the water by dialysis tubing. The batch experiment indicated that the EPCs of the three Holocene-age sediments were similar to one another and increased with decreasing redox potential. In the stirred flow reactors, more dissolved P was released from the Camp Creek and Roberts Creek sediments under anaerobic conditions than from the other sediments. This observation suggests that these two sediments, which are younger and higher in the stratigraphic sequence, are more likely to be P sources in suboxic settings. The P buffering capacity was greatest in the till. Where it is in contact with the stream water, the till is likely to serve as an adsorbing sink for P in the water column.	[Rahutomo, Suroso] Indonesian Oil Palm Res Inst, Medan, North Sumatra, Indonesia; [Kovar, John L.] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA; [Thompson, Michael L.] Iowa State Univ, Agron Dept, Ames, IA 50011 USA	Riset Perkebunan Nusantara; Indonesian Oil Palm Research Institute (IOPRI); United States Department of Agriculture (USDA); Iowa State University	Thompson, ML (corresponding author), Iowa State Univ, Agron Dept, Ames, IA 50011 USA.	mlthomps@iastate.edu		Kovar, John/0000-0002-3503-234X; Thompson, Michael L./0000-0002-9275-8948	Foundational Program of the Agriculture & Food Research Initiative [2013-67019-21393]; USDA National Institute of Food Agriculture	Foundational Program of the Agriculture & Food Research Initiative; USDA National Institute of Food Agriculture	This research was supported by the Foundational Program of the Agriculture & Food Research Initiative (https://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri) (Grant no. 2013-67019-21393) from the USDA National Institute of Food & Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelo J, 2007, GEODERMA, V138, P12, DOI 10.1016/j.geoderma.2006.10.011; BARYOSEF B, 1988, SOIL SCI SOC AM J, V52, P1580, DOI 10.2136/sssaj1988.03615995005200060011x; Beck W, 2018, WATER-SUI, V10, DOI 10.3390/w10020111; Brand-Klibanski S, 2007, SOIL SCI SOC AM J, V71, P1128, DOI 10.2136/sssaj2006.0222; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; Briggs MA, 2015, GEOPHYS RES LETT, V42, P4402, DOI 10.1002/2015GL064200; Briggs MA, 2013, FRESHW SCI, V32, P622, DOI 10.1899/12-110.1; Burchsted D, 2010, BIOSCIENCE, V60, P908, DOI 10.1525/bio.2010.60.11.7; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; D'Angelo E, 2001, J ENVIRON QUAL, V30, P2206, DOI 10.2134/jeq2001.2206; Essington M. E., 2015, Soil and water chemistry: an integrative approach; Grybos M, 2009, GEODERMA, V154, P13, DOI 10.1016/j.geoderma.2009.09.001; Guppy CN, 2005, AUST J SOIL RES, V43, P189, DOI 10.1071/SR04049; Haggard BE, 2007, J ENVIRON QUAL, V36, P1725, DOI 10.2134/jeq2006.0517; Hill CR, 2012, SCI TOTAL ENVIRON, V437, P315, DOI 10.1016/j.scitotenv.2012.06.109; Hoffmann CC, 2009, J ENVIRON QUAL, V38, P1942, DOI 10.2134/jeq2008.0087; Hongthanat N, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5437-6; Hongthanat N, 2011, SOIL SCI, V176, P237, DOI 10.1097/SS.0b013e318214fa9b; Jacobson LM, 2011, J ENVIRON QUAL, V40, P931, DOI 10.2134/jeq2010.0386; Jarvie HP, 2005, J HYDROL, V304, P51, DOI 10.1016/j.jhydrol.2004.10.002; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Jin XC, 2006, ENVIRON POLLUT, V139, P288, DOI 10.1016/j.envpol.2005.05.010; Kaiser K, 1999, SOIL SCI SOC AM J, V63, P1157, DOI 10.2136/sssaj1999.6351157x; Kettler TA, 2001, SOIL SCI SOC AM J, V65, P849, DOI 10.2136/sssaj2001.653849x; Kim LH, 2003, CHEMOSPHERE, V50, P53, DOI 10.1016/S0045-6535(02)00310-7; Konen ME, 2002, SOIL SCI SOC AM J, V66, P1878, DOI 10.2136/sssaj2002.1878; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lai DYF, 2008, MAR POLLUT BULL, V57, P349, DOI 10.1016/j.marpolbul.2008.01.038; Li HY, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/104316; Martins G, 2014, REV ENVIRON SCI BIO, V13, P265, DOI 10.1007/s11157-014-9343-5; McDaniel MD, 2009, J ENVIRON QUAL, V38, P607, DOI 10.2134/jeq2008.0094; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Nair VD, 1999, J ENVIRON QUAL, V28, P1308, DOI 10.2134/jeq1999.00472425002800040035x; Pant HK, 2001, J ENVIRON QUAL, V30, P1474, DOI 10.2134/jeq2001.3041474x; Pettersson K, 1998, HYDROBIOLOGIA, V374, P21, DOI 10.1023/A:1017011420035; Ponnamperuma F. N., 1972, Advances in Agronomy, V24, P29, DOI 10.1016/S0065-2113(08)60633-1; Rahutomo S, 2019, J SOIL SEDIMENT, V19, P1029, DOI 10.1007/s11368-018-2139-4; Rahutomo S, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3721-5; Reddy KR, 1998, J ENVIRON QUAL, V27, P438, DOI 10.2134/jeq1998.00472425002700020027x; REDFIELD AC, 1958, AM SCI, V46, P205; SAS Institute, 2012, SAS STAT 9 4 US GUID; Schilling KE, 2004, J HYDROL, V286, P236, DOI 10.1016/j.jhydrol.2003.09.017; Schilling KE, 2008, BIOGEOCHEMISTRY, V87, P199, DOI 10.1007/s10533-008-9177-8; Schilling KE, 2006, J HYDROL, V327, P140, DOI 10.1016/j.jhydrol.2005.11.014; Schilling KE, 2018, SCI TOTAL ENVIRON, V625, P1330, DOI 10.1016/j.scitotenv.2018.01.035; Schilling KE, 2011, J AM WATER RESOUR AS, V47, P672, DOI 10.1111/j.1752-1688.2011.00533.x; Schilling KE, 2009, CATENA, V77, P266, DOI 10.1016/j.catena.2009.02.006; Shang C., 2008, SSSA BOOK SERIES, P33; TRAINA SJ, 1987, SOIL SCI SOC AM J, V51, P1483, DOI 10.2136/sssaj1987.03615995005100060015x; Wang DJ, 2016, ENVIRON SCI-NANO, V3, P768, DOI 10.1039/c6en00085a; Watanabe FS, 1965, SOIL SCI SOC AM J, V29, P677, DOI DOI 10.2136/SSSAJ1965.03615995002900060025X; Yao WS, 1996, ENVIRON SCI TECHNOL, V30, P536, DOI 10.1021/es950290x	52	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209208	10.1371/journal.pone.0209208	http://dx.doi.org/10.1371/journal.pone.0209208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550573	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000048
J	Qian, Q; Zhang, J; He, FP; Bao, WX; Zheng, TT; Zhou, DM; Pan, HY; Zhang, H; Zhang, XQ; He, X; Sun, BG; Luo, BY; Chen, C; Peng, GP				Qian, Qi; Zhang, Jian; He, Fang-Ping; Bao, Wang-Xiao; Zheng, Ting-Ting; Zhou, Dong-Ming; Pan, Hong-Yu; Zhang, Heng; Zhang, Xiao-Qin; He, Xiao; Sun, Bing-Gui; Luo, Ben-Yan; Chen, Chu; Peng, Guo-Ping			Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease	FASEB JOURNAL			English	Article						BACE1; neuroinflammation; NF-B; noncoding small RNA; epigenetics	NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; GENE-EXPRESSION; MOUSE MODEL; ROBUSTNESS; GLUTAMATE; RECEPTOR; ROLES	Alzheimer's disease (AD) is a leading cause of dementia. However, the mechanisms responsible for development of AD, especially for the sporadic variant, are still not clear. In our previous study, we discovered that a small noncoding RNA (miR-188-3p) targeting -site amyloid precursor protein cleaving enzyme (BACE)-1, a key enzyme responsible for A formation, plays an important role in the development of neuropathology in AD. In the present study, we identified that miR-338-5p, a new miRNA that also targets BACE1, contributes to AD neuropathology. We observed that expression of miR-338-5p was significantly down-regulated in the hippocampus of patients with AD and 5XFAD transgenic (TG) mice, an animal model of AD. Overexpression of miR-338-5p in the hippocampus of TG mice reduced BACE1 expression, A formation, and neuroinflammation. Overexpression of miR-338-5p functionally prevented impairments in long-term synaptic plasticity, learning ability, and memory retention in TG mice. In addition, we provide evidence that down-regulated expression of miR-338-5p in AD is regulated through the NF-B signaling pathway. Our results suggest that down-regulated expression of miR-338-5p plays an important role in the development of AD.Qian, Q., Zhang, J., He, F.-P., Bao, W.-X., Zheng, T.-T., Zhou, D.-M., Pan, H.-Y., Zhang, H., Zhang, X.-Q., He, X., Sun, B.-G., Luo, B.-Y., Chen, C., Peng, G.-P. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.	[Qian, Qi; He, Fang-Ping; Bao, Wang-Xiao; Luo, Ben-Yan; Peng, Guo-Ping] Zhejiang Univ, Affiliated Hosp 1, Ctr Brain Sci, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Zheng, Ting-Ting; Zhou, Dong-Ming; Pan, Hong-Yu; Zhang, Heng; Zhang, Xiao-Qin; He, Xiao; Sun, Bing-Gui] Zhejiang Univ, Dept Neurobiol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Qian, Qi; Zhang, Jian; Chen, Chu] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Qian, Qi] Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Zheng, Ting-Ting] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Chen, C (corresponding author), LSU Hlth Sci Ctr, Neurosci Ctr, 2020 Gravier St, New Orleans, LA 70112 USA.; Peng, GP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	cchen@lsuhsc.edu; guopingpeng@zju.edu.cn	Sun, Binggui/J-9028-2016	Sun, Binggui/0000-0002-0386-6569	National Natural Science Fund of China [81471284]; U.S. National Institutes of Health (from the National Institute of Neurological Disorders and Stroke) [R01NS076815]; U.S. National Institutes of Health (from the National Institute on Aging) [R01AG058621]; National Key Technology Research and Development Program of China [2016YFC1306402]; Research fund of Zhejiang Chinese Medical University [2018ZR04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG058621] Funding Source: NIH RePORTER	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (from the National Institute of Neurological Disorders and Stroke); U.S. National Institutes of Health (from the National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Research fund of Zhejiang Chinese Medical University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. XiaodongWang for suggestions on data analysis and for providing some of the reagents, and Dr. Sanhua Fang and Qiaoling Ding (all from Zhejiang University School of Medicine) for help with the experimental process. This work was supported by the National Natural Science Fund of China (81471284, to G.-P.P.), U.S. National Institutes of Health Grants (R01NS076815 from the National Institute of Neurological Disorders and Stroke and R01AG058621 from the National Institute on Aging, to C.C.), the National Key Technology Research and Development Program of China (2016YFC1306402, to B.-Y.L.), and the Research fund of Zhejiang Chinese Medical University (2018ZR04 to Q.Q.). C.C. and G.-P.P. conceived the study and designed the experiments as well as analyzed the data. Dr. Benyan Luo made constructive amendments to the project. Also, the majority of the experiments were performed in Dr. Luo's laboratory. The authors declare no conflicts of interest.	Ahmed T, 2011, BRAIN RES, V1400, P1, DOI 10.1016/j.brainres.2011.05.022; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emmanouil M, 2011, ADV EXP MED BIOL, V691, P575, DOI 10.1007/978-1-4419-6612-4_60; Gaughwin P, 2011, CEREB CORTEX, V21, P1857, DOI 10.1093/cercor/bhq262; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hydbring Per, 2013, F1000Res, V2, P136, DOI 10.12688/f1000research.2-136.v1; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Iranifar E., 2018, J CELL PHYSL; Jones SV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01805; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim JH, 2001, J NEUROSCI, V21, P1327; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lee K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34433; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Li GF, 2017, J MOL NEUROSCI, V61, P159, DOI 10.1007/s12031-016-0873-x; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long JM, 2014, J BIOL CHEM, V289, P5184, DOI 10.1074/jbc.M113.518241; Lukiw WJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt150; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Prasad KN, 2017, MECH AGEING DEV, V162, P63, DOI 10.1016/j.mad.2016.12.003; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Rago L, 2014, EMBO J, V33, P906, DOI 10.1002/embj.201386591; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Satoh J, 2012, EXP NEUROL, V235, P436, DOI 10.1016/j.expneurol.2011.09.003; Schaeffer V, 2008, NEUROCHEM INT, V52, P948, DOI 10.1016/j.neuint.2008.01.010; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Valles A, 2014, J PSYCHIATR NEUROSCI, V39, P312, DOI 10.1503/jpn.130269; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wong J, 2013, SCHIZOPHRENIA BULL, V39, P396, DOI 10.1093/schbul/sbr177; Zhang J, 2014, J NEUROSCI, V34, P14919, DOI 10.1523/JNEUROSCI.1165-14.2014; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	64	28	32	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4404	4417		10.1096/fj.201801846R	http://dx.doi.org/10.1096/fj.201801846R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576233	Green Published			2022-12-26	WOS:000459794800104
J	Tang, W; Li, MM; Liu, YJ; Liang, N; Yang, Z; Zhao, YX; Wu, S; Lu, SW; Li, YL; Liu, FY				Tang, Wei; Li, Manmei; Liu, Yujun; Liang, Ning; Yang, Zhu; Zhao, Yanxiang; Wu, Shuai; Lu, Sangwei; Li, Yaolan; Liu, Fenyong			Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane	FASEB JOURNAL			English	Article						RSV; viral entry; antiviral; mice; drug resistance	ANTIVIRAL ACTIVITY; RNASE P; RSV; GLYCOPROTEIN; REPLICATION; RECEPTOR; BINDING; IDENTIFICATION; ATTACHMENT; ANTIBODIES	Antiviral drug development against respiratory syncytial virus (RSV) is urgently needed due to the public health significance of the viral infection. Here, we report the anti-RSV activity of a small molecule, (1S,3R,4R,5R)-3,4-bis{[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,5-dihydroxycyclohexane-1-carboxylic methyl ester (3,4-DCQAME) or 3,4-O-Dicaffeoylquinic acid methyl ester, which can be isolated from several plants of traditional Chinese medicine. We showed for the first time that compound 3,4-DCQAME potently inhibits RSV entry and infection. In vitro, 3,4-DCQAME can interact with F(ecto), the ectodomain of RSV fusion (F) protein. In cultured cells, the compound can block the interaction of F(ecto) protein with the cellular membrane and inhibit viral fusion during RSV entry, leading to inhibition of viral gene expression and infection. In RSV-infected mice that were treated with 3,4-DCQAME, we observed a reduction of RSV-induced pathologic changes and substantial inhibition of viral infection and growth in the lung tissues. Our results provide the first direct evidence of the anti-RSV activity of 3,4-DCQAME. Furthermore, these results suggest that 3,4-DCQAME represents a promising lead compound for anti-RSV therapeutic development.Tang, W., Li, M., Liu, Y., Liang, N., Yang, Z., Zhao, Y., Wu, S., Lu, S., Li, Y., Liu, F. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.	[Tang, Wei; Li, Manmei; Liang, Ning; Li, Yaolan; Liu, Fenyong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China; [Tang, Wei; Liu, Yujun; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, 326 Barker Hall,MC 7354, Berkeley, CA 94720 USA; [Liu, Yujun] St Georges Univ, Sch Med, True Blue, Grenada; [Liu, Yujun; Yang, Zhu] Guangzhou Qinheli Biotechnolgies Inc, Guangzhou, Guangdong, Peoples R China; [Yang, Zhu] Jiangsu Affynigen Biotechnolgies Inc, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu] Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan, Shandong, Peoples R China; [Zhao, Yanxiang; Wu, Shuai] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Jinan University; University of California System; University of California Berkeley; Shandong University of Traditional Chinese Medicine; Hong Kong Polytechnic University	Li, YL (corresponding author), Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China.; Liu, FY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 326 Barker Hall,MC 7354, Berkeley, CA 94720 USA.	tliyl@jnu.edu.cn; liu_fy@berkeley.edu	Li, Yao/AAE-3550-2019		National Natural Science Foundation of China [81473116]; Guangdong Innovative and Entrepreneurial Research Team Program [2014ZT05S136]; Science and Technology Planning Project of Guangdong Province [2016A030303011]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, 2014ZX09509001-001]; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province [XTCX2014B01-09]; Project for Construction of Guangzhou Key Laboratory of Virology [201705030003]; National Small Business Innovation and Research (SBIR) Program of China; Technology Research and Development Program of Jiangsu Province [BG2007035, BG2008662]; Open Research Fund Program of the State Key Laboratory of Virology of China [2018IOV006, 2013005, 2015KF011]; Science and Technology Program of Guangzhou [201707010399]; Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research [2016B 030301004]; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [RO1-AI041927, RO1-AI091536]; NIH National Institute of Dental and Craniofacial Research [RO1-DE023935, RO1-DE025462]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023935, R01DE025462] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Science and Technology Planning Project of Guangdong Province; National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province; Project for Construction of Guangzhou Key Laboratory of Virology; National Small Business Innovation and Research (SBIR) Program of China; Technology Research and Development Program of Jiangsu Province; Open Research Fund Program of the State Key Laboratory of Virology of China; Science and Technology Program of Guangzhou; Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Phong Trang, Marco Paliza-Carre, Adam Smith, (all from University of California-Berkeley) and Ting Wang (Jinan University) for critical comments, reagents, and technical assistance. This research has been supported by grants from National Natural Science Foundation of China (81473116), the Guangdong Innovative and Entrepreneurial Research Team Program (2014ZT05S136), the Science and Technology Planning Project of Guangdong Province (2016A030303011), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207), the National Mega Project on Major Drug Development (2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, and 2014ZX09509001-001), the Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province (XTCX2014B01-09), the Project for Construction of Guangzhou Key Laboratory of Virology (201705030003), the National Small Business Innovation and Research (SBIR) Program of China, the Technology Research and Development Program of Jiangsu Province (BG2007035 and BG2008662), the Open Research Fund Program of the State Key Laboratory of Virology of China (2018IOV006, 2013005, and 2015KF011), the Science and Technology Program of Guangzhou (No. 201707010399), the Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research (2016B 030301004), and the U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (RO1-AI041927, RO1-AI091536), and NIH National Institute of Dental and Craniofacial Research (RO1-DE023935, and RO1-DE025462). The authors declare that Y.L. and Z.Y., are employed by Guangzhou Qinheli Biotechnologies and Jiangsu Affynigen Biotechnologies. The authors declare no other conflicts of interest.	Andries K, 2003, ANTIVIR RES, V60, P209, DOI 10.1016/j.antiviral.2003.07.004; Bai Y, 2011, P NATL ACAD SCI USA, V108, P3222, DOI 10.1073/pnas.1014975108; Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Budge PJ, 2004, J VIROL, V78, P5015, DOI 10.1128/JVI.78.10.5015-5022.2004; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; Chu HY, 2013, CURR TOP MICROBIOL, V372, P235, DOI 10.1007/978-3-642-38919-1_12; Cianci C, 2005, J ANTIMICROB CHEMOTH, V55, P289, DOI 10.1093/jac/dkh558; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P413, DOI 10.1128/AAC.48.2.413-422.2004; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Crim RL, 2007, J VIROL, V81, P261, DOI 10.1128/JVI.01226-06; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; Fan L, 2013, PLANTA MED, V79, P1558, DOI 10.1055/s-0033-1350804; German P, 2018, J CLIN PHARMACOL, V58, P1025, DOI 10.1002/jcph.1112; Graham BS, 2013, CURR TOP MICROBIOL, V372, P391, DOI 10.1007/978-3-642-38919-1_20; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Hicks SN, 2018, J VIROL, V92, DOI 10.1128/JVI.00621-18; Karger A, 2001, J GEN VIROL, V82, P631, DOI 10.1099/0022-1317-82-3-631; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Krilov LR, 2002, PEDIATR INFECT DIS J, V21, P479, DOI 10.1097/00006454-200205000-00037; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mejias A, 2005, ANTIMICROB AGENTS CH, V49, P4700, DOI 10.1128/AAC.49.11.4700-4707.2005; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Perron M, 2016, ANTIMICROB AGENTS CH, V60, P1264, DOI 10.1128/AAC.01497-15; Plotnicky-Gilquin H, 2002, VIROLOGY, V303, P130, DOI 10.1006/viro.2002.1563; Roymans D, 2010, P NATL ACAD SCI USA, V107, P308, DOI 10.1073/pnas.0910108106; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Samuel D, 2015, ANTIMICROB AGENTS CH, V59, P7109, DOI 10.1128/AAC.00761-15; San-Juan-Vergara H, 2012, J VIROL, V86, P1832, DOI 10.1128/JVI.06274-11; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Simoes EAF, 2015, PEDIATR INFECT DIS J, V34, P1086, DOI 10.1097/INF.0000000000000813; Sun ZW, 2013, VIRUSES-BASEL, V5, P211, DOI 10.3390/v5010211; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Xin Y, 2018, J CLIN PHARMACOL, V58, P771, DOI 10.1002/jcph.1073; Xu JJ, 2015, J AGR FOOD CHEM, V63, P9520, DOI 10.1021/acs.jafc.5b03482; Xu JJ, 2014, J AGR FOOD CHEM, V62, P2182, DOI 10.1021/jf404310y; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	44	16	16	3	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4287	4299		10.1096/fj.201800579R	http://dx.doi.org/10.1096/fj.201800579R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30571312	Bronze, Green Published			2022-12-26	WOS:000459794800095
J	Moritzer, AC; Minges, H; Prior, T; Frese, M; Sewald, N; Niemann, HH				Moritzer, Ann-Christin; Minges, Hannah; Prior, Tina; Frese, Marcel; Sewald, Norbert; Niemann, Hartmut H.			Structure-based switch of regioselectivity in the flavin-dependent tryptophan 6-halogenase Thal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme structure; enzyme catalysis; flavoprotein; protein engineering; tryptophan; biocatalysis; enzyme design; enzyme engineering; FAD-dependent halogenase; enzyme structure; protein design	ENZYMATIC HALOGENATION; 7-HALOGENASE PRNA; BIOCATALYTIC SCOPE; DIRECTED EVOLUTION; BIOSYNTHESIS; REBH; CHLORINATION; REFINEMENT; MECHANISM; PHENIX	Flavin-dependent halogenases increasingly attract attention as biocatalysts in organic synthesis, facilitating environmentally friendly halogenation strategies that require only FADH(2), oxygen, and halide salts. Different flavin-dependent tryptophan halogenases regioselectively chlorinate or brominate trypto-phan's indole moiety at C5, C6, or C7. Here, we present the first substrate-bound structure of a tryptophan 6-halogenase, namely Thal, also known as ThdH, from the bacterium Streptomyces albogriseolus at 2.55 angstrom resolution. The structure revealed that the C6 of tryptophan is positioned next to the epsilon-amino group of a conserved lysine, confirming the hypothesis that proximity to the catalytic residue determines the site of electrophilic aromatic substitution. Although Thal is more similar in sequence and structure to the tryptophan 7-halogenase RebH than to the tryptophan 5-halogenase PyrH, the indole binding pose in the Thal active site more closely resembled that of PyrH than that of RebH. The difference in indole orientation between Thal and RebH appeared to be largely governed by residues positioning the Trp backbone atoms. The sequences of Thal and RebH lining the substrate binding site differ in only few residues. Therefore, we exchanged five amino acids in the Thal active site with the corresponding counterparts in RebH, generating the quintuple variant Thal-RebH5. Overall conversion of l-Trp by the Thal-RebH5 variant resembled that of WT Thal, but its regioselectivity of chlorination and bromination was almost completely switched from C6 to C7 as in RebH. We conclude that structure-based protein engineering with targeted substitution of a few residues is an efficient approach to tailoring flavin-dependent halogenases.	[Moritzer, Ann-Christin; Prior, Tina; Niemann, Hartmut H.] Bielefeld Univ, Struct Biochem Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany; [Minges, Hannah; Frese, Marcel; Sewald, Norbert] Bielefeld Univ, Organ & Bioorgan Chem Res Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Niemann, HH (corresponding author), Bielefeld Univ, Struct Biochem Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	hartmut.niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011; Sewald, Norbert/A-2541-2012	Niemann, Hartmut/0000-0002-8582-0360; Sewald, Norbert/0000-0002-0309-2655; Frese, Marcel/0000-0002-2232-7755				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Almeida C, 2018, J NAT PROD, V81, P1488, DOI 10.1021/acs.jnatprod.8b00041; Andorfer MC, 2018, ANNU REV BIOCHEM, V87, P159, DOI 10.1146/annurev-biochem-062917-012042; Andorfer MC, 2016, CHEM SCI, V7, P3720, DOI 10.1039/c5sc04680g; Belsare KD, 2017, ACS SYNTH BIOL, V6, P416, DOI 10.1021/acssynbio.6b00297; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Chang FY, 2013, P NATL ACAD SCI USA, V110, P2478, DOI 10.1073/pnas.1218073110; Chankhamjon P, 2016, ANGEW CHEM INT EDIT, V55, P11955, DOI 10.1002/anie.201604516; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraley AE, 2017, J AM CHEM SOC, V139, P12060, DOI 10.1021/jacs.7b06773; Frese M, 2016, CHEMCATCHEM, V8, P1799, DOI 10.1002/cctc.201600317; Frese M, 2015, ANGEW CHEM INT EDIT, V54, P298, DOI 10.1002/anie.201408561; Frese M, 2014, CHEMCATCHEM, V6, P1270, DOI 10.1002/cctc.201301090; Glenn WS, 2011, J AM CHEM SOC, V133, P19346, DOI 10.1021/ja2089348; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Lang A, 2011, ANGEW CHEM INT EDIT, V50, P2951, DOI 10.1002/anie.201007896; Latham J, 2018, CHEM REV, V118, P232, DOI 10.1021/acs.chemrev.7b00032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon BRK, 2017, ANGEW CHEM INT EDIT, V56, P11841, DOI 10.1002/anie.201706342; Menon BRK, 2016, ORG BIOMOL CHEM, V14, P9354, DOI 10.1039/c6ob01861k; Milbredt D, 2014, CHEMBIOCHEM, V15, P1011, DOI 10.1002/cbic.201400016; Neubauer PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196797; Ortega MA, 2017, ACS CHEM BIOL, V12, P548, DOI 10.1021/acschembio.6b01031; Payne JT, 2015, ANGEW CHEM INT EDIT, V54, P4226, DOI 10.1002/anie.201411901; Payne JT, 2013, ANGEW CHEM INT EDIT, V52, P5271, DOI 10.1002/anie.201300762; Poor CB, 2014, CHEMBIOCHEM, V15, P1286, DOI 10.1002/cbic.201300780; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Schnepel C, 2017, CHEM-EUR J, V23, P12064, DOI 10.1002/chem.201701209; Schnepel C, 2016, ANGEW CHEM INT EDIT, V55, P14159, DOI 10.1002/anie.201605635; Seibold C, 2006, BIOCATAL BIOTRANSFOR, V24, P401, DOI 10.1080/10242420601033738; Shepherd SA, 2016, CHEMBIOCHEM, V17, P821, DOI 10.1002/cbic.201600051; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; Smith DRM, 2017, ACS CHEM BIOL, V12, P1281, DOI 10.1021/acschembio.6b01115; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Pee KH, 2001, ARCH MICROBIOL, V175, P250, DOI 10.1007/s002030100263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Zeng J, 2013, BIOORG MED CHEM LETT, V23, P1001, DOI 10.1016/j.bmcl.2012.12.038; Zeng J, 2011, BIOTECHNOL LETT, V33, P1607, DOI 10.1007/s10529-011-0595-7; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhu T, 2013, METAB ENG, V19, P69, DOI 10.1016/j.ymben.2013.06.003; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	53	28	30	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2529	2542		10.1074/jbc.RA118.005393	http://dx.doi.org/10.1074/jbc.RA118.005393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559288	Green Published, hybrid			2022-12-26	WOS:000458895400027
J	Lakshman, B; Messing, S; Schmid, EM; Clogston, JD; Gillette, WK; Esposito, D; Kessing, B; Fletcher, DA; Nissley, DV; McCormick, F; Stephen, AG; Jean-Francois, FL				Lakshman, Bindu; Messing, Simon; Schmid, Eva M.; Clogston, Jeffrey D.; Gillette, William K.; Esposito, Dominic; Kessing, Bailey; Fletcher, Daniel A.; Nissley, Dwight V.; McCormick, Frank; Stephen, Andrew G.; Jean-Francois, Frantz L.			Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-lipid interaction; liposome; lipid raft; Raf kinase; Ras protein; surface plasmon resonance (SPR); mitogen-activated protein kinase (MAPK); MAPK pathway; GTPase	K-RAS; H-RAS; LIPID RAFTS; PHOSPHATIDIC-ACID; BCL-XL; BINDING; SIGNAL; PEPTIDES; DYNAMICS; PROMOTES	The gene encoding the GTPase KRAS is frequently mutated in pancreatic, lung, and colorectal cancers. The KRAS fraction in the plasma membrane (PM) correlates with activation of the mitogen-activated protein kinase (MAPK) pathway and subsequent cellular proliferation. Understanding KRAS's interaction with the PM is challenging given the complexity of the cellular environment. To gain insight into key components necessary for KRAS signal transduction at the PM, we used synthetic membranes such as liposomes and giant unilamellar vesicles. Using surface plasmon resonance (SPR) spectroscopy, we demonstrated that KRAS and Raf-1 proto-oncogene Ser/Thr kinase (RAF1) domains interact with these membranes primarily through electrostatic interactions with negatively charged lipids reinforced by additional interactions involving phosphatidyl ethanolamine and cholesterol. We found that the RAF1 region spanning RBD through CRD (RBDCRD) interacts with the membrane significantly more strongly than the isolated RBD or CRD domains and synergizes KRAS partitioning to the membrane. We also found that calmodulin and phosphodiesterase 6 delta (PDE6), but not galectin3 previously proposed to directly interact with KRAS, passively sequester KRAS and prevent it from partitioning into the PM. RAF1 RBDCRD interacted with membranes preferentially at nonraft lipid domains. Moreover, a C-terminal O-methylation was crucial for KRAS membrane localization. These results contribute to a better understanding of how the KRAS-membrane interaction is tuned by multiple factors whose identification could inform drug discovery efforts to disrupt this critical interaction in diseases such as cancer.	[Lakshman, Bindu; Messing, Simon; Gillette, William K.; Esposito, Dominic; Kessing, Bailey; Nissley, Dwight V.; McCormick, Frank; Stephen, Andrew G.; Jean-Francois, Frantz L.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, NCI RAS Initiat, Frederick, MD 21702 USA; [Schmid, Eva M.; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Clogston, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Nanotechnol Characterizat Lab, Frederick, MD 21702 USA; [Fletcher, Daniel A.] Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Jean-Francois, FL (corresponding author), POB B, Frederick, MD 21702 USA.	Frantz.jean-francois@nih.gov	Clogston, Jeffrey/E-1872-2013; Jean-Francois, Frantz/AAH-9429-2019; Stephen, Andrew/W-2636-2019; Clogston, Jeffrey Dean/AAE-8982-2022; Nanotechnology Characterization Lab, (NCL)/K-8454-2012	Stephen, Andrew/0000-0002-8259-621X; Clogston, Jeffrey Dean/0000-0003-1860-9271; Gillette, William/0000-0002-8592-3642; Esposito, Dominic/0000-0002-9987-1687	NCI, National Institutes of Health [HHSN261200800001E]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the NCI, National Institutes of Health, under contract number HHSN261200800001E. The authors declare that they have no conflicts of interest with the contents of this article. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Blazevits O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24165; Cho KJ, 2016, MOL CELL BIOL, V36, P3086, DOI 10.1128/MCB.00365-16; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Erwin N, 2017, BIOL CHEM, V398, P547, DOI 10.1515/hsz-2016-0289; Erwin N, 2016, PHYS CHEM CHEM PHYS, V18, P8954, DOI 10.1039/c6cp00563b; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Figueira TN, 2017, SCI REP-UK, V7, DOI 10.1038/srep45647; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Gillette WK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15916; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Jansen JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174706; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2009, FASEB J, V23, P3692, DOI 10.1096/fj.09-135574; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mizutani S, 2001, FEBS LETT, V507, P295, DOI 10.1016/S0014-5793(01)02992-1; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P3153, DOI 10.1021/bi00063a030; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; Travers T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26832-4; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Wang TY, 2000, BIOPHYS J, V79, P919, DOI 10.1016/S0006-3495(00)76347-8; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Werkmuller A, 2013, CHEMPHYSCHEM, V14, P3698, DOI 10.1002/cphc.201300617; WHITTINGTON SG, 1975, J CHEM PHYS, V63, P779, DOI 10.1063/1.431357; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	69	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2193	2207		10.1074/jbc.RA118.005669	http://dx.doi.org/10.1074/jbc.RA118.005669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559287	Green Published, hybrid			2022-12-26	WOS:000459711400038
J	Chancharoenthana, W; Leelahavanichkul, A; Wattanatorn, S; Avihingsanon, Y; Praditpornsilpa, K; Eiam-Ong, S; Townamchai, N				Chancharoenthana, Wiwat; Leelahavanichkul, Asada; Wattanatorn, Salin; Avihingsanon, Yingyos; Praditpornsilpa, Kearkiat; Eiam-Ong, Somchai; Townamchai, Natavudh			Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; TUBULAR ATROPHY; GRAFT RECOVERY; RECIPIENTS; OUTCOMES; RISK; CYCLOSPORINE; METAANALYSIS; NEPHROPATHY; PROTEINURIA	Despite tacrolimus (TAC) drug-level monitoring, TAC-induced chronic renal allograft fibrosis remains an important problem. This study investigated the potential of urinary neutrophil gelatinase-associated lipocalin (uNGAL) as a chronic renal allograft fibrosis biomarker in a two-phase study (proof of concept and cohort). In the proof of concept stage of the study, increased TAC-doses at 3 days after dose adjustment compared with the baseline were associated with elevated uNGAL (+Delta uNGAL) and urinary interleukin 18 (IL-18), but normal serum creatinine (SCr), despite the therapeutic trough levels of TAC. In the cohort study, the patients with elevated uNGAL post-recruitment in comparison with the baseline (+Delta uNGAL) was associated with the more severe renal allograft fibrosis from renal pathology of the protocol biopsy at 12 months post kidney transplantation (post-KT). A cut-off value of uNGAL >= 125.2 ng/mL during a 3, 6, 9 and 12 months post-KT was associated with a higher fibrosis score, with an area under the receiver operating characteristics curve of 0.80 (95% confidence interval [CI] 0.72 to 0.88, p < 0.0001) and a hazard ratio (HR) of 2.54 (95% CI 1.45 to 9.33; p < 0.001). We conclude that uNGAL is a sensitive biomarker of TAC induced subtle renal injury and TAC-induced chronic renal allograft fibrosis. We propose that uNGAL measurements, in addition to trough levels of TAC, should be used to predict TAC-induced chronic renal allograft fibrosis in the recipients of KT.	[Chancharoenthana, Wiwat; Wattanatorn, Salin; Avihingsanon, Yingyos; Praditpornsilpa, Kearkiat; Eiam-Ong, Somchai; Townamchai, Natavudh] Chulalongkorn Univ, Div Nephrol, Dept Med, Bangkok, Thailand; [Chancharoenthana, Wiwat; Wattanatorn, Salin; Avihingsanon, Yingyos; Townamchai, Natavudh] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, ECOT, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Immunol Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University	Chancharoenthana, W (corresponding author), Chulalongkorn Univ, Div Nephrol, Dept Med, Bangkok, Thailand.; Chancharoenthana, W (corresponding author), King Chulalongkorn Mem Hosp, Thai Red Cross Soc, ECOT, Bangkok, Thailand.	wiwatmd@hotmail.com	Praditpronsilpa, Kearkiat/AFT-5058-2022; Chancharoenthana, Wiwat/ABA-8259-2021	Chancharoenthana, Wiwat/0000-0002-2965-146X	Ratchadapiseksomphot fund, Faculty of Medicine, Chulalongkorn University; National Science and Technology Development Agency [NSTDA: P-13-00505]	Ratchadapiseksomphot fund, Faculty of Medicine, Chulalongkorn University; National Science and Technology Development Agency	All of the funding supports during study period including the Development of New Faculty Staff fund and Ratchadapiseksomphot fund, Faculty of Medicine, Chulalongkorn University and National Science and Technology Development Agency (NSTDA: P-13-00505) - Dr. Asada Leelahavanichkul. A.L. is under Center of Excellence in Immunology and Immune Mediated Diseases group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Charpentier B, 2003, TRANSPLANTATION, V75, P844, DOI 10.1097/01.TP.0000056635.59888.EF; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DIMENY E, 1995, CLIN TRANSPLANT, V9, P79; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hardinger KL, 2005, TRANSPLANTATION, V80, P41, DOI 10.1097/01.TP.0000162980.68628.5A; Heilman RL, 2010, AM J TRANSPLANT, V10, P563, DOI 10.1111/j.1600-6143.2009.02966.x; Helmersson-Karlqvist J, 2013, CLIN BIOCHEM, V46, P70, DOI 10.1016/j.clinbiochem.2012.09.022; Heylen L, 2015, AM J TRANSPLANT, V15, P2900, DOI 10.1111/ajt.13397; Heyne N, 2012, TRANSPLANTATION, V93, P1252, DOI 10.1097/TP.0b013e31824fd892; Hiremath S, 2017, AM J KIDNEY DIS, V69, P78, DOI 10.1053/j.ajkd.2016.08.018; Hollmen ME, 2011, KIDNEY INT, V79, P89, DOI 10.1038/ki.2010.351; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lertrit A, 2016, INT J NEPHROL RENOV, V9, P111, DOI 10.2147/IJNRD.S103512; Loupy A, 2015, J AM SOC NEPHROL, V26, P1721, DOI 10.1681/ASN.2014040399; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Naesens M, 2016, J AM SOC NEPHROL, V27, P281, DOI 10.1681/ASN.2015010062; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Praditpornsilpa K, 2011, NEPHROL DIAL TRANSPL, V26, P2780, DOI 10.1093/ndt/gfq815; Schinstock CA, 2013, NEPHROL DIAL TRANSPL, V28, P1175, DOI 10.1093/ndt/gfs127; Schwarz A, 2005, KIDNEY INT, V67, P341, DOI 10.1111/j.1523-1755.2005.00087.x; Seron D, 2002, KIDNEY INT, V61, P727, DOI 10.1046/j.1523-1755.2002.00174.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stypmann J, 2015, J CARDIOL, V66, P347, DOI 10.1016/j.jjcc.2014.12.010; Szeto CC, 2010, CLIN J AM SOC NEPHRO, V5, P2329, DOI 10.2215/CJN.01910310; Townamchai N, 2015, TRANSPL P, V47, P2433, DOI 10.1016/j.transproceed.2015.08.013; Tsuchimoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110527; Tsuchiya T, 2013, TRANSPLANTATION, V96, P198, DOI 10.1097/TP.0b013e318296c9d5; Vanhove T, 2016, AM J TRANSPLANT, V16, P2954, DOI 10.1111/ajt.13803; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P889, DOI 10.1007/s00467-009-1397-1; Williams WW, 2012, NAT REV NEPHROL, V8, P110, DOI 10.1038/nrneph.2011.213; Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011; Zaza G, 2015, INT J MOL SCI, V16, P4281, DOI 10.3390/ijms16024281	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209708	10.1371/journal.pone.0209708	http://dx.doi.org/10.1371/journal.pone.0209708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576367	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400074
J	Caravaggio, F; Plaven-Sigray, P; Matheson, GJ; Plitman, E; Chakravarty, MM; Borg, J; Graff-Guerrero, A; Cervenka, S				Caravaggio, Fernando; Plaven-Sigray, Pontus; Matheson, Granville James; Plitman, Eric; Chakravarty, M. Mailer; Borg, Jacqueline; Graff-Guerrero, Ariel; Cervenka, Simon			Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men	PLOS ONE			English	Article							D-2/3 RECEPTOR AVAILABILITY; DOPAMINE-RECEPTORS; COCAINE; HUMANS; AMPHETAMINE; METHAMPHETAMINE; SEGMENTATION; HIPPOCAMPUS; RELIABILITY; ASSOCIATION	High levels of trait impulsivity are considered a risk factor for substance abuse and drug addiction. We recently found that non-planning trait impulsivity was negatively correlated with post-commissural putamen volumes in men, but not women, using the Karolinska Scales of Personality (KSP). Here, we attempted to replicate this finding in an independent sample using an updated version of the KSP: the Swedish Universities Scales of Personality (SSP). Data from 88 healthy male participants (Mean Age: 28.16 +/- 3.34), who provided structural T1-weighted magnetic resonance images (MRIs) and self-reported SSP impulsivity scores, were analyzed. Striatal sub-region volumes were acquired using the Multiple Automatically Generated Templates (MAGeT-Brain) algorithm. Contrary to our previous findings trait impulsivity measured using SSP was not a significant predictor of post-commissural putamen volumes (beta = .14, df = 84, p = .94). A replication Bayes Factors analysis strongly supported this null result. Consistent with our previous findings, secondary exploratory analyses found no relationship between ventral striatum volumes and SSP trait impulsivity (beta = -.05, df = 84, p = .28). An exploratory analysis of the other striatal compartments showed that there were no significant associations with trait impulsivity. While we could not replicate our previous findings in the current sample, we believe this work will aide future studies aimed at establishing meaningful brain biomarkers for addiction vulnerability in healthy humans.	[Caravaggio, Fernando; Plitman, Eric; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Caravaggio, Fernando; Graff-Guerrero, Ariel] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Plaven-Sigray, Pontus; Matheson, Granville James; Borg, Jacqueline; Cervenka, Simon] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Plaven-Sigray, Pontus; Matheson, Granville James; Borg, Jacqueline; Cervenka, Simon] Stockholm Cty Council, Stockholm, Sweden; [Chakravarty, M. Mailer] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Chakravarty, M. Mailer] McGill Univ, Cerebral Imaging Ctr, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [Chakravarty, M. Mailer] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Karolinska Institutet; Stockholm County Council; McGill University; McGill University; McGill University	Caravaggio, F (corresponding author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada.; Caravaggio, F (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	fem.caravaggio@mail.utoronto.ca		Borg, Jacqueline/0000-0003-0732-2232; Matheson, Granville/0000-0002-5646-4547	Swedish Research Council [523-2014-3467]; Canadian Institutes of Health Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Author SC is supported by the Swedish Research Council (523-2014-3467) (https://www.vr.se/english.html). Author FC is supported by a post-doctoral fellowship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim R, 2007, PROC SPIE, V6512, DOI 10.1117/12.708950; Anderson BA, 2017, J NEUROPHYSIOL, V118, P64, DOI 10.1152/jn.00125.2017; [Anonymous], 2016, NATURE, V533, P437, DOI 10.1038/533437a; Ashok AH, 2017, JAMA PSYCHIAT, V74, P511, DOI 10.1001/jamapsychiatry.2017.0135; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Ballard ME, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu119; Barlow RL, 2018, INT J NEUROPSYCHOPH, V21, P705, DOI 10.1093/ijnp/pyy030; Beland S, 2019, SCHIZOPHR RES, V204, P245, DOI 10.1016/j.schres.2018.08.024; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Borg J, 2016, MOL PSYCHIATR, V21, P1077, DOI 10.1038/mp.2015.147; Broos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036781; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caprioli D, 2015, J NEUROSCI, V35, P3747, DOI 10.1523/JNEUROSCI.3890-14.2015; Caprioli D, 2014, BIOL PSYCHIAT, V75, P115, DOI 10.1016/j.biopsych.2013.07.013; Caprioli D, 2013, NEUROPSYCHOPHARMACOL, V38, P1460, DOI 10.1038/npp.2013.44; Caravaggio F, 2018, J PSYCHOPHARMACOL, V32, P357, DOI 10.1177/0269881118756059; Caravaggio F, 2018, INT J GERIATR PSYCH, V33, P523, DOI 10.1002/gps.4818; Caravaggio F, 2017, HUM BRAIN MAPP, V38, P5519, DOI 10.1002/hbm.23744; Caravaggio F, 2017, EUR J NEUROSCI, V46, P2253, DOI 10.1111/ejn.13661; Caravaggio F, 2016, EUR NEUROPSYCHOPHARM, V26, P644, DOI 10.1016/j.euroneuro.2016.02.010; Chakravarty MM, 2015, HUM BRAIN MAPP, V36, P1458, DOI 10.1002/hbm.22715; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chakravarty MM, 2006, NEUROIMAGE, V30, P359, DOI 10.1016/j.neuroimage.2005.09.041; Cho SS, 2013, BRAIN TOPOGR, V26, P479, DOI 10.1007/s10548-012-0270-x; Cyders MA, 2011, CLIN PSYCHOL REV, V31, P965, DOI 10.1016/j.cpr.2011.06.001; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2017, NAT REV NEUROSCI, V18, P158, DOI 10.1038/nrn.2017.8; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Farde L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0156; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Grant JE, 2014, ADDICT BEHAV, V39, P1632, DOI 10.1016/j.addbeh.2014.04.022; Guo T, 2015, NEUROIMAGE-CLIN, V9, P176, DOI 10.1016/j.nicl.2015.07.019; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Jentsch JD, 2014, ANN NY ACAD SCI, V1327, P1, DOI 10.1111/nyas.12388; Jonsson EG, 2001, PSYCHIAT GENET, V11, P11, DOI 10.1097/00041444-200103000-00003; Kim JH, 2014, ACTA NEUROPSYCHIATR, V26, P35, DOI 10.1017/neu.2013.29; Kohli A, 2018, NEUROIMAGE, V178, P552, DOI 10.1016/j.neuroimage.2018.05.021; Le Bouc R, 2016, J NEUROSCI, V36, P6623, DOI 10.1523/JNEUROSCI.3078-15.2016; Le Heron C, 2018, NEUROPSYCHOLOGIA, V118, P54, DOI 10.1016/j.neuropsychologia.2017.07.003; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Mackey S, 2017, BIOL PSYCHIAT, V82, P275, DOI 10.1016/j.biopsych.2015.12.027; MacKillop J, 2016, PSYCHOPHARMACOLOGY, V233, P3361, DOI 10.1007/s00213-016-4372-0; Makowski C, 2018, NEUROIMAGE, V170, P182, DOI 10.1016/j.neuroimage.2017.02.069; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; Mitchell Marci R, 2014, Curr Behav Neurosci Rep, V1, P1; Muhlert N, 2015, NEUROIMAGE, V115, P138, DOI 10.1016/j.neuroimage.2015.04.061; Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473; Oswald LM, 2007, NEUROIMAGE, V36, P153, DOI 10.1016/j.neuroimage.2007.01.055; Passamonti L, 2018, CURR OPIN BEHAV SCI, V22, P14, DOI 10.1016/j.cobeha.2017.12.015; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Plaven-Sigray P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193770; Plaven-Sigray P, 2014, NEUROIMAGE, V102, P590, DOI 10.1016/j.neuroimage.2014.08.018; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Reeves SJ, 2012, PSYCHIAT RES-NEUROIM, V202, P60, DOI 10.1016/j.pscychresns.2011.09.011; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Schain M, 2012, NEUROIMAGE, V60, P800, DOI 10.1016/j.neuroimage.2011.12.047; Schalling D., 1993, KAROLINSKA SCALES PE; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Trifilieff P, 2017, SEMIN NUCL MED, V47, P64, DOI 10.1053/j.semnuclmed.2016.09.003; Tschernegg M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00384; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Wagenmakers EJ, 2016, BEHAV RES METHODS, V48, P413, DOI 10.3758/s13428-015-0593-0; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Weiland BJ, 2014, PSYCHIAT RES-NEUROIM, V223, P244, DOI 10.1016/j.pscychresns.2014.05.015; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Woodward ND, 2009, NEUROIMAGE, V46, P31, DOI 10.1016/j.neuroimage.2009.01.049; Yeung AWK, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00468	72	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209584	10.1371/journal.pone.0209584	http://dx.doi.org/10.1371/journal.pone.0209584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571791	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700088
J	Fingerhuth, M; Babej, T; Wittek, P				Fingerhuth, Mark; Babej, Tomas; Wittek, Peter			Open source software in quantum computing	PLOS ONE			English	Review								Open source software is becoming crucial in the design and testing of quantum algorithms. Many of the tools are backed by major commercial vendors with the goal to make it easier to develop quantum software: this mirrors how well-funded open machine learning frameworks enabled the development of complex models and their execution on equally complex hardware. We review a wide range of open source software for quantum computing, covering all stages of the quantum toolchain from quantum hardware interfaces through quantum compilers to implementations of quantum algorithms, as well as all quantum computing paradigms, including quantum annealing, and discrete and continuous-variable gate-model quantum computing. The evaluation of each project covers characteristics such as documentation, licence, the choice of programming language, compliance with norms of software engineering, and the culture of the project. We find that while the diversity of projects is mesmerizing, only a few attract external developers and even many commercially backed frameworks have shortcomings in software engineering. Based on these observations, we highlight the best practices that could foster a more active community around quantum computing software that welcomes newcomers to the field, but also ensures high-quality, well-documented code.	[Fingerhuth, Mark; Babej, Tomas] ProteinQure Inc, Toronto, ON, Canada; [Fingerhuth, Mark] Univ KwaZulu Natal, Durban, South Africa; [Wittek, Peter] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Wittek, Peter] Creat Destruct Lab, Toronto, ON, Canada; [Wittek, Peter] Vector Inst Artificial Intelligence, Toronto, ON, Canada; [Wittek, Peter] Perimeter Inst Theoret Phys, Waterloo, ON, Canada	University of Kwazulu Natal; University of Toronto; Perimeter Institute for Theoretical Physics	Fingerhuth, M (corresponding author), ProteinQure Inc, Toronto, ON, Canada.; Fingerhuth, M (corresponding author), Univ KwaZulu Natal, Durban, South Africa.	markfingerhuth@gmail.com		Babej, Tomas/0000-0002-8222-3595; Fingerhuth, Mark/0000-0002-0867-4697	Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation	Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation	This research was supported by Perimeter Institute for Theoretical Physics. Research at Perimeter Institute is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Economic Development and Innovation.	Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Aggarwal KK, 2002, P A REL MAI, P235, DOI 10.1109/RAMS.2002.981648; Babbush R, 2018, OPENFERMION; Bacchelli A, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P712, DOI 10.1109/ICSE.2013.6606617; Berglund E., 2001, PROC 19 ANN INT C CO, P132; Berliner B, 1990, P USENIX WINT 1990 T, P352; Blischak JD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004668; Butscher B, 2003, SIMULATION QUANTENCO; Chacon S, 2018, GIT EVERYTHING IS LO; Chen R, 2018, QISKIT AQUA; Choi V, 2008, QUANTUM INF PROCESS, V7, P193, DOI 10.1007/s11128-008-0082-9; Choi V, 2011, QUANTUM INF PROCESS, V10, P343, DOI 10.1007/s11128-010-0200-3; Coecke B, 2008, LECT NOTES COMPUT SC, V5126, P298, DOI 10.1007/978-3-540-70583-3_25; Coecke B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043016; Condello A, 2018, DIMOD; Condello A., 2018, DWAVE SYSTEM; Cross Andrew W., 2017, OPEN QUANTUM ASSEMBL; D-Wave Systems, 2018, TYP POSTPR; de Alwis B, 2009, 2009 ICSE WORKSHOP ON COOPERATIVE AND HUMAN ASPECTS OF SOFTWARE ENGINEERING, P36, DOI 10.1109/CHASE.2009.5071408; Deimel L. E.  Jr., 1985, SIGCSE Bulletin, V17, P5, DOI 10.1145/382204.382524; DelFrate F, 1995, SIXTH INTERNATIONAL SYMPOSIUM ON SOFTWARE RELIABILITY ENGINEERING, PROCEEDINGS, P124, DOI 10.1109/ISSRE.1995.497650; Douglass A, 2018, QBSOLV; Farhi E, 2014, QUANTUM APPROXIMATE; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fitzgerald B, 2006, MIS QUART, V30, P587; Fogel K., 2017, PRODUCING OPEN SOURC, V2nd; Free Software Foundation, 2018, VAR LIC COMM THEM; Gambetta J, 2018, QISKIT TUTORIALS; Gheorghiu V., 2014, QUANTUM C 11 QUANTUM; Gheorghiu V, 2018, QUANTUM; Gidney C, 2018, QUIRK; Gidney C, 2018, CIRQ; GitHub, 2018, COMM PROF PUBL REP; GitHub, 2018, START OP SOURC PROJ; GitHub, 2018, NO LIC; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Gottesman D., 1998, HEISENBERG REPRESENT; Green Alexander S., 2013, Reversible Computation. 5th International Conference, RC 2013. Proceedings. LNCS 7936, P110, DOI 10.1007/978-3-642-38986-3_10; Gutwin C., 2004, Computer Supported Cooperative Work Conference Proceedings, P72, DOI 10.1145/1031607.1031621; Guzzi A, 2013, IEEE WORK CONF MIN S, P277, DOI 10.1109/MSR.2013.6624039; Haner T, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aaa5cc; HARRISON PM, 1960, AM SOCIOL REV, V25, P232, DOI 10.2307/2092628; Hars A, 2002, INT J ELECTRON COMM, V6, P25; International Business Machines, 2018, IBM QUANT EXP; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Izaac J, 2018, STRAWBERRY FIELDS; Javadi-Abhari A, 2018, SCAFFCC; JavadiAbhari A., 2014, P 11 ACM C COMPUTING, P1; Johnson B, 2018, CLIFFORDS JL; Johnson BR, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/11/113019; Killoran N., 2018, STRAWBERRY FIELDS SO; Kissinger A., 2018, PYZX; Kivlichan I, 2018, FERMILIB; Koch S., 2004, Electronic Markets, V14, P77, DOI 10.1080/10196780410001675031; Koch S., 2005, P 1 INT C OP SOURC S, P148; Lakhani K.R., 2004, PRODUKTENTWICKLUNG V, P303, DOI DOI 10.1007/978-3-322-84540-5_13; Lethbridge TC, 2003, IEEE SOFTWARE, V20, P35, DOI 10.1109/MS.2003.1241364; McCabe T. J., 1976, IEEE Transactions on Software Engineering, VSE-2, P308, DOI 10.1109/TSE.1976.233837; McCaskey A, 2018, XACC VQE; McCaskey  A., 2018, VALIDATING QUANTUM C; McCaskey A, 2018, HYBRID PROGRAMMING N; McCaskey A, 2018, XACC; McCaskey AJ, 2018, SOFTWAREX, V7, P245, DOI 10.1016/j.softx.2018.07.007; McClean J. R., 2017, OPENFERMION ELECT ST; McKay D. C., 2018, QISKIT BACKEND SPECI; Mockus A, 2002, ACM T SOFTW ENG METH, V11, P309, DOI 10.1145/567793.567795; Morin Andrew S P, 2012, PLOS COMPUTATIONAL B, V8, P1, DOI [10.1371/journal.pcbi.1002598, DOI 10.1371/JOURNAL.PCBI.1002598]; O'Mahony S, 2007, ACAD MANAGE J, V50, P1079; Onoma AK, 1998, COMMUN ACM, V41, P81, DOI 10.1145/274946.274960; OpenNebula project, 2018, ROADM OPENNEBULA; Paszke Adam, 2017, PYTORCH TENSORS DYNA; Perez J, 2018, QISKIT JS; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Polloreno A, 2018, GROVE; Posnett D., 2011, P 8 WORKING C MINING, P73, DOI [10.1145/1985441.1985454, DOI 10.1145/1985441.1985454]; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Rafi D. M., 2012, 2012 Proceedings of 7th International Workshop on Automation of Software Test (AST 2012), P36, DOI 10.1109/IWAST.2012.6228988; Raymond Eric, 1999, CATHEDRAL BAZAAR, DOI DOI 10.1007/S12130-999-1026-0; Rodriguez D, 2018, QISKIT TERRA; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Rubin N, 2018, REFERENCE QVM; Ryan C, 2018, QGL JL; Sedano T, 2016, CONF SOFTW ENG EDUC, P111, DOI 10.1109/CSEET.2016.36; Smith R S, 2016, PRACTICAL QUANTUM IN; Steiger D, 2018, PROJECTQ; Steiger DS, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-01-31-49; Stodden V, 2016, SCIENCE, V354, P1240, DOI 10.1126/science.aah6168; Strano D, 2018, QRACK; TEMPLETON R, 1983, ASLIB PROC, V35, P440, DOI 10.1108/eb050908; TENNY T, 1988, IEEE T SOFTWARE ENG, V14, P1271, DOI 10.1109/32.6171; The OpenStack project, 2018, OPENSTACK ROADM; Tucci R, 2018, QUBITER; Tucci R. R., 1999, RUDIMENTARY QUANTUM, V2cnd; van Rossum G, 2001, STYLE GUIDE PYTHON C; Venturelli D, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031040; Verner JM, 2005, IEEE SOFTWARE, V22, P86, DOI 10.1109/MS.2005.12; von Krogh G, 2003, RES POLICY, V32, P1217, DOI 10.1016/S0048-7333(03)00050-7; Ware M, 2018, EXPT DEMONSTRATION P; Wheeler D.A, 2007, FREE LIBRE OPEN SOUR; Williams TW, 2001, P REL MAINT S, P420, DOI 10.1109/RAMS.2001.902502; Yamamoto K.Y., 2002, P INT WORK PRINC SOF, DOI 10.1145/512035.512055; Yu Y, 2018, P EUROSYS 2018 13 EU, V16, P265; Zandstra M, 2010, PHP OBJECTS PATTERNS, P361, DOI [10.1007/978-1-4302-2926-1_17, DOI 10.1007/978-1-4302-2926-1_17]; Zeng W, 2018, PYQUIL; Zhu W., 2018, QUANTUM ALGORITHM IM	107	33	34	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208561	10.1371/journal.pone.0208561	http://dx.doi.org/10.1371/journal.pone.0208561			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571700	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700015
J	Agyemang-Yeboah, F; Yorke, J; Obirikorang, C; Batu, EN; Acheampong, E; Frimpong, EA; Anto, EO; Amankwaa, B				Agyemang-Yeboah, Francis; Yorke, Joseph; Obirikorang, Christian; Batu, Emmanuella Nsenbah; Acheampong, Emmanuel; Frimpong, Emmanuel Amankwaa; Anto, Enoch Odame; Amankwaa, Bright			Colorectal cancer survival rates in Ghana: A retrospective hospital-based study	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; RECTAL-CANCER; COLON; CARCINOMA; CHEMOTHERAPY; PREDICTORS	Background Colorectal cancer (CRC) is one of the commonest cancers associated with diverse prognosis times in different parts of the world. Despite medical interventions, the overall clinical outcomes and survival remains very poor for most patients in developing countries. This study therefore investigated the survival rate of colorectal cancer and its prognostic factors among patients at Komfo Anokye Teaching Hospital, Ghana. Methodology In this retrospective cohort study, a total of 221 patients diagnosed with CRC from 2009 to 2015 at the Surgical and Oncological units of Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana were employed. The survival graphs were obtained using the Kaplan-Meier method and compared by the Log-rank test. Cox regression analysis was used to assess prognostic factors. All analyses were performed by SPSS version 22. Results The median survival time was 15 months 95% CI (11.79-18.21). The overall survival rate for CRC over the 5 years period was 16.0%. The survival rates at the 1st, 2nd, 3rd, 4th, and 5th years were 64% 95% CI (56.2-71.1), 40% 95% CI (32.2-50.1), 21% 95% CI (11.4-30.6) 16% 95% CI (8.9-26.9) and 16% 95% CI (7.3-24.9). There was a significant difference in the survival rate of colorectal cancer according to the different stages (p = 0.0001). Family history [HR = (3.44), p = 0.029)], Chemotherapy [HR = (0.23), p = <0.0001)], BMI [HR = (1.78), p = 0.017)] and both chemo/radiotherapy (HR = (3.63), p = 0.042)] were the significant social and clinical factors influencing the overall survival. Pathological factors such as TNM tumour stage (p = 0.012), depth of tumour invasion (p = 0.036), lymph node metastasis (p = 0.0001), and distance metastasis (p = 0.001) were significantly associated with overall survival. Conclusion The study has clearly demonstrated that survival rate for CRC patients at KATH, Ghana is very low in a 5 years period. This is influenced by significant number of clinical and pathological prognostic factors. Identification of prognostic factors would be a primary basis for early prediction and treatment of patients with colorectal cancer.	[Agyemang-Yeboah, Francis; Obirikorang, Christian; Batu, Emmanuella Nsenbah; Acheampong, Emmanuel; Anto, Enoch Odame; Amankwaa, Bright] KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Yorke, Joseph] Komfo Anokye Teaching Hosp, Dept Surg, Kumasi, Ghana; [Acheampong, Emmanuel; Anto, Enoch Odame] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Frimpong, Emmanuel Amankwaa] Komfo Anokye Teaching Hosp, Oncol Unit, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Edith Cowan University; Kwame Nkrumah University Science & Technology	Acheampong, E (corresponding author), KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.; Acheampong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia.	emmanuelachea1990@yahoo.com	Anto, Enoch Odame/AAJ-7426-2020; Acheampong, Emmanuel/I-9309-2019; Obirikorang, Christian/F-5843-2011	Anto, Enoch Odame/0000-0001-9023-6612; Acheampong, Emmanuel/0000-0002-5338-3258; Obirikorang, Christian/0000-0002-6128-1358				Akhoond M, 2011, IRANIAN J EPIDEMIOLO, V6, P40; Al-Ahwal MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-73; Alici S, 2006, MED SCI MONITOR, V12, pCR221; Amersi Farin, 2005, Clin Colon Rectal Surg, V18, P133, DOI 10.1055/s-2005-916274; Badoe E A, 1966, West Afr Med J, V15, P181; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Boyle T, 2013, BRIT J CANCER, V109, P814, DOI 10.1038/bjc.2013.310; Bufalari A, 2006, J SURG ONCOL, V93, P173, DOI 10.1002/jso.20300; CHALYA PL, 2013, WORLD J SURG ONCOL, V11; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Dakubo J, 2010, W AFRICAN J MED, V29; De Divitiis C, 2014, WORLD J GASTROENTERO, V20, P15049, DOI 10.3748/wjg.v20.i41.15049; El Zouhairi Majed, 2011, Gastrointest Cancer Res, V4, P15; Faivre-Finn C, 2002, GUT, V51, P60, DOI 10.1136/gut.51.1.60; Gharbi O, 2010, Bull Cancer, V97, P445, DOI 10.1684/bdc.2010.1083; Ghazali AK, 2010, ASIAN J SURG, V33, P127, DOI 10.1016/S1015-9584(10)60022-X; Glimelius B, 2011, ACTA ONCOLOGICA; GRIFFIN MR, 1987, CANCER-AM CANCER SOC, V60, P2318, DOI 10.1002/1097-0142(19871101)60:9<2318::AID-CNCR2820600934>3.0.CO;2-B; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; He Wei-jie, 2002, Ai Zheng, V21, P1222; Jackson-Thompson J, 2006, CANCER, V107, P1103, DOI 10.1002/cncr.22007; Kohne CH, 1998, ONKOLOGIE, V21, P280, DOI 10.1159/000026851; Kumar Shiyam, 2015, Asian Pac J Cancer Prev, V16, P4853; Laryea DO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-362; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120706; Liang Jun-Lin, 2004, Ai Zheng, V23, P564; Marzouk Ola, 2011, Cancers (Basel), V3, P2767, DOI 10.3390/cancers3022767; MCARDLE CS, 1990, BRIT J SURG, V77, P280, DOI 10.1002/bjs.1800770314; Mehrabani D, 2012, MIDDLE EAST J SCI RE, V12, P1072, DOI DOI 10.5829/idosi.mejsr.2012.12.8.6562; Mehrkhani F, 2009, COLORECTAL DIS, V11, P157, DOI 10.1111/j.1463-1318.2008.01556.x; Moghimi-Dehkordi B, 2008, INT J COLORECTAL DIS, V23, P683, DOI 10.1007/s00384-008-0463-7; Moghimi-Dehkordi B, 2012, WORLD J GASTRO ONCOL, V4, P71, DOI 10.4251/wjgo.v4.i4.71; NAAEDER SB, 1994, BRIT J SURG, V81, P456, DOI 10.1002/bjs.1800810346; Oya M, 2003, JPN J CLIN ONCOL, V33, P38, DOI 10.1093/jjco/hyg010; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Roncucci L, 1996, EUR J CANCER, V32A, P295, DOI 10.1016/0959-8049(95)00532-3; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Safaee A., 2012, IRANIAN J CANC PREVE, V2, P137; Saha AK, 2011, COLORECTAL DIS, V13, P1390, DOI 10.1111/j.1463-1318.2010.02507.x; Sankaranarayanan R, 2011, IARC Sci Publ, P257; Tsang NM, 2016, CANC MED; Vrieling A, 2010, AM J CLIN NUTR; WIGGERS T, 1988, DIS COLON RECTUM, V31, P33, DOI 10.1007/BF02552567; Zell JA, 2008, CANCER EPIDEM BIOMAR, V17, P3134, DOI 10.1158/1055-9965.EPI-08-0587; Zhang S, 2010, COLORECTAL DIS, V12, P754, DOI 10.1111/j.1463-1318.2009.01911.x	46	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209307	10.1371/journal.pone.0209307	http://dx.doi.org/10.1371/journal.pone.0209307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566456	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300082
J	Beltran-Pavez, C; Ferreira, CB; Merino-Mansilla, A; Fabra-Garcia, A; Casadella, M; Noguera-Julian, M; Paredes, R; Olvera, A; Haro, I; Brander, C; Garcia, F; Gatell, JM; Yuste, E; Sanchez-Merino, V				Beltran-Pavez, Carolina; Ferreira, Carolina B.; Merino-Mansilla, Alberto; Fabra-Garcia, Amanda; Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger; Olvera, Alex; Haro, Isabel; Brander, Christian; Garcia, Felipe; Gatell, Jose M.; Yuste, Eloise; Sanchez-Merino, Victor			Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING MONOCLONAL-ANTIBODIES; N-LINKED GLYCAN; PASSIVE TRANSFER; REPLICATION-COMPETENT; GLYCOSYLATION SITES; DIRECTED EVOLUTION; VACCINE EFFICACY; CLADE-A; GP120	Preventive HIV-1 vaccine strategies rely on the elicitation of broadly neutralizing antibody (bNAb) responses, but their induction in vivo by vaccination remains challenging. Considering that the ability of an epitope to elicit effective humoral immunity depends on its exposure on the virion, we have used a reverse genetics approach to select variants from an HIV-1 AC10_29 randomly mutated envelope library that showed increased affinity for a selected bNAb (4E10 bNAb targeting the HIV-1 MPER region). Isolated envelope sequences were analyzed by deep-sequencing showing a small number of dominant changes, including the loss of four potential N-linked glycosylation sites and disruption of the V1/V2 loop. Accordingly, the dominant variant (LR1-C1), showed not only increased affinity for MPER bNAbs 4E10 and 2F5, but also higher affinity for an additional antibody targeting the V3 loop (447-52D) that could be a consequence of an open conformation tier 1-like Env. Furthermore, the amino acids specific for the selected variant are associated with an increased sensitivity for 4E10 and 2F5 antibodies. In vivo studies showed that sera from mice immunized with LR1 - C1 viruses possessed an improved neutralizing activity compared to the wild-type AC10_29 env. While Virus Like Particles (VLPs) carrying this envelope were unable to induce detectable neutralizing activity in immunized rabbits, one animal showed antibody response to the 4E10-proximal region. Our data establish a novel approach that has the potential to yield HIV envelope immunogen sequences that direct antibody responses to specific envelope regions.	[Beltran-Pavez, Carolina; Ferreira, Carolina B.; Merino-Mansilla, Alberto; Fabra-Garcia, Amanda; Garcia, Felipe; Gatell, Jose M.; Yuste, Eloise; Sanchez-Merino, Victor] Inst Invest Biomed August Pi i Sunyer, AIDS Res Unit, Barcelona, Spain; [Beltran-Pavez, Carolina; Ferreira, Carolina B.; Merino-Mansilla, Alberto; Fabra-Garcia, Amanda; Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger; Olvera, Alex; Brander, Christian; Garcia, Felipe; Gatell, Jose M.; Yuste, Eloise; Sanchez-Merino, Victor] HIVACAT, Barcelona, Spain; [Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger; Olvera, Alex; Brander, Christian] Hosp Germans Trias i Pujol, IrsiCaixa AIDS Res Inst, Badalona, Spain; [Noguera-Julian, Marc; Paredes, Roger; Brander, Christian] Univ Vic Univ Cent Catalunya UVic UCC, Barcelona, Vic, Spain; [Haro, Isabel] IQAC CSIC, Unit Synth & Biomed Applicat Peptides, Barcelona, Spain; [Brander, Christian] ICREA, Pg Llurs Companys 23, Barcelona 08010, Spain; [Garcia, Felipe; Gatell, Jose M.] Hosp Clin Barcelona, Infect Dis Unit, Barcelona, Spain; [Ferreira, Carolina B.] UCL, Mol & Cellular Immunol Unit, Inst Child Hlth, London, England; [Fabra-Garcia, Amanda] Radboud Univ Nijmegen, Med Ctr, Med Parasitol Dept, Nijmegen, Netherlands	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); ICREA; University of Barcelona; Hospital Clinic de Barcelona; University of London; University College London; Radboud University Nijmegen	Sanchez-Merino, V (corresponding author), Inst Invest Biomed August Pi i Sunyer, AIDS Res Unit, Barcelona, Spain.; Sanchez-Merino, V (corresponding author), HIVACAT, Barcelona, Spain.	vmsm70@gmail.com	Fabra-García, Amanda/E-9610-2018; Gatell, Jose M/ABC-3607-2020; , Felipe/F-4242-2014; Yuste, Eloisa/R-9493-2019; Noguera-Julian, Marc/F-8651-2016; Casadella, Maria/L-8295-2016; Haro, Isabel/N-8719-2014	Fabra-García, Amanda/0000-0001-6663-213X; , Felipe/0000-0001-7658-5832; Yuste, Eloisa/0000-0002-9484-9974; Noguera-Julian, Marc/0000-0002-6194-1395; Casadella, Maria/0000-0002-4115-2305; Haro, Isabel/0000-0001-8677-2340; Sanchez-Merino, Victor/0000-0001-9400-427X; Olvera, Alex/0000-0002-9934-5759	COMISION NACIONAL DE INVESTIGACION CIENTIFICA Y TECNOLOGICA (CHILE); PORTUGUESE FOUNDATION FOR SCIENCE AND TECHNOLOGY (PORTUGAL); SPANISH MINISTRY OF ECONOMY, INDUSTRY AND COMPETITIVENESS; EUROPEAN REGIONAL DEVELOPMENT FUND [CTQ2015-63919-R]; Horizon 2020: H2020-SCI-2016-2017 [731626]; H2020-SC1-2016-RTD [SAF2015-66193-R]; EAVI2020 [GA681137]; EHVA [681032]; RED ESPANOLA DE INVESTIGACION EN SIDA [RD16/0025/0014, RD12/0017/0001]; MINISTERIO DE ECONOMIA Y COMPETITIVIDAD. SUBPROGRAMA INNPACTO [IP-2012-0325-010000]; MINISTERIO DE CIENCIA E INNOVACION [RYC-2007-00788]; FIPSE [36780/80]; HIVACAT PROGRAM	COMISION NACIONAL DE INVESTIGACION CIENTIFICA Y TECNOLOGICA (CHILE); PORTUGUESE FOUNDATION FOR SCIENCE AND TECHNOLOGY (PORTUGAL)(Portuguese Foundation for Science and Technology); SPANISH MINISTRY OF ECONOMY, INDUSTRY AND COMPETITIVENESS(Spanish Government); EUROPEAN REGIONAL DEVELOPMENT FUND(European Commission); Horizon 2020: H2020-SCI-2016-2017; H2020-SC1-2016-RTD; EAVI2020; EHVA; RED ESPANOLA DE INVESTIGACION EN SIDA; MINISTERIO DE ECONOMIA Y COMPETITIVIDAD. SUBPROGRAMA INNPACTO; MINISTERIO DE CIENCIA E INNOVACION(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FIPSE; HIVACAT PROGRAM	Funded by COMISION NACIONAL DE INVESTIGACION CIENTI ' FICA Y TECNOLOGICA (CHILE): CAROLINA BELTRAN-PAVEZ, PORTUGUESE FOUNDATION FOR SCIENCE AND TECHNOLOGY (PORTUGAL): CAROLINA B FERREIRA, SPANISH MINISTRY OF ECONOMY, INDUSTRY AND COMPETITIVENESS AND EUROPEAN REGIONAL DEVELOPMENT FUND (CTQ2015-63919-R): ISABEL HARO. HIVACAT PROGRAM: CHRISTIAN BRANDER, FELIPE GARCIA, JOSEM GATELL, ELOISA YUSTE AND VICTOR SANCHEZ-MERINO, Horizon 2020: H2020-SCI-2016-2017 (731626), FELIPE GARCIA; H2020-SC1-2016-RTD (SAF2015-66193-R), FELIPE GARCIA; EAVI2020 (GA681137), CHRISTIAN BRANDER; EHVA (681032), ELOISA YUSTE, VICTOR SANCHEZ-MERINO AND FELIPE GARCIA. RED ESPANOLA DE INVESTIGACION EN SIDA RD16/0025/0014 and RD12/0017/0001): FELIPE GARCIA, ELOISA YUSTE AND VICTOR SANCHEZ-MERINO. MINISTERIO DE ECONOMIA Y COMPETITIVIDAD. SUBPROGRAMA INNPACTO (IP-2012-0325-010000): ELOISA YUSTE, MINISTERIO DE CIENCIA E INNOVACION (RYC-2007-00788): ELOISA YUSTE, FIPSE (36780/80): ELOISA YUSTE.	Alvarez-Fernandez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048848; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bolmstedt A, 1996, J ACQ IMMUN DEF SYND, V12, P213, DOI 10.1097/00042560-199607000-00001; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Caskey M, 2015, NATURE; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; GRAM GJ, 1994, ARCH VIROL, V139, P253, DOI 10.1007/BF01310789; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Johnson WE, 2002, J VIROL, V76, P2075, DOI 10.1128/JVI.76.5.2075-2086.2002; Kim S, 2011, ANTIMICROB AGENTS CH, V55, P5090, DOI 10.1128/AAC.00687-11; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Lavinder JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101322; Li DZ, 2015, VIROL SIN, V30, P449, DOI 10.1007/s12250-015-3664-6; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Llano A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-48; Ly A, 2000, J VIROL, V74, P6769, DOI 10.1128/JVI.74.15.6769-6776.2000; Lynch A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-210; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC, 2018, CURR OPIN HIV AIDS, V13, P128, DOI [10.1097/COH.0000000000000442, 10.1097/coh.0000000000000442]; Mothe B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0392-5; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Jaworski JP, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00661; Pankrac J, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-017-0040-6; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanchez-Merino V, 2016, J VIROL, V90, P5231, DOI 10.1128/JVI.00049-16; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Saunders KO, 2017, CELL REP, V21, P3681, DOI 10.1016/j.celrep.2017.12.028; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schonning K, 1996, VIROLOGY, V218, P134, DOI 10.1006/viro.1996.0173; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stoddart CA, 2014, VIROLOGY, V462, P115, DOI 10.1016/j.virol.2014.05.036; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Turpin JA, 1996, J VIROL, V70, P6180, DOI 10.1128/JVI.70.9.6180-6189.1996; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; You L, 1996, PROTEIN ENG, V9, P77, DOI 10.1093/protein/9.1.77; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Yuste E, 2008, J VIROL, V82, P12472, DOI 10.1128/JVI.01382-08; Zhang RJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0618; Zhao CB, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4010002	83	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208345	10.1371/journal.pone.0208345	http://dx.doi.org/10.1371/journal.pone.0208345			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566493	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300038
J	Halama, JJ; Kennedy, RE; Graham, JJ; McKane, RB; Barnhart, BL; Djang, KS; Pettus, PB; Brookes, AF; Wingo, PC				Halama, Jonathan J.; Kennedy, Robert E.; Graham, James J.; McKane, Robert B.; Barnhart, Brad L.; Djang, Kevin S.; Pettus, Paul B.; Brookes, Allen F.; Wingo, Patrick C.			Penumbra: A spatially distributed, mechanistic model for simulating ground-level incident solar energy across heterogeneous landscapes	PLOS ONE			English	Article								Landscape solar energy is a significant environmental driver, yet it remains complicated to model well. Several solar radiation models simplify the complexity of light by estimating it at discrete point locations or by averaging values over larger areas. These modeling approaches may be useful in certain cases, but they are unable to provide spatially distributed and temporally dynamic representations of solar energy across entire landscapes. We created a landscape-scale ground-level shade and solar energy model called Penumbra to address this deficiency. Penumbra simulates spatially distributed ground-level shade and incident solar energy at user-defined timescales by modeling local and distant topographic shading and vegetative shading. Spatially resolved inputs of a digital elevation model, a normalized digital surface model, and landscape object transmittance are used to estimate spatial variations in solar energy at user-defined temporal timesteps. The research goals for Penumbra included: 1) simulations of spatiotemporal variations of shade and solar energy caused by both objects and topographic features, 2) minimal user burden and parameterization, 3) flexible user defined temporal parameters, and 4) flexible external model coupling. We test Penumbra's predictive skill by comparing the model's predictions with monitored open and forested sites, and achieve calibrated mean errors ranging from -17.3 to 148.1 mu moles/m(2)/s. Penumbra is a dynamic model that can produce spatial and temporal representations of shade percentage and ground-level solar energy. Outputs from Penumbra can be used with other ecological models to better understand the health and resilience of aquatic, near stream terrestrial, and upland ecosystems.	[Halama, Jonathan J.] Oregon State Univ, Environm Sci, Corvallis, OR 97331 USA; [Halama, Jonathan J.; McKane, Robert B.; Barnhart, Brad L.; Pettus, Paul B.; Brookes, Allen F.; Wingo, Patrick C.] US EPA, Corvallis, OR 97333 USA; [Kennedy, Robert E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Graham, James J.] Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA; [Djang, Kevin S.] CSRA, Corvallis, OR USA; [Halama, Jonathan J.; McKane, Robert B.; Barnhart, Brad L.; Djang, Kevin S.; Pettus, Paul B.; Brookes, Allen F.] US EPA, Western Ecol Div, Corvallis, OR 97333 USA	Oregon State University; United States Environmental Protection Agency; Oregon State University; California State University System; California State Polytechnic University, Humboldt; United States Environmental Protection Agency	Halama, JJ (corresponding author), Oregon State Univ, Environm Sci, Corvallis, OR 97331 USA.; Halama, JJ (corresponding author), US EPA, Corvallis, OR 97333 USA.; Halama, JJ (corresponding author), US EPA, Western Ecol Div, Corvallis, OR 97333 USA.	halamaj@oregonstate.edu		Halama, Jonathan/0000-0003-3862-7629	Department of Energy (DOE) Oak Ridge Institute for Science and Education (ORISE) - United States Environmental Protection Agency (EPA) [92429801]	Department of Energy (DOE) Oak Ridge Institute for Science and Education (ORISE) - United States Environmental Protection Agency (EPA)	This work was supported by Department of Energy (DOE) Oak Ridge Institute for Science and Education (ORISE) - United States Environmental Protection Agency (EPA) Interagency Agreement number: 92429801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel E, 2012, INTERACTIVE COMPUTER, P264; [Anonymous], [No title captured]; [Anonymous], 2009, CALAPOOIA S SANTIAM; [Anonymous], 1996, SUN MICROSYSTEMS; [Anonymous], 1990, COMPLETE SUN MOON DA; Arvo James, 1986, BACKWARD RAY TRACING; Bode CA, 2014, REMOTE SENS ENVIRON, V154, P387, DOI 10.1016/j.rse.2014.01.028; Cushing J. B., 2015, P 16 ANN INT C DIG G, P61; Esri Inc., ESRI GRID FORM ARGIS; Fatichi S, 2016, J HYDROL, V537, P45, DOI 10.1016/j.jhydrol.2016.03.026; Glassner AS, 1989, INTRO RAY TRACING, P10; Heckbert Paul S., 1987, COMPUT GRAPHICS-US, V21, P73, DOI [10.1145/37402.37411, DOI 10.1145/37402.37411]; Holbert KE, 2011, SOLAR ENERGY CALCULA, P189; Johnson SL, 2003, HYDROL PROCESS, V17, P497, DOI 10.1002/hyp.5091; Langhans R.W., 1997, PLANT GROWTH CHAMBER; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Musselman KN, 2013, REMOTE SENS ENVIRON, V136, P402, DOI 10.1016/j.rse.2013.05.021; Patreon, LEARNING OPENGL SHAD; Rhodes DM, 2016, BIOSYSTEMS, V147, P21, DOI 10.1016/j.biosystems.2016.06.002; Rost RJ, 2010, OPENGL SHADING LANGU, p[385, 698]; Seidl R, 2012, ECOL MODEL, V231, P87, DOI 10.1016/j.ecolmodel.2012.02.015; Tague CL, 2004, EARTH INTERACT, V8; Trenberth KE, 2002, EARTHS ENERGY BALANC, P5; Wigmosta M. S., 2002, Mathematical models of small watershed hydrology and applications, P7	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0206439	10.1371/journal.pone.0206439	http://dx.doi.org/10.1371/journal.pone.0206439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566478	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300005
J	Johnson, RW; Ng, KWP; Dietz, AR; Hartman, ME; Baty, JD; Hasan, N; Zaidman, CM; Shoykhet, M				Johnson, Ryan W.; Ng, Kay W. P.; Dietz, Alexander R.; Hartman, Mary E.; Baty, Jack D.; Hasan, Nausheen; Zaidman, Craig M.; Shoykhet, Michael			Muscle atrophy in mechanically-ventilated critically ill children	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ICU-ACQUIRED WEAKNESS; ELECTRICAL-IMPEDANCE MYOGRAPHY; RISK-FACTORS; METABOLIC-RESPONSE; POLYNEUROPATHY; DYSFUNCTION; ULTRASOUND; PARESIS; INJURY	Importance ICU-acquired muscle atrophy occurs commonly and worsens outcomes in adults. The incidence and severity of muscle atrophy in critically ill children are poorly characterized. Objective To determine incidence, severity and risk factors for muscle atrophy in critically ill children. Design, setting and participants A single-center, prospective cohort study of 34 children receiving invasive mechanical ventilation for >= 48 hours. Patients 1 week- 18 years old with respiratory failure and without preexisting neuromuscular disease or skeletal trauma were recruited from a tertiary Pediatric Intensive Care Unit (PICU) between June 2015 and May 2016. We used serial bedside ultrasound to assess thickness of the diaphragm, biceps brachii/brachialis, quadriceps femoris and tibialis anterior. Serial electrical impedance myography (EIM) was assessed in children >1 year old. Medical records were abstracted from an electronic database. Exposures Respiratory failure requiring endotracheal intubation for >= 48 hours. Main outcome and measures The primary outcome was percent change in muscle thickness. Secondary outcomes were changes in EIM-derived fat percentage and "quality". Results Of 34 enrolled patients, 30 completed >= 2 ultrasound assessments with a median interval of 6 (IQR 6-7) days. Mean age was 5.42 years, with 12 infants <1 year (40%) and 18 children >1 year old (60%). In the entire cohort, diaphragm thickness decreased 11.1% (95%CI, -19.7% to -2.52%) between the first two assessments or 2.2%/day. Quadriceps thickness decreased 8.62% (95%CI, -15.7% to -1.54%) or 1.5%/day. Biceps (-1.71%; 95%CI, -8.15% to 4.73%) and tibialis (0.52%; 95%CI, -5.81% to 3.40%) thicknesses did not change. Among the entire cohort, 47% (14/30) experienced diaphragm atrophy (defined a priorias >= 10% decrease in thickness). Eighty three percent of patients (25/30) experienced atrophy in >= 1 muscle group, and 47% (14/30)-in >= 2 muscle groups. On multivariate linear regression, increasing age and traumatic brain injury (TBI) were associated with greater muscle loss. EIM revealed increased fat percentage and decreased muscle "quality". Conclusions and relevance In children receiving invasive mechanical ventilation, diaphragm and other skeletal muscle atrophy is common and rapid. Increasing age and TBI may increase severity of limb muscle atrophy. Prospective studies are required to link muscle atrophy to functional outcomes in critically ill children.	[Johnson, Ryan W.; Hartman, Mary E.; Shoykhet, Michael] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Ng, Kay W. P.; Dietz, Alexander R.; Zaidman, Craig M.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Ng, Kay W. P.] Natl Univ, Dept Med, Singapore, Singapore; [Dietz, Alexander R.] Blue Sky Neurol, Englewood, CO USA; [Baty, Jack D.] Washington Univ, Div Biostat, Sch Med, St Louis, MO 63110 USA; [Hasan, Nausheen] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Shoykhet, Michael] Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA	Washington University (WUSTL); Washington University (WUSTL); National University of Singapore; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Children's National Health System	Shoykhet, M (corresponding author), Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA.; Shoykhet, M (corresponding author), Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA.	mshoykhet@childrensnational.org		Shoykhet, Michael/0000-0001-5031-2377	Washington University [ICTS CTSA808]	Washington University	This work was supported by MS (Washington University ICTS CTSA808). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banwell BL, 2003, NEUROLOGY, V61, P1779, DOI 10.1212/01.WNL.0000098886.90030.67; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Corpeno R, 2014, J PHYSIOL-LONDON, V592, P3859, DOI 10.1113/jphysiol.2014.277962; Curley MAQ, 2006, PEDIATR CRIT CARE ME, V7, P107, DOI 10.1097/01.PCC.0000200955.40962.38; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; de Letter MACJ, 2001, CRIT CARE MED, V29, P2281, DOI 10.1097/00003246-200112000-00008; Dejonghe B, 2009, CERAMICS-ART PERCEPT, P37; Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Field-Ridley A, 2016, PEDIATR CRIT CARE ME, V17, P53, DOI 10.1097/PCC.0000000000000538; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Garnacho-Montero J, 2005, CRIT CARE MED, V33, P349, DOI 10.1097/01.CCM.0000153521.41848.7E; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Glau CL, 2018, PEDIATR CRIT CARE ME, V19, P406, DOI 10.1097/PCC.0000000000001485; Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Hirose T, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.02.010; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Khemani RG, 2017, CRIT CARE MED, V45, pE798, DOI 10.1097/CCM.0000000000002433; Koch S, 2011, J NEUROL NEUROSUR PS, V82, P287, DOI 10.1136/jnnp.2009.192997; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; LEIJTEN FSS, 1995, JAMA-J AM MED ASSOC, V274, P1221, DOI 10.1001/jama.274.15.1221; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lu ZH, 2016, RESP CARE, V61, P1316, DOI 10.4187/respcare.04746; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Ng KW, 2018, MUSCLE NERVE; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rodriguez PO, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.010; Sanchez B, 2017, NEUROTHERAPEUTICS, V14, P107, DOI 10.1007/s13311-016-0491-x; Shahidi B, 2018, J NEUROTRAUM, V35, P398, DOI 10.1089/neu.2017.5172; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; Valla FV, 2017, PEDIATR CRIT CARE ME, V18, pE339, DOI 10.1097/PCC.0000000000001235; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wieske L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0937-2; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Zaidman CM, 2015, MUSCLE NERVE, V52, P592, DOI 10.1002/mus.24611; Zaidman CM, 2014, MUSCLE NERVE, V50, P124, DOI 10.1002/mus.24117	44	35	38	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207720	10.1371/journal.pone.0207720	http://dx.doi.org/10.1371/journal.pone.0207720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566470	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300015
J	Wu, T; Perrings, C				Wu, Tong; Perrings, Charles			The live poultry trade and the spread of highly pathogenic avian influenza: Regional differences between Europe, West Africa, and Southeast Asia	PLOS ONE			English	Article							WILDLIFE TRADE; H5N1; RISK; DISEASES; INVASIONS; TRANSPORT; NETWORKS; PATTERNS; VIRUSES	In the past two decades, avian influenzas have posed an increasing international threat to human and livestock health. In particular, highly pathogenic avian influenza H5N1 has spread across Asia, Africa, and Europe, leading to the deaths of millions of poultry and hundreds of people. The two main means of international spread are through migratory birds and the live poultry trade. We focus on the role played by the live poultry trade in the spread of H5N1 across three regions widely infected by the disease, which also correspond to three major trade blocs: the European Union (EU), the Economic Community of West African States (ECOWAS), and the Association of Southeast Asian Nations (ASEAN). Across all three regions, we found per-capita GDP (a proxy for modernization, general biosecurity, and value-at-risk) to be risk reducing. A more specific biosecurity measure-general surveillance-was also found to be mitigating at the all-regions level. However, there were important inter-regional differences. For the EU and ASEAN, intra-bloc live poultry imports were risk reducing while extra-bloc imports were risk increasing; for ECOWAS the reverse was true. This is likely due to the fact that while the EU and ASEAN have long-standing biosecurity standards and stringent enforcement (pursuant to the World Trade Organization's Agreement on the Application of Sanitary and Phytosanitary Measures), ECOWAS suffered from a lack of uniform standards and lax enforcement.	[Wu, Tong; Perrings, Charles] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Wu, T (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	twu11@asu.edu		Wu, Tong/0000-0002-5467-2094	NSF [1414374]	NSF(National Science Foundation (NSF))	This work was funded by NSF grant 1414374 to CP as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachabi F., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P12142, DOI 10.18697/ajfand.79.16985; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Callahan JR, 2009, EMERGING BIOL THREAT; Cassey P, 2004, GLOBAL CHANGE BIOL, V10, P417, DOI 10.1111/j.1529-8817.2003.00748.x; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Cobb SP, 2011, REV SCI TECH OIE, V30, P149; Cobb SP, 2011, REV SCI TECH OIE, V30, P165; Dehnen-Schmutz K, 2010, SCI HORTIC-AMSTERDAM, V125, P1, DOI 10.1016/j.scienta.2010.02.017; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Desiere S, 2018, ASSESSING CURRENT FU; Desvaux S, 2016, TRANSBOUND EMERG DIS, V63, P389, DOI 10.1111/tbed.12279; Drew TW, 2011, REV SCI TECH OIE, V30, P95; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Food and Agriculture Organization, 2018, H7N9 SIT UPD; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Hennessy DA, 2012, HLTH ANIMAL AGR DEV; Hogerwerf L, 2010, ECOHEALTH, V7, P213, DOI 10.1007/s10393-010-0324-z; Hughes JdA, 2008, MYCOTOXINS DETECTION; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Manuja BK, 2014, AGR RES, V3, P22, DOI 10.1007/s40003-014-0097-7; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Otte M., 2004, TRANSBOUNDARY ANIMAL; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Pavlin BI, 2009, EMERG INFECT DIS, V15, P1721, DOI [10.3201/eid1511.090467, 10.3201/eid1511.090419]; Perrings C, 2000, EC BIOL INVASIONS, P17, DOI DOI 10.4337/9781781008645.00010; Perrings C, 2016, FOOD SECUR, V8, P27, DOI 10.1007/s12571-015-0523-0; Perrings C, 2010, P NATL ACAD SCI USA, V107, P12063, DOI 10.1073/pnas.1007335107; Pike J, 2014, P NATL ACAD SCI USA, V111, P18519, DOI 10.1073/pnas.1412661112; Rweyemamu MM, 2002, REV SCI TECH OIE, V21, P765; Sanchez-Vizcaino F, 2010, RISK ANAL, V30, P798, DOI 10.1111/j.1539-6924.2009.01351.x; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697; Welte VR, 2004, ANN NY ACAD SCI, V1026, P19, DOI 10.1196/annals.1307.003; WHO, 2018, CUM NUMB CONF HUM CA; World Organisation for Animal Health (OIE), 2010, TRAIN MAN WILDL DIS; World Organization for Animal Health, 2018, OIE SIT REP HIGHL PA; Xu RH, 2004, EMERG INFECT DIS, V10, P1030, DOI 10.3201/eid1006.030852; Zhu GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093390	57	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208197	10.1371/journal.pone.0208197	http://dx.doi.org/10.1371/journal.pone.0208197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566454	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300028
J	Degani, O; Dor, S; Movshowitz, D; Fraidman, E; Rabinovitz, O; Graph, S				Degani, Ofir; Dor, Shlomit; Movshowitz, Daniel; Fraidman, Eyal; Rabinovitz, Onn; Graph, Shaul			Effective chemical protection against the maize late wilt causal agent, Harpophora maydis, in the field	PLOS ONE			English	Article							CEPHALOSPORIUM-MAYDIS; RESISTANCE; DIAGNOSIS; PATHOGEN; BEHAVIOR	Late wilt, a disease severely affecting maize fields throughout Israel, is characterized by relatively rapid wilting of maize plants before tasseling and until shortly before maturity. The disease's causal agent is the fungus Harpophora maydis, a soil-borne and seed-borne pathogen, which is currently controlled using reduced sensitivity maize cultivars. In a former study, we showed that Azoxystrobin (AS) injected into a drip irrigation line assigned for each row can suppress H. maydis in the field and that AS seed coating can provide an additional layer of protection. In the present study, we examine a more cost-effective protective treatment using this fungicide with Difenoconazole mixture (AS+DC), or Fluazinam, or Fluopyram and Trifloxystrobin mixture, or Prothioconazole and Tebuconazole mixture in combined treatment of seed coating and a drip irrigation line for two coupling rows. A recently developed Real-Time PCR method revealed that protecting the plants using AS+DC seed coating alone managed to delay pathogen DNA spread in the maize tissues, in the early stages of the growth season (up to the age of 50 days from sowing), but was less effective in protecting the crops later. AS+DC seed coating combined with drip irrigation using AS+DC was the most successful treatment, and in the double-row cultivation, it reduced fungal DNA in the host tissues to near zero levels. This treatment minimized the development of wilt symptoms by 41% and recovered cob yield by a factor of 1.6 (to the level common in healthy fields). Moreover, the yield classified as A class (cob weight of more than 250 g) increased from 58% to 75% in this treatment. This successful treatment against H. maydis in Israel can now be applied in vast areas to protect sensitive maize cultivars against maize late wilt disease.	[Degani, Ofir; Dor, Shlomit; Movshowitz, Daniel] Tel Hai Coll, Tel Hai, Israel; [Degani, Ofir; Dor, Shlomit; Movshowitz, Daniel; Graph, Shaul] Migal Galilee Res Inst, Kiryat Shmona, Israel; [Fraidman, Eyal] Netafim Ltd, Tel Aviv, Israel; [Rabinovitz, Onn] Minist Agr & Rural Dev, Consultat Serv Shaham, Bet Dagan, Israel	Tel Hai Academy College	Degani, O (corresponding author), Tel Hai Coll, Tel Hai, Israel.; Degani, O (corresponding author), Migal Galilee Res Inst, Kiryat Shmona, Israel.	d-ofir@bezeqint.net	Degani, Ofir/K-2762-2019; Degani, Ofir/F-3978-2014	Degani, Ofir/0000-0001-6204-9406	Israel Ministry of Agriculture and Rural Development [21-35-0003]; Israel Northern R&D, MIGAL - Galilee Research Institute, Kiryat Shmona, Israel; Netafim Ltd. (Tel Aviv, Israel); Shemesh Field Crops Partnership (Upper Galilee, northern Israel)	Israel Ministry of Agriculture and Rural Development; Israel Northern R&D, MIGAL - Galilee Research Institute, Kiryat Shmona, Israel; Netafim Ltd. (Tel Aviv, Israel); Shemesh Field Crops Partnership (Upper Galilee, northern Israel)	This work was supported by a research grant from the Israel Ministry of Agriculture and Rural Development, the Chief Scientist and a research grant number 21-35-0003, and from the Israel Northern R&D, MIGAL - Galilee Research Institute, Kiryat Shmona, Israel.; We would like to thank Netafim Ltd. (Tel Aviv, Israel) and Shemesh Field Crops Partnership (Upper Galilee, northern Israel) for their assistance and support. We would also like to thank Roei Yonai (Netafim Ltd., Tel Aviv, Israel) for his many helpful suggestions, and Roan Halabi, Uri Bar, Heba Riad Shawahni, Shahar Nitzan and Daniel Vise (Tel-Hai College, Israel) for their technical assistance.	Abd el-Rahim MF, 1998, PLANT PATHOL, V47, P216, DOI 10.1046/j.1365-3059.1998.00211.x; Abd-El-Rahim M. F., 1982, Agricultural Research Review, V60, P31; Abendroth, 2011, IOWA STATE U PUBLICA; Castroagudin VL, 2015, PHYTOPATHOLOGY, V105, P284, DOI 10.1094/PHYTO-06-14-0184-R; Committee FRAC, 2018, LIST PLANT PATH ORG; Degani O., 2014, Agricultural Sciences, V5, P571, DOI 10.4236/as.2014.57060; Degani O., 2014, ADV MICROBIOL-NY, V4, P94, DOI [10.4236/aim.2014.42014, DOI 10.4236/AIM.2014.42014]; Degani O, 2019, PLANT DIS, V103, P238, DOI [10.1094/pdis-05-18-0759-re, 10.1094/PDIS-05-18-0759-RE]; Degani O, 2015, PHYSIOL MOL BIOL PLA, V21, P137, DOI 10.1007/s12298-014-0265-z; Degani O, 2014, PHYTOPARASITICA, V42, P559, DOI 10.1007/s12600-014-0394-5; Drori R, 2013, PHYTOPATHOL MEDITERR, V52, P16; El-Assiuty EM., 1991, EGYPTIAN J APPL SCI, V6, P824; El-Assiuty EM., 1988, PHYTOPATHOLOGY, V88, pS25; El-Gremi SMA, 2007, J AGR SCI MANSOURA U, V32, P7605; El-Hosary AAA., 2015, INT J AGR SCI RES, V5, P199; El-Mehalawy A. A., 2004, International Journal of Agriculture and Biology, V6, P599; El-Shafey H.A., 1988, AGR RES REV, V66, P221; Elshahawy IE, 2018, EGYPT J BIOL PEST CO, V28, DOI 10.1186/s41938-018-0052-1; Fayzalla E. A., 1994, Egyptian Journal of Phytopathology, V22, P171; Fernandez-Ortuno D, 2008, INT MICROBIOL, V11, P1, DOI 10.2436/20.1501.01.38; Gams W., 1971, CEPHALOSPORIUM ARTIG; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Johal L., 2004, PATHWAYS ANAL INTRO; Khokhar MK, 2014, MAYDICA, V59, P226; Michail S. H., 1999, Acta Phytopathologica et Entomologica Hungarica, V34, P35; Molinero-Ruiz ML, 2010, PLANT DIS, V94, P379, DOI 10.1094/PDIS-94-3-0379A; Muhammad S., 2003, African Journal of Biotechnology, V2, P161; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ortiz-Bustos CM, 2016, EUR J PLANT PATHOL, V144, P383, DOI 10.1007/s10658-015-0775-8; PAYAK M M, 1970, Indian Phytopathology, V23, P562; SABET K. A., 1961, Plant Protection Bulletin, F.A.O., V9, P121; SABET KA, 1970, ANN APPL BIOL, V66, P257, DOI 10.1111/j.1744-7348.1970.tb06432.x; SABET KA, 1966, ANN APPL BIOL, V58, P93, DOI 10.1111/j.1744-7348.1966.tb05074.x; SABET KA, 1970, ANN APPL BIOL, V66, P265, DOI 10.1111/j.1744-7348.1970.tb06433.x; SAHAB A F, 1985, Egyptian Journal of Phytopathology, V17, P23; Saleh AA, 2004, MYCOLOGIA, V96, P1294, DOI 10.2307/3762146; SAMRA A. S., 1962, PLANT DIS REPTR, V46, P481; Samra A.S., 1966, EFFECT SOIL CONDITIO, P117; SAMRA AS, 1963, PHYTOPATHOLOGY, V53, P402; Singh S. D., 1988, Indian Phytopathology, V41, P489; SINGH S D, 1990, Summa Phytopathologica, V16, P140; Tej R, 2018, EUR J PLANT PATHOL, V152, P249, DOI 10.1007/s10658-018-1469-9; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zeller KA, 2002, PLANT DIS, V86, P373, DOI 10.1094/PDIS.2002.86.4.373	45	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208353	10.1371/journal.pone.0208353	http://dx.doi.org/10.1371/journal.pone.0208353			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562344	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100014
J	Nesti, A; Rognini, G; Herbelin, B; Bulthoff, HH; Chuang, L; Blanke, O				Nesti, Alessandro; Rognini, Giulio; Herbelin, Bruno; Buelthoff, Heinrich H.; Chuang, Lewis; Blanke, Olaf			Modulation of vection latencies in the full-body illusion	PLOS ONE			English	Article							SELF; MECHANISMS; BRAIN; PERCEPTIONS; SENSITIVITY; EXPERIENCES; OWNERSHIP; DAMAGE; FEEL; TILT	Current neuroscientific models of bodily self-consciousness (BSC) argue that inaccurate integration of sensory signals leads to altered states of BSC. Indeed, using virtual reality technology, observers viewing a fake or virtual body while being exposed to tactile stimulation of the real body, can experience illusory ownership over-and mislocalization towards-the virtual body (Full-Body Illusion, FBI). Among the sensory inputs contributing to BSC, the vestibular system is believed to play a central role due to its importance in estimating self-motion and orientation. This theory is supported by clinical evidence that vestibular loss patients are more prone to altered BSC states, and by recent experimental evidence that visuo-vestibular conflicts can disrupt BSC in healthy individuals. Nevertheless, the contribution of vestibular information and self-motion perception to BSC remains largely unexplored. Here, we investigate the relationship between alterations of BSC and self-motion sensitivity in healthy individuals. Fifteen participants were exposed to visuo-vibrotactile conflicts designed to induce an FBI, and subsequently to visual rotations that evoked illusory self-motion (vection). We found that synchronous visuo-vibrotactile stimulation successfully induced the FBI, and further observed a relationship between the strength of the FBI and the time necessary for complete vection to arise. Specifically, higher self-reported FBI scores across synchronous and asynchronous conditions were associated to shorter vection latencies. Our findings are in agreement with clinical observations that vestibular loss patients have higher FBI susceptibility and lower vection latencies, and argue for increased visual over vestibular dependency during altered states of BSC.	[Nesti, Alessandro; Buelthoff, Heinrich H.; Chuang, Lewis] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Nesti, Alessandro; Rognini, Giulio; Herbelin, Bruno; Blanke, Olaf] Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet & Brain Mind Inst, Lab Cognit Neurosci, Geneva, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Nesti, A (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.; Nesti, A; Blanke, O (corresponding author), Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet & Brain Mind Inst, Lab Cognit Neurosci, Geneva, Switzerland.	alessandro.nesti@epfl.ch; olaf.blanke@epfl.ch	Chuang, Lewis/U-4430-2017; Bülthoff, Heinrich/AAC-8818-2019	Chuang, Lewis/0000-0002-1975-5716; herbelin, bruno/0000-0003-4570-5146	Max Planck Society; German Research Foundation (DFG) [SFB/Transregio 161]; Swiss Federal Institute of Technology (EPFL); Bertarelli Foundation	Max Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss Federal Institute of Technology (EPFL); Bertarelli Foundation	AN, LC and HHB were supported by funds from the Max Planck Society and by the German Research Foundation (DFG) within project C03 of SFB/Transregio 161. GR, BH and OB were supported by funds from the Swiss Federal Institute of Technology (EPFL) and by the Bertarelli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre JM, 2001, NEUROPSY NEUROPSY BE, V14, P190; Aspell JE, 2010, EUR J NEUROSCI, V31, P1868, DOI 10.1111/j.1460-9568.2010.07210.x; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Aspell JE, 2013, PSYCHOL SCI, V24, P2445, DOI 10.1177/0956797613498395; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bourdin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169343; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; CHEUNG BSK, 1989, ACTA OTO-LARYNGOL, V108, P336, DOI 10.3109/00016488909125537; CHEUNG BSK, 1990, EXP BRAIN RES, V81, P391; Collins KL, 2017, P NATL ACAD SCI USA, V114, P166, DOI 10.1073/pnas.1616305114; de Haan AM, 2017, ACTA PSYCHOL, V179, P68, DOI 10.1016/j.actpsy.2017.07.003; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Dichgans J, 1978, HDB SENSORY PHYSL, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ferre ER, 2014, PSYCHOL SCI, V25, P2106, DOI 10.1177/0956797614547917; Gallo S., 2016, THESIS; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; Harrar V, 2008, PERCEPT PSYCHOPHYS, V70, P807, DOI 10.3758/PP.70.5.807; Henry P., 2007, ARLTR4138; Heydrich L, 2013, BRAIN, V136, P790, DOI 10.1093/brain/aws364; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jurgens R, 2016, EXP BRAIN RES, V234, P67, DOI 10.1007/s00221-015-4433-3; Kaliuzhna M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26301; Kaliuzhna M, 2015, MULTISENS RES, V28, P613, DOI 10.1163/22134808-00002506; Kannape OA, 2013, J NEUROPHYSIOL, V110, P1837, DOI 10.1152/jn.01042.2012; Lederman SJ, 2011, IEEE T HAPTICS, V4, P273, DOI [10.1109/TOH.2011.2, 10.1109/ToH.2011.2]; Lenggenhager B., 2015, OPEN MIND; Lenggenhager B, 2015, VESTIBULAR CONTRIBUT, V23; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lepecq JC, 1999, PERCEPTION, V28, P63, DOI 10.1068/p2749; Lopez C, 2018, CORTEX, V104, P193, DOI 10.1016/j.cortex.2017.05.026; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Macauda G, 2015, EUR J NEUROSCI, V41, P810, DOI 10.1111/ejn.12809; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Nesti A, 2015, EXP BRAIN RES, V233, P861, DOI 10.1007/s00221-014-4161-0; Niwa Masataka, 2004, INT C ART REAL TEL, P126; Noel JP, 2015, COGNITION, V144, P49, DOI 10.1016/j.cognition.2015.07.012; Pamment J, 2017, EUR J PAIN, V21, P334, DOI 10.1002/ejp.927; Pfeiffer C, 2016, NEUROSCI CONSCIOUS, DOI 10.1093/nc/niw006; Pfeiffer C, 2014, EXP BRAIN RES, V232, P4021, DOI 10.1007/s00221-014-4080-0; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Pfeiffer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061751; Preston C, 2015, SCI REP-UK, V5, DOI 10.1038/srep18345; Rabbitt RD, 2004, SPR HDB AUD, P153; Rahal L, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON VIRTUAL ENVIRONMENTS, HUMAN-COMPUTER INTERFACES AND MEASUREMENT SYSTEMS, P310, DOI 10.1109/VECIMS.2009.5068914; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Salomon R, 2012, CONSCIOUS COGN, V21, P1355, DOI 10.1016/j.concog.2012.06.012; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Schwabe L, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.017.2008; Tegtmeyer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071220; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van der Hoort B, 2014, ATTEN PERCEPT PSYCHO, V76, P1414, DOI 10.3758/s13414-014-0664-9; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; von Helmholtz H., 1925, TREATISE PHYSL OPTIC; WONG SCP, 1981, PERCEPT PSYCHOPHYS, V30, P228, DOI 10.3758/BF03214278; YOUNG LR, 1986, EXP BRAIN RES, V64, P299; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	66	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209189	10.1371/journal.pone.0209189	http://dx.doi.org/10.1371/journal.pone.0209189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562381	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100041
J	Gyvyte, U; Kupcinskas, J; Juzenas, S; Inciuraite, R; Poskiene, L; Salteniene, V; Link, A; Fassan, M; Franke, A; Kupcinskas, L; Skieceviciene, J				Gyvyte, Ugne; Kupcinskas, Juozas; Juzenas, Simonas; Inciuraite, Ruta; Poskiene, Lina; Salteniene, Violeta; Link, Alexander; Fassan, Matteo; Franke, Andre; Kupcinskas, Limas; Skieceviciene, Jurgita			Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs)	PLOS ONE			English	Article							CELL-PROLIFERATION; GASTRIC-CANCER; UP-REGULATION; KIT; METASTASIS; EXPRESSION; RESISTANCE; MIR-675; MALAT1; GROWTH	Long intergenic non-coding RNAs (lincRNAs) are >200 nucleotides long non-coding RNAs, which have been shown to be implicated in carcinogenic processes by interacting with cancer associated genes or other non-coding RNAs. However, their role in development of rare gastrointestinal stromal tumors (GISTs) is barely investigated. Therefore, the aim of this study was to define lincRNAs deregulated in GIST and find new GIST-lincRNA associations. Next-generation sequencing data of paired GIST and adjacent tissue samples from 15 patients were subjected to a web-based lincRNA analysis. Three deregulated lincRNAs (MALAT1, H19 and FENDRR; adjusted p-value < 0.05) were selected for expression validation in a larger group of patients (n = 22) by RT-qPCR method. However, only H19 and FENDRR showed significant upregulation in the validation cohort (adjusted p < 0.05). Further, we performed correlation analyses between expression levels of deregulated lincRNAs and GIST-associated oncogenes or GIST deregulated microRNAs. We found high positive correlations between expression of H19 and known GIST related oncogene ETV1, and between H19 and miR-455-3p. These findings expand the knowledge on lincRNAs deregulated in GIST and may be an important resource for the future studies investigating lincRNAs functionally relevant to GIST carcinogenesis.	[Gyvyte, Ugne; Kupcinskas, Juozas; Juzenas, Simonas; Inciuraite, Ruta; Salteniene, Violeta; Kupcinskas, Limas; Skieceviciene, Jurgita] Lithuanian Univ Hlth Sci, Acad Med, Inst Digest Res, Kaunas, Lithuania; [Kupcinskas, Juozas; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Acad Med, Dept Gastroenterol, Kaunas, Lithuania; [Juzenas, Simonas; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Poskiene, Lina] Lithuanian Univ Hlth Sci, Acad Med, Dept Pathol Anat, Kaunas, Lithuania; [Link, Alexander] Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Fassan, Matteo] Univ Padua, Dept Med DMID, Surg Pathol & Cytopathol Unit, Padua, Italy	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of Kiel; Lithuanian University of Health Sciences; Otto von Guericke University; University of Padua	Skieceviciene, J (corresponding author), Lithuanian Univ Hlth Sci, Acad Med, Inst Digest Res, Kaunas, Lithuania.	jurgita.skieceviciene@lsmuni.lt	Kupcinskas, Juozas/AAU-6968-2021; ravegnini, gloria/K-1330-2016; Franke, Andre/B-2151-2010; Juzenas, Simonas/F-3187-2018; Fassan, Matteo/F-5152-2012	ravegnini, gloria/0000-0002-7774-402X; Franke, Andre/0000-0003-1530-5811; Kulokiene, Ugne/0000-0002-1130-2472; Juzenas, Simonas/0000-0001-9293-0691; Link, Alexander/0000-0002-9514-4562; Fassan, Matteo/0000-0001-6515-5482	Research Council of Lithuania [MIP-006/2014]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This work of UG and JS was supported by the Research Council of Lithuania (https://www.lmt.lt/en/) under the initiative of Researcher teams' projects, Grant no. MIP-006/2014. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **DATA OBJECT**, DOI DOI 10.0.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=TABLE0NE; Baldassarre A, 2012, INT J MOL SCI, V13, P16708, DOI 10.3390/ijms131216708; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cao K, 2018, AM J TRANSL RES, V10, P274; Chai L, 2018, CANCER MANAG RES, V10, P989, DOI 10.2147/CMAR.S163335; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; Fehlmann T, 2017, NUCLEIC ACIDS RES, V45, P8731, DOI 10.1093/nar/gkx595; Fletcher CDM, 2002, INT J SURG PATHOL, V10, P81, DOI 10.1177/106689690201000201; Gao XZ, 2018, BIOCHEM BIOPH RES CO, V495, P1074, DOI 10.1016/j.bbrc.2017.11.123; Gong Y, 2015, WORLD J GASTROENTERO, V21, P2949, DOI 10.3748/wjg.v21.i10.2949; Gyvyte U, 2017, ONCOTARGET, V8, P37225, DOI 10.18632/oncotarget.16664; Hayashi Y, 2015, GASTROENTEROLOGY, V149, P420, DOI 10.1053/j.gastro.2015.04.006; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hu J, 2015, DOWNREGULATION MIR 1, DOI [10.1371/journal.pone.0121175, DOI 10.1371/JOURNAL.PONE.0121175]; Hu LW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0123-z; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Jiang N, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0604-3; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee NK, 2016, ONCOTARGET, V7, P75307, DOI 10.18632/oncotarget.12171; Li Y, 2018, ONCOTARGETS THER, V11, P1403, DOI 10.2147/OTT.S149511; Li ZS, 2017, ONCOTARGET, V8, P19455, DOI 10.18632/oncotarget.14307; Liu AB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0669-9; Liu X, LONG NONCODING RNA E, DOI [10.1007/s13277-016-5434-y, DOI 10.1007/S13277-016-5434-Y]; Ma L, 2016, CANCER BIOL THER, V17, P1051, DOI 10.1080/15384047.2016.1219814; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Min L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040731; Mukaka MM, 2012, MALAWI MED J, V24, P69; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Pantaleo MA, 2016, EPIGENOMICS-UK, V8, P1347, DOI 10.2217/epi-2016-0030; R Core Team, 2013, R LANG ENV STAT COMP; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Shao Y, 2016, ONCOTARGET, V7, P34011, DOI [10.18632/oncotarget.8514, 10.18632/oncotarget.12708]; Soreide K, 2016, CANCER EPIDEMIOL, V40, P39, DOI 10.1016/j.canep.2015.10.031; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Vennin C, 2015, ONCOTARGET, V6, P29209, DOI 10.18632/oncotarget.4976; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Walter RFH, 2013, PATHOL RES PRACT, V209, P784, DOI 10.1016/j.prp.2013.09.007; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xia HW, 2016, ONCOTARGET, V7, P56209, DOI 10.18632/oncotarget.10941; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Yamamura S, 2018, CELL MOL LIFE SCI, V75, P467, DOI 10.1007/s00018-017-2626-6; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yang WW, 2018, ONCOL LETT, V16, P3365, DOI 10.3892/ol.2018.9052; Zhan T, 2018, MOL THER-NUCL ACIDS, V10, P215, DOI 10.1016/j.omtn.2017.12.002; Zhang GY, 2018, BIOMARKERS, V23, P435, DOI 10.1080/1354750X.2018.1443509; Zhang K, 2015, J CELL PHYSIOL, V230, P903, DOI 10.1002/jcp.24821; Zhang L, 2018, MOL MED REP, V17, P6449, DOI 10.3892/mmr.2018.8655; Zhang L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020450; Zhang XJ, 2017, RNA BIOL, V14, P1705, DOI 10.1080/15476286.2017.1358347; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985; Zong L, 2012, EJSO-EUR J SURG ONC, V38, P189, DOI 10.1016/j.ejso.2011.12.012	60	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209342	10.1371/journal.pone.0209342	http://dx.doi.org/10.1371/journal.pone.0209342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557328	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000095
J	Hortlund, M; Elfstrom, KM; Sparen, P; Almstedt, P; Strander, B; Dillner, J				Hortlund, Maria; Elfstrom, K. Miriam; Sparen, Par; Almstedt, Pouran; Strander, Bjorn; Dillner, Joakim			Cervical cancer screening in Sweden 2014-2016	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS	Background To enable incremental optimization of screening, regular reporting of quality indicators is required. Aim To report key quality indicators and basic statistics about cervical screening in Sweden. Methods We collected individual level data on all cervical cytologies, histopathologies, human papillomavirus tests and all invitations for cervical screening in Sweden during 2013-2016. Results There were over 2,278,000 cervical samples collected in Sweden in 2014-2016. Organized samples (resulting from an invitation) constituted 69% of samples. The screening test coverage of all resident women aged 23-60 was 82%. The coverage has slowly increased for >10 years. There is large variability between counties (from 71% to 92%) over time. There were 25,725 women with high-grade lesions in cytology during 2013-2015. Only 96% of these women had a follow-up histopathology within a year. Cervical cancer incidence showed an increasing trend. Conclusion Key quality indicators such as population coverage and follow-up rates were stable or improving, but there was nevertheless an unexplained cervical cancer increase.	[Hortlund, Maria; Elfstrom, K. Miriam; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Sparen, Par; Almstedt, Pouran] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Strander, Bjorn] Reg Canc Ctr West, Swedish Cerv Screening Registry, Gothenburg, Sweden; [Strander, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Dillner, Joakim] Karolinska Hosp, Swedish Natl Cerv Screening Registry, Ctr Cerv Canc Prevent, Dept Pathol,Karolinska Univ Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.; Dillner, J (corresponding author), Karolinska Hosp, Swedish Natl Cerv Screening Registry, Ctr Cerv Canc Prevent, Dept Pathol,Karolinska Univ Lab, Stockholm, Sweden.	joakim.dillner@sll.sef	Strander, Björn/AAB-2609-2021; Hortlund, Maria/AAA-1613-2020	Strander, Björn/0000-0001-8369-7955; Hortlund, Maria/0000-0002-2627-4451; Sparen, Par/0000-0002-5184-8971	Swedish Association of Local Authorities and Regions [14/2665]; Swedish Foundation for Strategic Research [KF10-0046]	Swedish Association of Local Authorities and Regions; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The submitted work was financed by the Swedish Association of Local Authorities and Regions, grant number 14/2665 to JD and URL: https://strategiska.se/en/research/ongoing-research/klinisk-forskning-2010/project/4756/and the Swedish Foundation for Strategic Research, grant number KF10-0046 to PS and URL https://skl.se/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dillner J, 2018, LAKARTIDNINGEN, P115; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Elfstrom KM, 2016, J MED SCREEN, V23, P217, DOI 10.1177/0969141316632023; Elfstrom KM, 2015, EUR J CANCER, V51, P950, DOI 10.1016/j.ejca.2015.03.008; Hortlund M, 2016, J CLIN VIROL, V75, P33, DOI 10.1016/j.jcv.2015.12.007; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Organization WH, 2013, GUIDELINES FOR SCREE; Ponti A AA, 2017, CANC SCREENING EUROP, P2; Rygaard C, 2016, CLIN EPIDEMIOL, V8, P655, DOI 10.2147/CLEP.S99509; Silfverdal L, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.006; Socialstyrelsen, 2015, SCREEN LIVM REK OCH	11	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209003	10.1371/journal.pone.0209003	http://dx.doi.org/10.1371/journal.pone.0209003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557367	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000062
J	Munoz-Medina, JE; Garcia-Knight, MA; Sanchez-Flores, A; Monroy-Munoz, IE; Grande, R; Esbjornsson, J; Santacruz-Tinoco, CE; Gonzalez-Bonilla, CR				Esteban Munoz-Medina, Jose; Antonio Garcia-Knight, Miguel; Sanchez-Flores, Alejandro; Eloisa Monroy-Munoz, Irma; Grande, Ricardo; Esbjornsson, Joakim; Esperanza Santacruz-Tinoco, Clara; Raul Gonzalez-Bonilla, Cesar			Evolutionary analysis of the Chikungunya virus epidemic in Mexico reveals intra-host mutational hotspots in the E1 protein	PLOS ONE			English	Article							ZIKA VIRUS; ANTIBODIES; DIVERSITY; MOSQUITOS; GENOTYPE; FITNESS; HUMANS; DENGUE	The epidemic potential of Chikungunya virus (CHIKV) was recently made evident by its introduction and rapid expansion in the Caribbean and the Americas. We sought to gain a detailed understanding of the dynamics of the epidemic in Mexico, the country with the highest number of confirmed CHIKV cases in the Americas, and to characterise viral evolution at the population and intra-host level. Analysis of the spatiotemporal distribution of 2,739 diagnosed cases in Mexico from December 2014 to December 2015 showed a rapid nationwide expansion of the epidemic with focalisation in the South West of the country. We sequenced the envelope glycoprotein 1 gene (E1) from 25 patients using the Illumina MiSeq platform and report synonymous and non-synonymous consensus mutations. Bayesian phylogenetic analysis using 249 Asian lineage E1 sequences gave updated estimates of nucleotide substitution rates for E1 and time to most recent common ancestor of major lineages. The analysis indicates phylogenetically-related emergent Latin American clusters in South Western Mexico, Nicaragua and Honduras and transmission of American strains in the Pacific islands. Detailed analysis showed that intra-host changes in E1 mainly occurred in two variable regions (E1:189-220 and E1:349-358) in domains II and III, respectively, in residues involved in inter and intra-envelope spike interactions. At the population level, this study sheds light on the introduction and evolutionary dynamics of CHIKV in the Americas. At the intra-host level, this study identifies mutational hotspots of the E1 protein with implications for understanding the relationship between the CHIKV quasispecies, viral fitness and pathogenesis.	[Esteban Munoz-Medina, Jose; Esperanza Santacruz-Tinoco, Clara] Ctr Med Nacl La Raza, Inst Mexicano Seguro Social, Lab Cent Epidemiol, Mexico City, DF, Mexico; [Antonio Garcia-Knight, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Sanchez-Flores, Alejandro; Grande, Ricardo] Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Mas & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Eloisa Monroy-Munoz, Irma] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Lab Genom, Dept Genet & Genom Humana, Mexico City, DF, Mexico; [Esbjornsson, Joakim] Lund Univ, Dept Lab Med, Syst Virol, Lund, Sweden; [Esbjornsson, Joakim] Univ Oxford, Nuffield Dept Med, NDM Res Bldg, Oxford, England; [Raul Gonzalez-Bonilla, Cesar] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico; [Antonio Garcia-Knight, Miguel] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Instituto Mexicano del Seguro Social; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico; Lund University; University of Oxford; Instituto Mexicano del Seguro Social; University of California System; University of California San Francisco	Munoz-Medina, JE (corresponding author), Ctr Med Nacl La Raza, Inst Mexicano Seguro Social, Lab Cent Epidemiol, Mexico City, DF, Mexico.; Garcia-Knight, MA (corresponding author), Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico.; Sanchez-Flores, A (corresponding author), Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Mas & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico.	eban10@hotmail.com; miguel.garciaknight@ucsf.edu; alexsf@ibt.unam.mx	Esteban, Muñoz Medina José/B-6186-2015; Sanchez-Flores, Alejandro/L-9454-2016	Esteban, Muñoz Medina José/0000-0002-1289-4457; Garcia Knight, Miguel Antonio/0000-0001-9556-3719; Esbjornsson, Joakim/0000-0002-3822-4953; Gonzalez Bonilla, Cesar/0000-0002-2225-5069; Sanchez-Flores, Alejandro/0000-0003-0476-3139	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G16/1575]; Secretaria de Educacion Publica [103.5/16/10420]; Consejo Nacional de Ciencia y Tecnologia [264598]; Programa de Laboratorios Nacionales CONACyT	Instituto Mexicano del Seguro Social; Secretaria de Educacion Publica; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Laboratorios Nacionales CONACyT	This study was supported by the Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G16/1575 to JEMM), the Secretaria de Educacion Publica (103.5/16/10420 to MAGK), the Consejo Nacional de Ciencia y Tecnologia (264598 to MAGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Unidad Universitaria de Secuenciacion Masiva y Bioinformatica (UUSMB) of the Instituto de Biotecnologia, UNAM, for advice on DNA sequencing and bioinformatic analysis. The UUSMB is part of the Laboratorio Nacional de Apoyo a las Tecnologias en Ciencias Genomicas which was created and funded by the Programa de Laboratorios Nacionales CONACyT. We also express our gratitude to the working team from the Molecular Biology Department of the Laboratorio Central de Epidemiologia for technical assistance. Finally, we would like to thank Dr. Carlos Arias for his feedback and discussion for this manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Abraham R, 2016, INFECT GENET EVOL, V37, P174, DOI 10.1016/j.meegid.2015.11.019; Diaz-Quinonez JA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00300-15; Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P127, DOI 10.1007/s11262-015-1275-9; Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2011, PREP RESP ANT EV INT; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Carrera JP, 2017, PLOS NEGLECT TROP D, V11, P1; Chen R, 2016, J VIROL, V90; Chien L-J, 2014, LIN VIF EP EP DENG L, P51; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; CHRONIC INFLAMMATORY RHEUMATISM, 2016, F1000RES, V5, P360, DOI DOI 10.12688/F1000RESEARCH.8235.2; Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Danis LR, 2017, PLOS ONE, V12; Direccion General de Epidemiologia I, 2014, LIN VIG EP DIAGN LAB; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Forrester NL, 2011, J VIROL, V85, P8709, DOI 10.1128/JVI.00165-11; Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991; Galan-Huerta KA, 2018, VIRUSES, V10, P1; Geller R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9571; Gobierno de los Estados Unidos Mexicanos-Presidencia de la Republica, 2016, CUART INF GOV 2015 2; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Pan American Health Organization, 2016, CAS CHIK FEV AM CUM; Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Rodriguez-Roche R, 2016, J VIROL, V90, P4320, DOI 10.1128/JVI.02647-15; ROSS R. W., 1956, JOUR HYG, V54, P177; Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877; Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Secretaria de Salud, 2017, NON TRADITIONAL REF; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402; Sun S, 2013, ELIFE, V2013, P1; Tan K- K, 2015, SCI REP, P1; Tan Y, 2018, PLOS NEGLECT TROP D, V12, P1; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x; Venturi Giulietta, 2017, Euro Surveill, V22, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wang CL, 2016, AM J TROP MED HYG, V94, P400, DOI 10.4269/ajtmh.15-0497; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921	62	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209292	10.1371/journal.pone.0209292	http://dx.doi.org/10.1371/journal.pone.0209292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550577	gold, Green Submitted, Green Published			2022-12-26	WOS:000453248000055
J	Datta, BK; Husain, MJ; Fatehin, S; Kostova, D				Datta, Biplab Kumar; Husain, Muhammad Jami; Fatehin, Sohani; Kostova, Deliana			Consumption displacement in households with noncommunicable diseases in Bangladesh	PLOS ONE			English	Article							IMPACT; HEALTH	The economic burden of noncommunicable diseases (NCDs), including treatment costs and income and productivity losses, is a growing concern in developing countries, where NCD medical expenditure may offset consumption of other essential commodities. This study examines the role of NCDs in household resource allocation in Bangladesh. We use the Bangladesh Household Income and Expenditure Survey (HIES) 2010 to obtain expenditure data on 11 household expenditure categories and 12 food expenditure sub-categories for 12,240 households. Household NCD status was determined through self-report of at least one of the six major NCDs within the household-heart disease, hypertension, diabetes, kidney diseases, asthma, and cancer. We estimated unadjusted and regression-adjusted differences in household expenditure shares between NCD and non-NCD households. We further investigated how consumption of different food sub-categories is related to NCD status, distinguishing between household economic levels. The medical expenditure share was estimated to be 59% higher for NCD households than non-NCD households, and NCD households had lower expenditure shares on food, clothing, hygiene, and energy. Regression results indicated that presence of NCDs was associated with lower relative expenditure on clothing and housing in all economic subgroups, and with lower expenditure on food among marginally poor households. Having an NCD was significantly associated with higher household spending on tobacco and higher-calorie foods such as sugar, beverages, meat, dairy, and fruit, and with lower spending on fish, vegetables, and legumes. The findings indicate a link between NCDs and the possibility of adverse economic effects on the household by highlighting the potential displacement effect on household consumption that might occur through higher medical expenditure and lower spending on essentials. The findings might also point to a need for raising awareness about the link between NCDs and diet in Bangladesh.	[Datta, Biplab Kumar; Husain, Muhammad Jami; Kostova, Deliana] Ctr Dis Control & Prevent, Global Noncommunicable Dis Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA; [Fatehin, Sohani] Dickinson Coll, Dept Econ, Carlisle, PA 17013 USA	Dickinson College	Datta, BK (corresponding author), Ctr Dis Control & Prevent, Global Noncommunicable Dis Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.	BDatta@cdc.gov	Datta, Biplab/AAI-1631-2020	Datta, Biplab/0000-0002-2559-850X; Husain, Muhammad Jami/0000-0001-6049-0505; fatehin, sohani/0000-0002-4508-3538				Alam K, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-21; Alwan A, 2009, INT HEALTH, V1, P3, DOI 10.1016/j.inhe.2009.02.003; Bangladesh Bureau of Statistics Ministry of Planning, 2011, REP HOUS INC EXP SUR; Bangladesh Health Watch, 2017, NONC DIS BANGL CURR; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chaker L, 2015, EUR J EPIDEMIOL, V30, P357, DOI 10.1007/s10654-015-0026-5; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Minh HV, 2013, GLOBAL HEALTH ACTION, V6, P16, DOI 10.3402/gha.v5i0.18892; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kumara AS, 2017, SOC SCI MED, V195, P68, DOI 10.1016/j.socscimed.2017.11.015; Mahal A. S., 2010, EC IMPLICATIONS COMM; Ministry of Health and Family Welfare, 2015, 42 GOV PEOPL REP BAN; Mirelman AJ, 2016, HEALTH POLICY PLANN, V31, P785, DOI 10.1093/heapol/czv134; Pal R, 2013, OXF DEV STUD, V41, P258, DOI 10.1080/13600818.2013.794897; Stanciole A., 2006, ESTIMATION EC IMPACT; Wang Q, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1716-8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	20	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208504	10.1371/journal.pone.0208504	http://dx.doi.org/10.1371/journal.pone.0208504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543648	gold, Green Submitted, Green Published			2022-12-26	WOS:000453247500025
J	Strandberg, S; Hashemi, A; Axelsson, J; Riklund, K				Strandberg, Sara; Hashemi, Armin; Axelsson, Jan; Riklund, Katrine			Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical C-11-acetate PET/CT	PLOS ONE			English	Article							PROSTATECTOMY; F-18-FDG	Introduction C-11-acetate (ACE)-PET/CT is used for staging of high-risk prostate cancer. PET data is reconstructed with iterative algorithms, such as VUEPointHD ViP (VPHD) and VUEPoint HD Sharp IR (SharpIR), the latter with additional resolution recovery. It is expected that the resolution recovery algorithm should render more accurate maximum and mean standardized uptake values (SUVmax and SUVmean) and functional tumor volumes (FTV) than the ordinary OSEM. Performing quantitative analysis, choice of volume-of-interest delineation algorithm (SUV threshold) may influence FTV. Optimizing PET acquisition time is justified if image quality and quantitation do not deteriorate. The aim of this study is to identify the optimal reconstruction algorithm, SUV threshold and acquisition time for ACE-PET/CT. Methods ACE-PET/CT data acquired with a General Electric Discovery 690 PET/CT from 16 consecutive high-risk prostate cancer patients was reconstructed with VPHD and SharpIR. Forty pelvic lymph nodes (LNs) and 14 prostate glands were delineated with 42% and estimated threshold. SUVmax, SUVmean, FTV and total lesion uptake were measured. Default acquisition time was four minutes per bed position. In a subset of lesions, acquisition times of one, two and four minutes were evaluated. Structural tumor volumes (STV) of the LNs were measured with CT for correlation with functional volumetric parameters. To validate SUV quantification under different conditions with SharpIR 42%, recovery coefficients (RCs) of SUVmean and FTV were calculated from a phantom with F-18-fluorodeoxy-glucose (FDG)-filled volumes 0.1-9.2cm(3) and signal-to-background (S/B) ratios 4.3-15.9. Results With SharpIR, SUVmax and SUVmean were higher and FTV lower compared with VPHD, regardless of threshold method, in both prostates and LNs. Total lesion uptake determined with both threshold methods was lower with SharpIR compared with VPHD with both threshold methods, except in subgroup analysis of prostate targets where estimated threshold returned higher values. Longer acquisition times returned higher FTV for both threshold methods, regardless of reconstruction algorithm. The FTV difference was most pronounced with one minute's acquisition per bed position, which also produced visually the highest noise. SUV parameters were unaffected by varying acquisition times. FTV with SharpIR 42% showed the best correspondence with STV. SharpIR 42% gave higher RCs of SUVmean and FTV with increasing phantom size and S/B-ratio, as expected. Conclusions Delineation with SharpIR 42% seems to provide the most accurate combined information from SUVmax, SUVmean, FTV and total lesion uptake. Acquisition time may be shortened to two minutes per bed position with preserved image quality.	[Strandberg, Sara; Hashemi, Armin; Axelsson, Jan; Riklund, Katrine] Umea Univ, Dept Radiat Sci, Diagnost Radiol, Umea, Sweden	Umea University	Strandberg, S (corresponding author), Umea Univ, Dept Radiat Sci, Diagnost Radiol, Umea, Sweden.	sara.strandberg@vll.se		Riklund, Katrine/0000-0001-5227-8117	Umea University; Cancer Research Foundation Norrland [VLL-757781]; Vasterbotten County Council	Umea University; Cancer Research Foundation Norrland; Vasterbotten County Council	Author KR received funding from Umea University, Vasterbotten County Council and Cancer Research Foundation Norrland, grant number VLL-757781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Brogsitter C, 2013, EUR J NUCL MED MOL I, V40, pS18, DOI 10.1007/s00259-013-2358-2; Buchegger F, 2014, EUR J NUCL MED MOL I, V41, P68, DOI 10.1007/s00259-013-2540-6; Cagiannos I, 2003, J UROLOGY, V170, P1798, DOI 10.1097/01.ju.0000091805.98960.13; Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Haseebuddin M, 2013, J NUCL MED, V54, P699, DOI 10.2967/jnumed.112.111153; Ross S, 2010, GE HEALTHCARE; Vavere AL, 2008, J NUCL MED, V49, P327, DOI 10.2967/jnumed.107.046672; Wallsten E, 2013, J NUCL MED TECHNOL, V41, P85, DOI 10.2967/jnmt.112.117234	10	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209169	10.1371/journal.pone.0209169	http://dx.doi.org/10.1371/journal.pone.0209169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543705	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500076
J	Delbecq, SP; Klevit, RE				Delbecq, Scott P.; Klevit, Rachel E.			HSPB5 engages multiple states of a destabilized client to enhance chaperone activity in a stress-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small heat shock protein (sHSP); protein aggregation; molecular chaperone; crystallin; stress response; unfolded protein response (UPR); -lactalbumin; B-crystallin; client binding; HSPB5; wHsp16; 9	ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; MOLTEN GLOBULE; PHOSPHORYLATION; SUBSTRATE; POLYDISPERSITY; ACTIVATION; MECHANISM; MUTATION	Small heat shock proteins (sHSPs) delay protein aggregation in an ATP-independent manner by interacting with client proteins that are in states susceptible to aggregation, including destabilized states related to cellular stress. Up-regulation of sHSPs under stress conditions supports their critical role in cellular viability. Widespread distribution of sHSPs in most organisms implies conservation of function, but it remains unclear whether sHSPs implement common or distinct mechanisms to delay protein aggregation. Comparisons among various studies are confounded by the use of different model client proteins, different assays for both aggregation and sHSP/client interactions, and variable experimental conditions used to mimic cellular stress. To further define sHSP/client interactions and their relevance to sHSP chaperone function, we implemented multiple strategies to characterize sHSP interactions with -lactalbumin, a model client whose aggregation pathway is well defined. We compared the chaperone activity of human B-crystallin (HSPB5) with HSPB5 variants that mimic states that arise under conditions of cellular stress or disease. The results show that these closely related sHSPs vary not only in their activity under identical conditions but also in their interactions with clients. Importantly, under nonstress conditions, WT HSPB5 delays client aggregation solely through transient interactions early in the aggregation pathway, whereas HSPB5 mutants that mimic stress-activated conditions can also intervene at later stages of the aggregation pathway to further delay client protein aggregation.	[Delbecq, Scott P.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@uw.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NEI, National Institutes of Health [5R01 EY017370]; NIGMS, National Institutes of Health [2T32 GM008268]; NATIONAL EYE INSTITUTE [R01EY017370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NEI, National Institutes of Health Grant 5R01 EY017370. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by NIGMS, National Institutes of Health 2T32 GM008268.	Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bumagina ZM, 2010, BIOPHYS CHEM, V146, P108, DOI 10.1016/j.bpc.2009.11.002; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Clouser AF, 2017, CELL STRESS CHAPERON, V22, P569, DOI 10.1007/s12192-017-0783-z; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Gast K, 1998, PROTEIN SCI, V7, P2004, DOI 10.1002/pro.5560070917; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Lee GJ, 1998, METHOD ENZYMOL, V290, P350, DOI 10.1016/S0076-6879(98)90031-3; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nefedova VV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1734, DOI 10.1134/S000629791513009X; Pasta SY, 2004, MOL VIS, V10, P655; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	34	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3261	3270		10.1074/jbc.RA118.003156	http://dx.doi.org/10.1074/jbc.RA118.003156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30567736	Green Published, hybrid			2022-12-26	WOS:000464980100023
J	Czauderna, C; Palestino-Dominguez, M; Castven, D; Becker, D; Zanon-Rodriguez, L; Hajduk, J; Mahn, FL; Herr, M; Strand, D; Strand, S; Heilmann-Heimbach, S; Gomez-Quiroz, LE; Worns, MA; Galle, PR; Marquardt, JU				Czauderna, Carolin; Palestino-Dominguez, Mayrel; Castven, Darko; Becker, Diana; Zanon-Rodriguez, Luis; Hajduk, Jovana; Mahn, Friederike L.; Herr, Monika; Strand, Dennis; Strand, Susanne; Heilmann-Heimbach, Stefanie; Gomez-Quiroz, Luis E.; Woerns, Marcus A.; Galle, Peter R.; Marquardt, Jens U.			Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver	PLOS ONE			English	Article							PHASE-II; EXTRACT; FIBROSIS; 5-FLUOROURACIL; DEREGULATION; PATHOGENESIS; INHIBITION; MECHANISMS; MICE; RAT	Ginkgo biloba (EGb761) is a widely used botanical drug. Several reports indicate that EGb761 confers preventive as well as anti-tumorigenic properties in a variety of tumors, including hepatocellular carcinoma (HCC). We here evaluate functional effects and molecular alterations induced by EGb761 in hepatoma cells and non-malignant hepatocytes. Hepatoma cell lines, primary human HCC cells and immortalized human hepatocytes (IH) were exposed to various concentrations (0-1000 mu g/ml) of EGb761. Apoptosis and proliferation were evaluated after 72h of EGb761 exposure. Response to oxidative stress, tumorigenic properties and molecular changes were further investigated. While anti-oxidant effects were detected in all cell lines, EGb761 promoted anti-proliferative and pro-apoptotic effects mainly in hepatoma cells. Consistently, EGb761 treatment caused a significant reduction in colony and sphere forming ability in hepatoma cells and no mentionable changes in IH. Transcriptomic changes involved oxidative stress response as well as key oncogenic pathways resembling Nrf2- and mTOR signaling pathway. Taken together, EGb761 induces differential effects in non-transformed and cancer cells. While treatment confers protective effects in non-malignant cells, EGb761 significantly impairs tumorigenic properties in cancer cells by affecting key oncogenic pathways. Results provide the rational for clinical testing of EGb761 in preventive and therapeutic strategies in human liver diseases.	[Czauderna, Carolin; Castven, Darko; Becker, Diana; Zanon-Rodriguez, Luis; Hajduk, Jovana; Mahn, Friederike L.; Herr, Monika; Strand, Dennis; Strand, Susanne; Woerns, Marcus A.; Galle, Peter R.; Marquardt, Jens U.] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany; [Czauderna, Carolin; Castven, Darko; Becker, Diana; Zanon-Rodriguez, Luis; Hajduk, Jovana; Mahn, Friederike L.; Herr, Monika; Marquardt, Jens U.] Lichtenberg Res Grp Mol Hepatocarcinogenesis, Mainz, Germany; [Palestino-Dominguez, Mayrel; Gomez-Quiroz, Luis E.] Univ Autonoma Metropolitana Iztapalapa, Div Ciencias Biol & Salud, Dept Ciencias Salud, Iztapalapa, Mexico; [Heilmann-Heimbach, Stefanie] Univ Bonn, Life & Brain Ctr, Inst Human Genet, Dept Genom, Bonn, Germany	Johannes Gutenberg University of Mainz; Universidad Autonoma Metropolitana - Mexico; University of Bonn	Marquardt, JU (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany.; Marquardt, JU (corresponding author), Lichtenberg Res Grp Mol Hepatocarcinogenesis, Mainz, Germany.	marquarj@uni.mainz.de	Galle, Peter/ABE-2872-2021; Galle, Peter R/T-5292-2018	Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992; Palestino Dominguez, Mayrel/0000-0002-1442-9719; Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985	Dr. Willmar Schwabe GmBH; Transmed-Fellowship of the University of Mainz; Transmed Fellowship of the University of Mainz	Dr. Willmar Schwabe GmBH; Transmed-Fellowship of the University of Mainz; Transmed Fellowship of the University of Mainz	This project was financially supported by Dr. Willmar Schwabe GmBH. Dr. Wilmar Schwabe GmBH had no influence on the experimental design, results and content of the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. C. Czauderns is supported by a personal physician-scientist grant of the Transmed-Fellowship of the University of Mainz.; This project was supported by Dr. Willmar Schwabe GmBH. CC is supported by a Transmed Fellowship of the University of Mainz. We thank the FACS core facility of the Institute of Molecular Biology (IMB, Mainz, Germany) for providing excellent technical support.	Agha AM, 2001, J EXP CLIN CANC RES, V20, P39; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; [Anonymous], 2003, Drugs R D, V4, P188; BASS DA, 1983, J IMMUNOL, V130, P1910; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Cai Z, 2016, PHYTOMEDICINE, V23, P1295, DOI 10.1016/j.phymed.2016.07.002; Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Dias MC, 2008, CHEM-BIOL INTERACT, V173, P32, DOI 10.1016/j.cbi.2008.01.012; El Mesallamy Hala O, 2011, Cancer Cell Int, V11, P38, DOI 10.1186/1475-2867-11-38; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; HAGUENAUER JP, 1986, PRESSE MED, V15, P1569; Hauns B, 2001, PHYTOTHER RES, V15, P34, DOI 10.1002/1099-1573(200102)15:1&lt;34::AID-PTR755&gt;3.0.CO;2-2; Hauns B, 1999, ARZNEIMITTEL-FORSCH, V49, P1030; Hectors SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02706-z; Jeon YJ, 2015, CANCER SCI, V106, P413, DOI 10.1111/cas.12608; Jung IH, 2012, EXP MOL MED, V44, P311, DOI 10.3858/emm.2012.44.5.035; KIM M, 2016, IEICE ELECTRON EXPR, V13, DOI DOI 10.5620/EHT.E2016010; Kirstein MM, 2014, DIGEST DIS, V32, P545, DOI 10.1159/000360499; KLEIJNEN J, 1992, LANCET, V340, P1136, DOI 10.1016/0140-6736(92)93158-J; Koltermann A, 2009, J CELL MOL MED, V13, P2122, DOI 10.1111/j.1582-4934.2008.00561.x; Liu K, 2015, MED SCI MONIT BASIC, V21, P15, DOI 10.12659/MSMBR.893327; Liu SQ, 2015, ONCOL REP, V33, P2871, DOI 10.3892/or.2015.3923; Liu SQ, 2006, AM J CHINESE MED, V34, P99, DOI 10.1142/S0192415X06003679; Liu XP, 2007, LIFE SCI, V80, P1586, DOI 10.1016/j.lfs.2007.01.034; Lu G, 2006, BRAIN RES, V1090, P23, DOI 10.1016/j.brainres.2006.02.138; Lu Q, 2015, PHYTOMEDICINE, V22, P1071, DOI 10.1016/j.phymed.2015.08.010; Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012; Marquardt JU, 2011, HEPATOLOGY, V54, P1031, DOI 10.1002/hep.24454; Matter MS, 2016, HEPATOLOGY, V63, P1888, DOI 10.1002/hep.28487; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Park YJ, 2016, FOOD CHEM TOXICOL, V87, P157, DOI 10.1016/j.fct.2015.12.007; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Qian Y, 2016, CLIN TRANSL ONCOL, V18, P521, DOI 10.1007/s12094-015-1399-3; Raggi C, 2014, HEPATOLOGY, V59, P2251, DOI 10.1002/hep.27026; Rider CV, 2014, TOXICOL PATHOL, V42, P830, DOI 10.1177/0192623313501235; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sun BC, 2013, FRONT MED-PRC, V7, P242, DOI 10.1007/s11684-013-0256-4; Tsai JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091331; Wang H, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2014-7; Wang Wei-Wei, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P325; Wang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124812; Yao P, 2007, AM J CHINESE MED, V35, P643, DOI 10.1142/S0192415X07005132; Yao P, 2007, FOOD CHEM TOXICOL, V45, P1333, DOI 10.1016/j.fct.2007.01.016; Yuan GJ, 2007, PHYTOTHER RES, V21, P234, DOI 10.1002/ptr.2054	49	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209067	10.1371/journal.pone.0209067	http://dx.doi.org/10.1371/journal.pone.0209067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576355	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400027
J	Fisher, EE; Choat, JH; McCormick, MI; Cappo, M				Fisher, Eric E.; Choat, John H.; McCormick, Mark I.; Cappo, Mike			Relative influence of environmental factors on the timing and occurrence of multi-species coral reef fish aggregations	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SPAWNING AGGREGATIONS; REPRODUCTIVE-BIOLOGY; HERBIVOROUS FISHES; TROPHIC STATUS; SHELF REEFS; BEHAVIOR; ISLANDS; ZOOPLANKTON; LETHRINIDAE	Reef configuration and hydrodynamics were identified as the principle physical drivers behind coral reef fish aggregations on a mid-shelf patch reef in the northern section of the Great Barrier Reef (-16.845 degrees, 146.23 degrees). The study was carried out over a six-year period at a large reef pass on the oceanic margin of the northern Great Barrier Reef. Over this period (February 2006-December 2012) tidal state, moon phase and surface seawater temperature were monitored. The timing of sampling was organised to assess variation in physical environment at daily, monthly, seasonal and annual time scales. Over these time scales, temporal patterns of occurrence of 10 species of coral reef fish from 5 families representing 5 defined trophic groups were monitored. The study incorporated 1,357 underwater visual census counts involving 402,370 fish and these estimates were collated with data on tidal state, water temperature, lunar and seasonal periodicity. Aggregated boosted regression trees analysed the univariate responses of fish abundance and species richness to the variation in the physical environment of the reef pass. Flood tides or when water flows from open water through the pass and into the Moore Reef lagoon had 2.3 times as many fish and 1.75 times as many species compared to counts made on ebb tides. Fish abundance was highest in late winter and spring months (Austral calendar), but notably when water temperatures were below the long-term mean of 27 degrees C. Multivariate regression trees and Dufrene-Legendre indicator predicted 4 out of 10 times the occurrence of all 10 species at any temporal scale ranging from hours to years. Flood tides were the principle driver underlying the occurrence of all 10 species regardless of their trophic classification and produced distinct seasonal assemblages, indicative of fishes aggregating to forage and reproduce.	[Fisher, Eric E.; Choat, John H.; McCormick, Mark I.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Fisher, Eric E.] Reef Magic Cruises, Reef Educ, Cairns, Qld, Australia; [Cappo, Mike] Australian Inst Marine Sci, Cape Cleveland, Qld, Australia	James Cook University; Australian Institute of Marine Science	Fisher, EE (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; Fisher, EE (corresponding author), Reef Magic Cruises, Reef Educ, Cairns, Qld, Australia.	eric.fisher@my.jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Reef Magic Cruises; James Cook University (JCU); AIMS@JCU	Reef Magic Cruises; James Cook University (JCU); AIMS@JCU	The authors received no specific funding for this work, the project was supported by Reef Magic Cruises and internal student grants from James Cook University (JCU) and AIMS@JCU.The funder Reef Magic Cruises/Experience Co. provided support in the form of salary for author [EEF] and the funder JCU provide support in the form of salaries for authors [JHC & MIM]. These funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; Andutta FP, 2013, CONT SHELF RES, V53, P11, DOI 10.1016/j.csr.2012.11.016; Archer SK, 2015, CORAL REEFS, V34, P19, DOI 10.1007/s00338-014-1208-4; Asch RG, 2018, DIVERS DISTRIB, V24, P1712, DOI 10.1111/ddi.12809; Babcock RC, 2017, MAR FRESHWATER RES, V68, P1422, DOI 10.1071/MF16194; BARLOW GW, 1974, AM ZOOL, V14, P9; Basford AJ, 2016, MAR FRESHWATER RES, V67, P75, DOI 10.1071/MF14208; Bijoux JP, 2013, CORAL REEFS, V32, P1135, DOI 10.1007/s00338-013-1075-4; BLABER SJM, 1990, FISH RES, V8, P263, DOI 10.1016/0165-7836(90)90027-S; Borcard D, 2011, NEMERICAL ECOLOGY R; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Carpenter K.E., 1989, FAO SPECIES CATALOGU, V9; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; Colin PL, 2012, FISH FISH SER, V35, P117, DOI 10.1007/978-94-007-1980-4_5; COLIN PL, 1991, ENVIRON BIOL FISH, V31, P229, DOI 10.1007/BF00000690; COLIN PL, 1988, B MAR SCI, V43, P249; Colin PL, 2003, MANUAL STUDY CONSERV; Craig P. C., 1998, Pacific Science, V52, P35; Currey LM, 2013, J FISH BIOL, V82, P764, DOI 10.1111/jfb.3495; Damgaard C, 2017, TRENDS ECOL EVOL, V32, P86, DOI 10.1016/j.tree.2016.12.001; De Caceres M, 2008, J VEG SCI, V19, P779, DOI 10.3170/2008-8-18446; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Donahoe M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127771; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dumas F, 2012, MAR POLLUT BULL, V65, P425, DOI 10.1016/j.marpolbul.2012.05.041; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Farmer BM, 2011, ENVIRON BIOL FISH, V91, P71, DOI 10.1007/s10641-010-9761-3; Farmer NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172968; Fraser MR, 2014, MAR ECOL PROG SER, V517, P209, DOI 10.3354/meps11021; Hamilton Richard, 2005, RESSOURCES MARINES T, V18, P9; Hamner WM, 2007, MAR ECOL PROG SER, V334, P83, DOI 10.3354/meps334083; HAMNER WM, 1988, B MAR SCI, V42, P459; Hartup JA, 2013, CORAL REEFS, V32, P367, DOI 10.1007/s00338-013-1022-4; Henschke N, 2016, TRENDS ECOL EVOL, V31, P720, DOI 10.1016/j.tree.2016.06.007; HIATT RW, 1960, ECOL MONOGR, V30, P66; Hobson E.S., 1978, FISH B, V76; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hoffmann GCS, 2017, J FISH BIOL, V90, P2111, DOI 10.1111/jfb.13293; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Johannes R.E., 1981, WORDS LAGOON FISHING; Johannes RE, 1999, MARINE CONSERVATION, P144; Karnauskas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022067; Kerry JT, 2015, CORAL REEFS, V34, P41, DOI 10.1007/s00338-014-1232-4; King B, 1996, J MARINE SYST, V9, P187, DOI 10.1016/S0924-7963(95)00048-8; Lieske E., 2001, CORAL REEF FISHES IN; Lowe RJ, 2015, ANNU REV MAR SCI, V7, P43, DOI 10.1146/annurev-marine-010814-015834; Mourier J, 2016, CURR BIOL, V26, P2011, DOI 10.1016/j.cub.2016.05.058; MOYER JT, 1989, JPN J ICHTHYOL, V36, P371, DOI 10.1007/BF02905624; Nemeth RS, 2012, FISH FISH SER, V35, P21, DOI 10.1007/978-94-007-1980-4_2; Newman SJ, 2001, MAR FRESHWATER RES, V52, P843, DOI 10.1071/MF99131; Ouellette MH, 2012, METHODS ECOL EVOL, V3, P234, DOI 10.1111/j.2041-210X.2011.00171.x; Palazon-Fernandez JL, 2007, SCI MAR, V71, P429, DOI 10.3989/scimar.2007.71n3429; Robbins WD, 2016, CORAL REEFS, V35, P253, DOI 10.1007/s00338-015-1366-z; ROBERTSON DR, 1983, ENVIRON BIOL FISH, V9, P193, DOI 10.1007/BF00692372; ROBERTSON DR, 1982, MAR ECOL PROG SER, V7, P253, DOI 10.3354/meps007253; Sakaue J, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-44; Samoilys MA, 2006, P 10 INT COR REEF S, V1, P1335; Sancho G, 2000, MAR ECOL PROG SER, V203, P275, DOI 10.3354/meps203275; Shantz AA, 2015, ECOL APPL, V25, P2142, DOI 10.1890/14-2209.1.sm; Taylor BM, 2013, CORAL REEFS, V32, P1077, DOI 10.1007/s00338-013-1065-6; Thresher RE, 1984, REPROD REEF FISHES; Williams AJ, 2006, MAR FRESHWATER RES, V57, P403, DOI 10.1071/MF05127; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; WOLANSKI E, 1988, SCIENCE, V241, P177, DOI 10.1126/science.241.4862.177; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2; Wolanski E., 1994, PHYS OCEANOGRAPHIC P; WRIGHT A, 1986, J FISH BIOL, V28, P533, DOI 10.1111/j.1095-8649.1986.tb05191.x	76	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209234	10.1371/journal.pone.0209234	http://dx.doi.org/10.1371/journal.pone.0209234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576357	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000454149400034
J	Kato, C; Kawai, E; Shimizu, N; Mikekado, T; Kimura, F; Miyazawa, T; Nakagawa, K				Kato, Chikara; Kawai, Emiko; Shimizu, Naoki; Mikekado, Tsuyoshi; Kimura, Fumiko; Miyazawa, Teruo; Nakagawa, Kiyotaka			Determination of pyrroloquinoline quinone by enzymatic and LC-MS/MS methods to clarify its levels in foods	PLOS ONE			English	Article							D-GLUCOSE DEHYDROGENASE; ACINETOBACTER-CALCOACETICUS; OXIDATIVE STRESS; PQQ; COENZYME; BINDING; GENES; DEATH	Pyrroloquinoline quinone (PQQ) is believed to be a new B vitamin-like compound, and PQQ supplementation has received attention as a possible treatment for diseases including dementia and diabetes. However, the distribution of PQQ in foods is unclear, due to the difficulty in analyzing the compound. Therefore, in this study, enzymatic and LC-MS/MS methods were optimized to enable an accurate analysis of PQQ in foods. The optimized methods were applied to the screening of foods, in which PQQ contents were identified in ng/g or ng/mL levels. Furthermore, we newly found that some foods related to acetic acid bacteria contain PQQ at 1.94 similar to 5.59 ng/mL higher than beer, which is known to contain relatively high amounts of PQQ. These results suggest that the optimized methods are effective for the screening of foods containing PQQ. Such foods with high PQQ content may be valuable as functional foods effective towards the treatment of certain diseases.	[Kato, Chikara; Kawai, Emiko; Shimizu, Naoki; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan; [Mikekado, Tsuyoshi] Mitsubishi Gas Chem Co Inc, Niigata Res Lab, Niigata, Japan; [Kimura, Fumiko] Shokei Gakuin Univ, Dept Human Hlth & Nutr, Natori, Miyagi, Japan; [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi, Japan; [Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Hlth Sci Res Unit, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Nakagawa, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan.	nkgw@m.tohoku.ac.jp	Shimizu, Naoki/AAF-3554-2020		Mitsubishi Gas Chemical Company, Inc.	Mitsubishi Gas Chemical Company, Inc.	Mitsubishi Gas Chemical Company, Inc. provided support in the form of salaries for author TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akagawa M., 2016, SCI REPORTS, V6, P1; AMEYAMA M, 1985, ANAL BIOCHEM, V151, P263, DOI 10.1016/0003-2697(85)90174-5; AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, AGR BIOL CHEM TOKYO, V45, P851, DOI 10.1080/00021369.1981.10864633; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; AMEYAMA M, 1984, AGR BIOL CHEM TOKYO, V48, P561, DOI 10.1080/00021369.1984.10866184; Ando Atsumasa, 2014, Vitamins (Kyoto), V88, P601; Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; Felder M, 2000, FEMS MICROBIOL LETT, V193, P231, DOI 10.1111/j.1574-6968.2000.tb09429.x; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; GEIGER O, 1989, BIOCHEM J, V261, P415, DOI 10.1042/bj2610415; GEIGER O, 1987, ANAL BIOCHEM, V164, P418, DOI 10.1016/0003-2697(87)90513-6; GOOSEN N, 1987, J BACTERIOL, V169, P303, DOI 10.1128/jb.169.1.303-307.1987; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; HAUGE JG, 1964, J BIOL CHEM, V239, P3630; ISHIDA T, 1995, J AM CHEM SOC, V117, P3278, DOI 10.1021/ja00116a035; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Kim J, 2010, PRION, V4, P26, DOI 10.4161/pri.4.1.10889; Kimura K, 2012, FREE RADICAL BIO MED, V53, P1239, DOI 10.1016/j.freeradbiomed.2012.07.015; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; MATSUSHITA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1548, DOI 10.1271/bbb.59.1548; MATSUSHITA K, 1988, FEMS MICROBIOL LETT, V55, P53, DOI 10.1016/0378-1097(88)90150-4; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Mukai K, 2011, J AGR FOOD CHEM, V59, P1705, DOI 10.1021/jf104420y; Noji N, 2007, J AGR FOOD CHEM, V55, P7258, DOI 10.1021/jf070483r; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; Oubrie A, 1999, EMBO J, V18, P5187, DOI 10.1093/emboj/18.19.5187; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; SMIDT CR, 1991, BIOFACTORS, V3, P53; SUZUKI O, 1990, LIFE SCI, V47, P2135, DOI 10.1016/0024-3205(90)90313-G; Takada M., 2012, COMMUNICATIONS, V428, P315, DOI [10.1016/j.bbrc.2012.10.055, DOI 10.1016/J.BBRC.2012.10.055]; URAKAMI T, 1992, APPL ENVIRON MICROB, V58, P3970, DOI 10.1128/AEM.58.12.3970-3976.1992; VANKLEEF MAG, 1989, EUR J BIOCHEM, V183, P41; Zhang Q, 2012, GENET MOL RES, V11, P2652, DOI 10.4238/2012.June.27.3; ZHANG ZP, 1995, BIOCHEM BIOPH RES CO, V212, P41, DOI 10.1006/bbrc.1995.1933	40	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209700	10.1371/journal.pone.0209700	http://dx.doi.org/10.1371/journal.pone.0209700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576372	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400072
J	Cortes, JP; Espinoza, VM; Ghassemi, M; Mehta, DD; Van Stan, JH; Hillman, RE; Guttag, JV; Zanartu, M				Cortes, Juan P.; Espinoza, Victor M.; Ghassemi, Marzyeh; Mehta, Daryush D.; Van Stan, Jarrad H.; Hillman, Robert E.; Guttag, John, V; Zanartu, Matias			Ambulatory assessment of phonotraumatic vocal hyperfunction using glottal airflow measures estimated from neck-surface acceleration	PLOS ONE			English	Article							AERODYNAMIC MEASURES; VOICE PRODUCTION; WAVE-FORM; SPEECH; SYSTEM; MODEL; DISORDERS; FREQUENCY; VIBRATION; QUALITY	Phonotraumatic vocal hyperfunction (PVH) is associated with chronic misuse and/or abuse of voice that can result in lesions such as vocal fold nodules. The clinical aerodynamic assessment of vocal function has been recently shown to differentiate between patients with PVH and healthy controls to provide meaningful insight into pathophysiological mechanisms associated with these disorders. However, all current clinical assessment of PVH is incomplete because of its inability to objectively identify the type and extent of detrimental phonatory function that is associated with PVH during daily voice use. The current study sought to address this issue by incorporating, for the first time in a comprehensive ambulatory assessment, glottal airflow parameters estimated from a neck-mounted accelerometer and recorded to a smartphone-based voice monitor. We tested this approach on 48 patients with vocal fold nodules and 48 matched healthy-control subjects who each wore the voice monitor for a week. Seven glottal airflow features were estimated every 50 ms using an impedance-based inverse filtering scheme, and seven high-order summary statistics of each feature were computed every 5 minutes over voiced segments. Based on a univariate hypothesis testing, eight glottal airflow summary statistics were found to be statistically different between patient and healthy-control groups. L-1-regularized logistic regression for a supervised classification task yielded a mean (standard deviation) area under the ROC curve of 0.82 (0.25) and an accuracy of 0.83 (0.14). These results outperform the state-ofthe-art classification for the same classification task and provide a new avenue to improve the assessment and treatment of hyperfunctional voice disorders.	[Cortes, Juan P.; Espinoza, Victor M.; Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile; [Espinoza, Victor M.] Univ Chile, Dept Sound, Santiago, Chile; [Ghassemi, Marzyeh; Guttag, John, V] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Mehta, Daryush D.; Van Stan, Jarrad H.; Hillman, Robert E.] Massachusetts Gen Hosp, Ctr Laryngeal Surg & Voice Rehabil, Boston, MA 02114 USA; [Mehta, Daryush D.; Van Stan, Jarrad H.; Hillman, Robert E.] Massachusetts Gen Hosp, MGH Inst Hlth Profess, Boston, MA 02114 USA; [Mehta, Daryush D.; Van Stan, Jarrad H.] Harvard Med Sch, Dept Surg, Boston, MA USA	Universidad Tecnica Federico Santa Maria; Universidad de Chile; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Cortes, JP (corresponding author), Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile.	juan.cortes.5@sansano.usm.cl	Espinoza, Victor M/P-2334-2015; Zañartu, Matías/N-1338-2019	Espinoza, Victor M/0000-0001-9013-6830; Zañartu, Matías/0000-0001-5581-4392; Cortes, Juan/0000-0002-4346-2489	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R33DC011588, P50DC015446]; CONICYT [FONDECYT 1151077, BASAL FB0008]; CONICYT doctoral scholarship [21161606]; Universidad Tecnica Federico Santa Maria, Direccion General de Investigacion, Innovacion, y Postgrado; Programa de iniciacion a la Investigacion Cientifica (PIIC) [038/2017]; Voice Health Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC015446] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT doctoral scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Tecnica Federico Santa Maria, Direccion General de Investigacion, Innovacion, y Postgrado; Programa de iniciacion a la Investigacion Cientifica (PIIC); Voice Health Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under awards number R33DC011588 and P50DC015446 (https://www.nidcd.nih.gov/ and the Voice Health Institute, authors who received funding: R.H., D.M., J.V.S., J.G., M.G., M.Z., V.E., and J.C.); CONICYT grants FONDECYT 1151077 and BASAL FB0008 and CONICYT doctoral scholarship 21161606 (http://www.conicyt.cl/, authors who received funding: M.Z., J.C., and V.E.); Universidad Tecnica Federico Santa Maria, Direccion General de Investigacion, Innovacion, y Postgrado. Programa de iniciacion a la Investigacion Cientifica (PIIC) Number 038/2017 (http://dgiip.usm.cl/, author who received funding: J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisa Z, LARYNGOSCOPE, V125, P191; Alku P, 2006, ACTA ACUST UNITED AC, V92, P717; Alku P, 2013, J ACOUST SOC AM, V134, P1295, DOI 10.1121/1.4812756; Alku P, 2011, SADHANA-ACAD P ENG S, V36, P623, DOI 10.1007/s12046-011-0041-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drugman T, 2014, COMPUT SPEECH LANG, V28, P1117, DOI 10.1016/j.csl.2014.03.003; Espinoza VM, 2017, J SPEECH LANG HEAR R, V60, P2159, DOI 10.1044/2017_JSLHR-S-16-0337; Espinoza VM, 2017, J ACOUST SOC AM, V141, P3579, DOI [10.1121/1.4987622, DOI 10.1121/1.4987622]; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Galindo GE, 2017, J SPEECH LANG HEAR R, V60, P2452, DOI 10.1044/2017_JSLHR-S-16-0412; Ghassemi Marzyeh, 2016, JMLR Workshop Conf Proc, V56, P239; Ghassemi M, 2014, IEEE T BIO-MED ENG, V61, P1668, DOI 10.1109/TBME.2013.2297372; Harper P, 2001, J APPL PHYSIOL, V77, P554; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HILLMAN RE, 1989, J SPEECH HEAR RES, V32, P373, DOI 10.1044/jshr.3202.373; Ho JC, 2011, J ACOUST SOC AM, V129, P1531, DOI 10.1121/1.3543971; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; ISHIZAKA K, 1975, IEEE T ACOUST SPEECH, V23, P370, DOI 10.1109/TASSP.1975.1162701; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kreiman J, 2012, J ACOUST SOC AM, V132, P2625, DOI 10.1121/1.4747007; Kunduk M, 2009, CURR OPIN OTOLARYNGO, V17, P449, DOI 10.1097/MOO.0b013e3283328b6d; Llico AF, 2015, J ACOUST SOC AM, V138, pEL14, DOI 10.1121/1.4922364; Mehta DD, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00155; Mehta DD, 2008, CURR OPIN OTOLARYNGO, V16, P211, DOI 10.1097/MOO.0b013e3282fe96ce; Mehta DD, 2013, IEEE 10 ANN WEAR IMP; Muhammad G, 2018, IEEE COMMUN MAG, V56, P60, DOI 10.1109/MCOM.2018.1700790; PERKELL JS, 1994, J ACOUST SOC AM, V96, P695, DOI 10.1121/1.410307; PERKELL JS, 1991, J ACOUST SOC AM, V89, P1777, DOI 10.1121/1.401011; Pinho CMR, 2013, LOGOP PHONIATR VOCO, V38, P19, DOI 10.3109/14015439.2012.696138; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Rabiner L. R., 1978, DIGITAL PROCESSING S; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; ROTHENBERG M, 1973, J ACOUST SOC AM, V53, P1632, DOI 10.1121/1.1913513; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Svec JG, 2005, J ACOUST SOC AM, V117, P1386, DOI 10.1121/1.1850074; Titze IR, 2003, J SPEECH LANG HEAR R, V46, P919, DOI 10.1044/1092-4388(2003/072); Van Stan JH, 2015, ANN OTO RHINOL LARYN, V124, P864, DOI 10.1177/0003489415589363; Zanartu M, 2010, ACOUSTIC COUPLING PH; Zanartu M, 2014, J ACOUST SOC AM, V136, P3262, DOI 10.1121/1.4901714; Zanartu M, 2013, IEEE T AUDIO SPEECH, V21, P1929, DOI 10.1109/TASL.2013.2263138; Zraick RI, 2012, J VOICE, V26, P164, DOI 10.1016/j.jvoice.2011.01.006	46	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209017	10.1371/journal.pone.0209017	http://dx.doi.org/10.1371/journal.pone.0209017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571719	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700033
J	Humayoun, SB; Hiott, LM; Gupta, SK; Barrett, JB; Woodley, TA; Johnstone, JJ; Jackson, CR; Frye, JG				Humayoun, Shaheen B.; Hiott, Lari M.; Gupta, Sushim K.; Barrett, John B.; Woodley, Tiffanie A.; Johnstone, John J.; Jackson, Charlene R.; Frye, Jonathan G.			An assay for determining the susceptibility of Salmonella isolates to commercial and household biocides	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; ORGANIC-ACIDS; ANTIMICROBIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; BENZALKONIUM CHLORIDE; ANTIBIOTIC-RESISTANCE; POULTRY LITTER; UNITED-STATES; SODIUM METASILICATE	Poultry and meat products contaminated with Salmonella enterica are a major cause of foodborne illness in the United States. The food industries use a wide variety of antimicrobial interventions to reduce bacterial contamination. However, little is known about Salmonella susceptibility to these compounds and some studies have shown a concerning link between biocide resistance and antibiotic resistance. To investigate this, a 96 well panel of 17 common household and commercially used biocides was designed to determine the minimum inhibitory concentrations (MIC) of these compounds for Salmonella. The panel contained two-fold serial dilutions of chemicals including Dodecyltrimethylammonium chloride (DC), Benzalkonium chloride (BKC), Cetylpyridinium chloride (CPC), Hexadecyltrimethylammonium bromide (HB), Hexadecyltrimethylammonium chloride (HC), Acetic acid (AA), Lactic acid (LA), Citric acid (CA), Peroxyacetic acid (PXA), Acidified sodium chlorite (ASC), Sodium hypochlorite (SHB), 1,3 dibromo, 5,5 dimethylhydantoin (DBH), Chlorhexidine (CHX), Sodium metasilicate (SM), Trisodium phosphate (TSP), Arsenite (ARI), and Arsenate (ARA). The assay was used to test the susceptibility of 88 multidrug resistant (MDR) Salmonella isolates from animal sources. Bacteria are defined as multidrug resistant (MDR) if it exhibited non-susceptibility to at least one agent in three or more antimicrobial categories. The concentration of biocide at which >= 50% of the isolates could not grow was designated as the minimum inhibitory concentration or MIC50 and was used as the breakpoint in this study. The MIC50 (mu g ml(-1)) for the tested MDR Salmonella was 256 for DC, 40 for BKC, 80 for CPC. HB and HC, 1,640 for AA, 5664 for LA, 3,156 for CA, 880 for PXA, 320 for ASC, 3.0 for CHX, 1,248 for DBH, 3,152 (6%) for SHB, 60,320 for SM, 37,712 for TSP, 56 for ARI and 832 for ARA. A few isolates were not susceptible at the MIC50 breakpoint to some chemicals indicating possible resistance. Isolates with MICs of two 2-fold dilutions above the MIC50 were considered resistant. Biocides for which resistant isolates were detected included CPC (n = 1 isolate), HB (1), CA (18), ASC (7), CHX (22), ARA (16), and ARI (4). There was no correlation detected between the biocide susceptibility of Salmonella isolates and antibiotic resistance. This assay can determine the MICs of bacteria to 17 biocides in a single test and will be useful in evaluating the efficacy of biocides and to detect the development of resistance to them.	[Humayoun, Shaheen B.; Hiott, Lari M.; Gupta, Sushim K.; Barrett, John B.; Woodley, Tiffanie A.; Jackson, Charlene R.; Frye, Jonathan G.] ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, USDA, US Natl Poultry Res Ctr, Athens, GA 30605 USA; [Johnstone, John J.] USDA, Food Safety & Inspect Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Frye, JG (corresponding author), ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, USDA, US Natl Poultry Res Ctr, Athens, GA 30605 USA.	jonathan.frye@ars.usda.gov	Gupta, Sushim Kumar/L-5082-2019; Frye, Jonathan G./I-6382-2013	Frye, Jonathan G./0000-0002-8500-3395; Gupta, Sushim/0000-0001-6520-6817	U.S. Department of Agriculture (USDA) [6040-32000-006-00, 6040-32000-009-00]; Foundation for Meat & Poultry Research Education; American Meat Institute Foundation	U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Foundation for Meat & Poultry Research Education; American Meat Institute Foundation	This work was funded by U.S. Department of Agriculture (USDA) Project Numbers 6040-32000-006-00 and 6040-32000-009-00, https://www.ars.usda.gov/research/project/? accnNo=430182; and Foundation for Meat & Poultry Research & Education, American Meat Institute Foundation, "Determination of the prevalence of resistance to biocides in Salmonella and identification of the genetic mechanisms of resistance", http://meatpoultryfoundation.org/research/determination-prevalence-resistancebiocides-salmonella-and-identification-genetic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the U.S. Department of Agriculture (USDA) Project Numbers 6040-32000-006-00 and 6040-32000-009-00, and by a grant from the American Meat Institute Foundation. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The authors would like to thank University of Georgia graduate students Trace Borchart, Christian Keggie, Sohyun Cho for their technical help and Dr. Gary Gamble and Dr. Mark Berrang of ARS for helpful discussions. We would also like to thank Dian Herson for supplying strains of Salmonella. Keywords: Salmonella, food animals, chemical resistance, Biocides, MICs. Note: The mention of trade names or commercial products in this manuscript is solely for providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; Altekruse SF, 1997, EMERG INFECT DIS, V3, P285, DOI 10.3201/eid0303.970304; Andino A, 2015, THESCIENTIFICWORLDJO, V13; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; [Anonymous], 2017, J FOOD CHEM NANOTECH; Barillo David J, 2014, Burns, V40 Suppl 1, pS3, DOI 10.1016/j.burns.2014.09.009; Bednar AJ, 2003, SCI TOTAL ENVIRON, V302, P237, DOI 10.1016/S0048-9697(02)00322-4; Beier RC, 2005, B ENVIRON CONTAM TOX, V75, P835, DOI 10.1007/s00128-005-0826-5; Beier RC, 2011, FOODBORNE PATHOG DIS, V8, P593, DOI 10.1089/fpd.2010.0702; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Beuchat LR, 1996, J FOOD PROTECT, V59, P204, DOI 10.4315/0362-028X-59.2.204; BEUMER R, 2000, MICROBIAL RESISTANCE; Bloomfield SF, 2002, J APPL MICROBIOL, V92, p144S, DOI 10.1046/j.1365-2672.92.5s1.15.x; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Byrd JA, 2001, POULTRY SCI, V80, P278, DOI 10.1093/ps/80.3.278; Capita R, 2013, APPL ENVIRON MICROB; Carrasco E, 2012, FOOD RES INT, V45, P545, DOI 10.1016/j.foodres.2011.11.004; Castillo A, 1999, J FOOD PROTECT, V62, P580, DOI 10.4315/0362-028X-62.6.580; CDC, 2013, ANTIBIOTIC RESISTANC; CDC (Center for Disease Control and Prevention), 2011, MULT OUTBR HUM SALM; Center for Disease Control and Prevention (CDC), 2011, NAT ENT DIS SURV SAL; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Christensen EG, 2011, ANTIMICROB AGENTS CH, V55, P4064, DOI 10.1128/AAC.00460-11; Clinical and Laboratory Standards Institute, 2015, PERF STAND ANT SUSC, P17; Clinical Laboratory and Standards Institute, 2018, M07 CLSI, Veleventh; Coelho JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055582; Cortesia C, 2014, MBIO, V5, DOI 10.1128/mBio.00013-14; Cozad A, 2003, AM J INFECT CONTROL, V31, P243, DOI 10.1067/mic.2003.49; Dynes JJ, 2009, CAN J MICROBIOL, V55, P163, DOI [10.1139/w08-109, 10.1139/W08-109]; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; FDA, 2015, PROD SAF INF QUEST A; FDA, 2015, FDA ANN PEND WITHDR; Federal-Register, 1994, FED REGISTER, V59, P551; Frye JG, 2006, INT J ANTIMICROB AG, V27, P138, DOI 10.1016/j.ijantimicag.2005.09.021; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Gadea R, 2017, FOOD MICROBIOL, V63, P58, DOI 10.1016/j.fm.2016.10.037; Gantzhom MR, 2014, INT J FOOD MICROBIOL, V181, P53, DOI 10.1016/j.ijfoodmicro.2014.04.021; Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q; Gilbert P, 2003, CLIN MICROBIOL REV, V16, P189, DOI 10.1128/CMR.16.2.189-208.2003; Gonzalez RC, 2002, FOOD SCI TECHNOLOGY, V8, P11; Grimont P.A.D., 2007, AESTHETICS COSMETIC, P9; Helms M, 2004, J INFECT DIS, V190, P1652, DOI 10.1086/424570; Huang H, 2010, EFFECTS SODIUM METAS; Hugo WB, 1995, INT BIODETER BIODEGR, V36, P197, DOI 10.1016/0964-8305(95)00055-0; Inatsu Y, 2005, J FOOD PROTECT, V68, P251, DOI 10.4315/0362-028X-68.2.251; Jorgensen J. H., 1999, MANUAL CLIN MICROBIO; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Joynson JA, 2002, J APPL MICROBIOL, V93, P96, DOI 10.1046/j.1365-2672.2002.01667.x; Kalchayanand N, 2012, J FOOD PROTECT, V75, P1207, DOI 10.4315/0362-028X.JFP-11-531; Kalcrayanand N, 2009, J FOOD PROTECT, V72, P151, DOI 10.4315/0362-028X-72.1.151; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kang JH, 2015, INT J ORAL MAX IMPL, V30, P1341, DOI 10.11607/jomi.3824; Karam G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1320-7; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Kautz M, 2010, EFFECTS REDUCED SUSC; Kautz MJM, 2013, APPL ENVIRON MICROB, V79, P2371, DOI 10.1128/AEM.03228-12; Keener KM, 2004, COMPR REV FOOD SCI F, V3, P105, DOI 10.1111/j.1541-4337.2004.tb00060.x; Khan SH, 2016, J APPL ANIM RES, V44, P359, DOI 10.1080/09712119.2015.1079527; Kong Y. J, 2001, KOREAN J FOOD SCI TE, V33, P178; KOTULA KL, 1994, J FOOD PROTECT, V57, P665, DOI 10.4315/0362-028X-57.8.665; KOWALSKI LM, 1975, POULTRY SCI, V54, P1544, DOI 10.3382/ps.0541544; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Lambert RJW, 2001, J APPL MICROBIOL, V91, P972, DOI 10.1046/j.1365-2672.2001.01460.x; Leader BT, 2009, J CLIN MICROBIOL, V47, P1290, DOI 10.1128/JCM.02095-08; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; Leung P, 2004, OPHTHAL PHYSL OPT, V24, P218, DOI 10.1111/j.1475-1313.2004.00189.x; Loughlin MF, 2002, J ANTIMICROB CHEMOTH, V49, P631, DOI 10.1093/jac/49.4.631; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maillard JY, 2002, J APPL MICROBIOLOGY, V92; Mani-Lopez E, 2012, FOOD RES INT, V45, P713, DOI 10.1016/j.foodres.2011.04.043; Mc Cay PH, 2010, MICROBIOL-SGM, V156, P30, DOI 10.1099/mic.0.029751-0; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mellon M., 2001, HOGGING IT ESTIMATES; Molina-Gonzalez D, 2014, FOOD CONTROL, V40, P329, DOI 10.1016/j.foodcont.2013.11.046; Moretro T, 2012, FOOD RES INT, V45, P532, DOI 10.1016/j.foodres.2011.02.002; Nde CW, 2009, ENVIRON SCI TECHNOL, V43, P8406, DOI 10.1021/es9015475; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; [NOAA] National Oceanic and Atmospheric Association, 2004, FED REG, V69; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Rakic-Martinez M, 2011, APPL ENVIRON MICROB, V77, P8714, DOI 10.1128/AEM.05941-11; Ransom J. R., 2003, Food Protection Trends, V23, P24; Rao M. V, 2007, ACIDIFIED SODIUM CHL; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; Routh JA, 2015, EPIDEMIOL INFECT, V143, P3227, DOI 10.1017/S0950268815000497; Russell A, 2002, J APPL MICROBIOLOGY, V92; Russell A, 1996, J APPL BACTERIOLOGY, V81; Russell AD, 2000, J PHARM PHARMACOL, V52, P227, DOI 10.1211/0022357001773742; Rutala W.A., 2019, GUIDELINE DISINFECTI; Rutherford DW, 2003, ENVIRON SCI TECHNOL, V37, P1515, DOI 10.1021/es026222+; Sanders F. T., 2003, Pesticide Outlook, V14, P251, DOI 10.1039/b314854h; Sapkota AR, 2006, APPL ENVIRON MICROB, V72, P3069, DOI 10.1128/AEM.72.4.3069-3071.2006; Sarjit A, 2015, INT J FOOD MICROBIOL, V203, P63, DOI 10.1016/j.ijfoodmicro.2015.02.026; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), 2009, ASS ANT RES EFF BIOC, P1; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Selvi M. S., 2014, International Journal of Agricultural Policy and Research, V2, P393; Sharma CS, 2012, POULTRY SCI, V91, P719, DOI 10.3382/ps.2011-01848; Sharma CS, 2013, FOODBORNE PATHOG DIS, V10, P995, DOI 10.1089/fpd.2013.1556; Sheridan A, 2012, FOOD CONTROL, V26, P98, DOI 10.1016/j.foodcont.2012.01.018; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Smulders FJM, 1998, INT J FOOD MICROBIOL, V44, P149, DOI 10.1016/S0168-1605(98)00123-8; Stevenson NW, 2008, REDUCED SUSCEPTIBILI; Su LH, 2004, CLIN INFECT DIS, V39, P546, DOI 10.1086/422726; Tanwar J., 2014, INTERDISCIPLINARY PE, V2014; Tezel U, 2011, ANTIMICROBIAL RESIST, P349, DOI [10.1002/9781118156247.ch20, DOI 10.1002/9781118156247.CH20]; Tezel U, 2015, CURR OPIN BIOTECH, V33, P296, DOI 10.1016/j.copbio.2015.03.018; Trachoo N, 2002, J FOOD PROTECT, V65, P1117, DOI 10.4315/0362-028X-65.7.1117; USDA, 2012, SAF SUIT INGR US PRO; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; Wales A, 2013, AVIAN PATHOL, V42, P268, DOI 10.1080/03079457.2013.782097; Wang HH, 2016, LWT-FOOD SCI TECHNOL, V66, P298, DOI 10.1016/j.lwt.2015.10.049; Wang HH, 2014, J FOOD PROCESS PRES, V38, P397, DOI 10.1111/j.1745-4549.2012.00787.x; Warf C, 2001, CHEM MODE ACTION ACI, P1; Webber MA, 2013, MBIO, V4, DOI 10.1128/mBio.00273-13; Wei C-I, 1985, FOOD TECHNOLOGY; Yang HC, 2016, BIOMED J, V39, P5, DOI 10.1016/j.bj.2015.08.003	121	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209072	10.1371/journal.pone.0209072	http://dx.doi.org/10.1371/journal.pone.0209072			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571686	gold, Green Submitted, Green Published			2022-12-26	WOS:000453841700034
J	Umu, OCO; Fauske, AK; Akesson, CP; de Nanclares, MP; Sorby, R; Press, CM; Overland, M; Sorum, H				Umu, Ozgun Candan Onarman; Fauske, Aud Kari; Akesson, Caroline Piercey; de Nanclares, Marta Perez; Sorby, Randi; Press, Charles McLean; Overland, Margareth; Sorum, Henning			Gut microbiota profiling in Norwegian weaner pigs reveals potentially beneficial effects of a high-fiber rapeseed diet	PLOS ONE			English	Article							SOYBEAN-MEAL; DIGESTIBILITY; SEQUENCES; NUTRIENT; GROWTH; ILEAL; ACIDS	Rapeseed meal (RSM) is an alternative feed ingredient to soybean meal (SBM) in pig diets. However, knowledge on the effect of RSM on gut health, especially in relation to changes in gut microbiota is still limited. In our study, Norwegian Landrace weaner pigs were fed with either a control diet (CON) based on wheat, barley and SBM, or a high-fiber experimental diet where SBM was replaced by RSM (RSF). We found no large differences in the gut microbiota of pigs fed the two diets, suggesting that RSF does not disturb the gut microbiota and the normal gut function. The relative abundance of SCFA-producing phylotypes and colon-health related phylotypes increased in the large intestine of RSF-fed pigs. Among them, Lachnospira and Coprococcus were negatively associated with the presence of neutrophils in the colon wall. The higher abundance of these bacteria in colon of RSF pigs may suggest an anti-inflammatory stimulus effect of the RSF diet. The gut microbiota of RSF-fed pigs was relatively unaltered following episodes of diarrhea suggesting that the RSF diet may promote robustness in weaner pigs and reduce the risk of dysbiosis.	[Umu, Ozgun Candan Onarman; Fauske, Aud Kari; Sorum, Henning] Norwegian Univ Life Sci, Fac Vet Med, Dept Food Safety & Infect Biol, Oslo, Norway; [Akesson, Caroline Piercey; Sorby, Randi; Press, Charles McLean] Norwegian Univ Life Sci, Fac Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway; [de Nanclares, Marta Perez; Overland, Margareth] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Umu, OCO (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Dept Food Safety & Infect Biol, Oslo, Norway.	ozgun.umu@nmbu.no		Onarman Umu, Ozgun Candan/0000-0003-4060-7766	Feed Mileage-Efficient use of feed resources for a sustainable Norwegian food production (the Research Council of Norway) [233685/E50]	Feed Mileage-Efficient use of feed resources for a sustainable Norwegian food production (the Research Council of Norway)	This research was financially supported by Feed Mileage-Efficient use of feed resources for a sustainable Norwegian food production (the Research Council of Norway; grant no. 233685/E50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; [Anonymous], 2016, ASIAN J ANIM VET ADV, DOI DOI 10.3923/AJAVA.2016.89.97; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERTSCHINGER HU, 1979, VET MICROBIOL, V3, P281, DOI 10.1016/0378-1135(79)90004-X; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen C, 2018, J ANIM SCI, V96, P1757, DOI 10.1093/jas/sky080; Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168; Choi HB, 2015, ASIAN AUSTRAL J ANIM, V28, P1345, DOI 10.5713/ajas.14.0802; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; de Nanclares MP, 2017, LIVEST SCI, V203, P1, DOI 10.1016/j.livsci.2017.06.008; de Visser CLM, 2014, OCL OILS FAT CROP LI, V21, DOI 10.1051/ocl/2014021; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dion C, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0086-x; Downes J, 2002, INT J SYST EVOL MICR, V52, P1469, DOI 10.1099/00207713-52-5-1469; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kelly G S, 1999, Altern Med Rev, V4, P96; KRITCHEVSKY D, 1990, DIETARY FIBER CHEM P; LI DF, 1990, J ANIM SCI, V68, P1790; Licht TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-13; Lindberg JE, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-15; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchandin H., 2014, PROKARYOTES, P433, DOI DOI 10.1007/978-3-642-30120-9_361; Mathew AG, 1996, NUTR RES, V16, P1689, DOI 10.1016/0271-5317(96)00188-1; Mejicanos G., 2016, Journal of Animal Science and Technology, V58, P7, DOI 10.1186/s40781-016-0085-5; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; Noblet J, 2001, ANIM FEED SCI TECH, V90, P35, DOI 10.1016/S0377-8401(01)00195-X; Pieper R, 2016, ANIM HEALTH RES REV, V17, P137, DOI 10.1017/S1466252316000141; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; RODE LM, 1981, APPL ENVIRON MICROB, V42, P20, DOI 10.1128/AEM.42.1.20-22.1981; Roh SG, 2015, ANIM SCI J, V86, P508, DOI 10.1111/asj.12319; SAUER WC, 1991, J ANIM SCI, V69, P4070, DOI 10.2527/1991.69104070x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Umu Ozgun C. O., 2017, Microbial Ecology in Health and Disease, V28, P1348886, DOI 10.1080/16512235.2017.1348886; Umu OCO, 2013, ANTON LEEUW INT J G, V104, P609, DOI 10.1007/s10482-013-0008-0; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19876; Weightman R., 2014, NUTR VALUE OILSEED R; Whittemore, 2006, WHITTEMORES SCI PRAC	55	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209439	10.1371/journal.pone.0209439	http://dx.doi.org/10.1371/journal.pone.0209439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571797	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700072
J	Bourke, JM; Porter, WR; Witmer, LM				Bourke, Jason M.; Porter, Wm Ruger; Witmer, Lawrence M.			Convoluted nasal passages function as efficient heat exchangers in ankylosaurs (Dinosauria: Ornithischia: Thyreophora)	PLOS ONE			English	Article							3-DIMENSIONAL MESH GENERATION; UNIDIRECTIONAL AIR-FLOW; BODY-TEMPERATURE; RESPIRATORY VARIABLES; ARMORED DINOSAURS; ASIAN ELEPHANTS; FLUID-DYNAMICS; EXHALED AIR; EVOLUTION; ANATOMY	Convoluted nasal passages are an enigmatic hallmark of Ankylosauria. Previous research suggested that these convoluted nasal passages functioned as heat exchangers analogous to the respiratory turbinates of mammals and birds. We tested this hypothesis by performing a computational fluid dynamic analysis on the nasal passages of two ankylosaurs: Panoplosaurus mirus and Euoplocephalus tutus. Our models predicted that Panoplosaurus and Euoplocephalus would have required 833 and 1568 thermal calories, respectively, to warm a single breath of air by 20 degrees C. Heat recovery during exhalation resulted in energy savings of 65% for Panoplosaurus and 84% for Euoplocephalus. Our results fell well within the range of values for heat and water savings observed in extant terrestrial amniotes. We further tested alternate airway reconstructions that removed nasal passage convolutions or reduced nasal vestibule length. Our results revealed that the extensive elaboration observed in the nasal vestibules of ankylosaurs was a viable alternative to respiratory turbinates with regards to air conditioning. Of the two dinosaurs tested, Euoplocephalus repeatedly exhibited a more efficient nasal passage than Panoplosaurus. We suggest that the higher heat loads associated with the larger body mass of Euoplocephalus necessitated these more efficient nasal passages. Our findings further indicate that the evolution of complicated airways in dinosaurs may have been driven by the thermal requirements of maintaining cerebral thermal homeostasis.	[Bourke, Jason M.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Porter, Wm Ruger; Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Bourke, Jason M.] NY Inst Technol Coll Osteopath Med Arkansas State, Dept Basic Sci, Jonesboro, AR 72401 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Bourke, JM (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.; Bourke, JM (corresponding author), NY Inst Technol Coll Osteopath Med Arkansas State, Dept Basic Sci, Jonesboro, AR 72401 USA.	jbourke@nyit.edu		Bourke, Jason/0000-0002-6966-8020; Witmer, Lawrence/0000-0002-7610-0118	National Science Foundation (NSF) Graduate Research Fellowship; Doris O. and Samuel P. Welles Research Fund; Jurassic Foundation research grant; National Science Foundation [IBN-0343744, IOB-0517257, IOS-1050154, IOS-1456503]	National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); Doris O. and Samuel P. Welles Research Fund; Jurassic Foundation research grant; National Science Foundation(National Science Foundation (NSF))	National Science Foundation (NSF) Graduate Research Fellowship to JMB. Doris O. and Samuel P. Welles Research Fund to JMB and WRP. Jurassic Foundation research grant to JMB and WRP. National Science Foundation grants: IBN-0343744, IOB-0517257, IOS-1050154, IOS-1456503 to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBROOK DB, 1958, J PHYSIOL-LONDON, V143, pP51; Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; Arbour VM, 2017, FACETS, V2, P764, DOI 10.1139/facets-2017-0063; Arbour VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062421; BAKER MA, 1974, RESP PHYSIOL, V22, P325, DOI 10.1016/0034-5687(74)90081-4; BAKER MA, 1982, ANNU REV PHYSIOL, V44, P85, DOI 10.1146/annurev.ph.44.030182.000505; Bang BG, 2007, FORM FUNCTION BIRDS, P195; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; BENNETT AF, 1973, COMP BIOCHEM PHYSIOL, V46, P653, DOI 10.1016/0300-9629(73)90119-9; Biswas R, 1998, APPL NUMER MATH, V26, P135, DOI 10.1016/S0168-9274(97)00092-5; BLIGH J, 1965, J PHYSIOL-LONDON, V176, P145, DOI 10.1113/jphysiol.1965.sp007541; BLIGH JOHN, 1965, IBIS, V107, P104, DOI 10.1111/j.1474-919X.1965.tb07287.x; Bourke JM, 2016, RESP PHYSIOL NEUROBI, V234, P32, DOI 10.1016/j.resp.2016.09.005; Bourke JM, 2014, ANAT REC, V297, P2148, DOI 10.1002/ar.23046; Bourke JM, 2015, IMPLICATIONS AIRFLOW; Brown B, 1908, B AM MUS NAT HIST, V24, P187; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Caputa M, 2004, J THERM BIOL, V29, P691, DOI 10.1016/j.jtherbio.2004.08.079; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K., 1990, P281, DOI 10.1017/CBO9780511608377.024; CAVE AJE, 1967, J ZOOL, V153, P277; Chen XB, 2009, LARYNGOSCOPE, V119, P1730, DOI 10.1002/lary.20585; Citino SB, 2007, J ZOO WILDLIFE MED, V38, P375, DOI 10.1638/2006-0007R1.1; COLLINS JC, 1971, BIOPHYS J, V11, P886, DOI 10.1016/S0006-3495(71)86262-8; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; COOMBS WP, 1972, J PALEONTOL, V46, P637; Coombs WPJ, 1971, THE ANKYLOSAURIA; Craven B.A., 2009, J BIOMECHANICAL ENG, V131, P1, DOI DOI 10.1115/1; Craven BA, 2007, ANAT REC, V290, P1325, DOI 10.1002/ar.20592; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; CRAWFORD EC, 1977, COMP BIOCHEM PHYS A, V56, P161, DOI 10.1016/0300-9629(77)90178-5; Crole MR, 2010, ANAT HISTOL EMBRYOL, V39, P207, DOI 10.1111/j.1439-0264.2010.00998.x; Dinets V, 2013, COPEIA, P517, DOI 10.1643/CE-12-125; Eagle RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9296; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Eiting TP, 2014, J EXP BIOL, V217, P1799, DOI 10.1242/jeb.097402; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Foss JF, 1998, HDB FLUID DYNAMICS; Frappell PB, 2001, PHYSIOL BIOCHEM ZOOL, V74, P75, DOI 10.1086/319300; Frey R, 2007, J ANAT, V211, P717, DOI 10.1111/j.1469-7580.2007.00818.x; Geist HR, 2000, PHYSIOL BIOCHEM ZOOL, V73, P581, DOI 10.1086/317750; Georges P, 1988, NUMERICAL GRID GENER, P589; Hayashi S, 2010, ACTA PALAEONTOL POL, V55, P213, DOI 10.4202/app.2009.0103; HEATH JAMES EDWARD, 1964, PHYSIOL ZOOL, V37, P273; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; HILLENIUS WJ, 1992, PALEOBIOLOGY, V18, P17, DOI 10.1017/S0094837300012197; HILLENIUS WJ, 1994, EVOLUTION, V48, P207, DOI 10.1111/j.1558-5646.1994.tb01308.x; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Horschler I, 2006, EUR J MECH B-FLUID, V25, P471, DOI 10.1016/j.euromechflu.2005.11.006; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Holmes WM, 2011, ANAT REC, V294, P1045, DOI 10.1002/ar.21382; JACKSON DC, 1964, P NATL ACAD SCI USA, V51, P1192, DOI 10.1073/pnas.51.6.1192; Jarvik E, 1941, ZOOL BIDR UPPS, V21, P235; Jiang JB, 2010, J AEROSOL SCI, V41, P1030, DOI 10.1016/j.jaerosci.2010.06.005; JOHNSON CR, 1973, COMP BIOCHEM PHYSIOL, V45, P1065, DOI 10.1016/0300-9629(73)90343-5; JOHNSON CR, 1974, COMP BIOCHEM PHYSIOL, V49, P3, DOI 10.1016/0300-9629(74)90538-6; Katz J., 2006, AERODYNAMICS RACE CA; Kierszenbaum AL, 2007, HISTOLOGY CELL BIOL, P437; Kimbell JS, 1997, TOXICOL APPL PHARM, V145, P388, DOI 10.1006/taap.1997.8206; Kinahan AA, 2007, PHYSIOL BEHAV, V92, P560, DOI 10.1016/j.physbeh.2007.05.001; KOCK MD, 1990, J ZOO WILDLIFE MED, V21, P155; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; LANGMAN VA, 1979, RESP PHYSIOL, V37, P325, DOI 10.1016/0034-5687(79)90079-3; LANGMAN VA, 1982, RESP PHYSIOL, V50, P141, DOI 10.1016/0034-5687(82)90013-5; Langman VA, 1985, NATL GEOGR SOC RES R, V21, P251; Leahey LG, 2015, PEERJ, V3, DOI 10.7717/peerj.1475; Longest PW, 2007, MED ENG PHYS, V29, P350, DOI 10.1016/j.medengphy.2006.05.012; Lucas AM, 1934, ARCHIV OTOLARYNGOL, V20, P518; Luckring JM, 2014, AIAA, V419, P1; MACKAY RS, 1964, NATURE, V204, P355, DOI 10.1038/204355a0; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; Mallon JC, 2014, PALAEOGEOGR PALAEOCL, V394, P29, DOI 10.1016/j.palaeo.2013.11.014; MALONEY SK, 1993, CONDOR, V95, P1034, DOI 10.2307/1369441; MARTIN BGH, 1977, J ZOOL, V182, P541; Maryanska T, 1971, PALAEONTOLOGIA POLON, V25, P45; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; MCNAB BK, 1976, COMP BIOCHEM PHYS A, V55, P345, DOI 10.1016/0300-9629(76)90058-X; Michaeli G, 2001, J EXP BIOL, V204, P3803; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; MURRISH DE, 1973, RESP PHYSIOL, V19, P262, DOI 10.1016/0034-5687(73)90030-3; MURRISH DE, 1970, RESP PHYSIOL, V10, P151, DOI 10.1016/0034-5687(70)90079-4; Naftali S, 2005, ANN BIOMED ENG, V33, P545, DOI 10.1007/s10439-005-2513-4; Negus V., 1958, COMP ANATOMY PHYSL N; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Osi A, 2017, HIST BIOL, V29, P539, DOI 10.1080/08912963.2016.1208194; OSMOLSKA H, 1979, Acta Palaeontologica Polonica, V24, P205; Owerkowicz Tomasz, 2015, P143; Parsons T. S., 1970, P99; PARSONS THOMAS S., 1959, BULL MUS COMP ZOOL HARVARD UNIV, V120, P101; PARSONS TS, 1959, EVOLUTION, V13, P175, DOI 10.2307/2405871; PARSONS TS, 1967, AM ZOOL, V7, P397; Paul G.S., 2016, PRINCETON FIELD GUID; PHILLIPS PK, 1995, J THERM BIOL, V20, P281, DOI 10.1016/0306-4565(94)00061-M; Porter WMR, 2016, ANAT REC, V299, P1461, DOI 10.1002/ar.23375; Porter WR, 2016, J ANAT, V229, P800, DOI 10.1111/joa.12539; Porter WR, 2015, PHYSIOLOGICAL IMPLIC; Porter WR, 2015, VASCULAR PATTERNS IG, P1, DOI [10.1371/journal.pone.0139215, DOI 10.1371/JOURNAL.PONE.0139215]; POUGH FH, 1976, COMP BIOCHEM PHYS A, V53, P301, DOI 10.1016/S0300-9629(76)80040-0; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; Rieppel O, 2008, ZOOL J LINN SOC-LOND, V152, P131, DOI 10.1111/j.1096-3642.2007.00337.x; Romer A, 1956, OSTEOLOGY REPTILES; Rowe MF, 2013, J EXP BIOL, V216, P1774, DOI 10.1242/jeb.076521; Ruben JA, 1998, BIOESSAYS, V20, P852; Ruben JA, 1996, NEW SERIES, V273, P1204; Schachner ER, 2014, NATURE, V506, P367, DOI 10.1038/nature12871; Schachner ER, 2013, PEERJ, V1, DOI 10.7717/peerj.60; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHMIDTN.K, 1970, RESP PHYSIOL, V9, P263, DOI 10.1016/0034-5687(70)90075-7; SCHMIDTNIELSEN K, 1981, PROC R SOC SER B-BIO, V211, P305, DOI 10.1098/rspb.1981.0009; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; SHEPHARD MS, 1991, INT J NUMER METH ENG, V32, P709, DOI 10.1002/nme.1620320406; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; STEBBINS RC, 1948, AM J ANAT, V83, P183, DOI 10.1002/aja.1000830202; Tattersall GJ, 2006, RESP PHYSIOL NEUROBI, V154, P302, DOI 10.1016/j.resp.2006.02.011; Tu J., 2013, COMPUTATIONAL FLUID, V1st; Van Valkenburgh B, 2004, J ZOOL, V264, P281, DOI 10.1017/S0952836904005771; Vickaryous MK, 2006, J VERTEBR PALEONTOL, V26, P1011, DOI 10.1671/0272-4634(2006)26[1011:NIOTCA]2.0.CO;2; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2009, J ANAT, V214, P441, DOI 10.1111/j.1469-7580.2008.01043.x; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Vickaryous MK, 2001, LIFE O PAST, P318; Vickaryous MK, 2001, SKULL MORPHOLOGY ANK; Vogel S, 1994, LIFE MOVING FLUIDS; Vogel S, 2003, COMP BIOMECHANICS LI, P117; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Weissenbock NM, 2012, J COMP PHYSIOL B, V182, P311, DOI 10.1007/s00360-011-0609-8; WELDON PJ, 1993, BRAIN BEHAV EVOLUT, V41, P239, DOI 10.1159/000113845; WILCOX DC, 1988, AIAA J, V26, P1311, DOI 10.2514/3.10042; Winet H, 1982, FLUORESCENT TRACER M, V34, P29; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Witmer LM, NASAL CONCHAE BLOOD; Witmer LM, 2008, ANAT IMAGING, V33; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; Yam R, 2011, J HOSP INFECT, V77, P31, DOI 10.1016/j.jhin.2010.08.010; YERRY MA, 1984, INT J NUMER METH ENG, V20, P1965, DOI 10.1002/nme.1620201103; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008; Zusi RL, 2006, ANN CARNEGIE MUS, V75, P137, DOI 10.2992/0097-4463(2006)75[137:VITOPA]2.0.CO;2	147	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207381	10.1371/journal.pone.0207381	http://dx.doi.org/10.1371/journal.pone.0207381			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566469	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300009
J	Janiszewska, K; Mazur, M; Machalski, M; Stolarski, J				Janiszewska, Katarzyna; Mazur, Maciej; Machalski, Marcin; Stolarski, Jarostaw			From pristine aragonite to blocky calcite: Exceptional preservation and diagenesis of cephalopod nacre in porous Cretaceous limestones	PLOS ONE			English	Article							VISTULA RIVER SECTION; ORGANIC MATRIX; SCLERACTINIAN CORALS; ISOTOPE COMPOSITION; FOSSIL RECORD; HARD PARTS; MOLLUSKS; DISSOLUTION; NEOMORPHISM; MINERALOGY	Aragonite (along with calcite) is one of the most common polymorphs of the crystalline calcium carbonate that forms the skeletal structures of organisms, but it has relatively low preservation potential. Under ambient conditions and in the presence of water, aragonite transforms into calcite, the stable polymorph. Aragonite is also more soluble therefore, in water-permeable siliceous limestones (opokas) that are typical of Upper Cretaceous deposits of Poland and Ukraine, the primary aragonitic skeletons are either entirely dissolved and found as moulds and casts or transformed into secondary calcite, whereas the primary calcitic shells remain well preserved. Contrary to the common notion of the lack of aragonite in such porous carbonate deposits, we show that relics of aragonite can be preserved as a nacreous lining on cephalopod moulds or as thin, lenticular structures entrapped in neomorphic calcite. Based on the observed intermediate steps of aragonite alteration, we propose an extended model of nacre diagenesis. Among the originally aragonitic biota, only nautilids and ammonites have retained relics of pristine skeletons. Such selective preservation of only some aragonitic structures (nacre but not the prismatic aragonitic layers) points to the role of microstructural and biochemical differences between cephalopod shell layers that may set a threshold for the dissolution, dissolution/precipitation or preservation of original biomineral structures.	[Janiszewska, Katarzyna; Machalski, Marcin; Stolarski, Jarostaw] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Mazur, Maciej] Univ Warsaw, Dept Chem, Lab Electrochem, Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Warsaw	Janiszewska, K; Stolarski, J (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	k.janiszewska@twarda.pan.pl; stolacy@twarda.pan.pl	Janiszewska, Katarzyna/AAZ-1186-2020; Stolarski, Jaroslaw/AAF-7331-2019; Machalski, Marcin/AAX-1074-2020; Stolarski, Jaroslaw/V-9586-2017	Janiszewska, Katarzyna/0000-0002-7094-1821; Stolarski, Jaroslaw/0000-0003-0994-6823; Machalski, Marcin/0000-0002-1121-4093; Stolarski, Jaroslaw/0000-0003-0994-6823; Mazur, Maciej/0000-0002-9197-5553	European Regional Development Fund within the Innovation Economy Operational Programme [POIG.02.02.00-00-025/09]; National Science Centre (Poland) [2017/25/B/ST10/02221]	European Regional Development Fund within the Innovation Economy Operational Programme; National Science Centre (Poland)	Cathodoluminescence imaging was performed in the NanoFun laboratory (Laboratory of Cathodoluminescence, Institute of Paleobiology, Polish Academy of Science, Warsaw) co-financed by the European Regional Development Fund within the Innovation Economy Operational Programme POIG.02.02.00-00-025/09. This work was partially supported by National Science Centre (Poland) research grant 2017/25/B/ST10/02221 to J.S.; Cathodoluminescence imaging was performed in the NanoFun laboratory (Laboratory of Cathodoluminescence, Institute of Paleobiology, Polish Academy of Science, Warsaw) co-financed by the European Regional Development Fund within the Innovation Economy Operational Programme POIG.02.02.00-00-025/09. This work was partially supported by National Science Centre (Poland) research grant 2017/25/B/ST10/02221 to J.S. The authors wish to thank Oksana Malchyk, M.Sc. for identification of nautilid specimens used in this study and Dr Cyprian Kulicki for help with SEM analysis. We also gratefully thank to the reviewers of this paper (Dr Rene Hoffmann and an anonymous reviewer) for the constructive comments.	ABDEL-GAWAD G I, 1986, Acta Geologica Polonica, V36, P69; Balthasar U, 2011, GEOLOGY, V39, P967, DOI 10.1130/G32269.1; Barbin V, 2000, CATHODOLUMINESCENCE IN GEOSCIENCES, P303; Barbin V, 1995, GEOBIOS-LYON, V28, P701, DOI 10.1016/S0016-6995(95)80064-6; Bathurst R., 1975, CARBONATE SEDIMENTS, P475; BOGER P D, 1973, Ohio Journal of Science, V73, P28; BUCHARDT B, 1981, SEDIMENTOLOGY, V28, P423, DOI 10.1111/j.1365-3091.1981.tb01691.x; CHAVE KE, 1962, LIMNOL OCEANOGR, V7, P218, DOI 10.4319/lo.1962.7.2.0218; Checa AG, 2013, J STRUCT BIOL, V183, P368, DOI 10.1016/j.jsb.2013.07.014; Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011; Cherns L, 2008, PALAEOGEOGR PALAEOCL, V270, P220, DOI 10.1016/j.palaeo.2008.07.012; Cherns L, 2011, GEOL SOC SPEC PUBL, V358, P9, DOI 10.1144/SP358.2; Cherns L, 2011, TOP GEOBIOL, V32, P79, DOI 10.1007/978-90-481-8643-3_3; Cherns L, 2009, PALAIOS, V24, P756, DOI 10.2110/palo.2008.p08-134r; Clark GR, 1999, PALAEOGEOGR PALAEOCL, V149, P305, DOI 10.1016/S0031-0182(98)00208-9; Clements T, 2017, PALAEONTOLOGY, V60, P1, DOI 10.1111/pala.12267; Cochran JK, 2010, AM J SCI, V310, P69, DOI 10.2475/02.2010.01; Cooper RA, 2006, GEOLOGY, V34, P241, DOI 10.1130/G22206.1; Dauphin Y, 2002, INT J EARTH SCI, V91, P1071, DOI 10.1007/s00531-002-0262-2; De Baets K, 2018, PALAEONTOLOGY, V61, P173, DOI 10.1111/pala.12343; DEECHOLS CMHMS, 1993, PALAIOS, V8, P278, DOI 10.2307/3515150; Dullo W.-C., 1988, P719; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Fatherree JW, 1998, PALAIOS, V13, P376, DOI 10.2307/3515325; FLESSA KW, 1983, LETHAIA, V16, P193, DOI 10.1111/j.1502-3931.1983.tb00654.x; Flugel E., 2010, MICROFACIES CARBONAT, DOI DOI 10.1007/978-3-642-03796-2; Folk R.L., 1965, SOC ECON PALEONTOLOG, V13, P14, DOI DOI 10.2110/PEC.65.07.0014; Frank TD, 2011, SEDIMENTOLOGY, V58, P670, DOI 10.1111/j.1365-3091.2010.01178.x; Frankowiak K, 2013, PALAIOS, V28, P333, DOI 10.2110/palo.2012.p12-116r; Gavrilishin VI, 1991, AKAD NAUK USSR I GEO, V59, P1; Gilbert PUPA, 2005, REV MINERAL GEOCHEM, V59, P157, DOI 10.2138/rmg.2005.59.7; Gill JR, 1966, USGS PROF PAP, P393; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Gorzelak P, 2016, GLOBAL PLANET CHANGE, V144, P142, DOI 10.1016/j.gloplacha.2016.07.010; Gothmann AM, 2015, GEOCHIM COSMOCHIM AC, V160, P188, DOI 10.1016/j.gca.2015.03.018; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Halamski A., 2011, ACTA PALAENTOL POL, V58, P407; HALL A, 1967, PROC R SOC SER B-BIO, V168, P377, DOI 10.1098/rspb.1967.0071; HALLAM A, 1962, NATURE, V195, P273, DOI 10.1038/195273a0; Hans F., 1964, BEITRAGE MINERALOGIE, V10, P184; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Henderson RA, 2002, LETHAIA, V35, P215, DOI 10.1080/00241160260288811; HENDRY JP, 1995, J SEDIMENT RES A, V65, P214; Hikida Y., 1993, STRUCTURE FORMATION, P81; Hovden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10097; Immenhauser A, 2016, SEDIMENTOLOGY, V63, P1, DOI 10.1111/sed.12231; James NP, 2005, J SEDIMENT RES, V75, P454, DOI 10.2110/jsr.2005.035; JAMES NP, 1974, J PALEONTOL, V48, P785; Janiszewska K, 2017, GEOLOGY, V45, P319, DOI 10.1130/G38593.1; Jordan N, 2015, LETHAIA, V48, P540, DOI 10.1111/let.12126; Jurkowska A, CRETAC RES, V93, P170; Katti KS, 2006, MAT SCI ENG C-BIO S, V26, P1317, DOI 10.1016/j.msec.2005.08.013; Kennedy WJ, 1967, P GEOL SOC LONDON, V1943, P253; Keupp H, 2000, AMMONITEN PALAOBIOLO; KIDWELL SM, 1989, J GEOL, V97, P1, DOI 10.1086/629278; Klug Christian, 2004, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V88, P63; Kner R., 1848, NATURWISSENSCHAFTLIC, V3, P1; Knoll K, 2016, AM J SCI, V316, P591, DOI 10.2475/07.2016.01; Konhauser KO, 2002, RADIOACTIV ENVIRONM, V2, P61; Kulicki C, 1999, ADVANCING RESEARCH ON LIVING AND FOSSIL CEPHALOPODS, P233; Kulicki C, 2015, TOP GEOBIOL, V43, P321, DOI 10.1007/978-94-017-9630-9_8; Landman Neil H., 1997, American Museum Novitates, V3197, P1; Lepot K, 2008, NAT GEOSCI, V1, P118, DOI 10.1038/ngeo107; Lowenstam HA, 1989, BIOMINERALIZATION; Machalski M, 2005, CRETACEOUS RES, V26, P813, DOI 10.1016/j.cretres.2005.05.007; Machalski Marcin, 2016, Przeglad Geologiczny, V64, P570; Machalski M, 2012, ACTA GEOL POL, V62, P91, DOI 10.2478/v10263-012-0004-0; Malchyk O, 2017, CRETACEOUS RES, V80, P1, DOI 10.1016/j.cretres.2017.08.006; Maliva RG, 2000, SEDIMENT GEOL, V136, P147, DOI 10.1016/S0037-0738(00)00102-0; MARTIN GD, 1986, J SEDIMENT PETROL, V56, P194; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; MUTVEI H, 1983, LETHAIA, V16, P233, DOI 10.1111/j.1502-3931.1983.tb00660.x; Mutvei H., 1972, Bulletin geol lnstn Univ Uppsala (NS), V3, P263; Mutvei H, 2008, PALAEONTOL Z, V82, P85, DOI 10.1007/BF02988434; Mutvei H, 2010, PALAEONTOL Z, V84, P457, DOI 10.1007/s12542-010-0060-2; Niechwedowicz M., 2018, PALYNOLOGY, P1; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Petrochenkov DA, 2018, OCEANOLOGY+, V58, P38, DOI 10.1134/S0001437018010101; Pozaryska K., 1952, B PANSTWOWEGO I GEOL, V81, P1; Radtke G, 2017, ACTA PALAEONTOL POL, V62, P59, DOI 10.4202/app.00263.2016; Remin Z, 2018, CRETACEOUS RES, V87, P368, DOI 10.1016/j.cretres.2017.06.010; Revelle R., 1957, GEOL SOC AM MEM, V67, P239; SANDBERG PA, 1973, NATURE-PHYS SCI, V245, P133, DOI 10.1038/physci245133a0; SANDBERG PA, 1983, SEDIMENTOLOGY, V30, P879, DOI 10.1111/j.1365-3091.1983.tb00716.x; SANDBERG PA, 1975, J PALEONTOL, V49, P587; Sanders D, 2003, J AFR EARTH SCI, V36, P99, DOI 10.1016/S0899-5362(03)00027-7; Seuss B, 2012, ACTA PALAEONTOL POL, V57, P375, DOI 10.4202/app.2011.0008; Seuss B, 2009, FACIES, V55, P609, DOI 10.1007/s10347-009-0181-9; Stevens K, 2017, PALAEOGEOGR PALAEOCL, V468, P388, DOI 10.1016/j.palaeo.2016.12.022; Tushtev K, 2008, MAT SCI ENG C-BIO S, V28, P1164, DOI 10.1016/j.msec.2007.10.039; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Vendrasco MJ, 2018, PALAIOS, V33, P451, DOI 10.2110/palo.2018.007; Vendrasco MJ, 2013, GEOSCIENCES, V3, P1, DOI 10.3390/geosciences3010001; Walaszczyk I, 2004, ACTA GEOL POL, V54, P95; Walaszczyk I, 2016, ACTA GEOL POL, V66, P313, DOI 10.1515/agp-2016-0016; WALTER LM, 1984, J SEDIMENT PETROL, V54, P1081; Webb GE, 2009, SEDIMENTOLOGY, V56, P1433, DOI 10.1111/j.1365-3091.2008.01041.x; WENDT J, 1977, NATURE, V267, P335, DOI 10.1038/267335b0; WRAY JL, 1957, J AM CHEM SOC, V79, P2031, DOI 10.1021/ja01566a001; Wright P, 2003, GEOLOGY, V31, P211, DOI 10.1130/0091-7613(2003)031<0211:MMFTTL>2.0.CO;2	100	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208598	10.1371/journal.pone.0208598	http://dx.doi.org/10.1371/journal.pone.0208598			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566495	gold, Green Submitted, Green Published			2022-12-26	WOS:000453779300051
J	Lechene, A; Lobry, J; Boet, P; Laffaille, P				Lechene, Alain; Lobry, Jeremy; Boet, Philippe; Laffaille, Pascal			Change in fish functional diversity and assembly rules in the course of tidal marsh restoration	PLOS ONE			English	Article							SALT-MARSH; ENVIRONMENTAL GRADIENTS; ECOLOGICAL PROCESSES; COMMUNITY RESPONSES; SUCCESSION INSIGHTS; CONTRASTING CHANGES; PATTERNS; ESTUARY; TRAIT; MECHANISMS	Functional trait theory provides a mechanistic framework to understand change in community composition and community assembly through time and space. Despite this, trait-based approaches have seldom been used in ecological restoration. Succession theory predicts that habitat complexity and resource availability will increase with restoration time, leading to increased functional dissimilarity among coexisting species. However, in the case of tidal marsh restoration, it is not clear whether reestablishing the harsh abiotic conditions typical of estuaries will initiate successional trajectories. We investigated monotonic changes in the functional structure of fish communities and shifts in assembly mechanisms, with tidal restoration time. A five-level gradient of 'intertidal habitat naturalness' was constructed from a set of artificialized (dyked), restored (with different ages) and natural intertidal sites, and used as a surrogate for restoration progress. The fish ecophases were described using ten functional traits related to food acquisition and swimming ability. The trends in six functional dimensions (identity, richness, evenness, dispersion, originality and specialization) were investigated along the naturalness gradient. Consistenly with succession theory, functional specialization, dispersion and, less markedly, richness increased with intertidal naturalness meaning that restored and natural intertidal habitats supplied fish with specific foraging and dwelling conditions absent from dyked marshes. Community assembly patterns varied with respect to traits and differed at both ends of the naturalness gradient. Dyked marshes were more affected by trait convergence possibly due to limiting resources. Environmental filtering was detected all along the naturalness gradient although the traits affected varied depending on the naturalness level of habitats. Environmental filtering tended to decrease in restored and natural intertidal habitats. Increased naturalness restored the attractivity of benthic habitats as feeding or settling grounds, promoted shelter-seeking vs. free-swimming strategists and favoured ecophases with carnivorous diets, feeding on microinvertebrates and benthic low-mobility macroinvertebrates. Approaches based on functional trait diversity have the potential to question and refine the theoretical frame of ecological restoration and to assist managers in their efforts to restore tidal wetlands.	[Lechene, Alain; Lobry, Jeremy; Boet, Philippe] Irstea, UR EABX, Ctr Bordeaux, 50 Ave Verdun, F-33612 Cestas, France; [Laffaille, Pascal] Univ Toulouse, EcoLab, INP, UPS,ENSAT, Castanet Tolosan, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Lechene, A (corresponding author), Irstea, UR EABX, Ctr Bordeaux, 50 Ave Verdun, F-33612 Cestas, France.	alain.lechene@irstea.fr		Lobry, Jeremy/0000-0002-4567-3714	Region Nouvelle-Aquitaine; General Council of Gironde; Adour-Garonne Water Agency; French Agency for Biodiversity	Region Nouvelle-Aquitaine(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); General Council of Gironde; Adour-Garonne Water Agency; French Agency for Biodiversity	The study was funded by the Region Nouvelle-Aquitaine, the General Council of Gironde, the Adour-Garonne Water Agency and the French Agency for Biodiversity. The General Council of Gironde provided technical assistance in field work on the Nouvelle island. Funders had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Aiba M, 2013, ECOLOGY, V94, P2873, DOI 10.1890/13-0269.1; Astor T, 2014, ECOL EVOL, V4, P2090, DOI 10.1002/ece3.1084; Bernard-Verdier M, 2012, J ECOL, V100, P1422, DOI 10.1111/1365-2745.12003; Bohnke M, 2014, J VEG SCI, V25, P897, DOI 10.1111/jvs.12114; Brancalion PHS, 2016, RESTOR ECOL, V24, P1, DOI 10.1111/rec.12312; Brandl SJ, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1557; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cattrijsse A, 2006, MAR ECOL PROG SER, V324, P293, DOI 10.3354/meps324293; Chalmandrier L, 2013, J VEG SCI, V24, P853, DOI 10.1111/jvs.12031; Chang Cynthia, 2016, F1000Res, V5; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Comte L, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1356; de Bello F, 2016, OECOLOGIA, V180, P933, DOI 10.1007/s00442-016-3546-0; de Bello F, 2012, GLOBAL ECOL BIOGEOGR, V21, P312, DOI 10.1111/j.1466-8238.2011.00682.x; Delpech C, 2010, MAR POLLUT BULL, V60, P908, DOI 10.1016/j.marpolbul.2010.01.001; Dionne M, 1998, AM FISH S S, V22, P384; Dolbeth M, 2016, MAR POLLUT BULL, V112, P244, DOI 10.1016/j.marpolbul.2016.08.011; Dumay O, 2004, J FISH BIOL, V64, P970, DOI 10.1111/j.1095-8649.2004.00365.x; Elliott M, 2011, ESTUAR COAST SHELF S, V94, P306, DOI 10.1016/j.ecss.2011.06.016; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Feunteun E., 1992, Revue des Sciences de l'Eau, V5, P509; Fitzgerald DB, 2017, ECOLOGY, V98, P21, DOI 10.1002/ecy.1616; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; GATZ AJ, 1979, ECOLOGY, V60, P711, DOI 10.2307/1936608; Goeldner-Gianella L., 2007, ANN GEOGR, V656, P339, DOI [DOI 10.3917/AG.656.0339, 10.3917/ag.656.0339]; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Green BC, 2009, ESTUAR COAST SHELF S, V85, P247, DOI 10.1016/j.ecss.2009.08.008; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; HARRINGTON RW, 1982, B MAR SCI, V32, P523; Hedberg P, 2013, APPL VEG SCI, V16, P658, DOI 10.1111/avsc.12042; Henriques S, 2017, J BIOGEOGR, V44, P627, DOI 10.1111/jbi.12824; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hobbs, 2008, SPRINGER SERIES ENV, P150; Kapsimalis V, 2004, J COASTAL RES, P1; KEAST A, 1966, J FISH RES BOARD CAN, V23, P1845, DOI 10.1139/f66-175; Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665; Kneib Ronald T., 1997, Oceanography and Marine Biology an Annual Review, V35, P163; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lafon V., 2014, 13 JOURN NAT GEN COT, P809, DOI [10.5150/jngcgc.2014.089, DOI 10.5150/JNGCGC.2014.089]; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lechene A, 2018, ESTUAR COAST SHELF S, V207, P368, DOI 10.1016/j.ecss.2017.08.038; Leitao RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0084; Leps J, 2006, PRESLIA, V78, P481; Levin LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P661; Lobry J., 2004, THESIS; MAHON R, 1984, CAN J FISH AQUAT SCI, V41, P330, DOI 10.1139/f84-037; Mason N.W.H., 2013, ENCY BIODIVERSITY, P597, DOI DOI 10.1016/B978-0-12-384719-5.00356-7; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mathieson S, 2000, MAR ECOL PROG SER, V204, P225, DOI 10.3354/meps204225; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Moreno-Valcarcel R, 2016, MAR ECOL PROG SER, V543, P209, DOI 10.3354/meps11578; Moreno-Valcarcel R, 2013, ESTUAR COAST SHELF S, V119, P54, DOI 10.1016/j.ecss.2012.12.012; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2007, ESTUAR COAST SHELF S, V71, P443, DOI 10.1016/j.ecss.2006.08.022; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Munsch SH, 2016, MAR ECOL PROG SER, V557, P1, DOI 10.3354/meps11862; Passos CVB, 2016, J FISH BIOL, V89, P847, DOI 10.1111/jfb.13029; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pecuchet L, 2016, MAR ECOL PROG SER, V546, P239, DOI 10.3354/meps11613; Persson L, 1998, ECOL STU AN, V131, P3; Piet GJ, 1998, ENVIRON BIOL FISH, V51, P67, DOI 10.1023/A:1007338532482; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Raevel V, 2012, OIKOS, V121, P1761, DOI 10.1111/j.1600-0706.2012.20261.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Raposa KB, 2003, ESTUARIES, V26, P98, DOI 10.1007/BF02691697; Roscher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101928; Russo T, 2007, J FISH BIOL, V71, P629, DOI 10.1111/j.1095-8649.2007.01528.x; Sagouis A, 2016, ECOLOGY FRESHWATER F; Salgado J, 2004, CAH BIOL MAR, V45, P213; Salgado JP, 2007, HYDROBIOLOGIA, V587, P225, DOI 10.1007/s10750-007-0685-7; Schleuter D, 2012, GLOBAL ECOL BIOGEOGR, V21, P1083, DOI 10.1111/j.1466-8238.2012.00763.x; Shaffer JA, 2018, ESTUAR COAST SHELF S, V213, P245, DOI 10.1016/j.ecss.2018.08.030; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Team RC, 2016, R A LANGUAGE AND ENV; Teichert N, 2017, ESTUAR COAST SHELF S, V188, P18, DOI 10.1016/j.ecss.2017.02.006; Telesh IV, 2010, MAR POLLUT BULL, V61, P149, DOI 10.1016/j.marpolbul.2010.02.008; Troia MJ, 2015, OECOLOGIA, V177, P545, DOI 10.1007/s00442-014-3178-1; van der Linden P, 2016, ECOL INDIC, V61, P378, DOI 10.1016/j.ecolind.2015.09.039; Villeger S., 2008, THESIS; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Warren RS, 2002, RESTOR ECOL, V10, P497, DOI 10.1046/j.1526-100X.2002.01031.x; White PS, 2001, PROG BOT, V62, P399; Wilfahrt PA, 2014, FOREST ECOL MANAG, V324, P179, DOI 10.1016/j.foreco.2014.01.018; Wilson JG, 2002, ESTUAR COAST SHELF S, V55, P953, DOI 10.1006/ecss.2002.1038; Wolters M, 2005, BIOL CONSERV, V123, P249, DOI 10.1016/j.biocon.2004.11.013; Zhang H, 2015, ECOGRAPHY, V38, P1176, DOI 10.1111/ecog.01123; Zhao T, 2014, ECOL EVOL, V4, P4649, DOI 10.1002/ece3.1260	102	6	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209025	10.1371/journal.pone.0209025	http://dx.doi.org/10.1371/journal.pone.0209025			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566467	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300066
J	Smolle, C; Sendlhofer, G; Sandner-Kiesling, A; Herbert, MK; Jantscher, L; Pichler, B; Kamolz, LP; Brunner, G				Smolle, Christian; Sendlhofer, Gerald; Sandner-Kiesling, Andreas; Herbert, Michael K.; Jantscher, Lydia; Pichler, Bernd; Kamolz, Lars-Peter; Brunner, Gernot			Implementation and maintenance of a pain management quality assurance program at intensive care units: 360 degree feedback of physicians, nurses and patients	PLOS ONE			English	Article							POSTOPERATIVE PAIN; IMPROVEMENT; ALGORITHM	Background Pain management quality assurance programs (PMQP) have been successfully implemented in numerous hospitals across Europe. We aimed to evaluate the medium-term sustainability of a PMQP implemented at intensive care units (ICUs). Methods Two surveys, the first in 2012, immediately after introduction of the PMQP, and the second in 2015, were carried out amongst patients, physicians and nurses. Demographic parameters of all participants were assessed. Patients were asked after their pain levels during ICU stay. Staff members answered a questionnaire regarding familiarity with standards and processes of PMQP and self-perception of their knowledge as well as contentment with interdisciplinary communication. Results In total (2012/2015), 267 (125/142) patients, 113 (65/48) physicians and 510 (264/246) members of the nursing staff participated. Minimum and maximum pain levels of patients did not differ between both surveys. Patients' tolerance of pain 24 hours before the survey was better (p = 0.023), and vomiting occurred less often (p = 0.037) in 2015. Physicians' and nurses' contentment with the own knowledge about pharmacological pain treatment had increased from 2012 to 2015 (p = 0.002 and 0.004). Satisfaction with communication between nurses and physicians was better in 2015 (p<0.001 and p = 0.002). Familiarity with PMQP standards and processes remained stable in both collectives. Conclusion The implementation of our PMQP achieved a high standard of care, guarantying a high patient and staff member satisfaction. Continuous education, ongoing training, regular updates and implementation of feedback-loops ensure continuity, in some parameters even an increase in knowledge and competencies. This is mirrored in high patient and staff member satisfaction.	[Smolle, Christian; Sendlhofer, Gerald; Kamolz, Lars-Peter; Brunner, Gernot] Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Res Unit Safety Hlth, Graz, Austria; [Smolle, Christian; Kamolz, Lars-Peter] Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria; [Sendlhofer, Gerald; Jantscher, Lydia; Pichler, Bernd] Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria; [Sandner-Kiesling, Andreas; Herbert, Michael K.] Med Univ Graz, Dept Anaesthesiol & Intens Care Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Sendlhofer, G (corresponding author), Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Res Unit Safety Hlth, Graz, Austria.; Sendlhofer, G (corresponding author), Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria.	gerald.sendlhofer@medunigraz.at		Sendlhofer, Gerald/0000-0002-6538-3116				Aguirre-Raya KA, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0681-6; Ament Stephanie M C, 2015, BMJ Open, V5, pe008073, DOI 10.1136/bmjopen-2015-008073; Andersson V, 2017, SCAND J PAIN, V15, P22, DOI 10.1016/j.sjpain.2016.11.006; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bohmer AB, 2012, SCHMERZ, V26, P425, DOI 10.1007/s00482-012-1205-x; Bohmer AB, 2012, SCHMERZ BERL GER, V26, P432; Cao XZ, 2017, J ANESTH, V31, P617, DOI 10.1007/s00540-017-2363-x; Cornet C, 2007, ANN FR ANESTH, V26, P292, DOI 10.1016/j.annfar.2006.12.008; Desbiens NA, 1996, CRIT CARE MED, V24, P1953, DOI 10.1097/00003246-199612000-00005; Diby M, 2008, J CRIT CARE, V23, P359, DOI 10.1016/j.jcrc.2007.11.005; Frykman M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-218; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Lehmkuhl D, 2011, SCHMERZ, V25, P508, DOI 10.1007/s00482-011-1054-z; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; Medrzycka-Dabrowska WA, 2016, ARCH MED SCI, V12, P808, DOI 10.5114/aoms.2015.54768; Olsen BF, 2015, HEART LUNG J CRIT CA, V42, P190; Olsen BF, 2016, J CRIT CARE, V36, P207, DOI 10.1016/j.jcrc.2016.07.011; Olsen BF, 2015, HEART LUNG, V44, P521, DOI 10.1016/j.hrtlng.2015.09.001; Sigakis MJG, 2015, CRIT CARE MED, V43, P2468, DOI 10.1097/CCM.0000000000001256; van Gulik L, 2017, PAIN RES MANAG, V2017, DOI 10.1155/2017/7187232; van Gulik L, 2010, EUR J ANAESTH, V27, P900, DOI 10.1097/EJA.0b013e32833d91c3; World Health Organization (WHO), WHOS CANC PAIN LADD; Wurm WE, 2015, FORTSCHR NEUROL PSYC, V83, P149, DOI 10.1055/s-0034-1399111	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208527	10.1371/journal.pone.0208527	http://dx.doi.org/10.1371/journal.pone.0208527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566446	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300046
J	Hong, T; Lin, H; He, DJ				Hong, Tao; Lin, Han; He, Dongjin			Characteristics and correlations of leaf stomata in different Aleurites montana provenances	PLOS ONE			English	Article							DENSITY; PHOTOSYNTHESIS; CONDUCTANCE; TRAITS; LEAVES; SIZE	Stomata are important indexes in studies of plant origin, evolution, and classification and are important organs in plant phylogenetic relationship studies. Nine Aleurites montana provenances were used in this study to examine stomatal density, stomatal area, stomatal perimeter, long axis length, and short axis length. The correlation and cluster analyses were conducted among the morphological parameters of the pores. The results showed that there were significant differences in different A. Montana provenances in terms of stomatal morphology parameters. The average stomatal density, stomatal area, stomatal perimeter, stomatal long axis length, and stomatal short axis length of each provenance was between 224.16-307.10 stomata/mm(2), 80.42-99.76 mu m, 36.39-41.32 mu m, 15.89-18.44 mu m, and 6.53-7.46 mu m, respectively, and the coefficient of variation was between 9.18%-20.15%, 17.57%-33.77%, 9.31%-18.79%, 9.71%-18.48%, and 10.26%-21.57%, respectively. Correlation analysis shows that there was a significant negative correlation between stomatal density and stomatal shape parameters (stomatal area, stomatal perimeter, stomatal long axis, stomatal short axis) and there was a significant positive correlation between stomatal parameters. There was no significant correlation between geographical environment factors and stomatal characteristics. There is a close relationship between stomatal morphology and stomatal conductance whereby dense small stomata can quickly adapt to changes in the environment; considering the characteristics A. montana stomata in terms of stomatal stability and ability to adapt to the environment, the Jianyang, Zhenghe, Fuding, Shaxian provenances were identified as being more suitable for planting at different sites. This study provides a theoretical basis for the genetic improvement and breeding of high quality A. montana provenances.	[Hong, Tao; Lin, Han; He, Dongjin] Fujian Agr & Forestry Univ, Forestry Coll, Fuzhou, Fujian, Peoples R China; [Hong, Tao] Fujian Yongan Forestry Grp Joint Stock CO LTD, Yongan, Fujian, Peoples R China	Fujian Agriculture & Forestry University	He, DJ (corresponding author), Fujian Agr & Forestry Univ, Forestry Coll, Fuzhou, Fujian, Peoples R China.	4231989@qq.com			National Key Research Project [2017YFD060130403]; Fujian Yongan Forestry (Group) Joint-Stock CO., LTD - National Key Research Project [2017YFD060130403]	National Key Research Project; Fujian Yongan Forestry (Group) Joint-Stock CO., LTD - National Key Research Project	This study was supported and funded by National Key Research Project (2017YFD060130403). Fujian Yongan Forestry (Group) Joint-Stock CO., LTD provided support in the form of salary for author Tao HONG during his post doctoral study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This study was supported and funded by National Key Research Project (2017YFD060130403). We thank Wei Wu for assistance with the experiments and Jian Li for valuable discussions. We are grateful to the reviewers for their insightful and constructive suggestions on the manuscript.	Alec JJ, 2002, PARAGUAYAN TUNG IMPO; Baruch Z, 2017, AUSTRAL ECOLOGY, V42, P1; Beghin T, 2010, ADV CONCEPTS INTELLI, V64, P345; Casson SA, 2010, CURR OPIN PLANT BIOL, V13, P90, DOI 10.1016/j.pbi.2009.08.005; Chen LQ, 2001, AM J BOT, V88, P1309, DOI 10.2307/3558342; Chen Wei-yue, 2014, Shengtaixue Zazhi, V33, P1839; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jia Chun-hong, 2015, Forest Research, V28, P844; Jiang RongBo, 2011, Journal of Northeast Forestry University, V39, P9; Li RunTang, 2004, Journal of Fruit Science, V21, P419; [林晗 Lin Han], 2013, [自然资源学报, Journal of Natural Resources], V28, P1328; [林晗 Lin Han], 2012, [热带作物学报, Chinese Journal of Tropical Crops], V33, P1937; Lin Han, 2012, Chinese Journal of Applied and Environmental Biology, V18, P539, DOI 10.3724/SP.J.1145.2012.00539; [林晗 Lin Han], 2012, [福建林学院学报, Journal of Fujian College of Forestry], V32, P102; Lin Han, 2012, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V41, P34; [刘静 Liu Jing], 2014, [电子显微学报, Journal of Chinese Electronic Microscopy Society], V33, P69; Martins GA, 2012, TREES-STRUCT FUNCT, V26, P571, DOI 10.1007/s00468-011-0620-4; Massonnet C, 2007, ANN BOT-LONDON, V100, P1347, DOI 10.1093/aob/mcm222; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; REICH PB, 1984, NEW PHYTOL, V98, P231, DOI 10.1111/j.1469-8137.1984.tb02733.x; Singh SK, 2011, J PHOTOCH PHOTOBIO B, V105, P40, DOI 10.1016/j.jphotobiol.2011.07.001; Taylor SH, 2012, NEW PHYTOL, V193, P387, DOI 10.1111/j.1469-8137.2011.03935.x; Tobin RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191396; Wen Shan-Na, 2017, Bulletin of Botanical Research, V37, P288, DOI 10.7525/j.issn.1673-5102.2017.02.018; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Yang ChuanYou, 1998, Journal of Shandong Agricultural University, V29, P8; Yi XL, 2008, NO FRUITS, V1, P4; Yin X.L., 2006, CHIN AGR SCI B, V22, P237, DOI DOI 10.3969/J.ISSN.1000-6850.2006.05.063; Zhu Li-li, 2016, Forest Research, V29, P162; Zhu Yan-hua, 2011, Yingyong Shengtai Xuebao, V22, P250	32	12	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208899	10.1371/journal.pone.0208899	http://dx.doi.org/10.1371/journal.pone.0208899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562378	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100028
J	Readhead, A; Chang, AH; Ghosh, JK; Sorvillo, F; Detels, R; Higashi, J				Readhead, Adam; Chang, Alicia H.; Ghosh, Jo Kay; Sorvillo, Frank; Detels, Roger; Higashi, Julie			Challenges and solutions to estimating tuberculosis disease incidence by country of birth in Los Angeles County	PLOS ONE			English	Article							FOREIGN-BORN PERSONS	Background Among U.S. residents, tuberculosis (TB) disease disproportionally affects non-U.S.-born persons and varies substantially by country of birth. Yet TB disease incidence rates by country of birth are not routinely reported despite these large, known health disparities. This is in part due to the technical challenges of using standard regression analysis with a communicable disease. Here, we estimate tuberculosis disease incidence rates by country of birth and demonstrate methods for overcoming these challenges using TB surveillance data from Los Angeles County which has more than 3.5 million non-U.S.-born residents. Methods Cross-sectional data on 5,447 cases of TB disease from Los Angeles County were combined with population estimates from the American Community Survey to calculate TB disease incidence rates for 2005 through 2011. Adjusted incidence rates were modelled using Poisson and negative binomial regressions. Bayesian models were used to account for the uncertainty in population estimates. Results The unadjusted incidence rate among non-U.S.-born persons was 15 per 100,000 person-years in contrast to the rate among U.S-born persons, 2 per 100,000. The unadjusted incidence rates were 44 and 12 per 100,000 person-years among persons born in the Philippines and Mexico, respectively. In adjusted analysis, persons born in the Philippines were 2.6 (95% CI: 2.3-3.1) times as likely to be reported as a TB case than persons born in Mexico. Bayesian models showed similar results. Conclusion This study confirms substantial disparities in TB disease by country of birth in Los Angeles County. Accounting for age, gender, years in residence and year of diagnosis, persons from the Philippines, Vietnam and several other countries had much higher rates of reported TB disease than other foreign countries. We demonstrated that incidence rates by country of birth can be estimated using available data despite technical challenges.	[Readhead, Adam; Sorvillo, Frank; Detels, Roger] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Chang, Alicia H.; Higashi, Julie] Los Angeles Cty Dept Publ Hlth, TB Control Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; Los Angeles County Department of Public Health	Readhead, A (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.	adamreadhead@ucla.edu	Chang, Alicia/GYA-2155-2022; Readhead, Adam/AAK-3511-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER; NIMH NIH HHS [P30 MH058107] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2017, POLICYLINK USC PROGR; [Anonymous], [No title captured]; Baker Brian J, 2014, Ann Am Thorac Soc, V11, P480, DOI 10.1513/AnnalsATS.201402-065OC; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; California Department of Public Health, 2017, REP TUB CAL 2016; Centers for Disease Control and Prevention (CDC), 2015, REP TUB US 2015; Centers for Disease Control and Prevention (CDC), EXT DRUG RES TUB XDR; Centers for Disease Control and Prevention (CDC), 2011, MORBIDITY MORTALITY; Centers for Disease Control and Prevention (CDC), 2009, REP VER CAS TUB RVCT; Centers for Disease Control and Prevention (CDC), 2017, REP TUB US 2016; Curtis AB, 2001, AM J PREV MED, V20, P108, DOI 10.1016/S0749-3797(00)00284-1; Department of Health and Human Services, NAT PARTN ACT END HL; Hilbe J.M., 2014, MODELING COUNT DATA; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; IPUMS USA, REPL WEIGHTS AM COMM; Lee JH, 2012, EPIDEMIOL INFECT, V140, P1087, DOI 10.1017/S095026881100166X; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; National Research Council, 2012, SMALL POP LARG EFF I; NIMBLE Development Team, 2017, NIMBLE R PACK PROGR; R Development Core Team, 2016, R LANG ENV STAT COMP; Ruggles Steven, 2015, INTEGRATED PUBLIC US; Scopilliti M., 2015, DEMOGRAPHIC ANAL 201; U.S. Census Bureau, 1992, US CENS 1990 SUMM GE; U.S. Census Bureau, 2018, AM COMM SURV 2010 AM; U. S. Census Bureau, 2015, AM COMM SURV 2015 AM; U.S. Census Bureau, 2018, US CENS 2010 PROF SE; U.S. Census Bureau, 2002, US CENS 2000 TABL P0; U.S. Census Bureau, 2009, COMP UND US AM COMM; U.S. Census Bureau, 2018, US CENS 2000 PROF SE; U.S. Census Bureau, AM COMM SURV TABL B0; United States Census Bureau, 2014, AM COMMUNITY SURVEY; WHO, 2017, GLOB TUB REP; Winston CA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-846; World Health Organization (WHO), 2015, TB DRUG RES TYP; Zuber PLF, 1996, TUBERCLE LUNG DIS, V77, P524, DOI 10.1016/S0962-8479(96)90050-7	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209051	10.1371/journal.pone.0209051	http://dx.doi.org/10.1371/journal.pone.0209051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562366	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100034
J	Borrajo, CI; Sanchez-Moreiras, AM; Reigosa, MJ				Borrajo, Celina, I; Sanchez-Moreiras, Adela M.; Reigosa, Manuel J.			Morpho-physiological responses of tall wheatgrass populations to different levels of water stress	PLOS ONE			English	Article							SALT TOLERANCE; PHYSIOLOGICAL-RESPONSES; CROP PLANTS; DROUGHT; FORAGE; RYEGRASS; FESCUE; VARIABILITY; RESISTANCE; EXPANSION	Tall wheatgrass [Elymus elongatus subsp. ponticus (Podp.) Melderis] is a perennial forage grass cultivated in dry, saline or alkaline environments. The morpho-physiological characteristics of four populations of tall wheatgrass from different climatic-edaphic origins were evaluated under three conditions of water stress (100%-50%-30% of field capacity). The trial was analyzed with three replicates and two-factor ANOVA in pots within the greenhouse during 35 days. Only dry matter and tiller number showed interaction between populations and water conditions. The most relevant changes in morpho-physiological parameters under strong water stress were reduced dry matter production (48-32% differing among populations), smaller leaf and tiller size (46% and 28%), together with higher water use efficiency (74%), and increased proline and protein contents (144% and 71%), smaller tiller number (30-11% differing among populations) and a slight decrease in leaf water content (3%). The populations differed in growth strategies and morpho-physiological mechanisms to survive water stress, which could be related to their habitat background. The study shows the stability in dry matter production under all levels of water stress, which can be related to the higher tiller number. Due to this plasticity, tall wheatgrass should be studied as a species with great potential to adapt to drought stress.	[Borrajo, Celina, I; Sanchez-Moreiras, Adela M.; Reigosa, Manuel J.] Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo, Pontevedra, Spain; [Borrajo, Celina, I] Natl Inst Agr Technol, Agr Expt Stn Cuenca Salado, Rauch, Buenos Aires, Argentina	Universidade de Vigo; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Borrajo, CI (corresponding author), Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo, Pontevedra, Spain.; Borrajo, CI (corresponding author), Natl Inst Agr Technol, Agr Expt Stn Cuenca Salado, Rauch, Buenos Aires, Argentina.	borrajo.celina@inta.gob.ar	Reigosa, Manuel J/K-3551-2013; Roger, Manuel Joaquín Reigosa/O-4438-2019; Sanchez-Moreiras, ADELA M/A-8222-2011	Reigosa, Manuel J/0000-0003-0527-1849; Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Sanchez-Moreiras, ADELA M/0000-0002-0771-9259	Department of Plant Biology and Soil Science, Faculty of Biology, University of Vigo	Department of Plant Biology and Soil Science, Faculty of Biology, University of Vigo	This work was financially supported by the Department of Plant Biology and Soil Science, Faculty of Biology, University of Vigo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S. I., 2007, AVANCES INVESTIGACIO, P9; BAL, ACT GERMPL BANK BALC; Borrajo C. I., 2004, Revista Argentina de Produccion Animal, V24, P29; Borrajo C. I., 1998, THESIS; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Ceoloni C., 2014, ADV GENOMICS PLANT G, P333, DOI DOI 10.1007/978-94-007-7575-6_14; Chapman D. F., 1993, P 17 INT GRASSL C PA, P95; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Cyriac D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194977; Durand JL, 1997, EUR J AGRON, V7, P99, DOI 10.1016/S1161-0301(97)00021-X; Fariaszewska A, 2017, J AGRON CROP SCI, V203, P103, DOI 10.1111/jac.12168; Gazanchian A, 2007, J EXP BOT, V58, P291, DOI 10.1093/jxb/erl226; Heckathorn SA, 1997, PHYSIOL PLANTARUM, V101, P173, DOI 10.1034/j.1399-3054.1997.1010123.x; Hessini K, 2009, ENVIRON EXP BOT, V67, P312, DOI 10.1016/j.envexpbot.2009.06.010; Hui DF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192555; JOHNSON RC, 1991, CROP SCI, V31, P730, DOI 10.2135/cropsci1991.0011183X003100030039x; Maddaloni J, 2001, FORRAJERAS PASTURAS; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; Mazzanti A, 1992, CARACTERISTICAS AGRO; MCGUIRE PE, 1981, CROP SCI, V21, P702, DOI 10.2135/cropsci1981.0011183X002100050018x; Melderis A, 1980, FLORA EUROPAEA, V5, P192; NEUMANN PM, 1995, CROP SCI, V35, P1258, DOI 10.2135/cropsci1995.0011183X003500050002x; Pagter M, 2005, AQUAT BOT, V81, P285, DOI 10.1016/j.aquabot.2005.01.002; Pedrol BN, HDB PLANT ECOPHYSIOL; Pedrol N, 2000, J PLANT PHYSIOL, V157, P383, DOI 10.1016/S0176-1617(00)80023-1; Rasband WS, 2016, IMAGEJ 1 50I PROGRAM; Rasmussen S, 2012, ANN BOT-LONDON, V110, P1281, DOI 10.1093/aob/mcs023; ROUNDY BA, 1985, AGRON J, V77, P129, DOI 10.2134/agronj1985.00021962007700010031x; SAS Intitute, 2002, SAS SYST WIND REL 9; SHANNON MC, 1978, AGRON J, V70, P719, DOI 10.2134/agronj1978.00021962007000050006x; Smith KF, 1996, NEW ZEAL J AGR RES, V39, P623, DOI 10.1080/00288233.1996.9513222; Soil Science Glossary Terms Committee, 2008, GLOSS SOIL SCI TERMS; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamayo PR, 2001, HANDBOOK OF PLANT ECOPHYSIOLOGY TECHNIQUES, P365; Thomas H, 1999, J EXP BOT, V50, P221, DOI 10.1093/jexbot/50.331.221; Turner LR, 2012, GRASS FORAGE SCI, V67, P507, DOI 10.1111/j.1365-2494.2012.00866.x; VANLOO EN, 1992, ANN BOT-LONDON, V70, P511, DOI 10.1093/oxfordjournals.aob.a088511; Vogel KP, 1998, CROP SCI, V38, P509, DOI 10.2135/cropsci1998.0011183X003800020039x; Zhang Y, 2006, CROP SCI, V46, P497, DOI 10.2135/cropsci2004.0572	42	11	13	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209281	10.1371/journal.pone.0209281	http://dx.doi.org/10.1371/journal.pone.0209281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557312	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000087
J	Silva, CR; Ribas, CC; Da Silva, MNF; Leite, RN; Catzeflis, F; Rogers, DS; De Thoisy, B				Silva, Claudia Regina; Ribas, Camila Cherem; Da Silva, Maria Nazareth F.; Leite, Rafael Nascimento; Catzeflis, Francois; Rogers, Duke S.; De Thoisy, Benoit			The role of Pleistocene climate change in the genetic variability, distribution and demography of Proechimys cuvieri and P-guyannensis (Rodentia: Echimyidae) in northeastern Amazonia	PLOS ONE			English	Article							SPINY RATS; MAXIMUM-LIKELIHOOD; MOLECULAR PHYLOGEOGRAPHY; POPULATION-GROWTH; GUIANA SHIELD; RAIN-FOREST; DIVERSIFICATION; MAMMALS; EVOLUTION; PATTERNS	The spiny rats, genus Proechimys, have the highest species richness within the Echimyidae family, as well as species with high genetic variability. The genus distribution includes tropical South America and Central America south to Honduras. In this study, we evaluate the phylogeographic histories of Proechimys guyannensis and P. cuvieri using cytochrome b, in a densely sampled area in northeastern Amazon where both species are found in sympatry in different environments. For each species, Bayesian and Maximum Likelihood phylogenetic analysis were congruent and recovered similar clades in the studied area. Bayesian phylogenetic analysis using a relaxed molecular clock showed that these clusters of haplotypes diversified during Pleistocene for both species. Apparently, the large rivers of the region did not act as barriers, as some clades include specimens collected from opposite banks of Oiapoque, Araguari and Jari rivers. Bayesian skyline plot analysis showed recent demographic expansion in both species. The Pleistocene climatic changes in concert with the geologic changes in the Amazon fan probably acted as drivers in the diversification that we detected in these two spiny rats. Proechimys cuvieri and P. guyannensis show genetic structure in the eastern part of the Guiana region. Greater genetic distances observed in P. guyannensis, associated with highly structured groups, suggest that more detailed studies of systematics and ecology should be directed to this species.	[Silva, Claudia Regina; Ribas, Camila Cherem; Leite, Rafael Nascimento] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil; [Silva, Claudia Regina] Inst Pesquisas Cient & Tecnol Estado Amapa IEPA, Lab Mamiferos, Macapa, AP, Brazil; [Ribas, Camila Cherem; Da Silva, Maria Nazareth F.] Inst Nacl de Pesquisas da Amazonia, Programa Coleco Cient Biol, Manaus, Amazonas, Brazil; [Catzeflis, Francois] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR 5554, Montpellier, France; [Rogers, Duke S.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [De Thoisy, Benoit] Inst Pasteur, Cayenne, French Guiana; [De Thoisy, Benoit] Assoc Kwata, Cayenne, French Guiana	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Brigham Young University	Silva, CR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil.; Silva, CR (corresponding author), Inst Pesquisas Cient & Tecnol Estado Amapa IEPA, Lab Mamiferos, Macapa, AP, Brazil.	crsilva.ap@gmail.com	Ribas, Camila C/H-1769-2014; Silva, Claudia/AAG-5898-2019	de thoisy, benoit/0000-0002-8420-5112; Silva, Claudia Regina/0000-0002-3280-0235; Ribas, Camila/0000-0002-9088-4828; Leite, Rafael/0000-0002-3945-1007	Fundacao de Amparo a Pesquisa do Estado do Amapa (FAPEAP) through the Guyamazon II research program [250203021/2014]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) through the Guyamazon II research program [250203021/2014]; Intitut de Recherche pour le Developpement (IRD) through the Guyamazon II research program [250203021/2014]; "Investissement d'Avenir" grant [ANR-10-LABX-25-01]; FAPEAP through the Thesis Funding Programme [250203052/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq [150069 / 2014-6, 457267 / 2014-3]	Fundacao de Amparo a Pesquisa do Estado do Amapa (FAPEAP) through the Guyamazon II research program; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) through the Guyamazon II research program; Intitut de Recherche pour le Developpement (IRD) through the Guyamazon II research program; "Investissement d'Avenir" grant(French National Research Agency (ANR)); FAPEAP through the Thesis Funding Programme(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank Fundacao de Amparo a Pesquisa do Estado do Amapa (FAPEAP), Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) and Intitut de Recherche pour le Developpement (IRD) for financial support through the Guyamazon II research program (Process 250203021/2014). The project benefited from the support of an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, Ref. ANR-10-LABX-25-01). We also thank FAPEAP for support through the Thesis Funding Programme (Process 250203052/2014). CRS thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a scholarship. RNL was supported by CNPq (150069 / 2014-6; 457267 / 2014-3).	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P436, DOI 10.1016/j.ympev.2014.09.004; Alvarez-Berrios NL, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/029501; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bonvicino Cibele R., 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P191; Bonvicino Cibele R., 2012, P259; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Bush MB, 2002, J PALEOLIMNOL, V27, P341, DOI 10.1023/A:1016059415848; Catzeflis F, 2000, MAMMALIA, V64, P209, DOI 10.1515/mamm.2000.64.2.209; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Conroy CJ, 2000, MOL ECOL, V9, P165, DOI 10.1046/j.1365-294x.2000.00846.x; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Granville J. J., 1982, BIOL DIVERSIFICATION, P159; DeSalle R, 2017, FRONT BIOSCI-LANDMRK, V22, P873, DOI 10.2741/4522; Dixon J.R., 1986, REPTILES UPPER AMAZO; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond JA., 2008, ATLAS UNIDADES CONSE; Eler ES, 2012, GENET MOL RES, V11, P830, DOI 10.4238/2012.April.3.5; Fabre PH, 2017, MOL BIOL EVOL, V34, P613, DOI 10.1093/molbev/msw261; Fabre PH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0266; Silva CEFE, 2012, GENET MOL BIOL, V35, P88, DOI 10.1590/S1415-47572012005000007; Faulkes CG, 1997, MOL ECOL, V6, P615, DOI 10.1046/j.1365-294X.1997.00227.x; Fouquet A, 2015, J TROP ECOL, V31, P361, DOI 10.1017/S0266467415000206; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Fu YX, 1997, GENETICS, V147, P915; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Gond V, 2009, ECOSYSTEMES FORESTIE, P461; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; Hammond DS, 2007, AMBIO, V36, P661, DOI 10.1579/0044-7447(2007)36[661:CACOAT]2.0.CO;2; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hung CM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2340; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; IBGE Instituto Brasileiro de Geografia e Estatistica, REA PLANT AR COLH QU; Lara MC, 1996, MOL PHYLOGENET EVOL, V5, P403, DOI 10.1006/mpev.1996.0035; Latrubesse EM, 2007, J S AM EARTH SCI, V23, P61, DOI 10.1016/j.jsames.2006.09.021; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Leite RN, 2013, ORG DIVERS EVOL, V13, P639, DOI 10.1007/s13127-013-0140-8; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim BK, 2005, P ACAD NAT SCI PHILA, V154, P71, DOI 10.1635/0097-3157(2004)154[0071:MOIF]2.0.CO;2; Machado T, 2005, GENET MOL BIOL, V28, P682, DOI 10.1590/S1415-47572005000500007; MAIA V, 1993, REV BRAS GENET, V16, P145; MALCOLM JR, 1992, J ZOOL, V227, P537, DOI 10.1111/j.1469-7998.1992.tb04414.x; MARTINS R., 2013, MAMMALIA, V74, P409, DOI [10.1515/mammalia-2012-0121, DOI 10.1515/MAMMALIA-2012-0121]; Matocq MD, 2000, EVOLUTION, V54, P1423; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Mustin K, 2017, NAT CONSERV-BULGARIA, P107, DOI 10.3897/natureconservation.22.13823; Nabholz B, 2007, MOL BIO EV, V25, P795; Patton JL, 1998, ENDLESS FORMS, P202; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Patton JL, 1899, MAMMALS S AM RODENTS, P2932; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Rambaut A., 2014, TRACER V1 6; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rocha RG, 2015, J HERED, V106, P593, DOI 10.1093/jhered/esv058; Rocha RG, 2014, ECOL EVOL, V4, P4598, DOI 10.1002/ece3.1336; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossetti DF, 2012, GEOMORPHOLOGY, V177, P74, DOI 10.1016/j.geomorph.2012.07.015; Santos D, 2012, UNIDADES CONSERVAC A; Soares-Filho Britaldo Silveira, 2005, Estud. av., V19, P137, DOI 10.1590/S0103-40142005000200008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiner C, 2000, BIOCHEM SYST ECOL, V28, P963, DOI 10.1016/S0305-1978(00)00021-1; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; Van Vuuren BJ, 2004, BIOL J LINN SOC, V81, P203, DOI 10.1111/j.1095-8312.2003.00278.x; Voss Robert S., 1996, Bulletin of the American Museum of Natural History, V230, P1; Voss RS, 2001, B AM MUS NAT HIST, P3; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Weksler M, 2001, J MAMMAL, V82, P109, DOI 10.1644/1545-1542(2001)082<0109:SOPRAP>2.0.CO;2; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2018, MOL BIOL EVOL, V35, P1550, DOI 10.1093/molbev/msy073	87	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0206660	10.1371/journal.pone.0206660	http://dx.doi.org/10.1371/journal.pone.0206660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557386	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000011
J	da Silva, PRA; Vidal, MS; Soares, CD; Polese, V; Tadra-Sfeir, MZ; de Souza, EM; Simoes-Araujo, JL; Baldani, JI				Alves da Silva, Paula Renata; Vidal, Marcia Soares; Soares, Cleiton de Paula; Polese, Valeria; Tadra-Sfeir, Michelle Zibetti; de Souza, Emanuel Maltempi; Simoes-Araujo, Jean Luiz; Baldani, Jose Ivo			Sugarcane apoplast fluid modulates the global transcriptional profile of the diazotrophic bacteria Paraburkholderia tropica strain Ppe8	PLOS ONE			English	Article							NITROGEN-FIXING ENDOPHYTE; PLANT-GROWTH-PROMOTION; C-DI-GMP; BIOFILM FORMATION; SP-NOV.; ACETOBACTER-DIAZOTROPHICUS; BURKHOLDERIA-TROPICA; COLONIZATION; AZOSPIRILLUM; PROTEIN	The stalk apoplast fluid of sugarcane contains different sugars, organic acids and amino acids that may supply the demand for carbohydrates by endophytic bacteria including diazotrophs P. tropica (syn. B. tropica) strain Ppe8, isolated from sugarcane, is part of the bacterial consortium recommended as inoculant to sugarcane. However, little information has been accumulated regarding this plant-bacterium interaction considering that it colonizes internal sugarcane tissues. Here, we made use of the RNA-Seq transcriptomic analysis to study the influence of sugarcane stalk apoplast fluid on Ppe8 gene expression. The bacterium was grown in JMV liquid medium (100 ml), divided equally and then supplemented with 50 ml of fresh JMV medium or 50 ml of apoplast fluid extracted from sugarcane variety RB867515. Total RNA was extracted 2 hours later, the rRNAs were depleted and mRNAs used to construct libraries to sequence the fragments using Ion Torrent technology. The mapping and statistical analysis were carried out with CLC Genomics Workbench software. The RNA-seq data was validated by RT-qPCR using the reference genes fliP1, paaF, and groL. The data analysis showed that 544 genes were repressed and 153 genes were induced in the presence of apoplast fluid. Genes that induce plant defense responses, genes related to chemotaxis and movements were repressed in the presence of apoplast fluid, indicating that strain Ppe8 recognizes the apoplast fluid as a plant component. The expression of genes involved in bacterial metabolism was regulated (up and down), suggesting that the metabolism of strain Ppe8 is modulated by the apoplast fluid. These results suggest that Ppe8 alters its gene expression pattern in the presence of apoplast fluid mainly in order to use compounds present in the fluid as well as to avoid the induction of plant defense mechanisms. This is a pioneer study showing the role played by the sugarcane apoplast fluid on the global modulation of genes in P. tropica strain Ppe8.	[Alves da Silva, Paula Renata; Soares, Cleiton de Paula; Polese, Valeria] UFRRJ, Dept Crop Sci, BR-465 Seropedica, RJ, Brazil; [Vidal, Marcia Soares; Simoes-Araujo, Jean Luiz; Baldani, Jose Ivo] Embrapa Agrobiol, Seropedica, RJ, Brazil; [Tadra-Sfeir, Michelle Zibetti; de Souza, Emanuel Maltempi] UFPR, Ctr Politecn, Dept Biochem & Mol Biol, Rua 15 Novembro, Curitiba, Parana, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Parana	Baldani, JI (corresponding author), Embrapa Agrobiol, Seropedica, RJ, Brazil.	ivo.baldani@embrapa.br		Baldani, Jose Ivo/0000-0002-5363-7123; Soares, Cleiton/0000-0002-4801-7691	Embrapa [02.13.08.006.00.03.001]; CAPES; CNPq [308818/2016-4, 306011/2017-4, 304750/2013-1]	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by a grant from Embrapa (02.13.08.006.00.03.001). Paula Renata Alves da Silva was supported by fellowship from CAPES, while Jose Ivo Baldani was supported by fellowship from CNPq (process no 306011/2017-4 and 304750/2013-1) and a bench fee from FAPERJ-CNE (E26/203.011/2016). Jean Luiz Simoes-Araujo also thanks CNPq (process no 308818/2016-4) for the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2004, J BACTERIOL, V186, P6186, DOI 10.1128/JB.186.18.6186-6197.2004; da Silva PRA, 2016, ANTON LEEUW INT J G, V109, P1493, DOI 10.1007/s10482-016-0751-0; Asis C. A. Jr., 2004, Philippine Journal of Crop Science, V29, P45; Asis JuCnior C., 2003, MICROBES ENVIRON, V18, P133, DOI [10.1264/jsme2.18.133, DOI 10.1264/JSME2.18.133]; Baldani JI, 2014, PLANT SOIL, V384, P413, DOI 10.1007/s11104-014-2186-6; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; Bashan Y, 2004, CAN J MICROBIOL, V50, P521, DOI 10.1139/W04-035; Bernabeu PR, 2015, SCI HORTIC-AMSTERDAM, V191, P113, DOI 10.1016/j.scienta.2015.05.014; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Cordeiro FA, 2013, J PROTEOME RES, V12, P1142, DOI 10.1021/pr300746j; Coutinho BG, 2015, MOL PLANT MICROBE IN, V28, P10, DOI 10.1094/MPMI-07-14-0225-R; da Silva LG, 2003, BRAZ J MICROBIOL, V34, P69, DOI 10.1590/S1517-83822003000500023; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; de Bernonville TD, 2014, FEMS MICROBIOL ECOL, V89, P527, DOI 10.1111/1574-6941.12345; de Souza ALSR, 2016, PLANT SOIL, V399, P257, DOI 10.1007/s11104-015-2672-5; de Souza AP, 2013, BIOENERG RES, V6, P564, DOI 10.1007/s12155-012-9268-1; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Dong Z, 1997, ANN BOT-LONDON, V80, P147, DOI 10.1006/anbo.1997.0426; DONG ZM, 1994, PLANT PHYSIOL, V105, P1139, DOI 10.1104/pp.105.4.1139; Edwards AN, 2011, FEMS MICROBIOL LETT, V314, P131, DOI 10.1111/j.1574-6968.2010.02156.x; Fuentes-Ramirez LE, 1999, FEMS MICROBIOL ECOL, V29, P117, DOI 10.1016/S0168-6496(98)00125-1; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez-Morales A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-257; Jacobs JM, 2013, MBIO, V4, DOI 10.1128/mBio.00875-13; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim S, 2014, GENE, V547, P77, DOI 10.1016/j.gene.2014.06.029; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Li JY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-31; Lu GT, 2007, MICROBIOL-SGM, V153, P737, DOI 10.1099/mic.0.2006/001388-0; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; McCully ME, 2001, AUST J PLANT PHYSIOL, V28, P983, DOI 10.1071/PP01101; Meneses CHSG, 2011, MOL PLANT MICROBE IN, V24, P1448, DOI 10.1094/MPMI-05-11-0127; Mott GA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00677; Nicolas MF, 2007, GENET MOL BIOL, V30, P202, DOI 10.1590/S1415-47572007000200006; Oren A, 2015, INT J SYST EVOL MICR, V65, P2013, DOI 10.1099/ijs.0.000189; Pechanova O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-674; Perin L, 2006, INT J SYST EVOL MICR, V56, P1931, DOI 10.1099/ijs.0.64362-0; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Reis VM, 2004, INT J SYST EVOL MICR, V54, P2155, DOI 10.1099/ijs.0.02879-0; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell MH, 2012, T DUNNE BOOKS, P1; Sant'Anna FH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-409; Sarkar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086527; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schultz N, 2012, PESQUI AGROPECU BRAS, V47, P261, DOI 10.1590/S0100-204X2012000200015; Sheibani-Tezerji R, 2015, MBIO, V6, DOI 10.1128/mBio.00621-15; Shidore T, 2012, ENVIRON MICROBIOL, V14, P2775, DOI 10.1111/j.1462-2920.2012.02777.x; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Steudle E, 1996, PLANT SOIL, V187, P67, DOI 10.1007/BF00011658; Tadra-Sfeir MZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00491; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tejera N, 2006, J PLANT PHYSIOL, V163, P80, DOI 10.1016/j.jplph.2005.03.010; Tejera N, 2005, PLANT SOIL, V270, P223, DOI 10.1007/s11104-004-1522-7; Tenorio-Salgado S, 2013, BIOENGINEERED, V4, P236, DOI 10.4161/bioe.23808; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xie SS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0353-4; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110	68	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207863	10.1371/journal.pone.0207863	http://dx.doi.org/10.1371/journal.pone.0207863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550601	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000010
J	Lee, HC; Ryu, HG; Kim, HJ; Park, Y; Yoon, SB; Yang, SM; Oh, HW; Jung, CW				Lee, Hyung-Chul; Ryu, Ho-Geol; Kim, Hyung-Jun; Park, Yoonsang; Yoon, Soo Bin; Yang, Seong Mi; Oh, Hye-Won; Jung, Chul-Woo			Excessive remifentanil during total intravenous anesthesia is associated with increased risk of pain after robotic thyroid surgery	PLOS ONE			English	Article							OPIOID-INDUCED HYPERALGESIA; POSTOPERATIVE PAIN; CARDIAC-SURGERY; TOLERANCE	The widespread use of remifentanil during total intravenous anesthesia (TIVA) has raised concerns about the risk of postoperative remifentanil-associated pain. Although a recent meta-analysis suggests that remifentanil-associated pain is unlikely to occur in patients with TIVA because of the protective effect of co-administered propofol, the evidence is not conclusive. We retrospectively assessed 635 patients who received robotic thyroid surgery under TIVA to evaluate the risk of remifentanil-associated pain. Postoperative pain was evaluated using 11-point numeric rating scale (NRS). Time dependent Cox proportional hazards regression analysis was used to determine the risk factors of treatment-requiring pain (NRS > 4) during the first 48 postoperative hours. Postoperative pain rapidly decreased, and treatment-requiring pain remained in 12.8% (81 out of 635) of patients at 48 hours postoperatively. After adjusting for the time-dependent analgesic consumption, intraoperative use of remifentanil > 0.2 mcg/kg/min was a positive predictor of postoperative pain with a hazard ratio of 1.296 (95% C.I., 1.014-1.656, P=0.039) during 48 hours after surgery. In conclusion, excessive use of remifentanil during TIVA was associated with increased risk of pain after robotic thyroid surgery. Prospective trials are required to confirm these results and determine whether decreasing remifentanil consumption below the threshold can reduce postoperative pain.	[Lee, Hyung-Chul; Ryu, Ho-Geol; Kim, Hyung-Jun; Park, Yoonsang; Yoon, Soo Bin; Yang, Seong Mi; Oh, Hye-Won; Jung, Chul-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Jung, CW (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.	jungcwoo@gmail.com	Lee, Hyung-chul/AAP-7101-2021; Lee, Hyung-Chul/U-1910-2019	Lee, Hyung-Chul/0000-0003-0048-7958; Park, Yoonsang/0000-0001-6200-2157; Oh, Hye-Won/0000-0001-9819-5915; Jung, Chul-Woo/0000-0001-7876-8659				Angst MS, 2015, J CARDIOTHOR VASC AN, V29, pS16, DOI 10.1053/j.jvca.2015.01.026; Barden J, 2004, LEAGUE TABLE ANALGES; Chai YJ, 2016, ANN SURG TREAT RES, V90, P239, DOI 10.4174/astr.2016.90.5.239; Deiner S, 2010, SEMIN CARDIOTHORAC V, V14, P51, DOI 10.1177/1089253210362792; Fletcher D, 2014, BRIT J ANAESTH, V112, P991, DOI 10.1093/bja/aeu137; HUGHES MA, 1992, ANESTHESIOLOGY, V76, P334, DOI 10.1097/00000542-199203000-00003; Jo HR, 2011, KOREAN J ANESTHESIOL, V60, P198, DOI [10.4097/kjae.2011.60.3.198, 10.4097/kjae.2011.61.2.166]; Kim SH, 2015, AM J THER, V22, pE62, DOI 10.1097/MJT.0000000000000019; Kim SY, 2010, SURG ENDOSC, V24, P2776, DOI 10.1007/s00464-010-1045-7; Koo CH, 2016, J CLIN ANESTH, V35, P47, DOI 10.1016/j.jclinane.2016.07.017; Larsen R, 1988, Anaesthesia, V43 Suppl, P25, DOI 10.1111/j.1365-2044.1988.tb09064.x; Lee KE, 2011, SURG LAPARO ENDO PER, V21, P230, DOI 10.1097/SLE.0b013e31822d0455; Leslie K, 2010, ANESTH ANALG, V110, P816, DOI 10.1213/ANE.0b013e3181c3bfb2; Minto CF, 1997, ANESTHESIOLOGY, V86, P24, DOI 10.1097/00000542-199701000-00005; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Rauf K, 2005, BRIT J ANAESTH, V95, P611, DOI 10.1093/bja/aei237; Richebe P, 2011, J CARDIOTHOR VASC AN, V25, P917, DOI 10.1053/j.jvca.2011.03.185; Rivosecchi RM, 2014, EXPERT OPIN DRUG SAF, V13, P587, DOI 10.1517/14740338.2014.902931; Shaheen PE, 2009, J PAIN SYMPTOM MANAG, V38, P409, DOI 10.1016/j.jpainsymman.2009.06.004; Shin SW, 2010, BRIT J ANAESTH, V105, P661, DOI 10.1093/bja/aeq257; Singler B, 2007, ANESTH ANALG, V104, P1397, DOI 10.1213/01.ane.0000261305.22324.f3; Yu EHY, 2016, ANAESTHESIA, V71, P1347, DOI 10.1111/anae.13602	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209078	10.1371/journal.pone.0209078	http://dx.doi.org/10.1371/journal.pone.0209078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550587	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000041
J	O'Keefe, D; Wilkinson, A; Aitken, C; Dietze, P				O'Keefe, Daniel; Wilkinson, Anna; Aitken, Campbell; Dietze, Paul			Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia	PLOS ONE			English	Article							INJECTION-DRUG USERS; EXCHANGE PROGRAMS; VENDING MACHINES; STERILE SYRINGES; HIV-INFECTION; ACCESS; PEOPLE; COHORT; RISK; ODDS	Distance to health services is known to be negatively associated with usage and needle and syringe programs (NSPs) for people who inject drugs (PWID) are no different. Australia has a mixture of NSP modalities (primary or secondary fixed-site NSPs), which may present unique barriers to access. In this study, we explore 1) the effect of distance to NSPs on individual-level needle and syringe coverage, and 2) differences in coverage dependent on NSP modality. Using data from 219 PWID in an ongoing cohort study in Melbourne, Australia, we measured the straight-line distance from participants' residence to their nearest primary or secondary fixed-site NSP. We analysed the relationship between geographical distance and coverage via regression analysis. The median distance to any type of NSP was 1872 metres. Regardless of service type, 52% of participants lived within 2 kms of a fixed-site NSP and 87% lived within 5 kms. We found no association between distance to NSPs and syringe coverage or a significant difference in coverage by nearest service type. Our findings suggest that the number and distribution of NSPs in Melbourne, Australia caters adequately for the population of PWID.	[O'Keefe, Daniel; Wilkinson, Anna; Aitken, Campbell; Dietze, Paul] Burnet Inst, Behav & Hlth Risks, Melbourne, Vic, Australia; [O'Keefe, Daniel; Wilkinson, Anna; Aitken, Campbell; Dietze, Paul] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Burnet Institute; Monash University	O'Keefe, D (corresponding author), Burnet Inst, Behav & Hlth Risks, Melbourne, Vic, Australia.; O'Keefe, D (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	daniel.okeefe@burnet.edu.au		Aitken, Campbell/0000-0002-0923-4837; , Daniel/0000-0001-6799-2372; Wilkinson, Anna/0000-0002-4475-5224; Dietze, Paul/0000-0001-7871-6234	Colonial Foundation Trust; National Health and Medical Research Council (NHMRC) [1126090]; NHMRC [1136908]; Burnet Institute	Colonial Foundation Trust; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Burnet Institute	The MIX study is supported by the Colonial Foundation Trust and the National Health and Medical Research Council (NHMRC Grant #1126090). PD is an NHMRC Senior Research Fellow (NHMRC#1136908). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program's support of the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Quader AS, 2013, AIDS BEHAV, V17, P2878, DOI 10.1007/s10461-013-0593-y; Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; Australian Federal Government Department of Health, POSSS NEDDL SYR 2018; Bluthenthal RN, 2007, DRUG ALCOHOL DEPEN, V89, P214, DOI 10.1016/j.drugalcdep.2006.12.035; Bluthenthal RN, 2004, ADDICTION, V99, P1136, DOI 10.1111/j.1360-0443.2004.00694.x; Brener L, 2017, HLTH PSYCHOL OPEN, V4; Bryant J, 2012, AIDS BEHAV, V16, P1156, DOI 10.1007/s10461-011-0010-3; Cooper H, 2012, J URBAN HEALTH, V89, P678, DOI 10.1007/s11524-012-9673-y; Cooper HLF, 2011, AM J PUBLIC HEALTH, V101, P1118, DOI 10.2105/AJPH.2009.184580; Cooper HLF, 2009, J URBAN HEALTH, V86, P929, DOI 10.1007/s11524-009-9399-7; Day Carolyn, 2006, Aust J Rural Health, V14, P120, DOI 10.1111/j.1440-1584.2006.00775.x; Fisher K, 2017, AUST J RURAL HEALTH, V25, P94, DOI 10.1111/ajr.12304; Gindi RM, 2009, DRUG ALCOHOL DEPEN, V103, P93, DOI 10.1016/j.drugalcdep.2008.12.018; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Hammett TM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-261; Horyniak D, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-11; Institute Kirby, 2017, AUSTR NSP SURV PREV; Islam MM, 2008, INT J DRUG POLICY, V19, P436, DOI 10.1016/j.drugpo.2007.07.006; Iversen J., 2017, NEEDLE SYRINGE PROGR; Iversen J, 2012, DRUG ALCOHOL DEPEN, V122, P195, DOI 10.1016/j.drugalcdep.2011.09.030; Karlsson A, 2018, ILLICIT DRUG REPORTI; Klein A, 2007, STICKING POINTS BARR; MacDonald M., 2003, International Journal of Drug Policy, V14, P353, DOI 10.1016/S0955-3959(03)00133-6; Marshall BDL, 2011, AIDS BEHAV, V15, P1546, DOI 10.1007/s10461-010-9876-8; McCormack AR, 2016, AM J EPIDEMIOL, V183, P852, DOI 10.1093/aje/kwv259; Moatti JP, 2001, EUR ADDICT RES, V7, P40, DOI 10.1159/000050713; O'Keefe D, 2017, DRUG ALCOHOL DEPEN, V176, P7, DOI 10.1016/j.drugalcdep.2017.02.013; O'Keefe D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1668-z; Rockwell R, 1999, AIDS CARE, V11, P437, DOI 10.1080/09540129947811; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Scott N, 2016, DRUG ALCOHOL DEPEN, V168, P140, DOI 10.1016/j.drugalcdep.2016.08.638; Scott N, 2015, ADDICTION, V110, P120, DOI 10.1111/add.12740; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Sharma M, 2007, INT J DRUG POLICY, V18, P92, DOI 10.1016/j.drugpo.2006.11.012; Stafford J, 2016, ILLICIT DRUG REPORTI; Strathdee SA, 2001, AIDSCIENCE, V1; Treloar C, 2005, INT J DRUG POLICY, V16, P308, DOI 10.1016/j.drugpo.2005.06.005; Treloar C, 2015, DRUG-EDUC PREV POLIC, V22, P437, DOI 10.3109/09687637.2015.1057553; Victorian State Government Data.vic, DAT VIC VICM ADM 201; Victorian State Government Department of Health, NEEDL SYR PROGR 2018; Victorian State Government Department of Health, DEP HLTH REG BOUND L; Wodak A, 2006, SUBST USE MISUSE, V41, P777, DOI 10.1080/10826080600669579; Zamani S, 2010, AIDS BEHAV, V14, P885, DOI 10.1007/s10461-008-9404-2	43	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209280	10.1371/journal.pone.0209280	http://dx.doi.org/10.1371/journal.pone.0209280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IQ	30550588	Green Submitted, gold, Green Published			2022-12-26	WOS:000453248000054
J	Fang, JD; Tung, HH; Lee, SL				Fang, Jung-Da; Tung, Hsiu-Hui; Lee, Sheau-Ling			Mitochondrial localization of St14-encoding transmembrane serine protease is involved in neural stem/progenitor cell bioenergetics through binding to F0F1-ATP synthase complex	FASEB JOURNAL			English	Article						ETC complex; oxygen consumption; reserve capacity; membrane potential; mitochondria	HEPATOCYTE GROWTH-FACTOR; ATP SYNTHASE; ACTIVATION; MATRIPTASE; SURFACE; MET	Knockdown of the suppression of tumorigenicity 14-encoding type II transmembrane serine protease matriptase (MTP) in neural stem/progenitor (NS/P) cells impairs cell mobility, response to chemo-attractants, and neurovascular niche interaction. In the present study, we showed by Western blot that a portion of MTP can be detected in the mitochondrial fraction of mouse NS/P cells by immunostaining that it is co-stained with the mitochondrial dye MitoTracker (Thermo Fisher Scientific, Waltham, MA, USA) inside the cells. Co-immunoprecipitation showed that MTP is bound to the subunit of mitochondrial F0F1-ATP synthase complex (ATP-). Cyto-immunofluorescence staining and an in situ proximity ligation assay further confirmed a physical interaction between MTP and ATP-. This interaction relied on the presence of both Cls/Clr urchin embryonic growth factor, bone morphogenic protein 1 and low-density lipoprotein receptor motifs of MTP. We found that NS/P cell mitochondrial membrane potential is impaired by MTP knockdown, and ATP synthesis and oxygen consumption rate are significantly reduced in MTP-knockdown NS/P cells. Among the oxidative phosphorylation functions, the greatest effect of MTP knockdown is the reduction by over 50% in the mitochondrial energy reserve capacity. This made MTP-knockdown NS/P cells unable to overcome hydrogen peroxide stress, which leads to cessation of cell growth. This work identifies 2 previously unknown functions for MTP: first as a binding protein in the mitochondrial F1F0-ATP synthase complex and second as a regulatory mechanism of mitochondrial bioenergetics. Mitochondrial MTP may serve a protective function for NS/P cells in response to stress.Fang, J.-D., Tung, H.-H., Lee, S.-L. Mitochondrial localization of St14-encoding transmembrane serine protease is involved in neural stem/progenitor cell bioenergetics through binding to F0F1-ATP synthase complex.	[Fang, Jung-Da; Tung, Hsiu-Hui; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes Grants [06A1-CSPP10-014, 05A1-CSPP10-014]; National Health Research Institutes; Central Government Science and Technology Grant [NP106-SP-06]	National Health Research Institutes Grants; National Health Research Institutes(National Health Research Institutes, Japan); Central Government Science and Technology Grant	This work was supported by National Health Research Institutes Grants 06A1-CSPP10-014 and 05A1-CSPP10-014, and National Health Research Institutes and Central Government Science and Technology Grant NP106-SP-06 (to S.-L.L.). The authors declare no conflicts of interest.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Chen CY, 2016, J DERMATOL SCI, V83, P34, DOI 10.1016/j.jdermsci.2016.03.006; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Fang JD, 2014, BBA-MOL CELL RES, V1843, P1285, DOI 10.1016/j.bbamcr.2014.03.020; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Lee D, 2011, BIOCHEM BIOPH RES CO, V405, P644, DOI 10.1016/j.bbrc.2011.01.084; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Maniam S, 2015, CELL DEATH DIFFER, V22, P156, DOI 10.1038/cdd.2014.135; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Tung HH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05131-4; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Zoratti GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7776	33	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4327	4340		10.1096/fj.201801307R	http://dx.doi.org/10.1096/fj.201801307R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566397				2022-12-26	WOS:000459794800098
J	Chinnakkannu, P; Reese, C; Gaspar, JA; Panneerselvam, S; Pleasant-Jenkins, D; Mukherjee, R; Baicu, C; Tourkina, E; Hoffman, S; Kuppuswamy, D				Chinnakkannu, Panneerselvam; Reese, Charles; Gaspar, John Antony; Panneerselvam, Saraswathi; Pleasant-Jenkins, Dorea; Mukherjee, Rupak; Baicu, Catalin; Tourkina, Elena; Hoffman, Stanley; Kuppuswamy, Dhandapani			Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; INDUCED CARDIAC-HYPERTROPHY; FIBROBLAST PRECURSORS; SYSTEMIC-SCLEROSIS; MOUSE MODEL; FIBROSIS; EXPRESSION; COLLAGEN; KINASE; MICE	Dysregulation of the renin-angiotensin system leads to systemic hypertension and maladaptive fibrosis in various organs. We showed recently that myocardial fibrosis and the loss of cardiac function in mice with transverse aortic constriction (TAC) could be averted by treatment with the caveolin-1 scaffolding domain (CSD) peptide. Here, we used angiotensin II (AngII) infusion (2.1 mg/kg/day for 2 wk) in mice as a second model to confirm and extend our observations on the beneficial effects of CSD on heart and kidney disease. AngII caused cardiac hypertrophy (increased heart weight to body weight ratio (HW/BW) and cardiomyocyte cross-sectional area); fibrosis in heart and kidney (increased levels of collagen I and heat shock protein-47 (HSP47)); and vascular leakage (increased levels of IgG in heart and kidney). Echocardiograms of AngII-infused mice showed increased left ventricular posterior wall thickness (pWTh) and isovolumic relaxation time (IVRT), and decreased ejection fraction (EF), stroke volume (SV), and cardiac output (CO). CSD treatment (i. p. injections, 50 mu g/mouse/day) of AngII-infused mice significantly suppressed all of these pathological changes in fibrosis, hypertrophy, vascular leakage, and ventricular function. AngII infusion increased beta 1 and beta 3 integrin levels and activated Pyk2 in both heart and kidney. These changes were also suppressed by CSD. Finally, bone marrow cell (BMC) isolated from AngII-infused mice showed hyper-migration toward SDF1. When AngII-infused mice were treated with CSD, BMC migration was reduced to the basal level observed in cells from control mice. Importantly, CSD did not affect the AngII-induced increase in blood pressure (BP), indicating that the beneficial effects of CSD were not mediated via normalization of BP. These results strongly indicate that CSD suppresses AngII-induced pathological changes in mice, suggesting that CSD can be developed as a treatment for patients with hypertension and pressure overloadinduced heart failure.	[Chinnakkannu, Panneerselvam; Panneerselvam, Saraswathi; Baicu, Catalin; Kuppuswamy, Dhandapani] Med Univ South Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Reese, Charles; Tourkina, Elena; Hoffman, Stanley] Med Univ South Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Gaspar, John Antony] Ananda Coll, Res Ctr, Devakottai, Tamil Nadu, India; [Pleasant-Jenkins, Dorea] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Mukherjee, Rupak] Med Univ South Carolina, Dept Surg, Div Cardiothorac Surg, Charleston, SC 29425 USA; [Gaspar, John Antony] RC Diocese Charleston, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Kuppuswamy, D (corresponding author), Med Univ South Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	kuppusd@musc.edu		Jenkins, Dorea/0000-0001-9510-8601	MUSC College of Medicine Enhancement of Team Science (COMETS); Lung Therapeutics, Inc.; NIH predoctoral fellowship [T32HL007260, T32DK083262, T32DE017551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE017551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083262] Funding Source: NIH RePORTER	MUSC College of Medicine Enhancement of Team Science (COMETS); Lung Therapeutics, Inc.; NIH predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the MUSC College of Medicine Enhancement of Team Science (COMETS) grant to Stanley Hoffman and Dhandapani Kuppuswamy, a Sponsored Research Agreement from Lung Therapeutics, Inc., to Stanley Hoffman, NIH predoctoral fellowship (T32HL007260) to Charles Reese, and NIH postdoctoral fellowships (T32DK083262 and T32DE017551) to Dorea Pleasant-Jenkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Balasubramanian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140273; Balasubramanian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045076; Bian ZY, 2012, J MOL MED, V90, P895, DOI 10.1007/s00109-012-0883-2; Biernacka A, 2011, AGING DIS, V2, P158; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chidlow JH, 2009, GASTROENTEROLOGY, V136, P575, DOI 10.1053/j.gastro.2008.10.085; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; Cieslik KA, 2015, FASEB J, V29, P3160, DOI 10.1096/fj.14-268136; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Del Gaido F, 2008, ARTHRITIS RHEUM-US, V58, P2854, DOI 10.1002/art.23791; Forrester SJ, 2017, HYPERTENSION, V69, P79, DOI 10.1161/HYPERTENSIONAHA.116.08278; Foulquier S, 2018, HYPERTENS RES, V41, P817, DOI 10.1038/s41440-018-0090-9; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; Gradman Alan H, 2009, Curr Cardiol Rep, V11, P422; Graf K, 2000, HYPERTENSION, V35, P978, DOI 10.1161/01.HYP.35.4.978; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hall JE, 2003, MOL BIOTECHNOL, V24, P27, DOI 10.1385/MB:24:1:27; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Honjo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131731; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Keeley EC, 2012, J HYPERTENS, V30, P1856, DOI 10.1097/HJH.0b013e32835639bb; Keeley EC, 2009, THROMB HAEMOSTASIS, V101, P613, DOI 10.1160/TH08-11-0726; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee R, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0028-7; Lee R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00140; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li QX, 2009, BASIC RES CARDIOL, V104, P269, DOI 10.1007/s00395-008-0754-8; Li XC, 2014, AM J PHYSIOL-RENAL, V307, pF949, DOI 10.1152/ajprenal.00199.2014; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Loot AE, 2009, J EXP MED, V206, P2889, DOI 10.1084/jem.20090449; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Mattsson CL, 2010, BBA-MOL CELL RES, V1803, P983, DOI 10.1016/j.bbamcr.2010.03.015; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Miyasato SK, 2011, MATRIX BIOL, V30, P318, DOI 10.1016/j.matbio.2011.05.003; Moore-Morris T, 2016, J MOL CELL CARDIOL, V91, P1, DOI 10.1016/j.yjmcc.2015.12.031; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z; Peng HM, 2015, HYPERTENSION, V66, P582, DOI 10.1161/HYPERTENSIONAHA.115.05627; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pleasant-Jenkins D, 2017, LAB INVEST, V97, P370, DOI 10.1038/labinvest.2016.153; Poobalarahi F, 2006, AM J PHYSIOL-HEART C, V291, pH2924, DOI 10.1152/ajpheart.00153.2006; REDDY HK, 1995, J LAB CLIN MED, V126, P307; Reese C, 2014, ARTHRITIS RHEUMATOL, V66, P1909, DOI 10.1002/art.38572; Regan JA, 2015, AM J PHYSIOL-HEART C, V309, pH771, DOI 10.1152/ajpheart.00282.2015; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Savoia C, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/281240; Schnee JM, 2000, CARDIOVASC RES, V46, P264, DOI 10.1016/S0008-6363(00)00044-4; Shimojo N, 2015, HYPERTENSION, V66, P757, DOI 10.1161/HYPERTENSIONAHA.115.06004; Shivshankar P, 2014, J MOL CELL CARDIOL, V76, P84, DOI 10.1016/j.yjmcc.2014.07.020; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Tourkina E, 2005, J BIOL CHEM, V280, P13879, DOI 10.1074/jbc.M412551200; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Tourkina E, 2010, ANN RHEUM DIS, V69, P1220, DOI 10.1136/ard.2009.117580; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Van Amerongen MJ, 2008, J PATHOL, V214, P377, DOI 10.1002/path.2281; VARAGIC J, 2014, CURR HYPERTENS REP, V16; Wang L, 2018, EUR HEART J, V39, P1818, DOI 10.1093/eurheartj/ehy085; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Xu J, 2011, AM J PHYSIOL-HEART C, V301, pH538, DOI 10.1152/ajpheart.01114.2010; Xu Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep44911; Yamaguchi Y, 2011, J CELL MOL MED, V15, P957, DOI 10.1111/j.1582-4934.2010.01063.x; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou MS, 2004, SEMIN NEPHROL, V24, P366, DOI 10.1016/j.semnephrol.2004.04.008; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	78	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0207844	10.1371/journal.pone.0207844	http://dx.doi.org/10.1371/journal.pone.0207844			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576317	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400007
J	Perret, M				Perret, Martine			Revisiting the Trivers-Willard theory on birth sex ratio bias: Role of paternal condition in a Malagasy primate	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LEMURS MICROCEBUS-MURINUS; GREY MOUSE LEMURS; TESTICULAR FUNCTION; FACULTATIVE ADJUSTMENT; PHTHALATE METABOLITES; REPRODUCTIVE FUNCTION; SPERM COMPETITION; MATE CHOICE; DECLINE	Within current theories on potential adaptive manipulation of offspring sex ratio, giving birth to a male or to a female is assumed to depend on the capacity of the mother to invest in offspring to maximize her fitness. The active role of the father in sex ratio bias at birth has been neglected until recently. The human sex ratio at birth is biased towards sons, although in occidental populations, the ratio has decreased regularly for 30 years and could be the consequence of the adverse effects of environmental chemicals on male hormones. In a Malagasy primate, the lesser mouse lemur, the potential effect of paternal testosterone levels on sex ratio bias at birth was tested on 130 litters (278 babies) produced in 52 mixed-sex groups. For each group, social dominance among males was characterized based on aggressive interactions and sexual behaviours. Using a multi correspondence analysis, high testosterone levels in grouped males, particularly those of the dominant male, were significantly correlated with more infants produced in male-biased litters, independent of the female condition. According to these results, predictions for sex ratio bias towards one sex or the other in mouse lemurs were discussed considering the influence of both parents.	[Perret, Martine] MNHN, CNRS, UMR Mecadev 7179, Dept Adaptat Vivant, Brunoy, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Perret, M (corresponding author), MNHN, CNRS, UMR Mecadev 7179, Dept Adaptat Vivant, Brunoy, France.	martine.perret@mnhn.fr			UMR CNRS-MNHN 7179	UMR CNRS-MNHN 7179	UMR CNRS-MNHN 7179 supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2003, FOLIA PRIMATOL, V74, P355, DOI 10.1159/000073319; Andres M, 2001, BEHAVIOUR, V138, P1047, DOI 10.1163/156853901753286560; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Bae J, 2015, ANIM BEHAV, V83, P301, DOI [10.1016/j.anbehav.2011.10.031, DOI 10.1016/J.ANBEHAV.2011.10.031]; Bae J, 2017, ASIAN J ANDROL, V19, P374, DOI 10.4103/1008-682X.173445; Bae J, 2016, SCI TOTAL ENVIRON, V543, P28, DOI 10.1016/j.scitotenv.2015.11.019; Ben Slima A, 2017, HUM EXP TOXICOL, V36, P218, DOI 10.1177/0960327116646617; Brown GR, 2002, P NATL ACAD SCI USA, V99, P11252, DOI 10.1073/pnas.162360599; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano R, 2006, HUM REPROD, V21, P3127, DOI 10.1093/humrep/del283; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Chang WH, 2015, HUM REPROD, V30, P2658, DOI 10.1093/humrep/dev225; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Craul M, 2004, PRIMATES, V45, P271, DOI 10.1007/s10329-004-0097-5; Den Hond E, 2015, ENVIRON INT, V84, P154, DOI 10.1016/j.envint.2015.07.017; Dupont P, 2015, OECOLOGIA, V179, P753, DOI 10.1007/s00442-015-3375-6; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P77, DOI 10.1007/s00265-004-0826-1; Eberle M, 2007, INT J PRIMATOL, V28, P1267, DOI 10.1007/s10764-007-9220-y; Figa-Talamanca I, 2003, G Ital Med Lav Ergon, V25 Suppl, P52; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Gomez D, 2012, AM J PHYS ANTHROPOL, V147, P370, DOI 10.1002/ajpa.21653; Grant VJ, 2009, J THEOR BIOL, V258, P38, DOI 10.1016/j.jtbi.2009.01.013; Grech V, 2003, J EPIDEMIOL COMMUN H, V57, P612, DOI 10.1136/jech.57.8.612; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; HIRAIWAHASEGAWA M, 1993, TRENDS ECOL EVOL, V8, P395, DOI 10.1016/0169-5347(93)90040-V; Huchard E, 2012, P ROY SOC B-BIOL SCI, V279, P1371, DOI 10.1098/rspb.2011.1326; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; James WH, 2015, EARLY HUM DEV, V91, P795, DOI 10.1016/j.earlhumdev.2015.10.004; James WH, 2013, J THEOR BIOL, V334, P141, DOI 10.1016/j.jtbi.2013.06.023; James WH, 2011, J BIOSOC SCI, V43, P167, DOI 10.1017/S0021932010000660; Joensen UN, 2012, ENVIRON HEALTH PERSP, V120, P1397, DOI 10.1289/ehp.1205113; Johnson CN, 2001, P ROY SOC B-BIOL SCI, V268, P2001, DOI 10.1098/rspb.2001.1723; JOHNSON CN, 1988, NATURE, V332, P726, DOI 10.1038/332726a0; Jorgensen N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000990; Jurewicz J, 2016, ENVIRON POLLUT, V213, P732, DOI 10.1016/j.envpol.2016.02.008; Kanninen O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158943; Knez J, 2013, REPROD BIOMED ONLINE, V26, P440, DOI 10.1016/j.rbmo.2013.02.005; Le Tallec T, 2016, J MAMMAL, V97, P753, DOI 10.1093/jmammal/gyw003; Lea RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep31281; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Lutermann H, 2006, P ROY SOC B-BIOL SCI, V273, P2527, DOI 10.1098/rspb.2006.3603; Majolo B, 2012, AM J PHYS ANTHROPOL, V147, P652, DOI 10.1002/ajpa.22031; Monclus R, 2012, J ANIM ECOL, V81, P80, DOI 10.1111/j.1365-2656.2011.01888.x; Nordkap L, 2016, FERTIL STERIL, V105, P174, DOI 10.1016/j.fertnstert.2015.09.016; Packer C, 2000, PHILOS T ROY SOC B, V355, P1627, DOI 10.1098/rstb.2000.0725; Pan YT, 2015, J HAZARD MATER, V300, P729, DOI 10.1016/j.jhazmat.2015.08.011; Parazzini F, 1998, HUM REPROD, V13, P1394, DOI 10.1093/humrep/13.5.1394; Perret M, 2005, HUM REPROD, V20, P1504, DOI 10.1093/humrep/deh802; Perret M, 2001, INT J PRIMATOL, V22, P5, DOI 10.1023/A:1026457813626; PERRET M, 1992, FOLIA PRIMATOL, V59, P1; PERRET M, 1990, BEHAV ECOL SOCIOBIOL, V27, P447, DOI 10.1007/BF00164072; Perret M, 1996, BEHAV ECOL SOCIOBIOL, V38, P259, DOI 10.1007/s002650050241; Radespiel L, 2003, ANIM BEHAV, V65, P709, DOI 10.1006/anbe.2003.2121; Radespiel U, 2002, ANIM BEHAV, V63, P259, DOI 10.1006/anbe.2001.1924; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Schindler S, 2015, NATURE, V526, P249, DOI 10.1038/nature14968; Schino G, 2004, BEHAV ECOL, V15, P850, DOI 10.1093/beheco/arh094; Schnettler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057446; Setchell JM, 2015, PHYSIOL BEHAV, V147, P245, DOI 10.1016/j.physbeh.2015.04.051; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VANSCHAIK CP, 1991, AM NAT, V138, P1552; Wang YX, 2016, ENVIRON POLLUT, V211, P173, DOI 10.1016/j.envpol.2015.12.052; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	68	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209640	10.1371/journal.pone.0209640	http://dx.doi.org/10.1371/journal.pone.0209640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576370	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400068
J	Yoon, A; Im, S; Lee, J; Park, D; Jo, DH; Kim, JH; Kim, JH; Park, WJ				Yoon, Aeri; Im, Sora; Lee, Juyeon; Park, Daeho; Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun; Park, Woo Jin			The matricellular protein CCN5 inhibits fibrotic deformation of retinal pigment epithelium	PLOS ONE			English	Article							GROWTH-FACTOR; SUBRETINAL FLUID; CELLS; WISP-2/CCN5; PHENOTYPE; CANCER; RPE	Retinal pigment epithelium (RPE) plays an essential role in maintaining retinal function, and its defect is thought to be critically implicated in various ocular disorders. This study demonstrated that the matricellular protein CCN5 was down-regulated in ARPE-19 cells treated with the pro-fibrotic agent transforming growth factor (TGF)-beta. A recombinant adenovirus expressing CCN5 (AdCCN5) was used to restore the level of CCN5 in these cells. AdCCN5 prevented TGF-beta-induced fibrotic changes, including disruption of tight junctions, up-regulation of mesenchymal marker proteins, and down-regulation of epithelial marker proteins. In addition, AdCCN5 prevented TGF-beta-induced functional defects, including increased migratory activity and reduced phagocytic activity. Notably, AdCCN5 reversed morphological and functional defects pre-established by TGF-beta prior to viral infection. The CCN5 level was down-regulated in RPE of 18-month-old Ccl2(-/)(-) mice, which exhibited retinal defects. Restoration of the CCN5 level via intravitreal injection of a recombinant adeno-associated virus expressing CCN5 (AAV9-CCN5) normalized the altered expression of mesenchymal, epithelial, and functional marker proteins, as assessed by western blotting and immunohistochemistry. Taken together, these data suggest that down-regulation of CCN5 is associated with fibrotic deformation of RPE under pathological conditions and that restoration of the CCN5 level effectively promotes recovery of deformed RPE.	[Yoon, Aeri; Im, Sora; Lee, Juyeon; Park, Daeho; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Biomed Res Inst, Fight Angiogenesis Related Blindness Lab, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.	woojinpark@icloud.com	Jo, Dong Hyun/D-5962-2012	Jo, Dong Hyun/0000-0002-6320-6829; Kim, Jeong Hun/0000-0003-2957-1766; Lee, Juyeon/0000-0001-7149-9767	Bio & Medical Technology Development Program of the National Research Foundation [NRF-2015M3A9E6028951, 2015M3A9E6028949, 2017M3A9B4062654]; MSIP [NRF-2015M3A9E6028951, 2015M3A9E6028949, 2017M3A9B4062654]; Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science [KRISS-2017-GP2017-0020]; Basic Research Laboratory [2016R1A4A1009895]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2017R1A2B4007340, 2017R1A6A3A04004741]; Gwangju Institute of Science and Technology (GIST)	Bio & Medical Technology Development Program of the National Research Foundation; MSIP; Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science; Basic Research Laboratory; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Gwangju Institute of Science and Technology (GIST)	This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation, and MSIP (NRF-2015M3A9E6028951, 2015M3A9E6028949, and 2017M3A9B4062654), the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science (KRISS-2017-GP2017-0020), the Basic Research Laboratory 2016R1A4A1009895), the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2017R1A2B4007340 and 2017R1A6A3A04004741), and a grant from the Systems Biology Infrastructure Establishment provided by the Gwangju Institute of Science and Technology (GIST).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; BAUDOUIN C, 1991, OPHTHALMOLOGICA, V203, P38, DOI 10.1159/000310223; Bonilha VL, 2014, EXP EYE RES, V126, P38, DOI 10.1016/j.exer.2013.09.015; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Chen HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036864; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Ferrand N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087878; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Hirase K, 1998, ARCH OPHTHALMOL-CHIC, V116, P738, DOI 10.1001/archopht.116.6.738; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Inadera H, 2009, BIOCHEM BIOPH RES CO, V379, P969, DOI 10.1016/j.bbrc.2008.12.185; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khankan R, 2011, INVEST OPHTH VIS SCI, V52, P5068, DOI 10.1167/iovs.11-7191; Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lake Andrew C, 2003, Cell Commun Signal, V1, P5; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023322; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P1429, DOI 10.1167/iovs.07-0451; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Radeke MJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0183-x; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208897	10.1371/journal.pone.0208897	http://dx.doi.org/10.1371/journal.pone.0208897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571728	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700027
J	Keng, BMH; Gao, F; Tan, RS; Ewe, SH; Teo, LLY; Xie, BQ; Goh, GBB; Koh, WP; Koh, AS				Keng, Bryan M. H.; Gao, Fei; Tan, Ru San; Ewe, See Hooi; Teo, Louis L. Y.; Xie, Bei Qi; Goh, George B. B.; Koh, Woon-Puay; Koh, Angela S.			N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing	PLOS ONE			English	Article							HEART-FAILURE; ATRIAL; DYSFUNCTION; CYTOKINES; FIBROSIS; RECEPTOR; CYCLASE; SYSTEM	Ageing-related alterations in cardiovascular structure and function are commonly associated with chronic inflammation. A potential blood-based biomarker indicative of a chronic inflammatory state is N-Terminal Pro C-Type Natriuretic Peptide (NTproCNP). We aim to investigate associations between NTproCNP and ageing-related impairments in cardiovascular function. Community-based participants underwent same-day assessment of cardiovascular function and circulating profiles of plasma NTproCNP. Associations between cardiovascular and biomarker profiles were studied in adjusted models including standard covariates. We studied 93 participants (mean age 73 +/- 5.3 years, 36 women), of whom 55 (59%) had impaired myocardial relaxation (ratio of peak velocity flow in early diastole E (m/s) to peak velocity flow in late diastole by atrial contraction A (m/s) <0.84). Participants with impaired myocardial relaxation were also found to have lower peak early phase filling velocity (0.6 +/- 0.1 vs 0.7 +/- 0.1, p < 0.0001) and higher peak atrial phase filling velocity (0.9 +/- 0.1 vs 0.7 +/- 0.1, p < 0.0001). NTproCNP levelswere significantly lower among participants with impaired myocardial relaxation (16.4% vs 39.5% with NTproCNP >= 19, p = 0.012). After multivariable adjustments, NTproCNP was independently associated with impaired myocardial relaxation (OR 2.99, 95%CI 1.12-8.01, p = 0.029). Community elderly adults with myocardial ageing have lower NTproCNP levels compared to those with preserved myocardial function. Given that impaired myocardial relaxation probably represents early changes within the myocardium with ageing, NTproCNP may be useful as an 'upstream' biomarker useful for charting myocardial ageing.	[Keng, Bryan M. H.; Gao, Fei; Tan, Ru San; Ewe, See Hooi; Teo, Louis L. Y.; Xie, Bei Qi; Koh, Angela S.] Natl Heart Ctr Singapore, Singapore, Singapore; [Gao, Fei; Tan, Ru San; Ewe, See Hooi; Goh, George B. B.; Koh, Woon-Puay; Koh, Angela S.] Duke NUS Med Sch, Singapore, Singapore; [Goh, George B. B.] Singapore Gen Hosp, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National Heart Centre Singapore; National University of Singapore; Singapore General Hospital; National University of Singapore	Koh, AS (corresponding author), Natl Heart Ctr Singapore, Singapore, Singapore.; Koh, AS (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	angela.koh.s.m@nhcs.com.sg	Koh, Angela S./AAX-7078-2021; Koh, Angela/HHF-3247-2022	Koh, Angela S./0000-0001-5629-9732; Tan, Ru San/0000-0003-2086-6517	National Medical Research Council of Singapore [NMRC/TA/0031/2015]; Hong Leong Foundation; Duke-NUS Medical School; Estate of Tan Sri Khoo Teck Puat; United States National Institutes of Health [NIH R01 CA144034, UM1 CA182876]; NATIONAL CANCER INSTITUTE [UM1CA182876] Funding Source: NIH RePORTER	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Hong Leong Foundation; Duke-NUS Medical School; Estate of Tan Sri Khoo Teck Puat; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Cardiac Aging Study has received funding support from the National Medical Research Council of Singapore (NMRC/TA/0031/2015), Hong Leong Foundation, Duke-NUS Medical School and the Estate of Tan Sri Khoo Teck Puat to ASK. Those participants recruited from the Singapore Chinese Health Study were supported by the United States National Institutes of Health (NIH R01 CA144034 and UM1 CA182876) to WK. The funder had no role in the design and conduct of the study; collection; management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abassi Z, 2004, PHARM THER, V102; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Barr CS, 1996, PEPTIDES, V17, P1243, DOI 10.1016/S0196-9781(96)00110-6; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; Chen HH, 1998, J CARDIOVASC PHAR S3, V32; Chiao YA, 2012, CARDIOVASC RES, V96, P444, DOI 10.1093/cvr/cvs275; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Del Ry S, 2011, REGUL PEPT, V166; Doi K, 2001, ARTERIOSCLER THROMB, V21; FULLER F, 1988, J BIOL CHEM, V263, P9395; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Ichiki T, 2014, J MOL CELL CARDIOL, V75, P199, DOI 10.1016/j.yjmcc.2014.08.001; Kalra PR, 2003, CIRCULATION, V107, P571, DOI 10.1161/01.CIR.0000047280.15244.EB; KINNUNEN P, 1993, ENDOCRINOLOGY, V132, P1961, DOI 10.1210/en.132.5.1961; Koh AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26456-8; Koh AS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0668-0; Kohno M, 1997, CIRC RES, V81; Kuehnl A, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-7; LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22; Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Moyes AJ, 2014, J CLIN INVEST, V124, P4039, DOI 10.1172/JCI74281; NAKAO K, 1992, J HYPERTENS, V10, P907; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Pandey KN, 2008, J AM SOC HYPERTENS, V2, P210, DOI 10.1016/j.jash.2008.02.001; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Santaguida PL, 2014, HEART FAIL REV, V19; Soeki T, 2005, J AM COLL CARDIOL, V45, p420A; SUGA S, 1993, ENDOCRINOLOGY, V133, P3038, DOI 10.1210/en.133.6.3038; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Tokudome T, 2004, ENDOCRINOLOGY, V145; Wright SP, 2004, HYPERTENSION, V43, P94, DOI 10.1161/01.HYP.0000105623.04382.C0; Zakeri R, 2015, CLIN CHIM ACTA, V443, P108, DOI 10.1016/j.cca.2014.12.009	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209517	10.1371/journal.pone.0209517	http://dx.doi.org/10.1371/journal.pone.0209517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566484	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300094
J	Roether, J; Bertels, S; Oelschlaeger, C; Bastmeyer, M; Willenbacher, N				Roether, Johanna; Bertels, Sarah; Oelschlaeger, Claude; Bastmeyer, Martin; Willenbacher, Norbert			Microstructure, local viscoelasticity and cell culture suitability of 3D hybrid HA/collagen scaffolds	PLOS ONE			English	Article							HYALURONIC-ACID; IN-VITRO; MECHANICAL-PROPERTIES; CROSS-LINKING; COLLAGEN; SOFT; HYDROGELS; MATRIX; CARTILAGE; CRYOGELS	As mechanical properties of cell culture substrates matter, methods for mechanical characterization of scaffolds on a relevant length scale are required. We used multiple particle tracking microrheology to close the gap between elasticity determined from bulk measurements and elastic properties sensed by cells. Structure and elasticity of macroporous, three-dimensional cryogel scaffolds from mixtures of hyaluronic acid (HA) and collagen (Coll) were characterized. Both one-component gels formed homogeneous networks, whereas hybrid gels were heterogeneous in terms of elasticity. Most strikingly, local elastic moduli were significantly lower than bulk moduli presumably due to non-equilibrium chain conformations between crosslinks. This was more pronounced in Coll and hybrid gels than in pure HA gels. Local elastic moduli were similar for all gels, irrespective of their different swelling ratio and bulk moduli. Fibroblast cell culture proved the biocompatibility of all investigated compositions. Coll containing gels enabled cell migration, adhesion and proliferation inside the gels.	[Roether, Johanna; Oelschlaeger, Claude; Willenbacher, Norbert] KIT, Inst Mech Proc Engn & Mech, Appl Mech Grp, Karlsruhe, Germany; [Bertels, Sarah; Bastmeyer, Martin] KIT, Zool Inst, Dept Cell & Neurobiol, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Roether, J (corresponding author), KIT, Inst Mech Proc Engn & Mech, Appl Mech Grp, Karlsruhe, Germany.	johanna.Roether@kit.edu	Bastmeyer, Martin/H-9342-2013	Bastmeyer, Martin/0000-0003-3471-8400				Ahearne M, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0038; Berillo D, 2012, J COLLOID INTERF SCI, V368, P226, DOI 10.1016/j.jcis.2011.11.006; Bhat S, 2012, J BIOSCI BIOENG, V114, P663, DOI 10.1016/j.jbiosc.2012.07.005; Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455; Chang KH, 2013, ACTA BIOMATER, V9, P9012, DOI 10.1016/j.actbio.2013.06.046; Colby R.H., 2003, POLYM PHYS; Collins MN, 2011, J APPL POLYM SCI, V120, P1040, DOI 10.1002/app.33241; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Daviran M, 2018, SOFT MATTER, V14, P3078, DOI 10.1039/c8sm00408k; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; EISENBERG SR, 1987, J BIOMECH ENG-T ASME, V109, P79, DOI 10.1115/1.3138647; Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2014, J MATER CHEM B, V2, P2345, DOI 10.1039/c3tb21604g; Gardel ML, MICRORHEOLOGY, P1, DOI [10.1007/3-540-26449-3_1, DOI 10.1007/3-540-26449-3_1]; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Haugh M.G., 2009, THESIS; Holmes R, 2017, MAT SCI ENG C-MATER, V77, P823, DOI 10.1016/j.msec.2017.03.267; Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489; Hwang HD, 2012, COLLOID SURFACE B, V91, P106, DOI 10.1016/j.colsurfb.2011.10.052; Indei T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021504; Kaufman JD, 2008, J MATER RES, V23, P1472, DOI 10.1557/JMR.2008.0185; Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P57, DOI 10.1007/s13770-012-0007-7; Kowalczyk A, 2015, POLYMER, V58, P170, DOI 10.1016/j.polymer.2014.12.041; Kuboki T, 2014, LANGMUIR, V30, P6187, DOI 10.1021/la501058j; Lai VK, 2016, ANN BIOMED ENG, V44, P2984, DOI 10.1007/s10439-016-1636-0; Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9; Lee-Thedieck C, 2012, J CELL SCI, V125, P3765, DOI 10.1242/jcs.095596; Loo SL, 2013, SOFT MATTER, V9, P224, DOI 10.1039/c2sm26859k; Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Oelschlaeger C, 2016, BIOMACROMOLECULES, V17, P580, DOI 10.1021/acs.biomac.5b01529; Oelschlaeger C, 2013, BIOMACROMOLECULES, V14, P3689, DOI 10.1021/bm4010436; Oppong FK, 2011, RHEOL ACTA, V50, P317, DOI 10.1007/s00397-010-0519-9; Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w; Pawelzyk P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093194; Rother S, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700154; Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407; Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a; Sharma A, 2015, MAT SCI ENG C-MATER, V47, P298, DOI 10.1016/j.msec.2014.11.031; Singh D, 2010, INT J BIOL SCI, V6, P371; Torres DS, 2000, BIOMATERIALS, V21, P1607; Tripathi A, 2013, MACROMOL BIOSCI, V13, P838, DOI 10.1002/mabi.201200398; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; VANHOVE L, 1954, PHYS REV, V95, P249, DOI 10.1103/PhysRev.95.249; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Wang H, 2013, PLOS ONE, V8; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Young JS, 1998, MACROMOL CHEM PHYSIC, V199, P1043, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1043::AID-MACP1043>3.3.CO;2-Q; Zhang XZ, 2001, LANGMUIR, V17, P6094, DOI 10.1021/la010105v	56	21	21	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207397	10.1371/journal.pone.0207397	http://dx.doi.org/10.1371/journal.pone.0207397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566463	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300010
J	Summerfield, M; Zhou, Y; Zhou, TH; Wu, CD; Alpini, G; Zhang, KK; Xie, LL				Summerfield, Michelle; Zhou, Yi; Zhou, Tianhao; Wu, Chaodong; Alpini, Gianfranco; Zhang, Ke K.; Xie, Linglin			A long-term maternal diet transition from high-fat diet to normal fat diet during pre-pregnancy avoids adipose tissue inflammation in next generation	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; INSULIN-RESISTANCE; ANIMAL-MODELS; LIVER-DISEASE; IN-UTERO; OBESITY; MACROPHAGES; PREGNANCY; CHILDHOOD; NUTRITION	Recent studies have suggested that maternal high-fat (HF) diet caused inflammation changes in adipose tissue; however, it remains unclear if maternal diet intervention before pregnancy rescues such effects in offspring. To address this question, female mice were continued on a normal-fat (NF group), or a HF diet (HF group) or transitioned from a HF diet to a NF diet at 1 (H1N group), 5 (H5N group) or 9 weeks (H9N group) prior to pregnancy. Among the three intervention groups, the H9N offspring displayed less and steady body weight gain, and maintained glucose tolerance, whereas the H1N and H5N offspring showed exacerbate these phenotypes. The H1N and H5N, but not the H9N offspring, displayed adipocyte hypertrophy associated with increased expression of genes involved in fat deposition. The H1N and H5N, but not the H9N adipose tissue, displayed increased macrophage infiltration with enhanced expression of inflammatory cytokine genes. In addition, overactivation of the NF-kappa B and the JNK signaling were observed in the H1N adipose tissue. Overall, our study showed that a long-term but not a short- or medium-term diet intervention before pregnancy released offspring adipose tissue inflammation induced by maternal HF diet, which adds details in our understanding how the maternal environment either promotes or discourages onset of disease in offspring. Clinically, this study is of great value for providing evidence in the design of clinical trials to evaluate the urgently required intervention strategies to minimize the intergenerational cycle of obesity.	[Summerfield, Michelle; Zhou, Yi; Wu, Chaodong; Zhang, Ke K.; Xie, Linglin] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Zhou, Yi] Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan, Hubei, Peoples R China; [Zhou, Tianhao; Alpini, Gianfranco] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA; [Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA; [Zhang, Ke K.] Texas A&M Univ, Ctr Epigenet & Dis Prevent, Inst Biosci & Technol, Coll Med, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Huazhong University of Science & Technology; Texas A&M University System; Texas A&M University System	Xie, LL (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.	Linglin.xie@tamu.edu	Zhou, Tianhao/AAO-3542-2021	Zhou, Tianhao/0000-0002-5722-6954	National Institutes of Health [NIDDK 1R01DK112368-01]; USDA National Institute of Food and Agriculture [1010406]; VA Merit award [5I01BX000574]; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott White; VA Research Career Scientist Award; Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112368] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); VA Merit award(US Department of Veterans Affairs); Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott White; VA Research Career Scientist Award; Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This project is supported by grants from the National Institutes of Health (NIDDK 1R01DK112368-01 to LX and KZ) and the USDA National Institute of Food and Agriculture, [Hatch] project [1010406] to LX. This work was supported in part by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott & White, a VA Research Career Scientist Award, a VA Merit award to Dr. Alpini (5I01BX000574). This material is the result of work supported by resources at the Central Texas Veterans Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H., 2010, INT J OBES LOND, V35, P325; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; An R, 2018, OBES REV, V19, P150, DOI 10.1111/obr.12624; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Baglioni S, 2009, FASEB J, V23, P3494, DOI 10.1096/fj.08-126946; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Denis GV, 2013, MOL ASPECTS MED, V34, P59, DOI 10.1016/j.mam.2012.10.004; Engin A, 2017, ADV EXP MED BIOL, V960, P221, DOI 10.1007/978-3-319-48382-5_9; Engin AB, 2017, ADV EXP MED BIOL, V960, P327, DOI 10.1007/978-3-319-48382-5_14; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Frew PM, 2014, CLIN INFECT DIS, V59, pS400, DOI 10.1093/cid/ciu726; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Friedman JE, 2015, DIABETES CARE, V38, P1402, DOI 10.2337/dc15-0628; Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V318, P603, DOI 10.1001/jama.2017.10693; Fu Q, 2016, INT J OBESITY, V40, P564, DOI 10.1038/ijo.2015.236; Ghosh AK, 2017, AGING-US, V9, P1971, DOI 10.18632/aging.101288; Goossens GH, 2017, OBESITY FACTS, V10, P207, DOI 10.1159/000471488; Gregg EW, 2017, NEW ENGL J MED, V377, P80, DOI 10.1056/NEJMe1706095; Gunasekaran MK, 2016, ADIPOCYTE, V5, P384, DOI 10.1080/21623945.2016.1245818; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Ickes MJ, 2014, INT J ENV RES PUB HE, V11, P8940, DOI 10.3390/ijerph110908940; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Le Clair C, 2009, CAN J PHYSIOL PHARM, V87, P161, DOI [10.1139/Y09-006, 10.1139/y09-006]; Lecoutre S, 2018, TRENDS ENDOCRIN MET, V29, P675, DOI 10.1016/j.tem.2018.07.004; Lecoutre S, 2018, FASEB J, V32, P2768, DOI 10.1096/fj.201700997R; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu PH, 2017, BBA-MOL CELL BIOL L, V1862, P946, DOI 10.1016/j.bbalip.2017.05.012; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Manna P. R., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Metges CC, 2009, ADV EXP MED BIOL, V646, P105, DOI 10.1007/978-1-4020-9173-5_11; Muhlhausler B. S., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P189; Munoz-Garach A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060320; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ornellas F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124737; Ortega MT, 2011, CELL IMMUNOL, V271, P124, DOI 10.1016/j.cellimm.2011.06.012; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Poulain L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620258; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Roldan M, 2011, FASEB J, V25, P4111, DOI 10.1096/fj.10-171439; Rooney K, 2011, INT J OBESITY, V35, P883, DOI 10.1038/ijo.2011.96; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simar D, 2012, NUTR METAB CARDIOVAS, V22, P269, DOI 10.1016/j.numecd.2010.11.007; Stolarczyk E, 2017, CURR OPIN PHARMACOL, V37, P35, DOI 10.1016/j.coph.2017.08.006; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tenenbaum-Gavish K, 2013, FETAL DIAGN THER, V34, P1, DOI 10.1159/000350170; Testa R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050437; Wall Alison, 2017, J Fam Health, V27, P17; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wells CS, 2006, MATERN CHILD HLTH J, V10, P55, DOI 10.1007/s10995-005-0034-2; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818; Xie LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169581; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Xu HT, 2018, J NUTR BIOCHEM, V62, P210, DOI 10.1016/j.jnutbio.2018.09.008; Yang X, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090935; Yang ZY, 2013, MATERN CHILD NUTR, V9, P105, DOI 10.1111/mcn.12010	73	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209053	10.1371/journal.pone.0209053	http://dx.doi.org/10.1371/journal.pone.0209053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562363	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100035
J	Alegre-Cortes, J; Soto-Sanchez, C; Fernandez, E				Alegre-Cortes, J.; Soto-Sanchez, C.; Fernandez, E.			Multiscale dynamics of interstimulus interval integration in visual cortex	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; TIME-FREQUENCY ANALYSIS; NEURONAL OSCILLATIONS; THETA OSCILLATIONS; NEURAL MECHANISMS; REPRESENTATION; INFORMATION; POPULATIONS	Although the visual cortex receives information at multiple temporal patterns, much of the research in the field has focused only on intervals shorter than 1 second. Consequently, there is almost no information on what happens at longer temporal intervals. We have tried to address this question recording neuronal populations of the primary visual cortex during visual stimulation with repetitive grating stimuli and intervals ranging from 1 to 7 seconds. Our results showed that firing rate and response stability were dependent of interval duration. In addition, there were collective oscillations with different properties in response to changes in intervals duration. These results suggest that visual cortex could encode visual information at several time scales using oscillations at multiple frequencies.	[Alegre-Cortes, J.; Soto-Sanchez, C.; Fernandez, E.] Miguel Hernandez Univ UMH, Bioengn Inst, Alicante, Spain; [Soto-Sanchez, C.; Fernandez, E.] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Madrid, Spain; [Soto-Sanchez, C.] Univ Alicante AU, Biotechnol Dept, Alicante, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat d'Alacant	Soto-Sanchez, C (corresponding author), Miguel Hernandez Univ UMH, Bioengn Inst, Alicante, Spain.; Soto-Sanchez, C (corresponding author), CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Madrid, Spain.; Soto-Sanchez, C (corresponding author), Univ Alicante AU, Biotechnol Dept, Alicante, Spain.	sotosanc@gmail.com	Alegre-Cortés, Javier/AAB-3261-2021; Sánchez, Cristina Soto/Y-8008-2018	Alegre-Cortes, Javier/0000-0003-0888-7542; Soto-Sanchez, Cristina/0000-0003-4447-5967	Spanish national research program [MAT2015-69967-C3-1]; Research Chair Bidons Egara; Spanish Blind Organization (ONCE)	Spanish national research program(Spanish Government); Research Chair Bidons Egara; Spanish Blind Organization (ONCE)	This work was supported in part by the Spanish national research program (MAT2015-69967-C3-1; http://www.mineco.gob.es/portal/site/mineco/), by Research Chair Bidons Egara (http://www.bidonsegara.com/) and by a research grant of the Spanish Blind Organization (ONCE; https://www.once.es/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Cortes J, 2016, J NEUROSCI METH, V267, P35, DOI 10.1016/j.jneumeth.2016.03.018; Alegre-Cortes J, 2018, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00077; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Buzsaki G, 2014, NEURONAL OSCILLATION, V1926, P1926, DOI [10.1126/science.1099745, DOI 10.1126/SCIENCE.1099745]; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Finnerty GT, 2015, J NEUROSCI, V35, P13912, DOI 10.1523/JNEUROSCI.2654-15.2015; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Fries P, 2002, J NEUROSCI, V22, P3739; Gavornik JP, 2014, NAT NEUROSCI, V17, P732, DOI 10.1038/nn.3683; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099793; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kim J, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.038.2009; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Levy JM, 2017, J NEUROSCI, V37, P10408, DOI 10.1523/JNEUROSCI.0923-17.2017; Luczak A, 2015, NAT REV NEUROSCI, V16, P745, DOI 10.1038/nrn4026; Mandic DP, 2013, IEEE SIGNAL PROC MAG, V30, P74, DOI 10.1109/MSP.2013.2267931; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2006, BRAIN RES, V1108, P157, DOI 10.1016/j.brainres.2006.06.046; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Namboodiri VMK, 2015, NEURON, V86, P319, DOI 10.1016/j.neuron.2015.02.043; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502; Rehman NU, 2011, IEEE T SIGNAL PROCES, V59, P2421, DOI 10.1109/TSP.2011.2106779; Rilling G., 2003, IEEE EURASIP WORKSH, P8; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Victor JD, 2000, BRAIN RES, V886, P33, DOI 10.1016/S0006-8993(00)02751-7; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xu M, 2014, P NATL ACAD SCI USA, V111, P480, DOI 10.1073/pnas.1321314111; Zold CL, 2015, J NEUROSCI, V35, P9603, DOI 10.1523/JNEUROSCI.0296-15.2015	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208822	10.1371/journal.pone.0208822	http://dx.doi.org/10.1371/journal.pone.0208822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557375	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000047
J	Cook, CL; Staras, SAS; Zhou, Z; Chichetto, N; Cook, RL				Cook, Christa L.; Staras, Stephanie A. S.; Zhou, Zhi; Chichetto, Natalie; Cook, Robert L.			Disclosure of HIV serostatus and condomless sex among men living with HIV/AIDS in Florida	PLOS ONE			English	Article							SEROPOSITIVE GAY; SELF-DISCLOSURE; RISK BEHAVIOR; SAFER-SEX; PARTNERS; INTERVENTION; TRANSMISSION; PREVENTION; CARE	Despite campaigns to increase safer sex practices, there are people living with HIV/AIDS (PLWH) who do not disclose their HIV status to sexual partners and engage in condomless sex. The purpose of this research was to: 1) describe factors associated with disclosure of HIV status to sexual partners; and 2) determine if disclosure and/or receipt of prevention counseling are independently associated with condomless sex. We used the Florida Medical Monitoring Project to analyze data from 376 HIV positive men with more than one sexual partner. Results indicated that 55% consistently disclosed their HIV status to sexual partners, 30% inconsistently disclosed, 15% did not disclose, and 48% reported any condomless sex. The odds of having condomless sex was 3.3 (CI = 1.5, 7.3) times greater in men who disclosed to all partners. Results suggest that men who disclose are also those who are more likely to have condomless sex. More research is needed to better understand the complex nature of disclosure and sexual risk behaviors and how disclosure impacts sexual risk.	[Cook, Christa L.] Univ Cent Florida, Dept Nursing Syst, Coll Nursing, Orlando, FL 32816 USA; [Staras, Stephanie A. S.] Univ Florida, Dept Hlth Outcomes & Biomed Informat, Coll Med, Gainesville, FL USA; [Zhou, Zhi; Cook, Robert L.] Univ Florida, Dept Epidemiol, Coll Med, Gainesville, FL USA; [Zhou, Zhi; Cook, Robert L.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Chichetto, Natalie] Vanderbilt Univ, Div Gen Internal Med & Publ Hlth, Med Ctr, Nashville, TN USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Vanderbilt University	Cook, CL (corresponding author), Univ Cent Florida, Dept Nursing Syst, Coll Nursing, Orlando, FL 32816 USA.	christa.cook@ucf.edu	Cook, Robert Lewis/ABI-4866-2020; Cook, Christa L./AAC-7452-2021	Cook, Christa L./0000-0002-2378-8043	National Institute on Alcohol Abuse and Alcoholism [U24AA022002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA022002] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by National Institute on Alcohol Abuse and Alcoholism (PI-Cook, RL, U24AA022002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, SAS WINDOWS VERSION; Boscoe FP, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140395; Cassels S, 2013, CURR HIV-AIDS REP, V10, P305, DOI 10.1007/s11904-013-0188-2; Center for hiv Law and Policy, 2017, HIV CRIM US SOURC ST, V3rd; Chaudoir SR, 2011, SOC SCI MED, V72, P1618, DOI 10.1016/j.socscimed.2011.03.028; Chaudoir SR, 2010, PSYCHOL BULL, V136, P236, DOI 10.1037/a0018193; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Committee to Review Data Systems for Monitoring HIV Care Board on Population Health and Public Health Practice Institute of Medicine, 2013, MON HIV CAR US STRAT; Conserve DF, 2015, AIDS BEHAV, V19, P1763, DOI 10.1007/s10461-015-1006-1; Cook SH, 2015, J BEHAV MED, V38, P507, DOI 10.1007/s10865-015-9624-7; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Dempsey AG, 2012, J ADOLESCENT HEALTH, V50, P315, DOI 10.1016/j.jadohealth.2011.06.003; Derlega VJ, 2002, J HEALTH PSYCHOL, V7, P415, DOI 10.1177/1359105302007004330; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Office of AIDS Research Advisory Council (OARAC), 2015, VIR FAIL AD AD ARV G; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Florida Department of Health HIV/ AIDS Section, 2016, EP HIV INF TRENDS FL; Gilbert P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001988; Hart TA, 2005, AIDS BEHAV, V9, P155, DOI 10.1007/s10461-005-3897-8; Hightow-Weidman LB, 2013, AIDS BEHAV, V17, P360, DOI 10.1007/s10461-012-0331-x; ICF International, 2014, MMP 2014 AN TRAIN; Kalichman SC, 2016, AIDS PATIENT CARE ST, V30, P221, DOI 10.1089/apc.2015.0333; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lehman JS, 2014, AIDS BEHAV, V18, P997, DOI 10.1007/s10461-014-0724-0; Maddox L, 2015, HIV AIDS PREV COORD; Marks G, 2001, J ACQ IMMUN DEF SYND, V27, P79, DOI 10.1097/00126334-200105010-00013; Mattson C, PREVALENCE PREDICTOR; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Mizuno Y, 2014, AIDS, V28, P407, DOI 10.1097/QAD.0000000000000057; O'Byrne P, 2015, NURS INQ, V22, P134, DOI 10.1111/nin.12075; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Parsons JT, 2005, AIDS, V19, pS87, DOI 10.1097/01.aids.0000167355.87041.63; Poppen PJ, 2005, AIDS EDUC PREV, V17, P227, DOI 10.1521/aeap.17.4.227.66530; Przybyla S, 2014, AIDS PATIENT CARE ST, V28, P677, DOI 10.1089/apc.2014.0203; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Rosser BRS, 2008, AIDS CARE, V20, P925, DOI 10.1080/09540120701767265; Serovich JM, 2009, AIDS EDUC PREV, V21, P207, DOI 10.1521/aeap.2009.21.3.207; Simbayi LC, 2017, AIDS BEHAV, V21, P82, DOI 10.1007/s10461-015-1278-5; Simoni Jane M, 2004, Top HIV Med, V12, P109; St De Lore J, 2012, J HOMOSEXUAL, V59, P592, DOI 10.1080/00918369.2012.665704; Stein MD, 1998, ARCH INTERN MED, V158, P253, DOI 10.1001/archinte.158.3.253; Sullivan Kathleen M, 2009, Issues Ment Health Nurs, V30, P687; Sullivan KM, 2005, J ASSOC NURSE AIDS C, V16, P33, DOI 10.1016/j.jana.2005.09.005; U. S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, 2015, PRIOR HHS POV GUID F; Valverde Eduardo, 2014, J Int Assoc Provid AIDS Care, V13, P127, DOI 10.1177/2325957413516496; Weintraub A, 2017, AIDS BEHAV, V21, P129, DOI 10.1007/s10461-016-1337-6; Wolitski RJ, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000167356.94664.59	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0207838	10.1371/journal.pone.0207838	http://dx.doi.org/10.1371/journal.pone.0207838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557362	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000015
J	Kwan, NCL; Yamada, A; Sugiura, K				Kwan, Nigel C. L.; Yamada, Akio; Sugiura, Katsuaki			Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan	PLOS ONE			English	Article							EFFICACY; RISK	Japan is one of the few rabies-free countries/territories which implement the policy of mandatory vaccination of domestic dogs. In order to assess the economic efficiency of such policy in reducing the economic burden of a future canine rabies outbreak in Japan, a benefit-cost analysis (BCA) was performed using probabilistic decision tree modelling. Input data derived from simulation results of published mathematical model, field investigation conducted by the authors at prefectural governments, literature review, international or Japanese database and empirical data of rabies outbreaks in other countries/territories. The current study revealed that the annual costs of implementing the current vaccination policy would be US$160,472,075 (90% prediction interval [PI]: $149,268,935-171,669,974). The economic burden of a potential single canine rabies outbreak in Japan were estimated to be US$1,682,707 (90% PI: $1,180,289-2,249,283) under the current vaccination policy, while it would be US$5,019,093 (90% PI: $3,986,882-6,133,687) under hypothetical abolition of vaccination policy, which is 3-fold higher. Under a damage-avoided approach, the annual benefits of implementing the current vaccination policy in expected value were estimated to be US$85.75 (90% PI: $55.73-116.89). The benefit-cost ratio (BCR) was estimated to be 5.35 X 10(-7) (90% PI: 3.46 X 10(-7)-7.37 X 10(-7)), indicating that the implementation of the current policy is very economically inefficient for the purpose of reducing the economic burden of a potential canine rabies outbreak. In worse-case scenario analysis, the BCR would become above 1 (indicating economic efficiency) if the risk of rabies introduction increased to 0.04 corresponding to a level of risk where rabies would enter Japan in 26 years while the economic burden of a rabies outbreak under the abolition of vaccination policy increased to $7.53 billion. Best-case analysis further revealed that under relatively extreme circumstances the economic efficiency of the current policy could be improved by decreasing the vaccination price charged to dog owners, relaxing the frequency of vaccination to every two to three years and implementing the policy on a smaller scale, e.g. only in targeted prefectures instead of the whole Japan.	[Kwan, Nigel C. L.; Sugiura, Katsuaki] Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamada, Akio] Univ Tokyo, Dept Vet Med Sci, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Sugiura, K (corresponding author), Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Tokyo, Japan.	aksugiur@mail.ecc.u-tokyo.ac.jp		Kwan, Nigel C.L./0000-0003-3314-5882; Sugiura, Katsuaki/0000-0002-8807-7584				Adger WN, 2010, NEW POLIT ECON, V15, P275, DOI 10.1080/13563460903290912; Arai YT, 2002, VACCINE, V20, P2448, DOI 10.1016/S0264-410X(02)00188-3; Bamaiyi PH, 2018, J VET ADV, V5, P1181; Benjavongkulchai M, 1997, VACCINE, V15, P1816, DOI 10.1016/S0264-410X(97)00143-6; Bourhy H, 2018, WHO TECH REP SER, V1012, P1; Bourhy H, 2015, B WORLD HEALTH ORGAN, V93, P503, DOI 10.2471/BLT.14.149849; Chang SS, 2016, ZOONOSES PUBLIC HLTH, V63, P396, DOI 10.1111/zph.12240; FAO-Food and Agriculture Organization of the United Nations, 2016, EC AN AN DIS; Gamoh K., 2008, Journal of the Japan Veterinary Medical Association, V61, P557; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hidano A, 2012, JPN J INFECT DIS, V65, P396, DOI 10.7883/yoken.65.396; Huang JJ, 2013, TAIWAN EPIDEMIOLOGY, V2013, P29; Jibat T, 2016, PREV VET MED, V130, P67, DOI 10.1016/j.prevetmed.2016.06.005; JPFA-Japan Pet Food Association, 2018, NAT SURV PET DOGS CA; Kadowaki H, 2018, EPIDEMIOL INFECT, V146, P1245, DOI [10.1017/S0950268818001267, 10.1017/s0950268818001267]; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kurosawa A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005435; Kwan NCL, 2017, EPIDEMIOL INFECT, V145, P1168, DOI [10.1017/S0950268816002995, 10.1017/s0950268816002995]; Kwan NCL, 2017, PREV VET MED, V147, P172, DOI 10.1016/j.prevetmed.2017.09.007; Kwan NCL, 2016, PREV VET MED, V128, P112, DOI 10.1016/j.prevetmed.2016.04.015; Lavan RP, 2017, VACCINE, V35, P1668, DOI 10.1016/j.vaccine.2017.02.014; Maki J, 2017, VET RES, V48, DOI 10.1186/s13567-017-0459-9; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; MHLW-Ministry of Health Labour and Welfare, 2017, NUM DOGS REG VACC RA; MHLW-Ministry of Health Labour and Welfare, 2013, GUID RAB CONTR JAP 2; Ministry of the Environment, 2017, SIT DET DOG CATS INJ; Morimoto K, 2009, J DISASTER RES, V4, P346, DOI 10.20965/jdr.2009.p0346; Morimoto K, 2016, ARCH VIROL, V161, P2537, DOI 10.1007/s00705-016-2916-6; Ren JP, 2015, CLIN VACCINE IMMUNOL, V22, P1, DOI 10.1128/CVI.00531-14; Ribadeau-Dumas F, 2016, EMERG INFECT DIS, V22, P1268, DOI 10.3201/eid2207.151733; Shiota S, 2008, VACCINE, V26, P6441, DOI 10.1016/j.vaccine.2008.08.068; Shwiff SA, 2016, HUM-WILDL INTERACT, V10, P91; Sterner RT, 2009, EMERG INFECT DIS, V15, P1176, DOI 10.3201/eid1508.081061; Suganuma A, 2013, REV HUMAN RABIES CAS; Takahashi-Omoe H, 2008, EMERG INFECT DIS, V14, P1368, DOI 10.3201/eid1409.070845; Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 2018, VACC PRIC LIST; Tsiodras S, 2013, EUROSURVEILLANCE, V18, P2; Van Rijckevorsel GG, 2012, EUROSURVEILLANCE, P17; Wera E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083654; WHO-World Organisation of Health, 2017, RABIES B EUROPE; WHO-World Organisation of Health, 2014, WHO GUID RAB PRE POS; World Health Organization, 2018, Weekly Epidemiological Record, V93, P201; Yanagisawa N, 2012, J INFECT CHEMOTHER, V18, P66, DOI 10.1007/s10156-011-0286-2; Yanagisawa N, 2010, J INFECT CHEMOTHER, V16, P38, DOI 10.1007/s10156-009-0019-y; Zhang Y, 2016, ANTIVIR RES, V135, P56, DOI 10.1016/j.antiviral.2016.10.002	45	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0206717	10.1371/journaI.pone.0206717	http://dx.doi.org/10.1371/journaI.pone.0206717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557398				2022-12-26	WOS:000453451000012
J	Lezkan, A; Drewing, K				Lezkan, Alexandra; Drewing, Knut			Interdependences between finger movement direction and haptic perception of oriented textures	PLOS ONE			English	Article							TACTILE DISCRIMINATION; SURFACE GEOMETRY; TEMPORAL CUES; EYE-MOVEMENT; ROUGHNESS; INFORMATION; PERFORMANCE; AMPLITUDE; GRATINGS; MOTION	Although the natural haptic perception of textures includes active finger movements, it is unclear how closely perception and movements are linked. Here we investigated this question using oriented textures. Textures that are composed of periodically repeating grooves have a clear orientation defined by the grooves. The direction of finger movement relative to texture orientation determines the availability of temporal cues to the spatial period of the texture. These cues are absent during movements directed in line with texture orientation, whereas movements orthogonal to texture orientation maximize the temporal frequency of stimulation. This may optimize temporal cues. In Experiment 1 we tested whether texture perception gets more precise the more orthogonal the movement direction is to the texture. We systematically varied the movement direction within a 2IFC spatial period discrimination task. As expected, perception was more precise (lower discrimination thresholds) when finger movements were directed closer towards the texture orthogonal as compared to in parallel to the texture. In Experiment 2 we investigated whether people adjust movement directions to the texture orthogonal in free exploration. We recorded movement directions during free exploration of standard and comparison gratings. The standard gratings were clearly oriented. The comparison gratings did not have a clear orientation defined by grooves. Participants adjusted movement directions to the texture orthogonal only for clearly oriented textures (standards). The adjustment to texture orthogonal was present in the final movement but not in the first movement. This suggests that movement adjustment is based on sensory signals for texture orientation that were gathered over the course of exploration. In Experiment 3 we assessed whether the perception of texture orientation and movement adjustments are based on shared sensory signals. We determined perceptual thresholds for orientation discrimination and computed 'movometric' thresholds from the stroke-by-stroke adjustment of movement direction. Perception and movements were influenced by a common factor, the spatial period, suggesting that the same sensory signals for texture orientation contribute to both. We conclude that people optimize texture perception by adjusting their movements in directions that maximize temporal cue frequency. Adjustments are performed on the basis of sensory signals that are also used for perception.	[Lezkan, Alexandra; Drewing, Knut] Justus Liebig Univ, Dept Gen Psychol, Giessen, Germany	Justus Liebig University Giessen	Lezkan, A (corresponding author), Justus Liebig Univ, Dept Gen Psychol, Giessen, Germany.	alexandra.lezkan@psychol.uni-giessen.de			Deutsche Forschungsgemeinschaft [SFB/TRR135]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), SFB/TRR135, A05 assigned to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Braun DI, 2016, J VISION, V16, DOI 10.1167/16.13.4; Callier T, 2015, J NEUROPHYSIOL, V113, P3013, DOI 10.1152/jn.00703.2014; Cascio CJ, 2001, J NEUROSCI, V21, P5289, DOI 10.1523/JNEUROSCI.21-14-05289.2001; Drewing K, 2016, LECT NOTES COMPUT SC, V9775, P206, DOI 10.1007/978-3-319-42324-1_21; Drewing K, 2012, ACTA PSYCHOL, V141, P295, DOI 10.1016/j.actpsy.2012.09.011; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gegenfurtner KR, 2007, J VISION, V7, DOI 10.1167/7.5.11; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Henriques DYP, 2005, J NEUROPHYSIOL, V93, P3036, DOI 10.1152/jn.00010.2005; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; HOLLINS M, 1993, PERCEPT PSYCHOPHYS, V54, P697, DOI 10.3758/BF03211795; JOHNSON KO, 1994, CAN J PHYSIOL PHARM, V72, P488, DOI 10.1139/y94-072; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; Kaim L, 2011, IEEE T HAPTICS, V4, P242, DOI [10.1109/TOH.2011.19, 10.1109/ToH.2011.19]; Klatzky RL, 1999, PERCEPT PSYCHOPHYS, V61, P591, DOI 10.3758/BF03205532; Klatzky RL, 2003, PERCEPT PSYCHOPHYS, V65, P613, DOI 10.3758/BF03194587; Klatzky RL, 1999, ATTENTION PERFORM, V17, P165; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; LAMB GD, 1983, J PHYSIOL-LONDON, V338, P551, DOI 10.1113/jphysiol.1983.sp014689; Lederman S.J., 1986, HDB PERCEPTION HUMAN, V2, P1, DOI 10.1167/9.8.1126; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1986, J EXP PSYCHOL HUMAN, V12, P169, DOI 10.1037/0096-1523.12.2.169; Lezkan A, 2018, ATTEN PERCEPT PSYCHO, V80, P177, DOI 10.3758/s13414-017-1426-2; Lezkan A, 2016, LECT NOTES COMPUT SC, V9774, P430, DOI 10.1007/978-3-319-42321-0_40; Lezkan A, 2015, 2015 IEEE WORLD HAPTICS CONFERENCE (WHC), P69, DOI 10.1109/WHC.2015.7177693; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mardia KV, 2000, DIRECTIONAL STAT; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Nefs HT, 2002, PERCEPT PSYCHOPHYS, V64, P969, DOI 10.3758/BF03196800; Nefs HT, 2001, PERCEPTION, V30, P1263, DOI 10.1068/p3217; Ross NM, 2017, J NEUROPHYSIOL, V118, P1762, DOI 10.1152/jn.00324.2017; Saig A, 2012, J NEUROSCI, V32, P14022, DOI 10.1523/JNEUROSCI.2432-12.2012; Sathian K, 2016, J NEUROPHYSIOL, V116, P1795, DOI 10.1152/jn.00546.2015; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; SATHIAN K, 1989, TRENDS NEUROSCI, V12, P513, DOI 10.1016/0166-2236(89)90112-4; Schutt HH, 2016, VISION RES, V122, P105, DOI 10.1016/j.visres.2016.02.002; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Tanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093363; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VANBOVEN RW, 1994, BRAIN, V117, P149, DOI 10.1093/brain/117.1.149; Vetter P, 2002, CURR BIOL, V12, P488, DOI 10.1016/S0960-9822(02)00715-7; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; Weber AI, 2013, P NATL ACAD SCI USA, V110, P17107, DOI 10.1073/pnas.1305509110; Wexler M, 2008, CURR BIOL, V18, P1872, DOI 10.1016/j.cub.2008.10.059; Wismeijer DA, 2010, J VISION, V10, DOI 10.1167/10.6.25; Wismeijer DA, 2012, VISION RES, V58, P19, DOI 10.1016/j.visres.2012.02.003; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107	60	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208988	10.1371/journal.pone.0208988	http://dx.doi.org/10.1371/journal.pone.0208988			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IQ	30550578	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000037
J	Turner, RE; McClenachan, G				Turner, R. Eugene; McClenachan, Giovanna			Reversing wetland death from 35,000 cuts: Opportunities to restore Louisiana's dredged canals	PLOS ONE			English	Article								We determined the number of permits for oil and gas activities in 14 coastal Louisiana parishes from 1900 to 2017, compared them to land loss on this coast, and estimated their restoration potential. A total of 76,247 oil and gas recovery wells were permitted, of which 35,163 (46%) were on land (as of 2010) and 27,483 of which are officially abandoned. There is a direct spatial and temporal relationship between the number of these permits and land loss, attributable to the above and belowground changes in hydrology resulting from the dredged material levees placed parallel to the canal (spoil banks). These hydrologic modifications cause various direct and indirect compromises to plants and soils resulting in wetland collapse. Although oil and gas recovery beneath southern Louisiana wetlands has dramatically declined since its peak in the early 1960s, it has left behind spoil banks with a total length sufficient to cross coastal Louisiana 79 times from east to west. Dragging down the remaining material in the spoil bank back into the canal is a successful restoration technique that is rarely applied in Louisiana, but could be a dramatically cost-effective and proven long-term strategy if political will prevails. The absence of a State or Federal backfilling program is a huge missed opportunity to: 1) conduct cost-effective restoration at a relatively low cost, and, 2) conduct systematic restoration monitoring and hypothesis testing that advances knowledge and improves the efficacy of future attempts. The price of backfilling all canals is about $335 million dollars, or 0.67% of the State's Master Plan for restoration and a pittance of the economic value gained from extracting the oil and gas beneath over the last 100 years.	[Turner, R. Eugene] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [McClenachan, Giovanna] Univ Cent Florida, Orlando, FL 32816 USA	Louisiana State University System; Louisiana State University; State University System of Florida; University of Central Florida	Turner, RE (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	euturne@lsu.edu		McClenachan, Giovanna/0000-0002-3076-4795	Gulf of Mexico Research Initiative	Gulf of Mexico Research Initiative	This analysis was made possible by a grant from The Gulf of Mexico Research Initiative (http://gulfresearchinitiative.org/) to the Coastal Waters Consortium at The Louisiana Universities Marine Consortium to Louisiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY RK, 1988, WETLANDS, V8, P109, DOI 10.1007/BF03160596; Austin DE, 2004, PAPERS EVOLVING OFFS, V1; Bass AS, 1997, J COASTAL RES, V13, P895; BAUMANN RH, 1990, ENVIRON GEOL WATER S, V15, P189, DOI 10.1007/BF01706410; Baustian JJ, 2006, RESTOR ECOL, V14, P636, DOI 10.1111/j.1526-100X.2006.00175.x; Baustian JJ, 2009, WETL ECOL MANAG, V17, P445, DOI 10.1007/s11273-008-9122-6; BRITSCH LD, 1993, J COASTAL RES, V9, P324; CPRA (Coastal Projection and Restoration Authority of Louisiana), 2017, LOU COMPR MAST PLAN; Houck O.A., 2015, TULANE ENV LAW J, V28, P185; Kaiser MJ, 2012, MATH COMPUT MODEL, V55, P564, DOI 10.1016/j.mcm.2011.08.033; MENDELSSOHN IA, 1981, SCIENCE, V214, P439, DOI 10.1126/science.214.4519.439; NEILL C, 1987, ENVIRON MANAGE, V11, P823, DOI 10.1007/BF01867248; Nichols LG, 1959, TECH REP; Ohimain B. L., 2003, P 8 INT MIN WAT ASS, P503; Pate H, 2014, QUANTIFYING PRIORITI; SWENSON EM, 1987, ESTUAR COAST SHELF S, V24, P599, DOI 10.1016/0272-7714(87)90101-6; Turner R.E., 2002, APPROACHES COASTAL W; Turner R.E., 1994, WETL ECOL MANAG, V3, P63, DOI [10.1007/BF00177297, DOI 10.1007/BF00177297]; Turner RE, 2016, MAR POLLUT BULL, V110, P316, DOI 10.1016/j.marpolbul.2016.06.046; Turner RE, 2014, J COASTAL RES, V30, P1330, DOI 10.2112/JCOASTRES-D-14-00076.1; Turner RE, 2009, ESTUAR COAST, V32, P1054, DOI 10.1007/s12237-009-9214-4; Turner RE, 2004, ESTUARIES, V27, P265, DOI 10.1007/BF02803383; TURNER RE, 1990, ESTUARIES, V13, P272, DOI 10.2307/1351918; Zedler JB, 2017, ESTUAR COAST, V40, P1, DOI 10.1007/s12237-016-0162-5	24	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207717	10.1371/journal.pone.0207717	http://dx.doi.org/10.1371/journal.pone.0207717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550603	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000008
J	Tan, JZA; Gleeson, PA				Tan, Jing Zhi A.; Gleeson, Paul A.			The trans-Golgi network is a major site for alpha-secretase processing of amyloid precursor protein in primary neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-secretase 1 (BACE1); amyloid precursor protein (APP); membrane trafficking; enzyme processing; protein trafficking (Golgi); neurodegenerative disease; secretion; adaptor protein; secretase; alpha-secretase; trans-Golgi network	ALZHEIMERS-DISEASE; CELL-SURFACE; GAMMA-SECRETASE; BETA-SECRETASE; CLEAVAGE; APP; ADAPTER; TRAFFICKING; ENDOSOMES; ADAM10	Amyloid precursor protein (APP) is processed along the amyloidogenic pathway by the beta-secretase, BACE1, generating beta-amyloid (A beta), or along the nonamyloidogenic pathway by alpha-secretase, precluding A beta production. The plasma membrane is considered the major site for alpha-secretase-mediated APP cleavage, but other cellular locations have not been rigorously investigated. Here, we report that APP is processed by endogenous alpha-secretase at the trans-Golgi network (TGN) of both transfected HeLa cells and mouse primary neurons. We have previously shown the adaptor protein complex, AP-4, and small G protein ADP-ribosylation factor-like GTPase 5b (Arl5b) are required for efficient post-Golgi transport of APP to endosomes. We found here that AP-4 or Arl5b depletion results in Golgi accumulation of APP and increased secretion of the soluble alpha-secretase cleavage product sAPP alpha. Moreover, inhibition of gamma-secretase following APP accumulation in the TGN increases the levels of the membrane-bound C-terminal fragments of APP from both alpha-secretase cleavage (alpha-CTF, named C83 according to its band size) and BACE1 cleavage (beta-CTF/C99). The level of C83 was similar to 4 times higher than that of C99, indicating that alpha-secretase processing is the major pathway and that BACE1 processing is the minor pathway in the TGN. AP-4 silencing in mouse primary neurons also resulted in the accumulation of endogenous APP in the TGN and enhanced alpha-secretase processing. These findings identify the TGN as a major site for alpha-secretase processing in HeLa cells and primary neurons and indicate that both APP processing pathways can occur within the TGN compartment along the secretory pathway.	[Tan, Jing Zhi A.; Gleeson, Paul A.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Melbourne	Gleeson, PA (corresponding author), Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Tan, Jing Zhi Anson/GNH-6481-2022	Tan, Jing Zhi Anson/0000-0002-6537-1166; Gleeson, Paul/0000-0002-5336-6503	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Bauereiss A, 2015, TRAFFIC, V16, P655, DOI 10.1111/tra.12270; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Boncompain Gaelle, 2012, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1519s57; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Brisco MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks588; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; De Pace R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007363; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunning CJR, 2016, J NEUROCHEM, V137, P518, DOI 10.1111/jnc.13571; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hefter D, 2016, J NEUROSCI, V36, P8356, DOI 10.1523/JNEUROSCI.4130-15.2016; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Houghton FJ, 2012, EXP CELL RES, V318, P464, DOI 10.1016/j.yexcr.2011.12.023; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; Kimura A, 2016, J BIOL CHEM, V291, P24041, DOI 10.1074/jbc.M116.744722; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Koo EH, 1996, J CELL SCI, V109, P991; KOOY J, 1992, J BIOL CHEM, V267, P20255; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Penke B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101692; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toh WH, 2018, MOL BIOL CELL, V29, P191, DOI 10.1091/mbc.E17-05-0270; Toh WH, 2017, TRAFFIC, V18, P159, DOI 10.1111/tra.12465; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vincent B, 2016, BRAIN RES BULL, V126, P154, DOI 10.1016/j.brainresbull.2016.03.020; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	67	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1618	1631		10.1074/jbc.RA118.005222	http://dx.doi.org/10.1074/jbc.RA118.005222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30545942	Green Published, hybrid			2022-12-26	WOS:000457879200017
J	Aznar, F; Echarri, V; Rizo, C; Rizo, R				Aznar, Fidel; Echarri, Victor; Rizo, Carlos; Rizo, Ramon			Modelling the thermal behaviour of a building facade using deep learning	PLOS ONE			English	Article							OPTIMUM INSULATION-THICKNESS; ARTIFICIAL NEURAL-NETWORK; IN-SITU MEASUREMENT; EXTERNAL WALLS	This article aims to model the thermal behaviour of a wall using deep learning techniques. The Fourier theoretical model which is traditionally used to model such enclosures is not capable of considering several factors that affect a prediction that is often incorrect. These results motivate us to try to obtain a better thermal model of the enclosure. For this reason, a connexionist model is provided capable of modelling the behaviour of the enclosure from actual observed temperature data. For the training of this model, several measurements have been obtained over the course of more than one year in a specific enclosure, distributing the readings among the different layers of it. In this work, the predictions of both the theoretical model and the connexionist model have been tested, contrasting them with the measurements obtained previously. It has been observed that the connexionist model substantially improves the theoretical predictions of the Fourier method, thus allowing better approximations to be made regarding the real energy consumption of the building and, in general, the prediction of the energy behaviour of the enclosure.	[Aznar, Fidel; Rizo, Ramon] Univ Alicante, Dept Comp Sci & Artificial Intelligence, Alicante, Spain; [Echarri, Victor; Rizo, Carlos] Univ Alicante, Dept Architectural Construct, Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant	Aznar, F (corresponding author), Univ Alicante, Dept Comp Sci & Artificial Intelligence, Alicante, Spain.	fidel@dccia.ua.es	Echarri-Iribarren, Víctor/AAA-4274-2019; Rizo-Maestre, Carlos/AAA-4142-2019; Rizo, Ramon/D-3774-2018	Echarri-Iribarren, Víctor/0000-0002-3117-7904; Rizo-Maestre, Carlos/0000-0002-9570-9818; Aznar Gregori, Fidel/0000-0003-4521-956X; Rizo, Ramon/0000-0001-7250-2067				Al-Sanea S.A., 2002, INT J AMBIENT ENERGY, V23, P115, DOI [10.1080/01430750.2002.9674880, DOI 10.1080/01430750.2002.9674880]; Al-Sanea SA, 2005, APPL ENERG, V82, P313, DOI 10.1016/j.apenergy.2004.10.014; Al-Sanea SA, 2003, J BUILD PHYS, V26, P285, DOI DOI 10.1177/109719603027973; Alfano FRD, 2017, ENERG BUILDINGS, V152, P243, DOI 10.1016/j.enbuild.2017.07.052; American Society of Heating R Engineers AC, 2010, 2010 ASHRAE HDB REFR; Marquez JMA, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17092017; [Anonymous], 2007, 137862007 ISO; [Anonymous], 2014, 163SC1 ISOTC; Axaopoulos I, 2014, APPL ENERG, V117, P167, DOI 10.1016/j.apenergy.2013.12.008; Balocco C, 2002, ENERG BUILDINGS, V34, P469, DOI 10.1016/S0378-7788(01)00130-X; Bejan A., 2003, HEAT TRANSFER HDB; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Buratti C, 2012, APPL ENERG, V98, P425, DOI 10.1016/j.apenergy.2012.04.004; Daouas N, 2011, APPL ENERG, V88, P156, DOI 10.1016/j.apenergy.2010.07.030; de Dear RJ, 2013, INDOOR AIR, V23, P442, DOI 10.1111/ina.12046; De Vito S, 2018, SENSOR ACTUAT B-CHEM, V255, P1191, DOI 10.1016/j.snb.2017.07.155; Desogus G, 2011, ENERG BUILDINGS, V43, P2613, DOI 10.1016/j.enbuild.2011.05.025; Dong M, 2008, J CIV ARCHIT ENV ENG, V2007, P5; Echarri Iribarren V, 2016, INFORM CONSTRUCCIO, V68; Echarri Iribarren V, 2016, ENERGY EFFICIENCY FL, P163; Echarri V, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122848; Fanger O.P., 1970, THERMAL COMFORT ANAL; Ficco G, 2015, ENERG BUILDINGS, V104, P108, DOI 10.1016/j.enbuild.2015.06.071; Gamboa J., 2017, ARXIV170101887; Garay R, 2014, ENERG BUILDINGS, V85, P579, DOI 10.1016/j.enbuild.2014.09.024; Gaspar K, 2016, ENERG BUILDINGS, V130, P592, DOI 10.1016/j.enbuild.2016.08.072; Halawa E, 2012, ENERG BUILDINGS, V51, P101, DOI 10.1016/j.enbuild.2012.04.011; How DNT, 2016, INT J ADV ROBOT SYST, V13, DOI 10.1177/1729881416663369; Huang W, 2017, NEURAL NETWORKS, V90, P21, DOI 10.1016/j.neunet.2017.03.002; Le Q. V., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3361, DOI 10.1109/CVPR.2011.5995496; Marques F. D., 2005, J. Braz. Soc. Mech. Sci. & Eng., V27, P97, DOI 10.1590/S1678-58782005000200001; Mateus NM, 2014, ENERG BUILDINGS, V75, P511, DOI 10.1016/j.enbuild.2014.02.043; Molina D., 2011, P IEEE S COMP INT SM; Monge-Barrio A, 2015, ENERG BUILDINGS, V108, P244, DOI 10.1016/j.enbuild.2015.09.037; Ozel M, 2014, ENERG BUILDINGS, V72, P288, DOI 10.1016/j.enbuild.2013.11.015; Ozel M, 2011, APPL ENERG, V88, P2429, DOI 10.1016/j.apenergy.2011.01.049; Qiu X, 2014, 2014 IEEE S COMP INT, P1, DOI DOI 10.1109/CIEL.2014.7015739; Quinten J, 2016, ENERG BUILDINGS, V110, P284, DOI 10.1016/j.enbuild.2015.11.003; Sablani SS, 2005, INT J HEAT MASS TRAN, V48, P665, DOI 10.1016/j.ijheatmasstransfer.2004.09.005; Sendra JI, 2013, INF CONSTR, V65, P457, DOI 10.3989/ic.13.074; Singh R, 2011, BUILD ENVIRON, V46, P2603, DOI 10.1016/j.buildenv.2011.06.019; Sulaiman J, 2018, LECT NOTES ELECTR EN, V449, P68, DOI 10.1007/978-981-10-6451-7_9; Talyor RA, 2014, APPL ENERG, V128, P156, DOI 10.1016/j.apenergy.2014.04.061; Tyasnurita R, 2017, IEEE C EVOL COMPUTAT, P1474, DOI 10.1109/CEC.2017.7969477; Wang SW, 2002, APPL THERM ENG, V22, P333, DOI 10.1016/S1359-4311(01)00086-2	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0207616	10.1371/journal.pone.0207616	http://dx.doi.org/10.1371/journal.pone.0207616			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576329	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400005
J	Rogers, SC; Dosier, LB; McMahon, TJ; Zhu, HM; Timm, D; Zhang, HT; Herbert, J; Atallah, J; Palmer, GM; Cook, A; Ernst, M; Prakash, J; Terng, M; Towfighi, P; Doctor, R; Said, A; Joens, MS; Fitzpatrick, JAJ; Hanna, G; Lin, X; Reisz, JA; Nemkov, T; D'Alessandro, A; Doctor, A				Rogers, Stephen C.; Dosier, Laura B.; McMahon, Timothy J.; Zhu, Hongmei; Timm, David; Zhang, Hengtao; Herbert, Joseph; Atallah, Jacqueline; Palmer, Gregory M.; Cook, Asa; Ernst, Melanie; Prakash, Jaya; Terng, Mark; Towfighi, Parhom; Doctor, Reid; Said, Ahmed; Joens, Matthew S.; Fitzpatrick, James A. J.; Hanna, Gabi; Lin, Xue; Reisz, Julie A.; Nemkov, Travis; D'Alessandro, Angelo; Doctor, Allan			Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes	PLOS ONE			English	Article							40-PERCENT WT/VOL GLYCEROL; PREVIOUSLY FROZEN; NITRIC-OXIDE; RBCS FROZEN; IN-VITRO; 4-DEGREES-C; HEMOLYSIS; SURVIVAL; ADHESION; STORAGE	Intact red blood cells (RBCs) are required for phenotypic analyses. In order to allow separation (time and location) between subject encounter and sample analysis, we developed a research-specific RBC cryopreservation protocol and assessed its impact on data fidelity for key biochemical and physiological assays. RBCs drawn from healthy volunteers were aliquotted for immediate analysis or following glycerol-based cryopreservation, thawing, and deglycerolization. RBC phenotype was assessed by (1) scanning electron microscopy (SEM) imaging and standard morphometric RBC indices, (2) osmotic fragility, (3) deformability, (4) endothelial adhesion, (5) oxygen (O-2) affinity, (6) ability to regulate hypoxic vasodilation, (7) nitric oxide (NO) content, (8) metabolomic phenotyping (at steady state, tracing with [1,2,3-C-13(3)]glucose +/- oxidative challenge with superoxide thermal source; SOTS-1), as well as in vivo quantification (following human to mouse RBC xenotransfusion) of (9) blood oxygenation content mapping and flow dynamics (velocity and adhesion). Our revised glycerolization protocol (40% v/v final) resulted in >98.5% RBC recovery following freezing (-80 degrees C) and thawing (37 degrees C), with no difference compared to the standard reported method (40% w/v final). Full deglycerolization (>99.9% glycerol removal) of 40% v/v final samples resulted in total cumulative lysis of similar to 8%, compared to similar to 12-15% with the standard method. The post cryopreservation/deglycerolization RBC phenotype was indistinguishable from that for fresh RBCs with regard to physical RBC parameters (morphology, volume, and density), osmotic fragility, deformability, endothelial adhesivity, O-2 affinity, vasoregulation, metabolomics, and flow dynamics. These results indicate that RBC cryopreservation/deglycerolization in 40% v/v glycerol final does not significantly impact RBC phenotype (compared to fresh cells).	[Rogers, Stephen C.; Timm, David; Cook, Asa; Ernst, Melanie; Prakash, Jaya; Terng, Mark; Towfighi, Parhom; Doctor, Reid; Said, Ahmed; Lin, Xue; Doctor, Allan] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Rogers, Stephen C.; Doctor, Allan] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Dosier, Laura B.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [McMahon, Timothy J.; Zhu, Hongmei; Atallah, Jacqueline] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [McMahon, Timothy J.; Zhu, Hongmei] Durham VA Med Ctr, Dept Med, Durham, NC 27705 USA; [Zhang, Hengtao; Herbert, Joseph; Palmer, Gregory M.; Hanna, Gabi] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Joens, Matthew S.; Fitzpatrick, James A. J.] Washington Univ, Sch Med, Ctr Cellular Imaging, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Neurosci & Cell Biol, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Psychol, St Louis, MO USA; [Reisz, Julie A.; Nemkov, Travis; D'Alessandro, Angelo] Univ Colorado Denver, Dept Biochem, Aurora, CO USA	Washington University (WUSTL); Washington University (WUSTL); Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Doctor, A (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA.; Doctor, A (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; McMahon, TJ (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.; McMahon, TJ (corresponding author), Durham VA Med Ctr, Dept Med, Durham, NC 27705 USA.	tim.mcmahon@duke.edu; doctor@wustl.edu	Timm, David Daniel/AAX-9362-2021; Palmer, Gregory M/C-6910-2008; Said, Ahmed/AAA-1152-2022; McMahon, Tim/K-3986-2012; D'Alessandro, Angelo/AAA-4695-2019	Palmer, Gregory M/0000-0003-2955-8297; Said, Ahmed/0000-0002-1215-2664; McMahon, Tim/0000-0002-3404-3223; D'Alessandro, Angelo/0000-0002-2258-6490; Rogers, Stephen/0000-0003-1139-4730; Prakash, Jaya/0000-0002-5845-6647; Timm, Dave/0000-0003-1246-2707	National Institutes of Health (NIH) [R01 GM113838-01]; Boettcher Foundation Webb-Waring Early career Award; VA Merit Award [I01 BX-003478]; Washington University School of Medicine; Childrens Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; Foundation for Barnes-Jewish Hospital [3770];  [T32 HL-098099]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113838] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003478] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boettcher Foundation Webb-Waring Early career Award; VA Merit Award(US Department of Veterans Affairs); Washington University School of Medicine; Childrens Discovery Institute of Washington University; St. Louis Children's Hospital; Foundation for Barnes-Jewish Hospital; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	A. D. National Institutes of Health (NIH) R01 GM113838-01, Angelo d'Alessandro (Boettcher Foundation Webb-Waring Early career Award), Timothy McMahon (R01 GM113838-01; VA Merit Award I01 BX-003478), Laura Dosier (T32 HL-098099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Dr. Yulin Zhao and Mr. Husam Mikati for expert technical assistance. Electron microscopy studies were performed at the Washington University Center for Cellular Imaging (WUCCI), which is supported by the Washington University School of Medicine, the Childrens Discovery Institute of Washington University and the St. Louis Children's Hospital (CDI-CORE-2015-505) and the Foundation for Barnes-Jewish Hospital (3770).	AABB, 2014, STANDARDS BLOOD BANK, V29th; Alshaiban A, 2016, CLIN APPL THROMB-HEM, V22, P230, DOI 10.1177/1076029614565880; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Capicciotti CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09692; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Clasquin MF, 2012, CURRENT PROTOCOLS BI, V37; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; D'Alessandro A, 2017, TRANSFUSION, V57, P325, DOI 10.1111/trf.13892; Doctor A, 2011, NITRIC OXIDE TRANSPO; Dosier LBM, 2017, THROMB HAEMOSTASIS, V117, P1402, DOI 10.1160/TH16-05-0373; Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2; Gao D, 2000, ILAR J, V41, P187; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; Hall NH, 2012, J VET DIAGN INVEST, V24, P688, DOI 10.1177/1040638712445770; Henkelman S, 2010, TRANSFUSION, V50, P2393, DOI 10.1111/j.1537-2995.2010.02730.x; Hess JR, 2004, TRANSFUSION MED, V14, P1, DOI 10.1111/j.0958-7578.2004.00472.x; Holovati JL, 2008, TRANSFUSION, V48, P1658, DOI 10.1111/j.1537-2995.2008.01735.x; Huggins CE, 1970, MODERN PROBLEMS BLOO, P138; HUNTER FR, 1970, AM J PHYSIOL, V218, P1765, DOI 10.1152/ajplegacy.1970.218.6.1765; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KOSTELEC.A, 1966, B ACAD POL SCI BIOL, V14, P343; KRIJNEN HW, 1964, VOX SANG, V9, P559, DOI 10.1111/j.1423-0410.1964.tb03326.x; Lagerberg JW, 2015, METHODS MOL BIOL, V1257, P353, DOI 10.1007/978-1-4939-2193-5_17; Lecak J, 2004, TRANSFUSION, V44, P1306, DOI 10.1111/j.1537-2995.2004.03271.x; Leibo S P, 1977, Ciba Found Symp, P69; Lelkens CCM, 2003, TRANSFUSION, V43, P157, DOI 10.1046/j.1537-2995.2003.00293.x; LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V10, P414, DOI 10.1016/0006-3002(53)90273-X; LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V11, P28, DOI 10.1016/0006-3002(53)90005-5; Lusianti RE, 2013, BIOTECHNOL PROGR, V29, P609, DOI 10.1002/btpr.1710; MAZUR P, 1988, ANN NY ACAD SCI, V541, P514, DOI 10.1111/j.1749-6632.1988.tb22288.x; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Meryman HT, 2001, DEV HEMATOL, V36, P69; MERYMAN HT, 1977, TRANSFUSION, V17, P438, DOI 10.1046/j.1537-2995.1977.17578014580.x; MERYMAN HT, 1972, TRANSFUSION, V12, P145; MOORE GL, 1987, VOX SANG, V53, P15, DOI 10.1111/j.1423-0410.1987.tb04906.x; Pallotta V, 2012, BLOOD CELL MOL DIS, V48, P226, DOI 10.1016/j.bcmd.2012.02.004; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Pinder AG, 2009, ADV EXP MED BIOL, V645, P13, DOI 10.1007/978-0-387-85998-9_3; Reisz JA, 2016, BLOOD, V128, pE32, DOI 10.1182/blood-2016-05-714816; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; Sen Alok, 2013, Med J Armed Forces India, V69, P345, DOI 10.1016/j.mjafi.2013.06.005; SILVERSTEIN E, 1961, AM J PATHOL, V38, P143; SMITH AU, 1950, LANCET, V259, P910; Souza HP, 2002, AM J PHYSIOL-HEART C, V282, pH466, DOI 10.1152/ajpheart.00482.2001; Tullis J. L., 1970, MOD PROBL BLOOD PRES, P161; Turgeon M. L., 2004, CLIN HEMATOLOGY THEO; UMLAS J, 1991, TRANSFUSION, V31, P648, DOI 10.1046/j.1537-2995.1991.31791368344.x; USRY RT, 1975, VOX SANG, V28, P176, DOI 10.1111/j.1423-0410.1975.tb02756.x; Valeri C R, 1970, CRC Crit Rev Clin Lab Sci, V1, P381, DOI 10.3109/10408367009027949; VALERI CR, 1989, TRANSFUSION, V29, P429, DOI 10.1046/j.1537-2995.1989.29589284145.x; Valeri CR, 2000, VOX SANG, V79, P168, DOI 10.1159/000031236; Valeri CR, 2000, TRANSFUSION, V40, P1337, DOI 10.1046/j.1537-2995.2000.40111337.x; Valeri CR, 2004, TRANSFUSION, V44, P990, DOI 10.1111/j.1537-2995.2004.04001.x; Valeri CR, 2001, TRANSFUSION, V41, P933, DOI 10.1046/j.1537-2995.2001.41070933.x; Valeri CR, 2001, TRANSFUSION, V41, P928, DOI 10.1046/j.1537-2995.2001.41070928.x; WAYMOUTH C, 1970, IN VITRO CELL DEV B, V6, P109; WOLK E, 1983, ACTA THERIOL, V28, P73; WOLK E, 1970, Acta Theriologica, V15, P283; WOLK E, 1974, Acta Theriologica, V19, P315; WOLK E, 1985, ACTA THERIOL, V30, P337; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101; ZHU H, 2013, AM J RESP CELL MOL B, V187; Zhu HM, 2011, CRIT CARE MED, V39, P2478, DOI 10.1097/CCM.0b013e318225754f	68	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209201	10.1371/journal.pone.0209201	http://dx.doi.org/10.1371/journal.pone.0209201			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576340	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400031
J	Chokesuwattanaskul, S; Phelan, MM; Edwards, SW; Wright, HL				Chokesuwattanaskul, Susama; Phelan, Marie M.; Edwards, Steven W.; Wright, Helen L.			A robust intracellular metabolite extraction protocol for human neutrophil metabolic profiling	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS NEUTROPHILS; RESPIRATORY BURST; NMR; HMDB; IMMUNOMETABOLISM; MITOCHONDRIAL; INFLAMMATION; INHIBITORS; DATABASE; THERAPY	Neutrophils are phagocytic innate immune cells that play essential roles in host defence, but are also implicated in inflammatory diseases such as rheumatoid arthritis (RA) where they contribute to systemic inflammation and joint damage. Transcriptomic analysis of neutrophils has revealed significant changes in gene expression in neutrophils activated in vitro by cytokines and in vivo during inflammation in RA. However, there are no reports on the global metabolomic changes that occur as a consequence of this activation. The aim of this study was to establish protocols for the study of changes in the metabolome of human neutrophils using H-1 NMR spectroscopy. Sample preparation and spectral analysis protocols were optimised using neutrophils isolated by Ficoll-Paque, with decreased washing steps and inclusion of a heat-shock step to quench metabolite turnover. Cells were incubated +/- PMA for 15 min in HEPES-free media and samples were analysed by NMR using a 700 MHz NMR Avance IIIHD Bruker NMR spectrometer equipped with a TCI cryoprobe. Chenomx, Bruker TopSpin and AMIX software were used to process spectra and identify metabolites. Principal Component Analysis (PCA) and signalling pathway analysis was carried out using Meta-boanalyst. Cell number and number of scans (NS) were optimised as >3.6 million cells and 512 NS. 327 spectral bins were defined in the neutrophil spectra, of which 287 (87.7%) were assigned to 110 metabolites that included: amino acids, peptides and analogues; carbohydrates, carbonyls and alcohols; nucleotides, nucleosides and analogues; lipids and lipid-like molecules; benzenoids; and other organic compounds. 43 metabolites changed at least 1.5 fold (increase or decrease) after the addition of PMA for 5 or 15 min. Pathway analysis revealed that PMA affected nicotinate and nicotinamide metabolism, aminoacyl-tRNA biosynthesis and glycolysis, suggesting a redirection of glucose metabolism from glycolysis to the pentose phosphate pathway and production of NADPH for activation of the NADPH oxidase and subsequent respiratory burst. We have developed protocols for the study of human neutrophils by H-1 NMR spectroscopy. Importantly, this methodology has sufficient sensitivity and reproducibility to detect changes in metabolite abundance from cell numbers typically collected from clinical samples or experiments with multiple assay conditions.	[Chokesuwattanaskul, Susama; Phelan, Marie M.; Edwards, Steven W.] Univ Liverpool, Inst Integrat Biol, Biochem Dept, Liverpool, Merseyside, England; [Chokesuwattanaskul, Susama] Chulalongkorn Univ, Fac Med, Bangkok, Thailand; [Phelan, Marie M.] Univ Liverpool, HLS Technol Directorate, Liverpool, Merseyside, England; [Wright, Helen L.] Univ Liverpool, Dept Musculoskeletal Biol 1, Inst Ageing & Chron Dis, Liverpool, Merseyside, England	University of Liverpool; Chulalongkorn University; University of Liverpool; University of Liverpool	Wright, HL (corresponding author), Univ Liverpool, Dept Musculoskeletal Biol 1, Inst Ageing & Chron Dis, Liverpool, Merseyside, England.	hlwright@liverpool.ac.uk	Wright, Helen/O-2555-2019	Wright, Helen/0000-0003-0442-3134; CHOKESUWATTANASKUL, SUSAMA/0000-0002-0741-7154; Edwards, Steven/0000-0002-7074-0552	Arthritis Research UK [21430]; Medical Research Council [MR/M009114/1]; 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; Overseas Research Experience Scholarship for Graduate Students, Chulalongkorn University; University of Liverpool Technology Directorate; MRC Clinical Research Capabilities and Technologies Initiative [MR/M009114/1]; MRC [MR/M009114/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; Overseas Research Experience Scholarship for Graduate Students, Chulalongkorn University(Chulalongkorn University); University of Liverpool Technology Directorate; MRC Clinical Research Capabilities and Technologies Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK (Grant No 21430, https://www.arthritisresearchuk.org) awarded to HLW, The Medical Research Council (Grant No MR/M009114/1, https://mrc.ukri.org) awarded to Prof. M. Pirmohamed, the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship (https://www.chula.ac.th/en/) awarded to SC, the Overseas Research Experience Scholarship for Graduate Students, Chulalongkorn University (https://www.chula.ac.th/en/) awarded to SC and the University of Liverpool Technology Directorate (https://www.liverpool.ac.uk/technology-directorate/) awarded to HLW. Software licences for data analysis used in the Shared Research Facility for NMR metabolomics were funded by the MRC Clinical Research Capabilities and Technologies Initiative (MR/M009114/1, https://mrc.ukri.org) awarded to Prof M. Pirmohamed. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Anderson JR, 2018, J PROTEOME RES, V17, P3780, DOI 10.1021/acs.jproteome.8b00455; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Berg JM, 2012, BIOCH INT EDITION; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Calzetti F, 2017, J ALLERGY CLIN IMMUN, V139, P352, DOI 10.1016/j.jaci.2016.06.025; Corcoran O, 2003, DRUG DISCOV TODAY, V8, P624, DOI 10.1016/S1359-6446(03)02749-1; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Edwards S.L., 1994, BIOCH PHYSL NEUTROPH; Edwards Steven W., 1996, Methods (Orlando), V9, P563, DOI 10.1006/meth.1996.0064; Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Gaber T, 2017, NAT REV RHEUMATOL, V13, P267, DOI 10.1038/nrrheum.2017.37; Glennon-Alty L, 2018, FREE RADICAL BIOL ME, V125; Gupte RS, 2011, ANTIOXID REDOX SIGN, V14, P543, DOI 10.1089/ars.2010.3207; HALLETT MB, 1995, IMMUNOL TODAY, V16, P264, DOI 10.1016/0167-5699(95)80178-2; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Maueroder C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00583; Mitchell TS, 2017, CLIN EXP IMMUNOL, V189, P250, DOI 10.1111/cei.12970; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Phelan MM, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1289-5; Phelan MM, 2016, CURR METABOL, V4, P78, DOI 10.2174/2213235X03666151006220726; Richer BC, 2018, INFLAMMATION, V41, P710, DOI 10.1007/s10753-017-0725-z; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salek RM, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-13; Smolinska A, 2011, J PROTEOME RES, V10, P4428, DOI 10.1021/pr200203v; STJERNHOLM RL, 1972, ENZYME, V13, P7, DOI 10.1159/000459647; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Thomas HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138982; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wright HL, 2017, J LEUKOCYTE BIOL, V101, P785, DOI 10.1189/jlb.5A0616-258R; Wright HL, 2017, J LEUKOCYTE BIOL, V101, P599, DOI 10.1189/jlb.5A0116-022R; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021; Zhang D, 2008, DRUG METABOLISM IN DRUG DESIGN AND DEVELOPMENT: BASIC CONCEPTS AND PRACTICE, P1	62	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209270	10.1371/journal.pone.0209270	http://dx.doi.org/10.1371/journal.pone.0209270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571714	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700048
J	Ibiloye, O; Decroo, T; Eyona, N; Eze, P; Agada, P				Ibiloye, Olujuwon; Decroo, Tom; Eyona, Nathaniel; Eze, Peter; Agada, Peter			Characteristics and early clinical outcomes of key populations attending comprehensive community-based HIV care: Experiences from Nasarawa State, Nigeria	PLOS ONE			English	Article							FEMALE SEX WORKERS; ANTIRETROVIRAL TREATMENT; MEN; ADHERENCE; AFRICA	Background Despite a call for differentiated care, there are limited data from sub-Saharan Africa on comprehensive community-based HIV care for key populations (KP), including commercial sex workers (CSW), men who have sex with men (MSM), and people who inject drugs (PWID). In Nigeria, a programme was implemented that liaised with community-based organizations and offered HIV testing, same-day ART initiation, and ART follow-up to KP. Here we characterize KP and their partners enrolled on ART. Our objective is to assess the early treatment outcomes and to estimate predictors of attrition among KP. Method This is a retrospective cohort study of routinely collected data in a community-based HIV program for KP in Nasarawa state, Nigeria from August 2016 to November 2017. Variables of interest were socio-demographic, KP types, treatment outcomes, ART adherence, WHO stage, TB status and viral load. Summary statistics, logistic and Cox proportional hazard regression were used to describe the characteristics of KP and estimate predictors of attrition (patients either lost to follow-up (LTFU) or dead). Result Seven hundred and ten (710) KP and their partners were enrolled into this study, 77.3% (549) of study participants were female and the median age was 30 years (IQR: 24-35). Respectively, 74.2%, 4.5%, 1.1% and 20% were FSW, MSM, PWID and their partners. Of 710 KP who started ART, 13.9% (99/710) discontinued after the first visit. After a median follow-up time of 7 months on ART 73.2% of patients were retained, 23.4% were LTFU, and 3.4% were dead. Lack of formal education (aHR 1.8; 95% CI 1.3-2.6) and unemployment (aHR 1.8; 95% CI 1.2-2.6) were significantly associated with attrition. Conclusion Comprehensive community-based HIV care, including HIV testing and same-day ART is feasible. However, ART initiation on the same day of confirmatory HIV testing resulted in a high uptake of ART, but possibly inflated early attrition on ART. To mitigate early attrition among KP after same-day ART initiation, the psychosocial readiness of clients should be assessed better. We strongly recommend further studies to understand factors contributing to high attrition among the KP.	[Ibiloye, Olujuwon; Eyona, Nathaniel; Eze, Peter; Agada, Peter] Lafia Integrated Sexual Hlth Ctr, Soc Family Hlth, Lafia, Nigeria; [Ibiloye, Olujuwon] APIN Publ Hlth Initiat, Clin Serv, Abuja, Nigeria; [Decroo, Tom] Inst Trop Med, Antwerp, Belgium; [Decroo, Tom] Res Fdn Flanders, Brussels, Belgium	Institute of Tropical Medicine (ITM)	Ibiloye, O (corresponding author), Lafia Integrated Sexual Hlth Ctr, Soc Family Hlth, Lafia, Nigeria.; Ibiloye, O (corresponding author), APIN Publ Hlth Initiat, Clin Serv, Abuja, Nigeria.	juonib26@gmail.com	Decroo, Tom/AAV-7208-2020; Ibiloye, Olujuwon/ABE-7875-2021	Decroo, Tom/0000-0002-1205-1484; Ibiloye, Olujuwon/0000-0002-2995-1534	United States Agency for International Development through Society for Family Health in Nigeria	United States Agency for International Development through Society for Family Health in Nigeria(United States Agency for International Development (USAID))	This study used data collected as part of routine care and treatment services that were supported by United States Agency for International Development through Society for Family Health in Nigeria. The funders were not involved in the study design or the writing of the study findings	[Anonymous], 2013, NAT HIV AIDS REPR HL; Asiimwe S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21633; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Holland CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122881; Holland CE, 2015, JAIDS-J ACQ IMM DEF, V68, pS232, DOI 10.1097/QAI.0000000000000443; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Kaplan SR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002407; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Lall P, 2015, J INT AIDS SOC S1, V18; Lancaster KE, 2016, AJAR-AFR J AIDS RES, V15, P377, DOI 10.2989/16085906.2016.1255652; Larsson EC, 2007, T ROY SOC TROP MED H, V101, P885, DOI 10.1016/j.trstmh.2007.04.024; MacAllister J, 2015, JAIDS-J ACQ IMM DEF, V68, pS83, DOI 10.1097/QAI.0000000000000457; Maheu-Giroux M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002321; Micheni M, 2017, AIDS PATIENT CARE ST, V31, P113, DOI 10.1089/apc.2016.0213; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; National Agency for the Control of AIDS, 2014, FED REP NIG GLOB AID; Onovo A, 2016, OPEN FORUM INFECT S1, V3, DOI [10.1093/ofid/ofw194.35, DOI 10.1093/OFID/OFW194.35]; Pustil R., 2016, AIDS S4, V17, pS3, DOI 10.1073/pnas.86.15.5781; Rifkin SB, 2009, INT HEALTH, V1, P31, DOI 10.1016/j.inhe.2009.02.001; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Van Blerk L, 2007, AIDS CARE, V19, P79, DOI 10.1080/09540120600805091; Vogt F, 2017, JAIDS-J ACQ IMM DEF, V74, P326, DOI 10.1097/QAI.0000000000001215; Vu L, 2013, JAIDS-J ACQ IMM DEF, V63, P221, DOI 10.1097/QAI.0b013e31828a3e60	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209477	10.1371/journal.pone.0209477	http://dx.doi.org/10.1371/journal.pone.0209477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571744	gold, Green Submitted, Green Published			2022-12-26	WOS:000453841700079
J	Loss, J; Muller, D; Weigl, J; Helbig, H; Brandl, C; Heid, IM; Finger, RP; Weber, BHF; Curbach, J				Loss, Julika; Mueller, Daniel; Weigl, Johannes; Helbig, Horst; Brandl, Caroline; Heid, Iris M.; Finger, Robert P.; Weber, Bernhard H. F.; Curbach, Janina			Views of ophthalmologists on the genetics of age-related macular degeneration: Results of a qualitative study	PLOS ONE			English	Article							HEALTH-CARE; PREVALENCE; KNOWLEDGE; SUSCEPTIBILITY; EPIDEMIOLOGY; ACCELERATE; ATTITUDES; EDUCATION; SMOKING; US	Background Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized countries. It is a multifactorial disease of the retina modified by environmental/individual (e.g. smoking) and genetic factors. 34 independent genomic loci are associated with the risk to develop AMD; an interaction between smoking and genetics is currently investigated. It is unclear how the knowledge on the strong genetic component has entered the knowledge base of practicing ophthalmologists, and how they inform and counsel their (AMD) patients about it. In this study, we explore the ophthalmologist's view on AMD genetics, and their inclination towards communicating genetic risks to patients. Methods We recruited a purposive sample of thirty German ophthalmologists (office based: n = 15, hospital employees: n = 15, f:8/30), who took part in a recorded semi-standardized interview. Transcripts were analyzed using content analysis. Results The majority of office-based ophthalmologists claimed to be unfamiliar with genetics of AMD, in contrast to hospital-affiliated ophthalmologists. Both office and hospital ophthalmologists were convinced that genetics lacks practical relevance in everyday patient care. Many withhold information on heritability or genetic background of AMD from patients and their relatives, for fear of unsettling those individuals. The relevance of the genetic component of AMD or an individual's high genetic risk for prevention, e.g. screening or lifestyle modifications in persons with adverse genetic profile, was rated low. Conclusion Developing genetic educational programs tailored to the routine care of ophthalmologists may be indicated, as well as a better two-way communication between research and practice. Exploring patient views about their expectations to being informed about genetic disease etiology, or about their individual risk, would help inform communication strategies.	[Loss, Julika; Mueller, Daniel; Weigl, Johannes; Curbach, Janina] Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany; [Helbig, Horst; Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Brandl, Caroline; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Finger, Robert P.] Univ Bonn, Univ Eye Hosp, Bonn, Germany; [Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Bonn; University of Regensburg	Loss, J (corresponding author), Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany.	julika.loss@ukr.de		Brandl, Caroline/0000-0001-8223-6137	Bundesministerium fur Bildung und Forschung, Germany Ministry for Research and Education [FK 01GP1308]	Bundesministerium fur Bildung und Forschung, Germany Ministry for Research and Education	The study is part of a Research Network: "Prevention in the postgenomic era: communication of genetic risks using the case of age-related macular degeneration (AMD)", funded by the Bundesministerium fur Bildung und Forschung, Germany Ministry for Research and Education (FK 01GP1308), https://www.bmbf.de/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Ophthalmology Retina Vitreous Panel, 2008, AG REL MAC DEG; Anand A, 2014, CURR GENOMICS, V15, P266, DOI 10.2174/1389202915666140516204512; [Anonymous], 2018, AG REL MAC DEG; Bailey JNC, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030031; Batra S, 2002, AM J GASTROENTEROL, V97, P729; Brandl C, 2016, OPHTHALMOLOGE, V113, P735, DOI 10.1007/s00347-016-0341-6; Callard F, 2012, HEALTH EXPECT, V15, P389, DOI 10.1111/j.1369-7625.2011.00681.x; Carroll JC, 2009, CAN FAM PHYSICIAN, V55, pE92; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cherkas LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013473; Chew EY, 2015, OPHTHALMOLOGY, V122, P2155, DOI 10.1016/j.ophtha.2015.08.007; Chew EY, 2015, OPHTHALMOLOGY, V122, P212, DOI 10.1016/j.ophtha.2014.10.012; Colijn JM, 2017, OPHTHALMOLOGY, V124, P1753, DOI 10.1016/j.ophtha.2017.05.035; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Fernandez-Robredo P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/510285; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Grassmann F, 2015, ANNU REV VIS SCI, V1, P73, DOI 10.1146/annurev-vision-082114-035609; Haga SB, 2013, GENET TEST MOL BIOMA, V17, P327, DOI 10.1089/gtmb.2012.0350; Houwink EJF, 2014, EUR J HUM GENET, V22, P310, DOI 10.1038/ejhg.2013.163; Houwink EJF, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-5; Jain S, 2006, EYE, V20, P471, DOI 10.1038/sj.eye.6701916; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; Korb CA, 2014, GRAEF ARCH CLIN EXP, V252, P1403, DOI 10.1007/s00417-014-2591-9; Kumaramanickavel G, 2016, ASIA-PAC J OPHTHALMO, V5, P229, DOI 10.1097/APO.0000000000000223; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Mares JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P470, DOI 10.1001/archophthalmol.2010.314; Marincola Francesco M, 2003, J Transl Med, V1, P1, DOI 10.1186/1479-5876-1-1; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCarty CA, 2018, OPTOMETRY VISION SCI, V95, P166, DOI 10.1097/OPX.0000000000001188; Merle BMJ, 2015, AM J CLIN NUTR, V102, P1196, DOI 10.3945/ajcn.115.111047; Narimatsu H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020302; Oliveri S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6824581; Paneque M, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0483-2; Panic N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418416; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Rim Priscila Hae Hyun, 2006, Arq. Bras. Oftalmol., V69, P481, DOI 10.1590/S0004-27492006000400005; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schully SD, 2014, APPL TRANSL GENOM, V3, P82, DOI 10.1016/j.atg.2014.09.006; Schwartz SG, 2016, CLIN OPHTHALMOL, V10, P1229, DOI 10.2147/OPTH.S109723; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sobrin L, 2014, PROG RETIN EYE RES, V40, P1, DOI 10.1016/j.preteyeres.2013.12.004; Stone EM, 2015, JAMA OPHTHALMOL, V133, P598, DOI 10.1001/jamaophthalmol.2015.0369; Sutherland JE, 2009, CURR OPIN OPHTHALMOL, V20, P343, DOI 10.1097/ICU.0b013e32832f7f0d; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Velez-Montoya R, 2014, RETINA-J RET VIT DIS, V34, P423, DOI 10.1097/IAE.0000000000000036	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209328	10.1371/journal.pone.0209328	http://dx.doi.org/10.1371/journal.pone.0209328			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571778	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700055
J	Maruyama, AT; Komai, S				Maruyama, Atsuko T.; Komai, Shoji			Auditory-induced response in the primary sensory cortex of rodents	PLOS ONE			English	Article							WHOLE-CELL RECORDINGS; MULTISENSORY INTEGRATION; INHIBITION; P300; MODULATION; CORTICES; NEURONS; IDENTIFICATION; PHYSIOLOGY; MODALITY	The details of auditory response at the subthreshold level in the rodent primary somatosensory cortex, the barrel cortex, have not been studied extensively, although several phenomenological reports have been published. Multisensory features may act as neuronal representations of links between inputs from one sensory modality to other sensory modalities. Here, we examined the basic multisensory postsynaptic responses in the rodent barrel cortex using in vivo whole-cell recordings of neurons. We observed robust responses to acoustic stimuli in most barrel cortex neurons. Acoustically evoked responses were mediated by hearing and reached approximately 60% of the postsynaptic response amplitude elicited by strong somatosensory stimuli. Compared to tactile stimuli, auditory stimuli evoked postsynaptic potentials with a longer latency and longer duration. Specifically, auditory stimuli in barrel cortex neurons appeared to trigger "up states", episodes associated with membrane depolarization and increased synaptic activity. Taken together, our data suggest that barrel cortex neurons have multisensory properties, with distinct synaptic mechanisms underlying tactile and non-tactile responses.	[Maruyama, Atsuko T.; Komai, Shoji] Nara Inst Sci Technol, Dept Sci & Technol, Takayama, Japan	Nara Institute of Science & Technology	Komai, S (corresponding author), Nara Inst Sci Technol, Dept Sci & Technol, Takayama, Japan.	skomai@bs.naist.jp		Komai, Shoji/0000-0002-8474-7800	Max-Planck Institute for Medical Research; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; ERASMUS; Max-Planck Institute for Medical Research, Heidelberg; JST PRESTO	Max-Planck Institute for Medical Research; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); ERASMUS; Max-Planck Institute for Medical Research, Heidelberg; JST PRESTO(Japan Science & Technology Agency (JST))	This research was supported from Max-Planck Institute for Medical Research, ERASMUS, and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (http://www.jst.go.jp/presto/bmi/researcher_2_E.html). Funding was received by SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding support was provided by the Max-Planck Institute for Medical Research, Heidelberg (MB), ERASMUS (GB), and JST PRESTO (SK).	Bieler M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0037-17.2017; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Cote KA, 1999, NEUROREPORT, V10, P2313, DOI 10.1097/00001756-199908020-00017; Cui JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169449; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; Dooley JC, 2013, J COMP NEUROL, V521, P3877, DOI 10.1002/cne.23383; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Ehlers CL, 2002, BRAIN RES, V957, P117, DOI 10.1016/S0006-8993(02)03612-0; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Ghoshal A, 2011, J NEUROSCI, V31, P2526, DOI 10.1523/JNEUROSCI.5547-10.2011; Goto K, 2004, PSYCHIAT CLIN NEUROS, V58, P441, DOI 10.1111/j.1440-1819.2004.01281.x; Henschke JU, 2015, BRAIN STRUCT FUNCT, V220, P955, DOI 10.1007/s00429-013-0694-4; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HURLBUT BJ, 1987, PHYSIOL BEHAV, V39, P483, DOI 10.1016/0031-9384(87)90377-5; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Ibrahim LA, 2016, NEURON, V89, P1031, DOI 10.1016/j.neuron.2016.01.027; Ito J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4572; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Keniston LP, 2010, EXP BRAIN RES, V202, P725, DOI 10.1007/s00221-010-2163-0; Kheradpezhouh E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11477-6; Kim SS, 2015, NEURON, V86, P555, DOI 10.1016/j.neuron.2015.03.020; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lemus L, 2010, NEURON, V67, P335, DOI 10.1016/j.neuron.2010.06.015; Loeb GE, 2014, FRONT NEUROSCI, P8, DOI [10.3389/fnins.2014.00008, DOI 10.3389/FNINS.2014.00008]; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Molnar Z, 2014, BRAIN BEHAV EVOLUT, V83, P126, DOI 10.1159/000357753; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nishimura M, 2015, NEUROSCI RES, V99, P55, DOI 10.1016/j.neures.2015.06.001; O'Donnell BF, 2004, INT J PSYCHOPHYSIOL, V53, P45, DOI 10.1016/j.ijpsycho.2004.02.001; Olcese U, 2013, NEURON, V79, P579, DOI 10.1016/j.neuron.2013.06.010; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pitas A, 2017, CEREB CORTEX, V27, P1758, DOI 10.1093/cercor/bhw006; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Sieben K, 2013, J NEUROSCI, V33, P5736, DOI 10.1523/JNEUROSCI.4432-12.2013; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; Stein BE, 2014, NAT REV NEUROSCI, V15, P520, DOI 10.1038/nrn3742; STEIN BE, 1990, ANN NY ACAD SCI, V608, P51, DOI 10.1111/j.1749-6632.1990.tb48891.x; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Valeriani M, 2001, MUSCLE NERVE, V24, P1677, DOI 10.1002/mus.1203; van Looij MAJ, 2004, HEARING RES, V193, P75, DOI 10.1016/j.heares.2004.02.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Xu JH, 2017, CEREB CORTEX, V27, P5568, DOI 10.1093/cercor/bhw324; YAMAGUCHI S, 1991, ELECTROEN CLIN NEURO, V78, P50, DOI 10.1016/0013-4694(91)90018-Y; Yu LP, 2016, CEREB CORTEX, V26, P1130, DOI 10.1093/cercor/bhu295; Zhou YD, 2000, P NATL ACAD SCI USA, V97, P9777, DOI 10.1073/pnas.97.17.9777; Zhou YD, 2004, BEHAV BRAIN RES, V153, P573, DOI 10.1016/j.bbr.2003.12.024; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	61	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209266	10.1371/journal.pone.0209266	http://dx.doi.org/10.1371/journal.pone.0209266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571722	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700047
J	Carter, JM; Brown, EM; Grace, JP; Salem, AK; Irish, EE; Bowden, NB				Carter, Justin M.; Brown, Eric M.; Grace, James P.; Salem, Aliasger K.; Irish, Erin E.; Bowden, Ned B.			Improved growth of pea, lettuce, and radish plants using the slow release of hydrogen sulfide from GYY-4137	PLOS ONE			English	Article							DONOR SODIUM HYDROSULFIDE; NITRIC-OXIDE; STRESS-RESPONSE; HEAT TOLERANCE; POSTHARVEST SENESCENCE; ANTIOXIDATIVE ROLE; DEFENSE RESPONSES; SEED-GERMINATION; UP-REGULATION; MAIZE	Hydrogen sulfide (H2S) is a key gasotransmitter in agriculture and has been reported to increase the growth of plants in the first two weeks and to mitigate the effects of environmental stressors. GYY-4137 is widely used in these studies because it slowly releases H2S, but there is disagreement as to whether it requires enzymes to release H2S. In this article we describe the release of H2S in water without enzymes and that it releases H2S faster in organic solvents than in water or when mixed in topsoil. Furthermore, we describe the long-term effect of dosing pea, radish, and lettuce plants with GYY-4137 for up to six weeks. The effect of GYY-4137 on plant growth for six weeks was either positive or negative depending on the loading of GYY-4137 and how it was applied to plants. The addition of GYY-4137 to lettuce plants via potting mix resulted in reduced growth and death of the plants. In contrast, application of GYY-4137 to the leaves of lettuce plants increased the harvest weight of the leaves by up to 86%. Our results demonstrate that GYY-4137 can have a positive, important effect on the growth of plants but that this effect is dependent on several factors.	[Carter, Justin M.; Brown, Eric M.; Grace, James P.; Bowden, Ned B.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Salem, Aliasger K.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Irish, Erin E.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Bowden, NB (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	ned-bowden@uiowa.edu		Bowden, Ned/0000-0003-1628-8515	USDA [NIFA-2018-67030-27352]; Leopold Center for Sustainable Agriculture; Lyle and Sharon Bighley Chair of Pharmaceutical Sciences	USDA(United States Department of Agriculture (USDA)); Leopold Center for Sustainable Agriculture; Lyle and Sharon Bighley Chair of Pharmaceutical Sciences	N.B.B. would like to acknowledge USDA NIFA-2018-67030-27352 and the Leopold Center for Sustainable Agriculture, and A.K.S. acknowledges the Lyle and Sharon Bighley Chair of Pharmaceutical Sciences for funding. https://nifa.usda.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BE, 2015, MEDCHEMCOMM, V6, P1649, DOI 10.1039/c5md00170f; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Beydler B, 2016, PLANT PHYSIOL, V171, P2648, DOI 10.1104/pp.15.01707; Bloem E, 2011, J AGRON CROP SCI, V197, P311, DOI 10.1111/j.1439-037X.2010.00461.x; Capaldi FR, 2015, TROP PLANT BIOL, V8, P60, DOI 10.1007/s12042-015-9152-1; Capper Judith L, 2012, Animals (Basel), V2, P127, DOI 10.3390/ani2020127; Chen J, 2015, J EXP BOT, V66, P6605, DOI 10.1093/jxb/erv368; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Cheng W, 2013, PLANT PHYSIOL BIOCH, V70, P278, DOI 10.1016/j.plaphy.2013.05.042; Christou A, 2013, J EXP BOT, V64, P1953, DOI 10.1093/jxb/ert055; Dooley FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062048; Duan BB, 2015, PLANT GROWTH REGUL, V75, P33, DOI 10.1007/s10725-014-9929-5; Fang T, 2014, PLANT PHYSIOL BIOCH, V76, P44, DOI 10.1016/j.plaphy.2013.12.024; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fotopoulos V, 2015, J HORTIC SCI BIOTECH, V90, P227, DOI 10.1080/14620316.2015.11513176; Fotopoulos V, 2014, HYDROGEN SULFIDE POT; Fu PN, 2013, ACTA SOC BOT POL, V82, P295, DOI 10.5586/asbp.2013.031; Gao SP, 2013, HORTSCIENCE, V48, P1385, DOI 10.21273/HORTSCI.48.11.1385; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guo HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2038-x; Hancock JT, 2016, ADV BOT RES, V77, P1, DOI 10.1016/bs.abr.2015.10.012; Hou ZH, 2013, J INTEGR PLANT BIOL, V55, P277, DOI 10.1111/jipb.12004; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Khalil M. S., 1996, Egyptian Journal of Physiological Sciences, V20, P81; Kloesch B, 2016, PHARMACOL REP, V68, P37, DOI 10.1016/j.pharep.2015.05.026; Kord M., 1993, Egyptian Journal of Physiological Sciences, V17, P139; Kord M, 1993, EGYPT J PHYSL SCI, V17, P117; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; KRAUSE GHM, 1979, STAUB REINHALT LUFT, V39, P165; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li SP, 2014, J AGR FOOD CHEM, V62, P1119, DOI 10.1021/jf4047122; Li Y-J, 2014, J AGR FOOD CHEM, V62, P1119, DOI [10.1021/jf4047122, DOI 10.1021/JF4047122]; Li ZG, 2013, RUSS J PLANT PHYSL+, V60, P733, DOI 10.1134/S1021443713060058; Li ZR, 2015, HORTSCIENCE, V50, P416, DOI 10.21273/HORTSCI.50.3.416; Li ZG, 2014, BIOLOGIA, V69, P1001, DOI 10.2478/s11756-014-0396-2; Li ZG, 2013, PLANT CELL ENVIRON, V36, P1564, DOI 10.1111/pce.12092; Li ZG, 2013, J PLANT PHYSIOL, V170, P741, DOI 10.1016/j.jplph.2012.12.018; Li ZG, 2012, ACTA PHYSIOL PLANT, V34, P2207, DOI 10.1007/s11738-012-1021-z; Lin YT, 2012, J PLANT GROWTH REGUL, V31, P519, DOI 10.1007/s00344-012-9262-z; Lisjak M, 2011, PLANT SIGNAL BEHAV, V6, P1444, DOI 10.4161/psb.6.10.17104; Liu JB, 2011, CHINESE SCI BULL, V56, P2464, DOI 10.1007/s11434-011-4592-y; Liu RQ, 2015, COMMUN SOIL SCI PLAN, V46, P576, DOI 10.1080/00103624.2014.998341; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Park CM, 2013, MOL BIOSYST, V9, P2430, DOI 10.1039/c3mb70145j; Pearce ME, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/17/175103; Shi HT, 2014, PLANT PHYSIOL BIOCH, V74, P99, DOI 10.1016/j.plaphy.2013.11.001; Shi HT, 2013, PLANT PHYSIOL BIOCH, V71, P226, DOI 10.1016/j.plaphy.2013.07.021; Singh VP, 2015, J PLANT PHYSIOL, V181, P20, DOI [10.1016/j.plph.03.015, 10.1016/j.jplph.2015.03.015]; STEUBING L, 1978, ANGEW BOT, V52, P137; STEUBING L, 1979, STAUB REINHALT LUFT, V39, P161; Sun YongDong, 2013, Journal of Food, Agriculture & Environment, V11, P1097; THOMPSON CR, 1978, ENVIRON SCI TECHNOL, V12, P550, DOI 10.1021/es60141a001; THOMPSON CR, 1979, CALIF AGR, V33, P9; United Nations Department of Economic and Social Affairs Population Division, 2013, ESAPWP228; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2009, J INTEGR PLANT BIOL, V51, P1086, DOI 10.1111/j.1744-7909.2009.00885.x; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1; Ziogas V, 2015, PLANT MOL BIOL, V89, P433, DOI 10.1007/s11103-015-0379-x	64	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208732	10.1371/journal.pone.0208732	http://dx.doi.org/10.1371/journal.pone.0208732			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557337	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000041
J	Korja, R; Nolvi, S; Kataja, EL; Scheinin, N; Junttila, N; Lahtinen, H; Saarni, S; Karlsson, L; Karlsson, H				Korja, Riikka; Nolvi, Saara; Kataja, Eeva-Leena; Scheinin, Noora; Junttila, Niina; Lahtinen, Henna; Saarni, Suoma; Karlsson, Linnea; Karlsson, Hasse			The courses of maternal and paternal depressive and anxiety symptoms during the prenatal period in the FinnBrain Birth Cohort study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; HPA AXIS; PREGNANCY; STRESS; POSTPARTUM; VALIDATION; FATHERS; SCALE; TRAJECTORIES; REACTIVITY	Maternal prenatal symptoms of depression and anxiety have been suggested to impose differential effects on later offspring development, depending on their characteristics, such as timing, intensity and persistence. Paternal symptoms have been less investigated. While knowledge on these trajectory characteristics is essential for improved comprehension of prenatal stress, prospective studies including both expecting parents have been scarce. We aim at identifying and comparing the trajectories of prenatal depressive and anxiety symptoms in both parents in a pregnancy cohort design. The sample included 3202 mothers and 2076 fathers who were recruited to the FinnBrain Birth Cohort study (WWW.finnbrain.fi). Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS) and general anxiety by the anxiety scale of the Symptom Checklist-90 (SCL-90) repeatedly at 14, 24, and 34 gestational weeks. Five differential depressive and four anxiety symptom trajectories were identified across pregnancy both in mothers and in fathers. The trajectories of consistently low depressive or anxiety symptoms were associated with higher educational level in both parents, and with nulliparity and non-smoking during pregnancy in mothers. Parents with consistently high or increasing levels of symptoms had more often prenatal SSRI medication. The congruences between elevated depressive and anxiety symptoms at any point in pregnancy, as well as parental trajectories within families were low. However, in this population-based sample, the self-reported symptom levels of both parents were generally very low. Variance in timing and persistence of parent-reported prenatal depressive and anxiety symptoms is potentially important, while symptom trajectories are very similar in mothers and fathers. These differential symptom trajectories and the significance of their correlates should be acknowledged when studying prenatal stress exposures and the related outcomes in children.	[Korja, Riikka; Nolvi, Saara; Kataja, Eeva-Leena; Scheinin, Noora; Saarni, Suoma; Karlsson, Linnea; Karlsson, Hasse] Univ Turku, Turku Brain & Mind Ctr, Inst Clin Med, FinnBrain Birth Cohort Study, Turku, Finland; [Korja, Riikka; Kataja, Eeva-Leena; Lahtinen, Henna] Univ Turku, Dept Psychol, Turku, Finland; [Scheinin, Noora; Saarni, Suoma; Karlsson, Linnea; Karlsson, Hasse] Univ Turku, Turku, Finland; [Scheinin, Noora; Saarni, Suoma; Karlsson, Hasse] Turku Univ Hosp, Dept Psychiat, Turku, Finland; [Junttila, Niina] Univ Turku, Dept Teacher Educ, Turku, Finland; [Saarni, Suoma] Helsinki Univ Hosp, Dept Psychiat, Helsinki, Finland; [Karlsson, Linnea] Turku Univ Hosp, Inst Clin Med, Dept Child Psychiat, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Turku	Korja, R (corresponding author), Univ Turku, Turku Brain & Mind Ctr, Inst Clin Med, FinnBrain Birth Cohort Study, Turku, Finland.; Korja, R (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	riikka.korja@utu.fi	Nolvi, Saara/AAO-5668-2021; Karlsson, Linnea/AAI-5959-2020; Korja, Riikka/M-9344-2015	Nolvi, Saara/0000-0003-4959-1473; Karlsson, Linnea/0000-0002-4725-0176; Karlsson, Hasse/0000-0002-4992-1893; Junttila, Niina/0000-0002-9096-377X; Korja, Riikka/0000-0002-6833-1565	Academy of Finland [129839, 134950, 253270, 286829, 287908, 308176, 308252]; Emil Aaltonen Foundation; Finnish Medical Association; Jane and Aatos Erkko Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; State Grants for Clinical Research (ERVA)	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Medical Association; Jane and Aatos Erkko Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; State Grants for Clinical Research (ERVA)	This study is funded by the Academy of Finland (129839, 134950, 253270, 286829, 287908, 308176, 308252), Emil Aaltonen Foundation, Finnish Medical Association, Jane and Aatos Erkko Foundation, Signe and Ane Gyllenberg Foundation, State Grants for Clinical Research (ERVA) and Yrjo Jahnsson Foundation.	Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Baron E, 2017, J AFFECT DISORDERS, V223, P194, DOI 10.1016/j.jad.2017.07.046; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Buist A, 2003, JOGNN-J OBST GYN NEO, V32, P172, DOI 10.1177/0884217503252127; Cents RAM, 2013, PSYCHOL MED, V43, P13, DOI 10.1017/S0033291712000657; Chaudron LH, 2014, J PSYCHOSOM RES, V76, P489, DOI 10.1016/j.jpsychores.2014.03.011; Condon JT, 2003, 1 TIME FATHERS STUDY, DOI [10.1017/S0033291712000657, DOI 10.1017/S0033291712000657]; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Davis EP, 2004, INFANCY, V6, P319, DOI 10.1207/s15327078in0603_1; de Almeida CP, 2012, J REPROD INFANT PSYC, V30, P341, DOI 10.1080/02646838.2012.736689; de Weerth C, 2013, PSYCHONEUROENDOCRINO, V38, P2863, DOI 10.1016/j.psyneuen.2013.07.014; Deconinck H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162534; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Egliston KA, 2007, PSYCHONEUROENDOCRINO, V32, P1, DOI 10.1016/j.psyneuen.2006.10.003; Elovainio M, 2012, SOC SCI MED, V74, P923, DOI 10.1016/j.socscimed.2011.12.017; Escriba-Agueir V, 2008, J EPIDEMIOL COMMUN H, V62, P410, DOI 10.1136/jech.2007.063016; Field T, 2006, INFANT BEHAV DEV, V29, P579, DOI 10.1016/j.infbeh.2006.07.010; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Figueiredo B, 2011, J AFFECT DISORDERS, V132, P146, DOI 10.1016/j.jad.2011.02.007; Fredriksen E, 2017, J ABNORM PSYCHOL, V126, P173, DOI 10.1037/abn0000246; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Grant KA, 2010, INFANT BEHAV DEV, V33, P453, DOI 10.1016/j.infbeh.2010.05.001; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hill J, 2013, GENES BRAIN BEHAV, V12, P388, DOI 10.1111/gbb.12033; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ibanez G, 2012, EARLY HUM DEV, V88, P643, DOI 10.1016/j.earlhumdev.2012.01.014; JEDIDI K, 1993, PSYCHOMETRIKA, V58, P375, DOI 10.1007/BF02294647; Karlsson L, 2017, INT J EPIDEMIOL; Karlsson L, 2017, ARCH WOMEN MENT HLTH, V20, P39, DOI 10.1007/s00737-016-0672-y; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Korja R, 2017, CHILD PSYCHIAT HUM D, V48, P851, DOI 10.1007/s10578-017-0709-0; Leinonen JA, 2002, INT J BEHAV DEV, V26, P423, DOI 10.1080/01650250143000364; Lemche E, 2016, CNS SPECTRUMS, V21, P35, DOI 10.1017/S1092852913000588; Liu C, 2016, BJOG-INT J OBSTET GY, V123, P1973, DOI 10.1111/1471-0528.13891; Massoudi P, 2013, J AFFECT DISORDERS, V149, P67, DOI 10.1016/j.jad.2013.01.005; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; Matthey S, 2001, J AFFECT DISORDERS, V64, P175, DOI 10.1016/S0165-0327(00)00236-6; McMahon CA, 2013, HUM REPROD, V28, P997, DOI 10.1093/humrep/det029; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Morse CA, 2000, J PSYCHOSOM OBST GYN, V21, P109, DOI 10.3109/01674820009075616; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Muthen B., 2010, MPLUS USERS GUIDE; Mychasiuk R, 2013, NEUROSCIENCE, V241, P100, DOI 10.1016/j.neuroscience.2013.03.025; Navaratne P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33544; Ngai FW, 2015, J PSYCHOSOM RES, V78, P156, DOI 10.1016/j.jpsychores.2014.12.003; Nolvi S, 2016, J AFFECT DISORDERS, V199, P163, DOI 10.1016/j.jad.2016.04.020; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; O'Donnell KJ, 2017, AM J PSYCHIAT, V174, P999, DOI 10.1176/appi.ajp.2017.17040376r; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; Parfitt Y, 2014, INFANT MENT HEALTH J, V35, P263, DOI 10.1002/imhj.21443; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Prenoveau JM, 2017, DEV PSYCHOL, V53, P50, DOI 10.1037/dev0000221; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Ramchandani P, 2009, LANCET, V374, P646, DOI 10.1016/S0140-6736(09)60238-5; Ramchandani PG, 2008, J CHILD PSYCHOL PSYC, V49, P1069, DOI 10.1111/j.1469-7610.2008.02000.x; Ramchandani PG, 2010, J AM ACAD CHILD PSY, V49, P239, DOI 10.1016/j.jaac.2009.11.013; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Skouteris H, 2009, J AFFECT DISORDERS, V113, P303, DOI 10.1016/j.jad.2008.06.002; Slade A., 2009, HDB INFANT MENTAL HL, V3, P22; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Sutter-Dallay AL, 2012, J AFFECT DISORDERS, V139, P23, DOI 10.1016/j.jad.2011.08.018; Teixeira C, 2009, J AFFECT DISORDERS, V119, P142, DOI 10.1016/j.jad.2009.03.005; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; Van den Bergh B. R. H., 2017, NEUROSCI BIOBEHAV RE; van der Waerden J, 2017, DEPRESS ANXIETY, V34, P105, DOI 10.1002/da.22552; Vanska M, 2013, INT J BEHAV DEV, V35, P517, DOI [10.1177/1359105313484781, DOI 10.1177/1359105313484781]; Vanska M, 2016, PATERNAL MENTAL HLTH; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013	77	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0207856	10.1371/journal.pone.0207856	http://dx.doi.org/10.1371/journal.pone.0207856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557345	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000016
J	Graustein, AD; Misch, EA; Musvosvi, M; Shey, M; Shah, JA; Seshadri, C; Aguoju, A; Bowman, K; Mulenga, H; Veldsman, A; Hanekom, WA; Hatherill, M; Scriba, TJ; Hawn, TR				Graustein, Andrew D.; Misch, Elizabeth A.; Musvosvi, Munyaradzi; Shey, Muki; Shah, Javeed A.; Seshadri, Chetan; Aguoju, Augustine; Bowman, Kathryn; Mulenga, Humphrey; Veldsman, Ashley; Hanekom, Willem A.; Hatherill, Mark; Scriba, Thomas J.; Hawn, Thomas R.			Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; T-CELL FREQUENCY; TUBERCULOSIS; SUSCEPTIBILITY; POLYMORPHISMS; EXPRESSION; VACCINE; COMMON; BCG; PROTECTION	Rationale HSP90B1, also known as gp96, is a chaperone for multiple Toll-like receptors (TLRs) and is necessary for TLR-mediated inflammatory responses in murine myeloid cells. The molecule is also expressed in T-cells though its specific role is unknown. We hypothesized that human HSP90B1 regulates monocyte and T-cell responses to Mycobacterium tuberculosis (Mtb) and bacilli Calmette-Guerin (BCG) and that its variants are associated with susceptibility to TB disease. Methods We screened 17 haplotype-tagging SNPs in the HSP90B1 gene region for association with BCG-induced T-cell cytokine responses using both an ex-vivo whole blood assay (N = 295) and an intracellular cytokine staining assay (N = 180) on samples collected 10 weeks after birth. Using a case-control study design, we evaluated the same SNPs for association with TB disease in a South African pediatric cohort (N = 217 cases, 604 controls). A subset of these SNPs was evaluated for association with HSP90B1 expression in human monocytes, monocyte-derived dendritic cells, and T-cells using RT-PCR. Lastly, we used CRISPR/Cas9 gene editing to knock down HSP90B1 expression in a human monocyte cell line (U937). Knockdown and control cell lines were tested for TLR surface expression and control of Mtb replication. Results We identified three SNPs, rs10507172, rs10507173 and rs1920413, that were associated with BCG-induced IL-2 secretion (p = 0.017 for rs10507172 and p = 0.03 for rs10507173 and rs1920413, Mann-Whitney, dominant model). SNPs rs10507172 and rs10507173 were associated with TB disease in an unadjusted analysis (p = 0.036 and 0.025, respectively, dominant model) that strengthened with sensitivity analysis of the definite TB cases, which included only those patients with microbiologically confirmed Mtb (p = 0.007 and 0.012, respectively). Knockdowns of HSP90B1 in monocyte cell lines with CRISPR did not alter TLR2 surface expression nor influence Mtb replication relative to controls. Conclusion Among infants, an HSP90B1 gene-region variant is associated with BCG-induced IL-2 production and may be associated with protection from TB disease. HSP90B1 knockdown in human monocyte-like cell lines did not influence TLR2 surface localization nor Mtb replication. Together, these data suggest that HSP90B1 regulates T-cell, but not monocyte, responses to mycobacteria in humans.	[Graustein, Andrew D.; Misch, Elizabeth A.; Shah, Javeed A.; Seshadri, Chetan; Aguoju, Augustine; Bowman, Kathryn; Hawn, Thomas R.] Univ Washington, Seattle, WA 98195 USA; [Musvosvi, Munyaradzi; Shey, Muki; Mulenga, Humphrey; Veldsman, Ashley; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, Cape Town, South Africa; [Musvosvi, Munyaradzi; Shey, Muki; Mulenga, Humphrey; Veldsman, Ashley; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, Dept Pathol, Div Immunol, Cape Town, South Africa; [Shah, Javeed A.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Hanekom, Willem A.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Bill & Melinda Gates Foundation	Graustein, AD (corresponding author), Univ Washington, Seattle, WA 98195 USA.	adg2001@u.washington.edu	Shey, Muki/M-1273-2016; Shah, Javeed/J-2716-2019; Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/AAH-9413-2020	Shey, Muki/0000-0002-8776-4737; Shah, Javeed/0000-0002-2997-7988; Scriba, Thomas/0000-0002-0641-1359; Hanekom, Willem/0000-0003-3070-6154; Bowman, Kathryn/0000-0003-4222-5286	NIH [NO1-AI-70022]; Burroughs Wellcome Foundation [K08 AI102971]; Dana Foundation;  [T32HL002787];  [K24AI137310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI102971, K24AI137310, R01AI136921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Dana Foundation; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant T32HL002787 (ADG), K24AI137310 (TRH), NIH NO1-AI-70022 (Tuberculosis Research Unit) (TRH, WAH), the Burroughs Wellcome Foundation (TRH), K08 AI102971 (JAS), and the Dana Foundation (TRH and WAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Anas AA, 2016, J PATHOL, V238, P74, DOI 10.1002/path.4637; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Dai J, 2007, J IMMUNOL, V178, P3219, DOI 10.4049/jimmunol.178.5.3219; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Ding Y, 2016, SCAND J IMMUNOL, V84, P222, DOI 10.1111/sji.12463; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Graustein AD, 2017, TUBERCULOSIS, V104, P38, DOI 10.1016/j.tube.2017.02.005; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Horne DJ, 2016, J INFECT DIS, V214, P1260, DOI 10.1093/infdis/jiw347; Horne DJ, 2012, J INFECT DIS, V205, P586, DOI 10.1093/infdis/jir785; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seshadri C, 2013, J IMMUNOL, V191, P1586, DOI 10.4049/jimmunol.1300575; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Shah JA, 2017, AM J RESP CRIT CARE, V196, P502, DOI [10.1164/rccm.201611-2346OC, 10.1164/rccm.201611-2346oc]; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Thada S, 2013, SCAND J IMMUNOL, V78, P221, DOI 10.1111/sji.12066; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wu BX, 2016, ADV CANCER RES, V129, P165, DOI 10.1016/bs.acr.2015.09.001; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014; Zhang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063357; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208940	10.1371/journal.pone.0208940	http://dx.doi.org/10.1371/journal.pone.0208940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550567	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000034
J	Yao, QY; Liu, J; Xiao, L; Wang, NP				Yao, Qinyu; Liu, Jia; Xiao, Lei; Wang, Nanping			Sonic hedgehog signaling instigates high-fat diet-induced insulin resistance by targeting PPAR stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sonic hedgehog (SHH); peroxisome proliferator-activated receptor (PPAR); protein degradation; ubiquitylation (ubiquitination); obesity; insulin resistance; type 2 diabetes; NEDD4-1	ADIPOSE-TISSUE; PEROXISOME PROLIFERATOR; NUCLEAR RECEPTORS; GAMMA ACTIVITY; PRIMARY CILIA; OBESITY; LIVER; ACTIVATION; ADIPOCYTES; INFLAMMATION	Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes. Sonic hedgehog (Shh) is a morphogen that regulates the pancreas and adipose tissue formation during embryonic development. Peroxisome proliferator-activated receptor (PPAR) is a member of the nuclear receptor superfamily and one of the most important regulators of insulin action. Here, we evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPAR. We showed that Shh expression was up-regulated in subcutaneous fat from obese mice. In differentiated 3T3-L1 and primary cultured adipocytes from rats, recombinant Shh protein and SAG (an agonist of Shh signaling) activated an extracellular signal-regulated kinase (ERK)-dependent noncanonical pathway and induced PPAR phosphorylation at serine 112, which decreased PPAR activity. Meanwhile, Shh signaling degraded PPAR protein via binding of PPAR to neural precursor cell-expressed developmentally down-regulated protein 4-1 (NEDD4-1). Furthermore, vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPAR protein level, thus ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPAR activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Inhibition of Shh may serve as a potential therapeutic approach to treat obesity-related diabetes.	[Yao, Qinyu; Liu, Jia; Xiao, Lei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710061, Shaanxi, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China	Xi'an Jiaotong University; Dalian Medical University	Wang, NP (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China.	nanpingwang2003@yahoo.com			National Science Foundation of China [81830015, 81500345, 31430045, 81470373, 81600389, 81770497, 2015M582674, 2016T90928]; China Postdoctoral Science Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Science Foundation of China Grants 81830015, 81500345, 31430045, 81470373, 81600389, and 81770497 and General Financial Grants 2015M582674 and 2016T90928 from the China Postdoctoral Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Braune J, 2017, DIABETOLOGIA, V60, P889, DOI 10.1007/s00125-017-4223-5; Bushman W, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4040030; Chandrahas VK, 2018, CURR TOP MICROBIOL, V414, P103, DOI 10.1007/82_2017_41; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chapouly C, 2016, CARDIOVASC RES, V109, P217, DOI 10.1093/cvr/cvv263; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Emanuel AL, 2017, ARTERIOSCL THROM VAS, V37, P411, DOI 10.1161/ATVBAHA.116.308670; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Fernandes-Silva H, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5010003; Gould SE, 2014, EXPERT OPIN DRUG DIS, V9, P969, DOI 10.1517/17460441.2014.920816; Han LM, 2013, PROTEIN CELL, V4, P310, DOI 10.1007/s13238-013-2124-z; He J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0252-x; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ji S, 2012, BIOCHEM BIOPH RES CO, V417, P1158, DOI 10.1016/j.bbrc.2011.12.086; Kabir A, 2019, CURR DIABETES REV, V15, P49, DOI 10.2174/1573399814666180403164529; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Koren D, 2018, METABOLISM, V84, P67, DOI 10.1016/j.metabol.2018.04.001; Kwon H, 2016, HEPATOLOGY, V63, P1155, DOI 10.1002/hep.28289; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Lau J, 2010, DIABETES, V59, P1211, DOI 10.2337/db09-0914; Lee KW, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.31; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Li JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38550; Li PS, 2017, DIABETES, V66, P300, DOI 10.2337/db16-0743; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Page MM, 2018, TRENDS ENDOCRIN MET, V29, P389, DOI 10.1016/j.tem.2018.03.018; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Quintana MT, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0028-z; Redonnet A, 2001, METABOLISM, V50, P1161, DOI 10.1053/meta.2001.26759; Seppala M, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5020006; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shi Y, 2017, ELIFE, V6, DOI [10.7554/elife.31649, 10.7554/eLife.31649]; Song DK, 2018, DIABETES METAB J, V42, P117, DOI 10.4093/dmj.2018.42.2.117; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095; Xu Y, 2016, CARCINOGENESIS, V37, P215, DOI 10.1093/carcin/bgv252; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yao QY, 2014, BLOOD, V123, P2429, DOI 10.1182/blood-2013-06-508689; Yin RY, 2015, FREE RADICAL BIO MED, V89, P895, DOI 10.1016/j.freeradbiomed.2015.10.406	56	14	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3284	3293		10.1074/jbc.RA118.004411	http://dx.doi.org/10.1074/jbc.RA118.004411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30573683	Green Published, hybrid			2022-12-26	WOS:000464980100025
J	Harold, LK; Antoney, J; Ahmed, FH; Hards, K; Carr, PD; Rapson, T; Greening, C; Jackson, CJ; Cook, GM				Harold, Liam K.; Antoney, James; Ahmed, F. Hafna; Hards, Kiel; Carr, Paul D.; Rapson, Trevor; Greening, Chris; Jackson, Colin J.; Cook, Gregory M.			FAD-sequestering proteins protect mycobacteria against hypoxic and oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reactive oxygen species (ROS); mycobacteria; Mycobacterium smegmatis; hypoxia; flavin; flavin adenine dinucleotide (FAD); bacterial genetics; oxidative stress; anoxia; dos regulon; DosR; oxidoreductase	ELECTRON-TRANSFER; SMEGMATIS; FLAVODOXIN; DODECIN; SYSTEM; OXYGEN; DOSR	The ability to persist in the absence of growth triggered by low oxygen levels is a critical process for the survival of mycobacterial species in many environmental niches. MSMEG_5243 (fsq), a gene of unknown function in Mycobacterium smegmatis, is up-regulated in response to hypoxia and regulated by DosRDosS/DosT, an oxygen- and redox-sensing two-component system that is highly conserved in mycobacteria. In this communication, we demonstrate that MSMEG_5243 is a flavin-sequestering protein and henceforth refer to it as Fsq. Using an array of biochemical and structural analyses, we show that Fsq is a member of the diverse superfamily of flavin- and deazaflavin-dependent oxidoreductases (FDORs) and is widely distributed in mycobacterial species. We created a markerless deletion mutant of fsq and demonstrate that fsq is required for cell survival during hypoxia. Using fsq deletion and overexpression, we found that fsq enhances cellular resistance to hydrogen peroxide treatment. The X-ray crystal structure of Fsq, solved to 2.7 A, revealed a homodimeric organization with FAD bound noncovalently. The Fsq structure also uncovered no potential substrate-binding cavities, as the FAD is fully enclosed, and electrochemical studies indicated that the Fsq:FAD complex is relatively inert and does not share common properties with electron-transfer proteins. Taken together, our results suggest that Fsq reduces the formation of reactive oxygen species (ROS) by sequestering free FAD during recovery from hypoxia, thereby protecting the cofactor from undergoing autoxidation to produce ROS. This finding represents a new paradigm in mycobacterial adaptation to hypoxia.	[Harold, Liam K.; Hards, Kiel; Cook, Gregory M.] Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Harold, Liam K.; Cook, Gregory M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1042, New Zealand; [Antoney, James; Ahmed, F. Hafna; Carr, Paul D.; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Antoney, James; Ahmed, F. Hafna; Rapson, Trevor; Greening, Chris] CSIRO, Land & Water Flagship, Canberra, ACT, Australia; [Greening, Chris] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia	University of Otago; University of Auckland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Cook, GM (corresponding author), Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand.; Cook, GM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1042, New Zealand.; Jackson, CJ (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.; Greening, C (corresponding author), CSIRO, Land & Water Flagship, Canberra, ACT, Australia.; Greening, C (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.	chris.greening@monash.edu; colin.jackson@anu.edu.au; greg.cook@otago.ac.nz	Cook, Gregory/ABF-4208-2020; Greening, Chris/J-4408-2019; Ahmed, F. Hafna/I-4930-2019; Antoney, James/AAB-8005-2021; Hards, Kiel J/L-1942-2018; Ahmed, F. Hafna/B-7734-2019; Jackson, Colin J/C-1500-2008; Rapson, Trevor/B-3510-2012	Greening, Chris/0000-0001-7616-0594; Ahmed, F. Hafna/0000-0002-9153-2699; Antoney, James/0000-0003-4033-6898; Hards, Kiel J/0000-0002-7887-4977; Ahmed, F. Hafna/0000-0002-9153-2699; Jackson, Colin J/0000-0001-6150-3822; Rapson, Trevor/0000-0003-1289-0146; Harold, Liam/0000-0002-7570-7348	Maurice Wilkins Centre for Molecular Biodiscovery; Marsden Fund, Royal Society, NewZealand; University of Otago; Sandy Smith Scholarship; CSIRO OCE Postdoctoral Fellowship; ARC DECRA Fellowship [DE170100310]; NHMRC [APP1139832, APP1128929]	Maurice Wilkins Centre for Molecular Biodiscovery; Marsden Fund, Royal Society, NewZealand; University of Otago; Sandy Smith Scholarship; CSIRO OCE Postdoctoral Fellowship; ARC DECRA Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Maurice Wilkins Centre for Molecular Biodiscovery and the Marsden Fund, Royal Society, NewZealand. This work was also supported by a University of Otago Doctoral Scholarship and a Sandy Smith Scholarship (to L. K. H.) and by a CSIRO OCE Postdoctoral Fellowship, ARC DECRA Fellowship DE170100310, and NHMRC New Investigator Grant APP1139832 (to C. G.). In addition, this workwassupported byNHMRCProject Grant APP1128929 (to C. J. J., C. G., and G. M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed FH, 2016, PROTEIN SCI, V25, P1692, DOI 10.1002/pro.2975; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berney M, 2014, P NATL ACAD SCI USA, V111, P11479, DOI 10.1073/pnas.1407034111; Berney M, 2014, ENVIRON MICROBIOL, V16, P318, DOI 10.1111/1462-2920.12320; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Bourdeaux F, 2018, ACS INFECT DIS, V4, P1082, DOI 10.1021/acsinfecdis.7b00237; Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chauviac FX, 2012, J BIOL CHEM, V287, P44372, DOI 10.1074/jbc.M112.406264; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Goran JM, 2013, LANGMUIR, V29, P13605, DOI 10.1021/la403020y; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Heering HA, 1996, J ELECTROANAL CHEM, V404, P249, DOI 10.1016/0022-0728(95)04248-2; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Liu FX, 2011, J STRUCT BIOL, V175, P31, DOI 10.1016/j.jsb.2011.04.013; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Segal HM, 2017, PROTEIN SCI, V26, P1984, DOI 10.1002/pro.3236; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029	48	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2903	2912		10.1074/jbc.RA118.006237	http://dx.doi.org/10.1074/jbc.RA118.006237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567740	Green Published, hybrid			2022-12-26	WOS:000459601600027
J	Loerch, S; Leach, JR; Horner, SW; Maji, D; Jenkins, JL; Pulvino, MJ; Kielkopf, CL				Loerch, Sarah; Leach, Justin R.; Horner, Steven W.; Maji, Debanjana; Jenkins, Jermaine L.; Pulvino, Mary J.; Kielkopf, Clara L.			The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; protein-protein interaction; isothermal titration calorimetry (ITC); RNA splicing; protein structure; RNA-binding protein; protein domain; gene regulation	N-TERMINAL DOMAIN; BRANCH POINT; P-TEFB; RECOGNITION; COMPLEX; BINDING; PHOSPHORYLATION; ELONGATION; REQUIREMENT; SF1	The transcription elongation and pre-mRNA splicing factor Tat-SF1 associates with the U2 small nuclear ribonucleoprotein (snRNP) of the spliceosome. However, the direct binding partner and underlying interactions mediating the Tat-SF1-U2 snRNP association remain unknown. Here, we identified SF3b1 as a Tat-SF1-interacting subunit of the U2 snRNP. Our 1.1 A resolution crystal structure revealed that Tat-SF1 contains a U2AF homology motif (UHM) protein-protein interaction module. We demonstrated that Tat-SF1 preferentially and directly binds the SF3b1 subunit compared with other U2AF ligand motif (ULM)-containing splicing factors, and further established that SF3b1 association depends on the integrity of the Tat-SF1 UHM. We next compared the Tat-SF1-binding affinities for each of the five known SF3b1 ULMs and then determined the structures of representative high- and low-affinity SF3b1 ULM complexes with the Tat-SF1 UHM at 1.9 A and 2.1 A resolutions, respectively. These structures revealed a canonical UHM-ULM interface, comprising a Tat-SF1 binding pocket for a ULM tryptophan (SF3b1 Trp(338)) and electrostatic interactions with a basic ULM tail. Importantly, we found that SF3b1 regulates Tat-SF1 levels and that these two factors influence expression of overlapping representative transcripts, consistent with a functional partnership of Tat-SF1 and SF3b1. Altogether, these results define a new molecular interface of the Tat-SF1-U2 snRNP complex for gene regulation.	[Loerch, Sarah; Leach, Justin R.; Horner, Steven W.; Maji, Debanjana; Jenkins, Jermaine L.; Pulvino, Mary J.; Kielkopf, Clara L.] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Loerch, Sarah] Janelia Res Campus, Ashburn, VA 20147 USA; [Horner, Steven W.] Broad Inst, Cambridge, MA 02142 USA	University of Rochester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kielkopf, CL (corresponding author), Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14642 USA.	clara_kielkopf@urmc.rochester.edu		Loerch, Sarah/0000-0002-1731-516X	United States Dept. of Energy [DE-AC02-76SF00515]; NIH [P41 GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070503, P41GM103393, R01GM117005] Funding Source: NIH RePORTER	United States Dept. of Energy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Manuel Ares (University of California, Santa Cruz) and Aaron Hoskins (University of Wisconsin, Madison, WI) for stimulating discussions and sharing unpublished data. We appreciate the skilled technical assistance of Nazish Jeffery and Eliezra Glasser. SSRL is supported by the United States Dept. of Energy under Contract No. DE-AC02-76SF00515 and NIH Grant P41 GM103393.	Abramczuk MK, 2017, DEVELOPMENT, V144, P3932, DOI 10.1242/dev.152199; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Chatrikhi R, 2016, BIOPHYS J, V111, P2570, DOI 10.1016/j.bpj.2016.11.007; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; Corsini NS, 2018, CELL STEM CELL, V22, P143, DOI 10.1016/j.stem.2018.01.012; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dolatshad H, 2015, LEUKEMIA, V29, P1798, DOI 10.1038/leu.2015.178; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finci LI, 2018, GENE DEV, V32, P309, DOI 10.1101/gad.311043.117; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Guth S, 1999, MOL CELL BIOL, V19, P8263; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Huang YM, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0558-8; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Konde E, 2010, BIOCHEMISTRY-US, V49, P8020, DOI 10.1021/bi101153w; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Loerch S, 2016, RNA, V22, P1795, DOI 10.1261/rna.057950.116; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043946; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller HB, 2011, RNA, V17, P665, DOI 10.1261/rna.2462011; Miller HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005710; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Paolella BR, 2017, ELIFE, V6, DOI 10.7554/eLife.23268; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2000, GENE DEV, V14, P97; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rodgers ML, 2016, RNA, V22, P225, DOI 10.1261/rna.052233.115; Rosel-Hillgartner TD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003856; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Turunen JJ, 2013, RNA, V19, P380, DOI 10.1261/rna.036715.112; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wang WH, 2013, STRUCTURE, V21, P197, DOI 10.1016/j.str.2012.10.020; Webb CJ, 2005, MOL BIOL CELL, V16, P584, DOI 10.1091/mbc.E04-09-0768; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yoshida H, 2015, GENE DEV, V29, P1649, DOI 10.1101/gad.267104.115; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	65	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2892	2902		10.1074/jbc.RA118.006764	http://dx.doi.org/10.1074/jbc.RA118.006764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567737	hybrid, Green Published			2022-12-26	WOS:000459601600026
J	Lai, JI; Nachun, D; Petrosyan, L; Throesch, B; Campau, E; Gao, FY; Baldwin, KK; Coppola, G; Gottesfeld, JM; Soragni, E				Lai, Jiun-I; Nachun, Daniel; Petrosyan, Lina; Throesch, Benjamin; Campau, Erica; Gao, Fuying; Baldwin, Kristin K.; Coppola, Giovanni; Gottesfeld, Joel M.; Soragni, Elisabetta			Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Friedreich ataxia; induced pluripotent stem cell (iPS cell) (iPSC); transcriptomics; histone deacetylase inhibitor (HDAC inhibitor); neuron; gene editing; neurodegeneration; repeat expansion	PLURIPOTENT STEM-CELLS; KIKO MOUSE MODEL; OXIDATIVE STRESS; FRATAXIN DEFICIENCY; REPEAT EXPANSION; EXPRESSION; METABOLISM; MECHANISM; MUTATION; REVEALS	Friedreich ataxia (FRDA) is a neurodegenerative disorder caused by transcriptional silencing of the frataxin (FXN) gene, resulting in loss of the essential mitochondrial protein frataxin. Based on the knowledge that a GAA<bold>TTC repeat expansion in the first intron of FXN induces heterochromatin</bold>, we previously showed that 2-aminobenzamide-type histone deacetylase inhibitors (HDACi) increase FXN mRNA levels in induced pluripotent stem cell (iPSC)-derived FRDA neurons and in circulating lymphocytes from patients after HDACi oral administration. How the reduced expression of frataxin leads to neurological and other systemic symptoms in FRDA patients remains unclear. Similar to other triplet-repeat disorders, it is unknown why FRDA affects only specific cell types, primarily the large sensory neurons of the dorsal root ganglia and cardiomyocytes. The combination of iPSC technology and genome-editing techniques offers the unique possibility to address these questions in a relevant cell model of FRDA, obviating confounding effects of variable genetic backgrounds. Here, using scarless gene-editing methods, we created isogenic iPSC lines that differ only in the length of the GAA<bold>TTC repeats</bold>. To uncover the gene expression signatures due to the GAA<bold>TTC repeat expansion in FRDA neuronal cells and the effect of HDACi on these changes</bold>, we performed RNA-seq-based transcriptomic analysis of iPSC-derived central nervous system (CNS) and isogenic sensory neurons. We found that cellular pathways related to neuronal function, regulation of transcription, extracellular matrix organization, and apoptosis are affected by frataxin loss in neurons of the CNS and peripheral nervous system and that these changes are partially restored by HDACi treatment.	[Lai, Jiun-I; Petrosyan, Lina; Campau, Erica; Gottesfeld, Joel M.; Soragni, Elisabetta] Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Throesch, Benjamin; Baldwin, Kristin K.] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA; [Nachun, Daniel; Gao, Fuying; Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Lai, Jiun-I] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; National Yang Ming Chiao Tung University	Soragni, E (corresponding author), Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	soragni@scripps.edu	Lai, Jiun-I/ABA-2904-2021	Lai, Jiun-I/0000-0002-8233-5466; Baldwin, Kristin/0000-0002-6137-030X	National Institutes of Health NINDS [5R01 NS062856]; Friedreich's Ataxia Research Alliance; Bio-Marin Pharmaceutical, Inc.; National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; National Institutes of Health NIDCD [DC012592]; NIMH [MH102698]; NIA [DP1 AG055944]; Dorris Neuroscience Center; BioMarin Pharmaceuticals; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691, R01NS062856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG055944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012592] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance; Bio-Marin Pharmaceutical, Inc.; National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics; National Institutes of Health NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dorris Neuroscience Center; BioMarin Pharmaceuticals; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health NINDS Grant 5R01 NS062856, the Friedreich's Ataxia Research Alliance (to E.S.), Bio-Marin Pharmaceutical, Inc. (to the Gottesfeld lab), National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics Grant P30 NS062691, and National Institutes of Health NIDCD Grant DC012592, NIMH Grant MH102698, and NIA Grant DP1 AG055944, and the Dorris Neuroscience Center (to the Baldwin lab). J.M.G. serves as a consultant to BioMarin Pharmaceutical for the development of histone deacetylase inhibitors as therapeutics and is an inventor on patents licensed by The Scripps Research Institute to BioMarin Pharmaceutical. E.S. is supported in part by BioMarin Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Aranca TV, 2016, NEURODEGENER DIS MAN, V6, P49, DOI 10.2217/nmt.15.73; Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Bolinches-Amoros A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00124; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Carletti B, 2014, INT J MOL SCI, V15, P5789, DOI 10.3390/ijms15045789; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; Chandran V, 2017, ELIFE, V6, DOI 10.7554/eLife.30054; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen KC, 2016, ELIFE, V5, DOI 10.7554/eLife.20732; Chen KC, 2016, ELIFE, V5, DOI 10.7554/eLife.16043; Chiang S, 2018, NEUROCHEM INT, V117, P35, DOI 10.1016/j.neuint.2017.08.002; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Cnop M, 2012, ANN NEUROL, V72, P971, DOI 10.1002/ana.23698; Codazzi F, 2016, HUM MOL GENET, V25, P4847, DOI 10.1093/hmg/ddw308; Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Flegel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128951; Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Igoillo-Esteve M, 2015, HUM MOL GENET, V24, P2274, DOI 10.1093/hmg/ddu745; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Kearney M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub3; Kitsak M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35241; Koeppen AH, 2017, J NEUROPATH EXP NEUR, V76, P101, DOI 10.1093/jnen/nlw111; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li L, 2018, CELL TISSUE RES, V371, P143, DOI 10.1007/s00441-017-2713-x; Li LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10606; Li XJ, 2018, NAT REV MOL CELL BIO, V19, P563, DOI 10.1038/s41580-018-0029-7; Lin H, 2017, DIS MODEL MECH, V10, P1529, DOI 10.1242/dmm.030049; Lin H, 2017, DIS MODEL MECH, V10, P1343, DOI 10.1242/dmm.030502; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749; Loria F, 2015, NEUROBIOL DIS, V76, P1, DOI 10.1016/j.nbd.2014.12.017; Lupoli F, 2018, FEBS LETT, V592, P718, DOI 10.1002/1873-3468.12928; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mincheva-Tasheva S, 2014, HUM MOL GENET, V23, P1829, DOI 10.1093/hmg/ddt576; Mitani K, 2014, METHODS MOL BIOL, V1114, P163, DOI 10.1007/978-1-62703-761-7_10; Molla B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00264; Nachun D, 2018, HUM MOL GENET, V27, P2965, DOI 10.1093/hmg/ddy198; Nair M, 2017, CURR MED CHEM, V24, P4368, DOI 10.2174/0929867324666170727100508; Napierala JS, 2017, DIS MODEL MECH, V10, P1353, DOI 10.1242/dmm.030536; Nityanandam A, 2015, STEM CELLS DEV, V24, P1265, DOI 10.1089/scd.2015.0044; Obis E, 2014, FREE RADICAL BIO MED, V73, P21, DOI 10.1016/j.freeradbiomed.2014.04.016; Ohbayashi F, 2005, P NATL ACAD SCI USA, V102, P13628, DOI 10.1073/pnas.0506598102; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palomo GM, 2011, HUM MOL GENET, V20, P2807, DOI 10.1093/hmg/ddr187; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Panopoulos AD, 2017, STEM CELL REP, V8, P1086, DOI 10.1016/j.stemcr.2017.03.012; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Quesada MP, 2015, EXP CELL RES, V335, P51, DOI 10.1016/j.yexcr.2015.04.013; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Piermarini E, 2016, HUM MOL GENET, V25, P4288, DOI 10.1093/hmg/ddw260; Piguet F, 2018, MOL THER, V26, P1940, DOI 10.1016/j.ymthe.2018.05.006; Poon A, 2017, NEW BIOTECHNOL, V39, P190, DOI 10.1016/j.nbt.2017.05.009; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocca CJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2347; Rufini A, 2015, NEUROBIOL DIS, V75, P91, DOI 10.1016/j.nbd.2014.12.011; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Schwartzentruber J, 2018, NAT GENET, V50, P54, DOI 10.1038/s41588-017-0005-8; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Stram AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178354; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamarit J, 2016, FREE RADICAL BIO MED, V100, P138, DOI 10.1016/j.freeradbiomed.2016.06.007; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zagami CJ, 2009, J CELL BIOCHEM, V107, P1063, DOI 10.1002/jcb.22221	102	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1846	1859		10.1074/jbc.RA118.006515	http://dx.doi.org/10.1074/jbc.RA118.006515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30552117	Green Published, hybrid			2022-12-26	WOS:000459711400007
J	Vangala, JR; Radhakrishnan, SK				Vangala, Janakiram R.; Radhakrishnan, Senthil K.			Nrf1-mediated transcriptional regulation of the proteasome requires a functional TIP60 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; transcription coactivator; transcription regulation; cancer; proteostasis; NFE2L1; Nrf1; RUVBL1; TIP60	FACTOR NRF1; INHIBITORS; PONTIN; GENE; IDENTIFICATION; ACETYLATION; DEGRADATION; ONCOPROTEIN; EXPRESSION; CHROMATIN	Inhibition of the proteasome leads to proteotoxic stress, which is characterized by the buildup of ubiquitinated proteins that cannot be degraded properly. The transcription factor Nrf1 (also called NFE2L1) counteracts proteotoxic stress by inducing transcription of proteasome subunit genes, resulting in the restoration of proteasome activity. Further understanding of the Nrf1 pathway is therefore of interest in both neurodegeneration, where proteasome activity could be enhanced, and cancer, where suppression of this pathway could potentiate the cell-killing effect mediated by proteasome inhibitor drugs. Here, to identify novel regulators of Nrf1, we performed an RNAi screen in an engineered cell line, reporting on Nrf1 transcriptional activity. In addition to validating known regulators, we discovered that the AAA+ ATPase RUVBL1 is necessary for Nrf1's transcriptional activity. Given that RUVBL1 is part of different multisubunit complexes that play key roles in transcription, we dissected this phenomenon further and found that the TIP60 chromatin-regulatory complex is essential for Nrf1-dependent transcription of proteasome genes. Consistent with these observations, Nrf1, RUVBL1, and TIP60 proteins were co-recruited to the promoter regions of proteasome genes after proteasome inhibitor treatments. More importantly, depletion of RUVBL1 or TIP60 in various cancer cells sensitized them to cell death induced by proteasome inhibition. Overall, our study provides a framework for manipulating the TIP60-Nrf1 axis to alter proteasome function in various human diseases, including cancer.	[Vangala, Janakiram R.; Radhakrishnan, Senthil K.] Virginia Commonwealth Univ, Dept Pathol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Vangala, Janakiram R.; Radhakrishnan, Senthil K.] Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Radhakrishnan, SK (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	senthil.radhakrishnan@vcuhealth.org			National Cancer Institute [R00CA154884]; Grace Science Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grace Science Foundation	Supported by a K99/R00 award from the National Cancer Institute (R00CA154884) and by a grant from the Grace Science Foundation. To whom correspondence should be addressed. E-mail: senthil.radhakrishnan@vcuhealth.org.	Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Elkaim J, 2014, BIOORG MED CHEM LETT, V24, P2512, DOI 10.1016/j.bmcl.2014.04.003; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Gao CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04712; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gnatovskiy L, 2013, MOL CELL BIOL, V33, P3817, DOI 10.1128/MCB.01562-12; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2013, MOL CELL BIOL, V33, P1164, DOI 10.1128/MCB.01567-12; Kim HM, 2016, GENE, V584, P17, DOI 10.1016/j.gene.2016.03.002; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Le Moigne R, 2017, MOL CANCER THER, V16, P2375, DOI 10.1158/1535-7163.MCT-17-0233; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mao YQ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00058; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Perez-Perri JI, 2016, CELL REP, V16, P37, DOI 10.1016/j.celrep.2016.05.082; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Qiu ZJ, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0238-5; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rajendra E, 2014, NUCLEIC ACIDS RES, V42, P13736, DOI 10.1093/nar/gku1230; Roeten MSF, 2018, CANCER CHEMOTH PHARM, V81, P227, DOI 10.1007/s00280-017-3489-0; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; Ru BB, 2018, NUCLEIC ACIDS RES, V46, pD918, DOI 10.1093/nar/gkx877; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Sekine H, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00252-18; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tarangelo A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10028; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tomlin FM, 2017, ACS CENTRAL SCI, V3, P1143, DOI 10.1021/acscentsci.7b00224; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Vangala JR, 2016, CURR BIOL, V26, pR834, DOI 10.1016/j.cub.2016.08.008; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Zhao LJ, 2016, VIROLOGY, V499, P178, DOI 10.1016/j.virol.2016.09.005	45	12	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2036	2045		10.1074/jbc.RA118.006290	http://dx.doi.org/10.1074/jbc.RA118.006290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559296	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000459711400022
J	Vereshchaga, Y; Arnold, N; Baumgartner, W				Vereshchaga, Yana; Arnold, Nikita; Baumgartner, Werner			Physiological relevance of epithelial geometry: New insights into the standing gradient model and the role of LI cadherin	PLOS ONE			English	Article							COUPLED WATER TRANSPORT; RAT PROXIMAL TUBULE; FLUID TRANSPORT; TIGHT JUNCTION; CELL-ADHESION; PUMP SITES; MATHEMATICAL-MODEL; INTESTINE; EXPRESSION; MECHANISM	We introduce a mathematical model of an absorbing leaky epithelium to reconsider the problem formulated by Diamond and Bossert in 1967: whether "... some distinctive physiological properties of epithelia might arise as geometrical consequences of epithelial ultra-structure". A standing gradient model of the intercellular cleft (IC) is presented that includes tight junctions (TJ) and ion channels uniformly distributed along the whole cleft. This nonlinear system has an intrinsic homogeneous concentration and the spatial scale necessary to establish it along the cleft. These parameters have not been elucidated so far. We further provide non-perturbative analytical approximations for a broad range of parameters. We found that narrowing of the IC increases ion concentration dramatically and can therefore prevent outflow through tight junctions (TJs) and the lateral membrane, as long as extremely high luminal osmolarities are not reached. Our model predicts that the system is to some extent self-regulating and thereby prevents fluxes into the lumen. Recent experimental evidence has shown that liver-intestine (LI) cadherin can control the up/down flux in intestines via regulation of the cleft width. This finding is in full agreement with predictions of our model. We suggest that LI-cadherin may increase water transport through epithelia via sequential narrowing of the cleft, starting from the highest concentration area at the beginning of the cleft and triggering a propagating squeezing motion.	[Vereshchaga, Yana; Baumgartner, Werner] Johannes Kepler Univ Linz, Inst Biomed Mechatron, Linz, Austria; [Arnold, Nikita] Johannes Kepler Univ Linz, Inst Expt Phys Soft Matter Phys, Linz, Austria	Johannes Kepler University Linz; Johannes Kepler University Linz	Vereshchaga, Y (corresponding author), Johannes Kepler Univ Linz, Inst Biomed Mechatron, Linz, Austria.	yana.vereshchaga@jku.at	Baumgartner, Werner/C-5013-2012; Arnold, Nikita/C-7790-2013	Baumgartner, Werner/0000-0002-3160-2050; Arnold, Nikita/0000-0003-3673-1772	Linz Institute of Technology (LIT), project ADAPT; Austrian Science Fund (FWF) [P 29603]	Linz Institute of Technology (LIT), project ADAPT; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Linz Institute of Technology (LIT), project ADAPT, and the Austrian Science Fund (FWF), project P 29603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl M, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-18; Angres B, 2001, DEV DYNAM, V221, P182, DOI 10.1002/dvdy.1146; Bakker R, 2012, NACL TRANSPORT EPITH; Baumgartner W, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23815; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; CURRAN PF, 1957, J GEN PHYSIOL, V41, P143, DOI 10.1085/jgp.41.1.143; DIAMOND JM, 1964, J GEN PHYSIOL, V48, P15, DOI 10.1085/jgp.48.1.15; DIAMOND JM, 1967, J GEN PHYSIOL, V50, P2061, DOI 10.1085/jgp.50.8.2061; DIBONA DR, 1979, FED PROC, V38, P134; Erokhova L, 2011, J BIOL CHEM, V286, P39926, DOI 10.1074/jbc.M111.291864; Fischbarg J, 2006, J MEMBRANE BIOL, V210, P117, DOI 10.1007/s00232-005-0850-8; Fischbarg J, 2010, PHYSIOL REV, V90, P1271, DOI 10.1152/physrev.00025.2009; Gauss A, 2013, INT J MED SCI, V10, P1259, DOI 10.7150/ijms.6358; Gessner R, 2000, ANN NY ACAD SCI, V915, P136; Guo P, 2003, AM J PHYSIOL-RENAL, V285, pF241, DOI 10.1152/ajprenal.00331.2002; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Keener J, 2009, SYSTEMS PHYSL; Keener JP, 2009, MATH PHYSL; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; KYTE J, 1976, J CELL BIOL, V68, P287, DOI 10.1083/jcb.68.2.287; Larsen EH, 2006, ACTA PHYSIOL, V187, P177, DOI 10.1111/j.1748-1716.2006.01580.x; Larsen EH, 2000, J GEN PHYSIOL, V116, P101, DOI 10.1085/jgp.116.2.101; Larsen EH, 2014, COMPR PHYSIOL, V4, P405, DOI 10.1002/cphy.c130004; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; MILLS JW, 1978, NATURE, V271, P273, DOI 10.1038/271273a0; O'Brien SBG, 2011, SIAM REV, V53, P775, DOI 10.1137/100794274; PARSONS DS, 1961, BIOCHIM BIOPHYS ACTA, V46, P170, DOI 10.1016/0006-3002(61)90660-6; SEGEL LA, 1970, J THEOR BIOL, V29, P233, DOI 10.1016/0022-5193(70)90020-2; Shachar-Hill B, 2002, INT REV CYTOL, V215, P319; SKADHAUGE E, 1969, J PHYSIOL-LONDON, V204, P135, DOI 10.1113/jphysiol.1969.sp008904; STIRLING CE, 1972, J CELL BIOL, V53, P704, DOI 10.1083/jcb.53.3.704; Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Waymouth E, 1901, J PHYSIOL-LONDON, V26, P436; Weinstein AM, 2015, AM J PHYSIOL-RENAL, V308, pF1076, DOI 10.1152/ajprenal.00504.2014; WEINSTEIN AM, 1981, BIOPHYS J, V35, P167, DOI 10.1016/S0006-3495(81)84781-9; Weinstein AM, 2001, J MEMBRANE BIOL, V184, P241, DOI 10.1007/s00232-001-0099-9; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Weth A, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1285390; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wildman, 2015, ADV HUMAN NUTR; WINDHAGER EE, 1959, AM J PHYSIOL, V197, P313, DOI 10.1152/ajplegacy.1959.197.2.313; Zahn A, 2007, WORLD J GASTROENTERO, V13, P1687, DOI 10.3748/wjg.v13.i11.1687	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208791	10.1371/journal.pone.0208791	http://dx.doi.org/10.1371/journal.pone.0208791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576326	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400016
J	Cui, Y; Wang, Y; Li, G; Ma, W; Zhou, XS; Wang, J; Liu, B				Cui, Yu; Wang, Yu; Li, Gen; Ma, Wan; Zhou, Xiao-shuang; Wang, Jia; Liu, Bin			The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NADPH OXIDASE; ISCHEMIA/REPERFUSION INJURY; PULMONARY ISCHEMIA; OXIDATIVE STRESS; TRANSPLANTATION; AUTOPHAGY; ANESTHESIA	Lung ischemia and reperfusion injury (LIRI) were mediated by several processes including over-production of reactive oxygen species (ROS) and inflammatory activation. ROS generated by nicotinamide adenine dinucletide phosphate (NADPH) oxidase (Nox) may play a pivotal role in pathophysiological changes in a range of disease. However, it was poorly understood in LIRI. Thus, the purpose of our study was to explore whether GKT137831, as a special dual inhibitor of Nox1 and 4, could alleviate LIRI in mice model and explore the minimal dose. According to the protocol, this study was divided into two parts. The first part was to determine the minimal dose of Nox1/4 inhibitor in attenuating LIRI via histopathology and apoptosis analysis. Eighteen C57BL/6J male wild-type mice were randomly divided in to sham, 2.5Nox+sham, 5.0Nox+sham, IR, 2.5Nox+IR and 5.0Nox+IR groups. According to the different group, mice were pretreated with corresponding dose of Nox1/4 inhibitors or normal saline. After LIRI, the results showed 5.0mg/kg Nox1/4 inhibitor could be considered as the minimal dose to alleviate injury by decreasing of lung injury score and the number of TUNEL-positive cells. The second part was to further verify the benefit of 5.0mg/kg Nox1/4 inhibitor in lung protective effects. Thirty-seven C57BL/6J male wild-type mice were divided in to sham, IR and 5.0Nox+IR groups randomly. The results showed that expressions of inflammatory, autophagy cytokines were markedly elevated and PH value was declined after LIRI. However, 5.0 mg/kg Nox1/4 inhibitor significantly attenuated cytokine production as reflected by immunohistochemistry, western blotting and Q-PCR analysis. In conclusion, our findings suggested that 5.0mg/kg Nox1/4 inhibitor contributed to protect lung tissue damage after LIRI via the suppression of inflammatory and autophagy activation.	[Cui, Yu; Ma, Wan; Zhou, Xiao-shuang; Wang, Jia; Liu, Bin] Sichuan Univ, Dept Anesthesiol, West China Hosp, Chengdu, Sichuan, Peoples R China; [Cui, Yu] Chengdu Womens & Childrens Cent Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Wang, Yu] 363 Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Li, Gen] Vanderbilt Univ, Ctr Med, Dept Anesthesiol, Nashville, TN 37232 USA	Sichuan University; Vanderbilt University	Liu, B (corresponding author), Sichuan Univ, Dept Anesthesiol, West China Hosp, Chengdu, Sichuan, Peoples R China.	liubinhxyy@163.com		LI, GEN/0000-0002-8417-6569	Science & Technology Department of Sichuan Province [2012FZ0121]	Science & Technology Department of Sichuan Province	This research was financially supported by Science & Technology Department of Sichuan Province (No. 2012FZ0121) to Dr. Bin Liu. The funding source had no involvement in design, in collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the article for publication.	AlMehdi AB, 1997, AM J PHYSIOL-LUNG C, V272, pL294, DOI 10.1152/ajplung.1997.272.2.L294; Ansari B, 2012, CRIT CARE MED, V40, P688, DOI 10.1097/CCM.0b013e3182372b7e; Aviello G, 2018, MUCOSAL IMMUNOL, V11, P1011, DOI 10.1038/s41385-018-0021-8; Baxter MG, 2009, ANESTHESIOLOGY, V111, P209, DOI 10.1097/ALN.0b013e3181a8617e; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen X, 2015, MOL MED REP, V11, P2513, DOI 10.3892/mmr.2014.2999; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Deliyanti D, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0363-z; Demiryurek AT, 1999, PHARMACOL THERAPEUT, V84, P355, DOI 10.1016/S0163-7258(99)00041-8; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fard N, 2014, J SURG RES, V189, P274, DOI 10.1016/j.jss.2014.02.034; Ferrari RS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/590987; Ge M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8787392; Gielis JF, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.32; Gielis JF, 2015, EUR J CARDIO-THORAC, V48, P622, DOI 10.1093/ejcts/ezu518; Kreisel D, 2013, TRANSPL INT, V26, P2, DOI 10.1111/j.1432-2277.2012.01549.x; Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304; Li Y, 2017, FREE RADICAL BIO MED, V109, P33, DOI 10.1016/j.freeradbiomed.2017.02.049; Liu S, 2016, AM J TRANSL RES, V8, P3593; Liu ZH, 2018, INFLAMMATION, V41, P1546, DOI 10.1007/s10753-018-0801-z; Lukasik VM, 2003, NMR BIOMED, V16, P459, DOI 10.1002/nbm.836; Lunardi F, 2017, TRANSPL P, V49, P722, DOI 10.1016/j.transproceed.2017.02.037; Ma Y, 2017, ONCOTARGET, V8, P53084, DOI 10.18632/oncotarget.18088; Martens A, 2016, TRANSPL INT, V29, P1237, DOI 10.1111/tri.12823; Matsushima S, 2013, CIRC RES, V112, P1135, DOI 10.1161/CIRCRESAHA.111.300171; Minter MR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-43; NEMERY B, 1992, PULM PHARMACOL, V5, P53, DOI 10.1016/0952-0600(92)90018-C; Padilla J, 2002, ARCH BRONCONEUMOL, V38, P16, DOI 10.1016/S0300-2896(02)75141-7; Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232; Sakai Y, 2018, FREE RADICAL RES, V52, P92, DOI 10.1080/10715762.2017.1416112; Shibata K, 1998, AM J RESP CRIT CARE, V158, P1578, DOI 10.1164/ajrccm.158.5.9804039; STEVEN L, 2013, AVMA GUIDELINES EUTH; Sun QM, 2017, PROT CONTR MOD POW, V2, DOI 10.1186/s41601-017-0035-3; Teixeira G, 2017, BRIT J PHARMACOL, V174, P1647, DOI 10.1111/bph.13532; van der Kaaij NP, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-28; Yokota H, 2017, J PHARMACOL EXP THER, V360, P192, DOI 10.1124/jpet.116.235580; Zhang D, 2017, AM J PHYSIOL-LUNG C, V313, pL384, DOI 10.1152/ajplung.00391.2016	38	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209444	10.1371/journal.pone.0209444	http://dx.doi.org/10.1371/journal.pone.0209444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571757	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700074
J	Lin, YY; Chen, JS; Wu, XB; Shyu, WC; Chaunchaiyakul, R; Zhao, XL; Kuo, CH; Cheng, YJ; Yang, AL; Lee, SD				Lin, Yi-Yuan; Chen, Jwo-Sheng; Wu, Xu-Bo; Shyu, Woei-Cherng; Chaunchaiyakul, Rungchai; Zhao, Xian-Li; Kuo, Chia-Hua; Cheng, Yu-Jung; Yang, Ai-Lun; Lee, Shin-Da			Combined effects of 17 beta-estradiol and exercise training on cardiac apoptosis in ovariectomized rats	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; AEROBIC EXERCISE; HEART-FAILURE; ESTROGEN; HYPERTROPHY; MECHANISMS; DISEASE	Background The purpose of this study was to investigate the combined 17 beta-estradiol (E2) and exercise training on cardiac pro-survival and anti-apoptotic pathways in ovariectomized rats. Methods Fifty-six female Sprague-Dawley rats were divided into a sham-operated (Sham), a bilaterally ovariectomized (OVX), an OVX treated with E2 (OVX-E2; 10 mu g/kg/day), and an OVX with E2 and treadmill exercise training (OVX-E2-EX; 60 min/day, 5 days/week) for 10 weeks. Following 10 weeks of exercise training, rat hearts were isolated for the evaluation of Histopathological analysis, TUNEL assay, and Western blotting. Results The protein levels of estrogen receptor alpha (ER alpha), estrogen receptor beta (ER beta), insulin-like growth factor 1 (IGF-1), IGF-1 receptor (IGF-1 R), phospho-phosphatidylinositol 3-kinase (pP13K) (estrogen receptors/IGF-1-related survival pathway) were significantly increased in either the OVX-E2 or OVX-E2-EX group when compared with the OVX group. The protein levels of B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra-large (Bcl-xL) and phosphorylated-Bad (p-Bad) (Bcl-2 family survival pathway) were significantly increased in the OVX-E2 group when compared with the OVX group. Only the p-Bad was significantly increased in the OVX-E2 group when compared with the OVX group. The protein levels of truncation of Bid (t-Bid), Bcl-2-associated death promotor (Bad), Bcl-2-associated X protein (Bax), Cytochrome c, caspases-9, and caspases-3 (mitochondria-dependent apoptotic pathway), as well as the protein levels of tumor necrosis factor-a (TNF-alpha), Fas ligand, Fas receptors, Fas-associated death domain (FADD), activated caspase-8 and activated caspase-3 (Fas receptor-dependent apoptotic pathway) were significantly decreased in either the OVX-E2 or OVX-E2-EX group when compared with the OVX group. Furthermore, when compared with the OVX-E2 group, the protein levels of ER beta, IGF-1, IGF-1R, Bcl-2 and BclxL were further enhanced in the OVX-E2-EX group as well as the protein levels of Cytochrome c, Fas receptors, FADD, activated caspase-8, activated caspase-9 and activated caspase-3 were further decreased in the OVX-EX-E2 group. Conclusions Combined E2 and exercise training exhibited a positive effect of protection on ovariectomy-induced cardiac apoptosis by enhancing ER beta-related survival pathways, which might provide a more effective therapeutic effect on cardiac protection in bilaterally oophorectomized or menopausal women than E2 treatment only.	[Lin, Yi-Yuan; Wu, Xu-Bo; Lee, Shin-Da] Shanghai Univ Tradit Chinese Med, Dept Rehabil, Peoples Hosp 7, Shanghai, Peoples R China; [Lin, Yi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, Jwo-Sheng] China Med Univ, Dept Sports Med, Taichung, Taiwan; [Wu, Xu-Bo; Zhao, Xian-Li; Lee, Shin-Da] Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China; [Shyu, Woei-Cherng] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Chaunchaiyakul, Rungchai] Mahidol Univ, Coll Sports Sci & Technol, Salaya, Nakhon Pathom, Thailand; [Kuo, Chia-Hua; Yang, Ai-Lun] Univ Taipei, Dept Sports Sci, Taipei, Taiwan; [Cheng, Yu-Jung; Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan	Shanghai University of Traditional Chinese Medicine; China Medical University Taiwan; China Medical University Taiwan; Shanghai University of Traditional Chinese Medicine; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Mahidol University; University of Taipei; China Medical University Taiwan; Asia University Taiwan	Lee, SD (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Rehabil, Peoples Hosp 7, Shanghai, Peoples R China.; Lee, SD (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China.; Lee, SD (corresponding author), China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan.; Lee, SD (corresponding author), Asia Univ, Dept Occupat Therapy, Taichung, Taiwan.	shinda@mail.cmu.edu.tw	Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Kuo, Chia-Hua/0000-0002-1731-4984; Lin, Yi-Yuan/0000-0002-6147-0183	Ministry of Science and Technology [MOST101-2410-H-845-015-MY3, MOST104-2314-B-039-013-MY3, MOST106-2420-H-039-003-DR]; China Medical University [CMU100-N2-11]; Asia University [CMU99-ASIA-04]; University of Taipei, Taiwan; Program for Eastern Scholar, Honorary Chair Professor at Shanghai Institute of Higher Education [201247]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University(China Medical University); Asia University; University of Taipei, Taiwan; Program for Eastern Scholar, Honorary Chair Professor at Shanghai Institute of Higher Education	This study was supported by the Ministry of Science and Technology (MOST101-2410-H-845-015-MY3 to A-LY, MOST104-2314-B-039-013-MY3 to S-DL, and MOST106-2420-H-039-003-DR to Y-YL), China Medical University (CMU100-N2-11 to Y-JC) and Asia University (CMU99-ASIA-04 J-SC), and University of Taipei, Taiwan. Research was supported by The Program for Eastern Scholar, Honorary Chair Professor at Shanghai Institute of Higher Education (No 201247 to S-DL). There was no additional external funding received for this study.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bernecker Oliver Y, 2003, Cardiovasc Toxicol, V3, P183, DOI 10.1385/CT:3:3:183; Bhuiyan MS, 2010, MENOPAUSE, V17, P213, DOI 10.1097/gme.0b013e3181b57489; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Brower GL, 2003, MOL CELL BIOCHEM, V251, P89, DOI 10.1023/A:1025438000942; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868, DOI 10.1152/jappl.2001.91.4.1868; Dworatzek E, 2014, CARDIOVASC RES, V102, P418, DOI 10.1093/cvr/cvu065; Guetta V, 1996, CIRCULATION, V93, P1928, DOI 10.1161/01.CIR.93.10.1928; Haddock BL, 2000, SPORTS MED, V29, P39, DOI 10.2165/00007256-200029010-00004; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P753, DOI 10.1097/HJR.0b013e3281eacef1; Huang CY, 2016, J APPL PHYSIOL, V121, P457, DOI 10.1152/japplphysiol.01042.2015; Huang CY, 2012, BIOMEDICINE-TAIWAN, V2, P36, DOI 10.1016/j.biomed.2011.12.004; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Katholi RE, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/495349; Lavie CJ, 2009, MAYO CLIN PROC, V84, P373, DOI [10.4065/84.4.373, 10.1016/S0025-6196(11)60548-X]; Lee SD, 2007, OBESITY, V15, P2407, DOI 10.1038/oby.2007.286; Lee SD, 2008, MATURITAS, V61, P268, DOI 10.1016/j.maturitas.2008.07.004; Lim WK, 1999, AM J CARDIOL, V83, P1132, DOI 10.1016/S0002-9149(99)00029-6; Lin YY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092523; Lin YY, 2017, CARDIOVASC TOXICOL, V17, P163, DOI 10.1007/s12012-016-9370-2; Lin YY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122036; Liou CM, 2010, CELL BIOCHEM FUNCT, V28, P521, DOI 10.1002/cbf.1687; Ma YL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-118; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Marques CMM, 2006, MENOPAUSE, V13, P87, DOI 10.1097/01.gme.0000191209.13115.46; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Moolman JA, 2006, CARDIOVASC RES, V69, P777, DOI 10.1016/j.cardiores.2006.01.001; Morgan N A, 1996, J Am Pharm Assoc (Wash), VNS36, P360; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Narula J, 2006, NAT CLIN PRACT CARD, V3, P681, DOI 10.1038/ncpcardio0710; O'Donnell E, 2009, MENOPAUSE, V16, P770, DOI 10.1097/gme.0b013e318198cddb; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Smith AJ, 2013, CANCER EPIDEM BIOMAR, V22, P756, DOI 10.1158/1055-9965.EPI-12-1325; Strom JO, 2009, J CEREBR BLOOD F MET, V29, P1359, DOI 10.1038/jcbfm.2009.66; Tao LC, 2015, ONCOTARGET, V6, P20773, DOI 10.18632/oncotarget.4770; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Wietlisbach V, 2013, NUTR METAB CARDIOVAS, V23, P432, DOI 10.1016/j.numecd.2011.09.002; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8; Zanesco A, 2009, REV BRAS GINECOL OBS, V31, P254, DOI 10.1590/S0100-72032009000500009	41	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208633	10.1371/journal.pone.0208633	http://dx.doi.org/10.1371/journal.pone.0208633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571718	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700017
J	Matsueda, Y; Arinuma, Y; Nagai, T; Hirohata, S				Matsueda, Yu; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei			Synergistic enhancement of production of proinflammatory cytokines of human peripheral blood monocytes by anti-Sm and anti-RNP antibodies	PLOS ONE			English	Article							NF-KAPPA-B; ARTERY ENDOTHELIAL-CELLS; ACTIVATION; EXPRESSION; INTERLEUKIN-6; INHIBITION; PROTEIN; KB	The present study was performed to elucidate the roles of serum anti-Sm antibodies in the pathogenesis of systemic lupus erythematosus (SLE). Highly purified peripheral blood monocytes obtained from healthy donors were cultured in the presence of monoclonal anti-Sm antibody (anti-Sm mAb), monoclonal anti-U1 -RNP antibody (anti-RNP mAb) or control murine IgG1 or IgG3. After various periods of incubation, levels of IL-6 and TNF-alpha in the culture supernatants were measured by ELISA and the expression of mRNA for various molecules in monocytes was determined using RT-PCR. Flow cytometry analysis confirmed the bindings of anti-Sm mAb and anti-RNP mAb on viable human monocytes. Both anti-Sm mAb and anti-RNP mAb significantly increased the production of IL-6 and TNF-alpha of human monocytes in a dose-dependent manner, although the latter was more potent than the former. Of note, anti-Sm mAb synergistically enhanced the production and mRNA expression of IL-6 and TNF-alpha of human monocytes in the presence of anti-RNP mAb. Notably, anti-RNP mAb, but not anti-Sm mAb, significantly enhanced the mRNA expression of ReIA in human monocytes. Finally, anti-Sm mAb still up-regulated the IL-6 production of monocytes in the presence of anti-RNP mAb under the influence of N-acetyl cysteine or pyrrolidine dithiocarbamate that totally abrogated the IL-6 production provoked by anti-Sm mAb alone in the absence of anti-RNP mAb. These results demonstrate that anti-Sm and anti-RNP antibodies synergistically up-regulate the expression of IL-6 and TNF-alpha in human monocytes. The data also suggest that the effect of anti-Sm in the synergy with anti-RNP might not involve NFkB activation.	[Matsueda, Yu; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa, Japan	Kitasato University	Hirohata, S (corresponding author), Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa, Japan.	shunsei@med.kitasato.ac.jp	Arinuma, Yoshiyuki/CAH-4707-2022	Hirohata, Shunsei/0000-0003-1911-7383	Ministry of Education, Culture, Science and Sports of Japan [15K09556]; Japan Agency for Medical Research and Development [15eK0410022h0001]	Ministry of Education, Culture, Science and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grant-in-aid (c) from the Ministry of Education, Culture, Science and Sports of Japan (recipient: SH) (No. 15K09556) and by a grant from Japan Agency for Medical Research and Development (No. 15eK0410022h0001) (recipient: SH). These funders do not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2013, J NEPHROL, V26, P778, DOI 10.5301/jn.5000167; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Du ZY, 2012, J INTERF CYTOK RES, V32, P368, DOI 10.1089/jir.2012.0002; Gomes A, 2015, MED CHEM, V11, P560, DOI 10.2174/1573406411666150209114702; HIROHATA S, 1994, LANCET, V343, P796, DOI 10.1016/S0140-6736(94)91875-9; Hirohata S, 2017, ANN RHEUM DIS, V76, P598, DOI 10.1136/annrheumdis-2017-eular.2806; Hirohata S, 2018, CLIN EXP RHEUM; Hirohata S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0450-z; Hirohata S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2184; Hirohata S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1915; Hoshiyama T, 2018, MOD RHEUMATOL, V28, P506, DOI 10.1080/14397595.2017.1354796; Ichiyama T, 2001, CLIN IMMUNOL, V99, P373, DOI 10.1006/clim.2001.5026; KELLEY JL, 1987, EXP MOL PATHOL, V46, P266, DOI 10.1016/0014-4800(87)90049-9; Lee MKS, 2016, BRIT J PHARMACOL, V173, P741, DOI 10.1111/bph.13319; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Migliorini P, 2005, AUTOIMMUNITY, V38, P47, DOI 10.1080/08916930400022715; Munoz C, 1996, BLOOD, V88, P3482, DOI 10.1182/blood.V88.9.3482.bloodjournal8893482; Nagai T, 2005, ARTHRITIS RHEUM-US, V52, P847, DOI 10.1002/art.20869; NETTER HJ, 1988, ARTHRITIS RHEUM, V31, P616, DOI 10.1002/art.1780310506; Okawa-Takatsuji M, 1999, CLIN EXP IMMUNOL, V116, P174; Okawa-Takatsuji M, 1999, CLIN EXP RHEUMATOL, V17, P705; Okawa-Takatsuji M, 2001, CLIN EXP IMMUNOL, V126, P345, DOI 10.1046/j.1365-2249.2001.01669.x; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Sugawara E, 2017, INTERNAL MED, V56, P445, DOI 10.2169/internalmedicine.56.7668; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878	28	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209282	10.1371/journal.pone.0209282	http://dx.doi.org/10.1371/journal.pone.0209282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571738	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700049
J	Passos, JF; Nascimento, DB; Menezes, RST; Adaime, R; Araujo, EL; Lima, KM; Zucchi, RA; Teles, BR; Nascimento, RR; Arce, RR; Barr, NB; McPheron, BA; Silva, JG				Passos, Joseane F.; Nascimento, Danilo B.; Menezes, Rodolpho S. T.; Adaime, Ricardo; Araujo, Elton L.; Lima, Katia M.; Zucchi, Roberto A.; Teles, Beatriz Ronchi; Nascimento, Ruth R.; Arce, Raul Ruiz; Barr, Norman B.; McPheron, Bruce A.; Silva, Janisete G.			Genetic structure and diversity in Brazilian populations of Anastrepha obliqua (Diptera: Tephritidae)	PLOS ONE			English	Article							MANAGEMENT; NEUTRALITY; RESOLUTION; INFERENCE; REVEAL; GROWTH; TESTS	Anastrepha obliqua (Macquart), the West Indian fruit fly, is one of the most economically important pest species in the Neotropical region. It infests an extensive range of host plants that include over 60 species. The geographic range of A. obliqua is from northern Mexico to southern Brazil and includes the Caribbean Islands. Previous molecular studies have revealed significant genetic structure among populations. We used sequences from a fragment of the mitochondrial protein-coding gene cytochrome c oxidase Ito estimate structure and genetic diversity of A. obliqua populations from Brazil. We analyzed a total of 153 specimens from the Amazon Forest, Atlantic Forest, Cerrado, and Caatinga biomes. Our study revealed weak genetic structure among the A. obliqua Brazilian populations sampled. Collections from the Amazon Forest had similar haplotype diversity compared to previously reported estimates for collections from the Caribbean and both populations are also closely related to each other, thus challenging the hypothesis that A. obliqua originated in the Caribbean and then moved to other regions of the Americas. Therefore, further evidence is necessary to draw a definite conclusion about the putative center of origin for A. obliqua. Additionally, we suggest a putative historical migration from the west to the east for the A. obliqua Brazilian populations, which could explain the high genetic diversity for this fly in the Amazon Forest and low genetic diversity in the other Brazilian biomes.	[Passos, Joseane F.; Lima, Katia M.; Silva, Janisete G.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Nascimento, Danilo B.] Univ Fed Amapa, Dept Ciencias Biol, Macapa, Amapa, Brazil; [Menezes, Rodolpho S. T.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras, Dept Biol, Ribeirao Preto, SP, Brazil; [Adaime, Ricardo] Empresa Brasileira Pesquisa Agr, Macapa, Amapa, Brazil; [Araujo, Elton L.] Univ Fed Rural Semi Arido, Dept Ciencias Biol, Mossoro, RN, Brazil; [Zucchi, Roberto A.] Univ Sao Paulo, Dept Entomol, Sao Paulo, Brazil; [Teles, Beatriz Ronchi] Inst Nacl de Pesquisas da Amazonia, Dept Entomol, Manaus, Amazonas, Brazil; [Nascimento, Ruth R.] Univ Fed Alagoas, Dept Ciencias Biol, Maceio, Alagoas, Brazil; [Arce, Raul Ruiz; Barr, Norman B.] USDA APHIS Sci & Technol, Mission Lab, Edinburg, TX USA; [McPheron, Bruce A.] Ohio Univ, Dept Entomol, Columbus, OH USA	Universidade Estadual de Santa Cruz; Fundacao Universidade Federal do Amapa; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural do Semi-Arido (UFERSA); Universidade de Sao Paulo; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Alagoas; University System of Ohio; Ohio University	Silva, JG (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.	jgs10@uol.com.br	Menezes, Rodolpho Santos Telles/B-2952-2014; Nascimento, Ruth Rufino do/AAB-4246-2019; Araujo, Elton L/O-2617-2018; Silva, Janisete/D-2245-2013	Menezes, Rodolpho Santos Telles/0000-0002-6612-3543; Nascimento, Ruth Rufino do/0000-0002-2005-4941; Araujo, Elton L/0000-0001-8274-502X; Silva, Janisete/0000-0002-5570-5484	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477945/2009-0, 447822/2014-4, 308554/2015-9]; Alfred P. Sloan Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado da Bahia; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2015/02432-0]; Universidade Estadual de Santa Cruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Estadual de Santa Cruz	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (URL: www.cnpq.br) (grants##477945/2009-0, 447822/2014-4, and 308554/2015-9) and the Alfred P. Sloan Foundation. JFACP was a recipient of a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (URL: http://www.capes.gov.br) during her MSc and a fellowship from Fundacao de Amparo a Pesquisa do Estado da Bahia (URL: http://www.fapesb.ba.gov.br) during her PhD. RSTM is thankful to FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) (URL: http://www.fapesp.br) (grant #2015/02432-0). ELA, JGS, RRN, RAZ, RA are CNPq fellows. This publication was made possible by the financial support from Universidade Estadual de Santa Cruz (URL: www.uesc.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALUJA M, 1993, ANN ENTOMOL SOC AM, V86, P799, DOI 10.1093/aesa/86.6.799; ALUJA M, 1994, ANNU REV ENTOMOL, V39, P155, DOI 10.1146/annurev.en.39.010194.001103; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Araujo EL, 2006, NEOTROP ENTOMOL, V35, P329, DOI 10.1590/S1519-566X2006000300006; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Castaneda MR, 2015, ZOOKEYS, P61, DOI 10.3897/zookeys.540.6013; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2006, ARLEQUIN V3 1 INTEGR; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Henning F, 2006, NEOTROP ENTOMOL, V35, P145, DOI 10.1590/S1519-566X2006000100021; Hernandez-Ortiz Vicente, 1994, Folia Entomologica Mexicana, V88, P89; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima W. C., 2017, ESTUDO CLASSIFICADOR; MANTEL N, 1967, CANCER RES, V27, P209; Norrbom A.L., 1988, LIST RECORDED HOST P; Norrbom AL, 2015, ZOOTAXA, V4041, P1, DOI 10.11646/zootaxa.4041.1.1; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Arce R, 2015, J ECON ENTOMOL, V108, P1324, DOI 10.1093/jee/tov082; Ruiz-Arce R, 2012, J ECON ENTOMOL, V105, P2147, DOI 10.1603/EC12211; Scally M, 2016, MOL PHYLOGENET EVOL, V101, P286, DOI 10.1016/j.ympev.2016.04.020; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; SLATKIN M, 1991, GENETICS, V129, P555; Smith-Caldas Martha R. B., 2001, Neotropical Entomology, V30, P565, DOI 10.1590/S1519-566X2001000400009; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wei SJ, 2015, MOL ECOL, V24, P4094, DOI 10.1111/mec.13300; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Werneck FP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0368-3; Wu Y, 2011, J ECON ENTOMOL, V104, P1065, DOI 10.1603/EC10395; Zucchi RA, 2008, FRUIT FLIES BRAZIL A	40	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208997	10.1371/journal.pone.0208997	http://dx.doi.org/10.1371/journal.pone.0208997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571687	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700031
J	Wilkins, SS; Akhtar, N; Salam, A; Bourke, P; Joseph, S; Santos, M; Shuaib, A				Wilkins, Stacy Schantz; Akhtar, Naveed; Salam, Abdul; Bourke, Paula; Joseph, Sujatha; Santos, Mark; Shuaib, Ashfaq			Acute post stroke depression at a Primary Stroke Center in the Middle East	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; PHQ-9; VALIDITY; IDENTIFICATION	Objective Depression occurs in approximately 30 percent of stroke patients, leading to increased disability, lower quality of life and increased mortality. Given new recommendations to assess depression in acute stroke patients this study evaluated rates of acute post stroke depression at a Primary Stroke Center in Doha, Qatar. Methods Acute stroke patients (n = 233) were given the PHQ-9 and the Mini-Cog test by stroke unit nurses within the first few days post stroke. This was part of a clinical improvement project conducted from March 2016 thru March 2017. Results Approximately 20% of acute post stroke patients (46/233) scored in the moderately depressed range on the Patient Health Questionnaire (PHQ-9 >= 10 with item 1 and/or 2 endorsed). Nationality and dysarthria were significantly associated with depression. Females were twice as likely to be depressed. A significantly greater number of Middle Eastern and African patients were depressed (30.18%) than Southeast Asian and Western Pacific patients (16.76%). A PHQ-2 cut off of 2 was optimal with sensitivity of 91.3 and specificity of 71.6. Conclusions Almost 20% of acute stroke patients were moderately depressed on the PHQ-9, with Middle Eastern/African patients almost twice as likely to be depressed. This may reflect higher baseline pre-stroke depression levels in those of Middle Eastern/African background, perhaps due to greater levels or stress or trauma exposure in these groups. Dysarthria was found to be significantly associated with depression. Initial screening with the PHQ-2 using a cut-off of 2 (versus the cut-off of 3 used in primary care settings) may be beneficial. Based on these results acute post stroke depression screening is recommended in the Middle East, coupled with culturally sensitive psychiatric care.	[Wilkins, Stacy Schantz; Akhtar, Naveed; Salam, Abdul; Bourke, Paula; Joseph, Sujatha; Santos, Mark; Shuaib, Ashfaq] Hamad Med Corp, Acad Hlth, Neurosci Inst, Stroke Ctr Excellence, Doha, Qatar; [Wilkins, Stacy Schantz] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Shuaib, Ashfaq] Univ Alberta, Dept Med, Edmonton, AB, Canada	Hamad Medical Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Alberta	Wilkins, SS (corresponding author), Hamad Med Corp, Acad Hlth, Neurosci Inst, Stroke Ctr Excellence, Doha, Qatar.; Wilkins, SS (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	stacy.wilkins@va.gov	Salam, Abdul/GWC-1029-2022	Wilkins, Stacy/0000-0002-5278-7832				Akhtar N, 2016, EURO STROKE J, P1; Al-Qadhi W, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-190; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bartoli F, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/862978; Borson S, 2006, INT J GERIATR PSYCH, V21, P349, DOI 10.1002/gps.1470; Casaubon LK, 2016, INT J STROKE, V11, P239, DOI 10.1177/1747493015622461; de Man-van Ginkel JM, 2012, STROKE, V43, P854, DOI 10.1161/STROKEAHA.111.640276; De Ryck A, 2014, J GERIATR PSYCH NEUR, V27, P147, DOI 10.1177/0891988714527514; Elklit Ask, 2009, Clin Pract Epidemiol Ment Health, V5, P1, DOI 10.1186/1745-0179-5-1; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M.B., 2016, STRUCTURED CLIN INTE; Gilsanz P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001923; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; Kaadan MI, 2017, J NEUROL SCI, V378, P220, DOI 10.1016/j.jns.2017.05.026; Karamchandani RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128246; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Poongothai S, 2009, J Assoc Physicians India, V57, P147; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Sayar K, 2012, J MOOD DISORD, V2, P21, DOI 10.5455/jmood.20111217094801; Vatanagul J, 2014, INT J MED HLTH SCI, V1; Williams LS, 2005, STROKE, V36, P635, DOI 10.1161/01.STR.0000155688.18207.33; Winstein CJ, 2016, GUIDELINES ADULT STR, V2016, pe13	28	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208708	10.1371/journal.pone.0208708	http://dx.doi.org/10.1371/journal.pone.0208708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571716	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700021
J	Osorio-Valencia, JS; Wongviriyawong, C; Winkler, T; Kelly, VJ; Harris, RS; Venegas, JG				Osorio-Valencia, Juan S.; Wongviriyawong, Chanikarn; Winkler, Tilo; Kelly, Vanessa J.; Harris, Robert S.; Venegas, Jose G.			Elevation in lung volume and preventing catastrophic airway closure in asthmatics during bronchoconstriction	PLOS ONE			English	Article							INSPIRATORY MUSCLE-ACTIVITY; BRONCHIAL THERMOPLASTY; PULMONARY PERFUSION; COMPUTED-TOMOGRAPHY; VERTICAL GRADIENTS; DEEP INSPIRATIONS; BODY ORIENTATION; HYPER-INFLATION; SMOOTH-MUSCLE; IN-VIVO	Background Asthma exacerbations cause lung hyperinflation, elevation in load to inspiratory muscles, and decreased breathing capacity that, in severe cases, may lead to inspiratory muscle fatigue and respiratory failure. Hyperinflation has been attributed to a passive mechanical origin; a respiratory system time-constant too long for full exhalation. However, because the increase in volume is also concurrent with activation of inspiratory muscles during exhalation it is unclear whether hyperinflation in broncho-constriction is a passive phenomenon or is actively controlled to avoid airway closure. Methods Using CT scanning, we measured the distensibility of individual segmental airways relative to that of their surrounding parenchyma in seven subjects with asthma and nine healthy controls. With this data we tested whether the elevation of lung volume measured after methacholine (MCh) provocation was associated with airway narrowing, or to the volume required to preventing airway closure. We also tested whether the reduction in FVC post-MCh could be attributed to gas trapped behind closed segmental airways. Findings The changes in lung volume by MCh in subjects with and without asthma were inversely associated with their reduction in average airway lumen. This finding would be inconsistent with hyperinflation by passive elevation of airway resistance. In contrast, the change in volume of each subject was associated with the lung volume estimated to cause the closure of the least stable segmental airway of his/her lungs. In addition, the measured drop in FVC post MCh was associated with the estimated volume of gas trapped behind closed segmental airways at RV. Conclusions Our data supports the concept that hyperinflation caused by MCh-induced bronchoconstriction is the result of an actively controlled process where parenchymal distending forces on airways are increased to counteract their closure. To our knowledge, this is the first imagingbased study that associates inter-subject differences in whole lung behavior with the interdependence between individual airways and their surrounding parenchyma.	[Osorio-Valencia, Juan S.] Tech Univ Munich, Dept Comp Sci, Grad Program Biomed Comp, Munich, Germany; [Osorio-Valencia, Juan S.; Wongviriyawong, Chanikarn; Winkler, Tilo; Venegas, Jose G.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Osorio-Valencia, Juan S.; Wongviriyawong, Chanikarn; Winkler, Tilo; Kelly, Vanessa J.; Harris, Robert S.; Venegas, Jose G.] Harvard Med Sch, Boston, MA 02115 USA; [Wongviriyawong, Chanikarn] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Wongviriyawong, Chanikarn] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Wongviriyawong, Chanikarn] King Mongkuts Univ Technol Thonburi, Inst Field Robot, Bangkok, Thailand	Technical University of Munich; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; King Mongkuts University of Technology Thonburi	Osorio-Valencia, JS (corresponding author), Tech Univ Munich, Dept Comp Sci, Grad Program Biomed Comp, Munich, Germany.; Osorio-Valencia, JS; Venegas, JG (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA.; Osorio-Valencia, JS; Venegas, JG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	juan.s.osorio@gmail.com; Jvenegas@alum.mit.edu	Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550; Perez Venegas, Jose Javier/0000-0001-8737-7123; Osorio-Valencia, Juan Sebastian/0000-0002-2973-8290	NIH [HL68011]; Otto Bayer Fellowship by Bayer Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Otto Bayer Fellowship by Bayer Foundation	This work was funded in part by NIH grant HL68011, and Otto Bayer Fellowship by Bayer Foundation (JSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2014, MECH BREATHING, P215; Aliverti A, 2013, EUR RESPIR J, V41, P1179, DOI 10.1183/09031936.00050112; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Brown N, 2007, AM J RESP CRIT CARE, V176, P129, DOI 10.1164/rccm.200609-1317OC; Brown RH, 2000, AM J RESP CRIT CARE, V162, P2113, DOI 10.1164/ajrccm.162.6.2004055; Brown RH, 2000, J APPL PHYSIOL, V89, P956, DOI 10.1152/jappl.2000.89.3.956; Brown RH, 2005, EUR RESPIR J, V26, P277, DOI 10.1183/09031936.05.00006605; Brown RH, 2000, AM J RESP CRIT CARE, V161, P1256, DOI 10.1164/ajrccm.161.4.9806051; Brown RH, 2003, RESP PHYSIOL NEUROBI, V137, P327, DOI 10.1016/S1569-9048(03)00156-3; Brown RH, 1997, J APPL PHYSIOL, V82, P491, DOI 10.1152/jappl.1997.82.2.491; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; Brown R, 2007, CLIN MED INSIGHTS-CI, V1, P1; Brown RH, 2016, J APPL PHYSIOL, V121, P223, DOI 10.1152/japplphysiol.00545.2015; Brown RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010332; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; CITTERIO G, 1981, J APPL PHYSIOL, V51, P1388, DOI 10.1152/jappl.1981.51.6.1388; COLLETT PW, 1986, AM REV RESPIR DIS, V133, P1143; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Cressoni M, 2013, CRIT CARE, V17, DOI 10.1186/cc12738; Diaz AA, 2012, CHEST, V141, P736, DOI 10.1378/chest.11-1026; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Golnabi AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112443; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2012, PLOS ONE, V7, P6, DOI [10.1164/ajrccm/136.3.730, DOI 10.1164/AJRCCM/136.3.730]; Hill A R, 1991, J Assoc Acad Minor Phys, V2, P100; HOFFMAN EA, 1985, J APPL PHYSIOL, V59, P481, DOI 10.1152/jappl.1985.59.2.481; HOFFMAN EA, 1985, J APPL PHYSIOL, V59, P468, DOI 10.1152/jappl.1985.59.2.468; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; HRUBY J, 1975, THORAX, V30, P548, DOI 10.1136/thx.30.5.548; Kee ST, 1996, ACAD RADIOL, V3, P389, DOI 10.1016/S1076-6332(05)80671-3; LAIFOOK SJ, 1978, J APPL PHYSIOL, V44, P859, DOI 10.1152/jappl.1978.44.6.859; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Ma BS, 2014, J APPL PHYSIOL, V116, P628, DOI 10.1152/japplphysiol.01180.2013; MACKLEM P T, 1989, European Respiratory Journal, V2, p516S; MARTIN J, 1980, AM REV RESPIR DIS, V121, P441, DOI 10.1164/arrd.1980.121.3.441; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; MILLAR AB, 1989, THORAX, V44, P485, DOI 10.1136/thx.44.6.485; Mullan BF, 1997, ACAD RADIOL, V4, P674, DOI 10.1016/S1076-6332(97)80138-9; MULLER N, 1980, J APPL PHYSIOL, V49, P869, DOI 10.1152/jappl.1980.49.5.869; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Nguyen Trang T B, 2008, Proc Am Thorac Soc, V5, P58, DOI 10.1513/pats.200705-055VS; Oliven A, 1987, JAPPLPHYSIOL; Pare PD, 2012, COMPR PHYSIOL, V2, P1921, DOI 10.1002/cphy.c110039; Pellegrini M, 2017, AM J RESP CRIT CARE, V195, P1608, DOI 10.1164/rccm.201605-0992OC; Pellegrino R, 1997, EUR RESPIR J, V10, P468, DOI 10.1183/09031936.97.10020468; Petersen J, 2014, EUR RADIOL, V24, P2319, DOI 10.1007/s00330-014-3261-3; Pyrgos G, 2011, J APPL PHYSIOL, V110, P472, DOI 10.1152/japplphysiol.00603.2010; Reber A, 1996, ANAESTHESIA, V51, P733, DOI 10.1111/j.1365-2044.1996.tb07885.x; Scichilone N, 2014, MECH BREATHING SE 16, P231; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Ward C, 2001, AM J RESP CRIT CARE, V164, P1718, DOI 10.1164/ajrccm.164.9.2102039; Wille MMW, 2013, AM J RESP CRIT CARE, V187; Williamson JP, 2011, AM J RESP CRIT CARE, V183, P612, DOI 10.1164/rccm.201002-0178OC; WILSON TA, 1972, J APPL PHYSIOL, V33, P472, DOI 10.1152/jappl.1972.33.4.472; Wongviriyawong C, 2013, J APPL PHYSIOL, V114, P504, DOI 10.1152/japplphysiol.00273.2012; Wongviriyawong C, 2012, J APPL PHYSIOL, V112, P237, DOI 10.1152/japplphysiol.01400.2010; YANG QH, 1991, J APPL PHYSIOL, V71, P76, DOI 10.1152/jappl.1991.71.1.76	62	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208337	10.1371/journal.pone.0208337	http://dx.doi.org/10.1371/journal.pone.0208337			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566496	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300037
J	dos Santos, LF; Polveiro, RC; Moreira, TS; Vidigal, PMP; Chang, YF; Moreira, MAS				dos Santos, Lucas Fernando; Polveiro, Richard Costa; Moreira, Thalita Scatamburlo; Pereira Vidigal, Pedro Marcus; Chang, Yung-Fu; Scatamburlo Moreira, Maria Aparecida			Polymorphism analysis of the apxIA gene of Actinobacillus pleuropneumoniae serovar 5 isolated in swine herds from Brazil	PLOS ONE			English	Article							ESCHERICHIA-COLI; MULTIPLEX PCR; RTX-TOXINS; VIRULENCE; IDENTIFICATION; POPULATION; SEROTYPES; HEMOLYSIN; ACCURACY; ALLELES	The bacterium Actinobacillus pleuropneumoniae is the etiological agent of Contagious Porcine Pleuropneumonia, a disease responsible for economic losses in the swine industry worldwide. A. pleuropneumoniae is capable of producing proteinaceous exotoxins responsible for inducing hemorrhagic lesions, one of which is ApxI. Few studies have conducted an in-depth evaluation of polymorphisms of the nucleotides that make up the ApxI toxin gene. Here we analyze the polymorphisms of the apxIA gene region of A. pleuropneumoniae serovar 5 isolated from swine in different regions in Brazil and report the results of molecular sequencing and phylogenetic analysis. Analysis of the apxIA gene in 60 isolates revealed the presence of genetic diversity and variability. The polymorphisms in the nucleotide sequences determined the grouping of the Brazilian sequences and five more sequences from the GenBank database into 14 different haplotypes, which formed three main groups and revealed the presence of mutations in the nucleotide sequences. The estimation of selection pressures suggests the occurrence of genetic variations by positive selective pressure on A. pleuropneumoniae in large groups of animals in relatively small spaces. These conditions presumably favor the horizontal dissemination of apxIA gene mutations within bacterial populations with host reservoirs. As a result, the same serovar can demonstrate different antigenic capacities due to mutations in the apxIA gene. These alterations in sequences of the apxIA gene could occur in other areas of countries with intense swine production, which could lead to differences in the pathogenicity and immunogenicity of each serovar and have implications for the clinical status or diagnosis of A. pleuropneumoniae.	[dos Santos, Lucas Fernando; Polveiro, Richard Costa; Moreira, Thalita Scatamburlo; Scatamburlo Moreira, Maria Aparecida] Univ Fed Vicosa, Vet Dept, Sect Prevent Vet Med & Publ Hlth, Lab Bacterial Dis, Vicosa, MG, Brazil; [dos Santos, Lucas Fernando] Microbiol Vet Especial LTDA Microvet, Vicosa, MG, Brazil; [Pereira Vidigal, Pedro Marcus] Univ Fed Vicosa, Ctr Biol Sci, Nucleo Anal Biomol NuBioMol, Vicosa, MG, Brazil; [Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Cornell University	Moreira, MAS (corresponding author), Univ Fed Vicosa, Vet Dept, Sect Prevent Vet Med & Publ Hlth, Lab Bacterial Dis, Vicosa, MG, Brazil.	masm@ufv.br	Moreira, Maria Aparecida Scatamburlo/Q-2304-2019; Vidigal, Pedro Marcus/G-3100-2011; Polveiro, Richard Costa/AAP-3075-2020	Moreira, Maria Aparecida Scatamburlo/0000-0002-6902-2502; Vidigal, Pedro Marcus/0000-0002-5116-9856; Polveiro, Richard Costa/0000-0002-1714-9720; Dos Santos, Lucas Fernando/0000-0003-0095-8473; Chang, Yung-Fu/0000-0001-8902-3089	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasilia, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais, Belo Horizonte, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasilia, Brazil) [001]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais, Belo Horizonte, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge the staff of the laboratory of Microvet for the supply of the lyophilized samples for the accomplishment of this study. The authors also acknowledge the financial support from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasilia, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais, Belo Horizonte, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasilia, Brazil, Finance Code 001). Maria Aparecida Scatamburlo Moreira is supported by CNPq.; The authors acknowledge the staff of the laboratory of Microvet for the supply of the lyophilized samples for the accomplishment of this study. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001. The authors also acknowledge the financial support from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasilia, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais, Belo Horizonte, Brazil). Maria Aparecida Scatamburlo Moreira is supported by CNPq.	Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2002, ACTINOBACILLUS PLEUR, P225, DOI [10.1016/S1286-4579(01)01534-9, DOI 10.1016/S1286-4579(01)01534-9]; BRANDRETH SR, 1985, VET REC, V117, P143, DOI 10.1136/vr.117.7.143; CASPERMEYER J, 2016, MOL BIOL EVOL, V33, P1887, DOI DOI 10.1093/M0LBEV/MSW074; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHANG YF, 1995, DNA SEQUENCE, V5, P291, DOI 10.3109/10425179509030983; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; CHANG YF, 1989, DNA-J MOLEC CELL BIO, V8, P635, DOI 10.1089/dna.1.1989.8.635; Chang YF, 1993, INFECT IMMUN; Chang YF, 1991, J BACTERIOL, DOI [10.1128/jb.173.16.5151-5158.1991, DOI 10.1128/JB.173.16.5151-5158.1991]; Chang YF, 1987, INFECT IMMUN; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FENWICK B, 1994, J AM VET MED ASSOC, V204, P1334; Franzo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep39458; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; Frey J, 2002, INT J MED MICROBIOL, V292, P149, DOI 10.1078/1438-4221-00200; FREY J, 1993, J GEN MICROBIOL, V139, P1723, DOI 10.1099/00221287-139-8-1723; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hathroubi S, 2015, VET MICROBIOL, V179, P277, DOI 10.1016/j.vetmic.2015.06.011; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2005, GENETICS, V169, P533, DOI 10.1534/genetics.104.036939; Ito H, 2010, J VET MED SCI, V72, P653, DOI 10.1292/jvms.09-0529; Jacobsen MJ, 1996, VET MICROBIOL, V49, P159, DOI 10.1016/0378-1135(95)00184-0; JANSEN R, 1993, INFECT IMMUN, V61, P3688, DOI 10.1128/IAI.61.9.3688-3695.1993; Jessing SG, 2003, J CLIN MICROBIOL, V41, P4095, DOI 10.1128/JCM.41.9.4095-4100.2003; KAMP EM, 1994, INFECT IMMUN, V62, P4063, DOI 10.1128/IAI.62.9.4063-4065.1994; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kuchiishi S. S., 2007, Acta Scientiae Veterinariae, V35, P79; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Lemey P., 2009, PHYLOGENETIC HDB PRA, DOI [10.1111/j.1541-0420.2010.01388.x, DOI 10.1111/J.1541-0420.2010.01388.X]; Lin LW, 2007, FEMS MICROBIOL LETT, V274, P55, DOI 10.1111/j.1574-6968.2007.00813.x; Liu JL, 2009, VET MICROBIOL, V137, P282, DOI 10.1016/j.vetmic.2009.01.011; Lopez-Bermudez J, 2014, VACCINE, V32, P6805, DOI 10.1016/j.vaccine.2014.09.056; Maas A, 2006, VACCINE, V24, P7226, DOI 10.1016/j.vaccine.2006.06.047; MACINNES JI, 1990, CAN J VET RES, V54, P244; McWhinney DR, 1992, J BACTERIOL, DOI [10.1128/jb.174.1.291-297.1992, DOI 10.1128/JB.174.1.291-297.1992]; MOLLER K, 1992, J CLIN MICROBIOL, V30, P623; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NAGAI S, 1993, MICROB PATHOGENESIS, V15, P485, DOI 10.1006/mpat.1993.1096; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; NIELSEN R, 1991, J CLIN MICROBIOL, V29, P794, DOI 10.1128/JCM.29.4.794-797.1991; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pulido-Tamayo S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv478; PUPO GM, 1995, MICROBIOL-UK, V141, P1037, DOI 10.1099/13500872-141-4-1037; R Development Core Team, 2016, R LANG ENV STAT COMP; Rayamajhi N, 2005, J VET DIAGN INVEST, V17, P359, DOI 10.1177/104063870501700410; Reid SD, 1999, J BACTERIOL, V181, P153, DOI 10.1128/JB.181.1.153-160.1999; REIMER D, 1995, MICROB PATHOGENESIS, V18, P197, DOI 10.1016/S0882-4010(95)90049-7; ROUSSEAU P, 1988, CAN VET J, V29, P989; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sadilkova L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-2; Saraiva GL, 2018, VIRUS GENES, P1; Sarkozi R, 2015, ACTA VET HUNG, V63, P444, DOI 10.1556/004.2015.041; Sassu EL, 2018, TRANSBOUND EMERG DIS, V65, P72, DOI 10.1111/tbed.12739; Schaller A, 2000, VET MICROBIOL, V74, P365, DOI 10.1016/S0378-1135(00)00204-2; Schaller A, 1999, MICROBIOL-SGM, V145, P2105, DOI 10.1099/13500872-145-8-2105; Seah JN, 2002, INFECT IMMUN, V70, P6464, DOI 10.1128/IAI.70.11.6464-6467.2002; Shin MK, 2013, VET IMMUNOL IMMUNOP, V151, P132, DOI 10.1016/j.vetimm.2012.11.003; Shin Sung Jae, 2003, J Vet Sci, V4, P225; Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50; Torremorell M, 1997, AM J VET RES, V58, P828; TU AHT, 1994, INFECT IMMUN, V62, P2119, DOI 10.1128/IAI.62.5.2119-2121.1994; Vidigal PMP, 2012, VIRUS RES, V163, P320, DOI 10.1016/j.virusres.2011.10.019; Wagner A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2763; Wales A, 2013, ISRN Vet Sci, V2013, P943126, DOI 10.1155/2013/943126; WEAVER S, 2018, MOL BIOL EVOL; WELCH RA, 1992, FEMS MICROBIOL IMMUN, V105, P29; Xu ZF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-203	81	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208789	10.1371/journal.pone.0208789	http://dx.doi.org/10.1371/journal.pone.0208789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562362	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100022
J	Jussila, MP; Remes, T; Anttonen, J; Harila-Saari, A; Niinimaki, J; Pokka, T; Koskenkorva, P; Sutela, A; Toiviainen-Sale, S; Arikoski, P; Riikonen, P; Arola, M; Lahteenmaki, P; Sirkia, K; Rantala, H; Suo-Palosaari, M; Ojaniemi, M				Jussila, Miro-Pekka; Remes, Tiina; Anttonen, Julia; Harila-Saari, Arja; Niinimaki, Jaakko; Pokka, Tytti; Koskenkorva, Paivi; Sutela, Anna; Toiviainen-Sale, Sanna; Arikoski, Pekka; Riikonen, Pekka; Arola, Mikko; Lahteenmaki, Paivi; Sirkia, Kirsti; Rantala, Heikki; Suo-Palosaari, Maria; Ojaniemi, Marja			Late vertebral side effects in long-term survivors of irradiated childhood brain tumor	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GROWTH-HORMONE; RADIATION-THERAPY; ADULT SURVIVORS; FRACTURES; ENDOCRINE; HEALTH; MASS	Purpose Long-term side effects of the treatments are common in survivors of irradiated pediatric brain tumors. Ionizing radiation in combination with surgery and chemotherapy during childhood may reduce vertebral height and bone mineral density (BMD), and cause growth failure. The aim of this study was to evaluate the late consequences of tumor treatments on vertebrae in survivors of childhood brain tumors. Methods 72 adult survivors (mean age 27.8 years, standard deviation 6.7) of irradiated childhood brain tumor were studied by spinal magnetic resonance imaging (MRI) for vertebral abnormalities from the national cohort of Finland. Patients were treated in five university hospitals in Finland between the years 1970 and 2008. Subject height and weight were measured and body mass index (BMI) was calculated. The morphology and height/ depth ratio of the vertebrae in the middle of the kyphotic thoracic curvature (Th8) and lumbar lordosis (L3) were examined. Vertebrae were analyzed by Genant's semiquantative (SQ) method and spinal deformity index (SDI) was calculated. BMD was measured by using dual X-ray absorptiometry. Results 4.2% (3/72) of the patients had undiagnosed asymptomatic vertebral fracture and 5.6% (4/72) of patients had radiation- induced decreased vertebral body height. Male patients had flatter vertebrae compared with females. Patient age at the time of irradiation, BMI and irradiation area correlated to vertebral morphology differentially in males and females. BMD had no association with the vertebral shape. Patients who had received craniospinal irradiation were shorter than the general population. Conclusion Childhood brain tumor survivors had a high number of vertebral abnormalities in young adulthood. Irradiation was associated with abnormal vertebral morphology and compromised final height. Male gender may predispose vertebrae to the side effects of irradiation.	[Jussila, Miro-Pekka; Niinimaki, Jaakko; Suo-Palosaari, Maria] Univ Oulu, Res Unit Med Imaging Phys & Technol, Fac Med, Oulu, Finland; [Jussila, Miro-Pekka; Niinimaki, Jaakko; Suo-Palosaari, Maria; Ojaniemi, Marja] Univ Oulu, Med Res Ctr, Oulu, Finland; [Remes, Tiina; Anttonen, Julia; Pokka, Tytti; Rantala, Heikki; Ojaniemi, Marja] Oulu Univ Hosp, Dept Pediat & Adolescence, Oulu, Finland; [Remes, Tiina; Anttonen, Julia; Pokka, Tytti; Rantala, Heikki; Ojaniemi, Marja] Oulu Univ Hosp, PEDEGO Res Unit, Oulu, Finland; [Remes, Tiina; Anttonen, Julia; Niinimaki, Jaakko; Pokka, Tytti; Rantala, Heikki; Suo-Palosaari, Maria; Ojaniemi, Marja] Univ Oulu, Oulu, Finland; [Harila-Saari, Arja] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Niinimaki, Jaakko; Suo-Palosaari, Maria] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland; [Koskenkorva, Paivi; Sutela, Anna] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Toiviainen-Sale, Sanna] Univ Helsinki, Dept Pediat Radiol, HUS Med Imaging Ctr, Radiol, Helsinki, Finland; [Toiviainen-Sale, Sanna] Helsinki Univ Hosp, Helsinki, Finland; [Arikoski, Pekka; Riikonen, Pekka] Kuopio Univ Hosp, Dept Pediat & Adolescence, Kuopio, Finland; [Arikoski, Pekka; Riikonen, Pekka] Univ Eastern Finland, Kuopio, Finland; [Arola, Mikko] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Arola, Mikko] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Lahteenmaki, Paivi] Turku Univ Hosp, Dept Pediat & Adolescent Med, Turku, Finland; [Lahteenmaki, Paivi] Turku Univ, Turku, Finland; [Sirkia, Kirsti] Helsinki Univ Hosp, Dept Pediat & Adolescence, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Uppsala University; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Hyvinkaan Sairaala; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Ojaniemi, M (corresponding author), Univ Oulu, Med Res Ctr, Oulu, Finland.; Ojaniemi, M (corresponding author), Oulu Univ Hosp, Dept Pediat & Adolescence, Oulu, Finland.; Ojaniemi, M (corresponding author), Oulu Univ Hosp, PEDEGO Res Unit, Oulu, Finland.; Ojaniemi, M (corresponding author), Univ Oulu, Oulu, Finland.	marja.ojaniemei@oulu.fi	Remes, Tiina/CAG-3378-2022; Harila-Saari, Arja/E-2124-2014	Harila-Saari, Arja/0000-0003-2767-5828; Remes, Tiina/0000-0003-4318-5343; Niinimaki, Jaakko/0000-0002-5591-3726; Jussila, Miro-Pekka/0000-0002-4105-975X; Lahteenmaki, Paivi Maria/0000-0002-5500-9606; Anttonen, Julia/0000-0002-4949-6997	Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland; Vare Foundation for Pediatric Cancer Research, Finland; Paivikki and Sakari Sohlberg Foundation, Finland; Arvo and Lea Ylppo Foundation, Finland; Foundation for Pediatric Research, Finland; Cancer Society of Finland; Thelma Makikyro Foundation, Finland; Cancer Foundation of Northern Finland; Alma and K. A. Snellman Foundation, Finland; Foundation of the Marta Donner Foundation, Finland	Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland; Vare Foundation for Pediatric Cancer Research, Finland; Paivikki and Sakari Sohlberg Foundation, Finland; Arvo and Lea Ylppo Foundation, Finland; Foundation for Pediatric Research, Finland; Cancer Society of Finland; Thelma Makikyro Foundation, Finland; Cancer Foundation of Northern Finland; Alma and K. A. Snellman Foundation, Finland; Foundation of the Marta Donner Foundation, Finland	This work was supported by Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland (http://www.ppshp.fi) (TR); Vare Foundation for Pediatric Cancer Research, Finland (http://vareensaatio.fi/) (M-PJ TR); the Paivikki and Sakari Sohlberg Foundation, Finland (http://www.pss-saatio.fi/english.htm) (TR); the Arvo and Lea Ylppo Foundation, Finland (http://www.alys.fi/) (TR); the Foundation for Pediatric Research, Finland (http://www.lastentautientutkimussaatio.fi/) (TR); the Cancer Society of Finland (https://www.cancersociety.fi/) (MO HR); the Thelma Makikyro Foundation, Finland (TR); the Cancer Foundation of Northern Finland (https://www.pohjois-suomensyopayhdistys.fi/) (TR); the Alma and K. A. Snellman Foundation, Finland (https://www.snellmansaatio.fi) (MO TR); and Foundation of the Marta Donner Foundation, Finland (TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Briot K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000014; Brownstein CM, 2004, J CLIN ENDOCR METAB, V89, P4422, DOI 10.1210/jc.2004-0160; Carey Dennis E, 2015, Adolesc Med State Art Rev, V26, P291; Cohen LE, 2012, PEDIATR BLOOD CANCER, V58, P959, DOI 10.1002/pbc.23300; Davies JH, 2005, CLIN ENDOCRINOL, V63, P1, DOI 10.1111/j.1365-2265.2005.02263.x; Galloway TJ, 2012, AM J CLIN ONCOL-CANC, V35, P279, DOI 10.1097/COC.0b013e318210f533; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Guglielmi G, 2008, EUR RADIOL, V18, P1484, DOI 10.1007/s00330-008-0899-8; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Han JW, 2015, PEDIATR BLOOD CANCER, V62, P1838, DOI 10.1002/pbc.25581; Harindhanavudhi T, 2018, J INVEST MED, V66, P980, DOI 10.1136/jim-2018-000738; Hartley KA, 2008, INT J RADIAT ONCOL, V70, P1343, DOI 10.1016/j.ijrobp.2007.08.085; Hoorweg-Nijman JJG, 1999, CLIN ENDOCRINOL, V50, P237, DOI 10.1046/j.1365-2265.1999.00654.x; Hopewell JW, 2003, MED PEDIATR ONCOL, V41, P208, DOI 10.1002/mpo.10338; Il Yu J, 2015, RADIOTHER ONCOL, V114, P384, DOI 10.1016/j.radonc.2015.02.016; International Society for Clinical Densitometry, 2015, OFF POS 2015 AD PED; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Jaremko JL, 2015, PEDIATR RADIOL, V45, P593, DOI 10.1007/s00247-014-3210-y; Katz JR, 2001, ARCH DIS CHILD, V84, P436, DOI 10.1136/adc.84.5.436; Klein Gordon L, 2015, Osteoporos Sarcopenia, V1, P39, DOI 10.1016/j.afos.2015.07.008; Kumar R, 1988, Radiographics, V8, P455; Lai JS, 2007, CHILD NERV SYST, V23, P47, DOI 10.1007/s00381-006-0176-6; Laprie A, 2015, CANCER RADIOTHER, V19, P775, DOI 10.1016/j.canrad.2015.05.028; Lerner SE, 2004, J CLIN ENDOCR METAB, V89, P6100, DOI 10.1210/jc.2004-1515; Mitchell MJ, 1998, RADIOGRAPHICS, V18, P1125, DOI 10.1148/radiographics.18.5.9747611; Mitchell RM, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0363-y; Ng LW, 2018, INT J RAD ONCOL BIOL; Palermo A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060544; Pandya NA, 2001, ARCH DIS CHILD, V85, P492, DOI 10.1136/adc.85.6.492; Petraroli M, 2007, CHILD NERV SYST, V23, P59, DOI 10.1007/s00381-006-0175-7; Remes TM, 2018, ACTA ONCOL, V27, P1; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; Seo GH, 2018, J NEURO-ONCOL, V138, P55, DOI 10.1007/s11060-018-2765-0; SHALET SM, 1987, ARCH DIS CHILD, V62, P461, DOI 10.1136/adc.62.5.461; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; TESTER WJ, 1984, J CLIN ONCOL, V2, P762, DOI 10.1200/JCO.1984.2.7.762; van Niekerk G, 2018, CYTOKINE GROWTH FACT; Willey JS, 2011, CLIN REV BONE MINER, V9, P54, DOI 10.1007/s12018-011-9092-8	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209193	10.1371/journal.pone.0209193	http://dx.doi.org/10.1371/journal.pone.0209193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562369	Green Published, gold			2022-12-26	WOS:000453774100042
J	Xiong, TN; Rohm, D; Workman, RE; Roundtree, L; Novina, CD; Timp, W; Ostermeier, M				Xiong, Tina; Rohm, Dahlia; Workman, Rachael E.; Roundtree, Lauren; Novina, Carl D.; Timp, Winston; Ostermeier, Marc			Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria	PLOS ONE			English	Article							DNA METHYLATION; SYSTEM	Mammalian gene expression is a complex process regulated in part by CpG methylation. The ability to target methylation for de novo gene regulation could have therapeutic and research applications. We have previously developed a dCas9-MC/MN protein for targeting CpG methylation. dCas9-MC/MN is composed of an artificially split M. SssI methyltransferase (MC/MN), with the MC fragment fused to a nuclease-null CRISPR/Cas9 (dCas9). Guide RNAs directed dCas9-MC/MN to methylate target sites in E. coli and human cells but also caused some low-level off-target methylation. Here, in E. coli, we show that shortening the dCas9-MC linker increases methylation of CpG sites located at select distances from the dCas9 binding site. Although a shortened linker decreased methylation of other CpGs proximal to the target site, it did not reduce off-target methylation of more distant CpG sites. Instead, targeted mutagenesis of the methyltransferase's DNA binding domain, designed to reduce DNA affinity, significantly and preferentially reduced methylation of such sites.	[Xiong, Tina; Rohm, Dahlia; Roundtree, Lauren; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Workman, Rachael E.; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Novina, Carl D.] Harvard Med Sch, Dept Med, Boston, MA USA; [Novina, Carl D.] Broad Inst Harvard & MIT, Cambridge, MA USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ostermeier, M (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010; Timp, Winston/B-5215-2008	Ostermeier, Marc/0000-0003-0900-3665; Timp, Winston/0000-0003-2083-6027; Sparklin, Rachael/0000-0002-4119-2948	US National Science Foundation [CBET-1510652, CBET-1505793]; National Institute of Health [1DP1 DK105602-01]	US National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Science Foundation (CBET-1510652 to MO, and CBET-1505793 to CDN) and a National Institute of Health Director's Pioneer award 1DP1 DK105602-01 (CDN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Elliott G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7363; Galonska C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02708-5; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Koudan EV, 2004, J BIOMOL STRUCT DYN, V22, P339, DOI 10.1080/07391102.2004.10507005; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Lei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16026; Lin L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy011; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Shayevitch R, 2018, RNA, V24, P1351, DOI 10.1261/rna.064865.117; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stepper P., 2016, NUCLEIC ACIDS RES, P1; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; WU JC, 1987, J BIOL CHEM, V262, P4778; Xiong TN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06757-0; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Yamazaki T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177764; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239	33	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209408	10.1371/journal.pone.0209408	http://dx.doi.org/10.1371/journal.pone.0209408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562388	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100054
J	Yang, XX; Chen, ZQ; Meng, XY; Sun, CG; Li, MT; Shu, L; Fan, DW; Fan, TQ; Huang, AY; Zhang, C				Yang, Xiaoxi; Chen, Zhongqiang; Meng, Xiangyu; Sun, Chuiguo; Li, Mengtao; Shu, Li; Fan, Dongwei; Fan, Tianqi; Huang, Ann Y.; Zhang, Chi			Angiopoietin-2 promotes osteogenic differentiation of thoracic ligamentum flavum cells via modulating the Notch signaling pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TNF-ALPHA; OSSIFICATION; ANGIOGENESIS; VEGF	Thoracic ossification of the ligamentum flavum (TOLF) is heterotopic ossification of spinal ligaments, which may cause serious thoracic spinal canal stenosis and myelopathy. However, the underlying etiology remains inadequately understood. In this study, the ossification patterns of TOLF were analyzed by micro-computer tomography (micro-CT). The expression profile of genes associated with angiogenesis was analyzed in thoracic ligamentum flavum cells at sites of different patterns of ossification using RNA sequencing. Significant differences in the expression profile of several genes were identified from Gene Ontology (GO) analysis. Angiopoietin-2 (ANGPT2) was significantly up-regulated in primary thoracic ligamentum flavum cells during osteogenic differentiation. To address the effect of ANGPT2 on Notch signaling and osteogenesis, ANGPT2 stimulation increased the expression of Notch2 and osteogenic markers of primary thoracic ligamentum flavum cells of immature ossification, while inhibition of ANGPT2 exhibited opposite effect on Notch pathway and osteogenesis of cells of mature ossification. These findings provide the first evidence for positive regulation of ANGPT2 on osteogenic differentiation in human thoracic ligamentum flavum cells via modulating the Notch signaling pathway.	[Yang, Xiaoxi; Chen, Zhongqiang; Sun, Chuiguo; Fan, Dongwei; Fan, Tianqi] Peking Univ, Dept Orthoped, Hosp 3, Beijing, Peoples R China; [Meng, Xiangyu; Li, Mengtao; Shu, Li; Zhang, Chi] Peking Univ, Cent Lab, Int Hosp, Beijing, Peoples R China; [Huang, Ann Y.] Daobio Inc, Dallas, TX USA; [Zhang, Chi] Peking Univ, Dept Orthoped, Int Hosp, Beijing, Peoples R China; [Zhang, Chi] Univ Texas Southwestern Med Ctr Dallas, Bone Res Lab, Dallas, TX 75080 USA	Peking University; Peking University; Peking University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZQ (corresponding author), Peking Univ, Dept Orthoped, Hosp 3, Beijing, Peoples R China.; Zhang, C (corresponding author), Peking Univ, Cent Lab, Int Hosp, Beijing, Peoples R China.; Zhang, C (corresponding author), Peking Univ, Dept Orthoped, Int Hosp, Beijing, Peoples R China.; Zhang, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Bone Res Lab, Dallas, TX 75080 USA.	puth_czq@126.com; chi.zhang@case.edu	Yang, Xiaoxi/AAA-1760-2021; Sun, Chuiguo/AAF-4353-2020	Meng, Xiangyu/0000-0003-3382-587X	National Natural Science Foundation of China [81772381, 81700779]; Beijing Municipal Science&Technology Commission [Z181100001818006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science&Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (ZC, Grant numbers: 81772381 and 81700779) and Beijing Municipal Science&Technology Commission (CZ, Grant number: Z181100001818006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai HX, 2012, SPINE, V37, pE639, DOI 10.1097/BRS.0b013e318242a132; De Spiegelaere W, 2010, ANAT HISTOL EMBRYOL, V39, P376, DOI 10.1111/j.1439-0264.2010.01005.x; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Feng FB, 2015, ORTHOP SURG, V7, P87, DOI 10.1111/os.12165; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gao W, 2013, ANN RHEUM DIS, V72, P1080, DOI 10.1136/annrheumdis-2012-201978; Guo JJ, 2010, SPINE, V35, P51, DOI 10.1097/BRS.0b013e3181b3f779; Hou XF, 2016, CLIN SPINE SURG, V29, P86, DOI 10.1097/BSD.0000000000000081; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Hur JW, 2015, NEUROSURGERY, V77, P274, DOI 10.1227/NEU.0000000000000755; Hyzy SL, 2017, J BIOMED MATER RES A, V105, P2742, DOI 10.1002/jbm.a.36137; Katoh Y, 2006, INT J MOL MED, V17, P1145; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lang N, 2013, EUR SPINE J, V22, P857, DOI 10.1007/s00586-012-2492-8; Lin SS, 2017, ONCOTARGET, V8, P110426, DOI 10.18632/oncotarget.22786; Liu KG, 2015, GENET MOL RES, V14, P6852, DOI 10.4238/2015.June.18.28; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Liu YC, 2014, BIOSCI TRENDS, V8, P138, DOI 10.5582/bst.2014.01047; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; Murakami J, 2017, BIOCHEM BIOPH RES CO, V484, P710, DOI 10.1016/j.bbrc.2017.02.001; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Ning SL, 2017, INT J MOL MED, V39, P135, DOI 10.3892/ijmm.2016.2803; Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992; Qu XC, 2017, J CELL MOL MED, V21, P1159, DOI 10.1111/jcmm.13047; Qu XC, 2017, EUR J HUM GENET, V25, P565, DOI 10.1038/ejhg.2017.2; Qu XC, 2016, J ORTHOP RES, V34, P1481, DOI 10.1002/jor.23303; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Tanoue H, 2018, OSTEOARTHR CARTILAGE, V26, P108, DOI 10.1016/j.joca.2017.10.011; Wang BX, 2017, BIOCHEM BIOPH RES CO, V487, P834, DOI 10.1016/j.bbrc.2017.04.136; Wang K, 2018, INT J MOL MED, V41, P3551, DOI 10.3892/ijmm.2018.3576; Yang M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16003; Yayama T, 2018, J ORTHOP SCI, V23, P26, DOI 10.1016/j.jos.2017.09.024; Yu SZ, 2017, MOL MED REP, V16, P7692, DOI 10.3892/mmr.2017.7543; Zhang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178986	35	9	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209300	10.1371/journal.pone.0209300	http://dx.doi.org/10.1371/journal.pone.0209300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557327	Green Submitted, gold, Green Published			2022-12-26	WOS:000453451000092
J	Chagomerana, MB; Miller, WC; Tang, JH; Hoffman, IF; Harrington, BJ; DiPrete, B; Wallie, S; Jumbe, A; Limarzi, L; Hosseinipour, MC				Chagomerana, Maganizo B.; Miller, William C.; Tang, Jennifer H.; Hoffman, Irving F.; Harrington, Bryna J.; DiPrete, Bethany; Wallie, Shaphil; Jumbe, Allan; Limarzi, Laura; Hosseinipour, Mina C.			Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B plus in Malawi	PLOS ONE			English	Article							DRUG-RESISTANCE; INITIATION; RETENTION; SUPPRESSION; VIREMIA; RISK; ART	Background In Malawi's PMTCT Option B+ program, HIV-infected pregnant women who are already receiving ART are continued on their current therapy regimen without testing for treatment failure at the first antenatal care (ANC) visit. HIV RNA screening at ANC may identify women with treatment failure and ensure that viral suppression is maintained throughout the pregnancy. Methods We conducted a cross-sectional study of HIV-infected pregnant women who had been receiving ART for at least 6 months at the first ANC visit under the PMTCT Option B+ program at Bwaila Hospital in Lilongwe, Malawi from June 2015 to December 2017. Poisson regression models with robust variance were used to investigate the predictors of ART treatment failure defined as viral load >= 1000 copies/ml. Results The median age of 864 women tested for ART failure was 31.1 years (interquartile range: 26.9-34.5). The prevalence of treatment failure was 7.6% (95% confidence interval (CI): 6.0-9.6). CD4 cell count (adjusted prevalence ratio (aPR) = 0.57; 95% CI: 0.50-0.65) was strongly associated with treatment failure. Conclusion The low prevalence of treatment failure among women presenting for their first ANC in urban Malawi demonstrates success of Option B+ in maintaining viral suppression and suggests progress towards the last 90% of the UNAIDS 90-90-90 targets. Women failing on ART should be identified early for adherence counseling and may require switching to an alternative ART regimen.	[Chagomerana, Maganizo B.; Tang, Jennifer H.; Hoffman, Irving F.; Harrington, Bryna J.; Wallie, Shaphil; Jumbe, Allan; Limarzi, Laura; Hosseinipour, Mina C.] UNC Project Malawi, Kamuzu Cent Hosp, Lilongwe, Malawi; [Miller, William C.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Tang, Jennifer H.] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hoffman, Irving F.; Hosseinipour, Mina C.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Harrington, Bryna J.; DiPrete, Bethany] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chagomerana, MB (corresponding author), UNC Project Malawi, Kamuzu Cent Hosp, Lilongwe, Malawi.	mchagomerana@unclilongwe.org	Miller, William C/H-4800-2014; Tang, Jennifer/K-9974-2017	Miller, William C/0000-0002-1934-7827; Tang, Jennifer/0000-0003-4238-2791	National Institutes of Health [P30 AI50410, R01 HD080485, F30 MH111370, T32 GM008719, R25 TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080485] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH111370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant numbers P30 AI50410 (MBC), R01 HD080485 (MCH), F30 MH111370 (BJH), T32 GM008719 (BJH), and R25 TW009340 (BJH)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health (grant numbers P30 AI50410, R01 HD080485, F30 MH111370, T32 GM008719 and R25 TW009340). We would like to thank all "Option B+: ART Safety and Durability during First and Subsequent Pregnancies (S4)" study participants. Special thanks to the ever-enthusiastic S4 study team for their support.	Aziz N, 2013, BJOG-INT J OBSTET GY, V120, P1534, DOI 10.1111/1471-0528.12226; Babo YD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187694; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boerma RS, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21140; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Chimbwandria F, 2013, MMWR-MORBID MORTAL W, V62, P148; Evans DH, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19139; Gill MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168671; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta-Wright A, 2018, URINE BASED SCREENIN; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Hosseinipour M, 2017, JAIDS-J ACQ IMM DEF, V75, pS149, DOI 10.1097/qai.0000000000001368; Kityo C, 2016, AIDS RES HUM RETROV, V32, P628, DOI [10.1089/AID.2015.0215, 10.1089/aid.2015.0215]; Koss CA, 2017, JAIDS-J ACQ IMM DEF, V74, P279, DOI 10.1097/QAI.0000000000001228; Lesosky M, 2017, J INT AIDS SOC, V20, P26, DOI 10.1002/jia2.25000; Lyons FE, 2005, AIDS, V19, P63, DOI 10.1097/00002030-200501030-00007; Manasa J, 2016, AIDS RES HUM RETROV, V32, P763, DOI [10.1089/aid.2015.0225, 10.1089/AID.2015.0225]; MOH, 2016, INT HIV PROGR REP JA; Mutagoma M, 2016, ANTIVIR THER, V21, P247, DOI 10.3851/IMP2999; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Myer L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002375; Myer L, 2017, CLIN INFECT DIS, V64, P422, DOI 10.1093/cid/ciw792; Onywera H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171124; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Republic of Malawi MoH, 2014, MAL GUID CLIN MAN HI; Republic of Malawi MoH, 2016, MAL GUID CLIN MAN HI; Republic of Malawi MoH, 2010, INT HIV PROGR Q REP, P2010; Republic of Malawi MoH, 2017, INT HIV PROGR Q REP; Republic of Malawi MoH, 2016, INT HIV PROGR Q REP; Steegen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166305; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, 2014, 90 90 90 AMB TREATM, P33; UNAIDS, 2014, THE GAP REP; Uy J, 2009, JAIDS-J ACQ IMM DEF, V51, P450, DOI 10.1097/QAI.0b013e3181acb630; Wadonda-Kabondo N, 2017, 9 INT AIDS SOC C HIV; World Health Organization, 2016, CONS GUID US ANT DRU; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209052	10.1371/journal.pone.0209052	http://dx.doi.org/10.1371/journal.pone.0209052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543685	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500067
J	Gillet, B; Cottet, M; Destanque, T; Kue, K; Descloux, S; Chanudet, V; Hughes, S				Gillet, Benjamin; Cottet, Maud; Destanque, Thibault; Kue, Kaoboun; Descloux, Stephane; Chanudet, Vincent; Hughes, Sandrine			Direct fishing and eDNA metabarcoding for biomonitoring during a 3-year survey significantly improves number of fish detected around a South East Asian reservoir	PLOS ONE			English	Article							THEUN 2 RESERVOIR; ENVIRONMENTAL DNA; NAM THEUN; BIODIVERSITY; RIVER; HYDROPOWER; DIVERSITY; CONGO	Biodiversity has to be accurately evaluated to assess more precisely possible dam effects on fish populations, in particular on the most biodiverse rivers such as the Mekong River. To improve tools for fish biodiversity assessment, a methodological survey was performed in the surroundings of a recent hydropower dam in the Mekong basin, the Nam Theun 2 project. Results of two different approaches, experimental surface gillnets capture and environmental DNA metabarcoding assays based on 12S ribosomal RNA and cytochrome b, were compared during 3 years (2014-2016). Pitfalls and benefits were identified for each method but the combined use of both approaches indisputably allows describing more accurately fish diversity around the reservoir. Importantly, striking convergent results were observed for biodiversity reports. 75% of the fish species caught by gillnets (62/82) were shown by the metabarcoding study performed on DNA extracted from water samples. eDNA approach also revealed to be sensitive by detecting 30 supplementary species known as present before the dam construction but never caught by gillnets during 3 years. Furthermore, potential of the marker-genes study might be underestimated since it was not possible to assign some sequences at lower taxonomic levels. Although 121 sequences were generated for this study, a third of species in the area, that exhibits high endemism, are still unknown in DNA databases. Efforts to complete local reference libraries must continue to improve the taxonomic assignment quality when using the non-invasive and promising eDNA approach. These results are of broader interest because of increasing number of hydropower projects in the Mekong Basin. They reveal the crucial importance to sample tissues/DNA of species before dam projects, i.e. before the species could become endangered and difficult to catch, to obtain more precise biomonitoring in the future as we believe eDNA metabarcoding will rapidly be integrated as a standard tool in such studies.	[Gillet, Benjamin; Destanque, Thibault; Hughes, Sandrine] Univ Claude Bernard Lyon 1, Inst Genom Fonct Lyon, Univ Lyon, Unite Mixte Rech,CNRS,Ecole Normale Super Lyon, Lyon, France; [Cottet, Maud; Kue, Kaoboun] Nam Theun 2 Power Co Ltd, Environm & Social Div, Environm Dept, Gnommalath Off, Viangchan, Laos; [Descloux, Stephane; Chanudet, Vincent] Hydro Engn Ctr, EDF, Environm & Social Dept, Le Bourget Du Lac, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Electricite de France (EDF)	Hughes, S (corresponding author), Univ Claude Bernard Lyon 1, Inst Genom Fonct Lyon, Univ Lyon, Unite Mixte Rech,CNRS,Ecole Normale Super Lyon, Lyon, France.	sandrine.hughes@ens-lyon.fr	Gillet, Benjamin/ABD-6704-2020	Destanque, Thibault/0000-0002-7396-8659; Hughes, Sandrine/0000-0003-3932-9180	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	The authors received funding for this project from the CNRS (Defi Enviromics project, 2014-2016). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Four authors are working for private companies. Two are working for the Nam Theun 2 Power Company (MC and KK) and two are working for EDF (SD and VC). The NTPC and EDF funders provided support in the form of salaries for authors MC, KK, SD, VC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostinho AA, 2008, BRAZ J BIOL, V68, P1119, DOI 10.1590/S1519-69842008000500019; Anthony EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14745; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chanudet V., 2015, HYDROECOL APPL, V19, P27, DOI DOI 10.1051/hydro/2015001; Chanudet V, 2012, J GREAT LAKES RES, V38, P260, DOI 10.1016/j.jglr.2012.01.008; Civade R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157366; Costanza R, 2007, SUSTAINABILITY COLLA, P417; Cottet Maud, 2017, Lakes & Reservoirs Research and Management, V22, P334, DOI 10.1111/lre.12196; Cottet Maud, 2016, Hydroecologie Appliquee, V19, P321; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; De Silva SS, 2007, DIVERS DISTRIB, V13, P172, DOI 10.1111/j.1472-4642.2006.00311.x; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Decru E, 2016, MOL ECOL RESOUR, V16, P342, DOI 10.1111/1755-0998.12445; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Descloux Stephane, 2016, Hydroecologie Appliquee, V19, P5; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Esguicero ALH, 2010, HYDROBIOLOGIA, V638, P41, DOI 10.1007/s10750-009-0008-2; FERNANDO CH, 1991, INT REV GES HYDROBIO, V76, P149, DOI 10.1002/iroh.19910760202; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2016, MOL ECOL RESOUR, V16, P604, DOI 10.1111/1755-0998.12508; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002; Gubiani EA, 2010, RIVER RES APPL, V26, P848, DOI 10.1002/rra.1298; Jane SF, 2014, THESIS; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kottelat M., 2016, Hydroecologie Appliquee, V19, P271; Kottelat M, 2001, FISHES LAOS; Kottelat M, 2013, RAFFLES B ZOOL, P1; Kottelat Maurice, 1998, Ichthyological Exploration of Freshwaters, V9, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Olds BP, 2016, ECOL EVOL, V6, P4214, DOI 10.1002/ece3.2186; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phonvisay S., 2013, INTRO FISHERIES LAO, P1; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Roberts JH, 2013, FRESHWATER BIOL, V58, P2050, DOI 10.1111/fwb.12190; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Valbo-Jorgensen J, 2009, AQUAT ECOL-SAN DIEGO, P161, DOI 10.1016/B978-0-12-374026-7.00008-5; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	60	22	24	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208592	10.1371/journal.pone.0208592	http://dx.doi.org/10.1371/journal.pone.0208592			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543655	gold, Green Submitted, Green Published			2022-12-26	WOS:000453247500026
J	Abdelwahab, EMM; Pal, S; Kvell, K; Sarosi, V; Bai, P; Rue, R; Krymskaya, V; McPhail, D; Porter, A; Pongracz, JE				Abdelwahab, E. M. M.; Pal, S.; Kvell, K.; Sarosi, V; Bai, P.; Rue, R.; Krymskaya, V; McPhail, D.; Porter, A.; Pongracz, J. E.			Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target	ONCOGENE			English	Article							CYTOCHROME-C; CELL; BIOGENESIS; TSC2; PHOSPHORYLATION; ESTROGEN; FEATURES; CHAIN; GENE	Lymphangioleiomyomatosis (LAM) is a rare and progressive systemic disease affecting mainly young women of childbearing age. A deterioration in lung function is driven by neoplastic growth of atypical smooth muscle-like LAM cells in the pulmonary interstitial space that leads to cystic lung destruction and spontaneous pneumothoraces. Therapeutic options for preventing disease progression are limited and often end with lung transplantation temporarily delaying an inevitable decline. To identify new therapeutic strategies for this crippling orphan disease, we have performed array based and metabolic molecular analysis on patient-derived cell lines. Our results point to the conclusion that mitochondrial biogenesis and mitochondrial dysfunction in LAM cells provide a novel target for treatment.	[Abdelwahab, E. M. M.; Kvell, K.; Pongracz, J. E.] Univ Pecs, Sch Pharm, Dept Pharmaceut Biotechnol, Pecs, Hungary; [Abdelwahab, E. M. M.; Kvell, K.; Pongracz, J. E.] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Pal, S.] Univ Pecs, Sch Pharm, Dept Pharmaceut Technol, Pecs, Hungary; [Sarosi, V] Univ Pecs, Sch Med, Dept Internal Med, Pecs, Hungary; [Sarosi, V] Univ Pecs, Clin Ctr, Pecs, Hungary; [Bai, P.] Univ Debrecen, Dept Med Chem, MTA DE Lendulet Lab Cellular Metab, Debrecen, Hungary; [Bai, P.] Univ Debrecen, Fac Med, Res Ctr Mol Med, Debrecen, Hungary; [Rue, R.; Krymskaya, V] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [McPhail, D.; Porter, A.] Antoxis Ltd, Aberdeen, Scotland; [Porter, A.] Univ Aberdeen, Sch Med & Med Sci, Aberdeen, Scotland	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Debrecen; University of Debrecen; University of Pennsylvania; Pennsylvania Medicine; University of Aberdeen	Pongracz, JE (corresponding author), Univ Pecs, Sch Pharm, Dept Pharmaceut Biotechnol, Pecs, Hungary.; Pongracz, JE (corresponding author), Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary.	judit.e.pongracz@gmail.com	Pongracz, Judit E/N-7927-2018; Pongracz, Judit E/J-7517-2019	Pongracz, Judit E/0000-0002-0278-5556; Pongracz, Judit E/0000-0002-0278-5556; ELHUSSEINY, MOHAMED MAHMOUD ABDELWAHAB/0000-0003-4102-2233	European Union; State of Hungary - European Social Fund [TAMOP-4.2.4, A/2-11/1-2012-0001]	European Union(European Commission); State of Hungary - European Social Fund	JEP was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 "National Excellence Program".	Astrinidis A, 2000, J MED GENET, V37, P55, DOI 10.1136/jmg.37.1.55; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Bennett CJ, 2004, BIOORGAN MED CHEM, V12, P2079, DOI 10.1016/j.bmc.2004.02.031; Chang WYC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-34; Drummond NJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12072-5; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Gozuacik D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00065; Gyftopoulos K, 2000, EUR UROL, V38, P323, DOI 10.1159/000020301; Hald SM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1446-z; Harknett EC, 2011, QJM-INT J MED, V104, P971, DOI 10.1093/qjmed/hcr116; Hayashi K, 2001, JPN J CANCER RES, V92, P42, DOI 10.1111/j.1349-7006.2001.tb01046.x; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Julian LM, 2017, CANCER RES, V77, P5491, DOI 10.1158/0008-5472.CAN-17-0925; Kovacs T, 2014, AGING CELL, V13, P838, DOI 10.1111/acel.12240; Krymskaya VP, 2017, ANNU REV MED, V68, P69, DOI 10.1146/annurev-med-050715-104245; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lu C, 2017, ANN AM THORAC SOC, V14, P919, DOI 10.1513/AnnalsATS.201610-824OC; MacKeigan JP, 2015, NEURO-ONCOLOGY, V17, P1550, DOI 10.1093/neuonc/nov152; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Mei LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185636; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Moini H, 1999, REDOX REP, V4, P35, DOI 10.1179/135100099101534729; Motalleb G, 2014, CELL J, V15, P324; Rigobello MP, 2002, BRIT J PHARMACOL, V136, P1162, DOI 10.1038/sj.bjp.0704823; Shao D, 2010, MITOCHONDRION, V10, P516, DOI 10.1016/j.mito.2010.05.012; Simiantonaki N, 2008, INT J ONCOL, V32, P585; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002	33	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3093	3101		10.1038/s41388-018-0625-1	http://dx.doi.org/10.1038/s41388-018-0625-1			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30573768	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000465167600015
J	Mao, PZ; Wortham, AM; Enns, CA; Zhang, AS				Mao, Peizhong; Wortham, Aaron M.; Enns, Caroline A.; Zhang, An-Sheng			The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; liver; serine protease; bone morphogenetic protein (BMP); receptor; hemojuvelin; hepcidin; HFE; matriptase-2; transferrin receptor-2	SERINE-PROTEASE TMPRSS6; DEFICIENCY ANEMIA; GENE-EXPRESSION; DOWN-REGULATION; CLEAVAGE SITES; HEMOJUVELIN; MUTATIONS; LIVER; IDENTIFICATION; HOMEOSTASIS	Matriptase-2 (MT2) is a type-II transmembrane, trypsin-like serine protease that is predominantly expressed in the liver. It is a key suppressor for the expression of hepatic hepcidin, an iron-regulatory hormone that is induced via the bone morphogenetic protein signaling pathway. A current model predicts that MT2 suppresses hepcidin expression by cleaving multiple components of the induction pathway. MT2 is synthesized as a zymogen that undergoes autocleavage for activation and shedding. However, the biologically active form of MT2 and, importantly, the contributions of different MT2 domains to its function are largely unknown. Here we examined the activities of truncated MT2 that were generated by site-directed mutagenesis or Gibson assembly master mix, and found that the stem region of MT2 determines the specificity and efficacy for substrate cleavage. The transmembrane domain allowed MT2 activation after reaching the plasma membrane, and the cytoplasmic domain facilitated these processes. Further in vivo rescue studies indicated that the entire extracellular and transmembrane domains of MT2 are required to correct the low-hemoglobin, low-serum iron, and high-hepcidin status in MT2(-/-) mice. Unlike in cell lines, no autocleavage of MT2 was detected in vivo in the liver, implying that MT2 may also function independently of its proteolytic activity. In conjunction with our previous studies implicating the cytoplasmic domain as an intracellular iron sensor, these observations reveal the importance of each MT2 domain for MT2-mediated substrate cleavage and for its biological function.	[Mao, Peizhong; Wortham, Aaron M.; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), OHSU, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [R01DK102791, R01DK072166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R37DK054488, R01DK102791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK102791 (to A. S. Z.) and R01DK072166 (to C. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bartnikas TB, 2013, HAEMATOLOGICA, V98, P854, DOI 10.3324/haematol.2012.074617; Beckmann AM, 2016, CHEMBIOCHEM, V17, P595, DOI 10.1002/cbic.201500651; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Camaschella C, 2015, NEW ENGL J MED, V373, P485, DOI 10.1056/NEJMc1507104; Canali S, 2017, AM J HEMATOL, V92, P1204, DOI 10.1002/ajh.24888; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; De Falco L, 2014, HUM MUTAT, V35, P1321, DOI 10.1002/humu.22632; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gurieva I, 2017, BLOOD CELL MOL DIS, V64, P1, DOI 10.1016/j.bcmd.2017.02.007; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kodama K, 2014, PEDIATR INT, V56, pE41, DOI 10.1111/ped.12395; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; McDonald CJ, 2015, AM J PHYSIOL-CELL PH, V308, pC539, DOI 10.1152/ajpcell.00264.2014; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Rausa M, 2015, J CELL MOL MED, V19, P879, DOI 10.1111/jcmm.12462; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Sal E, 2016, PEDIATR HEMAT ONCOL, V33, P226, DOI 10.3109/08880018.2016.1157229; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wang CY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00114; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yaish HM, 2017, BLOOD CELL MOL DIS, V65, P38, DOI 10.1016/j.bcmd.2017.04.002; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhao NN, 2016, J BIOL CHEM, V291, P12322, DOI 10.1074/jbc.M116.721191; Zhao NN, 2015, J BIOL CHEM, V290, P4432, DOI 10.1074/jbc.M114.611913	54	7	8	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2060	2073		10.1074/jbc.RA118.006468	http://dx.doi.org/10.1074/jbc.RA118.006468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559294	Green Published, hybrid			2022-12-26	WOS:000459711400024
J	Litman, J; Chittaro, Y; Birrer, S; Praz, C; Wermeille, E; Fluri, M; Stalling, T; Schmid, S; Wyler, S; Gonseth, Y				Litman, Jessica; Chittaro, Yannick; Birrer, Stefan; Praz, Christophe; Wermeille, Emmanuel; Fluri, Markus; Stalling, Thomas; Schmid, Sarah; Wyler, Sofia; Gonseth, Yves			A DNA barcode reference library for Swiss butterflies and forester moths as a tool for species identification, systematics and conservation	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BRITISH BUTTERFLIES; LEPIDOPTERA; DIVERSIFICATION; PERFORMANCE; DIVERSITY; CLIMATE	Butterfly monitoring and Red List programs in Switzerland rely on a combination of observations and collection records to document changes in species distributions through time. While most butterflies can be identified using morphology, some taxa remain challenging, making it difficult to accurately map their distributions and develop appropriate conservation measures. In this paper, we explore the use of the DNA barcode (a fragment of the mitochondrial gene COI) as a tool for the identification of Swiss butterflies and forester moths (Rhopalocera and Zygaenidae). We present a national DNA barcode reference library including 868 sequences representing 217 out of 224 resident species, or 96.9% of Swiss fauna. DNA barcodes were diagnostic for nearly 90% of Swiss species. The remaining 10% represent cases of para-and polyphyly likely involving introgression or incomplete lineage sorting among closely related taxa. We demonstrate that integrative taxonomic methods incorporating a combination of morphological and genetic techniques result in a rate of species identification of over 96% in females and over 98% in males, higher than either morphology or DNA barcodes alone. We explore the use of the DNA barcode for exploring boundaries among taxa, understanding the geographical distribution of cryptic diversity and evaluating the status of purportedly endemic taxa. Finally, we discuss how DNA barcodes may be used to improve field practices and ultimately enhance conservation strategies.	[Litman, Jessica] Museum Nat Hist Neuchatel, Neuchatel, Switzerland; [Chittaro, Yannick; Wyler, Sofia; Gonseth, Yves] Info Fauna CSCF, Neuchatel, Switzerland; [Birrer, Stefan; Fluri, Markus; Stalling, Thomas] Hintermann & Weber AG, Reinach, Switzerland; [Birrer, Stefan; Fluri, Markus; Stalling, Thomas] Biodivers Monitoring Switzerland, Bern, Switzerland; [Praz, Christophe] Univ Neuchatel, Inst Biol, Lab Evolut Entomol, Neuchatel, Switzerland; [Wermeille, Emmanuel] Freelance Biologist, Villiers, Switzerland; [Schmid, Sarah] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland	University of Neuchatel; University of Lausanne	Litman, J (corresponding author), Museum Nat Hist Neuchatel, Neuchatel, Switzerland.	jessica.litman@unine.ch		Litman, Jessica/0000-0003-2481-5709; Chittaro, Yannick/0000-0003-0236-5110	SwissBOL project - Swiss Federal Office for the Environment (OFEV); Info fauna - CSCF; SwissBOL	SwissBOL project - Swiss Federal Office for the Environment (OFEV); Info fauna - CSCF; SwissBOL	This study was supported by the SwissBOL project (www.swissbol.ch), financed by the Swiss Federal Office for the Environment (OFEV), and by Info fauna - CSCF (www.cscf.ch). Funding was awarded to JL, YC and SB by Info fauna - CSCF and SwissBOL, and to CP and EW by SwissBOL. YG (Info fauna - CSCF) played a role in study design, interpretation of data and preparation of the manuscript. The company Hintermann & Weber provided support in the form of salaries for SB, MF and TS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these individual authors are articulated in the 'Author contributions' section.	Aagaard K, 2002, BIOL J LINN SOC, V75, P27, DOI 10.1046/j.1095-8312.2002.00004.x; Agashe D, 2009, AM NAT, V174, P255, DOI 10.1086/600085; [Anonymous], 2017, SEQ VERS 5 4 6; Balletto E, 2014, ZOOTAXA, V3853, P1, DOI 10.11646/zootaxa.3853.1.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Capblancq T, 2015, MOL ECOL, V24, P6209, DOI 10.1111/mec.13479; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; De Moya RS, 2017, SYST ENTOMOL, V42, P635, DOI 10.1111/syen.12236; Descimon H., 1980, Nota Lepidopterologica, V2, P123; Descimon Henri, 2009, P219; Dinca V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12395; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dupont P, 2013, 201319 MMNHNSPN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eskildsen A, 2015, DIVERS DISTRIB, P1; Favre E, 1899, FAUNE MACROLE VALAIS; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Gaedike R, 2017, VERZEICHNIS SCHMETTE, P1; Gonseth Y, 2001, CAHIER ENV; Gratton P, 2016, SYST BIOL, V65, P292, DOI 10.1093/sysbio/syv087; Guenin Raymond, 2012, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V85, P51; Habel JC, 2016, CONSERV BIOL, V30, P754, DOI 10.1111/cobi.12656; Hausmann A, 2011, SPIXIANA, V34, P47; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins LG, 1971, GUIDE PAPILLONS EURO; Higgins LG, 1975, CLASSIFICATION EUROP; Huemer P, 2017, WISSENSCHAFTLICHES J, P8; Huemer Peter, 2016, Gredleriana, V16, P141; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; IUCN, 2020, IUCN RED LIST THREAT; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kudrna O., 2015, DISTRIBUTION ATLAS E; Leneveu J, 2009, BIOL J LINN SOC, V97, P346, DOI 10.1111/j.1095-8312.2009.01208.x; Lin XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138993; LSPN, 1987, PAP JOUR LEURS BIOT, V1; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison W., 2018, MESQUITE MODULAR SYS; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller M.A., 2010, P GAT COMP ENV WORKS; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mutanen M, 2016, SYST BIOL, V65, P1024, DOI 10.1093/sysbio/syw044; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Naumann C. M., 1999, The Western Palaearctic Zygaenidae (Lepidoptera).; Oorschot van H, 2014, GENUS MELITAEA FABRI; Pitteloud C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0208; Pro Natura -LSPN, 1999, PAP LEURS BIOT DANG, V2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Renner F., 1991, Neue Entomologische Nachrichten, V28, P1; Ross HA, 2014, MOL PHYLOGENET EVOL, V76, P10, DOI 10.1016/j.ympev.2014.02.021; Schultz CB, 2017, BIOL CONSERV, V214, P343, DOI 10.1016/j.biocon.2017.08.019; Sonderegger P., 2005, EREBIEN SCHWEIZ LEPI; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swengel SR, 2015, J INSECT CONSERV, V19, P293, DOI 10.1007/s10841-014-9731-8; SwissLepTeam, 2017, SCI REP-UK, V7, P13752; Talavera G, 2013, MOL PHYLOGENET EVOL, V69, P469, DOI 10.1016/j.ympev.2013.08.004; Tarmann G. M., 2013, Entomologist's Gazette, V64, P169; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Tschudin P, 2017, ENDEMITEN SCHWEIZ ME; Van Swaay CAM, 2015, VS2015009; Vorbrodt K, 1914, SCHMETTERLINGE SCHWE, V2; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wermeille E, 2014, ENV PRATIQUE	66	11	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208639	10.1371/journal.pone.0208639	http://dx.doi.org/10.1371/journal.pone.0208639			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576327	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400011
J	Loke, MF; Chua, EG; Gan, HM; Thulasi, K; Wanyiri, JW; Thevambiga, I; Goh, KL; Wong, WF; Vadivelu, J				Loke, Mun Fai; Chua, Eng Guan; Gan, Han Ming; Thulasi, Kumar; Wanyiri, Jane W.; Thevambiga, Iyadorai; Goh, Khean Lee; Wong, Won Fen; Vadivelu, Jamuna			Metabolomics and 16S rRNA sequencing of human colorectal cancers and adjacent mucosa	PLOS ONE			English	Article							STRATEGIES; MICROBIOTA; SOFTWARE; ACID	Colorectal cancer (CRC) is ranked the third most common cancer in human worldwide. However, the exact mechanisms of CRC are not well established. Furthermore, there may be differences between mechanisms of CRC in the Asian and in the Western populations. In the present study, we utilized a liquid chromatography-mass spectrometry (LC-MS) metabolomic approach supported by the 16S rRNA next-generation sequencing to investigate the functional and taxonomical differences between paired tumor and unaffected (normal) surgical biopsy tissues from 17 Malaysian patients. Metabolomic differences associated with steroid biosynthesis, terpenoid biosynthesis and bile metabolism could be attributed to microbiome differences between normal and tumor sites. The relative abundances of Anaerotruncus, Intestinimonas and Oscillibacter displayed significant relationships with both steroid biosynthesis and terpenoid and triterpenoid biosynthesis pathways. Metabolites involved in serotonergic synapse/tryptophan metabolism (Serotonin and 5-Hydroxy-3indoleacetic acid [5-HIAA]) were only detected in normal tissue samples. On the other hand, S-Adenosyl-L-homocysteine (SAH), a metabolite involves in methionine metabolism and methylation, was frequently increased in tumor relative to normal tissues. In conclusion, this study suggests that local microbiome dysbiosis may contribute to functional changes at the cancer sites. Results from the current study also contributed to the list of metabolites that are found to differ between normal and tumor sites in CRC and supported our quest for understanding the mechanisms of carcinogenesis.	[Loke, Mun Fai; Thulasi, Kumar; Thevambiga, Iyadorai; Wong, Won Fen; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Chua, Eng Guan] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia; [Gan, Han Ming] Monash Univ Malaysia, Sch Sci, Genom Facil, Selangor Darul Ehsan, Malaysia; [Wanyiri, Jane W.] Johns Hopkins Univ, Johns Hopkins Med Inst, Sch Med, Dept Med, Baltimore, MD USA; [Goh, Khean Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Loke, Mun Fai] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore, Singapore; [Gan, Han Ming] Deakin Univ, Dept Life & Environm Sci, Geelong, Vic, Australia	Universiti Malaya; University of Western Australia; Monash University; Monash University Sunway; Johns Hopkins University; Johns Hopkins Medicine; Universiti Malaya; Deakin University	Wong, WF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	wonfen@um.edu.my	Iyadorai, Thevambiga/GSN-4683-2022; Goh, Khean-Lee/B-6404-2009; Chua, Eng Guan/W-3023-2019; Gan, Han Ming/AAF-9519-2019; Wong, Won Fen/D-3087-2012; VADIVELU, JAMUNARANI S/B-8696-2010; Loke, Mun Fai/B-1060-2011	Iyadorai, Thevambiga/0000-0002-9258-620X; Goh, Khean-Lee/0000-0002-9965-1561; Chua, Eng Guan/0000-0002-1508-5284; Gan, Han Ming/0000-0001-7987-738X; Wong, Won Fen/0000-0003-1082-1956; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Loke, Mun Fai/0000-0002-3554-5313	University of Malaya Research Grant [RP016B-13HTM]; Swami Institute for International Medical Education Award of Johns Hopkins University School of Medicine; ShenZhen's Sanming Project [SZSM201510050]; University of Malaya-Ministry of Education High Impact Research Grant [UM.C/625/1/HIR/MoE/CHAN/13/4]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK097430] Funding Source: NIH RePORTER	University of Malaya Research Grant; Swami Institute for International Medical Education Award of Johns Hopkins University School of Medicine; ShenZhen's Sanming Project; University of Malaya-Ministry of Education High Impact Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the University of Malaya Research Grant RP016B-13HTM to WFW, University of Malaya-Ministry of Education High Impact Research Grant UM.C/625/1/HIR/MoE/CHAN/13/4 (Account No. H-50001-A000029) to JV, and Swami Institute for International Medical Education Award of Johns Hopkins University School of Medicine. EGC was supported by ShenZhen's Sanming Project (Grant No: SZSM201510050 to EGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09743; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borrego SL, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0148-6; Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dabdoub SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29123; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3; Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C, V11; Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fukui Y., 2010, THE OPEN ANALYTICAL, V4, P1, DOI DOI 10.2174/1874065001004010001; Gao X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1670-4; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Lei ZT, 2011, J BIOL CHEM, V286, P25435, DOI 10.1074/jbc.R111.238691; Manocha M, 2012, CLIN TRANSL GASTROEN, V3, pe13, DOI [10.1038/ctg.2012.8, DOI 10.1038/CTG.2012.8]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Parikh HI, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1358-1; Park SY, 2009, J EPIDEMIOL, V19, P63, DOI 10.2188/jea.JE20080078; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Saltzstein SL, 2007, J CLIN GASTROENTEROL, V41, P173, DOI 10.1097/01.mcg.0000225550.26751.6a; Satoh K, 2017, P NATL ACAD SCI USA, V114, pE7697, DOI 10.1073/pnas.1710366114; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen H, 2015, WORLD J GASTROENTERO, V21, P6470, DOI 10.3748/wjg.v21.i21.6470; Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61; Tian Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20790; Warschkow R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2412-0	36	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208584	10.1371/journal.pone.0208584	http://dx.doi.org/10.1371/journal.pone.0208584			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576312	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400010
J	Zhang, XT; Yang, B; Li, YH; Zuo, CL; Wang, XW; Zhang, WX				Zhang, Xuetao; Yang, Ben; Li, Yunhao; Zuo, Changle; Wang, Xuewei; Zhang, Wanxu			A method of partially overlapping point clouds registration based on differential evolution algorithm	PLOS ONE			English	Article							CURVES	3D point cloud registration is a key technology in 3D point cloud processing, such as 3D reconstruction, object detection. Trimmed Iterative Closest Point algorithm is a prevalent method for registration of two partially overlapping clouds. However, it relies heavily on the initial value and is liable to be trapped in to local optimum. In this paper, we adapt the Differential Evolution algorithm to obtain global optimal solution. By design appropriate evolutionary operations, the algorithm can make the populations distributed more widely, and keep the individuals from concentrating to a local optimum. In the experiment, the proposed algorithm is compared with existing methods which are based on global optimization algorithm such as Genetic Algorithm and particle filters. And the results have demonstrated that the proposed algorithm is more robust and can converge to a good result in fewer generations.	[Zhang, Xuetao; Yang, Ben; Zuo, Changle] Natl Engn Lab Visual Informat Proc & Applicat, Xian 710049, Shaanxi, Peoples R China; [Zhang, Xuetao; Yang, Ben; Li, Yunhao; Zuo, Changle] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Wang, Xuewei] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310027, Zhejiang, Peoples R China; [Zhang, Wanxu] Northwest Univ, Sch Informat Sci & Techonol, Xian 710127, Shaanxi, Peoples R China	Xi'an Jiaotong University; Zhejiang University; Northwest University Xi'an	Zhang, WX (corresponding author), Northwest Univ, Sch Informat Sci & Techonol, Xian 710127, Shaanxi, Peoples R China.	wxzhang@nwu.edu.cn			National Science and Technology Major Project [2018ZX01008103]; National Science and Technology Major Project of China [2018ZX01008103]	National Science and Technology Major Project; National Science and Technology Major Project of China	This work was supported by National Science and Technology Major Project, No. 2018ZX01008103.; This work was supported by the National Science and Technology Major Project of China grant number 2018ZX01008103.	BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chetverikov D, 2005, IMAGE VISION COMPUT, V23, P299, DOI 10.1016/j.imavis.2004.05.007; Chetverikov D, 2002, INT C PATT RECOG, P545, DOI 10.1109/ICPR.2002.1047997; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Jiang J, 2018, IEEE INT C VEH EL SA; Ma B, 2004, LECT NOTES COMPUT SC, V3216, P566; Melanie M, 1999, INTRO GENETIC ALGORI; Phillips J, 2005, IMAGE VISION COMPUT, V23, P299; Schmid BJ, 2018, IEEE T IMAGE PROCESS, V27, P5491, DOI 10.1109/TIP.2018.2859594; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Wang X, 2018, J VIS COMMUN IMAGE R, V57, P234, DOI 10.1016/j.jvcir.2018.11.008; Yang Y, 2018, IEEE T MULTIMEDIA; Yang Y, 2019, IEEE T IMAGE PROCESS, V28, P302, DOI 10.1109/TIP.2018.2867740; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhu JH, 2014, IET IMAGE PROCESS, V8, P582, DOI 10.1049/iet-ipr.2013.0545; [祝继华 Zhu Jihua], 2014, [中国科学. 信息科学, Scientia Sinica Informationis], V44, P886; Zinsser Timo, 2003, IEEE INT C IM PROC	19	5	5	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209227	10.1371/journal.pone.0209227	http://dx.doi.org/10.1371/journal.pone.0209227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576346	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400033
J	Franzo, G; Cecchinato, M; Tosi, G; Fiorentini, L; Faccin, F; Tucciarone, CM; Trogu, T; Barbieri, I; Massi, P; Moreno, A				Franzo, Giovanni; Cecchinato, Mattia; Tosi, Giovanni; Fiorentini, Laura; Faccin, Francesca; Tucciarone, Claudia Maria; Trogu, Tiziana; Barbieri, Ilaria; Massi, Paola; Moreno, Ana			GI-16 lineage (624/I or Q1), there and back again: The history of one of the major threats for poultry farming of our era	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; MOLECULAR CHARACTERIZATION; POPULATION-DYNAMICS; GENETIC DIVERSITY; AVIAN CORONAVIRUS; STRAIN; PERFORMANCE; VARIANTS; GENOME; S1	The genetic variability of Infectious bronchitis virus (IBV) is one of the main challenges for its control, hindering not only the development of effective vaccination strategies but also its classification and, consequently, epidemiology understanding. The 624/I and Q1 genotypes, now recognized to be part of the GI-16 lineage, represent an excellent example of the practical consequences of IBV molecular epidemiology limited knowledge. In fact, being their common origin unrecognized for a long time, independent epidemiological pictures were drawn for the two genotypes. To fix this misinterpretation, the present study reconstructs the history, population dynamics and spreading patterns of GI-16 lineage as a whole using a phylodynamic approach. A collection of worldwide available hypervariable region 1 and 2 (HVR12) and 3 (HVR3) sequences of the S1 protein was analysed together with 258 HVR3 sequences obtained from samples collected in Italy (the country where this genotype was initially identified) since 1963. The results demonstrate that after its emergence at the beginning of the XX century, GI-16 was able to persist until present days in Italy. Approximately in the late 1980s, it migrated to Asia, which became the main nucleus for further spreading to Middle East, Europe and especially South America, likely through multiple introduction events. A remarkable among-country diffusion was also demonstrated in Asia and South America. Interestingly, although most of the recent Italian GI-16 strains originated from ancestral viruses detected in the same country, a couple were closely related to Chinese ones, supporting a backward viral flow from China to Italy. Besides to the specific case-study results, this work highlights the misconceptions that originate from the lack of a unified nomenclature and poor molecular epidemiology data generation and sharing. This shortcoming appears particularly relevant since the described scenario could likely be shared by many other IBV genotypes and pathogens in general.	[Franzo, Giovanni; Cecchinato, Mattia; Tucciarone, Claudia Maria] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Legnaro, PD, Italy; [Tosi, Giovanni; Fiorentini, Laura; Massi, Paola] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Sez Forli, Forli Cesena, Italy; [Faccin, Francesca; Trogu, Tiziana; Barbieri, Ilaria; Moreno, Ana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Dept Virol, Brescia, Italy	University of Padua; IZS Lombardia e Emilia; IZS Lombardia e Emilia	Franzo, G (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Legnaro, PD, Italy.; Moreno, A (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Dept Virol, Brescia, Italy.	giovanni.franzo@unipd.it; anamaria.morenomartin@izsler.it	Moreno, Ana/Q-2173-2019; Trogu, Tiziana/AAC-3422-2022	Moreno, Ana/0000-0002-8497-9708; Trogu, Tiziana/0000-0001-5683-6083; Franzo, Giovanni/0000-0003-2991-217X; Tucciarone, Claudia Maria/0000-0002-0340-8920; Cecchinato, Mattia/0000-0002-2269-7879	Ministry of Health (Italy) [PRC2015009]	Ministry of Health (Italy)(Ministry of Health, Italy)	The study was partially funded by the Ministry of Health (Italy), Progetto di Recerca Corrente PRC2015009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh Mustafa, 2012, ISRN Vet Sci, V2012, P201721, DOI 10.5402/2012/201721; Abdel-Sabour MA, 2017, AVIAN DIS, V61, P307, DOI 10.1637/11566-121516-RegR; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bochkov YA, 2007, VIRUS GENES, V35, P65, DOI 10.1007/s11262-006-0037-0; Bochkov YA, 2006, AVIAN PATHOL, V35, P379, DOI 10.1080/03079450600921008; CAPUA I, 1994, J VET MED B, V41, P83, DOI 10.1111/j.1439-0450.1994.tb00211.x; Capua I, 1999, AVIAN PATHOL, V28, P587, DOI 10.1080/03079459994380; Cavanagh D, 1999, AVIAN PATHOL, V28, P593, DOI 10.1080/03079459994399; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chen HW, 2009, VIRUS RES, V140, P121, DOI 10.1016/j.virusres.2008.11.012; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Wit JJ, 2018, AVIAN PATHOL, V47, P140, DOI 10.1080/03079457.2017.1387231; de Wit JJ, 2017, AVIAN PATHOL, V46, P666, DOI 10.1080/03079457.2017.1346782; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; Domanska-Blicharz K, 2014, AVIAN PATHOL, V43, P406, DOI 10.1080/03079457.2014.949619; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Franzo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184401; Franzo G, 2016, VACCINE, V34, P5670, DOI 10.1016/j.vaccine.2016.09.014; Franzo G, 2015, VIRUS RES, V210, P77, DOI 10.1016/j.virusres.2015.07.008; Franzo G, 2014, VACCINE, V32, P6765, DOI 10.1016/j.vaccine.2014.10.006; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall MD, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew003; Jackwood MW, 2012, AVIAN DIS, V56, P634, DOI 10.1637/10227-043012-Review.1; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krapez U, 2010, VIRUS GENES, V41, P414, DOI 10.1007/s11262-010-0528-x; Laconi A, 2019, TRANSBOUND EMERG DIS, V66, P207, DOI 10.1111/tbed.13000; Lee EK, 2008, AVIAN DIS, V52, P332, DOI 10.1637/8117-092707-ResNote.1; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Marandino A, 2017, INFECT GENET EVOL, V54, P245, DOI 10.1016/j.meegid.2017.07.009; Marandino A, 2015, J GEN VIROL, V96, P1340, DOI 10.1099/vir.0.000077; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Pi Chendong, 2014, FAIR FOWL IND POULTR; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Taddei R., 2012, P 51 CONVEGNO ANNUAL, P332; Toffan A, 2011, VET REC, V169, P212, DOI 10.1136/vr.d5285; Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015; Wickramasinghe INA, 2014, VIRUS RES, V194, P37, DOI 10.1016/j.virusres.2014.10.009; Yu L, 2001, AVIAN DIS, V45, P416, DOI 10.2307/1592981; Zanella A, 2003, AVIAN DIS, V47, P180, DOI 10.1637/0005-2086(2003)047[0180:AIBCON]2.0.CO;2	46	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0203513	10.1371/journal.pone.0203513	http://dx.doi.org/10.1371/journal.pone.0203513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571679	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700004
J	Frasao, B; Costa, M; Silva, F; Rodrigues, B; Baltar, J; Araujo, J; Moreira, D; Torrezan, R; Conte, C				Frasao, Beatriz; Costa, Marion; Silva, Fabricio; Rodrigues, Bruna; Baltar, Jessica; Araujo, Jasmim; Moreira, Daniel; Torrezan, Renata; Conte-Junior, Carlos			Effect of pequi (Caryocar brasiliense) and jucara (Euterpe edulis) waste extract on oxidation process stability in broiler meat treated by UV-C	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ANTIOXIDANT ACTIVITY; BIOACTIVE COMPOUNDS; PROTEIN OXIDATION; ROSEMARY EXTRACT; TROPICAL FRUITS; BIOGENIC-AMINES; SHELF-LIFE; CHICKEN; COLOR	The aim of this study was to determine the potential for waste extracts from the pequi (Caryocar brasiliense) and jucara (Euterpe edulis) to reduce oxidatiove processes in antibiotic-free broiler meat. The use of natural antioxidants extracted from fruit-processing wastes has been neglected. Although these residues contain high amounts of these bioactive compounds, they are often discarded by industry. Meat samples were exposed previously submitted to UV-C radiation at 1.161 mW / cm(2) for 10 minutes to accelerate the rancidity process. Pequi and jucara waste extracts were obtained by microwave-assisted extraction (MAE). A total of four conditions were tested using antibiotic-free broiler thighs and drumstick meat: BN - with no antioxidant (negative control), BP-with BHT (Butylated hydroxytoluene) (positive control), BE-with jucara extract, BC-with pequi extract. The color, pH, lipid and protein oxidation (days 0, 2, 4, 6, 8 and 10), antioxidant contents and activity (days 0 and 10), and proximal composition and fatty acid profile (day 0) were tested, followed by principal component analysis (PCA). Pequi waste extract presented the highest antioxidant content and activity. BE and BC treatments presented the highest total phenolic (TPC) and flavonoid (TFC) content, and BE presented the highest total monomeric anthocyanin content (TAC). TFC increased during storage in all treatments. The waste extracts of C. brasiliense presented the highest antioxidant activity against lipid oxidation in the antibiotic-free broiler meat. Moreover, both extracts presented high antioxidant activity against protein oxidation. Although the pequi peel extract had a better effect in terms of suppressing both types of oxidation, either this extract or the jussara waste extract could be used as a technological strategy to reduce the oxidative processes in antibiotic-free broiler meat for the poultry industry. Thus, waste extracts can be a potential technology to reduce the oxidative processes in antibiotic-free broiler meat.	[Frasao, Beatriz] Univ Fed Oeste Bahia, Multidisciplinary Ctr, Coll Vet Med, Barra Campus, Barra, BA, Brazil; [Costa, Marion] Univ Fed Bahia, Escola Med Vet & Zootecnia, Dept Prevent Vet Med & Anim Prod, Salvador, BA, Brazil; [Silva, Fabricio; Baltar, Jessica; Moreira, Daniel; Conte-Junior, Carlos] Univ Fed Rio de Janeiro, Chem Inst, Food Sci Programe, Rio De Janeiro, Brazil; [Rodrigues, Bruna; Araujo, Jasmim; Conte-Junior, Carlos] Univ Fed Fluminense, Fac Vet, Dept Food Technol, Rio De Janeiro, Brazil; [Torrezan, Renata] Brazilian Agr Res Corp, Embrapa Food Technol, Rio De Janeiro, Brazil; [Conte-Junior, Carlos] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Hlth Qual Control, Rio De Janeiro, Brazil; [Costa, Marion] Univ Fed Bahia, Dept Prevent Vet Med & Anim Prod, Salvador, BA, Brazil; [Conte-Junior, Carlos] Fluminense Fed Univ, Dept Food Technol, Niteroi, RJ, Brazil	Universidade Federal do Oeste da Bahia; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal Fluminense	Conte, C (corresponding author), Univ Fed Rio de Janeiro, Chem Inst, Food Sci Programe, Rio De Janeiro, Brazil.; Conte, C (corresponding author), Univ Fed Fluminense, Fac Vet, Dept Food Technol, Rio De Janeiro, Brazil.; Conte, C (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Hlth Qual Control, Rio De Janeiro, Brazil.; Conte, C (corresponding author), Fluminense Fed Univ, Dept Food Technol, Niteroi, RJ, Brazil.	carlosconte@id.uff.br	Conte-Junior, Carlos A./J-5815-2014; Costa, Marion/AAL-1269-2020; Silva, Fabricio/L-5502-2018	Conte-Junior, Carlos A./0000-0001-6133-5080; Costa, Marion/0000-0002-3003-6763; Silva, Fabricio/0000-0003-3248-1358	Coordination of Enhancement of People of a Superior Level [CAPES, Brazil] [125, CAPES/Embrapa 15/2014]; Research Foundation of the State of Rio de Janeiro [FAPERJ, Brazil] [E-26/201.185/2014]; National Council of Technological and Scientific Development [CNPq, Brazil] [311361/2013-7, 311422/2016-0, 439731/2016-0, 150200/2017-0]	Coordination of Enhancement of People of a Superior Level [CAPES, Brazil]; Research Foundation of the State of Rio de Janeiro [FAPERJ, Brazil]; National Council of Technological and Scientific Development [CNPq, Brazil](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Coordination of Enhancement of People of a Superior Level [process no. 125, CAPES/Embrapa 15/2014, CAPES, Brazil], Research Foundation of the State of Rio de Janeiro [process no. E-26/201.185/2014, FAPERJ, Brazil], the National Council of Technological and Scientific Development [processes no. 311361/2013-7, 311422/2016-0, 439731/2016-0 and 150200/2017-0, CNPq, Brazil].	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Amaral LFB, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-154; Andres AI, 2017, MEAT SCI, V129, P62, DOI 10.1016/j.meatsci.2017.02.013; AOAC, 2002, OFFICIAL METHODS ANA, Vfifteenth; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; Ascari J, 2010, B LATINOAM CARIBE PL, V9, P20; Azevedo-Meleiro CH, 2004, J FOOD COMPOS ANAL, V17, P385, DOI 10.1016/j.jfca.2004.02.004; Baptista A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3753562; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boschetti E, 2016, ANIMAL, V10, P700, DOI 10.1017/S1751731115002712; Borges GDC, 2011, FOOD RES INT, V44, P2128, DOI 10.1016/j.foodres.2010.12.006; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Cheynier V, 2005, AM J CLIN NUTR, V81, p223S, DOI 10.1093/ajcn/81.1.223S; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; Costa MP, 2017, J DAIRY SCI, V100, P157, DOI 10.3168/jds.2016-11315; da Cunha ALA, 2017, GRASAS ACEITES, V68, DOI 10.3989/gya.0442171; Dalziel CJ, 2015, FOOD CHEM, V179, P103, DOI 10.1016/j.foodchem.2015.01.118; De Alcantara A., 2015, J FOOD STUD, V4, P34, DOI [10.5296/jfs.v4i1.8362, DOI 10.5296/JFS.V4I1.8362]; Feng LF, 2016, INT J FOOD PROP, V19, P2338, DOI 10.1080/10942912.2015.1130053; Ferreira VCS, 2017, J FOOD SCI, V82, P622, DOI 10.1111/1750-3841.13640; Frasao B. da S., 2017, Journal of Agricultural Science (Toronto), V9, P178, DOI 10.5539/jas.v9n3p178; Frasao BS, 2017, THESIS; Fukada Y, 2016, J FOOD SCI TECH MYS, V53, P2476, DOI 10.1007/s13197-016-2233-9; Hwang KE, 2015, RADIAT PHYS CHEM, V106, P315, DOI 10.1016/j.radphyschem.2014.08.014; Incedayi B, 2006, FOOD SCI TECH-BRAZIL, V36, P171; Jayawardana BC, 2015, LWT-FOOD SCI TECHNOL, V64, P1204, DOI 10.1016/j.lwt.2015.07.028; Joseph P, 2012, J AGR FOOD CHEM, V60, P3196, DOI 10.1021/jf204188v; Karre L, 2013, MEAT SCI, V94, P220, DOI 10.1016/j.meatsci.2013.01.007; Kishino S, 2002, BIOSCI BIOTECH BIOCH, V66, P2283, DOI 10.1271/bbb.66.2283; Klangpetch W, 2016, INT FOOD RES J, V23, P700; Krishnan KR, 2014, INT J FOOD MICROBIOL, V171, P32, DOI 10.1016/j.ijfoodmicro.2013.11.011; Kumar Y, 2015, COMPR REV FOOD SCI F, V14, P796, DOI 10.1111/1541-4337.12156; Lazaro CA, 2014, POULTRY SCI, V93, P2304, DOI 10.3382/ps.2013-03642; Lee J, 2005, J AOAC INT, V88, P1269; Memon NN, 2011, FOOD CHEM, V126, P405, DOI 10.1016/j.foodchem.2010.10.107; Monteiro SS, 2015, INT FOOD RES J, V22, P1985; Moreira da SILVA PP, 2013, BRAZ J FOOD NUTR E, V24; Bicudo MOP, 2014, PLANT FOOD HUM NUTR, V69, P142, DOI 10.1007/s11130-014-0406-0; Ramana KV, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2163285; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Ribeiro DM, 2014, FOOD SCI TECH-BRAZIL, V34, P507, DOI [10.1590/1678-457X.6369, 10.1590/1678-457x.6369]; ROCHA L. B., 2015, Rev. bras. plantas med., V17, P592, DOI 10.1590/1983-084X/14_062; Roesler R, 2008, FOOD CHEM, V110, P711, DOI 10.1016/j.foodchem.2008.02.048; Roesler R, 2007, CIENCIA TECNOL ALIME, V27, P53, DOI 10.1590/S0101-20612007000100010; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Sebranek JG, 2005, MEAT SCI, V69, P289, DOI 10.1016/j.meatsci.2004.07.010; Shao Y, 2014, ANAL METHODS-UK, V6, P170, DOI 10.1039/c3ay41279b; Sohaib M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0426-5; Soladoye OP, 2015, COMPR REV FOOD SCI F, V14, P106, DOI 10.1111/1541-4337.12127; Zhang QQ, 2017, FOOD CONTROL, V78, P324, DOI 10.1016/j.foodcont.2017.02.054; Zhang WG, 2013, CRIT REV FOOD SCI, V53, P1191, DOI 10.1080/10408398.2011.577540; Zhuang H, 2016, LWT-FOOD SCI TECHNOL, V69, P233, DOI 10.1016/j.lwt.2016.01.054	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208306	10.1371/journal.pone.0208306	http://dx.doi.org/10.1371/journal.pone.0208306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571713	Green Submitted, gold, Green Published			2022-12-26	WOS:000453841700010
J	Dimobe, K; Tondoh, JE; Weber, JC; Bayala, J; Ouedraogo, K; Greenough, K				Dimobe, Kangbeni; Tondoh, Jerome Ebagnerin; Weber, John C.; Bayala, Jules; Ouedraogo, Korotimi; Greenough, Karen			Farmers' preferred tree species and their potential carbon stocks in southern Burkina Faso: Implications for biocarbon initiatives	PLOS ONE			English	Article							PARADOXA CF GAERTN.; ABOVEGROUND BIOMASS; ECOSYSTEM SERVICES; ALLOMETRIC MODELS; WOOD DENSITY; AGROFORESTRY; KNOWLEDGE; LESSONS; FOREST; SAHEL	The success of terrestrial carbon sequestration projects for rural development in sub-Saharan Africa lies in the (i) involvement of local populations in the selection of woody species, which represent the biological assets they use to meet their daily needs, and (ii) information about the potential of these species to store carbon. Although the latter is a prerequisite, there is very little information available. To help fill this gap, the present study was under-taken in four pilot villages (Kou, Dao, Vrassan and Cassou) in Ziro Province, south-central Burkina Faso. The objective was to determine carbon storage potential for top-priority woody species preferred by local smallholders. We used (i) participatory rural appraisal consisting of group discussions and informant interviews to identify priority species and functions, and (ii) landscape assessment of carbon stocks in the preferred woody species. Results revealed 79 priority tree and shrub species grouped into six functions, of which medicine, food and income emerge as the most important ones for the communities. For these functions, smallholders overwhelmingly listed Vitellaria paradoxa, Parkia biglobosa, Afzelia africana, Adansonia digitata, Detarium microcarpum, and Lannea microcarpa among the most important tree species. Among the preferred woody species in Cassou and Kou, the highest quantity of carbon was stored by V. paradoxa (1180 +/- 209 kg C ha(-1) to 2089 +/- 522 kg C ha(-1)) and the lowest by Grewia bicolor (5 +/- 1.2 kg C ha(-1)). The potential carbon stored by the preferred tree communities was estimated at 587.9 Mg C ha(-1) (95% CI: 456.7; 719.1 Mg C ha(-1)) in Kou and256.8 Mg C ha(-1) (95% CI: 67.6; 324.4 Mg C ha(-1)) in Cassou. The study showed that the species that farmers preferred most stored more carbon than species that were less preferred.	[Dimobe, Kangbeni; Tondoh, Jerome Ebagnerin] Competence Ctr, West African Sci Serv Ctr Climate Change & Adapte, Ouagadougou, Burkina Faso; [Dimobe, Kangbeni; Ouedraogo, Korotimi] Univ Ouaga I Pr Joseph Ki Zerbo, UFR SVT, Lab Plant Biol & Ecol, Ouagadougou, Burkina Faso; [Tondoh, Jerome Ebagnerin] Univ Nangui Abrogoua, UFR Sci Nat, Abidjan, Cote Ivoire; [Weber, John C.] World Agroforestry Ctr ICRAF, Lima, Peru; [Bayala, Jules] World Agroforestry Ctr ICRAF, Bamako, Mali; [Greenough, Karen] Univ Faso UFA, Ouagadougou, Burkina Faso		Dimobe, K (corresponding author), Competence Ctr, West African Sci Serv Ctr Climate Change & Adapte, Ouagadougou, Burkina Faso.; Dimobe, K (corresponding author), Univ Ouaga I Pr Joseph Ki Zerbo, UFR SVT, Lab Plant Biol & Ecol, Ouagadougou, Burkina Faso.	kangbenidimobe@gmail.com	Dimobe, Kangbeni/AFP-4490-2022	Dimobe, Kangbeni/0000-0001-5536-9700	Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV) project; Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV)	Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV) project; Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV)	The authors would like to acknowledge the Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV) project for providing financial support for conducting this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Ministry of Foreign Affairs of Finland through the Building Biocarbon and Rural Development in West Africa (BIODEV) project implemented in Burkina Faso, Guinea-Conakry, Mali and Sierra Leone. This project contributed to both CCAFS and FTA CRP agendas. The authors are thankful to Institut de l'Environnement et de Recherches Agricoles (INERA) of Burkina Faso for their logistic support. They also extend their special thanks to the smallholders from the study villages who willingly accepted to be interviewed despite their busy schedules during the cropping season. Drs. Kangbeni Dimobe and Jerome Ebagnerin Tondoh greatly acknowledge the endless and multifaceted supports of the West African Science Service Centre and Adapted Land Use (WASCAL) which enabled the write-up of this manuscript. The authors are grateful to the three anonymous reviewers and the editor who constructively helped to improve the manuscript. The actual inventory data can be found in the supplementary materials.	Akpona TJD, 2016, AGROFOREST SYST, V90, P607, DOI 10.1007/s10457-015-9847-1; [Anonymous], 2014, J GEOSCIENCE ENV PRO, V2, P157, DOI DOI 10.4236/GEP.2014.22022; Assogbadjo AE, 2012, FOREST POLICY ECON, V14, P41, DOI 10.1016/j.forpol.2011.07.013; Bayala J, 2014, CURR OPIN ENV SUST, V6, P28, DOI 10.1016/j.cosust.2013.10.004; Bayala J, 2008, ACTA OECOL, V34, P370, DOI 10.1016/j.actao.2008.06.010; Bayen P, 2016, ENVIRON DEV SUSTAIN, V18, P143, DOI 10.1007/s10668-015-9631-4; Boffa J. M., 2000, Unasylva (English ed.), V51, P11; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Coulibaly-Lingani P, 2011, FOREST POLICY ECON, V13, P292, DOI 10.1016/j.forpol.2011.02.005; Coulibaly-Lingani P, 2009, FOREST POLICY ECON, V11, P516, DOI 10.1016/j.forpol.2009.06.002; Cowie AL, 2011, LAND DEGRAD DEV, V22, P248, DOI 10.1002/ldr.1086; Dagnelie P., 1998, APPL AGR, V2, P464; Dimobe K, 2019, AGROFOREST SYST, V93, P1119, DOI 10.1007/s10457-018-0213-y; Dimobe K, 2018, BIOMASS BIOENERG, V115, P151, DOI 10.1016/j.biombioe.2018.04.022; Dimobe K, 2015, GLOB ECOL CONSERV, V4, P559, DOI 10.1016/j.gecco.2015.10.006; Etongo D, 2015, FORESTS, V6, P2655, DOI 10.3390/f6082655; Faye M. D., 2011, Forests, Trees and Livelihoods, V20, P113; Faye MD, 2010, DEV PRACT, V20, P428, DOI 10.1080/09614521003710013; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fontes J, 1995, VEGETATION MAP LAND; Foster K, 2014, CURR OPIN ENV SUST, V6, P148, DOI 10.1016/j.cosust.2013.12.002; Goetz SJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/123001; Graves S., 2012, MULTCOMPVIEW VISUALI; Hair J. F., 2009, MULTIVARIATE DATA AN, V6; INSD, 2007, RES PREL REC GEN POP; Kebenzikato AB, 2015, AU TOGO BASE, V19, P247; Kuyah S, 2012, AGR ECOSYST ENVIRON, V158, P225, DOI 10.1016/j.agee.2012.05.010; Lamien N, 2006, ENVIRON EXP BOT, V55, P142, DOI 10.1016/j.envexpbot.2004.10.010; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Luedeling E, 2012, CLIMATIC CHANGE, V115, P443, DOI 10.1007/s10584-012-0438-0; Lykke AM, 2000, J ENVIRON MANAGE, V59, P107, DOI 10.1006/jema.2000.0336; Mahanty S, 2013, LAND USE POLICY, V31, P38, DOI 10.1016/j.landusepol.2011.10.009; Mander M., 1998, MARKETING INDIGENOUS, DOI 10.13140/2.1.1073.4084; Maranz S, 2009, J BIOGEOGR, V36, P1181, DOI 10.1111/j.1365-2699.2008.02081.x; McNeely JA, 2006, BIODIVERS CONSERV, V15, P549, DOI 10.1007/s10531-005-2087-3; Mensah S, 2016, FORESTS, V7, DOI 10.3390/f7040079; Mitchell K., 2007, QUANTITATIVE ANAL PO; Montes CS, 2011, BIOMASS BIOENERG, V35, P346, DOI 10.1016/j.biombioe.2010.08.058; Naah JBSN, 2017, J ENVIRON MANAGE, V188, P297, DOI 10.1016/j.jenvman.2016.11.064; Nolan JM, 1999, CULTURAL CONSERVATIO, P67; Ouedraogo B, 2006, ENERG POLICY, V34, P3787, DOI 10.1016/j.enpol.2005.09.006; Ouedraogo I., 2014, BOIS FOR TROP, V319, P31, DOI DOI 10.19182/BFT2014.319.A20550; Ouedraogo I, 2015, LAND, V4, P560, DOI 10.3390/land4030560; Ouedraogo Issaka, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P313, DOI 10.1080/21513732.2014.950980; Padakale E., 2015, Annual Research & Review in Biology, V6, P103, DOI 10.9734/ARRB/2015/14105; Pare Souleymane, 2010, Environment Development and Sustainability, V12, P277, DOI 10.1007/s10668-009-9194-3; R Core Team, 2013, R LANG ENV STAT COMP; Reij C., 2009, INT FOOD POLICY RES, V914; Rejou-Mechain M, 2017, METHODS ECOL EVOL, V8, P1163, DOI 10.1111/2041-210X.12753; Sakkatat P, 1997, BANG PHRA CTR J, V4, P27; Sakkatat P, 2007, MAEJO INT J SCI TECH, V1, P64; Sawadogo Louis, 2010, Journal of Forestry Research (Harbin), V21, P475, DOI 10.1007/s11676-010-0101-4; Scherr S.J., 2012, AGR FOOD SECURITY, V1, P1, DOI DOI 10.1186/2048-7010-1-12; Simons AJ, 2004, AGROFOREST SYST, V61-2, P167, DOI 10.1023/B:AGFO.0000028997.74147.f9; Sinare H, 2016, ECOSYST SERV, V21, P141, DOI 10.1016/j.ecoser.2016.08.004; Sinare H, 2015, AGR ECOSYST ENVIRON, V200, P186, DOI 10.1016/j.agee.2014.11.009; Sinsin B, 2004, BIODIVERS CONSERV, V13, P1555, DOI 10.1023/B:BIOC.0000021328.56517.46; Sop Tene Kwetche, 2012, Environment Development and Sustainability, V14, P627, DOI 10.1007/s10668-012-9345-9; Teklehaimanot Z, 2004, AGROFOREST SYST, V61-2, P207, DOI 10.1023/B:AGFO.0000029000.22293.d1; Thiombiano A, 2012, BOISSIERA, V65, P1; Tran DB, 2013, LAND USE POLICY, V35, P417, DOI 10.1016/j.landusepol.2013.04.018; Vagen T, 2010, AFSIS TECHNICAL SPEC; Weber JC, 2018, NEW FOREST, V49, P35, DOI 10.1007/s11056-017-9603-7; Weber JC, 2015, EUPHYTICA, V205, P809, DOI 10.1007/s10681-015-1413-4; World Bank, 2016, BIOEN 2016, P1; Zanne AE, 2009, GLOBAL WOOD DENSITY; Zizka A, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-9; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	71	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0199488	10.1371/journal.pone.0199488	http://dx.doi.org/10.1371/journal.pone.0199488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562359	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100001
J	de Barros, BDV; Chagas, EN; Bezerra, LW; Ribeiro, LG; Duarte, JWB; Pereira, D; da Penha, ET; Silva, JR; Bezerra, DAM; Bandeira, RS; Pinheiro, HHC; Guerra, SDD; Guimaraes, RJDSE; Mascarenhas, JDP				Veloso de Barros, Bruno de Cassio; Chagas, Elaine Nunes; Bezerra, Luna Wanessa; Ribeiro, Laila Graziela; Duarte Junior, Jose Wandilson Barboza; Pereira, Diego; da Penha Junior, Edvaldo Tavares; Silva, Julia Rezende; Melo Bezerra, Delana Andreza; Bandeira, Renato Silva; Costa Pinheiro, Helder Henrique; dos Santos Guerra, Sylvia de Fatima; Souza e Guimaraes, Ricardo Jose de Paula; Pereira Mascarenhas, Joana Darc			Rotavirus A in wild and domestic animals from areas with environmental degradation in the Brazilian Amazon	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; VP7 GENES; MOLECULAR CHARACTERIZATION; INTERSPECIES TRANSMISSION; NUCLEOTIDE-SEQUENCE; INFECTIOUS-DISEASES; CLOSE RELATIONSHIP; DIARRHEA OUTBREAK; BOVINE ROTAVIRUS; RT-PCR	Acute gastroenteritis is one of the main causes of mortality in humans and young animals. Domestic and mainly wild animals such as bats, small rodents and birds are highly diversified animals in relation to their habitats and ecological niches and are widely distributed geographically in environments of forest fragmentation in some areas of the Amazon, being considered important sources for viruses that affect humans and other animals. Due to the anthropical activities, these animals changed their natural habitat and adapted to urbanized environments, thus representing risks to human and animal health. Although the knowledge of the global diversity of enteric viruses is scarce, there are reports demonstrating the detection of rotavirus in domestic animals and animals of productive systems, such as bovines and pigs. The present study investigated the prevalence of Rotavirus A in 648 fecal samples of different animal species from the northeastern mesoregion of the state of Para, Brazil, which is characterized as an urbanized area with forest fragments. The fecal specimens were collected from October 2014 to April 2016 and subjected to a Qualitative Real-Time Polymerase Chain Reaction (RT-qPCR), using the NSP3 gene as a target. It was observed that 27.5% (178/648) of the samples presented positive results for RVA, with 178 samples distributed in birds (23.6%), canines (21.35%), chiropterans (17.98%), bovines (14.6%), horses (8.43%), small rodents (6.74%), pigs (3.93%) and felines (3.37%), demonstrating the circulation of RVA in domestic animals and suggesting that such proximity could cause transmissions between different species and the occurrence of rearrangements in the genome of RVA as already described in the literature, associated to the traces of environmental degradation in the studied areas.	[Veloso de Barros, Bruno de Cassio; Chagas, Elaine Nunes; da Penha Junior, Edvaldo Tavares; Melo Bezerra, Delana Andreza; Bandeira, Renato Silva; dos Santos Guerra, Sylvia de Fatima; Souza e Guimaraes, Ricardo Jose de Paula; Pereira Mascarenhas, Joana Darc] Minist Hlth, Evandro Chagas Inst, Ananindeua, Para, Brazil; [Bezerra, Luna Wanessa; Ribeiro, Laila Graziela; Duarte Junior, Jose Wandilson Barboza; Pereira, Diego; dos Santos Guerra, Sylvia de Fatima] Amazon Metropolitan Univ Ctr, Belem, Para, Brazil; [Silva, Julia Rezende] Univ State Para, Belem, Para, Brazil; [Costa Pinheiro, Helder Henrique] Fed Univ Para, Belem, Para, Brazil	Instituto Evandro Chagas; Universidade Federal do Para	Mascarenhas, JDP (corresponding author), Minist Hlth, Evandro Chagas Inst, Ananindeua, Para, Brazil.	joanamascarenhas@iec.gov.br	de Paula Souza e Guimarães, Ricardo José/AAV-2973-2021; Pereira, Diego/ABD-9422-2021; Pinheiro, Helder Henrique Costa/F-9166-2014; Duarte Júnior, José/AAZ-8645-2021; Guimaraes, Ricardo J P S/F-7182-2015	de Paula Souza e Guimarães, Ricardo José/0000-0002-5767-4765; Pinheiro, Helder Henrique Costa/0000-0001-5567-3550; Duarte Júnior, José/0000-0002-4801-2356; Guimaraes, Ricardo J P S/0000-0002-5767-4765; NUNES CHAGAS, ELAINE HELLEN/0000-0002-3623-1711; Pereira, Diego/0000-0002-2612-4672; Bezerra, Delana/0000-0002-9141-692X	Coordination for the Improvement of Higher Education Personnel (CAPES) [2303800717/2013-52]; National Council for Scientific and Technological Development (CNPq); Evandro Chagas Institute, Ministry of Health, Ananindeua, Brazil; Capes grant; CNPq; Amazon Support Foundation of the studies and research (FAPESPA) [ICAAF166/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES; Evandro Chagas Institute	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Evandro Chagas Institute, Ministry of Health, Ananindeua, Brazil; Capes grant(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Amazon Support Foundation of the studies and research (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Evandro Chagas Institute	This research was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) n. 2303800717/2013-52, National Council for Scientific and Technological Development (CNPq) and Evandro Chagas Institute, Ministry of Health, Ananindeua, Brazil. BARROS BCV is a beneficiary of the Capes grant; Chagas EHN and Mascarenhas JDP are recipients of grants from CNPq. The authors would like to acknowledge the Amazon Support Foundation of the studies and research (FAPESPA) for funding (ICAAF166/2014). Thanks also to the Evandro Chagas Institute for financial and technicoscientific support for the execution of this work. Finally, thanks are due to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for awarding doctoral and pos doctoral' scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the invaluable technical support provided by Euzenir Menezes, Livia Casseb and Luana Soares. They are also grateful to the Laboratory of Geoprocessing (LABGEO), and the staff of the Library, both of the Evandro Chagas Institute. They also thank the health workers and community leaders of the cities surveyed. Comments on the manuscript of Dr. Ana Cecilia Ribeiro Cruz were acknowledged with gratitude. Finally, we thank CAPES for the granting of doctoral and postdoctoral scholarships. BARROS BCV is the beneficiary of the Capes concession; CHAGAS EHN and MASCARENHAS JDP are beneficiaries of grants from CNPq.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Araujo IT, 2007, J MED VIROL, V79, P995, DOI 10.1002/jmv.20918; Asano KM, 2016, ARCH VIROL, V161, P3225, DOI 10.1007/s00705-016-3010-9; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Barquez R, 2018, DESMODUS ROTUNDUS CO; Dulgheroff ACB, 2016, BRAZ J MICROBIOL, V47, P731, DOI 10.1016/j.bjm.2016.04.012; Brasil I, 2018, PRODES COORD TERR OB; Brower J.E., 1998, FIELD LAB METHODS GE; Zanella JRC, 2016, PESQUI AGROPECU BRAS, V51, P510, DOI 10.1590/S0100-204X2016000500011; Ciarlet M, 2000, ARCH VIROL, V145, P371, DOI 10.1007/s007050050029; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Colwell R, 2018, ESTIMATES BIODIVERSI; Cruz EC, 2013, PESQUI VET BRASIL, V33, P963, DOI 10.1590/S0100-736X2013000800002; Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Almeida CA, 2016, ACTA AMAZON, V46, P291, DOI 10.1590/1809-4392201505504; De Grazia S, 2007, EMERG INFECT DIS, V13, P1091, DOI 10.3201/eid1307.070239; Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x; Doan YH, 2013, J CLIN MICROBIOL, V51, P182, DOI 10.1128/JCM.02062-12; Doro R, 2015, EXPERT REV ANTI-INFE, V13, P1337, DOI 10.1586/14787210.2015.1089171; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P595, DOI 10.1128/CMR.00022-06; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fumian TM, 2018, LETT APPL MICROBIOL, V66, P313, DOI 10.1111/lam.12848; Gomes M, 2018, AREAS PROPICIAS ATAQ; Guerreiro AN, 2018, BRAZ J POULTRY SCI, V20, P161, DOI 10.1590/1806-9061-2017-0589; Hassine-Zaafrane M, 2014, J APPL MICROBIOL, V116, P1387, DOI 10.1111/jam.12469; Hayman DTS, 2013, ZOONOSES PUBLIC HLTH, V60, P2, DOI 10.1111/zph.12000; He B, 2013, J VIROL, V87, P12357, DOI 10.1128/JVI.02013-13; Honma S, 2007, J CLIN MICROBIOL, V45, P2641, DOI 10.1128/JCM.00736-07; INPE-Instituto Nacional de Pesquisas Espaciais, 2018, INP; Ito H, 2001, VIRUS RES, V75, P123, DOI 10.1016/S0168-1702(01)00234-9; Jing JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169208; Jing Z, 2018, TRANSBOUND EMERG DIS, V65, pe317, DOI 10.1111/tbed.12756; Kattoor JJ, 2017, VET QUART, V37, P252, DOI 10.1080/01652176.2017.1346849; Liu Y, 2012, J VIROL, V86, P9899, DOI 10.1128/JVI.00979-12; Lorenzetti E, 2011, VET MICROBIOL, V154, P191, DOI 10.1016/j.vetmic.2011.06.026; Luchs A, 2016, EINSTEIN-SAO PAULO, V14, P278, DOI 10.1590/S1679-45082016RB3582; Luchs A, 2012, J CLIN VIROL, V54, P89, DOI 10.1016/j.jcv.2012.01.025; Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271; Martella V, 2006, VIROLOGY, V344, P509, DOI 10.1016/j.virol.2005.08.029; Mascarenhas JDP, 2016, ARCH VIROL, V161, P2263, DOI 10.1007/s00705-016-2882-z; Mascarenhas JDP, 2007, VIRUS RES, V126, P149, DOI 10.1016/j.virusres.2007.02.010; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Medeiros TNS, 2014, PESQUI VET BRASIL, V34, P717, DOI 10.1590/S0100-736X2014000800001; Bezerra DAM, 2014, AVIAN PATHOL, V43, P238, DOI 10.1080/03079457.2014.913097; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Mijatovic-Rustempasic S, 2016, J VIROL METHODS, V236, P41, DOI 10.1016/j.jviromet.2016.07.007; Okadera K, 2013, INFECT GENET EVOL, V20, P54, DOI 10.1016/j.meegid.2013.07.029; Otte PH, 2015, VET MICROBIOL, V179, P168, DOI 10.1016/j.vetmic.2015.07.021; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Pauly M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0778-5; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Rotavirus Classification Working Group: RCWG, 2018, REG; Schatzmayr H, 2001, CAD SAUDE PUBLICA, V17, pS209, DOI [10.1590/s0102-311x2001000700031, DOI 10.1590/S0102-311X2001000700031]; Silva FDF, 2012, PESQUI VET BRASIL, V32, P237, DOI 10.1590/S0100-736X2012000300010; Soltan MA, 2016, J VIROL METHODS, V235, P99, DOI 10.1016/j.jviromet.2016.05.006; Teodoroff TA, 2005, J CLIN MICROBIOL, V43, P1377, DOI 10.1128/JCM.43.3.1377-1384.2005; Theuns S, 2014, VET MICROBIOL, V172, P23, DOI 10.1016/j.vetmic.2014.04.002; Tonietti PO, 2013, J CLIN MICROBIOL, V51, P2750, DOI 10.1128/JCM.01175-13; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; UNICEF, 2018, UNICEF BRAS IMPR UNI; Vlasova AN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030048; Waruhiu C, 2017, VIROL SIN, V32, P101, DOI 10.1007/s12250-016-3930-2; Xia LL, 2014, INFECT GENET EVOL, V28, P1, DOI 10.1016/j.meegid.2014.09.005; Yinda CK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3632-7; Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004; Zhou X, 2015, INFECT GENET EVOL, V33, P55, DOI 10.1016/j.meegid.2015.04.010	70	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209005	10.1371/journal.pone.0209005	http://dx.doi.org/10.1371/journal.pone.0209005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562373	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100030
J	Barroso, R; Garcia-Maurino, SM; Tomas-Gallardo, L; Andujar, E; Perez-Alegre, M; Santero, E; Canosa, I				Barroso, Rock; Garcia-Maurino, Sofia M.; Tomas-Gallardo, Laura; Andujar, Eloisa; Perez-Alegre, Monica; Santero, Eduardo; Canosa, Ines			The CbrB Regulon: Promoter dissection reveals novel insights into the CbrAB expression network in Pseudomonas putida	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; ENHANCER-BINDING PROTEINS; INTEGRATION HOST FACTOR; CRC GLOBAL REGULATOR; TRANSCRIPTIONAL ACTIVATOR; RESPONSE REGULATOR; AERUGINOSA; RNAS; PLASMID; SITES	CbrAB is a high ranked global regulatory system exclusive of the Pseudomonads that responds to carbon limiting conditions. It has become necessary to define the particular regulon of CbrB and discriminate it from the downstream cascades through other regulatory components. We have performed in vivo binding analysis of CbrB in P. putida and determined that it directly controls the expression of at least 61 genes; 20% involved in regulatory functions, including the previously identified CrcZ and CrcY small regulatory RNAs. The remaining are porines or transporters (20%), metabolic enzymes (16%), activities related to protein translation (5%) and orfs of uncharacterised function (38%). Amongst the later, we have selected the operon PP2810-13 to make an exhaustive analysis of the CbrB binding sequences, together with those of crcZ and crcY. We describe the implication of three independent non-palindromic subsites with a variable spacing in three different targets; CrcZ, CrcY and operon PP2810-13 in the CbrAB activation. CbrB is a quite peculiar sigma(N)-dependent activator since it is barely dependent on phosphorylation for transcriptional activation. With the depiction of the precise contacts of CbrB with the DNA, the analysis of the multimerisation status and its dependence on other factors such as RpoN o IHF, we propose a model of transcriptional activation.	[Barroso, Rock; Garcia-Maurino, Sofia M.; Santero, Eduardo; Canosa, Ines] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, CSIC, Junta Andalucia, Seville, Spain; [Tomas-Gallardo, Laura] UPO, CSIC, CABD, Prote & Biochem Unit,JA, Seville, Spain; [Andujar, Eloisa; Perez-Alegre, Monica] Univ Seville, Univ Pablo de Olavide, Genom Unit, Junta Andalucia,CABIMER,CSIC, Seville, Spain; [Garcia-Maurino, Sofia M.] Univ Seville, Ctr Invest Cient Isla Cartuja CicCartuja, IIQ, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ)	Canosa, I (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, CSIC, Junta Andalucia, Seville, Spain.	icanper@upo.es	García-Mauriño, Sofía M./V-9713-2019; Santero, Eduardo/K-6510-2014; Tomas-Gallardo, Laura/L-1084-2014; Canosa, Ines/L-1186-2014	García-Mauriño, Sofía M./0000-0002-9057-3421; Tomas-Gallardo, Laura/0000-0001-9661-0521; Canosa, Ines/0000-0002-5883-9728; Barroso Garcia, Rocio/0000-0003-0942-2499; Perez Alegre, Monica/0000-0002-6060-6990; Andujar, Eloisa/0000-0002-8434-5078	Spanish Ministry of Economy, Industry y Competitivity [BIO2014-57545-R]	Spanish Ministry of Economy, Industry y Competitivity	This work was supported by the Spanish Ministry of Economy, Industry y Competitivity, grant BIO2014-57545-R awarded to IC and ES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2011, J BACTERIOL, V193, P2784, DOI 10.1128/JB.00164-11; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; ALVAREZMORALES A, 1984, EMBO J, V3, P501, DOI 10.1002/j.1460-2075.1984.tb01837.x; Amador CI, 2010, ENVIRON MICROBIOL, V12, P1748, DOI 10.1111/j.1462-2920.2010.02254.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Camacho EM, 2005, MOL MICROBIOL, V57, P1700, DOI 10.1111/j.1365-2958.2005.04788.x; CANNON W, 1991, J MOL BIOL, V220, P915, DOI 10.1016/0022-2836(91)90363-B; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Filiatrault MJ, 2013, RNA BIOL, V10, P245, DOI 10.4161/rna.23019; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Garcia-Maurino SM, 2013, MOL MICROBIOL, V89, P189, DOI 10.1111/mmi.12270; Ghosh T, 2010, FEMS MICROBIOL REV, V34, P611, DOI 10.1111/j.1574-6976.2010.00239.x; Groisman EA, 2016, ANNU REV MICROBIOL, V70, P103, DOI 10.1146/annurev-micro-102215-095331; Hervas AB, 2010, MOL MICROBIOL, V78, P305, DOI 10.1111/j.1365-2958.2010.07329.x; Hervas AB, 2009, J BACTERIOL, V191, P6123, DOI 10.1128/JB.00744-09; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; MANDELBAUM RT, 1993, APPL ENVIRON MICROB, V59, P1695, DOI 10.1128/AEM.59.6.1695-1701.1993; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moreno R, 2008, J BACTERIOL, V190, P1539, DOI 10.1128/JB.01604-07; Moreno R, 2012, MOL MICROBIOL, V83, P24, DOI 10.1111/j.1365-2958.2011.07912.x; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Ozen AI, 2012, MICROB ECOL, V63, P239, DOI 10.1007/s00248-011-9914-8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quiroz-Rocha E, 2017, MICROBIOL-SGM, V163, P1105, DOI 10.1099/mic.0.000457; Quiroz-Rocha E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00980-5; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; SANTERO E, 1992, J MOL BIOL, V227, P602, DOI 10.1016/0022-2836(92)90211-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnleitner E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044637; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tucker NP, 2010, NUCLEIC ACIDS RES, V38, P1182, DOI 10.1093/nar/gkp1065; Valentini M, 2014, MICROBIOL-SGM, V160, P2243, DOI 10.1099/mic.0.078873-0; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x; Zhang XX, 2008, GENETICS, V178, P185, DOI 10.1534/genetics.107.081984	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209191	10.1371/journal.pone.0209191	http://dx.doi.org/10.1371/journal.pone.0209191			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557364	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000080
J	Leiser, OP; Blackburn, JK; Hadfield, TL; Kreuzer, HW; Wunschel, DS; Bruckner-Lea, CJ				Leiser, Owen P.; Blackburn, Jason K.; Hadfield, Ted L.; Kreuzer, Helen W.; Wunschel, David S.; Bruckner-Lea, Cindy J.			Laboratory strains of Bacillus anthracis exhibit pervasive alteration in expression of proteins related to sporulation under laboratory conditions relative to genetically related wild strains	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; GENOME EVOLUTION; SOJ PARA; SUBTILIS; CODY; IDENTIFICATION; DATABASE; SPO0A	The spore forming pathogen Bacillus anthracis is the etiologic agent of anthrax in humans and animals. It cycles through infected hosts as vegetative cells and is eventually introduced into the environment where it generates an endospore resistant to many harsh conditions. The endospores are subsequently taken up by another host to begin the next cycle. Out-breaks of anthrax occur regularly worldwide in wildlife and livestock, and the potential for human infection exists whenever humans encounter infected animals. It is also possible to encounter intentional releases of anthrax spores, as was the case in October 2001. Consequently, it is important to be able to rapidly establish the provenance of infectious strains of B. anthracis. Here, we compare protein expression in seven low-passage wild isolates and four laboratory strains of B. anthracis grown under identical conditions using LC-MS/MS proteomic analysis. Of the 1,023 total identified proteins, 96 had significant abundance differences between wild and laboratory strains. Of those, 28 proteins directly related to sporulation were upregulated in wild isolates, with expression driven by Spo0A, CodY, and AbrB/ScoC. In addition, we observed evidence of changes in cell division and fatty acid biosynthesis between the two classes of strains, despite being grown under identical experimental conditions. These results suggest wild B. anthracis cells are more highly tuned to sporulate than their laboratory cousins, and this difference should be exploited as a method to differentiate between laboratory and low passage wild strains isolated during an anthrax out-break. This knowledge should distinguish between intentional releases and exposure to strains in nature, providing a basis for the type of response by public health officials and investigators.	[Leiser, Owen P.; Kreuzer, Helen W.; Wunschel, David S.; Bruckner-Lea, Cindy J.] Pacific Northwest Natl Lab, Chem & Biol Signat Sci, Richland, WA 99354 USA; [Blackburn, Jason K.; Hadfield, Ted L.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Blackburn, Jason K.; Hadfield, Ted L.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Leiser, OP (corresponding author), Pacific Northwest Natl Lab, Chem & Biol Signat Sci, Richland, WA 99354 USA.	owen.leiser@pnnl.gov	Blackburn, Jason/AAV-9445-2020; Leiser, Owen/ABA-8089-2021	Blackburn, Jason/0000-0003-0928-4831; Leiser, Owen/0000-0003-1190-5596	U.S. Department of Energy [DE-AC06-76RLO]; internal laboratory directed research and development funding through PNNL	U.S. Department of Energy(United States Department of Energy (DOE)); internal laboratory directed research and development funding through PNNL	This work was supported by internal laboratory directed research and development funding through PNNL to OPL, HWK, CJBL, and DSW in collaboration with JKB and TLH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Josh Powell for his assistance with sample preparation, Jennifer Arce and Charlie Doll for assistance with LC-MS/MS operation, and Andy Lin for assistance with the custom R script. PNNL is a multiprogram national laboratory operated by Battelle Memorial Institute for the U.S. Department of Energy under Contract DE-AC06-76RLO.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Barak I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201979; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Belitsky BR, 2015, MOL MICROBIOL, V97, P698, DOI 10.1111/mmi.13056; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Blackburn JK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003931; Blackburn JK, 2014, ANN ASSOC AM GEOGR, V104, P939, DOI 10.1080/00045608.2014.914834; Blackburn JK, 2014, J WILDLIFE DIS, V50, P393, DOI 10.7589/2013-08-204; Blackburn JK, 2010, NATO SCI PEACE SEC A, P59, DOI 10.1007/978-90-481-9637-1_7; Brinsmade SR, 2017, CURR GENET, V63, P417, DOI 10.1007/s00294-016-0656-5; Brinsmade SR, 2011, J BACTERIOL, V193, P5637, DOI 10.1128/JB.05510-11; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Chateau A, 2013, J BACTERIOL, V195, P1204, DOI 10.1128/JB.02041-12; Chen HJ, 2010, FEMS MICROBIOL LETT, V304, P74, DOI [10.1111/j.1574-6968.2010.01888.x, 10.1111/j.1574-6968.2009.01888.x]; Cox J., 2014, MOL CELLULAR PROTEOM, VM113; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Driks A, 2009, MOL ASPECTS MED, V30, P368, DOI 10.1016/j.mam.2009.08.001; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Gopalani M, 2016, BIOCHEM BIOPH RES CO, V469, P672, DOI 10.1016/j.bbrc.2015.12.019; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Kaiser BLD, 2015, J MICROBIOL METH, V118, P18, DOI 10.1016/j.mimet.2015.08.008; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Koide A, 1999, J BACTERIOL, V181, P4114, DOI 10.1128/JB.181.13.4114-4117.1999; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; Leiser OP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142997; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Merkley ED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183478; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Paradzik T, 2013, NUCLEIC ACIDS RES, V41, P3659, DOI 10.1093/nar/gkt050; Pedrido ME, 2013, MOL MICROBIOL, V87, P348, DOI 10.1111/mmi.12102; Perez AR, 2006, J BACTERIOL, V188, P1159, DOI 10.1128/JB.188.3.1159-1164.2006; Perez CA, 1998, MICROBIOL-SGM, V144, P895, DOI 10.1099/00221287-144-4-895; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Saxer G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004872; Schujman GE, 1998, MOL MICROBIOL, V29, P1215, DOI 10.1046/j.1365-2958.1998.01004.x; Shafikhani SH, 2003, CURR MICROBIOL, V47, P327, DOI 10.1007/s00284-002-4013-1; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; STRAUCH MA, 1989, MOL MICROBIOL, V3, P1203, DOI 10.1111/j.1365-2958.1989.tb00270.x; STRAUCH MA, 1993, MOL MICROBIOL, V7, P337, DOI 10.1111/j.1365-2958.1993.tb01125.x; Tenaillon O, 2016, NATURE, V536, P165, DOI 10.1038/nature18959; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Vasudevan P, 2007, MOL MICROBIOL, V65, P1582, DOI 10.1111/j.1365-2958.2007.05896.x; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099	66	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209120	10.1371/journal.pone.0209120	http://dx.doi.org/10.1371/journal.pone.0209120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557394	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000071
J	Loya, TJ; O'Rourke, TW; Simke, WC; Kelley, JB; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Simke, William C.; Kelley, Joshua B.; Reines, Daniel			Nab3 ' s localization to a nuclear granule in response to nutrient deprivation is determined by its essential prion-like domain	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CELL-FREE FORMATION; TRANSCRIPTION TERMINATION; POLYMERASE-II; IMD2 TRANSCRIPTION; GENE-EXPRESSION; YEAST; NRD1; TRANSFORMATION; NUCLEOPORINS	Ribonucleoprotein (RNP) granules are higher order assemblies of RNA, RNA-binding proteins, and other proteins, that regulate the transcriptome and protect RNAs from environmental challenge. There is a diverse range of RNP granules, many cytoplasmic, which provide various levels of regulation of RNA metabolism. Here we present evidence that the yeast transcription termination factor, Nab3, is targeted to intranuclear granules in response to glucose starvation by Nab3's proline/glutamine-rich, prion-like domain (PrLD) which can assemble into amyloid in vitro. Localization to the granule is reversible and sensitive to the chemical probe 1,6 hexanediol suggesting condensation is driven by phase separation. Nab3's RNA recognition motif is also required for localization as seen for other PrLD-containing RNA-binding proteins that phase separate. Although the PrLD is necessary, it is not sufficient to localize to the granule. A heterologous PrLD that functionally replaces Nab3's essential PrLD, directed localization to the nuclear granule, however a chimeric Nab3 molecule with a heterologous PrLD that cannot restore termination function or viability, does not form granules. The Nab3 nuclear granule shows properties similar to well characterized cytoplasmic compartments formed by phase separation, suggesting that, as seen for other elements of the transcription machinery, termination factor condensation is functionally important.	[Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Simke, William C.; Kelley, Joshua B.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	Emory University; University of Maine System; University of Maine Orono	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dreines@emory.edu	Kelley, Joshua Brian/S-1031-2019; excellency, Your/R-2357-2019	Kelley, Joshua Brian/0000-0002-5700-1173; excellency, Your/0000-0003-0832-6243; Simke, William/0000-0003-3016-9969	National Institute of General Medical Sciences of the National Institutes of Health [R01GM120271, R15 [GM128026]]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120271, R15GM128026] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number [R01GM120271] to D. R. and R15 [GM128026] to J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arndt KM, 2015, ANNU REV BIOCHEM, V84, P381, DOI 10.1146/annurev-biochem-060614-034457; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Bresson S, 2017, MOL CELL, V65, P787, DOI 10.1016/j.molcel.2017.01.005; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Carneiro T, 2008, MOL BIOL CELL, V19, P1499, DOI 10.1091/mbc.E07-10-1015; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen SX, 1998, NUCLEIC ACIDS RES, V26, P4965, DOI 10.1093/nar/26.21.4965; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Conrad NK, 2000, GENETICS, V154, P557; Darby MM, 2012, MOL CELL BIOL, V32, P1762, DOI 10.1128/MCB.00050-12; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Guet D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9882; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hegeman JH, 1999, YEAST, V15, P1009, DOI 10.1002/(SICI)1097-0061(199907)15:10B<1009::AID-YEA396>3.3.CO;2-9; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kelley JB, 2015, CURR BIOL, V25, P275, DOI 10.1016/j.cub.2014.11.047; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kopcewicz KA, 2007, MOL CELL BIOL, V27, P2821, DOI 10.1128/MCB.02159-06; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; Lee S., 2013, INT J DISTRIB SENS N, V2013, P12, DOI DOI 10.1038/0NCSIS.2013.12; Lord CL, 2015, J CELL BIOL, V208, P729, DOI 10.1083/jcb.201412024; Loya TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186187; Loya TJ, 2013, J BIOL CHEM, V288, P34158, DOI 10.1074/jbc.M113.516765; Loya TJ, 2013, J BIOL CHEM, V288, P2111, DOI 10.1074/jbc.M112.430678; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; O'Rourke TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150865; O'Rourke TW, 2015, PRION, V9, P34, DOI 10.1080/19336896.2014.997618; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; QUAIN DE, 1987, J GEN MICROBIOL, V133, P1675; REINES D, 1985, J BIOL CHEM, V260, P4248; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shah KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158776; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Steinmetz EJ, 2006, MOL CELL BIOL, V26, P2688, DOI 10.1128/MCB.26.7.2688-2696.2006; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	63	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209195	10.1371/journal.pone.0209195	http://dx.doi.org/10.1371/journal.pone.0209195			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557374	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000081
J	Montanucci, L; Laayouni, H; Dobon, B; Keys, KL; Bertranpetit, J; Pereto, J				Montanucci, Ludovica; Laayouni, Hafid; Dobon, Begona; Keys, Kevin L.; Bertranpetit, Jaume; Pereto, Juli			Influence of pathway topology and functional class on the molecular evolution of human metabolic genes	PLOS ONE			English	Article							GLOBAL RECONSTRUCTION; NETWORK; ENZYMES; CONSTRAINT; SELECTION; PATTERNS	Metabolic networks comprise thousands of enzymatic reactions functioning in a controlled manner and have been shaped by natural selection. Thanks to the genome data, the footprints of adaptive (positive) selection are detectable, and the strength of purifying selection can be measured. This has made possible to know where, in the metabolic network, adaptive selection has acted and where purifying selection is more or less strong and efficient. We have carried out a comprehensive molecular evolutionary study of all the genes involved in the human metabolism. We investigated the type and strength of the selective pressures that acted on the enzyme-coding genes belonging to metabolic pathways during the divergence of primates and rodents. Then, we related those selective pressures to the functional and topological characteristics of the pathways. We have used DNA sequences of all enzymes (956) of the metabolic pathways comprised in the HumanCyc database, using genome data for humans and five other mammalian species. We have found that the evolution of metabolic genes is primarily constrained by the layer of the metabolism in which the genes participate: while genes encoding enzymes of the inner core of metabolism are much conserved, those encoding enzymes participating in the outer layer, mediating the interaction with the environment, are evolutionarily less constrained and more plastic, having experienced faster functional evolution. Genes that have been targeted by adaptive selection are endowed by higher out-degree centralities than non-adaptive genes, while genes with high in-degree centralities are under stronger purifying selection. When the position along the pathway is considered, a funnel-like distribution of the strength of the purifying selection is found. Genes at bottom positions are highly preserved by purifying selection, whereas genes at top positions, catalyzing the first steps, are open to evolutionary changes. These results show how functional and topological characteristics of metabolic pathways contribute to shape the patterns of evolutionary pressures driven by natural selection and how pathway network structure matters in the evolutionary process that shapes the evolution of the system.	[Montanucci, Ludovica; Laayouni, Hafid; Dobon, Begona; Keys, Kevin L.; Bertranpetit, Jaume] Univ Pompeu Fabra, PRBB, CSIC, IBE Evolutionary Biol Inst, Barcelona, Catalonia, Spain; [Laayouni, Hafid] ESCI UPF, Bioinformat Studies, Barcelona, Catalonia, Spain; [Keys, Kevin L.] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pereto, Juli] Univ Valencia, Inst Syst Biol, Dept Biochem & Mol Biol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Valencia	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, PRBB, CSIC, IBE Evolutionary Biol Inst, Barcelona, Catalonia, Spain.	jaume.bertranpetit@upf.edu	Peretó, Juli/G-5969-2015; Bertranpetit, Jaume/F-8550-2012; Miquel-Descalzo, Julio/C-8848-2009; Laayouni, Hafid/AAA-9254-2019; Keys, Kevin Lawrence/I-8292-2019	Peretó, Juli/0000-0002-5756-1517; Bertranpetit, Jaume/0000-0003-0100-0590; Miquel-Descalzo, Julio/0000-0001-5118-7299; Laayouni, Hafid/0000-0003-1297-5078; Keys, Kevin Lawrence/0000-0003-4886-6666; Dobon, Begona/0000-0002-5608-6021; MONTANUCCI, LUDOVICA/0000-0003-2375-7359	Agencia Estatal de Investigacion (Spain) [BFU2016-77961-P, BFU2012-39816-C02-0]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2014 SGR 866]; Generalitat Valenciana [PROMETEOII/2014/065]; FPU grant from Ministerio de Educacion, Cultura y Deporte (Spain) [FPU13/06813]; Fulbright Student Research grant; United States National Science Foundation Graduate Student Research Fellowship [DGE-0707424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135156] Funding Source: NIH RePORTER	Agencia Estatal de Investigacion (Spain)(Spanish Government); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); FPU grant from Ministerio de Educacion, Cultura y Deporte (Spain)(German Research Foundation (DFG)); Fulbright Student Research grant; United States National Science Foundation Graduate Student Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by BFU2016-77961-P and BFU2012-39816-C02-0 (AEI/FEDER, UE) awarded by the Agencia Estatal de Investigacion (Spain); and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2014 SGR 866) Generalitat Valenciana (grant reference: PROMETEOII/2014/065). BD is supported by FPU grant (FPU13/06813) from the Ministerio de Educacion, Cultura y Deporte (Spain). KLK was supported by a Fulbright Student Research grant to Spain and by the United States National Science Foundation Graduate Student Research Fellowship under Grant Number DGE-0707424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Caspi R, 2013, FEMS MICROBIOL LETT, V345, P85, DOI 10.1111/1574-6968.12194; Diaz-Mejia JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r26; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Grassi L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-301; Greenberg AJ, 2008, MOL BIOL EVOL, V25, P2537, DOI 10.1093/molbev/msn205; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hudson CM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-89; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Invergo BM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-52; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Lazcano A, 1995, Adv Space Res, V15, P345, DOI 10.1016/S0273-1177(99)80106-9; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Light S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-15; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Montanez R, 2010, BIOESSAYS, V32, P246, DOI 10.1002/bies.200900145; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Pereto J, 2011, ORIGINS EVOLUTION LI; Pereto J, 2012, CHEM SOC REV, V41, P5394, DOI 10.1039/c2cs35054h; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Romero P, 2005, GENOME BIOL, V6; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208782	10.1371/journaI.pone.0208782	http://dx.doi.org/10.1371/journaI.pone.0208782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550546				2022-12-26	WOS:000453248000025
J	Zhao, ZZ; Partridge, V; Sousares, M; Shelton, SD; Holland, CL; Pertsemlidis, A; Du, LQ				Zhao, Zhenze; Partridge, Veronica; Sousares, Michaels; Shelton, Spencer D.; Holland, Cory L.; Pertsemlidis, Alexander; Du, Liqin			microRNA-2110 functions as an oncosuppressor in neuroblastoma by directly targeting Tsukushi	PLOS ONE			English	Article							CELL-DIFFERENTIATION; NEURONAL DIFFERENTIATION; EXPRESSION; APOPTOSIS; CANCER; ACID; PROLIFERATION; CYCLE; IDENTIFICATION; PROTEOGLYCANS	microRNA-2110 (miR-2110) was previously identified as inducing neurite outgrowth in a neuroblastoma cell lines BE(2)-C, suggesting its differentiation-inducing and oncosuppressive function in neuroblastoma. In this study, we demonstrated that synthetic miR-2110 mimic had a generic effect on reducing cell survival in neuroblastoma cell lines with distinct genetic backgrounds, although the induction of cell differentiation traits varied between cell lines. In investigating the mechanisms underlying such functions of miR-2110, we identified that among its predicted target genes down-regulated by miR-2110, knockdown of Tsukushi (TSKU) expression showed the most potent effect in inducing cell differentiation and reducing cell survival, suggesting that TSKU protein plays a key role in mediating the functions of miR-2110. In investigating the clinical relevance of miR-2110 and TSKU expression in neuroblastoma patients, we found that low tumor miR-2110 levels were significantly correlated with high tumor TSKU mRNA levels, and that both low miR-2110 and high TSKU mRNA levels were significantly correlated with poor patient survival. These findings altogether support the oncosuppressive function of miR-2110 and suggest an important role for miR-2110 and its target TSKU in neuroblastoma tumorigenesis and in determining patient prognosis.	[Zhao, Zhenze; Partridge, Veronica; Sousares, Michaels; Shelton, Spencer D.; Holland, Cory L.; Du, Liqin] Texas State Univ, Dept Chem & Biochem, San Marcos, TX 78666 USA; [Pertsemlidis, Alexander] UT Hlth San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Pertsemlidis, Alexander] Univ Texas Hlth, Dept Cell Syst & Anat, San Antonio, TX USA; [Pertsemlidis, Alexander] Univ Texas Hlth, Dept Pediat, San Antonio, TX USA	Texas State University System; Texas State University San Marcos; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Du, LQ (corresponding author), Texas State Univ, Dept Chem & Biochem, San Marcos, TX 78666 USA.	liqindu6@txstate.edu	Du, Liqin/AAW-5880-2020; Zhao, Zhenze/AAW-5870-2020; Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	PRMRP Discovery Award [PR121532]; Department of Defense; Texas State University; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	PRMRP Discovery Award; Department of Defense(United States Department of Defense); Texas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the PRMRP Discovery Award (grant number PR121532) from the Department of Defense (to L. Du) and the Startup funds from Texas State University (to L. Du). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the PRMRP Discovery Award (grant number PR121532) from the Department of Defense (to L. Du) and the Startup funds from Texas State University (to L. Du). The authors thank Dr. Tania Betancourt (Department of Chemistry and Biochemistry, Texas State University) for critical reading of the manuscript and providing constructive suggestions.	Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Charpentier AH, 2000, CANCER RES, V60, P5977; Costa D, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-59; Ferracin M, 2015, ONCOTARGET, V6, P14545, DOI 10.18632/oncotarget.3859; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Henke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042516; Hossain M, 2013, DEV BIOL, V374, P58, DOI 10.1016/j.ydbio.2012.11.029; Huang JM, 2010, MOL CANCER THER, V9, P3289, DOI 10.1158/1535-7163.MCT-10-0562; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Li ZH, 2018, ONCOGENE, V37, P2714, DOI 10.1038/s41388-018-0133-3; Lovat PE, 1997, JNCI-J NATL CANCER I, V89, P446, DOI 10.1093/jnci/89.6.446; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Mohlin SA, 2011, SEMIN CANCER BIOL, V21, P276, DOI 10.1016/j.semcancer.2011.09.002; Naito Zenya, 2005, Journal of Nippon Medical School, V72, P137, DOI 10.1272/jnms.72.137; Niimori D, 2014, J CELL COMMUN SIGNAL, V8, P173, DOI 10.1007/s12079-014-0241-y; Niimori D, 2012, DEV BIOL, V372, P81, DOI 10.1016/j.ydbio.2012.08.030; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pieraccioli M, 2018, P NATL ACAD SCI USA, V115, P7356, DOI 10.1073/pnas.1801435115; PREIS PN, 1988, CANCER RES, V48, P6530; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Samaraweera L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-309; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shimizu-Hirota R, 2004, CIRC RES, V94, P1067, DOI 10.1161/01.RES.0000126049.79800.CA; Singh A, 2011, CANCER-AM CANCER SOC, V117, P5189, DOI 10.1002/cncr.26145; Su Z, 2014, GENOME BIOL, V15, P3273; Tanno B, 2005, CELL DEATH DIFFER, V12, P213, DOI 10.1038/sj.cdd.4401546; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zhao ZZ, 2016, ONCOTARGET, V7, P79358, DOI 10.18632/oncotarget.12676; Zhao ZZ, 2015, RNA BIOL, V12, P538, DOI 10.1080/15476286.2015.1023495; Zhao ZZ, 2014, ONCOTARGET, V5, P2499, DOI 10.18632/oncotarget.1703; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	42	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208777	10.1371/journal.pone.0208777	http://dx.doi.org/10.1371/journal.pone.0208777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550571	Green Submitted, Green Published, gold			2022-12-26	WOS:000453248000024
J	Armstrong, AE; Gadd, S; Huff, V; Gerhard, DS; Dome, JS; Perlman, EJ				Armstrong, Amy E.; Gadd, Samantha; Huff, Vicki; Gerhard, Daniela S.; Dome, Jeffrey S.; Perlman, Elizabeth J.			A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; EMBRYONIC STEM-CELLS; ZINC-FINGER GENES; ENDOGENOUS RETROVIRUSES; KIDNEY DEVELOPMENT; REPRESSOR DOMAIN; DNA METHYLATION; TRANSCRIPTION; BINDING; METHYLTRANSFERASE	This study explores the genomic alterations that contribute to the formation of a unique subset of low-risk, epithelial differentiated, favorable histology Wilms tumors (WT), tumors that have been characterized by their expression of post-induction renal developmental genes (Subset 1 WT). We demonstrate copy neutral loss of heterozygosity involving 19q13.32-q13.43, unaccompanied by evidence for imprinting by DNA methylation. We further identified loss-of-function somatic mutations in TRIM28 (also known as KAP1), located at 19q13, in 8/9 Subset 1 tumors analyzed. An additional germline TRIM28 mutation was identified in one patient. Retrospective evaluation of previously analyzed WT outside of Subset 1 identified an additional tumor with anaplasia and both TRIM28 and TP53 mutations. A major function of TRIM28 is the repression of endogenous retroviruses early in development. We depleted TRIM28 in HEK293 cells, which resulted in increased expression of endogenous retroviruses, a finding also demonstrated in TRIM28-mutant WT. TRIM28 has been shown by others to be active during early renal development, and to interact with WTX, another gene recurrently mutated in WT. Our findings suggest that inactivation of TRIM28 early in renal development contributes to the formation of this unique subset of FHWTs, although the precise manner in which TRIM28 impacts both normal renal development and oncogenesis remains elusive.	[Armstrong, Amy E.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Transplantat, Feinberg Sch Med, Chicago, IL 60611 USA; [Gadd, Samantha; Perlman, Elizabeth J.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol & Lab Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Gadd, Samantha; Perlman, Elizabeth J.] Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Huff, Vicki] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Dome, Jeffrey S.] Childrens Natl Med Ctr, Div Pediat Hematol Oncol, Washington, DC 20010 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Children's National Health System	Perlman, EJ (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol & Lab Med, Feinberg Sch Med, Chicago, IL 60611 USA.; Perlman, EJ (corresponding author), Robert H Lurie Canc Ctr, Chicago, IL 60611 USA.	eperlman@luriechildrens.org	Dome, Jeffrey/AAH-7825-2019	Perlman, Elizabeth/0000-0001-6853-6221; Armstrong, Amy/0000-0002-7784-0476; Gadd, Samantha/0000-0001-5033-8585; Dome, Jeffrey/0000-0002-9037-369X	TARGET National Institutes of Health (NIH) [U10 CA98543, HHSN261200800001E]; NIH [U10CA180886, U01CA88131, U10CA42326, U10CA98543, U24 CA114766]; NATIONAL CANCER INSTITUTE [U10CA180886] Funding Source: NIH RePORTER	TARGET National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by TARGET National Institutes of Health (NIH) U10 CA98543 contract HHSN261200800001E (EJP); NIH U10CA42326 (EJP); NIH U10CA98543 (JSD, EJP); NIH U24 CA114766 (EJP, JSD); NIH U10CA180886 (JSD, EJP); U01CA88131 (EJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brattas PL, 2017, CELL REP, V18, P1, DOI 10.1016/j.celrep.2016.12.010; Bunch H, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0040-x; Cammas F, 2000, DEVELOPMENT, V127, P2955; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Czerwinska P, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0374-4; Damineni S, 2017, TUMOUR BIOL J INT SO, V9; Dihazi GH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13951; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Ellis J, 2007, CELL, V131, P13, DOI 10.1016/j.cell.2007.09.029; Fasching L, 2015, CELL REP, V10, P20, DOI 10.1016/j.celrep.2014.12.004; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gadd S, 2017, NAT GENET, V49, P1487, DOI 10.1038/ng.3940; Gadd S, 2012, NEOPLASIA, V14, P742, DOI 10.1593/neo.12714; Gooskens SL, 2015, ONCOTARGET, V6, P15828, DOI 10.18632/oncotarget.4682; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Halliday BJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007399; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Hohenstein P, 2015, GENE DEV, V29, P467, DOI 10.1101/gad.256396.114; Huang CC, 2009, CLIN CANCER RES, V15, P1770, DOI 10.1158/1078-0432.CCR-08-1030; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kim WJ, 2015, J BIOL CHEM, V290, P14381, DOI 10.1074/jbc.M114.631945; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Lukic S, 2014, CELL DEATH DIFFER, V21, P381, DOI 10.1038/cdd.2013.150; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ooms AHAG, 2016, CLIN CANCER RES, V22, P5582, DOI 10.1158/1078-0432.CCR-16-0985; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pavlaki I, 2018, EMBO J, V37, DOI 10.15252/embj.201798219; Perlman EJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10013; Qi ZX, 2016, J NEURO-ONCOL, V126, P19, DOI 10.1007/s11060-015-1897-8; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rakheja D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5802; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2013, DEVELOPMENT, V140, P519, DOI 10.1242/dev.087585; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Schmidt-Ott KM, 2007, DEVELOPMENT, V134, P3177, DOI 10.1242/dev.006544; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tao Y, 2018, STEM CELL REP, V10, P243, DOI 10.1016/j.stemcr.2017.11.020; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torrezan GT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5039; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Walz AL, 2015, CANCER CELL, V27, P286, DOI 10.1016/j.ccell.2015.01.003; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YQ, 2016, J GEN VIROL, V97, P1, DOI 10.1099/jgv.0.000320; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yu C, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0025-5	67	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208936	10.1371/journal.pone.0208936	http://dx.doi.org/10.1371/journal.pone.0208936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543698	gold, Green Submitted, Green Published			2022-12-26	WOS:000453247500053
J	Cheng, HR; Hu, P; Wen, WH; Liu, L				Cheng, Huirong; Hu, Pei; Wen, Weihua; Liu, Ling			Relative miRNA and mRNA expression involved in arsenic methylation	PLOS ONE			English	Article							DNA-DAMAGE; CANCER; POLYMORPHISMS; CAPACITY; AS3MT; GENE	Three arsenic species in urine are measured using an atomic absorption spectrophotometer. RT-PCR is performed to detect the expression levels of AS3MT, 3 miRNAs, and 17 relative mRNAs in 43 workers producing arsenic trioxide, 36 workers who stopped exposure to arsenic for 85 days, and 24 individuals as the control group. The concentrations of urinary arsenic are very high in workers. A negative correlation between AS3MT and MiR-548c-3p is found. There exist significant changes for most selected miRNAs and mRNAs in workers. There are no significant differences between workers who stopped exposure to arsenic and the control group for most miRNAs and mRNAs, but the MiR-548c-3p levels show significant changes. Similar positive correlations between the expression of AS3MT and all selected mRNAs are found. Negative correlations between the expression of MiR-548c-3p and many relative mRNAs are found as well. AS3MT and MiR-548c-3p may regulate arsenic methylation jointly, which when involved in a group of relative mRNAs may play roles in arsenic metabolism and epigenetic changes caused by this metabolism.	[Cheng, Huirong; Hu, Pei; Wen, Weihua] Yunnan Prov Ctr Dis Control & Prevent, Dept Occupat Hlth, Kunming, Yunnan, Peoples R China; [Liu, Ling] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China	Kunming Medical University	Wen, WH (corresponding author), Yunnan Prov Ctr Dis Control & Prevent, Dept Occupat Hlth, Kunming, Yunnan, Peoples R China.; Liu, L (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	Dongsijiehua@sina.com; 54319937@qq.com		Wen, Weihua/0000-0002-0163-0691				Antonelli R, 2014, ENVIRON RES, V132, P156, DOI 10.1016/j.envres.2014.03.012; Chitkara D, 2015, ADV DRUG DELIVER REV, V81, P34, DOI 10.1016/j.addr.2014.09.006; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Fujihara J, 2010, TOXICOL APPL PHARM, V243, P292, DOI 10.1016/j.taap.2009.11.020; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2011, BREAST, V20, pS63, DOI 10.1016/S0960-9776(11)70297-1; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Meakin Cassandra J., 2017, Current Opinion in Toxicology, V6, P1, DOI 10.1016/j.cotox.2017.06.003; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Ren XF, 2015, TOXICOL APPL PHARM, V283, P198, DOI 10.1016/j.taap.2015.01.014; Shi YF, 2015, BIOMED PHARMACOTHER, V75, P111, DOI 10.1016/j.biopha.2015.07.027; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Sonkoly E, 2011, MUTAT RES-FUND MOL M, V717, P46, DOI 10.1016/j.mrfmmm.2011.02.002; Sturchio E, 2014, SCI TOTAL ENVIRON, V472, P672, DOI 10.1016/j.scitotenv.2013.11.092; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Valenzuela-Miranda D, 2015, GENE, V555, P231, DOI 10.1016/j.gene.2014.11.008; Wen JH, 2012, ENVIRON TOXICOL PHAR, V34, P624, DOI 10.1016/j.etap.2012.07.003; Wen WH, 2011, TOXICOL APPL PHARM, V254, P41, DOI 10.1016/j.taap.2011.04.013; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yamauchi H, 2004, TOXICOL APPL PHARM, V198, P291, DOI 10.1016/j.taap.2003.10.021; Yang TY, 2014, ENVIRON RES, V128, P57, DOI 10.1016/j.envres.2013.10.006; Yu RC, 2000, CANCER EPIDEM BIOMAR, V9, P1259; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	25	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209014	10.1371/journal.pone.0209014	http://dx.doi.org/10.1371/journal.pone.0209014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543710	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500062
J	Klein, W; Rutz, C; Eckhard, J; Provinciael, B; Specker, E; Neuenschwander, M; Kleinau, G; Scheerer, P; von Kries, JP; Nazare, M; Vermeire, K; Schulein, R				Klein, Wolfgang; Rutz, Claudia; Eckhard, Jamina; Provinciael, Becky; Specker, Edgar; Neuenschwander, Martin; Kleinau, Gunnar; Scheerer, Patrick; von Kries, Jens-Peter; Nazare, Marc; Vermeire, Kurt; Schuelein, Ralf			Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway	PLOS ONE			English	Article							ENDOTHELIN B RECEPTOR; PROTEIN-TRANSLOCATION; SIGNAL-PEPTIDE; DRUG DISCOVERY; SUBSTRATE; APRATOXIN; CHANNEL	The SRP-Sec61 targeting/translocation pathway of eukaryotic cells targets nascent protein chains to the membrane of the endoplasmic reticulum. Using this machinery, secretory proteins are translocated across this membrane whereas membrane proteins are integrated into the lipid bilayer. One of the key players of the pathway is the protein-conducting Sec61 (translocon) complex of the endoplasmic reticulum. The Sec61 complex has no enzymatic activity, is expressed only intracellularly and is difficult to purify and to reconstitute. Screening for small molecule inhibitors impairing its functions is thus notoriously difficult. Such inhibitors may not only be valuable tools for cell biology, they may also represent novel anti-tumor drugs. Here we have developed a two-step, sequential screening assay for inhibitors of the whole SRP-Sec61 targeting/translocation pathway which might include molecules affecting Sec61 complex functions. The resulting hit compounds were analyzed using a whole cell biosynthesis assay and a cell free transcription/translation/translocation assay. Using this methodology, we identified novel compounds inhibiting this pathway. Following structure-based back screening, one of these substances was analyzed in more detail and we could show that it indeed impairs translocation at the level of the Sec61 complex. A slightly modified methodology may be used in the future to screen for substances affecting SecYEG, the bacterial ortholog of the Sec61 complex in order to derive novel antibiotic drugs.	[Klein, Wolfgang; Rutz, Claudia; Eckhard, Jamina; Specker, Edgar; Neuenschwander, Martin; von Kries, Jens-Peter; Nazare, Marc; Schuelein, Ralf] Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany; [Provinciael, Becky; Vermeire, Kurt] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst, Leuven, Belgium; [Kleinau, Gunnar; Scheerer, Patrick] Charite Univ Med Berlin, Charite Centrum Grundlagenmed CC2, Inst Med Phys & Biophys, Grp Prot Xray Crystallog & Signal Transduct, Campus Charite Mitte, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); KU Leuven; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulein, R (corresponding author), Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany.	schuelein@fmp-berlin.de	Nazare, Marc/AAD-6082-2022; Kleinau, Gunnar/GPX-6330-2022; Nazare, Marc/X-4996-2018; Vermeire, Kurt/P-9992-2017	Nazare, Marc/0000-0002-1602-2330; Nazare, Marc/0000-0002-1602-2330; Scheerer, Patrick/0000-0001-5028-2075; Vermeire, Kurt/0000-0003-1123-1907	Deutsche Forschungsgemeinschaft (DFG); Catholic University of Leuven (KU Leuven); DFG [SFB740, Schu-1116/2-1]; KU Leuven [PF/10/018]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Catholic University of Leuven (KU Leuven)(KU Leuven); DFG(German Research Foundation (DFG)); KU Leuven(KU Leuven)	No commercial sponsor contributed to our studies. No salary was awarded to any of the authors by the funding institutions. This work was supported by: Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de), Catholic University of Leuven (KU Leuven) (www.kuleuven.be); KV: grant PF/10/018 (KU Leuven), PS+GK: grant SFB740; project B6 (DFG), RS: grant Schu-1116/2-1 (DFG). We state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Alken M, 2009, MOL PHARMACOL, V75, P801, DOI 10.1124/mol.108.051581; Baron L, 2016, J EXP MED, V213, P2885, DOI 10.1084/jem.20160662; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Dudek J, 2015, J MOL BIOL, V427, P1159, DOI 10.1016/j.jmb.2014.06.011; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061; Hommel U, 1996, FEBS LETT, V379, P69, DOI 10.1016/0014-5793(95)01453-5; Junne T, 2015, J CELL SCI, V128, P1217, DOI 10.1242/jcs.165746; Kalies KU, 2015, TRAFFIC, V16, P1027, DOI 10.1111/tra.12308; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Klein W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120886; Kobayashi K, 2018, SCIENCE, V360, P323, DOI 10.1126/science.aar7924; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Liu YX, 2009, MOL PHARMACOL, V76, P91, DOI 10.1124/mol.109.056085; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Maifeld SV, 2011, CHEM BIOL, V18, P1082, DOI 10.1016/j.chembiol.2011.06.015; McKenna M, 2016, J CELL SCI, V129, P1404, DOI 10.1242/jcs.182352; Paatero AO, 2016, CELL CHEM BIOL, V23, P561, DOI 10.1016/j.chembiol.2016.04.008; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Van Puyenbroeck V, 2017, MOL CELL PROTEOMICS, V16, P157, DOI 10.1074/mcp.M116.061051; Vermeire K, 2015, ANAL BIOCHEM, V484, P102, DOI 10.1016/j.ab.2015.05.019; Vermeire K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002011; Voorhees RM, 2016, CURR OPIN CELL BIOL, V41, P91, DOI 10.1016/j.ceb.2016.04.009; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Westendorf C, 2011, J BIOL CHEM, V286, P35588, DOI 10.1074/jbc.M111.239244; Zampatis DE, 2012, FEBS LETT, V586, P2351, DOI 10.1016/j.febslet.2012.05.042; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208641	10.1371/journal.pone.0208641	http://dx.doi.org/10.1371/journal.pone.0208641			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543669	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000453247500031
J	Zhang, HY; Deng, T; Ge, SH; Liu, Y; Bai, M; Zhu, KG; Fan, Q; Li, JL; Ning, T; Tian, F; Li, HL; Sun, W; Ying, GG; Ba, Y				Zhang, Haiyang; Deng, Ting; Ge, Shaohua; Liu, Ying; Bai, Ming; Zhu, Kegan; Fan, Qian; Li, Jialu; Ning, Tao; Tian, Fei; Li, Hongli; Sun, Wu; Ying, Guoguang; Ba, Yi			Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7	ONCOGENE			English	Article							CELL-PROLIFERATION; CIRCULAR RNAS; BETA-CATENIN; CANCER; STABILIZATION; BIOGENESIS; DELIVERY; PROTEIN	Hepatocellular carcinoma (HCC), the major form of liver cancer, has shown increasing incidence and poor prognosis. Adipose tissue is known to function in energy storage and metabolism regulation by the secretion of adipokines. Circular RNAs (circRNAs), a novel type of noncoding RNA, have recently been recognized as key factors in tumor development, but the role of exosome circRNAs derived from adipose tissues has not been defined yet. Here, adipose-secreted circRNAs were found to regulate deubiquitination in HCC, thus facilitating cell growth. It was observed that exosome circ-deubiquitination (circ-DB) is upregulated in HCC patients with higher body fat ratios. Moreover, in vitro and in vivo studies showed that exocirc-DB promotes HCC growth and reduces DNA damage via the suppression of miR-34a and the activation of deubiquitination-related USP7. Finally, the results showed that the effects of adipose exosomes on HCC cells can be reversed by knockdown of circ-DB. These results indicate that exosome circRNAs secreted from adipocytes promote tumor growth and reduce DNA damage by suppressing miR-34a and activating the USP7/Cyclin A2 signaling pathway.	[Zhang, Haiyang; Deng, Ting; Ge, Shaohua; Liu, Ying; Bai, Ming; Zhu, Kegan; Fan, Qian; Ning, Tao; Tian, Fei; Li, Hongli; Sun, Wu; Ying, Guoguang; Ba, Yi] Tianjin Med Univ, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp,Tianjins Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Li, Jialu] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Shanghai Inst Digest Dis, Sch Med,Renji Hosp, Shanghai 200001, Peoples R China; [Li, Jialu] Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Minist Hlth, Sch Med,Renji Hosp, Shanghai 200001, Peoples R China	Tianjin Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ying, GG; Ba, Y (corresponding author), Tianjin Med Univ, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp,Tianjins Clin Res Ctr Canc, Tianjin 300060, Peoples R China.	yingguoguang163@163.com; bayi@tjmuch.com	li, jia/GVT-7587-2022	ying, guoguang/0000-0002-9563-991X	National Natural Science Foundation of China [81772629, 81772843, 81702431, 81702275, 81702437, 81602158, 81602156]; Individualized Medical Platform of National Clinical Research Center for Cancer [13ZCZCSY20300]; Demonstrative research platform of clinical evaluation technology for new anticancer drugs [2018ZX09206004]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-017, 2017-I2M-BR-13]; Nature Science Foundation of Tianjin City [16PTSYJC00170]; Science& Technology Development fund of Tianjin Education Commission for Higher Education [2018KJ046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Individualized Medical Platform of National Clinical Research Center for Cancer; Demonstrative research platform of clinical evaluation technology for new anticancer drugs; CAMS Innovation Fund for Medical Sciences (CIFMS); Nature Science Foundation of Tianjin City; Science& Technology Development fund of Tianjin Education Commission for Higher Education	This work was supported by National Natural Science Foundation of China (Nos. 81772629, 81772843, 81702431, 81702275, 81702437, 81602158, and 81602156), Individualized Medical Platform of National Clinical Research Center for Cancer (13ZCZCSY20300) and Demonstrative research platform of clinical evaluation technology for new anticancer drugs (No. 2018ZX09206004). This study was also supported by CAMS Innovation Fund for Medical Sciences (CIFMS, 2016-I2M-1-017 and 2017-I2M-B&R-13), Nature Science Foundation of Tianjin City (16PTSYJC00170) and the Science& Technology Development fund of Tianjin Education Commission for Higher Education (2018KJ046). The funders had no role in study design, collection, analysis, or interpretation of the data, in the writing of the report, or in the decision to submit this article for publication.	Aspichueta P, 2018, GUT, V67, P1376, DOI 10.1136/gutjnl-2018-316047; Axley P, 2018, J CLIN TRANSL HEPATO, V6, P79, DOI 10.14218/JCTH.2017.00067; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Carra G, 2017, ONCOTARGET, V8, P35508, DOI 10.18632/oncotarget.16348; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Cooks T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03224-w; Coombs N, 2011, INT J MED MICROBIOL, V301, P213, DOI 10.1016/j.ijmm.2010.09.004; Deng XJ, 2018, EXP THER MED, V15, P3705, DOI 10.3892/etm.2018.5920; Dong L, 2018, ONCOGENE, V37, P2702, DOI 10.1038/s41388-018-0137-z; Farooqi AA, 2018, BIOTECHNOL ADV, V36, P328, DOI 10.1016/j.biotechadv.2017.12.010; Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2; Gan L, 2018, BBA-REV CANCER, V1869, P97, DOI 10.1016/j.bbcan.2017.12.006; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Hagstrom H, 2018, GUT, V67, P1536, DOI 10.1136/gutjnl-2016-313622; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Ji Q, 2018, ONCOL LETT, V15, P23, DOI 10.3892/ol.2017.7348; Li SS, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0579-3; Lv T, 2018, BIOCHEM CELL BIOL, V96, P663, DOI 10.1139/bcb-2018-0031; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Morra F, 2017, ONCOTARGET, V8, P31815, DOI 10.18632/oncotarget.16463; Novellasdemunt L, 2017, CELL REP, V21, P612, DOI 10.1016/j.celrep.2017.09.072; Palmer C, 2010, GUT, V59, P397, DOI 10.1136/gut.2008.165316; Petruzziello Arnolfo, 2018, Open Virol J, V12, P26, DOI 10.2174/1874357901812010026; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sun L, 2016, CYTOTHERAPY, V18, P413, DOI 10.1016/j.jcyt.2015.11.018; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Wei Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21060777; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Yin Y, 2014, CELL RES, V24, P1164, DOI 10.1038/cr.2014.121; Yu B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34562; Zhang C, 2016, INT J BIOCHEM CELL B, V79, P209, DOI 10.1016/j.biocel.2016.08.025; Zhang HY, 2016, CANCER LETT, V375, P331, DOI 10.1016/j.canlet.2016.03.026; Ziogas IA, 2017, WORLD J GASTRO SURG, V9, P233, DOI 10.4240/wjgs.v9.i12.233	39	206	219	11	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2844	2859		10.1038/s41388-018-0619-z	http://dx.doi.org/10.1038/s41388-018-0619-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30546088	Green Published, hybrid			2022-12-26	WOS:000464121600013
J	Nguyen, HT; Nguyen, TT; Pham, HTT; Nguyen, QTN; Tran, MT; Nguyen, AH; Phan, TN; Bui, HTV; Dao, HTT; Nguyen, ATV				Huong Thi Nguyen; Tham Thi Nguyen; Huong Thi Thu Pham; Que Thi Ngoc Nguyen; My Thi Tran; Anh Hoa Nguyen; Tuan Nghia Phan; Ha Thi Viet Bui; Hien Thi Thanh Dao; Anh Thi Van Nguyen			Fate of carotenoid-producing Bacillus aquimaris SH6 colour spores in shrimp gut and their dose-dependent probiotic activities	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; GENE-EXPRESSION; LITOPENAEUS-VANNAMEI; PENAEUS-JAPONICUS; SUBTILIS; PHAGOCYTOSIS; GERMINATION; RESISTANCE; SYSTEM	Bacillus aquimaris SH6 spores produce carotenoids that are beneficial to white-leg shrimp (Litopenaeus vannamei) health. However, the optimal dose and mechanisms behind these effects are not well understood. We investigated the fate of SH6 spores in the gut of L. vannamei. Shrimp were divided into six groups administrated with either feed only (negative control) or SH6 spores at 5 x 10(6) CFU/g pellet (high dose, SH6 spore-H group), 1 x 10(6) CFU/g pellet (medium dose, SH6 spore-M group), 2 x 10(5) CFU/g pellet (low dose, SH6 spore-L group), astaxanthin at 0.5 mg/g pellet (Carophyll group), or carotenoids from SH6 vegetative cells at 5 mu g/g pellet (SH6 carotenoid group). The growth rate was highest in SH6 spore-H (3.38%/day), followed by SH6 spore-M (2.84%/day) and SH6 spore-L (2.25%/day), which was significantly higher than the control (1.45%/day), Carophyll (1.53%/day) or SH6 carotenoid (1.57%/day) groups. The astaxanthin levels (1.9-2.0 mu g/g shrimp) and red-colour scores (21-22) in SH6 spore-H/M were higher than the control (astaxanthin: 1.2 mu g/g shrimp; red score: 20) or SH6 spore-L, but lower than the Carophyll and SH6 carotenoids. Feeding with medium and high doses of SH6 spores after 28 days resulted in respective 1.3-2-fold increases in phenol oxidase activity and 8-9 fold increases in Rho mRNA expression compared to the control and low dose group. The live-counts of SH6 in the gut gradually increased during the 28-day feeding period with SH6 spores at different concentrations, starting from 4.1, 8.2, and 5.4 x 10(4) CFU/g gut at day 1 and reaching 5.3, 5.1, and 4.4 x 10(5) CFU/g gut in the SH6-H/M/L groups, respectively, at day 28. Gut microbiota became more diversified, resulting in a 2-8-fold increase in total bacterial live-counts compared to the controls. SH6 spore germination was detected by measuring the mRNA expression of a specific sequence coding for SH6 amylase at 4 h, reaching saturation at 24 h. Our results confirm that SH6 spores colonize and germinate in the gut to improve the microbial diversity and boost the immune system of shrimp, exhibiting beneficial effects at >1 x 10(6) CFU/g pellet.	[Huong Thi Nguyen; Tham Thi Nguyen; Huong Thi Thu Pham; Que Thi Ngoc Nguyen; Tuan Nghia Phan; Ha Thi Viet Bui; Anh Thi Van Nguyen] Vietnam Natl Univ, VNU Univ Sci, Key Lab Enzyme & Prot Technol, Hanoi, Vietnam; [My Thi Tran; Anh Hoa Nguyen] ANABIO Res & Dev JSC, Hanoi, Vietnam; [Hien Thi Thanh Dao] Hanoi Pharm Univ, Tradit Pharm Dept, Hanoi, Vietnam	Vietnam National University Hanoi; Hanoi University of Pharmacy	Nguyen, ATV (corresponding author), Vietnam Natl Univ, VNU Univ Sci, Key Lab Enzyme & Prot Technol, Hanoi, Vietnam.	vananhbiolab@gmail.com		Nguyen, Anh Thi Van/0000-0003-1215-6910	Third World Academy of Science (TWAS) [16-549 RG/BIO/AS_G - FR3240293311]; Vietnam National University_Hanoi, Key Laboratory of Enzyme and Protein Technology (KLEPT) [KLEPT. 18.01]; TWAS; KLEPT	Third World Academy of Science (TWAS); Vietnam National University_Hanoi, Key Laboratory of Enzyme and Protein Technology (KLEPT); TWAS; KLEPT	This study was funded by a grant from Third World Academy of Science (TWAS) to A.T.V. Nguyen under project number 16-549 RG/BIO/AS_G - FR3240293311, and a grant from Vietnam National University_Hanoi, Key Laboratory of Enzyme and Protein Technology (KLEPT) to Dr. Thang Dinh Nguyen and A.T.V. Nguyen under project number KLEPT. 18.01. While Dr. Thang Dinh Nguyen is the PI for KLEPT. 18.01 and A.T.V. Nguyen is a key member, Dr. Thang Dinh Nguyen is not an author of the present study. The authors would like to express sincere thanks to TWAS and KLEPT for funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campa-Codova AI, 2002, COMP BIOCHEM PHYS C, V133, P557, DOI 10.1016/S1532-0456(02)00125-4; Cartman ST, 2008, APPL ENVIRON MICROB, V74, P5254, DOI 10.1128/AEM.00580-08; Casula G, 2002, APPL ENVIRON MICROB, V68, P2344, DOI 10.1128/AEM.68.5.2344-2352.2002; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chai KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23126; Chubb JR, 2000, J CELL SCI, V113, P709; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Diler Ibrahim, 2002, Turkish Journal of Fisheries and Aquatic Sciences, V2, P97; FEAVERS IM, 1990, MOL MICROBIOL, V4, P275, DOI 10.1111/j.1365-2958.1990.tb00594.x; HernandezLopez J, 1996, COMP BIOCHEM PHYS C, V113, P61, DOI 10.1016/0742-8413(95)02033-0; Hong HA, 2008, J APPL MICROBIOL, V105, P510, DOI 10.1111/j.1365-2672.2008.03773.x; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Huang JM, 2008, FEMS IMMUNOL MED MIC, V53, P195, DOI 10.1111/j.1574-695X.2008.00415.x; Khaneja R, 2010, J APPL MICROBIOL, V108, P1889, DOI 10.1111/j.1365-2672.2009.04590.x; Kim JS, 2004, J BIOL CHEM, V279, P21589, DOI 10.1074/jbc.M308386200; Li EC, 2018, REV FISH SCI AQUAC, V26, P381, DOI 10.1080/23308249.2018.1440530; Li JQ, 2009, AQUACULTURE, V291, P35, DOI 10.1016/j.aquaculture.2009.03.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luis-Villasenor IE, 2015, LAT AM J AQUAT RES, V43, P766, DOI 10.3856/vol43-issue4-fulltext-15; MOIR A, 1990, ANNU REV MICROBIOL, V44, P531, DOI 10.1146/annurev.mi.44.100190.002531; Mukai T, 2008, INFECT IMMUN, V3, P553; Ngo HT, 2016, J APPL MICROBIOL, V121, P1357, DOI 10.1111/jam.13274; Nguyen ATV, 2014, FEMS MICROBIOL LETT, V358, P202, DOI 10.1111/1574-6968.12546; Ninawe AS, 2009, CRIT REV MICROBIOL, V35, P43, DOI 10.1080/10408410802667202; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Perez-Fons L, 2011, BBA-MOL CELL BIOL L, V1811, P177, DOI 10.1016/j.bbalip.2010.12.009; Perkel Jeffrey M, 2009, J Proteome Res, V8, P1107, DOI 10.1021/pr8010777; Pham KC, 2017, LETT APPL MICROBIOL, V64, P184, DOI 10.1111/lam.12708; Puspasari F, 2013, J APPL MICROBIOL, V114, P108, DOI 10.1111/jam.12025; Sachindra NM, 2005, J SCI FOOD AGR, V85, P167, DOI 10.1002/jsfa.1977; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Vieira FN, 2010, ARQ BRAS MED VET ZOO, V62, P631, DOI 10.1590/S0102-09352010000300019; YAMADA S, 1990, AQUACULTURE, V87, P323, DOI 10.1016/0044-8486(90)90069-Y; Zhang Q, 2011, AQUAC RES, V42, P943, DOI 10.1111/j.1365-2109.2010.02677.x; Zhou J, 2008, AQUACULTURE, V275, P356, DOI 10.1016/j.aquaculture.2007.12.005; Zokaeifar H, 2014, FISH SHELLFISH IMMUN, V36, P68, DOI 10.1016/j.fsi.2013.10.007	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209341	10.1371/journal.pone.0209341	http://dx.doi.org/10.1371/journal.pone.0209341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576365	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400044
J	Lam, SF; Shirure, VS; Chu, YE; Soetikno, AG; George, SC				Lam, Sandra F.; Shirure, Venktesh S.; Chu, Yunli E.; Soetikno, Alan G.; George, Steven C.			Microfluidic device to attain high spatial and temporal control of oxygen	PLOS ONE			English	Article							IN-VITRO; INTERSTITIAL FLOW; SODIUM-SULFITE; CELL-CULTURE; HYPOXIA; GRADIENTS; DIFFUSION; TRANSPORT; OXIDATION; PLATFORM	Microfluidic devices have been successfully used to recreate in vitro biological microenvironments, including disease states. However, one constant issue for replicating microenvironments is that atmospheric oxygen concentration (21% O-2) does not mimic physiological values (often around 5% O-2). We have created a microfluidic device that can control both the spatial and temporal variations in oxygen tensions that are characteristic of in vivo biology. Additionally, since the microcirculation is responsive to hypoxia, we used a 3D sprouting angiogenesis assay to confirm the biological relevance of the microfluidic platform. Our device consists of three parallel connected tissue chambers and an oxygen scavenger channel placed adjacent to these tissue chambers. Experimentally measured oxygen maps were constructed using phosphorescent lifetime imaging microscopy and compared with values from a computational model. The central chamber was loaded with endothelial and fibroblast cells to form a 3D vascular network. Four to six days later, fibroblasts were loaded into the side chambers, and a day later the oxygen scavenger (sodium sulfite) was flowed through the adjacent channel to induce a spatial and temporal oxygen gradient. Our results demonstrate that both constant chronic and intermittent hypoxia can bias vessel growth, with constant chronic hypoxia showing higher degrees of biased angiogenesis. Our simple design provides consistent control of spatial and temporal oxygen gradients in the tissue microenvironment and can be used to investigate important oxygen-dependent biological processes in conditions such as cancer and ischemic heart disease.	[Lam, Sandra F.; Chu, Yunli E.; Soetikno, Alan G.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Shirure, Venktesh S.; George, Steven C.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis	George, SC (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	scgeorge@ucdavis.edu	; Shirure, Venktesh/M-8806-2015	, Sandra/0000-0001-5242-9763; Shirure, Venktesh/0000-0002-4430-2612; Chu, Yunli/0000-0001-6120-1496; Soetikno, Alan/0000-0003-3404-1671	National Institutes of Health [UH3TR00048, R01 CA170879, UC4 DK104202]; National Science Foundation [DGE-1143954]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (UH3TR00048, R01 CA170879, and UC4 DK104202, SCG) as well as the National Science Foundation (DGE-1143954, SFL). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo LF, 2015, LAB CHIP; BARRON CH, 1966, CHEM ENG SCI, V21, P397, DOI 10.1016/0009-2509(66)85050-9; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h; COX ME, 1986, J POLYM SCI POL CHEM, V24, P621, DOI 10.1002/pola.1986.080240405; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ehsan SM, 2015, J BIOSCI BIOENG, V120, P347, DOI 10.1016/j.jbiosc.2015.01.017; Ehsan SM, 2013, TISSUE ENG PT A, V19, P1433, DOI [10.1089/ten.tea.2012.0587, 10.1089/ten.TEA.2012.0587]; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Funamoto K, 2012, LAB CHIP, V12, P4855, DOI 10.1039/c2lc40306d; Gaustad JV, 2013, MICROVASC RES, V85, P10, DOI 10.1016/j.mvr.2012.11.002; Germain T, 2016, ANAL CHIM ACTA, V936, P179, DOI 10.1016/j.aca.2016.07.040; GOODALL C. M., 1965, J NAT CANCER INST, V35, P497; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Hsu YH, 2013, LAB CHIP, V13, P2990, DOI 10.1039/c3lc50424g; Hsu YH, 2013, LAB CHIP, V13, P81, DOI [10.1039/c2lc40787f, 10.1039/c2lc407871]; HUI PK, 1991, BIOTECHNOL BIOENG, V37, P392, DOI 10.1002/bit.260370416; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lo JF, 2012, ANAL CHEM, V84, P1987, DOI 10.1021/ac2030909; Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d; Moya M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt376; Moya ML, 2014, METHODS MOL BIOL, V1202, P21, DOI 10.1007/7651_2013_36; Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.tec.2012.0430, 10.1089/ten.TEC.2012.0430]; Rofstad EK, 2007, CLIN CANCER RES, V13, P1971, DOI 10.1158/1078-0432.CCR-06-1967; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shirure VS, 2017, ANGIOGENESIS, V20, P493, DOI 10.1007/s10456-017-9559-4; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; Tellier C, 2015, NEOPLASIA, V17, P66, DOI 10.1016/j.neo.2014.11.003; Toffoli S, 2009, ANGIOGENESIS, V12, P339, DOI 10.1007/s10456-009-9156-2; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; White SM, 2014, TISSUE ENG PT A, V20, P2316, DOI [10.1089/ten.tea.2013.0311, 10.1089/ten.TEA.2013.0311]	35	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209574	10.1371/journal.pone.0209574	http://dx.doi.org/10.1371/journal.pone.0209574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571786	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700087
J	Billa, O; Chalouni, M; Salmon, D; Poizot-Martin, I; Gilbert, C; Katlama, C; Neau, D; Chas, J; Morlat, P; Lacombe, K; Naqvi, A; Barange, K; Gervais, A; Bouchaud, O; Rosenthal, E; Lascoux-Combe, C; Garipuy, D; Alric, L; Dominguez, S; Vittecoq, D; Goujard, C; Duvivier, C; Aumaitre, H; Miailhes, P; Zucman, D; Simon, A; Lazaro, E; Raffi, F; Esterle, L; Wittkop, L; Bani-Sadr, F				Billa, Oumar; Chalouni, Mathieu; Salmon, Dominique; Poizot-Martin, Isabelle; Gilbert, Camille; Katlama, Christine; Neau, Didier; Chas, Julie; Morlat, Philippe; Lacombe, Karine; Naqvi, Alissa; Barange, Karl; Gervais, Anne; Bouchaud, Olivier; Rosenthal, Eric; Lascoux-Combe, Caroline; Garipuy, Daniel; Alric, Laurent; Dominguez, Stephanie; Vittecoq, Daniel; Goujard, Cecile; Duvivier, Claudine; Aumaitre, Hugues; Miailhes, Patrick; Zucman, David; Simon, Anne; Lazaro, Estibaliz; Raffi, Francois; Esterle, Laure; Wittkop, Linda; Bani-Sadr, Firouze		ANRS CO13 HEPAVIH Study Grp	Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients-ANRS-CO13 HEPAVIH cohort	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; ANTIRETROVIRAL THERAPY ERA; B-CELL; HIV; IMMUNODEFICIENCY; RISK; EPIDEMIOLOGY; MALIGNANCIES; MORTALITY; INFECTION	Compared to the general population, HIV-infected patients are at higher risk of developing non-AIDS-defining cancers. Chronic HCV infection has also been associated with a higher risk than that of the general population of developing cancers other than hepatocarcinoma. Evaluation of the impact of HCV-related factors on non-AIDS-defining and non HCV-liver (NANL) related cancers among HIV/HCV co-infected patients are scarce. The aim of this study was to identify the impact of HIV/HCV clinical characteristics on NANL related cancers in a large cohort of HIV/HCV-coinfected patients followed from 2005 to 2017. Cox proportional hazards models with delayed entry were used to estimate factors associated with NANL related cancer. Among 1391 patients followed for a median of 5 years, 60 patients developed NANL related cancers, yielding an incidence rate of 8.9 per 1000 person-years (95% CI, [6.6-11.1]). By final multivariable analysis, after adjustment for sex, tobacco or alcohol consumption, baseline CD4 cell count and HCV sustained viral response (SVR), age and a longer duration since HIV diagnosis were independently associated with a higher risk of NANL related cancer (aHR for each additional year 1.10, 95% CI 1.06-1.14, p<0.0001 and 1.06, 95% CI 1.01-1.11, p = 0.02, respectively). Duration of HCV infection, cirrhosis, HCV viral load, genotype and SVR were not associated with the occurrence of NANL related cancer. Among HIV/HCV-coinfected patients, age and the duration of HIV infection were the only characteristics found to be associated with the occurrence of NANL related cancer. In contrast, no association was observed with any HCV-related variables.	[Billa, Oumar; Chalouni, Mathieu; Gilbert, Camille; Morlat, Philippe; Esterle, Laure; Wittkop, Linda] Univ Bordeaux, Team MORPH3EUS, CIC EC 1401, Inserm Bordeaux Populat Hlth,ISPED,UMR 1219, Bordeaux, France; [Salmon, Dominique] Univ Paris 05, Paris, France; [Salmon, Dominique] Hop Univ Paris Ctr, AP HP, Unite Malad Infect Trop, Paris, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, Hop St Marguerite, AP HM, Serv Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM Marseille, Marseille, France; [Katlama, Christine] Hop La Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, Paris, France; [Katlama, Christine] UPMC, Inst Pierre Louis Epidemiol & Sante Publ, Sorbonne Univ, Paris, France; [Neau, Didier] Hop Pellegrin, Serv Malad Infect & Trop Bordeaux, Ctr Hosp Univ Bordeaux, Bordeaux, France; [Neau, Didier; Morlat, Philippe] Univ Bordeaux, Bordeaux, France; [Chas, Julie] Hop Tenon, AP HP, Serv Malad Infect & Trop, Paris, France; [Morlat, Philippe] Hop St Andre, CHU Bordeaux, Serv Med Interne, Bordeaux, France; [Lacombe, Karine] Hop St Antoine, AP HP, Serv Malad Infect Trop, Paris, France; [Lacombe, Karine] Inst Pierre Louis Epiderniol & Sante Publ, UMR S1136, Paris, France; [Naqvi, Alissa] Hop Archet 1, Serv Infectiol, CHU Nice, Nice, France; [Barange, Karl] Hop Purpan, Serv Gastroenterol & Hepatol, CHU Toulouse, Toulouse, France; [Gervais, Anne] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, AP HP, Paris, France; [Bouchaud, Olivier] Hop Avicenne, Ap HP, Serv Malad Infect & Trop, Bobigny, France; [Bouchaud, Olivier] Univ Paris 13 Nord, Bobigny, France; [Rosenthal, Eric] Hop Archet, Serv Med Interne & Cancerol, CHU Nice, Nice, France; [Rosenthal, Eric] Univ Nice Sophia Antipolis, Nice, France; [Lascoux-Combe, Caroline] Hop St Louis, AP HP, Serv Malad Infect & Trop, Paris, France; [Garipuy, Daniel] Hop Purpan, Serv Malad Infect & Trop, CHU Toulouse, Toulouse, France; [Alric, Laurent] Hop Purpan, Serv Med Interne Pole Digestif, CHU Toulouse, Toulouse, France; [Alric, Laurent] Univ Toulouse III, UMR 152, IRD, Toulouse, France; [Dominguez, Stephanie] Hop Henri Mondor, AP HP, Immunol Clin, Serv Immunol Clin & Malad Infect, Creteil, France; [Vittecoq, Daniel] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Malad Infect & Trop, Le Kremlin Bicetre, France; [Vittecoq, Daniel; Goujard, Cecile] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Duvivier, Claudine] IHU Imagine, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, Hop Necker Enfants Malades, Paris, France; [Aumaitre, Hugues] Ctr Hosp Perpignan, Serv Malad Infect & Tropicales, Perpignan, France; [Miailhes, Patrick] Hop Croix Rousse, Serv Malad Infect & Trop, Ctr Hosp Univ Lyon, Lyon, France; [Zucman, David] Hop Foch, Unite VIH, Suresnes, France; [Simon, Anne] Hop La Pitie Salpetriere, AP HP, Dept Med Interne & Immunol Clin, Paris, France; [Lazaro, Estibaliz] Hop Haut Leveque, Serv Med Interne Malad & Infect, CHU Bordeaux, Pessac, France; [Raffi, Francois] CHU Nantes, Dept Infect Dis, Nantes, France; [Raffi, Francois] Univ Nantes, INSERM, CIC 1413, Nantes, France; [Wittkop, Linda] CHU Bordeaux, Pole Sante Publ, Serv Informat Med, Bordeaux, France; [Bani-Sadr, Firouze] Hop Robert Debre, Unite Maladie Infect & Trop, CHU Reims, Reims, France; [Bani-Sadr, Firouze] Univ Reims, EA 4684, SFR CAP SANTE, Reims, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU de Toulouse; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU Bordeaux; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Bani-Sadr, F (corresponding author), Hop Robert Debre, Unite Maladie Infect & Trop, CHU Reims, Reims, France.; Bani-Sadr, F (corresponding author), Univ Reims, EA 4684, SFR CAP SANTE, Reims, France.	fbanisadr@chu-reims.fr	Scholtès, Caroline/B-9039-2011; Wittkop, Linda/E-3319-2014	Scholtès, Caroline/0000-0003-0691-8480; Wittkop, Linda/0000-0003-2403-0960; BILLA, Oumar/0000-0002-5661-9406; Poizot-Martin, Isabelle/0000-0002-5676-5411; BANI-SADR, Firouze/0000-0001-8268-866X				Allison RD, 2015, J HEPATOL, V63, P822, DOI 10.1016/j.jhep.2015.04.021; Berenguer J, 2017, HEPATOLOGY, V66, P344, DOI 10.1002/hep.29071; Fiorino S, 2015, WORLD J GASTROENTERO, V21, P12896, DOI 10.3748/wjg.v21.i45.12896; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Hema MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161594; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Mahale P, 2017, CANCER-AM CANCER SOC, V123, P1202, DOI 10.1002/cncr.30559; Mahale P, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw035; Marquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x; Meijide H, 1993, AIDS LOND ENGL, DOI [10.1097/QAD, DOI 10.1097/QAD]; Peveling-Oberhag J, 2013, J HEPATOL, V59, P169, DOI 10.1016/j.jhep.2013.03.018; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Riedel DJ, 2015, CURR HIV-AIDS REP, V12, P362, DOI 10.1007/s11904-015-0276-6; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Rubinstein PG, 2014, AIDS, V28, P453, DOI 10.1097/QAD.0000000000000071; Sandberg JK, 2010, VIRULENCE, V1, P177, DOI 10.4161/viru.1.3.11206; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Su FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048109; Tarallo PA, 2013, TRANSPL INFECT DIS, V15, P400, DOI 10.1111/tid.12086; Terrier B, 2013, JAIDS-J ACQ IMM DEF, V63, P249, DOI 10.1097/QAI.0b013e31828a77f0; Vallisa D, 2005, J CLIN ONCOL, V23, P468, DOI 10.1200/JCO.2005.06.008; Vandenhende MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129550; Yanik EL, 2014, AIDS, V28, P979, DOI 10.1097/QAD.0000000000000167; Zucchetto A, 2016, JAIDS-J ACQ IMM DEF, V73, P190, DOI 10.1097/QAI.0000000000001033	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208657	10.1371/journal.pone.0208657	http://dx.doi.org/10.1371/journal.pone.0208657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562358	Green Published, Green Submitted, gold			2022-12-26	WOS:000453774100019
J	Tamarozzi, F; Buonfrate, D; Monteiro, GB; Richter, J; Gobbi, FG; Bisoffi, Z				Tamarozzi, Francesca; Buonfrate, Dora; Monteiro, Geraldo Badona; Richter, Joachim; Gobbi, Federico Giovanni; Bisoffi, Zeno			Ultrasound and intestinal lesions in Schistosoma mansoni infection: A case-control pilot study outside endemic areas	PLOS ONE			English	Article							SONOGRAPHIC ASSESSMENT; MORBIDITY; HAEMATOBIUM; COMMUNITY; RESOLUTION; INTENSITY; EVOLUTION; PATHOLOGY; FIBROSIS; VILLAGES	Background Infection with Schistosoma mansoni is a major cause of morbidity and mortality in endemic areas, and is increasingly diagnosed in migrants and travellers outside transmission areas. Markers for the assessment of morbidity and impact of control programs in endemic areas and for the clinical management of patients in the clinical setting are scant, especially for intestinal involvement. Ultrasonography is well established to evaluate hepatosplenic pathology; on the contrary, ultrasound evaluation of intestinal schistosomiasis is virtually unexplored. In this pilot study, we aimed to describe and evaluate the accuracy of unenhanced intestinal ultrasound for morbidity due to intestinal S. mansoni infection. Methodology/Principal findings We performed a blind case-control study of unenhanced intestinal ultrasound on 107 adults accessing the outpatient clinic of our Centre for Tropical Diseases between January-July 2018 as part of a screening for tropical diseases in migrants and travellers returning from endemic areas. Other clinical and laboratory data were obtained routine examination reports. We could not find any overtly pathological thickness of the gut wall in the sigma, proximal ascending colon, and terminal ileum, in patients with S. mansoni infection (n = 17), S. haematobium infection (n = 7), positive anti-Schistosoma serology (n = 31), and uninfected individuals (n = 52), with no difference among groups as assessed by ANOVA. No polyps or other intestinal abnormalities were visualized. There was no significant change in gut wall thickness one month after treatment with praziquantel in patients with S. mansoni infection (n = 11). Conclusions/Significance Our preliminary results suggest that intestinal ultrasound might not be a sensitive tool for detecting minor intestinal morbidity due to schistosomiasis. Further studies in a hospital setting comparing colonoscopy and ultrasonography may be envisaged; in endemic areas, further studies are needed to describe and assess the usefulness of intestinal ultrasound in patients stratified by infection intensity and compared with markers such as calprotectin and fecal occult blood.	[Tamarozzi, Francesca; Buonfrate, Dora; Monteiro, Geraldo Badona; Gobbi, Federico Giovanni; Bisoffi, Zeno] RCCS Sacro Cuore Don Calabria Hosp, Ctr Trop Dis, Negrar, Italy; [Richter, Joachim] Univ Med, Inst Trop Med & Int Hlth, Berlin, Germany; [Bisoffi, Zeno] Univ Verona, Diagnost & Publ Hlth Dept, Infect Dis & Trop Med Sect, Verona, Italy	IRCCS Sacro Cuore Don Calabria; University of Verona	Tamarozzi, F (corresponding author), RCCS Sacro Cuore Don Calabria Hosp, Ctr Trop Dis, Negrar, Italy.	f_tamarozzi@yahoo.com	Bisoffi, Zeno/B-6438-2013; Buonfrate, Dora/N-2965-2016; Buonfrate, Dora/ABG-7386-2020; Tamarozzi, Francesca/J-2890-2016; Gobbi, Federico/ABG-7554-2020; Monteiro, Geraldo Badona/ABI-8137-2020	Bisoffi, Zeno/0000-0001-9530-8742; Buonfrate, Dora/0000-0003-0108-6822; Buonfrate, Dora/0000-0003-0108-6822; Tamarozzi, Francesca/0000-0003-0478-3914; Gobbi, Federico/0000-0002-6899-4545; 				Andrade G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005372; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; Belard S, 2016, AM J TROP MED HYG, V94, P8, DOI 10.4269/ajtmh.15-0421; Beltrame A, 2017, EUR J EPIDEMIOL; Berhe N, 2007, AM J TROP MED HYG, V77, P1079, DOI 10.4269/ajtmh.2007.77.1079; Bustinduy AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002542; Cao J, 2010, WORLD J GASTROENTERO, V16, P723, DOI 10.3748/wjg.v16.i6.723; Chow KU, 2016, RADIOLOGY, V279, P306, DOI 10.1148/radiol.2015150887; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; DITTRICH M, 1994, ACTA TROP, V58, P331, DOI 10.1016/0001-706X(94)90026-4; el Scheich T, 2014, PARASITOL RES, V113, P3915, DOI 10.1007/s00436-014-4117-0; El-Shabrawi MHF, 2011, ANN TROP PAEDIATR, V31, P213, DOI 10.1179/1465328111Y.0000000014; FLEISCHER AC, 1981, AM J ROENTGENOL, V136, P887, DOI 10.2214/ajr.136.5.887; French MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006484; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; HATZ C, 1990, T ROY SOC TROP MED H, V84, P84, DOI 10.1016/0035-9203(90)90392-R; Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775; ISHIBASHI H, 1991, J CLIN ULTRASOUND, V19, P21, DOI 10.1002/jcu.1870190106; Kanzaria HK, 2005, AM J TROP MED HYG, V72, P115, DOI 10.4269/ajtmh.2005.72.115; King CH, 2003, TROP MED INT HEALTH, V8, P109, DOI 10.1046/j.1365-3156.2003.00994.x; Kuzmich S, 2012, BRIT J RADIOL, V85, pE1155, DOI 10.1259/bjr/60593124; Lengeler C, 2002, TRENDS PARASITOL, V18, P375, DOI 10.1016/S1471-4922(02)02318-8; Malenganisho WLM, 2008, T ROY SOC TROP MED H, V102, P532, DOI 10.1016/j.trstmh.2008.03.006; Mohamed-Ali Q, 1999, J INFECT DIS, V180, P1298, DOI 10.1086/314999; NDAMBA J, 1991, INT J EPIDEMIOL, V20, P787, DOI 10.1093/ije/20.3.787; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Richter J, 1998, TROP MED INT HEALTH, V3, P728, DOI 10.1046/j.1365-3156.1998.00285.x; Richter J, 2016, PARASITOL RES, V115, P1733, DOI 10.1007/s00436-016-4944-2; SAAD AMA, 1985, E AFR MED J, V62, P397; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tukahebwa EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002268; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wagatsuma Y, 1999, J INFECT DIS, V179, P1515, DOI 10.1086/314786; WHO, 1996, TDRSTRSCH001 WHO	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209333	10.1371/journal.pone.0209333	http://dx.doi.org/10.1371/journal.pone.0209333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562400	Green Published, gold, Green Submitted			2022-12-26	WOS:000453774100050
J	Horn, MP; Peter, AM; Grunder, FR; Leichtle, AB; Spalinger, J; Schibli, S; Sokollik, C				Horn, Michael P.; Peter, Anna Maria; Grunder, Franziska Righini; Leichtle, Alexander B.; Spalinger, Johannes; Schibli, Susanne; Sokollik, Christiane			PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease	PLOS ONE			English	Article							ANTI-SACCHAROMYCES-CEREVISIAE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INDETERMINATE COLITIS; SERUM ANTIBODIES; AUTOANTIBODIES; ANCA; MARKERS; ASSOCIATION; PHENOTYPES; CHILDREN	Background Accurate classification of patients with inflammatory bowel disease into the subtypes ulcerative colitis (UC) and Crohn's disease (CD) is still a challenge, but important for therapy and prognosis. Objectives To evaluate the diagnostic utility of anti-neutrophil cytoplasmic antibodies specific for proteinase-3 (PR3-ANCA) for ulcerative colitis (UC) and the value of an antibody panel incorporating PR3-ANCA to differentiate between Crohn's disease (CD) and UC. Study design In this cohort study, 122 pediatric and adolescent individuals were retrospectively included (61 IBD patients of two clinical centers, 61 non-IBD controls). All subjects had a comprehensive antibody profile done from stored sera taken close to time of diagnosis. By employing quasi-exhaustive logistic regression the best discriminative model for UC and CD, subjects was determined in a training cohort and confirmed in a validation cohort. Results PR3-ANCA was specifically associated with UC (odds ratio (OR), 17.6; 95% confidence interval (CI); 3.6, 87); P < .001). A four antibody-panel including PR3-ANCA had an AUC of 90.81% (95%CI; 81.93, 99.69) to distinguish between UC and CD in the training cohort. In a smaller external validation cohort, the AUC was 84.13% (95%CI; 64.21, 100) for accurate diagnosis of CD and UC. Conclusion PR3-ANCA is highly specific for UC. The differentiating capability of a panel, which contains PR3-ANCA and weighs broadly available antibodies, is superior and utilization of the panel can support accurate classification in the work-up of pediatric and adolescent patients with IBD patients.	[Horn, Michael P.; Leichtle, Alexander B.] Univ Bern, Bern Univ Hosp, Univ Inst Clin Chem, Inselspital, Bern, Switzerland; [Peter, Anna Maria; Schibli, Susanne; Sokollik, Christiane] Univ Bern, Univ Childrens Hosp, Inselspital, Div Pediat Gastroenterol Hepatol & Nutr, Bern, Switzerland; [Grunder, Franziska Righini; Spalinger, Johannes] Childrens Hosp Lucerne, Div Pediat Gastroenterol, Luzern, Switzerland; [Grunder, Franziska Righini] St Justine Univ Hlth Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Montreal, PQ, Canada; [Leichtle, Alexander B.] Univ Bern, Bern Univ Hosp, Inselspital, IDSC Insel Data Sci Ctr, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Sokollik, C (corresponding author), Univ Bern, Univ Childrens Hosp, Inselspital, Div Pediat Gastroenterol Hepatol & Nutr, Bern, Switzerland.	christiane.sokollik@insel.ch	Righini-Grunder, Franziska/AAM-3404-2020		Batzebaer Foundation	Batzebaer Foundation	This work was supported by the Batzebaer Foundation (http://www.batzebaer.ch/) to CS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander F, 2003, J PEDIATR SURG, V38, P78, DOI 10.1053/jpsu.2003.50015; Ardesjo B, 2008, INFLAMM BOWEL DIS, V14, P652, DOI 10.1002/ibd.20370; Bogdanos DP, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-102; Bossuyt X, 2017, NAT REV RHEUMATOL, V13, P683, DOI 10.1038/nrrheum.2017.140; Carvalho RS, 2006, INFLAMM BOWEL DIS, V12, P258, DOI 10.1097/01.MIB.0000215093.62245.b9; Elkadri AA, 2013, INFLAMM BOWEL DIS, V19, P1499, DOI 10.1097/MIB.0b013e318281f2a1; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Frenzer A, 1998, J GASTROEN HEPATOL, V13, P950, DOI 10.1111/j.1440-1746.1998.tb00767.x; GROSS WL, 1993, CLIN EXP IMMUNOL, V91, P1; HIBI T, 1994, GUT, V35, P224, DOI 10.1136/gut.35.2.224; Homsak E, 2010, WIEN KLIN WOCHENSCHR, V122, P19, DOI 10.1007/s00508-010-1344-y; Jaskowski TD, 2006, CLIN VACCINE IMMUNOL, V13, P655, DOI 10.1128/CVI.00034-06; Komorowski L, 2013, J CROHNS COLITIS, V7, P780, DOI 10.1016/j.crohns.2012.10.011; Kovacs M, 2012, J PEDIATR GASTR NUTR, V55, P429, DOI 10.1097/MPG.0b013e318256b516; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2013, INFLAMM BOWEL DIS, V19, P370, DOI 10.1002/ibd.23013; Mahler M, 2013, CLIN CHIM ACTA, V424, P267, DOI 10.1016/j.cca.2013.06.005; Matsui T, 2003, J GASTROENTEROL, V38, P647, DOI 10.1007/s00535-003-1117-8; Michaels MA, 2015, INFLAMM BOWEL DIS, V21, P2864, DOI 10.1097/MIB.0000000000000564; Miller AJ, 1984, SELECTION SUBSETS RE, V147, P36; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Obuchowski NA, 2004, CLIN CHEM, V50, P1118, DOI 10.1373/clinchem.2004.031823; Olbjorn C, 2017, SCAND J GASTROENTERO, V52, P414, DOI 10.1080/00365521.2016.1259653; Papp M, 2015, J CROHNS COLITIS, V9, P659, DOI 10.1093/ecco-jcc/jjv087; Paul S, 2015, J CROHNS COLITIS, V9, P445, DOI 10.1093/ecco-jcc/jjv063; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Plevy S, 2013, INFLAMM BOWEL DIS, V19, P1139, DOI 10.1097/MIB.0b013e318280b19e; POOL MO, 1993, GUT, V34, P46, DOI 10.1136/gut.34.1.46; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Reese GE, 2006, AM J GASTROENTEROL, V101, P2410, DOI 10.1111/j.1572-0241.2006.00840.x; Russell RK, 2009, J PEDIATR GASTR NUTR, V48, P161, DOI 10.1097/MPG.0b013e318183e112; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1358, DOI 10.1002/ibd.20892; Takedatsu H, 2018, J GASTROENTEROL HEPA; Teml A, 2003, AM J GASTROENTEROL, V98, P2226, DOI 10.1016/S0002-9270(03)00658-0; Arias-Loste MT, 2013, CLIN REV ALLERG IMMU, V45, P109, DOI 10.1007/s12016-012-8349-4; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Zholudev A, 2004, AM J GASTROENTEROL, V99, P2235, DOI 10.1111/j.1572-0241.2004.40369.x	37	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208974	10.1371/journal.pone.0208974	http://dx.doi.org/10.1371/journal.pone.0208974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557305	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000058
J	Okumura, K; Matsumoto, J; Iwata, Y; Yoshida, K; Yoneda, N; Ogi, T; Kitao, A; Kozaka, K; Koda, W; Kobayashi, S; Inoue, D; Sakai, N; Furuichi, K; Wada, T; Gabata, T				Okumura, Kenichiro; Matsumoto, Junichi; Iwata, Yasunori; Yoshida, Kotaro; Yoneda, Norihide; Ogi, Takahiro; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Inoue, Dai; Sakai, Norihiko; Furuichi, Kengo; Wada, Takashi; Gabata, Toshifumi			Evaluation of renal oxygen saturation using photoacoustic imaging for the early prediction of chronic renal function in a model of ischemia-induced acute kidney injury	PLOS ONE			English	Article							ENDOTHELIAL INJURY; FAILURE; HYPOXIA; PATHOPHYSIOLOGY; HEMODYNAMICS; REPERFUSION; DYSFUNCTION; DEFINITION	Purpose To evaluate the utility of photoacoustic imaging in measuring changes in renal oxygen saturation after ischemia-induced acute kidney injury, and to compare these measurements with histological findings and serum levels of kidney function. Material and Methods Acute kidney injury was induced by clamping the left renal pedicle in C57BI/6 mice, with a 35-min ischemic period used to induce mild renal injury (14 mice) and a 50-min period for severe injury (13 mice). The oxygen saturation was measured before induction, and at 5 time-points over the first 48 h after induction, starting at 4 h after induction. Oxygen saturation, histological score, kidney volume, and the 24 h creatinine clearance rate and serum blood urea nitrogen were also measured on day 28. Between-group differences were evaluated using a Mann-Whitney U-test and Dunn's multiple comparisons. The association between oxygen saturation and measured variables was evaluated using Spearman's correlation. A receiver operator characteristic curve was constructed from oxygen saturation values at 24 h after heminephrectomy to predict chronic renal function. Results The oxygen saturation was higher in the mild than severe renal injury group at 24 h after induction (73.7% and 66.9%, respectively, P<0.05). Between-group comparison on day 28 revealed a higher kidney volume (P=0.007), lower tubular injury (P<0.001), lower serum level of blood urea nitrogen level (P=0.016), and lower 24 h creatinine clearance rate (P=0.042) in the mild compared with the severe injury group. The oxygen saturation at 24 h correlated with the 24 h creatinine clearance rate (P=0.036) and serum blood urea nitrogen (P<0.001) on day 28, with an area under the receiver operating curve of 0.825. Conclusion Oxygen saturation, measured by photoacoustic imaging at 24 h after acute kidney injury can predict the extent of subsequent histological alterations in the kidney early after injury.	[Okumura, Kenichiro; Matsumoto, Junichi; Yoshida, Kotaro; Yoneda, Norihide; Ogi, Takahiro; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Inoue, Dai; Gabata, Toshifumi] Kanazawa Univ, Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan; [Iwata, Yasunori; Sakai, Norihiko; Furuichi, Kengo] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Nephrol & Lab, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Inoue, D (corresponding author), Kanazawa Univ, Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan.	d-inoue@lake.ocn.ne.jp	Kobayashi, Satoshi/C-4645-2015	Kobayashi, Satoshi/0000-0001-7759-399X; Kitao, Azusa/0000-0002-5597-9346; Matsumoto, Junichi/0000-0002-0190-7806; Okumura, Kenichiro/0000-0001-8131-7584	JSPS KAKENHI [16K10343]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, http://www.jsps.go.jp/english/e-grants/index.html, Number 16K19813, Recipient KO; JSPS KAKENHI, http://www.jsps.go.jp/english/e-grants/index.html, Grant Number 16K10343, recipient WK.	Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Chae HD, 2017, KOREAN J RADIOL, V18, P821, DOI 10.3348/kjr.2017.18.5.821; Dogra VS, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.119139; Druml W, 2005, INTENS CARE MED, V31, P1145, DOI 10.1007/s00134-005-2682-5; Gerling M, 2014, THERANOSTICS, V4, P604, DOI 10.7150/thno.7996; Hueper K, 2014, RADIOLOGY, V270, P117, DOI 10.1148/radiol.13130367; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; KRUGER RA, 1995, MED PHYS, V22, P1605, DOI 10.1118/1.597429; KRUGER RA, 1994, MED PHYS, V21, P127, DOI 10.1118/1.597367; Laufer J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056016; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Legrand M, 2009, AM J PHYSIOL-RENAL, V296, pF1109, DOI 10.1152/ajprenal.90371.2008; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Li LL, 2016, AM J PHYSIOL-RENAL, V310, pF1197, DOI 10.1152/ajprenal.00575.2015; Lu X, 2012, J NEPHROL, V25, P738, DOI 10.5301/jn.5000053; Luke GP, 2015, RADIOLOGY, V277, P435, DOI 10.1148/radiol.2015141909; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Neugarten J, 2012, KIDNEY INT, V81, P613, DOI 10.1038/ki.2011.462; Okusa MD, 2013, CONTRIB NEPHROL, V182, P65, DOI 10.1159/000349967; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; Pickering JW, 2014, J RENAL INJ PREV, V3, P21, DOI 10.12861/jrip.2014.08; Pohlmann A, 2014, INVEST RADIOL, V49, P547, DOI 10.1097/RLI.0000000000000054; Redfors B, 2010, CRIT CARE MED, V38, P1695, DOI 10.1097/CCM.0b013e3181e61911; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Shao Q, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076019; Siegemund M, 2010, ANESTH ANALG, V111, P345, DOI 10.1213/ANE.0b013e3181e4255f; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786; Zackrisson S, 2014, CANCER RES, V74, P979, DOI 10.1158/0008-5472.CAN-13-2387; Zhou Q, 2009, MAGN RESON IMAGING, V27, P155, DOI 10.1016/j.mri.2008.07.002	37	14	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0206461	10.1371/journal.pone.0206461	http://dx.doi.org/10.1371/journal.pone.0206461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557371	gold, Green Submitted, Green Published			2022-12-26	WOS:000453451000010
J	Saleem, M; Ahmad, N				Saleem, M.; Ahmad, Naveed			Characterization of canola oil extracted by different methods using fluorescence spectroscopy	PLOS ONE			English	Article							EDIBLE OILS; OLIVE OIL	The potential of fluorescence spectroscopy has been utilized for the characterization of three types of canola oil samples: the first type was obtained by dissolving its seeds in hexane solvent, the second by cold press method, and the third from eight commercial brands. Fluorescence spectra from all samples have been acquired by using excitation wavelengths from 280 to 420 nm with step of 10 nm to investigate their valuable ingredients. The emission bands at 375, 525 and 673 nm that represent vitamin E/beta-carotene and chlorophyll, are present only in canola oil samples extracted by chemical and cold press methods and absolutely absent from all commercial brands. The emission band at 440 nm appearing only in the commercial oil brands, is assigned to oxidized products of isomers of vitamin E and fatty acids. In addition, the effect of temperature on the canola oil extracted by cold press method has been investigated which showed that up to 180 degrees C it does not lose much of its natural molecular composition. However, it showed a trend of thermal oxidation with rise of temperature.	[Saleem, M.] Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Lehtrar Rd, Islamabad, Pakistan; [Ahmad, Naveed] Mirpur Univ Sci & Technol MUST Mirpur, Dept Phys, Azad Kashmir, Pakistan		Saleem, M (corresponding author), Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Lehtrar Rd, Islamabad, Pakistan.	salim569mail@gmail.com	; Saleem, Muhammad/M-8215-2016	Fribourg, Miguel/0000-0003-1804-8136; Saleem, Muhammad/0000-0001-8376-0459				Ahmed N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197340; Ali H, 2018, APPL SPECTROSC, V72, P1371, DOI 10.1177/0003702818768485; Booth EJ, 2004, RAPESEED AND CANOLA OIL: PRODUCTION, PROCESSING, PROPERTIES AND USES, P1; Canola Council of Canada, CAN OIL; CHAPMAN DM, 1994, J AM OIL CHEM SOC, V71, P401, DOI 10.1007/BF02540521; CHERRY RJ, 1968, T FARADAY SOC, V64, P2304, DOI 10.1039/tf9686402304; Downey G, 2002, J AGR FOOD CHEM, V50, P5520, DOI 10.1021/jf0257188; DUPONT J, 1989, J AM COLL NUTR, V8, P360; Guimet Vila F, 2006, THESIS U ROVIRA VIRG; Gunstone F.D., 2002, VEGETABLE OILS FOOD, Vfirst, DOI DOI 10.1002/9781444339925; Karoui R, 2007, FOOD CHEM, V100, P632, DOI 10.1016/j.foodchem.2005.09.082; Karoui R., 2012, CHEM ANAL FOOD TECH, P499, DOI DOI 10.1016/B978-0-12-384862-8.00015-7; Karoui R, 2011, FOOD CHEM, V127, P743, DOI 10.1016/j.foodchem.2010.12.135; Katragadda HR, 2010, FOOD CHEM, V120, P59, DOI 10.1016/j.foodchem.2009.09.070; Kong F, 2011, WOODHEAD PUBL FOOD S, P381; Kongbonga Y. G. M., 2011, Food and Nutrition Sciences, V2, P692, DOI 10.4236/fns.2011.27095; Kyriakidis NB, 2000, J AOAC INT, V83, P1435; Lin L, 2013, NUTR REV, V71, P370, DOI 10.1111/nure.12033; Matthaus B, 2010, MANAG DIFFER IND SEC, V2, P183; MOULTON KJ, 1989, J AM OIL CHEM SOC, V66, P302, DOI 10.1007/BF02653278; Muik B, 2005, CHEM PHYS LIPIDS, V134, P173, DOI 10.1016/j.chemphyslip.2005.01.003; Nikolova K., 2012, J FOOD SCI ENG, V2, P674; Saleem M, 2017, LASER PHYS, V27, DOI 10.1088/1555-6611/aa8cd7; Sikorska E, 2005, FOOD CHEM, V89, P217, DOI 10.1016/j.foodchem.2004.02.028; Sikorska E, 2008, INT J FOOD SCI TECH, V43, P52, DOI 10.1111/j.1365-2621.2006.01384.x; Tena N, 2009, J AGR FOOD CHEM, V57, P10505, DOI 10.1021/jf902009b; Ullah R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178055; Velasco J, 2002, EUR J LIPID SCI TECH, V104, P661, DOI 10.1002/1438-9312(200210)104:9/10<661::AID-EJLT661>3.0.CO;2-D; Zandomeneghi M, 2005, J AGR FOOD CHEM, V53, P759, DOI 10.1021/jf048742p	29	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208640	10.1371/journal.pone.0208640	http://dx.doi.org/10.1371/journal.pone.0208640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557357	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000035
J	Chase, TJ; Pratchett, MS; Frank, GE; Hoogenboom, MO				Chase, T. J.; Pratchett, M. S.; Frank, G. E.; Hoogenboom, M. O.			Coral-dwelling fish moderate bleaching susceptibility of coral hosts	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; STYLOPHORA-PISTILLATA; PHOTOSYSTEM-II; TEMPERATURE; HABITAT; STRESS; GROWTH; ZOOXANTHELLAE; DAMSELFISHES	Global environmental change has the potential to disrupt well established species interactions, with impacts on nutrient cycling and ecosystem function. On coral reefs, fish living within the branches of coral colonies can promote coral performance, and it has been hypothesized that the enhanced water flow and nutrients provided by fish to corals could ameliorate coral bleaching. The aim of this study was to evaluate the influence of small, aggregating damselfish on the health of their host corals (physiology, recovery, and survival) before, during, and after a thermal-bleaching event. When comparing coral colonies with and without fish, those with resident fish exhibited higher Symbiodinium densities and chlorophyll in both field and experimentally-induced bleaching conditions, and higher protein concentrations in field colonies. Additionally, colonies with damselfish in aquaria exhibited both higher photosynthetic efficiency (F-V/F-M) during bleaching stress and post-bleaching recovery, compared to uninhabited colonies. These results demonstrate that symbiotic damselfishes, and the services they provide, translate into measureable impacts on coral tissue, and can influence coral bleaching susceptibility/resilience and recovery. By mediating how external abiotic stressors influence coral colony health, damselfish can affect the functional responses of these interspecific interactions in a warming ocean.	[Chase, T. J.; Frank, G. E.; Hoogenboom, M. O.] James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture, Townsville, Qld, Australia; [Chase, T. J.; Pratchett, M. S.; Frank, G. E.; Hoogenboom, M. O.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University	Chase, TJ (corresponding author), James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture, Townsville, Qld, Australia.; Chase, TJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	tory.chase@my.jcu.edu.au	Chase, Tory/ABF-9222-2020; Hoogenboom, Mia O/D-3664-2012; Pratchett, Morgan/AAW-5179-2020	Chase, Tory/0000-0002-2044-136X; Hoogenboom, Mia O/0000-0003-3709-6344; Pratchett, Morgan/0000-0002-1862-8459	James Cook University; ARC Centre of Excellence for Coral Reef Studies [CE140100020]; Lizard Island Research Station Postgraduate Internship	James Cook University; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Lizard Island Research Station Postgraduate Internship	This research was funded by James Cook University to TJC, the ARC Centre of Excellence for Coral Reef Studies (Grant CE140100020) to MOH (https://www.arc.gov.au/grants), and a Lizard Island Research Station Postgraduate Internship to TJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairey E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12285; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berenshtein I, 2004, MAR ECOL, V36, P1171; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bonin MC, 2009, MAR ECOL PROG SER, V394, P215, DOI 10.3354/meps08294; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Cantrell CE, 2015, MAR BIOL, V162, P2327, DOI 10.1007/s00227-015-2767-9; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Chase TJ, 2014, OECOLOGIA, V176, P1009, DOI 10.1007/s00442-014-3065-9; Chong-Seng KM, 2011, CORAL REEFS, V30, P473, DOI 10.1007/s00338-010-0707-1; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Coker DJ, 2012, J EXP MAR BIOL ECOL, V414, P62, DOI 10.1016/j.jembe.2012.01.014; Cole AJ, 2009, CORAL REEFS, V414-415, P62; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Dixson DL, 2012, SCIENCE, V338, P804, DOI 10.1126/science.1225748; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Eme J, 2009, J THERM BIOL, V34, P220, DOI 10.1016/j.jtherbio.2009.02.005; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Frisch AJ, 2007, J EXP MAR BIOL ECOL, V345, P101, DOI 10.1016/j.jembe.2007.02.004; Garcia-Herrera N, 2017, J EXP BIOL, V220, P1803, DOI 10.1242/jeb.152462; Gil MA, 2013, ECOLOGY, V94, P1871, DOI 10.1890/12-1697.1; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Goldshmid R, 2004, LIMNOL OCEANOGR, V49, P1832, DOI 10.4319/lo.2004.49.5.1832; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; Hernandez-Agreda A, 2017, TRENDS MICROBIOL, V25, P125, DOI 10.1016/j.tim.2016.11.003; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Holbrook SJ, 2008, MAR BIOL, V155, P521, DOI 10.1007/s00227-008-1051-7; Holbrook SJ, 2011, OECOLOGIA, V166, P739, DOI 10.1007/s00442-011-1912-5; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Hoogenboom MO, 2011, MAR ECOL PROG SER, V438, P119, DOI 10.3354/meps09271; Hoogenboom MO, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00376; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Javahery S, 2012, FISH PHYSIOL BIOCHEM, V38, P1545, DOI 10.1007/s10695-012-9682-5; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2000, MAR FRESHWATER RES, V51, P63, DOI 10.1071/MF99100; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; LIBERMAN T, 1995, MAR BIOL, V121, P741, DOI 10.1007/BF00349310; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marquis M, 2014, ECOLOGY, V95, P9, DOI 10.1890/13-0760.1; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McClanahan T, 2002, CONSERV ECOL, V6; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P157, DOI 10.4319/lo.1985.30.1.0157; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P146, DOI 10.4319/lo.1985.30.1.0146; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Nagelkerken I, 2016, GLOBAL CHANGE BIOL, V22, P974, DOI 10.1111/gcb.13167; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; Pironet FN, 2000, AQUACULT INT, V8, P349, DOI 10.1023/A:1009257011431; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; R Development Core Team, 2017, R LANG ENV STAT COMP; SALE PF, 1972, ECOLOGY, V53, P741, DOI 10.2307/1934795; Shantz AA, 2015, ECOL APPL, V25, P2142, DOI 10.1890/14-2209.1.sm; Shantz AA, 2014, ECOLOGY, V95, P1995, DOI 10.1890/13-1407.1; Six DL, 2009, NAT REV MICROBIOL, V7, P686, DOI [10.1038/nrmicro2232, 10.1038/nrmicro2234]; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sweet MJ, 2016, OCEANOGR MAR BIOL, V54, P271; Tunney TD, 2014, P NATL ACAD SCI USA, V111, P8077, DOI 10.1073/pnas.1319618111; van de Leemput IA, 2016, CORAL REEFS, V35, P857, DOI 10.1007/s00338-016-1439-7; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Woods EK, 2015, INTERRELATIONSHIPS P	78	20	20	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208545	10.1371/journal.pone.0208545	http://dx.doi.org/10.1371/journal.pone.0208545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550591	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000453248000020
J	Hoggarth, ZE; Osowski, DB; Freeberg, BA; Garrett, SH; Sens, DA; Sens, MA; Zhou, XD; Zhang, KK; Somji, S				Hoggarth, Zachary E.; Osowski, Danyelle B.; Freeberg, Brooke A.; Garrett, Scott H.; Sens, Donald A.; Sens, Mary Ann; Zhou, Xu Dong; Zhang, Ke K.; Somji, Seema			The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers	PLOS ONE			English	Article							BLADDER-CANCER; GLANDULAR DIFFERENTIATION; MESSENGER-RNA; KERATIN 6; EXPRESSION; CLASSIFICATION; CARCINOMA; SUBTYPES; CYSTECTOMY; CULTURE	Muscle invasive urothelial carcinomas are divided into various molecular subtypes with basal and luminal subtypes being the prominent ones. The basal muscle-invasive urothelial carcinomas are generally more aggressive at presentation and significantly enriched with squamous features. Our laboratory has developed an in-vitro model of urothelial cancer by transforming the immortalized cell line UROtsa with arsenite (As3+) and cadmium (Cd2+). In this study, we characterized the tumors formed by these transformed cell lines as more basal-like based on their gene expression patterns with increased expression of KRT1, KRT5, KRT6, KRT14, KRT16, KRT17 and CD44. In addition, histological examination of these tumor transplants showed squamous features enriched in basal muscle invasive urothelial carcinomas. The expression of these genes increased in the transformed cell lines as well as in the urospheres, which are putative cancer initiating cells/stem cells derived from the cell lines. There was also increased expression of these genes in the urospheres derived from the parent UROtsa cell line. Thus, our data shows that the As3+ and Cd2+-transformed cell lines and their derived tumor transplants have gene expression profiles similar to the basal subtype of muscle invasive bladder carcinomas with tumors having enriched squamous features. The increased expression of basal markers in the urospheres suggests that stem cells may be involved in the development of squamous differentiation seen in some of the muscle invasive bladder carcinomas.	[Hoggarth, Zachary E.; Osowski, Danyelle B.; Freeberg, Brooke A.; Garrett, Scott H.; Sens, Donald A.; Sens, Mary Ann; Zhou, Xu Dong; Zhang, Ke K.; Somji, Seema] Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Somji, S (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58202 USA.	seema.somji@med.und.edu			Department of Pathology, University of North Dakota; School of Medicine and Health Sciences, University of North Dakota; ND INBRE IDeA program from the National Institute of General Medical Sciences, NIH [P20 GM103442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	Department of Pathology, University of North Dakota; School of Medicine and Health Sciences, University of North Dakota; ND INBRE IDeA program from the National Institute of General Medical Sciences, NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research described was supported by funds provided by the Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota. Undergraduate research, graduate student mentoring, core facilities for bioinformatics, statistics, and gene expression were supported by the ND INBRE IDeA program P20 GM103442 from the National Institute of General Medical Sciences, NIH.	Aine M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10957; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Garrett SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085614; Garrett SH, 1998, ENVIRON HEALTH PERSP, V106, P825, DOI 10.1289/ehp.98106825; Kim SP, 2012, J UROLOGY, V188, P405, DOI 10.1016/j.juro.2012.04.020; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Mitra AP, 2014, UROL ONCOL-SEMIN ORI, V32, P117, DOI 10.1016/j.urolonc.2012.08.017; Mo QX, 2018, JNCI-J NATL CANCER I, V110, P448, DOI 10.1093/jnci/djx243; Patschan O, 2015, EUR UROL, V68, P824, DOI 10.1016/j.eururo.2015.02.021; PETZOLDT JL, 1994, UROL RES, V22, P67, DOI 10.1007/BF00310994; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sandquist EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156310; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Sjodahl G, 2017, J PATHOL, V242, P113, DOI 10.1002/path.4886; Sjodahl G, 2013, AM J PATHOL, V183, P681, DOI 10.1016/j.ajpath.2013.05.013; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Slusser-Nore A, 2017, TOXICOL APPL PHARM, V331, P41, DOI 10.1016/j.taap.2017.05.007; Somji S, 2008, ENVIRON HEALTH PERSP, V116, P434, DOI 10.1289/ehp.10279; Somji S, 2011, CELL BIOL TOXICOL, V27, P381, DOI 10.1007/s10565-010-9169-z; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Volmar KE, 2003, AM J SURG PATHOL, V27, P1243, DOI 10.1097/00000478-200309000-00008; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Young RH, 2009, MODERN PATHOL, V22, pS37, DOI 10.1038/modpathol.2008.201	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207877	10.1371/journal.pone.0207877	http://dx.doi.org/10.1371/journal.pone.0207877			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550540	gold, Green Submitted, Green Published			2022-12-26	WOS:000453248000011
J	Kageyama, Y; Miwa, H; Arakawa, R; Tawara, I; Ohishi, K; Masuya, M; Nakase, K; Katayama, N				Kageyama, Yuki; Miwa, Hiroshi; Arakawa, Rino; Tawara, Isao; Ohishi, Kohshi; Masuya, Masahiro; Nakase, Kazunori; Katayama, Naoyuki			Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ADVERSE PROGNOSTIC-FACTOR; RECEPTOR-ALPHA-CHAIN; STEM-CELLS; TARGET; RISK	CD25 is expressed on leukemic cells in 10-20% cases of acute myeloid leukemia (AML), and its expression is associated with poor prognosis. We reevaluated the relationship between CD25 expression and the leukemia-initiating cell (LIC) properties of AML using a patient-derived xenograft model. We divided lineage marker-negative (Lin(-)) CD34(+)CD38(-) or Lin(-)CD34(+) cells from CD25-positive AML into CD25-positive and -negative populations, and then transplanted each population into NOD.Cg-Prkde(scid)Il2rg(tm1Wjl)/Sz mice. Leukemic engraftment was observed with both CD25-positive and -negative populations from three of nine CD25-positive AML patients. In two of those three patients, CD25-positive and -negative Lin(-)CD34(+) cells engrafted at the primary transplantation led to leukemic engraftment at the secondary transplantation, in which engrafted cells contained both CD25-positive and -negative Lin(-)CD34(+) AML cells. In an in vitro culture system, expression of CD25 was considerably induced in the CD25-negative population of Lin(-)CD34(+) cells from two cases of CD25-positive AML. In one case, CD25-positive Lin(-)CD34(+ )cells gave rise to CD25-negative as well as -positive CD34(+) cells. These observations suggest that there exist CD25-positive and -negative populations that can reconstitute CD25-positive AML in a patient-derived xenograft model, and that CD25 expression fluctuates in the LICs of AML.	[Kageyama, Yuki; Miwa, Hiroshi; Tawara, Isao; Masuya, Masahiro; Katayama, Naoyuki] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie, Japan; [Arakawa, Rino] Mie Univ, Sch Med, Tsu, Mie, Japan; [Ohishi, Kohshi] Mie Univ Hosp, Dept Transfus Med & Cell Therapy, Tsu, Mie, Japan; [Nakase, Kazunori] Mie Univ Hosp, Canc Ctr, Tsu, Mie, Japan	Mie University; Mie University; Mie University; Mie University	Katayama, N (corresponding author), Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie, Japan.	n-Kata@clin.medic.mie-u.ac.jp	Kageyama, Yuki/AAD-1098-2020	Kageyama, Yuki/0000-0002-0564-2227	Japan Society for the Promotion of Science [17K099230K, 16K093070K, 17K099490K]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI grant numbers 17K099230K, 16K093070K, and 17K099490K to N. K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cerny J, 2013, BRIT J HAEMATOL, V160, P262, DOI 10.1111/bjh.12109; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fujiwara S, 2017, HEMATOLOGY, V22, P347, DOI 10.1080/10245332.2016.1276240; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gonen M, 2012, BLOOD, V120, P2297, DOI 10.1182/blood-2012-02-414425; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kobayashi CI, 2014, BLOOD, V123, P2540, DOI 10.1182/blood-2013-07-517847; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; NAKASE K, 1992, BRIT J HAEMATOL, V80, P317, DOI 10.1111/j.1365-2141.1992.tb08139.x; Nakase K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128998; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Pollyea DA, 2017, BLOOD, V129, P1627, DOI 10.1182/blood-2016-10-696039; Quek L, 2016, J EXP MED, V213, P1513, DOI 10.1084/jem.20151775; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Terwijn M, 2009, EUR J CANCER, V45, P1692, DOI 10.1016/j.ejca.2009.02.021	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209295	10.1371/journal.pone.0209295	http://dx.doi.org/10.1371/journal.pone.0209295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550585	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000056
J	Cortes, E; Lachowski, D; Rice, A; Thorpe, SD; Robinson, B; Yeldag, G; Lee, DA; Ghemtio, L; Rombouts, K; Hernandez, AED				Cortes, Ernesto; Lachowski, Dariusz; Rice, Alistair; Thorpe, Stephen D.; Robinson, Benjamin; Yeldag, Gulcen; Lee, David A.; Ghemtio, Leo; Rombouts, Krista; Hernandez, Armando E. del Rio			Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTORS; HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR-MATRIX; ACTIVATION; STIFFNESS; MECHANOTRANSDUCTION; EXPRESSION; PRESTRESS; RISK; GPER	Tamoxifen has been used for many years to target estrogen receptor signalling in breast cancer cells. Tamoxifen is also an agonist of the G protein-coupled estrogen receptor (GPER), a GPCR ubiquitously expressed in tissues that mediates the acute response to estrogens. Here we report that tamoxifen promotes mechanical quiescence in hepatic stellate cells (HSCs), stromal fibroblast-like cells whose activation triggers and perpetuates liver fibrosis in hepatocellular carcinomas. This mechanical deactivation is mediated by the GPER/RhoA/myosin axis and induces YAP deactivation. We report that tamoxifen decreases the levels of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the synthesis of extracellular matrix proteins through a mechanical mechanism that involves actomyosin-dependent contractility and mechanosensing of tissue stiffness. Our results implicate GPER-mediated estrogen signalling in the mechanosensory-driven activation of HSCs and put forward estrogenic signalling as an option for mechanical reprogramming of myofibroblast-like cells in the tumour microenvironment. Tamoxifen, with half a century of safe clinical use, might lead this strategy of drug repositioning.	[Cortes, Ernesto; Lachowski, Dariusz; Rice, Alistair; Robinson, Benjamin; Yeldag, Gulcen; Hernandez, Armando E. del Rio] Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England; [Thorpe, Stephen D.; Lee, David A.] Queen Mary Univ London, Sch Engn & Mat Sci, Inst Bioengn, London E1 4NS, England; [Ghemtio, Leo] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Drug Res Program, FI-00014 Helsinki, Finland; [Rombouts, Krista] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, Regenerat Med & Fibrosis Grp, London, England	Imperial College London; University of London; Queen Mary University London; University of Helsinki; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Hernandez, AED (corresponding author), Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England.	a.del-rio-hernandez@imperial.ac.uk	Cortes Lopez, Ernesto/ABE-5343-2021; del rio hernandez, armando e/N-4262-2013; Rombouts, Krista/ABB-2602-2020; Thorpe, Stephen/C-1656-2018; del Río Hernández, Armando E/D-3555-2012; Rombouts, Krista/AAE-8179-2020	Cortes Lopez, Ernesto/0000-0001-6106-1323; del rio hernandez, armando e/0000-0001-5062-8910; Thorpe, Stephen/0000-0002-4707-7756; del Río Hernández, Armando E/0000-0001-5062-8910; Rombouts, Krista/0000-0001-9440-0571; ghemtio, leo/0000-0003-3591-5676; Lee, David/0000-0001-7646-4643; Lachowski, Dariusz/0000-0003-1194-8019	European Research Council (ERC) [282051]; Drug Discovery and Chemical Biology - Biocenter Finland; BBSRC [BB/N018532/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)); Drug Discovery and Chemical Biology - Biocenter Finland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council (ERC grant 282051). LG gratefully acknowledges the support of The Drug Discovery and Chemical Biology - Biocenter Finland.	Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chen C, 2017, ONCOTARGET, V8, P46691, DOI 10.18632/oncotarget.17358; Chen SY, 2016, J CELL BIOCHEM, V117, P267, DOI 10.1002/jcb.25283; Chronopoulos A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12630; Copple BL, 2011, LIVER INT, V31, P230, DOI 10.1111/j.1478-3231.2010.02347.x; Cortes E, 2019, HEPATOLOGY, V69, P785, DOI 10.1002/hep.30193; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Cui XD, 2014, MOL MED REP, V9, P1641, DOI 10.3892/mmr.2014.2036; Cuzick J, 2004, JNCI-J NATL CANCER I, V96, P621, DOI 10.1093/jnci/djh106; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Feng S, 2017, ARTERIOSCL THROM VAS, V37, P2087, DOI 10.1161/ATVBAHA.117.309249; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Haining AWM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005599; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kelloff G J, 1994, J Cell Biochem Suppl, V20, P252; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lachowski D, 2018, FASEB J, V32, P1099, DOI 10.1096/fj.201700721R; Lachowski D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02689-x; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mandlekar S, 2000, CANCER RES, V60, P6601; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Robinson BK, 2016, BIOL OPEN, V5, P875, DOI 10.1242/bio.017632; Rodriguez-Hernandez Irene, 2016, F1000Res, V5, DOI 10.12688/f1000research.7909.1; Sakurai T, 2013, LIVER CANCER, V2, P365, DOI 10.1159/000343851; Sarper M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27639; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004; Stamenovic D, 2005, ACTA BIOMATER, V1, P255, DOI 10.1016/j.actbio.2005.01.004; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f; Wilson GK, 2014, J HEPATOL, V61, P1397, DOI 10.1016/j.jhep.2014.08.025; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zimmerman MA, 2016, CLIN SCI, V130, P1005, DOI 10.1042/CS20160114	54	33	34	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					2910	2922		10.1038/s41388-018-0631-3	http://dx.doi.org/10.1038/s41388-018-0631-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30575816	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000465167600003
J	Yan, YH; Zhou, AW; Carrell, RW; Read, RJ				Yan, Yahui; Zhou, Aiwu; Carrell, Robin W.; Read, Randy J.			Structural basis for the specificity of renin-mediated angiotensinogen cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						renin angiotensin system; serpin; crystal structure; conformational change; site-directed mutagenesis; kinetics; proteolysis; aspartic protease; hypertension; angiotensinogen	CORTICOSTEROID-BINDING GLOBULIN; AMINO-ACID-RESIDUES; SPECIES-SPECIFICITY; CRYSTAL-STRUCTURES; TRANSGENIC MICE; GLYCOSYLATION; MECHANISM; KINETICS; SYSTEM; SITE	The renin-angiotensin cascade is a hormone system that regulates blood pressure and fluid balance. Renin-mediated cleavage of the angiotensin I peptide from the N terminus of angiotensinogen (AGT) is the rate-limiting step of this cascade; however, the detailed molecular mechanism underlying this step is unclear. Here, we solved the crystal structures of glycosylated human AGT (2.30 A resolution), its encounter complex with renin (2.55 A), AGT cleaved in its reactive center loop (RCL; 2.97 A), and spent AGT from which the N-terminal angiotensin peptide was removed (2.63 A). These structures revealed that AGT undergoes profound conformational changes and binds renin through a tail-into-mouth allosteric mechanism that inserts the N terminus into a pocket equivalent to a hormone-binding site on other serpins. These changes fully extended the N-terminal tail, with the scissile bond for angiotensin release docked in renin's active site. Insertion of the N terminus into this pocket accompanied a complete unwinding of helix H of AGT, which, in turn, formed key interactions with renin in the complementary binding interface. Mutagenesis and kinetic analyses confirmed that renin-mediated production of angiotensin I is controlled by interactions of amino acid residues and glycan components outside renin's active-site cleft. Our findings indicate that AGT adapts unique serpin features for hormone delivery and binds renin through concerted movements in the N-terminal tail and in its main body to modulate angiotensin release. These insights provide a structural basis for the development of agents that attenuate angiotensin release by targeting AGT's hormone binding pocket.	[Yan, Yahui; Carrell, Robin W.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England; [Zhou, Aiwu] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ,Hongqiao Int Inst Med, Shanghai Tongren Hosp,Fac Basic Med,Key Lab Cell, Shanghai 200025, Peoples R China	University of Cambridge; Shanghai Jiao Tong University	Read, RJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China.	aiwu.zhou@googlemail.com; rjr27@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; Yan, Yahui/0000-0001-6934-9874; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation [PG/12/41/29679]; Wellcome Trust [082961/Z/07/Z, 100140]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Natural Science Foundation of China [31370727, 81870309]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by British Heart Foundation Grant PG/12/41/29679 and Wellcome Trust Principal Research Fellowship 082961/Z/07/Z (to R. J. R.). The research was facilitated by Wellcome Trust Strategic Award 100140 (to the Cambridge Institute for Medical Research). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and by National Natural Science Foundation of China Grants 31370727 and 81870309.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva NS, 2001, PROTEIN SCI, V10, P2439, DOI 10.1110/ps.ps.25801; BARRETT JD, 1979, J CLIN ENDOCR METAB, V48, P96, DOI 10.1210/jcem-48-1-96; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bras NF, 2012, PHYS CHEM CHEM PHYS, V14, P12605, DOI 10.1039/c2cp41422h; BURTON J, 1988, BIOCHIM BIOPHYS ACTA, V952, P8, DOI 10.1016/0167-4838(88)90095-7; Celerier J, 2002, HYPERTENSION, V39, P224, DOI 10.1161/hy0202.103441; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; CUMIN F, 1987, BIOCHIM BIOPHYS ACTA, V913, P10, DOI 10.1016/0167-4838(87)90226-3; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DHANARAJ V, 1992, NATURE, V357, P466, DOI 10.1038/357466a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fournier D, 2012, J MOL MED, V90, P495, DOI 10.1007/s00109-012-0894-z; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GENAIN C, 1984, J CLIN ENDOCR METAB, V59, P478, DOI 10.1210/jcem-59-3-478; Gimenez-Roqueplo AP, 1998, J BIOL CHEM, V273, P21232, DOI 10.1074/jbc.273.33.21232; HATAE T, 1994, MOL CELL BIOCHEM, V131, P43, DOI 10.1007/BF01075723; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inui Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1612, DOI 10.1271/bbb.62.1612; Iwata H, 2008, BIOSCI BIOTECH BIOCH, V72, P179, DOI 10.1271/bbb.70541; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu H, 2016, ARTERIOSCL THROM VAS, V36, P256, DOI 10.1161/ATVBAHA.115.306740; Lutteke T, 2009, ACTA CRYSTALLOGR D, V65, P156, DOI 10.1107/S0907444909001905; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Mangan MSJ, 2016, J BIOL CHEM, V291, P3626, DOI 10.1074/jbc.M115.699298; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nabi AHMN, 2005, INT J MOL MED, V16, P103; Pol-Fachin L, 2011, PROTEINS, V79, P2735, DOI 10.1002/prot.23102; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Rahgozar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135905; RAHUEL J, 1991, J STRUCT BIOL, V107, P227, DOI 10.1016/1047-8477(91)90048-2; Rong P, 2003, HYPERTENSION, V42, P523, DOI 10.1161/01.HYP.0000093383.18302.A7; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Selo I, 1996, J IMMUNOL METHODS, V199, P127, DOI 10.1016/S0022-1759(96)00173-1; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Sumer-Bayraktar Z, 2016, J BIOL CHEM, V291, P17727, DOI 10.1074/jbc.M116.735258; TAKAHASHI S, 1991, BIOCHEM BIOPH RES CO, V180, P1103, DOI 10.1016/S0006-291X(05)81180-5; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Wei H, 2016, J BIOL CHEM, V291, P24900, DOI 10.1074/jbc.M116.725895; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	54	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2353	2364		10.1074/jbc.RA118.006608	http://dx.doi.org/10.1074/jbc.RA118.006608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30563843	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000458895400013
J	Cordes, N; Ney, M; Beleites, T; Aust, D; Baretton, G; Thames, H; Baumann, M; Krause, M; Lock, S; Appold, S				Cordes, Nils; Ney, Michael; Beleites, Thomas; Aust, Daniela; Baretton, Gustavo; Thames, Howard; Baumann, Michael; Krause, Mechthild; Loeck, Steffen; Appold, Steffen			Retrospective investigation of the prognostic value of the beta 1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy	PLOS ONE			English	Article							PHASE-II TRIAL; RADIATION ONCOLOGY; MARKER EXPRESSION; METASTATIC HEAD; CANCER; INTEGRIN; RADIOTHERAPY; RADIOCHEMOTHERAPY; MULTICENTER; CETUXIMAB	This retrospective study evaluated the expression of beta 1 integrins and associated proteins as prognostic markers for primary radio(chemo)therapy outcome of patients with locally advanced head and neck squamous cell carcinomas (HNSCC). Tissue microarrays were prepared from 224 HNSCC patients undergoing curative primary radio(chemo)therapy from 1996 to 2005. Staining intensities of beta 1 integrin and its downstream-proteins FAK, phosphorylated FAK as well as the beta 1 integrin ECM ligands fibronectin and collagen type-I were determined. Their association to the primary endpoint loco-regional control and the secondary endpoints overall survival and freedom from distant metastasis was analyzed by Cox regression. None of the considered molecular parameters showed a significant association with loco-regional control and freedom from distant metastasis. Patients with p16 positive tumors or tumors with a low intensity of fibronectin showed significantly higher overall survival in univariable regression. In multivariable regression including additional clinical parameters, however, these parameters were not significantly associated with overall survival. Our study in a HNSCC patient cohort treated with primary radio(chemo)therapy does not reveal a prognostic value of beta 1 integrin expression.	[Cordes, Nils; Ney, Michael; Thames, Howard; Baumann, Michael; Krause, Mechthild; Loeck, Steffen; Appold, Steffen] Tech Univ Dresden, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany; [Cordes, Nils; Ney, Michael; Thames, Howard; Baumann, Michael; Krause, Mechthild; Loeck, Steffen; Appold, Steffen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Cordes, Nils; Ney, Michael; Thames, Howard; Baumann, Michael; Krause, Mechthild; Loeck, Steffen; Appold, Steffen] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Cordes, Nils; Thames, Howard; Baumann, Michael; Krause, Mechthild; Loeck, Steffen; Appold, Steffen] Tech Univ Dresden, Dept Radiat Oncol, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Cordes, Nils; Baumann, Michael; Krause, Mechthild; Loeck, Steffen] German Canc Consortium DKTK, Dresden, Germany; [Cordes, Nils; Baumann, Michael; Krause, Mechthild; Loeck, Steffen] German Canc Res Ctr, Heidelberg, Germany; [Cordes, Nils; Baumann, Michael; Krause, Mechthild] Helmholtz Zentrum Dresden Rossendorf, Inst Radiat Oncol OncoRay, Dresden, Germany; [Ney, Michael] Charite, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany; [Beleites, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Aust, Daniela; Baretton, Gustavo] Tech Univ Dresden, Dept Pathol, Univ Hosp Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Cordes, N (corresponding author), Tech Univ Dresden, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Cordes, N (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Dept Radiat Oncol, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Cordes, N (corresponding author), German Canc Consortium DKTK, Dresden, Germany.; Cordes, N (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Cordes, N (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiat Oncol OncoRay, Dresden, Germany.	Nils.Cordes@OncoRay.de		Krause, Mechthild/0000-0003-1776-9556; Cordes, Nils/0000-0001-5684-629X; Baumann, Michael/0000-0002-9340-974X; Lock, Steffen/0000-0002-7017-3738	Bundesministerium fur Bildung und Forschung (BMBF) [03ZIK041, BMBF-02NUK006B]; EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen [100066308]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen	The research and authors were in part supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF Contracts 03ZIK041 to M.B. and N.C. and BMBF-02NUK006B to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann M, 2016, NAT REV CANCER, V16, P234, DOI 10.1038/nrc.2016.18; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Berry MG, 2004, EJSO, V30, P484, DOI 10.1016/j.ejso.2004.01.016; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bossi P, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0431-3; Bottger TC, 1999, HEPATO-GASTROENTEROL, V46, P938; Bottger TC, 1999, ONCOLOGY-BASEL, V56, P308, DOI 10.1159/000011984; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Chang MH, 2012, APMIS, V120, P28, DOI 10.1111/j.1600-0463.2011.02788.x; Choi SH, 2006, LARYNGOSCOPE, V116, P1228, DOI 10.1097/01.mlg.0000224499.93774.77; Cooper JS, 2009, HEAD NECK-J SCI SPEC, V31, P748, DOI 10.1002/hed.21022; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Dickreuter E, 2016, ONCOGENE, V35, P1353, DOI 10.1038/onc.2015.212; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; dos Santos PB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-104; Eke I, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju419; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Fabricius EM, 2011, EXP THER MED, V2, P9, DOI 10.3892/etm.2010.171; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Geiger JL, 2016, HEAD NECK-J SCI SPEC, V38, P1759, DOI 10.1002/hed.24501; Glorieux M, 2017, ONCOTARGET, V8, P81662, DOI 10.18632/oncotarget.20953; Goesswein D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25512-7; Haase M, 2008, J HISTOCHEM CYTOCHEM, V56, P819, DOI 10.1369/jhc.2008.951095; Hehlgans S, 2012, INT J RAD ONCOL BIOL, V83; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Janssens GO, 2012, J CLIN ONCOL, V30, P1777, DOI 10.1200/JCO.2011.35.9315; Jayaram SC, 2016, HEAD NECK-J SCI SPEC, V38, P1855, DOI 10.1002/hed.24531; Jimeno A, 2015, ANN ONCOL, V26, P556, DOI 10.1093/annonc/mdu574; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Echarri MJ, 2016, CANCERS, V8, DOI 10.3390/cancers8030027; Koukourakis MI, 2012, BRIT J CANCER, V106, P846, DOI 10.1038/bjc.2012.33; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Linge A, 2016, RADIOTHER ONCOL, V121, P364, DOI 10.1016/j.radonc.2016.11.008; Linge A, 2016, CLIN CANCER RES, V22, P2639, DOI 10.1158/1078-0432.CCR-15-1990; Liu QZ, 2015, INT J CLIN EXP PATHO, V8, P12802; Lothaire P, 2006, HEAD NECK-J SCI SPEC, V28, P256, DOI 10.1002/hed.20326; Machiels Jean-Pascal, 2014, F1000Prime Rep, V6, P44, DOI 10.12703/P6-44; Mallen-St Clair J, 2016, BBA-REV CANCER, V1866, P141, DOI 10.1016/j.bbcan.2016.07.005; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mirghani H, 2015, CANCER TREAT REV, V41, P844, DOI 10.1016/j.ctrv.2015.10.001; Misawa K, 2014, MOL CLIN ONCOL, V2, P285, DOI 10.3892/mco.2013.233; Muller-Klingspor V, 2001, ANTICANCER RES, V21, P2185; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Shinohara M, 1999, AM J CLIN PATHOL, V111, P75; Skinner HD, 2016, CLIN CANCER RES, V22, P4643, DOI 10.1158/1078-0432.CCR-15-2785; Sobin LH., 2010, TNM CLASSIFICATION M; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Steglich A, 2015, CANCER LETT, V357, P542, DOI 10.1016/j.canlet.2014.12.009; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Tinhofer I, 2016, EUR J CANCER, V57, P78, DOI 10.1016/j.ejca.2016.01.003; van Dijk LK, 2015, ACTA ONCOL, V54, P1263, DOI 10.3109/0284186X.2015.1063778; Vassos N, 2014, INT J CLIN EXP PATHO, V7, P288; Vehlow A, 2017, ONCOTARGET, V8, P49224, DOI 10.18632/oncotarget.17480; Vihinen P, 2000, MELANOMA RES, V10, P243, DOI 10.1097/00008390-200010030-00006; Vitolo D, 2000, HEAD NECK-J SCI SPEC, V22, P48, DOI 10.1002/(SICI)1097-0347(200001)22:1<48::AID-HED8>3.0.CO;2-L; Wang DS, 2012, CLIN CANCER RES, V18, P4589, DOI 10.1158/1078-0432.CCR-11-3127; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zhou G, 2016, J CELL BIOCHEM, V117, P2682, DOI 10.1002/jcb.25592; Zips D, 2011, STRAHLENTHER ONKOL, V187, P306, DOI 10.1007/s00066-011-2210-1; Zscheppang K, 2016, J CANCER, V7, P736, DOI 10.7150/jca.14232	67	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209479	10.1371/journal.pone.0209479	http://dx.doi.org/10.1371/journal.pone.0209479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571736	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700080
J	Daniels, CN; Zyla, TR; Lew, DJ				Daniels, Christine N.; Zyla, Trevin R.; Lew, Daniel J.			A role for Gic1 and Gic2 in Cdc42 polarization at elevated temperature	PLOS ONE			English	Article							CELL-POLARITY; SYMMETRY-BREAKING; ACTIN POLARIZATION; NEGATIVE FEEDBACK; PROTEINS GIC1; GENE DELETION; YEAST; PHOSPHORYLATION; GTPASE; ESTABLISHMENT	The conserved Rho-family GTPase Cdc42 is a master regulator of polarity establishment in many cell types. Cdc42 becomes activated and concentrated in a region of the cell cortex, and recruits a variety of effector proteins to that site. In turn, many effectors participate in regulation of cytoskeletal elements in order to remodel the cytoskeleton in a polarized manner. The budding yeast Saccharomyces cerevisiae has served as a tractable model system for studies of cell polarity. In yeast cells, Cdc42 polarization involves a positive feedback loop in which effectors called p21-activated kinases (PAKs) act to recruit a Cdc42-directed guanine nucleotide exchange factor (GEF), generating more GTP-Cdc42 in areas that already have GTP-Cdc42. The GTPase-interacting components (GICs) Gic1 and Gic2 are also Cdc42 effectors, and have been implicated in regulation of the actin and septin cyto-skeleton. However, we report that cells lacking GICs are primarily defective in polarizing Cdc42 itself, suggesting that they act upstream as well as downstream of Cdc42 in yeast. Our findings suggest that feedback pathways involving GTPase effectors may be more prevalent than had been appreciated.	[Daniels, Christine N.; Zyla, Trevin R.; Lew, Daniel J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Duke University	Lew, DJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	daniel.lew@duke.edu			National Institute of General Medical Sciences [GM62300, GM122488]; NIH/NIGMS [GM62300, GM122488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300, R25GM086262, R35GM122488] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institute of General Medical Sciences, via grants GM62300 and GM122488 to Daniel Lew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kyle Moran for help with the statistics, and members of the Lew lab for productive discussions and input. This work was funded by NIH/NIGMS grants GM62300 and GM122488 to D.J.L.	Alekhina O, 2017, J CELL SCI, V130, P2235, DOI 10.1242/jcs.199570; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Bi EF, 1996, MOL CELL BIOL, V16, P5264; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen GC, 1997, GENE DEV, V11, P2958, DOI 10.1101/gad.11.22.2958; Chen H, 2012, MOL BIOL CELL, V23, P3814, DOI 10.1091/mbc.E12-05-0400; Chiou JG, 2017, ANNU REV CELL DEV BI, V33, P77, DOI 10.1146/annurev-cellbio-100616-060856; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; HALL A, 1993, PHILOS T ROY SOC B, V340, P267, DOI 10.1098/rstb.1993.0067; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Jaquenoud M, 2000, MOL CELL BIOL, V20, P6244, DOI 10.1128/MCB.20.17.6244-6258.2000; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kang PJ, 2018, MOL BIOL CELL, V29, P2359, DOI 10.1091/mbc.E18-02-0145; Kawasaki R, 2003, GENES CELLS, V8, P235, DOI 10.1046/j.1365-2443.2003.00629.x; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Kuo CC, 2014, CURR BIOL, V24, P753, DOI 10.1016/j.cub.2014.02.024; Liu XL, 2015, ELIFE, V4, DOI 10.7554/eLife.03977; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Mitin N, 2012, METHODS MOL BIOL, V827, P87, DOI 10.1007/978-1-61779-442-1_6; Mutavchiev DR, 2016, CURR BIOL, V26, P2921, DOI 10.1016/j.cub.2016.08.048; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Rane Chetan K, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28003; Rapali P, 2017, ELIFE, V6, DOI 10.7554/eLife.25257; Sadian Y, 2013, ELIFE, V2, DOI 10.7554/eLife.01085; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Wai SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006563	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0200863	10.1371/journal.pone.0200863	http://dx.doi.org/10.1371/journal.pone.0200863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566437	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300002
J	Zezza, MA; Bachhuber, MA				Zezza, Mark A.; Bachhuber, Marcus A.			Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing	PLOS ONE			English	Article							UNITED-STATES; INDUSTRY PAYMENTS; OVERDOSE; TRENDS	Background While the rise in opioid analgesic prescribing and overdose deaths was multifactorial, financial relationships between opioid drug manufacturers and physicians may be one important factor. Methods Using national data from 2013 to 2015, we conducted a retrospective cohort study linking the Open Payments database and Medicare Part D drug utilization data. We created two cohorts of physicians, those receiving opioid-related payments in 2014 and 2015, but not in 2013, and those receiving opioid-related payments in 2015 but not in 2013 and 2014. Our main outcome measures were expenditures on filled prescriptions, daily doses filled, and expenditures per daily dose. For each cohort, we created a comparison group that did not receive an opioid-related payment in any year and was matched on state, specialty, and baseline opioid expenditures. We used a difference-in-differences analysis with linear generalized estimating equations regression models. Results We identified 6,322 physicians who received opioid-related payments in 2014 and 2015, but not in 2013; they received a mean total of $251. Relative to comparison group physicians, they had a significantly larger increase in mean opioid expenditures ($6,171; 95% CI: 4,997 to 7,346), daily doses dispensed (1,574; 95%CI: 1,330 to 1,818) and mean expenditures per daily dose ($0.38; 95% CI: 0.29 to 0.47). We identified 8,669 physicians who received opioid-related payments in 2015, but not in 2013 or 2014; they received a mean total of $40. Relative to comparison physicians, they also had a larger increase in mean opioid expenditures ($1,031; 95% CI: 603 to 1,460), daily doses dispensed (557; 95% CI: 417 to 697), and expenditures per daily dose ($0.06; 95% CI: 0.002 to 0.13). Conclusions Our findings add to the growing public policy concern that payments from opioid drug manufacturers can influence physician prescribing. Interventions are needed to reduce such promotional activities or to mitigate their influence.	[Zezza, Mark A.] New York State Hlth Fdn, New York, NY 10018 USA; [Bachhuber, Marcus A.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Zezza, MA (corresponding author), New York State Hlth Fdn, New York, NY 10018 USA.	zezza@nyshealth.org		Bachhuber, Marcus/0000-0002-5610-8382; Zezza, Mark/0000-0003-1905-4343	National Institute on Drug Abuse of the National Institutes of Health [K08DA043050]; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA043050] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by a grant from the National Institute on Drug Abuse of the National Institutes of Health (K08DA043050) to MAB. The funding agency had no role in design of the study, collection, analysis, and interpretation of data, or in writing the manuscript.	[Anonymous], 2013, CBHSQ DATA REV; Centers for Disease Control and Prevention, 2015, NAMCS MICR FIL DOC; Centers for Disease Control and Prevention, OP DAT AN; Centers for Medicare and Medicaid Services, MED PROV UT PAYM D D; Centers for Medicare & Medicaid Services, NHE DEFL INT SUMM; Centers for Medicare & Medicaid Services, 2018, MED D; Centers for Medicare & Medicaid Services, 1980, NAT HLTH EXP DAT HIS; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Fleischman W, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4189; Grande D, 2010, J GEN INTERN MED, V25, P79, DOI 10.1007/s11606-009-1016-7; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hadland SE, 2018, JAMA INTERN MED, V178, P861, DOI 10.1001/jamainternmed.2018.1999; Hadland SE, 2017, AM J PUBLIC HEALTH, V107, P1493, DOI 10.2105/AJPH.2017.303982; Hasegawa K, 2014, PAIN MED, V15, P1765, DOI 10.1111/pme.12461; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kessler A, 2018, CNN EXCLUSIVE MORE O; King G., 2012, EXPLANATION CEM WEIG; Larson MJ, 2018, SUBST ABUS, V39, P218, DOI 10.1080/08897077.2018.1449175; Liebschutz JM, 2017, JAMA INTERN MED, V177, P1265, DOI 10.1001/jamainternmed.2017.2468; New York State Health Foundation, 2018, FOLL MON PHARM MAN P; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Perlis RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155474; Pope GC, 2011, EVALUATION CMS HCC R; Seth P, 2018, AM J TRANSPLANT, V18, P1556, DOI 10.1111/ajt.14905; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209383	10.1371/journal.pone.0209383	http://dx.doi.org/10.1371/journal.pone.0209383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566426	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300088
J	van Wijmen, MPS; Pasman, HRW; Twisk, JWR; Widdershoven, GAM; Onwuteaka-Philipsen, BD				van Wijmen, Matthijs P. S.; Pasman, H. Roeline W.; Twisk, Jos W. R.; Widdershoven, Guy A. M.; Onwuteaka-Philipsen, Bregje D.			Stability of end-of-life preferences in relation to health status and life-events: A cohort study with a 6-year follow-up among holders of an advance directive	PLOS ONE			English	Article							SUSTAINING TREATMENT; PATIENT PREFERENCES; PERSPECTIVE; CHOICES; CARE	Background Stating preferences about care beforehand using advance care planning and advance directives has become increasingly common in current medicine. There is still lack of clarity what happens over the course of time in relation to these preferences. We wanted to determine whether the preferences about end-of-life care of a person owning an advance directive stay stable after the experience of a life-event; how often advance directives are altered and discussed with family members and physicians over time. Design A longitudinal cohort study with a population consisting of people owning the most common advance directives in the Netherlands, with a follow-up of 6-years from 2005 until 2011. Respondents were recruited using two associations that provided the advance directives, Right to Die-NL (n = 4463) and the Dutch Patient Organisation (n = 1263). Each 1.5 year a questionnaire was sent. We analyzed the relationship between variables using generalized estimated equations. Results 96.9-98.1% of the respondents who had experienced a life-event had stable preferences. 89.9-93.7% of Right-to-Die-NL-members who had experienced a life-event didn't make any alterations in their advance directives. During the 6-year course of our study, a minority of both groups didn't discuss their advance directive with anyone (8.7-16.4%), while a majority didn't discuss it with physicians (ranging 58.1-95.1%). Factors related to health, such as deterioration in experienced health, increased the odds to discuss advance directives. Conclusion Our results largely dispute criticism concerning usability of advance directives due to lack of stability of preferences. Whereas a change in health status and the experience of other life-events were not related to instability in preferences, they did increase the odds of communication about advance directives. Because our results show that the possession of an advance directive does not necessarily result in frequent discussions between patients and caregivers, a more structured approach like advance care planning might be a solution.	[van Wijmen, Matthijs P. S.; Pasman, H. Roeline W.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Widdershoven, Guy A. M.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Humanities, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Wijmen, MPS (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	m.vanwijmen@vumc.nl		van Wijmen, Matthijs/0000-0003-1173-4985; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Innovational Research Incentives Scheme VICI 2008 from the Netherlands Organisation for Scientific Research (NWO) [NWO VICI 916.96.628]; Pieter van Foreest Stichting, Right to Die-NL (NVVE); Nederlandse Patienten Vereniging (NPV)	Innovational Research Incentives Scheme VICI 2008 from the Netherlands Organisation for Scientific Research (NWO); Pieter van Foreest Stichting, Right to Die-NL (NVVE); Nederlandse Patienten Vereniging (NPV)	This study was funded by the Innovational Research Incentives Scheme VICI 2008 from the Netherlands Organisation for Scientific Research (NWO) (grant number: NWO VICI 916.96.628), Pieter van Foreest Stichting, Right to Die-NL (NVVE) and the Nederlandse Patienten Vereniging (NPV) (all received by BO). The NVVE and NPV helped with the collection of the data by providing the addresses of the respondents and preparing the sending of the questionnaires. The other funders had no role in the data collection. None of the funders had a role in study design, data analysis, decision to publish, or preparation of the manuscript.	Almack K, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-15; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Barrio-Cantalejo IM, 2013, J BIOETHIC INQ, V10, P103, DOI 10.1007/s11673-012-9417-4; Bischoff K, 2018, JAMA INTERN MED, V178, P48, DOI 10.1001/jamainternmed.2017.6313; Bolt EE, 2016, J AM GERIATR SOC, V64, P1628, DOI 10.1111/jgs.14208; Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Burchardi N, 2005, J NEUROL SCI, V237, P67, DOI 10.1016/j.jns.2005.05.013; Carmel S, 1999, SOC SCI MED, V49, P303, DOI 10.1016/S0277-9536(99)00121-5; DANIS M, 1994, ANN INTERN MED, V120, P567, DOI 10.7326/0003-4819-120-7-199404010-00006; de Beaufort I, 2005, NEW ENGL J MED, V352, P2373, DOI 10.1056/NEJMp058094; Ditto PH, 2006, MED DECIS MAKING, V26, P313, DOI 10.1177/0272989X06290494; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; EMANUEL LL, 1994, ARCH INTERN MED, V154, P209, DOI 10.1001/archinte.1994.00420020131014; Evans N, 2014, PALLIATIVE MED, V28, P1206, DOI 10.1177/0269216314540017; EVERHART MA, 1990, CHEST, V97, P159, DOI 10.1378/chest.97.1.159; GANZINI L, 1994, AM J PSYCHIAT, V151, P1631; Janssen DJA, 2012, CHEST, V141, P1251, DOI 10.1378/chest.11-1472; Kohut N, 1997, J CLIN ETHIC, V8, P124; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; McParland E, 2003, MT SINAI J MED, V70, P85; Ministerie van VolksgezondheidWen S, 2011, KENN OPV PUBL PROF M; Pruchno RA, 2008, J GERONTOL B-PSYCHOL, V63, pS81, DOI 10.1093/geronb/63.2.S81; van Wijmen MPS, 2015, J MED ETHICS, V41, P599, DOI 10.1136/medethics-2013-101544; van Wijmen MPS, 2014, PATIENT EDUC COUNS, V95, P393, DOI 10.1016/j.pec.2014.03.009; van Wijmen MPS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-166; van Wijmen MPS, 2010, BIOETHICS, V24, P118, DOI 10.1111/j.1467-8519.2009.01788.x; Weissman JS, 1999, MED DECIS MAKING, V19, P16, DOI 10.1177/0272989X9901900103; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittink MN, 2008, ARCH INTERN MED, V168, P2125, DOI 10.1001/archinte.168.19.2125	29	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209315	10.1371/journal.pone.0209315	http://dx.doi.org/10.1371/journal.pone.0209315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562403	Green Submitted, gold, Green Published			2022-12-26	WOS:000453774100048
J	Hu, ZG; Li, WX; Ruan, YS; Zeng, FJ				Hu, Zhi Gang; Li, Wen Xin; Ruan, Yu Shu; Zeng, Fan Jun			Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors	PLOS ONE			English	Article							SMOKING; STATISTICS; REGRESSION; SELECTION	Background This study was designed to estimate the trends in 5-year incidence of metachronous second primary lung cancer(SPLC) and to establish a risk prediction model to identify candidates who were at high risk of developing metachronous SPLC. Methods Incidence data between 2004 and 2007 were obtained from SEER database, including 42453 participants who survived >= 2 years after the initial diagnosis of lung cancer. Join-point regression analysis was used to calculate the 5-year incidence rates of metachronous SPLC per 100 000 population. Related risk factors of the survivors who developed MSPLC during five years were identified through logistic regression analysis, followed by establishment of risk prediction nomogram. Discrimination (C-index), calibration and decision analysis were further performed to assess the validation and clinical net benefit of risk prediction nomogram. Results A total of 1412 survivors with lung cancer developed MSPLC during five years, with 3546 per 100 000 population of age-adjusted 5-year incidence. Age, histology, tumor stage, and radiation were recognized as risk factors of metachronous SPLC, as indicated by logistic regression analysis. The risk prediction nomogram of metachronous SPLC harbored moderate discrimination(C-index = 0.67) and good calibration, with the risk of 0.01 to 0.11. The decision curve analysis showed that clinical net benefit of this risk prediction nomogram in a range of risk thresholds (0.01 to 0.06) was higher compared to all-screening or no-screening strategies. Conclusions Collectively, the cumulative risk of metachronous SPLC of the survivors increased over time. The risk prediction nomogram was available to select high-risk survivors who should regularly undergo computed tomography screening.	[Hu, Zhi Gang; Li, Wen Xin; Ruan, Yu Shu; Zeng, Fan Jun] Three Gorges Univ, Coll Clin Med Sci 1, Resp Dis Res Inst China, Yichang, Peoples R China; [Hu, Zhi Gang; Li, Wen Xin; Ruan, Yu Shu; Zeng, Fan Jun] Yichang Cent Peoples Hosp, Dept Resp Med, Yichang, Peoples R China	China Three Gorges University	Hu, ZG; Zeng, FJ (corresponding author), Three Gorges Univ, Coll Clin Med Sci 1, Resp Dis Res Inst China, Yichang, Peoples R China.; Hu, ZG; Zeng, FJ (corresponding author), Yichang Cent Peoples Hosp, Dept Resp Med, Yichang, Peoples R China.	hxq910813@163.com; hzg7602589@163.com	Hu, Zhigang/GRF-2430-2022	Hu, Zhigang/0000-0003-3421-0674				Balachandran VP, 2015, LANCET ONCOL, V16, pE173, DOI 10.1016/S1470-2045(14)71116-7; Bhaskarla A, 2010, J SURG RES, V162, P1, DOI 10.1016/j.jss.2009.12.030; Boyle JM, 2015, CANCER-AM CANCER SOC, V121, P598, DOI 10.1002/cncr.29095; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Ghosh P, 2011, STAT MED, V30, P127, DOI 10.1002/sim.4077; Han SS, 2017, J CLIN ONCOL, V35, P2893, DOI 10.1200/JCO.2017.72.4203; Johnson BE, 1998, JNCI-J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; Kawaguchi T, 2006, JPN J CLIN ONCOL, V36, P7, DOI 10.1093/jjco/hyi208; Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654; Khanal A, 2018, ACTA ONCOL, V57, P239, DOI 10.1080/0284186X.2017.1390250; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KOBAYASHI Y, 1991, JPN J CLIN ONCOL, V21, P233; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Muller DC, 2017, J CLIN ONCOL, V35, P861, DOI 10.1200/JCO.2016.69.2467; National Cancer Institute, 2015, JOINP REGR PROGR VER; Park SM, 2007, J CLIN ONCOL, V25, P4835, DOI 10.1200/JCO.2006.10.3416; Rampinelli C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j347; RICHARDSON GE, 1993, ANN INTERN MED, V119, P383, DOI 10.7326/0003-4819-119-5-199309010-00006; Ripley RT, 2014, ANN THORAC SURG, V98, P968, DOI 10.1016/j.athoracsur.2014.04.098; SAGMAN U, 1992, J CLIN ONCOL, V10, P1525, DOI 10.1200/JCO.1992.10.10.1525; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Surapaneni R, 2012, J THORAC ONCOL, V7, P1252, DOI 10.1097/JTO.0b013e3182582a79; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi MC, 2017, LANCET ONCOL, V18, P1523, DOI [10.1016/S1470-2045(17)30597-1, 10.1016/s1470-2045(17)30597-1]; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; Thakur MK, 2018, J THORAC ONCOL, V13, P46, DOI 10.1016/j.jtho.2017.09.1964; Tucker MA, 1997, J NATL CANCER I, V89, P1782, DOI 10.1093/jnci/89.23.1782	27	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209002	10.1371/journal.pone.0209002	http://dx.doi.org/10.1371/journal.pone.0209002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557376	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000061
J	Liu, LW; Bonventre, JV; Rittenhouse, AR				Liu, Liwang; Bonventre, Joseph, V; Rittenhouse, Ann R.			cPLA(2)alpha(-)(/-) sympathetic neurons exhibit increased membrane excitability and loss of N-Type Ca2+ current inhibition by M-1 muscarinic receptor signaling	PLOS ONE			English	Article							ARACHIDONIC-ACID; CALCIUM CURRENT; K+ CHANNELS; MEDIATED INHIBITION; ALPHA-SUBUNIT; ION CHANNELS; BK-CHANNELS; A(2); MODULATION; PHOSPHOLIPASES	Group IVa cytosolic phospholipase A(2) (cPLA(2)alpha) mediates GPCR-stimulated arachidonic acid (AA) release from phosphatidylinositol 4,5-bisphosphate (PIP2) located in plasma membranes. We previously found in superior cervical ganglion (SCG) neurons that PLA(2) activity is required for voltage-independent N-type Ca2+ (N-) current inhibition by M-1 muscarinic receptors (M(1)Rs). These findings are at odds with an alternative model, previously observed for M-current inhibition, where PIP2 dissociation from channels and subsequent metabolism by phospholipase C suffices for current inhibition. To resolve cPLA(2)alpha's importance, we have investigated its role in mediating voltage-independent N-current inhibition (similar to 40%) that follows application of the muscarinic agonist oxotremorine-M (Oxo-M). Preincubation with different cPLA(2)alpha antagonists or dialyzing cPLA(2)alpha antibodies into cells minimized N-current inhibition by Oxo-M, whereas antibodies to Ca2+-independent PLA(2) had no effect. Taking a genetic approach, we found that SCG neurons from cPLA(2)alpha(-/-) mice exhibited little N-current inhibition by Oxo-M, confirming a role for cPLA(2)alpha. In contrast, cPLA(2)alpha antibodies or the absence of cPLA(2)alpha had no effect on voltage-dependent N-current inhibition by M-2/M(4)Rs or on M-current inhibition by M(1)Rs. These findings document divergent M1R signaling mediating M-current and voltage-independent N-current inhibition. Moreover, these differences suggest that cPLA(2)alpha acts locally to metabolize PIP2 intimately associated with N- but not M-channels. To determine cPLA(2)alpha's functional importance more globally, we examined action potential firing of cPLA(2)alpha(+/+) and cPLA(2)alpha(-/-) SCG neurons, and found decreased latency to first firing and interspike interval resulting in a doubling of firing frequency in cPLA(2)alpha(-/- ) neurons. These unanticipated findings identify cPLA(2)alpha as a tonic regulator of neuronal membrane excitability.	[Liu, Liwang; Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA; [Liu, Liwang; Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [Bonventre, Joseph, V] Harvard Med Sch, Harvard Inst Med, Boston, MA USA; [Bonventre, Joseph, V] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Liu, Liwang] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Program Neurosci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Northwell Health; University of Massachusetts System; University of Massachusetts Worcester	Rittenhouse, AR (corresponding author), Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA.; Rittenhouse, AR (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA.; Rittenhouse, AR (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Program Neurosci, Worcester, MA 01655 USA.	Ann.Rittenhouse@umassmed.edu		Rittenhouse, Ann R/0000-0002-7446-230X	National Institutes of Health (NIH): National Institute of Neurological Disorders and Stroke [NS34195]; NIH: National Institute of Digestive Disorders and Kidney [DK39773, DK72381]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK072381] Funding Source: NIH RePORTER	National Institutes of Health (NIH): National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH: National Institute of Digestive Disorders and Kidney; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was funded by grants from the National Institutes of Health (NIH): National Institute of Neurological Disorders and Stroke. URL = https://www.ninds.nih.gov/. #NS34195 (ARR); NIH: National Institute of Digestive Disorders and Kidney. URL = https://www.niddk.nih.gov/. #DK39773 and #DK72381 (JVB).	Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BERNHEIM L, 1992, P NATL ACAD SCI USA, V89, P9544, DOI 10.1073/pnas.89.20.9544; Bonventre JV, 1997, J LIPID MEDIAT CELL, V16, P199; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BROWN DA, 1980, BRIT J PHARMACOL, V70, P593, DOI 10.1111/j.1476-5381.1980.tb09778.x; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; D'Avanzo N, 2016, CURR TOP MEMBR, V78, P353, DOI 10.1016/bs.ctm.2016.04.003; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Delgado-Ramirez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20280-w; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Denson DD, 2006, BIOCHEM BIOPH RES CO, V350, P39, DOI 10.1016/j.bbrc.2006.08.193; Denson DD, 2005, J NEUROPHYSIOL, V93, P3146, DOI 10.1152/jn.00865.2004; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Guerard P, 2004, EUR J PHARMACOL, V501, P127, DOI 10.1016/j.ejphar.2004.08.007; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Hornfelt M, 1999, NEUROSCI LETT, V265, P87, DOI 10.1016/S0304-3940(99)00046-4; Hosseini R, 2001, J PHYSIOL-LONDON, V535, P323, DOI 10.1111/j.1469-7793.2001.00323.x; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Kaur G, 2015, J BIOL CHEM, V290, P21086, DOI 10.1074/jbc.M115.645671; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kim DI, 2015, BIOPHYS J, V109, P922, DOI 10.1016/j.bpj.2015.07.040; Kruse M, 2013, CHANNELS, V7, P530, DOI 10.4161/chan.25816; Kullmann PHM, 2016, J NEUROPHYSIOL, V116, P438, DOI 10.1152/jn.00223.2016; Le TD, 2010, P NATL ACAD SCI USA, V107, P3198, DOI 10.1073/pnas.0915020107; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; LEVEY AI, 1993, LIFE SCI, V52, P441, DOI 10.1016/0024-3205(93)90300-R; Li J, 2010, AM J PHYSIOL-CELL PH, V298, pC251, DOI 10.1152/ajpcell.00221.2009; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Liu LW, 2004, EUR BIOPHYS J BIOPHY, V33, P255, DOI 10.1007/s00249-003-0387-7; Liu LW, 2003, BRIT J PHARMACOL, V138, P1259, DOI 10.1038/sj.bjp.0705157; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; Liu LW, 2001, AM J PHYSIOL-CELL PH, V280, pC1293, DOI 10.1152/ajpcell.2001.280.5.C1293; Liu NK, 2011, TRANSL STROKE RES, V2, P608, DOI 10.1007/s12975-011-0089-x; Liu PW, 2014, J NEUROSCI, V34, P4991, DOI 10.1523/JNEUROSCI.1925-13.2014; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Malin SA, 2002, J NEUROSCI, V22, P10094; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; MEVES H, 1994, PROG NEUROBIOL, V43, P175, DOI 10.1016/0301-0082(94)90012-4; Michailidis IE, 2007, PFLUG ARCH EUR J PHY, V455, P147, DOI 10.1007/s00424-007-0272-9; OKADA T, 1994, J BIOL CHEM, V269, P3563; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Rapoport SI, 2014, ACS CHEM NEUROSCI, V5, P459, DOI 10.1021/cn500058v; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sapirstein A, 2000, NEUROCHEM RES, V25, P745, DOI 10.1023/A:1007583708713; Shapiro MS, 2001, LIFE SCI, V68, P2481, DOI 10.1016/S0024-3205(01)01042-6; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Springer MG, 2015, J PHYSIOL-LONDON, V593, P803, DOI 10.1113/jphysiol.2014.284125; Su LD, 2013, CEREBELLUM, V12, P297, DOI 10.1007/s12311-012-0444-9; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Vivas O, 2013, BIOCHEM BIOPH RES CO, V432, P275, DOI 10.1016/j.bbrc.2013.01.117; Wang DJ, 2014, J NEUROSCI, V34, P2355, DOI 10.1523/JNEUROSCI.4064-13.2014; Wheeler DW, 2004, J NEUROPHYSIOL, V92, P2659, DOI 10.1152/jn.00470.2004; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhou HP, 2003, AM J PHYSIOL-GASTR L, V284, pG472, DOI 10.1152/ajpgi.00345.2002; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	69	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0201322	10.1371/journaI.pone.0201322	http://dx.doi.org/10.1371/journaI.pone.0201322			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557348				2022-12-26	WOS:000453451000003
J	Southworth, J; Bunting, E; Zhu, LK; Ryan, SJ; Herrero, HV; Waylen, P; Munoz-Carpena, R; Campo-Bescos, MA; Kaplan, D				Southworth, Jane; Bunting, Erin; Zhu, Likai; Ryan, Sadie J.; Herrero, Hannah, V; Waylen, Peter; Munoz-Carpena, Rafael; Campo-Bescos, Miguel A.; Kaplan, David			Using a coupled dynamic factor - random forest analysis (DFRFA) to reveal drivers of spatiotemporal heterogeneity in the semi-arid regions of southern Africa	PLOS ONE			English	Article							LAND-USE; WOODY COVER; TRENDS; LANDSCAPE; RAINFALL; CARBON; BUDGET	Understanding the drivers of large-scale vegetation change is critical to managing land-scapes and key to predicting how projected climate and land use changes will affect regional vegetation patterns. This study aimed to improve our understanding of the role, magnitude, and spatial distribution of the key environmental and socioeconomic factors driving vegetation change in a southern African savanna. This research was conducted across the Kwando, Okavango and Zambezi catchments of southern Africa (Angola, Namibia, Botswana and Zambia) and explored vegetation cover change across the region from 2001-2010. A novel coupled analysis was applied to model the dynamic biophysical factors then to determine the discrete / social drivers of spatial heterogeneity on vegetation. Previous research applied Dynamic Factor Analysis (DFA), a multivariate times series dimension reduction technique, to ten years of monthly remotely sensed vegetation data (MODIS-derived normalized difference vegetation index, NDVI), and a suite of time-series (monthly) environmental covariates: precipitation, mean, minimum and maximum air temperature, soil moisture, relative humidity, fire and potential evapotranspiration. This initial research was performed at a regional scale to develop meso-scale models explaining mean regional NDVI patterns. The regional DFA predictions were compared to the fine-scale MODIS time series using Kendall's Tau and Sen's Slope to identify pixels where the DFA model we had developed, under or over predicted NDVI. Once identified, a Random Forest (RF) analysis using a series of static social and physical variables was applied to explain these remaining areas of under- and over- prediction to fully explore the drivers of heterogeneity in this savanna system. The RF analysis revealed the importance of protected areas, elevation, soil type, locations of higher population, roads, and settlements, in explaining fine scale differences in vegetation biomass. While the previously applied DFA generated a model of environmental variables driving NDVI, the RF work developed here highlighted human influences dominating that signal. The combined DFRFA model approach explains almost 90% of the variance in NDVI across this landscape from 2001-2010. Our methodology presents a unique coupling of dynamic and static factor analyses, yielding novel insights into savanna heterogeneity, and providing a tool of great potential for researchers and managers alike.	[Southworth, Jane; Ryan, Sadie J.; Herrero, Hannah, V; Waylen, Peter] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Bunting, Erin] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [Bunting, Erin] Michigan State Univ, Remote Sensing & GIS Res & Outreach Serv, E Lansing, MI 48824 USA; [Zhu, Likai] Univ Wisconsin, Silvis Lab, Madison, WI USA; [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Ryan, Sadie J.] Univ KwaZulu Natal, Coll Life Sci, Pietermaritzburg, South Africa; [Munoz-Carpena, Rafael] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL USA; [Campo-Bescos, Miguel A.] Univ Publ Navarra, Dept Projects & Rural Engn, Pamplona, Spain; [Kaplan, David] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida; University of Kwazulu Natal; State University System of Florida; University of Florida; Universidad Publica de Navarra; State University System of Florida; University of Florida	Southworth, J (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	jsouthwo@ufl.edu	Herrero, Hannah/Y-6549-2019; Ryan, Sadie Jane/H-7488-2019; Campo-Bescós, Miguel Ángel/P-1849-2016; Munoz-Carpena, Rafael/A-7588-2010	Herrero, Hannah/0000-0003-2338-947X; Ryan, Sadie Jane/0000-0002-4308-6321; Campo-Bescós, Miguel Ángel/0000-0002-0435-3765; Kaplan, David/0000-0002-0103-0928; Southworth, Jane/0000-0002-7246-7879; Munoz-Carpena, Rafael/0000-0003-2838-1514	NASA [NNX09AI25G]; Okavango Research Institute (ORI); Center for African Studies (UF)	NASA(National Aeronautics & Space Administration (NASA)); Okavango Research Institute (ORI); Center for African Studies (UF)	This research was funded by NASA grant NNX09AI25G to JS: Understanding and predicting the impact of climate variability and climate change on land use and land cover change via socioeconomic institutions in southern Africa May 2009-May 2013. We would like to thank the Center for African Studies (UF) and the Okavango Research Institute (ORI) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We would like to thank the Center for African Studies (UF) and the Okavango Research Institute (ORI) for their support. There are multiple people and organizations that made this publication possible and the authors wish to express their gratitude. The authors wish to acknowledge the other PIs on the project: Dr. Brian Child, Dr. Eric Keys, Dr. Michael Binford, and Dr. Greg Kiker.	ArcGIS E, 2011, ARCGIS RELEASE 10 2; Beck HE, 2011, REMOTE SENS ENVIRON, DOI [10.1016/j.rse.2010.07.007, DOI 10.1016/J.RSE.2010.07.007]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bunting E, 2013, LAND-BASEL, V2, P225, DOI 10.3390/land2020225; Campo-Bescos MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072348; Fauchereau N, 2003, NAT HAZARDS, V29, P139, DOI 10.1023/A:1023630924100; Freeman E, 2016, MODELING MAP PRODUCT, P134; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Gambiza J., 2001, PRIMER SAVANNA ECOLO; Gan TY, 1998, WATER RESOUR RES, V34, P3009, DOI 10.1029/98WR01265; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Horning NAM of NHC for B and C horning@ amnhorg, 2010, RAND FOR ALG IM CLAS; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Huntley B. J, 1982, ECOLOGY TROPICAL SAV, P1; HUNTLEY BJ, 1982, ECOL STUD, V42, P101; LONG SP, 1989, PLANT SOIL, V115, P155, DOI 10.1007/BF02202584; Long SP, 1992, PRIMARY PRODUCTIVITY; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy JJ, 2011, CLIMATE CHANGE 2001; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; OJIMA DS, 1993, WATER AIR SOIL POLL, V70, P95, DOI 10.1007/BF01104990; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Peters J, 2007, ECOL MODEL, V207, P304, DOI 10.1016/j.ecolmodel.2007.05.011; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Rouse J.W, 1974, MONITORING VERNAL AD, P1; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Scholes R.J., 1996, SCOPE, V56, P69; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1993, NUTRIENT CYCLING SEM; Tian F, 2013, REMOTE SENS-BASEL, V5, P4255, DOI 10.3390/rs5094255; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; WALKER J, 1982, ECOL STUD, V42, P5; Western D., 1989, P158; WESTERN D, 1981, AFR J ECOL, V19, P7, DOI 10.1111/j.1365-2028.1981.tb00648.x	39	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208400	10.1371/journal.pone.0208400	http://dx.doi.org/10.1371/journal.pone.0208400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550542	Green Submitted, Green Published, gold			2022-12-26	WOS:000453248000018
J	Kaplan, JL; Stern, JA; Fascetti, AJ; Larsen, JA; Skolnik, H; Peddle, GD; Kienle, RD; Waxman, A; Cocchiaro, M; Gunther-Harrington, CT; Klose, T; LaFauci, K; Lefbom, B; Lamy, MM; Malakoff, R; Nishimura, S; Oldach, M; Rosenthal, S; Stauthammer, C; O'Sullivan, L; Visser, LC; William, R; Ontiveros, E				Kaplan, Joanna L.; Stern, Joshua A.; Fascetti, Andrea J.; Larsen, Jennifer A.; Skolnik, Hannah; Peddle, Gordon D.; Kienle, Richard D.; Waxman, Andrew; Cocchiaro, Michael; Gunther-Harrington, Catherine T.; Klose, Tyler; LaFauci, Kendra; Lefbom, Bonnie; Lamy, Maggie Machen; Malakoff, Rebecca; Nishimura, Satoko; Oldach, Maureen; Rosenthal, Steven; Stauthammer, Christopher; O'Sullivan, Lynne; Visser, Lance C.; William, Regan; Ontiveros, Eric			Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets	PLOS ONE			English	Article							WHOLE-BLOOD TAURINE; PLASMA TAURINE; NORMAL DOGS; SIMPSONS METHOD; CARNITINE; MAINTENANCE; DEPLETION; FIBER; BREED; CATS	Introduction Golden retrievers are over-represented in cases of taurine-deficient dilated cardiomyopathy and recently a surge in cases has prompted further investigation. Objective To describe the clinical, dietary, and echocardiographic features in golden retrievers diagnosed with taurine deficiency and dilated cardiomyopathy, and to determine specific dietary associations. A second aim was to determine the whole blood taurine concentrations in a representative sample of healthy golden retrievers. Animals Twenty-four client-owned golden retrievers with documented taurine deficiency and dilated cardiomyopathy and 52 healthy client-owned golden retrievers. Methods In this multicenter prospective observational study, baseline and follow-up echocardiographic data, complete diet and medical histories, and whole blood, plasma, or serum taurine concentrations were obtained. Baseline and follow-up echocardiographic data were compared. Associations were evaluated between specific diets and taurine deficiency or congestive heart failure. The prevalence of low whole blood taurine concentrations in the healthy golden retrievers was calculated. Results Twenty-three of 24 dogs diagnosed with taurine deficiency and dilated cardiomyopathy were fed diets that were either grain-free, legume-rich, or a combination of these factors. None of these diets were feeding trial tested using Association of American Feed Control Officials (AAFCO) procedures. Twenty-three of 24 dogs had significant improvement in their echocardiographic parameters and normalization of taurine concentrations following diet change and taurine supplementation. Nine of 11 dogs diagnosed with congestive heart failure (CHF) had resolution of their congestion at follow-up with five no longer requiring diuretic therapy and four tolerating diuretic dose reduction by >50%. Conclusions Certain diets and diet characteristics were associated with the development of taurine deficiency. Taurine deficiency and dilated cardiomyopathy in golden retrievers is likely multifactorial, including a combination of dietary, metabolic, and genetic factors.	[Kaplan, Joanna L.; Stern, Joshua A.; Skolnik, Hannah; Gunther-Harrington, Catherine T.; Nishimura, Satoko; Oldach, Maureen; Visser, Lance C.; Ontiveros, Eric] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [Fascetti, Andrea J.; Larsen, Jennifer A.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Peddle, Gordon D.] Anim Emergency & Referral Associates, Fairfield, NJ USA; [Kienle, Richard D.] Mission Valley Vet Cardiol, Gilroy, CA USA; [Waxman, Andrew] SAGE Ctr Vet Specialty & Emergency Care, Dublin, CA USA; [Cocchiaro, Michael] Vet Specialty Hosp Carolinas, Durham, NC USA; [Klose, Tyler] Lakeshore Vet Specialists, Glendale, WI USA; [LaFauci, Kendra] CVCA Cardiac Care Pets Annapolis, Annapolis, MD USA; [Lefbom, Bonnie] CVCA Cardiac Care Pets, Reg Vet Referral Ctr, Springfield, VA USA; [Lamy, Maggie Machen] Vet Cardiopulm Care Ctr, W Palm Beach, FL USA; [Malakoff, Rebecca] MSPCA Angell West, Waltham, MA USA; [Rosenthal, Steven] CVCA Cardiac Care Pets, Towson, MD USA; [Stauthammer, Christopher] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [O'Sullivan, Lynne] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Compan Anim, Charlottetown, PE, Canada; [William, Regan] Vet Emergency Clin, Toronto, ON, Canada	University of California System; University of California Davis; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; University of Prince Edward Island	Stern, JA (corresponding author), Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA.	jstern@ucdavis.edu		Skolnik, Hannah/0000-0002-5633-1947; Stern, Joshua/0000-0001-5611-5745				Backus RC, 2003, J AM VET MED ASSOC, V223, P1130, DOI 10.2460/javma.2003.223.1130; Belanger MC, 2005, J AM ANIM HOSP ASSOC, V41, P284, DOI 10.5326/0410284; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18&lt;311:ASOMCM&gt;2.0.CO;2; Delaney SJ, 2003, J ANIM PHYSIOL AN N, V87, P236, DOI 10.1046/j.1439-0396.2003.00433.x; Farcas AK, 2013, JAVMA-J AM VET MED A, V242, P936, DOI 10.2460/javma.242.7.936; Fascetti AJ, 2003, J AM VET MED ASSOC, V223, P1137, DOI 10.2460/javma.2003.223.1137; Freeman LM, 1996, J AM VET MED ASSOC, V209, P1592; GUPTA YP, 1987, PLANT FOOD HUM NUTR, V37, P201, DOI 10.1007/BF01091786; Hayes KC., 1998, NUTR RES REV, V1, P99; HICKMAN MA, 1990, J NUTR, V120, P995, DOI 10.1093/jn/120.9.995; HIV in Asia and the Pacific, 2013, NON TRADITIONAL REF; Johnson ML, 1998, J ANIM SCI, V76, P1112; Kathrani A, 2018, J VET INTERN MED, V32, P1026, DOI 10.1111/jvim.15116; Kim SW, 1996, J NUTR, V126, P195, DOI 10.1093/jn/126.1.195; Kittleson MD, 1997, J VET INTERN MED, V11, P204, DOI 10.1111/j.1939-1676.1997.tb00092.x; Ko KS, 2007, J NUTR, V137, P1171, DOI 10.1093/jn/137.5.1171; Ko Kwang Suk, 2016, Journal of Animal Science and Technology, V58, P29, DOI 10.1186/s40781-016-0112-6; KRAMER GA, 1995, J VET INTERN MED, V9, P253, DOI 10.1111/j.1939-1676.1995.tb01076.x; Marie-Claude B., 2000, TXB VET INTERNAL MED, P393; McCusker S, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.33; MOISE NS, 1991, AM HEART J, V121, P541, DOI 10.1016/0002-8703(91)90724-V; MORRISON SA, 1992, J VET INTERN MED, V6, P220, DOI 10.1111/j.1939-1676.1992.tb00342.x; Owens TJ, 2014, JAVMA-J AM VET MED A, V245, P99, DOI 10.2460/javma.245.1.99; Owens TJ, 2016, WALTH INT NUTR SCI S; Pacioretty L, 2001, AMINO ACIDS, V21, P417, DOI 10.1007/s007260170006; PION PD, 1987, SCIENCE, V237, P764, DOI 10.1126/science.3616607; Pion PD, 1998, VET CLIN N AM-SMALL, V28, P1495, DOI 10.1016/S0195-5616(98)50134-9; Ramsey JJ, 2012, APPLIED VETERINARY CLINICAL NUTRITION, P23; Rishniw M, 2000, J VET INTERN MED, V14, P429, DOI 10.1892/0891-6640(2000)014&lt;0429:EOFEMO&gt;2.3.CO;2; Sanderson SL, 2006, VET CLIN N AM-SMALL, V36, P1325, DOI 10.1016/j.cvsm.2006.08.010; Sanderson SL, 2001, J VET INTERN MED, V15, P94, DOI 10.1892/0891-6640(2001)015&lt;0094:EOUCAT&gt;2.3.CO;2; Sanderson SL, 2001, AM J VET RES, V62, P1616, DOI 10.2460/ajvr.2001.62.1616; Smets P, 2014, J VET INTERN MED, V28, P116, DOI 10.1111/jvim.12234; Spitze AR, 2003, J ANIM PHYSIOL AN N, V87, P251, DOI 10.1046/j.1439-0396.2003.00434.x; Sterrett JW, 2018, PRAYER AND PERFORMANCE IN EARLY MODERN ENGLISH LITERATURE, P1; Stratton-Phelps M, 2002, J NUTR, V132, p1745S, DOI 10.1093/jn/132.6.1745S; Thatcher CD, 2000, SMALL ANIMAL CLIN NU, P3; The World Small Animal Veterinary Association, 2018, NON TRADITIONAL REF; Torres CL, 2003, J ANIM PHYSIOL AN N, V87, P359, DOI 10.1046/j.1439-0396.2003.00446.x; U.S. Food and Drug Administration, FDA INV POT CONN DIE; Vollmar AC, 2013, J VET CARDIOL, V15, P189, DOI 10.1016/j.jvc.2013.03.005; Wess G, 2010, J VET INTERN MED, V24, P1069, DOI 10.1111/j.1939-1676.2010.0575.x	42	39	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209112	10.1371/journal.pone.0209112	http://dx.doi.org/10.1371/journal.pone.0209112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543707	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500074
J	Ling, A; Hay, E; Aggrey, SE; Rekaya, R				Ling, Ashley; Hay, El Hamidi; Aggrey, Samuel E.; Rekaya, Romdhane			A Bayesian approach for analysis of ordered categorical responses subject to misclassification	PLOS ONE			English	Article							BINARY RESPONSES; LOGISTIC-REGRESSION; GENETIC-PARAMETERS; COMPOSITE LINE; CALVING EASE; BEEF-CATTLE; BIAS; MODELS; ERRORS	Ordinal categorical responses are frequently collected in survey studies, human medicine, and animal and plant improvement programs, just to mention a few. Errors in this type of data are neither rare nor easy to detect. These errors tend to bias the inference, reduce the statistical power and ultimately the efficiency of the decision-making process. Contrarily to the binary situation where misclassification occurs between two response classes, noise in ordinal categorical data is more complex due to the increased number of categories, diversity and asymmetry of errors. Although several approaches have been presented for dealing with misclassification in binary data, only limited practical methods have been proposed to analyze noisy categorical responses. A latent variable model implemented within a Bayesian framework was proposed to analyze ordinal categorical data subject to misclassification using simulated and real datasets. The simulated scenario consisted of a discrete response with three categories and a symmetric error rate of 5% between any two classes. The real data consisted of calving ease records of beef cows. Using real and simulated data, ignoring misclassification resulted in substantial bias in the estimation of genetic parameters and reduction of the accuracy of predicted breeding values. Using our proposed approach, a significant reduction in bias and increase in accuracy ranging from 11% to 17% was observed. Furthermore, most of the misclassified observations (in the simulated data) were identified with a substantially higher probability. Similar results were observed for a scenario with asymmetric misclassification. While the extension to traits with more categories between adjacent classes is straightforward, it could be computationally costly. For traits with high heritability, the performance of the methodology would be expected to improve.	[Ling, Ashley; Rekaya, Romdhane] Univ Georgia, Dept Anismal & Dairy Sci, Athens, GA 30602 USA; [Hay, El Hamidi] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA; [Aggrey, Samuel E.; Rekaya, Romdhane] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Aggrey, Samuel E.] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Rekaya, Romdhane] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ling, A (corresponding author), Univ Georgia, Dept Anismal & Dairy Sci, Athens, GA 30602 USA.	Asling@uga.edu			United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) through the National Needs Grant [11754154]	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) through the National Needs Grant	AL was funded by the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) through the National Needs Grant, grant number 11754154 to RR, https://nifa.usda.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRON BA, 1977, BIOMETRICS, V33, P414, DOI 10.2307/2529795; BROSS I, 1954, BIOMETRICS, V10, P478, DOI 10.2307/3001619; Chyou PH, 2007, EUR J EPIDEMIOL, V22, P7, DOI 10.1007/s10654-006-9078-x; Diagnostic error in acute care (Editorial), 2010, PA PATIENT SAF ADVIS, V7, P76; Dustmann C, 2004, J BUS ECON STAT, V22, P312, DOI 10.1198/073500104000000163; Edwards JK, 2013, AM J EPIDEMIOL, V177, P904, DOI 10.1093/aje/kws340; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; GABA A, 1992, MANAGE SCI, V38, P913, DOI 10.1287/mnsc.38.7.913; GOLDBERG JD, 1975, J AM STAT ASSOC, V70, P561, DOI 10.2307/2285933; Hausman JA, 1998, J ECONOMETRICS, V87, P239, DOI 10.1016/S0304-4076(98)00015-3; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; Huang YD, 2013, BRIEF BIOINFORM, V14, P391, DOI 10.1093/bib/bbs078; Joseph Sandeep, 2008, In Silico Biol, V8, P545; Korsgaard IR, 2003, GENET SEL EVOL, V35, P159, DOI [10.1186/1297-9686-35-2-159, 10.1051/gse:2003002]; Ladha KS, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0165-y; Lyles RH, 2011, EPIDEMIOLOGY, V22, P589, DOI 10.1097/EDE.0b013e3182117c85; Magder LS, 1997, AM J EPIDEMIOL, V146, P195; Manchia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076295; Mujibi FDN, 2009, J ANIM SCI, V87, P2759, DOI 10.2527/jas.2008-1141; Neuhaus JM, 1999, BIOMETRIKA, V86, P843, DOI 10.1093/biomet/86.4.843; NEWMAN S, 1993, J ANIM SCI, V71, P2026, DOI 10.2527/1993.7182026x; NEWMAN S, 1993, J ANIM SCI, V71, P2033, DOI 10.2527/1993.7182033x; Newman-Toker DE, 2014, DIAGNOSIS, V1, P43, DOI 10.1515/dx-2013-0027; Ogburn EL, 2013, BIOMETRIKA, V100, P241, DOI 10.1093/biomet/ass054; Poon WY, 2010, BRIT J MATH STAT PSY, V63, P17, DOI 10.1348/000711008X401314; Redman TC, 1998, COMMUN ACM, V41, P79, DOI 10.1145/269012.269025; Rekaya R, 2001, BIOMETRICS, V57, P1123, DOI 10.1111/j.0006-341X.2001.01123.x; Rekaya R, 2016, APPL CLIN GENET, V9, P169, DOI 10.2147/TACG.S122250; Sapp RL, 2005, GENET SEL EVOL, V37, P615, DOI 10.1051/gse:2005018; Smith S, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-124; SORENSEN DA, 1995, GENET SEL EVOL, V27, P229, DOI 10.1051/gse:19950303; Sun LR, 2017, J STAT COMPUT SIM, V87, P3440, DOI 10.1080/00949655.2017.1370649; Tang L, 2015, STAT MED, V34, P1605, DOI 10.1002/sim.6440; TAVARE CJ, 1995, STAT MED, V14, P1307, DOI 10.1002/sim.4780141204; TENENBEI.A, 1972, TECHNOMETRICS, V14, P187, DOI 10.2307/1266930; TENENBEIN A, 1970, J AM STAT ASSOC, V65, P1350, DOI 10.2307/2284301; Tennekoon V, 2016, COMMUN STAT-THEOR M, V45, P2538, DOI 10.1080/03610926.2014.887105; Vanderick S, 2014, J ANIM BREED GENET, V131, P513, DOI 10.1111/jbg.12105; Wang D., 2014, EPIDEMIOLOGIC METHOD, V3, P97, DOI DOI 10.1515/EM-2013-0017; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Zhu XQ, 2004, ARTIF INTELL REV, V22, P177, DOI 10.1007/s10462-004-0751-8	41	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208433	10.1371/journal.pone.0208433	http://dx.doi.org/10.1371/journal.pone.0208433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543662	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500022
J	McSherry, LA; O'Leary, E; Dombrowski, SU; Francis, JJ; Martin, CM; O'Leary, JJ; Sharp, L				McSherry, Lisa A.; O'Leary, Eamonn; Dombrowski, Stephan U.; Francis, Jill J.; Martin, Cara M.; O'Leary, John J.; Sharp, Linda		ATHENS A Trial HPV Educ Support	Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives	PLOS ONE			English	Article							CERVICAL-CANCER; GENERAL-PRACTITIONERS; PHYSICIANS KNOWLEDGE; CLINICIAN KNOWLEDGE; VACCINATION; ATTITUDES; WOMEN; GIRLS; BARRIERS; ADOLESCENTS	Background Primary care practitioners (PCP) play key roles in cervical cancer prevention. Human papillomavirus (HPV) knowledge is an important influence on PCPs' cervical cancer prevention-related behaviours. We investigated HPV knowledge, and associated factors, among general practitioners (GPs) and practice nurses. Methods A survey, including factual questions about HPV infection and vaccination, was mailed to GPs and practice nurses in Ireland. Multivariable logistic regression was used to determine which PCPs had low knowledge (questions correctly answered: infection <= 5/11; vaccination: <= 4/10). Questions least often answered correctly were identified. Results 697 PCPs participated. For HPV infection, GPs and practice nurses answered a median of nine and seven questions correctly, respectively (p<0.001). Significantly associated with low HPV infection knowledge were: being a practice nurse/male GP; working fewer hours/ week; not having public patients; and having never taken a cervical smear. For HPV vaccination, both GPs and practice nurses answered a median of six questions correctly (p = 0.248). Significantly associated with low HPV vaccination knowledge were: being a practice nurse/male GP; working more years in general practice, fewer hours/week, in a smaller practice or in a practice not specialising in women's health; and having never taken a smear. Six HPV infection questions, and seven HPV vaccination questions, were not answered correctly by > of PCPs. Conclusions There are important limitations in HPV infection and vaccination knowledge among PCPs. By identifying factors associated with poor knowledge, and areas of particular uncertainty, these results can inform development of professional education initiatives thereby ensuring women have access to uniformly high-quality HPV-related information and advice.	[McSherry, Lisa A.; O'Leary, Eamonn] Natl Canc Registry, Cork, Ireland; [Dombrowski, Stephan U.] Univ Stirling, Div Psychol, Stirling, Scotland; [Francis, Jill J.] City Univ London, Sch Hlth Sci, London, England; [Martin, Cara M.; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Dublin, Ireland; [Sharp, Linda] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	University of Stirling; City University London; Trinity College Dublin; Newcastle University - UK	Sharp, L (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.	linda.sharp@ncl.ac.uk	Francis, Jill/AHE-6998-2022	Francis, Jill/0000-0001-5784-8895; Sharp, Linda/0000-0001-9515-1722; O'Leary, John/0000-0001-7311-9326	Friends of the Coombe Hospital	Friends of the Coombe Hospital	This work was supported by Friends of the Coombe Hospital (no grant number available). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich T, 2005, SEX TRANSM INFECT, V81, P135, DOI 10.1136/sti.2003.008557; Anderson A, 2017, J IMMIGR MINOR HLTH; Arbyn M, 2012, INT J CANCER, V131, P1969, DOI 10.1002/ijc.27650; Askelson NM, 2010, WOMEN HEALTH, V50, P144, DOI 10.1080/03630241003705094; CervicalCheck Ireland, CERVICALCHECK NAT CE; Chow SN, 2010, VACCINE, V28, P3809, DOI 10.1016/j.vaccine.2010.03.027; Dodd RH, 2014, SEX TRANSM INFECT, V90, P201, DOI 10.1136/sextrans-2013-051402; Donati S, 2012, VACCINE, V30, P2075, DOI 10.1016/j.vaccine.2012.01.057; Duval B, 2007, VACCINE, V25, P7841, DOI 10.1016/j.vaccine.2007.08.041; Edwards P. J., 2009, COCHRANE DB SYST REV, V8; Esposito S, 2007, VACCINE, V25, P6437, DOI 10.1016/j.vaccine.2007.06.053; Ferrer HB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-700; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Health Service Executive, HUM PAP SCH IMM PROG; Hendry M, 2012, BRIT J CANCER, V107, P243, DOI 10.1038/bjc.2012.256; Hendry M, 2013, VACCINE, V31, P5152, DOI 10.1016/j.vaccine.2013.08.091; Henninger J, 2009, J PRIM HEALTH CARE, V1, P278, DOI 10.1071/HC09278; HIQA-Health Information and Quality Authority, 2017, HLTH TECHN ASS HUM P; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Hopkins TG, 2009, J PAEDIATR CHILD H, V45, P652, DOI 10.1111/j.1440-1754.2009.01589.x; Jain N, 2006, FAM MED, V38, P483; Jeyachelvi K, 2016, Asian Pac J Cancer Prev, V17, P3983; Kahn JA, 2009, CANCER EPIDEM BIOMAR, V18, P2325, DOI 10.1158/1055-9965.EPI-09-0184; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kwan TTC, 2012, INT J GYNECOL OBSTET, V116, P52, DOI 10.1016/j.ijgo.2011.07.035; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; Marlow LAV, 2013, VACCINE, V31, P763, DOI 10.1016/j.vaccine.2012.11.083; Mazza D, 2012, AUST NZ J OBSTET GYN, V52, P528, DOI 10.1111/ajo.12002; McCarthy G, 2009, NURSING GEN PRACTICE, V6, P38; McSherry LA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-73; Murphy J, 2008, J EPIDEMIOL COMMUN H, V62, pA21; Nilsen K, 2017, SCAND J PRIM HEALTH, V35, P387, DOI 10.1080/02813432.2017.1358433; O'Connor M, 2014, FAM PRACT, V31, P475, DOI 10.1093/fampra/cmu029; Patel H, 2017, J PUBLIC HEALTH-UK, V39, P601, DOI 10.1093/pubmed/fdw063; Pitts M, 2009, WOMEN HEALTH, V49, P334, DOI 10.1080/03630240903158420; Rambout L, 2014, PREV MED, V58, P22, DOI 10.1016/j.ypmed.2013.10.009; RICHARDS JG, 1979, NEW ZEAL MED J, V89, P311; Riedesel J M, 2005, J Pediatr Adolesc Gynecol, V18, P391, DOI 10.1016/j.jpag.2005.09.004; Roland KB, 2013, PREV MED, V57, P419, DOI 10.1016/j.ypmed.2013.04.012; Rutten LJF, 2017, VACCINE, V35, P164, DOI 10.1016/j.vaccine.2016.11.012; Saraiya M, 2012, J WOMENS HEALTH, V21, P111, DOI 10.1089/jwh.2011.3313; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071827; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Zhao FH, 2012, ASIAN PAC J CANCER P, V13, P2369, DOI 10.7314/APJCP.2012.13.5.2369	44	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208482	10.1371/journal.pone.0208482	http://dx.doi.org/10.1371/journal.pone.0208482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IL	30543647	Green Published, gold, Green Accepted			2022-12-26	WOS:000453247500024
J	Han, QR; Xu, LJ; Lin, WH; Yao, XQ; Jiang, MH; Zhou, R; Sun, XG; Zhao, L				Han, Qinrui; Xu, Lijun; Lin, Weihao; Yao, Xueqing; Jiang, Muhong; Zhou, Rui; Sun, Xuegang; Zhao, Liang			Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; CANCER; PROGRESSION; CHROMATIN; COLON; PROTEINS; PROMOTES; BINDING; CELLS; LIM	Long noncoding RNAs (lncRNAs) are pervasive transcripts that play pivotal roles in regulating chromatin dynamics, gene and protein expression. Aberrant expression and mutations of lncRNAs represent a driving force behind tumor invasion and metastasis, making them attractive cancer targets. However, most of the lncRNAs are still being discovered and conclusive experimental evidence for their functional relevance is still lacking for most malignancies. In this study, a differentially expressed 1ncRNA, designated as lnc-CRCMSL, is identified by microarray-based screenings on non-metastatic and metastatic CRC specimens. Lnc-CRCMSL is verified as an anti-metastatic gene and negatively correlated with the poor prognosis of CRC patients. Lnc-CRCMSL overexpression restricts tumor growth and metastasis in vivo and in vitro. Instead, lnc-CRCMSL silencing accelerates CRC cell proliferation and migration. RNA-pulldown assay identifies high mobility group box 2 (HMGB2) as a downstream protein of lnc-CRCMSL. Mechanically, lnc-CRCMSL physically binds to HMGB2 and stabilizes the localization of HMGB2 in the cytoplasm. Notably, lnc-CRCMSL knockdown lead to the shift of HMGB2 into nuclear, in which it triggers epithelial to mesenchymal transition (EMT) programming. Importantly, lnc-CRCMSL controls the cytoplasmic retention of HMGB2 and attenuates the interaction between HMGB2 and OCT4 to suppress EMT. Treatment of leptomycin B (LMB), a potent and specific nuclear export inhibitor, counteracts lnc-CRCMSL-mediated suppression of aggressive phenotypes and EMT process by accumulating the nuclear HMGB2. Conclusion Our data highlight the anti-metastatic role of lnc-CRCMSL in stabilizing HMGB2 through lncRNA-protein interactions in the cytoplasm, and suggest that targeting lnc-CRCMSL may represent a therapeutic opportunity for managing metastatic CRC.	[Han, Qinrui; Sun, Xuegang] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Lijun; Zhao, Liang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Lijun; Lin, Weihao; Jiang, Muhong; Zhou, Rui; Zhao, Liang] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Lin, Weihao] Southern Med Univ, Sch Clin Med 2, Guangzhou 510515, Guangdong, Peoples R China; [Yao, Xueqing] Guangdong Gen Hosp, Dept Gastrointestinal Surg, Guangzhou 510120, Guangdong, Peoples R China; [Jiang, Muhong; Zhou, Rui; Zhao, Liang] Southern Med Univ, Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Sun, XG (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou 510515, Guangdong, Peoples R China.	sxg_smu@126.com; liangsmu@foxmail.com	Zhao, Liang/T-9147-2019		National Natural Science Foundation of China [81572813, 81773082, 81573848, 81774172]; Guangdong Natural Science Foundation [2015A030313274]; Science and Technology Program of Guangzhou [1563000235]; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation [pdjhb0105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation	This work was supported by the National Natural Science Foundation of China (Nos. 81572813, 81773082, 81573848, 81774172), Guangdong Natural Science Foundation (2015A030313274), Science and Technology Program of Guangzhou (1563000235) and Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation (pdjhb0105).	Aird KM, 2016, J CELL BIOL, V215, P325, DOI 10.1083/jcb.201608026; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Castillo-Quan JI, 2016, CELL, V167, P1670, DOI 10.1016/j.cell.2016.11.058; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fu DY, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0219-0; Huang QH, 2018, CANCER METAST REV, V37, P75, DOI 10.1007/s10555-017-9713-x; Islam SS, 2016, MOL CARCINOGEN, V55, P537, DOI 10.1002/mc.22300; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825; Lagarde J, 2017, NAT GENET, V49, P1731, DOI 10.1038/ng.3988; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Mandal G, 2018, BBA-MOL BASIS DIS, V1864, P2053, DOI 10.1016/j.bbadis.2018.03.010; Pennisi E, 2013, SCIENCE, V340, P910; Reeves R, 2015, DNA REPAIR, V36, P122, DOI 10.1016/j.dnarep.2015.09.015; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Takeuchi T, 2013, UROL J, V10, P960; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Ugrinova I, 2009, BIOCHEMISTRY-US, V48, P6502, DOI 10.1021/bi9004304; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Wang H, 2014, CLIN CANCER RES, V20, P5835, DOI 10.1158/1078-0432.CCR-14-0485; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2016, ONCOL LETT, V12, P4605, DOI 10.3892/ol.2016.5288; Weidle UH, 2017, CANCER GENOM PROTEOM, V14, P143, DOI 10.21873/cgp.20027; Yue B, 2016, J GASTROEN HEPATOL, V31, P595, DOI 10.1111/jgh.13206; Zhang FF, 2016, CANCER LETT, V373, P203, DOI 10.1016/j.canlet.2016.01.037; Zhang Yan-Fei, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P126; Zhang YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37821; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhao YL, 2017, HEPATOL COMMUN, V1, P816, DOI 10.1002/hep4.1086; Zhi XL, 2015, HEPATOLOGY, V61, P598, DOI 10.1002/hep.27558	35	35	38	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3019	3032		10.1038/s41388-018-0614-4	http://dx.doi.org/10.1038/s41388-018-0614-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30575817				2022-12-26	WOS:000465167600011
J	Makwana, K; Gosai, N; Poe, A; Kondratov, RV				Makwana, Kuldeep; Gosai, Neha; Poe, Allan; Kondratov, Roman V.			Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism	FASEB JOURNAL			English	Article						ACOTs; lipid metabolism; mRNA-sequencing	ACYL-COA THIOESTERASE; CIRCADIAN-RHYTHM; LIPID-METABOLISM; GENE-EXPRESSION; ENERGY-INTAKE; CELL-SIZE; LIVER; CLOCKS; CONSEQUENCES; DISRUPTION	Calorie restriction (CR) delays aging and affects the circadian clocks by reprogramming circadian rhythms in gene expression. To expand on the circadian mechanisms in CR, we assayed rhythms in the protein translation by analyzing polysome-associated mRNAs in the liver of mice fed ad libitum (AL) and CR diets. Global comparison of the diets revealed that <1% of transcripts were differentially abundant in the polysomes. In contrast, the large differential, up to 10%, was detected when CR and AL diets were compared at individual times throughout the day. Most transcripts that were rhythmic under AL lost their rhythms, and many new transcripts gained rhythms under CR. Only a small fraction of transcripts, including the circadian clock genes, were rhythmic under both diets. Thus, CR strongly reprograms translation. CR affected translation of enzymes regulating long-chain acetyl-coenzyme A (Acyl-CoA) metabolism. The expression of the Acyl-CoA thioesterase (ACOT) family was induced upon CR, leading to the increased transcriptional activity of peroxisome proliferator-activated receptor , the transcriptional factor regulated by the ACOT products. We propose that the differential translation induced by CR leads to a temporal partition and reprogramming of metabolic processes and provides a link between CR, lipid metabolism, and the circadian clock.Makwana, K., Gosai, N., Poe, A., Kondratov, R. V. Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism.	[Makwana, Kuldeep; Gosai, Neha; Poe, Allan; Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University	Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu	Makwana, Kuldeep/AAD-9386-2022	Makwana, Kuldeep/0000-0003-0890-8120; Kondratov, Roman/0000-0003-3449-745X	U.S. National Institues of Health, National Institute on Aging Grant [5RO1-AG039547]; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD025252] Funding Source: NIH RePORTER	U.S. National Institues of Health, National Institute on Aging Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institues of Health, National Institute on Aging Grant 5RO1-AG039547 (to R.V.K.), and internal support by the Gene Regulation in Health and Diseases Department at Cleveland State University (to R.V.K.). The authors declare no conflicts of interest.	Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Brocker Chad, 2010, Hum Genomics, V4, P411; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Hernandez-Rodas MC, 2015, INT J MOL SCI, V16, P25168, DOI 10.3390/ijms161025168; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chaudhari Amol, 2017, Nutr Healthy Aging, V4, P101, DOI 10.3233/NHA-160006; Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3; Chou SH, 2010, CARDIOVASC RES, V87, P751, DOI 10.1093/cvr/cvq095; DCOSTA AP, 1993, MECH AGEING DEV, V71, P59, DOI 10.1016/0047-6374(93)90035-P; Dermit M, 2017, MOL BIOSYST, V13, P2477, DOI 10.1039/c7mb00476a; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Froy O, 2013, AGEING RES REV, V12, P931, DOI 10.1016/j.arr.2013.09.002; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Iwasaki S, 2017, TRENDS BIOCHEM SCI, V42, P612, DOI 10.1016/j.tibs.2017.05.004; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Jove M, 2014, AGING CELL, V13, P828, DOI 10.1111/acel.12241; Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lee C, 2016, F1000 RES, V5, P5, DOI DOI 10.12688/F1000RESEARCH.7136.1; Li Min-Dian, 2012, Yale Journal of Biology and Medicine, V85, P387; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; Melamed D, 2007, METHOD ENZYMOL, V431, P177, DOI 10.1016/S0076-6879(07)31010-0; Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Park CY, 2017, BIOCHEM BIOPH RES CO, V490, P636, DOI 10.1016/j.bbrc.2017.06.090; PARVIN R, 1970, J BIOL CHEM, V245, P5773; Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033	67	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4473	4489		10.1096/fj.201802167R	http://dx.doi.org/10.1096/fj.201802167R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566374	Green Published, Bronze			2022-12-26	WOS:000459794800109
J	Rajan, S; Jagatheesan, G; Petrashevskaya, N; Biesiadecki, BJ; Warren, CM; Riddle, T; Liggett, S; Wolska, BM; Solaro, RJ; Wieczorek, DF				Rajan, Sudarsan; Jagatheesan, Ganapathy; Petrashevskaya, Natalia; Biesiadecki, Brandon J.; Warren, Chad M.; Riddle, Tara; Liggett, Stephen; Wolska, Beata M.; Solaro, R. John; Wieczorek, David F.			Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tropomyosin; phosphorylation; cardiomyopathy; muscle physiology; transgenic mice; cardiac muscle; casein kinase; myofilament; phosphomimetic	ALPHA-TROPOMYOSIN; RABBIT SKELETAL; THIN FILAMENT; KINASE; MYOSIN; DEPHOSPHORYLATION; RELAXATION; STRESS; CELLS	Phosphorylation of cardiac sarcomeric proteins plays a major role in the regulation of the physiological performance of the heart. Phosphorylation of thin filament proteins, such as troponin I and T, dramatically affects calcium sensitivity of the myofiber and systolic and diastolic functions. Phosphorylation of the regulatory protein tropomyosin (Tpm) results in altered biochemical properties of contraction; however, little is known about the physiological effect of Tpm phosphorylation on cardiac function. To address the in vivo significance of Tpm phosphorylation, here we generated transgenic mouse lines having a phosphomimetic substitution in the phosphorylation site of alpha-Tpm (S283D). High expression of Tpm S283D variant in one transgenic mouse line resulted in an increased heart:body weight ratio, coupled with a severe dilated cardiomyopathic phenotype resulting in death within 1 month of birth. Moderate Tpm S283D mice expression in other lines caused mild myocyte hypertrophy and fibrosis, did not affect lifespan, and was coupled with decreased expression of extracellular signal-regulated kinase 1/2 kinase signaling. Physiological analysis revealed that the transgenic mice exhibit impaired diastolic function, without changes in systolic performance. Surprisingly, we observed no alterations in calcium sensitivity of the myofibers, cooperativity, or calcium-ATPase activity in the myofibers. Our experiments also disclosed that casein kinase 2 plays an integral role in Tpm phosphorylation. In summary, increased expression of pseudo-phosphorylated Tpm impairs diastolic function in the intact heart, without altering calcium sensitivity or cooperativity of myofibers. Our findings provide the first extensive in vivo assessment of Tpm phosphorylation in the heart and its functional role in cardiac performance.	[Rajan, Sudarsan; Jagatheesan, Ganapathy; Riddle, Tara; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Petrashevskaya, Natalia; Liggett, Stephen] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Biesiadecki, Brandon J.; Warren, Chad M.; Wolska, Beata M.; Solaro, R. John] Univ Illinois, Chicago Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Biesiadecki, Brandon J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Biesiadecki, Brandon J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Wolska, Beata M.] Univ Illinois, Dept Med, Div Cardiol, Chicago, IL 60612 USA; [Rajan, Sudarsan] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, 3500 N Broad St, Philadelphia, PA 19140 USA; [Jagatheesan, Ganapathy] Univ Louisville, Inst Mol Cardiol, Dept Med, 580 S Preston St, Louisville, KY 40202 USA; [Petrashevskaya, Natalia] NIA, Lab Cardiovasc Sci, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Liggett, Stephen] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Dept Pharmacol & Physiol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA	University System of Ohio; University of Cincinnati; University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; University of South Florida	Wieczorek, DF (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	david.wieczorek@uc.edu		Liggett, Stephen B./0000-0002-0128-3669	National Institutes of Health [HL081680, HL128468, HL062426, HL114940]; American Heart Association Scientist Development Grant [11SDG4980029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114940, P01HL062426, R01HL128468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL081680 (to D. F. W.), HL128468 and HL062426 (to R. J. S. and B. M. W.), and HL114940 (to B. J. B.), and American Heart Association Scientist Development Grant 11SDG4980029 (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alves ML, 2017, CARDIOVASC RES, V113, P915, DOI 10.1093/cvr/cvx068; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Heeley D., 2014, J MUSCLE RES CELL M, V24, P233; HEELEY DA, 1982, FEBS LETT, V146, P115, DOI 10.1016/0014-5793(82)80716-3; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HEELEY DH, 1994, EUR J BIOCHEM, V221, P129, DOI 10.1111/j.1432-1033.1994.tb18721.x; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; Jagatheesan G, 2003, J BIOL CHEM, V278, P23204, DOI 10.1074/jbc.M303073200; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Lu XY, 2010, J MUSCLE RES CELL M, V31, P93, DOI 10.1007/s10974-010-9213-x; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; Miyata Y, 2008, MOL CELL BIOCHEM, V316, P127, DOI 10.1007/s11010-008-9818-1; MONTGOMERY K, 1984, J BIOL CHEM, V259, P5555; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nixon BR, 2013, ARCH BIOCHEM BIOPHYS, V535, P30, DOI 10.1016/j.abb.2012.11.010; Nuesch JPF, 2007, P NATL ACAD SCI USA, V104, P12482, DOI 10.1073/pnas.0705533104; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rajan S, 2010, CIRCULATION, V121, P410, DOI 10.1161/CIRCULATIONAHA.109.889725; Rao VS, 2011, J BIOL CHEM, V286, P24135, DOI 10.1074/jbc.M110.167957; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; Schulz EM, 2013, J BIOL CHEM, V288, P28925, DOI 10.1074/jbc.M113.466466; Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; Wolska BM, 1999, CIRC RES, V84, P745; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yuen M, 2015, HUM MOL GENET, V24, P6278, DOI 10.1093/hmg/ddv334	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2913	2923		10.1074/jbc.RA118.004879	http://dx.doi.org/10.1074/jbc.RA118.004879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567734	hybrid, Green Published			2022-12-26	WOS:000459601600028
J	Cuesta, R; Berman, AY; Alayev, A; Holz, MK				Cuesta, Rafael; Berman, Adi Y.; Alayev, Anya; Holz, Marina K.			Estrogen receptor alpha promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; translation; estrogen receptor; eukaryotic translation initiation; gene expression; eIF3f; ER alpha; mTORC1	PHOSPHORYLATION; BINDING; STIMULATION; ACTIVATION; RESISTANCE; MECHANISM; COMPLEX; EIF4G; MTOR	Approximately two thirds of all breast cancer cases are estrogen receptor (ER)-positive. The treatment of this breast cancer subtype with endocrine therapies is effective in the adjuvant and recurrent settings. However, their effectiveness is compromised by the emergence of intrinsic or acquired resistance. Thus, identification of new molecular targets can significantly contribute to the development of novel therapeutic strategies. In recent years, many studies have implicated aberrant levels of translation initiation factors in cancer etiology and provided evidence that identifies these factors as promising therapeutic targets. Accordingly, we observed reduced levels of the eIF3 subunit eIF3f in ER-positive breast cancer cells compared with ER-negative cells, and determined that low eIF3f levels are required for proper proliferation and survival of ER-positive MCF7 cells. The expression of eIF3f is tightly controlled by ER alpha at the transcriptional (genomic pathway) and translational (nongenomic pathway) level. Specifically, estrogen-bound ER alpha represses transcription of the EIF3F gene, while promoting eIF3f mRNA translation. To regulate translation, estrogen activates the mTORC1 pathway, which enhances the binding of eIF3 to the eIF4F complex and, consequently, the assembly of the 48S preinitiation complexes and protein synthesis. We observed preferential translation of mRNAs with highly structured 5 '-UTRs that usually encode factors involved in cell proliferation and survival (e.g. cyclin D1 and survivin). Our results underscore the importance of estrogen-ER alpha-mediated control of eIF3f expression for the proliferation and survival of ER-positive breast cancer cells. These findings may provide rationale for the development of new therapies to treat ER-positive breast cancer.	[Cuesta, Rafael; Holz, Marina K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Berman, Adi Y.; Alayev, Anya] Yeshiva Univ, Dept Biol, New York, NY 10016 USA; [Holz, Marina K.] Albert Einstein Canc Ctr, Bronx, NY 10461 USA	New York Medical College; Yeshiva University; Yeshiva University	Holz, MK (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.; Holz, MK (corresponding author), Albert Einstein Canc Ctr, Bronx, NY 10461 USA.	mholz@nymc.edu		Holz, Marina/0000-0001-5030-7973	American Cancer Society [RSG-13-287-01-TBE]; NIGMS, National Institutes of Health [GM128675]; NCI, National Institutes of Health [CA151112]; Atol Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128675] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Atol Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Grant RSG-13-287-01-TBE; NIGMS, National Institutes of Health Grant GM128675; NCI, National Institutes of Health Grant CA151112; and a research award from the Atol Charitable Trust (to M. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alayev A, 2016, CELL CYCLE, V15, P3230, DOI 10.1080/15384101.2016.1241927; Altucci L, 1996, ONCOGENE, V12, P2315; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chu J, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032995; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; Chu J, 2015, BBA-GENE REGUL MECH, V1849, P781, DOI 10.1016/j.bbagrm.2014.09.006; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Cuesta R, 2016, ONCOTARGET, V7, P27567, DOI 10.18632/oncotarget.8375; de la Parra C, 2018, CURR OPIN GENET DEV, V48, P82, DOI 10.1016/j.gde.2017.11.001; De Marchi T, 2016, DRUG DISCOV TODAY, V21, P1181, DOI 10.1016/j.drudis.2016.05.012; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Gao BC, 2015, BBA-GENE REGUL MECH, V1849, P753, DOI 10.1016/j.bbagrm.2014.11.006; Guertin MJ, 2014, MOL ENDOCRINOL, V28, P1522, DOI 10.1210/me.2014-1130; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lu CW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.20; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller WR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2931; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Nishidate T, 2004, INT J ONCOL, V25, P797; Rondon-Lagos M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081357; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Truitt ML, 2016, NAT REV CANCER, V16, P288, DOI 10.1038/nrc.2016.27; Vaklavas C, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00158; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wen FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034194; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Zhang LL, 2008, J BIOL CHEM, V283, P24047, DOI 10.1074/jbc.M800956200; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhao WP, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.906389	45	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2267	2278		10.1074/jbc.RA118.004383	http://dx.doi.org/10.1074/jbc.RA118.004383			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573685	Green Published, hybrid			2022-12-26	WOS:000458895400006
J	Tan, C; Byrne, EFX; Ah-Cann, C; Call, MJ; Call, ME				Tan, Cyrus; Byrne, Eamon F. X.; Ah-Cann, Casey; Call, Melissa J.; Call, Matthew E.			A serine in the first transmembrane domain of the human E3 ubiquitin ligase MARCH9 is critical for down-regulation of its protein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; receptor endocytosis; ubiquitin ligase; membrane protein; nuclear magnetic resonance (NMR); major histocompatibility complex (MHC); T-cell; E3 ligase; membrane-associated RING-CH (MARCH); transmembrane domain	COMPLEX CLASS-I; ANTIGEN PRESENTATION; CELL SELECTION; EXPRESSION; RECOGNITION; ASSOCIATION; INHIBITION; SURFACE; MODEL; DIMER	The membrane-associated RING-CH (MARCH) family of membrane-bound E3 ubiquitin ligases regulates the levels of cell-surface membrane proteins, many of which are involved in immune responses. Although their role in ubiquitin-dependent endocytosis and degradation of cell-surface proteins is extensively documented, the features of MARCH proteins and their substrates that drive the molecular recognition events leading to ubiquitin transfer remain poorly defined. In this study, we sought to determine the features of human MARCH9 that are required for regulating the surface levels of its substrate proteins. Consistent with previous studies of other MARCH proteins, we found that susceptibility to MARCH9 activity is encoded in the transmembrane (TM) domains of its substrates. Accordingly, substitutions at specific residues and motifs within MARCH9's TM domains resulted in varying degrees of functional impairment. Most notably, a single serine-to-alanine substitution in the first of its two TM domains rendered MARCH9 completely unable to alter the surface levels of two different substrates: the major histocompatibility class I molecule HLA-A2 and the T-cell co-receptor CD4. Solution NMR analysis of a MARCH9 fragment encompassing the two TM domains and extracellular connecting loop revealed that the residues contributing most to MARCH9 activity are located in the alpha-helical portions of TM1 and TM2 that are closest to the extracellular face of the lipid bilayer. This observation defines a key region required for substrate regulation. In summary, our biochemical and structural findings demonstrate that specific sequences in the alpha-helical MARCH9 TM domains make crucial contributions to its ability to down-regulate its protein substrates.	[Tan, Cyrus; Call, Melissa J.; Call, Matthew E.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia; [Tan, Cyrus; Ah-Cann, Casey; Call, Melissa J.; Call, Matthew E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Byrne, Eamon F. X.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ah-Cann, Casey] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne; Stanford University; Walter & Eliza Hall Institute	Call, MJ; Call, ME (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia.; Call, MJ; Call, ME (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	call@wehi.edu.au; call@wehi.edu.au	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841; Ah-Cann, Casey/0000-0001-9210-3776; Call, Matthew/0000-0001-5846-6469; Byrne, Eamon/0000-0001-7513-5944	Australian National Health and Medical Research Council [GNT1030902]; IRIISS Infrastructure Support and Human Frontier Science Program [RGP0064/2011]; University of Melbourne; Australian Research Council Future Fellowship [FT120100145]; QEII Fellowship from the Australian Research Council [DP110104369]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); IRIISS Infrastructure Support and Human Frontier Science Program; University of Melbourne(University of Melbourne); Australian Research Council Future Fellowship(Australian Research Council); QEII Fellowship from the Australian Research Council(Australian Research Council)	This work was supported in part by Australian National Health and Medical Research Council Grant GNT1030902 and IRIISS Infrastructure Support and Human Frontier Science Program Grant RGP0064/2011. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Melbourne Research and Fee Remission Scholarships (University of Melbourne).; Supported by Australian Research Council Future Fellowship FT120100145.; Supported by QEII Fellowship DP110104369 from the Australian Research Council.	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bauer J, 2017, NEW BIOTECHNOL, V38, P7, DOI 10.1016/j.nbt.2016.12.002; Bayer-Santos E, 2016, CELL HOST MICROBE, V20, P584, DOI 10.1016/j.chom.2016.10.007; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Chipot C, 2018, CHEM REV, V118, P3559, DOI 10.1021/acs.chemrev.7b00570; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Elazar A, 2016, ELIFE, V5, DOI 10.7554/eLife.12125; Fatehchand K, 2016, J BIOL CHEM, V291, P3895, DOI 10.1074/jbc.M115.701151; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Knoblich K, 2015, CELL REP, V11, P1184, DOI 10.1016/j.celrep.2015.04.045; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Sharma P, 2013, JOVE-J VIS EXP, DOI 10.3791/50141; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Trenker R, 2015, J AM CHEM SOC, V137, P15676, DOI 10.1021/jacs.5b11354; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	58	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2470	2485		10.1074/jbc.RA118.004836	http://dx.doi.org/10.1074/jbc.RA118.004836			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30554144	Green Published, hybrid			2022-12-26	WOS:000458895400023
J	Allard, CAH; Decker, F; Weiner, OD; Toettcher, JE; Graziano, BR				Allard, Corey A. H.; Decker, Franziska; Weiner, Orion D.; Toettcher, Jared E.; Graziano, Brian R.			A size-invariant bud-duration timer enables robustness in yeast cell size control	PLOS ONE			English	Article							BUDDING-YEAST; GROWTH; CYCLE; HOMEOSTASIS; DIVISION; DNA; COORDINATION; BACTERIA; MITOSIS	Cell populations across nearly all forms of life generally maintain a characteristic cell type-dependent size, but how size control is achieved has been a long-standing question. The G1/S boundary of the cell cycle serves as a major point of size control, and mechanisms operating here restrict passage of cells to Start if they are too small. In contrast, it is less clear how size is regulated post-Start, during S/G2/M. To gain further insight into post-Start size control, we prepared budding yeast that can be reversibly blocked from bud initiation. While blocked, cells continue to grow isotropically, increasing their volume by more than an order of magnitude over unperturbed cells. Upon release from their block, giant mothers reenter the cell cycle and their progeny rapidly return to the original unperturbed size. We found this behavior to be consistent with a size-invariant 'timer' specifying the duration of S/G2/M. These results indicate that yeast use at least two distinct mechanisms at different cell cycle phases to ensure size homeostasis.	[Allard, Corey A. H.; Decker, Franziska; Weiner, Orion D.; Toettcher, Jared E.; Graziano, Brian R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Allard, Corey A. H.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH USA; [Decker, Franziska] Max Planck Inst Mol Cell Biol & Genet, Max Planck Inst Phys Complex Syst, Ctr Syst Biol Dresden, Dresden, Germany; [Weiner, Orion D.; Graziano, Brian R.] UC San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Weiner, Orion D.; Graziano, Brian R.] UC San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Toettcher, Jared E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Marine Biological Laboratory - Woods Hole; Dartmouth College; Max Planck Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Princeton University	Weiner, OD; Toettcher, JE; Graziano, BR (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Weiner, OD; Graziano, BR (corresponding author), UC San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Weiner, OD; Graziano, BR (corresponding author), UC San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Toettcher, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	orion.weiner@ucsf.edu; toettcher@princeton.edu; brian.graziano@ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543; Decker, Franziska/0000-0002-3241-6575; Graziano, Brian/0000-0003-1081-908X; Allard, Corey/0000-0002-3554-2059	Marine Biological Laboratory; Thomas B. Grave and Elizabeth F. Grave Scholarship; National Institutes of Health [GM118167, DP2EB024247, T32HL773125]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118167] Funding Source: NIH RePORTER	Marine Biological Laboratory; Thomas B. Grave and Elizabeth F. Grave Scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was provided by a Post-Physiology Course Award from the Marine Biological Laboratory to C.A.H.A., the Thomas B. Grave and Elizabeth F. Grave Scholarship to F.D., and the National Institutes of Health [GM118167 to O.D.W., DP2EB024247 to J.E.T., and T32HL773125 to B.R.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amir A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208102; Amodeo AA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019083; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BROOKS RF, 1985, EXP CELL RES, V156, P1, DOI 10.1016/0014-4827(85)90255-1; Cadart C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05393-0; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Chandler-Brown D, 2017, CURR BIOL, V27, P2774, DOI 10.1016/j.cub.2017.08.015; Charvin G, 2009, P NATL ACAD SCI USA, V106, P6632, DOI 10.1073/pnas.0809227106; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; Eun YJ, 2018, NAT MICROBIOL, V3, P148, DOI 10.1038/s41564-017-0082-6; FANTES PA, 1977, J CELL SCI, V24, P51; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jost APT, 2015, ACS SYNTH BIOL, V4, P1077, DOI 10.1021/acssynbio.5b00053; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Leitao RM, 2017, J CELL BIOL, V216, P3463, DOI 10.1083/jcb.201609114; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Marshall WF, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-57; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Pan KZ, 2014, ELIFE, V3, DOI 10.7554/eLife.02040; REED SI, 1990, P NATL ACAD SCI USA, V87, P5697, DOI 10.1073/pnas.87.15.5697; Schmoller KM, 2017, CURR OPIN CELL BIOL, V49, P53, DOI 10.1016/j.ceb.2017.11.011; Schmoller KM, 2015, NATURE, V526, P268, DOI 10.1038/nature14908; SIKORSKI RS, 1989, GENETICS, V122, P19; Soifer I, 2016, CURR BIOL, V26, P356, DOI 10.1016/j.cub.2015.11.067; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Varsano G, 2017, CELL REP, V20, P397, DOI 10.1016/j.celrep.2017.06.057	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209301	10.1371/journal.pone.0209301	http://dx.doi.org/10.1371/journal.pone.0209301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576342	Green Published, gold			2022-12-26	WOS:000454149400037
J	Howing, T; Dann, M; Muller, B; Helm, M; Scholz, S; Schneitz, K; Hammes, UZ; Gietl, C				Hoewing, Timo; Dann, Marcel; Mueller, Benedikt; Helm, Michael; Scholz, Sebastian; Schneitz, Kay; Hammes, Ulrich Z.; Gietl, Christine			The role of KDEL-tailed cysteine endopeptidases of Arabidopsis (AtCEP2 and AtCEP1) in root development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CASTOR BEAN ENDOSPERM; EXPRESSION ANALYSIS; PROTEASE; LOCALIZATION; RICINOSOMES; RICINUS; GENES; MATURATION; EMERGENCE	Plants encode a unique group of papain-type cysteine endopeptidases (CysEP) characterized by a C-terminal KDEL endoplasmic reticulum retention signal (KDEL-CysEP) and an unusually broad substrate specificity. The three Arabidopsis KDEL-CysEPs (AtCEP1, AtCEP2, and AtCEP3) are differentially expressed in vegetative and generative tissues undergoing programmed cell death (PCD). While KDEL-CysEPs have been shown to be implicated in the collapse of tissues during PCD, roles of these peptidases in processes other than PCD are unknown. Using mCherry-AtCEP2 and EGFP-AtCEP1 reporter proteins in wild type versus atcep2 or atcep1 mutant plants, we explored the participation of AtCEP in young root development. Loss of AtCEP2, but not AtCEP1 resulted in shorter primary roots due to a decrease in cell length in the lateral root (LR) cap, and impairs extension of primary root epidermis cells such as trichoblasts in the elongation zone. AtCEP2 was localized to root cap corpses adherent to epidermal cells in the rapid elongation zone. AtCEP1 and AtCEP2 are expressed in root epidermis cells that are separated for LR emergence. Loss of AtCEP1 or AtCEP2 caused delayed emergence of LR primordia. KDEL-CysEPs might be involved in developmental tissue remodeling by supporting cell wall elongation and cell separation.	[Hoewing, Timo; Dann, Marcel; Helm, Michael; Gietl, Christine] Tech Univ Muenchen, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany; [Mueller, Benedikt; Hammes, Ulrich Z.] Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, Regensburg, Germany; [Scholz, Sebastian; Schneitz, Kay] Tech Univ Muenchen, Ctr Life & Food Sci Weihenstephan, Plant Dev Biol, Freising Weihenstephan, Germany; [Dann, Marcel] Ludwig Maximilians Univ Muenchen, Dept Biol 1, Lehrstuhl Bot Mol Biol Pflanzen, Martinsried, Germany; [Hammes, Ulrich Z.] Tech Univ Muenchen, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Syst Biol Pflanzen, Freising Weihenstephan, Germany	Technical University of Munich; University of Regensburg; Technical University of Munich; University of Munich; Technical University of Munich	Gietl, C (corresponding author), Tech Univ Muenchen, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany.	christine.gietl@wzw.tum.de	; Scholz, Sebastian/H-6237-2015	Hammes, Ulrich/0000-0002-3663-4908; Scholz, Sebastian/0000-0001-5142-0003	Deutsche Forschungsgemeinschaft [SFB924]; German Research Foundation (DFG); Technische Universitat Munchen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de): SFB924 to Kay Schneitz (A02), Christine Gietl (A07) and Ulrich Z. Hammes (A08). We would like to thank CSIRO Plant Industry (Canberra, Australia) for providing the pHannibal/pKannibal vector system. This work was also supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programm Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud C, 2010, CR BIOL, V333, P335, DOI 10.1016/j.crvi.2010.01.011; Battelli R, 2014, PLANT SCI, V214, P38, DOI 10.1016/j.plantsci.2013.09.011; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chen XD, 2016, PLANT PHYSIOL, V170, P2136, DOI 10.1104/pp.15.01733; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dickman MB, 2013, ANNU REV PHYTOPATHOL, V51, P543, DOI 10.1146/annurev-phyto-081211-173027; Driouich A, 2010, J EXP BOT, V61, P3827, DOI 10.1093/jxb/erq216; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Greenwood JS, 2005, P NATL ACAD SCI USA, V102, P2238, DOI 10.1073/pnas.0409429102; Hall Q, 2002, PLANT CELL, V14, P1161, DOI 10.1105/tpc.010477; He X, 2003, PLANT MOL BIOL, V52, P729, DOI 10.1023/A:1025008117046; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hierl G, 2014, PLANT MOL BIOL, V84, P605, DOI 10.1007/s11103-013-0157-6; Hierl G, 2012, PHYSIOL PLANTARUM, V145, P103, DOI 10.1111/j.1399-3054.2012.01580.x; Hijazi M, 2014, FRONT PLANT SCI, V5, P525, DOI [10.3389/fpls.2014.00525, DOI 10.3389/FPLS.2014.00525]; Howing T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183870; Howing T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00058; Kumpf RP, 2013, P NATL ACAD SCI USA, V110, P5235, DOI 10.1073/pnas.1210835110; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Nakano RT, 2017, PLANT J, V89, P204, DOI 10.1111/tpj.13377; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Nakashima J, 2004, PLANTA, V218, P729, DOI 10.1007/s00425-003-1167-4; Okamoto T, 2003, PLANT PHYSIOL, V132, P1892, DOI 10.1104/pp.103.021147; Olvera-Carrillo Y, 2015, PLANT PHYSIOL, V169, P2684, DOI 10.1104/pp.15.00769; Lopez-Fernandez MP, 2015, J INTEGR PLANT BIOL, V57, P996, DOI 10.1111/jipb.12367; Peret B, 2012, NAT CELL BIOL, V14, P991, DOI 10.1038/ncb2573; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Rocha AJ, 2018, GENE EXPR PATTERNS, V27, P122, DOI 10.1016/j.gep.2017.12.002; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; Schmid M, 1998, PLANTA, V206, P466, DOI 10.1007/s004250050423; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Senatore A, 2009, PLANT PHYSIOL, V149, P775, DOI 10.1104/pp.108.132720; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Trobacher CP, 2013, PLANTA, V237, P665, DOI 10.1007/s00425-012-1780-1; Tsiatsiani L, 2013, PLANT CELL, V25, P2831, DOI 10.1105/tpc.113.115287; Van Durme M, 2016, CURR OPIN PLANT BIOL, V29, P29, DOI 10.1016/j.pbi.2015.10.013; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Velasquez M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00093; Verbelen JP, 2006, PLANT SIGNAL BEHAV, V1, P296, DOI 10.4161/psb.1.6.3511; Wilson MH, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00010; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282; Zhou LZ, 2016, PLANT REPROD, V29, P265, DOI 10.1007/s00497-016-0288-4; Zimmermann D, 2016, PLANT PHYSIOL, V171, P1456, DOI 10.1104/pp.16.00513	58	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209407	10.1371/journal.pone.0209407	http://dx.doi.org/10.1371/journal.pone.0209407			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576358	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400048
J	Itakura, Y; Inagaki, S; Wada, H; Hayashi, S				Itakura, Yuki; Inagaki, Sachi; Wada, Housei; Hayashi, Shigeo			Trynity controls epidermal barrier function and respiratory tube maturation in Drosophila by modulating apical extracellular matrix nano-patterning	PLOS ONE			English	Article							ZP-DOMAIN PROTEINS; CUTICLE; CHITIN; SKIN; CELL; MORPHOGENESIS; ADHESION; PIOPIO; GENES; SHAPE	The outer surface of insects is covered by the cuticle, which is derived from the apical extracellular matrix (aECM). The aECM is secreted by epidermal cells during embryogenesis. The aECM exhibits large variations in structure, function, and constituent molecules, reflecting the enormous diversity in insect appearances. To investigate the molecular principles of aECM organization and function, here we studied the role of a conserved aECM protein, the ZP domain protein Trynity, in Drosophila melanogaster. We first identified trynity as an essential gene for epidermal barrier function. trynity mutation caused disintegration of the outermost envelope layer of the cuticle, resulting in small-molecule leakage and in growth and molting defects. In addition, the tracheal tubules of trynity mutants showed defects in pore-like structures of the cuticle, and the mutant tracheal cells failed to absorb luminal proteins and liquid. Our findings indicated that trynity plays essential roles in organizing nano-level structures in the envelope layer of the cuticle that both restrict molecular trafficking through the epidermis and promote the massive absorption pulse in the trachea.	[Itakura, Yuki; Wada, Housei; Hayashi, Shigeo] RIKEN Ctr Biosyst Dynam Res, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo, Japan; [Inagaki, Sachi] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo, Japan; [Hayashi, Shigeo] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo, Japan	RIKEN; Kobe University; Kobe University	Hayashi, S (corresponding author), RIKEN Ctr Biosyst Dynam Res, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo, Japan.; Hayashi, S (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo, Japan.	shigeo.hayashi@riken.jp	Hayashi, Shigeo/J-9628-2019; Inagaki, Sachi/P-8036-2019	Hayashi, Shigeo/0000-0001-7785-1290; Inagaki, Sachi/0000-0002-2365-9938; Itakura, Yuki/0000-0001-7513-0529	ministry of education, science, sports and technology JAPAN	ministry of education, science, sports and technology JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	YI was supported by "Initiative for the implementation of the diversity research environment" from ministry of education, science, sports and technology JAPAN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Bouwstra JA, 2006, BBA-BIOMEMBRANES, V1758, P2080, DOI 10.1016/j.bbamem.2006.06.021; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Dong B, 2015, CURR OPIN GENET DEV, V32, P129, DOI 10.1016/j.gde.2015.02.009; Dong B, 2014, CELL REP, V7, P941, DOI 10.1016/j.celrep.2014.03.066; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Jaspers MHJ, 2014, DEV BIOL, V385, P23, DOI 10.1016/j.ydbio.2013.10.022; Jazwinska A, 2004, GENE EXPR PATTERNS, V4, P413, DOI 10.1016/j.modgep.2004.01.003; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones TA, 2013, JOVE-J VIS EXP, DOI 10.3791/50496; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; LOCKE M, 1961, J BIOPHYS BIOCHEM CY, V10, P589, DOI 10.1083/jcb.10.4.589; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Magie Craig R., 2002, Development (Cambridge), V129, P3771; McDonald Kent L, 2012, Cold Spring Harb Protoc, V2012, P516, DOI 10.1101/pdb.prot068411; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B., 2010, DROSOPHILA INF SERV, V93, P215; Moussian B, 2006, ARTHROPOD STRUCT DEV, V35, P137, DOI 10.1016/j.asd.2006.05.003; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Ozturk-Colak A, 2016, ELIFE, V5, DOI 10.7554/eLife.09373; Onda K., 1970, J CHEM ENGNG JAPAN, V3, P18, DOI [DOI 10.1252/JCEJ.3.18, DOI 10.1252/JCEJ.3.18.]; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Pesch YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18340; Plaza S, 2010, TRENDS CELL BIOL, V20, P524, DOI 10.1016/j.tcb.2010.06.002; Prout M, 1997, GENETICS, V146, P275; Ray RP, 2015, DEV CELL, V34, P310, DOI 10.1016/j.devcel.2015.06.019; Seidl B, 2011, J STRUCT BIOL, V174, P512, DOI 10.1016/j.jsb.2011.03.005; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Sobala LF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006100; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wang YW, 2018, DEV BIOL, V437, P75, DOI 10.1016/j.ydbio.2018.02.019; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; WIGGLESWORTH VB, 1953, J CELL SCI, V94, P507; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Yasugi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01754-9; Zuber R, 2018, EUR J CELL BIOL, V97, P90, DOI 10.1016/j.ejcb.2017.12.003	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209058	10.1371/journal.pone.0209058	http://dx.doi.org/10.1371/journal.pone.0209058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576352	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400026
J	Liao, Q; Zhou, T; Yao, JY; Han, QF; Song, HX; Guan, CY; Hua, YP; Zhang, ZH				Liao, Qiong; Zhou, Ting; Yao, Jun-yue; Han, Qing-fen; Song, Hai-xing; Guan, Chun-yun; Hua, Ying-peng; Zhang, Zhen-hua			Genome-scale characterization of the vacuole nitrate transporter Chloride Channel (CLC) genes and their transcriptional responses to diverse nutrient stresses in allotetraploid rapeseed	PLOS ONE			English	Article							NITROGEN ASSIMILATION; GLUTAMINE-SYNTHETASE; ARABIDOPSIS; PROTEIN; RICE; EFFICIENCY; EXPRESSION; FAMILY; ROOTS; IDENTIFICATION	The Chloride Channel (CLC) gene family is reported to be involved in vacuolar nitrate (NO3-) transport. Nitrate distribution to the cytoplasm is beneficial for enhancing NO(3)(- )assimilation and plays an important role in the regulation of nitrogen (N) use efficiency (NUE). In this study, genomic information, high-throughput transcriptional profiles, and gene co-expression analysis were integrated to identify the CLCs (BnaCLCs) in Brassica napus. The decreased NO3- concentration in the cica-2 mutant up-regulated the activities of nitrate reductase and glutamine synthetase, contributing to increase N assimilation and higher NUE in Arabidopsis thaliana. The genome-wide identification of 22BnaCLC genes experienced strong purifying selection. Segmental duplication was the major driving force in the expansion of the BnaCLC gene family. The most abundant cis-acting regulatory elements in the gene promoters, including DNA-binding One Zinc Finger, W-box, MYB, and GATA-box, might be involved in the transcriptional regulation of BnaCLCs expression. High-throughput transcriptional profiles and quantitative real-time PCR results showed that BnaCLCs responded differentially to distinct NO3- regimes. Transcriptomics-assisted gene co-expression network analysis identified BnaA7.CLCa-3 as the core member of the BnaCLC family, and this gene might play a central role in vacuolar NO3- transport in crops. The BnaCLC members also showed distinct expression patterns under phosphate depletion and cadmium toxicity. Taken together, our results provide comprehensive insights into the vacuolar BnaCLCs and establish baseline information for future studies on BnaCLCs-mediated vacuolar NO3- storage and its effect on NUE.	[Liao, Qiong; Zhou, Ting; Yao, Jun-yue; Han, Qing-fen; Song, Hai-xing; Hua, Ying-peng; Zhang, Zhen-hua] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China; [Guan, Chun-yun] Natl Ctr Oilseed Crops Improvement, Hunan Branch, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Hua, YP; Zhang, ZH (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China.	yingpenghua89@126.com; zhzh1468@163.com		Zhang, Zhenhua/0000-0002-8877-1090	National Key Research and Development Program of China [2017YFD0200100, 2017YFD0200103]; National Natural Science Foundation of China [31801923, 31101596, 31372130]; Hunan Provincial Recruitment Program of Foreign Experts; National Oilseed Rape Production Technology System of China; "2011 Plan" - Ministry of Education of China; Double First-class Construction Project of Hunan Agricultural University [kxk201801005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Recruitment Program of Foreign Experts; National Oilseed Rape Production Technology System of China; "2011 Plan" - Ministry of Education of China(Ministry of Education, China); Double First-class Construction Project of Hunan Agricultural University	This study was financially supported by the National Key Research and Development Program of China (2017YFD0200100 and 2017YFD0200103), National Natural Science Foundation of China (31801923, 31101596 and 31372130), Hunan Provincial Recruitment Program of Foreign Experts, National Oilseed Rape Production Technology System of China, "2011 Plan" supported by the Ministry of Education of China and Double First-class Construction Project of Hunan Agricultural University (kxk201801005).	Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Baetz U, 2016, PLANT PHYSIOL, V172, P1167, DOI 10.1104/pp.16.00183; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balotf S, 2016, BIOTECHNOL APPL BIOC, V63, P220, DOI 10.1002/bab.1362; Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Bayer PE, 2017, PLANT BIOTECHNOL J, V15, P1602, DOI 10.1111/pbi.12742; Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; Nguyen CT, 2016, PLANT CELL PHYSIOL, V57, P764, DOI 10.1093/pcp/pcv169; CULLIMORE JV, 1980, PLANTA, V150, P392, DOI 10.1007/BF00390175; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; Fan XR, 2016, P NATL ACAD SCI USA, V113, P7118, DOI 10.1073/pnas.1525184113; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Guo LL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-18; Guo W, 2014, J EXP BOT, V65, P1205, DOI 10.1093/jxb/ert484; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Han YL, 2016, PLANT PHYSIOL, V170, P1684, DOI 10.1104/pp.15.01377; Han YL, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1744-0; Harada H, 2004, J EXP BOT, V55, P2005, DOI 10.1093/jxb/erh224; He Y, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1511-9; Herdean A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00115; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hua YP, 2018, G3-GENES GENOM GENET, V8, P2757, DOI 10.1534/g3.118.200481; Hua YP, 2018, PLANT SOIL, V427, P245, DOI 10.1007/s11104-018-3652-3; Huang CaiBian, 2011, Journal of Agro-Environment Science, V30, P613; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Imamura S, 2009, P NATL ACAD SCI USA, V106, P12548, DOI 10.1073/pnas.0902790106; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jossier M, 2010, PLANT J, V64, P563, DOI 10.1111/j.1365-313X.2010.04352.x; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Kurai T, 2011, PLANT BIOTECHNOL J, V9, P826, DOI 10.1111/j.1467-7652.2011.00592.x; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LH, 2009, SCI CHINA SER C, V52, P1055, DOI 10.1007/s11427-009-0137-x; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Lisal J, 2009, PHILOS T R SOC B, V364, P181, DOI 10.1098/rstb.2008.0123; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maillard A, 2016, J EXP BOT, V67, P5631, DOI 10.1093/jxb/erw322; Marmagne A, 2007, J EXP BOT, V58, P3385, DOI 10.1093/jxb/erm187; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Migocka M, 2015, J EXP BOT, V66, P1001, DOI 10.1093/jxb/eru459; Miller AJ, 2008, ANN BOT-LONDON, V101, P485, DOI 10.1093/aob/mcm313; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Noguero M, 2013, PLANT SCI, V209, P32, DOI 10.1016/j.plantsci.2013.03.016; Rathke GW, 2006, AGR ECOSYST ENVIRON, V117, P80, DOI 10.1016/j.agee.2006.04.006; Sahito ZA, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1161-9; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Sharma SS, 2016, PLANT CELL ENVIRON, V39, P1112, DOI 10.1111/pce.12706; Shen QiRong, 2003, Acta Pedologica Sinica, V40, P465; Shi WM, 2010, PLANT SOIL, V326, P291, DOI 10.1007/s11104-009-0007-0; Sun FM, 2017, PLANT J, V92, P452, DOI 10.1111/tpj.13669; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YF, 2013, PLANT PHYSIOL BIOCH, V70, P14, DOI 10.1016/j.plaphy.2013.04.027; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; U. N., 1935, Japanese Journal of Botany, V7, P389; von der Fecht-Bartenbach J, 2007, PLANT J, V50, P466, DOI 10.1111/j.1365-313X.2007.03061.x; von der Fecht-Bartenbach J, 2010, PLANT CELL PHYSIOL, V51, P960, DOI 10.1093/pcp/pcq062; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang GL, 2014, ANN BOT-LONDON, V114, P549, DOI 10.1093/aob/mcu135; Wang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01709; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang X., 2015, IEEE T COMPUT IMAG, V2, P1; Wang YY, 2018, ANNU REV PLANT BIOL, V69, P85, DOI 10.1146/annurev-arplant-042817-040056; Wege S, 2010, PLANT J, V63, P861, DOI 10.1111/j.1365-313X.2010.04288.x; Wilkins MR, 1999, METH MOL B, V112, P531; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu Y, 2017, MOL CELLS, V40, P178, DOI 10.14348/molcells.2017.2261; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yu JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-664; Zhang ZhenHua, 2012, Australian Journal of Crop Science, V6, P1377; Zifarelli G, 2010, FEBS LETT, V584, P2122, DOI 10.1016/j.febslet.2009.12.042	84	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208648	10.1371/journal.pone.0208648	http://dx.doi.org/10.1371/journal.pone.0208648			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571734	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700018
J	Mahnic, A; Rupnik, M				Mahnic, Aleksander; Rupnik, Maja			Different host factors are associated with patterns in bacterial and fungal gut microbiota in Slovenian healthy cohort	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOME; BODY-MASS INDEX; COMMENSAL FUNGI; AGE; INFLAMMATION; DEGRADATION; DIVERSITY; STABILITY; STRAINS; GENDER	Gut microbiota in a healthy population is shaped by various geographic, demographic and lifestyle factors. Although the majority of research remains focused on the bacterial community, recent efforts to include the remaining microbial members like viruses, archaea and especially fungi revealed various functions they perform in the gut. Using the amplicon sequencing approach we analysed bacterial and fungal gut communities in a Slovenian cohort of 186 healthy volunteers. In the bacterial microbiome we detected 253 different genera. A core microbiome analysis revealed high consistency with previous studies, most prominently showing that genera Faecalibacterium, Bacteroides and Roseburia regularly comprise the core community. We detected a total of 195 fungal genera, but the majority of these showed low prevalence and are likely transient foodborne contaminations. The fungal community showed a low diversity per sample and a large interindividual variability. The most abundant fungi were Saccharomyces cerevisiae and Candida albicans. These, along with representatives from genera Penicillium and Debaryomyces, cover 82% of obtained reads. We report three significant questionnaire-based host covariates associated with microbiota composition. Bacterial community was associated with age and gender. More specifically, bacterial diversity was increased with age and was higher in the female population compared to male. The analysis of fungal community showed that more time dedicated to physical activity resulted in a higher fungal diversity and lower abundance of S. cerevisiae. This is likely dependent on different diets, which were reported by participants according to the respective rates of physical activity.	[Mahnic, Aleksander; Rupnik, Maja] Natl Lab Hlth Environm & Food, Dept Microbiol Res, Maribor, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, Maribor, Slovenia	University of Maribor	Rupnik, M (corresponding author), Natl Lab Hlth Environm & Food, Dept Microbiol Res, Maribor, Slovenia.; Rupnik, M (corresponding author), Univ Maribor, Fac Med, Maribor, Slovenia.	maja.rupnik@nlzoh.si		Rupnik, Maja/0000-0003-1930-3290	Slovenian Research Agency [P3-0387]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the Slovenian Research Agency (research core funding P3-0387 and PhD program 'Mladi raziskovalci').; The authors acknowledge the financial support from the Slovenian Research Agency (research core funding P3-0387 and PhD program 'Mladi raziskovalci'). Authors also acknowledge the technical support of Aleksander Kocuvan.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Ahonen T, 2012, GENDER MED, V9, P1, DOI 10.1016/j.genm.2012.01.002; Auchtung TA, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00092-18, 10.1128/msphere.00092-18]; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Borgo F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00213; Bullerman LB, 2018, ENCY FOOD SCI NUTR, DOI [10.4315/0362-028X.JFP-18-031, DOI 10.4315/0362-028X.JFP-18-031]; Chehoud C, 2015, INFLAMM BOWEL DIS, V21, P1948, DOI 10.1097/MIB.0000000000000454; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Beeck MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097629; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Elmer GW, 1999, ALIMENT PHARM THERAP, V13, P1663; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Freire AC, 2011, INT J PHARMACEUT, V415, P15, DOI 10.1016/j.ijpharm.2011.04.069; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Gori K, 2012, MICROBIOLOGYOPEN, V1, P161, DOI 10.1002/mbo3.11; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; Hallen-Adams HE, 2015, FUNGAL ECOL, V15, P9, DOI 10.1016/j.funeco.2015.01.006; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huseyin CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01432; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Kourelis A, 2010, J APPL MICROBIOL, V109, P260, DOI 10.1111/j.1365-2672.2009.04651.x; Lagkouvardos I, 2017, PEERJ, V5, DOI 10.7717/peerj.2836; Leblanc V, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.2; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luan CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep07980; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu XY, 2017, ONCOTARGET, V8, P107577, DOI 10.18632/oncotarget.22534; Salazar N, 2017, GUT MICROBES, V8, P82, DOI 10.1080/19490976.2016.1256525; Salazar N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00406; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Senghor B., 2018, HUM MICROBIOME J, V7-8, P1, DOI [DOI 10.1016/J.HUMIC.2018.01.001, 10.1016/j.humic.2018.01.001]; Sirohi SK, 2013, ANN MICROBIOL, V63, P1187, DOI 10.1007/s13213-012-0577-6; Sket R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188556; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Strati F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01227; Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004; Wheeler ML, 2017, ANNU REV PATHOL-MECH, V12, P359, DOI 10.1146/annurev-pathol-052016-100342; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Wu BN, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/391809; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	69	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209209	10.1371/journal.pone.0209209	http://dx.doi.org/10.1371/journal.pone.0209209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571698	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700043
J	Palacios-Abrantes, J; Herrera-Correal, J; Rodriguez, S; Brunkow, J; Molina, R				Palacios-Abrantes, Juliano; Herrera-Correal, Juliana; Rodriguez, Salvador; Brunkow, Jacy; Molina, Renato			Evaluating the bio-economic performance of a Callo de hacha (Atrina maura, Atrina tuberculosa & Pinna rugosa) fishery restoration plan in La Paz, Mexico	PLOS ONE			English	Article							BIVALVIA; MANAGEMENT	Small-scale fisheries are large contributors to regional economies and livelihoods in coastal communities of Latin America. While Mexico is one of the cases where small-scale fisheries play an important role, overfishing and poor management strategies have led to the collapse of many of its fisheries. The cello de hacha scallop fishery of the Ensenada de La Paz in Baja California Sur is an example of such a fishery which, after years of mismanagement, was closed by the Mexican authorities in 2009. The present study evaluated the recovery efforts in the cove and the potential outcomes of a collaboration between a non-governmental organization and a fishing community working towards the restoration of this pen-shell fishery. After more than four years of closure and active monitoring of the recovering process, the cello de hacha population has shown a significant population recovery, with potential solvency for reopening fishing activities. Four scenarios of uncertainty are evaluated with two of them providing positive net present values from reopening the fishery. We also document the involvement of a non-governmental organization with a fishing community, which created social capital and, in our opinion, was essential for a successful restoration. Having an actively involved community helped raise funds for the fishing closure so fishers were able to comply with Mexican legislation; it also fostered community building and self-organization that will be crucial to maintaining the sustainability of the fishery.	[Palacios-Abrantes, Juliano; Herrera-Correal, Juliana; Rodriguez, Salvador; Brunkow, Jacy] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Molina, Renato] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL USA; [Molina, Renato] Univ Miami, Dept Econ, Miami, FL USA; [Palacios-Abrantes, Juliano] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada	University of California System; University of California Santa Barbara; University of Miami; University of Miami; University of British Columbia	Palacios-Abrantes, J (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; Palacios-Abrantes, J (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	j.palacios@oceans.ubc.ca		Palacios-Abrantes, Juliano/0000-0001-8969-5416	Latin American Fisheries Fellowship	Latin American Fisheries Fellowship	Funded by Latin American Fisheries Fellowship, http://www.laff.bren.ucsb.edu/.JEPA, JHC, SR, RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Systems Change, 2018, JOURN MANGL NOR SUST; Ahumada-Sempoal MA, 2002, REV BIOL TROP, V50, P1091; Alvarado E, 2017, ARISTEGUI NOTICIAS; [Anonymous], 2013, EL FINANCIERO; Arizpe-C. O., 1995, Aquaculture Research, V26, P843, DOI 10.1111/j.1365-2109.1995.tb00878.x; Arreguin-Sanchez F, 2011, HIDROBIOLOGICA, V21, P431; Basurto X, 2005, SOC NATUR RESOUR, V18, P643, DOI 10.1080/08941920590959631; Basurto X, 2008, ECOLOGY SOC; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Camacho-Mondragon MA, 2012, SCI MAR, V76, P539, DOI 10.3989/scimar.03522.05A; Castilla J.C., 2007, MANAGEMENT, P23, DOI [10.1002/9780470996072.ch2, DOI 10.1002/9780470996072.CH2]; Castilla JC, 2008, FAO FISHERIES TECHNI; Centro de Colaboracion Civica A. C. (CCC), 2013, PESC IL IRR MEX BARR, P1; Charles AT, 1998, FISH RES, V37, P37, DOI 10.1016/S0165-7836(98)00125-8; Cisneros-Montemayor AM, 2013, MAR POLICY, V39, P283, DOI 10.1016/j.marpol.2012.12.003; Costea C, 2016, INT CONF EXPO ELECTR, P1, DOI 10.1109/ICEPE.2016.7781291; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edwards S. F., 2001, Marine Resource Economics, V16, P263; Espinosa-Romero M. J., 2017, MARE PUBLICATION SER, P423, DOI [10.1007/978-3-319-55074-9_20, DOI 10.1007/978-3-319-55074-9_20]; Guzman L, 2010, REGION MAGALLANES AN, P1; Hadley W, 2018, GGPLOT2 CREATE ELEGA, pGPL; Karthik R, WES A PALETTE GENERA; Kelly CJ, 2006, ICES J MAR SCI, V63, P600, DOI 10.1016/j.icesjms.2005.12.001; de la Lama RL, 2018, OCEAN COAST MANAGE, V165, P235, DOI 10.1016/j.ocecoaman.2018.08.030; Lopez-Rocha JA, 2010, HIDROBIOLOGICA, V20, P230; Mangin T, 2018, MAR POLICY, V88, P1, DOI 10.1016/j.marpol.2017.10.042; Martinet V, 2007, ECOL ECON, V64, P411, DOI 10.1016/j.ecolecon.2007.02.036; Morales-Bojorquez E, 2009, ANAL DECLINE ABALONE, V27, P865; NOS NS, 2018, PROY REST CALL HACH; Perez D, 2018, EL SUDCALIFORNIANO; Robles A, 2014, STORY MANGLITO RESTO; Secretaria de Economia (SE), 2017, SIST NAC INF INT MER; Serrano-Guzman SJ., 2004, CIENCIA MAR, P1; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209431	10.1371/journal.pone.0209431	http://dx.doi.org/10.1371/journal.pone.0209431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571780	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700071
J	Roberts, SL; Swann, GEA; McGowan, S; Panizzo, VN; Vologina, EG; Sturm, M; Mackay, AW				Roberts, Sarah L.; Swann, George E. A.; McGowan, Suzanne; Panizzo, Virginia N.; Vologina, Elena G.; Sturm, Michael; Mackay, Anson W.			Diatom evidence of 20th century ecosystem change in Lake Baikal, Siberia	PLOS ONE			English	Article							CLIMATE-CHANGE; TRENDS; PHYTOPLANKTON; SEDIMENTS; ECOLOGY; REGIME; CARBON; SHIFTS; DEPTH	Lake Baikal has been experiencing limnological changes from recent atmospheric warming since the 1950s, with rising lake water temperatures, reduced ice cover duration and reduced lake surface-water mixing due to stronger thermal stratification. This study uses lake sediment cores to reconstruct recent changes (c. past 20 years) in Lake Baikal's pelagic diatom communities relative to previous 20th century diatom assemblage records collected in 1993 and 1994 at the same locations in the lake. Recent changes documented within the core-top diatom records agree with predictions of diatom responses to warming at Lake Baikal. Sediments in the south basin of the lake exhibit clear temporal changes, with the most rapid occurring in the 1990's with shifts towards higher abundances of the cosmopolitan Synedra acus and a decline in endemic species, mainly Cyclotella minuta and Stephanodiscus meyerii and to a lesser extent Aulacoseira baicalensis and Aulacoseira skvortzowii. The north basin, in contrast, shows no evidence of recent diatom response to lake warming despite marked declines in north basin ice cover in recent decades. This study also shows no diatom-inferred evidence of eutrophication from deep water sediments. However, due to the localised impacts seen in areas of Lake Baikal's shoreline from nutrient pollution derived from inadequate sewage treatment, urgent action is vital to prevent anthropogenic pollution extending into the open waters.	[Roberts, Sarah L.] Environm & Climate Change Canada, Canada Ctr Inland Waters, Burlington, ON, Canada; [Roberts, Sarah L.; Swann, George E. A.; McGowan, Suzanne; Panizzo, Virginia N.] Univ Nottingham, Sch Geog, Nottingham, England; [Vologina, Elena G.] Russian Acad Sci, Siberian Branch, Inst Earths Crust, Irkutsk, Russia; [Sturm, Michael] Swiss Fed Inst Aquat Sci & Technol EAWAG ETH, Zurich, Switzerland; [Mackay, Anson W.] UCL, Dept Geog, Environm Change Res Ctr, London, England	Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW); University of Nottingham; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University of London; University College London	Roberts, SL (corresponding author), Environm & Climate Change Canada, Canada Ctr Inland Waters, Burlington, ON, Canada.; Roberts, SL (corresponding author), Univ Nottingham, Sch Geog, Nottingham, England.	sarah.roberts2@canada.ca	McGowan, Suzanne/GZB-0118-2022; Vologina, Elena G/A-6414-2014; Swann, George/B-2794-2011	Swann, George/0000-0002-4750-9504; Panizzo, Virginia/0000-0002-3411-9945	Natural Environment Research Council, (NERC) Standard Grants [NE/J00829X/1, NE/J010227/1, NE/J007765/1]; NERC [NE/J00829X/1, NE/J010227/1] Funding Source: UKRI	Natural Environment Research Council, (NERC) Standard Grants(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (grants NE/J00829X/1, NE/J010227/1, and NE/J007765/1), (NERC) Standard Grants.	APPLEBY PG, 1986, HYDROBIOLOGIA, V143, P21, DOI 10.1007/BF00026640; Attermeyer K, 2014, BIOGEOSCIENCES, V11, P1479, DOI 10.5194/bg-11-1479-2014; Bartington Instruments, 1995, OP MAN MS2; BATTARBEE RW, 1982, LIMNOL OCEANOGR, V27, P184, DOI 10.4319/lo.1982.27.1.0184; Belykh O. I., 2003, Aquatic Ecosystem Health & Management, V6, P251, DOI 10.1080/14634980301489; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Bradbury J. Platt, 1994, Journal of Paleolimnology, V10, P213, DOI 10.1007/BF00684034; CALLENDER E, 1995, WATER-ROCK INTERACTION, P341; Chraibi VLS, 2014, J GREAT LAKES RES, V40, P886, DOI 10.1016/j.jglr.2014.09.016; Cohen AS, 2016, P NATL ACAD SCI USA, V113, P9563, DOI 10.1073/pnas.1603237113; Creed IF, 2018, GLOBAL CHANGE BIOL, V24, P3692, DOI 10.1111/gcb.14129; Davi NK, 2015, QUATERNARY SCI REV, V121, P89, DOI 10.1016/j.quascirev.2015.05.020; Edlund MB, 2017, WATER, V9, P1; Fietz S, 2005, J PLANKTON RES, V27, P793, DOI 10.1093/plankt/fbi054; Findlay DL, 2001, LIMNOL OCEANOGR, V46, P1784, DOI 10.4319/lo.2001.46.7.1784; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; Hampton SE, 2015, J PLANKTON RES, P1; Hampton SE, 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI 10.1111/j.1365-2486.2008.01616.x; Hampton SE, 2018, LIMNOL OCEANOGR, V63, P2277, DOI 10.1002/lno.10938; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hampton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088920; Izmest'eva LR, 2016, J GREAT LAKES RES, V42, P6, DOI 10.1016/j.jglr.2015.11.006; Jewson DH, 2008, LIMNOL OCEANOGR, V53, P1125, DOI 10.4319/lo.2008.53.3.1125; Jewson DH, 2015, FRESHWATER BIOL, V60, P2113, DOI 10.1111/fwb.12636; Jewson DH, 2010, EUR J PHYCOL, V45, P354, DOI 10.1080/09670262.2010.492915; Jewson DH, 2009, AQUAT ECOL, V43, P673, DOI 10.1007/s10452-009-9267-2; Jewson DH, 2014, EUROP J PHYCOL, P1; Khodzher TV, 2017, INLAND WATERS, V7, P250, DOI 10.1080/20442041.2017.1329982; Khursevich GK, 2001, QUATERN INT, V80-1, P47, DOI 10.1016/S1040-6182(01)00018-0; KILHAM P, 1990, FRESHWATER BIOL, V23, P379, DOI 10.1111/j.1365-2427.1990.tb00280.x; Kouraev A. V., 2006, ESA SPECIAL PUBLICAT, V614; Kravtsova LS, 2014, J GREAT LAKES RES, V40, P441, DOI 10.1016/j.jglr.2014.02.019; Likhoshway EV, 2005, GEOL GEOFIZ, V46, P34; Likhoshway Ye.V, 1993, DIATOM ALGAE INDICAT, P77; Mackay AW, 2006, GLOBAL CHANGE BIOL, V12, P2297, DOI 10.1111/j.1365-2486.2006.01270.x; Mackay AW, 1998, PHILOS T R SOC B, V353, P1011, DOI 10.1098/rstb.1998.0264; Mackay AW, 1999, GR310529 NERC ECRC U, V59; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Moore MV, 2009, BIOSCIENCE, V59, P405, DOI 10.1525/bio.2009.59.5.8; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Muggeo V.M., 2008, R NEWS, V8, P20; Muller B, 2005, GLOBAL PLANET CHANGE, V46, P101, DOI 10.1016/j.gloplacha.2004.11.008; O'Beirne MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15713; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Ozersky T, 2018, FRESHWATER SCI, V37; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Panizzo VN, 2018, LIMNOLOGY OCEANOGRAP, P1; Popovskaya G.I., 2000, Aquatic Ecosystem Health & Management, V3, P215, DOI 10.1016/S1463-4988(00)00021-X; R Core Team, 2021, R LANGUAGE ENV STAT; Reavie ED, 2017, LIMNOL OCEANOGR, V62, P768, DOI 10.1002/lno.10459; Rosenberger EE, 2008, FRESHWATER BIOL, V53, P1673, DOI 10.1111/j.1365-2427.2008.01990.x; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Ryves DB, 2009, QUATERNARY SCI REV, V28, P120, DOI 10.1016/j.quascirev.2008.08.021; Ryves DB, 2003, LIMNOL OCEANOGR, V48, P1643, DOI 10.4319/lo.2003.48.4.1643; Saros JE, 2014, J PLANKTON RES, V36, P450, DOI 10.1093/plankt/fbt126; Saros JE, 2012, ECOLOGY, V93, P2155, DOI 10.1890/11-2218.1; Shimaraev MN, 2013, CLIMATE CHANGE GLOBA; Silow Eugene A., 2016, Lakes & Reservoirs Research and Management, V21, P40, DOI 10.1111/lre.12119; Sizova LN, 2013, GEOGR NAT RESOUR, V34, P158, DOI 10.1134/S187537281302008X; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Swann GEA, 2018, QUATERNARY SCI REV, V189, P210, DOI 10.1016/j.quascirev.2018.04.013; Timoshkin OA, 2016, J GREAT LAKES RES, V42, P487, DOI 10.1016/j.jglr.2016.02.011; Todd MC, 2003, J CLIMATE, V16, P3186, DOI 10.1175/1520-0442(2003)016<3186:LCCOLB>2.0.CO;2; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; Yan Y, 2018, PALAEOGEOGR PALAEOCL, V495, P48, DOI 10.1016/j.palaeo.2017.12.023; Yoshii K, 1999, LIMNOL OCEANOGR, V44, P502, DOI 10.4319/lo.1999.44.3.0502; Yoshioka Takahito, 2002, Limnology, V3, P159, DOI 10.1007/s102010200019	70	14	14	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208765	10.1371/journal.pone.0208765	http://dx.doi.org/10.1371/journal.pone.0208765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566423	Green Submitted, Green Published, gold			2022-12-26	WOS:000453779300056
J	Kripke, K; Opuni, M; Odoyo-June, E; Onyango, M; Young, P; Serrem, K; Ojiambo, V; Schnure, M; Stegman, P; Njeuhmeli, E				Kripke, Katharine; Opuni, Marjorie; Odoyo-June, Elijah; Onyango, Mathews; Young, Peter; Serrem, Kennedy; Ojiambo, Vincent; Schnure, Melissa; Stegman, Peter; Njeuhmeli, Emmanuel			Data triangulation to estimate age-specific coverage of voluntary medical male circumcision for HIV prevention in four Kenyan counties	PLOS ONE			English	Article							MEN	Background Kenya is 1 of 14 priority countries in Africa scaling up voluntary medical male circumcision (VMMC) for HIV prevention following the recommendations of the World Health Organization and the Joint United Nations Programme on HIV/AIDS. To inform VMMC target setting, we modeled the impact of circumcising specific client age groups across several Kenyan geographic areas. Methods The Decision Makers' Program Planning Tool, Version 2 (DMPPT 2) was applied in Kisumu, Siaya, Homa Bay, and Migori counties. Initial modeling done in mid-2016 showed coverage estimates above 100% in age groups and geographic areas where demand for VMMC continued to be high. On the basis of information obtained from country policy makers and VMMC program implementers, we adjusted circumcision coverage for duplicate reporting, county-level population estimates, migration across county boundaries for VMMC services, and replacement of traditional circumcision with circumcisions in the VMMC program. To address residual inflated coverage following these adjustments we applied county-specific correction factors computed by triangulating model results with coverage estimates from population surveys. Results A program record review identified duplicate reporting in Homa Bay, Kisumu, and Siaya. Using county population estimates from the Kenya National Bureau of Statistics, we found that adjusting for migration and correcting for replacement of traditional circumcision with VMMC led to lower estimates of 2016 male circumcision coverage especially for Kisumu, Migori, and Siaya. Even after addressing these issues, overestimation of 2016 male circumcision coverage persisted, especially in Homa Bay. We estimated male circumcision coverage in 2016 by applying correction factors. Modeled estimates for 2016 circumcision coverage for the 10- to 14-year age group ranged from 50% in Homa Bay to approximately 90% in Kisumu. Results for the 15- to 19-year age group suggest almost complete coverage in Kisumu, Migori, and Siaya. Coverage for the 20- to 24-year age group ranged from about 80% in Siaya to about 90% in Homa Bay, coverage for those aged 25-29 years ranged from about 60% in Siaya to 80% in Migori, and coverage in those aged 30-34 years ranged from about 50% in Siaya to about 70% in Migori. Conclusions Our analysis points to solutions for some of the data issues encountered in Kenya. Kenya is the first country in which these data issues have been encountered because baseline circumcision rates were high. We anticipate that some of the modeling methods we developed for Kenya will be applicable in other countries.	[Kripke, Katharine; Stegman, Peter] Avenir Hlth, Project SOAR, Glastonbury, CT 06033 USA; [Odoyo-June, Elijah; Young, Peter] US CDC, Div Global AIDS & TB, Nairobi, Kenya; [Onyango, Mathews] FHI 360, Nairobi, Kenya; [Serrem, Kennedy] NASCOP, Nairobi, Kenya; [Ojiambo, Vincent] USAID, Nairobi, Kenya; [Schnure, Melissa] Palladium Grp, Project SOAR, Washington, DC USA; [Njeuhmeli, Emmanuel] USAID, Mbabane, Swaziland	United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Project SOAR, Glastonbury, CT 06033 USA.	kkripke@avenirhealth.org	Odoyo-June, Elijah/AAJ-6074-2021; Kripke, Katharine/J-2146-2019	Odoyo-June, Elijah/0000-0002-1370-2306; Kripke, Katharine/0000-0001-8228-4577; Opuni, Marjorie/0000-0002-0939-7695	American people through PEPFAR; USAID U.S. President's Emergency Plan for AIDS Relief under the cooperative agreement Project SOAR [AID-OAA-14-00060]	American people through PEPFAR; USAID U.S. President's Emergency Plan for AIDS Relief under the cooperative agreement Project SOAR(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The information provided does not necessarily reflect the views of USAID, CDC, PEPFAR, or the US government, and the contents of this article are the sole responsibility of Project SOAR (Supporting Operational AIDS Research), the Population Council, and the authors. This manuscript was made possible by the generous support of the American people through PEPFAR with USAID U.S. President's Emergency Plan for AIDS Relief under the cooperative agreement Project SOAR (number AID-OAA-14-00060).	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2014, KEN HIV PREV REV ROA; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145729; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140818; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Futures Institute, 2011, GOALS MAN MOD EST EF; Government of Kenya MoH National AIDS and STI Control Program, 2008, NAT GUID VMMC KEN; Government of Kenya MoH National AIDS and STI Control Program, 2015, NAT VOL MED MAL CIRC; Government of Kenya MoH National AIDS and STI Control Program, 2009, NAT VOL MED MAL CIRC; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160699; Isdory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142805; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164144; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157071; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153363; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156521; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158767; National AIDS Control Council Ministry of Health, 2014, KEN AIDS STRAT FRAM; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209385	10.1371/journal.pone.0209385	http://dx.doi.org/10.1371/journal.pone.0209385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562394	Green Published, gold, Green Submitted			2022-12-26	WOS:000453774100052
J	Marchuk, DS; Crooks, K; Strande, N; Kaiser-Rogers, K; Milko, LV; Brandt, A; Arreola, A; Tilley, CR; Bizon, C; Vora, NL; Wilhelmsen, KC; Evans, JP; Berg, JS				Marchuk, Daniel S.; Crooks, Kristy; Strande, Natasha; Kaiser-Rogers, Kathleen; Milko, Laura, V; Brandt, Alicia; Arreola, Alexandra; Tilley, Christian R.; Bizon, Chris; Vora, Neeta L.; Wilhelmsen, Kirk C.; Evans, James P.; Berg, Jonathan S.			Increasing the diagnostic yield of exome sequencing by copy number variant analysis	PLOS ONE			English	Article							ASPHYXIATING THORACIC DYSTROPHY; MENTAL-RETARDATION; DYNC2H1 MUTATIONS; CLINICAL EXOME; MOSAIC LOSS; DUPLICATION	As whole exome sequencing (WES) becomes more widely used in the clinical realm, a wealth of unanalyzed information will be routinely generated. Using WES read depth data to predict copy number variation (CNV) could extend the diagnostic utility of this previously underutilized data by providing clinically important information such as previously unsuspected deletions or duplications. We evaluated ExomeDepth, a free R package, in addition to an aneuploidy prediction method, to detect CNVs in WES data. First, in a blinded pilot study, five out of five genomic alterations were correctly identified from clinical samples with previously defined chromosomal gains or losses, including submicroscopic deletions, duplications, and chromosomal trisomy. We then examined CNV calls among 53 patients participating in the NCGENES research study and undergoing WES, who had existing clinical chromosomal microarray (CMA) data that could be used for validation. For unique CNVs that overlap well with WES coverage regions, sensitivity was 89% for deletions and 65% for duplications. While specificity of the algorithm calls remains a concern, this is less of an issue at high threshold filtering levels. When applied to all 672 patients from the exome sequencing study, ExomeDepth identified eleven diagnostically relevant CNVs ranging in size from a two exon deletion to whole chromosome duplications, as well as numerous other CNVs with varying clinical significance. This opportunistic analysis of WES data yields an additional 1.6% of patients in this study with pathogenic or likely pathogenic CNVs that are clinically relevant to their phenotype as well as clinically relevant secondary findings. Finally, we demonstrate the potential value of copy number analysis in cases where a single heterozygous likely or known pathogenic single nucleotide alteration is identified in a gene associated with an autosomal recessive condition.	[Marchuk, Daniel S.; Strande, Natasha; Kaiser-Rogers, Kathleen; Milko, Laura, V; Brandt, Alicia; Tilley, Christian R.; Wilhelmsen, Kirk C.; Evans, James P.; Berg, Jonathan S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Crooks, Kristy; Strande, Natasha; Kaiser-Rogers, Kathleen; Arreola, Alexandra] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Kaiser-Rogers, Kathleen] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC 27515 USA; [Bizon, Chris; Wilhelmsen, Kirk C.] Univ N Carolina, Renaissance Comp Inst, Chapel Hill, NC 27515 USA; [Vora, Neeta L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Arreola, Alexandra] Ctr Mol Biol & Pathol, Lab Corp Amer, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Berg, JS (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	jonathan_berg@med.unc.edu	Facility, Biospecimen Processing/AAC-7837-2022	Berg, Jonathan/0000-0003-2360-2664; Strande, Natasha/0000-0001-5148-9772; Tilley, Christian/0000-0003-3519-8152	National Human Genome Research Institute [U01 HG006487]; Eunice Kennedy Shriver National Institute of Child Health and Human Development Award [K23 HD088742, K12 HD001441]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD088742, K12HD001441] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006487] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by National Human Genome Research Institute Award Number: U01 HG006487 vertical bar Recipient: James P. Evans (https://www.genome.gov/). Eunice Kennedy Shriver National Institute of Child Health and Human Development Award Number: K12 HD001441 vertical bar Recipient: Neeta Vora (www.nichd.nih.gov). Eunice Kennedy Shriver National Institute of Child Health and Human Development Award Number: K23 HD088742 vertical bar Recipient: Neeta Vora (www.nichd.nih.gov).	[Anonymous], 2015, ONL MEND INH MAN; Berg JS, 2016, GENET MED, V18, P467, DOI 10.1038/gim.2015.104; Bierhals T, 2013, AM J MED GENET A, V161A, P352, DOI 10.1002/ajmg.a.35730; Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Concolino D, 2012, EUR J MED GENET, V55, P67, DOI 10.1016/j.ejmg.2011.09.001; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Foreman Ann Katherine M, 2013, N C Med J, V74, P500; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Jiang YC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1363; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mitchell E, 2015, AM J MED GENET A, V167, P3038, DOI 10.1002/ajmg.a.37351; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Reilly J, TECHNOLOGIES GENOMIC, DOI [10.7921/G0VD6WCF, DOI 10.7921/G0VD6WCF]; Retterer K, 2015, GENET MED, V17, P623, DOI 10.1038/gim.2014.160; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Samarakoon PS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2374-2; Samarakoon PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-661; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Tan RJ, 2014, HUM MUTAT, V35, P899, DOI 10.1002/humu.22537; Tucker ME, 2007, AM J MED GENET A, V143A, P505, DOI 10.1002/ajmg.a.31535; Vora NL, 2017, GENET MED, V19, P1207, DOI 10.1038/gim.2017.33; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	29	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209185	10.1371/journal.pone.0209185	http://dx.doi.org/10.1371/journal.pone.0209185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557390	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000079
J	Miao, XY; Miao, HL; Jia, YJ; Guo, YT				Miao, Xiangying; Miao, Hongli; Jia, Yongjun; Guo, Yingting			Using a stacked-autoencoder neural network model to estimate sea state bias for a radar altimeter	PLOS ONE			English	Article								This paper constructed a stacked-autoencoder neural network model (SAE model) to estimate sea state bias (SSB) based on radar altimeter data. Six cycles of the geophysical data record (GDR) from Jason-1/2 radar altimeters were used as a training dataset, and the other 2 cycles of the GDR from Jason-1/2 were used for testing. The inputs to this SAE model include the significant wave height (SWH), wind speed (U), sea surface height (SSH), backscatter coefficient (sigma-(0)) and automatic gain control (AGC), and the model outputs the SSB. The model includes one input layer, three hidden layers and one output layer. The SSBs in the GDR of Jason-1/2 were obtained from a nonparametric model based on the SWH and U as input variables; thus, the model has high accuracy but low efficiency. The SSBs in the GDR of HY-2A were computed using a four-parameter parametric model that uses the SWH and U. as input variables; therefore, this model's computational speed is high but its accuracy is low. Thus, we used the HY-2A radar altimeter as an unseen validation dataset to evaluate the performance of the SAE model. Then, we analyzed the contrasting results of these methods, including the differences in the SSB, explained variance, residual error and operational efficiency. The results demonstrate not only that the accuracy of the SAE model is superior to that of the conventional parametric model but also that its operational efficiency is better than that of the nonparametric model.	[Miao, Xiangying; Miao, Hongli; Guo, Yingting] Ocean Univ China, Coll Informat Sci & Engn, Qingdao, Shandong, Peoples R China; [Jia, Yongjun] State Ocean Adm, Natl Satellite Ocean Applicat Serv, Beijing, Peoples R China	Ocean University of China; National Satellite Ocean Application Service; State Oceanic Administration	Jia, YJ (corresponding author), State Ocean Adm, Natl Satellite Ocean Applicat Serv, Beijing, Peoples R China.	jiayongjun@mail.nsoas.org.cn	Miao, Xiangying/GSN-5938-2022	Miao, Xiangying/0000-0002-1723-8213	National Key Research and Development Program [2016YFC1401004]	National Key Research and Development Program	This work is supported by The National Key Research and Development Program (Grant number: 2016YFC1401004, http://program.most.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180944; Fu L.L., 2001, EOS T AM GEOPHYS UNI, V82, P376, DOI [10.1029/01eo00233, DOI 10.1029/01EO00233, 10.1029/01EO00233]; FU LL, 1994, J GEOPHYS RES-OCEANS, V99, P24369, DOI 10.1029/94JC01761; Gaspar P, 1998, J GEOPHYS RES-OCEANS, V103, P15803, DOI 10.1029/98JC01194; GASPAR P, 1994, J GEOPHYS RES-OCEANS, V99, P24981, DOI 10.1029/94JC01430; Javeed S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192069; Larochelle H, 2009, J MACH LEARN RES, V10, P1; Li J, 2016, COMPUTER APPL RES, V33, P3843, DOI [10.3969/j.issn.1001-3695.2016.12.072, DOI 10.3969/J.ISSN.1001-3695.2016.12.072]; Miao HL, 2017, ACTA OCEANOL SIN, V36, P108, DOI 10.1007/s13131-017-1116-x; [苗洪利 Miao Hongli], 2016, [遥感技术与应用, Remote Sensing Technology and Application], V31, P1031; [苗洪利 Miao Hongli], 2015, [中国海洋大学学报. 自然科学版, Periodical of Ocean University of China], V45, P119; Nielsen Michael, 2015, NEURAL NETWORKS DEEP, DOI DOI 10.1007/978-3-319-94463-0; Qazi KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194151; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Zhang G S, 2016, INT C IM SIGN PROC, P1100, DOI [10.1109/CISP.2015.7408044, DOI 10.1109/CISP.2015.7408044]	15	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208989	10.1371/journal.pone.0208989	http://dx.doi.org/10.1371/journal.pone.0208989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557315	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000059
J	Pare, GE; Jee, WH; Lee, SY; Sung, JK; Jung, JY; Grimm, R; Son, Y; Paek, MY; Min, CK; Ha, KY				Pare, Ga Eun; Jee, Won-Hee; Lee, So-Yeon; Sung, Jin-Kyeong; Jung, Joon-Yong; Grimm, Robert; Son, Yohan; Paek, Mun Young; Min, Chang-Kee; Ha, Kee-Yong			Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T	PLOS ONE			English	Article							WHOLE-BODY; CANCER	Background Metastasis and multiple myeloma are common malignant bone marrow lesions which may be difficult to distinguish because of similar imaging findings. The purpose of this study was to determine the value of adding diffusion-weighted imaging (DWI) to standard MR imaging to differentiate multiple myeloma from metastasis. Methods 25 patients with metastasis and 18 patients with multiple myeloma underwent 3T MR imaging with DWI (b = 0, 800 s/mm(2)) were enrolled. They all had pathologically confirmed bone lesions and were in a treatment naive state. Two readers who were blind of final diagnosis measured the average ADC (ADCav) and minimum ADC (ADCmin) on the DWI. They then estimated the diagnosis, based on the standard MR imaging and measured ADC values. Another reader performed histogram analysis on the whole tumor volume and obtained mean ADC (ADCvol), standard deviation (SDvol), skewness, and kurtosis. Comparison of the obtained values from DWI was performed by the t-test or Mann-Whitney U test. The receiver operating characteristic (ROC) curve with areas under the curve (AUC) was used to obtain the cut off values and to evaluate the diagnostic performance of the two readers. Results ADCav, ADCmin, and ADCvol of multiple myeloma were significantly lower than those of metastasis: ADCav, 752 mu m(2)/sec versus 1081 mu m(2)/sec; ADCmin, 704 mu m(2)/sec vs 835 mu m(2)/sec; ADCvol 761 mu m(2)/sec vs 1184 mu m(2)/sec (p < .001). In histogram analysis, ADC values of multiple myeloma showed narrow distribution than metastasis: SDvol, 144 vs 257 (p < .001). Areas under the receiver operating characteristic curve was significantly higher with additive DWI than standard MR alone: 0.762 vs 0.953; 0.706 vs 0.950 (p < .05) for two readers. Conclusions This study suggested that the addition of axial DWI to standard MR imaging can be helpful to diagnose multiple myeloma from metastasis at 3T.	[Pare, Ga Eun; Jee, Won-Hee; Sung, Jin-Kyeong; Jung, Joon-Yong] Catholic Univ Korea, Dept Radiol, Seoul, South Korea; [Lee, So-Yeon] Sungkyunkwan Univ, KangbukSamsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea; [Grimm, Robert] Siemens Healthcare, Erlangen, Germany; [Son, Yohan; Paek, Mun Young] Siemens Healthcare Ltd, Poongsan Bldg, Seoul, South Korea; [Min, Chang-Kee] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea; [Ha, Kee-Yong] Catholic Univ Korea, Dept Orthoped Surg, Seoul, South Korea	Catholic University of Korea; Sungkyunkwan University (SKKU); Siemens AG; Siemens Germany; Siemens AG; Catholic University of Korea; Catholic University of Korea	Jee, WH (corresponding author), Catholic Univ Korea, Dept Radiol, Seoul, South Korea.	whjee12@gmail.com		Jee, Won-Hee/0000-0002-1875-3997				Bauerle T, 2009, RADIOLOGY, V252, P477, DOI 10.1148/radiol.2522081756; Cowan AJ, 2018, JAMA ONCOLOGY; Giles SL, 2015, CLIN RADIOL, V70, P614, DOI 10.1016/j.crad.2015.02.013; Hillengass J, 2011, BRIT J HAEMATOL, V153, P721, DOI 10.1111/j.1365-2141.2011.08658.x; Horger M, 2011, AM J ROENTGENOL, V196, pW790, DOI 10.2214/AJR.10.5979; Kim HJ, 1999, CLIN IMAG, V23, P125, DOI 10.1016/S0899-7071(99)00105-9; Lang N, 2013, MAGN RESON IMAGING, V31, P1285, DOI 10.1016/j.mri.2012.10.006; Lecouvet FE, 1998, RADIOLOGY, V209, P653, DOI 10.1148/radiology.209.3.9844655; Lee YJ., 2001, J KOREAN RADIOL SOC, V44, P229, DOI DOI 10.3348/JKRS.2001.44.2.229; Li SY, 2010, ADV ANAT PATHOL, V17, P1, DOI 10.1097/PAP.0b013e3181bb6b9c; Messiou C, 2011, EUR RADIOL, V21, P1713, DOI 10.1007/s00330-011-2116-4; Messiou C, 2010, CANCER BIOMARK, V6, P21, DOI 10.3233/CBM-2009-0116; Nonomura Y, 2001, J MAGN RESON IMAGING, V13, P757, DOI 10.1002/jmri.1105; Padhani AR, 2011, RADIOLOGY, V261, P700, DOI 10.1148/radiol.11110474; Pearce T, 2012, BRIT J RADIOL, V85, P1102, DOI 10.1259/bjr/30649204; Rajwanshi A, 2009, J CYTOL, V26, P1, DOI 10.4103/0970-9371.54861; Resnick D, 1996, BONE JOINT IMAGING, P1076; Sachpekidis C, 2015, AM J NUCL MED MOLEC, V5, P479; Stabler A, 1996, AM J ROENTGENOL, V167, P1029; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208860	10.1371/journal.pone.0208860	http://dx.doi.org/10.1371/journal.pone.0208860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557373	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000052
J	Castaldi, E; Mirassou, A; Dehaene, S; Piazze, M; Eger, E				Castaldi, Elisa; Mirassou, Anne; Dehaene, Stanislas; Piazze, Manuela; Eger, Evelyn			Asymmetrical interference between number and item size perception provides evidence for a domain specific impairment in dyscalculia	PLOS ONE			English	Article							APPROXIMATE NUMBER; CONTINUOUS QUANTITY; DEVELOPMENTAL DYSCALCULIA; INDIVIDUAL-DIFFERENCES; NEURAL FOUNDATIONS; NUMEROSITY; REPRESENTATION; DISCRIMINATION; ACUITY; MATHEMATICS	Dyscalculia, a specific learning disability that impacts arithmetical skills, has previously been associated to a deficit in the precision of the system that estimates the approximate number of objects in visual scenes (the so called 'number sense' system). However, because in tasks involving numerosity comparisons dyscalculics' judgements appears disproportionally affected by continuous quantitative dimensions (such as the size of the items), an alternative view linked dyscalculia to a domain-general difficulty in inhibiting task-irrelevant responses. To arbitrate between these views, we evaluated the degree of reciprocal interference between numerical and non-numerical quantitative dimensions in adult dyscalculics and matched controls. We used a novel stimulus set orthogonally varying in mean item size and numerosity, putting particular attention into matching both features' perceptual discriminability. Participants compared those stimuli based on each of the two dimensions. While control subjects showed no significant size interference when judging numerosity, dyscalculics' numerosity judgments were strongly biased by the unattended size dimension. Importantly however, both groups showed the same degree of interference from the unattended dimension when judging mean size. Moreover, only the ability to discard the irrelevant size information when comparing numerosity (but not the reverse) significantly predicted calculation ability across subjects. Overall, our results show that numerosity discrimination is less prone to interference than discrimination of another quantitative feature (mean item size) when the perceptual discriminability of these features is matched, as here in control subjects. By quantifying, for the first time, dyscalculic subjects' degree of interference on another orthogonal dimension of the same stimuli, we are able to exclude a domain-general inhibition deficit as explanation for their poor/biased numerical judgement. We suggest that enhanced reliance on non-numerical cues during numerosity discrimination can represent a strategy to cope with a less precise number sense.	[Castaldi, Elisa; Dehaene, Stanislas; Eger, Evelyn] Univ Paris Saclay, Univ Paris Sud, Cognit Neuroimaging Unit, CEA DRF I2BM,INSERM,NeuroSpin Ctr, Gif Sur Yvette, France; [Mirassou, Anne] Ctr Hosp Rives Seine, Serv Pediat & Neonatol, Unite Depistage Troubles Apprentissages, Neuilly Sur Seine, France; [Piazze, Manuela] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Trento	Castaldi, E (corresponding author), Univ Paris Saclay, Univ Paris Sud, Cognit Neuroimaging Unit, CEA DRF I2BM,INSERM,NeuroSpin Ctr, Gif Sur Yvette, France.	elisa.castaldi@gmail.com	Eger, Evelyn/B-1393-2019; Castaldi, Elisa/I-1653-2019	Eger, Evelyn/0000-0002-7164-2356; Castaldi, Elisa/0000-0003-0327-6697; Piazza, Manuela/0000-0003-2557-9701	INSERM; CEA; French National Research Agency (ANR) [ANR-14-CE13-0020-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by INSERM, CEA, and the French National Research Agency (ANR) through grant No ANR-14-CE13-0020-01 awarded to E.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algom D, 1996, MEM COGNITION, V24, P557, DOI 10.3758/BF03201083; Anobile G, 2013, PSYCHOL SCI; Anobile G, 2018, DEV PSYCHOL, V54, P458, DOI 10.1037/dev0000448; Anobile G, 2016, DEV PSYCHOL, V52, P1206, DOI 10.1037/dev0000155; Anobile G, 2016, PERCEPTION, V45, P5, DOI 10.1177/0301006615602599; Anobile G, 2015, J VISION, V15, DOI 10.1167/15.5.4; Anobile G, 2013, J EXP CHILD PSYCHOL, V116, P380, DOI 10.1016/j.jecp.2013.06.006; Anobile G, 2012, VISION RES, V74, P102, DOI 10.1016/j.visres.2012.06.005; Anobile G, 2012, COGNITION, V122, P454, DOI 10.1016/j.cognition.2011.11.006; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Barth HC, 2008, COGNITION, V109, P251, DOI 10.1016/j.cognition.2008.09.002; Bayard S., 2009, TEST STROOP VICTORIA; Bell J, 2015, J VISION, V15, DOI 10.1167/15.2.18; Bellon E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00825; Biancardi A., 2004, BATTERIA DISCALCULIA; Borghesani V, 2019, CORTEX, V114, P17, DOI 10.1016/j.cortex.2018.07.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Bugden S, 2016, DEVELOPMENTAL SCI, V19, P817, DOI 10.1111/desc.12324; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Butterworth B, 2013, SCIENCE, V340, P300, DOI 10.1126/science.1231022; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Cappelletti M, 2014, NEUROIMAGE-CLIN, V4, P18, DOI 10.1016/j.nicl.2013.10.004; Cappelletti M, 2014, J COGNITIVE NEUROSCI, V26, P986, DOI 10.1162/jocn_a_00546; Cappelletti M, 2014, COGNITIVE PSYCHOL, V69, P25, DOI 10.1016/j.cogpsych.2013.11.004; Castaldi E, 2016, NEUROIMAGE, V143, P364, DOI 10.1016/j.neuroimage.2016.09.020; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Chong SC, 2005, VISION RES, V45, P891, DOI 10.1016/j.visres.2004.10.004; Cicchini GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12536; Collins E, 2017, P NATL ACAD SCI USA, V114, pE2806, DOI 10.1073/pnas.1613982114; Corbett JE, 2012, VIS COGN, V20, P211, DOI 10.1080/13506285.2012.657261; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2008, CHILD DEV, V79, P476, DOI 10.1111/j.1467-8624.2007.01137.x; Cordes S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00065; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; Cragg L, 2014, TRENDS NEUROSCI EDUC, V3, P63, DOI 10.1016/j.tine.2013.12.001; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; de Hevia MD, 2017, BEHAV BRAIN SCI, V40, P21, DOI 10.1017/S0140525X16002090; De Visscher A, 2017, J LEARNING DISABILIT, P1; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 2011, NUMBER SENSE MIND CR; DeWind NK, 2015, COGNITION, V142, P247, DOI 10.1016/j.cognition.2015.05.016; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Ferrigno S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13968; Fias W., 2016, DEV MATH COGNITION N, V2, P195, DOI [10.1016/B978-0-12-801871-2.00008, DOI 10.1016/B978-0-12-801871-2.00008]; Fias W, 2013, TRENDS NEUROSCI EDUC, V2, P43, DOI 10.1016/j.tine.2013.06.006; Fornaciai M, 2016, COGNITION, V151, P63, DOI 10.1016/j.cognition.2016.03.006; Fornaciai M, 2017, NEUROIMAGE, V157, P429, DOI 10.1016/j.neuroimage.2017.05.069; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Geary DC, 2016, PROG BRAIN RES, V227, P75, DOI 10.1016/bs.pbr.2016.03.008; Gebuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037426; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gebuis T, 2009, COGN PROCESS, V10, P133, DOI 10.1007/s10339-008-0219-x; Gilaie-Dotan S., 2014, TIMING TIME PERCEPT, V2, P169, DOI [10.1163/22134468-00002026, DOI 10.1163/22134468-00002026]; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; GINSBURG N, 1988, PERCEPT MOTOR SKILL, V67, P656, DOI 10.2466/pms.1988.67.2.656; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Harvey BM, 2017, NEUROIMAGE, V149, P200, DOI 10.1016/j.neuroimage.2017.02.012; Harvey BM, 2015, P NATL ACAD SCI USA, V112, P13525, DOI 10.1073/pnas.1515414112; Houde O, 2003, NAT REV NEUROSCI, V4, P507, DOI 10.1038/nrn1117; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Im HY, 2013, ATTEN PERCEPT PSYCHO, V75, P278, DOI 10.3758/s13414-012-0399-4; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Izard V, 2008, PLOS BIOL, V6, P275, DOI 10.1371/journal.pbio.0060011; Keller L, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fusyg.2015.00685, 10.3389/fpsyg.2015.00685]; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Lasne G, 2019, CORTEX, V114, P90, DOI 10.1016/j.cortex.2018.03.008; Lefavrais P., 1967, TEST DE LALOUETTE; Leibovich T., 2016, BEHAV BRAIN SCI; Leibovich T, 2016, J COGNITIVE NEUROSCI, V28, P166, DOI 10.1162/jocn_a_00887; Libertus ME, 2014, DEV PSYCHOL, V50, P108, DOI 10.1037/a0032986; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Linzarini A, 2015, J EXP CHILD PSYCHOL, V139, P71, DOI 10.1016/j.jecp.2015.05.010; Lourenco SF, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02050; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mejias S, 2012, LEARN INDIVID DIFFER, V22, P164, DOI 10.1016/j.lindif.2011.09.013; Menon V, 2016, PROG BRAIN RES, V227, P159, DOI 10.1016/bs.pbr.2016.04.026; Morgan MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1137; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2007, J NEUROSCI, V27, P5986, DOI 10.1523/JNEUROSCI.1056-07.2007; Nieder A, 2016, NAT REV NEUROSCI, V17, P366, DOI 10.1038/nrn.2016.40; Noel M.P., 2015, TEDI MATH GRANDS TES; Nys J, 2012, Q J EXP PSYCHOL, V65, P675, DOI 10.1080/17470218.2011.619661; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2016, NEUROPSYCHOLOGIA, V83, P257, DOI 10.1016/j.neuropsychologia.2015.09.025; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Poirel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040802; Ross J, 2003, PERCEPTION, V32, P867, DOI 10.1068/p5029; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Salti M, 2017, BEHAV RES METHODS, V49, P1120, DOI 10.3758/s13428-016-0772-7; Schutt HH, 2016, VISION RES, V122, P105, DOI 10.1016/j.visres.2016.02.002; Sophian C, 2008, COGNITION, V107, P460, DOI 10.1016/j.cognition.2007.10.009; Stoianov I, 2017, BEHAV BRAIN SCI, V40; Sweeny TD, 2015, DEVELOPMENTAL SCI, V18, P556, DOI 10.1111/desc.12239; Szucs D, 2013, CORTEX, V49, P2674, DOI 10.1016/j.cortex.2013.06.007; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Tibber MS, 2012, J VISION, V12, DOI 10.1167/12.6.8; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Vanbinst K, 2016, PROG BRAIN RES, V227, P105, DOI 10.1016/bs.pbr.2016.04.001; Vanbinst K, 2014, RES DEV DISABIL, V35, P3001, DOI 10.1016/j.ridd.2014.06.023; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zimmermann E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32810	118	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209256	10.1371/journal.pone.0209256	http://dx.doi.org/10.1371/journal.pone.0209256			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IQ	30550549	Green Submitted, gold, Green Published			2022-12-26	WOS:000453248000052
J	Choudhury, SA; Xie, F; Kutty, S; Lof, J; Stolze, E; Porter, TR				Choudhury, Songita A.; Xie, Feng; Kutty, Shelby; Lof, John; Stolze, Elizabeth; Porter, Thomas R.			Selective infarct zone imaging with intravenous acoustically activated droplets	PLOS ONE			English	Article							CONTRAST ENHANCEMENT; VAPORIZATION; STABILITY; KINETICS; EVENTS; INJURY	Background Microbubbles (MB) can be compressed to nanometer-sized droplets and reactivated with diagnostic ultrasound; these reactivated MB possess unique imaging characteristics. Objective We hypothesized that droplets formed from compressing Definity MB may be used for infarct-enhancement imaging. Methods Fourteen rats underwent ligation of their left anterior descending (LAD) artery, and five pigs underwent 90 minute balloon occlusions of their mid LAD. At 48 hours in rats, transthoracic ultra-sound was performed at two and four minutes following 200 mu L intravenous injections (IVI) of Definity droplets (DD), at which point the MI was increased from 0.5 to 1.5 to assess for a transient contrast enhancement zone (TEZ) within akinetic segments. In pigs, 1.0 mL injections of DD were administered and low frame rate (triggered end systolic or 10 Hz) imaging 2-4 minutes post IVI to selectively activate and image the infarct zone (IZ). Infarct size was defined by delayed enhancement magnetic resonance imaging (DE-MRI) and post-mortem staining (TTC). Results Increasing MI to 1.5 (at two or four minutes after IVI) resulted in a TEZ in rats, which correlated with infarct size (r = 0.94, p < 0.001). A TEZ was not seen at 2-4 minutes in any rat (n = 8) following Definity MB injections. Fluorescent staining confirmed DD presence within the infarct zone 10 minutes after intravenous injection. In pigs, selective enhancement within the IZ was achieved by using a low frame rate single pulse harmonic mode; IZ size matched the location seen with DE-MRI and correlated with TIC defect size (r = 0.90, p < 0.05). Conclusion DD formulated from commercially available MB can be acoustically activated for selective infarct enhancement imaging.	[Choudhury, Songita A.; Xie, Feng; Kutty, Shelby; Lof, John; Stolze, Elizabeth; Porter, Thomas R.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Porter, TR (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.	trporter@unmc.edu			Lantheus Medical Imaging Inc.; Bracco Diagnostics Inc.; American Heart Association predoctoral fellowship	Lantheus Medical Imaging Inc.; Bracco Diagnostics Inc.; American Heart Association predoctoral fellowship(American Heart Association)	Dr. Porter has received research support from Lantheus Medical Imaging Inc. He also has received equipment support from Philips Research North America and educational and research support from Bracco Diagnostics Inc. Songita A. Choudhury was partially supported by an American Heart Association predoctoral fellowship. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, the Theodore F. Hubbard Foundation provided research coordinator support for the study.	[Anonymous], 2017, DEFINITY PACK INS; Arena CB, 2015, IEEE T ULTRASON FERR, V62, P1623, DOI 10.1109/TUFFC.2014.006883; Choudhury SA, 2017, J AM SOC ECHOCARDIOG, V30, DOI 10.1016/j.echo.2016.10.015; Cui WJ, 2013, BIOMATERIALS, V34, P4926, DOI 10.1016/j.biomaterials.2013.03.020; Eckhouse SR, 2012, HEART FAIL CLIN, V8, P7, DOI 10.1016/j.hfc.2011.08.012; Fisher NG, 2002, J AM COLL CARDIOL, V40, P811, DOI 10.1016/S0735-1097(02)02038-7; Hillenbrand HB, 2000, CIRCULATION, V102, P1678, DOI 10.1161/01.CIR.102.14.1678; Hollander MR, 2016, PLOS ONE, V11, DOI [10:1371/journal.pone.0157233, DOI 10:1371/JOURNAL.PONE.0157233]; Ingkanisorn WP, 2004, J AM COLL CARDIOL, V43, P2253, DOI 10.1016/j.jacc.2004.02.046; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 1996, CIRCULATION, V94, P3318, DOI 10.1161/01.CIR.94.12.3318; Li SA, 2015, ULTRASOUND MED BIOL, V41, P1422, DOI 10.1016/j.ultrasmedbio.2014.12.021; Lindner JR, 2000, CIRCULATION, V101, P668, DOI 10.1161/01.CIR.101.6.668; Matsunaga TO, 2012, THERANOSTICS, V2, P1185, DOI 10.7150/thno.4846; Novell A, 2016, J ACOUST SOC AM, V139, P3193, DOI 10.1121/1.4953580; Porter TR, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005249; Puett C, 2014, ULTRASONICS, V54, P2024, DOI 10.1016/j.ultras.2014.05.013; Redfors B, 2012, EXP CLIN CARDIOL, V17, P268; Reznik N, 2014, ULTRASOUND MED BIOL, V40, P1379, DOI 10.1016/j.ultrasmedbio.2013.11.025; Reznik N, 2013, ULTRASONICS, V53, P1368, DOI 10.1016/j.ultras.2013.04.005; Reznik N, 2012, PHYS MED BIOL, V57, P7205, DOI 10.1088/0031-9155/57/21/7205; Sheeran PS, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/579684; Sheeran PS, 2015, ULTRASOUND MED BIOL, V41, P814, DOI 10.1016/j.ultrasmedbio.2014.10.020; Sheeran PS, 2014, PHYS MED BIOL, V59, P379, DOI 10.1088/0031-9155/59/2/379; Shpak O, 2014, P NATL ACAD SCI USA, V111, P1697, DOI 10.1073/pnas.1312171111; Srikanth GVN, 2009, J STEM CELLS REGEN, V5, P30; Vicenzini E, 2007, STROKE, V38, P2841, DOI 10.1161/STROKEAHA.107.487918; Zhou YF, 2015, J THER ULTRASOUND, V3, DOI 10.1186/s40349-015-0041-8	28	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207486	10.1371/journal.pone.0207486	http://dx.doi.org/10.1371/journal.pone.0207486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30551125	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000007
J	Morgan, KD; Noehren, B				Morgan, Kristin D.; Noehren, Brian			Identification of knee gait waveform pattern alterations in individuals with patellofemoral pain using fast Fourier transform	PLOS ONE			English	Article							MUSCLE ACTIVATION; CONTACT FORCE; KINEMATICS; HIP; ACCURACY; STRENGTH; WALKING; COORDINATION; ATTENUATION; VARIABILITY	Patellofemoral pain (PFP) is one of the most common overuse injuries of the knee. Previous research has found that individuals with PFP exhibit differences in peak hip kinematics; however, differences in peak knee kinematics, where the pain originates, are difficult to elucidate. To better understand the mechanism behind PFP, we sought to characterize differences in knee gait kinematic waveform patterns in individuals with PFP compared to healthy individuals using fast Fourier transform (FFT). Sixteen control and sixteen individuals with PFP participated in a fast walk protocol. FFT was used to decompose the sagittal, frontal and transverse plane knee gait waveforms into sinusoidal signals. A two-way ANOVA and Bonferroni post hoc analysis compared group, limb and interaction effects on sagittal, frontal and transverse amplitude, frequency and phase components between control and PFP individuals gait waveforms. Differences in frequency and phase values were found in the sagittal and frontal plane knee waveforms between the control and PFP groups. The signal-to-noise ratio also reported significant differences between the PFP and control limbs in the sagittal (p<0.01) and frontal planes (p = 0.04). The findings indicate that differences in gait patterns in the individuals with PFP were not the result of amplitude differences, but differences attributed to temporal changes in gait patterns detected by the frequency and phase metrics. These changes suggest that individuals with PFP adopted a more deliberate, stiffer gait and exhibit altered joint coordination. And the FFT technique could serve as a fast, quantifiable tool for clinicians to detect PFP.	[Morgan, Kristin D.] Univ Connecticut, Sch Engn, Biomed Engn, Storrs, CT 06269 USA; [Noehren, Brian] Univ Kentucky, Coll Hlth Sci, Div Phys Therapy, Lexington, KY USA	University of Connecticut; University of Kentucky	Morgan, KD (corresponding author), Univ Connecticut, Sch Engn, Biomed Engn, Storrs, CT 06269 USA.	Kristin.2.Morgan@uconn.edu		Morgan, Kristin/0000-0003-3731-1374; Morgan, Kristin/0000-0002-5803-2107	American Physical Therapy Association Orthopedic Section Research grant	American Physical Therapy Association Orthopedic Section Research grant	This research was partially funded by American Physical Therapy Association Orthopedic Section Research grant no other external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JG, 1997, GAIT POSTURE, V5, P28, DOI 10.1016/S0966-6362(96)01070-3; Besier TF, 2009, J BIOMECH, V42, P898, DOI 10.1016/j.jbiomech.2009.01.032; Blond L, 1998, Acta Orthop Belg, V64, P393; Bolgla LA, 2008, J ORTHOP SPORT PHYS, V38, P12, DOI 10.2519/jospt.2008.2462; Boling M, 2010, SCAND J MED SCI SPOR, V20, P725, DOI 10.1111/j.1600-0838.2009.00996.x; Cowan SM, 2001, ARCH PHYS MED REHAB, V82, P183, DOI 10.1053/apmr.2001.19022; Cowan SM, 2002, CLIN J SPORT MED, V12, P339, DOI 10.1097/00042752-200211000-00004; Cunningham TJ, 2014, CLIN BIOMECH, V29, P317, DOI 10.1016/j.clinbiomech.2013.12.008; Dierks TA, 2008, J ORTHOP SPORT PHYS, V38, P448, DOI 10.2519/jospt.2008.2490; Gajic Z., 2003, LINEAR DYNAMIC SYSTE; Gruber AH, 2014, J SPORT HEALTH SCI, V3, P113, DOI 10.1016/j.jshs.2014.03.004; HAGG G, 1981, PFLUG ARCH EUR J PHY, V391, P78, DOI 10.1007/BF00580699; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C; Han JH, 2003, P ANN INT IEEE EMBS, V25, P1863; Handojoseno AMA, 2015, IEEE T NEUR SYS REH, V23, P887, DOI 10.1109/TNSRE.2014.2381254; Heiderscheit BC, 2002, J APPL BIOMECH, V18, P110, DOI 10.1123/jab.18.2.110; Ichinoseki-Sekine N, 2006, MED SCI SPORT EXER, V38, P1674, DOI 10.1249/01.mss.0000227641.68360.c2; JORDAAN G, 1994, MIL MED, V159, P421, DOI 10.1093/milmed/159.6.421; Kamen E., 2000, FUNDAMENTALS SIGNALS; Kannus P, 1999, J BONE JOINT SURG AM, V81A, P355, DOI 10.2106/00004623-199903000-00007; Lamoth CJC, 2002, SPINE, V27, pE92, DOI 10.1097/00007632-200202150-00016; Manal K, 2003, CLIN BIOMECH, V18, P126, DOI 10.1016/S0268-0033(02)00176-6; Noehren B, 2013, MED SCI SPORT EXER, V45, P1340, DOI 10.1249/MSS.0b013e318285c6b6; Noehren B, 2012, CLIN BIOMECH, V27, P366, DOI 10.1016/j.clinbiomech.2011.10.005; Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P639, DOI 10.2519/jospt.2003.33.11.639; Robertson G, 2013, RES METHODS BIOMECHA; Rubenstein JD, 1997, AM J ROENTGENOL, V169, P1089, DOI 10.2214/ajr.169.4.9308470; Salsich Gretchen B., 2010, Physiotherapy Theory and Practice, V26, P150, DOI 10.3109/09593980903423111; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; SCHNEIDER E, 1983, J BIOMECH, V16, P591, DOI 10.1016/0021-9290(83)90109-4; Solnik S, 2008, ACTA BIOENG BIOMECH, V10, P65; Souza RB, 2009, J ORTHOP SPORT PHYS, V39, P12, DOI 10.2519/jospt.2009.2885; Stathopulu E, 2003, RHEUMATOLOGY, V42, P380, DOI 10.1093/rheumatology/keg093; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tingley M, 2002, GAIT POSTURE, V16, P149, DOI 10.1016/S0966-6362(02)00012-7; Toumi H, 2013, CLIN BIOMECH, V28, P544, DOI 10.1016/j.clinbiomech.2013.04.005; Winfree KN, 2015, IEEE T NEUR SYS REH, V23, P1012, DOI 10.1109/TNSRE.2014.2382641; WINTER DA, 1983, J MOTOR BEHAV, V15, P302; Zhang LQ, 2003, J ORTHOPAED RES, V21, P565, DOI 10.1016/S0736-0266(02)00196-1	40	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209015	10.1371/journal.pone.0209015	http://dx.doi.org/10.1371/journal.pone.0209015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550589	Green Published, gold			2022-12-26	WOS:000453248000038
J	Sanchez, J; Huma, ZE; Lane, JR; Liu, XY; Bridgford, JL; Payne, RJ; Canals, M; Stone, MJ				Sanchez, Julie; Huma, Zil E.; Lane, J. Robert; Liu, Xuyu; Bridgford, Jessica L.; Payne, Richard J.; Canals, Meritxell; Stone, Martin J.			Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; receptor structure-function; G protein-coupled receptor (GPCR); molecular pharmacology; signaling; cytokine; innate immunity; binding; CCR1; chemokine receptor; receptor activation; three-step model	N-TERMINAL DOMAIN; TYROSINE SULFATION; PHARMACOLOGICAL CHARACTERIZATION; SULFOTYROSINE RECOGNITION; STRUCTURAL BASIS; MCP-1 RECEPTOR; PROTEIN; LIGAND; RANTES; CXCR4	Interactions between secreted immune proteins called chemokines and their cognate G protein-coupled receptors regulate the trafficking of leukocytes in inflammatory responses. The two-site, two-step model describes these interactions. It involves initial binding of the chemokine N-loop/3 region to the receptor's N-terminal region and subsequent insertion of the chemokine N-terminal region into the transmembrane helical bundle of the receptor concurrent with receptor activation. Here, we test aspects of this model with C-C motif chemokine receptor 1 (CCR1) and several chemokine ligands. First, we compared the chemokine-binding affinities of CCR1 with those of peptides corresponding to the CCR1 N-terminal region. Relatively low affinities of the peptides and poor correlations between CCR1 and peptide affinities indicated that other regions of the receptor may contribute to binding affinity. Second, we evaluated the contributions of the two CCR1-interacting regions of the cognate chemokine ligand CCL7 (formerly monocyte chemoattractant protein-3 (MCP-3)) using chimeras between CCL7 and the non-cognate ligand CCL2 (formerly MCP-1). The results revealed that the chemokine N-terminal region contributes significantly to binding affinity but that differences in binding affinity do not completely account for differences in receptor activation. On the basis of these observations, we propose an elaboration of the two-site, two-step modelthe three-step modelin which initial interactions of the first site result in low-affinity, nonspecific binding; rate-limiting engagement of the second site enables high-affinity, specific binding; and subsequent conformational rearrangement gives rise to receptor activation.	[Sanchez, Julie; Huma, Zil E.; Bridgford, Jessica L.; Stone, Martin J.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Sanchez, Julie; Huma, Zil E.; Bridgford, Jessica L.; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Sanchez, Julie; Huma, Zil E.; Lane, J. Robert; Bridgford, Jessica L.; Canals, Meritxell] Monash Univ, Drug Discovery Biol Program, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Liu, Xuyu; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Lane, J. Robert; Canals, Meritxell] Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham NG7 2UH, England	Monash University; Monash University; Monash University; University of Sydney; University of Nottingham	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Canals, M (corresponding author), Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham NG7 2UH, England.	meritxell.canals@nottingham.ac.uk; martin.stone@monash.edu	Payne, Richard/AAH-3666-2021; Liu, Xuyu/AAV-8725-2021; Stone, Martin/C-2492-2012	Liu, Xuyu/0000-0003-4096-3090; Sanchez, Julie/0000-0002-5765-4342; Payne, Richard/0000-0002-3618-9226; Bridgford, Jessica/0000-0001-8381-1121; Lane, J. Robert/0000-0002-7361-7875; Stone, Martin/0000-0002-6468-4427	National Health and Medical Research Council [APP1140874]; Australian Research Council [DP130101984]; Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant [JMP16-18]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant	This work was supported by National Health and Medical Research Council Project Grant APP1140874 (to M. J. S., M. C., and J. R. L.), Australian Research Council Discovery Grant DP130101984 (to R. J. P. and M. J. S.), the Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme (to M. C.), and Monash University Joint Medicine-Pharmacy Grant JMP16-18 (to M. J. S. and M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayoub MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119803; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chaudhuri A, 2013, J PHYS CHEM B, V117, P1225, DOI 10.1021/jp3095352; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Chou CC, 2002, BRIT J PHARMACOL, V137, P663, DOI 10.1038/sj.bjp.0704907; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Coulin F, 1997, EUR J BIOCHEM, V248, P507, DOI 10.1111/j.1432-1033.1997.00507.x; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Escher SE, 2004, J PEPT RES, V63, P36, DOI 10.1046/j.1399-3011.2004.00102.x; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gladue Ronald P, 2004, Curr Opin Investig Drugs, V5, P499; Haldar S, 2010, BBA-BIOMEMBRANES, V1798, P1056, DOI 10.1016/j.bbamem.2010.02.029; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; HUFF S, 1994, J BIOL CHEM, V269, P15563; Huma ZE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8529; Karash AR, 2011, FUTURE MED CHEM, V3, P1889, DOI [10.4155/fmc.11.144, 10.4155/FMC.11.144]; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Ludeman JP, 2015, ORG BIOMOL CHEM, V13, P2162, DOI 10.1039/c4ob02262a; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mayer MR, 2001, J BIOL CHEM, V276, P13911, DOI 10.1074/jbc.M011202200; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ninichuk V, 2005, AM J NEPHROL, V25, P365, DOI 10.1159/000087185; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ribeiro S, 2005, PHARMACOL THERAPEUT, V107, P44, DOI 10.1016/j.pharmthera.2005.01.004; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Schnur E, 2013, FEBS J, V280, P2068, DOI 10.1111/febs.12230; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stone MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020342; Stone MJ, 2015, ACCOUNTS CHEM RES, V48, P2251, DOI 10.1021/acs.accounts.5b00255; Tak PP, 2013, ANN RHEUM DIS, V72, P337, DOI 10.1136/annrheumdis-2011-201605; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Vallet S, 2011, EXPERT OPIN THER TAR, V15, P1037, DOI 10.1517/14728222.2011.586634; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vilardaga JP, 2010, J RECEPT SIG TRANSD, V30, P304, DOI 10.3109/10799893.2010.509728; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Ziarek JJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5756; Zweemer AJM, 2013, MOL PHARMACOL, V84, P551, DOI 10.1124/mol.113.086850	58	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3464	3475		10.1074/jbc.RA118.006535	http://dx.doi.org/10.1074/jbc.RA118.006535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30567735	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000461853900014
J	Buthelezi, SG; Dirr, HW; Chakauya, E; Chilcwamba, R; Martens, L; Tsekoa, TL; Vandermarliere, E; Stoychev, SH				Buthelezi, Sindisiwe G.; Dirr, Heini W.; Chakauya, Ereck; Chilcwamba, Rachel; Martens, Lennart; Tsekoa, Tsepo L.; Vandermarliere, Elien; Stoychev, Stoyan H.			The study of degradation mechanisms of glyco-engineered plant produced anti-rabies monoclonal antibodies E559 and 62-71-3	PLOS ONE			English	Article							CIRCULAR-DICHROISM; HYDROGEN-EXCHANGE; PROTEIN-STRUCTURE; RABIES; BIOTHERAPEUTICS; AGGREGATION; PLATFORM; SURFACE	Rabies is an ancient and neglected zoonotic disease caused by the rabies virus, a neurotropic RNA virus that belongs to the Rhabdoviridae family, genus Lyssavirus. It remains an important public health problem as there are cost and health concerns imposed by the current human post exposure prophylaxis therapy. The use of monoclonal antibodies (mAbs) is therefore an attractive alternative. Rabies mostly affects people that reside in resource-limited areas where there are occasional failures in the cold-chain. These environmental changes may upset the stability of the mAbs. This study focused on mAbs 62-71-3 and E559; their structures, responses to freeze/thaw (F/T) and exposure to reactive oxygen species were therefore studied with the aid of a wide range of biophysical and in silico techniques in order to elucidate their stability and identify aggregation prone regions. E559 was found to be less stable than 62-71-3. The complementarity determining regions (CDR) contributed the most to its instability, more specifically: peptides (EIWD102)-E-99 and (92)ATSPYT(97) found in CDR3, Trp33 found in CDR1 and the oxidised Met34. The constant region "(158)SWNSGALTGHTFPAVL(175)" was also flagged by the special aggregation propensity (SAP) tool and F/T experiments to be highly prone to aggregation. The E559 peptides "(4)LQESGSVL(11) from the heavy chain and (4)LTQSPSSL(11) from the light chain, were also highly affected by F/T. These residues may serve as good candidates for mutation, in the aim to bring forward more stable therapeutic antibodies, thus paving a way to a more safe and efficacious antibody-based cocktail treatment against rabies.	[Buthelezi, Sindisiwe G.; Chakauya, Ereck; Chilcwamba, Rachel; Tsekoa, Tsepo L.; Stoychev, Stoyan H.] CSIR, Biosci Unit, Pretoria, South Africa; [Buthelezi, Sindisiwe G.; Dirr, Heini W.] Univ Witwatersrand, Prot Struct Funct Res Unit, Sch Mol & Cell Biol, Johannesburg, South Africa; [Martens, Lennart; Vandermarliere, Elien] VIB, Unit Computat Omics & Syst Biol, VIB UGent Ctr Med Biotechnol, Ghent, Belgium; [Martens, Lennart; Vandermarliere, Elien] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, Ghent, Belgium	Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Stoychev, SH (corresponding author), CSIR, Biosci Unit, Pretoria, South Africa.	sstoychev@csir.co.za		Tsekoa, Tsepo/0000-0002-5561-5462; Chakauya, Ereck/0000-0002-4282-1742; Stoychev, Stoyan/0000-0001-7504-4313	National Research Foundation: Professional Development Programme (DST-NRF: PDP), Council for Scientific and Industrial Research (CSIR) [78993]	National Research Foundation: Professional Development Programme (DST-NRF: PDP), Council for Scientific and Industrial Research (CSIR)	This work was was funded by the National Research Foundation (http://www.nrf.ac.za/): Professional Development Programme (DST-NRF: PDP), Council for Scientific and Industrial Research (CSIR) (Grant 78993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argiriadi MA, 2009, J BIOL CHEM, V284, P24478, DOI 10.1074/jbc.M109.023887; Baskakov IV, 1998, BIOCHEMISTRY-US, V37, P18010, DOI 10.1021/bi981849j; Becker M, 2005, J BIOL CHEM, V280, P17363, DOI 10.1074/jbc.M412842200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Buthelezi SG, 2016, VIROLOGY, V498, P250, DOI 10.1016/j.virol.2016.08.034; Champion JM, 2000, J IMMUNOL METHODS, V235, P81, DOI 10.1016/S0022-1759(99)00223-9; Chelius D, 2010, MABS-AUSTIN, V2, P309, DOI 10.4161/mabs.2.3.11791; Dassault Systemes BIOVIA, 2017, DISC STUD MOD ENV; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; Deng YZ, 1999, ANAL BIOCHEM, V276, P150, DOI 10.1006/abio.1999.4347; DOI E, 1970, BIOCHEMISTRY-US, V9, P1066, DOI 10.1021/bi00807a003; FISCHMANN TO, 1991, J BIOL CHEM, V266, P12915; Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Hasija M., 2013, VDT, V3, P11, DOI 10.2147/vdt.s41998.; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kalyaanamoorthy S, 2014, PROG BIOPHYS MOL BIO, V114, P123, DOI 10.1016/j.pbiomolbio.2013.06.004; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kuzmina N.A., 2013, J ANTIVIRALS ANTIRET, V5, P37, DOI DOI 10.4172/JAA.1000061; Lebiletsa Tsekoa T, EFFICIENT IN VITRO I, DOI [10.1371/journal.pone.0159313, DOI 10.1371/JOURNAL.PONE.0159313]; Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803; Mariuzza RA, 2006, IMMUNITY, V24, P359, DOI 10.1016/j.immuni.2006.03.009; Moss D, 1993, J APPL CRYST, V26; Muller T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000542; Peters B, 2006, BIOCHEMISTRY-US, V45, P5384, DOI 10.1021/bi052438n; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348, DOI 10.2174/138920109788488932; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Velasco-Villa A, 2008, EMERG INFECT DIS, V14, P1849, DOI 10.3201/eid1412.080876; Vermeer AWP, 1998, BBA-GEN SUBJECTS, V1425, P1, DOI 10.1016/S0304-4165(98)00048-8; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	44	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209373	10.1371/journal.pone.0209373	http://dx.doi.org/10.1371/journal.pone.0209373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571707	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700063
J	Hoffmann, R; Pasotti, F; Vazquez, S; Lefaible, N; Torstensson, A; MacCormack, W; Wenzhofer, F; Braeckman, U				Hoffmann, Ralf; Pasotti, Francesca; Vazquez, Susana; Lefaible, Nene; Torstensson, Anders; MacCormack, Walter; Wenzhoefer, Frank; Braeckman, Ulrike			Spatial variability of biogeochemistry in shallow coastal benthic communities of Potter Cove (Antarctica) and the impact of a melting glacier	PLOS ONE			English	Article							KING-GEORGE-ISLAND; SEA-ICE; MARINE; SEDIMENT; WATER; CARBON; DYNAMICS; BACTERIA; SHELF; MICROSENSOR	Measurements of biogeochemical fluxes at the sediment-water interface are essential to investigate organic matter mineralization processes but are rarely performed in shallow coastal areas of the Antarctic. We investigated biogeochemical fluxes across the sediment-water interface in Potter Cove (King George Island/Isla 25 de Mayo) at water depths between 6-9 m. Total fluxes of oxygen and inorganic nutrients were quantified in situ. Diffusive oxygen fluxes were also quantified in situ, while diffusive inorganic nutrient fluxes were calculated from pore water profiles. Biogenic sediment compounds (concentration of pigments, total organic and inorganic carbon and total nitrogen), and benthic prokaryotic, meio-, and macrofauna density and biomass were determined along with abiotic parameters (sediment granulometry and porosity). The measurements were performed at three locations in Potter Cove, which differ in terms of sedimentary influence due to glacial melt. In this study, we aim to assess secondary effects of glacial melting such as ice scouring and particle release on the benthic community and the biogeochemical cycles they mediate. Furthermore, we discuss small-scale spatial variability of biogeochemical fluxes in shallow water depth and the required food supply to cover the carbon demand of Potter Cove's shallow benthic communities. We found enhanced mineralization in soft sediments at one location intermediately affected by glacial melt-related effects, while a reduced mineralization was observed at a location influenced by glacial melting. The benthic macrofauna assemblage constituted the major benthic carbon stock (>87% of total benthic biomass) and was responsible for most benthic organic matter mineralization. However, biomass of the dominant Antarctic bivalve Latemula elliptica, which contributed 39-69% to the total macrofauna biomass, increased with enhanced glacial melt-related influence. This is contrary to the pattern observed for the remaining macrofauna. Our results further indicated that pelagic primary production is able to fully supply Potter Cove's benthic carbon demand. Therefore, Potter Cove seems to be an autotrophic ecosystem in the summer season.	[Hoffmann, Ralf; Wenzhoefer, Frank] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Join Res Grp Deep Sea Ecol & Technol, Bremen, Germany; [Pasotti, Francesca; Lefaible, Nene; Braeckman, Ulrike] Univ Ghent, Marine Biol Res Grp, Ghent, Belgium; [Vazquez, Susana; MacCormack, Walter] Univ Buenos Aires, Catedra Biotecnol, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Vazquez, Susana; MacCormack, Walter] Nanobiotec UBA Conicet, Buenos Aires, DF, Argentina; [Torstensson, Anders] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [MacCormack, Walter] Inst Antarctico Argentino, San Martin, Buenos Aires, Argentina; [Wenzhoefer, Frank; Braeckman, Ulrike] Max Planck Inst Marine Microbiol, HGF MPG Join Res Grp Deep Sea Ecol & Technol, Bremen, Germany; [Torstensson, Anders] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ghent University; University of Buenos Aires; University of Gothenburg; Max Planck Society; University of Washington; University of Washington Seattle	Hoffmann, R (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Join Res Grp Deep Sea Ecol & Technol, Bremen, Germany.	ralf.hoffmann@awi.de	Braeckman, Ulrike/AAJ-4801-2021	Torstensson, Anders/0000-0002-8283-656X; Braeckman, Ulrike/0000-0002-7558-6363; Vazquez, Susana/0000-0002-0760-6254; Mac Cormack, Walter/0000-0002-5280-5463; Hoffmann, Ralf/0000-0001-9799-5662	European Union FP7 Project SenseOCEAN Marine Sensors for the 21st century [614141]; European Union FP7 Project IMCONet [319718]; Alfred-Wegener-Institut, Helmholtz Zentrum fur Polar-und Meeresforschung (PACES); Max-Planck Institute for Marine Microbiology; Research Foundation Flanders (FWO) [1201716N]; vERSO project (Belgian Science Policy Office) [BR/132/A1/vERSO]	European Union FP7 Project SenseOCEAN Marine Sensors for the 21st century; European Union FP7 Project IMCONet; Alfred-Wegener-Institut, Helmholtz Zentrum fur Polar-und Meeresforschung (PACES); Max-Planck Institute for Marine Microbiology; Research Foundation Flanders (FWO)(FWO); vERSO project (Belgian Science Policy Office)	This research was funded by European Union FP7 Project SenseOCEAN Marine Sensors for the 21st century (Grant agreement no 614141, www.senseocean.eu), by European Union FP7 Project IMCONet (Grant agreement no 319718), by institutional funds of the Alfred-Wegener-Institut, Helmholtz Zentrum fur Polar-und Meeresforschung (PACES), and the Max-Planck Institute for Marine Microbiology. UB is financed by a postdoctoral fellow from the Research Foundation Flanders (FWO; grant no 1201716N). FP is financed by the vERSO project (Belgian Science Policy Office, grant number BR/132/A1/vERSO).	Ahn IY, 2016, OCEAN SCI J, V51, P273, DOI 10.1007/s12601-016-0023-y; Al-Handal AY, 2008, BOT MAR, V51, P51, DOI 10.1515/BOT.2008.007; ARRIGO KR, 2008, J GEOPHYS RES OCEANS, V113; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Barnes DKA, 1999, J MAR BIOL ASSOC UK, V79, P401, DOI 10.1017/S0025315498000514; BORSHEIM KY, 1990, APPL ENVIRON MICROB, V56, P352; Boudreau BP, 1997, DIAGENETIC MODELS TH, V1st; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Burdige DJ, 2006, GEOCHEMISTRY MARINE, DOI DOI 10.2307/J.CTV131BW7S; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; Cook AJ, 2016, SCIENCE, V353, P283, DOI 10.1126/science.aae0017; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Deregibus D, 2016, POLAR BIOL, V39, P153, DOI 10.1007/s00300-015-1679-y; Dierssen HM, 2002, P NATL ACAD SCI USA, V99, P1790, DOI 10.1073/pnas.032206999; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fennel K, 2010, OCEAN SCI, V6, P539, DOI 10.5194/os-6-539-2010; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; Fox J., 2018, R COMPANION APPL REG, VThird; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Giblin AE, 1997, ESTUARIES, V20, P346, DOI 10.2307/1352349; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GREBMEIER JM, 1989, MAR ECOL PROG SER, V53, P79, DOI 10.3354/meps053079; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; GROSSMANN S, 1991, MAR ECOL PROG SER, V77, P85, DOI 10.3354/meps077085; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Haumann FA, 2014, GEOPHYS RES LETT, V41, P8429, DOI 10.1002/2014GL061659; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hoffmann R, 2018, SITU MEASURED OXYGEN, DOI [10.1594/PANGAEA.885472, DOI 10.1594/PANGAEA.885472]; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Huettel M, 2014, ANNU REV MAR SCI, V6, P23, DOI 10.1146/annurev-marine-051413-012706; Jerosch K, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0178; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kim H, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0174; KRISTENSEN E, 1992, LIMNOL OCEANOGR, V37, P1404, DOI 10.4319/lo.1992.37.7.1404; Lagger C, 2017, PLOS ONE, V12, DOI [10.1371/Journal.pone.0186756, 10.1371/journal.pone.0186756]; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lichtschlag A, 2010, LIMNOL OCEANOGR, V55, P931, DOI 10.4319/lo.2009.55.2.0931; Lim CH, 2013, OCEAN DYNAM, V63, P1151, DOI 10.1007/s10236-013-0651-z; LUSTWERK RL, 1995, LIMNOL OCEANOGR, V40, P1011, DOI 10.4319/lo.1995.40.5.1011; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; Monien D, 2017, ANTARCT SCI, V29, P277, DOI [10.1017/S095410201600064X, 10.1017/s095410201600064x]; Monien P, 2014, GEOCHIM COSMOCHIM AC, V141, P26, DOI 10.1016/j.gca.2014.06.003; NEDWELL DB, 1993, APPL ENVIRON MICROB, V59, P3989, DOI 10.1128/AEM.59.12.3989-3995.1993; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Pasotti F, 2015, MAR ECOL-EVOL PERSP, V36, P716, DOI 10.1111/maec.12179; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; Piepenburg D, 1997, J MARINE SYST, V10, P467, DOI 10.1016/S0924-7963(96)00050-4; Pohlert T., PAIRWISE MULTIPLE CO; Queiros AM, 2015, PROG OCEANOGR, V137, P559, DOI 10.1016/j.pocean.2015.04.027; Queiros AM, 2013, ECOL EVOL, V3, P3958, DOI 10.1002/ece3.769; Redfield A. C., 1934, P176; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Schloss IR, 1991, POTTER COVE COASTAL, V299, P67; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Schulz HD, 2006, MARINE GEOCHEMISTRY, V1st, DOI DOI 10.1007/3-540-32144-6_3; Seefeldt MA, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0248-3; Shim J, 2011, ANTARCT SCI, V23, P358, DOI 10.1017/S0954102011000137; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith WO, 2010, GLOB CHANGE IGBP SER, P289, DOI 10.1007/978-3-540-92735-8_6; Sorensen HL, 2015, MAR ECOL PROG SER, V539, P1, DOI 10.3354/meps11503; Strickland J.D., 1972, J FISH RES BOARD CAN; Thiel H, 1978, UPWELLING ECOSYSTEMS, P124, DOI [DOI 10.1007/978-3-642-66985-9_11, 10.1007/978-3-642-66985-9_11]; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Torre L, 2012, POLAR BIOL, V35, P1743, DOI 10.1007/s00300-012-1208-1; Turner J, 2017, GEOPHYS RES LETT, V44, P6868, DOI 10.1002/2017GL073656; VANREUSEL A, 1995, INT REV GES HYDROBIO, V80, P313, DOI 10.1002/iroh.19950800218; WALSH JJ, 1991, NATURE, V350, P53, DOI 10.1038/350053a0; Wenzhofer F, 2000, MAR CHEM, V69, P43, DOI 10.1016/S0304-4203(99)00091-2; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wijsman JWM, 1999, MAR ECOL PROG SER, V181, P25, DOI 10.3354/meps181025; Wolfl AC, 2014, GEO-MAR LETT, V34, P435, DOI 10.1007/s00367-014-0375-1; WOODWORTHLYNAS CMT, 1991, CONT SHELF RES, V11, P939, DOI 10.1016/0278-4343(91)90086-L; WRIGHT SW, 1997, MONOGR ON OCEAN METH, V10, P327; Wulff A, 1997, ESTUARIES, V20, P547, DOI 10.2307/1352613; Zaklan SD, 1997, J EXP MAR BIOL ECOL, V215, P1, DOI 10.1016/S0022-0981(97)00021-X	82	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207917	10.1371/journal.pone.0207917	http://dx.doi.org/10.1371/journal.pone.0207917			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566444	Green Published, gold			2022-12-26	WOS:000453779300020
J	Yousafzai, AK; Rasheed, MA; Rizvi, A; Shaheen, F; Ponguta, LA; Reyes, CR				Yousafzai, Aisha K.; Rasheed, Muneera A.; Rizvi, Arjumand; Shaheen, Fariha; Ponguta, Liliana A.; Reyes, Chin R.			Effectiveness of a youth-led early childhood care and education programme in rural Pakistan: A cluster-randomised controlled trial	PLOS ONE			English	Article							NUTRITION INTERVENTIONS; RESPONSIVE STIMULATION; QUALITY; FUTURE; GROWTH; HEALTH; BRAIN	Background The United Nation's Sustainable Development Goals encompass lifelong learning from birth to youth to adulthood (Goal 4) and economic opportunities for young people (Goal 8). The targets include improving access to quality early childhood care and education (ECCE) as well as learning and training opportunities for adolescents and youth. Cross-generational models for young children and youth may offer opportunities to address the interconnections between goals and targets for the next generation. We investigated whether an ECCE programme for young children (3.5-6.5 years) delivered by female youth (18-24 years) in rural Pakistan would be effective on children's school readiness. Methods In partnership with the National Commission for Human Development in Pakistan, we implemented the 'Youth Leaders for Early Childhood Assuring Children are Prepared for School' (LEAPS) programme to train female youth to deliver ECCE. The effectiveness of the LEAPS programme on children's school readiness was evaluated in a cluster-randomised controlled trial. We randomly allocated five clusters (villages) to receive the intervention (n = 170 children) and five clusters to control (n = 170 children). Children's school readiness was assessed after nine months of intervention exposure using the International Development and Early Learning Assessment tool. Analyses was by intention-to-treat. The trial is registered with ClinicalTrials.gov, number NCT02645162. Findings At endline, the intervention group had significantly higher school readiness scores (n = 166, mean percentage score 59.4, 95% CI 52.7 to 66.2) compared with the control group (n = 168, mean percentage score 45.5, 95% CI 38.8 to 52.3). The effect size (Cohen's d) was 0.3. Conclusion Trained female youth delivered an ECCE programme that was effective in benefitting young children's school readiness. The cross-generational model is a promising approach to support early child development; however, further evaluation of the model is needed to assess the specific benefits to youth including their skills and economic development.	[Yousafzai, Aisha K.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Rasheed, Muneera A.; Rizvi, Arjumand; Shaheen, Fariha] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Ponguta, Liliana A.; Reyes, Chin R.] Yale Univ, Yale Child Study Ctr, New Haven, CT USA	Harvard University; Harvard T.H. Chan School of Public Health; Aga Khan University; Yale University	Yousafzai, AK (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	ayousafzai@hsph.harvard.edu			Saving Brains Program, Grand Challenges Canada [0705-03]; UNICEF	Saving Brains Program, Grand Challenges Canada; UNICEF	The research was co-funded by the Saving Brains Program, Grand Challenges Canada, 0705-03 to A.Y. and UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud FE, 2011, EARLY CHILD RES Q, V26, P237, DOI 10.1016/j.ecresq.2010.07.001; Arnold C., 2007, WORKING PAPERS EARLY; Bartlett S., 2013, LEARNING LEARNING RE; Britto P.R., 2011, SOCIAL POLICY REPORT, V25, P2, DOI DOI 10.1002/j.2379-3988.2011.tb00067.x; Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cogill B, 2003, ANTHROPOMETRIC INDIC; Fernald LC, 2009, EXAMINING EARLY CHIL; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Mahmood N., 2011, WORKING PAPERS RES R, V2011; Moisala M, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1063; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; Moore AC, 2008, INT J EDUC DEV, V28, P118, DOI 10.1016/j.ijedudev.2007.05.003; Nelson CA., 2000, HDB EARLY CHILDHOOD, V2nd Edition., P204, DOI DOI 10.1017/CBO9780511529320.012; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Noel MP, 2009, DEV PSYCHOL, V45, P1630, DOI 10.1037/a0016224; Nores M, 2018, ANN NY ACAD SCI, V1489, P57; Pakistan Go, 2009, NATL ED POLICY; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Ponguta LA, 2018, NEW DIR CHILD ADOLES, V159, P71, DOI 10.1002/cad.20233; Rao N, 2003, EARLY CHILD RES Q, V18, P331, DOI 10.1016/S0885-2006(03)00043-7; Rashid Muhammad H., 2017, 2017 International Conference on Innovations in Electrical Engineering and Computational Technologies (ICIEECT), DOI 10.1109/ICIEECT.2017.7916589; Richter LM, 2016, LANCET; Shonkoff JP, 2013, DEV PSYCHOPATHOL, V25, P1635, DOI 10.1017/S0954579413000813; Tran TD, 2017, CHILD CARE HLTH DEV, V43, P415, DOI 10.1111/cch.12395; UNICEF, 2013, OUT OF SCH CHILDR BA; Wesher D., 2002, WESHLER PRESCHOOL PR, VIII; Yoshikawa H, 2015, DEV PSYCHOL, V51, P309, DOI 10.1037/a0038785; Yousafzai AK, 2016, LANCET GLOB HEALTH, V4, pE548, DOI 10.1016/S2214-109X(16)30100-0; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208335	10.1371/journal.pone.0208335	http://dx.doi.org/10.1371/journal.pone.0208335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566498	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300036
J	Johnson, C; Chaput, JP; Rioux, F; Diasparra, M; Richard, C; Dubois, L				Johnson, Claire; Chaput, Jean-Philippe; Rioux, France; Diasparra, Maikol; Richard, Catherine; Dubois, Lise			An exploration of reported food intake among inmates who gained body weight during incarceration in Canadian federal penitentiaries	PLOS ONE			English	Article								Background Canadian penitentiaries have recently been shown to be obesogenic. However, little is known about the eating habits of inmates who gained weight while living in the prison environment. Methods This retrospective cohort study examined the reported food intake of inmates during incarceration in federal penitentiaries. During a face to face interview, anthropometric measures (2016-2017) were taken and compared to anthropometric data at the beginning of incarceration (mean follow-up of 5.0 +/- 8.3 years). Self-reported data on food intake were collected via a food frequency questionnaire. Results Inmates who gained the most weight (15.7 kg) during incarceration reported not eating vegetables. They were followed by inmates who gained 14.3 kg and reported not eating fruit. Other inmates who gained a significant amount of weight reported not eating cereal, dairy or legumes. Moreover, inmates' weight gain was also assessed by special diets: inmates following a religious diet (4.5 kg) or a diet of conscience (-0.3 kg) gained less weight than inmates not following a diet (5.8 kg). In comparison to other types of diets, inmates on a medical diet gained the most weight (7.5 kg). Furthermore, inmates who gained significant weight (8.0 kg) also reported not purchasing healthy foods from the commissary store (or "canteen"), whereas inmates who gained less weight (4.8 kg) reported purchasing healthy foods from the commissary store (or "canteen"). The observed weight gain was positively associated with food purchased from the commissary store (or "canteen"), but was not associated with the feeding system of the penitentiary (tray, cafeteria or meal plan). Discussion Food intake during incarceration is a modifiable risk factor that could be the target of weight management interventions with inmates. Our findings suggest that inmates who gained the most weight also reported having low intake of foods deemed healthy (vegetables, fruit, cereal, dairy and legumes) from food services and from the commissary store (or "canteen") purchases.	[Johnson, Claire] Univ Ottawa, Interdisciplinary Sch Hlth, Ottawa, ON, Canada; [Chaput, Jean-Philippe] Childrens Hosp Eastern Ontario, Hlth Act Living & Obes Res Grp, Res Inst, Ottawa, ON, Canada; [Rioux, France] Univ Ottawa, Fac Hlth Sci, Sch Nutr Sci, Ottawa, ON, Canada; [Diasparra, Maikol; Richard, Catherine; Dubois, Lise] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Johnson, C (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth, Ottawa, ON, Canada.	cjohn127@uottawa.ca	Chaput, Jean-Philippe/ABE-6307-2020	Chaput, Jean-Philippe/0000-0002-5607-5736; Johnson, Claire/0000-0001-7972-6055	Consortium national de formation en sante (CNFS)	Consortium national de formation en sante (CNFS)	This study was funded by the Consortium national de formation en sante (CNFS). The funders had no involvement in study design; collection, analysis or interpretation of data; writing the manuscript; or the decision to submit the manuscript for publication.	[Anonymous], 2013, CSC I PROFILES; Baldwin N, 2016, J HEALTH CARE POOR U, V27, P1567, DOI 10.1353/hpu.2016.0144; Camplin E., 2017, PRISON FOOD AM; Canada H, 2018, EATING WELL CANADAS; Collins SA, 2012, J CORRECT HEALTH CAR, V18, P210, DOI 10.1177/1078345812444875; Gostin L, 2007, ETHICAL CONSIDERATIO; Hannan-Jones M, 2016, EUR J CLIN NUTR, V70, P212, DOI 10.1038/ejcn.2015.100; Health Canada, 2013, MEAS FOOD ENV CAN; Jacobs ET, 2015, NUTRITION, V31, P659, DOI 10.1016/j.nut.2014.10.010; Johnson C, 2018, CANADIAN MED ASS J; Johnson C, 2018, CANADIAN MED ASS J O; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Lagarrigue A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170413; Le Cook Benjamin, 2013, Shanghai Arch Psychiatry, V25, P55, DOI 10.3969/j.issn.1002-0829.2013.01.011; Le Cook B, 2009, HEALTH SERV RES, V44, P1603, DOI 10.1111/j.1475-6773.2009.01004.x; Lenthe F. J. van, 2010, Obesogenic environments: complexities, perceptions and objective measures, P199; Meek R., 2014, SPORT PRISON EXPLORI; Ministry of Health PaPHD, 2013, 9780772667250 MIN HL; Nutrition resource center, 2015, TRANSF FOOD ENV CAP; Porta M, 2008, DICT EPIDEMIOLOGY; Public Health Agency of Canada, 2022, REP ADV EV FOLL IMM; Renaud D., 2017, NOUVEAU COMMERCE ILL; Rybicki M, 2015, POCKET RESOURCE MANA; Sapers Howard, 2016, ANN REPORT OFFICE CO; Sharma AM, 2010, BEST WEIGHT PRACTICA; Taylor VH, 2012, CAN J PSYCHIAT, V57, P13, DOI 10.1177/070674371205700104; Turner NE, 2013, J GAMBL STUD, V29, P435, DOI 10.1007/s10899-012-9321-1; WHO, 2015, WORLD HEALTH ORGANIS; World Health Organization, 2016, OB OV FACT SHEET	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208768	10.1371/journal.pone.0208768	http://dx.doi.org/10.1371/journal.pone.0208768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9MF	30562361	gold, Green Published			2022-12-26	WOS:000453774100021
J	Chawla, AS; Ankur, P; Mukherjee, A; Jain, V; Kaur, G; Coshic, P; Chatterjee, K; Wadhwa, N; Natchu, UCM; Sopory, S; Bhatnagar, S; Majumder, PP; George, A; Bal, V; Rath, S; Prabhu, SB				Chawla, Amanpreet Singh; Ankur, Parna; Mukherjee, Ankur; Jain, Vaibhav; Kaur, Gurvinder; Coshic, Poonam; Chatterjee, Kabita; Wadhwa, Nitya; Natchu, Uma Chandra Mouli; Sopory, Shailaja; Bhatnagar, Shinjini; Majumder, Partha P.; George, Anna; Bal, Vineeta; Rath, Satyajit; Prabhu, Savit B.			Cell-intrinsic regulation of peripheral memory-phenotype T cell frequencies	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; BONE-MARROW; IMMUNOLOGICAL MEMORY; TOLERANCE; EVOLUTION; RESPONSES; MICE; VARIABILITY; VACCINATION; COMPETITION	Memory land B lymphocyte numbers are thought to be regulated by recent and cumulative microbial exposures. We report here that memory-phenotype lymphocyte frequencies in B, CD4 and CD8 T-cells in 3-monthly serial bleeds from healthy young adult humans were relatively stable over a 1-year period, while Plasmablast frequencies were not, suggesting that recent environmental exposures affected steady state levels of recently activated but not of memory lymphocyte subsets. Frequencies of memory B and CD4 T cells were not correlated, suggesting that variation in them was unlikely to be determined by cumulative antigenic exposures. Immunophenotyping of adult siblings showed high concordance in memory, but not of recently activated lymphocyte subsets. To explore the possibility of cell-intrinsic regulation of T cell memory, we screened effector memory-phenotype T cell (TEM) frequencies in common independent inbred mice strains. Using two pairs from these strains that differed predominantly in either CD4 TEM and/or CD8 TEM frequencies, we constructed bi-parental bone marrow chimeras in F1 recipient mice, and found that memory T cell frequencies in recipient mice were determined by donor genotypes. Together, these data suggest cell-autonomous determination of memory T niche size, and suggest mechanisms maintaining immune variability.	[Chawla, Amanpreet Singh; Ankur, Parna; Jain, Vaibhav; George, Anna; Bal, Vineeta; Rath, Satyajit; Prabhu, Savit B.] Natl Inst Immunol, New Delhi, India; [Mukherjee, Ankur; Majumder, Partha P.] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Kaur, Gurvinder] All India Inst Med Sci, Lab Oncol, Rotary Canc Hosp, Dr BR Ambedkar Inst, New Delhi, India; [Coshic, Poonam; Chatterjee, Kabita] All India Inst Med Sci, Dept Transfus Med, New Delhi, India; [Wadhwa, Nitya; Natchu, Uma Chandra Mouli; Sopory, Shailaja; Bhatnagar, Shinjini; Prabhu, Savit B.] Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Faridabad, Haryana, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Prabhu, SB (corresponding author), Natl Inst Immunol, New Delhi, India.; Prabhu, SB (corresponding author), Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Faridabad, Haryana, India.	savit@thsti.res.in	Chawla, Amanpreet Singh/AAA-3261-2019	Chawla, Amanpreet Singh/0000-0001-5265-3431; Prabhu, Savit/0000-0003-3486-8951	Department of Biotechnology [BT/PR12849/MED/15/35/2009, BT/PR14420/Med/29/213/2010, BT/PR14592/BRB/10/858/2010, BT/MB/01/THSTI-ChBC/2009, BT/PR14723/MED/15/44/2010]; Department of Science and Technology, Government of India [SR/SO/HS-0005/2011, EMR/2015/001074, SB/SO/HS/210/2013]; Department of Biotechnology, Government of India; Department of Science and Technology, Government of India	Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was supported in part by grants from the Department of Biotechnology (to A.G. # BT/PR12849/MED/15/35/2009; to V.B. # BT/PR14420/Med/29/213/2010; to S.R. # BT/PR14592/BRB/10/858/2010; to S.B. BT/MB/01/THSTI-ChBC/2009; and to U.C.M.N. # BT/PR14723/MED/15/44/2010), and from the Department of Science and Technology, Government of India (to V.B. # SR/SO/HS-0005/2011 and #EMR/2015/001074; to S.R. # SB/SO/HS/210/2013). The National Institute of Immunology and the Translational Health Science and Technology Institute are supported by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Department of Biotechnology, Government of India and Department of Science and Technology, Government of India for funding the study.	Angela M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13683; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Bergmann B, 2013, SCAND J IMMUNOL, V78, P149, DOI 10.1111/sji.12073; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Boots M, 2004, P ROY SOC B-BIOL SCI, V271, P715, DOI 10.1098/rspb.2003.2655; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Burel JG, 2017, J IMMUNOL, V198, P1748, DOI 10.4049/jimmunol.1601750; Capece T, 2016, MOL CELLS, V39, P515, DOI 10.14348/molcells.2016.0089; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Farber DL, 2016, NAT REV IMMUNOL, V16, P124, DOI 10.1038/nri.2016.13; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; Graw F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-380; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; Holl EK, 2013, METHODS MOL BIOL, V1032, P315, DOI 10.1007/978-1-62703-496-8_24; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huster KM, 2009, J IMMUNOL, V183, P6898, DOI 10.4049/jimmunol.0902454; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Lee YC, 2006, VACCINE, V24, P5335, DOI 10.1016/j.vaccine.2006.04.021; Li SS, 2014, CELL MOL IMMUNOL, V11, P326, DOI 10.1038/cmi.2014.25; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Lu Y, 2016, IMMUNITY, V45, P1162, DOI 10.1016/j.immuni.2016.10.025; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Majumder PP, 2013, EUR J HUM GENET, V21, P1000, DOI 10.1038/ejhg.2012.278; Mostafavi S, 2014, J IMMUNOL, V193, P4485, DOI 10.4049/jimmunol.1401280; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Paparo L, 2014, NUTRIENTS, V6, P4706, DOI 10.3390/nu6114706; Prabhu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162242; Rathore DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123589; Rubelt F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11112; San Segundo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080601; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; SPRENT J, 1975, J EXP MED, V142, P321, DOI 10.1084/jem.142.2.321; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wodarz D, 2003, CURR BIOL, V13, P1648, DOI 10.1016/j.cub.2003.08.055; Yan K, 2013, J HUM GENET, V58, P293, DOI 10.1038/jhg.2013.18; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhao Y, 2003, J IMMUNOL, V170, P5398, DOI 10.4049/jimmunol.170.11.5398; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0200227	10.1371/journaI.pone.0200227	http://dx.doi.org/10.1371/journaI.pone.0200227			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557341				2022-12-26	WOS:000453451000001
J	Al-Mamun, MA; Smith, RL; Nigsch, A; Schukken, YH; Grohn, YT				Al-Mamun, Mohammad A.; Smith, Rebecca L.; Nigsch, Annette; Schukken, Ynte H.; Grohn, Yrjo T.			A data-driven individual-based model of infectious disease in livestock operation: A validation study for paratuberculosis	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; VIRAL DIARRHEA VIRUS; RISK-BASED CONTROL; JOHNES-DISEASE; MILK-PRODUCTION; DAIRY HERDS; COMPARTMENTAL MODEL; CATTLE; DYNAMICS; IMPACT	Chronic livestock diseases cause large financial loss and affect animal health and welfare. Controlling these diseases mostly requires precise information on both individual animal and population dynamics to inform the farmer's decisions, but even successful control programmes do by no means assure elimination. Mathematical models provide opportunities to test different control and elimination options rather than implementing them in real herds, but these models require robust parameter estimation and validation. Fitting these models to data is a difficult task due to heterogeneities in livestock processes. In this paper, we develop an infectious disease modeling framework for a livestock disease (paratuberculosis) that is caused by Mycobacterium avium subsp. paratuberculosis (MAP). Infection with MAP leads to reduced milk production, pregnancy rates, and slaughter value and increased culling rates in cattle and causes significant economic losses to the dairy industry. These economic effects are particularly important motivations in the control and elimination of MAP. In this framework, an individual-based model (IBM) of a dairy herd was built and MAP infection dynamics was integrated. Once the model produced realistic dynamics of MAP infection, we implemented an evaluation method by fitting it to data from three dairy herds from the Northeast region of the US. The model fitting exercises used least-squares and parameter space searching methods to obtain the best-fitted values of selected parameters. The best set of parameters were used to model the effect of interventions. The results show that the presented model can complement real herd statistics where the intervention strategies suggest a reduction in MAP prevalence without elimination. Overall, this research not only provides a complete model for MAP infection dynamics in a dairy herd but also offers a method for estimating parameters by fitting IBM models.	[Al-Mamun, Mohammad A.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Smith, Rebecca L.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Nigsch, Annette; Schukken, Ynte H.] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands; [Grohn, Yrjo T.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Tower Rd, Ithaca, NY 14853 USA	Yale University; University of Illinois System; University of Illinois Urbana-Champaign; Wageningen University & Research; Cornell University	Al-Mamun, MA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.	mohammad.al-mamun@yale.edu	Schukken, Ynte H/C-3405-2008	Schukken, Ynte H/0000-0002-8250-4194; Al-Mamun, Mohammad A/0000-0001-9509-4414; Smith, Rebecca/0000-0002-8343-794X	National Institute of Food and Agriculture of the United States Department of Agriculture through NIFA [2014-67015-2240]	National Institute of Food and Agriculture of the United States Department of Agriculture through NIFA	This work was supported by National Institute of Food and Agriculture of the United States Department of Agriculture through NIFA Award No. 2014-67015-2240. The funder provided support in the form of salaries for authors [MAAI-Mamun], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Mamun MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12078-z; Al-Mamun MA, 2017, P 50 ANN SIM INT; Al-Mamun MA, 2016, J THEOR BIOL, V408, P105, DOI 10.1016/j.jtbi.2016.08.014; Aly SS, 2010, J DAIRY SCI, V93, P1030, DOI 10.3168/jds.2009-2611; Behr MA, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P1, DOI 10.1079/9781845936136.0000; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Broughan JM, 2016, EPIDEMIOL INFECT, V144, P2899, DOI 10.1017/S095026881600131X; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Chi J, 2002, PREV VET MED, V55, P137, DOI 10.1016/S0167-5877(02)00094-6; Chiu LJV, 2018, J DAIRY SCI, V101, P6443, DOI 10.3168/jds.2017-13175; Davidson RS, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-159; Dematawewa CMB, 2007, J DAIRY SCI, V90, P3924, DOI 10.3168/jds.2006-790; Elliott GN, 2015, CRIT REV MICROBIOL, V41, P488, DOI 10.3109/1040841X.2013.867830; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Kirkeby C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27518-7; Kirkeby C, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1119-z; Kirkeby C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167219; Kirkeby C, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00090; Kirkeby C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0512-8; Kudahl AB, 2011, J DAIRY SCI, V94, P3824, DOI 10.3168/jds.2010-3933; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Kudahl AB, 2008, J DAIRY SCI, V91, P4599, DOI 10.3168/jds.2008-1257; Kudahl AB, 2007, PREV VET MED, V78, P97, DOI 10.1016/j.prevetmed.2006.05.015; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Li LL, 2016, ANNU REV ANIM BIOSCI, V4, P155, DOI 10.1146/annurev-animal-021815-111304; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lombard JE, 2005, JAVMA-J AM VET MED A, V227, P1975, DOI 10.2460/javma.2005.227.1975; Lu Z, 2008, J THEOR BIOL, V254, P135, DOI 10.1016/j.jtbi.2008.05.008; Lu Z, 2013, PREV VET MED, V110, P335, DOI 10.1016/j.prevetmed.2013.01.006; Lu Z, 2013, PREV VET MED, V108, P148, DOI 10.1016/j.prevetmed.2012.08.001; Lu ZA, 2010, J THEOR BIOL, V264, P1190, DOI 10.1016/j.jtbi.2010.03.034; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Mitchell RM, 2008, PREV VET MED, V83, P360, DOI 10.1016/j.prevetmed.2007.09.006; Mitchell RM, 2015, VET RES, V46, DOI 10.1186/s13567-015-0188-x; Mitchell RM, 2015, PREV VET MED, V118, P215, DOI 10.1016/j.prevetmed.2014.12.009; NAHMS. National Animal Health Monitoring System, 2007, DAIR 2007 JOHN DIS U; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Nielsen SS, 2009, J DAIRY SCI, V92, P149, DOI 10.3168/jds.2008-1488; Nielsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063009; Nielsen SS, 2009, IN PRACTICE, V31, P150; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Pradhan AK, 2009, J DAIRY SCI, V92, P1811, DOI 10.3168/jds.2008-1486; Pradhan AK, 2011, J CLIN MICROBIOL, V49, P893, DOI 10.1128/JCM.01107-10; Rathnaiah G, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00187; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; Slater N, 2016, VET RES, V47, DOI 10.1186/s13567-016-0323-3; Smith RL, 2017, PREV VET MED, V138, P17, DOI 10.1016/j.prevetmed.2017.01.007; Smith RL, 2011, PREV VET MED, V102, P1, DOI 10.1016/j.prevetmed.2011.06.009; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Smith RL, 2009, J DAIRY SCI, V92, P2653, DOI 10.3168/jds.2008-1832; Smith RL, 2016, J DAIRY SCI, V99, P1383, DOI 10.3168/jds.2015-9822; Smith RL, 2015, PREV VET MED, V122, P298, DOI 10.1016/j.prevetmed.2015.10.008; Smith RL, 2013, JAVMA-J AM VET MED A, V243, P411, DOI 10.2460/javma.243.3.411; Sorge US, 2007, J DAIRY SCI, V90, P5784, DOI 10.3168/jds.2006-0813; Tiwari A, 2005, VET MICROBIOL, V109, P147, DOI 10.1016/j.vetmic.2005.05.011; van Roermund HJW, 2007, VET MICROBIOL, V122, P270, DOI 10.1016/j.vetmic.2007.01.016; Whittington RJ, 2009, VET J, V179, P60, DOI 10.1016/j.tvjl.2007.08.023; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0203177	10.1371/journal.pone.0203177	http://dx.doi.org/10.1371/journal.pone.0203177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550580	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000002
J	de Knegt, MC; Haugen, M; Linde, JJ; Kuhl, JT; Nordestgaard, BG; Kober, LV; Hove, JD; Kofoed, KF				de Knegt, Martina C.; Haugen, Morten; Linde, Jesper J.; Kuhl, Jorgen Tobias; Nordestgaard, Borge G.; Kober, Lars, V; Hove, Jens D.; Kofoed, Klaus F.			Reproducibility of quantitative coronary computed tomography angiography in asymptomatic individuals and patients with acute chest pain	PLOS ONE			English	Article							ARTERY-DISEASE; CT ANGIOGRAPHY; PLAQUE BURDEN; HIGH-RISK; QUANTIFICATION; AGREEMENT; SOFTWARE; LESIONS	Purpose Quantitative computed tomography (QCT) provides important prognostic information of coronary atherosclerosis. We investigated intraobserver and interobserver QCT reproducibility in asymptomatic individuals, patients with acute chest pain without acute coronary syndrome (ACS), and patients with acute chest pain and ACS. Methods Fifty patients from each cohort, scanned between 01/02/2010-14/11/2013 and matched according to age and gender, were retrospectively assessed for inclusion. Patients with no coronary artery disease, previous coronary artery bypass graft surgery, and poor image quality were excluded. Coronary atherosclerosis was measured semi-automatically by 2 readers. Reproducibility of minimal lumen area (MLA), minimal lumen diameter (MLD), area stenosis, diameter stenosis, vessel remodeling, plaque eccentricity, plaque burden, and plaque volumes was assessed using concordance correlation coefficient (CCC), Bland-Altman, coefficient of variation, and Cohen's kappa. Results A total of 84 patients (63 matched) were included. Intraobserver and interobserver reproducibility estimates were acceptable for MLA (CCC = 0.94 and CCC = 0.91, respectively), MLD (CCC = 0.92 and CCC = 0.86, respectively), plaque burden (CCC = 0.86 and CCC = 0.80, respectively), and plaque volume (CCC = 0.97 and CCC = 0.95, respectively). QCT detected area and diameter stenosis >= 50%, positive remodeling, and eccentric plaque with moderate-good intraobserver and interobserver reproducibility (kappa: 0.64-0.66, 0.69-0.76, 0.46-0.48, and 0.41-0.62, respectively). Reproducibility of plaque composition decreased with decreasing plaque density (intraobserver and interobserver CCC for dense calcium (>0.99; 0.98), fibrotic (0.96; 0.93), fibro-fatty (0.95; 0.91), and necrotic core tissue (0.89; 0.84). Reproducibility generally decreased with worsening clinical risk profile. Conclusions Semi-automated QCT of coronary plaque morphology is reproducible, albeit with some decline in reproducibility with worsening patient risk profile.	[de Knegt, Martina C.; Haugen, Morten; Linde, Jesper J.; Kuhl, Jorgen Tobias; Kober, Lars, V; Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [de Knegt, Martina C.; Hove, Jens D.] Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Radiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	de Knegt, MC (corresponding author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark.; de Knegt, MC (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark.	martinadeknegt@gmail.com	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Kofoed, Klaus Fuglsang/0000-0001-9742-1554; Hove, Jens/0000-0002-5600-5623; de Knegt, Martina/0000-0001-7668-0338; Kuhl, Jorgen Tobias/0000-0002-7726-689X; Kober, Lars/0000-0002-6635-1466	Department of Cardiology, Hvidovre Hospital, Copenhagen, Denmark; Danish Agency for Science, Technology and Innovation by The Danish Council for Strategic Research [09-066994]	Department of Cardiology, Hvidovre Hospital, Copenhagen, Denmark; Danish Agency for Science, Technology and Innovation by The Danish Council for Strategic Research	This study was funded by Department of Cardiology, Hvidovre Hospital, Copenhagen, Denmark and Danish Agency for Science, Technology and Innovation by The Danish Council for Strategic Research (EDITORS: Eastern Denmark initiative to improve Revascularization Strategies, Grant 09-066994). These funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Arbab-Zadeh A, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.007992; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; Blackmon KN, 2009, J THORAC IMAG, V24, P96, DOI 10.1097/RTI.0b013e31819b674b; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boogers MJ, 2012, EUR HEART J, V33, P1007, DOI 10.1093/eurheartj/ehr465; Broersen A, 2016, INT J CARDIOVAS IMAG, V32, P543, DOI 10.1007/s10554-015-0820-x; Cho IJ, 2018, J AM COLL CARDIOL, V71, P1998, DOI [10.1016/S0735-1097(18)32539-7, 10.1016/j.jacc.2018.02.079]; Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC; Dalager MG, 2011, INT J CARDIOVAS IMAG, V27, P593, DOI 10.1007/s10554-010-9695-z; de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x; de Knegt MC, 2019, EUR HEART J-CARD IMG, V20, P1221, DOI 10.1093/ehjci/jey146; de Knegt MC, 2016, INT J CARDIOVAS IMAG, V32, P1555, DOI 10.1007/s10554-016-0932-y; Dey D, 2014, J CARDIOVASC COMPUT, V8, P368, DOI 10.1016/j.jcct.2014.07.007; Ferencik M, 2015, J CARDIOVASC COMPUT, V9, P538, DOI 10.1016/j.jcct.2015.07.003; Kang DK, 2011, EUR RADIOL, V21, P712, DOI 10.1007/s00330-010-1970-9; Kristensen TS, 2011, J AM COLL CARDIOL, V58, P502, DOI 10.1016/j.jacc.2011.01.058; Kuhl JT, 2017, SCAND CARDIOVASC J, V51, P28, DOI 10.1080/14017431.2016.1207799; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laqmani A, 2016, ROFO-FORTSCHR RONTG, V188, P933, DOI 10.1055/s-0042-110099; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Linde JJ, 2013, INT J CARDIOL, V168, P5257, DOI 10.1016/j.ijcard.2013.08.020; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Ovrehus KA, 2016, J CARDIOVASC COMPUT, V10, P114, DOI 10.1016/j.jcct.2015.11.003; Papadopoulou SL, 2013, INT J CARDIOVAS IMAG, V29, P1095, DOI 10.1007/s10554-012-0167-5; Rinehart S, 2011, J CARDIOVASC COMPUT, V5, P35, DOI 10.1016/j.jcct.2010.09.006; Szilveszter B, 2016, INT J CARDIOVAS IMAG, V32, P161, DOI 10.1007/s10554-015-0741-8; Versteylen MO, 2013, J AM COLL CARDIOL, V61, P2296, DOI 10.1016/j.jacc.2013.02.065; Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0207980	10.1371/journal.pone.0207980	http://dx.doi.org/10.1371/journal.pone.0207980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550593	Green Published, gold, Green Submitted			2022-12-26	WOS:000453248000012
J	Esnaola, A; Arrizabalaga-Escudero, A; Gonzalez-Esteban, J; Elosegi, A; Aihartza, J				Esnaola, Amaiur; Arrizabalaga-Escudero, Aitor; Gonzalez-Esteban, Jorge; Elosegi, Arturo; Aihartza, Joxerra			Determining diet from faeces: Selection of metabarcoding primers for the insectivore Pyrenean desman (Galemys pyrenaicus)	PLOS ONE			English	Article							TROPHIC INTERACTIONS; DNA; PREY; PREDATOR; ECOLOGY; BIOLOGY; PCR	Molecular techniques allow non-invasive dietary studies from faeces, providing an invaluable tool to unveil ecological requirements of endangered or elusive species. They contribute to progress on important issues such as genomics, population genetics, dietary studies or reproductive analyses, essential knowledge for conservation biology. Nevertheless, these techniques require general methods to be tailored to the specific research objectives, as well as to substrate- and species-specific constraints. In this pilot study we test a range of available primers to optimise diet analysis from metabarcoding of faeces of a generalist aquatic insectivore, the endangered Pyrenean desman (Galemys pyrenaicus, E. Geoffroy Saint-Hilaire, 1811, Talpidae), as a step to improve the knowledge of the conservation biology of this species. Twenty-four faeces were collected in the field, DNA was extracted from them, and fragments of the standard barcode region (COI) were PCR amplified by using five primer sets (Brandon-Mong, Gillet, Leray, Meusnier and Zeale). PCR outputs were sequenced on the Illumina MiSeq platform, sequences were processed, clustered into OTUs (Operational Taxonomic Units) using UPARSE algorithm and BLASTed against the NCBI database. Although all primer sets successfully amplified their target fragments, they differed considerably in the amounts of sequence reads, rough OTUs, and taxonomically assigned OTUs. Primer sets consistently identified a few abundant prey taxa, probably representing the staple food of the Pyrenean desman. However, they differed in the less common prey groups. Overall, the combination of Gillet and Zeale primer sets were most cost-effective to identify the widest taxonomic range of prey as well as the desman itself, which could be further improved stepwise by adding sequentially the outputs of Leray, Brandon-Mong and Meusnier primers. These results are relevant for the conservation biology of this endangered species as they allow a better characterization of its food and habitat requirements.	[Esnaola, Amaiur; Arrizabalaga-Escudero, Aitor; Aihartza, Joxerra] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, Basque County, Spain; [Gonzalez-Esteban, Jorge] DESMA Estudios Ambientales, Navarra, Spain; [Elosegi, Arturo] Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Leioa, Basque County, Spain	University of Basque Country; University of Basque Country	Esnaola, A (corresponding author), Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, Basque County, Spain.	amaiur.esnaola@ehu.eus	Aihartza, Joxerra/Z-3061-2019; Aihartza, Joxerra/GSO-2446-2022; Elosegi, Arturo/B-7796-2009; Esnaola, Amaiur/O-1159-2019	Aihartza, Joxerra/0000-0003-0882-8964; Elosegi, Arturo/0000-0001-8809-8484; Esnaola, Amaiur/0000-0001-5030-385X	EU project LIFE IREKIBAI [LIFE14 NAT/ES/000186]; Provincial Council of Gipuzkoa, Basque Government [156P/2016, IT754-13]; City Council of San Sebastian, Basque Government [156P/2016, IT754-13]; Basque Government [PRE_2015_1_0408]; University of the Basque Country UPV/EHU	EU project LIFE IREKIBAI; Provincial Council of Gipuzkoa, Basque Government; City Council of San Sebastian, Basque Government; Basque Government(Basque Government); University of the Basque Country UPV/EHU	The study was funded by the EU project LIFE IREKIBAI (LIFE14 NAT/ES/000186), as well as by the Provincial Council of Gipuzkoa, City Council of San Sebastian, Basque Government (156P/2016 and IT754-13) and the University of the Basque Country UPV/EHU. The Basque Government granted AEs (PRE_2015_1_0408). DESMA Estudios Ambientales provided support in the form of salaries for author JGE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberdi A, 2018, METHODS ECOL EVOL, V9, P134, DOI 10.1111/2041-210X.12849; Alberdi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035692; Ando H, 2013, ECOL EVOL, V3, P4057, DOI 10.1002/ece3.773; [Anonymous], 2013, ESTR CONS DESM IB GA; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Arrizabalaga-Escud, 2018, MOL ECOL, V0027; Arrizabalaga-Escudero A, 2015, BIOL CONSERV, V191, P512, DOI 10.1016/j.biocon.2015.07.043; Biffi M, 2017, J MAMMAL, V98, P1497, DOI 10.1093/jmammal/gyx070; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075962; Brandon-Mong GJ, 2015, B ENTOMOL RES, V105, P717, DOI 10.1017/S0007485315000681; Buglione M, 2018, MAMM BIOL, V88, P31, DOI 10.1016/j.mambio.2017.10.010; Burgar JM, 2014, MOL ECOL, V23, P3605, DOI 10.1111/mec.12531; Casper RM, 2007, MAR BIOL, V152, P815, DOI 10.1007/s00227-007-0732-y; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2014, EVOL APPL, V7, P1144, DOI 10.1111/eva.12225; Clare EL, 2014, MOL ECOL, V23, P3618, DOI 10.1111/mec.12542; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Divoll TJ, 2018, MOL ECOL RESOUR, V18, P590, DOI 10.1111/1755-0998.12770; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbrecht V, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00011; Esnaola A, 2018, AQUAT CONSERV, V28, P600, DOI 10.1002/aqc.2893; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Fernandes G, 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T8826A12934876.en, DOI 10.2305/IUCN.UK.2008.RLTS.T8826A12934876.EN]; Gerwing TG, 2016, AUK, V133, P168, DOI 10.1642/AUK-15-176.1; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Gillet F, 2015, MAMM BIOL, V80, P505, DOI 10.1016/j.mambio.2015.08.002; Gonzalez-Esteban J, HYSTRIX; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hawlitschek O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201763; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hines J, 2012, J ANIM ECOL, V81, P1146, DOI 10.1111/j.1365-2656.2012.02003.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Krauel JJ, 2018, OECOLOGIA, V186, P49, DOI 10.1007/s00442-017-3995-0; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lopes CM, 2015, HEREDITY, V114, P525, DOI 10.1038/hdy.2014.109; Marches L, 2002, J RAPTOR RES, V36, P11; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Nemoz M, 2008, PLAN NATL ACTIONS FA; Oehm J, 2011, MOL ECOL RESOUR, V11, P620, DOI 10.1111/j.1755-0998.2011.03001.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; Pompanon F, 2015, GENETICA, V143, P133, DOI 10.1007/s10709-015-9816-7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Schwarz D, 2018, ECOL EVOL, P1; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Shiel CB, 1997, IDENTIFICATION ARTHR; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Sutherland WJ, 2000, CONSERVATION HDB RES; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Waraniak JM, 2018, J FISH BIOL, V93, P616, DOI 10.1111/jfb.13726; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	68	12	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208986	10.1371/journal.pone.0208986	http://dx.doi.org/10.1371/journal.pone.0208986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550548	Green Published, gold			2022-12-26	WOS:000453248000036
J	da Silva, TF; Cirilo-Souza, MD; de Souza, MF; Neto, GV; dos Santos, MAP; Silva, AS				da Silva, Tais Feitosa; Cirilo-Souza, Maria do Socorro; de Souza, Marizangela Ferreira; Neto, Geraldo Veloso; Pereira dos Santos, Marcos Antonio; Silva, Alexandre Sergio			Energy demand in an active videogame session and the potential to promote hypotension after exercise in hypertensive women	PLOS ONE			English	Article							POSTEXERCISE HYPOTENSION; BLOOD-PRESSURE	The aim of this study was to determine the energy demand of one session of active video game (AVG) and its potential to reduce blood pressure (BP). Fourteen hypertensive (56.4 +/- 7.5 years) individuals performed sessions of AVG, a traditional sedentary video game sessions (SVG) and walking (WAL), as negative and positive controls, in a randomly determined order. Oxygen consumption and energy expenditure (EE) were measured during sessions. BP and cardiac autonomic modulation (CAM) were measured at rest and every 15 minutes of a 60-minute period of recovery from activities. A rating of enjoyment scale was also applied. AVG and WAL resulted in higher oxygen consumption (10.0 +/- 0.5 ml/kg/min and 16.6 +/- 3.1 ml/kg/min, respectively) and EE (3.5 +/- 0.2 kcal/min and 4.2 +/- 0.5 kcal/min) compared to 4.1 +/- 0.8 ml/kg/min and 1.4 +/- 0.1 kcal/min in SVG. A reduction in systolic and diastolic BP was evident following AVG sessions (-11.6 +/- 2.5 mmHg and -8.7 +/- 2.5 mmHg) and WAL (-10.8 +/- 2.8 mmHg and -8.6 +/- 2.3 mmHg) compared to pre-experiment value, and the same did not occur in SVG. All sessions promoted a feeling of enjoyment, with no difference between them. The parasympathetic activity was significantly lower at 30 and 45 minutes in post-WAL recovery (34.6 +/- 15.0 ms(2) and 34.4 +/- 16.0 ms(2)) in the frequency domain (HF) in relation to both AVG (195.5 +/- 67.0 ms(2) and 164.5 +/- 55.0 ms(2)) and the SVG (158.9 +/- 45.0 and 281.3 +/- 98.0 ms(2)). It is concluded that an AVG session promotes increased metabolic activity and is able to promote acute reduction of BP in hypertensive individuals similar to traditional walking exercise.	[da Silva, Tais Feitosa; Cirilo-Souza, Maria do Socorro; de Souza, Marizangela Ferreira; Neto, Geraldo Veloso; Silva, Alexandre Sergio] Univ Fed Paraiba, Phys Educ Dept, Joao Pessoa, Paraiba, Brazil; [Pereira dos Santos, Marcos Antonio] Univ Fed Piaui, Biophys & Physiol Dept, Teresina, Piaui, Brazil	Universidade Federal da Paraiba; Universidade Federal do Piaui	Silva, AS (corresponding author), Univ Fed Paraiba, Phys Educ Dept, Joao Pessoa, Paraiba, Brazil.	alexandresergiosilva@yahoo.com.br	dos Santos Santos, Marcos Antonio Pereira/N-5109-2019; Silva, Alexandre S/N-8883-2014; dos santos, marcos antonio/J-5016-2016	dos Santos Santos, Marcos Antonio Pereira/0000-0002-0755-6138; Silva, Alexandre S/0000-0003-3576-9023; dos santos, marcos antonio/0000-0002-0755-6138	Commission for the Improvement of Higher Education Personnel (CAPES)	Commission for the Improvement of Higher Education Personnel (CAPES)	This research was funded by the Commission for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi Alexandre, 2005, Arq. Bras. Cardiol., V85, P1, DOI 10.1590/S0066-782X2005002100001; Carvalho RSTR, 2015, ARQ BRAS CARDIOL, V3, P234; Casonatto J, 2009, REV BRAS MED ESPORTE, V15, P151, DOI 10.1590/S1517-86922009000200014; Cavalli AS, 2014, SBC P SBGAMES PORT A; Coelho CD, 2009, REV NUTR, V22, P937; FITZGERALD W, 1981, BRIT MED J, V282, P542, DOI 10.1136/bmj.282.6263.542; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gomes Anunciacao Paulo, 2011, Arq Bras Cardiol, V96, pe100; Graves LEF, 2008, EUR J APPL PHYSIOL, V104, P617, DOI 10.1007/s00421-008-0813-8; Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393; Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065; Kenney MJ, 1993, HYPERTENSION, V5, P653; MacDonald JR, 2000, J HUM HYPERTENS, V14, P125, DOI 10.1038/sj.jhh.1000953; McLaughlin JE, 2011, INT J SPORTS MED STU, V31, P280; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; PEREIRA J. C., 2012, REV BRASILEIRA ATIVI, V17, P332; Siegel Shannon R, 2009, Int J Exerc Sci, V2, P165; Skutnik BC, 2016, PHYSICIAN SPORTSMED, V44, P177, DOI 10.1080/00913847.2016.1159501; Souza DD., 2010, REV BRAS HIPERTENS, V17, P103; Tsai JC, 2003, J ALTERN COMPLEM MED, V9, P747, DOI 10.1089/107555303322524599; Umpierre D, 2007, ARQ BRAS CARDIOL, V89, P256, DOI 10.1590/S0066-782X2007001600008; Wolff M, 2013, BMC CARDIOVASC DISOR, V13, P2	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0207505	10.1371/journal.pone.0207505	http://dx.doi.org/10.1371/journal.pone.0207505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543638	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500008
J	Lee, Y; Jin, U; Lee, WM; Lim, HS; Lim, YH				Lee, Yonggu; Jin, Uram; Lee, Won Moo; Lim, Hong-Seok; Lim, Young-Hyo			Relationship of body mass index and waist circumference with clinical outcomes following percutaneous coronary intervention	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; CARDIOVASCULAR EVENTS; ARTERY-DISEASE; CENTRAL OBESITY; RISK-FACTOR; MORTALITY; IMPACT; ASSOCIATION; WEIGHT; PREVALENCE	Background A biphasic, U-shape relationship has been reported between body mass index (BMI) and clinical outcomes following percutaneous coronary intervention (PCI). However, the relationship between waist circumference (WC) and the cardiovascular risk following PCI has not been reported. Methods A prospective cohort study was performed. A major adverse cardiac event (MACE) was defined as a composite of cardiac death (CD), nonfatal myocardial infarction (NFMI) and target vessel revascularization (TVR). Patients were evenly divided into 4 groups according to BMI (Q1(BMI), Q2(BMI), Q3(BMI) and Q4(BMI)) and WC (Q1(WC), Q2(WC), Q3(WC) and Q4(WC)). Results A total of 1,421 patients were observed for 5 years. The risk of the composite events of CD and NFMI (CD/NFMI) was lower in the Q3(WC) and Q4(WC) groups than in the Q1(WC) group, whereas it was only marginally lower in the Q2BMI group than in the Q1 BMI group (ANOVA, p = 0.062). The risk of MACE was highest in the Ql(WC) group and lowest in the Q3(WC) group; however, the risk of MACE did not differ among the 4 groups, according to BMI. Multivariate Cox-regression analyses showed that the risk of CD/NFMI gradually decreased with BMI (linear p = 0.030) and with WC (linear p = 0.015). The risks of TVR and MACEs that were driven by TVRs showed a distinguishing biphasic, U-shaped relationship with WC (nonlinear p = 0.009) but not with BMI (nonlinear p = 0.439). Landmark survival analysis showed that the incidences of CD and NFMI were higher in the lower BMI groups and lower WC groups than in the higher BMI groups and higher WC groups, respectively, until 1 year and did not differ afterward. In contrast, the incidence of MACE was highest in Q1(WC) and lowest in Q3(WC) (log-rank p = 0.003), whereas the incidence was not different among the groups according to BMI. Conclusions Both BMI and WC were associated with a lower risk of early episodes of CD and NFMI after PCI. In the late period after PCI, WC demonstrated a biphasic, U-shaped association between cardiovascular outcomes and adiposity, whereas BMI did not.	[Lee, Yonggu] Hanyang Univ, Dept Cardiol, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Jin, Uram; Lim, Hong-Seok] Ajou Univ, Dept Cardiol, Sch Med, Suwon, Gyeonggi Do, South Korea; [Lee, Won Moo] Hanyang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Lim, Young-Hyo] Hanyang Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea	Hanyang University; Ajou University; Hanyang University; Hanyang University	Lim, HS (corresponding author), Ajou Univ, Dept Cardiol, Sch Med, Suwon, Gyeonggi Do, South Korea.; Lim, YH (corresponding author), Hanyang Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.	mdoim@hanyang.ac.kr; camdhslim@ajou.ac.kr	Lee, Yonggu/Q-3832-2018	Lee, Yonggu/0000-0002-3757-3692; Jin, Uram/0000-0001-8406-8886; Lim, Hong-Seok/0000-0002-3127-2071	Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MSIT) [2017M3A9E2064741]	Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MSIT)(Korean Government)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) & funded by the Korean government (MSIT) (No. 2017M3A9E2064741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) & funded by the Korean government (MSIT) (No. 2017M3A9E2064741).	Brenner DR, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-28; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Coutinho T, 2013, J AM COLL CARDIOL, V61, P553, DOI 10.1016/j.jacc.2012.10.035; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; De Schutter A, 2014, PROG CARDIOVASC DIS, V56, P401, DOI 10.1016/j.pcad.2013.08.003; Diletti R, 2015, CATHETER CARDIO INTE, V85, P952, DOI 10.1002/ccd.25828; Gierach Marcin, 2014, ISRN Endocrinol, V2014, P514589, DOI 10.1155/2014/514589; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Holroyd EW, 2017, JACC-CARDIOVASC INTE, V10, P1283, DOI 10.1016/j.jcin.2017.03.013; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kang SJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI [10.1161/CIRCINTERVENTIONS.114.0031392, DOI 10.1161/CIRCINTERVENTIONS.114.0031392]; Kang Won Yu, 2012, Chonnam Med J, V48, P32, DOI 10.4068/cmj.2012.48.1.32; Kang WY, 2010, J CARDIOL, V55, P84, DOI 10.1016/j.jjcc.2009.10.004; Kim SH, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0238-8; Kim TN, 2011, DIABETES RES CLIN PR, V93, P285, DOI 10.1016/j.diabres.2011.06.013; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lavie CJ, 2011, MAYO CLIN PROC, V86, P857, DOI 10.4065/mcp.2011.0092; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lee SH, 2008, AM J CARDIOL, V102, P957, DOI 10.1016/j.amjcard.2008.06.022; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; McAuley PA, 2014, PROG CARDIOVASC DIS, V56, P434, DOI 10.1016/j.pcad.2013.09.006; Nikolsky E, 2006, AM HEART J, V151, P168, DOI 10.1016/j.ahj.2005.03.024; Numasawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124399; Park DW, 2013, CIRC-CARDIOVASC INTE, V6, P146, DOI 10.1161/CIRCINTERVENTIONS.112.000062; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Romero-Corral A, 2007, EUR HEART J, V28, P2087, DOI 10.1093/eurheartj/ehm243; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang ZJ, 2015, HEART, V101, P1631, DOI 10.1136/heartjnl-2014-307119; Zeller M, 2008, CIRCULATION, V118, P482, DOI 10.1161/CIRCULATIONAHA.107.753483	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208817	10.1371/journal.pone.0208817	http://dx.doi.org/10.1371/journal.pone.0208817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543687	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500043
J	Rimskaya-Korsakova, NN; Galkin, SV; Malakhov, VV				Rimskaya-Korsakova, Nadezhda N.; Galkin, Sergey, V; Malakhov, Vladimir V.			The neuroanatomy of the siboglinid Riftia pachyptila highlights sedentarian annelid nervous system evolution	PLOS ONE			English	Article							FIORDICUM WEBB POGONOPHORA; VESTIMENTIFERAN WORM; DEVELOPMENTAL STAGES; NEREIS-DIVERSICOLOR; GROUND PATTERN; ANTERIOR END; POLYCHAETE; MORPHOLOGY; ANATOMY; PHYLOGENY	Tracing the evolution of the siboglinid group, peculiar group of marine gutless annelids, requires the detailed study of the fragmentarily explored central nervous system of vestimentiferans and other siboglinids. 3D reconstructions of the neuroanatomy of Riftia revealed that the "brain" of adult vestimentiferans is a fusion product of the supraesophageal and subesophageal ganglia. The supraesophageal ganglion-like area contains the following neural structures that are homologous to the annelid elements: the peripheral perikarya of the brain lobes, two main transverse commissures, mushroom-like structures, commissural cell cluster, and the circumesophageal connectives with two roots which give rise to the palp neurites. Three pairs of giant perikarya are located in the supraesophageal ganglion, giving rise to the paired giant axons. The circumesophageal connectives run to the VNC. The subesophageal ganglion-like area contains a tripartite ventral aggregation of perikarya (= the postoral ganglion of the VNC) interconnected by the subenteral commissure. The paired VNC is intraepidermal, not ganglionated over most of its length, associated with the ciliary field, and comprises the giant axons. The pairs of VNC and the giant axons fuse posteriorly. Within siboglinids, the vestimentiferans are distinguished by a large and considerably differentiated brain. This reflects the derived development of the tentacle crown. The tentacles of vestimentiferans are homologous to the annelid palps based on their innervation from the dorsal and ventral roots of the circumesophageal connectives. Neuroanatomy of the vestimentiferan brains is close to the brains of Cirratuliiformia and Spionida/Sabellida, which have several transverse commissures, specific position of the giant somata (if any), and palp nerve roots (if any). The palps and palp neurite roots originally developed in all main annelid clades (basally branching, errantian and sedentarian annelids), show the greatest diversity in their number in sedentarian species. Over the course of evolution of Sedentaria, the number of palps and their nerve roots either dramatically increased (as in vestimentiferan siboglinids) or were lost.	[Rimskaya-Korsakova, Nadezhda N.; Malakhov, Vladimir V.] Lomonosov Moscow State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia; [Galkin, Sergey, V] Russian Acad Sci, Shirshov Inst Oceanol, Lab Ocean Benth Fauna, Moscow, Russia; [Malakhov, Vladimir V.] Far Eastern Fed Univ, Vladivostok, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Shirshov Institute of Oceanology; Far Eastern Federal University	Rimskaya-Korsakova, NN (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia.	nadezdarkorsakova@gmail.com	Galkin, Sergey/ABB-9941-2020; Rimskaya-Korsakova, Nadezhda/N-1087-2016	Rimskaya-Korsakova, Nadezhda/0000-0001-9576-2435	Russian Science Foundation [18-14-00141]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the Russian Science Foundation, #18-14-00141, http://rscf.ru/en.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AC, 2004, CAN J ZOOL, V82, P980, DOI 10.1139/Z04-049; Andrade SCS, 2015, MOL BIOL EVOL, V32, P2860, DOI 10.1093/molbev/msv157; BAKKE T, 1977, SARSIA, V63, P65, DOI 10.1080/00364827.1977.10411323; BAKKE T, 1974, SARSIA, P57; Beckers P, 2015, GFBS; Bright M, 2013, ORG DIVERS EVOL, V13, P163, DOI 10.1007/s13127-012-0117-z; Brinkmann N, 2008, EVOL DEV, V10, P606, DOI 10.1111/j.1525-142X.2008.00275.x; Brinkmann N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-270; BUBKO O V, 1972, Zoologicheskii Zhurnal, V51, P1288; BUBKO OV, 1981, ZOOL ZH, V60, P1749; BUBKO OV, 1977, ZOOL ZH, V56, P1277; Bullock T, 1965, ANNELIDA, V1, P661; de Quatrefages A., 1850, ANN SCI NAT ZOOL, P329; Eichinger I, 2013, ORG DIVERS EVOL, V13, P311, DOI 10.1007/s13127-012-0121-3; Faller S, 2012, ZOOMORPHOLOGY, V131, P149, DOI 10.1007/s00435-012-0150-7; Fofanova EG, 2014, RUSS J MAR BIOL+, V40, P43, DOI 10.1134/S1063074014010040; Gardiner Stephen L., 1993, P371; Gelder SR, 1976, T MICROSC SOC JSTOR, P156; Golding D, 1992, MICROSCOPIC ANATOMY, V7, P1; GUPTA B L, 1970, Tissue and Cell, V2, P637, DOI 10.1016/S0040-8166(70)80035-0; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Helm C, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0280-y; Helm C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0690-4; Hessling R, 2002, J MORPHOL, V252, P100, DOI 10.1002/jmor.1093; Hessling R, 2002, ZOOMORPHOLOGY, V121, P221, DOI 10.1007/s00435-002-0059-7; Heuer CM, 2008, CELL TISSUE RES, V331, P713, DOI 10.1007/s00441-007-0535-y; Heuer CM, 2009, ZOOMORPHOLOGY, V128, P219, DOI 10.1007/s00435-008-0063-7; Heuer CM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-13; IVANOV A. V., 1958, ZOOL ZHUR, V37, P1682; IVANOV AV, 1963, POGONOPHORA; Jones M., 1985, B BIOL SOC WASH, V6, P117; JONES ML, 1968, BIOL BULL, V134, P272, DOI 10.2307/1539604; JONES ML, 1989, BIOL BULL, V177, P254, DOI 10.2307/1541941; JONES ML, 1988, P BIOL SOC WASH, V101, P423; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; Karaseva NP, 2016, BIOL BULL+, V43, P937, DOI 10.1134/S1062359016090132; Karaseva NP, 2012, RUSS J MAR BIOL+, V38, P10, DOI 10.1134/S1063074012010075; Kerbl A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0181-x; Koza A, 2006, J COMP NEUROL, V497, P451, DOI 10.1002/cne.21008; Li YN, 2017, ZOOL SCR, V46, P200, DOI 10.1111/zsc.12201; LIWANOW N A, 1967, Biologisches Zentralblatt, V86, P177; Loesel R, 2010, ACTA ZOOL-STOCKHOLM, V91, P29, DOI 10.1111/j.1463-6395.2009.00422.x; Malakhov V. V., 1996, Biologiya Morya (Vladivostok), V22, P139; Mamkaev Yu. V., 1999, Biologiya Morya (Vladivostok), V25, P372; Meyer NP, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0108-y; Miyamoto N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055151; Muller MCM, 2006, INTEGR COMP BIOL, V46, P125, DOI 10.1093/icb/icj017; Muller MCM, 2004, J COMP NEUROL, V471, P49, DOI 10.1002/cne.20022; NICOL J. A. COLIN, 1948, QUART REV BIOL, V23, P291, DOI 10.1086/396594; Orrhage L, 1998, ACTA ZOOL-STOCKHOLM, V79, P215, DOI 10.1111/j.1463-6395.1998.tb01160.x; ORRHAGE L, 1990, ACTA ZOOL-STOCKHOLM, V71, P45, DOI 10.1111/j.1463-6395.1990.tb01180.x; ORRHAGE L, 1980, ZOOMORPHOLOGY, V96, P113, DOI 10.1007/BF00310081; ORRHAGE L, 1995, ACTA ZOOL-STOCKHOLM, V76, P229, DOI 10.1111/j.1463-6395.1995.tb00996.x; ORRHAGE L, 1974, Z MORPHOL TIERE, V79, P1, DOI 10.1007/BF00298840; ORRHAGE L, 1967, ARK ZOOL, V19, P99; Purschke G, 2002, ORG DIVERS EVOL, V2, P181, DOI 10.1078/1439-6092-00042; Purschke G, 1997, ACTA ZOOL-STOCKHOLM, V78, P123, DOI 10.1111/j.1463-6395.1997.tb01133.x; PURSCHKE G, 1993, ZOOMORPHOLOGY, V113, P1, DOI 10.1007/BF00430973; Purschke G., 2016, STRUCTURE EVOLUTION, P748; Quiroga SY, 2015, GENET MOL BIOL, V38, P233, DOI 10.1590/S1415-475738320150013; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rimskaya-Korsakova N N, 2010, Dokl Biol Sci, V433, P257, DOI 10.1134/S001249661004006X; Rimskaya-Korsakova N.N., 2016, FRONTIERS ZOOLOGY, V13, P1; Roskin GI, 1957, METHODS MICROSCOPY; Rouse GW, 2018, ZOOTAXA, V4377, P451, DOI 10.11646/zootaxa.4377.4.1; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Rousset V, 2004, CLADISTICS, V20, P518, DOI 10.1111/j.1096-0031.2004.00039.x; Schulze A, 2003, HYDROBIOLOGIA, V496, P199, DOI 10.1023/A:1026192715095; Schulze A, 2003, ZOOL SCR, V32, P321, DOI 10.1046/j.1463-6409.2003.00119.x; Selivanova RV., 1997, DOKL BIOL SCI, V354, P257; Shigeno S, 2014, FRONT ZOOL, V11; Southward E.C., 1975, Zeitschrift Zool Syst EvolForsch, V13, P64; Southward EC, 2005, HYDROBIOLOGIA, P535; Southward EC, 1961, OCEANOGR GEOL GEB VE, V25, P1; Southward Eve C., 1993, P327; Starunov VV, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0211-3; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Struck TH, 2015, CURR BIOL, V25, P1993, DOI 10.1016/j.cub.2015.06.007; USCHAKOW P., 1933, ZOOL ANZ, V104, P205; van der Land J., 1975, Z ZOOL SYST EVOL, V1, P86, DOI DOI 10.1126/SCIENCE.1064574; VANDERLAND J, 1977, BIOL SKR DAN VID SEL, V21, P1; Voronezhskaya EE, 2003, J COMP NEUROL, V455, P299, DOI 10.1002/cne.10488; Vortsepneva E, 2009, ZOOSYMPOSIA, V2, P437, DOI 10.11646/zoosymposia.2.1.31; Webb M., 1977, Zoologische Jb (Anat), V97, P455; WEBB M, 1969, B MAR SCI, V19, P18; WEBB MICHAEL, 1964, SARSIA, V15, P33; Weidhase M, 2015, ZOOL LETT BIOMED CEN, V1, P1; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Wilkens V, 2009, INVERTEBR BIOL, V128, P46, DOI 10.1111/j.1744-7410.2008.00145.x; Worsaae K, 2010, J MORPHOL, P271; Worsaae K, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0639-7; Zhadan A, 2015, ZOOMORPHOLOGY, V134, P509, DOI 10.1007/s00435-015-0282-7; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	97	1	1	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0198271	10.1371/journal.pone.0198271	http://dx.doi.org/10.1371/journal.pone.0198271			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543637	gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500001
J	Wang, SH; Zhang, XL; Hassan, MA; Chen, Q; Li, CK; Tang, ZG; Wang, YJ				Wang, Shuhan; Zhang, Xiaoli; Hassan, Mohammed Abdelmanan; Chen, Qi; Li, Chaokui; Tang, Zhiguang; Wang, Yanjun			QuickBird image-based estimation of tree stand density using local maxima filtering method: A case study in a Beijing forest	PLOS ONE			English	Article							MULTISPECTRAL IMAGERY; TEXTURE ANALYSIS; AIRBORNE; CLASSIFICATION; ATTRIBUTES; EXTRACTION; PARAMETERS; INVENTORY; DIVERSITY; LOCATIONS	The stand density of trees affects stand growth and is useful for estimating other forests structure parameters. We studied tree stand density in Jiufeng National Forest Park in Beijing. The number of spectral local maxima points (NSLMP) calculated within each sample plot was extracted by the spectral maximum filtering method using QuickBird imagery. Regression analysis of NSLMP and the true stand density collected by ground measurements using differential GPS and the total station were used to estimate stand density of the study area. We used NSLMP as an independent variable and the actual stand density as the dependent variable to develop separate statistical models for all stands in the coniferous forest and broadleaf forest. By testing the different combination of Normalized Difference Vegetation Index (NDVI) thresholds and window sizes, the optimal selection was identified. The combination of a 3 x 3 window size and NDVI >= 0.3 threshold in coniferous forest produced the best result using near-infrared band (coniferous forest R-2 = 0.79, RMSE = 12.60). The best combination for broadleaf forest was a 3 x 3 window size and NDVI >= 0.1 with R-2 = 0.44, RMSE = 9.02 using near-infrared band. The combination of window size and NDVI threshold for all unclassified forest was 3 x 3 window size and NDVI >= 0.3 with R-2 = 0.70, RMSE = 11.20 using near-infrared band. A stand density planning map was constructed using the best models applied for different forest types. Different forest types require the use of different combination strategies to best extract the stand density by using the local maximum (LM). The proposed method uses a combination of high spatial resolution imagery and sampling plots strategy to estimate stand density.	[Wang, Shuhan; Zhang, Xiaoli; Hassan, Mohammed Abdelmanan] Beijing Forestry Univ, Forestry Coll, Key Lab Precis Forestry, Beijing, Peoples R China; [Wang, Shuhan; Li, Chaokui; Tang, Zhiguang; Wang, Yanjun] Hunan Univ Sci & Technol, Natl Local Joint Engn Lab Geospatial Informat Tec, Xiangtan, Hunan, Peoples R China; [Chen, Qi] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA	Beijing Forestry University; Hunan University of Science & Technology; University of Hawaii System; University of Hawaii Manoa	Zhang, XL (corresponding author), Beijing Forestry Univ, Forestry Coll, Key Lab Precis Forestry, Beijing, Peoples R China.	zhang-xl@263.net	Wang, Yanjun/M-4014-2019	Wang, Yanjun/0000-0002-3317-6518; Zhang, Xiaoli/0000-0001-7443-1557	National Key R&D Program of China [2017YFD0600902]; National Natural Science Foundation of China [41771462]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Key R&D Program of China (2017YFD0600902) and the National Natural Science Foundation of China (Grant No. 41771462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2008, REMOTE SENS ENVIRON, V112, P1856, DOI 10.1016/j.rse.2007.09.009; Bozic M., 2005, Croatian Journal of Forest Engineering, V26, P91; Breidenbach J, 2008, CAN J FOREST RES, V38, P1611, DOI 10.1139/X07-237; Chopping M, 2011, REMOTE SENS LETT, V2, P21, DOI 10.1080/01431161.2010.486805; Foody GM, 2006, ECOL MODEL, V195, P37, DOI 10.1016/j.ecolmodel.2005.11.007; Gillespie TR, 2008, AM J PRIMATOL, V70, P222, DOI 10.1002/ajp.20475; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Gougeon F. A., 1995, CAN J REMOTE SENS, V21, P1, DOI [10.1080/07038992.1995.10874590, DOI 10.1080/07038992.1995.10874590]; Gougeon FA, 1999, P INT FOR AUT INT HI; Gougeon FA, 1997, P 3 INT AIRB REM SEN; Haywood A, 2011, AUST FORESTRY, V74, P13, DOI 10.1080/00049158.2011.10676341; Hirata Y, 2008, J FOREST RES-JPN, V13, P147, DOI 10.1007/s10310-008-0059-7; Hoja D., 2008, INT ARCH PHOTOGRAMME, P1617; Kayitakire F, 2006, REMOTE SENS ENVIRON, V102, P390, DOI 10.1016/j.rse.2006.02.022; Klobucar D, 2008, CROAT J FOR ENG, V29, P201; Levesque J, 2003, REMOTE SENS ENVIRON, V84, P589, DOI 10.1016/S0034-4257(02)00182-7; Lu DS, 2010, PHOTOGRAMM ENG REM S, V76, P1159, DOI 10.14358/PERS.76.10.1159; Mallinis G, 2008, ISPRS J PHOTOGRAMM, V63, P237, DOI 10.1016/j.isprsjprs.2007.08.007; Maltamo M, 2009, SILVA FENN, V43, P507, DOI 10.14214/sf.203; McCombs JW, 2003, FOREST SCI, V49, P457; MCROBERTS RE, 1994, CAN J FOREST RES, V24, P1766, DOI 10.1139/x94-228; Nelson T, 2005, J ENVIRON MANAGE, V74, P265, DOI 10.1016/j.jenvman.2004.10.002; OMULE SAY, 1980, FOREST CHRON, V56, P222, DOI 10.5558/tfc56222-5; Ota T, 2011, J FOREST RES-JPN, V16, P432, DOI 10.1007/s10310-010-0233-6; Ozdemir I, 2008, SENSORS-BASEL, V8, P4709, DOI 10.3390/s8084709; Ozdemir I, 2011, INT J APPL EARTH OBS, V13, P701, DOI 10.1016/j.jag.2011.05.006; Pasher J, 2010, REMOTE SENS ENVIRON, V114, P1718, DOI 10.1016/j.rse.2010.03.005; Peuhkurinen J, 2011, CAN J FOREST RES, V41, P583, DOI 10.1139/X10-223; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Rocchini D, 2009, INT J REMOTE SENS, V30, P2705, DOI 10.1080/01431160902755312; Sun FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097723; Tao CV, 2001, PHOTOGRAMM ENG REM S, V67, P1347; Wang H, 2005, INT J REMOTE SENS, V26, P1893, DOI 10.1080/01431160512331326684; Wu JA, 2010, SPECTROSC SPECT ANAL, V30, P2533, DOI 10.3964/j.issn.1000-0593(2010)09-2533-04; Wulder M, 2002, CAN J REMOTE SENS, V28, P621, DOI 10.5589/m02-059; Wulder M, 2000, REMOTE SENS ENVIRON, V73, P103, DOI 10.1016/S0034-4257(00)00101-2; Wulder MA, 2004, INT J REMOTE SENS, V25, P2225, DOI 10.1080/01431160310001659252	37	1	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208256	10.1371/journal.pone.0208256	http://dx.doi.org/10.1371/journal.pone.0208256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543639	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500017
J	Wiesweg, M; Kasper, S; Worm, K; Herold, T; Reis, H; Sara, L; Metzenmacher, M; Abendroth, A; Darwiche, K; Aigner, C; Wedemeyer, HH; Helfritz, FA; Stuschke, M; Schumacher, B; Markus, P; Paul, A; Rahmann, S; Schmid, KW; Schuler, M				Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner H.; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt W.; Schuler, Martin			Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer	ONCOGENE			English	Article							SIDED COLON-CANCER; DNA-DAMAGE; KRAS MUTATIONS; BRAF MUTANTS; ADENOCARCINOMA; SENSITIVITY; EGFR; CHEMOTHERAPY; MECHANISMS; INHIBITION	Mutated RAS onco-proteins are key drivers across many cancers. The distribution of somatic RAS mutations varies between cancer entities. Retrospective analyses have associated some RAS mutations with distinct clinical outcomes. However, the clinical impact of the full spectrum of RAS mutations in their disease contextuality remains to be defined. To improve upon this situation, we studied genomically and clinically annotated, prospectively recruited cohorts of patients with RAS-mutated metastatic lung cancer and colorectal cancer. Mutational spectra were compared with predictions derived from analyzing the mutagenic impact at the genome level for each entity. Interestingly, we found concordance of predicted signatures with those actually observed in our patients. Thus, composition of the functionally active RAS mutational subtypes is primarily determined by the mutagenic context. Most RAS mutations seemed dominant oncogenic drivers with entity-dependent clinical outcomes. RAS comutations were enriched in tumors harboring class 2/3 BRAF mutations, highlighting the functional dependency of some mutated BRAF isoforms on RAS. With our dataset, we established a probabilistic model for cross-entity comparison of the prognostic impact of specific RAS mutational subtypes. The resulting prognostic clusters showed largely consistent clinical categorizations in both entities. This suggests mutant subtype-specific functional properties leading to similar clinical effects. A notable exception is KRAS G12C, which imparted an adverse prognosis only in colorectal cancer. Our findings provide a framework for risk stratification of specific RAS mutations across several cancer entities, which is required to guide the analysis of clinical findings in patients treated with direct RAS inhibitors or agents targeting downstream pathways.	[Wiesweg, Marcel; Kasper, Stefan; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Schuler, Martin] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol, Hufelandstr 55, D-45122 Essen, Germany; [Wiesweg, Marcel; Rahmann, Sven] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Genome Informat, Hufelandstr 55, D-45122 Essen, Germany; [Kasper, Stefan; Stuschke, Martin; Schmid, Kurt W.; Schuler, Martin] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, Hufelandstr 55, D-45122 Essen, Germany; [Worm, Karl; Herold, Thomas; Reis, Henning; Schmid, Kurt W.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Inst Pathol, Hufelandstr 55, D-45122 Essen, Germany; [Darwiche, Kaid] Univ Duisburg Essen, Ruhrlandklin Univ Hosp Essen, Sect Intervent Pneumol, Dept Pulm Med, Tuschener Weg 40, D-45239 Essen, Germany; [Aigner, Clemens] Univ Duisburg Essen, Ruhrlandklin Univ Hosp Essen, Dept Thorac Surg & Endoscopy, Tuschener Weg 40, D-45239 Essen, Germany; [Wedemeyer, Heiner H.] Univ Duisburg Essen, Dept Gastroenterol & Hepatol, West German Canc Ctr, Univ Hosp Essen, Hufelandstr 55, D-45122 Essen, Germany; [Helfritz, Fabian A.; Paul, Andreas] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Gen Visceral & Transplantat Surg, Hufelandstr 55, D-45122 Essen, Germany; [Stuschke, Martin] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Radiotherapy, Hufelandstr 55, D-45122 Essen, Germany; [Schumacher, Brigitte] Elisabeth Hosp Essen, Dept Gastroenterol, Klara Kopp Weg 1, D-45138 Essen, Germany; [Markus, Peter] Elisabeth Hosp Essen, Dept Gen Visceral & Trauma Surg, Klara Kopp Weg 1, D-45138 Essen, Germany; [Schuler, Martin] Univ Duisburg Essen, Ruhrlandklin Univ Hosp Essen, Div Thorac Oncol, Tuschener Weg 40, D-45239 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Schuler, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol, Hufelandstr 55, D-45122 Essen, Germany.; Schuler, M (corresponding author), Partner Site Univ Hosp Essen, German Canc Consortium DKTK, Hufelandstr 55, D-45122 Essen, Germany.; Schuler, M (corresponding author), Univ Duisburg Essen, Ruhrlandklin Univ Hosp Essen, Div Thorac Oncol, Tuschener Weg 40, D-45239 Essen, Germany.	martin.schuler@uk-essen.de	Reis, Henning/AAX-9545-2020; Aigner, Clemens/A-7284-2019; Kasper, Stefan/I-4521-2015	Reis, Henning/0000-0003-1373-5295; Aigner, Clemens/0000-0002-7787-991X; Kasper, Stefan/0000-0002-5947-8733; Wiesweg, Marcel/0000-0002-9698-9559	Oncology Center of Excellence Program of the Deutsche Krebshilfe [110534]; German Federal government via the German Cancer Consortium (DKTK); Novartis Pharma AG; Medical Faculty of the University Duisburg-Essen (IFORES fellowship); North Rhine-Westphalian State government via the German Cancer Consortium (DKTK)	Oncology Center of Excellence Program of the Deutsche Krebshilfe; German Federal government via the German Cancer Consortium (DKTK); Novartis Pharma AG; Medical Faculty of the University Duisburg-Essen (IFORES fellowship); North Rhine-Westphalian State government via the German Cancer Consortium (DKTK)	This work was supported by the Oncology Center of Excellence Program of the Deutsche Krebshilfe (grant number 110534); the German Federal and North Rhine-Westphalian State governments via the German Cancer Consortium (DKTK); Novartis Pharma AG (research grant); the Medical Faculty of the University Duisburg-Essen (IFORES fellowship to M.W.). The funding sources had no influence on the analysis and interpretation of data, and contents of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Arnold D, 2017, ANN ONCOL, V28, P1713, DOI 10.1093/annonc/mdx175; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Blons H, 2014, ANN ONCOL, V25, P2378, DOI 10.1093/annonc/mdu464; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Castellucci E, 2017, ONCOLOGIST, V22, P497, DOI 10.1634/theoncologist.2017-0034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cserepes M, 2014, EUR J CANCER, V50, P1819, DOI 10.1016/j.ejca.2014.04.001; Deihimi S, 2017, ONCOTARGET, V8, P39945, DOI 10.18632/oncotarget.18098; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dion V, 2014, TRENDS GENET, V30, P220, DOI 10.1016/j.tig.2014.04.005; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guerrero S, 2000, CANCER RES, V60, P6750; Haigis KM, 2017, TRENDS CANCER, V3, P686, DOI 10.1016/j.trecan.2017.08.006; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jones JC, 2017, J CLIN ONCOL, V35, P2624, DOI 10.1200/JCO.2016.71.4394; Jones RP, 2017, BRIT J CANCER, V116, P923, DOI 10.1038/bjc.2017.37; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com; Kerner GSMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070346; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Kwak MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007882; Lans H, 2015, DNA REPAIR, V32, P141, DOI 10.1016/j.dnarep.2015.04.025; Larki P, 2017, CELL J, V19, P113, DOI 10.22074/cellj.2017.5123; Lee GH, 2015, EJSO-EUR J SURG ONC, V41, P300, DOI 10.1016/j.ejso.2014.11.001; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Messner I, 2013, J CANCER RES CLIN, V139, P201, DOI 10.1007/s00432-012-1319-7; Metro G, 2012, LUNG CANCER, V78, P81, DOI 10.1016/j.lungcan.2012.06.005; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Oh Bo-Young, 2011, J Korean Soc Coloproctol, V27, P127, DOI 10.3393/jksc.2011.27.3.127; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Ostrow SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21927; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Petrelli F, 2017, JAMA ONCOL, V3, P211, DOI 10.1001/jamaoncol.2016.4227; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shepherd FA, 2013, J CLIN ONCOL, V31, P2173, DOI 10.1200/JCO.2012.48.1390; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Takamochi K, 2013, ONCOL LETT, V6, P1207, DOI 10.3892/ol.2013.1551; Tejpar S, 2017, JAMA ONCOL, V3, P194, DOI 10.1001/jamaoncol.2016.3797; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Toyooka S, 2007, CLIN CANCER RES, V13, P3431, DOI 10.1158/1078-0432.CCR-07-0070; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Vittal A, 2017, CASE REP ONCOL MED, V2017, DOI 10.1155/2017/2321052; Wiesweg M, 2018, CLIN COLORECTAL CANC, V17, pE331, DOI 10.1016/j.clcc.2018.02.003; Wiesweg M, 2017, J THORAC ONCOL, V12, P54, DOI 10.1016/j.jtho.2016.08.137; Wiesweg M, 2013, EUR J CANCER, V49, P3076, DOI 10.1016/j.ejca.2013.06.014; Xing KL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0036-2; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yu HA, 2015, J THORAC ONCOL, V10, P431, DOI 10.1097/JTO.0000000000000432; Zhao H, 2014, ELIFE, V3, DOI 10.7554/eLife.02725; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	66	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					2953	2966		10.1038/s41388-018-0634-0	http://dx.doi.org/10.1038/s41388-018-0634-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30568222				2022-12-26	WOS:000465167600006
J	Liang, XT; Ding, Y; Lin, F; Zhang, YL; Zhou, XH; Meng, QS; Lu, XY; Jiang, GJ; Zhu, HM; Chen, Y; Lian, QZ; Fan, HM; Liu, ZM				Liang, Xiaoting; Ding, Yue; Lin, Fang; Zhang, Yuelin; Zhou, Xiaohui; Meng, Qingshu; Lu, Xingyue; Jiang, Guojun; Zhu, Hongming; Chen, Yu; Lian, Qizhou; Fan, Huimin; Liu, Zhongmin			Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways	FASEB JOURNAL			English	Article						MSC; aging; myocardial infarction	HEART; TRANSPLANTATION; PROLIFERATION; EXPRESSION; ISCHEMIA; EFFICACY; ROS	The age-related functional exhaustion limits potential efficacy of mesenchymal stem cells (MSC) in treating cardiovascular disease. Therefore, rejuvenation of aged MSC in the elderly population is of great interest. We have previously reported that Erb-B2 receptor tyrosine kinase 4 (ERBB4) plays a critical role in regulating MSC survival under hypoxia. The aim of this study was to investigate whether ERBB4 rejuvenates aged MSC and how ERBB4 enhances therapeutic efficacy of aged MSC in treating myocardial infarction (MI). Compared with vector aged MSC (aged-MSC), ERBB4-engineered aged MSC (ER4-aged-MSC) conferred resistance to oxidative stress-induced cell death and ameliorated the senescent phenotype in vitro. Four weeks after MI, the ER4-aged-MSC group exhibited enhanced blood vessel density, reduced cardiac remodeling and apoptosis with improved heart function compared with the aged-MSC group. Overexpression of ERBB4 caused an increase in phosphorylated v-akt murine thymoma viral oncogene homolog 1 (AKT), and phosphorylated ERK expression under hypoxia. ER4-aged-MSC secreted higher levels of angiopoietin, epithelial neutrophil activating peptide 78, VEGF, and fibroblast growth factor 2, and enhanced tube formation in HUVEC. The impact of ERBB4 on protein expression, proangiogenesis, cell behavior, and cytokine secretion was abolished by inhibiting PI3K/AKT and MAPK/ERK signaling pathway.Liang, X., Ding, Y., Lin, F., Zhang, Y., Zhou, X., Meng, Q., Lu, X., Jiang, G., Zhu, H., Chen, Y., Lian, Q., Fan, H., Liu, Z. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways.	[Liang, Xiaoting; Lin, Fang; Zhou, Xiaohui; Meng, Qingshu; Zhu, Hongming] Tongji Univ, Sch Med, Shanghai East Hosp, Clin Translat Med Res Ctr, Shanghai, Peoples R China; [Liang, Xiaoting; Zhu, Hongming; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai, Peoples R China; [Ding, Yue; Chen, Yu] Second Mil Med Univ, Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Zhang, Yuelin] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuelin; Lu, Xingyue; Jiang, Guojun] Bengbu Med Coll, Fac Pharm, Bengbu, Peoples R China; [Zhang, Yuelin; Lian, Qizhou] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China	Tongji University; Tongji University; Tongji University; Naval Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Bengbu Medical College; University of Hong Kong	Liang, XT; Fan, HM (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Shanghai, Peoples R China.	liangxt@tongji.edu.cn; frankfan@tongji.edu.cn	Zhang, Yuelin/C-4569-2009; Lian, Qizhou/Y-1613-2019	Zhang, Yuelin/0000-0002-0065-1116	National Natural Science Foundation of China [81500207, 81670458, 81600282]; Program for Young Excellent Talents of Tongji University [2015KJ073]; National Key Research and Development Program of China [2017YFA0105600]; Shanghai Sailing Program [16YF1409500]; Health industry Project of Pudong Health Bureau of Shanghai [PW2013E-1]; Shanghai Municipal Health and Family Planning Commission [(2018-2020)-FWTX-2007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Young Excellent Talents of Tongji University; National Key Research and Development Program of China; Shanghai Sailing Program; Health industry Project of Pudong Health Bureau of Shanghai; Shanghai Municipal Health and Family Planning Commission	The authors thank Ying Lu (Clinical Translational Medical Research Center, Shanghai East Hospital, Shanghai) for excellent technical assistance. This work was supported by the National Natural Science Foundation of China (Grants 81500207 to X.L.; 81670458 to X.Z.; and 81600282 to H.Z.), the Program for Young Excellent Talents of Tongji University (2015KJ073), the National Key Research and Development Program of China (2017YFA0105600), the Shanghai Sailing Program (16YF1409500), the Health industry Project of Pudong Health Bureau of Shanghai (PW2013E-1), and the Shanghai Municipal Health and Family Planning Commission [ZY(2018-2020)-FWTX-2007]. The authors declare no conflicts of interest.	An Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0082-8; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Charif N, 2017, BIO-MED MATER ENG, V28, pS57, DOI 10.3233/BME-171624; Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183; Denu RA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5841716; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao LR, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0399-z; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Heusch G, 2016, CIRC RES, V119, P194, DOI 10.1161/CIRCRESAHA.116.308925; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Liang HL, 2013, EUR HEART J, V34, P1681, DOI 10.1093/eurheartj/ehr131; Liang X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.91; Liu XB, 2014, J HEART LUNG TRANSPL, V33, P1083, DOI 10.1016/j.healun.2014.05.008; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Porrello ER, 2010, CIRC RES, V107, P1292, DOI 10.1161/CIRCRESAHA.110.235168; Rodrigo SF, 2013, J CARDIOVASC TRANSL, V6, P816, DOI 10.1007/s12265-013-9507-7; Shakeri H, 2018, CARDIOVASC RES, V114, P1041, DOI 10.1093/cvr/cvy059; Turinetto V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071164; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x; Zhang YL, 2017, EXP CELL RES, V356, P74, DOI 10.1016/j.yexcr.2017.04.012; Zhang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11235	33	58	59	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4559	4570		10.1096/fj.201801690R	http://dx.doi.org/10.1096/fj.201801690R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566395	Bronze			2022-12-26	WOS:000459794800116
J	Yu, XC; Hu, YF; Ding, J; Li, HW; Jin, CW				Yu, Xing-Chi; Hu, Yunfei; Ding, Jienv; Li, Hongwei; Jin, Changwen			Structural basis and mechanism of the unfolding-induced activation of HdeA, a bacterial acid response chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; nuclear magnetic resonance (NMR); protein dynamic; intrinsically disordered protein; protein structure; protein-protein interaction; acid resistance; conditional disorder	DISORDERED PROTEINS; PERIPLASMIC PROTEIN; INTRINSIC DISORDER; NMR; PH; BINDING; FLEXIBILITY; RESISTANCE; EXCHANGE; STATES	The role of protein structural disorder in biological functions has gained increasing attention in the past decade. The bacterial acid-resistant chaperone HdeA belongs to a group of conditionally disordered proteins, because it is inactive in its well-structured state and becomes activated via an order-to-disorder transition under acid stress. However, the mechanism for unfolding-induced activation remains unclear because of a lack of experimental information on the unfolded state conformation and the chaperone-client interactions. Herein, we used advanced solution NMR methods to characterize the activated-state conformation of HdeA under acidic conditions and identify its client-binding sites. We observed that the structure of activated HdeA becomes largely disordered and exposes two hydrophobic patches essential for client interactions. Furthermore, using the pH-dependent chemical exchange saturation transfer (CEST) NMR method, we identified three acid-sensitive regions that act as structural locks in regulating the exposure of the two client-binding sites during the activation process, revealing a multistep activation mechanism of HdeA's chaperone function at the atomic level. Our results highlight the role of intrinsic protein disorder in chaperone function and the self-inhibitory role of ordered structures under nonstress conditions, offering new insights for improving our understanding of protein structure-function paradigms.	[Yu, Xing-Chi; Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yu, Xing-Chi; Hu, Yunfei; Ding, Jienv; Li, Hongwei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ding, Jienv; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Ding, Jienv] NIH, Dept Hlth & Human Serv, 1050 Boyles St, Frederick, MD 21702 USA	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; National Institutes of Health (NIH) - USA	Hu, YF (corresponding author), Soochow Univ, Med Coll, Suzhou 215123, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Coll Chem & Mol Engn, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei_hu@suda.edu.cn; changwen@pku.edu.cn	Yu, Xing-Chi/AAO-2375-2020		National Key R&D Program of China [2016YFA0501201]; National Natural Science Foundation of China [31370718]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2016YFA0501201 from the National Key R&D Program of China (to C. J.) and Grant 31370718 from the National Natural Science Foundation of China (to Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlstrom LS, 2015, J MOL BIOL, V427, P1670, DOI 10.1016/j.jmb.2015.01.002; Ahlstrom LS, 2013, J PHYS CHEM B, V117, P13219, DOI 10.1021/jp403264s; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Burmann BM, 2015, PROG NUCL MAG RES SP, V86-87, P41, DOI 10.1016/j.pnmrs.2015.02.004; Crowley PB, 2012, CHEM COMMUN, V48, P10681, DOI 10.1039/c2cc35347d; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickson A, 2016, J COMPUT CHEM, V37, P587, DOI 10.1002/jcc.24004; Ding JN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16856; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Garrison MA, 2014, PROTEIN SCI, V23, P167, DOI 10.1002/pro.2402; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Hingorani KS, 2013, P NATL ACAD SCI USA, V110, P5279, DOI 10.1073/pnas.1303297110; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Marin M, 2013, PLANT CELL, V25, P3153, DOI 10.1105/tpc.113.116319; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Salmon L, 2018, J MOL BIOL, V430, P33, DOI 10.1016/j.jmb.2017.11.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Socher E, 2016, J PHYS CHEM B, V120, P11845, DOI 10.1021/acs.jpcb.6b06091; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Toth-Petroczy A, 2016, CELL, V167, P158, DOI 10.1016/j.cell.2016.09.010; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang F, 1998, NAT STRUCT BIOL, V5, P763, DOI 10.1038/1796; Yu BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34171; Yu XC, 2017, BIOCHEMISTRY-US, V56, P5748, DOI 10.1021/acs.biochem.7b00724; Yuwen TR, 2017, J BIOMOL NMR, V67, P295, DOI 10.1007/s10858-017-0104-y; Zhai ZN, 2016, CHEM SCI, V7, P2222, DOI 10.1039/c5sc04297f; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zhang S, 2016, P NATL ACAD SCI USA, V113, P10872, DOI 10.1073/pnas.1606360113	52	10	12	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3192	3206		10.1074/jbc.RA118.006398	http://dx.doi.org/10.1074/jbc.RA118.006398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30573682	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000464980100018
J	Sharpe, LJ; Howe, V; Scott, NA; Luu, W; Phan, L; Berk, JM; Hochstrasser, M; Brown, AJ				Sharpe, Laura J.; Howe, Vicky; Scott, Nicola A.; Luu, Winnie; Phan, Lisa; Berk, Jason M.; Hochstrasser, Mark; Brown, Andrew J.			Cholesterol increases protein levels of the E3 ligase MARCH6 and thereby stimulates protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein stability; E3 ubiquitin ligase; protein degradation; post-transcriptional regulation; cholesterol; proteasome; INSIG-2; RGS2; squalene monooxygenase; TEB4; Type 2 iodothyronine deiodinase	STEROL-SENSING DOMAIN; PICK C1 PROTEIN; UBIQUITIN LIGASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SQUALENE MONOOXYGENASE; DEPENDENT UBIQUITINATION; ENDOPLASMIC-RETICULUM; MEDIATED DEGRADATION; MEMBRANE TOPOLOGY; BINDING	The E3 ligase membrane-associated ring-CH-type finger 6 (MARCH6) is a polytopic enzyme bound to the membranes of the endoplasmic reticulum. It controls levels of several known protein substrates, including a key enzyme in cholesterol synthesis, squalene monooxygenase. However, beyond its own autodegradation, little is known about how MARCH6 itself is regulated. Using CRISPR/Cas9 gene-editing, MARCH6 overexpression, and immunoblotting, we found here that cholesterol stabilizes MARCH6 protein endogenously and in HEK293 cells that stably express MARCH6. Conversely, MARCH6-deficient HEK293 and HeLa cells lost their ability to degrade squalene monooxygenase in a cholesterol-dependent manner. The ability of cholesterol to boost MARCH6 did not seem to involve a putative sterol-sensing domain in this E3 ligase, but was abolished when either membrane extraction by valosin-containing protein (VCP/p97) or proteasomal degradation was inhibited. Furthermore, cholesterol-mediated stabilization was absent in two MARCH6 mutants that are unable to degrade themselves, indicating that cholesterol stabilizes MARCH6 protein by preventing its autodegradation. Experiments with chemical chaperones suggested that this likely occurs through a conformational change in MARCH6 upon cholesterol addition. Moreover, cholesterol reduced the levels of at least three known MARCH6 substrates, indicating that cholesterol-mediated MARCH6 stabilization increases its activity. Our findings highlight an important new role for cholesterol in controlling levels of proteins, extending the known repertoire of cholesterol homeostasis players.	[Sharpe, Laura J.; Howe, Vicky; Scott, Nicola A.; Luu, Winnie; Phan, Lisa; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Berk, Jason M.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA	University of New South Wales Sydney; Yale University	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Hochstrasser, Mark/0000-0002-1131-5484; Sharpe, Laura/0000-0002-9896-294X; Howe, Vicky/0000-0002-7319-0664	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Gold Star award from UNSW Sydney; National Institutes of Health [R01 GM046904, F32 GM113456]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046904, R01GM046904, F32GM113456] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Gold Star award from UNSW Sydney; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Health and Medical Research Council Grant 1060515 (to A. J. B.), Australian Research Council Grant DP170101178 (to A. J. B.), a Gold Star award from UNSW Sydney (to A. J. B.), and in part by National Institutes of Health Grants R01 GM046904 (to M. H.) and F32 GM113456 (to J. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown A. J., 2015, BIOCH LIPIDS LIPOPRO, P327; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Cook ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172721; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Jiang LY, 2018, J BIOL CHEM, V293, P4047, DOI 10.1074/jbc.RA117.001260; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Nguyen KT, 2019, J BIOL CHEM, V294, P379, DOI 10.1074/jbc.RA118.005556; Kielar D, 2001, CLIN CHEM, V47, P2089; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Libby AE, 2018, J LIPID RES, V59, P1482, DOI 10.1194/jlr.M086249; Loregger A, 2016, MOL CELL BIOL, V36, P285, DOI 10.1128/MCB.00890-15; Miller BT, 2012, ENDOCRINOLOGY, V153, P4039, DOI 10.1210/en.2012-1117; Nakamura N, 2014, EXP CELL RES, V328, P207, DOI 10.1016/j.yexcr.2014.07.025; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang L, 2008, HEPATOLOGY, V48, P1558, DOI 10.1002/hep.22499; Wangeline MA, 2018, J BIOL CHEM, V293, P14937, DOI 10.1074/jbc.RA118.001808; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Zattas D, 2016, J BIOL CHEM, V291, P12105, DOI 10.1074/jbc.M116.726877; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zhang L, 2017, ELIFE, V6, DOI 10.7554/eLife.28766.001	58	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2436	2448		10.1074/jbc.RA118.005069	http://dx.doi.org/10.1074/jbc.RA118.005069			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545937	Green Published, hybrid			2022-12-26	WOS:000458895400020
J	Zhang, Y; Lu, J; Ma, J; Liu, XQ				Zhang, You; Lu, Jing; Ma, Jing; Liu, Xinqi			Insulin-induced gene 1 (INSIG1) inhibits HIV-1 production by degrading Gag via activity of the ubiquitin ligase TRC8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; virology; viral protein; protein degradation; protein expression; insulin-induced gene 1 (INSIG1); HIV-1 production; TRC8; Gag protein; lysosome pathway degradation; ubiquitin ligase; endosome; ring finger protein 139 (RNF139); HIV replication	LIPID RAFTS; CHOLESTEROL-SYNTHESIS; INNATE IMMUNITY; DEGRADATION; PROTEIN; BINDING; TARGET; REPLICATION; METABOLISM; REGULATOR	Insulin-induced gene 1 (INSIG1) regulates sterol synthesis by mediating the activation of sterol regulatory element-binding protein (SREBP) and the degradation of the HMG-CoA reductase (HMGCR). INSIG1 is up-regulated during HIV-1 infection, but its role in HIV-1 infection is unknown. In this report, using pseudovirus production, protein overexpression, and gene knockouts, we found that INSIG1 inhibits HIV-1 production by accelerating the degradation of the HIV-1 Gag protein. Unlike the degradation of HMGCR via the E3 ubiquitin ligase autocrine motility factor receptor (AMFR), a process that depends on the proteasome, INSIG1 coordinated with another ligase, translocation in renal carcinoma chromosome 8 (TRC8), and promoted Gag degradation through the lysosome pathway. We conclude that INSIG1 functions as a sentinel responsive to HIV-1 production and inhibits HIV-1 replication by degrading Gag, a process occurring at intracellular membrane sites such as the endoplasmic reticulum and endosomes where both INSIG1 and Gag may be located.	[Zhang, You; Lu, Jing; Ma, Jing; Liu, Xinqi] Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Liu, XQ (corresponding author), Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China.	liu2008@nankai.edu.cn	Zhang, You/GYU-9078-2022; Ma, Jing/GQH-0676-2022	Ma, Jing/0000-0002-8096-4832; liu, xinqi/0000-0002-6045-718X; Zhang, You/0000-0002-5401-4593	Tianjin Natural Science Foundation Grant [17JCZDJC31900]; National Key Research and Development Program of China [2017YFD0200900]; Nankai University [63185024]	Tianjin Natural Science Foundation Grant; National Key Research and Development Program of China; Nankai University	Supported by Tianjin Natural Science Foundation Grant 17JCZDJC31900, National Key Research and Development Program of China Grant 2017YFD0200900, and Nankai University Intramural Funding Grant 63185024. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin 300071, China. Tel.: 86-22-23505130; E-mail: liu2008@nankai.edu.cn.	Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong Y, 2006, P NATL ACAD SCI USA, V103, P6154, DOI 10.1073/pnas.0601923103; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nayak DP, 2002, ADV VIRUS RES, V58, P1, DOI 10.1016/S0065-3527(02)58001-5; Nityanandam R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004151; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Suomalainen M, 2002, TRAFFIC, V3, P705, DOI 10.1034/j.1600-0854.2002.31002.x; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Zheng YH, 2003, P NATL ACAD SCI USA, V100, P8460, DOI 10.1073/pnas.1437453100	38	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2046	2059		10.1074/jbc.RA118.004630	http://dx.doi.org/10.1074/jbc.RA118.004630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30563842	Green Published, hybrid			2022-12-26	WOS:000459711400023
J	Cianfrani, C; Buri, A; Verrecchia, E; Guisan, A				Cianfrani, Carmen; Buri, Aline; Verrecchia, Eric; Guisan, Antoine			Generalizing soil properties in geographic space: Approaches used and ways forward	PLOS ONE			English	Article							ORGANIC-CARBON; OPTIMAL INTERPOLATION; REGIONAL-SCALE; LAND-USE; PREDICTION; MATTER; STOCKS; INFORMATION; VARIABILITY; MAPS	Soil is one of the most complex systems on Earth, functioning at the interface between the lithosphere, biosphere, hydrosphere, and atmosphere and generating a multitude of functions. Moreover, soil constitutes the belowground environment from which plants capture water and nutrients. Despite their great importance, soil properties are often not sufficiently considered in other disciplines, especially in spatial studies of plant distributions. Most soil properties are available as point data and, to be used in spatial analyses, need to be generalised over entire regions (i.e. digital soil mapping). Three categories of statistical approaches can be used for such purpose: geostatistical approaches (GSA), predictive-statistical approaches (PSA), and hybrid approaches (HA) that combine the two previous ones. How then to choose the best approach in a given soil study context? Does it depend on the soil properties to be spatialized, the study area's characteristics, and/or the availability of soil data? The main aims of this study was to review the use of these three approaches to derive maps of soil properties in relation to the soil parameters, the study area characteristics, and the number of soil samples. We evidenced that the approaches that tend to show the best performance for spatializing soil properties were not necessarily the ones most used in practice. Although PSA was the most widely used, it tended to be outperformed by HA in many cases, but the latter was far less used. However, as the study settings were not always properly described and not all situations were represented in the set of papers analysed, more comparative studies would be needed across a wider range of regions, soil properties, and spatial scales to provide robust conclusions on the best spatialization methods in a specific context.	[Cianfrani, Carmen; Buri, Aline; Verrecchia, Eric; Guisan, Antoine] Univ Lausanne UNIL, Inst Earth Surface Dynam IDYST, Lausanne, Switzerland; [Guisan, Antoine] Univ Lausanne UNIL, DEE, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Cianfrani, C (corresponding author), Univ Lausanne UNIL, Inst Earth Surface Dynam IDYST, Lausanne, Switzerland.	carmen.cianfrani@unil.ch	Guisan, Antoine/A-1057-2011; Verrecchia, Eric/O-7162-2014	Guisan, Antoine/0000-0002-3998-4815; Verrecchia, Eric/0000-0001-7105-256X	Swiss Nation Fund [26084125]	Swiss Nation Fund	Swiss Nation Fund (www.snf.ch) Grant number: 26084125 funded C.C. for this study.	Adhikari K, 2016, GEODERMA, V262, P101, DOI 10.1016/j.geoderma.2015.08.009; Ballabio C, 2012, GEODERMA, V187, P102, DOI 10.1016/j.geoderma.2012.04.002; Blum WE, 2005, REV ENV SCI BIOTECHN, V4; Brady NC, 2017, NATURE PROPERTIES SO, V15; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brevik EC, 2016, GEODERMA, V264, P256, DOI 10.1016/j.geoderma.2015.05.017; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; BURGESS TM, 1980, J SOIL SCI, V31, P333, DOI 10.1111/j.1365-2389.1980.tb02085.x; Cambule AH, 2013, GEODERMA, V192, P341, DOI 10.1016/j.geoderma.2012.08.020; Castrignano A, 2011, PEDOSPHERE, V21, P259, DOI 10.1016/S1002-0160(11)60126-4; Colombo C, 2015, GEODERMA, V239, P1, DOI 10.1016/j.geoderma.2014.09.017; de Carvalho W, 2014, GEODERMA, V232, P479, DOI 10.1016/j.geoderma.2014.06.007; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dieleman WIJ, 2013, GEODERMA, V204, P59, DOI 10.1016/j.geoderma.2013.04.005; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; Grunwald S, 2009, GEODERMA, V152, P195, DOI 10.1016/j.geoderma.2009.06.003; Guo PT, 2015, GEODERMA, V237, P49, DOI 10.1016/j.geoderma.2014.08.009; Hartemink AE, 2013, GEODERMA, V207, P256, DOI 10.1016/j.geoderma.2013.05.003; Hoffmann U, 2014, GEODERMA, V232, P270, DOI 10.1016/j.geoderma.2014.04.038; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Keskin H, 2018, GEODERMA, V326, P22, DOI 10.1016/j.geoderma.2018.04.004; Lagacherie P, 1997, INT J GEOGR INF SCI, V11, P183, DOI 10.1080/136588197242455; Lagacherie P, 2013, GEODERMA, V209, P168, DOI 10.1016/j.geoderma.2013.06.005; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Legros JP, 2006, MAPPING OF THE SOIL; Liess M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153673; Maclin R, 1997, EMPIRICAL EVALUATION; Matteodo M., 2018, THESIS; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McBratney AB, 2000, GEODERMA, V97, P293, DOI 10.1016/S0016-7061(00)00043-4; Miller BA, 2014, GEODERMA, V230, P329, DOI 10.1016/j.geoderma.2014.04.020; Minasny B, 2011, EUR J SOIL SCI, V62, P728, DOI 10.1111/j.1365-2389.2011.01386.x; Minasny B, 2016, GEODERMA, V264, P301, DOI 10.1016/j.geoderma.2015.07.017; Mod HK, 2016, J VEG SCI, V27, P1308, DOI 10.1111/jvs.12444; Pascucci S, 2014, EUR J SOIL SCI, V65, P865, DOI 10.1111/ejss.12203; Phachomphon K, 2010, GEODERMA, V155, P372, DOI 10.1016/j.geoderma.2009.12.020; Poggio L, 2013, GEODERMA, V209, P1, DOI 10.1016/j.geoderma.2013.05.029; Priori S, 2014, GEODERMA, V226, P354, DOI 10.1016/j.geoderma.2014.03.012; Rossel RAV, 2011, EUR J SOIL SCI, V62, P442, DOI 10.1111/j.1365-2389.2011.01372.x; Scull P, 2003, PROG PHYS GEOG, V27, P171, DOI 10.1191/0309133303pp366ra; Shi WJ, 2011, GEODERMA, V162, P347, DOI 10.1016/j.geoderma.2011.03.007; Slaymaker O, 2009, GEOMORPHOLOGY AND GL; TAN KH, 2009, ENV SOIL SCI, P1; Tasser E, 2003, BASIC APPL ECOL, V4, P271, DOI 10.1078/1439-1791-00153; Vasat R, 2014, GEODERMA, V232, P208, DOI 10.1016/j.geoderma.2014.05.012; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang ZQ, 2010, SOIL SCI PLANT NUTR, V56, P307, DOI 10.1111/j.1747-0765.2010.00457.x	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208823	10.1371/journal.pone.0208823	http://dx.doi.org/10.1371/journal.pone.0208823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576324	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400019
J	Pacifico, R; MacMullen, CM; Walkinshaw, E; Zhang, XF; Davis, RL				Pacifico, Rodrigo; MacMullen, Courtney M.; Walkinshaw, Erica; Zhang, Xiaofan; Davis, Ronald L.			Brain transcriptome changes in the aging Drosophila melanogaster accompany olfactory memory performance deficits	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; RNA-SEQ; OXIDATIVE STRESS; MODEL; MITOCHONDRIA; DYSFUNCTION; IMPAIRMENT; BEHAVIOR; SLEEP	Cognitive decline is a common occurrence of the natural aging process in animals and studying age-related changes in gene expression in the brain might shed light on disrupted molecular pathways that play a role in this decline. The fruit fly is a useful neurobiological model for studying aging due to its short generational time and relatively small brain size. We investigated age-dependent changes in the Drosophila melanogaster whole-brain transcriptome by comparing 5-, 20-, 30- and 40-day-old flies of both sexes. We used RNA-Sequencing of dissected brain samples followed by differential expression, temporal clustering, co-expression network and gene ontology enrichment analyses. We found an overall decline in expression of genes from the mitochondrial oxidative phosphorylation pathway that occurred as part of aging. We also detected, in females, a pattern of continuously declining expression for many neuronal function genes, which was unexpectedly reversed later in life. This group of genes was highly enriched in memory-impairing genes previously identified through an RNAi screen. We also identified deficits in short-term olfactory memory performance in older flies of both sexes, some of which matched the timing of certain changes in the brain transcriptome. Our study provides the first transcriptome profile of aging brains from fruit flies of both sexes, and it will serve as an important resource for those who study aging and cognitive decline in this model.	[Pacifico, Rodrigo; MacMullen, Courtney M.; Walkinshaw, Erica; Zhang, Xiaofan; Davis, Ronald L.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Davis, RL (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.	rdavis@scripps.edu	Pacifico, Rodrigo/L-6189-2017	Pacifico, Rodrigo/0000-0003-2581-6818	National Institute on Aging of the National Institutes of Health [R01AG049037]; NATIONAL INSTITUTE ON AGING [R01AG049037] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RD received grant R01AG049037 from the National Institute on Aging of the National Institutes of Health (https://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arslan-Ergul A, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-29; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Beck CDO, 2000, J NEUROSCI, V20, P2944; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bolger A, 2014, TRIMMOMATIC FLEXIBLE; Carey JR, 2006, EXP GERONTOL, V41, P93, DOI 10.1016/j.exger.2005.09.014; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fernandez JR, 1999, EXP GERONTOL, V34, P621, DOI 10.1016/S0531-5565(99)00040-6; Ghezzi A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00015; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Gupta VK, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002563; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Haddadi M, 2014, BEHAV BRAIN RES, V259, P60, DOI 10.1016/j.bbr.2013.10.036; Haywood AFM, 2006, GENOME, V49, P505, DOI 10.1139/G06-011; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Kim SN, 2005, NEUROBIOL AGING, V26, P1083, DOI 10.1016/j.neurobiolaging.2004.06.017; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Moskalev A, 2012, CELL CYCLE, V11, P4222, DOI 10.4161/cc.22545; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Qiu S, 2017, COMP BIOCHEM PHYS A, V206, P17, DOI 10.1016/j.cbpa.2017.01.003; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Schwammle V, 2010, BIOINFORMATICS, V26, P2841, DOI 10.1093/bioinformatics/btq534; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tonoki A, 2012, P NATL ACAD SCI USA, V109, P6319, DOI 10.1073/pnas.1118126109; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vienne J, 2016, SLEEP, V39, P1613, DOI 10.5665/sleep.6032; Walkinshaw E, 2015, GENETICS, V199, P1173, DOI 10.1534/genetics.114.173575; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	60	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209405	10.1371/journal.pone.0209405	http://dx.doi.org/10.1371/journal.pone.0209405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576353	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400047
J	AL-Saiagh, W; Tiun, S; AL-Saffar, A; Awang, S; Al-khaleefa, AS				AL-Saiagh, Wafaa; Tiun, Sabrina; AL-Saffar, Ahmed; Awang, Suryanti; Al-khaleefa, A. S.			Word sense disambiguation using hybrid swarm intelligence approach	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM; COLONY OPTIMIZATION; SIMILARITY	Word sense disambiguation (WSD) is the process of identifying an appropriate sense for an ambiguous word. With the complexity of human languages in which a single word could yield different meanings, WSD has been utilized by several domains of interests such as search engines and machine translations. The literature shows a vast number of techniques used for the process of WSD. Recently, researchers have focused on the use of meta-heuristic approaches to identify the best solutions that reflect the best sense. However, the application of meta-heuristic approaches remains limited and thus requires the efficient exploration and exploitation of the problem space. Hence, the current study aims to propose a hybrid meta-heuristic method that consists of particle swarm optimization (PSO) and simulated annealing to find the global best meaning of a given text. Different semantic measures have been utilized in this model as objective functions for the proposed hybrid PSO. These measures consist of JCN and extended Lesk methods, which are combined effectively in this work. The proposed method is tested using a three-benchmark dataset (SemCor 3.0, SensEval-2, and SensEval-3). Results show that the proposed method has superior performance in comparison with state-of-the-art approaches.	[AL-Saiagh, Wafaa; Tiun, Sabrina] Univ Kebangsaan Malaysia, Ctr Artificial Intelligent CAIT, Knowledge Technol Res Grp KT, Bangi, Selangor, Malaysia; [AL-Saffar, Ahmed; Awang, Suryanti] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Pahang, Malaysia; [Al-khaleefa, A. S.] Univ Tekn Malaysia Melaka UTeM, Broadband & Networking BBNET Res Grp, Fac Elect & Comp Engn, Durian Tunggal, Melaka, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaysia Pahang; University Teknikal Malaysia Melaka	AL-Saiagh, W (corresponding author), Univ Kebangsaan Malaysia, Ctr Artificial Intelligent CAIT, Knowledge Technol Res Grp KT, Bangi, Selangor, Malaysia.	wafaa.alsaiagh@siswa.ukm.edu.my	Al-Khaleefa, Ahmed Salih/AAH-3994-2020; Awang, Suryanti/L-8747-2016	Al-Khaleefa, Ahmed Salih/0000-0002-6746-6011; tiun, sabrina/0000-0002-1134-973X	Universiti Kebangsaan Malaysia (UKM) [DIP-2016-033]	Universiti Kebangsaan Malaysia (UKM)	The authors would like to express their deep gratitude to Universiti Kebangsaan Malaysia (UKM) for providing financial support by Dana Impak Perdana research grant no. DIP-2016-033. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their deep gratitude to Universiti Kebangsaan Malaysia (UKM) for providing financial support by Dana Impak Perdana research grant no. DIP-2016-033. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed SA, 2016, CONNECT SCI, V28, P226, DOI 10.1080/09540091.2016.1141874; Abed SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136614; Abualhaija S, 2016, SWARM EVOL COMPUT, V27, P188, DOI 10.1016/j.swevo.2015.12.002; Abualigah LM, 2017, J SUPERCOMPUT, V73, P4773, DOI 10.1007/s11227-017-2046-2; Agirre E., 2018, ARXIV180504277; Al-Saeedan Wojdan, 2015, International Journal of Artificial Intelligence and Soft Computing, V5, P117; Al-Saffar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194852; Alba E, 2005, IEEE T EVOLUT COMPUT, V9, P126, DOI 10.1109/TEVC.2005.843751; Alsaeedan W, 2015, INT C IND ENG OTH AP; Alsaeedan W, 2016, CAN C ART INT; Alsaeedan W, 2017, INFORM SCIENCES, V417, P20, DOI 10.1016/j.ins.2017.07.002; [Anonymous], 1997, CMPLG9709008 ARXIV; [Anonymous], 2011, INT J INFORM TECHNOL, DOI DOI 10.5815/IJITCS.2011.05.08; Banerjee S., 2002, Computational Linguistics and Intelligent Text Processing. Third International Conference, CICLing 2002. Proceedings (Lecture Notes in Computer Science Vol.2276), P136; Basile P., 2014, P COLING 2014 25 INT; Basu M, 2014, INT J INFORM TECHNOL, V20, P112; Bhingardive S., 2016, INWORDNET INDIAN LAN, P243; Bostamam JM, 2016, AIP CONF PROC, V1761, DOI 10.1063/1.4960898; Camacho-Collados J, 2018, LANG RESOUR EVAL, P1; Camacho-Collados J., 2017, P 11 INT WORKSHOP SE; Chang H.-S., 2018, ARXIV180403257; Chaplot D. S., 2018, ARXIV180101900; Correa EA, 2018, INFORM SCIENCES, V442, P103, DOI 10.1016/j.ins.2018.02.047; Cowie J, 1992, P 14 C COMP LING, V1; Cui X, 2005, P 2005 IEEE SWARM IN; Duque A, 2018, ARTIF INTELL MED, V87, P9, DOI 10.1016/j.artmed.2018.03.002; El-Dsouky A., 2018, INFORM RETRIEVAL MAN, P1841, DOI [10.4018/978-1-5225-5191-1.ch084, DOI 10.4018/978-1-5225-5191-1.CH084]; Elayeb B., 2018, ARTIF INTELL REV, P1, DOI DOI 10.1007/S10462-018-9622-6; Francis W. N., 1979, DEP LINGUISTICS; GALE WA, 1992, COMPUT HUMANITIES, V26, P415, DOI 10.1007/BF00136984; Gandhi RA, 2017, COMPUTING TEXTUAL SE; Gelbukh A., 2003, WSEAS Transactions on Computers, V2, P257; Hassan A, 2014, SERIES ADV INTELLIGE, P227; Hassan AKA, 2017, SENSE BASED INFORM R; Hausman M, 2011, GENETIC ALGORITHM US; Idoumghar L, 2011, APPL COMPUTATIONAL I, V2011, P3; Kang JY, 2012, ADV INTEL SOFT COMPU, V139, P247; Kang MY, 2018, BIG DAT SMART COMP B; Nguyen KH, 2013, ARTIF INTELL REV, V40, P405, DOI 10.1007/s10462-011-9288-9; Kim J, 2017, INT J GEOGR INF SCI, V31, P56, DOI 10.1080/13658816.2016.1188930; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; Lesk M., 1986, P 5 ANN INT C SYST D; Lynn HM, 2018, P 33 ANN ACM S APPL; Mihalcea R, 2005, P C HUM LANG TECHN E; Miller G.A., 1993, P WORKSH HUM LANG TE; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Navigli R, 2010, IEEE T PATTERN ANAL, V32, P678, DOI 10.1109/TPAMI.2009.36; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Noah SA, 2015, J QUANT LINGUIST, V22, P135, DOI 10.1080/09296174.2014.1001637; Palmer M, 2001, P 2 INT WORKSH EV WO; Pedersen T., 2005, 200525 UMSI, V25, P2005; Peyrard M, 2016, P COLING 2016 26 INT; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P., 1995, CMPLG9511007 ARXIV; Rodrigues Irene, 2012, 24 INT C COMP LING; Schutze H, 1998, COMPUT LINGUIST, V24, P97; Sieminiski A, 2018, AS C INT INF DAT SYS; Snyder Benjamin, 2004, P SENSEVAL 3 3 INT W; Ursem RK, 2002, DIVERSITY GUIDED EVO, P462; Ustalov D, 2018, ARXIV180410686; Valizadegan H, 2011, P 17 ACM SIGKDD INT; Vial L, 2017, 12 INT C COMP SEM; Wang X, 2017, BEH EC SOC COMP BESC; Wu Z, 1994, P 32 ANN M ASS COMP; Yepes AJ, 2017, J BIOMED INFORM, V73, P137, DOI 10.1016/j.jbi.2017.08.001; Zhang C, 2008, 2008 IITA 08 2 INT S	67	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208695	10.1371/journal.pone.0208695	http://dx.doi.org/10.1371/journal.pone.0208695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571777	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700019
J	Chohan, H; Esfandiarei, M; Arman, D; Van Raamsdonk, CD; van Breemen, C; Friedman, JM; Jett, KA				Chohan, Harleen; Esfandiarei, Mitra; Arman, Darian; Van Raamsdonk, Catherine D.; van Breemen, Cornelis; Friedman, Jan M.; Jett, Kimberly A.			Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1	PLOS ONE			English	Article							BLOOD-TESTIS BARRIER; ADHERENS JUNCTION DYNAMICS; ACTIVATED PROTEIN-KINASES; SEMINIFEROUS EPITHELIUM; PROGESTERONE-RECEPTOR; RAT TESTIS; SIGNALING PATHWAY; MUTATION-RATE; SELF-RENEWAL; IN-VITRO	The fertility of men with neurofibromatosis 1 (NF1) is reduced. Despite this observation, gonadal function has not been examined in patients with NF1. In order to assess the role of reduced neurofibromin in the testes, we examined testicular morphology and function in an Nf1(+/- )mouse model. We found that although Nf1(+/- )male mice are able to reproduce, they have significantly fewer pups per litter than Nf1(+/+) control males. Reduced fertility in Nf1(+/-) male mice is associated with disorganization of the seminiferous epithelium, with exfoliation of germ cells and immature spermatids into the tubule lumen. Morphometric analysis shows that these alterations are associated with decreased Leydig cell numbers and increased spermatid cell numbers. We hypothesized that hyper-activation of Ras in Nf1(+/-) males affects ectoplasmic specialization, a Sertoli-spermatid adherens junction involved in spermiation. Consistent with this idea, we found increased expression of phosphorylated ERK, a downstream effector of Ras that has been shown to alter ectoplasmic specialization, in Nf1(+/-) males in comparison to control Nf1(+/+) littermates. These data demonstrate that neurofibromin haploinsufficiency impairs spermatogenesis and fertility in a mouse model of NF1.	[Chohan, Harleen; Van Raamsdonk, Catherine D.; Friedman, Jan M.; Jett, Kimberly A.] Univ British Columbia, BC Children Hosp Res Inst, Dept Med Genet, Vancouver, BC, Canada; [Esfandiarei, Mitra; Arman, Darian; van Breemen, Cornelis] Univ British Columbia, BC Children Hosp Res Inst, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Esfandiarei, Mitra] Midwestern Univ, Coll Grad Studies, Dept Biomed Sci, Glendale, AZ 85308 USA	University of British Columbia; University of British Columbia; Midwestern University	Esfandiarei, M (corresponding author), Univ British Columbia, BC Children Hosp Res Inst, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; Esfandiarei, M (corresponding author), Midwestern Univ, Coll Grad Studies, Dept Biomed Sci, Glendale, AZ 85308 USA.	mesfan@midwestern.edu	Van Raamsdonk, Catherine D./B-6207-2017; Esfandiarei, Mitra/R-9903-2019; Esfandiarei, Mitra/V-1258-2019	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Esfandiarei, Mitra/0000-0003-3218-7781; Chohan, Harleen/0000-0003-4105-5705; Friedman, Jan/0000-0002-7482-9570				Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Almog T, 2008, MOL CELL ENDOCRINOL, V282, P39, DOI 10.1016/j.mce.2007.11.011; Almog T, 2010, MOL CELL ENDOCRINOL, V314, P239, DOI 10.1016/j.mce.2009.05.009; Armstrong L, 2013, AM J MED GENET A, V161A, P1654, DOI 10.1002/ajmg.a.36001; Banu J, 2013, DRUG DES DEV THER, V7, P849, DOI 10.2147/DDDT.S46101; BRICAIRE H, 1965, Sem Hop, V41, P757; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Chapin RE, 2001, J ANDROL, V22, P1030; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Crowe FW, 1956, CLIN PATHOLOGICALA G; Deo M, 2013, J INVEST DERMATOL, V133, P49, DOI 10.1038/jid.2012.240; Gadkar S, 2002, BIOL REPROD, V67, P1327, DOI 10.1095/biolreprod67.4.1327; Ganem TP, 1999, UROLOGY, V53, P209, DOI 10.1016/S0090-4295(98)00438-5; GUTMANN DH, 1995, CELL GROWTH DIFFER, V6, P315; Hasegawa K, 2013, STEM CELLS, V31, P2517, DOI 10.1002/stem.1486; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Hedger M, 2005, J ANDROL, V26, P379, DOI 10.2164/jandrol.04149; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; Jett K, 2010, GENET MED, V12, P1, DOI 10.1097/GIM.0b013e3181bf15e3; Kume H, 2001, LANCET, V357, P395, DOI 10.1016/S0140-6736(05)71531-2; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lee NPY, 2005, BIOL REPROD, V73, P458, DOI 10.1095/biolreprod.105.040766; Lin CC, 2009, J ANDROL, V30, P685, DOI 10.2164/jandrol.108.006460; Lue YH, 2013, ANDROLOGY-US, V1, P308, DOI 10.1111/j.2047-2927.2012.00047.x; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Ma W, 2015, MOL REPROD DEV, V82, P797, DOI 10.1002/mrd.22528; MCCORMICK F, 1991, COLD SH Q B, V56, P237; Meyhofer W, 1966, Hautarzt, V17, P108; O'Donnell L, 2000, BIOL REPROD, V63, P99, DOI 10.1095/biolreprod63.1.99; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Raygada M, 2010, PEDIATR BLOOD CANCER, V54, P173, DOI 10.1002/pbc.22297; SAMUELSSON B, 1989, Neurofibromatosis, V2, P84; SAMUELSSON B, 1988, HEREDITAS, V108, P169, DOI 10.1111/j.1601-5223.1988.tb00297.x; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Shao MH, 2008, DEV BIOL, V313, P246, DOI 10.1016/j.ydbio.2007.10.013; TAKANO T, 1992, HUM GENET, V89, P281; Tucker T, 2009, J MED GENET, V46, P259, DOI 10.1136/jmg.2008.061895; Virdis R, 2003, J PEDIATR ENDOCR MET, V16, P289; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Wong CH, 2005, DEV BIOL, V286, P1, DOI 10.1016/j.ydbio.2005.08.001; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Xia WL, 2005, CYTOKINE GROWTH F R, V16, P469, DOI 10.1016/j.cytogfr.2005.05.007; Xia WL, 2005, J CELL PHYSIOL, V205, P141, DOI 10.1002/jcp.20377; Xia WL, 2005, DEV BIOL, V280, P321, DOI 10.1016/j.ydbio.2004.12.036; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102; Zhou Y, 2015, INT J MOL SCI, V16, P12345, DOI 10.3390/ijms160612345	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208835	10.1371/journal.pone.0208835	http://dx.doi.org/10.1371/journal.pone.0208835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571760	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700025
J	Asami, T; Yoshida, H; Takaishi, M; Nakamura, R; Yoshimi, A; Whitford, TJ; Hirayasu, Y				Asami, Takeshi; Yoshida, Haruhisa; Takaishi, Masao; Nakamura, Ryota; Yoshimi, Asuka; Whitford, Thomas J.; Hirayasu, Yoshio			Thalamic shape and volume abnormalities in female patients with panic disorder	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; MAJOR DEPRESSIVE DISORDER; GRAY-MATTER ALTERATIONS; DRUG-NAIVE; CINGULATE CORTEX; 1ST-EPISODE; REDUCTION; EPIDEMIOLOGY; VALIDATION; DEFICITS	The thalamus is believed to play crucial role in processing viscero-sensory information, and regulating the activity of amygdala in patients with panic disorder (PD). Previous functional neuroimaging studies have detected abnormal activation in the thalamus in patients with PD compared with healthy control subjects (HC). Very few studies, however, have investigated for volumetric abnormalities in the thalamus in patients with PD. Furthermore, to the best of our knowledge, no previous study has investigated for shape abnormalities in the thalamus in patients with PD. Twenty-five patients with PD and 25 HC participants (all female) were recruited for the study. A voxel-wise volume comparison analysis and a vertex-wise shape analysis were conducted to evaluate structural abnormalities in the PD patients compared to HC. The patients with PD demonstrated significant gray matter volume reductions in the thalamus bilaterally, relative to the HC. The shape analysis detected significant inward deformation in some thalamic regions in the PD patients, including the anterior nucleus, mediodorsal nucleus, and pulvinar nucleus. PD patients showed shape deformations in key thalamic regions that are believed to play a role in regulating emotional and cognitive functions.	[Asami, Takeshi; Yoshida, Haruhisa; Takaishi, Masao; Nakamura, Ryota; Yoshimi, Asuka; Hirayasu, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Psychiat, Yokohama, Kanagawa, Japan; [Whitford, Thomas J.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Hirayasu, Yoshio] Heian Hosp, Urazoe, Japan	Yokohama City University; University of New South Wales Sydney	Asami, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Psychiat, Yokohama, Kanagawa, Japan.	t_asami@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare [Kokoro 200400762A, 200500806A, 200632005A]; JSPS KAKENHI [JP25861023, JP17K10313]; SENSHIN Medical Research Foundation	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This study was supported by grants from the Ministry of Health, Labor and Welfare (Kokoro 200400762A, 200500806A, and 200632005A, B) (Y.H.), and JSPS KAKENHI Grant Numbers JP25861023 and JP17K10313 (T.A.), and a grant from SENSHIN Medical Research Foundation (T. A.) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, STRUCTURED CLIN INTE; Asami T, 2018, J AFFECT DISORD; Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2013, JAMA PSYCHIAT, V70, P361, DOI 10.1001/jamapsychiatry.2013.665; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benarroch EE, 2015, NEUROLOGY, V84, P738, DOI 10.1212/WNL.0000000000001276; CORYELL W, 1988, PSYCHIAT CLIN N AM, V11, P433; de Jonge P, 2016, DEPRESS ANXIETY, V33, P1155, DOI 10.1002/da.22572; Dean DJ, 2016, SCHIZOPHRENIA BULL, V42, P161, DOI 10.1093/schbul/sbv086; Dupire A, 2013, HIPPOCAMPUS, V23, P392, DOI 10.1002/hipo.22098; EATON WW, 1994, AM J PSYCHIAT, V151, P413; Feldker K, 2016, HUM BRAIN MAPP, V37, P4439, DOI 10.1002/hbm.23320; Fujiwara A, 2011, PSYCHIAT CLIN NEUROS, V65, P365, DOI 10.1111/j.1440-1819.2011.02219.x; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hsu DT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00073; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kelly MM, 2006, BEHAV RES THER, V44, P1421, DOI 10.1016/j.brat.2005.10.012; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Kim JH, 2013, J NEUROL, V260, P1846, DOI 10.1007/s00415-013-6891-5; Lai CH, 2016, WORLD J BIOL PSYCHIA, V17, P58, DOI 10.3109/15622975.2015.1017604; Lai CH, 2015, J AFFECT DISORDERS, V186, P1, DOI 10.1016/j.jad.2015.07.022; Lai CH, 2013, J AFFECT DISORDERS, V151, P709, DOI 10.1016/j.jad.2013.08.006; Lai CH, 2012, J AFFECT DISORDERS, V142, P180, DOI 10.1016/j.jad.2012.04.021; Lai CH, 2012, J AFFECT DISORDERS, V140, P285, DOI 10.1016/j.jad.2012.01.049; Lyness RC, 2014, NEUROIMAGE, V100, P347, DOI 10.1016/j.neuroimage.2014.05.077; Maarouf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160750; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maron E, 2004, PSYCHIAT RES-NEUROIM, V132, P173, DOI 10.1016/j.pscychresns.2003.10.004; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Meng YJ, 2013, PSYCHIAT RES-NEUROIM, V214, P9, DOI 10.1016/j.pscychresns.2013.06.002; Menke RAL, 2014, HUM BRAIN MAPP, V35, P1681, DOI 10.1002/hbm.22282; Moon CM, 2014, NEUROREPORT, V25, P184, DOI 10.1097/WNR.0000000000000100; Nemmi F, 2015, NEUROBIOL AGING, V36, P424, DOI 10.1016/j.neurobiolaging.2014.07.010; Nieuwenhuys R, 1991, HUMAN CENTRAL NERVEO; Ohrmann P, 2010, DEPRESS ANXIETY, V27, P1034, DOI 10.1002/da.20721; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pfleiderer B, 2014, J NEURAL TRANSM, V121, P1417, DOI 10.1007/s00702-014-1248-5; Protopopescu X, 2006, NEUROREPORT, V17, P361, DOI 10.1097/01.wnr.0000203354.80438.1; Roppongi T, 2010, PSYCHIAT CLIN NEUROS, V64, P318, DOI 10.1111/j.1440-1819.2010.02085.x; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; SHEAR MK, 1994, ARCH GEN PSYCHIAT, V51, P346; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Stepan-Buksakowska I, 2014, ALZ DIS ASSOC DIS, V28, P65, DOI 10.1097/WAD.0b013e318299d3d6; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; van den Heuvel OA, 2011, PSYCHOL MED, V41, P2399, DOI 10.1017/S0033291711000535; Watanabe R, 2017, DEPRESS ANXIETY, V34, P401, DOI 10.1002/da.22604; Whitford TJ, 2005, PSYCHIAT RES-NEUROIM, V139, P229, DOI 10.1016/j.pscychresns.2005.05.010; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Yonkers KA, 2003, DEPRESS ANXIETY, V17, P173, DOI 10.1002/da.10106; Yoo HK, 2005, EUR J NEUROSCI, V22, P2089, DOI 10.1111/j.1460-9568.2005.04394.x	56	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208152	10.1371/journal.pone.0208152	http://dx.doi.org/10.1371/journal.pone.0208152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566534	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300025
J	Biesheuvel-Leliefeld, KEM; Bosmans, JE; Dijkstra-Kersten, SMA; Smit, F; Bockting, CLH; van Schaik, DJF; van Marwijk, HWJ; van der Horst, HE				Biesheuvel-Leliefeld, Karolien E. M.; Bosmans, Judith E.; Dijkstra-Kersten, Sandra M. A.; Smit, Filip; Bockting, Claudi L. H.; van Schaik, Digna J. F.; van Marwijk, Harm W. J.; van der Horst, Henriette E.			A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; COST-EFFECTIVENESS; COGNITIVE THERAPY; SUBTHRESHOLD DEPRESSION; PREVENT DEPRESSION; MAJOR DEPRESSION; GLOBAL BURDEN; RELAPSE; DISABILITY; DISORDERS	Background Major depression is a prevalent mental disorder with a high risk of relapse or recurrence. Only few studies have focused on the cost-effectiveness of interventions aimed at the prevention of relapse or recurrence of depression in primary care. Aim To evaluate the cost-effectiveness of a supported Self-help Preventive Cognitive Therapy (S-PCT) added to treatment-as-usual (TAU) compared with TAU alone for patients with a history of depression, currently in remission. Methods An economic evaluation alongside a multi-center randomised controlled trial was performed (n = 248) over a 12-month follow-up. Outcomes included relapse or recurrence of depression and quality-adjusted-life-years (QALYs) based on the EuroQol-5D. Analyses were performed from both a societal and healthcare perspective. Missing data were imputed using multiple imputations. Uncertainty was estimated using bootstrapping and presented using the cost-effectiveness plane and the Cost-Effectiveness Acceptability Curve (CEAC). Cost estimates were adjusted for baseline costs. Results S-PCT statistically significantly decreased relapse or recurrence by 15% (95%Cl 3;28) compared to TAU. Mean total societal costs were (sic)2,114 higher (95%CI -112;4261). From a societal perspective, the ICER for relapse or recurrence was 13,515. At a Willingness To Pay (WTP) of 22,000 (sic)/recurrence prevented, the probability that S-PCT is cost-effective, in comparison with TAU, is 80%. The ICER for QALYs was 63,051. The CEA curve indicated that at a WTP of 30,000 (sic)/QALY gained, the probability that S-PCT is cost-effective compared to TAU is 21%. Conclusions Though ultimately depending on the WTP of decision makers, we expect that for both relapse or recurrence and QALYs, S-PCT cannot be considered cost-effective compared to TAU.	[Biesheuvel-Leliefeld, Karolien E. M.; Dijkstra-Kersten, Sandra M. A.; van der Horst, Henriette E.] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Biesheuvel-Leliefeld, Karolien E. M.; Dijkstra-Kersten, Sandra M. A.; van der Horst, Henriette E.] Vrije Univ Amsterdam, EMGO, Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Smit, Filip] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin Psychol & Expt Psychopathol, Utrecht, Netherlands; [van Schaik, Digna J. F.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [van Schaik, Digna J. F.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [van Marwijk, Harm W. J.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [van Marwijk, Harm W. J.] NIHR Sch Primary Care Res, Manchester, Lancs, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Trimbos Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Manchester; University of Manchester	Biesheuvel-Leliefeld, KEM (corresponding author), Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands.; Biesheuvel-Leliefeld, KEM (corresponding author), Vrije Univ Amsterdam, EMGO, Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands.	karolien.biesheuvel@gmail.com	Van Marwijk, Harm/K-6306-2013	Van Marwijk, Harm/0000-0001-6206-485X; Bosmans, Judith/0000-0002-1443-1026; van Schaik, Anneke/0000-0002-7169-9600	ZonMW, the Netherlands association for Health Research and Development; Department Disease management Chronical Illnesses [80-82310-97-11087, 171102002]	ZonMW, the Netherlands association for Health Research and Development; Department Disease management Chronical Illnesses	This research was funded by ZonMW, the Netherlands association for Health Research and Development, Department Disease management Chronical Illnesses, grant number: 80-82310-97-11087 or 171102002 to KBL. The funding source did not play any role in the collection, analysis, interpretation of the data, writing the manuscript or the decision to submit for publication.	[Anonymous], MEER EFFECT MET DEPR; Bakker Ingrid M, 2007, PLoS Clin Trials, V2, pe26, DOI 10.1371/journal.pctr.0020026; Beck A, 1979, COGNITIVE THERAPY DE; Berto Patrizia, 2000, J Ment Health Policy Econ, V3, P3, DOI 10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H; Beshai S, 2011, CLIN PSYCHOL REV, V31, P1349, DOI 10.1016/j.cpr.2011.09.003; Biesheuvel-Leliefeld KEM, 2017, PSYCHOTHER PSYCHOSOM, V86, P220, DOI 10.1159/000472260; Biesheuvel-Leliefeld KEM, 2015, J AFFECT DISORDERS, V174, P400, DOI 10.1016/j.jad.2014.12.016; Biesheuvel-Leliefeld KEM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-59; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Bockting C. L, 2009, INGREDIENTS MOBILE P; Bockting CLH, 2009, J CLIN PSYCHIAT, V70, P1621, DOI 10.4088/JCP.08m04784blu; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; CAK. Centraal Administratie Kantoor, 2009, JAARV 2008, DOI [10.1136/bmj.b2393, DOI 10.1136/BMJ.B2393]; Conradi HJ, 2011, PSYCHOL MED, V41, P1165, DOI 10.1017/S0033291710001911; EFRON B, 1994, J AM STAT ASSOC, V89, P463, DOI 10.2307/2290846; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754, DOI 10.4088/JCP.v67n1113; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; First M.B., 2014, STRUCTURED CLIN INTE; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Greenberg PE, 2005, EXPERT OPIN PHARMACO, V6, P369, DOI 10.1517/14656566.6.3.369; Gunther OH, 2008, J AFFECT DISORDERS, V105, P81, DOI 10.1016/j.jad.2007.04.018; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; Kok G, 2015, PSYCHOTHER PSYCHOSOM, V84, P90, DOI 10.1159/000369469; Kuyken W, 2015, LANCET, V386, P63, DOI 10.1016/S0140-6736(14)62222-4; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lynch FL, 2005, ARCH GEN PSYCHIAT, V62, P1241, DOI 10.1001/archpsyc.62.11.1241; Mihalopoulos C, 2011, AUST NZ J PSYCHIAT, V45, P36, DOI 10.3109/00048674.2010.501024; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D, P63; Oostenbrink J., 2004, GUIDELINE EC EVALUAT; Oostenbrink JB, 2002, STANDARDISATION COST, V7; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P387, DOI 10.1001/archpsyc.61.4.387; Polder J, 2002, COST ILLNESS NETHERL; Rubin DB, 2004, MULTIPLE IMPUTATION; Simon GE, 2002, MED CARE, V40, P941, DOI 10.1097/00005650-200210000-00011; Smit A, 2006, PSYCHOL MED, V36, P15, DOI 10.1017/S0033291705006318; Smit F, 2006, BRIT J PSYCHIAT, V188, P330, DOI 10.1192/bjp.188.4.330; Smit F, 2006, ARCH GEN PSYCHIAT, V63, P290, DOI 10.1001/archpsyc.63.3.290; Smit F, 2004, J AFFECT DISORDERS, V81, P241, DOI 10.1016/j.jad.2003.08.007; Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590; Stant AD, 2009, J MENT HEALTH POLICY, V12, P195; STERNE JAC, 2009, BMJ BRIT MED J, V0339; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van den Berg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022884; Vasiliadis HM, 2013, AM J GERIAT PSYCHIAT, V21, P536, DOI 10.1016/j.jagp.2012.12.016; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; Willemse GRWM, 2004, BRIT J PSYCHIAT, V185, P416, DOI 10.1192/bjp.185.5.416	58	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208570	10.1371/journal.pone.0208570	http://dx.doi.org/10.1371/journal.pone.0208570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566441	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000453779300048
J	Bohman, T; Tegern, M; Halvarsson, A; Broman, L; Larsson, H				Bohman, Tony; Tegern, Matthias; Halvarsson, Alexandra; Broman, Lisbet; Larsson, Helena			Reliability and agreement of the IsoKai isokinetic lift test - A test used for admission to the Swedish Armed Forces	PLOS ONE			English	Article							SAMPLE-SIZE; INTRACLASS CORRELATIONS; STATISTICAL-METHODS; SQUAT DEVICE; FITNESS TEST; STRENGTH; LOADS; TASKS; POWER	This study was performed to evaluate the reliability and agreement of the IsoKai isokinetic lift test as it is currently administered in admission to the Swedish Armed Forces. The study included an intrarater (n = 534) and interrater reliability sample (n = 137), of Swedish male conscripts who performed the test on two test occasions about two hours apart. Two-to-four lifts were performed at each occasion, and the highest mean (IsoKai(MF)) and peak force (IsoKai(PF)) produced (N) were used for evaluation. All intraclass coefficients showed excellent reliability. The interrater analyses resulted in intraclass coefficients of 0.942 (95% CI; 0.920-0.959) and 0.858 (95% CI; 0.806-0.896) for the IsoKai(MF) and IsoKai(PF), respectively, while the corresponding coefficients for the intrarater analyses were 0.935 (95% CI; 0.923-0.946) and 0.865 (95% CI; 0.842-0.886). Agreement, the capability of a test to detect changes, was assessed by the standard error of measurement (SEM/SEM%) and the smallest real difference (SRD/SRD%). These estimate indicated that it is possible to achieve measurements relevant to use in real practice with the IsoKai isokinetic lift test. Bland and Altman analyses revealed no systematic errors in either sample. Based on these findings, the IsoKai isokinetic lift test is suggested to be a highly reliable test for maximal dynamic muscular strength. The test could be of use in selection procedures in order to accurately evaluate maximal dynamic muscular strength, and for evaluating longitudinal changes in strength.	[Bohman, Tony; Tegern, Matthias; Halvarsson, Alexandra; Broman, Lisbet; Larsson, Helena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden; [Tegern, Matthias] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Halvarsson, Alexandra] Karolinska Univ Hosp, Allied Hlth Profess Funct, Stockholm, Sweden; [Larsson, Helena] Swedish Armed Forces, Med Serv, Stockholm, Sweden	Karolinska Institutet; Umea University; Karolinska Institutet; Karolinska University Hospital	Bohman, T (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden.	tony.bohman@ki.se	Bohman, Tony/AAF-4991-2021	Tegern, Matthias/0000-0001-6871-1341; Bohman, Tony/0000-0001-9507-6101				ABERNETHY P, 1995, SPORTS MED, V19, P401, DOI 10.2165/00007256-199519060-00004; BALTZOPOULOS V, 1989, SPORTS MED, V8, P101, DOI 10.2165/00007256-198908020-00003; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Bridgeman LA, 2016, J STRENGTH COND RES, V30, P3261, DOI 10.1519/JSC.0000000000001410; Carter R, 2011, REHABILITATION RES P; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Currier D, 1990, ELEMENTS RES PHYS TH; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Feeler L, 2010, WORK, V37, P301, DOI 10.3233/WOR-2010-1082; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Hauschild VD, 2017, OCCUP ENVIRON MED, V74, P144, DOI 10.1136/oemed-2016-103684; Hydren JR, 2017, J STRENGTH COND RES, V31, P1142, DOI 10.1519/JSC.0000000000001790; Jaenen S, 2009, TRHFM080 RTO; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Larsson H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132185; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Lindberg AS, 2014, INT J OCCUP SAF ERGO, V20, P309, DOI 10.1080/10803548.2014.11077042; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Middleton KJ, 2017, APPL ERGON, V60, P255, DOI 10.1016/j.apergo.2016.12.004; Nindl BC, 2015, J STRENGTH COND RES, V29, pS216, DOI 10.1519/JSC.0000000000001037; Nordesjo LO, 1974, SWEDISH J DEFENCE ME, V10, P11; Paul DJ, 2015, J STRENGTH COND RES, V29, P1748, DOI 10.1519/JSC.0000000000000807; Portney LG, 2015, FDN CLIN RES APPL PR; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Roy TC, 2013, SPINE, V38, P1310, DOI 10.1097/BRS.0b013e31829265c4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Strating M, 2010, OCCUP MED-OXFORD, V60, P255, DOI 10.1093/occmed/kqq060; Swain DP., 2014, ACSMS RESOURCE MANUA; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wernbom M, 2007, SPORTS MED, V37, P225, DOI 10.2165/00007256-200737030-00004; Wilson GJ, 1997, EUR J APPL PHYSIOL O, V75, P455, DOI 10.1007/s004210050188	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209419	10.1371/journal.pone.0209419	http://dx.doi.org/10.1371/journal.pone.0209419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566536	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300090
J	Wallin, H; Asp, AM; Wallquist, C; Jansson, E; Caidahl, K; Rossner, BH; Jacobson, SH; Rickenlund, A; Eriksson, MJ				Wallin, Helena; Asp, Anna M.; Wallquist, Carin; Jansson, Eva; Caidahl, Kenneth; Rossner, Britta Hylander; Jacobson, Stefan H.; Rickenlund, Anette; Eriksson, Maria J.			Gradual reduction in exercise capacity in chronic kidney disease is associated with systemic oxygen delivery factors	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; MUSCLE STRENGTH; CARDIOVASCULAR RESERVE; BICYCLE EXERCISE; AEROBIC CAPACITY; DETERMINANTS; HEART; MASS; CONTRIBUTES; CONSUMPTION	Background The cause of reduced exercise capacity (ExCap) in chronic kidney disease (CKD) is multifactorial. The aim of this study was to investigate determinants of aerobic ExCap in patients with mild to severe CKD not undergoing dialysis. Methods We included 52 individuals with CKD stage 2-3, 47 with stage 4-5, and 54 healthy controls. Peak workload and peak heart rate (HR) were assessed by a maximal cycle exercise test. Cardiac function including stroke volume (SV) and vascular stiffness were evaluated by ultrasound at rest. Handgrip strength, body composition, haemoglobin level and self-reported physical activity were assessed. Results Peak workload (221 +/- 60, 185 +/- 59, 150 +/- 54 W for controls, CKD 2-3 and CKD 4-5 respectively), peak HR (177 +/- 11, 161 +/- 24, 144 +/- 31 beats/min) and haemoglobin level (14.2 +/- 1.2, 13.5 +/- 1.4, 12.2 +/- 1.3 g/dL) were all three significantly lower in CKD 2-3 than in controls, (p = 0.001, 0.001 and 0.03 respectively) and were even lower in stages 4-5 CKD than in CKD 2-3 (p = 0.01, 0.001 and <0.001 respectively). Resting SV and lean body mass did not differ between groups and handgrip strength was significantly lower only in CKD 4-5 compared to controls (p = 0.02). Peak workload was strongly associated with the systemic oxygen delivery factors: SV, peak HR and haemoglobin level. These three factors along with age, sex and height(2) explained 82% of variation in peak workload. Peak HR contributed most to the variation; the peripheral variables handgrip strength and vascular stiffness did not improve the explanatory value in regression analysis. Conclusions In this cross-sectional study of CKD patients not on dialysis, aerobic ExCap decreased gradually with disease severity. ExCap was associated mainly with systemic oxygen delivery factors, in particular peak HR. Neither muscle function and mass, nor vascular stiffness were independent determinants of aerobic ExCap in this group of CKD patients.	[Wallin, Helena; Jansson, Eva; Rickenlund, Anette] Karolinska Inst, Div Clin Physiol, Dept Lab Med, Stockholm, Sweden; [Wallin, Helena; Asp, Anna M.; Jansson, Eva; Caidahl, Kenneth; Rickenlund, Anette; Eriksson, Maria J.] Karolinska Univ Hosp, Dept Clin Physiol, Stockholm, Sweden; [Asp, Anna M.; Caidahl, Kenneth; Rickenlund, Anette; Eriksson, Maria J.] Karolinska Institutet, Dept Mol Med & Surg, Stockholm, Sweden; [Wallquist, Carin; Rossner, Britta Hylander] Karolinska Inst, Karolinska Univ Hosp, Dept Nephrol, Stockholm, Sweden; [Caidahl, Kenneth] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Jacobson, Stefan H.] Karolinska Inst, Dept Clin Sci, Div Nephrol, Danderyd Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; Danderyds Hospital; Karolinska Institutet	Wallin, H (corresponding author), Karolinska Inst, Div Clin Physiol, Dept Lab Med, Stockholm, Sweden.; Wallin, H (corresponding author), Karolinska Univ Hosp, Dept Clin Physiol, Stockholm, Sweden.	helena.wallin@ki.se	Caidahl, Kenneth/AAQ-2645-2021	Wallquist, Carin/0000-0001-7063-2925; Wallin, Helena/0000-0001-9187-2426	Stockholm County Council [20150555, 20120628]	Stockholm County Council(Stockholm County Council)	The study was supported by grants from: the Stockholm County Council (https://forskningsstod.vmi.se/Ansokan/start.asp), grant numbers 20150555 and 20120628 received by MJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2006, AM J PHYSIOL-RENAL, V290, pF753, DOI 10.1152/ajprenal.00296.2005; Asp AM, 2017, CLIN PHYSL FUNCT IMA; Asp AM, 2015, CLIN PHYSIOL FUNCT I, V35, P223, DOI 10.1111/cpf.12154; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Beetham KS, 2015, REDOX REP, V20, P126, DOI 10.1179/1351000214Y.0000000114; BEVEGARD S., 1963, ACTA PHYSIOL SCAND, V57, P26; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brudin L, 2014, CLIN PHYSIOL FUNCT I, V34, P297, DOI 10.1111/cpf.12097; Carrick-Ranson G, 2013, J GERONTOL A-BIOL, V68, P608, DOI 10.1093/gerona/gls220; Chinnappa S, 2017, NEPHROL DIAL TRANSPL; CLYNE N, 1994, NEPHRON, V67, P322, DOI 10.1159/000187987; CONJARD A, 1995, J AM SOC NEPHROL, V6, P68; DIESEL W, 1993, AM J KIDNEY DIS, V22, P677, DOI 10.1016/S0272-6386(12)80430-6; DIESEL W, 1990, AM J KIDNEY DIS, V16, P109, DOI 10.1016/S0272-6386(12)80563-4; EKBLOM B, 1972, SCAND J CLIN LAB INV, V30, P35, DOI 10.3109/00365517209081087; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Faria RD, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-184; Ferretti G, 2014, EUR J APPL PHYSIOL, V114, P2007, DOI 10.1007/s00421-014-2911-0; Hathaway DK, 1998, AM J KIDNEY DIS, V32, P221, DOI 10.1053/ajkd.1998.v32.pm9708605; Heimburger O, 2000, AM J KIDNEY DIS, V36, P1213, DOI 10.1053/ajkd.2000.19837; Heiwe S, 2005, AM J PHYS MED REHAB, V84, P865, DOI 10.1097/01.phm.0000184244.86297.6b; Heiwe Susanne, 2003, Physiother Res Int, V8, P167, DOI 10.1002/pri.287; HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281; Howden EJ, 2015, J SCI MED SPORT, V18, P492, DOI 10.1016/j.jsams.2014.07.005; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; JONDEAU G, 1992, CIRCULATION, V86, P1351, DOI 10.1161/01.CIR.86.5.1351; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; KRUTZEN E, 1984, J LAB CLIN MED, V104, P955; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leikis MJ, 2006, CLIN J AM SOC NEPHRO, V1, P488, DOI 10.2215/CJN.01501005; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; MACDOUGALL IC, 1990, LANCET, V335, P489, DOI 10.1016/0140-6736(90)90733-L; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; MOORE GE, 1993, AM J KIDNEY DIS, V22, P277, DOI 10.1016/S0272-6386(12)70319-0; MOORE GE, 1993, MED SCI SPORT EXER, V25, P18, DOI 10.1249/00005768-199301000-00004; Nelson A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000370; Odden MC, 2004, J AM SOC NEPHROL, V15, P2908, DOI 10.1097/01.ASN.0000143743.78092.E3; Padilla J, 2008, J NEPHROL, V21, P550; PAINTER P, 1987, AM J KIDNEY DIS, V10, P452, DOI 10.1016/S0272-6386(87)80192-0; Painter P, 2009, ADV CHRONIC KIDNEY D, V16, P437, DOI 10.1053/j.ackd.2009.09.002; Sala E, 2001, AM J PHYSIOL-REG I, V280, pR1240, DOI 10.1152/ajpregu.2001.280.4.R1240; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; SALTIN B, 1992, MED SCI SPORT EXER, V24, P30; Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Stray-Gundersen J, 2016, J AM SOC NEPHROL, V27, P3769, DOI 10.1681/ASN.2015091034; Tanabe Y, 2002, INT J CARDIOL, V83, P57, DOI 10.1016/S0167-5273(02)00013-X; Ting SMS, 2015, AM J KIDNEY DIS, V66, P274, DOI 10.1053/j.ajkd.2015.02.335; Ting SMS, 2014, J AM SOC NEPHROL, V25, P187, DOI 10.1681/ASN.2013040348; Van Craenenbroeck AH, 2016, NEPHROL DIAL TRANSPL, V31, P2064, DOI 10.1093/ndt/gfw303; WALLIN L, 1988, CLIN PHYSIOL, V8, P529, DOI 10.1111/j.1475-097X.1988.tb00218.x	52	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209325	10.1371/journal.pone.0209325	http://dx.doi.org/10.1371/journal.pone.0209325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566512	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300084
J	Wilson, AE; Sparks, DL; Knott, KK; Willard, S; Brown, A				Wilson, Abbey E.; Sparks, Darrell L.; Knott, Katrina K.; Willard, Scott; Brown, Ashli			Implementing solid phase microextraction (SPME) as a tool to detect volatile compounds produced by giant pandas in the environment	PLOS ONE			English	Article							ANOGENITAL GLAND SECRETIONS; AILUROPODA-MELANOLEUCA; ORGANIC-COMPOUNDS; GAS-CHROMATOGRAPHY; INDOOR AIR; CHEMICAL COMMUNICATION; SEX; PHEROMONES; COLEOPTERA; SIGNALS	Chemical cues are thought to play an important role in mate identification in the solitary giant panda (Ailuropoda melanoleuca). The goal of this study was to detect and identify volatile compounds present in the enclosure air of captive giant pandas. We hypothesized that a subset of compounds produced from breeding animals would be detected in environmental samples because highly volatile chemicals are likely to facilitate mate detection. Samples were collected from the enclosures of 8 giant pandas (n = 4 male, n = 4 female) during the Mar-June breeding season and the Aug-Jan non-breeding period from 2012-2015. Volatile compounds were captured by securing a solid phase micro extraction fiber approximately 3 meters above the ground within a panda enclosure for 6-12 hours. Compounds adsorbed onto the SPME fibers were analyzed by gas chromatography mass spectrometry. Thirty-three compounds were detected in at least 10% of all samples within individual and season and across all subjects within each season. Aromatic compounds made up 27.3% of the enclosure volatile profile, while 21.2% was made of cyclic aliphatic compounds and 51.5% of the enclosure profile was comprised of acyclic aliphatic compounds. Three compounds were likely to be present in male enclosures regardless of season, while Undecane, 4-methyl had a significant (p<0.05) predicted probability of being present in female enclosures. 3,3'-(1,1-Ethanediyl)bis(1H-indole) had a significant (p<0.05) probability of occurrence in male enclosures during the breeding season. Given the prevalence of these compounds, we suspect that these chemicals are important in giant panda communication. This novel sampling technique can detect volatile compounds produced by captive species and also may be a useful tool for detecting pheromones in free-ranging individuals.	[Wilson, Abbey E.; Sparks, Darrell L.; Willard, Scott; Brown, Ashli] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Wilson, Abbey E.] Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA; [Sparks, Darrell L.; Brown, Ashli] Mississippi State Univ, Mississippi State Chem Lab, Mississippi State, MS 39762 USA; [Knott, Katrina K.] Cent Reg Off & Conservat Res Ctr, Aquat Syst & Environm Hlth Unit, Resource Sci Div, Missouri Dept Conservat, Columbia, MO USA	Mississippi State University; Mississippi State University; University of Missouri System; University of Missouri Columbia	Sparks, DL (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.; Sparks, DL (corresponding author), Mississippi State Univ, Mississippi State Chem Lab, Mississippi State, MS 39762 USA.	dsparks@bch.msstate.edu		Wilson, Abbey/0000-0002-5659-6216	US Forest Service International Programs [07-DG-11132762-236]; Memphis Zoological Society [CTD 6-17-2016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	US Forest Service International Programs; Memphis Zoological Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Forest Service International Programs (Award Number: 07-DG-11132762-236; URL: https://www.fs.fed.us/about-agency/international-programs; DS), Memphis Zoological Society (Award Number: CTD 6-17-2016; URL: https://www.memphiszoo.org/; DS), and in part by a gift from the Leo Seal Family Foundation. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The Memphis Zoological Society assisted with data collection.	Achiraman S, 2006, THERIOGENOLOGY, V66, P1913, DOI 10.1016/j.theriogenology.2006.05.010; Aitken-Palmer C, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099044; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; An M, 2001, J CHROMATOGR A, V917, P245, DOI 10.1016/S0021-9673(01)00657-4; [Anonymous], 2014, PHEROMONES ANIMAL BE; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Brown AE, 2006, J CHEM ECOL, V32, P2489, DOI 10.1007/s10886-006-9158-0; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Burken JG, 2011, ENVIRON SCI TECHNOL, V45, P6218, DOI 10.1021/es2005286; Czekala N, 2003, ZOO BIOL, V22, P389, DOI 10.1002/zoo.10108; Davoli E, 2003, CHEMOSPHERE, V51, P357, DOI 10.1016/S0045-6535(02)00845-7; Dehnhard M, 2006, THERIOGENOLOGY, V66, P1755, DOI 10.1016/j.theriogenology.2006.01.012; Dehnhard M, 2005, CHEM SIGNAL, V10, P110, DOI 10.1007/0-387-25160-X_15; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ferrari F, 2004, ANAL BIOANAL CHEM, V379, P476, DOI 10.1007/s00216-004-2587-0; Gassett JW, 1997, J CHEM ECOL, V23, P569, DOI 10.1023/B:JOEC.0000006397.63647.5b; Gorlo D, 1999, FRESEN J ANAL CHEM, V363, P696, DOI 10.1007/s002160051273; Grote C, 1997, ANAL CHEM, V69, P587, DOI 10.1021/ac960749l; Guan J, 2014, BUILD ENVIRON, V72, P154, DOI 10.1016/j.buildenv.2013.11.002; Hagey L, 2003, J CHEM ECOL, V29, P1479, DOI 10.1023/A:1024225806263; Isetun S, 2005, ANALYST, V130, P94, DOI 10.1039/b410597d; Isetun S, 2004, ANAL BIOANAL CHEM, V380, P319, DOI 10.1007/s00216-004-2760-5; Isidorov VA, 2003, ATMOS ENVIRON, V37, P4645, DOI 10.1016/j.atmosenv.2003.07.005; Jia MY, 2000, FIELD ANAL CHEM TECH, V4, P73, DOI 10.1002/1520-6521(2000)4:2/3<73::AID-FACT2>3.0.CO;2-7; Ju Q, 2017, J CHEM ECOL, V43, P236, DOI 10.1007/s10886-017-0823-2; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Koziel JA, 2001, ENVIRON SCI TECHNOL, V35, P1481, DOI 10.1021/es001653i; Koziel Ja, 2001, J CHROMATOGR SCI, V44, P451; Larroque V, 2006, J ENVIRON MONITOR, V8, P106, DOI 10.1039/b511201j; Lestremau F, 2003, J CHROMATOGR A, V999, P71, DOI 10.1016/S0021-9673(03)00328-5; Liu DZ, 2008, CHINESE SCI BULL, V53, P2793, DOI 10.1007/s11434-008-0373-7; Liu DZ, 2006, CHINESE SCI BULL, V51, P1986, DOI 10.1007/s11434-006-2088-y; Liu DZ, 2013, CHEM SIGNAL, V12, P207, DOI 10.1007/978-1-4614-5927-9_16; MALOSSE C, 1995, HRC-J HIGH RES CHROM, V18, P669; Muller L, 1999, FRESEN J ANAL CHEM, V364, P610, DOI 10.1007/s002160051396; Pawliszyn J., 1997, SOLID PHASE MICROEXT; Rasmussen LEL, 2001, CHEM SENSES, V26, P611, DOI 10.1093/chemse/26.6.611; Raveane L, 2013, J FORESTRY RES, V24, P439, DOI 10.1007/s11676-013-0376-3; Rochat D, 2000, J CHROMATOGR A, V885, P433, DOI 10.1016/S0021-9673(99)01049-3; Sanusi A, 2003, J ENVIRON MONITOR, V5, P574, DOI 10.1039/b302608f; Schaller G.B., 1985, GIANT PANDAS WOLONG; Sergiel A, 2017, SCI REP, V7, P1; Spinhirne JP, 2004, J CHROMATOGR A, V1025, P63, DOI 10.1016/j.chroma.2003.08.062; Spinhirne JP, 2003, BIOSYST ENG, V84, P239, DOI 10.1016/S1537-5110(02)00240-4; Swaisgood R., 2016, IUCN RED LIST THREAT; Swaisgood Ronald R., 2004, P106; Swaisgood RR, 2000, ANIM BEHAV, V60, P227, DOI 10.1006/anbe.2000.1464; Swaisgood RR, 1999, ANIM BEHAV, V57, P1045, DOI 10.1006/anbe.1998.1070; Swaisgood RR, 2002, J ZOOL, V257, P381, DOI 10.1017/S0952836902000985; Tobey JRA, 2009, AGE SEASONAL CHANGES, P111; Vaglio S, 2009, J CHEM ECOL, V35, P131, DOI 10.1007/s10886-008-9573-5; White AM, 2003, J ZOOL, V259, P171, DOI 10.1017/S0952836902003187; White AM, 2002, BEHAV ECOL SOCIOBIOL, V51, P519, DOI 10.1007/s00265-002-0473-3; Wiedower EE, 2012, FECAL NEAR INFRARED, DOI [10.1371/journal.pone.0038908, DOI 10.1371/JOURNAL.PONE.0038908]; Wilson A., 2017, CHEM SIGNALING GIANT; Yassaa N, 2007, J CHROMATOGR A, V1141, P138, DOI 10.1016/j.chroma.2006.12.006; Yuan H, 2004, CAN J ZOOL, V82, P1596, DOI 10.1139/Z04-144; Zhang JX, 2008, CHEM SENSES, V33, P611, DOI 10.1093/chemse/bjn028; Zhang JX, 2008, J CHEM ECOL, V34, P398, DOI 10.1007/s10886-008-9441-3; ZHANG ZY, 1993, ANAL CHEM, V65, P1843, DOI 10.1021/ac00062a008; Zhou SN, 2008, ENVIRON SCI TECHNOL, V42, P6073, DOI 10.1021/es8001162	65	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208618	10.1371/journal.pone.0208618	http://dx.doi.org/10.1371/journal.pone.0208618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566455	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300052
J	Kitanaka, N; Nakano, R; Kitanaka, T; Namba, S; Konno, T; Nakayama, T; Sugiya, H				Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Nakayama, Tomohiro; Sugiya, Hiroshi			NF-kappa B p65 and p105 implicate in interleukin 1 beta-mediated COX-2 expression in melanoma cells	PLOS ONE			English	Article							MALIGNANT-MELANOMA; POSTTRANSLATIONAL MODIFICATIONS; CYCLOOXYGENASE-2 COX-2; INFLAMMATION; CANCER; PHOSPHORYLATION; KINASE; GROWTH; ACTIVATION; MIGRATION	Inflammatory and microenvironmental factors produced by cancer cells are thought to directly or indirectly promote cancer cell growth. Prostaglandins, including prostaglandin E2, have key roles as a microenvironment factor in influencing the development of tumors, and are produced by the rate limiting enzyme cyclooxygenase 2 (COX-2). In this study, we used canine melanoma cells treated with the proinflammatory cytokine interleukin 1 beta (IL-1 beta) and investigated the transcriptional factor nuclear factor-kappa B (NF-kappa B) signaling in IL-1 beta-induced COX-2 expression. IL-1 beta induced prostaglandin E2 release and COX-2 mRNA expression in a time- and dose-dependent manner. In the cells treated with the NF-kappa B inhibitors BAY11-7082 and TPC-1, IL-1 beta-mediated prostaglandin E2 release and COX-2 mRNA expression were inhibited. IL-1 beta also provoked phosphorylation of p65/RelA and p105/NF-kappa B1, which are members of the NF-kappa B families. The IL-1 beta-induced phosphorylation of p65 and p105 was attenuated in the presence of both NF-kappa B inhibitors. In melanoma cells transfected with siRNA of p65 or p105, IL-1 beta-mediated COX-2 mRNA expression was inhibited. These findings suggest that canonical activation of NF-kappa B signaling plays a crucial role for inflammatory states in melanoma cells.	[Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Labs Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN, Ctr Integrat Med Sci, Lab Cellular Funct Convers Technol, Suehiro Cho, Yokohama, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Vet Radiotherapy, Fujisawa, Kanagawa, Japan	Nihon University; RIKEN; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Labs Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022		Ministry of Education, Science, Sports, and Culture of Japan [18K14594]; Nihon University [17-019]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University	This study was funded by the Ministry of Education, Science, Sports, and Culture of Japan (#18K14594) to Rei Nakano and Nihon University Multidisciplinary Research Grant for 2017 (17-019) Tomohiro Nakayama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Atherton MJ, 2016, VET IMMUNOL IMMUNOP, V169, P15, DOI 10.1016/j.vetimm.2015.11.003; Becker MR, 2009, MELANOMA RES, V19, P8, DOI 10.1097/CMR.0b013e32831d7f52; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Bergman PJ, 2007, CLIN TECH SMALL AN P, V22, P55, DOI 10.1053/j.ctsap.2007.03.004; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bundscherer A, 2008, ONCOL REP, V19, P547; Cartwright T, 2016, FEBS J, V283, P1812, DOI 10.1111/febs.13627; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Christian F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010012; Chwirot BW, 2007, MELANOMA RES, V17, P139, DOI 10.1097/CMR.0b013e3280dec6ac; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; Denkert C, 2001, CANCER RES, V61, P303; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; FUJIMOTO K, 1995, GENE, V165, P183, DOI 10.1016/0378-1119(95)00507-3; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Goulet AC, 2003, CANCER BIOL THER, V2, P713; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Harris Randall E, 2012, J Exp Pharmacol, V4, P91, DOI 10.2147/JEP.S23826; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Iida Y, 2017, CLIN CANCER RES, V23, P4831, DOI 10.1158/1078-0432.CCR-17-0146; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim KM, 2016, CANCER SCI, V107, P181, DOI 10.1111/cas.12852; Kontos S, 2010, ADV UROL, V2010, DOI 10.1155/2010/871356; Konturek PC, 2004, DIGEST DIS SCI, V49, P1075, DOI 10.1023/B:DDAS.0000037790.11724.70; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kuzbicki L, 2006, MELANOMA RES, V16, P29; Lavi G, 2007, J CONTROL RELEASE, V123, P123, DOI 10.1016/j.jconrel.2007.07.015; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez CM, 2011, VET PATHOL, V48, P1204, DOI 10.1177/0300985810396517; Milanovic M, 2014, BIOCHEM J, V457, P401, DOI 10.1042/BJ20130780; Nakano R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26473-7; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Pang L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3453059; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Phelps CB, 2000, J BIOL CHEM, V275, P29840, DOI 10.1074/jbc.M004899200; Qin Y, 2011, MOL CANCER RES, V9, P1537, DOI 10.1158/1541-7786.MCR-11-0279; Rakhesh M, 2012, ONCOIMMUNOLOGY, V1, P1495, DOI 10.4161/onci.22089; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanz-Motilva V, 2012, CURR PHARM DESIGN, V18, P3966, DOI 10.2174/138161212802083680; Schneider SL, 2015, EXP DERMATOL, V24, P86, DOI 10.1111/exd.12502; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Vaid M, 2015, AM J CANCER RES, V5, P3325; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Xia LZ, 2018, ONCOTARGETS THER, V11, P2063, DOI 10.2147/OTT.S161109; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	74	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208955	10.1371/journal.pone.0208955	http://dx.doi.org/10.1371/journal.pone.0208955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562372	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100029
J	Blecher, E; Liber, A; Van Walbeek, C; Rossouw, L				Blecher, Evan; Liber, Alex; Van Walbeek, Corne; Rossouw, Laura			An international analysis of the price and affordability of beer	PLOS ONE			English	Article							CIGARETTE AFFORDABILITY; ALCOHOL AFFORDABILITY; CONSUMPTION; TRENDS; METAANALYSIS; DEMAND	Aims To apply methods for measuring the affordability of beer in a large cross section of countries, and to investigate trends in affordability of beer over time. Methods We use the Relative Income Price (RIP), which uses per capita GDP, to measure the affordability of beer in up to 92 countries from 1990 to 2016 (69 countries were included in 1990, however the survey has since grown to include 92 countries). In addition to affordability, we also investigate trends in the price of beer. Results While beer is, on average, similarly priced in high-income (HICs) and low- and middle-income countries (LMICs), it is significantly more affordable in HICs. There is significant variation in both price and affordability in HICs and in LMICs. Beer has become cheaper in real terms in 49% (18/37) of HICs and 43% (20/46) of LMICs. Beer became more affordable in most HICs (RIP: 30/37 or 81%) and LMICs (RIP: 42/44 or 95%) Conclusions The increased affordability over time of beer in most countries raises concerns about public health. Governments need to increase taxes on beer so that it becomes less affordable over time, in an effort to improve public health.	[Blecher, Evan] Univ Illinois, Hlth Policy Ctr, Inst Hlth Res & Policy, Chicago, IL USA; [Blecher, Evan; Van Walbeek, Corne] Univ Cape Town, Sch Econ, Cape Town, South Africa; [Liber, Alex] Amer Canc Soc, Econ & Hlth Policy Res, Atlanta, GA 30329 USA; [Liber, Alex] Univ Michigan, Hlth Management & Policy Dept, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Van Walbeek, Corne; Rossouw, Laura] Univ Cape Town, Econ Tobacco Control Project, Southern African Labour & Dev Res Unit, Cape Town, South Africa	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Cape Town; American Cancer Society; University of Michigan System; University of Michigan; University of Cape Town	Rossouw, L (corresponding author), Univ Cape Town, Econ Tobacco Control Project, Southern African Labour & Dev Res Unit, Cape Town, South Africa.	laura.rossouw@gmail.com	van Walbeek, Corne/AFV-9136-2022; Liber, Alex/K-5989-2013	van Walbeek, Corne/0000-0003-0933-435X; Rossouw, Laura/0000-0001-7697-9567; Liber, Alex/0000-0001-7863-3906	World Health Organization South Africa country office	World Health Organization South Africa country office	The World Health Organization South Africa country office funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. American Cancer Society Inc. purchased access to the EIU price data utilized in the project.	[Anonymous], 2014, ECONOMIST; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bandi P, 2013, NICOTINE TOB RES, V15, P1484, DOI 10.1093/ntr/nts348; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Blecher EH, 2009, TOB CONTROL, V18, P167, DOI 10.1136/tc.2008.026682; Blecher EH, 2004, TOB CONTROL, V13, P339, DOI 10.1136/tc.2003.006726; Blecher ELA, 2017, PREV CHRONIC DIS, P14; Blecher E, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050575; Bloom DE., 2012, GLOBAL EC BURDEN NON; Crotty A., 2014, SUNDAY TIMES S  0525; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Eriksen M, 2012, TOBACCO ATLAS AM CAN; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Grittner U, 2012, ALCOHOL ALCOHOLISM, V47, P597, DOI 10.1093/alcalc/ags040; Guindon G, 2010, LUNG; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Guindon GE., 2010, TOBACCO TAXATION VIE; Jiang H, 2015, ALCOHOL ALCOHOLISM, V50, P631, DOI 10.1093/alcalc/agv064; Kan MY, 2007, TOB CONTROL, V16, P429, DOI 10.1136/tc.2007.020487; Kan MY, 2013, DRUG ALCOHOL REV, V32, P19, DOI 10.1111/j.1465-3362.2012.00476.x; Kerr WC, 2013, AM J PREV MED, V44, P459, DOI 10.1016/j.amepre.2013.01.007; Lal A, 2002, TOB CONTROL, V11, P280, DOI 10.1136/tc.11.3.280-b; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mackay J, 2006, TOBACCO ATLAS; Nargis N, 2016, TREND AFFORDABILITY; Nelson JP, 2014, ALCOHOL CLIN EXP RES, V38, P1167, DOI 10.1111/acer.12345; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rabinovich L, 2012, RAND HLTH Q, V2; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Scollo M, 1996, Tob Control, V5, P69, DOI 10.1136/tc.5.1.69a; Sharma A, 2017, BRIT MED B, V1, P1; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Bank Group, 2020, WORLD DEV IND; World Health Organization, 2010, GLOB STRAT RED HARMF	36	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208831	10.1371/journal.pone.0208831	http://dx.doi.org/10.1371/journal.pone.0208831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557353	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000048
J	Moen, E; Handegard, NO; Allken, V; Albert, OT; Harbitz, A; Malde, K				Moen, Endre; Handegard, Nils Olav; Allken, Vaneeda; Albert, Ole Thomas; Harbitz, Alf; Malde, Ketil			Automatic interpretation of otoliths using deep learning	PLOS ONE			English	Article								The age structure of a fish population has important implications for recruitment processes and population fluctuations, and is a key input to fisheries-assessment models. The current method of determining age structure relies on manually reading age from otoliths, and the process is labor intensive and dependent on specialist expertise. Recent advances in machine learning have provided methods that have been remarkably successful in a variety of settings, with potential to automate analysis that previously required manual curation. Machine learning models have previously been successfully applied to object recognition and similar image analysis tasks. Here we investigate whether deep learning models can also be used for estimating the age of otoliths from images. We adapt a pre-trained convolutional neural network designed for object recognition, to estimate the age of fish from otolith images. The model is trained and validated on a large collection of images of Greenland halibut otoliths. We show that the model works well, and that its precision is comparable to documented precision obtained by human experts. Automating this analysis may help to improve consistency, lower cost, and increase the extent of age estimation. Given that adequate data are available, this method could also be used to estimate age of other species using images of otoliths or fish scales.	[Moen, Endre; Handegard, Nils Olav; Allken, Vaneeda; Albert, Ole Thomas; Harbitz, Alf; Malde, Ketil] Inst Marine Res, Bergen, Norway; [Malde, Ketil] Univ Bergen, Dept Informat, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Moen, E (corresponding author), Inst Marine Res, Bergen, Norway.	endre.moen@hi.no	M, Ketil/AAH-5604-2020	Moen, Endre/0000-0003-4805-8992	Research Council of Norway [270966/O70]; Norwegian Ministry of Trade, Industry and Fisheries	Research Council of Norway(Research Council of Norway); Norwegian Ministry of Trade, Industry and Fisheries	This work was funded in its entirety by the Research Council of Norway, grant 270966/O70, and by the Norwegian Ministry of Trade, Industry and Fisheries. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes S, 2015, CAN J FISH AQUAT SCI, V72, P938, DOI 10.1139/cjfas-2014-0408; Abadi M., 2016, TENSORFLOW LARGE SCA; Albert OT, 2016, MAR FRESHWATER RES, V67, P937, DOI 10.1071/MF15089; Albert O. T., 2009, J NW ATLANTIC FISHER, V40, P81, DOI DOI 10.2960/J.V40.M659; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bengio Y, 1994, ADV NEURAL INF PROCE, P937; Boureau Y-L., 2010, P 27 INT C MACH LEAR, P111, DOI DOI 10.5555/3104322.3104338; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CAMPANA SE, 1995, T AM FISH SOC, V124, P131, DOI 10.1577/1548-8659(1995)124<0131:GASMFD>2.3.CO;2; Chollet F, 2018, KERAS 2 1 3; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Fablet R, 2005, FISH RES, V72, P279, DOI 10.1016/j.fishres.2004.10.008; Fisher M, 2018, MAR ECOL PROG SER, V598, P213, DOI 10.3354/meps12531; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; HILBORN R, 1992; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; ICES, 2016, 2016SSGIEOM16 ICES C; ICES, 2011, 2011ACOM41 ICFS CM; Jones E., 2001, SCIPY OPEN SOURCE SC; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Panfili J, 2002, MANUAL FISH SCLEROCH; Robertson S, 2001, DEV ARITIFICIAL NEUR; Shen W, 2015, PROC CVPR IEEE, P3982, DOI 10.1109/CVPR.2015.7299024; Szegedy C., 2017, AAAI, DOI DOI 10.1016/J.PATREC.2014.01.008; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Talman S., 2003, AGE ESTIMATION DEEPW; van Gerven M., 2017, FRONT COMPUT NEUROSC, V11; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	31	26	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0204713	10.1371/journal.pone.0204713	http://dx.doi.org/10.1371/journal.pone.0204713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557335	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000009
J	Tornbom, K; Danielsson, A				Tornbom, Karin; Danielsson, Anna			Experiences of treadmill walking with non-immersive virtual reality after stroke or acquired brain injury - A qualitative study	PLOS ONE			English	Article							GAIT; SPEED; REHABILITATION; POSTSTROKE; MOBILITY; FEEDBACK; PROGRAM	Objectives It is well known that physical activity levels for persons after stroke or acquired brain injuries do not reach existing recommendations. Walking training is highly important since the ability to walk is considered to be a meaningful occupation for most people, and is often reduced after a brain injury. This suggests a need to innovate stroke rehabilitation, so that forms of walking training that are user-friendly and enjoyable can be provided. Method An interview study was carried out with persons after stroke (n = 8), or acquired brain injury (n = 2) at a rehabilitation unit at Sahlgrenska University Hospital. We used a semi-structured interview guide to investigate experiences and thoughts about walking on a treadmill with non-immersive virtual reality feedback. The contents were analyzed through an inductive approach, using qualitative content analysis. Results The virtual reality experience was perceived as enjoyable, exciting, and challenging. Participants stressed that the visual and auditory feedback increased their motivation to walk on a treadmill. However, for some participants, the virtual reality experience was too challenging, and extreme tiredness or fatigue were reported after the walking session. Conclusions Participants' thoughts and experiences indicated that the Virtual Reality walking system could serve as a complement to more traditional forms of walking training. Early after a brain injury, virtual reality could be a way to train the ability to handle individually adapted multisensory input while walking. Obvious benefits were that participants perceived it as engaging and exciting.	[Tornbom, Karin; Danielsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Res Grp Rehabil Med, Gothenburg, Sweden; [Tornbom, Karin] Univ Gothenburg, Ctr Person Ctr Care, Gothenburg, Sweden; [Danielsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Unit Physiotherapy,Dept Hlth & Rehabil, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Tornbom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Res Grp Rehabil Med, Gothenburg, Sweden.; Tornbom, K (corresponding author), Univ Gothenburg, Ctr Person Ctr Care, Gothenburg, Sweden.	karin.tombom@neuro.gu.se		Danielsson, Anna/0000-0002-6496-4066	John and Brit Wennerstrom foundation for Neurological Research; NorrbackaEugenia foundation [808-12]; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation [HJSV2012056, HJSV 201354, HJSV20166034]; Swedish Stroke Centre West	John and Brit Wennerstrom foundation for Neurological Research; NorrbackaEugenia foundation; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation; Swedish Stroke Centre West	This work was supported by: John and Brit Wennerstrom foundation for Neurological Research (A.D). The NorrbackaEugenia foundation, 808-12 (A.D). Rune and Ulla Amlovs foundation for Neurological Research (A.D). The Swedish Stroke association (A.D, K.T). Hjalmar Svensson foundation, HJSV2012056, HJSV 201354, HJSV20166034 (A. D). The Swedish Stroke Centre West (A.D, K.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Aminov A, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0370-2; Baram Y, 2012, NEUROMODULATION, V15, P48, DOI 10.1111/j.1525-1403.2011.00412.x; Bergmann J., 2017, EUROPEAN J PHYS REHA; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Celinder D, 2012, SCAND J OCCUP THER, V19, P457, DOI 10.3109/11038128.2012.655307; Danielsson A, 2014, TURK WORLD C NEUR RE; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; FARROW S, 2004, TECHNOLOGY DISABILIT, V16, P69; Fini NA, 2017, PHYS THER, V97, P707, DOI 10.1093/ptj/pzx038; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gubrium JF, 2003, J GERONTOL B-PSYCHOL, V58, pS203, DOI 10.1093/geronb/58.4.S203; Harris-Love ML, 2004, NEUROREHAB NEURAL RE, V18, P154, DOI 10.1177/0888439004267678; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Khan F, 2016, J REHABIL MED, V48, P417, DOI 10.2340/16501977-2081; Kuys S, 2006, PHYSIOTHER RES INT, V11, P219, DOI 10.1002/pri.344; Kvale S., 2012, DOING INTERVIEWS; Lauber B, 2014, EUR J SPORT SCI, V14, P36, DOI 10.1080/17461391.2012.725104; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lewek MD, 2012, PHYS THER, V92, P748, DOI 10.2522/ptj.20110206; Lledo LD, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00205; Mao Y, 2016, FRONTIERS PSYCHOL, V7; Mattlage AE, 2015, J NEUROL PHYS THER, V39, P166, DOI 10.1097/NPT.0000000000000092; Mirelman A, 2009, STROKE, V40, P169, DOI 10.1161/STROKEAHA.108.516328; Moreira MC, 2013, DISABIL REHABIL-ASSI, V8, P357, DOI 10.3109/17483107.2012.749428; Nascimento LR, 2015, J PHYSIOTHER, V61, P10, DOI 10.1016/j.jphys.2014.11.015; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; Nishiike S, 2013, J MED INVESTIG, V60, P236; Pallesen H, 2018, REHABIL RES PRACT, V2018, DOI 10.1155/2018/4318678; Pallesen H, 2014, DISABIL REHABIL, V36, P232, DOI 10.3109/09638288.2013.788217; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Richards CL, 2018, PHYSIOTHER CAN, V70, P221, DOI 10.3138/ptc.2016-97; Shema SR, 2014, PHYS THER, V94, P1319, DOI 10.2522/ptj.20130305; Tornbom K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173463; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Wingham J, 2015, CLIN REHABIL, V29, P295, DOI 10.1177/0269215514542638; Witte US, 1997, SCAND J REHABIL MED, V29, P161	39	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209214	10.1371/journal.pone.0209214	http://dx.doi.org/10.1371/journal.pone.0209214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE3IQ	30550607	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000049
J	Maxson, T; Blancett, CD; Graham, AS; Stefan, CP; Minogue, TD				Maxson, Tucker; Blancett, Candace D.; Graham, Amanda S.; Stefan, Christopher P.; Minogue, Timothy D.			Rapid antibiotic susceptibility testing from blood culture bottles with species agnostic real-time polymerase chain reaction	PLOS ONE			English	Article							RESISTANCE; PCR	Development and implementation of rapid antimicrobial susceptibility testing is critical for guiding patient care and improving clinical outcomes, especially in cases of sepsis. One approach to reduce the time-to-answer for antimicrobial susceptibility is monitoring the inhibition of DNA production, as differences in DNA concentrations are more quickly impacted compared to optical density changes in traditional antimicrobial susceptibility testing. Here, we use real-time PCR to rapidly determine antimicrobial susceptibility after short incubations with antibiotic. Application of this assay to a collection of 144 isolates in mock blood culture, covering medically relevant pathogens displaying high rates of resistance, provided susceptibility data in under 4 hours. This assay provided categorical agreement with a reference method in 96.3% of cases across all species. Sequencing of a subset of PCR amplicons showed accurate genus level identification. Overall, implementation of this method could provide accurate susceptibility results with a reduced time-to-answer for a number of medically relevant bacteria commonly isolated from blood culture.	[Maxson, Tucker; Blancett, Candace D.; Graham, Amanda S.; Stefan, Christopher P.; Minogue, Timothy D.] US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA		Minogue, TD (corresponding author), US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA.	timothy.d.minogue.civ@mail.mil	Stefan, Christopher/V-5970-2019	Stefan, Christopher/0000-0003-4891-447X	Defense Threat Reduction Agency (DTRA) [CB10097]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency (DTRA) project number CB10097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltekin O, 2017, P NATL ACAD SCI USA, V114, P9170, DOI 10.1073/pnas.1708558114; Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999; Beuving J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027689; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; CLSI, 2017, 3100 CLSI S; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Fredborg M, 2013, J CLIN MICROBIOL, V51, P2047, DOI 10.1128/JCM.00440-13; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Kostic T, 2015, APPL MICROBIOL BIOT, V99, P7711, DOI 10.1007/s00253-015-6774-z; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Lange C, 2014, J CLIN MICROBIOL, V52, P4155, DOI 10.1128/JCM.01872-14; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Liu CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23375; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Luo J, 2018, INT J INFECT DIS, V70, P86, DOI 10.1016/j.ijid.2018.03.014; Malani AN, 2013, AM J INFECT CONTROL, V41, P145, DOI 10.1016/j.ajic.2012.02.021; Maurer FP, 2017, INFECT DIS REP, V9, P18, DOI 10.4081/idr.2017.6839; Maxson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183899; Mezger A, 2015, J CLIN MICROBIOL, V53, P425, DOI 10.1128/JCM.02434-14; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Schoepp NG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3693; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Stefan CP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19501-z; Ventola C Lee, 2015, P T, V40, P277; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zboromyrska Y, 2015, INT J ANTIMICROB AG, V46, P355, DOI 10.1016/j.ijantimicag.2015.06.002	29	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209042	10.1371/journal.pone.0209042	http://dx.doi.org/10.1371/journal.pone.0209042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543695	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500065
J	Wang, QY; Perez, CI; Masis, M; Feinstein, M; Mora, M; Lin, SC; Hsia, YC				Wang, Qinyun; Perez, Claudio, I; Masis, Marisse; Feinstein, Max; Mora, Marta; Lin, Shan C.; Hsia, Yen C.			Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE REDUCTION; OPTICAL COHERENCE TOMOGRAPHY; ANTERIOR-CHAMBER DEPTH; PRIMARY ANGLE-CLOSURE; CLEAR CORNEAL PHACOEMULSIFICATION; CATARACT-SURGERY; LENS IMPLANTATION; SEGMENT PARAMETERS; PREDICTORS; WIDTH	Purpose This prospective study used anterior segment optical coherence tomography (AS-OCT) to determine how phacoemulsification (phaco) changes iris parameters in eyes with glaucoma or glaucoma suspect status. Methods Using Visante AS-OCT (Carl Zeiss Meditec AG), the following pre- and post-phaco parameters were measured: IT750 = iris thickness at 750 mu m from the scleral spur; IT2000 = iris thickness 2000 mu m from the scleral spur; ITCM = the maximum iris thickness at the middle one third of the iris; ICURV = iris curvature; IAREA = iris area; and pupil size = pupil diameter (mm). Only high-quality images with an identifiable scleral spur were included, and only the nasal quadrant was analyzed. A single glaucoma specialist analyzed the parameters according to the Zhongshan Angle Assessment Program (ZAAP, Guangzhou, China). Multivariate analysis was performed using mixed effects regression correcting for age, gender, and ethnicity. Results 89 subjects and 110 eyes were included in this study. The mean age of subjects was 74.83 {+/-} 8.69 years old. Most common diagnoses were POAG and glaucoma suspect (23% and 52%, respectively), and 16% of subjects had an LPI. In multivariate analysis of AS-OCT parameters, decreases in IT750, IT2000, ITCM, ICURV, and pupil size were statistically significant (p<0.05). Conclusions After phacoemulsification, eyes with glaucoma as well as glaucoma suspect eyes have thinner irises and smaller pupils. This may lead to less iris-mediated aqueous outflow obstruction, providing support for early phacoemulsification glaucoma treatment. Translational relevance Our AS-OCT imaging findings may guide clinical practice as iris parameters become increasingly relevant in preoperative phaco planning.	[Wang, Qinyun; Perez, Claudio, I; Masis, Marisse; Feinstein, Max; Mora, Marta; Lin, Shan C.; Hsia, Yen C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Perez, Claudio, I] Univ los Andes, Fdn Oftalmol los Andes, Santiago, Chile	University of California System; University of California San Francisco; Universidad de los Andes - Chile	Wang, QY (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	qinyun.wang@ucsf.edu	Mora, Marta/HDM-9133-2022	/0000-0002-8324-0928				Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Borras T, 2014, J GLAUCOMA, V23, pS42; Chen PP, 2015, OPHTHALMOLOGY, V122, P1294, DOI 10.1016/j.ophtha.2015.03.021; Chua J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18039-w; Chua J, 2016, OPHTHALMOLOGY, V123, P2077, DOI 10.1016/j.ophtha.2016.06.034; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1014, DOI 10.1136/bjo.2006.091447; Foo LL, 2012, OPHTHALMOLOGY, V119, P278, DOI 10.1016/j.ophtha.2011.07.049; Gedde SJ, 2012, CURR OPIN OPHTHALMOL, V23, P118, DOI 10.1097/ICU.0b013e32834ff2d1; Hayashi K, 2000, OPHTHALMOLOGY, V107, P698, DOI 10.1016/S0161-6420(00)00007-5; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; Hsia YC, 2017, J CATARACT REFR SURG, V43, P879, DOI 10.1016/j.jcrs.2017.03.044; Hsu CH, 2015, INVEST OPHTH VIS SCI, V56, P7807, DOI 10.1167/iovs.15-17926; Huang GF, 2012, J CATARACT REFR SURG, V38, P108, DOI 10.1016/j.jcrs.2011.06.037; Huang GF, 2011, ARCH OPHTHALMOL-CHIC, V129, P1283, DOI 10.1001/archophthalmol.2011.272; Issa SA, 2005, BRIT J OPHTHALMOL, V89, P543, DOI 10.1136/bjo.2004.047662; Kashiwagi K, 2006, J GLAUCOMA, V15, P103, DOI 10.1097/00061198-200604000-00005; Komatsu M, 1998, OPHTHALMOLOGICA, V212, P169, DOI 10.1159/000027270; Komatsu M, 1997, OPHTHALMOLOGICA, V211, P332, DOI 10.1159/000310823; Lee W, 2017, INT J OPHTHALMOL-CHI, V10, P1239, DOI 10.18240/ijo.2017.08.09; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Lin Shan C, 2017, Trans Am Ophthalmol Soc, V115, pT6; Mak H, 2013, OPHTHALMOLOGY, V120, P2517, DOI 10.1016/j.ophtha.2013.05.009; Masis M, 2017, SURV OPHTHALMOL; Mathalone N, 2005, J CATARACT REFR SURG, V31, P479, DOI 10.1016/j.jcrs.2004.06.046; Melese E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162283; Moghimi S, 2015, EYE, V29, P1469, DOI 10.1038/eye.2015.141; Moghimi S, 2017, BRIT J OPHTHALMOL, V101, P283, DOI 10.1136/bjophthalmol-2016-308601; Moghimi S, 2016, J CURR OPHTHALMOL, V28, P170, DOI 10.1016/j.joco.2016.06.005; Muzyka-Wozniak M, 2016, J CATARACT REFR SURG, V42, P563, DOI 10.1016/j.jcrs.2015.12.050; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2010, OPHTHALMOLOGY, V117, P1, DOI 10.1016/j.ophtha.2009.11.002; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Sengupta S, 2016, OPHTHALMOLOGY, V123, P1695, DOI 10.1016/j.ophtha.2016.04.014; Shao TT, 2015, J GLAUCOMA, V24, P647, DOI 10.1097/IJG.0000000000000061; Shingleton BJ, 2006, J GLAUCOMA, V15, P494, DOI 10.1097/01.ijg.0000212294.31411.92; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Sidhartha E, 2014, OPHTHALMOLOGY, V121, P1007, DOI 10.1016/j.ophtha.2013.11.028; Sihota R, 2017, INDIAN J OPHTHALMOL, V65, P128, DOI 10.4103/ijo.IJO_875_16; Silver DM, 2004, J GLAUCOMA, V13, P100, DOI 10.1097/00061198-200404000-00004; Slabaugh MA, 2014, AM J OPHTHALMOL, V157, P26, DOI 10.1016/j.ajo.2013.08.023; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tseng VL, 2012, JAMA-J AM MED ASSOC, V308, P493, DOI 10.1001/jama.2012.9014; Vold S, 2016, OPHTHALMOLOGY, V123, P2103, DOI 10.1016/j.ophtha.2016.06.032; Wang W, 2016, INVEST OPHTH VIS SCI, V57, P5872, DOI 10.1167/iovs.16-19894; Yang HS, 2013, AM J OPHTHALMOL, V156, P89, DOI 10.1016/j.ajo.2013.02.003; Zacharias J, 2008, J CATARACT REFR SURG, V34, P846, DOI 10.1016/j.jcrs.2008.01.013	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208776	10.1371/journal.pone.0208776	http://dx.doi.org/10.1371/journal.pone.0208776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543659	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500036
J	Koskimaki, F; Bernard, J; Yong, J; Arndt, N; Carroll, T; Lee, SK; Reder, AT; Javed, A				Koskimaki, Fredrika; Bernard, Jacqueline; Yong, Jeong; Arndt, Nancy; Carroll, Timothy; Lee, Seon-Kyu; Reder, Anthony T.; Javed, Adil			Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment	PLOS ONE			English	Article							SPIN-ECHO MRI; BRAIN ATROPHY; WHITE-MATTER; FOLLOW-UP; HYPOINTENSE LESIONS; BLACK-HOLES; GREY-MATTER; CEREBROSPINAL-FLUID; CORTICAL ATROPHY; CONTROLLED TRIAL	Background Brain volume loss is an important surrogate marker for assessing disability in MS; however, contribution of gray and white matter to the whole brain volume loss needs further examination in the context of specific MS treatment. Objectives To examine whole and segmented gray, white, thalamic, and corpus callosum volume loss in stable patients receiving natalizumab for 2-5 years. Methods This was a retrospective study of 20 patients undergoing treatment with natalizumab for 24-68 months. Whole brain volume loss was determined with SIENA. Gray and white matter segmentation was done using FAST. Thalamic and corpus callosum volumes were determined using Freesurfer. T1 relaxation values of chronic hypointense lesions (black holes) were determined using a quantitative, in-house developed method to assess lesion evolution. Results Over a mean of 36.6 months, median percent brain volume change (PBVC) was -2.0% (IQR 0.99-2.99). There was decline in gray (p = 0.001) but not white matter (p = 0.6), and thalamic (p = 0.01) but not corpus callosum volume (p = 0.09). Gray matter loss correlated with PBVC (Spearman's r = 0.64, p = 0.003) but not white matter (Spearman's r = 0.42, p = 0.07). Age significantly influenced whole brain volume loss (p = 0.010, multivariate regression), but disease duration and baseline T2 lesion volume did not. There was no change in T1 relaxation values of lesions or T2 lesion volume over time. All patients remained clinically stable. Conclusions These results demonstrate that brain volume loss in MS is primarily driven by gray matter changes and may be independent of clinically effective treatment.	[Koskimaki, Fredrika] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland; [Koskimaki, Fredrika] Univ Turku, Turku, Finland; [Bernard, Jacqueline] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Yong, Jeong] Northwestern Univ, Biomed Engn, Chicago, IL 60611 USA; [Arndt, Nancy; Reder, Anthony T.; Javed, Adil] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Carroll, Timothy; Lee, Seon-Kyu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	University of Turku; University of Turku; Oregon Health & Science University; Northwestern University; University of Chicago; University of Chicago	Javed, A (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ajaved@neurology.bsd.uchicago.edu	Carroll, Timothy/B-6934-2009		Turku University Hospital, Division of Clinical Neurosciences, Finland	Turku University Hospital, Division of Clinical Neurosciences, Finland	FK was supported by a personal research project grant from Turku University Hospital, Division of Clinical Neurosciences, Finland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; F. K. was supported by a personal research project grant from Turku University Hospital, Division of Clinical Neurosciences, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Andorra M, 2018, JAMA NEUROL, V75, P1246, DOI 10.1001/jamaneurol.2018.1596; Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Chard DT, 2003, J NEUROL NEUROSUR PS, V74, P1551, DOI 10.1136/jnnp.74.11.1551; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Chataway J, 2013, NEUROTHERAPEUTICS, V10, P19, DOI 10.1007/s13311-012-0171-4; Ciampi E, 2017, MULT SCLER J, V23, P556, DOI 10.1177/1352458516656808; Coles AJ, 2017, NEUROLOGY, V89, P1117, DOI 10.1212/WNL.0000000000004354; Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; De Stefano N, 2002, J NEUROL, V249, P1072, DOI 10.1007/s00415-002-0790-5; De Stefano N, 2016, MULT SCLER RELAT DIS, V7, P98, DOI 10.1016/j.msard.2016.03.017; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Gaetano L, 2018, NEUROLOGY; Granberg T, 2017, BRAIN, V140, P2912, DOI 10.1093/brain/awx247; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Rojas JI, 2015, J NEUROIMAGING, V25, P68, DOI 10.1111/jon.12182; Jaworski J, 2012, UPSALA J MED SCI, V117, P284, DOI 10.3109/03009734.2012.669423; Khalid F, 2017, INT J NEUROSCI, V127, P396, DOI 10.1080/00207454.2016.1185421; Lassmann H, 2014, EXP NEUROL, V262, P2, DOI 10.1016/j.expneurol.2013.12.003; Magraner M, 2012, EUR J RADIOL, V81, P3485, DOI 10.1016/j.ejrad.2012.01.028; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Meeker RB, 2012, CELL ADHES MIGR, V6, P390, DOI 10.4161/cam.21054; Mellergard J, 2017, EUR J NEUROL, V24, P112, DOI 10.1111/ene.13162; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mineev K K, 2009, Neurosci Behav Physiol, V39, P35, DOI 10.1007/s11055-008-9086-2; Pagani E, 2005, AM J NEURORADIOL, V26, P341; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Portaccio E, 2013, EUR J NEUROL, V20, P986, DOI 10.1111/j.1468-1331.2012.03882.x; Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2; Putzki N, 2010, EUR J NEUROL, V17, P31, DOI 10.1111/j.1468-1331.2009.02728.x; Raz E, 2010, RADIOLOGY, V257, P448, DOI 10.1148/radiol.10100626; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573; Rudick RA, 2006, ANN NEUROL, V60, P236, DOI 10.1002/ana.20883; Sastre-Garriga J, 2015, MULT SCLER J, V21, P749, DOI 10.1177/1352458514556300; Sdika M, 2009, HUM BRAIN MAPP, V30, P1060, DOI 10.1002/hbm.20566; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sormani MP, 2011, NEUROLOGY, V77, P1684, DOI 10.1212/WNL.0b013e31823648b9; Sormani MP, 2013, LANCET NEUROL, V12, P669, DOI 10.1016/S1474-4422(13)70103-0; Tedeschi G, 2005, NEUROLOGY, V65, P280, DOI 10.1212/01.wnl.0000168837.87351.1f; Thaler C, 2017, AM J NEURORADIOL, V38, P264, DOI 10.3174/ajnr.A5004; Thaler C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144693; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; VANWALDERVEEN MAA, 1995, NEUROLOGY, V45, P1684, DOI 10.1212/WNL.45.9.1684; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zivadinov R, 2016, EUR J NEUROL, V23, P1101, DOI 10.1111/ene.12992; Zivadinov R, 2016, MULT SCLER J, V22, P1709, DOI 10.1177/1352458516629769	64	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209326	10.1371/journal.pone.0209326	http://dx.doi.org/10.1371/journal.pone.0209326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576361	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400041
J	Halofsky, JS; Conklin, DR; Donato, DC; Halofsky, JE; Kim, JB				Halofsky, Joshua S.; Conklin, David R.; Donato, Daniel C.; Halofsky, Jessica E.; Kim, John B.			Climate change, wildfire, and vegetation shifts in a high-inertia forest landscape: Western Washington, USA	PLOS ONE			English	Article							PACIFIC-NORTHWEST; SPECIES DISTRIBUTION; CARBON DYNAMICS; LARGE FIRES; OREGON; MODEL; TREE; VARIABILITY; MANAGEMENT; HISTORY	Future vegetation shifts under changing climate are uncertain for forests with infrequent stand-replacing disturbance regimes. These high-inertia forests may have long persistence even with climate change because disturbance-free periods can span centuries, broadscale regeneration opportunities are fewer relative to frequent-fire systems, and mature tree species are long-lived with relatively high tolerance for sub-optimal growing conditions. Here, we used a combination of empirical and process-based modeling approaches to examine vegetation projections across high-inertia forests of Washington State, USA, under different climate and wildfire futures. We ran our models without forest management (to assess inherent system behavior/potential) and also with wildfire suppression. Projections suggested relatively stable mid-elevation forests through the end of the century despite anticipated increases in wildfire. The largest changes were projected at the lowest and uppermost forest boundaries, with upward expansion of the driest low-elevation forests and contraction of cold, high-elevation subalpine parklands. While forests were overall relatively stable in simulations, increases in early-seral conditions and decreases in late-seral conditions occurred as wildfire became more frequent. With partial fire suppression, projected changes were dampened or delayed, suggesting a potential tool to forestall change in some (but not all) high-inertia forests, especially since extending fire-free periods does little to alter overall fire regimes in these systems. Model projections also illustrated the importance of fire regime context and projection limitations; the time horizon over which disturbances will eventually allow the system to shift are so long that the prevailing climatic conditions under which many of those shifts will occur are beyond what most climate models can predict with any certainty. This will present a fundamental challenge to setting expectations and managing for long-term change in these systems.	[Halofsky, Joshua S.; Donato, Daniel C.] Washington State Dept Nat Resources, Olympia, WA 98504 USA; [Conklin, David R.] Oregon Freshwater Simulat, Portland, OR USA; [Donato, Daniel C.; Halofsky, Jessica E.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Kim, John B.] US Forest Serv, USDA, Pacific Northwest Res Stn, Corvallis, OR USA	University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); United States Forest Service	Halofsky, JS (corresponding author), Washington State Dept Nat Resources, Olympia, WA 98504 USA.	joshua.halofsky@dnr.wa.gov		Kim, John/0000-0002-3720-7916; Halofsky, Joshua/0000-0003-4120-7457	Washington State Department of Natural Resources	Washington State Department of Natural Resources	The Washington State Department of Natural Resources provided funding for this project.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Agne MC, 2018, FOREST ECOL MANAG, V409, P317, DOI 10.1016/j.foreco.2017.11.004; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Bachelet D, 2001, MC1 DYNAMIC VEGETATI, P95; Barbero R, 2015, INT J WILDLAND FIRE, V24, P892, DOI 10.1071/WF15083; BRUBAKER LB, 1986, VEGETATIO, V67, P119, DOI 10.1007/BF00037362; Case MJ, 2017, GLOBAL CHANGE BIOL, V23, P2005, DOI 10.1111/gcb.13570; Conklin DR, 2016, MCFIRE MODEL TECHNIC, P75; Crausbay SD, 2017, ECOLOGY, V98, P2356, DOI 10.1002/ecy.1897; Creutzburg MK, 2015, AIMS ENVIRON SCI, V2, P203, DOI 10.3934/environsci.2015.2.203; CWYNAR LC, 1987, ECOLOGY, V68, P791, DOI 10.2307/1938350; Dalton M.M., 2013, CLIMATE CHANGE NW IM; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daniel CJ, 2016, METHODS ECOL EVOL, V7, P1413, DOI 10.1111/2041-210X.12597; Drapek R, 2015, DYNAMIC GEN VEGETATI, P904; DUNWIDDIE PW, 1986, ECOLOGY, V67, P58, DOI 10.2307/1938503; Fisher RA, 2015, GEOSCI MODEL DEV, V8, P3593, DOI 10.5194/gmd-8-3593-2015; Flannigan MD, 2016, CLIMATIC CHANGE, V134, P59, DOI 10.1007/s10584-015-1521-0; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Franklin JF, 1991, WILDLIFE VEGETATION, P533; Gavin DG, 2013, ECOL MONOGR, V83, P471, DOI 10.1890/12-1742.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halofsky JE, 2011, ADAPTING CLIMATE CHA, P130; Halofsky JE, 2014, INTEGRATING SOCIAL E, P206; Halofsky JE, 2013, ECOL MODEL, V266, P131, DOI 10.1016/j.ecolmodel.2013.07.003; Halofsky JS, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2140; Halofsky JS, 2014, ECOL APPL, V24, P1908, DOI 10.1890/13-1653.1; Henderson J.A., 2011, LANDSCAPE MODEL PRED, P35; Henderson JA, 1989, FORESTED PLANT ASS O, P502; HEUSSER CJ, 1977, QUATERNARY RES, V8, P282, DOI 10.1016/0033-5894(77)90073-4; Holbrook S. H., 1960, BURNING EMPIRE STORY; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Keane RE, 2008, INT J WILDLAND FIRE, V17, P696, DOI 10.1071/WF07148; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Laflower DM, 2016, FOREST ECOL MANAG, V362, P194, DOI 10.1016/j.foreco.2015.12.015; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Luce CH, 2013, SCIENCE, V342, P1360, DOI 10.1126/science.1242335; Luce CH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039407; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Mauger G, 2015, STATE KNOWLEDGE CLIM, P288; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Nitschke CR, 2008, ECOL MODEL, V210, P263, DOI 10.1016/j.ecolmodel.2007.07.026; Nonaka E, 2005, ECOL APPL, V15, P1727, DOI 10.1890/04-0902; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Peterson DL, 1997, GLOBAL ECOL BIOGEOGR, V6, P7, DOI 10.2307/2997523; Prichard SJ, 2009, QUATERNARY RES, V72, P57, DOI 10.1016/j.yqres.2009.03.008; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rogers BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001695; ROMME WH, 1982, ECOL MONOGR, V52, P199, DOI 10.2307/1942611; Running SW, 1993, SCALING PHYSL PROCES, P414; Rupp DE, 2013, J GEOPHYS RES-ATMOS, V118, P10884, DOI 10.1002/jgrd.50843; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Sheehan T, 2015, ECOL MODEL, V317, P16, DOI 10.1016/j.ecolmodel.2015.08.023; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Spies TA, 2018, SYNTHESIS SCI INFORM, P1020; Stavros EN, 2014, INT J WILDLAND FIRE, V23, P899, DOI 10.1071/WF13169; Stine P.A., 2014, ECOLOGY MANAGEMENT M, P254; Stralberg D, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2156; Swanson ME, 2014, FOREST ECOL MANAG, V324, P160, DOI 10.1016/j.foreco.2014.03.046; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Syphard AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201680; Tepley AJ, 2013, ECOLOGY, V94, P1729, DOI 10.1890/12-1506.1; Turner MG, 2013, LANDSCAPE ECOL, V28, P1081, DOI 10.1007/s10980-012-9741-4; Walker B, 2004, ECOL SOC, V9; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; WHITLOCK C, 1992, NORTHWEST ENVIRON J, V8, P5; Yospin GI, 2015, ECOL APPL, V25, P226, DOI 10.1890/13-0906.1; Zolbrod AN, 1999, CAN J FOREST RES, V29, P1966, DOI 10.1139/cjfr-29-12-1966	74	17	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209490	10.1371/journal.pone.0209490	http://dx.doi.org/10.1371/journal.pone.0209490			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571775	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700082
J	De Paula, MMM; Bassous, NJ; Afewerki, S; Harb, SV; Ghannadian, P; Marciano, FR; Viana, BC; Tim, CR; Webster, TJ; Lobo, AO				Machado De Paula, Mirian Michelle; Bassous, Nicole Joy; Afewerki, Samson; Harb, Samarah Vargas; Ghannadian, Paria; Marciano, Fernanda Roberta; Viana, Bartolomeu Cruz; Tim, Carla Roberta; Webster, Thomas Jay; Lobo, Anderson Oliveira			Understanding the impact of crosslinked PCL/PEG/GeIMA electrospun nanofibers on bactericidal activity	PLOS ONE			English	Article							ANTIMICROBIAL HYDROGELS; ANTIBACTERIAL ACTIVITY; PROTEIN ADSORPTION; FIBROUS SCAFFOLDS; GELATIN; ADHESION; CYTOTOXICITY; MATRIX; PCL; DIFFERENTIATION	Herein, we report the design of electrospun ultrathin fibers based on the combination of three different polymers polycaprolactone (PCL), polyethylene glycol (PEG), and gelatin methacryloyl (GeIMA), and their potential bactericidal activity against three different bacteria Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Methicillin-resistant Staphylococcus aureus (MRSA). We evaluated the morphology, chemical structure and wettability before and after UV photocrosslinking of the produced scaffolds. Results showed that the developed scaffolds presented hydrophilic properties after PEG and GeIMA incorporation. Moreover, they were able to significantly reduce gram-positive, negative, and MRSA bacteria mainly after UV photocrosslinking (PCL:PEG:GelMa-UV). Furthermore, we performed a series of study for gaining a better mechanistic understanding of the scaffolds bactericidal activity through protein adsorption study and analysis of the reactive oxygen species (ROS) levels. Furthermore, the in vivo subcutaneous implantation performed in rats confirmed the biocompatibility of our designed scaffolds.	[Machado De Paula, Mirian Michelle; Lobo, Anderson Oliveira] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Machado De Paula, Mirian Michelle; Bassous, Nicole Joy; Harb, Samarah Vargas; Ghannadian, Paria; Marciano, Fernanda Roberta; Webster, Thomas Jay] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Afewerki, Samson] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Afewerki, Samson] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Afewerki, Samson] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA USA; [Harb, Samarah Vargas] UNESP Sao Paulo State Univ, Inst Chem, Araraquara, SP, Brazil; [Marciano, Fernanda Roberta; Tim, Carla Roberta; Lobo, Anderson Oliveira] Brasil Univ, Inst Sci & Technol, Sao Paulo, SP, Brazil; [Viana, Bartolomeu Cruz; Lobo, Anderson Oliveira] UFPI Fed Univ Piaui, PPGCM Mat Sci & Engn Grad Program, LIMAV Interdisciplinary Lab Adv Mat, Teresina, PI, Brazil; [Viana, Bartolomeu Cruz] UFPI Fed Univ Piaui, Dept Phys UFPI, Teresina, PI, Brazil; [Lobo, Anderson Oliveira] MIT, Dept Chem, Cambridge, MA 02139 USA	Universidade Estadual de Campinas; Northeastern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade Estadual Paulista; Massachusetts Institute of Technology (MIT)	Lobo, AO (corresponding author), Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil.; Lobo, AO (corresponding author), Brasil Univ, Inst Sci & Technol, Sao Paulo, SP, Brazil.; Lobo, AO (corresponding author), UFPI Fed Univ Piaui, PPGCM Mat Sci & Engn Grad Program, LIMAV Interdisciplinary Lab Adv Mat, Teresina, PI, Brazil.; Lobo, AO (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lobo@upfi.edu.br	Viana, Bartolomeu C/A-3900-2019; Marciano, Fernanda Roberta/X-6689-2019; Harb, Samarah Vargas/AAH-2694-2019; Lobo, Anderson Oliveira/B-2893-2011; Harb, Samarah Vargas/G-2905-2014; de Paula, Mirian Michelle Machado/AAE-2829-2021; Tim, Carla/G-6765-2014; Afewerki, Samson/J-8129-2015	Viana, Bartolomeu C/0000-0002-5207-4269; Marciano, Fernanda Roberta/0000-0001-7740-8766; Harb, Samarah Vargas/0000-0001-7148-4661; Lobo, Anderson Oliveira/0000-0002-2544-0438; Harb, Samarah Vargas/0000-0001-7148-4661; de Paula, Mirian Michelle Machado/0000-0002-0534-4596; Tim, Carla/0000-0002-4745-9375; Afewerki, Samson/0000-0002-5108-6487	Serrapilheira Institute [Serra-1709-19479]; Sweden-America Foundation (The family Mix Entrepreneur foundation); Olle Engkvist byggmastare foundation; Swedish Chemical Society (Bengt Lundqvist Memory Foundation); Northeastern University	Serrapilheira Institute; Sweden-America Foundation (The family Mix Entrepreneur foundation); Olle Engkvist byggmastare foundation; Swedish Chemical Society (Bengt Lundqvist Memory Foundation); Northeastern University	This work was supported by the Serrapilheira Institute (grant number Serra-1709-19479). The authors also acknowledge Northeastern University for funding this study. S.A. gratefully acknowledges financial support from the Sweden-America Foundation (The family Mix Entrepreneur foundation), Olle Engkvist byggmastare foundation and Swedish Chemical Society (Bengt Lundqvist Memory Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Annabi N, 2017, BIOMATERIALS, V139, P229, DOI 10.1016/j.biomaterials.2017.05.011; Aparnathi Mansi K, 2016, J Stem Cells, V11, P111; Barati D, 2016, J CONTROL RELEASE, V223, P126, DOI 10.1016/j.jconrel.2015.12.031; Bhardwaj G, 2017, INT J NANOMED, V12, P363, DOI 10.2147/IJN.S116105; Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004; Byambaa B, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700015; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cerkez I, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160911; Chakrapani VY, 2012, J APPL POLYM SCI, V125, P3221, DOI 10.1002/app.36504; Chan PH, 2012, ANAL CHEM, V84, P8952, DOI 10.1021/ac302417k; Chellat MF, 2016, ANGEW CHEM INT EDIT, V55, P6600, DOI 10.1002/anie.201506818; Chen HW, 2016, J IND TEXT, V45, P1490, DOI 10.1177/1528083714562089; Chen X, 2016, INT J NANOMED, V11, P4707, DOI 10.2147/IJN.S111701; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Correia TR, 2016, INT J BIOL MACROMOL, V93, P1539, DOI 10.1016/j.ijbiomac.2016.05.045; Dallas P, 2007, POLYMER, V48, P2007, DOI 10.1016/j.polymer.2007.01.058; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Flahaut E, 2006, CARBON, V44, P1093, DOI 10.1016/j.carbon.2005.11.007; Fukushima K, 2013, EUR POLYM J, V49, P706, DOI 10.1016/j.eurpolymj.2012.12.011; Guler S, 2016, EUR POLYM J, V84, P326, DOI 10.1016/j.eurpolymj.2016.09.031; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hassan MI, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0889-0; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Jiang PF, 2015, ACTA BIOMATER, V19, P76, DOI 10.1016/j.actbio.2015.03.018; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Khayat A, 2017, J DENT RES, V96, P192, DOI 10.1177/0022034516682005; Koser SA, 1938, J BACTERIOL, V36, P57, DOI 10.1128/JB.36.1.57-65.1938; Lee SH, 2013, ADV HEALTHC MATER, V2, P908, DOI 10.1002/adhm.201200423; Liu C, 2008, COLLOID SURFACE B, V61, P182, DOI 10.1016/j.colsurfb.2007.08.008; Martin JR, 2014, BIOMATERIALS, V35, P3766, DOI 10.1016/j.biomaterials.2014.01.026; Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Ng VWL, 2014, ADV DRUG DELIVER REV, V78, P46, DOI 10.1016/j.addr.2014.10.028; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; Orooji Y, 2017, CARBON, V111, P689, DOI 10.1016/j.carbon.2016.10.055; Pramanik S, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/043002; Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021; Ruseckaite R, 2012, PREPARATION CHARACTE, P3282; SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367; Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452; Seifpoor M, 2011, FIBER POLYM, V12, P706, DOI 10.1007/s12221-011-0706-z; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16336; Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Silva JP, 2015, ACTA BIOMATER, V26, P249, DOI 10.1016/j.actbio.2015.07.043; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thakur T, 2016, J BIOMED MATER RES A, V104, P879, DOI 10.1002/jbm.a.35621; Tiwari AP, 2017, COLLOID SURFACE A, V520, P105, DOI 10.1016/j.colsurfa.2017.01.054; Uhl FM, 2001, POLYM DEGRAD STABIL, V71, P317, DOI 10.1016/S0141-3910(00)00181-6; VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X; Veiga AS, 2013, BIOPOLYMERS, V100, P637, DOI 10.1002/bip.22412; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046; Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005; Xu LC, 2017, J BIOMED MATER RES B, V105, P668, DOI 10.1002/jbm.b.33592; Yoshimura A, 1999, J IMMUNOL, V163, P1; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045; Zhao X, 2017, ACTA BIOMATER, V49, P66, DOI 10.1016/j.actbio.2016.11.017; Zhong C, 2010, ACTA BIOMATER, V6, P3908, DOI 10.1016/j.actbio.2010.04.011; Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; Zupancic S, 2018, EUR J PHARM SCI, V122, P347, DOI 10.1016/j.ejps.2018.07.024	66	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209386	10.1371/journal.pone.0209386	http://dx.doi.org/10.1371/journal.pone.0209386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571704	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700066
J	Wang, S; Yabuki, Y; Matsuo, K; Xu, J; Izumi, H; Sakimura, K; Saito, T; Saido, TC; Fukunaga, K				Wang, Shuo; Yabuki, Yasushi; Matsuo, Kazuya; Xu, Jing; Izumi, Hisanao; Sakimura, Kenji; Saito, Takashi; Saido, Takaomi C.; Fukunaga, Kohji			T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; NEUROTRANSMITTER CHANGES; COGNITIVE FUNCTION; MOUSE MODELS; BRAIN; NORADRENALINE; ANTAGONISTS; GLUTAMATE; EXCITABILITY	T-type calcium channels in the brain mediate the pathophysiology of epilepsy, pain, and sleep. Recently, we developed a novel therapeutic candidate, SAK3 (ethyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopentane-1,3'-imidazo[1,2-a]pyridine]-2-ene-3-carboxylate), for Alzheimer's disease (AD). The cognitive improvement by SAK3 is closely associated with enhanced acetylcholine (ACh) release in the hippocampus. Since mono-amines such as dopamine (DA), noradrenaline (NA), and serotonin (5-HT) are also involved in hippocampus-dependent learning and psychomotor behaviors in mice, we investigated the effects of SAK3 on these monoamine releases in the mouse brain. Oral administration of SAK3 (0.5 mg/kg, p.o.) significantly promoted DA and 5-HT releases in the naive mouse hippocampal CA1 region but not in the medial prefrontal cortex (mPFC), while SAK3 did not affect NA release in either brain region. The T-type calcium channel-specific inhibitor, NNC 55-0396 (1 mu M) significantly antagonized SAK3-enhanced DA and 5-HT releases in the hippocampus. Interestingly, the alpha 7 nicotinic ACh receptor (nAChR) antagonist, methyllycaconitine (1 nM) significantly inhibited DA release, and the alpha 4 nAChR antagonist, dihydro-beta-erythroidine (100 mu M) significantly blocked both DA and 5-HT releases following SAK3 (0.5 mg/kg, p.o.) administration in the hippocampus. SAK3 did not alter basal monoamine contents both in the mPFC and hippocampus. SAK3 (0.5 mg/kg, p.o.) administration also significantly elevated DA and 5-HT releases in the hippocampal CA1 region of amyloid-precursor protein (APP)(NL-GF) knock-in (KI) mice. Moreover, hippocampal DA and 5-HT contents were significantly decreased in APP(NL-GF) KI mice. Taken together, our data suggest that SAK3 promotes monoamine DA and 5-HT releases by enhancing the T-type calcium channel and nAChR in the mouse hippocampus.	[Wang, Shuo; Yabuki, Yasushi; Matsuo, Kazuya; Xu, Jing; Izumi, Hisanao; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Saito, Takashi; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan	Tohoku University; Niigata University; RIKEN	Fukunaga, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan.	kfukunaga@m.tohoku.ac.jp	Matsuo, Kazuya/AAM-3888-2021; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Yabuki, Yasushi/AAF-7931-2021; Saito, Takashi/G-2563-2015; Fukunaga, Kohji/AAI-8811-2021	Matsuo, Kazuya/0000-0001-6138-8422; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Science, Sports, and Culture of Japan [Kakenhi 25293124, 17K15456]; Project of Translational and Clinical Research Core Centers from the Japan Agency for Medical Research and Development (AMED); Smoking Research Foundation; Research Foundation for Pharmaceutical Sciences; Japan Society for the Promotion of Science [266540]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project of Translational and Clinical Research Core Centers from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation; Research Foundation for Pharmaceutical Sciences; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (Kakenhi 25293124 to K.F. and 17K15456 to Y.Y.), by the Project of Translational and Clinical Research Core Centers from the Japan Agency for Medical Research and Development (AMED) (to K.F.), by the Smoking Research Foundation (K.F.), by the Research Fellow of the Japan Society for the Promotion of Science (266540 to Y.Y.), and by the The Research Foundation for Pharmaceutical Sciences (to Y.Y.).	Bergquist F, 2003, NEUROSCIENCE, V120, P757, DOI 10.1016/S0306-4522(03)00385-3; Blesneac I, 2015, P NATL ACAD SCI USA, V112, P13705, DOI 10.1073/pnas.1511740112; Blier P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0536; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Brunello N, 2002, EUR NEUROPSYCHOPHARM, V12, P461, DOI 10.1016/S0924-977X(02)00057-3; Chen BT, 2006, J NEUROCHEM, V96, P645, DOI 10.1111/j.1471-4159.2005.03519.x; Chow Tiffany W, 2007, Neuropsychiatr Dis Treat, V3, P627; CORTES R, 1988, BRAIN RES, V475, P164, DOI 10.1016/0006-8993(88)90212-0; Evans RC, 2017, J NEUROSCI, V37, P3704, DOI 10.1523/JNEUROSCI.0117-17.2017; Fusar-Poli P, 2011, MOL PSYCHIATR, V16, P67, DOI 10.1038/mp.2009.108; Garduno J, 2012, J NEUROSCI, V32, P15148, DOI 10.1523/JNEUROSCI.0941-12.2012; HAASS M, 1991, N-S ARCH PHARMACOL, V344, P527; Handforth A, 2010, NEUROPHARMACOLOGY, V59, P380, DOI 10.1016/j.neuropharm.2010.05.012; Henry G, 2011, AM J ALZHEIMERS DIS, V26, P169, DOI 10.1177/1533317511402051; Hiser J, 2018, BIOL PSYCHIAT, V83, P638, DOI 10.1016/j.biopsych.2017.10.030; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P4541, DOI 10.1007/s00213-014-3596-0; Izumi H, 2018, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2013.11.051, DOI 10.1016/J.NEUROSCIENCE.2013.11.051]; Johri AM, 1999, J PHARMACOL EXP THER, V290, P847; Kenny PJ, 2000, J NEUROCHEM, V75, P2409, DOI 10.1046/j.1471-4159.2000.0752409.x; Kim Y, 2008, BIOCHEM BIOPH RES CO, V373, P665, DOI 10.1016/j.bbrc.2008.06.099; KIMURA M, 1995, NEUROSCIENCE, V66, P609, DOI 10.1016/0306-4522(95)00023-C; Kraus RL, 2010, J PHARMACOL EXP THER, V335, P409, DOI 10.1124/jpet.110.171058; Kumar U, 2007, BRAIN RES, V1131, P187, DOI 10.1016/j.brainres.2006.10.049; Lambert RC, 2014, PFLUG ARCH EUR J PHY, V466, P415, DOI 10.1007/s00424-013-1353-6; Lin SF, 2017, BIOCHEM BIOPH RES CO, V487, P801, DOI 10.1016/j.bbrc.2017.04.127; Matschke LA, 2015, MOL CELL NEUROSCI, V68, P293, DOI 10.1016/j.mcn.2015.08.012; Mechan AO, 2011, BRIT J NUTR, V105, P1150, DOI 10.1017/S0007114510004940; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Moriguchi S, 2012, J NEUROCHEM, V121, P44, DOI 10.1111/j.1471-4159.2012.07667.x; NAZARALI AJ, 1992, CELL MOL NEUROBIOL, V12, P581, DOI 10.1007/BF00711237; Nilsson P, 2014, ACS CHEM NEUROSCI, V5, P499, DOI 10.1021/cn500105p; PALMER AM, 1993, J NEURAL TRANSM-GEN, V91, P135, DOI 10.1007/BF01245229; Pasumarthi RK, 2010, J NEUROCHEM, V113, P1023, DOI 10.1111/j.1471-4159.2010.06666.x; Paul S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00043, 10.3389/tnagi.2015.00043]; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Petersen AV, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00060; Powell KL, 2014, BRIT J CLIN PHARMACO, V77, P729, DOI 10.1111/bcp.12205; Rice RA, 2014, NEUROBIOL AGING, V35, P1002, DOI 10.1016/j.neurobiolaging.2013.10.090; RINNE JO, 1986, J NEUROL SCI, V73, P219, DOI 10.1016/0022-510X(86)90132-2; Rossi S, 2005, NEUROCHEM RES, V30, P541, DOI 10.1007/s11064-005-2689-x; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sershen H, 1997, NEUROSCIENCE, V77, P121, DOI 10.1016/S0306-4522(96)00425-3; Shearman E, 2008, BRAIN RES BULL, V76, P626, DOI 10.1016/j.brainresbull.2008.03.017; Shearman E, 2005, NEUROCHEM RES, V30, P1055, DOI 10.1007/s11064-005-7132-9; Shen L, 2016, NEUROPHARMACOLOGY, V105, P72, DOI 10.1016/j.neuropharm.2016.01.008; Stemkowski P, 2017, MOL PAIN, V13, DOI 10.1177/1744806917724698; Sumiyoshi T, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00395; Tajeddinn W, 2016, J ALZHEIMERS DIS, V53, P621, DOI 10.3233/JAD-160022; Talley EM, 1999, J NEUROSCI, V19, P1895; Wang ZZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11332; Wolfart J, 2002, J NEUROSCI, V22, P3404; Yabuki Y, 2014, NEUROSCIENCE, V259, P126, DOI 10.1016/j.neuroscience.2013.11.051; Yabuki Y, 2017, NEUROCHEM INT, V108, P272, DOI 10.1016/j.neuint.2017.04.015; Yasushi Y, 2017, NEUROPHARMACOLOGY, V117, P1, DOI 10.1016/j.neuropharm.2017.01.011; Yorgason JT, 2017, J NEUROSCI, V37, P2086, DOI 10.1523/JNEUROSCI.3064-16.2017; Zang X, 2018, BIOL PSYCHIAT, V81, P250, DOI [10.1016/j.pnpbp.2017.09.017, DOI 10.1016/J.PNPBP.2017.09.017]	58	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0206986	10.1371/journal.pone.0206986	http://dx.doi.org/10.1371/journal.pone.0206986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571684	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700006
J	Correa, ASD; Lamarao, LM; Vieira, PCM; de Castro, RBH; de Almeida, NCC; de Castro, JAA; de Lima, MSM; Palmeira, MK; Meireles, ALLP; Burbano, RR				de Miranda Correa, Angelita Silva; Lamarao, Leticia Martins; Moura Vieira, Priscilla Cristina; Hermes de Castro, Renata Bezerra; Costa de Almeida, Nubia Caroline; Americo de Castro, Jairo Augusto; Maciel de Lima, Maria Salete; Palmeira, Mauricio Koury; Langanke Pedroso Meireles, Ana Luiza; Burbano, Rommel Rodriguez			Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-DONORS; C-VIRUS; TRANSMISSION; MARKERS; EPIDEMIOLOGY; DONATIONS; SAFETY; HIV	Background Nucleic acid testing (NAT) for virus detection during blood screening has helped to prevent transfusion-transmitted infections worldwide. In northern Brazil, NAT was implemented in 2012 for HIV and HCV and more recently, in January 2015, the screening for HBV was included and currently used concomitant with serological tests (HBsAg and anti-HBc). This study aims to evaluate the prevalence and the incidence of HBV infection among voluntary blood donors at ten regional blood centers of HEMOPA Foundation in Para state and to compare the residual risk of transfusion-transmitted HBV infection before and after the Brazilian HBV-NAT implementation. Methods The prevalence (restricted to first time donors- FT) and seroconversion rate (restricted to repeat donors- RP) of HBV were calculated based on rates of confirmed positive samples. Residual risk was based on the incidence and window period (WP) model described by Schreiber and coauthors. Logistic and Poisson regression were used in the statistical analysis by SPSS v20.0. A p value <0.05 was considered statistically significant. Results HBV prevalence in the periods before and after the implementation of HBV-NAT were 247 and 251 per 100,000 donations, respectively. Seroconversion rates were 114 and 122 per 100,000 donations in the two periods, respectively. The residual risk (RR) for HBV decreased significantly in the posterior period to the HBV-NAT implementation, when compared to RR before implementation, with a reduction of 1:144,92 to 1:294,11 donations (p <0,001). Conclusions The RR to HBV decreased after the implementation of HBV-NAT, increasing significantly the transfusional security in the North region of Brazil at HEMOPA Foundation.	[de Miranda Correa, Angelita Silva; Lamarao, Leticia Martins; Moura Vieira, Priscilla Cristina; Hermes de Castro, Renata Bezerra; Costa de Almeida, Nubia Caroline; Americo de Castro, Jairo Augusto; Maciel de Lima, Maria Salete; Palmeira, Mauricio Koury; Langanke Pedroso Meireles, Ana Luiza] Fdn Ctr Hemotherapy & Hematol Para HEMOPA, Lab Nucle Acid Test NAT, Belem, Para, Brazil; [de Miranda Correa, Angelita Silva; Moura Vieira, Priscilla Cristina] Fed Univ Para, Inst Biol Sci, Lab Human Cytogenet, Belem, Para, Brazil; [Burbano, Rommel Rodriguez] Ophir Loyola Hosp, Lab Mol Biol, Belem, Para, Brazil	Universidade Federal do Para	Correa, ASD (corresponding author), Fdn Ctr Hemotherapy & Hematol Para HEMOPA, Lab Nucle Acid Test NAT, Belem, Para, Brazil.; Correa, ASD (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human Cytogenet, Belem, Para, Brazil.	angelitamcorrea@gmail.com	Burbano, Rommel R/C-4149-2012	Burbano, Rommel R/0000-0002-4872-234X; Correa, Angelita/0000-0001-5952-4392; Vieira, Priscilla/0000-0002-4357-2661; Lamarao, Leticia/0000-0002-6484-4988				Andrade AFB, 2006, MEM I OSWALDO CRUZ, V101, P673, DOI 10.1590/S0074-02762006000600016; Busch MP, 2006, TRANSFUSION, V46, P1624, DOI 10.1111/j.1537-2995.2006.00957.x; de Almeida-Neto C, 2013, TRANSFUSION, V53, P827, DOI 10.1111/j.1537-2995.2012.03840.x; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Flichman DM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-218; Gonzalez M, 2005, TRANSFUSION, V45, P1670, DOI 10.1111/j.1537-2995.2005.00576.x; Kim MJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-160; Kleinman S, 2012, TRANSFUS MED REV, V26, P281, DOI 10.1016/j.tmrv.2012.04.004; Korelitz JJ, 1997, TRANSFUSION, V37, P634, DOI 10.1046/j.1537-2995.1997.37697335159.x; Kupek Emil, 2011, J Transfus, V2011, P985383, DOI 10.4061/2011/985383; Lampe E, 2017, J GEN VIROL, V98, P1389, DOI 10.1099/jgv.0.000789; Levi Jose Eduardo, 2013, Rev. Bras. Hematol. Hemoter., V35, P167, DOI 10.5581/1516-8484.20130039; Li WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073472; Loua A, 2004, TRANSFUS CLIN BIOL, V11, P98, DOI 10.1016/j.tracli.2004.01.004; Ministerio da Saude (Brasil), 2016, B EP HEP VIR; Ministerio da Saude. Brasil, 2016, B EP HEP VIR; Ministerio da Saude. Brasil, 2012, B EP HEP VIR; Vieira PCM, 2017, TRANSFUSION, V57, P1968, DOI 10.1111/trf.14146; Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046; Niederhauser C, 2005, Euro Surveill, V10, P14; O'Brien SF, 2012, VOX SANG, V103, P83, DOI 10.1111/j.1423-0410.2012.01584.x; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Ouattara H, 2006, TRANSFUS CLIN BIOL, V13, P242, DOI 10.1016/j.tracli.2006.03.015; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Patavino GM, 2012, TRANSFUSION, V52, P151, DOI 10.1111/j.1537-2995.2011.03248.x; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Servant-Delmas A, 2013, TRANSFUSION, V53, P291, DOI 10.1111/j.1537-2995.2012.03736.x; Soldan K, 2003, VOX SANG, V84, P274, DOI 10.1046/j.1423-0410.2003.00296.x; Taira R, 2013, TRANSFUSION, V53, P1393, DOI 10.1111/j.1537-2995.2012.03909.x; Tosti ME, 2002, BRIT J HAEMATOL, V117, P215, DOI 10.1046/j.1365-2141.2002.03334.x; Toure-Fall AO, 2009, TRANSFUS CLIN BIOL, V16, P439, DOI 10.1016/j.tracli.2009.09.005; Tsoi WC, 2013, TRANSFUSION, V53, P2477, DOI 10.1111/trf.12165; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; Vermeulen M, 2009, TRANSFUSION, V49, P1115, DOI 10.1111/j.1537-2995.2009.02110.x; Wang BG, 2005, TRANSFUSION, V45, P1089, DOI 10.1111/j.1537-2995.2005.00178.x; Wendel S, 2008, TRANSFUSION, V48, P1602, DOI 10.1111/j.1537-2995.2008.01723.x; WHO, 2017, GUID PREV CAR TREATM; Zou SM, 2009, TRANSFUSION, V49, P1609, DOI 10.1111/j.1537-2995.2009.02195.x	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208414	10.1371/journal.pone.0208414	http://dx.doi.org/10.1371/journal.pone.0208414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566494	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300040
J	Flores, O; Seoane, J; Hevia, V; Azcarate, FM				Flores, Omar; Seoane, Javier; Hevia, Violeta; Azcarate, Francisco M.			Spatial patterns of species richness and nestedness in ant assemblages along an elevational gradient in a Mediterranean mountain range	PLOS ONE			English	Article							CLIMATE-CHANGE; HARVESTER ANTS; LAND-USE; DIVERSITY; BIODIVERSITY; RESPONSES; COMMUNITIES; TURNOVER; BEETLE; MODELS	Background The study of biodiversity spatial patterns along ecological gradients can serve to elucidate factors shaping biological community structure and predict ecosystem responses to global change. Ant assemblages are particularly interesting as study cases, because ant species play a key role in many ecosystem processes and have frequently been identified as useful bioindicators. Methods Here we analyzed the response of ant species richness and assemblage composition across elevational gradients in Mediterranean grasslands and subsequently tested whether these responses were stable spatially and temporally. We sampled ant assemblages in two years (2014, 2015) in two mountain ranges (Guadarrama, Serrota) in Central Spain, along an elevational gradient ranging from 685 to 2390 m a.s.l. Results Jackknife estimates of ant species richness ranged from three to 18.5 species and exhibited a hump-shaped relationship with elevation that peaked at mid-range values (1100-1400 m). This pattern was transferable temporally and spatially. Elevation was related to ant assemblage composition and facilitated separation of higher elevation assemblages (> 1700 m) from the remaining lower elevation species groups. Ant assemblages were nested; therefore species assemblages with a decreased number of species were a subset of the richer assemblages, although species turnover was more important than pure nestedness in all surveys. The degree of nestedness changed non-linearly as a cubic polynomial with elevation. These assembly patterns coincided more clearly over time than between the two study regions. Discussion We suggest double environmental stressors typical of Mediterranean mountains explained species richness patterns: drought at low elevations and cold temperatures at high elevations likely constrained richness at both extremes of elevational gradients. The fact that species turnover showed a dominant role over pure nestedness suggested current ant assemblages were context-dependent and highly vulnerable to global change, which threatens the conservation of present day native ant communities, particularly at high elevations.	[Flores, Omar] Spanish Natl Res Council MNCN CSIC, Dept Biogeog & Global Change, Natl Museum Nat Sci, Madrid, Spain; [Flores, Omar; Seoane, Javier; Azcarate, Francisco M.] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain; [Hevia, Violeta] Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Autonomous University of Madrid	Flores, O (corresponding author), Spanish Natl Res Council MNCN CSIC, Dept Biogeog & Global Change, Natl Museum Nat Sci, Madrid, Spain.; Flores, O (corresponding author), Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain.	omarf@mncn.csic.es	Azcárate, Francisco/M-1731-2013	Azcárate, Francisco/0000-0002-6517-6395; Hevia, Violeta/0000-0003-1623-4082; Flores, Omar/0000-0003-2760-3015	Ministerio de Economia y Competitividad (MINECO); Madrid's Government research group network REMEDINAL3-CM [S-2013/MAE-2719];  [CGL2014-53789-R]	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Madrid's Government research group network REMEDINAL3-CM; 	The study received most economical support from Ministerio de Economia y Competitividad (MINECO) and partial support by the Madrid's Government research group network REMEDINAL3-CM (S-2013/MAE-2719, https://remedinal.wordpress.com/). There was no additional external funding received for this study. This is a contribution to project CGL2014-53789-R.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ANDERSEN AN, 1991, AUST J ECOL, V16, P273, DOI 10.1111/j.1442-9993.1991.tb01054.x; Azcarate FM, 2005, FUNCT ECOL, V19, P273, DOI 10.1111/j.0269-8463.2005.00956.x; Azcarate FM, 2007, J INSECT BEHAV, V20, P315, DOI 10.1007/s10905-007-9074-3; Azcarate FM, 2013, ACTA OECOL, V49, P107, DOI 10.1016/j.actao.2013.03.011; Azcarate FM, 2012, INSECT CONSERV DIVER, V5, P279, DOI 10.1111/j.1752-4598.2011.00165.x; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benavides R, 2016, FOREST ECOL MANAG, V360, P287, DOI 10.1016/j.foreco.2015.10.043; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Breckle SW, 2002, WALTERS VEGETATION E; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; Casals MN, 2005, DIGITAL CLIMATIC ATL; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dean WRJ, 1997, BIODIVERS CONSERV, V6, P1293, DOI 10.1023/A:1018313025896; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Edenhofer O., 2014, CONTRIBUTION WORKING; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fielding CA, 1999, FUNCT ECOL, V13, P65, DOI 10.1046/j.1365-2435.1999.00009.x; Flexas J, 2014, ENVIRON EXP BOT, V103, P12, DOI 10.1016/j.envexpbot.2013.09.002; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gotelli NJ, 2002, ECOLOGY, V83, P1604, DOI 10.1890/0012-9658(2002)083[1604:BAARSD]2.0.CO;2; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hevia V, 2013, BIODIVERS CONSERV, V22, P2567, DOI 10.1007/s10531-013-0539-8; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; Joffre R, 1999, AGROFOREST SYST, V45, P57, DOI 10.1023/A:1006259402496; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kleinwaechter M, 2007, BIODIVERS CONSERV, V16, P3067, DOI 10.1007/s10531-007-9163-9; KODRICBROWN A, 1993, ECOLOGY, V74, P1847, DOI 10.2307/1939942; Kwon TS, 2014, J ASIA-PAC ENTOMOL, V17, P161, DOI 10.1016/j.aspen.2013.12.006; Laiolo P, 2017, GLOBAL ECOL BIOGEOGR, V26, P601, DOI 10.1111/geb.12565; Laiolo P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1808; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Telleria JL, 2018, ARDEOLA, V65, P221, DOI 10.13157/arla.65.2.2018.ra2; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Magurran A.E, 2004, MEASURING BIOL DIVER; Majer JD, 2000, ANTS STANDARD METHOD; Malsch AKF, 2008, ASIAN MYRMECOL, V2, P33; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Moore JE, 2007, OECOLOGIA, V152, P763, DOI 10.1007/s00442-007-0696-0; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; Munyai TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122035; Bravo DN, 2008, AMBIO, V37, P280, DOI 10.1579/0044-7447(2008)37[280:CCIMMD]2.0.CO;2; Nolte D, 2017, BIOL CONSERV, V213, P5, DOI 10.1016/j.biocon.2017.06.038; Nowrouzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153420; Oliver TH, 2014, WIRES CLIM CHANGE, V5, P317, DOI 10.1002/wcc.271; Orabi GM, 2011, ZOOL MIDDLE EAST, V54, P101, DOI 10.1080/09397140.2011.10648882; Philpott SM, 2006, ECOL ENTOMOL, V31, P369, DOI 10.1111/j.1365-2311.2006.00793.x; Reymond A, 2013, ECOL ENTOMOL, V38, P364, DOI 10.1111/een.12027; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Schmidt FA, 2013, ECOL INDIC, V24, P158, DOI 10.1016/j.ecolind.2012.05.031; Schob C, 2013, J ECOL, V101, P753, DOI 10.1111/1365-2745.12062; Seoane J, 2003, BIOL CONSERV, V111, P401, DOI 10.1016/S0006-3207(02)00309-9; Seoane J, 2017, J BIOGEOGR, V44, P556, DOI 10.1111/jbi.12877; Sfenthourakis S, 2001, BIODIVERS CONSERV, V10, P1387, DOI 10.1023/A:1016672415953; Smith MA, 2014, ECOGRAPHY, V37, P720, DOI 10.1111/j.1600-0587.2013.00631.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storch D, 2018, ECOL LETT, V21, P920, DOI 10.1111/ele.12941; Szewczyk T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155404; Torres LG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120014; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2013, OIKOS, V122, P2, DOI 10.1111/j.1600-0706.2012.20325.x; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Wolff A, 1999, OIKOS, V84, P443, DOI 10.2307/3546423; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; Zuur A. F., 2012, BEGINNERS GUIDE GEN	81	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0204787	10.1371/journal.pone.0204787	http://dx.doi.org/10.1371/journal.pone.0204787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566476	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300004
J	Kirirabwa, NS; Kimuli, D; DeJene, S; Nanziri, C; Birabwa, E; Okello, DA; Suarez, PG; Kasozi, S; Byaruhanga, R; Lukoye, D				Kirirabwa, Nicholas Sebuliba; Kimuli, Derrick; DeJene, Seyoum; Nanziri, Carol; Birabwa, Estella; Okello, Daniel Ayen; Suarez, Pedro Guillermo; Kasozi, Samuel; Byaruhanga, Raymond; Lukoye, Deus			Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; LIFE EXPECTANCY; DIAGNOSIS; HIV; COUNTRIES	While old age is a known risk factor for developing active tuberculosis (TB), studies on TB in the population aged 60 years and older (considered elderly in this study) are few, especially in the developing world. Results of the TB prevalence survey in Uganda found high TB prevalence (570/100,000) in people over 65. We focused on treatment outcomes in the elderly to understand this epidemic better. We conducted a retrospective analysis of data from TB facility registers in Kampala City for the period 2014-2015. We analyzed the 2014-15 cohort with respect to age, sex, disease class, patients' human immunodeficiency virus (HIV) and directly observed therapy (DOT) status, type of facility, and treatment outcomes and compared findings in the elderly (>= 60) and younger (<60) age groups. Of 15,429 records, 3.3% (514/15,429) were for elderly patients. The treatment success rate (TSR) among elderly TB patients (68.3%) was lower than that of the non-elderly (80.9%) and the overall TSR 80.5%, (12,417/15,429) in Kampala. Although the elderly were less likely to test positive for HIV than the young (AOR 0.39; 95% CI 0.33-0.48, p<0.001), they had a two-fold higher risk of unfavorable treatment outcomes (AOR 2.14; CI 1.84-2.72, p<0.001) and were more likely to die while on treatment (AOR 1.86; CI 1.27-2.73; p = 0.001). However, there was no statistically significantly difference between treatment outcomes among HIV-positive and HIV-negative elderly TB patients. Compared to the younger TB patients, elderly TB patients have markedly poorer treatment outcomes, although TB/HIV co-infection rates in this age group are lower.	[Kirirabwa, Nicholas Sebuliba; Kimuli, Derrick; Nanziri, Carol; Kasozi, Samuel; Byaruhanga, Raymond; Lukoye, Deus] TRACK TB Project, Management Sci Hlth, Kampala, Uganda; [DeJene, Seyoum; Birabwa, Estella] US Agcy Int Dev, Kampala, Uganda; [Okello, Daniel Ayen] Kampala Capital City Author, Directorate Publ Hlth & Environm, Kampala, Uganda; [Suarez, Pedro Guillermo] Management Sci Hlth, Arlington, VA USA	United States Agency for International Development (USAID)	Kirirabwa, NS (corresponding author), TRACK TB Project, Management Sci Hlth, Kampala, Uganda.	ksnicky@yahoo.co.uk	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761; Kirirabwa.S, Nicholas/0000-0003-2369-1556; Kimuli, Derrick/0000-0002-5302-7077	United States Agency for International Development (USAID) [AID - 623-A-13-0003]; President's Emergency Plan for AIDS Relief (PEPFAR) [AID - 623-A-13-0003]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The United States Agency for International Development (USAID) and the President's Emergency Plan for AIDS Relief (PEPFAR) supported this work through the TRACK TB Project under cooperative agreement number AID - 623-A-13-0003. The content of the article are the responsibility of authors alone and do not necessarily reflect the views of USAID, PEPFAR or the United States government.	Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; [Anonymous], 2017, TUBERCULOSIS; Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Bigna JJR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132394; Etwom A, 2015, INT J TUBERCULOSI S2, V19; Geeta Pardeshi, 2007, Indian Journal of Community Medicine, V32, P292; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Lee JH, 2005, J KOREAN MED SCI, V20, P784, DOI 10.3346/jkms.2005.20.5.784; Li J, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0284-4; Lin YS, 2015, AGE AGEING, V44, P490, DOI 10.1093/ageing/afv002; Marais BJ, 2014, LANCET RESP MED, V2, P254, DOI 10.1016/S2213-2600(14)70009-8; Ministry of Health (MOH), 2015, UG NAT TUB PREV SURV; Ministry of Health (MOH) Resource Centre Uganda, 2014, REV HLTH UN COMM PRO, V1, P586; Mitchell EMH, 2012, LESSONS LOSS GUIDE C; MOH & ICF, 2012, UG AIDS IND SURV AIS; Mohammadi-Moein HR, 2013, J RES MED SCI, V18, P1040; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Oshi DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111910; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; Phelan F, 2000, AGE AGEING, V29, P319, DOI 10.1093/ageing/29.4.319; RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515; Sood R, 2000, J INDIAN ACAD CLIN M, V5, P156; Tuberculosis Surveillance Center RIT JATA, 2016, KEKKAKU, V90, P553; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; United Nations, 2015, WORLD POP AG 2015; United Nations, AGEING; van Crevel R, 2014, LANCET DIABETES ENDO, V2, P270, DOI 10.1016/S2213-8587(14)70011-7; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; ZAGARIA MAE, 2008, US PHARM, V33, P23; Zevallos M, 2003, CLIN GERIATR MED, V19, P121, DOI 10.1016/S0749-0690(02)00057-5	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208390	10.1371/journal.pone.0208390	http://dx.doi.org/10.1371/journal.pone.0208390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566486	Green Submitted, gold, Green Published			2022-12-26	WOS:000453779300039
J	Labonte, AC; Kegerreis, B; Geraci, NS; Bachali, P; Madamanchi, S; Robl, R; Catalina, MD; Lipsky, PE; Grammer, AC				Labonte, Adam C.; Kegerreis, Brian; Geraci, Nicholas S.; Bachali, Prathyusha; Madamanchi, Sushma; Robl, Robert; Catalina, Michelle D.; Lipsky, Peter E.; Grammer, Amrie C.			Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; FUNCTIONAL PLASTICITY; POLARIZATION; CELLS; EXPRESSION; SIGNATURE; MOLECULES; IMMUNITY	Systemic lupus erythematosus (SLE) is characterized by abnormalities in B cell and T cell function, but the role of disturbances in the activation status of macrophages (M phi) has not been well described in human patients. To address this, gene expression profiles from isolated lymphoid and myeloid populations were analyzed to identify differentially expressed (DE) genes between healthy controls and patients with either inactive or active SLE. While hundreds of DE genes were identified in B and T cells of active SLE patients, there were no DE genes found in B or T cells from patients with inactive SLE compared to healthy controls. In contrast, large numbers of DE genes were found in myeloid cells (MC) from both active and inactive SLE patients. Among the DE genes were several known to play roles in M phi activation and polarization, including the M1 genes STAT1 and SOCS3 and the M2 genes STAT3, STAT6, and CD163. M1-associated genes were far more frequent in data sets from active versus inactive SLE patients. To characterize the relationship between M phi activation and disease activity in greater detail, weighted gene co-expression network analysis (WGCNA) was used to identify modules of genes associated with clinical activity in SLE patients. Among these were disease activity-correlated modules containing activation signatures of predominantly M1-associated genes. No disease activity-correlated modules were enriched in M2-associated genes. Pathway and upstream regulator analysis of DE genes from both active and inactive SLE MC were cross-referenced with high-scoring hits from the drug discovery Library of Integrated Network-based Cellular Signatures (LINCS) to identify new strategies to treat both stages of SLE. A machine learning approach employing MC gene modules and a generalized linear model was able to predict the disease activity status in unrelated gene expression data sets. In summary, altered MC gene expression is characteristic of both active and inactive SLE. However, disease activity is associated with an alteration in the activation of MC, with a bias toward the M1 proinflammatory phenotype. These data suggest that while hyperactivity of B cells and T cells is associated with active SLE, MC potentially direct flare-ups and remission by altering their activation status toward the M1 state.	[Labonte, Adam C.; Kegerreis, Brian; Geraci, Nicholas S.; Bachali, Prathyusha; Catalina, Michelle D.; Lipsky, Peter E.; Grammer, Amrie C.] AMPEL BioSolut LLC, Charlottesville, VA 22902 USA; [Labonte, Adam C.; Kegerreis, Brian; Geraci, Nicholas S.; Madamanchi, Sushma; Robl, Robert; Catalina, Michelle D.; Lipsky, Peter E.; Grammer, Amrie C.] RILITE Res Inst, Charlottesville, VA 22902 USA		Grammer, AC (corresponding author), AMPEL BioSolut LLC, Charlottesville, VA 22902 USA.; Grammer, AC (corresponding author), RILITE Res Inst, Charlottesville, VA 22902 USA.	amrie.grammer@ampelbiosolutions.com	Geraci, Nick/AAF-4668-2020	Geraci, Nicholas/0000-0003-4294-9188; Labonte, Adam/0000-0001-7378-2638; Grammer, Amrie/0000-0001-7142-2284	RILITE Research Institute, John and Marcia Goldman Foundation	RILITE Research Institute, John and Marcia Goldman Foundation	The work presented in this manuscript was funded by a grant awarded to P.E.L. and A.C. G. of the RILITE Research Institute by the John and Marcia Goldman Foundation (jmgoldmanfoundation.org). The funder provided support in the form of salaries for authors [A.C.L., B.K., N.S.G., S.M., R.R., M.D.C.], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors [A.C.L., B.K., N.S.G., P.B., M.D.C., P.E.L., A.C.G.] are employed by AMPEL BioSolutions, LLC, a biomedical research consultation firm. The specific roles of authors are articulated in the "Author Contributions" section.	Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Behar SM, 2014, SEMIN IMMUNOL, V26, P559, DOI 10.1016/j.smim.2014.09.003; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Bienkowska J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112545; Bloom BR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0006-2015; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chalmers SA, 2015, DISCOV MED, V20, P43; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deng W, 2015, CLIN IMMUNOL, V161, P209, DOI 10.1016/j.clim.2015.07.011; Ducreux Julie, 2016, Rheumatology (Oxford), V55, P1901, DOI 10.1093/rheumatology/kew262; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Festuccia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095432; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Grammer AC, 2016, LUPUS, V25, P1150, DOI 10.1177/0961203316657437; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gren ST, 2016, INFLAMM BOWEL DIS, V22, P1, DOI [10.1097/MIB.0000000000000574, DOI 10.1097/MIB.0000000000000574]; Griffiths HR, 2017, REDOX BIOL, V12, P50, DOI 10.1016/j.redox.2017.01.023; Healy LM, 2018, CLIN IMMUNOL, V189, P63, DOI 10.1016/j.clim.2016.04.006; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Jourde-Chiche N, 2017, RHEUMATOLOGY, V56, P477, DOI 10.1093/rheumatology/kew439; Kennedy WP, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000080; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kyogoku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083776; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lauwerys BR, 2013, ARTHRITIS RHEUM-US, V65, P447, DOI 10.1002/art.37785; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Ley K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00204; Li F, 2016, CELL PHYSIOL BIOCHEM, V38, P330, DOI 10.1159/000438633; Lin Q, 2015, NUCLEIC ACIDS RES, V43, P9680, DOI 10.1093/nar/gkv1056; Liu CL, 2015, MOL BIOSYST, V11, P714, DOI 10.1039/c4mb00677a; Lugar PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044362; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smiljanovic B, 2012, J MOL MED, V90, P1295, DOI 10.1007/s00109-012-0907-y; Snyder RJ, 2016, WOUND REPAIR REGEN, V24, P613, DOI 10.1111/wrr.12444; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Xiao PL, 2014, GENE, V547, P300, DOI 10.1016/j.gene.2014.06.065; Yoshida R, 2014, ADV IMMUNOL, V124, P207, DOI 10.1016/B978-0-12-800147-9.00007-8; Zhu YFP, 2016, ARTERIOSCL THROM VAS, V36, P1722, DOI 10.1161/ATVBAHA.116.304054	59	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208132	10.1371/journal.pone.0208132	http://dx.doi.org/10.1371/journal.pone.0208132			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562343	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100011
J	Ahirwar, RN; Mishra, VK; Chand, R; Budhlakoti, N; Mishra, DC; Kumar, S; Singh, S; Joshi, AK				Ahirwar, Ram Narayan; Mishra, Vinod Kumar; Chand, Ramesh; Budhlakoti, Neeraj; Mishra, Dwijesh Chandra; Kumar, Sundeep; Singh, Shweta; Joshi, Arun Kumar			Genome-wide association mapping of spot blotch resistance in wheat association mapping initiative (WAMI) panel of spring wheat (Triticum aestivum L.)	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; GENETIC DIVERSITY; LANDRACES; IMPROVEMENT; CHALLENGES; COMPONENTS; SOFTWARE; PLAINS	Spot blotch (SB) caused by Bipolaris sorokiniana, is one of the most important diseases of wheat in the eastern part of south Asia causing considerable yield loss to the wheat crop. There is an urgent need to identify genetic loci closely associated with resistance to this pathogen for developing resistant cultivars. Hence, genomic regions responsible for SB resistance were searched using a wheat association mapping initiative (WAMI) panel involving 287 spring wheat genotypes of different origin. Genome-wide association mapping (GWAM) was performed using single nucleotide polymorphism (SNP) markers from a custom 90 K wheat SNP array. A mixed linear model (MLM) was used for assessing the association of SNP markers with spot blotch resistance in three consecutive years. Three traits were measured: incubation period, lesion number and area under the disease progress curve (AUDPC). Significant SNP markers were found linked to five, six and four quantitative trait loci (QTLs) for incubation period, lesion number and AUDPC respectively. They were detected on 11 different chromosomes: 1A, 1B, 1D, 4A, 5A, 5B, 6A, 6B, 6D, 7A, 7B with marker R-2 range of 0.083 to 0.11. The greatest number of significant SNP-markers was found for lesion number and AUDPC on chromosome 6B and 5B, respectively, representing a better coverage of B-genome by SNPs. On the other hand, the most significant and largest SNP markers for incubation period were detected on 6A and 4A chromosomes indicating that this trait is associated with the A-genome of wheat. Although, QTLs for spot blotch resistance have been reported in wheat on these same chromosomes, the association of incubation period and lesion number with SB resistance has not been reported in previous studies. The panel exhibits considerable variation for SB resistance and also provides a good scope of marker-assisted selection using the identified SNP markers linked to resistant QTLs.	[Ahirwar, Ram Narayan; Mishra, Vinod Kumar; Singh, Shweta] Banaras Hindu Univ, Inst Agr Sci, Dept Genet & Plant Breeding, Varanasi, Uttar Pradesh, India; [Chand, Ramesh] Banaras Hindu Univ, Dept Mycol & Plant Pathol, Inst Agr Sci, Varanasi, Uttar Pradesh, India; [Budhlakoti, Neeraj; Mishra, Dwijesh Chandra] ICAR Indian Agr Stat Res Inst, New Delhi, India; [Kumar, Sundeep] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Joshi, Arun Kumar] Int Maize & Wheat Improvement Ctr CIMMYT, DPS Marg, New Delhi, India; [Joshi, Arun Kumar] BISA, DPS Marg, New Delhi, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Mishra, VK (corresponding author), Banaras Hindu Univ, Inst Agr Sci, Dept Genet & Plant Breeding, Varanasi, Uttar Pradesh, India.	vkmbhu@gmail.com	Chand, Ramesh/AAP-3291-2020; Mishra, Vinod Kumar/AAC-6474-2022	Mishra, Vinod/0000-0002-3068-1199; Chand, Ramesh/0000-0001-5231-224X				Adhikari TB, 2012, PLANT GENOME-US, V5, P1, DOI 10.3835/plantgenome2011.12.0032; Adhikari TB, 2011, PHYTOPATHOLOGY, V101, P1301, DOI 10.1094/PHYTO-03-11-0076; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Braun HJ, 2010, CABI CLIM CHANGE SER, V1, P115, DOI 10.1079/9781845936334.0115; BRAUN HJ, 1992, CROP SCI, V32, P1420, DOI 10.2135/cropsci1992.0011183X003200060022x; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chatrath R, 2007, EUPHYTICA, V157, P447, DOI 10.1007/s10681-007-9515-2; Chaurasia S, 1999, GENET RESOUR CROP EV, V46, P469, DOI 10.1023/A:1008797232108; Duveiller E, 2005, PHYTOPATHOLOGY, V95, P248, DOI 10.1094/PHYTO-95-0248; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Gurung S, 2011, THEOR APPL GENET, V123, P1029, DOI 10.1007/s00122-011-1645-1; GURUNG S, 2014, PLOS ONE, V9; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Joshi AK, 2007, FIELD CROP RES, V103, P53, DOI 10.1016/j.fcr.2007.04.010; Joshi AK, 2011, EUPHYTICA, V179, P187, DOI 10.1007/s10681-010-0314-9; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kumar U, 2010, MOL BREEDING, V26, P477, DOI 10.1007/s11032-009-9388-2; Panse VG, 1985, STAT METHOD AGR WORK, DOI [10.1093/bioinformatics/btm308, DOI 10.1093/BIOINFORMATICS/BTM308]; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Pritchard JK, 2000, GENETICS, V155, P945; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; ROUMEN EC, 1992, EUPHYTICA, V63, P271; SAARI EE, 1975, PLANT DIS REP, V59, P377; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sharma RC, 2007, CROP SCI, V47, P961, DOI 10.2135/cropsci2006.03.0201; Singh PK, 2015, EUR J PLANT PATHOL, V143, P595, DOI 10.1007/s10658-015-0712-x; Sivakumar S, 2016, CIMMYT RES DATA SOFT; WILCOXSON RD, 1981, PHYTOPATHOLOGY, V71, P989, DOI 10.1094/Phyto-71-989; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004	35	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208196	10.1371/journaI.pone.0208196	http://dx.doi.org/10.1371/journaI.pone.0208196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557301				2022-12-26	WOS:000453451000024
J	Aroca-Aguilar, JD; Fernandez-Navarro, A; Ontanon, J; Coca-Prados, M; Escribano, J				Aroca-Aguilar, Jose-Daniel; Fernandez-Navarro, Ana; Ontanon, Jesus; Coca-Prados, Miguel; Escribano, Julio			Identification of myocilin as a blood plasma protein and analysis of its role in leukocyte adhesion to endothelial cell monolayers	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RECOMBINANT MYOCILIN; SPANISH PATIENTS; CILIARY BODY; IN-VIVO; GENE; MUTATIONS; EXPRESSION; CLEAVAGE; SPARC	Myocilin is an extracellular glycoprotein with a poorly understood biological function and typically known because of its association with glaucoma. In this study, we analyzed the expression and biological activity of human myocilin in some non-ocular tissues. Western immunoblot showed the presence of myocilin in blood plasma as well as in liver and lymphoid tissues (thymus and lymph node). Quantitative PCR confirmed the expression of MYOC in these lymphoid organs and revealed that its mRNA is also present in T-Iymphocytes and leukocytes. In addition, detection of 30 kDa C-terminal myocilin fragments in thymus and liver suggested that myocilin undergoes an in vivo proteolytic processing that might regulate its biological activity. The presence of myocilin in blood was further corroborated by peptide mass fingerprinting of the HPLC-isolated protein, and gross estimation of its concentration by Western immunoblot indicated that it is a medium-abundance serum protein with an approximate concentration of 0.85 mg/ml (15.5 mu M). Finally, in vitro analyses indicated that myocilin acts as an anti-adhesive protein for human circulating leukocytes incubated with endothelial cell monolayers. Altogether, these data provide insightful information on new biological properties of myocilin and suggest its putative role as a blood matricellular protein.	[Aroca-Aguilar, Jose-Daniel; Fernandez-Navarro, Ana; Escribano, Julio] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Fac Med, Lab Genet Mol Humana, Albacete, Spain; [Aroca-Aguilar, Jose-Daniel; Escribano, Julio] Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain; [Ontanon, Jesus] Complejo Hosp Univ Albacete, Serv Inmunol, Castilla La Mancha, Spain; [Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Coca-Prados, Miguel] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo, Spain	Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Yale University	Escribano, J (corresponding author), Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Fac Med, Lab Genet Mol Humana, Albacete, Spain.; Escribano, J (corresponding author), Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain.	julio.escribano@uclm.es	Aroca-Aguilar, J.Daniel/B-7842-2008; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019	Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Ontanon Rodriguez, Jesus/0000-0002-2006-4357	Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" [PEII-2014-002-P]; Instituto de Salud Carlos III/FEDER [RD12/0034/0003, RD16/0008/0019, PI11/00662, PI15/01193]	Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha"; Instituto de Salud Carlos III/FEDER(Instituto de Salud Carlos IIIEuropean Commission)	This study has been supported by research grants (to JE) from the Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" (http://www.educa.jccm.es/es, PEII-2014-002-P to J.E.) and the "Instituto de Salud Carlos III/FEDER" (http://www.isciii.es/, RD12/0034/0003, RD16/0008/0019, PI11/00662 and PI15/01193, all to J.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2012, MOL VIS, V18, P1004; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Campos-Mollo E, 2007, MOL VIS, V13, P1666; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; ESCRIBANO J, 1995, J BIOCHEM-TOKYO, V118, P921, DOI 10.1093/jb/118.5.921; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fautsch MP, 2004, MOL VIS, V10, P417; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Girard JP, 1996, J BIOL CHEM, V271, P4511; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; Gonzalez-Iglesias H, 2014, J PROTEOMICS, V98, P65, DOI 10.1016/j.jprot.2013.12.006; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hill SE, 2017, STRUCTURE, V25, P1697, DOI 10.1016/j.str.2017.09.008; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Howell KG, 2010, J GLAUCOMA, V19, P569, DOI 10.1097/IJG.0b013e3181d13020; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim K, 2010, J PROTEOME RES, V9, P689, DOI 10.1021/pr901013d; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; LARSSON A, 1993, POULTRY SCI, V72, P1807, DOI 10.3382/ps.0721807; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li G, 1997, ELECTROPHORESIS, V18, P391, DOI 10.1002/elps.1150180313; Liu XY, 2007, J AM SOC MASS SPECTR, V18, P1249, DOI 10.1016/j.jasms.2007.04.012; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Martinez F, 2007, MOL VIS, V13, P862; Menaa F, 2011, MOLECULES, V16, P5402, DOI 10.3390/molecules16075402; Motamed K, 1998, J CELL BIOCHEM, V70, P543, DOI 10.1002/(SICI)1097-4644(19980915)70:4<543::AID-JCB10>3.0.CO;2-I; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Patterson-Orazem AC, 2018, EXP EYE RES, V173, P109, DOI 10.1016/j.exer.2018.05.002; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Shen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044902; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; TRIPATHI RC, 1989, EXP EYE RES, V48, P117, DOI 10.1016/0014-4835(89)90025-0; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2004, J CELL PHYSIOL, V200, P45, DOI 10.1002/jcp.10478; Zode GS, 2015, J CLIN INVEST, V125, P3303, DOI 10.1172/JCI82799	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209364	10.1371/journal.pone.0209364	http://dx.doi.org/10.1371/journal.pone.0209364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557320	Green Published, Green Submitted, gold			2022-12-26	WOS:000453451000096
J	Buja, A; Claus, M; Perin, L; Rivera, M; Corti, MC; Avossa, F; Schievano, E; Rigon, S; Toffanin, R; Baldo, V; Boccuzzo, G				Buja, Alessandra; Claus, Mirko; Perin, Lucia; Rivera, Michele; Corti, Maria Chiara; Avossa, Francesco; Schievano, Elena; Rigon, Stefano; Toffanin, Roberto; Baldo, Vincenzo; Boccuzzo, Giovanna			Multimorbidity patterns in high-need, high-cost elderly patients	PLOS ONE			English	Article							PRIMARY-CARE; OLDER-ADULTS; DISEASE; HEALTH; GUIDELINES	Introduction Patients with complex health care needs (PCHCN) are individuals who require numerous, costly care services and have been shown to place a heavy burden on health care resources. It has been argued that an important issue in providing value-based primary care concerns how to identify groups of patients with similar needs (who pose similar challenges) so that care teams and care delivery processes can be tailored to each patient subgroup. Our study aims to describe the most common chronic conditions and their combinations in a cohort of elderly PCHCN. Methods We focused on a cohort of PCHCN residing in an area served by a local public health unit (the "Azienda ULSS4-Veneto") and belonging to Resource Utilization Bands 4 and 5 according to the ACG System. For each patient we extracted Expanded Diagnosis Clusters, and combined them with information available from Rx-MGs diagnoses. For the present work we focused on 15 diseases/disorders, analyzing their combinations as dyads and triads. Latent class analysis was used to elucidate the patterns of the morbidities considered in the PCHCN. Results Five disease clusters were identified: one concerned metabolic-ischemic heart diseases; one was labelled as neurological and mental disorders; one mainly comprised cardiac diseases such as congestive heart failure and atrial fibrillation; one was largely associated with respiratory conditions; and one involved neoplasms. Conclusions Our study showed specific common associations between certain chronic diseases, shedding light on the patterns of multimorbidity often seen in PCHCN. Studying these patterns in more depth may help to better organize the intervention needed to deal with these patients.	[Buja, Alessandra; Claus, Mirko; Baldo, Vincenzo] Univ Padua, Dept Cardiol Vasc & Thorac Sci & Publ Hlth, Padua, Italy; [Perin, Lucia; Boccuzzo, Giovanna] Univ Padua, Dept Stat Sci, Padua, Italy; [Rivera, Michele] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Corti, Maria Chiara; Avossa, Francesco; Schievano, Elena; Rigon, Stefano; Toffanin, Roberto] Veneto Reg Local Hlth Unit, Venice, Italy	University of Padua; University of Padua; University of Padua	Rivera, M (corresponding author), Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy.	michelerivera1992@gmail.com	Vincenzo, Baldo/D-7822-2018; Baldo, Vincenzo/V-4005-2019; Buja, Alessandra/AAN-8141-2020	Vincenzo, Baldo/0000-0001-6012-9453; Baldo, Vincenzo/0000-0001-6012-9453; Buja, Alessandra/0000-0003-2216-3807; Claus, Mirko/0000-0002-4099-9838				Anderson GF, 2015, AM J MANAG CARE, V21, pE597; [Anonymous], 2016, MULTIMORBIDITY ASSES; [Anonymous], 2010, TITLE ERROR; [Anonymous], 2012, 439 DGR; [Anonymous], 2014, 1103 DGR; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Dharmarajan K, 2016, CLIN GERIATR MED, V32, P277, DOI 10.1016/j.cger.2016.01.002; Dunlay SM, 2016, CURR CARDIOVASC RISK, V10, DOI 10.1007/s12170-016-0491-8; Farmer C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4843; Ferre F, 2014, HEALT SYST TRANSIT, V16, P1; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631; Goodman RA, 2016, J GERONTOL A-BIOL, V71, P215, DOI 10.1093/gerona/glv199; Hayes S, 2016, HIGH NEED HIGH COST, P3; Hochman M, 2017, J GEN INTERN MED, V32, P392, DOI 10.1007/s11606-016-3945-2; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Limm B, 2012, J AM GERIATR SOC, V60, pS167; Marengoni A, 2010, REJUV RES, V13, P469, DOI 10.1089/rej.2009.1002; Mazza D, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12717; Morgan MAJ, 2015, AUSTRALAS MED J, V8, P208, DOI 10.4066/AMJ.2015.2377; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; National Institute for Health and Care Excellence (NICE), 2016, MULT CLIN ASS MAN; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Porter ME, 2013, HEALTH AFFAIR, V32, P516, DOI 10.1377/hlthaff.2012.0961; Reid MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h532; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schellevis FG, 1993, THESIS; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]; Starfield B, 2011, HEALTH POLICY, V103, P3, DOI 10.1016/j.healthpol.2011.09.004; The Johns Hopkins University, 2014, ACG SYST VERS 11 0; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425	40	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208875	10.1371/journal.pone.0208875	http://dx.doi.org/10.1371/journal.pone.0208875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE5TK	30557384	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000053
J	Blondeau-Patissier, D; Brando, VE; Lonborg, C; Leahy, SM; Dekker, AG				Blondeau-Patissier, David; Brando, Vittorio Ernesto; Lonborg, Christian; Leahy, Susannah M.; Dekker, Arnold G.			Phenology of Trichodesmium spp. blooms in the Great Barrier Reef lagoon, Australia, from the ESA-MERIS 10-year mission	PLOS ONE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; MARINE CYANOBACTERIUM; GROWTH-RATES; ENVIRONMENTAL CONTROLS; BIOGEOCHEMICAL MODEL; CENTRAL 17-DEGREES-S; FLOATING SARGASSUM; ORGANIC-MATTER; WATER-QUALITY	Trichodesmium, a filamentous bloom-forming marine cyanobacterium, plays a key role in the biogeochemistry of oligotrophic ocean regions because of the ability to fix nitrogen. Naturally occurring in the Great Barrier Reef (GBR), the contribution of Trichodesmium to the nutrient budget may be of the same order as that entering the system via catchment runoff. However, the cyclicity of Trichodesmium in the GBR is poorly understood and sparsely documented because of the lack of sufficient observations. This study provides the first systematic analysis of Trichodesmium spatial and temporal occurrences in the GBR over the decade-long MERIS ocean color mission (2002-2012). Trichodesmium surface expressions were detected using the Maximum Chlorophyll Index (MCI) applied to MERIS satellite imagery of the GBR lagoonal waters. The MCI performed well (76%), albeit tested on a limited set of images (N = 25) coincident with field measurements. A north (Cape York) to south (Fitzroy) increase in the extent, frequency and timing of the surface expressions characterized the GBR, with surface expressions extending over several hundreds of kilometers. The two southernmost subregions Mackay and Fitzroy accounted for the most (70%) bloom events. The bloom timing of Trichodesmium varied from May in the north to November in the south, with wet season conditions less favorable to Trichodesmium aggregations. MODIS-Aqua Sea Surface Temperature (SST) datasets, wind speed and field measurements of nutrient concentrations were used in combination with MCI positive instances to assess the blooms' driving factors. Low wind speed (<6 m.s(-1)) and SST > 24 degrees C were associated with the largest surface aggregations. Generalized additive models (GAM) indicated an increase in bloom occurrences over the 10-year period with seasonal bloom patterns regionally distinct. Interannual variability in SST partially (14%) explained bloom occurrences, and other drivers, such as the subregion and the nutrient budget, likely regulate Trichodesmium surface aggregations in the GBR.	[Blondeau-Patissier, David] Charles Darwin Univ, RIEL, Darwin, NT, Australia; [Blondeau-Patissier, David] NAMRA, Darwin, NT, Australia; [Brando, Vittorio Ernesto] Inst Atmospher Sci & Climate, Natl Res Council CNR, Rome, Italy; [Brando, Vittorio Ernesto; Dekker, Arnold G.] CSIRO, Canberra, ACT, Australia; [Lonborg, Christian] AIMS, Townsville, Qld, Australia; [Leahy, Susannah M.] James Cook Univ, Coll Sci & Engn, Cairns, Australia; [Blondeau-Patissier, David] CSIRO, Brisbane, Qld, Australia	Charles Darwin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Institute of Marine Science; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Blondeau-Patissier, D (corresponding author), Charles Darwin Univ, RIEL, Darwin, NT, Australia.; Blondeau-Patissier, D (corresponding author), NAMRA, Darwin, NT, Australia.; Blondeau-Patissier, D (corresponding author), CSIRO, Brisbane, Qld, Australia.	david.blondeau-patissier@csiro.au	Brando, Vittorio E/A-1321-2008; Lønborg, Christian/M-4456-2013; Blondeau-Patissier, David/D-3607-2013	Brando, Vittorio E/0000-0002-2193-5695; Lønborg, Christian/0000-0001-8380-0238; Leahy, Susannah/0000-0001-8517-201X; Blondeau-Patissier, David/0000-0002-1696-9022	NAMRA post-doctoral fellowship; CSIRO Oceans and Atmosphere funding; CNR; RITMARE flagship Project; European Union [600407]; Great Barrier Reef Marine Park Authority (GBRMPA) through Australian Government Caring for our Country Program; Great Barrier Reef Marine Park Authority (GBRMPA), through Australian Government Australian Institute of Marine Science	NAMRA post-doctoral fellowship; CSIRO Oceans and Atmosphere funding; CNR(Consiglio Nazionale delle Ricerche (CNR)); RITMARE flagship Project; European Union(European Commission); Great Barrier Reef Marine Park Authority (GBRMPA) through Australian Government Caring for our Country Program; Great Barrier Reef Marine Park Authority (GBRMPA), through Australian Government Australian Institute of Marine Science	For this study, DBP was partly supported by a NAMRA post-doctoral fellowship and by CSIRO Oceans and Atmosphere funding. VEB was supported by CNR, the RITMARE flagship Project and the European Union (FP7-427 People Co-funding of Regional, National and International Programmes, GA n. 600407). Collection of the nutrient data presented in this study was obtained with support from the Great Barrier Reef Marine Park Authority (GBRMPA), through funding from the Australian Government's Caring for our Country Program and from the Australian Institute of Marine Science.; For this study, DBP was partly supported by a NAMRA post-doctoral fellowship and by CSIRO Oceans and Atmosphere funding. CNR, the RITMARE Flagship Project and the European Union (FP7-427 People Co-funding of Regional, National and International Programmes, GA n. 600407) supported VEB. Collection of the nutrient data presented in this study was obtained with support from the Great Barrier Reef Marine Park Authority (GBRMPA), through funding from the Australian Government's Caring for our Country Program and from the Australian Institute of Marine Science. The authors acknowledge the data providers: The European Space Agency (ESA) and ACRI-ST (www.acri-st.fr/) for providing the MERIS RR dataset; The Bureau of Meteorology (BoM; www.bom.gov.au), IMOS (Integrated Marine Observing System; http://imos.org.au) and eReefs (http://ereefs.org.au).The authors are grateful to: Elsevier Language Editing Services for providing editing support; Jonathan Hodge (CSIRO Oceans and Atmosphere) for providing guidance in extracting the wind data from eReefs; CSIRO Data61 (Ecosciences Precinct) for advice for parts of the data analysis, and Dr Phillip Ford, Dr Peter Rothlisberg and Dr Tim Malthus (CSIRO Oceans and Atmosphere) for comments on previous versions of the manuscript. All the processing of the ESA MERIS imagery was performed with the Sentinel Application Platform (SNAP) (Brockmann Consult).	Ahern KS, 2007, MAR FRESHWATER RES, V58, P883, DOI 10.1071/MF07065; Alikas K, 2010, OCEANOLOGIA, V52, P237, DOI 10.5697/oc.52-2.237; ANDREWS JC, 1989, DEEP-SEA RES, V36, P957, DOI 10.1016/0198-0149(89)90037-X; Baird ME, 2016, ENVIRON MODELL SOFTW, V78, P79, DOI 10.1016/j.envsoft.2015.11.025; Bell PRF, 2005, HYDROBIOLOGIA, V543, P25, DOI 10.1007/s10750-004-5713-2; Bell PRF, 2005, HYDROBIOLOGIA, V532, P9, DOI 10.1007/s10750-004-8768-1; Bergman B, 2013, FEMS MICROBIOL REV, V37, P286, DOI 10.1111/j.1574-6976.2012.00352.x; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Binding CE, 2013, J GREAT LAKES RES, V39, P100, DOI 10.1016/j.jglr.2013.04.005; Binding CE, 2012, J GREAT LAKES RES, V38, P107, DOI 10.1016/j.jglr.2011.12.003; Binding CE, 2011, J PLANKTON RES, V33, P793, DOI 10.1093/plankt/fbq133; Binding CE, 2012, J PLANKTON RES, V34, P569, DOI 10.1093/plankt/fbs021; Blondeau-Patissier D, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005039; Blondeau-Patissier D, 2014, PROG OCEANOGR, V123, P123, DOI 10.1016/j.pocean.2013.12.008; Blondeau-Patissier D, 2014, REMOTE SENS-BASEL, V6, P2963, DOI 10.3390/rs6042963; Brando V.E., 2015, REEF RESCUE MARINE M; Breitbarth E, 2008, MAR ECOL PROG SER, V359, P25, DOI 10.3354/meps07241; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Brodie J., 2013, 2013 SCI CONSENSUS S; Brodie J, 2013, SCI CONSENSUS STATEM; Brodie JE, 2011, BIOGEOCHEMISTRY, V106, P281, DOI 10.1007/s10533-010-9542-2; Burrage DM, 1996, REMOTE SENS ENVIRON, V56, P21, DOI 10.1016/0034-4257(95)00226-X; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Clevers JGPW., 2001, INT J APPL EARTH OBS, V3, P313, DOI [10.1016/S0303-2434(01)85038-8, DOI 10.1016/S0303-2434(01)85038-8]; Cropp RA, 2013, J MARINE SYST, V117, P43, DOI 10.1016/j.jmarsys.2013.02.013; Crosbie ND, 2001, J PLANKTON RES, V23, P809, DOI 10.1093/plankt/23.8.809; Dekker A, 2011, REMOTE SENSING ALGAL; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; DUPOUY C, 1988, INT J REMOTE SENS, V9, P389, DOI 10.1080/01431168808954862; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fomferra N, 2005, MERIS ATSR WORKSH 26; Frouin R., 2018, BIOGEOSCI, P1, DOI [10.5194/bg-2017-570, DOI 10.5194/BG-2017-570]; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Fu FX, 2003, MAR ECOL PROG SER, V257, P69, DOI 10.3354/meps257069; Furnas M, 2011, CONT SHELF RES, V31, P1967, DOI 10.1016/j.csr.2011.09.007; Furnas M., 2003, CATCHMENTS CORALS TE; FURNAS MJ, 1992, NATO ADV SCI I C-MAT, V362, P265; Gower J, 2008, INT J REMOTE SENS, V29, P6209, DOI 10.1080/01431160802178110; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower J., 2008, P 2 MERIS AATSR WORK; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Gower J, 2011, REMOTE SENSING OF THE CHANGING OCEANS, P99, DOI 10.1007/978-3-642-16541-2_6; Gower J, 2006, IEEE T GEOSCI REMOTE, V44, P3619, DOI 10.1109/TGRS.2006.882258; Gower J, 2014, REMOTE SENSING OF THE AFRICAN SEAS, P31, DOI 10.1007/978-94-017-8008-7_2; Gower J, 2014, INT J REMOTE SENS, V35, P5459, DOI 10.1080/01431161.2014.926422; Gower J, 2013, REMOTE SENS LETT, V4, P764, DOI 10.1080/2150704X.2013.796433; Hewson I, 2004, AQUAT MICROB ECOL, V36, P1, DOI 10.3354/ame036001; Hutchings PA, 2008, GREAT BARRIER REEF B; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Jassby AD, 2011, PACKAGE WQ SOME TOOL; KARL DM, 1992, NATO ADV SCI I C-MAT, V362, P219; Leahy SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070400; Lenes JM, 2008, CONT SHELF RES, V28, P1091, DOI 10.1016/j.csr.2008.02.009; Lonborg C, 2018, LIMNOL OCEANOGR, V63, P1015, DOI 10.1002/lno.10717; Lonborg C, 2017, CONT SHELF RES, V138, P95, DOI 10.1016/j.csr.2017.01.010; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Luo YW, 2014, BIOGEOSCIENCES, V11, P691, DOI 10.5194/bg-11-691-2014; Mackenzie R, 2005, SUSTAINABLE LAND MAN; Marshall SM, 1933, 5 BRIT MUS; McKinna LIW, 2015, PROG OCEANOGR, V131, P177, DOI 10.1016/j.pocean.2014.12.013; McKinna LIW, 2011, LIMNOL OCEANOGR-METH, V9, P50, DOI 10.4319/lom.2011.9.50; Messer LF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00967; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moradi M, 2014, MAR POLLUT BULL, V87, P311, DOI 10.1016/j.marpolbul.2014.06.053; Mulholland MR, 2007, BIOGEOSCIENCES, V4, P37, DOI 10.5194/bg-4-37-2007; Olson EM, 2015, DEEP-SEA RES PT I, V104, P72, DOI 10.1016/j.dsr.2015.06.012; ONEIL JM, 1994, HYDROBIOLOGIA, V293, P235; Orcutt KM, 2008, LIMNOL OCEANOGR, V53, P2049; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Prange J., 2009, REEF WATER QUALITY P; Qi L, 2015, IEEE GEOSCI REMOTE S, V12, P1170, DOI 10.1109/LGRS.2014.2385800; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rees AP, 2016, J PLANKTON RES, V38, P673, DOI 10.1093/plankt/fbv123; REVELANTE N, 1982, J PLANKTON RES, V4, P47, DOI 10.1093/plankt/4.1.47; REVELANTE N, 1982, J EXP MAR BIOL ECOL, V63, P27, DOI 10.1016/0022-0981(82)90048-X; Rijkenberg MJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028989; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Robson BJ, 2015, ENVIRON MODELL SOFTW, V63, P97, DOI 10.1016/j.envsoft.2014.08.009; Robson BJ, 2013, MODSIM 2013 20 INT C; Rodier M, 2008, J EXP MAR BIOL ECOL, V358, P20, DOI 10.1016/j.jembe.2008.01.016; Rousset G, 2018, BIOGEOSCIENCES DISCU, V2018, P1, DOI [10.5194/bg-2017-571, DOI 10.5194/BG-2017-571]; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Shaw EC, 2008, MAR FRESHWATER RES, V59, P951, DOI 10.1071/MF08087; Sheridan CC, 2002, J PLANKTON RES, V24, P913, DOI 10.1093/plankt/24.9.913; Snow JT, 2015, GLOBAL BIOGEOCHEM CY, V29, P865, DOI 10.1002/2015GB005090; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Spatharis S, 2012, CAN J FISH AQUAT SCI, V69, P1444, DOI [10.1139/F2012-020, 10.1139/f2012-020]; Srokosz MA, 2013, J GEOPHYS RES-OCEANS, V118, P14, DOI 10.1029/2012JC008339; SUBRAMANIAM A, 1994, INT J REMOTE SENS, V15, P1559, DOI 10.1080/01431169408954191; Thompson PA, 2015, J PLANKTON RES, V37, P966, DOI 10.1093/plankt/fbv069; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405; Villareal TA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006268; Ward BA, 2013, LIMNOL OCEANOGR, V58, P2059, DOI 10.4319/lo.2013.58.6.2059; Webster IT, 2010, CONT SHELF RES, V30, P793, DOI 10.1016/j.csr.2010.01.017; Weeks S, 2012, REMOTE SENS-BASEL, V4, P3781, DOI 10.3390/rs4123781; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; White AE, 2010, LIMNOL OCEANOGR, V55, P1755, DOI 10.4319/lo.2010.55.4.1755; White AE, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00027; Wilson C, 2008, PROG OCEANOGR, V78, P107, DOI 10.1016/j.pocean.2008.05.002; Wolanski E, 2000, ESTUAR COAST SHELF S, V50, P27, DOI 10.1006/ecss.1999.0528; Zuur A.F, 2012, ZERO INFLATED MODELS	103	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0208010	10.1371/journal.pone.0208010	http://dx.doi.org/10.1371/journal.pone.0208010			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550568	Green Published, gold, Green Accepted			2022-12-26	WOS:000453248000013
J	Dussault, C; Nelder, MP; Russell, C; Johnson, S; Vrbova, L				Dussault, Camille; Nelder, Mark P.; Russell, Curtis; Johnson, Steven; Vrbova, Linda			Evaluating the impact of Aedes japonicus invasion on the mosquito community in the Greater Golden Horseshoe region (Ontario, Canada)	PLOS ONE			English	Article							CACHE VALLEY VIRUS; DIPTERA-CULICIDAE; OCHLEROTATUS-JAPONICUS; ENCEPHALITIS-VIRUS; INTRODUCED MOSQUITO; TRANSMISSION; ALBOPICTUS; VECTORS; ESTABLISHMENT; TRISERIATUS	Background Aedes japonicus was first documented in Ontario, Canada, in 2001. The objective of this study was to determine the effect of Ae. japonicus establishment on the abundance of other mosquitoes in the Greater Golden Horseshoe (GGH) region of Ontario. Methods Adult mosquito data from the Ontario West Nile virus surveillance program were used. Descriptive analyses, linear trends and distribution maps of average trap count per month for six mosquito species of interest were produced. Multivariable negative binomial regression models were constructed to 1) test whether the invasion of Ae. japonicus affected the abundance of other mosquitoes by comparing the time period before Ae. japonicus was identified in an area (pre-detection), to after it was first identified (detection), and subsequently (establishment), and 2) identify the variables that explain the abundance of the various mosquito species. Results The monthly seasonal average (May-October) of Ae. japonicus per trap night increased from 2002 to 2016, peaking in September, when the average of most other mosquitoes decrease. There were increased numbers of Ae. triseriatus/hendersoni (Odds Ratio (OR): 1.40, 95% Confidence Interval (CI): 1.02-1.94) and decreased numbers of Coquillettidia perturbans (OR: 0.43, 95% CI: 0.26-0.73) in the detection period, compared to the pre-detection period. Additionally, there was a decrease in Cx. pipiens/restuans (OR: 0.87, 95% CI: 0.76-0.99) and Cq. perturbans (OR: 0.68, 95% CI: 0.49-0.94) in the establishment period, compared to the pre-detection period. None of the most parsimonious explanatory models included the period of the establishment of Ae. japonicus. Conclusions There is no evidence that the introduction of Ae. japonicus significantly reduced populations of Ae. triseriatus/hendersoni, Cx. pipiens/restuans or An. punctipennis in the GGH. While further research is needed to understand the impact of the Ae. japonicus invasion on other mosquito species, our work indicates that, on a regional scale, little impact has been noted.	[Dussault, Camille; Vrbova, Linda] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Toronto, ON, Canada; [Dussault, Camille] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Nelder, Mark P.; Russell, Curtis] Emergency Preparedness & Response Publ Hlth Ontar, Enter Zoonot & Vector Borne Dis, Communicable Dis, Toronto, ON, Canada; [Johnson, Steven] Publ Hlth Ontario, Analyt Serv Informat, Toronto, ON, Canada; [Johnson, Steven] Publ Hlth Ontario, Knowledge Serv, Toronto, ON, Canada	Public Health Agency of Canada; McGill University	Vrbova, L (corresponding author), Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Toronto, ON, Canada.	Linda.Vrbova@canada.ca						Alto BW, 2005, OECOLOGIA, V146, P300, DOI 10.1007/s00442-005-0198-x; Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774; Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261; Bara JJ, 2016, J MED ENTOMOL, V53, P1415, DOI 10.1093/jme/tjw097; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653; Fielden MA, 2015, CAN ENTOMOL, V147, P737, DOI 10.4039/tce.2015.5; Jackson M, 2016, J MED ENTOMOL, V53, P241, DOI 10.1093/jme/tjv164; Kampen H, 2014, PARASITE VECTOR, V7; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Marini G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2041-8; McKenney D, 2013, FOREST CHRON, V89, P659, DOI 10.5558/tfc2013-118; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; Munstermann LE., 1999, VECTOR ECOL NEWSL, V30, P7; Oliver J, 2003, J AM MOSQUITO CONTR, V19, P121; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3; Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; Savignac R, 2002, JOINT M 68 ANN M AM; Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141; Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155; TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Turell MJ, 2001, ANN NY ACAD SCI, V951, P317; Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1; Williges E, 2008, J AM MOSQUITO CONTR, V24, P591, DOI 10.2987/5714.1; Wood DM, 1979, USITC PUBL, V1686; Yang F, 2018, EMERG INFECT DIS, V24, P553, DOI 10.3201/eid2403.161275	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208911	10.1371/journal.pone.0208911	http://dx.doi.org/10.1371/journal.pone.0208911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543700	gold, Green Published, Green Submitted			2022-12-26	WOS:000453247500051
J	Tiemann, K; Garri, C; Lee, SB; Malihi, PD; Park, M; Alvarez, RM; Yap, LP; Ma, P; Katz, JE; Gross, ME; Kani, K				Tiemann, Katrin; Garri, Carolina; Lee, Sang Bok; Malihi, Paymaneh D.; Park, Mincheol; Alvarez, Ruth M.; Yap, Li Peng; Ma, Parag; Katz, Jonathan E.; Gross, Mitchell E.; Kani, Kian			Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis	ONCOGENE			English	Article							ANTERIOR GRADIENT 2; PROSTATE-CANCER; ISOMERASE AGR2; HIPPO PATHWAY; SERUM AGR2; PROTEIN; EXPRESSION; GROWTH; BIOMARKER; GENE	Anterior gradient 2 (AGR2) is a member of the protein disulfide isomerase (PDI) family, which plays a role in the regulation of protein homeostasis and the unfolded protein response pathway (UPR). AGR2 has also been characterized as a protooncogene and a potential cancer biomarker. Cellular localization of AGR2 is emerging as a key component for understanding the role of AGR2 as a proto-oncogene. Here, we provide evidence that extracellular AGR2 (eAGR2) promotes tumor metastasis in various in vivo models. To further characterize the role of the intracellular-resident versus extracellular protein, we performed a comprehensive protein-protein interaction screen. Based on these results, we identify AGR2 as an interacting partner of the mTORC2 pathway. Importantly, our data indicates that eAGR2 promotes increased phosphorylation of RICTOR (T1135), while intracellular AGR2 (iAGR2) antagonizes its levels and phosphorylation. Localization of AGR2 also has opposing effects on the Hippo pathway, spheroid formation, and response to chemotherapy in vitro. Collectively, our results identify disparate phenotypes predicated on AGR2 localization. Our findings also provide credence for screening of eAGR2 to guide therapeutic decisions.	[Tiemann, Katrin; Garri, Carolina; Lee, Sang Bok; Malihi, Paymaneh D.; Park, Mincheol; Alvarez, Ruth M.; Katz, Jonathan E.; Gross, Mitchell E.; Kani, Kian] Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA 90007 USA; [Yap, Li Peng] Keck Sch Med, Dept Radiol, Los Angeles, CA USA; [Ma, Parag] Stanford Univ, Dept Radiol, Los Angeles, CA USA	University of Southern California; Stanford University	Kani, K (corresponding author), Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA 90007 USA.	Kani@usc.edu		Kani, Kian/0000-0001-7774-265X	Lawrence J. Ellison Medical Foundation	Lawrence J. Ellison Medical Foundation	Drs. Philip Roux and Dos Sarbossov provided valuable insight and reagents (Roux) on the mTOR pathway. We are grateful for the guidance of Dr. David Agus and the generous financial support of the Lawrence J. Ellison Medical Foundation. We appreciate the support of Autumn Beemer, Lisa Flashner, Laura Ng, and Jeffrey Wang.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Arumugam T, 2015, MOL CANCER THER, V14, P941, DOI 10.1158/1535-7163.MCT-14-0470; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Brychtova V, 2015, SEMIN CANCER BIOL, V33, P16, DOI 10.1016/j.semcancer.2015.04.005; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-149; Chung K, 2011, CANCER BIOMARK, V10, P101, DOI 10.3233/CBM-2012-0234; Clarke C, 2015, MOL CELL BIOCHEM, V408, P245, DOI 10.1007/s11010-015-2502-3; Darb-Esfahani S, 2012, VIRCHOWS ARCH, V461, P109, DOI 10.1007/s00428-012-1273-4; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fessart D, 2016, ELIFE, V5, DOI 10.7554/eLife.13887; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Garri Carolina, 2018, Oncotarget, V9, P27363, DOI 10.18632/oncotarget.25221; Gray TA, 2013, PROTEIN SCI, V22, P1266, DOI 10.1002/pro.2299; Guo H, 2017, ONCOGENE, V36, P5098, DOI 10.1038/onc.2017.132; Hengel SM, 2011, J PROTEOME RES, V10, P4567, DOI 10.1021/pr2004117; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Jia MQ, 2018, BBA-MOL BASIS DIS, V1864, P1622, DOI 10.1016/j.bbadis.2018.01.021; Jiang YQ, 2010, CLIN CHEM, V56, P1492, DOI 10.1373/clinchem.2010.143297; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kani K, 2017, MOL CANCER THER, V16, P1645, DOI 10.1158/1535-7163.MCT-16-0564; Kani K, 2013, PROSTATE, V73, P306, DOI 10.1002/pros.22569; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee S, 2006, ONCOL REP, V16, P747; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lundberg E, 2010, PROTEOMICS, V10, P3984, DOI 10.1002/pmic.201000125; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; Matoulkova E, 2017, EXP CELL RES, V356, P40, DOI 10.1016/j.yexcr.2017.04.011; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mohtar MA, 2018, MOL CELL PROTEOMICS, V17, P737, DOI 10.1074/mcp.RA118.000573; Muniz VP, 2011, MOL CANCER RES, V9, P867, DOI 10.1158/1541-7786.MCR-10-0475; Park K, 2011, EXP MOL MED, V43, P91, DOI 10.3858/emm.2011.43.2.011; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Rice GE, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-62; Riener MO, 2009, HISTOL HISTOPATHOL, V24, P1121, DOI 10.14670/HH-24.1121; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Ryu J, 2013, BIOCHEM BIOPH RES CO, V430, P610, DOI 10.1016/j.bbrc.2012.11.105; Salmans ML, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3408; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tian SB, 2018, EXP CELL RES, V364, P198, DOI 10.1016/j.yexcr.2018.02.004; Tohti M, 2017, CLIN NEUROL NEUROSUR, V154, P19, DOI 10.1016/j.clineuro.2017.01.004; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Xu CH, 2016, TUMOR BIOL, V37, P6091, DOI 10.1007/s13277-015-4481-0; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	55	20	21	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3003	3018		10.1038/s41388-018-0638-9	http://dx.doi.org/10.1038/s41388-018-0638-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30575818	Green Accepted			2022-12-26	WOS:000465167600010
J	Carlson, TL; Yildiz, H; Dar, Z; Lock, JY; Carrier, RL				Carlson, Taylor L.; Yildiz, Hasan; Dar, Zaineb; Lock, Jaclyn Y.; Carrier, Rebecca L.			Lipids alter microbial transport through intestinal mucus	PLOS ONE			English	Article							MUCIN; BACTERIA; THICKNESS; TRACKING; MOTILITY; BARRIER; CELLS; ACID; OIL	Mucus constitutes a protective layer which coats the gastrointestinal tract, controlling interactions of both commensal and pathogenic microbes with underlying tissues. Changes to the mucus barrier, for example due to altered mucin expression or external stimuli, may impact interactions with microbes and thus potentially contribute to altered gut homeostasis, onset of inflammation, or pathogen invasion. Food-associated stimuli, including lipids, have been shown to change mucus barrier properties and reduce transport of model drug carriers through mucus. Here, we explore the impact of lipids, specifically triglycerides in a model intestinal medium mimicking a fed state, on Escherichia coli (E. coli) transport through mucus by directly imaging swimming patterns and analyzing associated changes in mucus structure. Lipids in model fed state intestinal contents reduced E. coli speed and track linearity within mucus. These changes may be due in part to changes in molecular interactions within the mucus network as well as crowding of the mucus network by lipid emulsion droplets, which visibly stay intact in the mucus gel. In addition, observed physical interactions between bacteria and lipid structures may impact microbial speed and trajectories. As lipids are normal food components and thus represent safe, mild stimuli, these results support exploration of lipid-based strategies to alter the mucus barrier to control interactions with microbes and potentially prevent microbial invasion of underlying epithelium.	[Carlson, Taylor L.; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Yildiz, Hasan] Biogen, Antisense Oligonucleotide Mfg & Dev, Cambridge, MA USA; [Dar, Zaineb; Lock, Jaclyn Y.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA	Northeastern University; Biogen; Northeastern University	Carrier, RL (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.	rebecca@coe.neu.edu	yıldız, hasan/GSN-9276-2022; Carrier, Rebecca/AAK-2315-2020		March of Dimes [6-FY14-404]; National Institutes of Health [R21EB015750]; Northeastern University Dissertation Completion Fellowship; U.S. National Science Foundation Graduate Research Fellowship Program	March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University Dissertation Completion Fellowship; U.S. National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by March of Dimes (https://www.marchofdimes.org/; #6-FY14-404; RLC), National Institutes of Health Grants (https://www.nih.gov/; R21EB015750; RLC), Northeastern University Dissertation Completion Fellowship (https://www.northeastern.edu; JYL, TLC), and U.S. National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org/2012125281, JYL). The funder (Biogen) provided support in the form of salaries for author HY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Di Maio S, 2011, J CONTROL RELEASE, V151, P110, DOI 10.1016/j.jconrel.2010.11.034; EDELBROEK M, 1992, J NUCL MED, V33, P1283; Gaudier E, 2009, PHYSIOL RES, V58, P111, DOI 10.33549/physiolres.931271; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; Hedemann MS, 2009, BRIT J NUTR, V102, P117, DOI 10.1017/S0007114508143549; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Karim QN, 1998, J CLIN PATHOL, V51, P623, DOI 10.1136/jcp.51.8.623; KIM KC, 1990, EXP LUNG RES, V16, P279, DOI 10.3109/01902149009108845; Kwiatek MA, 2009, AM J PHYSIOL-GASTR L, V297, pG894, DOI 10.1152/ajpgi.00117.2009; Lafitte G, 2007, LANGMUIR, V23, P10933, DOI 10.1021/la701081s; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lopez D, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4887255; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MURTY VLN, 1984, BIOCHEM BIOPH RES CO, V121, P521, DOI 10.1016/0006-291X(84)90213-4; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Polizelli MA, 2006, COLLOID SURFACE A, V281, P230, DOI 10.1016/j.colsurfa.2006.02.043; Pontier-Bres R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033796; Rezhdo O, 2017, J COLLOID INTERF SCI, V499, P189, DOI 10.1016/j.jcis.2017.03.109; Ryan PA, 2001, INFECT IMMUN, V69, P7402, DOI 10.1128/IAI.69.12.7402-7412.2001; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SMIT B, 1991, J PHYS CHEM-US, V95, P6361, DOI 10.1021/j100169a052; Taute KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9776; Toley BJ, 2012, INTEGR BIOL-UK, V4, P165, DOI 10.1039/c2ib00091a; Yildiz HM, 2015, J DRUG TARGET, V23, P768, DOI 10.3109/1061186X.2015.1086359; Yildiz HM, 2015, BIOMATERIALS, V54, P1, DOI 10.1016/j.biomaterials.2015.02.118; Zhang JB, 2015, MOL PHARMACEUT, V12, P695, DOI 10.1021/mp500475y	28	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209151	10.1371/journal.pone.0209151	http://dx.doi.org/10.1371/journal.pone.0209151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576356	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400029
J	Gordon, DA; Huang, WH; Burns, DM; French, RH; Bruckman, LS				Gordon, Devin A.; Huang, Wei-Heng; Burns, David M.; French, Roger H.; Bruckman, Laura S.			Multivariate multiple regression models of poly(ethylene-terephthalate) film degradation under outdoor and multi-stressor accelerated weathering exposures	PLOS ONE			English	Article							PHOTOCHEMICAL DEGRADATION; PHOTODEGRADATION; STABILIZERS; HYDROLYSIS; MECHANISMS; SCATTERING; POLYMERS	Developing materials for use in photovoltaic (PV) systems requires knowledge of their performance over the warranted lifetime of the PV system. Poly(ethylene-terephthalate) (PET) is a critical component of PV module backsheets due to its dielectric properties and low cost. However, PET is susceptible to environmental stressors and degrades over time. Changes in the physical properties of nine PET grades were modeled after outdoor and accelerated weathering exposures to characterize the degradation process of PET and assess the influence of stabilizing additives and weathering factors. Multivariate multiple regression (MMR) models were developed to quantify changes in color, gloss, and haze of the materials. Natural splines were used to capture the non-linear relationship between predictors and responses. Model performance was evaluated via adjusted-R-2 and root mean squared error values from leave-one-out cross validation analysis. All models described over 85% of the variation in the data with low relative error. Model coefficients were used to assess the influence of weathering stressors and material additives on the property changes of films. Photodose was found to be the primary degradation stressor and moisture was found to increase the degradation rate of PET. Direct moisture contact was found to impose more stress on the material than airbone moisture (humidity). Increasing the concentration of TiO2 was found to generally decrease the degradation rate of PET and mitigate hydrolytic degradation. MMR models were compared to physics-based models and agreement was found between the two modeling approaches. Cross-correlation of accelerated exposures to outdoor exposures was achieved via determination of cross-correlation scale factors. Cross-correlation revealed that direct moisture contact is a key factor for reliable accelerated weathering testing and provided a quantitative method to determine when accelerated exposure results can be made more aggressive to better approximate outdoor exposure conditions.	[Gordon, Devin A.; French, Roger H.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Gordon, Devin A.; Huang, Wei-Heng; French, Roger H.; Bruckman, Laura S.] Case Western Reserve Univ, Dept Mat Sci & Engn, SDLE Res Ctr, Cleveland, OH 44106 USA; [Burns, David M.] 3M Co, Maplewood, MN USA	Case Western Reserve University; Case Western Reserve University; 3M	Bruckman, LS (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, SDLE Res Ctr, Cleveland, OH 44106 USA.	lsh41@case.edu	Bruckman, Laura/X-4067-2019; French, Roger H/E-1986-2011	Bruckman, Laura/0000-0003-1271-1072; French, Roger H/0000-0002-6162-0532; Huang, Wei-Heng/0000-0002-6609-4981; Gordon, Devin/0000-0003-2208-085X	3M Company Corporate Research Analytical Laboratory [1401945]; Ohio Third Frontier Wright Project Program Award Tech at Case Western Reserve University [12-004]; National Science Foundation [DGE-1451075]	3M Company Corporate Research Analytical Laboratory(3M); Ohio Third Frontier Wright Project Program Award Tech at Case Western Reserve University; National Science Foundation(National Science Foundation (NSF))	This research was supported by 3M Company Corporate Research Analytical Laboratory (Agreement Control Number: 1401945), and performed at the Solar Durability and Lifetime Extension (SDLE) (URL: http://engineering.case.edu/centers/sdle/) Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. This research was also supported by the National Science Foundation (URL: https://www.nsf.gov/) (Grant #DGE-1451075). 3M Company Corporate Research Analytical Laboratory assisted with the study design, data collection, interpretation of results, and preparation of this manuscript. Other funders had no role in study design, data collection and analysis, interpretation of data, writing of the paper, or decision to submit for publication.; This research was performed at the SDLE Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. This work made use of the RedCat High Performance Computing Resource in the Core Facility for Advanced Research Computing at Case Western Reserve University. The authors would like to acknowledge 3M Corporate Research Analytical Laboratory for funding and support throughout this project. This work was also supported by National Science Foundation Grant # DGE-1451075.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2016, G15416 ASTM, DOI [10.1520/g0154-16, DOI 10.1520/G0154-16]; [Anonymous], D100313 ASTM INT; [Anonymous], 2010, G15110 ASTM INT, DOI [10.1520/G0151-10, DOI 10.1520/G0151-10]; [Anonymous], 2016, D224416 ASTM INT, DOI [10.1520/D2244-16, DOI 10.1520/D2244-16]; [Anonymous], 2015, E134815E1 ASTM INT, DOI [10.1520/E1348-15E01, DOI 10.1520/E1348-15E01]; [Anonymous], 2014, D52314 ASTM INT, DOI [10.1520/D0523, DOI 10.1520/D0523]; [Anonymous], [No title captured], DOI [10.1520/D7869-17, DOI 10.1520/D7869-17]; [Anonymous], 2013, G155 ASTM, DOI [10.1520/G0155, DOI 10.1520/G0155]; ASTM International, 2012, G17703 ASTM, DOI [10.1520/G0177-03R12, DOI 10.1520/G0177-03R12]; Bauer T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225702; Breiman L, 1997, J ROY STAT SOC B MET, V59, P3, DOI 10.1111/1467-9868.00054; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; Chelsey B., 2017, KGC KOEPPEN GEIGER C; DAY M, 1971, J POLYM SCI POL LETT, V9, P665, DOI 10.1002/pol.1971.110090906; DAY M, 1972, J APPL POLYM SCI, V16, P191, DOI 10.1002/app.1972.070160117; DAY M, 1972, J APPL POLYM SCI, V16, P203, DOI 10.1002/app.1972.070160118; Diez D. M., 2019, OPENINTRO STAT, V4th; Fairgrieve S., 2009, DEGRADATION STABILIS; Fechine GJM, 2007, J APPL POLYM SCI, V104, P51, DOI 10.1002/app.24517; Fechine GJM, 2004, POLYMER, V45, P2303, DOI 10.1016/j.polymer.2004.02.003; Fechine GJM, 2002, J MATER SCI, V37, P4979, DOI 10.1023/A:1021067027612; Fechine GJM, 2002, POLYM DEGRAD STABIL, V75, P153, DOI 10.1016/S0141-3910(01)00214-2; Felder TC, 2014, PROC SPIE, V9179, DOI 10.1117/12.2062063; George A., 2003, LINEAR REGRESSION AN; Gok Abdulkerim, 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355601; Gok A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177614; Gu X, 2006, LINKING ACCELERATING; HAN MH, 1972, J THEOR BIOL, V35, P543, DOI 10.1016/0022-5193(72)90150-6; Hastie T., 1986, STAT SCI, V1, P297; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hong YL, 2015, TECHNOMETRICS, V57, P180, DOI 10.1080/00401706.2014.915891; Hulme A., 2012, SEAL TECHNOL, V2012, P8, DOI [10.1016/S1350-4789(12)70398-7, DOI 10.1016/S1350-4789(12)70398-7]; Hutchins MG, 1989, SERVICE LIFETIME PRE, DOI [10.1117/12.949942, DOI 10.1117/12.949942]; James G., 2017, INTRO STAT LEARNING, V8th ed.; Johnson R. A., 1988, APPL MULTIVARIATE ST; Johnson RW, 1997, TAPPI J, V80, P233; LAUNAY A, 1994, POLYM DEGRAD STABIL, V46, P319, DOI 10.1016/0141-3910(94)90148-1; Masters L.W., 1987, MATER STRUCT, V20, P55, DOI DOI 10.1007/BF02472728); McMahon W., 1959, J CHEM ENG DATA, V4, P57, DOI DOI 10.1021/JE60001A009; McNeil LE, 2001, APPL OPTICS, V40, P3726, DOI 10.1364/AO.40.003726; Nagai Y, 1997, POLYM DEGRAD STABIL, V56, P115, DOI 10.1016/S0141-3910(96)00189-9; Novoa FD, 2014, SOL ENERG MAT SOL C, V120, P87, DOI 10.1016/j.solmat.2013.08.020; Oreski G, 2005, SOL ENERGY, V79, P612, DOI 10.1016/j.solener.2005.02.008; Pickett JE, 2013, POLYM DEGRAD STABIL, V98, P1311, DOI 10.1016/j.polymdegradstab.2013.04.001; Pickett JE, EFFECTS TEMPERATURE, V93, P684; Rytz G, 1997, ANGEW MAKROMOL CHEM, V247, P213, DOI 10.1002/apmc.1997.052470114; Thiele ES, 1998, J AM CERAM SOC, V81, P469, DOI 10.1111/j.1151-2916.1998.tb02364.x; Tomiita Takashi, 1994, CONSTR BUILD MATER, V8, P223, DOI DOI 10.1016/S0950-0618(09)90005-8; Turnbull L, 2012, J APPL POLYM SCI, V124, P4517, DOI 10.1002/app.35476; Turner SR, 2002, CYCLOHEXANEDIMETHANO, DOI [10.1002/0471440264.pst257, DOI 10.1002/0471440264.PST257]; Wypych G., 2013, HDB MAT WEATHERING, P49, DOI 10.1016/B978-1-895198-62-1.50006-8; Zhu ZM, 2005, POLYMER, V46, P8883, DOI 10.1016/j.polymer.2005.05.135; Zhu ZY, 2004, RADIAT MEAS, V38, P255, DOI 10.1016/j.radmeas.2003.12.032	54	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209016	10.1371/journal.pone.0209016	http://dx.doi.org/10.1371/journal.pone.0209016			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571712	gold, Green Published, Green Submitted			2022-12-26	WOS:000453841700032
J	Lewis, MC; Sealy, JC				Lewis, Matthew C.; Sealy, Judith C.			Coastal complexity: Ancient human diets inferred from Bayesian stable isotope mixing models and a primate analogue	PLOS ONE			English	Article							DISCRIMINATION FACTORS DELTA-N-15; SOUTHWESTERN CAPE; BONE-COLLAGEN; SOUTH-AFRICA; BRITISH-COLUMBIA; WESTERN CAPE; NITROGEN; CARBON; MARINE; HOLOCENE	An extensive ecological literature applies stable isotope mixing models to derive quantitative dietary reconstructions from isotope ratios of consumer tissues. While this approach works well for some organisms, it is challenging for consumers with complex, varied diets, including humans; indeed, many archaeologists have avoided the use of mixing models because uncertainties in model outputs are sufficiently large that the findings are not helpful in understanding ancient lifeways. Here, we exploit an unparalleled opportunity to evaluate the feasibility of dietary quantification in a nutritionally and isotopically complex context on the Cape Peninsula, South Africa. Delta values (delta C-13 and delta N-15) of 213 indigenous food samples enable us to characterise four food groups: terrestrial plants, terrestrial vertebrates, marine invertebrates and marine vertebrates. A recent study of baboons that consumed marine and terrestrial foods provides insight into the relationship between such foods and consumer tissue isotopes. We use this information to refine our interpretation of delta N-15 and especially delta C-13 in bone collagen from 35 archaeological hunter-gatherers, achieving better estimates of the relative importance of marine and terrestrial foods in the diet than has hitherto been possible. Based on Bayesian stable isotope mixing model (SIMM) outputs, we infer that the trophic enrichment factor (TEF) for delta C-13(bone collagen) in these coastal humans is closer to +3 than +5 parts per thousand. In the most C-13- and N-15-rich individuals, 65-98% of bone collagen (95% credible intervals) derived from marine foods. Conversely, in C-13 and N-15-poor individuals, 7-44% of bone collagen derived from marine foods. The uncertainties discussed here highlight the need for caution when implementing SIMMs in studies of consumers with complex diets. To our knowledge, this work constitutes the most detailed and most tightly constrained study of this problem to date.	[Lewis, Matthew C.; Sealy, Judith C.] Univ Cape Town, Dept Archaeol, Cape Town, South Africa; [Lewis, Matthew C.] Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa; [Lewis, Matthew C.] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Lewis, MC (corresponding author), Univ Cape Town, Dept Archaeol, Cape Town, South Africa.; Lewis, MC (corresponding author), Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa.; Lewis, MC (corresponding author), Univ Cape Town, Dept Biol Sci, Cape Town, South Africa.	matt.lewis.uct@gmail.com		Lewis, Matthew/0000-0002-3460-7180	National Research Foundation of South Africa [84407]; University of Cape Town [44191]; South African National Research Foundation; German Academic Exchange Service	National Research Foundation of South Africa(National Research Foundation - South Africa); University of Cape Town; South African National Research Foundation(National Research Foundation - South Africa); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by the National Research Foundation (http://www.nrf.ac.za/) of South Africa (grant number 84407 to JS) and the University of Cape Town (http://www.uct.ac.za/) (grant number 44191 to M. Justin O'Riain which covered costs of sampling carried out by ML). ML's doctoral research, during which food samples analysed specifically for this study were collected, was funded by the South African National Research Foundation, German Academic Exchange Service (https://www.daad.de/en/) and University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 2005, AFR J MAR SCI, V27, P239, DOI 10.2989/18142320509504082; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Brett MT, 2014, MAR ECOL PROG SER, V514, P1, DOI 10.3354/meps11017; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; CHISHOLM BS, 1983, CURR ANTHROPOL, V24, P396, DOI 10.1086/203018; Codron D, 2008, INT J PRIMATOL, V29, P757, DOI 10.1007/s10764-008-9261-x; Coltrain JB, 2004, J ARCHAEOL SCI, V31, P39, DOI 10.1016/j.jas.2003.06.003; Commendador AS, 2014, RADIOCARBON, V56, P277, DOI 10.2458/56.16923; Commendador AS, 2013, AM J PHYS ANTHROPOL, V152, P173, DOI 10.1002/ajpa.22339; Cowling RM, 1996, BIODIVERS CONSERV, V5, P527, DOI 10.1007/BF00137608; Crowley BE, 2010, OECOLOGIA, V164, P611, DOI 10.1007/s00442-010-1701-6; DAVIDGE C, 1978, ZOOL AFR, V13, P329, DOI 10.1080/00445096.1978.11447633; Deacon J., 1984, P221; DeNecker L, 2017, TROPHIC DYNAMICS BRO; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; deVries MS, 2016, OECOLOGIA, V182, P429, DOI 10.1007/s00442-016-3667-5; Dewar G, 2010, RADIOCARBON, V52, P1611, DOI 10.1017/S0033822200056344; Doi H, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170633; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eide M, 2017, GLOBAL BIOGEOCHEM CY, V31, P492, DOI [10.1002/2016GB005472, 10.1002/2016GB005473]; Evans DH, 2004, CRC MAR BIOL SER, P247; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Fernandes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087436; Fogel ML, 1997, ORG GEOCHEM, V27, P275, DOI 10.1016/S0146-6380(97)00060-0; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Fry B, 2006, STABLE ISOTOPE ECOLO, DOI 10.1007/0-387-33745-8; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; HALL K. R., 1962, PROC ZOOL SOC LONDON, V139, P181; Hall K. R. L., 1963, P1; Hammerschlag N, 2006, MAR FRESHW BEHAV PHY, V39, P209, DOI 10.1080/10236240600815820; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Hellevang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17352; Hertz E, 2015, ECOL EVOL, V5, P4829, DOI 10.1002/ece3.1738; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Howland MR, 2003, INT J OSTEOARCHAEOL, V13, P54, DOI 10.1002/oa.658; Jarman CL, 2017, AM J PHYS ANTHROPOL, V164, P343, DOI 10.1002/ajpa.23273; Jim S, 2006, BRIT J NUTR, V95, P1055, DOI 10.1079/BJN20051685; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Kaczensky P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05329-6; Keeling RF, 2018, TRENDS COMPENDIUM DA; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Kusaka S, 2015, AM J PHYS ANTHROPOL, V158, P300, DOI 10.1002/ajpa.22775; Leal GR, 2017, MAR BIOL, V164, P1, DOI [10.1007/s00227-016-3030-8, DOI 10.1007/S00227-016-3030-8]; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Lewis MC, 2018, AM J PHYS ANTHROPOL, V165, P77, DOI 10.1002/ajpa.23332; Lewis MC, 2017, INT J PRIMATOL, V38, P751, DOI 10.1007/s10764-017-9978-5; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Maggs T, 1967, S AFRICAN ARCHAEOLOG, V22, P80, DOI [10.2307/3888441, DOI 10.2307/3888441]; Marean C. W., 1985, S AFRICAN ARCHAEOLOG, V40, P100, DOI DOI 10.2307/3888455; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; Meadows ME, 1999, QUATERN INT, V57-8, P193, DOI 10.1016/S1040-6182(98)00060-3; Mellbrand K, 2010, CAN J ZOOL, V88, P1077, DOI 10.1139/Z10-074; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; Milner N, 2004, ANTIQUITY, V78, P9, DOI 10.1017/S0003598X00092887; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moll EJ, 1984, DESCRIPTION MAJOR VE, P29; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Mucina I., 2006, STRELITZIA, V19; Mucina L., 2006, VEGETATION S AFRICA, P658; Mucina Ladislav, 2006, V19, P2; Neumann FH, 2011, HOLOCENE, V21, P1137, DOI 10.1177/0959683611400461; Newsome SD, 2004, J ARCHAEOL SCI, V31, P1101, DOI 10.1016/j.jas.2004.02.001; Newsome SD, 2015, OECOLOGIA, V178, P115, DOI 10.1007/s00442-014-3205-2; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; O'Regan HJ, 2008, J HUM EVOL, V55, P617, DOI 10.1016/j.jhevol.2008.05.001; Okes NC, 2017, CONSERVATION ECOLOGY; OOSTHUIZEN WH, 1991, S AFR J MARINE SCI, V11, P21, DOI 10.2989/025776191784287772; PARKINGTON J, 1991, J ARCHAEOL SCI, V18, P331, DOI 10.1016/0305-4403(91)90069-2; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Petchey F, 2011, J ARCHAEOL SCI, V38, P29, DOI 10.1016/j.jas.2010.07.029; Pfeiffer S, 2006, AM J PHYS ANTHROPOL, V129, P1, DOI 10.1002/ajpa.20231; Pfeiffer S, 2016, AM ANTIQUITY, V81, P515, DOI 10.7183/0002-7316.81.3.515; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Poggenpoel C. A., 1981, S AFRICAN ARCHAEOLOG, V36, P29, DOI DOI 10.2307/3888016; Polet C, 2016, J ARCHAEOL SCI-REP, V6, P709, DOI 10.1016/j.jasrep.2015.09.013; R Core Team, 2021, R LANGUAGE ENV STAT; Radloff FGT, 2008, ECOLOGY LARGE HERBIV; Resano-Mayor J, 2014, IBIS, V156, P176, DOI 10.1111/ibi.12095; Richards MP, 2006, ANTIQUITY, V80, P444, DOI 10.1017/S0003598X00093765; Richards MP, 2005, J HUM EVOL, V49, P390, DOI 10.1016/j.jhevol.2005.05.002; Richards MP, 2003, NATURE, V425, P366, DOI 10.1038/425366a; Rosing MN, 1998, J WILDLIFE MANAGE, V62, P380, DOI 10.2307/3802302; Rubino M, 2013, J GEOPHYS RES-ATMOS, V118, P8482, DOI 10.1002/jgrd.50668; Rumolo P, 2016, MAR ENVIRON RES, V115, P65, DOI 10.1016/j.marenvres.2016.02.004; Ryan C, 2014, MAR MAMMAL SCI, V30, P242, DOI 10.1111/mms.12034; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schulze R.E., 1978, BIOGEOGRAPHY ECOLOGY, V31, P19, DOI [10.1007/978-94-009-9951-0_2, DOI 10.1007/978-94-009-9951-0_]; Sealy J., 1997, ANCIENT BIOMOLECULES, V1, P131; Sealy J, 1989, S AFRICAN ARCHAEOLOG, V6, P69; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; SEALY JC, 1988, WORLD ARCHAEOL, V20, P87, DOI 10.1080/00438243.1988.9980058; SEALY JC, 1985, NATURE, V315, P138, DOI 10.1038/315138a0; SEALY JC, 1986, CURR ANTHROPOL, V27, P135, DOI 10.1086/203404; Sealy J, 2014, J ARCHAEOL SCI, V47, P64, DOI 10.1016/j.jas.2014.04.011; Sealy J, 2010, J AFR ARCHAEOL, V8, P65, DOI 10.3213/1612-1651-10160; Semmens BX, 2013, MAR ECOL PROG SER, V490, P285, DOI 10.3354/meps10535; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Stantis C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123156; Stock B., 2018, PROC 25 ANN NETW DIS, P1, DOI [10.7287/peerj.preprints.26884v1, DOI 10.7287/PEERJ.PREPRINTS.26884V1]; Stock B, 2016, PACKAGE MIXSIAR, P18; Stock BC, 2016, ECOLOGY, V97, P2562, DOI 10.1002/ecy.1517; Stowe MJ, 2016, QUATERN INT, V404, P57, DOI 10.1016/j.quaint.2015.09.055; Stynder DD, 2009, J HUM EVOL, V56, P431, DOI 10.1016/j.jhevol.2008.11.004; TAUBER H, 1981, NATURE, V292, P332, DOI 10.1038/292332a0; Tauber H, 1979, RADIOCARBON DATING, P447; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Underhill L.G., 1999, REV RING RECOVERIES; Van Noten FL, 1974, S AFRICAN ARCHAEOLOG, V29, P122, DOI [10.2307/3888340, DOI 10.2307/3888340]; VANDERMERWE NJ, 1978, NATURE, V276, P815, DOI 10.1038/276815a0; Alva JAV, 2009, COMMUN STAT-THEOR M, V38, P1870, DOI 10.1080/03610920802474465; VOGEL JC, 1977, AM ANTIQUITY, V42, P238, DOI 10.2307/278984; VOGEL JC, 1978, S AFR J SCI, V74, P209; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; Webb EC, 2017, SCI TECHNOL ARCHAEOL, V3, P28, DOI 10.1080/20548923.2016.1275477; Whittington PA, 2005, AFR J MAR SCI, V27, P215, DOI 10.2989/18142320509504080; Wolf N, 2015, RAPID COMMUN MASS SP, V29, P1448, DOI 10.1002/rcm.7239	139	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209411	10.1371/journal.pone.0209411	http://dx.doi.org/10.1371/journal.pone.0209411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF0HP	30571752	Green Submitted, Green Published, gold			2022-12-26	WOS:000453841700069
J	Prada, AF; George, AE; Stahlschmidt, BH; Chapman, DC; Tinoco, RO				Prada, Andres F.; George, Amy E.; Stahlschmidt, Benjamin H.; Chapman, Duane C.; Tinoco, Rafael O.			Survival and drifting patterns of grass carp eggs and larvae in response to interactions with flow and sediment in a laboratory flume	PLOS ONE			English	Article							ASIAN CARP; CTENOPHARYNGODON-IDELLA; BIGHEAD CARP; SILVER CARP; TRANSPORT; VELOCITY; DENSITY; STRESS; GROWTH; MODEL	A series of laboratory experiments was conducted to better understand the behavior of grass carp eggs and larvae in moving water in order to develop and implement new strategies for control and prediction of their dispersal and drift at early life stages. Settling velocity and density of a representative sample of eggs were estimated, and three trials of flume experiments with different flow conditions were conducted with live eggs in a temperature-controlled setting with a mobile sediment bed. In these trials, egg and larval stages were continuously analyzed over periods of 80 hours; and eggs and larvae interactions with the flow and sediment bed were monitored and characterized qualitatively and quantitatively. Survival rates were quantified after each trial, highlighting physical causes for increased mortality. Detailed flow analysis was correlated to the observed drifting and swimming behavior of eggs and larvae, to estimate distributions across the water depth, as well as traveling and swimming speeds. Evidence of the influence of mean and turbulent flow in the suspension and transport of eggs are reported, and swimming patterns of larvae at different developmental stages are described. These findings support the development of new strategies for monitoring the spread of grass carp eggs and larvae in rivers, and provide new inputs to predict conditions favorable for spawning and hatching, allowing for mitigation measures at early life stages, which are critical to control their dispersal.	[Prada, Andres F.; Tinoco, Rafael O.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [George, Amy E.; Stahlschmidt, Benjamin H.; Chapman, Duane C.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of the Interior; United States Geological Survey	Prada, AF (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	pradase2@illinois.edu		Prada, Andres F./0000-0002-7311-8793; George, Amy/0000-0003-1150-8646	U.S. Geological Survey (USGS) [G17AC00060]; USGS	U.S. Geological Survey (USGS)(United States Geological Survey); USGS(United States Geological Survey)	The U.S. Geological Survey (USGS) offered a funding opportunity to a CESU partner (the University of Illinois at Urbana-Champaign in this case) to work on these laboratory experiments: Cooperative Agreement (G17AC00060) for CESU-affiliated partner with USGS (https://www.cerc.usgs.gov/Branches.aspx?BranchId=20)- under the Great Rivers Cooperative Ecosystems Studies Unit (CESU, http://greatrivers-cesu.missouri.edu/agreement.shtml).The USGS provided funds to support Andres F. Prada's tuition and stipend, and personnel to deal with grass carp eggs from spawning at the Columbia Environmental Research Center in Columbia, MO to transportation to the University of Illinois in Champaign, IL, where the experiments were conducted. We had several meetings where methodology and experimental designs were discussed. Data collected was analyzed at the USGS Illinois-Iowa Water Science Center in Urbana, IL. We all agreed that PLOS ONE is an excellent journal to publish this work, and the manuscript passed a couple of internal reviews where USGS personnel provided valuable comments to improve it.	Chapman DC, 20115076 USGS SCI IN; Chapman DC, 2016, AM FISH S S, V84, P113; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Cudmore B., 2017, CAN SCI ADVIS SECR; Embke HS, 2016, J GREAT LAKES RES, V42, P899, DOI 10.1016/j.jglr.2016.05.002; Ferguson RI, 2004, J SEDIMENT RES, V74, P933, DOI 10.1306/051204740933; Garcia MH, 2007, SEDIMENTATION ENG PR; Garcia T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145775; Garcia T, 2015, J GREAT LAKES RES, V41, P374, DOI 10.1016/j.jglr.2015.02.003; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; Garner A.B., 2008, HIGH DENSITY GRASS C; George AE, 2015, J APPL ICHTHYOL, V31, P1120, DOI 10.1111/jai.12918; George AE, HYDRODYNAMIC TRANSPO; George AE, 2017, T AM FISH SOC, V146, P834, DOI 10.1080/00028487.2017.1310136; George AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119023; Gertzen E.L., 2017, 2016117 DFO CAN SCI; Hearn C. J., 2008, DYNAMICS COASTAL MOD; Hogan JD, 2005, MAR BIOL, V147, P1213, DOI 10.1007/s00227-005-0006-5; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Jones L.A., 2017, 2016101 CAN SCI ADV; Kirkagac M, 2004, J AQUAT PLANT MANAGE, V42, P32; Kocovsky PM, 2018, FISHERIES, V43, P311, DOI 10.1002/fsh.10087; Lamer JT, 2015, MOL ECOL, V24, P3931, DOI 10.1111/mec.13285; LONG CE, 1993, J HYDRAUL ENG-ASCE, V119, P1182, DOI 10.1061/(ASCE)0733-9429(1993)119:10(1182); Murphy EA, 20161011 USGS; Noatch MR, 2012, ENVIRON REV, V20, P71, DOI [10.1139/A2012-001, 10.1139/a2012-001]; ODELL GM, 1971, J FLUID MECH, V50, P535, DOI 10.1017/S002211207100274X; Schlichting H., 2017, BOUNDARY LAYER THEOR; Schrank SJ, 2002, ENVIRON BIOL FISH, V64, P443, DOI 10.1023/A:1016144529734; SOULSBY RL, 1981, J GEOPHYS RES-OCEANS, V86, P8067, DOI 10.1029/JC086iC09p08067; Stapleton KR, 1995, EARTH SURF PROCESSES, V20, P807, DOI 10.1002/esp.3290200906; Thompson CEL, 2003, J COASTAL RES, V19, P1094; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1613, DOI 10.1061/(ASCE)0733-9429(1984)110:11(1613); Wieringa JG, 2017, J GREAT LAKES RES, V43, P405, DOI 10.1016/j.jglr.2016.12.006; Wittmann ME, 2017, J GREAT LAKES RES, V43, P298, DOI 10.1016/j.jglr.2016.09.008; Yi B. L., 1988, GEZHOUBA WATER CONTR; Zens B, 2018, CAN J FISH AQUAT SCI, V75, P193, DOI 10.1139/cjfas-2016-0276	37	11	11	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208326	10.1371/journal.pone.0208326	http://dx.doi.org/10.1371/journal.pone.0208326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566492	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300035
J	Kajan, GL; Lipiec, A; Bartha, D; Allard, A; Arnberg, N				Kajan, Gyozo Laszlo; Lipiec, Agnieszka; Bartha, Daniel; Allard, Annika; Arnberg, Niklas			A multigene typing system for human adenoviruses reveals a new genotype in a collection of Swedish clinical isolates	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES TARGET; PHYLOGENETIC ANALYSIS; GENOME SEQUENCE; GENE-THERAPY; PCR; IDENTIFICATION; HEXON; RECOMBINANT; VACCINATION; INFECTIONS	Human adenoviruses (HAdVs) are common pathogens that can cause respiratory, gastrointestinal, urogenital, and ocular infections. They are divided into seven species containing 85 genotypes. Straightforward typing systems might help epidemiological investigations. As homologous recombination frequently shapes the evolution of HAdVs, information on a single gene is seldom sufficient to allow accurate and precise typing, and complete genome-based methods are recommended. Even so, complete genome analyses are not always easy to perform for practical reasons, and in such cases a multigene system can provide considerably more information about the strain under investigation than single-gene-based methods. Here we present a rapid, generic, multigene typing system for HAdVs based on three main deterministic regions of these viruses. Three PCR systems were used to amplify the genes encoding the DNA polymerase, the penton base hypervariable Arg-Gly-Asp-containing loop, and the hexon loop 1 (hypervariable region 1-6). Using this system, we typed 281 clinical isolates, detected members of six out of seven HAdV species (Human mastadenovirus A-F), and could also detect not only divergent strains of established types but also a new recombinant strain with a previously unpublished combination of adenovirus genomes. This strain was accepted by the Human Adenovirus Working Group as a novel genotype: HAdV-86. Seven strains that could not be typed with sufficient accuracy were also investigated using a PCR based on part of the fiber gene. By analysis of corresponding sequences of the 86 known HAdV genotypes, we determined that the proposed typing system should be able to distinguish all non-recombinant types, and with additional fiber information, all known HAdV genotypes.	[Kajan, Gyozo Laszlo; Lipiec, Agnieszka; Allard, Annika; Arnberg, Niklas] Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden; [Kajan, Gyozo Laszlo; Lipiec, Agnieszka; Allard, Annika; Arnberg, Niklas] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Kajan, Gyozo Laszlo; Bartha, Daniel] Hungarian Acad Sci, Inst Vet Med Res, Ctr Agr Res, Budapest, Hungary	Umea University; Umea University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Kajan, GL (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.; Kajan, GL (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.	kajan.gyozo@agrar.mta.hu	Kaján, Győző László/N-2117-2019; Arnberg, Niklas/K-5878-2019	Kaján, Győző László/0000-0001-8213-8238; Arnberg, Niklas/0000-0002-7069-6678; Allard, Annika/0000-0001-6949-1213	FP7 Marie Curie Actions via the ADVEC consortium [324325]	FP7 Marie Curie Actions via the ADVEC consortium	This project was made possible by funding from FP7 Marie Curie Actions via the ADVEC consortium (participant: NA, grant agreement no.: 324325). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary AK, 2004, J CLIN MICROBIOL, V42, P670, DOI 10.1128/JCM.42.2.670-673.2004; Al Qurashi YMA, 2011, J MED VIROL, V83, P1951, DOI 10.1002/jmv.22204; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Alonso-Padilla J, 2016, MOL THER, V24, P6, DOI 10.1038/mt.2015.194; Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Bradshaw AC, 2013, VASC PHARMACOL, V58, P174, DOI 10.1016/j.vph.2012.10.008; Chevreux B., 1999, GERM C BIOINF HEID; Dehghan S, 2013, VIROLOGY, V443, P197, DOI 10.1016/j.virol.2013.05.014; Denisov GA, 2004, US Patent, Patent No. 6681186; Duffy MR, 2018, J GEN VIROL, V99, P135, DOI 10.1099/jgv.0.000978; Ebner K, 2006, J CLIN MICROBIOL, V44, P2808, DOI 10.1128/JCM.00048-06; Esposito S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152375; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Gonzalez G, 2015, J VIROL, V89, P6209, DOI 10.1128/JVI.00515-15; Hage E, 2015, J GEN VIROL, V96, P2734, DOI 10.1099/vir.0.000196; Han Guiyuan, 2013, Virologica Sinica, V28, P103, DOI 10.1007/s12250-013-3308-7; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; HORWITZ M S, 1990, P1723; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ismail AM, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0004-y; Kajan GL, 2017, VIRUS RES, V242, P79, DOI 10.1016/j.virusres.2017.09.012; Kajon AE, 2014, J CLIN VIROL, V61, P496, DOI 10.1016/j.jcv.2014.09.009; Kajon Adriana E, 2007, Methods Mol Med, V131, P335; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kosulin K, 2016, J CLIN VIROL, V80, P60, DOI 10.1016/j.jcv.2016.05.001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ledgerwood JE, 2015, NEW ENGL J MED, V373, P776, DOI 10.1056/NEJMc1505499; LI QG, 1988, ARCH VIROL, V101, P65, DOI 10.1007/BF01314652; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Ma JT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004673; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Madisch I, 2006, J MED VIROL, V78, P1210, DOI 10.1002/jmv.20683; Majhen D, 2014, HUM GENE THER, V25, P301, DOI 10.1089/hum.2013.235; McCarthy T, 2009, J CLIN VIROL, V46, P80, DOI 10.1016/j.jcv.2009.06.008; Mei Y-F, 2011, SPRINGER INDEX VIRUS, P33; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nemerow GR, 2012, CURR OPIN VIROL, V2, P115, DOI 10.1016/j.coviro.2011.12.008; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; Pauly M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-25; PRINGAKERBLOM P, 1994, RES VIROLOGY, V145, P25, DOI 10.1016/S0923-2516(07)80004-5; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Sarantis H, 2004, J CLIN MICROBIOL, V42, P3963, DOI 10.1128/JCM.42.9.3963-3969.2004; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto D, 2013, J CLIN VIROL, V58, P741, DOI 10.1016/j.jcv.2013.09.025; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Singh G, 2013, J VIROL, V87, P12481, DOI 10.1128/JVI.01927-13; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Takeuchi S, 1999, J CLIN MICROBIOL, V37, P1839, DOI 10.1128/JCM.37.6.1839-1845.1999; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Xu WH, 2000, J CLIN MICROBIOL, V38, P4114, DOI 10.1128/JCM.38.11.4114-4120.2000; Yuan XH, 2009, VACCINE, V27, P5103, DOI 10.1016/j.vaccine.2009.06.041; Zhou XH, 2012, INVEST OPHTH VIS SCI, V53, P2804, DOI 10.1167/iovs.12-9656	62	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209038	10.1371/journal.pone.0209038	http://dx.doi.org/10.1371/journal.pone.0209038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550551	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000040
J	Chang, PK; Chen, WL; Wu, LW				Chang, Pi-Kai; Chen, Wei-Liang; Wu, Li-Wei			Mid-arm muscle circumference: A significant factor of all-cause and cancer mortalities in individuals with elevated platelet-to-lymphocyte ratio	PLOS ONE			English	Article							HEART-FAILURE; INFLAMMATION; EXERCISE; NEUTROPHIL; CYTOKINES; DISEASE; CELLS	Platelet-to-lymphocyte ratio (PLR) is an inflammatory maker, and high PLR is associated with mortality in several diseases. The predictors of mortality in individuals with high PLR is still lacking. Our aims were to assess if mid-arm muscle circumference (MAMC) can predict all-cause mortality, cancer mortality, and cardiovascular mortality in individuals with high PLR. Adult participants from the National Health and Nutrition Examination Survey III (1988-1994) were included. All participants were divided into low PLR and high PLR groups with the cut-off point being the median PLR level, and each group was evaluated for risk factors of mortality. MAMC was divided into tertiles and the general characteristics of the study population related to MAMC were evaluated. The study included 14,221 adults with 6,701 (47.1%) male and 7,520 (52.9%) female participants. The median PLR ratio was 122. Higher levels of systolic blood pressure, total triglycerides, total cholesterol, low-density lipoprotein, C-reactive protein, uric acid, and glucose, as well as a higher age, were associated with increased risk of mortality in both groups. After adjusting for all the covariates, in the higher PLR group, the highest MAMC tertile was significantly associated with lower hazard ratios for all-cause and cancer mortalities compared with the lowest MAMC tertile. However, this association was not observed in the low PLR group. The highest MAMC tertile showed protective effects from all-cause and cancer mortalities compared with the lowest MAMC tertile in individuals with PLR >= 122. In conclusion, the highest MAMC tertile was significantly associated with decreasing HRs for all-cause and cancer mortalities compared with the lowest MAMC tertile in individuals with elevated PLR.	[Chang, Pi-Kai] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan; [Chang, Pi-Kai; Chen, Wei-Liang; Wu, Li-Wei] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Pi-Kai; Chen, Wei-Liang; Wu, Li-Wei] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Wei-Liang; Wu, Li-Wei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang; Wu, Li-Wei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Wu, LW (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wu, LW (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Wu, LW (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Wu, LW (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.	bigmouth0825@hotmail.com		Wu, Li-Wei/0000-0003-4744-7646				Adamopoulos S, 2001, EUR HEART J, V22, P791, DOI 10.1053/euhj.2000.2285; Akkaya E, 2014, INT J CARDIOL, V177, P597, DOI 10.1016/j.ijcard.2014.08.143; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Balta S, 2013, HEMODIAL INT, V17, P668, DOI 10.1111/hdi.12058; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; Egan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026125; Ferroni Patrizia, 2003, Current Vascular Pharmacology, V1, P157, DOI 10.2174/1570161033476772; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hur S, 2014, J PHYS THER SCI, V26, P1933, DOI 10.1589/jpts.26.1933; IMAI T, 1991, BLOOD, V78, P1969; Kruk M, 2008, CIRC J, V72, P205, DOI 10.1253/circj.72.205; Landi F, 2010, CLIN NUTR, V29, P441, DOI 10.1016/j.clnu.2009.12.006; Lee DC, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2016-0028; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MAISEL AS, 1990, J CLIN INVEST, V85, P462, DOI 10.1172/JCI114460; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nishida Y, 2015, ARCH GERONTOL GERIAT, V61, P443, DOI 10.1016/j.archger.2015.06.017; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Okyay GU, 2013, RENAL FAILURE, V35, P29, DOI 10.3109/0886022X.2012.734429; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, PROGR COLL PROC V 1, V32, P1; Roubenoff R, 2000, EUR J CLIN NUTR, V54, pS40, DOI 10.1038/sj.ejcn.1601024; Suzuki K, 2004, PANCREAS, V29, P132, DOI 10.1097/00006676-200408000-00008; Templeton AJ, 2014, CANCER EPIDEM BIOMAR, V23, P1204, DOI 10.1158/1055-9965.EPI-14-0146; Waehre T, 2004, THROMB HAEMOSTASIS, V92, P1358, DOI 10.1160/TH04-03-0146; Wu LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171707; Yaprak M, 2016, INT UROL NEPHROL, V48, P1343, DOI 10.1007/s11255-016-1301-4; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; You J, 2016, ONCOTARGET, V7, P25516, DOI 10.18632/oncotarget.8334; Zuo H, 2016, AM J EPIDEMIOL, V183, P249, DOI 10.1093/aje/kwv242	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208750	10.1371/journal.pone.0208750	http://dx.doi.org/10.1371/journal.pone.0208750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543652	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500035
J	Angom, RS; Wang, Y; Wang, EF; Pal, K; Bhattacharya, S; Watzlawik, JO; Rosenberry, TL; Das, P; Mukhopadhyay, D				Angom, Ramcharan Singh; Wang, Ying; Wang, Enfeng; Pal, Krishnendu; Bhattacharya, Santanu; Watzlawik, Jens O.; Rosenberry, Terrone L.; Das, Pritam; Mukhopadhyay, Debabrata			VEGF receptor-1 modulates amyloid 1-42 oligomer-induced senescence in brain endothelial cells	FASEB JOURNAL			English	Article						oligomers; Alzheimer's disease; cerebrovascular; aging; dysfunction	TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; BETA PEPTIDES; ANGIOGENESIS; BARRIER; NEURODEGENERATION; HYPOTHESIS; IMPAIRMENT; MECHANISM	Aggregated amyloid (A) peptides in the Alzheimer's disease (AD) brain are hypothesized to trigger several downstream pathologies, including cerebrovascular dysfunction. Previous studies have shown that A peptides can have antiangiogenic properties, which may contribute to vascular dysfunction in the early stages of the disease process. We have generated data showing that brain endothelial cells (ECs) exposed to toxic A1-42 oligomers can readily enter a senescence phenotype. To determine the effect of A oligomers on brain ECs, we treated early passaged human brain microvascular ECs and HUVECs with high MW A1-42 oligomers (5 mu M, for 72 h). For controls, we used no peptide treatment, 5 mu M A1-42 monomers, and 5 mu M A1-42 fibrils, respectively. Brain ECs treated with A1-42 oligomers showed increased senescence-associated -galactosidase staining and increased senescence-associated p21/p53 expression. Treatment with either A1-42 monomer or A1-42 fibrils did not induce senescence in this assay. We then measured vascular endothelial growth factor receptor (VEGFR) expression in the A1-42 oligomer-treated ECs, and these cells showed significantly increased VEGFR-1 expression and decreased VEGFR-2 levels. Overexpression of VEGFR-1 in brain ECs readily induced senescence, suggesting a direct role of VEGFR-1 signaling events in this paradigm. More importantly, small interfering RNA-mediated knockdown of VEGFR-1 expression in brain ECs was able to prevent up-regulation of p21 protein expression and significantly reduced induction of senescence following A1-42 oligomer treatment. Our studies show that exposure to A1-42 oligomers may impair vascular functions by altering VEGFR-1 expression and causing ECs to enter a senescent phenotype. Altered VEGFR expression has been documented in brains of AD patients and suggests that this pathway may play a role in AD disease pathogenesis. These studies suggest that modulating VEGFR-1 expression and signaling events could potentially prevent senescence and rejuvenate EC functions, and provides us with a novel target to pursue for prevention and treatment of cerebrovascular dysfunction in AD.Angom, R. S., Wang, Y., Wang, E., Pal, K., Bhattacharya, S., Watzlawik, J. O., Rosenberry, T. L., Das, P., Mukhopadhyay, D. VEGF receptor-1 modulates amyloid 1-42 oligomer-induced senescence in brain endothelial cells.	[Angom, Ramcharan Singh; Wang, Ying; Wang, Enfeng; Pal, Krishnendu; Bhattacharya, Santanu; Das, Pritam; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 4500 San Pablo Rd.,Griffin 451, Jacksonville, FL 32224 USA; [Watzlawik, Jens O.; Rosenberry, Terrone L.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Das, P; Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 4500 San Pablo Rd.,Griffin 451, Jacksonville, FL 32224 USA.	das.pritam@mayo.edu; mukhopadhyay.debabrata@mayo.edu		Wang, Ying/0000-0002-7852-386X; Pal, Krishnendu/0000-0002-4006-213X	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL140411]; NIH National Cancer Institute [CA78383-20]; Florida Department of Health Cancer Research Chair's Fund [3J-02]	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Cancer Research Chair's Fund	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL140411 and NIH National Cancer Institute Grant CA78383-20 (to D.M.), and Florida Department of Health Cancer Research Chair's Fund Grant 3J-02 (to D.M.). The authors declare no conflicts of interest.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18042-1; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2013, NEUROLOGY, V81, P1732, DOI 10.1212/01.wnl.0000435556.21319.e4; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Koster KP, 2016, J CEREBR BLOOD F MET, V36, P1865, DOI 10.1177/0271678X16669956; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Rajani RM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam9507; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Religa P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02053; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; STEWART PA, 1992, LAB INVEST, V67, P734; Tai LM, 2016, ACTA NEUROPATHOL, V131, P709, DOI 10.1007/s00401-016-1547-z; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Thomas R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0387-3; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Wang P, 2011, BIOCHEM BIOPH RES CO, V411, P620, DOI 10.1016/j.bbrc.2011.07.003; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yamazaki Y, 2016, STROKE, V47, P1068, DOI 10.1161/STROKEAHA.115.010835; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	53	14	14	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4626	4637		10.1096/fj.201802003R	http://dx.doi.org/10.1096/fj.201802003R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576228	Bronze, Green Published			2022-12-26	WOS:000459794800121
J	Chen, KH; Feng, L; Hu, W; Chen, J; Wang, XY; Wang, LM; He, YN				Chen, Kehong; Feng, Lei; Hu, Wei; Chen, Jia; Wang, Xiaoyue; Wang, Liming; He, Yani			Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy	FASEB JOURNAL			English	Article						OPTN; tubulointerstitial inflammation; mitochondria; IL-1; IL-18	NF-KAPPA-B; INJURY; EXPRESSION; PATHWAY; DISEASE; KIDNEY; RECRUITMENT; SENESCENCE; AUTOPHAGY; DYNAMICS	Tubulointerstitial inflammation plays a critical role in the progression of diabetic nephropathy (DN), and nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes contribute to renal interstitial inflammation in DN. Decreased expression of optineurin (OPTN) is also associated with the progression of DN. We investigated the role of OPTN in activation of the NLRP3 inflammasome in DN. We initially examined the renal biopsy tissues of 172 patients with type 2 DN and 32 nondiabetic patients with renal hamartoma. Expression of renal OPTN was significantly lower in patients with DN and negatively correlated with urinary levels of IL-1 and IL-18. Confocal microscopy analysis of the biopsies indicated no NLRP3 or IL-1 staining in OPTN-positive renal tubular epithelial cells (RTECs), indicating a negative correlation of OPTN expression with the activation of NLRP3 inflammasome. In vitro studies of murine RTECs indicated the levels of OPTN mRNA and protein decreased significantly after stimulation by a high glucose (HG) treatment. Relative to RTECs given HG, RTECs overexpressing OPTN showed significantly lower levels of NLRP3 expression, cleavage of caspase-1 and IL-1, and release of IL-1 and IL-18. Overexpression of OPTN in the presence of HG significantly increased the costaining of microtubule-associated protein 1A/1B-light chain 3-II and translocase of outer mitochondrial membrane 20 in RTECs, suggesting that OPTN enhances mitophagy. In addition, mitochondrial division inhibitor 1 blocked the inhibitory effect of OPTN overexpression on the activation of NLRP3 inflammasome in the presence of HG, indicating that OPTN overexpression inhibited NLRP3 inflammasome activation by enhancement of mitophagy. OPTN gene silencing significantly enhanced production of mitochondrial reactive oxygen species (mtROS) in the presence of HG. Compared with HG+OPTN small interfering RNA (siRNA)-treated RTECs, HG+OPTN siRNA+MitoTempo-treated RTECs attenuated NLRP3 inflammasome activation, suggesting that OPTN gene silencing activates the NLRP3 inflammasome by increasing mtROS in HG-treated RTECs. Taken together, our results demonstrate that OPTN inhibits the activation of NLRP3 inflammasome by enhancing mitophagy.Chen, K., Feng, L., Hu, W., Chen, J., Wang, X., Wang, L., He, Y. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.	[Chen, Kehong; Feng, Lei; Hu, Wei; Chen, Jia; Wang, Xiaoyue; Wang, Liming; He, Yani] Army Mil Med Univ, Res Inst Surg, Daping Hosp, Dept Nephrol, Chongqing, Peoples R China; [Hu, Wei] Peoples Liberat Army PLA 324 Hosp, Dept Nephrol, Chongqing, Peoples R China	Army Medical University	He, YN (corresponding author), Army Med Univ, Daping Hosp, Res Inst Surg, Dept Nephrol, Daping St, Chongqing 400042, Peoples R China.	19346028@qq.com			National Natural Science Foundation of China [81770731, 81670661]; 12th Five-year Science Foundation [AWS14C003]; National Science and Technology Support Plan [2015BAI12B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Science Foundation; National Science and Technology Support Plan	The authors thank Dr. Jianhui Sun and Lihua Bo (both from Daping Hospital) for their clinical and technical support. This work was supported by grants from the National Natural Science Foundation of China (81770731, 81670661), the 12th Five-year Science Foundation (AWS14C003), and the National Science and Technology Support Plan (2015BAI12B06). Prof. Shan Youan (Army Military Medical University) kindly provided the green fluorescent protein-tagged pAdTrack-Vector adenovirus and the green fluorescent protein-tagged pAdTrack-optineurin adenovirus. K.C. and L.F. were joint first authors of this work. The authors declare no conflicts of interest.	Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; An Y, 2015, NEPHROL DIAL TRANSPL, V30, P257, DOI 10.1093/ndt/gfu250; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Bidani AK, 2004, HYPERTENSION, V44, P595, DOI 10.1161/01.HYP.0000145180.38707.84; Chen J, 2017, AM J PHYSIOL-RENAL, V313, pF273, DOI 10.1152/ajprenal.00689.2016; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; COHEN MP, 1979, J EXP MED, V149, P623, DOI 10.1084/jem.149.3.623; Dang WT, 2018, CLIN RHEUMATOL, V37, P2547, DOI 10.1007/s10067-018-4149-4; Dey S, 2018, CIRC RES, V123, P356, DOI 10.1161/CIRCRESAHA.118.312708; Elliott EI, 2018, J IMMUNOL, V200, P3047, DOI 10.4049/jimmunol.1701723; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Han YC, 2018, REDOX BIOL, V16, P32, DOI 10.1016/j.redox.2018.02.013; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Hwang S, 2017, J DIABETES COMPLICAT, V31, P1704, DOI 10.1016/j.jdiacomp.2017.08.009; Iannantuoni F, 2019, ANTIOXID REDOX SIGN, V30, P232, DOI 10.1089/ars.2018.7582; Iglesias-de la Cruz MC, 2002, KIDNEY INT, V62, P901, DOI 10.1046/j.1523-1755.2002.00528.x; Ito S, 2015, AUTOPHAGY, V11, P547, DOI 10.1080/15548627.2015.1017190; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Kim H, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0270-y; Lang Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1549549; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Legrand-Poels S, 2014, BIOCHEM PHARMACOL, V92, P131, DOI 10.1016/j.bcp.2014.08.013; Lei CY, 2017, NEUROSCIENCE, V360, P48, DOI 10.1016/j.neuroscience.2017.07.053; Li S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3537609; Liang X, 2017, TOXICOL IND HEALTH, V33, P737, DOI 10.1177/0748233717712409; Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002; Marshall CB, 2016, AM J PHYSIOL-RENAL, V311, pF831, DOI 10.1152/ajprenal.00313.2016; MAUER SM, 1981, AM J MED, V70, P603, DOI 10.1016/0002-9343(81)90582-9; Meena NP, 2016, FEBS LETT, V590, P1498, DOI 10.1002/1873-3468.12176; Moore AS, 2016, P NATL ACAD SCI USA, V113, pE3349, DOI 10.1073/pnas.1523810113; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Pirkle JL, 2013, MINERVA UROL NEFROL, V65, P37; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Rossing P, 2018, NEPHROL THER, V14, pS31, DOI 10.1016/j.nephro.2018.02.007; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Slowicka K, 2016, TRENDS IMMUNOL, V37, P621, DOI 10.1016/j.it.2016.07.002; Slowicka K, 2016, EUR J IMMUNOL, V46, P971, DOI 10.1002/eji.201545863; Tumurkhuu G, 2018, CELL METAB, V28, P432, DOI 10.1016/j.cmet.2018.05.027; Von Stockum S, 2016, NEUROBIOL DIS, V90, P58, DOI 10.1016/j.nbd.2015.11.002; Wang XC, 2013, EXP THER MED, V6, P1243, DOI 10.3892/etm.2013.1306; Wong YC, 2015, AUTOPHAGY, V11, P422, DOI 10.1080/15548627.2015.1009792; Wood LG, 2019, J ALLERGY CLIN IMMUN, V143, P305, DOI 10.1016/j.jaci.2018.04.037; Yu X, 2017, J HEPATOL, V66, P693, DOI 10.1016/j.jhep.2016.12.018; Zhai  Y., 2018, MOLECULES, V23; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhao WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33201; Zhou M, 2015, EUR REV MED PHARMACO, V19, P4866; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	58	40	40	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4571	4585		10.1096/fj.201801749RRR	http://dx.doi.org/10.1096/fj.201801749RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30571313	Bronze			2022-12-26	WOS:000459794800117
J	Egnatchik, RA; Leamy, AK; Sacco, SA; Cheah, YE; Shiota, M; Young, JD				Egnatchik, Robert A.; Leamy, Alexandra K.; Sacco, Sarah A.; Cheah, Yi Ern; Shiota, Masakazu; Young, Jamey D.			Glutamate-oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipotoxicity; hepatocyte; anaplerosis; glutamine; fatty acid; tricarboxylic acid cycle; TCA cycle; Krebs cycle; fatty liver disease; metabolic flux analysis	NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; OXIDATIVE STRESS; 1 PROTECTS; TCA CYCLE; LIVER; METABOLISM; GLUTAMINASE; ACTIVATION	Hepatocyte lipotoxicity is characterized by aberrant mitochondrial metabolism, which predisposes cells to oxidative stress and apoptosis. Previously, we reported that translocation of calcium from the endoplasmic reticulum to mitochondria of palmitate-treated hepatocytes activates anaplerotic flux from glutamine to -ketoglutarate (KG), which subsequently enters the citric acid cycle (CAC) for oxidation. We hypothesized that increased glutamine anaplerosis fuels elevations in CAC flux and oxidative stress following palmitate treatment. To test this hypothesis, primary rat hepatocytes or immortalized H4IIEC3 rat hepatoma cells were treated with lipotoxic levels of palmitate while modulating anaplerotic pathways leading to KG. We found that culture media supplemented with glutamine, glutamate, or dimethyl-KG increased palmitate lipotoxicity compared with media that lacked these anaplerotic substrates. Knockdown of glutamate-oxaloacetate transaminase activity significantly reduced the lipotoxic effects of palmitate, whereas knockdown of glutamate dehydrogenase (Glud1) had no effect on palmitate lipotoxicity. C-13 flux analysis of H4IIEC3 cells co-treated with palmitate and the pan-transaminase inhibitor aminooxyacetic acid confirmed that reductions in lipotoxic markers were associated with decreases in anaplerosis, CAC flux, and oxygen consumption. Taken together, these results demonstrate that lipotoxic palmitate treatments enhance anaplerosis in cultured rat hepatocytes, causing a shift to aberrant transaminase metabolism that fuels CAC dysregulation and oxidative stress.	[Egnatchik, Robert A.; Leamy, Alexandra K.; Sacco, Sarah A.; Cheah, Yi Ern; Young, Jamey D.] Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA; [Shiota, Masakazu; Young, Jamey D.] Vanderbilt Univ, Mol Physiol & Biophys, Nashville, TN 37235 USA; [Leamy, Alexandra K.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA	Vanderbilt University; Vanderbilt University; University System of Ohio; University of Cincinnati	Young, JD (corresponding author), Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA.	j.d.young@vanderbilt.edu		Sacco, Sarah/0000-0001-8256-7884	National Science Foundation CAREER Award [CBET-0955251]; NIDDK, National Institutes of Health [R01 DK106348, R01 DK060667]; NSF Graduate Research Fellowship Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK106348] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science Foundation CAREER Award CBET-0955251 and NIDDK, National Institutes of Health Grant R01 DK106348 (to J. D. Y). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NSF Graduate Research Fellowship Program.; Supported by NIDDK, National Institutes of Health Grant R01 DK060667.	Akagi S, 2016, FASEB J, V30, P2027, DOI 10.1096/fj.201500149; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Cheng XP, 2018, P NATL ACAD SCI USA, V115, pE4111, DOI 10.1073/pnas.1721403115; Cho CS, 2018, HEPATOLOGY, V68, P1331, DOI 10.1002/hep.29742; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37468; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Li H, 2011, J PROTEOME RES, V10, P2797, DOI 10.1021/pr200047c; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MATSUNO T, 1992, CANCER RES, V52, P1192; Miller RA, 2018, NAT MED, V24, P518, DOI 10.1038/nm.4514; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Qi YF, 2015, J BIOL CHEM, V290, P23282, DOI 10.1074/jbc.M115.677542; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; SHIOTA M, 1995, AM J PHYSIOL-ENDOC M, V268, pE1184, DOI 10.1152/ajpendo.1995.268.6.E1184; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhao NQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23141-8; Zhou Y, 2016, CLIN GASTROENTEROL H, V14, P1463, DOI 10.1016/j.cgh.2016.05.046	39	15	15	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3081	3090		10.1074/jbc.RA118.004869	http://dx.doi.org/10.1074/jbc.RA118.004869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30563841	hybrid, Green Published			2022-12-26	WOS:000464980100009
J	Giussani, S; Pietrocola, G; Donnarumma, D; Norais, N; Speziale, P; Fabbrini, M; Margarit, I				Giussani, Stefania; Pietrocola, Giampiero; Donnarumma, Danilo; Norais, Nathalie; Speziale, Pietro; Fabbrini, Monica; Margarit, Immaculada			The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands	FASEB JOURNAL			English	Article						GBS; neonatal infection; B cells; virulence factor	BINDING-PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FACTOR-H; ANTIGEN; POLYSACCHARIDE; PREVENTION; FIBRINOGEN; PATHWAYS; EVASION	Group B Streptococcus (GBS) colonizes the human lower intestinal and genital tracts and constitutes a major threat to neonates from pregnant carrier mothers and to adults with underlying morbidity. The pathogen expresses cell-surface virulence factors that enable cell adhesion and penetration and that counteract innate and adaptive immune responses. Among these, the complement interfering protein (CIP) was recently described for its capacity to interact with the human C4b ligand and to interfere with the classical- and lectin-complement pathways. In the present study, we provide evidence that CIP can also interact with C3, C3b, and C3d. Immunoassay-based competition experiments showed that binding of CIP to C3d interferes with the interaction between C3d and the complement receptor 2/cluster of differentiation 21 (CR2/CD21) receptor on B cells. By B-cell intracellular signaling assays, CIP was confirmed to down-regulate CR2/CD21-dependent B-cell activation. The CIP domain involved in C3d binding was mapped via hydrogen deuterium exchange-mass spectrometry. The data obtained reveal a new role for this GBS polypeptide at the interface between the innate and adaptive immune responses, adding a new member to the growing list of virulence factors secreted by gram-positive pathogens that incorporate multiple immunomodulatory functions.Giussani, S., Pietrocola, G., Donnarumma, D., Norais, N., Speziale, P., Fabbrini, M., Margarit, I. The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands.	[Giussani, Stefania; Donnarumma, Danilo; Norais, Nathalie; Fabbrini, Monica; Margarit, Immaculada] GlaxoSmithKline GSK, Via Fiorentina 1, I-53100 Siena, Italy; [Giussani, Stefania; Pietrocola, Giampiero; Speziale, Pietro] Univ Pavia, Mol Med Dept, Unit Biochem, Pavia, Italy	University of Pavia	Margarit, I (corresponding author), GlaxoSmithKline GSK, Via Fiorentina 1, I-53100 Siena, Italy.; Speziale, P (corresponding author), Univ Pavia, Mol Med Dept, Unit Biochem, Pavia, Italy.	pspeziale@unipv.it; immaculada.x.margarit-y-ros@gsk.com	Donnarumma, Danilo/AAH-1744-2021	Donnarumma, Danilo/0000-0001-9471-0254; Giussani, Stefania/0000-0002-6088-4958	GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	The authors thank Marzia Monica Giuliani for scientific discussion, Chiara Sammicheli and Simona Tavarini for their support in flow cytometry, Barbara Brogioni for her support on SPR, and Francesca Angiolini for her support on B cell experiments (all from GlaxoSmithKline, Siena, Italy). This study was sponsored by GlaxoSmithKline Biologicals SA (Rixensart, Belgium). D.D., N.N., M.F., and I.M. are employees of GlaxoSmithKline Vaccines. I.M. reports ownership of GSK shares and/or restricted GSK shares and is listed as an inventor on patents owned by the GSK group of companies.	Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Berends ETM, 2014, FEMS MICROBIOL REV, V38, P1146, DOI 10.1111/1574-6976.12080; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Buhlmann D, 2016, J IMMUNOL, V197, P620, DOI 10.4049/jimmunol.1600053; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Cheng Q, 2002, INFECT IMMUN, V70, P6409, DOI 10.1128/IAI.70.11.6409-6415.2002; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Chuzeville S, 2015, MICROB PATHOGENESIS, V88, P1, DOI 10.1016/j.micpath.2015.07.018; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Domina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160702; Fairlie T, 2013, OBSTET GYNECOL, V121, P570, DOI 10.1097/AOG.0b013e318280d4f6; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Haspel N, 2008, PROTEIN SCI, V17, P1894, DOI 10.1110/ps.036624.108; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heath PT, 2007, BEST PRACT RES CL OB, V21, P411, DOI 10.1016/j.bpobgyn.2007.01.003; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Maruvada R, 2009, FASEB J, V23, P3967, DOI 10.1096/fj.09-138149; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Pietrocola G, 2016, J IMMUNOL, V196, P385, DOI 10.4049/jimmunol.1501954; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Woehl JL, 2017, PROTEIN SCI, V26, P1595, DOI 10.1002/pro.3195; Woehl JL, 2014, J IMMUNOL, V193, P6161, DOI 10.4049/jimmunol.1401600	42	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4448	4457		10.1096/fj.201801991R	http://dx.doi.org/10.1096/fj.201801991R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566365	Green Published, hybrid			2022-12-26	WOS:000459794800107
J	Hara, S; Kawasaki, S; Yoshihara, M; Winegarner, A; Busch, C; Tsujikawa, M; Nishida, K				Hara, Susumu; Kawasaki, Satoshi; Yoshihara, Masahito; Winegarner, Andrew; Busch, Caleb; Tsujikawa, Motokazu; Nishida, Kohji			Transcription factor TFAP2B up-regulates human corneal endothelial cell-specific genes during corneal development and maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cornea; regenerative medicine; cell surface protein; collagen; differentiation; eye; gene regulation; molecular cell biology; corneal endothelial cells; neural crest; TFAP2B; ZP4; transcriptional regulation; development; eye development	CRANIAL NEURAL CREST; CAUSE CHAR-SYNDROME; IDENTIFICATION; EXPRESSION; COL8A2; MUTATIONS; AP-2-BETA; MARKERS; CANCER; FOXC1	The corneal endothelium, which originates from the neural crest via the periocular mesenchyme (PM), is crucial for maintaining corneal transparency. The development of corneal endothelial cells (CECs) from the neural crest is accompanied by the expression of several transcription factors, but the contribution of some of these transcriptional regulators to CEC development is incompletely understood. Here, we focused on activating enhancer-binding protein 2 (TFAP2, AP-2), a neural crest-expressed transcription factor. Using semiquantitative/quantitative RT-PCR and reporter gene and biochemical assays, we found that, within the AP-2 family, the TFAP2B gene is the only one expressed in human CECs in vivo and that its expression is strongly localized to the peripheral region of the corneal endothelium. Furthermore, the TFAP2B protein was expressed both in vivo and in cultured CECs. During mouse development, TFAP2B expression began in the PM at embryonic day 11.5 and then in CECs during adulthood. siRNA-mediated knockdown of TFAP2B in CECs decreased the expression of the corneal endothelium-specific proteins type VIII collagen alpha 2 (COL8A2) and zona pellucida glycoprotein 4 (ZP4) and suppressed cell proliferation. Of note, we also found that TFAP2B binds to the promoter of the COL8A2 and ZP4 genes. Furthermore, CECs that highly expressed ZP4 also highly expressed both TFAP2B and COL8A2 and showed high cell proliferation. These findings suggest that TFAP2B transcriptionally regulates CEC-specific genes and therefore may be an important transcriptional regulator of corneal endothelial development and homeostasis.	[Hara, Susumu] Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hara, Susumu; Kawasaki, Satoshi; Winegarner, Andrew; Busch, Caleb; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tsujikawa, Motokazu] Osaka Univ, Div Hlth Sci, Grad Sch Med, Area Med Technol & Sci,Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Yoshihara, Masahito] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Yoshihara, Masahito] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Osaka University; Osaka University; Osaka University; RIKEN; Karolinska Institutet	Hara, S (corresponding author), Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Hara, S; Nishida, K (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan.	susumu.hara@ophthal.med.osaka-u.ac.jp; knishida@ophthal.med.osaka-u.ac.jp	Yoshihara, Masahito/C-3711-2017	Yoshihara, Masahito/0000-0002-8915-9282; Winegarner, Andrew/0000-0001-9211-0861; Hara, Susumu/0000-0003-3377-0418; Busch, Caleb/0000-0003-0536-7832	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K20259, JP 17K169680]; Japan Eye Bank Association; Karolinska Institutet Research Foundation; Scandinavia-Japan Sasakawa Foundation; Astellas Foundation for Research on Metabolic Disorders; Healthcare New Frontier Policy, Kanagawa Prefecture, Japan	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Eye Bank Association; Karolinska Institutet Research Foundation(Karolinska Institutet); Scandinavia-Japan Sasakawa Foundation; Astellas Foundation for Research on Metabolic Disorders; Healthcare New Frontier Policy, Kanagawa Prefecture, Japan	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 15K20259 and JP 17K169680. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Japan Eye Bank Association, the Karolinska Institutet Research Foundation, the Scandinavia-Japan Sasakawa Foundation, the Astellas Foundation for Research on Metabolic Disorders, and the Healthcare New Frontier Policy, Kanagawa Prefecture, Japan.	BAHN CF, 1984, OPHTHALMOLOGY, V91, P558; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; Chen LS, 2016, INVEST OPHTH VIS SCI, V57, P1072, DOI 10.1167/iovs.15-18103; Chen P, 2015, EXP THER MED, V9, P351, DOI 10.3892/etm.2014.2103; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Fu LY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-89; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; He ZG, 2012, STEM CELLS, V30, P2523, DOI 10.1002/stem.1212; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Joyce NC, 2012, MOL VIS, V18, P547; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Lin JM, 2018, DEV BIOL, V441, P67, DOI 10.1016/j.ydbio.2018.06.007; Liu X, 2015, CELL CYCLE, V14, P1197, DOI 10.1080/15384101.2015.1013667; Martino VB, 2016, DIS MODEL MECH, V9, P849, DOI 10.1242/dmm.025262; McCabe KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145266; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Nelms B.L., 2010, TRANSCRIPTIONAL CONT; Raap M, 2018, LAB INVEST, V98, P117, DOI 10.1038/labinvest.2017.106; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Swamynathan SK, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/103947; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Yoshihara M, 2017, EBIOMEDICINE, V25, P175, DOI 10.1016/j.ebiom.2017.10.024; Yoshihara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117581; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang K, 2014, STEM CELLS DEV, V23, P1340, DOI 10.1089/scd.2013.0510; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	42	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2460	2469		10.1074/jbc.RA118.005527	http://dx.doi.org/10.1074/jbc.RA118.005527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30552118	hybrid, Green Published			2022-12-26	WOS:000458895400022
J	Bitra, A; Doukov, T; Destito, G; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Destito, Giuseppe; Croft, Michael; Zajonc, Dirk M.			Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein-protein interaction; protein structure; cell surface receptor; X-ray crystallography; 4-1BB; 4-1BB ligand; CD137; CD137L; TNFRSF9; immune cell	TNF; MEMBERS; UNIQUE; CELLS; ACTIVATION; PROGRAM; FAMILY; GITR	The interaction between the receptor 4-1BB and its ligand 4-1BBL provides co-stimulatory signals for T-cell activation and proliferation. However, differences in the mouse and human molecules might result in differential engagement of this pathway. Here, we report the crystal structure of mouse 4-1BBL and of the mouse 4-1BB/4-1BBL complex, which together provided insights into the molecular mechanism by which m4-1BBL and its cognate receptor recognize each other. Unlike all human or mouse tumor necrosis factor ligands that form noncovalent and mostly trimeric assemblies, the m4-1BBL structure formed a disulfide-linked dimeric assembly. The structure disclosed that certain differences in the amino acid composition along the intramolecular interface, together with two specific residues (Cys-246 and Ser-256) present exclusively in m4-1BBL, are responsible for this unique dimerization. Unexpectedly, upon m4-1BB binding, m4-1BBL undergoes structural changes within each protomer; moreover, the individual m4-1BBL protomers rotate relative to each other, yielding a dimerization interface with more inter-subunit interactions. We also observed that in the m4-1BB/4-1BBL complex, each receptor monomer binds exclusively to a single ligand subunit with contributions of cysteine-rich domain 1 (CRD1), CRD2, and CRD3. Furthermore, structure-guided mutagenesis of the binding interface revealed that novel binding interactions with the GH loop, rather than the DE loop, are energetically critical and define the m4-1BB receptor selectivity for m4-1BBL. A comparison with the human 4-1BB/4-1BBL complex highlighted several differences between the ligand- and receptor-binding interfaces, providing an explanation for the absence of inter-species cross-reactivity between human and mouse 4-1BB and 4-1BBL molecules.	[Bitra, Aruna; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] Stanford Synchrotron Radiat Lightsource, SLAC, Menlo Pk, CA 94025 USA; [Destito, Giuseppe] Kirin Kyowa Hakko Pharmaceut Res, La Jolla, CA 92037 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Immunol, Div Immune Regulat, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org		Bitra, Aruna/0000-0003-1675-3544; Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	National Institutes of Health NIAID [AI110929]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIAID Grant AI110929 (to M.C. and D.M.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bitra A, 2018, J BIOL CHEM, V293, P9958, DOI 10.1074/jbc.RA118.003176; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bricogne G., 2017, BUSTER; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eun SY, 2015, J IMMUNOL, V194, P134, DOI 10.4049/jimmunol.1401383; Gilbreth RN, 2018, J BIOL CHEM, V293, P9880, DOI 10.1074/jbc.RA118.002803; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rossmann MG, 2001, ACTA CRYSTALLOGR D, V57, P1360, DOI 10.1107/S0907444901009386; Sanchez-Paulete AR, 2016, EUR J IMMUNOL, V46, P513, DOI 10.1002/eji.201445388; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Tang QQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016129; Tickle I.J., 2018, STARANISO; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Yi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086337; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P641, DOI 10.1073/pnas.0711206105	44	10	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1831	1845		10.1074/jbc.RA118.006297	http://dx.doi.org/10.1074/jbc.RA118.006297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30545939	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000459711400006
J	Naim, N; White, AD; Reece, JM; Wankhede, M; Zhang, XF; Vilardaga, JP; Altschuler, DL				Naim, Nyla; White, Alex D.; Reece, Jeff M.; Wankhede, Mamta; Zhang, Xuefeng; Vilardaga, Jean-Pierre; Altschuler, Daniel L.			Luminescence-activated nucleotide cyclase regulates spatial and temporal cAMP synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); bioluminescence; optogenetics; fluorescence resonance energy transfer (FRET); signaling; second messenger; cell proliferation; thyroid; bPAC; compartmentalization; microdomains; nano-luciferase	PHOTOACTIVATED ADENYLYL-CYCLASE; THYROID-CELL PROLIFERATION; CYCLIC-AMP; CONSTITUTIVE ACTIVATION; ADENOSINE-MONOPHOSPHATE; PHOTO-DYNAMICS; RECEPTOR GENE; G-PROTEIN; IN-VITRO; PKA	cAMP is a ubiquitous second messenger that regulates cellular proliferation, differentiation, attachment, migration, and several other processes. It has become increasingly evident that tight regulation of cAMP accumulation and localization confers divergent yet specific signaling to downstream pathways. Currently, few tools are available that have sufficient spatial and temporal resolution to study location-biased cAMP signaling. Here, we introduce a new fusion protein consisting of a light-activated adenylyl cyclase (bPAC) and luciferase (nLuc). This construct allows dual activation of cAMP production through temporally precise photostimulation or chronic chemical stimulation that can be fine-tuned to mimic physiological levels and duration of cAMP synthesis to trigger downstream events. By targeting this construct to different compartments, we show that cAMP produced in the cytosol and nucleus stimulates proliferation in thyroid cells. The bPAC-nLuc fusion construct adds a new reagent to the available toolkit to study cAMP-regulated processes in living cells.	[Naim, Nyla; White, Alex D.; Reece, Jeff M.; Wankhede, Mamta; Zhang, Xuefeng; Vilardaga, Jean-Pierre; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Naim, Nyla; White, Alex D.] Univ Pittsburgh, Mol Pharmacol Training Program, Pittsburgh, PA 15261 USA; [Naim, Nyla] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Reece, Jeff M.] NIDDK, ALMIAC, NIH, Bethesda, MD 20814 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Vilardaga, Jean-Pierre/0000-0002-1217-1435	National Institutes of Health NIDDK grant; National Institutes of Health NIGMS grant; Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards [R01-GM09975, R01-DK102495, R01-DK111427, R01-DK116780]; National Institutes of Health [T32-GM008424, T32-GM00842419, T32-GM00842420, T32-GM00842421]; Winstar Morris' Cotswold Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111427, R01DK116780, R01DK102495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424, R01GM130612] Funding Source: NIH RePORTER	National Institutes of Health NIDDK grant; National Institutes of Health NIGMS grant; Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winstar Morris' Cotswold Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIDDK and NIGMS grants and the Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards R01-GM09975 (to D. L. A), R01-DK102495, R01-DK111427, and R01-DK116780 (to J. P. V.), National Institutes of Health Training Grants T32-GM008424 (to A. D. W.) and T32-GM00842419,20,21, and a Winstar Morris' Cotswold Foundation Fellowship (to N. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal SR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00332; Agarwal SR, 2017, BRIT J PHARMACOL, V174, P2784, DOI 10.1111/bph.13904; Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; BAPTIST M, 1993, J CELL SCI, V105, P69; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Berglund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059759; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Boot AM, 2011, J CLIN ENDOCR METAB, V96, pE1197, DOI 10.1210/jc.2010-3031; BROOKER G, 1973, SCIENCE, V182, P933, DOI 10.1126/science.182.4115.933; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cui W, 2007, LEARN MEMORY, V14, P126, DOI 10.1101/lm.496007; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dowlatshahi D, 1998, LANCET, V352, P1754, DOI 10.1016/S0140-6736(05)79827-5; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Efetova M, 2013, J CELL SCI, V126, P778, DOI 10.1242/jcs.114140; Fajardo AM, 2014, CANCERS, V6, P436, DOI 10.3390/cancers6010436; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Feinstein WP, 2012, AM J PHYSIOL-CELL PH, V302, pC839, DOI 10.1152/ajpcell.00361.2011; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gorshkov K, 2017, NAT CHEM BIOL, V13, P425, DOI 10.1038/nchembio.2298; HAISENLEDER DJ, 1992, ENDOCRINOLOGY, V131, P3027, DOI 10.1210/en.131.6.3027; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Inda C, 2016, J CELL BIOL, V214, P181, DOI 10.1083/jcb.201512075; INSEL PA, 1976, MOL PHARMACOL, V12, P1062; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jiang JY, 2017, CELL CALCIUM, V64, P47, DOI 10.1016/j.ceca.2017.02.010; Kapiloff MS, 2014, J GEN PHYSIOL, V143, P9, DOI 10.1085/jgp.201311020; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Koschinski A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13021-y; KOSUGI S, 1994, FEBS LETT, V356, P291, DOI 10.1016/0014-5793(94)01286-5; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lohse C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174856; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Min KS, 1998, J BIOL CHEM, V273, P34911, DOI 10.1074/jbc.273.52.34911; Neves SR, 2009, J BIOL CHEM, V284, P5445, DOI 10.1074/jbc.R800058200; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pavlos NJ, 2017, TRENDS ENDOCRIN MET, V28, P213, DOI 10.1016/j.tem.2016.10.007; Penzkofer A, 2011, CHEM PHYS, V387, P25, DOI 10.1016/j.chemphys.2011.05.028; Penzkofer A, 2015, J PHOTOCH PHOTOBIO B, V153, P90, DOI 10.1016/j.jphotobiol.2015.08.027; Perera RK, 2013, ACTA PHYSIOL, V207, P650, DOI 10.1111/apha.12077; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; ROSS EM, 1978, J BIOL CHEM, V253, P6401; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Scheib U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04428-w; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shipunova VO, 2018, RUSS J BIOORG CHEM+, V44, P225, DOI 10.1134/S1068162018020085; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Surdo NC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15031; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tian G, 2012, J CELL SCI, V125, P5084, DOI 10.1242/jcs.107201; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vedel L, 2015, J BIOMOL SCREEN, V20, P849, DOI 10.1177/1087057115580019; Vitalis EA, 2000, P NATL ACAD SCI USA, V97, P1861, DOI 10.1073/pnas.040545197; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zhang XF, 2018, J BIOL CHEM, V293, P7659, DOI 10.1074/jbc.RA118.001779; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119	83	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1095	1103		10.1074/jbc.AC118.004905	http://dx.doi.org/10.1074/jbc.AC118.004905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30559293	Green Published, hybrid			2022-12-26	WOS:000457879500003
J	Funderburk, L; Peterson, M; Beretich, K; Shah, N; Grandjean, PW				Funderburk, LesLee; Peterson, Matthew; Beretich, Kaitlan; Shah, Nish; Grandjean, Peter W.			Prevalence of metabolic disease and correlation to body composition and cardiovascular fitness in adults undergoing fitness assessments	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; PHYSICAL-ACTIVITY; ASSOCIATION; MORTALITY; POPULATION; HEMOGLOBIN; STANDARDS; TRENDS; FIBER	The purpose of this descriptive study was to assess the prevalence of metabolic syndrome (MetS), prediabetes and type 2 diabetes (T2DM) in participants who voluntarily participated in a fitness assessment, and to examine associations with routine nutrition intake and overall body composition. One hundred and six participants were recruited. Anthropometric measurements were taken with blood analyses completed for fasting glucose, glycosylated hemoglobin (HbA1c) and lipid panel. A 24-hour diet recall and a dietary screening survey was used to assess nutrient intake, in a sub-set of 36 participants. Statistical analyses utilized partial Spearmans' rank correlations, risk ratios, and Kendall's Tau correlations, with significance level at p < 0.05. Twenty five percent of this sample had >= three risk factors for MetS, with elevated fasting glucose and blood pressure being the most prevalent. Twenty percent of the participants had HbA1c levels elevated at the prediabetes range, with no previous diagnosis. Four percent of participants had HbA1c levels elevated at the T2DM range. Two nutrients of interest were correlated to BMI status. Percent kcal from carbohydrate (tau -0.207, p<0.05) had a negative correlation with BMI status and percent kcal from fat intake had a positive correlation (tau 0.217, p<0.05). Findings from this small sample of adults indicate the need for routine assessment of: clustering of MetS risk factors, risk of prediabetes and T2DM and treatment of same. Many participants would benefit from increasing their participation in physical activity, weight loss in regard to overall health improvement, and education to improve diet quality.	[Funderburk, LesLee; Peterson, Matthew; Beretich, Kaitlan; Grandjean, Peter W.] Baylor Univ, Robbins Coll Hlth & Human Sci, Waco, TX 76798 USA; [Shah, Nish] Houston Methodist, Orthoped & Sports Med, Sugar Land, TX USA	Baylor University	Funderburk, L (corresponding author), Baylor Univ, Robbins Coll Hlth & Human Sci, Waco, TX 76798 USA.	LesLee_Funderburk@baylor.edu						Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2002, PRACT GUID; [Anonymous], 2016, AUT SELF ADM 24 HOUR; [Anonymous], 2018, NATL HLTH STAT REPOR; [Anonymous], 2017, WHAT AR RISK FACT HE; [Anonymous], 2017, ACSMS GUIDELINES EXE, V10th ed; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Bergman RN, OBESITY S, V14, p16S; Bernstein M., 2018, NUTR LIFE STAGES; Bliss RM, 2004, AGR RES, V52, P10; BRUCE RA, 1971, ANN CLIN RES, V3, P323; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Foster C, J CARDIAC REHABILITA, V4, P537; Funderburk L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197903; Gebel K, 2015, JAMA INTERN MED, V175, P970, DOI 10.1001/jamainternmed.2015.0541; He D, 2014, ENDOCRINE, V46, P231, DOI 10.1007/s12020-013-0110-0; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Krzentowski G, 2004, ANN ENDOCRINOL-PARIS, V65, P429, DOI 10.1016/S0003-4266(04)95947-1; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Maud P, 2005, PHYSL ASSESSMENT HUM; McGill CR, 2015, NUTRIENTS, V7, P1119, DOI 10.3390/nu7021119; Moncada-Jimenez J, 2015, INT J SPORTS MED, V5, P80; National Center for Chronic Disease Prevention and Health Promotion, NAT DIAB STAT REP; Shantha GPS, 2012, DIABETES EDUCATOR, V38, P417, DOI 10.1177/0145721712443293; Sherling DH, 2017, J CARDIOVASC PHARM T, V22, P365, DOI 10.1177/1074248416686187; Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018; Speechly DP, 2000, EUR J CLIN NUTR, V54, P225, DOI 10.1038/sj.ejcn.1600924; Teegarden D, 2008, OBESITY, V16, P1566, DOI 10.1038/oby.2008.232; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Willems JM, 2010, J GERONTOL A-BIOL, V65, P764, DOI 10.1093/gerona/glq004	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209514	10.1371/journal.pone.0209514	http://dx.doi.org/10.1371/journal.pone.0209514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576347	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400055
J	Yin, R; Tran, VH; Zhou, XR; Zheng, J; Kwoh, CK				Yin, Rui; Viet Hung Tran; Zhou, Xinrui; Zheng, Jie; Kwoh, Chee Keong			Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; HEMAGGLUTINATION-INHIBITION; ADVISORY-COMMITTEE; RECOMMENDATIONS; PREVENTION; EVOLUTION	H1N1 is the earliest emerging subtype of influenza A viruses with available genomic sequences, has caused several pandemics and seasonal epidemics, resulting in millions of deaths and enormous economic losses. Timely determination of new antigenic variants is crucial for the vaccine selection and flu prevention. In this study, we chronologically divided the H1N1 strains into several periods in terms of the epidemics and pandemics. Computational models have been constructed to predict antigenic variants based on epidemic and pandemic periods. By sequence analysis, we demonstrated the diverse mutation patterns of HA1 protein on different periods and that an individual model built upon each period can not represent the variations of H1N1 virus. A stacking model was established for the prediction of antigenic variants, combining all the variation patterns across periods, which would help assess a new influenza strain's antigenicity. Three different feature extraction methods, i. e. residue-based, regional band-based and epitope region-based, were applied on the stacking model to verify its feasibility and robustness. The results showed the capability of determining antigenic variants prediction with accuracy as high as 0.908 which performed better than any of the single models. The prediction performance using the stacking model indicates clear distinctions of mutation patterns and antigenicity between epidemic and pandemic strains. It would also facilitate rapid determination of antigenic variants and influenza surveillance.	[Yin, Rui; Zhou, Xinrui; Zheng, Jie; Kwoh, Chee Keong] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Viet Hung Tran] Hanoi Univ Sci & Technol, Sch Informat & Commun Technol, Hanoi, Vietnam; [Zheng, Jie] ASTAR, Genome Inst Singapore, Biopolis, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Hanoi University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Kwoh, CK (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.	ASCKKWOH@ntu.edu.sg	Zheng, Jie/AAX-1454-2021; kwoh, chee keong/A-3727-2011	Yin, Rui/0000-0002-1403-0396; Zhou, Xinrui/0000-0002-4079-6475; kwoh, chee keong/0000-0002-8547-6387	AcRF Tier 2 grant, Ministry of Education, Singapore [MOE2014-T2-2-023]	AcRF Tier 2 grant, Ministry of Education, Singapore	This study is supported by AcRF Tier 2 grant MOE2014-T2-2-023, Ministry of Education, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JL, 2012, BIOINFORMATICS, V28, P1292, DOI 10.1093/bioinformatics/bts105; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Benesty J, 2009, SPRINGER TOP SIGN PR, V2, P1, DOI 10.1007/978-3-642-00296-0_1; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Burke DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112302; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1183; de Jong J C, 2003, Dev Biol (Basel), V115, P63; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Du XJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1710; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; gUnes F, STACKED ENSEMBLE MOD; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; LeDell E., 2016, H2OENSEMBLE H2O ENSE, P8; Lees WD, 2010, BIOINFORMATICS, V26, P1403, DOI 10.1093/bioinformatics/btq160; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; LIU M, 2015, SCI REPORTS, P5; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113; Peng YS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42051; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Qiu JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31156; Ren XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126742; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Yao YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01699-z; Yin R, 2017, ICBBS 17; Zacour M, 2016, CLIN VACCINE IMMUNOL, V23, P236, DOI 10.1128/CVI.00613-15	43	21	24	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0207777	10.1371/journal.pone.0207777	http://dx.doi.org/10.1371/journal.pone.0207777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576319	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400006
J	Camacho, S; Maldonado, N; Bustamante, J; Llorente, B; Cueto, E; Cardona, F; Arango, C				Camacho, Sandra; Maldonado, Norman; Bustamante, Juan; Llorente, Blanca; Cueto, Enriqueta; Cardona, Fabian; Arango, Carlos			How much for a broken heart? Costs of cardiovascular disease in Colombia using a person-based approach	PLOS ONE			English	Article							STROKE; BURDEN	The shift of the Noncommunicable Diseases (NCDs) epidemic, including cardiovascular disease, from developed to Low and Middle Income Countries (LMIC), creates new challenges in contexts where there is poor information on healthcare costs. Clearly this information is essential for planning, and its relevance is even more valuable as a driver for prevention and control of NCDs. This paper begins to address that handicap by estimating the healthcare cost of Cardiovascular Disease (Coronary Heart Disease and Stroke) in Colombia, using a person-based approach. Results show that the annual healthcare cost of a person with Coronary Heart Disease is between INT$ 4,277 and INT$ 4,846, while the cost for a person with Stroke varies between INT$5,816 and INT$6,616. The expansion of the NCDs epidemic combined with such high costs threatens the financial sustainability of health systems; primary prevention and policies targeting structural and intermediate determinants of health are a promising way to make health systems financially sustainable.	[Camacho, Sandra; Bustamante, Juan; Llorente, Blanca; Cueto, Enriqueta; Arango, Carlos] Fdn Salutia, Bogota, Colombia; [Maldonado, Norman] Univ Jorge Tadeo Lozano, Dept Econ Trade & Social Policy, Bogota, Colombia; [Cardona, Fabian] ACEMI, Bogota, Colombia	Universidad de Bogota Jorge Tadeo Lozano	Maldonado, N (corresponding author), Univ Jorge Tadeo Lozano, Dept Econ Trade & Social Policy, Bogota, Colombia.	normanmva@gmail.com	Maldonado, Norman/S-6090-2017	Maldonado, Norman/0000-0003-1937-0901; Llorente, Blanca/0000-0003-3350-1648	Fondo Ciencia Tecnologia e Innovacion del Sistema General de Regalias (National Fund for Science, Technology and Innovation) [2015000100017]; Office of the Government of Risaralda	Fondo Ciencia Tecnologia e Innovacion del Sistema General de Regalias (National Fund for Science, Technology and Innovation); Office of the Government of Risaralda	The study was funded with a grant from the Fondo Ciencia Tecnologia e Innovacion del Sistema General de Regalias (National Fund for Science, Technology and Innovation, from the national system of royalties) BPIN project #2015000100017.; We thank ACEMI for providing the data for this analysis. The project was funded by a grant from the Office of the Government of Risaralda.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2018, MINSALUD CIFR AS SAL; [Anonymous], 2016, DANE DEF FET AN EST; [Anonymous], 2017, MINSALUD EST SOST AS; [Anonymous], 2017, FUND SAL ERICA ENC R; [Anonymous], WHO WORLD HLTH REP 2; [Anonymous], 2012, CRES EST TECN EST UP; Barquera S, 2015, ARCH MED RES, V46, P328, DOI 10.1016/j.arcmed.2015.06.006; Bloom DE, 2011, GLOBAL EC BURDEN NON; Braunschweig F, 2011, EUROPACE, V13, pII13, DOI 10.1093/europace/eur081; Chevreul K, 2013, EUR J NEUROL, V20, P1094, DOI 10.1111/ene.12143; Epstein H, 2016, REV CEPAL, V119; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Ferdinand KC, 2011, CVD PREVENTION CONTR, V6, DOI [10.1016/j.cvdpc.2011.05.001, DOI 10.1016/J.CVDPC.2011.05.001]; Gallardo K, 2016, REV CIENCIAS SALUD, V14; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Huffman M.D., 2014, RACE TIME 2 CHALLENG; Kutzin J, 2016, WORLD SCI HDB GLOBAL; Amaya-Lara JL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0472-z; Mackay J, 2004, ATLAS HEART DIS STRO; Miller HD, 2009, HEALTH AFFAIR, V28, P1418, DOI 10.1377/hlthaff.28.5.1418; MinSalud INS ONS, 2015, ONS CARG ENF ENF CRO; MPS COLCIENCIAS, 2009, CENDEX ENC NAC SAL 2; OECD, 2015, OECD REV HLTH SYST C; Patel MS, 2017, CIRCULATION, V135; Pichon-Riviere A, 2013, CARGA ENFERMEDAD ATR; Pichon-Riviere A, 2011, VALUE HEALTH, V14, pS51, DOI 10.1016/j.jval.2011.05.010; Pinto D, 2007, WBI DEV STUD, P105; Prada S, 2016, GERENCIA POLITICAS S, V15; Reddy KS, 1998, CIRCULATION, V97, P596; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Smith P, 2016, RISK POOLING HLTH CA; Spieler JF, 2004, CEREBROVASC DIS, V17, P134, DOI 10.1159/000075782; Stroke association State of the nation, 2018, STROK STAT; Tarride Jean-Eric, 2009, Can J Cardiol, V25, pe195; Wang GJ, 2014, J STROKE CEREBROVASC, V23, P861, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.017; WHO, 2013, WHO GLOB ACT PLAN PR; Xu XM, 2018, EUR STROKE J, V3, P82, DOI 10.1177/2396987317746516	40	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208513	10.1371/journal.pone.0208513	http://dx.doi.org/10.1371/journal.pone.0208513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566516	gold, Green Published, Green Submitted			2022-12-26	WOS:000453779300045
J	Dargham, SR; Zahirovic, S; Hammoudeh, M; Al Emadi, S; Masri, BK; Halabi, H; Badsha, H; Uthman, I; Mahfoud, ZR; Ashour, H; El Haq, WG; Bayoumy, K; Kapiri, M; Saxena, R; Plenge, RM; Kazkaz, L; Arayssi, T				Dargham, Soha R.; Zahirovic, Sumeja; Hammoudeh, Mohammed; Al Emadi, Samar; Masri, Basel K.; Halabi, Hussein; Badsha, Humeira; Uthman, Imad; Mahfoud, Ziyad R.; Ashour, Hadil; El Haq, Wissam Gad; Bayoumy, Karim; Kapiri, Marianthi; Saxena, Richa; Plenge, Robert M.; Kazkaz, Layla; Arayssi, Thurayya			Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; BREAST-CANCER; DISEASE; POPULATION; DIAGNOSIS; COMORBIDITIES; METHOTREXATE; ASSOCIATION; PREVALENCE; MANAGEMENT	Objectives There is limited information on the epidemiology and treatment patterns of rheumatoid arthritis (RA) across the Arab region. We aim in this study to describe the demographic characteristics, clinical profile, and treatment patterns of patients of Arab ancestry with RA. Methods This is a cross sectional study of 895 patients with established rheumatoid arthritis enrolled from five sites (Jordan, Lebanon, Qatar, Kingdom of Saudi Arabia (KSA), and United Arab Emirates). Demographic characteristics, clinical profile, and treatment patterns are compared between the five countries. Results The majority of our patients are women, have an average disease duration of 10 years, are married and non-smokers, with completed secondary education. We report a high (>80%) ever-use of methotrexate (MTX) and steroids among our RA population, while the ever-use of disease modifying anti-rheumatic drugs (DMARDs) and TNF-inhibitors average around 67% and 33%, respectively. There are variations in RA treatment use between the five country sites. Highest utilization of steroids is identified in Jordan and KSA (p-value < 0.001), while the highest ever-use of TNF-inhibitors is reported in KSA (p-value < 0.001). Conclusion Disparities in usage of RA treatments among Arab patients are noted across the five countries. National gross domestic product (GDP), as well as some other unique features in each country likely affect these. Developing treatment guidelines specific to this region could contribute in delivering standardized therapies to RA patients.	[Dargham, Soha R.; Zahirovic, Sumeja; Mahfoud, Ziyad R.; Kapiri, Marianthi; Arayssi, Thurayya] Weill Cornell Med Qatar, Doha, Qatar; [Hammoudeh, Mohammed; Al Emadi, Samar; Ashour, Hadil; El Haq, Wissam Gad; Bayoumy, Karim] Hamad Med Corp, Doha, Qatar; [Masri, Basel K.] Jordan Hosp, Amman, Jordan; [Halabi, Hussein] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia; [Badsha, Humeira] Dr Humeira Badsha Med Ctr, Dubai, U Arab Emirates; [Uthman, Imad] Amer Univ Beirut, Beirut, Lebanon; [Saxena, Richa] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Saxena, Richa; Plenge, Robert M.] Broad Inst, Cambridge, MA USA; [Plenge, Robert M.] Merck Res Labs, Boston, MA USA; [Kazkaz, Layla] Tishreen Univ, Latakia, Syria	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; King Faisal Specialist Hospital & Research Center; American University of Beirut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Merck & Company	Arayssi, T (corresponding author), Weill Cornell Med Qatar, Doha, Qatar.	Tha2002@qatar-med.cornell.edu	Saxena, Richa/AAG-7279-2020; Arayssi, Thurayya/S-1725-2019	Arayssi, Thurayya/0000-0003-2469-0272; BADSHA, HUMEIRA/0000-0003-3112-0606; Dargham, Soha/0000-0003-2695-6564; Zahirovic, Sumeja/0000-0002-0221-1800; Saxena, Richa/0000-0003-2233-1065; Mahfoud, Ziyad/0000-0003-4098-6401	National Priorities Research Program (Qatar National Research Fund, Qatar Foundation) [4-344-3-105]	National Priorities Research Program (Qatar National Research Fund, Qatar Foundation)	This work was supported by National Priorities Research Program (grant 4-344-3-105 from the Qatar National Research Fund, a member of Qatar Foundation).	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Badsha H, 2008, CLIN RHEUMATOL, V27, P739, DOI 10.1007/s10067-007-0782-z; Bank TW, 2018, GDP CAP PPP CURR INT; Bener A, 2017, EGYPTIAN J MED HUMAN, V18, P315, DOI [10.1016/j.ejmhg.2017.01.002, DOI 10.1016/J.EJMHG.2017.01.002, 10.1016/J.EJMHG.2017.01.002]; Bittles AH, 2011, BACKGROUND SUMMARY C; CALLAHAN LF, 1988, ARTHRITIS RHEUM-US, V31, P1346, DOI 10.1002/art.1780311102; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Curtis JR, 2011, CLIN THER, V33, P679, DOI 10.1016/j.clinthera.2011.05.044; Dawson AL, 2014, AM J MED GENET A, V164, P2212, DOI 10.1002/ajmg.a.36625; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Edwards CJ, 2005, RHEUMATOLOGY, V44, P1394, DOI 10.1093/rheumatology/kei024; El-Zorkany B, 2016, CLIN RHEUMATOL, V35, P1153, DOI 10.1007/s10067-015-3142-4; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Halabi H, 2015, INT J RHEUM DIS, V18, P268, DOI 10.1111/1756-185X.12320; Hirko KA, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/916394; Humphreys JH, 2013, ANN RHEUM DIS, V72, P1315, DOI 10.1136/annrheumdis-2012-201960; Hunter TM, 2017, RHEUMATOL INT, V37, P1551, DOI 10.1007/s00296-017-3726-1; Jiang X, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0836-6; Jordan Joanne M., 1999, Current Opinion in Rheumatology, V11, P98, DOI 10.1097/00002281-199903000-00003; Karim SAM, 2015, INT J SURG, V13, P71, DOI 10.1016/j.ijsu.2014.11.029; Krause ML, 2014, THER ADV MUSCULOSKEL, V6, P169, DOI 10.1177/1759720X14551568; Lloyd ME, 1999, QJM-MON J ASSOC PHYS, V92, P551, DOI 10.1093/qjmed/92.10.551; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lutf A, 2014, INT J RHEUM DIS, V17, P63, DOI 10.1111/1756-185X.12135; Moufarrej MN, 2015, RHEUMATOL INT, V35, P759, DOI 10.1007/s00296-014-3151-7; Organization WH, 2018, GLOBAL HEALTH EXPEND; Pisetsky DS, 2012, BEST PRACT RES CL RH, V26, P251, DOI 10.1016/j.berh.2012.03.001; Putrik P, 2016, ANN RHEUM DIS, V75, P540, DOI 10.1136/annrheumdis-2014-206737; Putrik P, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2012-202603; Saxena R, 2017, ARTHRITIS RHEUMATOL, V69, P976, DOI 10.1002/art.40051; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Slimani S, 2014, RHEUMATOL INT, V34, P1235, DOI 10.1007/s00296-014-2981-7; Slimani S, 2011, JOINT BONE SPINE, V78, P484, DOI 10.1016/j.jbspin.2010.11.012; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Sokka T, 2008, MOD RHEUMATOL, V18, P228, DOI 10.1007/s10165-008-0056-x; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Symmons DPM, 2003, BEST PRACT RES CL RH, V17, P717, DOI 10.1016/S1521-6942(03)00063-9; Weber-Schoendorfer C, 2014, ARTHRITIS RHEUMATOL, V66, P1101, DOI 10.1002/art.38368; Yelin E, 2014, ARTHRIT CARE RES, V66, P980, DOI 10.1002/acr.22244; Youth UNPo, 2011, REGIONAL OVERVIEW YO	42	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208240	10.1371/journal.pone.0208240	http://dx.doi.org/10.1371/journal.pone.0208240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566451	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300030
J	Friedrichs, M; Hermoso, V; Bremerich, V; Langhans, SD				Friedrichs, Martin; Hermoso, Virgilio; Bremerich, Vanessa; Langhans, Simone D.			Evaluation of habitat protection under the European Natura 2000 conservation network - The example for Germany	PLOS ONE			English	Article							BIODIVERSITY LOSS; HUMAN FOOTPRINT; AREA NETWORK; GAP ANALYSIS; INDICATORS	The world's largest network of protected areas-Natura 2000 (N2000)-has been implemented to protect Europe's biodiversity. N2000 is built upon two cornerstones, the Birds Directive, which lists 691 bird species (plus one additional bird genus with no further classification) and the Habitats Directive, which lists next to a variety of species, 233 habitat types to be protected. There is evidence of the positive impact of the Directives on the EU 's biodiversity, although the overall improvement reported for species in favourable condition in the last assessment was low. However, most of the assessments are species focused, while habitats have received very little attention. Here we developed a generic workflow, which we exemplified for Germany, to assess the status of habitat coverage within the N2000 network combining information from publicly available data sources. Applying the workflow allows identification of gaps in habitat protection, followed by the prioritization of potential areas of high protection value using the conservation planning software Marxan. We found that, in Germany, N2000 covers all target habitats. However, common habitats were proportionally underrepresented relative to rare ones, which contrasts with studies focussing on the representation of species. Moreover, the German case study suggests that especially highly protected areas (i.e. covered by more than 90% with N2000 sites) build an excellent basis towards a cost-effective and efficient conservation network. Our workflow provides a generic approach to deal with the common problem of missing habitat distribution data outside of N2000 sites, information which is however crucial for managers to plan conservation actions appropriately across Europe. To avoid a biased representation of habitat types within N2000, our results underpin the importance of defining qualitative and quantitative conservation targets which will allow assesment of the trajectory of habitat protection in Europe as well as adjustment of the network accordingly-a future necessity in the light of climate change.	[Friedrichs, Martin; Bremerich, Vanessa; Langhans, Simone D.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Friedrichs, Martin] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hermoso, Virgilio] Ctr Tecnol Forestal Catalunya CEMFOR CTFC, Solsona, Lleida, Spain; [Langhans, Simone D.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Langhans, Simone D.] BC3 Basque Ctr Climate Change, Leioa, Spain	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Centre Tecnologic Forestal de Catalunya (CTFC); University of Otago; Basque Centre for Climate Change (BC3)	Friedrichs, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.; Friedrichs, M (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	friedrichs@igb-berlin.de	Langhans, Simone D/A-5314-2019; Hermoso, Virgilio/H-8276-2015	Hermoso, Virgilio/0000-0003-3205-5033; Friedrichs-Manthey, Martin/0000-0002-0132-7799	European Union's Horizon 2020 research and innovation programme [642317]; European Union's Horizon 2020 research and innovation programme [Marie Sklodowska-Curie] [748625]; German Federal Ministry of Education and Research [01LN1320A]; Ramon y Cajal contract - Spanish Ministry for Economy and Competitiveness [RYC-2013-13979]	European Union's Horizon 2020 research and innovation programme; European Union's Horizon 2020 research and innovation programme [Marie Sklodowska-Curie]; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ramon y Cajal contract - Spanish Ministry for Economy and Competitiveness	This work was supported by the European Union's Horizon 2020 research and innovation programme [grant number 642317 and the Marie Sklodowska-Curie grant number 748625], by the German Federal Ministry of Education and Research [grant number 01LN1320A], and by a Ramon y Cajal contract funded by the Spanish Ministry for Economy and Competitiveness [VH; grant number RYC-2013-13979]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Unions Horizon 2020 research and innovation programme [grant number 642317 and the Marie Sklodowska-Curie grant number 748625], by the German Federal Ministry of Education and Research [grant number 01LN1320A], and by a Ramon y Cajal contract funded by the Spanish Ministry for Economy and Competitiveness [VH; grant number RYC-2013-13979]. We thank Dr. A. Bonn, Y. V. Bhatnagar and one anonymous reviewer for helpful comments that significantly improved an earlier version of the manuscript. We thank Chris Livesey for proof reading and Dr. Bi-Song Yuefor handling our manuscript.	Abellan MD, 2011, ENVIRON MANAGE, V47, P983, DOI 10.1007/s00267-011-9640-5; Asaad I, 2017, BIOL CONSERV, V213, P309, DOI 10.1016/j.biocon.2016.10.007; Barnes M, 2015, NATURE, V526, P195, DOI 10.1038/526195e; Barnes MD, 2018, NAT ECOL EVOL, V2, P759, DOI 10.1038/s41559-018-0501-y; Berry P., 2016, MAPPING ASSESSING CO, V3rd ed.; BfN, 2018, FLIESSG PLAN BIS MON; Biro M, 2018, CONSERV BIOL, V32, P660, DOI 10.1111/cobi.13038; Bunce RGH, 2013, ECOL INDIC, V33, P19, DOI 10.1016/j.ecolind.2012.07.014; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Conference of the Parties, 2010, STRAT PLAN BIOD 2011; Davis M, 2014, EUROPEAN TOPIC CTR B, P5; Silva VDE, 2014, BIOL CONSERV, V180, P1, DOI 10.1016/j.biocon.2014.09.016; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dimitrakopoulos PG, 2004, GLOBAL ECOL BIOGEOGR, V13, P199, DOI 10.1111/j.1466-822X.2004.00086.x; Dimopoulos Panayotis, 2006, Biology and Environment, V106B, P175, DOI 10.3318/BIOE.2006.106.3.175; Ducarme Frederic, 2013, BIOSCIENCES MASTER R, P1, DOI DOI 10.1080/08927936.2015.1052279; EU, 2011, COM20110244 EU; European Commission, 2015, REP COMM EUR PARL CO, P2; European Commission, 2016, NAT 2000 BAR; European Commission, 2016, NAT 2000 NUTSH 2016; European Environment Agency, 2016, NAT 2000 DAT EUR NET; European Environment Agency, 2016, EUNIS HAB TYP 2016; European Environment Agency, 2015, STAT NAT EU RES REP; European Environment Agency, 2018, CROSSW EUNIS 2007 AN; Evans Doug, 2006, Biology and Environment, V106B, P167, DOI 10.3318/BIOE.2006.106.3.167; Gruber B, 2012, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.3.3732; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hermoso V, 2017, CONSERV LETT, V10, P231, DOI 10.1111/conl.12248; Hermoso V, 2015, FRESHWATER BIOL, V60, P698, DOI 10.1111/fwb.12519; Hermoso V, 2012, BIOL CONSERV, V147, P52, DOI 10.1016/j.biocon.2012.01.020; Hochkirch A, 2013, CONSERV LETT, V6, P462, DOI 10.1111/conl.12006; Hodge I, 2015, CONSERV BIOL, V29, P996, DOI 10.1111/cobi.12531; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; IUCN, 2017, IUCN RED LIST THREAT; IUCN, 2017, NEW RED LIST REV EUR; Juffe-Bignoli D, 2016, AQUAT CONSERV, V26, P133, DOI 10.1002/aqc.2638; Kukkala AS, 2016, BIOL CONSERV, V198, P193, DOI 10.1016/j.biocon.2016.04.016; Lawton J H., 2010, MAKING SPACE NATURE; Lison F, 2013, ANIM CONSERV, V16, P528, DOI 10.1111/acv.12025; Lison F, 2015, BIODIVERS CONSERV, V24, P2459, DOI 10.1007/s10531-015-0937-1; Maiorano L, 2015, CONSERV BIOL, V29, P986, DOI 10.1111/cobi.12535; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin-Lopez B, 2009, BIOL CONSERV, V142, P1370, DOI 10.1016/j.biocon.2009.01.030; Mikkonen N, 2013, ENVIRON SCI POLICY, V27, P11, DOI 10.1016/j.envsci.2012.10.022; Miklin J, 2014, J NAT CONSERV, V22, P35, DOI 10.1016/j.jnc.2013.08.002; Mucher CA, 2009, LANDSCAPE URBAN PLAN, V92, P148, DOI 10.1016/j.landurbplan.2009.04.003; Muller A, 2018, BIOL CONSERV, V227, P292, DOI 10.1016/j.biocon.2018.09.024; Orchids, 2016, KOORDINATENERMITTLER; Pellissier V, 2013, ANIM CONSERV, V16, P566, DOI 10.1111/acv.12030; Popescu VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113648; Porensky LM, 2013, CONSERV BIOL, V27, P509, DOI 10.1111/cobi.12042; Pott R., 1992, PFLANZENGESELLSCHAFT; Rosati L, 2008, COMMUNITY ECOL, V9, P147, DOI 10.1556/ComEc.9.2008.2.3; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Struebig MJ, 2015, CURR BIOL, V25, P372, DOI 10.1016/j.cub.2014.11.067; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TROCHET A, 2013, NAT CONSERV CRACOW, V4, P35, DOI DOI 10.3897/NATUREC0NSERVATI0N.4.3626; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Watts M., 2009, MARXAN RELATIVES SOF; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	67	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208264	10.1371/journal.pone.0208264	http://dx.doi.org/10.1371/journal.pone.0208264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566452	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300033
J	Huang, MH; Blackwood, J; Godoshian, M; Pfalzer, L				Huang, Min H.; Blackwood, Jennifer; Godoshian, Monica; Pfalzer, Lucinda			Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; GERIATRIC ASSESSMENT; FUNCTIONAL LIMITATIONS; PHYSICAL FUNCTION; FOLLOW-UP; ADULTS; PREVALENCE; POPULATION; WOMEN	Background Cancer and its treatment affect body systems that are important in preventing falls and controlling balance/walking. This study examined factors associated with self-reported falls and balance/walking difficulty in the past 12 months in older survivors of four major cancers. Methods This was a cross-sectional study analyzing population-based data from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey (SEER-MHOS). Data from cohorts 9 to 14 (January 2006 to December 2013) were extracted. Inclusion criteria were: age >= 65 years at cancer diagnosis, first MHOS completed during years 1-5 post-cancer diagnosis, first primary breast (n = 2725), colorectal (n = 1646), lung (n = 752), and prostate (n = 4245) cancer, and availability of cancer staging information. Primary outcomes were self-reported falls and balance/walking difficulty in the past 12 months. Multivariable logistic regression was constructed for each cancer type to examine independent factors associated with falls and balance/walking difficulty. Results In all cancer types, advancing age at cancer diagnosis and dependence in activities of daily living were significant independent factors associated with increased odds of reporting falls and balance/walking difficulty in the past 12 months. Additionally, depression was independently associated with falls and sensory impairment in feet was independently linked to balance/walking difficulty in all cancer types. Other independent factors of falls and balance/ walking difficulty varied across cancer types. In breast cancer only, localized or regional cancer stage was significantly associated with increased odds of reporting falls and balance/ walking difficulty, whereas treatment with radiation decreased the odds of falling. No association between falls and balance/walking difficulty with time since cancer diagnosis, cancer stage, or cancer treatment was found in colorectal, lung, and prostate cancer. Conclusion There exists some heterogeneity in factors associated with self-reported falls and balance/walking difficulty between different cancer types. Future research is necessary to ascertain factors predictive of falls and balance/walking difficulty in older cancer survivors, particularly factors related to cancer diagnosis and treatment.	[Huang, Min H.; Blackwood, Jennifer; Pfalzer, Lucinda] Univ Michigan, Phys Therapy Dept, Coll Hlth Sci, Flint, MI 48503 USA; [Godoshian, Monica] Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan Flint; University of Michigan System; University of Michigan	Huang, MH (corresponding author), Univ Michigan, Phys Therapy Dept, Coll Hlth Sci, Flint, MI 48503 USA.	mhhuang@umich.edu	Huang, Min-Hui/AAD-5791-2021	Huang, Min-Hui/0000-0003-1760-0072; Blackwood PT, PhD, GCS, Jennifer/0000-0003-1514-2186	University of Michigan-Flint Office of Research & Sponsored Programs and Physical Therapy Department	University of Michigan-Flint Office of Research & Sponsored Programs and Physical Therapy Department	University of Michigan-Flint Office of Research & Sponsored Programs and Physical Therapy Department funded this project.	Alibhai SMH, 2015, CANCER-AM CANCER SOC, V121, P2350, DOI 10.1002/cncr.29355; Ambs A, 2008, HEALTH CARE FINANC R, V29, P5; Anstey KJ, 2008, J GERONTOL B-PSYCHOL, V63, pP249, DOI 10.1093/geronb/63.4.P249; Antonio M, 2017, ONCOLOGIST, V22, P934, DOI 10.1634/theoncologist.2016-0462; Bolbecker AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019824; Brown JC, 2015, BRIT J CANCER, V112, P194, DOI 10.1038/bjc.2014.568; Bylow K, 2008, UROLOGY, V72, P422, DOI 10.1016/j.urology.2008.03.032; Capone LJ, 2012, ONCOL NURS FORUM, V39, pE407, DOI 10.1188/12.ONF.E407-E415; Chang L, 2018, J GERIATR ONCOL; Chen TY, 2014, SUPPORT CARE CANCER, V22, P479, DOI 10.1007/s00520-013-2000-7; Cheville AL, 2009, SUPPORT CARE CANCER, V17, P61, DOI 10.1007/s00520-008-0461-x; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Deschamps T, 2015, GAIT POSTURE, V42, P590, DOI 10.1016/j.gaitpost.2015.07.057; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Enewold L, 2018, CANCER CAUSE CONTROL, V29, P657, DOI 10.1007/s10552-018-1045-9; Forbat L, 2014, SUPPORT CARE CANCER, V22, P409, DOI 10.1007/s00520-013-1989-y; Freiberger E, 2011, EUR REV AGING PHYS A, V8, P105, DOI 10.1007/s11556-011-0078-9; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Gale CR, 2016, AGE AGEING, V45, P789, DOI 10.1093/ageing/afw129; Gerbershagen HJ, 2008, EUR J PAIN, V12, P339, DOI 10.1016/j.ejpain.2007.07.006; Giordano SH, 2005, J CLIN ONCOL, V23, P783, DOI 10.1200/JCO.2005.04.175; Guerard EJ, 2015, J ONCOL PRACT, V11, P470, DOI 10.1200/JOP.2014.003517; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Huang MH, 2017, J GERIATR ONCOL, V8, P255, DOI 10.1016/j.jgo.2017.05.008; Huang MH, 2015, CLIN INTERV AGING, V10, P1497, DOI 10.2147/CIA.S89067; Hurria A, 2007, J AM GERIATR SOC, V55, P1604, DOI 10.1111/j.1532-5415.2007.01367.x; Keating NL, 2009, MED CARE, V47, P765, DOI 10.1097/MLR.0b013e31819e1fe7; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kent EE, 2015, CANCER-AM CANCER SOC, V121, P758, DOI 10.1002/cncr.29119; Kenzik KM, 2016, J CANCER SURVIV, V10, P1096, DOI 10.1007/s11764-016-0553-4; Kuriya M, 2015, PALLIAT SUPPORT CARE, V13, P223, DOI 10.1017/S1478951513001181; Leach CR, 2016, CANCER-AM CANCER SOC, V122, P1946, DOI 10.1002/cncr.29914; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lyons KD, 2017, ARCH PHYS MED REHAB, V98, P904, DOI 10.1016/j.apmr.2016.11.015; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Michaelson MD, 2008, CA-CANCER J CLIN, V58, P196, DOI 10.3322/CA.2008.0002; Mohile SG, 2011, J CLIN ONCOL, V29, P1458, DOI 10.1200/JCO.2010.31.6695; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Ng CG, 2013, PSYCHO-ONCOLOGY, V22, P762, DOI 10.1002/pon.3056; Overcash JA, 2008, CLIN J ONCOL NURS, V12, P941, DOI 10.1188/08.CJON.941-949; Pandya C, 2016, J GERIATR ONCOL, V7, P201, DOI 10.1016/j.jgo.2016.01.007; Quach L, 2011, J AM GERIATR SOC, V59, P1069, DOI 10.1111/j.1532-5415.2011.03408.x; Rao AV, 2006, CRIT REV ONCOL HEMAT, V60, P131, DOI 10.1016/j.critrevonc.2006.06.003; Riley G, 2000, Health Serv Res, V35, P44; Sattar S, 2016, SUPPORT CARE CANCER, V24, P4459, DOI 10.1007/s00520-016-3342-8; Sbarra DA, 2009, PSYCHOSOM MED, V71, P828, DOI 10.1097/PSY.0b013e3181b4c4f2; Schlairet MC, 2012, J CANCER EDUC, V27, P21, DOI 10.1007/s13187-011-0279-y; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Schootman M, 2009, CANCER-AM CANCER SOC, V115, P5329, DOI 10.1002/cncr.24606; Sheppard KD, 2013, J AGING HEALTH, V25, P907, DOI 10.1177/0898264313497507; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Spoelstra S, 2010, CANCER NURS, V33, P149, DOI 10.1097/NCC.0b013e3181bbbe8a; Spoelstra Sandra L, 2013, Oncol Nurs Forum, V40, pE69, DOI 10.1188/13.ONF.E69-E78; Stenhagen M, 2014, CLIN INTERV AGING, V9, P1839, DOI 10.2147/CIA.S70075; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Stevens JA, 2012, AM J PREV MED, V43, P59, DOI 10.1016/j.amepre.2012.03.008; Stone CA, 2012, J CLIN ONCOL, V30, P2128, DOI 10.1200/JCO.2011.40.7791; Stout NL, 2016, ARCH PHYS MED REHAB, V97, P2006, DOI 10.1016/j.apmr.2016.05.002; Sweeney C, 2006, JNCI-J NATL CANCER I, V98, P521, DOI 10.1093/jnci/djj130; Timar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154654; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tofthagen C, 2012, SUPPORT CARE CANCER, V20, P583, DOI 10.1007/s00520-011-1127-7; Walle NV, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-135; Walsh ME, 2016, J EPIDEMIOL COMMUN H, V70, P513, DOI 10.1136/jech-2015-206475; Wampler MA, 2007, ARCH PHYS MED REHAB, V88, P1002, DOI 10.1016/j.apmr.2007.05.007; Ward PR, 2014, J GERIATR ONCOL, V5, P57, DOI 10.1016/j.jgo.2013.10.002; Welsch R, 1980, REGRESSION DIAGNOSTI; White AJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-377; Whittle AK, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12509; Wildes TM, 2015, J GERIATR ONCOL, V6, P70, DOI 10.1016/j.jgo.2014.10.003; Williams GR, 2015, SUPPORT CARE CANCER, V23, P2273, DOI 10.1007/s00520-014-2598-0; Winters-Stone KM, 2011, ARCH PHYS MED REHAB, V92, P646, DOI 10.1016/j.apmr.2010.10.039; Wo J, 2007, INT J RADIAT ONCOL, V69, P1347, DOI 10.1016/j.ijrobp.2007.07.2357; Yokomoto-Umakoshi M, 2017, ENDOCR J, V64, P727, DOI 10.1507/endocrj.EJ17-0011	77	17	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208573	10.1371/journal.pone.0208573	http://dx.doi.org/10.1371/journal.pone.0208573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566443	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300049
J	Zhang, L; Wu, LL; Si, YB; Shu, KH				Zhang, Li; Wu, Lingli; Si, Youbin; Shu, Kunhui			Size-dependent cytotoxicity of silver nanoparticles to Azotobacter vinelandii: Growth inhibition, cell injury, oxidative stress and internalization	PLOS ONE			English	Article							IN-VITRO; AQUEOUS ENVIRONMENT; INDUCED TOXICITY; ION RELEASE; NANOSILVER; APOPTOSIS; MEMBRANE; BACTERIA; MECHANISMS; GENERATION	The influence of nanomaterials on the ecological environment is becoming an increasingly hot research field, and many researchers are exploring the mechanisms of nanomaterial toxicity on microorganisms. Herein, we studied the effect of two different sizes of nanosilver (10 nm and 50 nm) on the soil nitrogen fixation by the model bacteria Azotobacter vinelandii. Smaller size AgNPs correlated with higher toxicity, which was evident from reduced cell numbers. Flow cytometry analysis further confirmed this finding, which was carried out with the same concentration of 10 mg/L for 12 h, the apoptotic rates were 20.23% and 3.14% for 10 nm and 50 nm AgNPs, respectively. Structural damage to cells were obvious under scanning electron microscopy. Nitrogenase activity and gene expression assays revealed that AgNPs could inhibit the nitrogen fixation of A. vinelandii. The presence of AgNPs caused intracellular reactive oxygen species (ROS) production and electron spin resonance further demonstrated that AgNPs generated hydroxyl radicals, and that AgNPs could cause oxidative damage to bacteria. A combination of Ag content distribution assays and transmission electron microscopy indicated that AgNPs were internalized in A. vinelandii cells. Overall, this study suggested that the toxicity of AgNPs was size and concentration dependent, and the mechanism of antibacterial effects was determined to involve damage to cell membranes and production of reactive oxygen species leading to enzyme inactivation, gene down-regulation and death by apoptosis.	[Zhang, Li; Wu, Lingli; Si, Youbin; Shu, Kunhui] Anhui Agr Univ, Anhui Prov Key Lab Farmland Ecol Conservat & Poll, Sch Resources & Environm, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Si, YB (corresponding author), Anhui Agr Univ, Anhui Prov Key Lab Farmland Ecol Conservat & Poll, Sch Resources & Environm, Hefei, Anhui, Peoples R China.	youbinsi@ahau.edu.cn			National Natural Science Foundation of China [41430752, 41471405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this study was provided by the National Natural Science Foundation of China [grant numbers 41430752, 41471405]. Youbin Si was the funding recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla MH, 2016, AGR ECOSYST ENVIRON, V218, P163, DOI 10.1016/j.agee.2015.11.022; Ahmed B, 2018, ADV POWDER TECHNOL, V29, P1601, DOI 10.1016/j.apt.2018.03.025; Ahmed KBR, 2017, TOXICOL IN VITRO, V38, P179, DOI 10.1016/j.tiv.2016.10.012; Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Bao L, 2015, PLOS ONE, V10; Basu S, 2008, J COLLOID INTERF SCI, V321, P288, DOI 10.1016/j.jcis.2008.02.015; Beddow J, 2014, ENV MICROBIOL REP, V6, P448, DOI 10.1111/1758-2229.12147; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bouallegui Y, 2018, DRUG CHEM TOXICOL, V41, P169, DOI 10.1080/01480545.2017.1329317; Braydich-Stolle LK, 2010, TOXICOL SCI, V116, P577, DOI 10.1093/toxsci/kfq148; Bryaskova Rayna, 2011, J Chem Biol, V4, P185, DOI 10.1007/s12154-011-0063-9; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chen Y, 2004, TOXICOL IND HEALTH, V20, P21, DOI 10.1191/0748233704th190oa; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Choi Y, 2018, J ENVIRON SCI, V66, P50, DOI 10.1016/j.jes.2017.04.028; Das B, 2017, ARAB J CHEM, V10, P862, DOI 10.1016/j.arabjc.2015.08.008; De Matteis V, 2015, NANOMED-NANOTECHNOL, V11, P731, DOI 10.1016/j.nano.2014.11.002; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Duran N, 2016, NANOMED-NANOTECHNOL, V12, P789, DOI 10.1016/j.nano.2015.11.016; Ellegaard-Jensen L, 2012, ECOTOX ENVIRON SAFE, V80, P216, DOI 10.1016/j.ecoenv.2012.03.003; Ema M, 2017, REPROD TOXICOL, V67, P149, DOI 10.1016/j.reprotox.2017.01.005; Farah MA, 2016, COLLOID SURFACE B, V141, P158, DOI 10.1016/j.colsurfb.2016.01.027; Gambino M, 2015, J APPL MICROBIOL, V118, P1103, DOI 10.1111/jam.12779; Geyik AG, 2016, BIORESOURCE TECHNOL, V211, P691, DOI 10.1016/j.biortech.2016.03.157; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Gopinath V, 2016, RSC ADV, V6, P110986, DOI 10.1039/c6ra13871c; Guan YD, 2017, PEDOSPHERE, V27, P42, DOI 10.1016/S1002-0160(17)60295-9; Gurunathan S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082269; Hakami O, 2015, ENVIRON SCI POLLUT R, V22, P3257, DOI 10.1007/s11356-014-3085-3; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Han SO, 1998, MICROB ECOL, V36, P193, DOI 10.1007/s002489900106; Haukka K, 1998, APPL ENVIRON MICROB, V64, P419; He WW, 2012, BIOMATERIALS, V33, P7547, DOI 10.1016/j.biomaterials.2012.06.076; Homaee MB, 2016, HORTIC ENVIRON BIOTE, V57, P544, DOI 10.1007/s13580-016-0083-z; Hou J, 2016, ECOTOX ENVIRON SAFE, V133, P10, DOI 10.1016/j.ecoenv.2016.06.014; Hunt PR, 2014, TOXICOL REP, V1, P923, DOI 10.1016/j.toxrep.2014.10.020; Kaiser JP, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-016-0244-3; Katsumiti A, 2018, TOXICOL IN VITRO, V48, P146, DOI 10.1016/j.tiv.2018.01.013; Kim S, 2013, J APPL TOXICOL, V33, P78, DOI 10.1002/jat.2792; Li M, 2014, J FOOD DRUG ANAL, V22, P76, DOI 10.1016/j.jfda.2014.01.006; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li Y, 2017, ARCH TOXICOL, V91, P509, DOI 10.1007/s00204-016-1730-y; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Long YM, 2017, INT J NANOMED, V12, P3193, DOI 10.2147/IJN.S132327; Michels C, 2017, SCI TOTAL ENVIRON, V586, P995, DOI 10.1016/j.scitotenv.2017.02.080; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Giao NT, 2017, ENVIRON SCI POLLUT R, V24, P9229, DOI 10.1007/s11356-017-8561-0; Orlowski P, 2018, INT J NANOMED, V13, P991, DOI 10.2147/IJN.S154797; Pajares S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01045; Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010; PUNITA SJ, 1989, J BACTERIOL, V171, P3133, DOI 10.1128/jb.171.6.3133-3138.1989; Quinteros MA, 2018, INT J BIOCHEM CELL B, V104, P87, DOI 10.1016/j.biocel.2018.09.006; Reyes VC, 2015, ENVIRON TOXICOL CHEM, V34, P887, DOI 10.1002/etc.2867; Seong M, 2017, CURR MICROBIOL, V74, P661, DOI 10.1007/s00284-017-1235-9; Shi TY, 2018, CURR PROTEIN PEPT SC, V19, P525, DOI 10.2174/1389203718666161108092149; Singh RP, 2012, TOXICOL LETT, V213, P249, DOI 10.1016/j.toxlet.2012.07.009; Tang B, 2011, J COLLOID INTERF SCI, V356, P513, DOI 10.1016/j.jcis.2011.01.054; Verma SK, 2017, RSC ADV, V7, P40034, DOI 10.1039/c7ra05943d; Vrcek IV, 2016, ENVIRON TOXICOL, V31, P679, DOI 10.1002/tox.22081; Wahab R, 2016, RSC ADV, V6, P26111, DOI 10.1039/c5ra25668b; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang EY, 2017, ENVIRON TOXICOL PHAR, V52, P193, DOI 10.1016/j.etap.2017.04.010; Wang LL, 2010, J HAZARD MATER, V177, P1134, DOI 10.1016/j.jhazmat.2009.12.001; Xia B, 2015, SCI TOTAL ENVIRON, V508, P525, DOI 10.1016/j.scitotenv.2014.11.066; Yu Z, 2018, ECOTOX ENVIRON SAFE, V156, P75, DOI 10.1016/j.ecoenv.2018.03.007; Yuan ZH, 2013, CHEMOSPHERE, V90, P1404, DOI 10.1016/j.chemosphere.2012.08.032; Yun J, 2018, BBA-BIOMEMBRANES, V1860, P357, DOI 10.1016/j.bbamem.2017.11.008; Zapor L, 2016, ARCH ENVIRON PROT, V42, P32, DOI 10.1515/aep-2016-0038; Zarate-Cruz GS, 2016, AGROCIENCIA-MEXICO, V50, P677; Zhang CQ, 2016, WATER RES, V88, P403, DOI 10.1016/j.watres.2015.10.025; Zhang TL, 2014, YONSEI MED J, V55, P283, DOI 10.3349/ymj.2014.55.2.283; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375	73	55	57	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0209020	10.1371/journal.pone.0209020	http://dx.doi.org/10.1371/journal.pone.0209020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566461	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300065
J	Barnes, CL; Beaudreau, AH; Hunsicker, ME; Ciannelli, L				Barnes, Cheryl L.; Beaudreau, Anne H.; Hunsicker, Mary E.; Ciannelli, Lorenzo			Assessing the potential for competition between Pacific Halibut (Hippoglossus stenolepis) and Arrowtooth Flounder (Atheresthes stomias) in the Gulf of Alaska	PLOS ONE			English	Article							FISH COMMUNITY; CLIMATE-CHANGE; NORTH PACIFIC; SIZE; FOOD; RECRUITMENT; CHALLENGES; EVERMANNI; ABUNDANCE; OVERLAP	Pacific Halibut (Hippoglossus stenolepis) support culturally and economically important fisheries in the Gulf of Alaska, though recent decreases in mean size-at-age have substantially reduced fishery yields, generating concerns among stakeholders and resource managers. Among the prevailing hypotheses for reduced size-at-age is intensified competition with Arrowtooth Flounder (Atheresthes stomias), a groundfish predator that exhibited nearly fivefold increases in biomass between the 1960s and mid-2010s. To assess the potential for competition between Pacific Halibut and Arrowtooth Flounder, we evaluated their degree of spatiotemporal and dietary overlap in the Gulf of Alaska using bottom trawl survey and food habits data provided by the Alaska Fisheries Science Center (NOAA; 1990 to 2017). We restricted analyses to fish measuring 30 to 69 cm fork length and used a delta modeling approach to quantify species-specific presence-absence and catch-per-unit-effort as a function of survey year, tow location, depth, and bottom temperature. We then calculated an index of spatial overlap across a uniform grid by multiplying standardized predictions of species' abundance. Dietary overlap was calculated across the same uniform grid using Schoener's similarity index. Finally, we assessed the relationship between spatial and dietary overlap as a measure of resource partitioning. We found increases in spatial overlap, moving from east to west in the Gulf of Alaska (eastern: 0.13 +/- 0.20; central: 0.21 +/- 0.11; western: 0.31 +/- 0.13 SD). Dietary overlap was low throughout the study area (0.13 +/- 0.20 SD). There was no correlation between spatial and dietary overlap, suggesting an absence of resource partitioning along the niche dimensions examined. This finding provides little indication that competition with Arrowtooth Flounder was responsible for changes in Pacific Halibut alHHsize-at-age in the Gulf of Alaska; however, it does not rule out competitive interactions that may have affected resource use prior to standardized data collection or at different spatiotemporal scales.	[Barnes, Cheryl L.; Beaudreau, Anne H.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA; [Hunsicker, Mary E.] NOAA, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Newport, OR USA; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Alaska System; University of Alaska Fairbanks; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Barnes, CL (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA.	cheryl.barnes@alaska.edu		Barnes, Cheryl L./0000-0002-2650-5299	Pollock Conservation Cooperative Research Center [G00009488]; Rasmuson Fisheries Research Center	Pollock Conservation Cooperative Research Center; Rasmuson Fisheries Research Center	This study was funded by the Pollock Conservation Cooperative Research Center (https://www.pccrc.org/), grant G00009488 (AB). Additional support was provided by the Rasmuson Fisheries Research Center (https://www.uaf.edu/cfos/research/major-research-programs/rasmuson-fisheries-resear/) in the form of a graduate student fellowship (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r All data were provided by the Alaska Fisheries Science Center (AFSC), National Oceanic and Atmospheric Association. The AFSC's Resource Assessment and Conservation Engineering (RACE) division conducted all bottom trawl surveys and the AFSC's Resource Ecology and Ecosystem Modeling (REEM) program and Food Habits lab collected and maintained all diet data. Our gratitude goes to Wayne Palsson and Kirstin Holsman for querying data and providing guidance regarding the use of these databases. We also appreciate analytical recommendations provided by Franz Mueter and Jordan Watson. This manuscript was improved upon by reviews from Brian Burke, Martin Dorn, Masami Fujiwara, Kirstin Holsman, Terrance Quinn, Ian Stewart, and one anonymous reviewer. Funding was provided by the Pollock Conservation Cooperative Research Center (G00009488) and through graduate student fellowships from the Rasmuson Fisheries Research Center. University of Alaska Fairbanks and University of Alaska Southeast (Sitka campus) provided facilities and other logistical support.	ABRAMS P, 1980, ECOLOGY, V61, P44, DOI 10.2307/1937153; Best EA, 1986, PACIFIC HALIBUT PRED; Bigler BS, 1996, CAN J FISH AQUAT SCI, V53, P455, DOI 10.1139/cjfas-53-2-455; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bivand RS, 2008, USE R, P1; Bowen Stephen H., 1996, P513; Breheny P, 2017, R J, V9, P56, DOI 10.32614/RJ-2017-046; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cadrin S.X., 2009, FUTURE FISHERIES SCI; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Chipps Steven R., 2007, P473; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Clark WG, 1999, CAN J FISH AQUAT SCI, V56, P242, DOI 10.1139/cjfas-56-2-242; Clark WG, 2002, N AM J FISH MANAGE, V22, P852, DOI 10.1577/1548-8675(2002)022<0852:EOCASS>2.0.CO;2; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; CROSSMAN E. J., 1959, TRANS AMER FISH SOC, V88, P36, DOI 10.1577/1548-8659(1959)88[36:YLACOF]2.0.CO;2; DAYTON PK, 1973, AM NAT, V107, P662, DOI 10.1086/282865; DIAMOND JM, 1978, AM SCI, V66, P322; Garrison LP, 2000, ICES J MAR SCI, V57, P723, DOI 10.1006/jmsc.2000.0713; Gotelli N.J., 1996, NULL MODELS ECOLOGY, P65; HANSON JM, 1985, CAN J FISH AQUAT SCI, V42, P280, DOI 10.1139/f85-035; Hare SR, 2007, ANN M HAND, P79; Hicks AC, 2018, W GROUNDF C 2018 FEB; Holsman KK, 2019, FISH OCEANOGR, V28, P345, DOI 10.1111/fog.12416; Holsman KK, 2015, MAR ECOL PROG SER, V521, P217, DOI 10.3354/meps11102; Hunsicker ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066025; Hunsicker ME, 2010, MAR ECOL PROG SER, V415, P91, DOI 10.3354/meps08750; Jennings S, 2002, MAR ECOL PROG SER, V226, P77, DOI 10.3354/meps226077; JOHANNES R. E., 1961, JOUR FISH RES BD CANADA, V18, P203; Kendall NW, 2012, ECOL APPL, V22, P804, DOI 10.1890/11-1189.1; Kong TM, 2004, 49 INT PAC HAL COMM; Larkin PA, 1954, T AM FISH SOC, V83, P161, DOI DOI 10.1577/1548-8659(1953)83%5B161:SEOIOT%5D2.0.CO;2; LARSON RJ, 1980, ECOL MONOGR, V50, P221, DOI 10.2307/1942480; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Link JS, 2013, B MAR SCI, V89, P213, DOI 10.5343/bms.2011.1121; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Livingston PA, 2017, ENVIRON BIOL FISH, V100, P443, DOI 10.1007/s10641-017-0587-0; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; Loher T., 2013, INT PAC HALIBUT COMM, V2012, P457; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Martell S. J. D., 2013, INT PAC HALIBUT COMM, V2012, P207; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; MAY RM, 1974, THEOR POPUL BIOL, V5, P297, DOI 10.1016/0040-5809(74)90055-0; Morita K, 2007, MAR ECOL PROG SER, V335, P289, DOI 10.3354/meps335289; Mueter FJ, 2002, FISH B-NOAA, V100, P559; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; NMFS, 2014, STAT REV SE AL HERR; Oksanen J., 2019, R PACKAGE VERSION; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Ono K, 2016, ECOL APPL, V26, P392, DOI 10.1890/14-1874; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Planas J., 2018, IPHC2018RAB01909; Quinn T.J., 1999, BIOL RES MANAG SER; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shelton AO, 2014, CAN J FISH AQUAT SCI, V71, P1655, DOI 10.1139/cjfas-2013-0508; Shelton AO, 2017, ICES J MAR SCI, DOI [10.1093/icesjms/fsx225, DOI 10.1093/ICESJMS/FSX225]; Shotwell K, 2018, W GROUNDF C 2018 FEB; SLOBODCHIKOFF CN, 1980, ECOLOGY, V61, P1051, DOI 10.2307/1936823; Spencer PD, 2016, ICES J MAR SCI, V73, P1330, DOI 10.1093/icesjms/fsw040; Spies I, 2017, STOCK ASSESSMENT FIS; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Stewart IJ, 2017, IPHC2018AM09410; Stewart IJ, 2017, IPHC2017IM09312; Sullivan JY, 2016, THESIS U ALASKA FAIR; Thompson W. F., 1930, HIST PACIFIC HALIBUT; von Szalay P.G., 2016, NOAA TECHNICAL MEMOR; Waite JN, 2013, PROG OCEANOGR, V116, P179, DOI 10.1016/j.pocean.2013.07.006; Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x; Ward EJ, 2015, ECOL APPL, V25, P2198, DOI 10.1890/15-0051.1.sm; Webster RA, 2013, CAN J FISH AQUAT SCI, V70, P642, DOI 10.1139/cjfas-2012-0371; Webster SR, 2014, THESIS; WIENS JA, 1977, AM SCI, V65, P590; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yang M-S, 1999, FOOD HABITS COMMERCI; Yang Mei-Sun, 1995, Alaska Sea Grant Report, V95-04, P205; YANG MS, 1986, FISH B-NOAA, V84, P615; Zador S, 2011, MAR ECOL PROG SER, V438, P229, DOI 10.3354/meps09316; Zimmermann M, 1996, FISH B-NOAA, V94, P358; [No title captured]	84	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209402	10.1371/journal.pone.0209402	http://dx.doi.org/10.1371/journal.pone.0209402			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562389	Green Published, gold, Green Submitted			2022-12-26	WOS:000453774100053
J	Lorme, F; Maataoui, N; Rondinaud, E; Esposito-Farese, M; Clermont, O; Ruppe, E; Arlet, G; Genel, N; Matheron, S; Andremont, A; Armand-Lefevre, L				Lorme, Florian; Maataoui, Naouale; Rondinaud, Emilie; Esposito-Farese, Marina; Clermont, Olivier; Ruppe, Etienne; Arlet, Guillaume; Genel, Nathalie; Matheron, Sophie; Andremont, Antoine; Armand-Lefevre, Laurence		VOYAG-R Study Grp	Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics	PLOS ONE			English	Article							AMPC BETA-LACTAMASES; MULTIDRUG-RESISTANT ENTEROBACTERIACEAE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; GENES; PREVALENCE; COMMUNITY; COLONIZATION; CARRIAGE; TRENDS	Travelers are at high risk of acquiring multi-drug resistant Enterobacteriaceae (MRE) while traveling abroad. Acquisition of extended spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) while traveling has been extensively described, but not that of plasmid-mediated cephalosporinase producing Enterobacteriaceae (pAmpC-E). Here, we characterized the pAmpC-E acquired in 574 French travelers to tropical areas enrolled in the VOYAG-R study. Among the 526 MRE isolated at return, 57 (10.8%) from 49 travelers were pAmpC-E. The acquisition rate of pAmpC-E was 8.5% (49/574) ranging from 12.8% (25/195) in Asia, 7.6% (14/184) in Latin America to 5.1% (10/195) in Africa. The highest acquisition rates were observed in Peru (21.9%), India (21.4%) and Vietnam (20%). The carriage of pAmpC-E decreased quickly after return with 92.5% of colonized travelers being negative at one month. Most enzymes were CMY types (96.5%, n = 55, only met in Escherichia coli), including 40 CMY-2 (70.2%), 12 CMY-42 (21.1%), 1 CMY-6 and two new CMY-2 variants. The remaining were two DHA observed in Klebsiella pneumoniae. CMY-2 producing strains were acquired worldwide whereas CMY-42, except for one, were all acquired in Asia. Bla(CMY-2) genes were associated with different plasmid types, including Incl1 (45.2%), IncF (10%), IncF-Incl (7.5%), IncA/C (5%) and IncR (2.5%) whereas bla(CMY-42) were all associated with Incl1 plasmids. Even though the pAmpC-E acquisition rate was much lower than that of ESBL-E, it was significant, especially in Asia, showing that pAmpC-E, especially CMY-type producing E. coli have spread in the community settings of tropical regions.	[Lorme, Florian; Maataoui, Naouale; Rondinaud, Emilie; Ruppe, Etienne; Andremont, Antoine; Armand-Lefevre, Laurence] Hop Bichat Claude Bernard, AP HP, Lab Bacteriol, Paris, France; [Maataoui, Naouale; Rondinaud, Emilie; Clermont, Olivier; Ruppe, Etienne; Matheron, Sophie; Andremont, Antoine; Armand-Lefevre, Laurence] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1137 France, INSERM,IAME, Paris, France; [Maataoui, Naouale; Rondinaud, Emilie; Esposito-Farese, Marina; Clermont, Olivier; Ruppe, Etienne; Matheron, Sophie; Andremont, Antoine; Armand-Lefevre, Laurence] Hop Bichat Claude Bernard, AP HP, URC Paris Nord, Paris, France; [Esposito-Farese, Marina] INSERM, CIC 1425 EC, UMR1123, Paris, France; [Arlet, Guillaume; Genel, Nathalie] Hop Univ Est Parisien, Grp Hosp, AP HP, Dept Bacteriol, Paris, France; [Arlet, Guillaume; Genel, Nathalie] INSERM U1135, CIMI, Team E13, Paris, France; [Arlet, Guillaume; Genel, Nathalie] UPMC Univ Paris, Sorbonne Univ, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Malad Infect & Trop, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Armand-Lefevre, L (corresponding author), Hop Bichat Claude Bernard, AP HP, Lab Bacteriol, Paris, France.; Armand-Lefevre, L (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, UMR 1137 France, INSERM,IAME, Paris, France.; Armand-Lefevre, L (corresponding author), Hop Bichat Claude Bernard, AP HP, URC Paris Nord, Paris, France.	laurence.armand@aphp.fr	Arlet, Guillaume/AAW-4918-2020; ARMAND-LEFEVRE, Laurence/A-4751-2018; RUPPE, ETIENNE/H-1073-2016; Arlet, Guillaume/P-2990-2017	ARMAND-LEFEVRE, Laurence/0000-0002-2013-3252; RUPPE, ETIENNE/0000-0001-5282-2178; 	Fondation pour la Recherche Medicale (Equipe FRM 2016) [DEQ20161136698]	Fondation pour la Recherche Medicale (Equipe FRM 2016)	This work was partially supported by a grant from the "Fondation pour la Recherche Medicale" (Equipe FRM 2016, grant number DEQ20161136698).	Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Bajaj P, 2015, SCI TOTAL ENVIRON, V505, P350, DOI 10.1016/j.scitotenv.2014.09.084; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Compain F, 2014, INT J MED MICROBIOL, V304, P236, DOI 10.1016/j.ijmm.2013.09.009; Rocha DAC, 2016, MICROB DRUG RESIST, V22, P321, DOI 10.1089/mdr.2015.0190; Ding H, 2008, EUR J CLIN MICROBIOL, V27, P915, DOI 10.1007/s10096-008-0532-4; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Harris PNA, 2018, J ANTIMICROB CHEMOTH, V73, P634, DOI 10.1093/jac/dkx466; Hassing RJ, 2015, EUROSURVEILLANCE, V20, P30, DOI 10.2807/1560-7917.ES.2015.20.47.30074; Helmy MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/171548; Hentschke M, 2011, MICROB DRUG RESIST, V17, P165, DOI 10.1089/mdr.2010.0137; Ingti B, 2018, J GLOB ANTIMICROB RE, V14, P78, DOI 10.1016/j.jgar.2018.02.021; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jean SS, 2017, J ANTIMICROB CHEMOTH, V72, P166, DOI 10.1093/jac/dkw398; Jorgensen SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173510; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Li Y, 2008, J CLIN MICROBIOL, V46, P1317, DOI 10.1128/JCM.00073-07; Mata C, 2012, J ANTIMICROB CHEMOTH, V67, P115, DOI 10.1093/jac/dkr412; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Oteo J, 2010, DIAGN MICR INFEC DIS, V67, P270, DOI 10.1016/j.diagmicrobio.2010.02.008; Pannaraj PS, 2015, PEDIATR INFECT DIS J, V34, P11, DOI 10.1097/INF.0000000000000471; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Pitart C, 2015, ANTIMICROB AGENTS CH, V59, P659, DOI 10.1128/AAC.04040-14; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Ruppe E, 2018, TRAVEL MED INFECT DI, V21, P28, DOI 10.1016/j.tmaid.2017.11.007; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Seiffert SN, 2013, J ANTIMICROB CHEMOTH, V68, P2249, DOI 10.1093/jac/dkt208; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Yoo JS, 2010, DIAGN MICR INFEC DIS, V67, P261, DOI 10.1016/j.diagmicrobio.2010.02.012; Zhang XQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-282	33	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0206909	10.1371/journal.pone.0206909	http://dx.doi.org/10.1371/journal.pone.0206909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562395	gold, Green Submitted, Green Published			2022-12-26	WOS:000453774100006
J	Hilton, B; Tempest-Mitchell, J; Davies, B; Kotter, M				Hilton, Bryn; Tempest-Mitchell, Jennifer; Davies, Benjamin; Kotter, Mark			Assessment of degenerative cervical myelopathy differs between specialists and may influence time to diagnosis and clinical outcomes	PLOS ONE			English	Article							QUALITY-OF-LIFE; SPONDYLOTIC MYELOPATHY; SURGICAL DECOMPRESSION; FUNCTIONAL OUTCOMES; PREDICTION RULE; NATURAL-HISTORY; SURGERY; NEUROPHOBIA; PREVALENCE; IMPROVE	Introduction Degenerative Cervical Myelopathy [DCM] often presents with non-specific symptoms and signs. It progresses insidiously and leads to permanent neurological dysfunction. Decompressive surgery can halt disease progression, however significant delays in diagnosis result in increased disability and limit recovery. The nature of early DCM symptoms is unknown, moreover it has been suggested incomplete examination contributes to missed diagnosis. This study examines how DCM is currently assessed, if assessment differs between stages of healthcare, and whether this influences patient management. Study design Retrospective cohort study. Methods Cervical MRI scans (N = 1123) at a tertiary neurosciences center, over a single year, were screened for patients with DCM (N = 43). Signs, symptoms, and disease severity of DCM were extracted from patient records. Patients were considered at 3 phases of clinical assessment: primary care, secondary care, and surgical assessment. Results Upper limb paraesthesia and urinary dysfunction were consistently the most and least prevalent symptoms respectively. Differences between assessing clinicians were present in the reporting of: limb pain (p<0.005), objective limb weakness (p=0.01), hyperreflexia (p<0.005), Hoffmann reflex (p<0.005), extensor plantar reflex (p=0.007), and lower limb spasticity (p<0.005). Pathological reflexes were least frequently assessed by primary care doctors. Conclusion DCM assessment varies significantly between assessors. Reporting of key features of DCM is especially low in primary care. Incomplete assessment may hinder early diagnosis and referral to spinal surgery.	[Hilton, Bryn; Tempest-Mitchell, Jennifer] Univ Cambridge, Sch Clin Med, Cambridge, England; [Davies, Benjamin; Kotter, Mark] Univ Cambridge, Acad Neurosurg Unit, Dept Clin Neurosurg, Cambridge, England	University of Cambridge; University of Cambridge	Kotter, M (corresponding author), Univ Cambridge, Acad Neurosurg Unit, Dept Clin Neurosurg, Cambridge, England.	mrk25@cam.ac.uk	Davies, Benjamin/AAB-6000-2019	Davies, Benjamin/0000-0003-0591-5069; Hilton, Bryn/0000-0001-9617-6753; Tempest-Mitchell, Jennifer/0000-0002-3990-140X	National Institute for Health Research [CS-2015-15-023]; Wellcome Trust; MRC; NIHR Clinician Scientist Award	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Clinician Scientist Award	MK is supported by National Institute for Health Research through the Clinician Scientist Award (CS-2015-15-023). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research in the senior author's laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. MRNK is supported by a NIHR Clinician Scientist Award.	Abulaban AA, 2015, NEUROSCIENCES, V20, P37; Behrbalk E, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.3.FOCUS1374; Chikuda H, 2010, EUR SPINE J, V19, P1684, DOI 10.1007/s00586-010-1364-3; Cook CE, 2011, J MANIP PHYSIOL THER, V34, P539, DOI 10.1016/j.jmpt.2011.08.008; Davies BM, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k186; Davies BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172564; Fehlings MG, 2017, GLOB SPINE J, V7, p70S, DOI 10.1177/2192568217701914; Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Houten JK, 2008, J NEUROSURG-SPINE, V9, P237, DOI 10.3171/SPI/2008/9/9/237; Kadanka Z, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.797; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Karpova A, 2014, SPINE, V39, P1488, DOI 10.1097/BRS.0000000000000436; King JT, 2003, NEUROSURGERY, V52, P113, DOI 10.1097/00006123-200301000-00014; Kovalova I, 2016, SPINE, V41, P1908, DOI 10.1097/BRS.0000000000001842; Matz PG, 2009, J NEUROSURG-SPINE, V11, P104, DOI 10.3171/2009.1.SPINE08716; McCarron MO, 2014, CLIN NEUROL NEUROSUR, V122, P124, DOI 10.1016/j.clineuro.2014.03.021; Micev AJ, 2013, J HAND SURG-AM, V38A, P2478, DOI 10.1016/j.jhsa.2013.07.020; National Institute for Health and Care Excellence,, 2013, FALLS OLDER PEOPLE A; National Institute for Health and Care Excellence, 2016, MOT NEUR DIS ASS MAN; Nemani VM, 2015, SPINE, V40, P6, DOI 10.1097/BRS.0000000000000659; Nicholl DJ, 2012, J ROY COLL PHYS EDIN, V42, P306, DOI 10.4997/JRCPE.2012.405; Nicholl DJ, 2015, J NEUROL NEUROSUR PS, V86, P229, DOI 10.1136/jnnp-2013-306881; Nouri A, 2015, SPINE, V40, P1092, DOI 10.1097/BRS.0000000000000919; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Oh T, 2017, WORLD NEUROSURG, V106, P699, DOI 10.1016/j.wneu.2016.12.124; Rhee JM, 2009, SPINE, V34, P890, DOI 10.1097/BRS.0b013e31819c944b; Tejus MN, 2015, CLIN NEUROL NEUROSUR, V134, P12, DOI 10.1016/j.clineuro.2015.04.009; Tetreault L, 2015, J BONE JOINT SURG AM, V97A, P2038, DOI 10.2106/JBJS.O.00189; Vilaca CD, 2016, NEUROL INT, V8, P69, DOI 10.4081/ni.2016.6330; Zhang JT, 2016, SPINAL CORD, V54, P1127, DOI 10.1038/sc.2016.64	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0207709	10.1371/journal.pone.0207709	http://dx.doi.org/10.1371/journal.pone.0207709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557368	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000013
J	Kim, DG; Choi, HY; Kim, HY; Lee, EJ; Huh, KH; Kim, MS; Nam, CM; Kim, BS; Kim, YS				Kim, Deok Gie; Choi, Hoon Young; Kim, Ha Yan; Lee, Eun Ju; Huh, Kyu Ha; Kim, Myoung Soo; Nam, Chung Mo; Kim, Beom Seok; Kim, Yu Seun			Association between post-transplant serum uric acid levels and kidney transplantation outcomes	PLOS ONE			English	Article							J-SHAPED ASSOCIATION; RENAL-TRANSPLANTATION; RISK-FACTOR; HYPERURICEMIA; DISEASE; PROGRESSION; MORTALITY; REJECTION; SURVIVAL; FAILURE	Background Serum uric acid (UA) level has been reported to be associated with chronic allograft nephropathy and graft failure in patients who undergo kidney transplantation (KT). However, the role of serum UA level in renal graft survival remains controversial. Objective This study aimed to investigate the effect of mean serum UA level during two different post-KT periods on long-term renal graft outcomes in a large population cohort in which living donor KT prevails. Material and methods A retrospective cohort study was performed using KT data prospectively collected at a single institution. Patients (n = 2,993) were divided into low-, normal-, and high-UA groups according to the mean serum UA level within the first year (1-YR) and 1-5 years (5-YR) after transplantation. Results In the 1-YR Cox proportional hazards analysis, the low- and high-UA groups had a significantly decreased and increased risk, respectively, for overall graft failure (OGF), death-censored graft failure (DCGF), and composite event (return to dialysis, retransplantation, death from graft dysfunction, and 40% decline in estimated glomerular filtration rate) compared with the normal-UA group. Similarly, in the 5-YR analysis, the low-UA group had a significantly reduced risk of DCGF compared with the normal-UA group, whereas the high-UA group had a significantly increased risk of all three graft outcomes. In a marginal structural model, hyperuricemia had a significant causal effect on worsening graft outcomes, with consideration of all confounding variables (OGF: hazard ratio [HR] 2.27, 95% confidence interval [Cl] 1.33-3.78; DCGF: HR 2.38, 95% Cl 1.09-4.9; composite event: HR 3.05, 95% Cl 1.64-5.49). Conclusions A low-to-normal serum UA level within the first year and 1-5 years after KT is an independent factor for better renal allograft outcomes in the long-term follow-up period rather than high serum UA level.	[Kim, Deok Gie; Huh, Kyu Ha; Kim, Myoung Soo; Kim, Yu Seun] Yonsei Univ Hlth Syst, Severance Hosp, Dept Transplantat Surg, Seoul, South Korea; [Choi, Hoon Young; Kim, Beom Seok] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Ha Yan; Lee, Eun Ju] Yonsei Univ, Biostat Collaborat Unit, Coll Med, Seoul, South Korea; [Huh, Kyu Ha; Kim, Myoung Soo; Kim, Yu Seun] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea; [Huh, Kyu Ha; Kim, Myoung Soo; Kim, Beom Seok; Kim, Yu Seun] Yonsei Univ, Res Inst Transplantat, Coll Med, Seoul, South Korea; [Nam, Chung Mo] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YS (corresponding author), Yonsei Univ Hlth Syst, Severance Hosp, Dept Transplantat Surg, Seoul, South Korea.; Kim, BS (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Kim, YS (corresponding author), Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea.; Kim, BS; Kim, YS (corresponding author), Yonsei Univ, Res Inst Transplantat, Coll Med, Seoul, South Korea.	DOCBSK@yuhs.ac; YUKIM@yuhs.ac		CHOI, HOON YOUNG/0000-0002-4245-0339; Kim, Myoun Soo/0000-0002-8975-8381; Kim, Yu Seun/0000-0002-5105-1567; Huh, Kyu Ha/0000-0003-1364-6989; Kim, Beom Seok/0000-0002-5732-2583; Nam, Chung Mo/0000-0003-0985-0928				Akalin E, 2008, TRANSPLANTATION, V86, P652, DOI 10.1097/TP.0b013e3181814f5b; Akgul A, 2007, TRANSPL P, V39, P1023, DOI 10.1016/j.transproceed.2007.03.028; Bassi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169077; Canepa M, 2017, HYPERTENSION, V69, P228, DOI 10.1161/HYPERTENSIONAHA.116.08114; Choi HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180406; Choi JY, 2013, TRANSPL P, V45, P1548, DOI 10.1016/j.transproceed.2012.10.062; Clive DM, 2000, J AM SOC NEPHROL, V11, P974, DOI 10.1681/ASN.V115974; Cristobal-Garcia M, 2015, OXIDATIVE MED CELLUL, V2015, P1; Dahle DO, 2014, CLIN TRANSPLANT, V28, P134, DOI 10.1111/ctr.12290; Dharnidharka VR, 2014, NEW ENGL J MED, V371, P549, DOI 10.1056/NEJMra1314376; Han M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176786; Haririan A, 2010, TRANSPLANTATION, V89, P573, DOI 10.1097/TP.0b013e3181c73c18; Hart A, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14124; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039457; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118031; Kang DH, 2005, SEMIN NEPHROL, V25, P43, DOI 10.1016/j.semnephrol.2004.10.001; Kasiske BL, 2011, AM J KIDNEY DIS, V57, P466, DOI 10.1053/j.ajkd.2010.10.054; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim ED, 2015, AM J TRANSPLANT, V15, P482, DOI 10.1111/ajt.13000; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li C, 2009, NAT REV NEPHROL, V5, P513, DOI 10.1038/nrneph.2009.113; LIN HY, 1989, NEW ENGL J MED, V321, P287, DOI 10.1056/NEJM198908033210504; Matsukuma Y, 2017, HYPERTENS RES, V40, P291, DOI 10.1038/hr.2016.134; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mazzali M, 2005, SEMIN NEPHROL, V25, P50, DOI 10.1016/j.semnephrol.2004.09.008; Meier-Kriesche HU, 2009, CLIN J AM SOC NEPHRO, V4, P1655, DOI 10.2215/CJN.02700409; Min SI, 2009, NEPHROL DIAL TRANSPL, V24, P2584, DOI 10.1093/ndt/gfp192; Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Numakura K, 2012, TRANSPLANTATION, V94, P145, DOI 10.1097/TP.0b013e318254391b; Oh IH, 2016, ARTIF ORGANS, V40, P136, DOI 10.1111/aor.12519; Pagonas N, 2016, ANN TRANSPL, V21, P350, DOI 10.12659/AOT.896821; Perico N, 2005, CONTRIB NEPHROL, V147, P124, DOI 10.1159/000082550; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Srivastava A, 2018, AM J KIDNEY DIS, V71, P362, DOI 10.1053/j.ajkd.2017.08.017; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Talaat KM, 2007, AM J NEPHROL, V27, P435, DOI 10.1159/000105142; Tsai CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170393; Wakasugi M, 2015, AM J NEPHROL, V41, P138, DOI 10.1159/000381106; Xiong Z, 2013, J NUTR HEALTH AGING, V17, P30, DOI 10.1007/s12603-012-0076-2; Zoccali C, 2018, NEPHROL DIAL TRANSPL, V33, P193, DOI 10.1093/ndt/gfx341	47	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209156	10.1371/journal.pone.0209156	http://dx.doi.org/10.1371/journal.pone.0209156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550582	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000047
J	Cichowitz, C; Pellegrino, R; Motlhaoleng, K; Martinson, NA; Variava, E; Hoffmann, CJ				Cichowitz, Cody; Pellegrino, Rachael; Motlhaoleng, Katlego; Martinson, Neil A.; Variava, Ebrahim; Hoffmann, Christopher J.			Hospitalization and post-discharge care in South Africa: A critical event in the continuum of care	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEART-FAILURE; HIV; TRANSITION; MORTALITY; ADMISSION; METAANALYSIS; RETENTION; LINKAGE; TRENDS	Objectives The purpose of this prospective cohort study is to characterize the event of acute hospitalization for people living with and without HIV and describe its impact on the care continuum. This study describes care-seeking behavior prior to an index hospitalization, inpatient HIV testing and diagnosis, discharge instructions, and follow-up care for patients for patients being discharged from a single hospital in South Africa. Methods A convenience sample of adult patients was recruited from the medical wards of a tertiary care facility. Baseline information at the time of hospital admission, subsequent diagnoses, and discharge instructions were recorded. Participants were prospectively followed with phone calls for six months after hospital discharge. Descriptive analyses were performed. Results A total of 293 participants were enrolled in the study. Just under half (46%) of the participants were known to be living with HIV at the time of hospital admission. Most participants (97%) were given a referral for follow-up care; often that appointment was scheduled within two weeks of discharge (64%). Only 36% of participants returned to care within the first month, 50% returned after at least one month had elapsed, and 14% of participants did not return for any follow up. Conclusions Large discrepancies were found between the type of post-discharge follow-up care recommended by providers and what patients were able to achieve. The period of time following hospital discharge represents a key transition in care. Additional research is needed to characterize patients' risk following hospitalization and to develop patient-centered interventions.	[Cichowitz, Cody; Pellegrino, Rachael] Johns Hopkins Sch Med, Baltimore, MD USA; [Motlhaoleng, Katlego; Martinson, Neil A.; Variava, Ebrahim] Perinatal HIV Res Unit, Gauteng, South Africa; [Variava, Ebrahim] Tshepong Hosp, Dept Med, Klerksdorp, South Africa; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020	Variava, Ebrahim/0000-0003-2888-789X; Cichowitz, Cody/0000-0002-9029-6508; Hoffmann, Christopher/0000-0002-9422-0519; Pellegrino, Rachael/0000-0002-7111-3040	National Institute of Allergy and Infectious Diseases (NIAID) [2U01-AI069924]; Johns Hopkins School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins School of Medicine(Johns Hopkins University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by National Institute of Allergy and Infectious Diseases (NIAID) grant 2U01-AI069924 and the Johns Hopkins School of Medicine; there was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinkuotu A, 2011, INT J STD AIDS, V22, P465, DOI 10.1258/ijsa.2011.011021; Department of Health, 2013, S AFR ANT TREATM GUI; Fox MP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002268; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Govender K, 2017, PAN AFRICAN MED J, V26; Grimsrud A, 2017, J INT AIDS SOC, V20, P492; Holmes CB, 2015, CURR OPIN HIV AIDS, V10, P447, DOI 10.1097/COH.0000000000000194; Iwuji CC, 2017, PUBLIC HEALTH ACTION, V7, P243, DOI 10.5588/pha.17.0111; Jaffray J, 2018, THROMB RES, V163, P146, DOI 10.1016/j.thromres.2018.01.043; Kingery JR, 2017, INT J CARDIOL, V243, P311, DOI 10.1016/j.ijcard.2017.05.025; LaManna JB, 2016, DIABETES EDUCATOR, V42, P72, DOI 10.1177/0145721715620020; Lee JI, 2013, J HOSP MED, V8, P619, DOI 10.1002/jhm.2084; May CR, 2014, BMC HEALTH SERV RES, V14, P437; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Murphy RA, 2010, INT J TUBERC LUNG D, V14, P903; Nabayigga B, 2016, EUR J INTERN MED, V28, P25, DOI 10.1016/j.ejim.2015.12.011; Nabayigga B, 2016, EUR J INTERN MED, V27, P24, DOI 10.1016/j.ejim.2015.11.018; Neeman M, 2017, EUR J INTERN MED, V38, P30, DOI 10.1016/j.ejim.2016.11.004; Peck RN, 2016, J ACQ IMMUN DEF SYND, P1; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Polinski JM, 2016, HEALTH AFFAIR, V35, P1222, DOI 10.1377/hlthaff.2015.0648; Reid A, 2005, JAIDS-J ACQ IMM DEF, V40, P53, DOI 10.1097/01.qai.0000174251.35398.72; Rosbach M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179916; Salas CM, 2015, AM J HEALTH-SYST PH, V72, pS43, DOI 10.2146/sp150012; Shah M, 2016, CLIN INFECT DIS, V62, P220, DOI 10.1093/cid/civ801; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Tang N, 2014, J GEN INTERN MED, V29, P1513, DOI 10.1007/s11606-014-2942-6; Wajanga BM, 2014, INPATIENT MORTALITY, P1; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Yehia BR, 2013, AIDS, V27, P1529, DOI 10.1097/QAD.0b013e328360104e	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208429	10.1371/journal.pone.0208429	http://dx.doi.org/10.1371/journal.pone.0208429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543667	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500021
J	Fisher, A; Rangel, J				Fisher, Adrian, II; Rangel, Juliana			Exposure to pesticides during development negatively affects honey bee (Apis mellifera) drone sperm viability	PLOS ONE			English	Article							SEMEN QUALITY; SEXUAL SELECTION; QUEEN; SPERMATHECA; RESISTANCE; ROUTE	Honey bee (Apis mellifera) colonies invest a substantial amount of colony resources in the production of drones during the reproductive season to enable mating with virgin queens from nearby colonies. Recent studies have shown significant differences in the production of sperm cells that are viable (i.e., sperm viability) and can fertilize an ovule among sexually mature drones that are exposed to different environmental conditions during development or as adults. In particular, sperm viability may be negatively affected during drone development from exposure to pesticides in contaminated beeswax. To assess whether sperm viability is negatively affected during drone development from exposure to beeswax contaminated with in-hive pesticides, we compared the viability of sperm collected from drones reared in pesticide-free beeswax with that of drones reared in beeswax contaminated with field-relevant concentrations of the pesticides most commonly found in wax from commercial beekeeping operations in the United States. These pesticides include the miticides fluvalinate, coumaphos and amitraz, and the agro-chemicals chlorothalonil and chlorpyrifos. Sperm from drones collected at 10 and 18 days post emergence were classified as viable or non-viable to calculate sperm viability. For all pesticide treatment groups, drones that were reared in pesticide-laden beeswax had lower sperm viability compared to those reared in pesticide-free beeswax. This difference was especially pronounced among drones reared in miticide-laden wax. Our results reinforce the notion that pesticide contamination of beeswax negatively affects the reproductive quality of drones, which can affect the queens they mate with, ultimately compromising colony health.	[Fisher, Adrian, II; Rangel, Juliana] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rangel, J (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	jrangel@tamu.edu			United States Department of Agriculture-National Institutes for Food and Agriculture [2015-67013-23170]; Texas A&M University's Hatch Project [TEX09557]; American Association of Professional Apiculturists; USDA-NIFA award [2015-67013-23170]	United States Department of Agriculture-National Institutes for Food and Agriculture; Texas A&M University's Hatch Project; American Association of Professional Apiculturists; USDA-NIFA award	This study was supported in part by funding to JR by a United States Department of Agriculture-National Institutes for Food and Agriculture (https://nifa.usda.gov/) award (2015-67013-23170) and Texas A&M University's Hatch Project (TEX09557), and by funding to AF from the American Association of Professional Apiculturists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Gene (ET) Ash for his advice and assistance in drone rearing and collection. We would also like to thank Dr. Dickson Varner, Dr. Charles Love and Ms. Shiela Teague of the Texas A&M University College of Veterinary Medicine for their help in processing and analyzing data. This study was supported in part by funding to Juliana Rangel by a USDA-NIFA award (2015-67013-23170) and Texas A&M University's Hatch Project (TEX09557), and by funding to Adrian Fisher II from the American Association of Professional Apiculturists.	Al-Lawati H, 2009, J INSECT PHYSIOL, V55, P116, DOI 10.1016/j.jinsphys.2008.10.010; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Ben Abdelkader F, 2014, APIDOLOGIE, V45, P215, DOI 10.1007/s13592-013-0240-7; Bienkowska M, 2011, J APIC SCI, V55, P161; Bishop GH, 1920, J EXP ZOOL, V31, P225; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bogdanov S, 2004, BEE WORLD, V85, P46, DOI 10.1080/0005772X.2004.11099623; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Burley L.M., 2007, THESIS; Chaimanee V, 2016, J INSECT PHYSIOL, V89, P1, DOI 10.1016/j.jinsphys.2016.03.004; Ciereszko A, 2017, APIDOLOGIE, V48, P211, DOI 10.1007/s13592-016-0466-2; Cobey SW, 2007, APIDOLOGIE, V38, P390, DOI 10.1051/apido:2007029; Collins AM, 2000, APIDOLOGIE, V31, P421, DOI 10.1051/apido:2000132; Couvillon MJ, 2010, BEHAV ECOL, V21, P520, DOI 10.1093/beheco/arq016; Czekonska K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.19; Elzen PJ, 2002, AM BEE J, V142, P291; Elzen PJ, 1998, AM BEE J, V138, P674; Harbo J.R., 1986, P361; HOLLDOBLER B, 1985, FORTS ZOOL, V31, P237; Johnson RM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.18; Kairo G, 2017, ENVIRON TOXICOL CHEM, V36, P2345, DOI 10.1002/etc.3773; Kairo G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08380-5; Kairo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep31904; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Mackensen O, 1948, ET250 USDA BUR ENT P, VET-250, P1; Moritz RFA, 1989, INSTRUMENTAL INSEMIN, P22; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nguyen V.N, 1995, THESIS; Rhodes JW, 2011, APIDOLOGIE, V42, P29, DOI 10.1051/apido/2010026; Rhodes JW, 2002, DRONE HONEY BEES REA, V112; Rhodes JW, 2008, NON TRADITIONAL REF; Rinderer TE, 1999, AM BEE J, V139, P134; Rousseau A, 2015, CAN ENTOMOL, V147, P702, DOI 10.4039/tce.2015.12; RUTTNER F, 1971, Z VERGL PHYSIOL, V72, P411, DOI 10.1007/BF00300712; Rzymski P, 2012, THERIOGENOLOGY, V77, P1642, DOI 10.1016/j.theriogenology.2011.12.009; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Shoukry R., 2013, EGYPTIAN J AGR RES, V91, P825, DOI DOI 10.21608/EJAR.2013.165098; Slowinska M, 2016, APIDOLOGIE, V47, P227, DOI 10.1007/s13592-015-0391-9; Straub L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0506; Sturup M, 2013, BEHAV ECOL, V24, P1192, DOI 10.1093/beheco/art049; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Tofilski A, 2012, APIDOLOGIE, V43, P63, DOI 10.1007/s13592-011-0089-6; Wilde J, 1994, ZOOTECHNICA, V39, P135; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Winston M.L., 1991, BIOL HONEY BEE; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	47	25	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208630	10.1371/journal.pone.0208630	http://dx.doi.org/10.1371/journal.pone.0208630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543709	gold, Green Submitted, Green Published			2022-12-26	WOS:000453247500029
J	Chen, LP; Guo, P; Zhang, HY; Li, WX; Gao, C; Huang, ZL; Fan, JL; Zhang, YL; Li, X; Liu, XL; Wang, FP; Wang, S; Li, QY; He, ZN; Li, HY; Chen, S; Wu, XN; Ye, LZ; Li, Q; Tang, HW; Wang, Q; Dong, GH; Xiao, YM; Chen, W; Li, DC				Chen, Liping; Guo, Ping; Zhang, Haiyan; Li, Wenxue; Gao, Chen; Huang, Zhenlie; Fan, Junling; Zhang, Yuling; Li, Xue; Liu, Xiaoling; Wang, Fangping; Wang, Shan; Li, Qingye; He, Zhini; Li, Huiyao; Chen, Shen; Wu, Xiaonen; Ye, Lizhu; Li, Qiong; Tang, Huanwen; Wang, Qing; Dong, Guanghui; Xiao, Yongmei; Chen, Wen; Li, Daochuan			Benzene-induced mouse hematotoxicity is regulated by a protein phosphatase 2A complex that stimulates transcription of cytochrome P4502E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (beta-catenin); hematopoiesis; metabolism; phosphorylation; protein phosphatase 2 (PP2A); gene regulation; beta-catenin phosphorylation; benzene; cyp2e1; hematotoxicity; protein phosphatase 2A	BETA-CATENIN; MYELOID-LEUKEMIA; PP2A COMPLEXES; DNA-DAMAGE; EXPRESSION; SUBUNIT; ACTIVATION; WORKERS; ALPHA; PHOSPHORYLATION	Chronic benzene exposure is associated with hematotoxicity and the development of aplastic anemia and leukemia. However, the signaling pathways underlying benzene-induced hematotoxicity remain to be defined. Here, we investigated the role of protein phosphatase 2A (PP2A) in the regulation of benzene-induced hematotoxicity in a murine model. Male mice with a hepatocyte-specific homozygous deletion of the Ppp2r1a gene (encoding PP2A A alpha subunit) (HO) and matched wildtype (WT) mice were exposed to benzene via inhalation at doses of 1, 10, and 100 ppm for 28 days. Peripheral white blood cell counts and activation of bone marrow progenitors were attenuated in the HO mice, indicating that Ppp2r1a deletion protects against benzene-induced hematotoxicity. Moreover, elevation of urinary S-phenyl mercapturic acid, a benzene metabolite, was much greater in WT mice than in HO mice. Real-time exhalation analysis revealed more exhaled benzene but fewer benzene metabolites in HO mice than in WT mice, possibly because of the down-regulation of Cyp2e1, encoding cytochrome P4502E1, in hepatocytes of the HO mice. Loss-of-function screening disclosed that PP2A complexes containing the B56 alpha subunit participate in regulating Cyp2e1 expression. Notably, PP2A-B56 alpha suppression in HepG2 cells resulted in persistent beta-catenin phosphorylation at Ser(33)-Ser(37)-Thr(41) in response to CYP2E1 agonists. In parallel, nuclear translocation of beta-catenin was inhibited, concomitant with a remarkable decrease of Cyp2e1 expression. These findings support the notion that a regulatory cascade comprising PP2A-B56 alpha, beta-catenin, and Cyp2e1 is involved in benzene-induced hematotoxicity, providing critical insight into the role of PP2A in responses to the environmental chemicals.	[Chen, Liping; Guo, Ping; Zhang, Haiyan; Gao, Chen; Fan, Junling; Liu, Xiaoling; Wang, Fangping; Wang, Shan; Li, Qingye; Li, Huiyao; Chen, Shen; Wu, Xiaonen; Ye, Lizhu; Li, Qiong; Wang, Qing; Dong, Guanghui; Xiao, Yongmei; Chen, Wen; Li, Daochuan] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Li, Wenxue] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou 510440, Guangdong, Peoples R China; [Huang, Zhenlie; He, Zhini] Southern Med Univ, Sch Publ Hlth, Food Safety & Hlth Res Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Yuling; Li, Xue] Jinan Univ, Inst Mass Spectrometer & Atmospher Environm, Guangzhou 510632, Guangdong, Peoples R China; [Tang, Huanwen] Guangdong Med Univ, Sch Publ Hlth, Dongguan Key Lab Environm Med, Dongguan 523808, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Jinan University; Guangdong Medical University	Li, DC (corresponding author), Sun Yat Sen Univ, Dept Toxicol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	lidchuan@mail.sysu.edu.cn	wang, fang/GYD-4295-2022; Liu, Xiaoling/HGD-3566-2022; Dong, Guanghui/AAN-4630-2020; Huang, Zhenlie/AAQ-9970-2020	Huang, Zhenlie/0000-0001-9818-8192; Chen, Shen/0000-0001-8640-4492; He, Zhini/0000-0002-9185-5500; Dong, Guang-Hui/0000-0002-2578-3369	Key Program of the National Natural Science Foundation of China [81430079]; Guangdong Provincial Natural Science Foundation Team Project [2018B030312005]; National Natural Science Foundation of China (NSFC) [31401213, 81602877, 81372962, 81402715, 81602882]; Fundamental Research Funds for the Central Universities [17ykpy13]; Natural Science Foundation of Guangdong Province Doctor Staring Program [2016A030310163]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation Team Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province Doctor Staring Program	This work was supported by Key Program of the National Natural Science Foundation of China Grant 81430079, Guangdong Provincial Natural Science Foundation Team Project Grant 2018B030312005, National Natural Science Foundation of China (NSFC) Grants 31401213, 81602877, 81372962, 81402715, and 81602882, the Fundamental Research Funds for the Central Universities Grant 17ykpy13, and the Natural Science Foundation of Guangdong Province Doctor Staring Program Grant 2016A030310163. The authors declare that they have no conflicts of interest with the contents of this article.	Arriazu E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00078; Badham HJ, 2010, CHEM-BIOL INTERACT, V184, P218, DOI 10.1016/j.cbi.2009.11.005; Bahadar H, 2015, ENVIRON TOXICOL PHAR, V39, P1161, DOI 10.1016/j.etap.2015.04.010; Bahadar H, 2014, TOXICOL APPL PHARM, V276, P83, DOI 10.1016/j.taap.2014.02.012; Billet S, 2010, ARCH TOXICOL, V84, P99, DOI 10.1007/s00204-009-0478-z; Chen LP, 2014, J BIOL CHEM, V289, P22413, DOI 10.1074/jbc.M114.548677; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen WQ, 2011, AM J PATHOL, V178, P2333, DOI 10.1016/j.ajpath.2011.01.041; Cordeiro MH, 2018, INT J BIOCHEM CELL B, V96, P148, DOI 10.1016/j.biocel.2017.10.017; Engin A, 2017, ADV EXP MED BIOL, V960, P111, DOI 10.1007/978-3-319-48382-5_5; Environment Protection Agency, 2002, TOX REV BENZ NONC EF; Ganzenberg K, 2013, TOXICOLOGY, V308, P113, DOI 10.1016/j.tox.2013.03.019; Groll N, 2016, TOXICOLOGY, V350, P40, DOI 10.1016/j.tox.2016.05.004; Gut I, 1996, ARCH TOXICOL, V71, P45, DOI 10.1007/s002040050357; Heijne WHM, 2005, MUTAT RES-FUND MOL M, V575, P85, DOI 10.1016/j.mrfmmm.2005.02.003; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Ishibashi K, 2018, CANCER GENOM PROTEOM, V15, P53, DOI 10.21873/cgp.20064; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kanaar R, 1998, NATURE, V391, P335, DOI 10.1038/34790; Li JQ, 2018, TOXICOL IN VITRO, V46, P361, DOI 10.1016/j.tiv.2017.08.018; Li J, 2018, ENVIRON POLLUT, V234, P127, DOI 10.1016/j.envpol.2017.11.042; Li J, 2017, BIOMARKERS, V22, P470, DOI 10.1080/1354750X.2016.1274335; Liu C, 2013, J ALZHEIMERS DIS, V37, P483, DOI 10.3233/JAD-130503; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu WH, 2013, CARCINOGENESIS, V34, P818, DOI 10.1093/carcin/bgs409; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Neviani P, 2013, J CLIN INVEST, V123, P4144, DOI 10.1172/JCI68951; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ramaswamy K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00016; Reynhout S, 2019, BBA-MOL CELL RES, V1866, P31, DOI 10.1016/j.bbamcr.2018.07.010; Ross D, 2000, J TOXICOL ENV HEAL A, V61, P357, DOI 10.1080/00984100050166361; Ruvolo PP, 2014, BBA-MOL CELL RES, V1843, P1969, DOI 10.1016/j.bbamcr.2014.05.006; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Schettgen T, 2008, J CHROMATOGR B, V863, P283, DOI 10.1016/j.jchromb.2008.01.024; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Sun RL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111068; Toop HD, 2016, ORG BIOMOL CHEM, V14, P4605, DOI 10.1039/c6ob00556j; Vlaanderen J, 2012, AM J IND MED, V55, P779, DOI 10.1002/ajim.22087; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang YL, 2017, CHEMOSPHERE, V184, P93, DOI 10.1016/j.chemosphere.2017.05.135; Zheng Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0226-x; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244; Zhu XN, 2014, CELL SIGNAL, V26, P825, DOI 10.1016/j.cellsig.2014.01.002	51	9	9	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2486	2499		10.1074/jbc.RA118.006319	http://dx.doi.org/10.1074/jbc.RA118.006319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30567741	Green Published, hybrid			2022-12-26	WOS:000458895400024
J	Chakraborty, S; von Mentzer, A; Begum, YA; Manzur, M; Hasan, M; Ghosh, AN; Hossein, MA; Camilli, A; Qadri, F				Chakraborty, Sajib; von Mentzer, Astrid; Begum, Yasmin Ara; Manzur, Mehnaz; Hasan, Mahmudul; Ghosh, Amar N.; Hossein, M. Anwar; Camilli, Andrew; Qadri, Firdausi			Phenotypic and genomic analyses of bacteriophages targeting environmental and clinical CS3-expressing enterotoxigenic Escherichia coli (ETEC) strains	PLOS ONE			English	Article							COLONIZATION FACTORS; MONOCLONAL-ANTIBODIES; CLASSIFICATION; ACQUISITION; ADAPTATION; PREVALENCE; RESISTANCE; MECHANISM; SELECTION; DYNAMICS	Diarrhea due to infection of enterotoxigenic Escherichia coli (ETEC) is of great concern in several low and middle-income countries. ETEC infection is considered to be the most common cause of diarrhea in Bangladesh and is mainly spread through contaminated water and food. ETEC pathogenesis is mediated by the expression of enterotoxins and colonization factors (CFs) that target the intestinal mucosa. ETEC can survive for extended time periods in water, where they are likely to be attacked by bacteriophages. Antibiotic resistance is common amongst enteric pathogens and therefore is the use of bacteriophages (phage) as a therapeutic tool an interesting approach. This study was designed to identify novel phages that specifically target ETEC virulence factors. In total, 48 phages and 195 ETEC isolates were collected from water sources and stool samples. Amongst the identified ETEC specific phages, an enterobacteria phage T7, designated as IMM-002, showed a significant specificity towards colonization factor CS3-expressing ETEC isolates. Antibody-blocking and phage-neutralization assays revealed that CS3 is used as a host receptor for the IMM-002 phage. The bacterial CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated) defence mechanism can invoke immunity against phages. Genomic analyses coupled with plaque assay experiments indicate that the ETEC CRISPR-Cas system is involved in the resistance against the CS3-specific phage (IMM-002) and the previously identified CS7-specific phage (IMM-001). As environmental water serves as a reservoir for ETEC, it is important to search for new antimicrobial agents such as phages in environmental water as well as the human gut. A better understanding of how the interplay between ETEC-specific phages and ETEC isolates affects the ETEC diversity, both in environmental ecosystems and within the host, is important for the development of new treatments for ETEC infections.	[Chakraborty, Sajib; Manzur, Mehnaz; Hasan, Mahmudul; Hossein, M. Anwar] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Chakraborty, Sajib; Begum, Yasmin Ara; Qadri, Firdausi] Icddr B, Dhaka, Bangladesh; [von Mentzer, Astrid] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [Ghosh, Amar N.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA	University of Dhaka; International Centre for Diarrhoeal Disease Research (ICDDR); University of Gothenburg; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Tufts University; Howard Hughes Medical Institute; Tufts University	Chakraborty, S (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.; Chakraborty, S (corresponding author), Icddr B, Dhaka, Bangladesh.	sajib@du.ac.bd	Qadri, Firdausi/AAF-4583-2019; von Mentzer, Astrid/I-5449-2018; Chakraborty, Sajib/P-5430-2019; Al, Mamun M./AAF-5850-2019	von Mentzer, Astrid/0000-0002-2167-1394; Chakraborty, Sajib/0000-0002-8900-503X; Hossain, M Anwar/0000-0002-1769-4884	icddr, b, University of Dhaka; USA National Institutes of Health [AI055058]; Swedish Sida grant [INT-ICDDR, B-HN-01-AV]; Swedish Foundation for Strategic Research [SB12-0072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055058] Funding Source: NIH RePORTER	icddr, b, University of Dhaka; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Sida grant; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the icddr, b, University of Dhaka; USA National Institutes of Health grant AI055058 (A.C.); The Swedish Sida grant INT-ICDDR, B-HN-01-AV (F.Q.); The Swedish Foundation for Strategic Research (grant no. SB120072).; This research was supported by the icddr, b, University of Dhaka, USA National Institutes of Health grant AI055058 (A.C.), the Swedish Sida grant INT-ICDDR, B-HN-01-AV (F.Q.), and the Swedish Foundation for Strategic Research (grant no. SB12-0072).	Almendros C, 2014, MBIO, V5, DOI 10.1128/mBio.00767-13; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Aydin S, 2017, J ANTIMICROB CHEMOTH, V72, P2213, DOI 10.1093/jac/dkx137; Begum YA, 2010, J MED MICROBIOL, V59, P266, DOI 10.1099/jmm.0.014795-0; Begum YA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003031; BLACK RE, 1993, PEDIATR INFECT DIS J, V12, P751, DOI 10.1097/00006454-199309000-00010; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Edwards P. R., 1972, IDENTIFICATION ENTER; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Filippov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025486; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; GHOSH AN, 1989, J GEN VIROL, V70, P2241, DOI 10.1099/0022-1317-70-8-2241; Gonzales-Siles L, 2016, ENVIRON MICROBIOL, V18, P741, DOI 10.1111/1462-2920.13106; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; GROSS RJ, 1977, J CLIN MICROBIOL, V6, P548; Hardies SC, 2013, J VIROL, V87, P9189, DOI 10.1128/JVI.01521-13; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; JANN K, 1971, J GEN MICROBIOL, V67, P289, DOI 10.1099/00221287-67-3-289; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lazinski DW, 2013, BIOTECHNIQUES, V54, P25, DOI 10.2144/000113981; LOPEZVIDAL Y, 1990, J CLIN MICROBIOL, V28, P1906, DOI 10.1128/JCM.28.9.1906-1912.1990; Madhavan TPV, 2015, ADV APPL MICROBIOL, V90, P155, DOI 10.1016/bs.aambs.2014.09.003; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; MCCONNELL MM, 1989, J GEN MICROBIOL, V135, P1135; McPartland J, 2009, J BACTERIOL, V191, P525, DOI 10.1128/JB.01423-08; MONSUR K A, 1985, Journal of Diarrhoeal Diseases Research, V3, P131; Qadri F, 2000, J INFECT DIS, V181, P2071, DOI 10.1086/315507; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Savitskaya E, 2017, MOL ECOL, V26, P2019, DOI 10.1111/mec.13961; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WENNERAS C, 1995, INFECT IMMUN, V63, P640; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yaung SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098811	55	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209357	10.1371/journal.pone.0209357	http://dx.doi.org/10.1371/journal.pone.0209357			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571788	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700058
J	Ejmal, MA; Holland, DJ; MacDiarmid, RM; Pearson, MN				Ejmal, Mahjoub A.; Holland, David J.; MacDiarmid, Robin M.; Pearson, Michael N.			A novel chrysovirus from a clinical isolate of Aspergillus thermomutatus affects sporulation	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; VIRUS-LIKE PARTICLES; PENICILLIUM-CHRYSOGENUM-VIRUS; MOLECULAR CHARACTERIZATION; NEOSARTORYA-PSEUDOFISCHERI; DSRNA MYCOVIRUSES; GENOMIC CHARACTERIZATION; VEGETATIVE GROWTH; IDENTIFICATION; SEQUENCE	A clinical isolate of Aspergillus thermomutatus (Teleomorph: Neosartorya pseudofischen) was found to contain similar to 35 nm isometric virus-like particles associated with four double-stranded (ds) RNA segments, each of which coded for a single open reading frame. The longest dsRNA element (3589 nt) encodes a putative RNA-dependent RNA polymerase (1114 aa), the second longest dsRNA element (2772 nt) encodes a coat protein (825 aa), and the other two dsRNAs (2676 nt, 2514 nt) encode hypothetical proteins of 768 aa and 711 aa, respectively. Phylogenetic analysis of the amino acid sequences showed 41-60% similarity to the proteins coded by the dsRNAs of the most closely related virus, Penicillium janczewskii chrysovirus 2, indicating that it is a new species based on the International Committee on Taxonomy of Viruses criteria for the genus Chrysovirus. This is the first virus reported from A. thermomutatus and was tentatively named Aspergillus thermomutatus chrysovirus 1. A virus free line of the fungal isolate, cured by cycloheximide treatment, produced large numbers of conidia but no ascospores at both 20 degrees C and 37 degrees C, whereas the virus infected line produced ten-fold fewer conidia at 20 degrees C and a large number of ascospores at both temperatures. The effects of the virus on fungal sporulation have interesting implications for the spread of the fungus and possible use of the virus as a biological control agent.	[Ejmal, Mahjoub A.; MacDiarmid, Robin M.; Pearson, Michael N.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Holland, David J.] Middlemore Hosp, Staff Ctr, Div Med, Infect Dis Unit, Auckland, New Zealand; [MacDiarmid, Robin M.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Ejmal, MA (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	mejm158@aucklanduni.ac.nz	MacDiarmid, Robin/H-5715-2013	MacDiarmid, Robin/0000-0002-7057-2018; Ejmal, Mahjoub/0000-0002-4843-7362	Faculty of Science at the University of Auckland	Faculty of Science at the University of Auckland	This work was funded by the Faculty of Science at the University of Auckland, for the Ph.D. studies of Mahjoub Ali Ejmal. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balajee SA, 2005, J CLIN MICROBIOL, V43, P5996, DOI 10.1128/JCM.43.12.5996-5999.2005; Bao XD, 2013, ADV VIRUS RES, V86, P37, DOI 10.1016/B978-0-12-394315-6.00002-7; Benassi VM, 2014, BRAZ J MICROBIOL, V45, P1459, DOI 10.1590/S1517-83822014000400042; Bhatti MF, 2012, MYCOPATHOLOGIA, V174, P323, DOI 10.1007/s11046-012-9556-5; Bhatti MF, 2011, FUNGAL GENET BIOL, V48, P1071, DOI 10.1016/j.fgb.2011.07.008; BUCK K W, 1973, Biochemical Society Transactions, V1, P1138; BUCK KW, 1975, J GEN VIROL, V27, P211, DOI 10.1099/0022-1317-27-2-211; Cao YF, 2011, VIRUS RES, V159, P73, DOI 10.1016/j.virusres.2011.04.029; Caston JR, 2003, J MOL BIOL, V331, P417, DOI 10.1016/S0022-2836(03)00695-8; Covelli L, 2004, J GEN VIROL, V85, P3389, DOI 10.1099/vir.0.80181-0; Darissa O, 2011, ARCH VIROL, V156, P647, DOI 10.1007/s00705-010-0904-9; De Beeck MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097629; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ejmal MA, 2017, THESIS; Elias KS, 1996, CAN J BOT, V74, P716, DOI 10.1139/b96-090; Ghabrial S. A, 2010, DESK ENCY PLANT FUNG, P500; Ghabrial SA, 2012, VIRUS TAXONOMY CLASS, P509; Ghabrial SA, 2013, ADV VIRUS RES, V86, P289, DOI 10.1016/B978-0-12-394315-6.00011-8; GIRARDIN H, 1995, APPL ENVIRON MICROB, V61, P1378, DOI 10.1128/AEM.61.4.1378-1383.1995; Guarro J, 2002, EMERG INFECT DIS, V8, P989, DOI 10.3201/eid0809.020073; Guarro J, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P7, DOI 10.1007/978-90-481-2408-4_2; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; HARMSEN MC, 1991, CURR GENET, V20, P137, DOI 10.1007/BF00312776; Henry T, 2000, J CLIN MICROBIOL, V38, P1510, DOI 10.1128/JCM.38.4.1510-1515.2000; Herrero N, 2017, ARCH VIROL, V162, P1113, DOI 10.1007/s00705-016-3194-z; Herrero N, 2011, VIRUS RES, V160, P409, DOI 10.1016/j.virusres.2011.06.015; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; Howitt RLJ, 1995, MYCOL RES, V99, P1472, DOI 10.1016/S0953-7562(09)80795-8; Hyder R, 2013, FUNGAL ECOL, V6, P387, DOI 10.1016/j.funeco.2013.05.005; Jamal A, 2010, VIRUS RES, V153, P64, DOI 10.1016/j.virusres.2010.07.008; Jarv H, 2004, J CLIN MICROBIOL, V42, P925, DOI 10.1128/JCM.42.2.925-928.2004; Jiang DH, 2004, J GEN VIROL, V85, P2111, DOI 10.1099/vir.0.79842-0; Kanhayuwa L, 2015, P NATL ACAD SCI USA, V112, P9100, DOI 10.1073/pnas.1419225112; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KEVEI F, 1977, J GEN MICROBIOL, V102, P255, DOI 10.1099/00221287-102-2-255; Khalifa ME, 2014, ARCH VIROL, V159, P3157, DOI 10.1007/s00705-014-2171-7; Khalifa ME, 2013, VIROLOGY, V441, P22, DOI 10.1016/j.virol.2013.03.002; Kim JM, 2009, J MICROBIOL, V47, P441, DOI 10.1007/s12275-009-0206-7; KIM JW, 1985, J GEN VIROL, V66, P1991, DOI 10.1099/0022-1317-66-9-1991; King AMQ, 2018, ARCH VIROL, V163, P2601, DOI 10.1007/s00705-018-3847-1; KOHN LM, 1991, PHYTOPATHOLOGY, V81, P480, DOI 10.1094/Phyto-81-480; Kotta-Loizou I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01699; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Lemus-Minor CG, 2015, ARCH VIROL, V160, P2375, DOI 10.1007/s00705-015-2509-9; Li LQ, 2013, VIRUS RES, V176, P169, DOI 10.1016/j.virusres.2013.06.004; Liu WX, 2008, VIRUS GENES, V37, P322, DOI 10.1007/s11262-008-0265-6; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; Melzer MJ, CHARACTERIZATI UNPUB; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Munoz-Adalia EJ, 2016, BIOCONTROL SCI TECHN, V26, P577, DOI 10.1080/09583157.2015.1135877; Nerva L, 2016, VIRUS RES, V219, P22, DOI 10.1016/j.virusres.2015.10.028; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Okada R, 2018, VIROLOGY, V519, P23, DOI 10.1016/j.virol.2018.03.027; PADEN JW, 1968, MYCOPATH MYCOL APPL, V36, P161, DOI 10.1007/BF02049682; PADHYE AA, 1994, J CLIN MICROBIOL, V32, P2832, DOI 10.1128/JCM.32.11.2832-2836.1994; PETERSON SW, 1992, MYCOL RES, V96, P547, DOI 10.1016/S0953-7562(09)80979-9; Pryce TM, 2003, MED MYCOL, V41, P369, DOI 10.1080/13693780310001600435; RATTI G, 1972, J GEN VIROL, V14, P165, DOI 10.1099/0022-1317-14-2-165; Refos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077381; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHMIDT FR, 1986, APPL MICROBIOL BIOT, V24, P248, DOI 10.1007/BF00261546; Sharzei A., 2007, Iranian Journal of Plant Pathology, V43, P9; Silva VN, 2001, BRAZ J MICROBIOL, V32, P56, DOI 10.1590/S1517-83822001000100013; Son Moonil, 2015, PLoS Pathog, V11, pe1005172, DOI 10.1371/journal.ppat.1005172; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urayama S, 2014, VIROLOGY, V448, P265, DOI 10.1016/j.virol.2013.10.022; Urayama S, 2010, J GEN VIROL, V91, P3085, DOI 10.1099/vir.0.025411-0; VALVERDE RA, 1990, PLANT DIS, V74, P255; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; vanDiepeningen AD, 1997, CURR GENET, V32, P209, DOI 10.1007/s002940050268; Varga J, 2003, ANTON LEEUW INT J G, V83, P191, DOI 10.1023/A:1023355707646; VARGA J, 1994, CAN J MICROBIOL, V40, P325, DOI 10.1139/m94-054; Varga J, 1998, CAN J MICROBIOL, V44, P569, DOI 10.1139/cjm-44-6-569; Villanueva F, MOL CHARACTERI UNPUB; Wang LP, 2014, J VIROL, V88, P7517, DOI 10.1128/JVI.00538-14; WOOD HA, 1974, J VIROL, V13, P532, DOI 10.1128/JVI.13.2.532-534.1974; Yu J, 2011, PLANT PATHOLOGY J, V27, P285, DOI 10.5423/PPJ.2011.27.3.285; Zhai LF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00754; Zhang J, 2017, ARCH VIROL, V162, P1107, DOI 10.1007/s00705-016-3196-x; Zheng L, 2014, VIROLOGY, V456, P220, DOI 10.1016/j.virol.2014.03.029; Zhong J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100268	84	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209443	10.1371/journal.pone.0209443	http://dx.doi.org/10.1371/journal.pone.0209443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571748	Green Published, gold, Green Submitted			2022-12-26	WOS:000453841700073
J	Msemo, OA; Bygbjerg, IC; Moller, SL; Nielsen, BB; Odum, L; Perslev, K; Lusingu, JPA; Kavishe, RA; Minja, DTR; Schmiegelow, C				Msemo, Omari A.; Bygbjerg, Ib C.; Moller, Sofie L.; Nielsen, Birgitte B.; Odum, Lars; Perslev, Kathrine; Lusingu, John P. A.; Kavishe, Reginald A.; Minja, Daniel T. R.; Schmiegelow, Christentze			Prevalence and risk factors of preconception anemia: A community based cross sectional study of rural women of reproductive age in northeastern Tanzania	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR CONCENTRATIONS; IRON-DEFICIENCY ANEMIA; FERRITIN CONCENTRATIONS; PLASMA FERRITIN; DETERMINANTS; INFLAMMATION; HEMOGLOBIN; PREGNANCY; CHILDREN; BIRTH	Background Anemia is a major public health problem that adversely affects pregnancy outcomes. The prevalence of anemia among pregnant women before conception is not well known in Tanzania. The aim of this study was to determine the prevalence, types, and risk factors of preconception anemia in women of reproductive age from a rural Tanzanian setting. Methods Trained field workers visited households to identify all female residents aged 18-40 years and invited them to the nearby health facility for screening and enrolment into this study. Baseline samples were collected to measure hemoglobin levels, serum ferritin, vitamin B-12, folate, C-reactive protein, alanine amino-transferase, the presence of malaria, HIV, and soil transmitted helminth infections. Anthropometric and socio-economic data were recorded alongside with clinical information of participants. Logistic regression analysis was used to determine the adjusted odds ratios (AOR) for the factors associated with preconception anemia. Findings Of 1248 women enrolled before conception, 36.7% (95% confidence interval (CI) 34.1-39.4) had anemia (hemoglobin <12 g/dL) and 37.6% (95% CI 34.9-40.4) had iron deficiency. For more than half of the anemic cases, iron deficiency was also diagnosed (58.8%, 95% CI 54.2-63.3). Anemia was independently associated with increased age (AOR 1.05, 95% CI 1.03-1.07), malaria infection at enrolment (AOR 2.21, 95% CI 1.37-3.58) inflammation (AOR 1.77, 95% CI 1.21-2.60) and iron deficiency (AOR 4.68, 95% CI 3.55-6.17). The odds of anemia were reduced among women with increased mid-upper arm circumference (AOR 0.90, 95% CI 0.84-0.96). Conclusion Anemia among women of reproductive age before conception was prevalent in this rural setting. Increased age, iron deficiency, malaria infection and inflammation were significant risk factors associated with preconception anemia, whereas increased mid-upper arm circumference was protective against anemia. Interventions to ensure adequate iron levels as well as malaria control before conception are needed to prevent anemia before and during pregnancy and improve birth outcomes in this setting.	[Msemo, Omari A.; Lusingu, John P. A.; Minja, Daniel T. R.] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Bygbjerg, Ib C.; Moller, Sofie L.] Univ Copenhagen, Dept Publ Hlth, Sect Global Hlth, Copenhagen, Denmark; [Nielsen, Birgitte B.] Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus, Denmark; [Odum, Lars] Roskilde Hosp, Dept Clin Biochem, Rokslide, Denmark; [Perslev, Kathrine; Schmiegelow, Christentze] Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Copenhagen, Denmark; [Kavishe, Reginald A.] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania	National Institute of Medical Research; University of Copenhagen; Aarhus University; University of Copenhagen	Msemo, OA (corresponding author), Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania.	mtengeti@gmail.com	Lusingu, John P. A./GSJ-3228-2022	shmiegelow, christentze/0000-0002-9360-9741; ABDUL, OMARI/0000-0002-7728-0149; Bygbjerg, Ib/0000-0001-9100-2754; perslev, kathrine/0000-0001-5201-8171; Lusingu, John P. A./0000-0002-9407-0602	Danish Council for Strategic Reseach [1309-00003B]; Lundbeck Foundation [R209-2015-3580] Funding Source: researchfish	Danish Council for Strategic Reseach; Lundbeck Foundation(Lundbeckfonden)	This study received funding from the Danish Council for Strategic Reseach (http://ufm.dk/en/research-and-innovation/councils-and-commissions/former-councils-and-commissions/the-danish-council-for-strategic-research) with grant number 1309-00003B received by ICB. The funders had no role in study design, data collection and analysis or preparation of this manuscript.	[Anonymous], 2016, OPENLY BRAVELY TOGET; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bellows AL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111258; Bermejo F, 2009, WORLD J GASTROENTERO, V15, P4638, DOI 10.3748/wjg.15.4638; Bruneel A, 2012, J CLIN LAB ANAL, V26, P384, DOI 10.1002/jcla.21539; Dewey KG, 2017, AM J CLIN NUTR, V106, p1694S, DOI 10.3945/ajcn.117.156075; Dixon J R Jr, 1998, Qual Assur, V6, P65; Douglas G., 1991, ALTMAN PRACTICAL STA, P349; Ecker O, 2010, AFR J AGRIC RESOUR E, V4, P175; Engle-Stone R, 2013, J NUTR, V143, P369, DOI 10.3945/jn.112.167775; Ford J, 2013, INT J LAB HEMATOL, V35, P351, DOI 10.1111/ijlh.12082; Ghosh S., 2017, FASEB J, V31, P788; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Haile ZT, 2017, SEX REPROD HEALTHC, V13, P97, DOI 10.1016/j.srhc.2017.07.003; Hinderaker SG, 2002, EUR J CLIN NUTR, V56, P192, DOI 10.1038/sj.ejcn.1601300; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Kozuki N, 2012, J NUTR, V142, P358, DOI 10.3945/jn.111.149237; Low MSY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009747.pub2; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Mwakitalu ME, 2014, ACTA TROP, V133, P35, DOI 10.1016/j.actatropica.2014.01.012; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; National Bureu of Statistics, 2016, TANZANIA DEMOGRAPHIC; Nyaradi A, 2013, FRONT HUM NEUROSCI, P7; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Petry N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110693; Nguyen P, 2014, FOOD NUTR BULL, V35, P301, DOI 10.1177/156482651403500303; Ribot B, 2012, HUM REPROD, V27, P1260, DOI 10.1093/humrep/des026; Rohner F, 2017, AM J CLIN NUTR, V106, p372S, DOI 10.3945/ajcn.116.142232; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Schmiegelow C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044773; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Suchdev PS, 2017, AM J CLIN NUTR, V106, p1626S, DOI 10.3945/ajcn.117.155937; Suwansaksri Jamsai, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P97; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2011, SER FERR CONC ASS IR; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; Wirth JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155031; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2016, GUID DAIL IR SUPPL A; Wrottesley SV, 2016, J DEV ORIG HLTH DIS, V7, P144, DOI 10.1017/S2040174415001439; Zillmer Krista, 2017, BMC Nutr, V3, P65, DOI 10.1186/s40795-017-0166-y; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0208413	10.1371/journal.pone.0208413	http://dx.doi.org/10.1371/journal.pone.0208413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562390	gold, Green Published, Green Submitted			2022-12-26	WOS:000453774100015
J	Wang, HY; Lian, PJ; Niu, XF; Zhao, LH; Mu, X; Feng, BY; Li, JY; Liang, ZN; Qiao, J				Wang, Hongyan; Lian, Pengjing; Niu, Xiaofei; Zhao, Lihong; Mu, Xiang; Feng, Bo; Li, Jingyun; Liang, Zhenni; Qiao, Jian			TLR4 deficiency reduces pulmonary resistance to Streptococcus pneumoniae in gut microbiota-disrupted mice	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; HOST-DEFENSE; IN-VITRO; INTESTINAL MICROBIOTA; BACTERIAL-INFECTION; CONFERS RESISTANCE; INNATE IMMUNITY; PNEUMOLYSIN	Streptococcus pneumoniae is a clinically important pathogen responsible for significant morbidity and mortality worldwide. Disruption of the host gut microbiota by antibiotics reduces the pulmonary resistance to S. pneumoniae. The aim of our study was to determine the potential role of TLR4 in the reduced pulmonary resistance to S. pneumoniae following gut microbiota disruption. Wild-type and TLR4-deficient mice were given broad-spectrum antibiotics for 3 weeks by oral gavage to disrupt the gut microbiota, and subsequently inoculated intra-nasally with S. pneumoniae. The extent of the decline in pulmonary resistance in both animal groups was evaluated in terms of the overall survival and pulmonary bacterial clearance. Both survival and pulmonary clearance of S. pneumoniae were lower in the TLR4-deficient mice with disrupted gut microbiota, compared to their intestinally healthy counterparts after pneumococcal infection. However, the degree of decline was much lower in the TLR4-deficient mice compared to the wild-type mice. Our findings indicate that impaired TLR4 function might be the basis of the reduced pulmonary resistance to S. pneumoniae caused by gut microbiota disruption.	[Wang, Hongyan; Lian, Pengjing; Niu, Xiaofei; Zhao, Lihong; Feng, Bo; Li, Jingyun; Liang, Zhenni; Qiao, Jian] China Agr Univ, Coll Vet Med, Dept Pathophysiol, Beijing, Peoples R China; [Niu, Xiaofei] Hebei Univ Engn, Coll Life Sci & Food Engn, Dept Vet Med, Handan, Peoples R China; [Mu, Xiang] Beijing Univ Agr, Anim Sci & Technol Coll, Beijing Key Lab Tradit Chinese Vet Med, Beijing, Peoples R China	China Agricultural University; Hebei University of Engineering; Beijing University of Agriculture	Qiao, J (corresponding author), China Agr Univ, Coll Vet Med, Dept Pathophysiol, Beijing, Peoples R China.	qiaojian@cau.edu.cn	Li, Jing/GYU-5036-2022; hongyan, wang/GWQ-6360-2022		National Natural Science Foundation of China [31372400, 30972163]; Earmarked Fund for Hebei Layer-Broiler Innovation Team of Modern Agro-industry Technology Research System [HBCT2018150208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Hebei Layer-Broiler Innovation Team of Modern Agro-industry Technology Research System	This work was supported by grants from the National Natural Science Foundation of China (No. 31372400 and No. 30972163) and the Earmarked Fund for Hebei Layer-Broiler Innovation Team of Modern Agro-industry Technology Research System (No. HBCT2018150208), http://www.nsfc.gov.cn/english/site_1/index.html, http://www.hbdrjcyjstx.com/.	Amaro R, 2016, EUR RESPIR J, V48, P797, DOI 10.1183/13993003.00039-2016; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Brown RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01803-x; Campbell GD, 1998, CLIN INFECT DIS, V26, P1188, DOI 10.1086/520286; Clarke TB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004506; Clarke TB, 2014, INFECT IMMUN, V82, P4596, DOI 10.1128/IAI.02212-14; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Nguyen CT, 2015, MOL CELLS, V38, P58, DOI 10.14348/molcells.2015.2231; Nguyen CT, 2014, J INFECT DIS, V210, P1745, DOI 10.1093/infdis/jiu352; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dockrell DH, 2012, CHEST, V142, P482, DOI 10.1378/chest.12-0210; Dogan S, 2011, MICROBES INFECT, V13, P65, DOI 10.1016/j.micinf.2010.10.003; dos Santos G, 2012, AM J PHYSIOL-LUNG C, V303, pL627, DOI 10.1152/ajplung.00225.2012; Duan YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179718; Fagundes CT, 2012, J IMMUNOL, V188, P1411, DOI 10.4049/jimmunol.1101682; Fukuda Y, 2006, EUR RESPIR J, V27, P1020, DOI 10.1183/09031936.06.00116805; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Guseinov TS, 2008, B EXP BIOL MED+, V145, P755, DOI 10.1007/s10517-008-0187-2; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Lankelma JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005548; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McAleer JP, 2018, EUR J IMMUNOL, V48, P39, DOI 10.1002/eji.201646721; Moreland JG, 2006, AM J PHYSIOL-LUNG C, V290, pL833, DOI 10.1152/ajplung.00333.2005; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rijneveld AW, 2001, J IMMUNOL, V167, P5240, DOI 10.4049/jimmunol.167.9.5240; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schmitz FJ, 2001, J ANTIMICROB CHEMOTH, V48, P588, DOI 10.1093/jac/48.4.588; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; Sings HL, 2017, VACCINE, V35, P5406, DOI 10.1016/j.vaccine.2017.05.075; SRISKANDAN S, 1995, J INFECTION, V30, P201, DOI 10.1016/S0163-4453(95)90647-9; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Strieter RM, 2003, CURR OPIN INFECT DIS, V16, P193, DOI 10.1097/00001432-200306000-00002; Sun XY, 2017, MOL IMMUNOL, V83, P1, DOI 10.1016/j.molimm.2017.01.002; Takashima K, 1997, INFECT IMMUN, V65, P257, DOI 10.1128/IAI.65.1.257-260.1997; Tsay TB, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-68; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; vanderPoll T, 1997, AM J RESP CRIT CARE, V155, P603, DOI 10.1164/ajrccm.155.2.9032201; Verhagen LM, 2016, EUR RESPIR J, V48, P1492, DOI 10.1183/13993003.00890-2016; Viasus D, 2017, EXPERT REV ANTI-INFE, V15, P351, DOI 10.1080/14787210.2017.1274232	51	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209183	10.1371/journal.pone.0209183	http://dx.doi.org/10.1371/journal.pone.0209183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562386	Green Published, gold, Green Submitted			2022-12-26	WOS:000453774100039
J	Maimouni, S; Issa, N; Cheng, S; Ouaari, C; Cheema, A; Kumar, D; Byers, S				Maimouni, Sara; Issa, Naiem; Cheng, Selina; Ouaari, Chokri; Cheema, Amrita; Kumar, Deepak; Byers, Stephen			Tumor suppressor RARRES1-A novel regulator of fatty acid metabolism in epithelial cells	PLOS ONE			English	Article							TAZAROTENE-INDUCED GENE-1; ACTIVATED RECEPTOR-GAMMA; DE-NOVO LIPOGENESIS; LIPID-METABOLISM; ALPHA; EXPRESSION; OXIDATION; HYPERMETHYLATION; LIVER; IDENTIFICATION	Retinoic acid receptor responder 1 (RARRES1) is silenced in many cancers and is differentially expressed in metabolism associated diseases, such as hepatic steatosis, hyperinsulinemia and obesity. Here we report a novel function of RARRES1 in metabolic reprogramming of epithelial cells. Using non-targeted LC-MS, we discovered that RARRES1 depletion in epithelial cells caused a global increase in lipid synthesis. RARRES1-depleted cells rewire glucose metabolism by switching from aerobic glycolysis to glucose-dependent de novo lipogenesis (DNL). Treatment with fatty acid synthase (FASN) inhibitor, C75, reversed the effects of RARRES1 depletion. The increased DNL in RARRES1-depleted normal breast and prostate epithelial cells proved advantageous to the cells during starvation, as the increase in fatty acid availability lead to more oxidized fatty acids (FAO), which were used for mitochondrial respiration. Expression of RARRES1 in several common solid tumors is also contextually correlated with expression of fatty acid metabolism genes and fatty acid-regulated transcription factors. Pathway enrichment analysis led us to determine that RARRES1 is regulated by peroxisome proliferating activated receptor (PPAR) signaling. These findings open up a new avenue for metabolic reprogramming and identify RARRES1 as a potential target for cancers and other diseases with impaired fatty acid metabolism.	[Maimouni, Sara; Byers, Stephen] Georgetown Univ1, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA; [Issa, Naiem; Cheng, Selina; Ouaari, Chokri; Cheema, Amrita; Byers, Stephen] Georgetown Univ, Dept Oncol, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Ouaari, Chokri] Univ Dist Columbia, Washington, DC USA; [Kumar, Deepak] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	Georgetown University; University of the District of Columbia; University of North Carolina; North Carolina Central University	Byers, S (corresponding author), Georgetown Univ1, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA.; Byers, S (corresponding author), Georgetown Univ, Dept Oncol, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu	Issa, Naiem/AAF-6209-2019	Issa, Naiem/0000-0002-5885-3909; Cheng, Selina/0000-0001-9104-8541; Maimouni, Sara/0000-0002-6085-0766; Byers, Stephen/0000-0003-3036-3518	TL-1 Fellowship from the Georgetown University CTSA; DOD [W81XWH-12-1-0424]; Medical graduate student organization (MCGSO) mini grant; Shared Resources of the Lombardi Comprehensive Cancer Center [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	TL-1 Fellowship from the Georgetown University CTSA; DOD(United States Department of Defense); Medical graduate student organization (MCGSO) mini grant; Shared Resources of the Lombardi Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a TL-1 Fellowship from the Georgetown University CTSA (SM), DOD grant W81XWH-12-1-0424 to SB and DK, a Medical graduate student organization (MCGSO) mini grant (SM) and Shared Resources of the Lombardi Comprehensive Cancer Center P30-CA051008.; We want to thank Evan Paankuk for helping us analyze the lipidomics data. This work was supported by a TL-1 Fellowship from the Georgetown University CTSA (SM), DOD grant W81XWH-12-1-0424 to SB and DK, a Medical graduate student organization (MCGSO) mini grant (SM) and by Shared Resources of the Lombardi Comprehensive Cancer Center (P30CA051008).	Abshagen K, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0229-0; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Coyle KM, 2016, ONCOTARGET, V7, P44096, DOI 10.18632/oncotarget.9858; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Ensenauer R, 2012, J LIPID RES, V53, P1012, DOI 10.1194/jlr.D022608; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Ghosh SP, 2013, MOL BIOSYST, V9, P723, DOI 10.1039/c3mb25454b; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gueuvoghlanian-Silva BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144027; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; HOLLOWAY PW, 1964, J BIOL CHEM, V239, P2489; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huebner H, 2017, J EXP CLIN CANC RES, V36, DOI [10.1186/s13046-017-0509-1, DOI 10.1186/S13046-017-0509-1]; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kloth M, 2012, INT J CANCER, V131, pE897, DOI 10.1002/ijc.27628; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Lee SJ, 2006, MOL PHARMACOL, V70, P415, DOI 10.1124/mol.106.022954; Listenberger L.L., 2007, CURR PROTOC CELL BIO, V35, p24.2.1, DOI [DOI 10.1002/0471143030.CB2401S35, 10.1002/0471143030.cb2402s35, DOI 10.1002/0471143030.CB2402S35]; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McFadden JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115642; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Nambiar DK, 2014, ONCOTARGET, V5, P10017, DOI 10.18632/oncotarget.2488; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180344; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shyu RY, 2016, MOL CELLS, V39, P877, DOI 10.14348/molcells.2016.0161; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Teufel A, 2012, J MOL MED, V90, P1439, DOI 10.1007/s00109-012-0919-7; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Ullah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069754; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yamashita Y, 2017, BMC CANCER, V17, P1, DOI [10.1186/s12885-016-3022-6, DOI 10.1186/S12885-016-3022-6]; Yanatatsaneejit P, 2008, ORAL ONCOL, V44, P400, DOI 10.1016/j.oraloncology.2007.05.008; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164	71	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208756	10.1371/journal.pone.0208756	http://dx.doi.org/10.1371/journal.pone.0208756			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557378	Green Published, gold, Green Submitted			2022-12-26	WOS:000453451000042
J	Backman, APE; Halin, J; Nurmi, H; Mouts, A; Kjellberg, MA; Mattjus, P				Backman, Anders P. E.; Halin, Josefin; Nurmi, Henrik; Mouts, Anna; Kjellberg, Matti A.; Mattjus, Peter			Glucosylceramide acyl chain length is sensed by the glycolipid transfer protein	PLOS ONE			English	Article							CERAMIDE SYNTHASE 2; MEMBRANE-PROTEIN; UDP-GALACTOSE; BINDING; VAP; SPHINGOLIPIDS; METABOLISM; SURFACE; GALACTOSYLCERAMIDE; SPHINGOMYELIN	The glycolipid transfer protein, GLTP, can be found in the cytoplasm, and it has a FFAT-like motif (two phenylalanines in an acidic tract) that targets it to the endoplasmic reticulum (ER). We have previously shown that GLTP can bind to a transmembrane ER protein, vesicle-associated membrane protein-associated protein A (VAP-A), which is involved in a wide range of ER functions. We have addressed the mechanisms that might regulate the association between GLTP and the VAP proteins by studying the capacity of GLTP to recognize different N-linked acyl chain species of glucosylceramide. We used surface plasmon resonance and a lipid transfer competition assay to show that GLTP prefers shorter N-linked fully saturated acyl chain glucosylceramides, such as C8, C12, and C16, whereas long C18, C20, and C24-glucosylceramides are all bound more weakly and transported more slowly than their shorter counterparts. Changes in the intrinsic GLTP tryptophan fluorescence blue-shifts, also indicate a break-point between C16- and C18-glucosylceramide in the GLTP sensing ability. It has long been postulated that GLTP would be a sensor in the sphingolipid synthesis machinery, but how this mechanistically occurs has not been addressed before. It is unclear what proteins the GLTP VAP association would influence. Here we found that if GLTP has a bound GIcCer the association with VAP-A is weaker. We have also used a formula for identifying putative FFAT-domains, and we identified several potential VAP-interactors within the ceramide and sphingolipid synthesis pathways that could be candidates for regulation by GLTP.	[Backman, Anders P. E.; Halin, Josefin; Nurmi, Henrik; Mouts, Anna; Kjellberg, Matti A.; Mattjus, Peter] Abo Akad Univ, Fac Sci & Engn, Biochem, Artillerigatan 6A,3, Turku, Finland	Abo Akademi University	Mattjus, P (corresponding author), Abo Akad Univ, Fac Sci & Engn, Biochem, Artillerigatan 6A,3, Turku, Finland.	pmattjus@abo.fi	Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; Halin, Josefin/0000-0002-0125-469X; Backman, Anders/0000-0001-8144-4030	Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Medicinska Understodsforeningen Liv och Halsa; Stiftelsen for Abo Akademi	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Medicinska Understodsforeningen Liv och Halsa; Stiftelsen for Abo Akademi	This research was supported by the Sigrid Juselius Foundation, Magnus Ehrnrooth Foundation, Svenska Kulturfonden, Medicinska Understodsforeningen Liv och Halsa and Stiftelsen for Abo Akademi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE A, 1989, BIOCHIM BIOPHYS ACTA, V985, P38, DOI 10.1016/0005-2736(89)90100-4; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BASU S, 1968, J BIOL CHEM, V243, P5802; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Castro BM, 2009, J BIOL CHEM, V284, P22978, DOI 10.1074/jbc.M109.026567; COHEN R, 1984, CHEM PHYS LIPIDS, V35, P371, DOI 10.1016/0009-3084(84)90079-3; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; Ebel P, 2014, BIOCHEM J, V461, P147, DOI 10.1042/BJ20131242; Engberg O, 2015, LANGMUIR, V31, P4255, DOI 10.1021/acs.langmuir.5b00403; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Garofalo T, 2016, AUTOPHAGY, V12, P917, DOI 10.1080/15548627.2016.1160971; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Kim YA, 2011, CHEM COMMUN, V47, P9236, DOI 10.1039/c1cc12345a; Kjellberg MA, 2017, METHODS MOL BIOL, V1609, P231, DOI 10.1007/978-1-4939-6996-8_19; Kjellberg MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143385; Kjellberg MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097263; Kjellberg MA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070283, 10.1371/annotation/712bb339-6073-4e62-9f68-b285caedd913]; Kremser C, 2013, HISTOCHEM CELL BIOL, V140, P533, DOI 10.1007/s00418-013-1091-z; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Ledeen R, 2011, J NEUROCHEM, V116, P714, DOI 10.1111/j.1471-4159.2010.07115.x; Ledeen RW, 2008, J LIPID RES, V49, P1176, DOI 10.1194/jlr.R800009-JLR200; Ledeen RW, 2006, BBA-MOL CELL BIOL L, V1761, P588, DOI 10.1016/j.bbalip.2006.04.010; Ledeen RW, 2006, J CELL BIOCHEM, V97, P893, DOI 10.1002/jcb.20731; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2015, Q REV BIOPHYS, P1, DOI [10.1017/S0033583514000110, DOI 10.1017/S0033583514000110]; Malinina L, 2017, ANNU REV BIOCHEM, V86, P609, DOI 10.1146/annurev-biochem-061516-044445; Mattjus P, 2002, J BIOL CHEM, V277, P19476, DOI 10.1074/jbc.M201305200; Mattjus P, 2016, CHEM PHYS LIPIDS, V194, P72, DOI 10.1016/j.chemphyslip.2015.07.018; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mitne-Neto M, 2007, PROTEIN EXPRES PURIF, V55, P139, DOI 10.1016/j.pep.2007.04.007; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Nyholm TKM, 2011, LANGMUIR, V27, P8339, DOI 10.1021/la201427w; Nylund M, 2005, BBA-BIOMEMBRANES, V1669, P87, DOI 10.1016/j.bbamem.2004.12.014; Nylund M, 2006, BBA-BIOMEMBRANES, V1758, P807, DOI 10.1016/j.bbamem.2006.04.023; Oertel S, 2017, CELL MOL LIFE SCI; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Olson DK, 2016, BBA-MOL CELL BIOL L, V1861, P784, DOI 10.1016/j.bbalip.2015.12.021; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Sandhoff K, 2013, BIOCHEM SOC T, V41, P1562, DOI 10.1042/BST20130083; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sprong H, 2000, METHOD ENZYMOL, V311, P59; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2014, CHEM PHYS LIPIDS, V178, P27, DOI 10.1016/j.chemphyslip.2013.10.013; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Viitanen L, 2006, FEBS J, V273, P5641, DOI 10.1111/j.1742-4658.2006.05553.x; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; West G, 2006, BBA-BIOMEMBRANES, V1758, P1732, DOI 10.1016/j.bbamem.2006.06.020; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200	71	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209230	10.1371/journal.pone.0209230	http://dx.doi.org/10.1371/journal.pone.0209230			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550553	gold, Green Published, Green Submitted			2022-12-26	WOS:000453248000050
J	Sinnesael, A; Eeckhout, S; Janssens, SB; Smets, E; Panis, B; Leroux, O; Verstraete, B				Sinnesael, Arne; Eeckhout, Sharon; Janssens, Steven B.; Smets, Erik; Panis, Bart; Leroux, Olivier; Verstraete, Brecht			Detection of Burkholderia in the seeds of Psychotria punctata (Rubiaceae) - Microscopic evidence for vertical transmission in the leaf nodule symbiosis	PLOS ONE			English	Article							ENDOPHYTES; COLONIZATION; ANGIOSPERMS; DIVERSITY; BACTERIA; GENOME; GENERA	Background and aims The bacterial leaf nodule symbiosis is a close interaction between endophytes and their plant hosts, mainly within the coffee family. The interaction between Rubiaceae species and Burkholderia bacteria is unique due to its obligate nature, high specificity, and predominantly vertical transmission of the endophytes to the next generation of host plants. This vertical transmission is intriguing since it is the basis for the uniqueness of the symbiosis. However, unequivocal evidence of the location of the endophytes in the seeds is lacking. The aim of this paper is therefore to demonstrate the presence of the host specific endophyte in the seeds of Psychotria punctata and confirm its precise location. In addition, the suggested location of the endophyte in other parts of the host plant is investigated. Methods To identify and locate the endophyte in Psychotria punctata, a two-level approach was adopted using both a molecular screening method and fluorescent in situ hybridisation microscopy. Key results The endophytes, molecularly identified as Candidatus Burkholderia kirkii, were detected in the leaves, vegetative and flower buds, anthers, gynoecium, embryos, and young twigs. In addition, they were in situ localised in leaves, flowers and shoot apical meristems, and, for the first time, in between the cotyledons of the embryos. Conclusions Both independent techniques detected the host specific endophyte in close proximity to the shoot apical meristem of the embryo, which confirms for the first time the exact location of the endophytes in the seeds. This study provides reliable proof that the endophytes are maintained throughout the growth and development of the host plant and are transmitted vertically to the offspring.	[Sinnesael, Arne; Smets, Erik] Katholieke Univ Leuven, Dept Biol, Plant Conservat & Populat Biol, Leuven, Belgium; [Sinnesael, Arne; Janssens, Steven B.] Bot Garden Meise, Meise, Belgium; [Eeckhout, Sharon; Leroux, Olivier] Univ Ghent, Dept Biol, Ghent, Belgium; [Smets, Erik] Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands; [Panis, Bart] Biovers Int, Leuven, Belgium; [Verstraete, Brecht] Univ Oslo, Nat Hist Museum, Oslo, Norway	KU Leuven; Ghent University; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Alliance; Bioversity International; University of Oslo	Sinnesael, A (corresponding author), Katholieke Univ Leuven, Dept Biol, Plant Conservat & Populat Biol, Leuven, Belgium.; Sinnesael, A (corresponding author), Bot Garden Meise, Meise, Belgium.	arne.sinnesael@kuleuven.be	Verstraete, Brecht/E-4141-2015; Smets, Erik F/A-9875-2011; Sinnesael, Arne/Y-8422-2019	Verstraete, Brecht/0000-0001-9332-7798; Smets, Erik F/0000-0002-9416-983X; Sinnesael, Arne/0000-0002-9723-0034; Panis, Bart/0000-0001-6717-947X	Research Foundation - Flanders (FWO) [11ZG118N]	Research Foundation - Flanders (FWO)(FWO)	AS is supported financially by the Research Foundation - Flanders (FWO) via a PhD fellowship (11ZG118N). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barret M, 2015, APPL ENVIRON MICROB, V81, P1257, DOI 10.1128/AEM.03722-14; Cardarelli M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00333; Carlier AL, 2013, MOL PLANT MICROBE IN, V26, P1325, DOI 10.1094/MPMI-05-13-0152-R; Carlier AL, 2012, ENVIRON MICROBIOL, V14, P2757, DOI 10.1111/j.1462-2920.2012.02763.x; Compant S, 2008, FEMS MICROBIOL ECOL, V63, P84, DOI 10.1111/j.1574-6941.2007.00410.x; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Darbyshire I., 2015, PLANTS SUDAN S SUDAN; Darsonval A, 2008, APPL ENVIRON MICROB, V74, P2669, DOI 10.1128/AEM.02906-07; Douglas A.E., 2010, SYMBIOTIC HABIT; Figueiredo RD, 2013, S AFR J BOT, V84, P110, DOI 10.1016/j.sajb.2012.10.008; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hodgson S, 2014, ECOL EVOL, V4, P1199, DOI 10.1002/ece3.953; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Lemaire B, 2016, SYST APPL MICROBIOL, V39, P41, DOI 10.1016/j.syapm.2015.09.006; Lemaire B, 2012, FEMS MICROBIOL ECOL, V81, P364, DOI 10.1111/j.1574-6941.2012.01356.x; Lemaire B, 2012, APPL ENVIRON MICROB, V78, P284, DOI 10.1128/AEM.06130-11; Lemaire B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024430; LERSTEN NR, 1976, BOT REV, V42, P145, DOI 10.1007/BF02860721; LERSTEN NR, 1974, AM J BOT, V61, P973, DOI 10.2307/2441988; LERSTEN NR, 1967, J BACTERIOL, V94, P2027, DOI 10.1128/JB.94.6.2027-2036.1967; Madmony A, 2005, FOLIA MICROBIOL, V50, P209, DOI 10.1007/BF02931568; MILLER IM, 1990, ADV BOT RES, V17, P163, DOI 10.1016/S0065-2296(08)60134-2; Mitter EK, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00849, 10.3389/fmicb.2017.00011]; Partida-Martinez LP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00100; Pinto-Carbo M, 2018, CURR OPIN PLANT BIOL, V44, P23, DOI 10.1016/j.pbi.2018.01.001; Pinto-Carbo M, 2016, ISME J, V10, P2092, DOI 10.1038/ismej.2016.27; Robinson RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25581; Schlaberg R, 2012, EMERG INFECT DIS, V18, P422, DOI 10.3201/eid1803.111481; Selosse MA, 2004, CR BIOL, V327, P639, DOI 10.1016/j.crvi.2003.12.008; Shade A, 2017, CURR OPIN MICROBIOL, V37, P15, DOI 10.1016/j.mib.2017.03.010; Sieber S, 2015, ANGEW CHEM INT EDIT, V54, P7968, DOI 10.1002/anie.201502696; Spilker T, 2009, J CLIN MICROBIOL, V47, P2607, DOI 10.1128/JCM.00770-09; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Truyens S, 2015, ENV MICROBIOL REP, V7, P40, DOI 10.1111/1758-2229.12181; Van Oevelen S., 2003, Bulgarian Journal of Plant Physiology, P242; Van Oevelen S, 2002, INT J SYST EVOL MICR, V52, P2023, DOI [10.1099/ijs.0.02103-0, 10.1099/00207713-52-6-2023]; VANWYK AE, 1990, S AFR J SCI, V86, P93; Verstraete B, 2013, AM J BOT, V100, P2380, DOI 10.3732/ajb.1300303; Verstraete B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055260; Verstraete B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019265; von Faber FC, 1992, JB WISS BOT, V51, P285	43	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209091	10.1371/journal.pone.0209091	http://dx.doi.org/10.1371/journal.pone.0209091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550604	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000043
J	van den Tempel, N; Naipal, KAT; Reams, A; van Gent, DC; Franckena, M; Boormans, JL; Kanaar, R				van den Tempel, Nathalie; Naipal, Kishan A. T.; Reams, Anja; van Gent, Dik C.; Franckena, Martine; Boormans, Joost L.; Kanaar, Roland			Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MITOMYCIN-C; CROSS-LINKS; CELL-LINES; REPAIR; CHEMOTHERAPY; CARCINOMA; CISPLATIN; THERAPY; FUTURE	Introduction Bladder cancer (urothelial carcinoma) is a common malignancy characterized by high recurrence rates and intense clinical follow-up, indicating the necessity for more effective therapies. Current treatment regimens include intra-vesical administration of mitomycin C (MMC) for non-muscle invasive disease and systemic cisplatin for muscle-invasive or metastatic disease. Hyperthermia, heating a tumor to 40-44 degrees C, enhances the efficacy of these chemotherapeutics by various modes of action, one of which is inhibition of DNA repair via homologous recombination. Here, we explore whether ex vivo assays on freshly obtained bladder tumors can be applied to predict the response towards hyperthermia. Material and methods The cytochrome C release assay (apoptosis) and the RAD51 focus formation assay (DNA repair) were first established in the bladder cancer cell lines RT112 and T24 as measurements for hyperthermia efficiency, and subsequently tested in freshly obtained bladder tumors (n = 59). Results Hyperthermia significantly increased the fraction of apoptotic cells after cisplatin or MMC treatment in both RT112 and T24 cells and in most of the bladder tumors (8/10). The RAD51 focus formation assay detected both morphological and numerical changes of RAD51 foci upon hyperthermia in the RT112 and T24 cell lines. In 64% of 37 analyzed primary bladder tumor samples, hyperthermia induced similar morphological changes in RAD51 foci. Conclusion The cytochrome C assay and the RAD51 focus formation assay are both feasible on freshly obtained bladder tumors, and could serve to predict the efficacy of hyperthermia together with cytotoxic agents, such as MMC or cisplatin.	[van den Tempel, Nathalie; Naipal, Kishan A. T.; Reams, Anja; van Gent, Dik C.; Kanaar, Roland] Erasmus Univ, Dept Mol Genet, Med Ctr, Rotterdam, Netherlands; [van Gent, Dik C.; Kanaar, Roland] Erasmus Univ, Oncode Inst, Dept Mol Genet, Med Ctr, Rotterdam, Netherlands; [Franckena, Martine] Erasmus MC Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands; [Boormans, Joost L.] Erasmus MC Canc Inst, Dept Urol, Rotterdam, Netherlands; [van den Tempel, Nathalie] Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Groningen	Kanaar, R (corresponding author), Erasmus Univ, Dept Mol Genet, Med Ctr, Rotterdam, Netherlands.; Kanaar, R (corresponding author), Erasmus Univ, Oncode Inst, Dept Mol Genet, Med Ctr, Rotterdam, Netherlands.; Boormans, JL (corresponding author), Erasmus MC Canc Inst, Dept Urol, Rotterdam, Netherlands.	j.boormans@erasmusmc.nl; r.kanaar@erasmusmc.nl		van Gent, Dik C./0000-0003-1473-8148; Naipal, Kishan/0000-0001-8267-8218	European Community's Seventh Framework Programme (FP7/2007-2013) [HEALTH-F2-2010-259893]; Erasmus MC MRace grant; Dutch Cancer Society [DDHK 2013-6072, EMCR 2015-7846]; Netherlands Organisation for Scientific Research (NWO); Oncode Institute - Dutch Cancer Society	European Community's Seventh Framework Programme (FP7/2007-2013); Erasmus MC MRace grant; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Oncode Institute - Dutch Cancer Society	DCvG received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F2-2010-259893 (https://ec.europa.eu/research/fp7/index_en.cfm).RK was supported by an Erasmus MC MRace grant (https://www.erasmusmc.nl/research/over-research/subsidies/subsidies/#). The Dutch Cancer Society awarded grants to MF (DDHK 2013-6072) and RK (EMCR 2015-7846) https://www.kwf.nl/pages/default.aspx.The work in RK's laboratory was funded by the gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO) and is part of the Oncode Institute, which is partly financed by the Dutch Cancer Society (https://www.oncode.nl/).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002; Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Arends TJH, 2016, EUR UROL, V69, P1046, DOI 10.1016/j.eururo.2016.01.006; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; BEDFORD P, 1987, CHEM-BIOL INTERACT, V61, P1, DOI 10.1016/0009-2797(87)90015-9; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Dewhirst MW, 2016, INT J HYPERTHER, V32, P4, DOI 10.3109/02656736.2015.1091093; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Heijkoop ST, 2014, INT J HYPERTHER, V30, P6, DOI 10.3109/02656736.2013.844366; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Karkoulis PK, 2016, TUMOR BIOL, V37, P6861, DOI 10.1007/s13277-015-4544-2; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Krawczyk PM, 2011, P NATL ACAD SCI USA, V108, P9851, DOI 10.1073/pnas.1101053108; Lammers RJM, 2011, EUR UROL, V60, P81, DOI 10.1016/j.eururo.2011.04.023; Landon CD, 2013, INT J HYPERTHER, V29, P528, DOI 10.3109/02656736.2013.790563; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Longo TA, 2016, INT J HYPERTHER, V32, P381, DOI 10.3109/02656736.2016.1157903; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Mutter RW, 2017, J PATHOL; Naipal KAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126029; Naipal KAT, 2014, CLIN CANCER RES, V20, P4816, DOI 10.1158/1078-0432.CCR-14-0571; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Oei AL, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0462-0; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Ploussard G, 2014, EUR UROL, V66, P361, DOI 10.1016/j.eururo.2013.09.050; Ploussard G, 2014, EUR UROL, V66, P120, DOI 10.1016/j.eururo.2014.02.038; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Steliarova-Foucher E, 2015, EUR J CANCER, V51, P1131, DOI 10.1016/j.ejca.2014.01.027; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tashiro S, 1996, ONCOGENE, V12, P2165; van den Tempel N, 2017, ONCOTARGET; van den Tempel N, 2016, INT J HYPERTHER, V32, P446, DOI 10.3109/02656736.2016.1157216; van der Heijden AG, 2004, EUR UROL, V46, P670, DOI 10.1016/j.eururo.2004.06.009; van der Heijden AG, 2016, INT J HYPERTHER, V32, P434, DOI 10.3109/02656736.2016.1155761; van Kessel KEM, 2015, NAT REV UROL, V12, P681, DOI 10.1038/nrurol.2015.231; van Valenberg H, 2016, INT J HYPERTHER, V32, P351, DOI 10.3109/02656736.2016.1140232; Vaughn JP, 1996, CANCER RES, V56, P4590; Volpe A, 2010, MINERVA UROL NEFROL, V62, P133; WALKER MC, 1987, J NATL CANCER I, V79, P213; Yang ZY, 2017, DNA REPAIR, V52, P1, DOI 10.1016/j.dnarep.2017.02.011	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2018	13	12							e0209101	10.1371/journal.pone.0209101	http://dx.doi.org/10.1371/journal.pone.0209101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IQ	30550547	Green Published, Green Submitted, gold			2022-12-26	WOS:000453248000045
J	Xie, YQ; Fan, HY; Lu, WF; Yang, Q; Nurkesh, A; Yeleussizov, T; Maipas, A; Lu, J; Manarbek, L; Chen, ZB; Benassi, E				Xie, Yingqiu; Fan, Haiyan; Lu, Wenfu; Yang, Qing; Nurkesh, Ayan; Yeleussizov, Tleubek; Maipas, Aisulu; Lu, Jiang; Manarbek, Limara; Chen, Zhenbang; Benassi, Enrico			Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer	ONCOGENE			English	Article							KINASE INHIBITORS; TUMOR-SUPPRESSOR; ERK ACTIVATION; C-MET; RECEPTOR; RESISTANCE; DOTS; KEGG; TRANSACTIVATION; NANOPARTICLES	Nuclear receptor tyrosine kinases (nRTKs) are aberrantly upregulated in many types of cancers, but the regulation of nRTK remains unclear. We previously showed androgen deprivation therapy (ADT) induces nMET in castration-resistant prostate cancer (CRPC) specimens. Through gene expression microarray profiles reanalysis, we identified that nMET signaling requires ARF for CRPC growth in Pten/Trp53 conditional knockout mouse model. Accordingly, aberrant MET/nMET elevation correlates with ARF in human prostate cancer (PCa) specimens. Mechanistically, ARF elevates nMET through binding to MET cytoplasmic domain to stabilize MET. Furthermore, carbon nanodots resensitize cancer cells to MET inhibitors through DNA damage response. The inhibition of phosphorylation by carbon nanodots was identified through binding to phosphate group of phospho-tyrosine via computational calculation and experimental assay. Thus, nMET is essential to precision therapy of MET inhibitor. Our findings reveal for the first time that targeting nMET axis by carbon nanodots can be a novel avenue for overcoming drug resistance in cancers especially prostate cancer.	[Xie, Yingqiu; Nurkesh, Ayan; Yeleussizov, Tleubek; Maipas, Aisulu; Manarbek, Limara] Nazarbayev Univ, Dept Biol, Sch Sci & Technol, Astana 010000, Kazakhstan; [Fan, Haiyan; Benassi, Enrico] Nazarbayev Univ, Dept Chem, Sch Sci & Technol, Astana 010000, Kazakhstan; [Lu, Wenfu; Yang, Qing; Chen, Zhenbang] Meharry Med Coll, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA; [Lu, Jiang] Shenzhen Univ, Luohu Hosp, Dept Urol, Shenzhen 51800, Peoples R China; [Lu, Jiang] Luohu Hosp Grp, Shenzhen Following Precis Med Res Inst, Shenzhen 51800, Peoples R China	Nazarbayev University; Nazarbayev University; Meharry Medical College; Shenzhen University	Xie, YQ (corresponding author), Nazarbayev Univ, Dept Biol, Sch Sci & Technol, Astana 010000, Kazakhstan.; Chen, ZB (corresponding author), Meharry Med Coll, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA.	xieautumnus@yahoo.com; zchen@mmc.edu	Xie, Yingqiu/C-5346-2011	Nurkesh, Ayan/0000-0001-6418-8223; Manarbek, Limara/0000-0002-6101-5025	NIH [U54 MD007593, G12 MD007586, R24 DA036420, S10RR0254970, CA091408, MD004038, MD007586, CA163069, UL1 RR02497501, UL1 TR000445-06]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007586, R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We would like to thank Drs. Simon W. Hayward and LaMonica Stewart for cell lines, Lynn M. Matrisian for providing MMP7-Luc plasmid. This work was supported in part by NIH grants MD004038, MD007586, CA091408 and CA163069, UL1 RR02497501 and UL1 TR000445-06. IF and IHC analysis was performed by Meharry Medical College Morphology Core, which is supported in part by NIH grants U54 MD007593, G12 MD007586, R24 DA036420, and S10RR0254970. We would like to thank Dr. Guoliang Li, Zhanna Alexeyeva, Aigerim Kabulova, Zhibek Keneskhanova, Akerke Altaikyzy for the kind help or assistant on research. Quantum mechanical calculations were performed on the clusters of the Siberian Supercomputer Center (http://www2.sscc.ru) of the Institute of Computational Mathematics and Mathematical Geophysics of the Siberian Branch of the Russian Academy of Sciences.	Ahn SY, 2017, ANTICANCER RES, V37, P1127, DOI 10.21873/anticanres.11426; Chen WY, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam6826; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Ding HM, 2018, NANOSCALE HORIZ, V3, P6, DOI 10.1039/c7nh00138j; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Humbey O, 2008, CANCER RES, V68, P9608, DOI 10.1158/0008-5472.CAN-08-2263; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kaur D, 2011, COMPUT THEOR CHEM, V963, P71, DOI 10.1016/j.comptc.2010.09.011; Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104; Kim SM, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.48; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Klahn M, 2004, J PHYS CHEM A, V108, P6186, DOI 10.1021/jp048617g; Lachat Y, 2004, ONCOGENE, V23, P6854, DOI 10.1038/sj.onc.1207872; Li CL, 2014, J MATER CHEM B, V2, P4564, DOI 10.1039/c4tb00216d; Likos CN, 2001, PHYS REP, V348, P267, DOI 10.1016/S0370-1573(00)00141-1; Liu ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep37761; Lu WF, 2013, MOL ENDOCRINOL, V27, P635, DOI 10.1210/me.2012-1294; Mizrachi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14292; Mudryj M, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-5051; Petrushev B, 2016, INT J NANOMED, V11, P641, DOI 10.2147/IJN.S94064; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pozner-Moulis S, 2006, CANCER RES, V66, P7976, DOI 10.1158/0008-5472.CAN-05-4335; Song A, 2015, CLIN CANCER RES, V21, P2379, DOI 10.1158/1078-0432.CCR-14-1350; Tu WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-556; Vacha R, 2011, NANO LETT, V11, P5391, DOI 10.1021/nl2030213; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Vivo M, 2017, ONCOGENE, V36, P4913, DOI 10.1038/onc.2017.104; Wanjala J, 2015, MOL CANCER THER, V14, P278, DOI 10.1158/1535-7163.MCT-14-0542-T; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xie YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16441-y; Xie YQ, 2017, CHEMISTRYSELECT, V2, P4079, DOI 10.1002/slct.201700575; Xie YQ, 2016, ONCOTARGET, V7, P47609, DOI 10.18632/oncotarget.10251; Xie YQ, 2016, CURR CANCER DRUG TAR, V16, P572, DOI 10.2174/1568009616666160105105250; Xie YQ, 2014, MOL ONCOL, V8, P1355, DOI 10.1016/j.molonc.2014.05.006; Xie YQ, 2014, MOL ENDOCRINOL, V28, P1629, DOI 10.1210/me.2014-1078; Xie YQ, 2010, MOL PHARMACOL, V78, P310, DOI 10.1124/mol.109.061713; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Yuan YF, 2017, COLLOID SURFACE B, V159, P349, DOI 10.1016/j.colsurfb.2017.07.030; Zhang M, 2017, CANCER BIOL MED, V14, P212, DOI 10.20892/j.issn.2095-3941.2017.0054	50	7	7	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					2967	2983		10.1038/s41388-018-0608-2	http://dx.doi.org/10.1038/s41388-018-0608-2			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30568225	Green Accepted, Green Submitted			2022-12-26	WOS:000465167600007
J	Sulistomo, HW; Nemoto, T; Yanagita, T; Takeya, R				Sulistomo, Hikmawan Wahyu; Nemoto, Takayuki; Yanagita, Toshihiko; Takeya, Ryu			Formin homology 2 domain-containing 3 (Fhod3) controls neural plate morphogenesis in mouse cranial neurulation by regulating multidirectional apical constriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; adherens junction; cell junction; cell-cell interaction; epithelial cell; formin; neural development; morphogenesis; apical constriction; Fhod3; neural tube closure; neurulation; rhombomere	E-CADHERIN; ADHERENS JUNCTIONS; SPINAL NEURULATION; RAT EMBRYOS; ACTIN; PROTEIN; MECHANISMS; PATTERNS; EXPRESSION; DAAM1	Neural tube closure requires apical constriction during which contraction of the apical F-actin network forces the cell into a wedged shape, facilitating the folding of the neural plate into a tube. However, how F-actin assembly at the apical surface is regulated in mammalian neurulation remains largely unknown. We report here that formin homology 2 domain-containing 3 (Fhod3), a formin protein that mediates F-actin assembly, is essential for cranial neural tube closure in mouse embryos. We found that Fhod3 is expressed in the lateral neural plate but not in the floor region of the closing neural plate at the hindbrain. Consistently, in Fhod3-null embryos, neural plate bending at the midline occurred normally, but lateral plates seemed floppy and failed to flex dorsomedially. Because the apical accumulation of F-actin and constriction were impaired specifically at the lateral plates in Fhod3-null embryos, we concluded that Fhod3-mediated actin assembly contributes to lateral plate-specific apical constriction to advance closure. Intriguingly, Fhod3 expression at the hindbrain was restricted to neuromeric segments called rhombomeres. The rhombomere-specific accumulation of apical F-actin induced by the rhombomere-restricted expression of Fhod3 was responsible for the outward bulging of rhombomeres involving apical constriction along the anteroposterior axis, as rhombomeric bulging was less prominent in Fhod3-null embryos than in the wild type. Fhod3 thus plays a crucial role in the morphological changes associated with neural tube closure at the hindbrain by mediating apical constriction not only in the mediolateral but also in the anteroposterior direction, thereby contributing to tube closure and rhombomere segmentation, respectively.	[Sulistomo, Hikmawan Wahyu; Nemoto, Takayuki; Takeya, Ryu] Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan; [Yanagita, Toshihiko] Univ Miyazaki, Fac Med, Sch Nursing, Dept Clin Pharmacol, Miyazaki 8891692, Japan	University of Miyazaki; University of Miyazaki	Takeya, R (corresponding author), Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan.	takeya@med.miyazaki-u.ac.jp		Sulistomo, Hikmawan Wahyu/0000-0002-5343-6428	Japan Society for the Promotion of Science (JSPS) [JP18K06701, JP26460371]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); joint research program of the Biosignal Research Center, Kobe University; President's Strategic Priority Budget of the University of Miyazaki; Otsuka Toshimi Scholarship Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); joint research program of the Biosignal Research Center, Kobe University; President's Strategic Priority Budget of the University of Miyazaki; Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical)	This work was supported in part by Grants-in-aid for Scientific Research (C) JP18K06701 (to T. N.) and JP26460371 (to R. T.) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-aid for Scientific Research on Innovative Areas, "Platform of Advanced Animal Model Support," (to R.T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the joint research program of the Biosignal Research Center, Kobe University (to R. T.); the President's Strategic Priority Budget of the University of Miyazaki (to R. T.); and a scholarship from the Otsuka Toshimi Scholarship Foundation (to H. W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharya BR, 2017, CELL REP, V18, P2854, DOI 10.1016/j.celrep.2017.02.078; Arnold TR, 2017, EXP CELL RES, V358, P20, DOI 10.1016/j.yexcr.2017.03.053; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Filas BA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066007; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grego-Bessa J, 2015, DEVELOPMENT, V142, P1305, DOI 10.1242/dev.115493; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; GUTHRIE S, 1991, J NEUROBIOL, V22, P742, DOI 10.1002/neu.480220709; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Higashi T, 2019, MOL BIOL CELL, V30, P82, DOI 10.1091/mbc.E18-02-0133; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kida Y, 2004, DEV BRAIN RES, V153, P143, DOI 10.1016/j.devbrainres.2004.07.014; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Krumlauf R, 2016, CURR TOP DEV BIOL, V116, P581, DOI 10.1016/bs.ctdb.2015.12.011; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Marin F, 2008, DEV BIOL, V323, P230, DOI 10.1016/j.ydbio.2008.08.017; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; Massarwa R, 2013, DEVELOPMENT, V140, P226, DOI 10.1242/dev.085001; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Matsuyama S, 2018, P NATL ACAD SCI USA, V115, pE4386, DOI 10.1073/pnas.1716498115; MORRISSKAY G, 1985, J EMBRYOL EXP MORPH, V88, P333; MORRISSKAY GM, 1981, J EMBRYOL EXP MORPH, V65, P225; NicholsonFlynn K, 1996, J NEUROSCI, V16, P6853; Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904; Nishimura T, 2016, J CELL BIOL, V215, P559, DOI 10.1083/jcb.201603107; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ohmura T, 2012, DEV DYNAM, V241, P1350, DOI 10.1002/dvdy.23816; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Sandell LL, 2012, GENESIS, V50, P844, DOI 10.1002/dvg.22344; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shum ASW, 1996, ANAT EMBRYOL, V194, P65; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Ushijima T, 2018, J BIOL CHEM, V293, P148, DOI 10.1074/jbc.M117.813931; Vaage S, 1969, Ergeb Anat Entwicklungsgesch, V41, P3; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; WILSON DB, 1995, J ANAT, V186, P209; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Ybot-Gonzalez P, 1999, DEV DYNAM, V215, P273, DOI 10.1002/(SICI)1097-0177(199907)215:3<273::AID-AJA9>3.0.CO;2-H; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	61	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2924	2934		10.1074/jbc.RA118.005471	http://dx.doi.org/10.1074/jbc.RA118.005471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573686	Green Published, hybrid			2022-12-26	WOS:000459601600029
J	Matsunaga, M; Masuda, T; Ishii, K; Ohtsubo, Y; Noguchi, Y; Ochi, M; Yamasue, H				Matsunaga, Masahiro; Masuda, Takahiko; Ishii, Keiko; Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki; Yamasue, Hidenori			Culture and cannabinoid receptor gene polymorphism interact to influence the perception of happiness	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; EMOTIONAL CONTAGION; GENDER; SELF; ASSOCIATION; ADOLESCENTS; DIFFERENCE; SYMPTOMS; 5-HTTLPR; REGION	Previous studies have shown that a cytosine (C) to thymine (T) single nucleotide polymorphism (SNP) of the human cannabinoid receptor 1 (CNR1) gene is associated with positive emotional processing. C allele carriers are more sensitive to positive emotional stimuli including happiness. The effects of several gene polymorphisms related to sensitivity to emotional stimuli, such as that in the serotonin transporter gene-linked polymorphic region (5HTTLPR), on emotional processing have been reported to differ among cultures-e.g., between those that are independent and interdependent. Thus, we postulated that the effects of the CNR1 genotype on happiness might differ among different cultures because the concept of happiness varies by culture. We recruited healthy male and female young adults in Japan, where favorable external circumstances determine the concept of happiness, and Canada, where the concept of happiness centers on positive inner feelings, and compared the effects of the CNR1 genotype on both subjective happiness levels (self-evaluation as being a happy person) and situation-specific happiness (happy feelings accompanying various positive events) by using a questionnaire. We found that the effect of CNR1 on subjective happiness was different between the Japanese and Canadian groups. The subjective happiness level was the highest in Japanese individuals with the CC genotype, whereas in Canadian participants, it was the highest in individuals with the TT genotype. Furthermore, the effects of CNR1 genotype on situation-specific happiness were also different between the groups. Happiness accompanied with being surrounded by happy people was the highest among Japanese individuals with the CC genotype, whereas among Canadian individuals, it was the highest in TT genotype carriers. These findings suggest that culture and CNR1 polymorphism interact to influence the perception of happiness.	[Matsunaga, Masahiro] Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Nagakute, Aichi, Japan; [Masuda, Takahiko] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Ishii, Keiko] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki] Kobe Univ, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo, Japan; [Yamasue, Hidenori] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan	Aichi Medical University; University of Alberta; Nagoya University; Kobe University; Hamamatsu University School of Medicine	Matsunaga, M (corresponding author), Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Nagakute, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	Ishii, Keiko/H-5607-2019		JSPS Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (Area Cultivation Responding-to-Real-Society)	JSPS Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (Area Cultivation Responding-to-Real-Society)	This work was supported by a JSPS Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (Area Cultivation Responding-to-Real-Society; to KI). The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Beadle JN, 2012, INT PSYCHOGERIATR, V24, P822, DOI 10.1017/S1041610211002547; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; Chakrabarti B, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-10; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Chopik WJ, 2017, J CROSS CULT PSYCHOL, V48, P23, DOI 10.1177/0022022116673910; De Neve JE, 2011, J HUM GENET, V56, P456, DOI 10.1038/jhg.2011.39; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DOHERTY RW, 1995, PSYCHOL WOMEN QUART, V19, P355, DOI 10.1111/j.1471-6402.1995.tb00080.x; Ewald A, 2016, EUR J NEUROSCI, V43, P98, DOI 10.1111/ejn.13118; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartman CA, 2009, DRUG ALCOHOL DEPEN, V104, P11, DOI 10.1016/j.drugalcdep.2009.01.022; Hatfield E., 2014, INTERPERSONA INT J P, V8, P159, DOI DOI 10.5964/IJPR.V8I2.162; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Ishii K., 2014, CULTURE BRAIN, V2, P72, DOI DOI 10.1007/S40167-014-0014-8; Kang P, 2013, J NEUROSCI, V33, P16200, DOI 10.1523/JNEUROSCI.5084-12.2013; Kawamichi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074958; Kim HS, 2010, SOC COGN AFFECT NEUR, V5, P212, DOI 10.1093/scan/nsp040; Kitayama S, 2014, PSYCHOL SCI, V25, P1169, DOI 10.1177/0956797614528338; Lee JC, 2018, PSYCHOL SCI, V29, P1031, DOI 10.1177/0956797617736386; Lyubomirsky S, 1997, J PERS SOC PSYCHOL, V73, P1141, DOI 10.1037/0022-3514.73.6.1141; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Matsunaga M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00718; Matsunaga M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180391; Matsunaga M, 2013, PSYCHOL WELL-BEING, V3, DOI 10.1186/2211-1522-3-5; Matsunaga M, 2016, NEUROIMAGE, V134, P132, DOI 10.1016/j.neuroimage.2016.04.020; Matsunaga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093771; Meisenberg G, 2015, J HAPPINESS STUD, V16, P1539, DOI 10.1007/s10902-014-9577-5; Minkov M, 2017, J HAPPINESS STUD, V18, P321, DOI 10.1007/s10902-015-9712-y; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Nobile M, 2007, DEV PSYCHOPATHOL, V19, P1147, DOI 10.1017/S0954579407000594; Oishi S, 2013, PERS SOC PSYCHOL B, V39, P559, DOI 10.1177/0146167213480042; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Oyama Y., 2012, JAPANESE PSYCHOL REV, V55, P90; Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028; Saphire-Bernstein S., 2013, OXFORD HDB HAPPINESS; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97, DOI DOI 10.5860/CHOICE.45-5867; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; White K, 2005, PERS SOC PSYCHOL B, V31, P232, DOI 10.1177/0146167204271326	51	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209552	10.1371/journal.pone.0209552	http://dx.doi.org/10.1371/journal.pone.0209552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576341	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400056
J	McKay, A; Wilman, HR; Dennis, A; Kelly, M; Gyngell, ML; Neubauer, S; Bell, JD; Banerjee, R; Thomas, EL				McKay, Andy; Wilman, Henry R.; Dennis, Andrea; Kelly, Matt; Gyngell, Michael L.; Neubauer, Stefan; Bell, Jimmy D.; Banerjee, Rajarshi; Thomas, E. Louise			Measurement of liver iron by magnetic resonance imaging in the UK Biobank population	PLOS ONE			English	Article							HEPATIC IRON; FATTY LIVER; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; OVERLOAD; DISEASE; HEMOCHROMATOSIS; ASSOCIATION; PREVALENCE; QUANTIFICATION	The burden of liver disease continues to increase in the UK, with liver cirrhosis reported to be the third most common cause of premature death. Iron overload, a condition that impacts liver health, was traditionally associated with genetic disorders such as hereditary haemochromatosis, however, it is now increasingly associated with obesity, type-2 diabetes and non-alcoholic fatty liver disease. The aim of this study was to assess the prevalence of elevated levels of liver iron within the UK Biobank imaging study in a cohort of 9108 individuals. Magnetic resonance imaging (MRI) was undertaken at the UK Biobank imaging centre, acquiring a multi-echo spoiled gradient-echo single-breath-hold MRI sequence from the liver. All images were analysed for liver iron and fat (expressed as proton density fat fraction or PDFF) content using LiverMultiScan. Liver iron was measured in 97.3% of the cohort. The mean liver iron content was 1.32 +/- 0.32 mg/g while the median was 1.25 mg/g (min: 0.85 max: 6.44 mg/g). Overall 4.82% of the population were defined as having elevated liver iron, above commonly accepted 1.8 mg/g threshold based on biochemical iron measurements in liver specimens obtained by biopsy. Further analysis using univariate models showed elevated liver iron to be related to male sex (p<10(-16), r(2) = 0.008), increasing age (p<10(-16), r(2) = 0.013), and red meat intake (p<10(-16), r(2) = 0.008). Elevated liver fat (>5.6% PDFF) was associated with a slight increase in prevalence of elevated liver iron (4.4% vs 6.3%, p = 0.0007). This study shows that population studies including measurement of liver iron concentration are feasible, which may in future be used to better inform patient stratification and treatment.	[McKay, Andy; Wilman, Henry R.; Dennis, Andrea; Kelly, Matt; Gyngell, Michael L.; Neubauer, Stefan; Banerjee, Rajarshi] Perspectum Diagnost, Oxford, England; [Wilman, Henry R.; Bell, Jimmy D.; Thomas, E. Louise] Univ Westminster, Sch Life Sci, Res Ctr Optimal Hlth, London, England; [Neubauer, Stefan] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford Ctr Clin Magnet Resonance Res OCMR, Oxford, England	University of Westminster; University of Oxford	Thomas, EL (corresponding author), Univ Westminster, Sch Life Sci, Res Ctr Optimal Hlth, London, England.	L.Thomas3@westminster.ac.uk	Thomas, Elizabeth Louise/AIF-0055-2022	Thomas, Elizabeth/0000-0003-4235-4694; Bell, Jimmy/0000-0003-3804-1281; Kelly, Matt/0000-0002-5834-635X; Wilman, Henry/0000-0002-3362-1204; Banerjee, Rajarshi/0000-0003-2022-5218; Neubauer, Stefan/0000-0001-9017-5645	Innovate UK [010271]; Oxford NIHR Biomedical Research Centre	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	Support was provided by Innovate UK 010271 [https://www.gov.uk/government/organisations/innovate-uk]. Perspectum Diagnostics provided support in the form of salaries for authors AM, AD, MK and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SN acknowledges support from the Oxford NIHR Biomedical Research Centre.	Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; [Anonymous], 2016, LIVERMULTISCAN DISC; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown KE, 2003, LIVER INT, V23, P232, DOI 10.1034/j.1600-0676.2003.00832.x; Bydder M, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3843; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Datz C, 2017, MINERVA ENDOCRINOL, V42, P173, DOI 10.23736/S0391-1977.16.02565-7; Deugnier Y, 2017, PRESSE MED, V46, pE306, DOI 10.1016/j.lpm.2017.05.036; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Freedman ND, 2010, J NATL CANCER I, V102, P1354, DOI 10.1093/jnci/djq301; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Garbowski MW, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-40; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Henninger B, 2015, ROFO-FORTSCHR RONTG, V187, P472, DOI 10.1055/s-0034-1399318; Henninger B, 2017, J MAGN RESON IMAGING, V46, P793, DOI 10.1002/jmri.25630; Hernando D, 2014, J MAGN RESON IMAGING, V40, P1003, DOI 10.1002/jmri.24584; Hu KQ, 2004, J HEPATOL, V40, P147, DOI 10.1016/S0168-8278(03)00479-3; Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP DAT VIS; Ko C, 2007, LIVER INT, V27, P1394, DOI 10.1111/j.1478-3231.2007.01596.x; Kuhn JP, 2017, RADIOLOGY, V284, P706, DOI 10.1148/radiol.2017161228; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Leporq B, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3766; Lok CY, 2009, BLOOD, V114, P20, DOI 10.1182/blood-2009-01-199109; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; MILLIKEN JA, 1963, CAN MED ASSOC J, V88, P1028; Milman N, 2003, EUR J HAEMATOL, V71, P51, DOI 10.1034/j.1600-0609.2003.00090.x; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nielsen P, 2000, J LAB CLIN MED, V135, P413, DOI 10.1067/mlc.2000.106456; Nomura Hideyuki, 1997, Fukuoka Acta Medica, V88, P345; Nuttall KL, 2003, ANN CLIN LAB SCI, V33, P443; Pacheco DAQ, 2018, AM J CLIN NUTR, V107, P113, DOI 10.1093/ajcn/nqx014; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Paisant A, 2017, PRESSE MED, V46, pE279, DOI 10.1016/j.lpm.2017.10.008; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; R Core Team, R LANG ENV STAT COMP; Ratib S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013752; Reeder SB, 2007, J MAGN RESON IMAGING, V25, P644, DOI 10.1002/jmri.20831; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Turlin B, 2001, AM J CLIN PATHOL, V116, P263; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Virtanen JM, 2008, MAGN RESON IMAGING, V26, P1175, DOI 10.1016/j.mri.2008.01.028; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Wilman HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172921; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zheng X, 2011, AM J CLIN NUTR, V94, P1012, DOI 10.3945/ajcn.111.015743	53	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209340	10.1371/journal.pone.0209340	http://dx.doi.org/10.1371/journal.pone.0209340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576354	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000454149400043
J	Salmeron-Sanchez, E; Fuertes-Aguilar, J; Spaniel, S; Perez-Garcia, FJ; Merlo, E; Garrido-Becerra, JA; Mota, J				Salmeron-Sanchez, Esteban; Fuertes-Aguilar, Javier; Spaniel, Stanislav; Javier Perez-Garcia, Francisco; Merlo, Encarna; Antonio Garrido-Becerra, Juan; Mota, Juan			Plant evolution in alkaline magnesium-rich soils: A phylogenetic study of the Mediterranean genus Hormathophylla (Cruciferae: Alysseae) based on nuclear and plastid sequences	PLOS ONE			English	Article							NICKEL HYPERACCUMULATION; HISTORICAL BIOGEOGRAPHY; BRASSICACEAE PHYLOGENY; NONCODING REGIONS; GENETIC DIVERSITY; FRUIT-DEVELOPMENT; DNA; DIVERSIFICATION; SERPENTINE; ECOLOGY	Habitats with alkaline edaphic substrates are often associated with plant speciation and diversification. The tribe Alysseae, in the family Brassicaceae, epitomizes this evolutionary trend. In this lineage, some genera, like Hormathophylla, can serve as a good case for testing the evolutionary framework. This genus is centered in the western Mediterranean. It grows on different substrates, but mostly on alkaline soils. It has been suggested that diversification in many lineages of the tribe Alysseae and in the genus Hormathophylla is linked to a tolerance for high levels of Mg + 2 in xeric environments. In this study, we investigated the controversial phylogenetic placement of Hormathophylla in the tribe, the generic limits and the evolutionary relationships between the species using ribosomal and plastid DNA sequences. We also examined the putative association between the evolution of different ploidy levels, trichome morphology and the type of substrates. Our analyses demonstrated the monophyly of the genus Hormathophylla including all previously described species. Nuclear sequences revealed two lineages that differ in basic chromosome numbers (x = 7 and x = 8 or derived 11, 15) and in their trichome morphology. Contrasting results with plastid genes indicates more complex relationships between these two lineages involving recent hybridization processes. We also found an association between chloroplast haplotypes and substrate, especially in populations growing on dolomites. Finally, our dated phylogeny demonstrates that the origin of the genus took place in the mid-Miocene, during the establishment of temporal land bridges between the Tethys and Paratethys seas, with a later diversification during the upper Pliocene.	[Salmeron-Sanchez, Esteban; Javier Perez-Garcia, Francisco; Merlo, Encarna; Antonio Garrido-Becerra, Juan; Mota, Juan] Univ Almeria, CEI MAR & CECOUAL, Dept Biol & Geol, Almeria, Spain; [Salmeron-Sanchez, Esteban] Univ Granada, Unidad Conservac Vegetal, Dept Bot, Granada, Spain; [Fuertes-Aguilar, Javier] CSIC, Real Jardin Bot, Madrid, Spain; [Spaniel, Stanislav] Slovak Acad Sci, Plant Sci & Biodivers Ctr, Inst Bot, Bratislava, Slovakia; [Spaniel, Stanislav] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Universidad de Almeria; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Slovak Academy of Sciences; Charles University Prague	Salmeron-Sanchez, E (corresponding author), Univ Almeria, CEI MAR & CECOUAL, Dept Biol & Geol, Almeria, Spain.; Salmeron-Sanchez, E (corresponding author), Univ Granada, Unidad Conservac Vegetal, Dept Bot, Granada, Spain.	esanchez@ual.es	Sánchez, Esteban Salmerón/A-7903-2015; Merlo, Encarna/M-1184-2014; Aguilar, Javier Fuertes/A-3974-2010; Španiel, Stanislav/G-4341-2011	Sánchez, Esteban Salmerón/0000-0002-2237-0163; Merlo, Encarna/0000-0002-8410-3490; Aguilar, Javier Fuertes/0000-0001-5649-4845; Španiel, Stanislav/0000-0003-4809-4379	Universidad de Almeria; European Social Fund; Czech Republic Government [CZ.1.07/2.3.00/30.0022]; Czech Science Foundation [16-10809S]; Spanish Ministry of Science and Innovation [CGL2007-63563]; Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia; FEDER [P07-RNM-03217]; ECORESGYP project - Explotaciones Rio de Aguas S.L.	Universidad de Almeria; European Social Fund(European Social Fund (ESF)); Czech Republic Government(Czech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia; FEDER(European Commission); ECORESGYP project - Explotaciones Rio de Aguas S.L.	The present research was supported with the following funding sources: 1. Contrato Puente, Funder: Universidad de Almeria, Award Number: Contrato Puente, Plan Propio 2016. Authors who received a salary: Esteban Salmeron Sanchez; 2. European Social Fund and Czech Republic Government, Award Number: CZ.1.07/2.3.00/30.0022. Authors who received a salary: Stanislav S. paniel; 3. Czech Science Foundation, Award Number: 16-10809S). Authors who received a salary: Stanislav Spaniel; 4. Spanish Ministry of Science and Innovation, Award Number: CGL2007-63563; 5. Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia, co-financed with FEDER, Award Number: P07-RNM-03217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful for the work of Mario Ruiz Girola, Luis Posadas and Milagros Torres Chispa in the collection of plant material. We kindly thank Manuel Yuste Salguero and Teresa Garnatje for provided information on plant vouchers. Sarah Young revised and corrected the English version. This work was supported by the ECORESGYP project, funded by Explotaciones Rio de Aguas S.L.	Aguilar JF, 2003, MOL PHYLOGENET EVOL, V28, P430, DOI 10.1016/S1055-7903(02)00301-9; Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz I. A., 2011, Edinburgh Journal of Botany, V68, P165, DOI 10.1017/S0960428611000060; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Al-Shehbaz IA, 2010, NORD J BOT, V28, P528, DOI 10.1111/j.1756-1051.2010.00951.x; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; AVETISYAN V E, 1983, Botanicheskii Zhurnal (St. Petersburg), V68, P1297; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Ball P.W., 1993, FLORA EUROPAEA, V1, P359; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; BOCQUET G, 1978, Candollea, V33, P269; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Brooks R. R., 1987, SERPENTINE ITS VEGET; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; Burge DO, 2011, INT J PLANT SCI, V172, P1137, DOI 10.1086/662028; Cecchi L, 2011, PLANT BIOSYST, V145, P818, DOI 10.1080/11263504.2011.580789; Cecchi L, 2013, BOT J LINN SOC, V173, P269, DOI 10.1111/boj.12084; Cecchi L, 2010, ANN BOT-LONDON, V106, P751, DOI 10.1093/aob/mcq162; Cecchi L, 2009, TAXON, V58, P700, DOI 10.1002/tax.583002; Celik N, 2007, BOT J LINN SOC, V154, P393, DOI 10.1111/j.1095-8339.2007.00662.x; Cetin O., 2012, AFR J BIOTECHNOL, V11, P109, DOI DOI 10.5897/AJB11.302; Chan R, 2001, INT J PLANT SCI, V162, P1347, DOI 10.1086/323277; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Cueto Romero M, 1986, AN JARDIN BOT MADRID, V43, P403; Dillenberger MS, 2013, AM J BOT, V100, P1171, DOI 10.3732/ajb.1300060; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Dixon CJ, 2007, MOL ECOL, V16, P3890, DOI 10.1111/j.1365-294X.2007.03342.x; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dudley T.R., 1965, FEDDES REPERT, V71, P218, DOI DOI 10.1002/FEDR.19650710105; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fauquette S, 1999, PALAEOGEOGR PALAEOCL, V152, P15, DOI 10.1016/S0031-0182(99)00031-0; Feliner GN, 2004, ANN BOT-LONDON, V93, P189, DOI 10.1093/aob/mch027; Feliner GN, 2002, PLANT SYST EVOL, V231, P19, DOI 10.1007/s006060200009; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Ferrandiz C, 1999, ANNU REV BIOCHEM, V68, P321, DOI 10.1146/annurev.biochem.68.1.321; Ferrandiz C, 2002, J EXP BOT, V53, P2031, DOI 10.1093/jxb/erf082; Fiz-Palacios O, 2013, PERSPECT PLANT ECOL, V15, P130, DOI 10.1016/j.ppees.2013.02.002; Aguilar JF, 2011, AN JARDIN BOT MADRID, V68, P175, DOI 10.3989/ajbm.2260; Galland N., 1988, TRAV I SCI U MOHAM B, V35, P1; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Guzman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006362; Guzman B, 2009, ORG DIVERS EVOL, V9, P83, DOI 10.1016/j.ode.2009.01.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayek A., 1911, GRUNDLAGE BEIH ZUM B, V27, P127; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janchen E., 1942, OESTER REICH BOT ZEITSCHR, V91, P1, DOI 10.1007/BF01257342; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Koch MA, 2012, TAXON, V61, P76, DOI 10.1002/tax.611006; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kropf M, 2008, PLANT ECOL DIVERS, V1, P217, DOI 10.1080/17550870802331938; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; KUPFER P, 1972, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V95, P43; Kupfer P., 1974, BOISSIERA, V23, P1; Kupfer PH, 1993, FLORA IBERICA, V4, P184; Kupfer PH, 1978, ANALES I BOT CAVANIL, V35, P119; Larena BG, 2006, FOLIA GEOBOT, V41, P305, DOI 10.1007/BF02904944; Larena BG, 2002, MOL ECOL, V11, P1965, DOI 10.1046/j.1365-294X.2002.01594.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maire R., 1967, FLORE DE L AFRIQUE D; Mengoni A, 2003, NEW PHYTOL, V159, P691, DOI 10.1046/j.1469-8137.2003.00837.x; Moore AJ, 2013, MOL ECOL, V22, P2218, DOI 10.1111/mec.12266; Moore MJ, 2007, SYST BOT, V32, P392, DOI 10.1600/036364407781179680; Morales Torres C, 1986, LAZAROA, V9, P147; Morales Torres C., 2009, FLORA VASCULAR ANDAL, V3, P108; MOTA JF, 1993, VEGETATIO, V109, P29, DOI 10.1007/BF00149543; MOTA JF, 2017, PLANT VEG, V13, P277, DOI DOI 10.1007/978-3-319-54867-8_6; Mota JF, 2016, LAZAROA, V37, P7, DOI 10.5209/LAZA.54044; Mota JF, 2008, FLORA, V203, P359, DOI 10.1016/j.flora.2007.06.006; Mummenhoff K, 2009, J EXP BOT, V60, P1503, DOI 10.1093/jxb/ern304; Feliner GN, 2014, PERSPECT PLANT ECOL, V16, P265, DOI 10.1016/j.ppees.2014.07.002; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Oberprieler C, 2005, TAXON, V54, P951, DOI 10.2307/25065480; OOSTERBROEK P, 1992, J BIOGEOGR, V19, P3, DOI 10.2307/2845616; Otto F, 1990, Methods Cell Biol, V33, P105; PALAMAREV E, 1989, PLANT SYST EVOL, V162, P93, DOI 10.1007/BF00936912; Perez-Latorre AV, 2013, AN JARDIN BOT MADRID, V70, P62, DOI 10.3989/ajbm.2334; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Mijarra JMP, 2009, J BIOGEOGR, V36, P2025, DOI 10.1111/j.1365-2699.2009.02142.x; Quezel P., 1985, PLANT CONSERVATION I; Ray N., 2001, INTERNET ARCHAEOL, V11; Resetnik I, 2013, MOL PHYLOGENET EVOL, V69, P772, DOI 10.1016/j.ympev.2013.06.026; Ribera I, 1998, J BIOGEOGR, V25, P969, DOI 10.1046/j.1365-2699.1998.00226.x; Rivas-Martinez S., 2002, ITINERA GEOBOT, V15, P5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenbaum G., 2002, J VIRTUAL EXPLORER, V8, P107, DOI DOI 10.3809/JVIRTEX.2002.00053; Rundel PW, 1982, DYNAMICS MANAGEMENT, P86; Salmeron-Sanchez E, 2016, PHYTOTAXA, V280, P45, DOI 10.11646/phytotaxa.280.1.4; Salmeron-Sanchez E, 2014, BOT J LINN SOC, V176, P506, DOI 10.1111/boj.12220; Salmeron-Sanchez E, 2014, PLANT SOIL, V374, P233, DOI 10.1007/s11104-013-1857-z; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Schonswetter P, 2007, J PLANT RES, V120, P721, DOI 10.1007/s10265-007-0108-x; Schulz OE, 1936, CRUCIFERAE NATURLICH; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Soltis DE, 1996, SYST BOT, V21, P169, DOI 10.2307/2419746; Spaniel S, 2015, PLANT SYST EVOL, V301, P2463, DOI 10.1007/s00606-015-1257-3; Spaniel S, 2012, WILLDENOWIA, V42, P37, DOI 10.3372/wi42.42104; Stamatakis A., 2006, Proceedings. 20th International Parallel and Distributed Processing Symposium (IEEE Cat. No.06TH8860); Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suda J, 2006, CYTOM PART A, V69A, P273, DOI 10.1002/cyto.a.20253; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taylor SI, 2002, NEW PHYTOL, V155, P437, DOI 10.1046/j.1469-8137.2002.00478.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Thiers B., INDEX HERBARIORUM GL; Thompson JD, 2005, PLANT EVOLUTION MEDI; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; Vargas P, 2009, J BIOGEOGR, V36, P1297, DOI 10.1111/j.1365-2699.2008.02059.x; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; Vitarelli NC, 2016, PERSPECT PLANT ECOL, V22, P23, DOI 10.1016/j.ppees.2016.07.002; WARWICK SI, 2006, PLANT SYST EVOL, V259, P237, DOI [DOI 10.1007/S00606-006-0422-0, DOI 10.1007/s00606-006-0421-1]; Warwick SI, 2008, BOTANY, V86, P315, DOI 10.1139/B08-013; Warwick SI, 2011, TAXON, V60, P1156, DOI 10.1002/tax.604017; Warwick SI, 2009, BOTANY, V87, P961, DOI 10.1139/B09-051; WING SL, 1987, ANN MO BOT GARD, V74, P748, DOI 10.2307/2399449; Zhang LB, 2001, AM J BOT, V88, P2331, DOI 10.2307/3558393; Zhang LB, 2004, INT J PLANT SCI, V165, P191, DOI 10.1086/380747; Zozomova-Lihova J, 2014, TAXON, V63, P562, DOI 10.12705/633.18	131	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208307	10.1371/journal.pone.0208307	http://dx.doi.org/10.1371/journal.pone.0208307			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576314	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400008
J	Milich, KM; Koestler, BJ; Simmons, JH; Nehete, PN; Di Fiore, A; Williams, LE; Dudley, JP; Vanchiere, J; Payne, SM				Milich, Krista M.; Koestler, Benjamin J.; Simmons, Joe H.; Nehete, Pramod N.; Di Fiore, Anthony; Williams, Lawrence E.; Dudley, Jaquelin P.; Vanchiere, John; Payne, Shelley M.			Methods for detecting Zika virus in feces: A case study in captive squirrel monkeys (Saimiri boliviensis boliviensis)	PLOS ONE			English	Article							YELLOW-FEVER; ARBOVIRUSES; TRANSMISSION; POPULATIONS; INFECTION; DISEASES; STATE	A strain of Zika virus (ZIKV) of Asian origin associated with birth defects and neurological disorders has emerged and spread through the Americas. ZIKV was first isolated in the blood of nonhuman primates in Africa and has been detected in the blood, saliva, and urine of a few catarrhine species in both Africa and Asia, suggesting that nonhuman primates may serve as both a source and a reservoir of the virus. The recent introduction of ZIKV to human populations in the Americas presents the potential for the virus to spread into nonhuman primate reservoirs. Thus, it is critical to develop efficient and noninvasive detection methods to monitor the spread of the virus in wild nonhuman primate populations. Here, we describe a method for ZIKV detection in noninvasively collected fecal samples of a Neotropical primate. Fecal samples were collected from two captive squirrel monkeys (Saimiri boliviensis boliviensis) that were experimentally infected with ZIKV (Strain Mexico_1_44) and an additional two uninfected squirrel monkeys. Nucleic acids were extracted from these samples, and RT-qPCR was used to assay for the presence of ZIKV using primers flanking a 101 bp region of the NS5 gene. In both ZIKV-inoculated animals, ZIKV was detected 5-11 days post-infection, but was not detected in the uninfected animals. We compare the fecal results to ZIKV detection in serum, saliva, and urine samples from the same individuals. Our results indicate that fecal detection is a cost-effective, noninvasive method for monitoring wild populations of Neotropical primates as possible ZIKV reservoirs.	[Milich, Krista M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Milich, Krista M.; Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Koestler, Benjamin J.; Dudley, Jaquelin P.; Payne, Shelley M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Koestler, Benjamin J.; Dudley, Jaquelin P.; Payne, Shelley M.] Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA; [Simmons, Joe H.; Nehete, Pramod N.; Williams, Lawrence E.] Univ Texas MD Anderson Canc Res Ctr, Bastrop, TX USA; [Vanchiere, John] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71105 USA	Washington University (WUSTL); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Milich, KM (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.; Milich, KM (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.	krista.milich@wust.edu	Williams, Lawrence/AAD-6685-2020; Vanchiere, John/AAD-8979-2019	Williams, Lawrence/0000-0003-2267-9918; Milich, Krista/0000-0003-1475-8720; Simmons, Joe/0000-0003-1815-6831; Dudley, Jaquelin/0000-0002-1581-1098; Koestler, Benjamin/0000-0001-7213-0953; Di Fiore, Anthony/0000-0001-8893-9052	National Science Foundation (NSF) [BCS1638822]; National Institutes of Health (NIH) [R21AI129505, P40OD010938]; University of Texas at Austin; University of Texas MD Anderson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129505] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010938] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at Austin; University of Texas MD Anderson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Science Foundation (NSF; https://nsf.gov/) award BCS1638822 to ADF, the National Institutes of Health (NIH; https://www.nih.gov/) awards R21AI129505 to JPD and P40OD010938 to LEW, and the University of Texas at Austin, and the University of Texas MD Anderson Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by the National Science Foundation (BCS 1638822), the National Institutes of Health (1R21AI129505 and P40OD010938), the University of Texas at Austin, and the University of Texas MD Anderson Cancer Research Center. We thank Bharti Nehete, Nikos Vasilakis, and Sasha R. Azar for their work on the plaque assays.	[Anonymous], 2016, ALL COUNTR TERR ACT; de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16; Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2; Childs JE, 2007, CURR TOP MICROBIOL, V315, P389; Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Favoretto S., 2016, BIORXIV, DOI [10.1101/049395049395, DOI 10.1101/049395]; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Gesquiere LR, 2018, GEN COMP ENDOCR, V260, P9, DOI 10.1016/j.ygcen.2018.02.004; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021; HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797; HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; Kowalewski Martin M., 2009, P433, DOI 10.1007/978-0-387-78705-3_17; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI [10.1371/journal.pntd.0005351, 10.1371/journal.pntd, DOI 10.1371/journal.pntd.0005351]; Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862; Ruch TC, 1959, DIS LAB PRIM; Sallis ESV, 2003, J VET DIAGN INVEST, V15, P574, DOI 10.1177/104063870301500611; Strode GK, 1951, YELLOW FEVER; Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6; Tomori O, 1999, ADV VIRUS RES, V53, P5, DOI 10.1016/S0065-3527(08)60341-3; Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; Wolf TM, 2016, ECOHEALTH, V13, P139, DOI 10.1007/s10393-015-1063-y; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	40	3	3	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0209391	10.1371/journal.pone.0209391	http://dx.doi.org/10.1371/journal.pone.0209391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571742	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700067
J	Salais-Lopez, H; Agustin-Pavon, C; Lanuza, E; Martinez-Garcia, F				Salais-Lopez, Hugo; Agustin-Pavon, Carmen; Lanuza, Enrique; Martinez-Garcia, Fernando			The maternal hormone in the male brain: Sexually dimorphic distribution of prolactin signalling in the mouse brain	PLOS ONE			English	Article							STIMULATES DOPAMINE RELEASE; ESTROGEN-RECEPTOR-ALPHA; LUTEINIZING-HORMONE; MESSENGER-RNA; REPRODUCTIVE-BEHAVIOR; TRANSDUCTION PATHWAYS; SOCIAL-BEHAVIOR; CORPUS STRIATUM; GROWTH-HORMONE; RAT-BRAIN	Research of the central actions of prolactin is highly focused on females, but this hormone has also documented roles in male physiology and behaviour. Here, we provide the first description of the pattern of prolactin-derived signalling in the male mouse brain, employing the immunostaining of phosphorylated signal transducer and activator of transcription 5 (pSTAT5) after exogenous prolactin administration. Next, we explore possible sexually dimorphic differences by comparing pSTAT5 immunoreactivity in prolactin-supplemented males and females. We also assess the role of testosterone in the regulation of central prolactin signalling in males by comparing intact with castrated prolactin-supplemented males. Prolactin-supplemented males displayed a widespread pattern of pSTAT5 immunoreactivity, restricted to brain centres showing expression of the prolactin receptor. Immunoreactivity for pSTAT5 was present in several nuclei of the preoptic, anterior and tuberal hypothalamus, as well as in the septofimbrial nucleus or posterodorsal medial amygdala of the telencephalon. Conversely, non-supplemented control males were virtually devoid of pSTAT5-immunoreactivity, suggesting that central prolactin actions in males are limited to situations concurrent with substantial hypophyseal prolactin release (e.g. stress or mating). Furthermore, comparison of prolactin-supplemented males and females revealed a significant, female-biased sexual dimorphism, supporting the view that prolactin has a preeminent role in female physiology and behaviour. Finally, in males, castration significantly reduced pSTAT5 immunoreactivity in some structures, including the paraventricular and ventromedial hypothalamic nuclei and the septofimbrial region, thus indicating a region-specific regulatory role of testosterone over central prolactin signalling.	[Salais-Lopez, Hugo; Agustin-Pavon, Carmen; Martinez-Garcia, Fernando] Univ Jaume 1, Fac Ciencies Salut, Unitat Predept Med, Castellon de La Plana, Spain; [Agustin-Pavon, Carmen; Lanuza, Enrique] Univ Valencia, Dept Biol Cellular & Biol Func, Fac Ciencies Biol, Valencia, Spain	Universitat Jaume I; University of Valencia	Martinez-Garcia, F (corresponding author), Univ Jaume 1, Fac Ciencies Salut, Unitat Predept Med, Castellon de La Plana, Spain.	femartin@uji.es	Agustín-Pavón, Carmen/ABA-8740-2021; Lanuza, Enrique/C-4068-2009; Martinez-Garcia, Fernando/K-7159-2013; Agustin-Pavon, Carmen/A-5638-2013	Lanuza, Enrique/0000-0001-9498-7966; Martinez-Garcia, Fernando/0000-0003-3181-4579; Agustin-Pavon, Carmen/0000-0002-6725-6954	Spanish Ministry of Economy and Competitiveness-FEDER [BFU2016-77691-C2-2-P, BFU2016-77691-C2-1-P]; Generalitat Valenciana [PROMETEO/2016/076]; Universitat Jaume I de Castello [UJI-B2016-45]; Spanish Ministry of Education, Culture and Sport [FPU12/05472]	Spanish Ministry of Economy and Competitiveness-FEDER(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat Jaume I de Castello; Spanish Ministry of Education, Culture and Sport(Spanish Government)	F.M.-G. and E.L. were funded by the Spanish Ministry of Economy and Competitiveness-FEDER (BFU2016-77691-C2-2-P and C2-1-P). F.M.-G., C.A.-P. and E.L. were funded by the Generalitat Valenciana (PROMETEO/2016/076). F.M.-G. was funded by the Universitat Jaume I de Castello (UJI-B2016-45). H.S.-L. has been a predoctoral fellow of the FPU (Formacion de Profesorado Universitario) programme of the Spanish Ministry of Education, Culture and Sport (FPU12/05472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2008, PROG BRAIN RES, V170, P29, DOI 10.1016/S0079-6123(08)00403-2; Akther S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-41; Anderson GM, 2008, ENDOCRINOLOGY, V149, P1562, DOI 10.1210/en.2007-0867; Bakowska JC, 2003, MOL BRAIN RES, V116, P50, DOI 10.1016/S0169-328X(03)00213-4; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; BARTKE A, 1987, J ENDOCRINOL, V112, P215, DOI 10.1677/joe.0.1120215; BJORKLUND A, 1973, BRAIN RES, V51, P171, DOI 10.1016/0006-8993(73)90371-5; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bosch OJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0085; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; BRIDGES RS, 1990, ENDOCRINOLOGY, V126, P837, DOI 10.1210/endo-126-2-837; BRONSON FH, 1982, ENDOCRINOLOGY, V111, P1286, DOI 10.1210/endo-111-4-1286; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; BURTON KA, 1992, ENDOCRINOLOGY, V131, P958, DOI 10.1210/en.131.2.958; Capozzi A, 2015, GYNECOL ENDOCRINOL, V31, P506, DOI 10.3109/09513590.2015.1017810; CHANDRASHEKAR V, 1988, Steroids, V51, P559, DOI 10.1016/0039-128X(88)90052-9; CHEN YF, 1982, ENDOCRINOLOGY, V111, P1740, DOI 10.1210/endo-111-5-1740; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; Cruz-Casallas PE, 1999, PSYCHONEUROENDOCRINO, V24, P681, DOI 10.1016/S0306-4530(99)00021-9; DeMaria JE, 1999, BRAIN RES, V837, P236, DOI 10.1016/S0006-8993(99)01667-4; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donner N, 2009, NEUROENDOCRINOLOGY, V90, P315, DOI 10.1159/000225986; Drago F, 2000, EUR J PHARMACOL, V405, P131, DOI 10.1016/S0014-2999(00)00678-6; DRAGO F, 1981, PHYSIOL BEHAV, V26, P277, DOI 10.1016/0031-9384(81)90023-8; Dugger BN, 2007, HORM BEHAV, V51, P195, DOI 10.1016/j.yhbeh.2006.10.001; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Furigo IC, 2017, BRAIN STRUCT FUNCT; Furigo IC, 2014, BRAIN RES, V1566, P47, DOI 10.1016/j.brainres.2014.04.018; Gil M, 2011, HORM BEHAV, V59, P435, DOI 10.1016/j.yhbeh.2010.12.012; Gill-Sharma MK, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/687259; GONZALEZMORA JL, 1990, BRAIN RES BULL, V25, P729, DOI 10.1016/0361-9230(90)90050-A; GOUDREAU JL, 1992, NEUROENDOCRINOLOGY, V56, P100, DOI 10.1159/000126214; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Grattan DR, 2001, HORM BEHAV, V40, P115, DOI 10.1006/hbeh.2001.1698; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; Hernandez ME, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-28; HERNANDEZ ML, 1994, J NEURAL TRANSM-GEN, V96, P63, DOI 10.1007/BF01277929; Hull EM, 1999, BEHAV BRAIN RES, V105, P105, DOI 10.1016/S0166-4328(99)00086-8; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; KALRA PS, 1983, ENDOCRINOLOGY, V113, P2065, DOI 10.1210/endo-113-6-2065; KAMEL F, 1977, ENDOCRINOLOGY, V101, P421, DOI 10.1210/endo-101-2-421; Kirk SE, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12477; Kokay Ilona C, 2018, J Neuroendocrinol, V30, pe12634, DOI 10.1111/jne.12634; Kokay IC, 2011, ENDOCRINOLOGY, V152, P526, DOI 10.1210/en.2010-0668; Kow LM, 1998, BEHAV BRAIN RES, V92, P169, DOI 10.1016/S0166-4328(97)00189-7; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; Kruger THC, 2005, WORLD J UROL, V23, P130, DOI 10.1007/s00345-004-0496-7; LAPING NJ, 1991, NEUROSCI LETT, V134, P1, DOI 10.1016/0304-3940(91)90494-E; LOOKINGLAND KJ, 1984, BRAIN RES, V323, P83, DOI 10.1016/0006-8993(84)90267-1; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Melcangi RC, 2015, NEUROSCI BIOBEHAV RE; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; MUCCIOLI G, 1991, NEUROENDOCRINOLOGY, V53, P47, DOI 10.1159/000125696; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; NEILL JD, 1971, ENDOCRINOLOGY, V89, P1448, DOI 10.1210/endo-89-6-1448; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Nishitani S, 2004, CELL MOL NEUROBIOL, V24, P283, DOI 10.1023/B:CEMN.0000018622.44317.14; O'Hara L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121657; Otero-Garcia M, 2016, BRAIN STRUCT FUNCT, V221, P3445, DOI 10.1007/s00429-015-1111-y; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Pi XJ, 2002, J NEUROSCI RES, V67, P551, DOI 10.1002/jnr.10147; Rehman J, 2000, INT J IMPOT RES, V12, P23, DOI 10.1038/sj.ijir.3900473; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; Rissman EF, 1997, ENDOCRINOLOGY, V138, P507, DOI 10.1210/en.138.1.507; Saito TR, 2013, PROLACTIN; Sakaguchi K, 1996, NEUROENDOCRINOLOGY, V63, P559, DOI 10.1159/000127085; Salais-Lopez H, 2017, BRAIN STRUCT FUNCT, V222, P895, DOI 10.1007/s00429-016-1254-5; Saltzman W, 2014, J NEUROENDOCRINOL, V26, P685, DOI 10.1111/jne.12176; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Semaan SJ, 2013, ADV EXP MED BIOL, V784, P221, DOI 10.1007/978-1-4614-6199-9_11; SHRENKER P, 1987, J ENDOCRINOL, V112, P221, DOI 10.1677/joe.0.1120221; SINHA YN, 1977, ENDOCRINOLOGY, V100, P786, DOI 10.1210/endo-100-3-786; Stanic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090451; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; TONG Y, 1989, ENDOCRINOLOGY, V125, P1821, DOI 10.1210/endo-125-4-1821; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00025; Veening JG, 2015, EUR J PHARMACOL, V753, P209, DOI 10.1016/j.ejphar.2014.07.045; Vega C, 2010, AM J PHYSIOL-REG I, V299, pR1701, DOI 10.1152/ajpregu.00575.2010; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104	84	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2018	13	12							e0208960	10.1371/journal.pone.0208960	http://dx.doi.org/10.1371/journal.pone.0208960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0HP	30571750	Green Published, Green Submitted, gold			2022-12-26	WOS:000453841700030
J	Hesselmar, B; Hicke-Roberts, A; Lundell, AC; Adlerberth, I; Rudin, A; Saalman, R; Wennergren, G; Wold, AE				Hesselmar, Bill; Hicke-Roberts, Anna; Lundell, Anna-Carin; Adlerberth, Ingegerd; Rudin, Anna; Saalman, Robert; Wennergren, Goren; Wold, Agnes E.			Pet-keeping in early life reduces the risk of allergy in a dose-dependent fashion	PLOS ONE			English	Article							HAY-FEVER; DOG OWNERSHIP; EXPOSURE; CHILDREN; SENSITIZATION; ASTHMA; INCREASE; ECZEMA; CAT; PREVALENCE	Objectives Several studies have indicated that early pet keeping could protect the infant from later allergy development. Here, we investigate if there is a dose-dependent association between cat- and dog-keeping during the first year of life and subsequent allergy development. Methods Two cohorts were investigated: a cross-sectional questionnaire-based study of 7- to 8-year-old children (N = 1029) from Molndal and Kiruna, and a birth-cohort of children from the Vastra Gotaland county clinically evaluated for asthma and allergy by paediatricians up to the age of 8-9 years (N = 249). The cross-sectional study asked validated questions on asthma and allergy that had been used in two previous studies of children from the same areas. In the birth-cohort study, a diagnosis of asthma and allergy was based on predefined clinical criteria, and laboratory evaluation included blood eosinophils, skin-prick tests and specific immunoglobulin E analyses. Information on pets during first year of life was collected retrospectively in the Cross-Sectional Cohort and prospectively in the Birth Cohort. Results A dose-response association was seen, with less allergic manifestations (any of asthma, allergic rhinoconjunctivitis, or eczema) with increasing number of household cats and dogs during the first year of life. In the Cross-Sectional Cohort, allergy ever decreased from 49% in those with no pets to zero in those with five or more pets (P-value for trend 0.038), and from 32% to zero for allergy last year (P-value for trend 0.006). The same pattern was seen in Birth Cohort. Sensitization to animals, as well as pollens, also decreased with increasing number of animals in the household. Conclusion The prevalence of allergic disease in children aged 7-9 years is reduced in a dose-dependent fashion with the number of household pets living with the child during their first year of life, suggesting a "mini-farm" effect, whereby cats and dogs protect against allergy development.	[Hesselmar, Bill; Hicke-Roberts, Anna; Saalman, Robert; Wennergren, Goren] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden; [Lundell, Anna-Carin; Rudin, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Adlerberth, Ingegerd; Wold, Agnes E.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Hesselmar, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden.	bill.hesselmar@vgregion.se			Sahlgrenska Academy at the University of Gothenburg; Swedish Asthma and Allergy Association Research Foundation; Swedish Research Council; Vardal Foundation; European Commission [QLK4-2000-00538]; Torsten and Ragnar Soderberg Foundation; Gothenburg Medical Society; Cancer and Allergy Foundation; Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning; Ekhaga Foundation; Food and Health Concept Centre, Gothenburg, West Gothia Region; AstraZeneca, IMed RIA (Respiratory Inflammation, Autoimmunity); Swedish state	Sahlgrenska Academy at the University of Gothenburg; Swedish Asthma and Allergy Association Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Vardal Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Torsten and Ragnar Soderberg Foundation; Gothenburg Medical Society; Cancer and Allergy Foundation; Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Ekhaga Foundation; Food and Health Concept Centre, Gothenburg, West Gothia Region; AstraZeneca, IMed RIA (Respiratory Inflammation, Autoimmunity)(AstraZeneca); Swedish state	The studies were funded by the Sahlgrenska Academy at the University of Gothenburg; the Swedish Asthma and Allergy Association Research Foundation (BH); the Swedish Research Council; the Vardal Foundation; the European Commission (QLK4-2000-00538); the Torsten and Ragnar Soderberg Foundation; Gothenburg Medical Society; the Cancer and Allergy Foundation; Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning; the Ekhaga Foundation; Food and Health Concept Centre, Gothenburg, West Gothia Region; The study was also financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (AR, AW, GW, IA). No one from the funding sources was involved in the design, execution, or analysis of the study. Anna Rudin reports that part of her salary for her university full professor position at The Sahlgrenska Academy at the University of Gothenburg is covered by grant from AstraZeneca IMed RIA (Respiratory Inflammation, Autoimmunity) in compensation for advice regarding basic research in inflammation at the company.	ABERG N, 1995, CLIN EXP ALLERGY, V25, P815, DOI 10.1111/j.1365-2222.1995.tb00023.x; ABERG N, 1989, ACTA PAEDIATR SCAND, V78, P246, DOI 10.1111/j.1651-2227.1989.tb11064.x; Almqvist C, 2010, PAEDIATR PERINAT EP, V24, P171, DOI 10.1111/j.1365-3016.2010.01095.x; [Anonymous], 1989, ALLERGY, V44, P1; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Campbell BE, 2015, CLIN EXP ALLERGY, V45, P744, DOI 10.1111/cea.12429; Carlsen KCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043214; Chen CM, 2008, EUR RESPIR J, V31, P963, DOI 10.1183/09031936.00092807; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Hesselmar B, 2003, CLIN EXP ALLERGY, V33, P1681, DOI 10.1111/j.1365-2222.2003.01821.x; Hesselmar B, 2010, ACTA PAEDIATR, V99, P1861, DOI 10.1111/j.1651-2227.2010.01939.x; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Hesselmar B, 2015, PEDIATRICS, V135, pE590, DOI 10.1542/peds.2014-2968; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; Hicke-Roberts A, 2017, ACTA PAEDIATR, V106, P75, DOI 10.1111/apa.13433; Lodge CJ, 2012, CLIN EXP ALLERGY, V42, P1377, DOI 10.1111/j.1365-2222.2012.04032.x; Mandhane PJ, 2009, J ALLERGY CLIN IMMUN, V124, P745, DOI 10.1016/j.jaci.2009.06.038; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millqvist E, 2007, CLIN EXP ALLERGY, V37, P948, DOI 10.1111/j.1365-2222.2007.02731.x; Nermes Merja, 2013, ISRN Allergy, V2013, P827934, DOI 10.1155/2013/827934; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Platts-Mills TAE, 2001, INT ARCH ALLERGY IMM, V124, P126, DOI 10.1159/000053689; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Stemeseder T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168686; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Williams HC, 1996, LANCET, V348, P1391, DOI 10.1016/S0140-6736(05)65466-9	32	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0208472	10.1371/journal.pone.0208472	http://dx.doi.org/10.1371/journal.pone.0208472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566481	Green Published, gold, Green Submitted			2022-12-26	WOS:000453779300042
J	Kitchingman, TA; Caputi, P; Woodward, A; Wilson, CJ; Wilson, I				Kitchingman, Taneile Ashlea; Caputi, Peter; Woodward, Alan; Wilson, Coralie Joy; Wilson, Ian			The impact of their role on telephone crisis support workers' psychological wellbeing and functioning: Quantitative findings from a mixed methods investigation	PLOS ONE			English	Article							SECONDARY TRAUMATIC STRESS; SHEEHAN DISABILITY SCALE; NATIONAL-SURVEY; VICARIOUS TRAUMATIZATION; SUICIDE-PREVENTION; COMPASSION FATIGUE; CONSTRUCT-VALIDITY; PERSONAL PROBLEMS; HOTLINE OUTCOMES; MENTAL-HEALTH	Research suggests that frequent empathic engagement with others in distress places helpers in registered professional roles (e.g. medical practitioners, psychologists) at risk of functional impairment related to symptoms of psychological distress, including the delivery of sub-optimal care to patients. Preliminary research suggests that telephone crisis support workers may also be impacted in a similar way. This repeated measures study is the first known research to examine telephone crisis support workers' functional impairment related to symptoms of psychological distress before and after speaking with callers in crisis. A representative sample of telephone crisis support workers from Lifeline Australia participated by completing three surveys: 1) directly before; 2) directly after; and 3) one week after completing a shift on the national crisis line. Surveys included standardised measures of functional impairment, psychological distress, lived experience of mental health issues and suicide, motivations for volunteering, coping strategies and help-seeking. Categorical items were used to assess personal and shift related factors. Repeated measures analyses of variance were used to identify changes in symptoms of psychological distress and impairment across time points. Structural equation modelling was used to test relationships within a hypothesised model of impairment. A significant proportion of participants reported functional impairment related to symptoms of psychological distress. Significant differences in functional impairment and symptoms of psychological distress were detected, and were associated with different mechanisms, across time points. An important outcome of this study is empirically-supported models which explain how telephone crisis support workers come to experience functional impairment in relation to their TCS role, as well as other work/study, home/family and social/leisure activities. Results warrant the deliberate development and/or modification of existing service strategies to optimise telephone crisis support workers' psychological wellbeing and functioning, including by structuring the work environment and emphasising certain messages during training and supervision.	[Kitchingman, Taneile Ashlea; Caputi, Peter] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Kitchingman, Taneile Ashlea; Wilson, Coralie Joy] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Woodward, Alan] Lifeline Australia, Canberra, ACT, Australia; [Woodward, Alan] Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Wilson, Coralie Joy; Wilson, Ian] Univ Wollongong, Sch Med, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong; University of Melbourne; University of Wollongong	Kitchingman, TA (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.; Kitchingman, TA (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	tak901@uowmail.edu.au	Kitchingman, Taneile/AAT-6326-2020	Woodward, Alan/0000-0002-5379-337X; Kitchingman, Taneile/0000-0003-3169-1222	Australian Government Research Training Program Scholarship; Dr Barbara Wright Postgraduate Scholarship - Central West Branch of the Australian Federation of Graduate Women	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Dr Barbara Wright Postgraduate Scholarship - Central West Branch of the Australian Federation of Graduate Women	This research has been conducted with the support of the Australian Government Research Training Program Scholarship (TAK), and the Dr Barbara Wright Postgraduate Scholarship awarded by the Central West Branch of the Australian Federation of Graduate Women (TAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the telephone crisis support workers who took part in this study and the service managers and supervisors who provided feedback and support. This research has been conducted with the support of the Australian Government Research Training Program Scholarship, and the Dr Barbara Wright Postgraduate Scholarship awarded by the Central West Branch of the Australian Federation of Graduate Women. Both organizations had no role in data analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Colleague Assistance, STRESS DISTR IMP CON; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychological Association, 2010, SURV FIND EMPH IMPR; [Anonymous], 2009, STROBE STATEMENT CHE; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arbuckle R, 2009, PSYCHIAT RES, V165, P163, DOI 10.1016/j.psychres.2007.11.018; Australian Bureau of Statistics, 2001, AUSTRALIAN STANDARD; Baird Stephanie, 2003, Violence Vict, V18, P71, DOI 10.1891/vivi.2003.18.1.71; Baker E.K., 2003, CARING OURSELVES THE; Beckner V, 2007, J CONSULT CLIN PSYCH, V75, P508, DOI 10.1037/0022-006X.75.3.508; Bohart A.C., 2002, PSYCHOTHERAPY RELATI, P89; Brady JL, 1999, PROF PSYCHOL-RES PR, V30, P386, DOI 10.1037/0735-7028.30.4.386; BUTOW P, 1991, ANN ONCOL, V2, P597, DOI 10.1093/oxfordjournals.annonc.a058027; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Clary EG, 1998, J PERS SOC PSYCHOL, V74, P1516, DOI 10.1037/0022-3514.74.6.1516; Coles T, 2014, NEUROPSYCH DIS TREAT, V10, P887, DOI 10.2147/NDT.S55220; Coman GJ, 2001, BRIT J GUID COUNS, V29, P247, DOI 10.1080/03069880124904; Cozolino L. J., 2006, NEUROSCIENCE HUMAN R; Creamer TL, 2005, J TRAUMA STRESS, V18, P89, DOI 10.1002/jts.20008; Creswell J.W., 2011, DESIGNING CONDUCTING; DARONGKAMAS J, 1994, CLIN PSYCHOL PSYCHOT, V1, P165; Deasy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115193; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; DEUTSCH CJ, 1985, PROF PSYCHOL-RES PR, V16, P305, DOI 10.1037/0735-7028.16.2.305; Figley CR, 2002, J CLIN PSYCHOL, V58, P1433, DOI 10.1002/jclp.10090; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Gibbons SB, 2011, CLIN SOC WORK J, V39, P243, DOI 10.1007/s10615-010-0305-2; Gilat I, 2007, PSYCHIATRY, V70, P12, DOI 10.1521/psyc.2007.70.1.12; Gilroy PJ, 2002, PROF PSYCHOL-RES PR, V33, P402, DOI 10.1037//0735-7028.33.4.402; Gould MS, 2007, SUICIDE LIFE-THREAT, V37, P338, DOI 10.1521/suli.2007.37.3.338; Greer TL, 2010, CNS DRUGS, V24, P267, DOI 10.2165/11530230-000000000-00000; GUY JD, 1989, PROF PSYCHOL-RES PR, V20, P48, DOI 10.1037/0735-7028.20.1.48; Guy JD, 2000, PROF PSYCHOL-RES PR, V31, P351, DOI 10.1037/0735-7028.31.3.351; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Jagannathan R., 2006, BRIEF TREATMENT CRIS, V6, P52, DOI [10.1093/brief-treatment/mhj001, DOI 10.1093/BRIEF-TREATMENT/MHJ001, 10.1093/brief-treatment/mhi029, DOI 10.1093/BRIEF-TREATMENT/MHI029]; Kalafat J, 2007, SUICIDE LIFE-THREAT, V37, P322, DOI 10.1521/suli.2007.37.3.322; Kassam-Adams N., 1999, SECONDARY TRAUMATIC; King R, 2003, SUICIDE LIFE-THREAT, V33, P400, DOI 10.1521/suli.33.4.400.25235; Kinzel A, 2000, Crisis, V21, P126, DOI 10.1027//0227-5910.21.3.126; Kitchingman TA, 2018, CRISIS, V39, P13, DOI 10.1027/0227-5910/a000454; Kitchingman TA, 2017, CRISIS, V38, P403, DOI 10.1027/0227-5910/a000435; Lam RW, 2011, J AFFECT DISORDERS, V132, pS9, DOI 10.1016/j.jad.2011.03.046; Lambert M.J., 2002, PSYCHOTHERAPY RELATI, P17; Leach LS, 2006, J TELEMED TELECARE, V12, P122, DOI 10.1258/135763306776738558; Lifeline Australia, 2014, VOLUNT MAN SURV; Lifeline Australia, 2015, VOLUNT ENG SURV; Lifeline Australia, 2015, ANN REPORT 14 15; Lovibond SH., 2004, MANUAL DEPRESSION AN, V4th; Luciano JV, 2010, J EVAL CLIN PRACT, V16, P895, DOI 10.1111/j.1365-2753.2009.01211.x; Mahoney MJ, 1997, PROF PSYCHOL-RES PR, V28, P14, DOI 10.1037/0735-7028.28.1.14; McKnight PE, 2009, CLIN PSYCHOL REV, V29, P243, DOI 10.1016/j.cpr.2009.01.005; McNair D., 1971, MANUAL PROFILE MOOD; Meldrum L, 2002, TREATING COMPASSION, P85; MISHARA BL, 1993, SUICIDE LIFE-THREAT, V23, P221; Mishara BL, 2007, SUICIDE LIFE-THREAT, V37, P291, DOI 10.1521/suli.2007.37.3.291; National Coalition for Suicide Prevention, 2014, PREV SUIC GLOB IMP; Nelson-Gardell D, 2003, CHILD WELFARE, V82, P5; O'Connor MF, 2001, PROF PSYCHOL-RES PR, V32, P345, DOI 10.1037/0735-7028.32.4.345; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; PEARLMAN LA, 1995, PROF PSYCHOL-RES PR, V26, P558, DOI 10.1037/0735-7028.26.6.558; POPE KS, 1987, AM PSYCHOL, V42, P993, DOI 10.1037/0003-066X.42.11.993; POPE KS, 1994, PROF PSYCHOL-RES PR, V25, P247, DOI 10.1037/0735-7028.25.3.247; Ray S.L., 2013, TRAUMATOLOGY, V19, P255, DOI [DOI 10.1177/1534765612471144, 10.1177/1534765612471144]; REYNOLDS WM, 1991, J PERS ASSESS, V56, P289, DOI 10.1207/s15327752jpa5602_9; RICKWOOD DJ, 1994, SOC SCI MED, V39, P563, DOI 10.1016/0277-9536(94)90099-X; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Rossi V, 2012, ANXIETY STRESS COPIN, V25, P603, DOI 10.1080/10615806.2011.582948; Rothschild B., 2006, HELP HELPER PSYCHOPH; Rupert PA, 2007, PROF PSYCHOL-RES PR, V38, P88, DOI 10.1037/0735-7028.38.1.88; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Sheehan DV., 1983, ANXIETY DIS; Sherman MD, 1998, PROF PSYCHOL-RES PR, V29, P79, DOI 10.1037/0735-7028.29.1.79; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Smith PL, 2009, CLIN PSYCHOL-SCI PR, V16, P1, DOI 10.1111/j.1468-2850.2009.01137.x; Sprang G, 2007, J LOSS TRAUMA, V12, P259, DOI 10.1080/15325020701238093; Stamm BH, 2010, CONCISE PROQOL MANUA; Stukas AA, 2016, NONPROF VOLUNT SEC Q, V45, P112, DOI 10.1177/0899764014561122; THORESON RW, 1989, PROF PSYCHOL-RES PR, V20, P153, DOI 10.1037/0735-7028.20.3.153; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; West Colin P, 2007, Minn Med, V90, P44; Wilson CJ, 2010, J YOUTH ADOLESCENCE, V39, P343, DOI 10.1007/s10964-009-9436-6	83	4	4	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207645	10.1371/journal.pone.0207645	http://dx.doi.org/10.1371/journal.pone.0207645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HE9NT	30566435	Green Published, Green Submitted, gold			2022-12-26	WOS:000453779300014
J	Meister, P; Wiedling, J; Lott, C; Bach, W; Kuhfuss, H; Wegener, G; Bottcher, ME; Deusner, C; Lichtschlag, A; Bernasconi, SM; Weber, M				Meister, Patrick; Wiedling, Johanna; Lott, Christian; Bach, Wolfgang; Kuhfuss, Hanna; Wegener, Gunter; Boettcher, Michael E.; Deusner, Christian; Lichtschlag, Anna; Bernasconi, Stefano M.; Weber, Miriam			Anaerobic methane oxidation inducing carbonate precipitation at abiogenic methane seeps in the Tuscan archipelago (Italy)	PLOS ONE			English	Article							ANGLE NORMAL FAULTS; ELBA ISLAND; MICROBIAL COMMUNITIES; SULFATE REDUCTION; ISOTOPE FRACTIONATION; ORGANIC-COMPOUNDS; ABIOTIC METHANE; MONTEREY BAY; MUD VOLCANO; FLUID-FLOW	Seepage of methane (CH4) on land and in the sea may significantly affect Earth's biogeochemical cycles. However processes of CH4 generation and consumption, both abiotic and microbial, are not always clear. We provide new geochemical and isotope data to evaluate if a recently discovered CH4 seepage from the shallow seafloor close to the Island of Elba (Tuscany) and two small islands nearby are derived from abiogenic or biogenic sources and whether carbonate encrusted vents are the result of microbial or abiotic processes. Emission of gas bubbles (predominantly CH4) from unlithified sands was observed at seven spots in an area of 100 m(2) at Pomonte (Island of Elba), with a total rate of 234 ml m(-2) d(-1). The measured carbon isotope values of CH4 of around -18 parts per thousand (VPDB) in combination with the measured delta H-2 value of -120 parts per thousand (VSMOW) and the inverse correlation of delta C-13-value with carbon number of hydrocarbon gases are characteristic for sites of CH4 formation through abiogenic processes, specifically abiogenic formation of CH4 via reduction of CO2 by H-2. The H-2 for methanogenesis likely derives from ophiolitic host rock within the Ligurian accretionary prism. The lack of hydrothermal activity allows CH4 gas to become decoupled from the stagnant aqueous phase. Hence no hyperalkaline fluid is currently released at the vent sites. Within the seep area a decrease in porewater sulphate concentrations by ca. 5 mmol/l relative to seawater and a concomitant increase in sulphide and dissolved inorganic carbon (DIC) indicate substantial activity of sulphate-dependent anaerobic oxidation of methane (AOM). In absence of any other dissimilatory pathway, the delta C-13-values between -17 and -5 parts per thousand in dissolved inorganic carbon and aragonite cements suggest that the inorganic carbon is largely derived from CH4. The formation of seep carbonates is thus microbially induced via anaerobic oxidation of abiotic CH4.	[Meister, Patrick] Univ Vienna, Dept Geodynam & Sedimentol, Vienna, Austria; [Wiedling, Johanna; Lott, Christian; Kuhfuss, Hanna; Weber, Miriam] HYDRA Marine Sci GmbH, Sinzheim, Italy; [Wiedling, Johanna; Lott, Christian; Kuhfuss, Hanna; Weber, Miriam] HYDRA Field Stn Elba, Campo Nellelba, Italy; [Wiedling, Johanna; Kuhfuss, Hanna; Wegener, Gunter; Weber, Miriam] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bach, Wolfgang; Wegener, Gunter] Univ Bremen, MARUM Ctr Marine Environm Res, Bremen, Germany; [Boettcher, Michael E.] Leibniz Inst Balt Sea Res IOW, Geochem & Isotope Biogeochem Grp, Warnemunde, Germany; [Deusner, Christian] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Lichtschlag, Anna] Univ Southampton, Natl Oceanog Ctr, Water Front Campus, Southampton, Hants, England; [Bernasconi, Stefano M.] Swiss Fed Inst Technol, Geol Inst, Zurich, Switzerland	University of Vienna; Max Planck Society; University of Bremen; Leibniz Institut fur Ostseeforschung Warnemunde; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; NERC National Oceanography Centre; University of Southampton; Swiss Federal Institutes of Technology Domain; ETH Zurich	Meister, P (corresponding author), Univ Vienna, Dept Geodynam & Sedimentol, Vienna, Austria.	patrick.meister@unive.ac.at	Bernasconi, Stefano M/E-5394-2010; Lichtschlag, Anna/P-6669-2015; Bach, Wolfgang/D-3713-2017	Bernasconi, Stefano M/0000-0001-7672-8856; Lichtschlag, Anna/0000-0001-8281-2165; Bach, Wolfgang/0000-0002-3099-7142; Bottcher, Michael Ernst/0000-0002-8877-0303; Meister, Patrick/0000-0003-3623-6456; Deusner, Christian/0000-0001-9331-2991; Wegener, Gunter/0000-0002-6819-373X	HYDRA Institute for Marine Sciences, its field station Centro Marino Elba; Max Planck Institute for Marine Microbiology; Leibniz IOW; European Commission [MRTN-CT-2006-035868, 626025]; Swiss National Science Foundation (SNF) [PA00P2-126221]	HYDRA Institute for Marine Sciences, its field station Centro Marino Elba; Max Planck Institute for Marine Microbiology(Max Planck Society); Leibniz IOW; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was financed by the HYDRA Institute for Marine Sciences, its field station Centro Marino Elba and the Max Planck Institute for Marine Microbiology. ICP-OES measurements were supported by Leibniz IOW. P. Meister received funding from the European Commission (Marie-Curie Research Training Network "Greenhouse-Gas Removal Apprenticeship and Student Program", GRASP, project MRTN-CT-2006-035868 and Intra European Fellowship no. 626025, project TRIADOL) and from the Swiss National Science Foundation (SNF, project PA00P2-126221).	ABRAJANO TA, 1988, CHEM GEOL, V71, P211, DOI 10.1016/0009-2541(88)90116-7; Aiello IW, 2005, PALAEOGEOGR PALAEOCL, V227, P124, DOI 10.1016/j.palaeo.2005.04.027; Aiello IW, 2001, GEOLOGY, V29, P1111, DOI 10.1130/0091-7613(2001)029<1111:AAOOCS>2.0.CO;2; Akal T, 1970, SACLANT ASW RES CTR; Bach W, 2011, EARTH PLANET SC LETT, V311, P242, DOI 10.1016/j.epsl.2011.09.021; Badran F, 2008, J MARINE SYST, V69, P126, DOI 10.1016/j.jmarsys.2007.02.018; BARNES I, 1969, GEOL SOC AM BULL, V80, P1947, DOI 10.1130/0016-7606(1969)80[1947:TRBFIS]2.0.CO;2; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7; Berner U, 1995, CHEM GEOL, V126, P233, DOI 10.1016/0009-2541(95)00120-4; Bernier P, 1997, MAR GEOL, V144, P163, DOI 10.1016/S0025-3227(97)00086-8; Bernoulli D., 1981, PUBLICATIONS CTR NAT, V23, P197; Birgel D, 2011, CHEM GEOL, V285, P82, DOI 10.1016/j.chemgeo.2011.03.004; Bortolotti V, 2001, OFIOLITI, V26, P97; Boschetti T, 2013, PROCED EARTH PLAN SC, V7, P248, DOI 10.1016/j.proeps.2013.02.004; BOUILLIN JP, 1993, EARTH PLANET SC LETT, V118, P263, DOI 10.1016/0012-821X(93)90172-6; Bradley AS, 2010, EARTH PLANET SC LETT, V297, P34, DOI 10.1016/j.epsl.2010.05.034; Brauchli M, 2013, QATAR MINERALOGICAL, V77, P764; BROOKS JM, 1986, ORG GEOCHEM, V10, P221, DOI 10.1016/0146-6380(86)90025-2; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; BURTON EA, 1993, CHEM GEOL, V105, P163, DOI 10.1016/0009-2541(93)90124-2; Chavagnac V, 2013, GEOCHEM GEOPHY GEOSY, V14, P2474, DOI 10.1002/ggge.20146; Claypool G.E., 1974, NATURAL GASES MARINE, P99, DOI DOI 10.1007/978-1-4684-2757-8_8; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Collettini C, 2006, J STRUCT GEOL, V28, P333, DOI 10.1016/j.jsg.2005.10.003; Cornamusini G., 2002, BOLLETTINO SOCIET GE, V1, P769; D'Alessandro W, 2018, MAR PETROL GEOL, V89, P174, DOI 10.1016/j.marpetgeo.2016.12.017; Della Vedova B., 2001, ANATOMY OROGEN APENN, P65, DOI DOI 10.1007/978-94-015-9829-3_7; DESMARAIS DJ, 1981, NATURE, V292, P826, DOI 10.1038/292826a0; Dini A, 2002, GEOL MAG, V139, P257, DOI 10.1017/S0016756802006556; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Fernandez-Diaz L, 2006, CHEM GEOL, V225, P314, DOI 10.1016/j.chemgeo.2005.08.024; Fiebig J, 2007, GEOCHIM COSMOCHIM AC, V71, P3028, DOI 10.1016/j.gca.2007.04.010; Fiebig J, 2015, CHEM GEOL, V396, P152, DOI 10.1016/j.chemgeo.2014.12.030; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Frisch W, 2008, ELBA GEOLOGIE STRUKT, V98; Frueh-Green GL, 2007, GEOCHIM COSMOCHIM AC, V71, pA298; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Gherardi F, 2005, GEOTHERMICS, V34, P442, DOI 10.1016/j.geothermics.2004.09.005; Greinert J, 2006, EARTH PLANET SC LETT, V244, P1, DOI 10.1016/j.epsl.2006.02.011; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Hoefs J, 2018, STABLE ISOTOPE GEOCH; Horita J, 2001, GEOCHIM COSMOCHIM AC, V65, P1907, DOI 10.1016/S0016-7037(01)00570-1; Hovland M., 1988, SEABED POCKMARKS SEE; Jessen GL, 2011, CONT SHELF RES, V31, P574, DOI 10.1016/j.csr.2010.12.012; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Judd AG, 2004, ENVIRON GEOL, V46, P988, DOI 10.1007/s00254-004-1083-3; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Keller J. V. A., 1990, B SOC GEOL ITAL, V109, P413; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Kim ST, 2007, GEOCHIM COSMOCHIM AC, V71, P4704, DOI 10.1016/j.gca.2007.04.019; Klein F, 2013, LITHOS, V178, P55, DOI 10.1016/j.lithos.2013.03.008; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Konn C, 2015, ASTROBIOLOGY, V15, P381, DOI 10.1089/ast.2014.1198; Kowalski N, 2012, ESTUAR COAST SHELF S, V100, P3, DOI 10.1016/j.ecss.2011.03.011; Lambe T.W., 1969, SOIL MECH; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; Land LS, 1998, AQUAT GEOCHEM, V4, P361, DOI 10.1023/A:1009688315854; Lazar C, 2005, AM GEOPHYS UNION; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; LOLLAR BS, 1993, GEOCHIM COSMOCHIM AC, V57, P5087; LUMSDEN DN, 1979, J SEDIMENT PETROL, V49, P429; Lund J.W., 2004, GHC B, V25, P11; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; McCollom TM, 2007, CHEM REV, V107, P382, DOI 10.1021/cr0503660; McCollom TM, 2016, P NATL ACAD SCI USA, V113, P13965, DOI 10.1073/pnas.1611843113; McCollom TM, 2009, GEOCHIM COSMOCHIM AC, V73, P856, DOI 10.1016/j.gca.2008.10.032; McDermott JM, 2015, P NATL ACAD SCI USA, V112, P7668, DOI 10.1073/pnas.1506295112; Meister P., 2011, ADV STROMATOLITE GEO, V131, P101; Meister P, 2013, GEOLOGY, V41, P499, DOI 10.1130/G34185.1; Minissale A, 1997, CHEM GEOL, V142, P175, DOI 10.1016/S0009-2541(97)00081-8; Monnin C., 2014, ASTROBIOL EXOBIOL, V11, P6221, DOI [10.5194/bgd-11-6221-2014, DOI 10.5194/BGD-11-6221-2014]; Morrill PL, 2013, GEOCHIM COSMOCHIM AC, V109, P222, DOI 10.1016/j.gca.2013.01.043; Natalicchio M, 2012, PALAEOGEOGR PALAEOCL, V329, P158, DOI 10.1016/j.palaeo.2012.02.026; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Pan CC, 2006, EARTH PLANET SC LETT, V246, P70, DOI 10.1016/j.epsl.2006.04.013; Parkhurst D.L., 2013, US GEOL SURV TECH ME; PERGENT G, 1994, MAR ECOL PROG SER, V106, P139, DOI 10.3354/meps106139; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; ROBERTS HH, 1994, GEO-MAR LETT, V14, P135, DOI 10.1007/BF01203725; Rossetti F, 2008, GEOFLUIDS, V8, P167, DOI 10.1111/j.1468-8123.2008.00215.x; Rossetti F, 2007, CONTRIB MINERAL PETR, V153, P743, DOI 10.1007/s00410-006-0175-3; Ruff SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00374; Scarascia S., 1994, Bollettino di Geofisica Teorica ed Applicada, V36, P5; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; SCHOELL M, 1980, GEOCHIM COSMOCHIM AC, V44, P649, DOI 10.1016/0016-7037(80)90155-6; Schwarzenbach EM, 2013, LITHOS, V177, P226, DOI 10.1016/j.lithos.2013.07.009; Scrocca D., 2003, MEM DESCRLLA CARTA G, V62, P15; Sevilgen D., 2008, THESIS; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Smith SAF, 2011, GEOL SOC AM BULL, V123, P329, DOI 10.1130/B30200.1; Stakes DS, 1999, MAR GEOL, V159, P93, DOI 10.1016/S0025-3227(98)00200-X; Tassi F, 2012, CHEM GEOL, V310, P36, DOI 10.1016/j.chemgeo.2012.03.018; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; VAN DEN BERG CMG, 1987, MAR CHEM, V20, P219, DOI 10.1016/0304-4203(87)90073-9; Viti C, 1998, EUR J MINERAL, V10, P1341; Wang DT, 2018, GEOCHIM COSMOCHIM AC, V223, P141, DOI 10.1016/j.gca.2017.11.030; Wegener G, 2008, ENVIRON MICROBIOL, V10, P2287, DOI 10.1111/j.1462-2920.2008.01653.x; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1990, APPL GEOCHEM, V5, P135, DOI 10.1016/0883-2927(90)90044-6; Widdel F, 1992, PROKARYOTES, P3352, DOI DOI 10.1007/978-1-4757-2191-1_	108	14	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207305	10.1371/journal.pone.0207305	http://dx.doi.org/10.1371/journal.pone.0207305			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9NT	30566474	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000453779300007
J	Zhou, L; Niu, JX; Quan, SW				Zhou, Li; Niu, Jianxin; Quan, Shaowen			Identification of appropriate reference genes for RT-qPCR analysis in Juglans regia L.	PLOS ONE			English	Article							REAL-TIME PCR; NORMALIZATION; SELECTION; VALIDATION; FRUIT	Reverse transcription quantitative real-time PCR (RT-qPCR) is a popular adopted technique to detect gene expression, and the selection of appropriate reference genes is crucial for data normalization. In the present study, seven candidate reference genes were screened to evaluate their expression stability in various flower buds, leaf buds, tissues and cultivars of the English walnut (Juglans regia L.) based on four algorithms (geNorm, Normfinder, Bestkeeper and RefFinder). The results demonstrated that TUA, EF1 and TUB were appropriate reference genes for flower buds at different stages of female flower buds differentiation; TUB and 18S rRNA were best for leaf buds at different stages of female flower buds differentiation; TUB and TUA were suitable for different cultivars; and ACT2, 18S rRNA and GAPDH were useful for different tissues. Moreover, the expression of ACT was not stable among different flower buds, leaf buds and cultivars. The stability of reference genes were confirmed through the analysis of the expression of SPL18 gene. These results will contribute to a reliable normalization of gene expression in J. regia.	[Zhou, Li; Niu, Jianxin; Quan, Shaowen] Shihezi Univ, Coll Agr, Dept Hort, Shihezi, Xinjiang, Peoples R China; [Zhou, Li; Niu, Jianxin; Quan, Shaowen] Xinjiang Prod & Construct Corps Key Lab Special F, Shihezi, Xinjiang, Peoples R China	Shihezi University	Niu, JX (corresponding author), Shihezi Univ, Coll Agr, Dept Hort, Shihezi, Xinjiang, Peoples R China.; Niu, JX (corresponding author), Xinjiang Prod & Construct Corps Key Lab Special F, Shihezi, Xinjiang, Peoples R China.	njx105@163.com	Niu, Jianxin/ABF-2221-2020; Zhou, Li/N-7868-2019	Zhou, Li/0000-0003-0748-8339	National Science and Technology Specific projects of Xinjiang [201130102-1-4]; National Natural Science Foundation of China [30560090]	National Science and Technology Specific projects of Xinjiang; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Science and Technology Specific projects of Xinjiang (No. 201130102-1-4) and the National Natural Science Foundation of China (No. 30560090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Fundel K, 2008, OSTEOARTHR CARTILAGE, V16, P947, DOI 10.1016/j.joca.2007.12.007; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gadiou S, 2012, INDIAN J VIROL, V23, P39, DOI 10.1007/s13337-012-0065-4; Huang YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168725; Karuppaiya P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172460; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kou SJ, 2012, PLANT CELL REP, V31, P2151, DOI 10.1007/s00299-012-1325-x; Kou XY, 2017, SCI HORTIC-AMSTERDAM, V225, P195, DOI 10.1016/j.scienta.2017.07.004; Li J, 2016, FRONT PLANT SCI, P7; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; [李雪 Li Xue], 2017, [植物生理学报, Plant Physiology Journal], V53, P1795; Liang CQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194436; Ma R, 2016, FRONT PLANT SCI, P7; Niu K, 2017, FRONT PLANT SCI, P8; Niu XP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00848; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perini P, 2014, MOL BREEDING, V34, P829, DOI 10.1007/s11032-014-0078-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sun HF, 2009, MOL BIOL REP, V36, P2183, DOI 10.1007/s11033-008-9433-y; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xiao XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00788; Xu YY, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1784-0; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Zhang CM, 2015, SCI HORTIC-AMSTERDAM, V197, P166, DOI 10.1016/j.scienta.2015.09.026; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	33	9	9	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2018	13	12							e0209424	10.1371/journal.pone.0209424	http://dx.doi.org/10.1371/journal.pone.0209424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE9MF	30562379	Green Submitted, Green Published, gold			2022-12-26	WOS:000453774100055
J	Alladagbin, DJ; Fernandes, PN; Tavares, MB; Brito, JT; Oliveira, GGS; Silva, LK; Khouri, NA; Oliveira, MB; Amorim, T; Matos, CM; Ribeiro, GS; Lopes, AA; Goncalves, MS; dos-Santos, WLC				Alladagbin, Dona J.; Fernandes, Paula N.; Tavares, Maria B.; Brito, Jean T.; Oliveira, Geraldo G. S.; Silva, Luciano K.; Khouri, Nadia A.; Oliveira, Marilia B.; Amorim, Tatiana; Matos, Cacia M.; Ribeiro, Guilherme S.; Lopes, Antonio A.; Goncalves, Marilda S.; dos-Santos, Washington L. C.			The sickle cell trait and end stage renal disease in Salvador, Brazil	PLOS ONE			English	Article							APOL1 RISK VARIANTS; CHRONIC KIDNEY-DISEASE; GENETIC-VARIATION	Background Carriers of the sickle cell trait (HbAS) usually remain asymptomatic. However, under conditions of low tissue oxygenation, red blood cell sickling and vascular obstruction may develop. Chronic kidney disease (CKD) can arise from conditions promoting low-oxygen in kidney tissue, which may be aggravated by the presence of the sickle cell trait. In addition, CKD can arise from other genetic traits. Aim To compare the frequency of HbAS among hemodialysis patients and the general newborn population of Salvador (Bahia-Brazil), as well as to investigate the frequencies of apolipoprotein L1 risk variants in patients undergoing hemodialysis. Methods A cross-sectional study included 306 patients with ESRD (End Stage Renal Disease) on hemodialysis for no more than three years. Hemoglobin profiles were characterized by high-performance liquid chromatography. To estimate the sickle cell trait frequency in the general population of Salvador, we analyzed data collected by a local neonatal screening program between 2011 and 2016. To exclude the potential contributing effect of the apolipoprotein L1 (APOL1) gene variants, we performed genotyping by PCR and DNA sequencing of 45 patients. Results The frequency of HbAS was significantly higher in hemodialysis patients (9.8%) than in the general population (4.6%): Odds Ratio = 2.32 (95% CI = 1.59-3.38). No differences in demographic, clinical or laboratory data were found among patients with or without the sickle cell trait. The frequency of patients with none, one or two APOL1 risk haplotypes (G1 and G2) for CKD were 80%, 18% and 2%, respectively. Conclusions The frequency of the sickle cell trait is higher in patients with ESRD on hemodialysis compared to the general population. APOL1 haplotypes do not seem to be the determinant of ESRD in these patients.	[Alladagbin, Dona J.; Fernandes, Paula N.; Tavares, Maria B.; Oliveira, Geraldo G. S.; Silva, Luciano K.; Ribeiro, Guilherme S.; Goncalves, Marilda S.; dos-Santos, Washington L. C.] Inst Goncalo Moniz FIOCRUZ Bahia, Salvador, BA, Brazil; [Brito, Jean T.; Ribeiro, Guilherme S.; Lopes, Antonio A.; Goncalves, Marilda S.] Univ Bahia, Salvador, BA, Brazil; [Khouri, Nadia A.] Hosp Geral Roberto Santos, Salvador, BA, Brazil; [Oliveira, Marilia B.] Hosp Ana Nery, Salvador, BA, Brazil; [Amorim, Tatiana] Serv Referencia Triagem Neonatal, Salvador, BA, Brazil; [Matos, Cacia M.] Inst Nefrol & Dialise, Salvador, BA, Brazil		dos-Santos, WLC (corresponding author), Inst Goncalo Moniz FIOCRUZ Bahia, Salvador, BA, Brazil.	wluis@bahia.fiocruz.br	Gonçalves, Marilda/AAO-4559-2021; de Sá Oliveira, Geraldo Gileno/AAO-4099-2021; dos-Santos, Washington LC/AAO-4649-2021; Ribeiro, Guilherme/B-6624-2008; Silva, Luciano/L-9041-2013	Gonçalves, Marilda/0000-0003-3000-1437; de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; dos-Santos, Washington LC/0000-0002-5075-1254; Ribeiro, Guilherme/0000-0002-6798-2059; Silva, Luciano/0000-0002-7739-4082	Bahia Research Foundation (FAPESB) [SUS0004/2013]	Bahia Research Foundation (FAPESB)	This study was funded by Bahia Research Foundation (FAPESB); grant SUS0004/2013 (http://www.fapesb.ba.gov.br) to WLCS, DJA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Elisângela Vitória, 2005, Cad. Saúde Pública, V21, P292, DOI 10.1590/S0102-311X2005000100032; Ajayi A.A., 2004, Eur J Intern Med, V15, P312, DOI 10.1016/j.ejim.2004.06.003; Bandeira ICJ, 2014, CYTOKINE, V65, P217, DOI 10.1016/j.cyto.2013.10.009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen TK, 2017, CLIN J AM SOC NEPHRO, V12, P1771, DOI 10.2215/CJN.01180117; Colah RB, 2015, INDIAN J MED RES, V141, P509; Derebail VK, 2010, J AM SOC NEPHROL, V21, P413, DOI 10.1681/ASN.2009070705; Foster MC, 2013, J AM SOC NEPHROL, V24, P1484, DOI 10.1681/ASN.2013010113; Friedman DJ, 2016, TRENDS ENDOCRIN MET, V27, P204, DOI 10.1016/j.tem.2016.02.002; Haque S, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160531; Hicks PJ, 2011, KIDNEY INT, V80, P1339, DOI 10.1038/ki.2011.286; Isaias Luana, 2013, J. Bras. Patol. Med. Lab., V49, P264, DOI 10.1590/S1676-24442013000400006; John Nitin, 2010, Oman Med J, V25, P3, DOI 10.5001/omj.2010.2; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lervolino Luciana Garcia, 2011, Rev. Bras. Hematol. Hemoter., V33, P49, DOI 10.5581/1516-8484.20110015; Li EJ, 2014, CLIN PEDIATR, V53, P1013, DOI 10.1177/0009922814533418; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peces R, 2011, NEFROLOGIA, V31, P162, DOI 10.3265/Nefrologia.pre2010.Dec.10660; Seegars MB, 2015, HEMATOLOGY, V20, P607, DOI 10.1179/1607845415Y.0000000024; Sesso Ricardo Cintra, 2014, Braz. J. Nephrol., V36, P48, DOI 10.5935/0101-2800.20140009; Shaw C, 2010, NEPHROL DIAL TRANSPL, V25, P2403, DOI 10.1093/ndt/gfq186; Sonati MD, 2008, J PEDIAT-BRAZIL, V84, pS40, DOI [10.2223/JPED.1802, 10.1590/S0021-75572008000500007]; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Tsaras G, 2009, AM J MED, V122, P507, DOI 10.1016/j.amjmed.2008.12.020; Vekilov PG, 2007, BRIT J HAEMATOL, V139, P173, DOI 10.1111/j.1365-2141.2007.06794.x; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0209036	10.1371/journal.pone.0209036	http://dx.doi.org/10.1371/journal.pone.0209036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557319	gold, Green Published, Green Submitted			2022-12-26	WOS:000453451000064
J	Dong, XD; Zhang, JH; Lai, HJ; Tang, M; Ou, SX; Dou, JH; Wang, C				Dong, Xunde; Zhang, Jinhe; Lai, Hongji; Tang, Min; Ou, Shanxing; Dou, Jianhong; Wang, Cong			The predictive value of Cardiodynamicsgram in myocardial perfusion abnormalities	PLOS ONE			English	Article								Myocardial perfusion abnormalities are the first sign of the ischemic cascade in the development of coronary artery disease (CAD). Thus, the early detection of myocardial perfusion abnormalities is significant for the prevention of CAD. Recently, a novel noninvasive method named Cardiodynamicsgram (CDG) has been proposed for early detection of CAD. This study aims to evaluate the predictive value of CDG in myocardial perfusion abnormalities for suspected ischemic heart disease. In the study, 86 suspected patients were enrolled. Standard 12-lead ECG and CDG were performed simultaneously before single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). Diagnostic accuracy of CDG for myocardial perfusion abnormalities detection is assessed using SPECT MPI as the reference standard. Of these 86 suspected patients, 37 patients were positive in CDG, 49 patients were negative in CDG. Diagnostic accuracy of CDG at presentation for myocardial perfusion abnormalities was 84.9%, sensitivity 84.0%, and specificity 89.4%. Further-more, of the 10 patients whose SPECT MPI results are reverse redistribution, 9 patients were positive in CDG. Underlying causes of false positive CDG findings included the factors that can change the stability of cardiac electrical conduction and measurement noise. Myocardial remodeling in patients with old myocardial infarction might be the major cause of false negative findings. Results show a good consistency between the CDG and SPECT MPI in evaluating myocardial perfusion abnormalities. It suggests that CDG might be used as a cost-effective tool for assessing the myocardial perfusion abnormalities in the clinic.	[Dong, Xunde; Lai, Hongji; Wang, Cong] South China Univ Technol, Sch Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Jinhe] Guangzhou Gen Hosp PLA, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China; [Tang, Min] Chinese Acad Med Sci, Dept Cardiol, State Key Lab Cardiovasc Dis, Cardiovasc Inst,Fuwai Hosp,Natl Ctr Cardiovasc Di, Beijing, Peoples R China; [Tang, Min] Peking Union Med Coll, Beijing, Peoples R China; [Ou, Shanxing] Guangzhou Gen Hosp PLA, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Dou, Jianhong] Guangzhou Gen Hosp PLA, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, C (corresponding author), South China Univ Technol, Sch Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	wangcong@scut.edu.cn			Natural Science Foundation of Guangdong Province [2018A030310367]; Fundamental Research Funds for the Central Universities, China [2018A030310367]; Natural Science Foundation of Guangdong Province, China [2017A030310493]; National Natural Science Foundation of China [61527811]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Natural Science Foundation of Guangdong Province and Fundamental Research Funds for the Central Universities, China grant to Xunde Dong (grant number: 2018A030310367); a Natural Science Foundation of Guangdong Province, China grant to Xunde Dong (grant number: 2017A030310493); and a National Natural Science Foundation of China grant to Cong Wang (grant number: 61527811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA LB, 1994, IEEE T SIGNAL PROCES, V42, P3084, DOI 10.1109/78.330368; [Anonymous], 2015, CARD DIS CVDS; Barizon GC, 2018, J NUCL CARDIOL, P1; Beller GA, 2018, J NUCL CARDIOL, V25, P375, DOI 10.1007/s12350-018-1211-1; Dedic A, 2013, AM J ROENTGENOL, V200, pW26, DOI 10.2214/AJR.11.8296; Deng M, 2017, EUR HEART J, V38, P189; Deng MQ, 2017, AM J CARDIOL, V119, P698, DOI 10.1016/j.amjcard.2016.11.028; Dong Xunde, 2014, [Control Theory and Technology, 控制理论与技术], V12, P333; EDENBRANDT L, 1988, J ELECTROCARDIOL, V21, P361, DOI 10.1016/0022-0736(88)90113-6; Hill D. J., 2009, DETERMINISTIC LEARNI; Huebner Thomas, 2010, Ger Med Sci, V8, pDoc27, DOI 10.3205/000116; McNulty EJ, 2014, JAMA-J AM MED ASSOC, V311, P1248, DOI 10.1001/jama.2014.472; Ortiz-Perez JT, 2008, JACC-CARDIOVASC IMAG, V1, P282, DOI 10.1016/j.jcmg.2008.01.014; Qayyum AA, 2015, CLIN RADIOL, V70, P576, DOI 10.1016/j.crad.2014.12.017; Suyama J, 2014, SHOWA U J MED SCI, V26, P159, DOI [10.15369/sujms.26.159, DOI 10.15369/SUJMS.26.159]; Tung R, 2015, HEART RHYTHM, V12, P2488, DOI 10.1016/j.hrthm.2015.08.014; Wang CX, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-015-5517-1; Wang C, 2007, IEEE T NEURAL NETWOR, V18, P617, DOI 10.1109/TNN.2006.889496; WATARIDA S, 1995, ANN THORAC SURG, V59, P1528, DOI 10.1016/0003-4975(95)00186-O; Wen X., 2018, J TAIWAN I CHEM ENG, P1; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Xiang DC, 2011, J NUCL CARDIOL, V18, P314, DOI 10.1007/s12350-011-9342-7; Yuan CZ, 2014, SCI CHINA INFORM SCI, V57, DOI 10.1007/s11432-012-4731-3	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0208859	10.1371/journal.pone.0208859	http://dx.doi.org/10.1371/journal.pone.0208859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557346	gold, Green Submitted, Green Published			2022-12-26	WOS:000453451000051
J	Zhao, YZ; Liu, XY; Li, XF				Zhao, Yuzhen; Liu, Xiyu; Li, Xiufeng			An improved DBSCAN algorithm based on cell-like P systems with promoters and inhibitors	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORK; CLUSTER-ANALYSIS; SYNAPSES WORKING; TIME; RULES	Density-based spatial clustering of applications with noise (DBSCAN) algorithm can find clusters of arbitrary shape, while the noise points can be removed. Membrane computing is a novel research branch of bio-inspired computing, which seeks to discover new computational models/framework from biological cells. The obtained parallel and distributed computing models are usually called P systems. In this work, DBSCAN algorithm is improved by using parallel evolution mechanism and hierarchical membrane structure in cell-like P systems with promoters and inhibitors, where promoters and inhibitors are utilized to regulate parallelism of objects evolution. Experiment results show that the proposed algorithm performs well in big cluster analysis. The time complexity is improved to O(n), in comparison with conventional DBSCAN of O(n(2)). The results give some hints to improve conventional algorithms by using the hierarchical framework and parallel evolution mechanism in membrane computing models.	[Zhao, Yuzhen; Liu, Xiyu; Li, Xiufeng] Shandong Normal Univ, Coll Business, Jinan 250014, Shandong, Peoples R China	Shandong Normal University	Liu, XY (corresponding author), Shandong Normal Univ, Coll Business, Jinan 250014, Shandong, Peoples R China.	sdxyliu@163.com	zhao, YZ/GXH-6401-2022		National Natural Science Foundation of China [61806114, 61472231, 61876101, 61602282, 61402187, 61502283, 61802234, 61703251]; China Postdoctoral Science Foundation [2018M642695]; Natural Science Foundation of Shandong Province [ZR2016AQ21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China (No.61806114 to Y. Zhao, No. 61472231 to X. Liu, No. 61876101 to X. Liu, No. 61602282, No. 61402187, No. 61502283, No. 61802234, No.61703251, http://www.nsfc.gov.cn/), China Postdoctoral Science Foundation (No.2018M642695 to Y. Zhao, http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx) and the Natural Science Foundation of Shandong Province (No. ZR2016AQ21, http://www.sdnsf.gov.cn/portal/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2015, EAI ENDORSED T IND N, V15, P1, DOI DOI 10.1007/s40745-015-0035-y; Andrade G, 2013, PROCEDIA COMPUT SCI, V18, P369, DOI 10.1016/j.procs.2013.05.200; Bearth A, 2014, FOOD CONTROL, V44, P166, DOI 10.1016/j.foodcont.2014.03.055; Cabarle FGC, 2017, IEEE T NANOBIOSCI, V16, P792, DOI 10.1109/TNB.2017.2762580; Chawla S, 2016, APPL SOFT COMPUT, V46, P90, DOI 10.1016/j.asoc.2016.04.042; Durante F, 2014, ADV DATA ANAL CLASSI, V8, P359, DOI 10.1007/s11634-013-0160-4; Edla DR, 2012, PROC TECH, V1, P485, DOI 10.1016/j.protcy.2012.10.058; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Gollapalli P, 2015, ADV BIORESEARCH, V6, P38; Han DW, 2016, IEEE SYM PARA DISTR, P1393, DOI 10.1109/IPDPSW.2016.57; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Ionescu M, 2006, FUND INFORM, V71, P279; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Karami A., 2014, INT J COMPUT APPL, V91, P1, DOI DOI 10.5120/15890-5059; Katariya K, 2014, INT J COMPUTER APPL, V89, P24, DOI [10.5120/15523-4306, DOI 10.5120/15523-4306]; Kou G, 2014, INFORM SCIENCES, V275, P1, DOI 10.1016/j.ins.2014.02.137; Li ZH, 2015, DIABETES TECHNOL THE, V17, P475, DOI 10.1089/dia.2014.0204; Liu Shu-fen, 2014, Journal of Jilin University (Engineering and Technology Edition), V44, P1135, DOI 10.13229/j.cnki.jdxbgxb201404035; Liu X., 2013, DISCRETE DYN NAT SOC, V5187, P845; Liu X, 2012, DISCRETE DYN NAT SOC, V2012, P132; Liu XR, 2015, IEEE T NANOBIOSCI, V14, P617, DOI 10.1109/TNB.2015.2438257; Liu XX, 2019, NAT PROD RES, V33, P472, DOI 10.1080/14786419.2017.1396594; Liu XY, 2017, DISCRETE DYN NAT SOC, V2017, DOI 10.1155/2017/6978146; Martin-Vide C, 2003, THEOR COMPUT SCI, V296, P295, DOI 10.1016/S0304-3975(02)00659-X; Mimaroglu S, 2011, PATTERN RECOGN LETT, V32, P1572, DOI 10.1016/j.patrec.2011.06.003; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Paun G, 2010, J LOGIC ALGEBR PROGR, V79, P291, DOI 10.1016/j.jlap.2010.04.002; Peng H, 2017, NEURAL NETWORKS, V95, P66, DOI 10.1016/j.neunet.2017.08.003; Peng H, 2017, KNOWL-BASED SYST, V125, P74, DOI 10.1016/j.knosys.2017.03.024; Pun G., 2010, OXFORD HDB MEMBRANE; Rodriguez SD, 2014, FOOD ANAL METHOD, V7, P2042, DOI 10.1007/s12161-014-9841-7; Selemetas N, 2015, GEOSPATIAL HEALTH, V9, P271, DOI 10.4081/gh.2015.349; Song T, 2017, ONCOTARGET; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; Song T, 2015, NEURAL PROCESS LETT, V42, P633, DOI 10.1007/s11063-014-9378-1; Song T, 2015, IEEE T NANOBIOSCI, V14, P465, DOI 10.1109/TNB.2015.2402311; Song T, 2015, IEEE T NANOBIOSCI, V14, P38, DOI 10.1109/TNB.2014.2367506; Song T, 2015, NEURAL PROCESS LETT, V42, P199, DOI 10.1007/s11063-014-9352-y; Song T, 2015, NEUROCOMPUTING, V151, P1439, DOI 10.1016/j.neucom.2014.10.044; Tian Y, 2018, IEEE T EVOLUT COMPUT, V22, P609, DOI 10.1109/TEVC.2017.2749619; Viswanath P, 2009, PATTERN RECOGN LETT, V30, P1477, DOI 10.1016/j.patrec.2009.08.008; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Zeng XX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005420; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2014, INFORM SCIENCES, V278, P423, DOI 10.1016/j.ins.2014.03.062; Zeng XX, 2014, NEURAL COMPUT, V26, P1340, DOI 10.1162/NECO_a_00605; Zeng XX, 2009, FUND INFORM, V97, P275, DOI 10.3233/FI-2009-200; Zhang Li-jie, 2014, Application Research of Computers, V31, P1972, DOI 10.3969/j.issn.1001-3695.2014.07.011; Zhang XY, 2018, IEEE T EVOLUT COMPUT, V22, P97, DOI 10.1109/TEVC.2016.2600642; Zhang XY, 2015, IEEE T NEUR NET LEAR, V26, P2816, DOI 10.1109/TNNLS.2015.2396940; Zhang XY, 2014, NEURAL COMPUT, V26, P2925, DOI 10.1162/NECO_a_00665; Zhang XY, 2014, NEURAL COMPUT, V26, P974, DOI 10.1162/NECO_a_00580; Zhao YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162882	56	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2018	13	12							e0200751	10.1371/journal.pone.0200751	http://dx.doi.org/10.1371/journal.pone.0200751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE5TK	30557333	Green Submitted, Green Published, gold			2022-12-26	WOS:000453451000002
J	Matsushima-Nishiwaki, R; Yamada, N; Fukuchi, K; Kozawa, O				Matsushima-Nishiwaki, Rie; Yamada, Noriko; Fukuchi, Kouki; Kozawa, Osamu			Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; INHIBITOR; DISCOVERY; RECURRENCE	A bioactive lipid, sphingosine 1-phosphate (S1P), acts extracellularly as a potent mediator, and is implicated in the progression of various cancers including hepatocellular carcinoma (HCC). S1P exerts its functions by binding to five types of specific receptors, S1P receptor 1 (S1PR1), S1PR2, S1PR3, S1PR4 and S1PR5 on the plasma membrane. However, the exact roles of S1P and each S1PR in HCC cells remain to be clarified. In the present study, we investigated the effect of S1P on the hepatocyte growth factor (HGF)-induced migration of human HCC-derived HuH7 cells, and the involvement of each S1PR. S1P dose-dependently reduced the HGF-induced migration of HuH7 cells. We found that all S1PRs exist in the HuH7 cells. Among each selective agonist for five S1PRs, CYM5520, a selective S1PR2 agonist, significantly suppressed the HGF-induced HuH7 cell migration whereas selective agonists for S1PR1, S1PR3, S1PR4 or S1PR5 failed to affect the migration. The reduction of the HGF-induced migration by S1P was markedly reversed by treatment of JTE013, a selective antagonist for S1PR2, and S1PR2-siRNA. These results strongly suggest that S1P reduces the HGF-induced HCC cell migration via S1PR2. Our findings may provide a novel potential of S1PR2 to therapeutic strategy for metastasis of HCC.	[Matsushima-Nishiwaki, Rie; Yamada, Noriko; Fukuchi, Kouki; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan	Gifu University	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okozawa@gifu-u.ac.jp			JSPS KAKENHI Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [JP25460989, JP17K09417]	JSPS KAKENHI Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This investigation was supported in part by JSPS KAKENHI Grant Numbers JP25460989 to OK, JP17K09417 to RM-N, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. http://www.mext.go.jp/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank Mrs. Yumiko Kurokawa for her skillful technical assistance. This investigation was supported in part by JSPS KAKENHI Grant Numbers JP25460989 to OK, JP17K09417 to RMN, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Guerrero M, 2012, BIOORG MED CHEM LETT, V22, P537, DOI 10.1016/j.bmcl.2011.10.096; Hobson AD, 2015, J MED CHEM, V58, P9154, DOI 10.1021/acs.jmedchem.5b00928; Jo EJ, 2012, ACS CHEM BIOL, V7, P1975, DOI 10.1021/cb300392z; Karimian G, 2013, BBA-MOL BASIS DIS, V1832, P1922, DOI 10.1016/j.bbadis.2013.06.011; Kleuser B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030722; Kwong E, 2015, ACTA PHARM SIN B, V5, P151, DOI 10.1016/j.apsb.2014.12.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Matsushima-Nishiwaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151907; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; MATSUSHIMANISHIWAK, 2017, BIOCH BIOPHYS ACTA M, V1863, P1629, DOI DOI 10.1016/J.BBADIS.2017.04.021; Muntane J, 2013, CURR CANCER DRUG TAR, V13, P300, DOI 10.2174/15680096113139990075; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Satsu H, 2013, BIOORGAN MED CHEM, V21, P5373, DOI 10.1016/j.bmc.2013.06.012; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Sneag DB, 2011, AM J ROENTGENOL, V197, pW658, DOI 10.2214/AJR.10.6402; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Toso C, 2011, AM J TRANSPLANT, V11, P2031, DOI 10.1111/j.1600-6143.2011.03689.x; Uranbileg B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149462; Ushitora Y, 2009, TRANSPLANTATION, V88, P980, DOI 10.1097/TP.0b013e3181b9ca69; Wang CY, 2014, EXP MOL PATHOL, V97, P259, DOI 10.1016/j.yexmp.2014.07.013; Wong CCL, 2010, LIVER INT, V30, P642, DOI 10.1111/j.1478-3231.2010.02232.x; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang Y, 2014, WORLD J GASTROENTERO, V20, P142, DOI 10.3748/wjg.v20.i1.142	35	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209050	10.1371/journal.pone.0209050	http://dx.doi.org/10.1371/journal.pone.0209050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543684	Green Submitted, Green Published, gold			2022-12-26	WOS:000453247500066
J	Matsuzawa, S; Isobe, M; Kurosawa, N				Matsuzawa, Shun; Isobe, Masaharu; Kurosawa, Nobuyuki			Guinea pig immunoglobulin VH and VL naive repertoire analysis	PLOS ONE			English	Article							MOUSE ANTIBODY TRANSGENE; GENE CONVERSION; SEQUENCE TRANSFERS; PEYERS PATCH; GENERATION; CHICKEN; MODEL; IMGT	The guinea pig has been used as a model to study various human infectious diseases because of its similarity to humans regarding symptoms and immune response, but little is known about the humoral immune response. To better understand the mechanism underlying the generation of the antibody repertoire in guinea pigs, we performed deep sequencing of full-length immunoglobulin variable chains from naive B and plasma cells. We gathered and analyzed nearly 16,000 full-length V-H, V-K and V-lambda genes and analyzed V and J gene segment usage profiles and mutation statuses by annotating recently reported genome data of guinea pig immunoglobulin genes. We found that approximately 70% of heavy, 73% of kappa and 81% of lambda functional germline V gene segments are integrated into the actual V(D)J recombination events. We also found preferential use of a particular V gene segment and accumulated mutation in CDRs 1 and 2 in antigen-specific plasma cells. Our study represents the first attempt to characterize sequence diversity in the expressed guinea pig antibody repertoire and provides significant insight into antibody repertoire generation and Ig-based immunity of guinea pigs.	[Matsuzawa, Shun; Isobe, Masaharu; Kurosawa, Nobuyuki] Univ Toyama, Grad Sch Sci & Engn Res, Lab Mol & Cellular Biol, Toyama, Toyama, Japan; [Matsuzawa, Shun] Med & Biol Labs Co Ltd, Ina, Nagano, Japan	University of Toyama	Kurosawa, N (corresponding author), Univ Toyama, Grad Sch Sci & Engn Res, Lab Mol & Cellular Biol, Toyama, Toyama, Japan.	kurosawa@eng.u-toyama.ac.jp		Kurosawa, Nobuyuki/0000-0002-1548-4541	Hokuriku Industrial Advancement Center (HIAC) [H27HIAC122]; Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical and Development (AMED) [15657579]; Emerging/Re-emerging Infectious Diseases Project of Japan from Japan Agency for Medical and Development (AMED) [16768665]; MEXT: Regional Innovation Strategy Support Program; Medical & Biological Laboratories Co., Ltd.	Hokuriku Industrial Advancement Center (HIAC); Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Emerging/Re-emerging Infectious Diseases Project of Japan from Japan Agency for Medical and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT: Regional Innovation Strategy Support Program; Medical & Biological Laboratories Co., Ltd.	This research was supported in part by grants from the Hokuriku Industrial Advancement Center (HIAC) (H27HIAC122) for Kurosawa, N., and the Basic Science and Platform Technology Program for Innovative Biological Medicine (15657579), and the Emerging/Re-emerging Infectious Diseases Project of Japan (16768665) from Japan Agency for Medical and Development (AMED) for Isobe, M., and MEXT: Regional Innovation Strategy Support Program for Matsuzawa, S. and Isobe, M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medical & Biological Laboratories Co., Ltd. provided support in the form of salaries for the author [SM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author is articulated in the 'author contributions' section.	Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; Boyd SD, 2016, CURR OPIN IMMUNOL, V40, P103, DOI 10.1016/j.coi.2016.03.008; Butler JE, 1996, VET IMMUNOL IMMUNOP, V54, P7, DOI 10.1016/S0165-2427(96)05680-2; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; D'Avirro N, 2005, J IMMUNOL, V175, P8133, DOI 10.4049/jimmunol.175.12.8133; Darlow JM, 2006, IMMUNOGENETICS, V58, P511, DOI 10.1007/s00251-006-0113-6; de Los Rios M, 2015, CURR OPIN STRUC BIOL, V33, P27, DOI 10.1016/j.sbi.2015.06.002; Deiss TC, 2017, CELL MOL IMMUNOL; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Guo YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039298; Hanly W. Carey, 1995, ILAR J, V37, P93; Jenne CN, 2006, DEV COMP IMMUNOL, V30, P165, DOI 10.1016/j.dci.2005.06.009; Kodangattil S, 2014, MABS-AUSTIN, V6, P628, DOI 10.4161/mabs.28059; Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4; Kurosawa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep25174; Kurosawa N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-80; Lavinder JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101322; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 1997, IMMUNOL TODAY, V18, P509, DOI 10.1016/S0167-5699(97)01163-8; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Liljavirta J, 2013, MUCOSAL IMMUNOL, V6, P942, DOI 10.1038/mi.2012.132; Martin V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0237; McGregor A, 2011, EXPERT OPIN DRUG MET, V7, P1245, DOI 10.1517/17425255.2011.613824; ODELL W, 1972, BIOL REPROD, V6, P427, DOI 10.1093/biolreprod/6.3.427; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; OTA T, 1994, MOL BIOL EVOL, V11, P469; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; Sun Y, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-18; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsai HF, 2002, INT IMMUNOL, V14, P55, DOI 10.1093/intimm/14.1.55; Van Lent S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162392; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; YALOW RS, 1970, GASTROENTEROLOGY, V58, P1; Yasuda M, 2006, VET RES, V37, P401, DOI 10.1051/vetres:2006008; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012	47	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0208977	10.1371/journal.pone.0208977	http://dx.doi.org/10.1371/journal.pone.0208977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543679	Green Published, gold, Green Submitted			2022-12-26	WOS:000453247500056
J	Ren, J; Wagner, AL; Zheng, AN; Sun, XD; Boulton, ML; Huang, ZY; Zikmund-Fisher, BJ				Ren, Jia; Wagner, Abram L.; Zheng, Anna; Sun, Xiaodong; Boulton, Matthew L.; Huang, Zhuoying; Zikmund-Fisher, Brian J.			The demographics of vaccine hesitancy in Shanghai, China	PLOS ONE			English	Article							KNOWLEDGE; IMMUNIZATION; INFECTION; ATTITUDES; DISEASES; PARENTS; REFUSAL; HEALTH	Background Vaccine hesitancy has been little studied in low- and middle-income countries but is a potential concern because vaccine refusal may increase the burden of infectious diseases and impede control efforts. The aim of this study was to compare vaccine hesitancy between locals, long-time city residents, and non-locals, who have more recently moved to the city from either other urban or rural areas, in Shanghai, China. Methods Parents of infants <= 3 months of age were surveyed at immunization clinics in Shanghai, China. Participants completed a paper questionnaire utilizing the 10-item Vaccine Hesitancy Scale, which was developed by the World Health Organization Strategic Advisory Group of Experts on Immunization. Items were grouped based on internal consistency, and regressed onto demographic variables using a negative binomial model. Results In total, 1,188 (92.5%) individuals participated. For most items on the scale, parents expressed positive beliefs about vaccines. However, about half of parents somewhat or strongly agreed that new vaccines carried more risks than older vaccines, and 71.6% some-what or strongly agreed that they were concerned about serious adverse effects. Seven items from the Vaccine Hesitancy Scale were highly correlated and mapped onto "lack of confidence"; the other three items were analysed separately. Compared to mothers, fathers had less lack of confidence (beta: -0.06, 95% CI: -0.12, -0.01), and individuals living in the outer suburbs (beta: 0.13, 95% CI: 0.01, 0.25) and rural non-locals (beta: 0.10, 95% CI: 0.02, 0.18) had greater lack of confidence in vaccines compared to their urban or local counterparts, respectively. Discussion Shanghai parents professed confidence in certain vaccine benefits, but vaccine messaging could focus on addressing misconceptions about vaccines for diseases no longer common, newer vaccines, and adverse effects associated with vaccination. These messages may need to be separately tailored to locals and non-locals, who have differing concerns.	[Ren, Jia; Sun, Xiaodong; Huang, Zhuoying] Shanghai Municipal Ctr Dis Control & Prevent, Dept Immunizat Program, Shanghai, Peoples R China; [Wagner, Abram L.; Boulton, Matthew L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Zheng, Anna] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; [Boulton, Matthew L.] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA; [Zikmund-Fisher, Brian J.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Zikmund-Fisher, Brian J.] Univ Michigan, Sch Med, Div Gen Med, Dept Internal Med, Ann Arbor, MI USA	Shanghai Center for Disease Control & Prevention; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Zikmund-Fisher, Brian/0000-0002-1637-4176; Boulton, Matthew/0000-0002-0565-9010	Fourth Round of Three-Year Public Health Action Plan of Shanghai, China [15GWZK0101]; University of Michigan; Health Outcomes Post Doctoral Fellowship from the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation); Office of Global Public Health at the University of Michigan School of Public Health	Fourth Round of Three-Year Public Health Action Plan of Shanghai, China; University of Michigan(University of Michigan System); Health Outcomes Post Doctoral Fellowship from the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation); Office of Global Public Health at the University of Michigan School of Public Health	This work was supported by The Fourth Round of Three-Year Public Health Action Plan of Shanghai, China (No. 15GWZK0101). This study was funded through an MCubed grant from the University of Michigan (https://mcubed.umich.edu/). AZ received an international internship funded by the Office of Global Public Health at the University of Michigan School of Public Health (https://sph.umich. edu/global/funding. html), and ALW's salary was funded by a Health Outcomes Post Doctoral Fellowship from the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) (http://www.phrmafoundation.org/). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614; Chan K. W., 2013, ENCY GLOBAL HUMAN MI, DOI [10.1002/9781444351071, DOI 10.1002/9781444351071]; Crocker-Buque T, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4473-7; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; Domek GJ, 2018, VACCINE, V36, P5273, DOI 10.1016/j.vaccine.2018.07.046; Edwards KM, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2146; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Henrikson NB, 2017, PUBLIC HEALTH REP, V132, P451, DOI 10.1177/0033354917711175; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Li HP, 2015, HABITAT INT, V46, P119, DOI 10.1016/j.habitatint.2014.11.003; Manca T, 2018, SOC SCI MED, V196, P182, DOI 10.1016/j.socscimed.2017.11.027; McClure CC, 2017, CLIN THER, V39, P1550, DOI 10.1016/j.clinthera.2017.07.003; Munoz DC, 2015, INT J PUBLIC HEALTH, V60, P767, DOI 10.1007/s00038-015-0715-6; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; Napolitano F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194920; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Peng YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-69; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Phillips DE, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2626-0; Pottinger HL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198655; SAGE, 2014, REP SAGE WORK GROUP; Shapiro GK, 2018, VACCINE, V36, P660, DOI 10.1016/j.vaccine.2017.12.043; Smith LE, 2017, VACCINE, V35, P6059, DOI 10.1016/j.vaccine.2017.09.046; Sun MP, 2010, VACCINE, V28, P1264, DOI 10.1016/j.vaccine.2009.11.015; Wagner AL, 2017, VACCINE, V35, P4362, DOI 10.1016/j.vaccine.2017.06.077; Wagner AL, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0900-2; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Yang S, 2014, TRANSFORM CHINESE CI, P48; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039	31	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0209117	10.1371/journal.pone.0209117	http://dx.doi.org/10.1371/journal.pone.0209117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543712	Green Published, Green Submitted, gold			2022-12-26	WOS:000453247500075
